- Jul 2023
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
The following is the authors’ response to the original reviews.
Reviewer #1 (Recommendations For The Authors):
- There were no mechanistic or causation-focused investigations that could have greatly strengthened the study. The study is ultimately providing two prioritized candidate genes that may be causative, reactive, or independent of the disease.
Answer: We thank the reviewer for their positive assessment and agree that our study lacks formal causal analyses. We are aware of this limitation and have made it clear throughout the text. Through triangulation of evidence across tissues and species, we point to very interesting candidates that merit further study, which is the usual scope of such systems genetics investigations. Nevertheless, to introduce some causal inference and reinforce the human relevance of our results, we have performed Mendelian randomization (MR) analysis to investigate the potential associations between MUC4’s gene expression in human colons and the risk of IBD. EPHA6 lacks detectable eQTLs in human colon so we could not include it in this analysis. We found suggestive evidence that increased expression of MUC4 in the sigmoid, but not transverse, colon may increase the risk of IBD (nominal p = 0.033).
The description in the manuscript:
However, it is unclear through what mechanisms the genetic variants in the candidate genes affect IBD susceptibility. One possibility is that genetic variation leads to altered levels of expression of the gene, ultimately affecting disease susceptibility. To test this possibility, we examined the GTEx resource (GTEx Consortium, 2013) and found that MUC4, but not EPHA6, has cis-eQTLs in the sigmoid and transverse colon. To establish likely causal links with IBD incidence, we used these associations as instruments in a two-sample Mendelian randomization (MR) (Hemani, Tilling and Smith, 2017; Hemani et al., 2018) analysis. Using publicly available GWAS summary statistics for IBD, Crohn’s disease, and ulcerative colitis (Liu et al., 2015; Elsworth et al., 2020) as outcomes, we found suggestive evidence that increased expression of MUC4 in the sigmoid, but not transverse, colon may increase the risk of IBD (nominal P value = 0.033, Appendix 1 - Table 6). No eQTLs were reported for EPHA6 in the colon, precluding us from investigating the potential consequences of changes in its expression in these tissues.
- Figures 3 and its supplement Figure 1: Among the 39 modules, the authors have only focused on significantly overlapping up-regulated IBD-related gene modules in both CD (M28 and M32) and HFD (M9 and M28) for their follow up analyses in Figures 4 and 5 to prioritize candidate genes. However, this reviewer thinks there is great value in also focusing on significantly overlapping down-regulated IBD-related gene modules in both CD (M17) and HFD (M15 and M26) for their follow up candidate gene prioritization analyses.
Answer: Thank you for your suggestion. We had initially performed overrepresentation analyses in HFD_M15, HFD_M26 and CD_M17, but did not find enrichments related to inflammation (see Author response image 1 below). We did not include this result in the manuscript.
Author response image 1.
Dot plot showing the enrichment of IBD-related modules in hallmark genesets. Gene ratios higher than 0.1 are shown and represented by dot size. Dots are colored by -Log10(BH-adjusted P values).
We also checked the module QTL mapping for the significantly overlapping down-regulated IBD-related gene modules in both CD and HFD. We did not find any loci that are significantly associated with these modules, indicating that they are not modulated by genetic variation and hence are less likely to inform on IBD susceptibility.
The description in the manuscript:
The ModQTL analysis was also performed on the modules that are significantly enriched in IBD-downregulated genes (HFD_M15, HFD_M24, and HFD_M26), but no significant or suggestive QTLs were detected. Therefore, we focused on the QTL for IBD-induced genes in HFD_M28 and annotated its candidate genes based on three criteria (Figure 5B).
Reviewer #2 (Recommendations For The Authors):
- One small addition that would be nice would be to indicate if the two candidate genes have cis eQTL in human tissues and/or have any protein-coding variants in humans. This would provide nice additional evidence of causality for these two genes.
Answer: Thank you for your positive assessment and suggestion. MUC4 and EPHA6 both have protein-coding variants in humans that were listed in the Appendix – Table 3 and Table 4. In addition, cis-eQTLs have been found for MUC4 in both the sigmoid and transverse colon in humans (GTEx, https://gtexportal.org/home/locusBrowserPage/ENSG00000145113.21). As indicated in our response to the first comment of Reviewer #1, we have now performed mendelian randomization on human eQTL for MUC4. However, no eQTLs were reported for EPHA6 in the colon, preventing us from performing MR analysis on its expression.
- Also, it would be helpful to include the size of the modules in the text of the manuscript. Especially the two modules that were followed up on.
Answer: Thank you for your suggestion, we have indicated the size of IBD-related modules in the text of the manuscript.
The description in the manuscript:
Enrichment analyses indicated that modules HFD_M9 (484 genes), HFD_M16 (328 genes), and HFD_M28 (123 genes) were enriched with genes that are upregulated by DSS-induced colitis, while HFD_M15 (368 genes), HFD_M24 (159 genes), and HFD_M26 (135 genes) were significantly enriched with downregulated genes (Figure 3C). Of note, more than 20% of genes involved in HFD_M9 and HFD_M28 were part of the dysregulated genes of the acute phase of mouse UC (day6 and day7) (Figure 3C). Interestingly, genes perturbed during IBD pathogenesis in humans were also enriched in HFD_M9 and HFD_M28 (Figure 3C).
While IBD-related genes were predominantly found in HFD modules, we also found that two modules, CD_M28 (185 genes) and CD_M32 (142 genes), in CD-fed mouse colons were associated with IBD (Figure 3—figure supplement 1A). These two-modules significantly overlapped with the IBD-related HFD_M9 and HFD_M28 modules, respectively (BH-adjusted P value < 0.05) (Figure 3—figure supplement 1B). Moreover, the molecular signatures underlying human UC and Crohn’s disease were also clustered in these two modules (CD_M28 and CD_M32) under CD (Figure 3—figure supplement 1C). Collectively, the co-expression and enrichment analyses identify HFD_M9 and HFD_M28 as IBD-related modules on which we focus our subsequent investigation.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
The following is the authors’ response to the original reviews.
Reviewer #1 (Public Review):
Jamge et al. sought to identify the relationships between histone variants and histone modifications in Arabidopsis by systematic genomic profiling of 13 histone variants and 12 histone modifications to define a set of "chromatin states". They find that H2A variants are key factors defining the major chromatin types (euchromatin, facultative heterochromatin, and constitutive heterochromatin) and that loss of the DDM1 chromatin remodeler leads to loss of typical constitutive heterochromatin and replacement of this state with features common to genes in euchromatin and facultative heterochromatin. This study deepens our understanding of how histone variants shape the Arabidopsis epigenome and provides a wealth of data for other researchers to explore.
Strengths:
1) The manuscript provides convincing evidence supporting the claims that: A) Arabidopsis nucleosomes are homotypic for H2A variants and heterotypic for H3 variants, B) that H3 variants are not associated with specific H2A variants, and C) H2A variants are strongly associated with specific histone post-translational modifications (PTMs) while H3 variants show no such strong associations with specific PTMs. These are important findings that contrast with previous observations in animal systems and suggest differences in plant and animal chromatin dynamics.
2) The authors also performed comprehensive epigenomic profiling of all H2A, H2B, and H3 variants and 12 histone PTMs to produce a Hidden Markov Model-based chromatin state map. These studies revealed that histone H2A variants are as important as histone PTMs in defining the various chromatin states, which is unexpected and of high significance.
3) The authors show that in ddm1 mutants, normally heterochromatic transposable element (TE) genes lose H2A.W and gain H2A.Z, along with the facultative heterochromatin and euchromatin signatures associated with H2A.Z at silent and expressed genes, respectively.
Weaknesses:
1) Following up on the finding that H2A.Z replaces H2A.W at TE genes in ddm1 mutants, the authors provide in vitro evidence that DDM1 binds to H2A.Z-H2B dimers. These results are taken together to conclude that DDM1 normally removes H2A.Z-H2B dimers from nucleosomes at TE genes and replaces them with H2A.W-H2B dimers. However, the evidence for this model is circumstantial and such a model raises a variety of other questions that are not addressed by the authors.
The Reviewer raises a series of interesting questions. We proposed that DDM1 exchanges H2A.Z to H2A.W because it is the simplest model and also because LSH - the mammalian ortholog of DDM1 exchanges H2A to macroH2A. However we do stress in the revised manuscript that this is a model and other possible models that could involve chaperones and additional remodelers are possible. Addressing why the loss of DDM1 results in a net exchange of H2A.W to H2A.Z is not the purpose of this study. Here we use the perturbation caused by ddm1 as a means to address the importance of the dynamics exchange of H2A variants in setting up the chromatin states. We do observe that perturbing this dynamic exchange causes an important perturbation of chromatin states. This further supports our main conclusion: H2A variants dynamics are one important factor that organizes chromatin states.
For example: if DDM1 does remove H2A.Z from TE genes, how does H2A.Z normally come to occupy these sites, given that they are highly DNA methylated and that H2A.Z is known to anticorrelate with DNA methylation in plants and animals?
The anticorrelation between H2A.Z and DNA methylation is observed at steady state. The exchange of H2A.Z to H2A.W that results from the action of DDM1 would indeed remove unwanted H2A.Z from regions occupied by DNA methylation as suggested by the Reviewer.
Given that H2A.Z does not accumulate in TEs in h2a.w mutants, how would H2A.X and H2A instead become enriched at these sites if DDM1 cannot bind these forms of H2A?
This is a valid question: We envisage that H2A.X and H2A are deposited by remodelers and chaperones other than DDM1 in the h2a.w mutant.
Given that there are no apparent regions with common sequence between H2A.Z and H2A.W variants that are not also shared with other H2A classes, how would DDM1 selectively bind to H2A.W-H2B and H2A.Z-H2B dimers to the exclusion of H2A(.X)-H2B dimers?
It was shown by the Muegge Lab both in vitro and in vivo that LSH - the mammalian ortholog of DDM1 binds to macroH2A and H2A, and these two H2A variants do not share similar specific region. Yet it remains to determine which region of H2A.Z and H2A.W binds to DDM1, which does not fit in the scope of this study.
Reviewer #2 (Public Review):
Jamge et al. set out to delineate the relationship between histone variants, histone modifications and chromatin states in Arabidopsis seedlings and leaves. A strength of the study is its use of multiple types of data: the authors present mass-spec, immunoblotting and ChIPseq from histone variants and histone modifications. They confirm the association between certain marks and variants, in particular for H2A, and nicely describe the loss of constitutive heterochromatin in the ddm1 mutant.
The support for some of the conclusions is weak. The title of the discussion, "histone variants drive the overall organization of chromatin states" implies a causation which wasn't investigated, and overstates the finding that some broad chromatin states can be further subdivided when one considers histone variants (adding variables to the model).
We have removed subtitles in the discussion and have taken care to avoid over simplified statements.
Adding variables to a ChromHMM model naturally increases the complexity of the models that can be built, however it is difficult to objectively define which level of complexity is optimal. The differences between states may be subtle to the point that they may be considered redundant. The authors claim that the sub-states they define are biologically important, but provide little evidence to support this claim. It is not obvious whether the 26 states model is much more useful than a 9-states model. Removing variables naturally affects the definition of states that depend on these variables, but it is also hard to define the biological significance of that change. This sensitivity analysis is thus not very developed.
We agree that adding more input tracks/ data will increase the complexity.
But we would like to mention the differences of this study and the 9-state model,
1) We have included the histone variants which have been previously missed in chromatin state definition.
2) The previous 9-state model used data from different tissue types. In this study all the data generated and analyzed is from seedlings.
3) Increasing the number of states allowed us to resolve heterochromatin states compared to 9-state model which was previously missed. (BioRXiv)
4) The biological relevance of the 26 states model is analyzed and described in depth (States BioRxiv paper).
In addition we have now updated the Figure 2F to include a more direct comparison of marks used in both models. And we have expanded the description in the methods section and our reasoning behind using 26 state model to be analyzed in depth.
There are issues with the logical sequence of arguments in Fig1 and Fig3. Fig1A shows that nucleosomes often contain both H3.1 and H3.3. Therefore pulling-down H3.1-containing nucleosomes also pulls down H3.3 and whether specific H2A variants associated with H3.1 cannot be answered in this way (Fig1B).
We thank the Reviewer for point this out. If 60% of nucleosomes are homotypic and if they would associate with a specific H2A variant this would be clearly visible on WB as a much stronger band. Also, the MS data presented in Figure1 figure supplement 1D clearly show that all H2A variants associate with both H3.1 and H3.3. We have included in the revised version more detailed explanation to clarify this point.
The same issue likely carries to the investigation of the association with H3 modifications if Fig1C and 1D, since the H3.1-HA pull-down also pulls down endogenous H3.1 (so presumably the rest of the nucleosome, with H3.3, as well).
We disagree on this point. The H3 band corresponding to the transgene copy is either H3.1 or H3.3, so all signals on upper band (T) in Figure 1C are associated with either H3.1 (H3.1 IP) or H3.3 (H3.3 IP), thus unambiguously showing that all modifications we analyzed are present on both H3.1 and H3.3. Furthermore, data shown in Figure 1D and E, where we analyzed modifications on K27 and K36 which are in the H3 region that can be distinguished between H3.1 and H3.3 by MS clearly demonstrate that these modifications are present on both H3.1 and H3.3. In order to make this clearer, we also extended the description of this part in the Results section to emphasize this.
In Fig3, the conclusion that it is the loss of H2A.Z -> H2A.W exchange in the ddm1 mutant that causes loss of constitutive heterochromatin is rushed. The fact that the h2a.w mutant does not recapitulate the loss of constitutive heterochromatin seen in ddm1 argues against this interpretation.
We agree that at first the minimal impact of the loss of H2A.W alone is surprising. However, we point to the preprint https://www.biorxiv.org/content/10.1101/2022.05.31.493688v1. There it is shown that the joint loss of H2A.W and H3K9 methylation (also observed in ddm1) affects silencing of a large range of transposons that also lose silencing in ddm1.
It's also difficult to conclude about the importance of dynamic exchanges when the ddm1 mutation has been present for generations and the chromatin landscape has fully readapted. Further work is needed to support the authors' hypothesis.
We apologize that the Reviewer could not find the information regarding the origin of ddm1 mutant material. We did not use a mutant where ddm1 mutations was kept for generations. We were in fact very careful on this point and used leaves from ddm1 first homozygous plants segregated from heterozygous ddm1 kept heterozygous.
The study also relies on a large number of custom (polyclonal) antibodies with no public validation data. Lack of specificity, a common issue with antibodies, would muddle the interpretation of the data.
We added information about validation of custom made antibodies into Methods: ”Specificities of custom made polyclonal antibodies against Arabidopsis H2A.Z.9, H2A.X, H2A.W.6, H2A.13, H2A.W.7, H2Bs, and linker histone H1 were validated in previous publications (Yelagandula et al., 2014; Lorkovic et al., 2017; Jiang et al., 2020; Osakabe et al., 2021).“ For H2A.2 and H2A.Z.11 antibodies we provide validation data as Figure 2 figure supplement 1.
Overall, this study nicely illustrates that, in Arabidopsis, histone variants (and H2A variants in particular) display specificity in modifications and genomic locations, and correlate with some chromatin sub-states. This encourages future work in epigenomics to consider histone variants with as much attention as histone modifications.
Reviewer #3 (Public Review):
How chromatin state is defined is an important question in the epigenetics field. Here, Jamge et al. proposed that the dynamics of histone variant exchange control the organization of histone modifications into chromatin states. They found 1) there is a tight association between H2A variants and histone modifications; 2) H2A variants are major factors that differentiate euchromatin, facultative heterochromatin, and constitutive heterochromatin; 3) the mutation in DDM1, a remodeler of H2A variants, causes the mis-assembly of chromatin states in TE region. The topic of this paper is of general interest and results are novel.
Overall, the paper is well-written and results are clearly presented. The biochemical analysis part is solid.
Reviewer #4 (Public Review):
This work aims at analyzing the impact of histone variants and histone modifications on chromatin states of the Arabidopsis genome. Authors claim that histone variants are as significant as histone modifications in determining chromatin states. They also study the effect of mutations in the DDM1 gene on the exchange of H2A.Z to H2A.W, which convert the silent state of transposons into a chromatin state normally found on protein coding genes.
This is an interesting and well done study on the organization of the Arabidopsis genome in different chromatin states, adding to the previous reports on this issue.
Reviewer #1 (Recommendations For The Authors):
1) The rationale for switching from using 10-day old seedlings for chromatin profiling to using mature leaves in Figure 3 and beyond is not explained and introduces additional complexity into the analyses. The reasoning should be clearly explained in the text, and there are several additional suggestions or questions related to this that should be addressed:
This was done for practical reasons. We had already obtained some profiles of marks in ddm1 mutants and extended the dataset using the same stage of development because this tied this study with our previous study. Using different stages of development provides an additional benefit. The same chromatin states are observed in 10 day old seedlings and leaves of older plants. Constitutive heterochromatin is occupied by the same chromatin states and logically euchromatin is positioned on different genes as expected by the distinct pattern of gene expression at the two stages of development.
A) In the 16-state model (Figure 3A), euchromatin states were not well defined compared to the 26-state model. Why did the authors not profile these marks also, and could this explain why ddm1 mutants did not show a significant effect on euchromatin states in this model?
We apologize for the lack of detailed explanation: In our previous study we used leaves of five weeks ld plants to show the impact of ddm1 on the profiles of H2A.W.6, H2A.X, H1, H3K9me2, H3K36me3 and H3K27me3 in leaves (Jamge, Osakabe et al., 2021). This study showed that DDM1 causes the deposition of H2A.W.6 to heterochromatin and we thus used leaves to extend this investigation to the two other marks of heterochromatin (constitutive or facultative) H3K9me1, H2A.W.7 and H2A.Z.9 and H2A.Z.11.
B) The authors state that the tissue types do not impact the definition of chromatin states. However, there is a clear difference in the portion of the genome occupied by each chromatin state between leaf and seedling (states 1, 5, 8, 13, and 14; Figure S3A).
We had missed a comment on supFig3B and have now provided more explanation: “Although the composition of the chromatin states did not vary significantly between seedlings and leaves, each state occupied a similar proportion of the genome in seedling or leaves to the exception of state 5 present primarily in leaves and state 13 only present in seedlings (Figure 3 figure supplement 3A, right column with green bars) and the euchromatin states occupied different genes (Figure 3 figure supplement 3B) as expected by the dissimilar transcriptomes of these two developmental stages.”
2) The naming of supplemental figures throughout the text is confusing as the legends refer to them as "Figure SX" but they are called out in the text as "Figure X figure supplement XA-B". The eLifeconvention is "Figure X figure supplement XA-B".
This was changed.
3) In Figure 4, Panel D is mislabeled as C in the figure, and C is lacking a label.
4) Please remove the word "the" from the title.
This was done
Reviewer #2 (Recommendations For The Authors):
Fig1D legend should also mention K37.
This was corrected.
Fig2F legend should say "no H3 modifications" rather than "no histone modifications" This was corrected.
Fig4 labels C/D do not correspond to the legend. D is missing and C should go to the ddm1 stacked barplot.
This was corrected.
H3 variants analysis: Taking the relative abundance of H3.1 and H3.3 (and transgenes) into account would be useful to interpret the results of the nucleosome composition results. If they are at equivalent amounts, the null hypothesis of independent association would give 50% heterotypic nucleosomes and 50% homotypic.
This is a valid comment. In an ideal system the last statement would be correct, but this does not take into account chromatin dynamics associated with replication, transcription, etc. Also, total amounts of H3.1 and H3.3 in tissue we used for the experiment is not known. It could possibly be inferred from RNAseq data, but if this would reflect real amounts of the protein is highly questionable. In Arabidopsis there are 5 H3.1 genes and 3 H3.3 genes. Nevertheless, we recalculated data for H3.1 and H3.3 and this has been updated in the main text (~60% of H3.1 and ~42% of H3.3 immunoprecipitated nucleosomes contained both H3 variants). Thus, from the available data these numbers are the best we can get.
p. 5 bottom paragraph. Repetition.
This was corrected
p12. The reference to LSH is dropped in without making clear how it is relevant. Expand on mechanism to suggest similar DDM1 mechanism?
This section was expanded to provide more background in the interpretation of the results.
p13. inversion between H2A.W and H2A.Z in "the loss of DDM1 prevents the replacement of H2A.W by H2A.Z".
This was corrected
p13. make it clear that the last sentence of the results is a working model, not a fully backed up conclusion.
Alternative models are mentioned in this section and in the discussion in the revised version.
p14 middle paragraph. Not clear what "in silico simulation" refers to. Simply chromatin-state classification with ChromHMM?
This refers to the Jacard index calculation in Fig. 2F that models the impact of the loss of H2A variants (or other elements of chromatin) on the definition of chromatin states by ChromHMM. This is now clarified.
p14 bottom paragraph: the H2A.Z tail repression of ubiquitin ligase but its being the favoured substrate for H2AK121Ub is apparently contradictory. Can this be explained?
This refers to H2B Ubiquitination and is now clarified
p15. Correlation between variants and modifications/chromatin states does not necessarily mean causation.
We agree and have improved the revised version in this respect.
p15 "forward feedback loop" is ambiguous (is it a feed-forward loop? A feedback loop?), just use "positive feedback loop".
This was corrected.
p23 top "$(Ingouff et al)" doesn't seem properly formatted.
This reference did not belong there and has been removed.
Data availability: GSE226469 is not public. The manuscript also mentions availability of source data for all the main figures, but I could not find it. It would be great to make the code publicly available too.
All the data and code will be public upon posting the revised version of the manuscript.
Reviewer #3 (Recommendations For The Authors):
My major concern is authors only used DDM1 as an example to show that the exchange of the histone variant contributes to definition and distribution of chromatin state on transposons (i.e., constitutive heterochromatin regions associated with H2A.W). Readers may wonder whether similar mechanisms also work at the euchromatin region. This point should be clearly discussed and mentioned in the Results (for example, cite recent work on INO80).
We discuss the impact of other remodelers in the Discussion in the revised version. We hope that the reviewer will understand that doing a study on the impact of other remodelers on chromatin states which would require dozens of new ChIP profiles and is clearly beyond the scope of revising a manuscript.
Minor:
1) Fig. 2A and 2B, what does color mean? I guess the color code is referred to chromatin states (Fig. 2F).
We have clarified on Figure 2A the attribution of a specific color to each chromatin state. This same color is used also in other panels of Figures 2 and S2.
2) Supplemental Figures: All the figure panels should be on the same page.
We rearranged supplemental figures so that each figure fits on one page. In places where this was not possible, we created additional supplemental figures.
3) "We observed that increasing state numbers from 26 to 27 gave rise to biologically redundant states.": Where are the data? Fig S2A? This figure is hard to understand.
In the updated manuscript, we have described the legend and the methods for FigS2A in more detail.
Reviewer #4 (Recommendations For The Authors):
A general concern refers to the text that frequently falls into excessive oversimplifications and/or overstatements, with the danger of being misleading for the reader. This needs to be thoroughly revised.
We added more careful statements and proposed alternative models when it was possible.
Specific comments.
1) Fig 1A. Authors found the ~40% of nucleosomes contained both H3.1 and H3.3. This is a significant finding that deserves a more detailed comment.
We now provide a more detailed description of IP and MS data presented in Figure 1. This should also help to avoid oversimplifications and/or overstatements as criticized in a general comment.
2) Fig 1C. "H3. And H3.3 bore the same sets and comparable levels of methylation and acetylation...". Too general statement, please specify. Is this also the case for H3K9me2? Others?
We did describe this part into more detail to emphasize more precisely what Figure 1 shows. We also included data on K9me into Figure 1 figure supplement 1H.
3) Fig 1D. Could you confirm the high level of H3K27me1 on H3.3?
H3K27me1 data are shown both by WB (Figure 1C) and Mass spectrometry (Figure 1D and E). We also provide a possible explanation for high levels of this mark on H3.3 by taking into account the fact that H3K27me1 is also produced by demethylation of H3K27me3 by JMJ demethylases.
4) All WB in Fig 1. They need to be quantified and normalized (plus statistical analysis) in order to provide strong support to the conclusions.
The conclusion of all WB are supported by quantified Mass spectrometry data and many WB were even repeatedly shown in Figure 1F (for example IPs for H2A variants and a large set of H3 marks used for WBs) with the same results. Also, association of H3K4me3 and H3K36me3 with H2A variants was analyzed in both ways (Figure 1F); IPs of variants and WBs of variants and marks and IPs of marks and WBs of marks and variants. For most of the data we do not have more than two repeats, so statistical analysis may not be possible.
Nevertheless, we are convinced that our major conclusions from data presented in Figure 1 and Supporting figure 1 (these are: that H3 variants form both homotypic and heterotypic nucleosomes, that H3 marks do not preferentially associate with H3 variants but some of them do so with H2A variants and that H3 modifications show very complex pattern of associations with each other) are fully valid as they were drawn from two orthogonal approaches and further supported by the chromatin states identified.
5) Fig. 2A. Authors focus on "the most parsimonious model" based on 26 chromatin states. This needs to be justified in a more explicit manner. It is surprising that this number emerges for an analysis of 27 independent variants and marks. What are the differences in the conclusions when other number of states are used? See also below (reduced number of number derived from the "concatenated model").
Why 26 states were chosen is now explained in great details in the method section. Since to the exception of H2A variants that are invariably homotypic, nucleosomes can be heterotypic for all other histone variants and histone modifications, the random combination of the 27 marks in one nucleosome representing one states is 4 H2A (without the subtypes) x 4H3 x 2H1 x 2(power16) (for each mark) which is well above the circa 26 states observed. This shows that our probabilistic model reduces the potential complexity of a theorical random association in a remarkable manner.
6) As a summary, it would be very helpful to generated a table (or similar) where is proposed chromatin state is ascribed to functional genomic elements.
This aspect of the work is presented in a preprint where the biological association with the chromatin is described in details. See Jamge et al 2002, https://www.biorxiv.org/content/10.1101/2022.06.02.494419v1
7) Fig 2F (and S2B). A comprehensive comparison a various approaches should include others and estimate the Jaccard similarity index: (1) the same of marks and variants used in the Sequeira-Mendes et al paper, and (2) the subset of marks and variants added in this study. In this way, a direct evaluation of the contributions could be more properly made.
We thank the reviewer for this suggestion and have now included a new column with the combination of marks and variants as used in Sequeira-Mendes et al., 2014 (see Figure 2F). These data clearly demonstrate that adding histone variants significantly contribute to the definition of chromatin states.
8) Fig. 3. Explain in more detail the concatenated model used here. Does the reduction in the number of chromatin states mean that the other do not add new information?
ChromHMM concatenated model allows to identify common definition of chromatin state in multiple tissue types. Here multiple cell types are concatenated leading to a shared definition of chromatin states, but specific to each cell type.
In our paper we used the concatenated model to identify common chromatin states in two different genotypes (WT and ddm1). The data for WT and ddm1 was obtained from leaves. As we had a limited number of ChIP-seq profiles in the leaves dataset The complexity of the concatenated model was also reduced compared to the extensive 26 chromatin state model. We chose to analyze 16-states in the concatenated model because this was the minimal number of states that gave rise to a similar complexity of heterochromatic states.
9) The ddm1 mutant. The text in page 14 is a bit confusing. It seems that H2A.Z is deposited on TEs and the exchanged by the H2A.W.
We have provided additional alternative models that could explain our observations.
10) Page 15: link between H2A.Z and H3K27me3. Gomez-Zambrano et al (2018, cited in the text, found that only a relatively small subset of (putative) targets are common to H2A.Z and H3K27me3. How do authors reconcile this with their statement supporting a link between both of them?
We refer to Gomez-Zambranao et al to illustrate the link between H2A.Z and H2AK121ub so we do not understand this comment. The strong link between H2A.Z and H3K27me3 is shown without ambiguity by our work and also Carter et al., 2018.
-
- Jun 2023
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
Reviewer #1 (Public Review):
The study investigates the nature of "trailblazer" cells in distinct tumor models, including luminal B (MMTV/PyMT) and triple negative (TNBC) tumors (C3-TAg). The authors note that the trail-blazer phenotypes in the TNBC model are more complex relative to the Luminal B model and represent distinct EMT programs associated with the expression of distinct EMT-TFs (Zeb1, Zeb2 and Fra-1). They demonstrated that of numerous EMT-TFs, Zeb1 and Fra-1 were required for increased cancer cell migration and invasion. They reveal that TGF-beta and EGF-mediated signaling are required for the diverse EMT states that are required for trailblazer cell activity and increased cell migration/invasion. TGF-beta signaling engaged Zeb 1 and Zeb2 while EGF sig-naling activated Fra-1. Indeed, inhibitors of either TGF-beta or EGF signaling could impair cell migration/invasion. While both pathways contributed to trailblazer phenotypes, EGF signaling was shown to interfere with certain TGF-beta induced transcriptional response, including the ex-pression of genes encoding extracellular matrix proteins.
One concern was the heavy reliance of the C3-TAg as the sole TNBC model in which the dis-tinct trailblazer phenotypes were described. The data in Fig. 3 of the submission reveals that the phenotypes observed in the C3-TAg model could be recapitulated in a TNBC patient-derived xenograft model (PDX). Using this PDX, the authors were able to show vimentin expression in lung metastatic TNBC cells that were intravascular, those that had extravasated and clusters of cancer cells fully within the lung parenchyma. This was an important addition to the manuscript. The additional experiments to investigate the role of Zeb1 and Zeb1 more fully, beyond the focus on Fra-1 in the initial submission was an additional strength of the new submission. Additional clarifications to the discussion also clarified the concepts articulated in the study. The study em-ploys multiple breast cancer models, utilizes numerous in vitro and in vivo assessments of the trailblazer phenotypes, and the experimental design is rigorous and the interpretation of the data is sound. The manuscript will be of general interest to the research community.
Thank you for the supportive comments. We are glad that the revisions addressed your prior concerns.
Reviewer #2 (Public Review):
This represents an important study that demonstrates a high degree of heterogeneity within trailblazer cells in clusters that participate in collective migration. Solid methods highlight this het-erogeneity and show that in TNBC cancers, trailblazer cells are defined by vimentin (and not Keratin 14) and are dependent on both TGFbeta and EGFR signaling. Additional, single cell stud-ies would further support this work.
Thank you for the suggestion. Our current data establishes that trailblazer cells are heterogene-ous using FACS, immunostaining and functional studies of fresh tumor organoids and estab-lished tumor organoid lines. In addition, our RNA-seq experiments provided deep insight into the nature of gene expression changes that corresponded with the evolution of new trailblazer states. This discovery of trailblazer cell heterogeneity was one of multiple key new discoveries in this manuscript, along with revealing a Krt14-independent invasion mechanism, the regulation of trailblazer cells by Tgfβ and Egfr signaling and a new compromise mode of signal integration. We agree that our results support further investigation of the nature and function of basal-like breast cancer heterogeneity during the progression to metastasis. However, a comprehensive implementation of scRNA-seq is mostly likely required to further unravel new aspects of hetero-geneity that substantially advance upon the conclusions supported by our current data. Such an undertaking is beyond the scope of this investigation.
We agree that scRNA-seq would be confirmatory of trailblazer cell heterogeneity that has been demonstrated with multiple approaches rather than a new discovery of heterogeneity.
Strengths:
The paper highlights that collective migration, and the nature of trailblazer cells can be highly heterogeneous. This is important as it suggests that the ability to move between states may su-persede a singular phenotype.
The paper uses animal models and organoids and in several areas attempts to correlate find-ings to human tissues.
The experiments are logically described.
Reviewer #3 (Public Review):
Cancer is a disease of many faces and in particular, the ability of cancers cells to change their phenotypes and cell behaviors - cancer cell plasticity - is a major contributor to cancer lethality and therapeutic challenge of treating this disease. In this study, Nasir, Pearson et al., investigate tumor cell plasticity through the lens of invasive heterogeneity, and in particular in models of tri-ple-negative breast cancer (TNBC), a subtype of breast cancer with particularly poor clinical prognosis and more limited treatment modalities. Using organoid models in a variety of matrix systems, microscopy, and signaling pathway inhibitors, they find that invading TNBC breast tu-mors, primarily in the C31-Tag genetically engineered mouse model of TNBC, are composed of heterogeneous invasive/"trailblazer" type tumor cells that in many cases express vimentin, a classical intermediate filament marker of epithelial-mesenchymal transition, and reduced keratin-14, another filament marker of basal epithelial cells associated with collective invasion in differ-ent breast cancer models. Supportive genetic and pharmacologic evidence is provided that gen-eration of these cells is TGF-beta signaling pathway driven, likely in vivo from the surrounding tumor microenvironment, in accord with published studies in this space. Another important as-pect of this study is the good transcriptional evidence for multiple migratory states showing dif-fering degrees of partial overlap with canonical EMT programs, dependent on TGF-beta, and suggestive but at present incomplete understanding of a parallel program involving Egfr/Fra-1 mediated effects on invasion. When taken in context with other recent studies (Grasset et al. Science Translational Medicine 2022), these data are broadly supportive of concept of targeting vimentin-dependent invasion programs in TNBC tumors.
The core conclusions of this paper are generally supported by the data, but there are some conceptual and technical considerations that should be taken into account when interpreting this study. Specific comments:
1) The contribution of the different vimentin-positive trailblazer cells to distant metastasis was not directly confirmed in vivo in this study. Given the limited proliferative potential of many fully EMT'd cells and in light of recent studies indicating that invasion can be uncoupled from meta-static potential, it seems important to directly test whether the different C31-tag isolates, varying in invasive potential in this study, produce metastases and if so do metastases abundance corre-late with the invasive potential in 3D culture. The collection of lungs at 34 days post injection de-scribed in methods is too short to evaluate metastatic frequency.
We agree that it is important to determine the contribution of trailblazer cells towards metastatic dissemination. In this manuscript, we show that Vimentin expressing cells in a triple negative breast cancer (TNBC) PDX model disseminate to the lungs (Figure 3F). We have also shown that Vimentin expressing SUM159 breast cancer (BC) trailblazer cells spontaneously metasta-size to the lungs in previous publications (Fig. 2–figure supplement 1C) and (Westcott et al, J Clin Invest, 2015, 10.1172/JCI77767 and Maine et al, Oncotarget, 2016, 10.18632/oncotarget.7408). Notably, the depletion of genes specifically expressed in trailblazer cells reduced spontaneous metastasis without significantly impinging on primary tumor growth (Westcott et al, J Clin Invest, 2015, 10.1172/JCI77767 and Maine et al, Oncotarget, 2016, 10.18632/oncotarget.7408). Our new results in Figure 5D show that Tgfβ activates genes that define the trailblazer state in the metastatic SUM159 trailblazer cell model. Thus, features of the Tgfβ regulated trailblazer program in the C3-TAg cells is active in the SUM159 trailblazer model of spontaneous metastasis. In addition, commonly employed BC cell line metastasis models, such as MDAMB231 derivatives are highly mesenchymal (Fig. 2–figure supplement 1C) and (Kang et al, Cell, 2003, 10.1016/S1535-6108(03)00132-6 and Minn et al, Nature, 2005, 10.1038/nature03799, as examples).
It is not technically feasible to establish a correlation between the relative invasion of The C3-TAg GEMM primary tumors and spontaneous metastasis. C3-TAg GEMM primary tumors de-velop rapidly and the mice must be euthanized prior to the detection of metastasis. This limitation of the model is mentioned in the Results section “Trailblazer cells are specified by Vimentin ex-pression in basal-like breast cancer patient tumors”. The aggressive primary tumor growth and limited spontaneous metastasis of the the C3-TAg model has also been previously reported by others (Green et al, Oncogene, 2000, 10.1038/sj.onc.1203280). Surgical resection of the original primary tumor is not feasible option to allow metastases to form since additional tumors develop in multiple mammary glands.
In response to reviewer requests, we initiated the growth of orthotopic primary tumors from con-trol or Tgfβ treated 1339-org cells to address the relationship between induction of the trailblazer state and primary tumor cell dissemination. We had to euthanize the mice at day 34 (d34) be-cause tumors within both cohorts had reached the maximum permitted diameter of 2 cm. This will be indicated in the Methods section with revised text. We detected CTCs from the mice bearing control and Tgfβ treated 1339-org cell tumors. However, no micrometastases were de-tected, which is indicated in the text describing Figure 4–figure supplement 3A-B. Thus, per-forming surgical resection in new experiments would not be expected to allow the later detection of metastasis, as there did not appear to be DTCs in the lungs that could initiate colonization. In addition, we would have to resect the tumors prior to d34 to successfully and humanely remove the primary tumors, further reducing the odds of metastases developing. We will continue our work to identify an experimental balance that permits sufficient primary tumor growth to initiate spontaneous metastasis. However, the time scale of resolving this technical challenge is uncer-tain and we believe that our published analysis of trailblazer cell metastasis and new findings here showing the dissemination of Vimentin expressing cells in a PDX model addresses the question of whether Vimentin expressing trailblazer cells metastasize.
We agree that certain cell states induced by EMT programs can limit the proliferative potential of tumor cells. As described in the Introduction, we previously found that the induction of a trailblaz-er state in a subset of breast cancer cell line models triggers a collateral cost in fitness that limits the ability of trailblazer cells to initiate tumor growth (Westcott et al, Cancer Res, 2020, 10.1158/0008-5472.CAN-20-0014). The traits that distinguish trailblazer cells which are capable of tumor initiation and metastasis versus trailblazer cells with reduced fitness have begun to be delineated. Our prior report suggested that cells that were dependent on p63 for growth lost their proliferative capacity when converting to a trailblazer state (Westcott et al, Cancer Res, 2020, 10.1158/0008-5472.CAN-20-0014). C3-TAg cells are not dependent on p63 for growth, which is indicated by the vast majority of the tumor cells lacking p63 expression in primary tumors and primary tumor organoids (Westcott et al, Cancer Res, 2020, 10.1158/0008-5472.CAN-20-0014), similar to the metastatic SUM159 breast cancer cell line model. We were also able to derive clonal trailblazer cell lines that lacked detectable p63 expression from a C3-TAg tumor (Figure 2—figure supplement 1B) and grow organoids even when the limited extent of p63 expression was further reduced by Tgfβ (Figure 5C). Additionally, the persistent Tgfβ treated 1339-org cells, which were enriched for trailblazer cells and had reduced p63 expression, were capable of initiating primary tumor growth (Figure 4F). Together, these results indicate that C3-TAg trail-blazer cells are capable of initiating metastatic colonization. However, given the heterogeneity in trailblazer states that we discovered, it is possible that a subset of trailblazer cell states have re-duced proliferative capacity. Our analysis approach in this manuscript would not necessarily de-tect these low fitness trailblazer cells if they were a relatively small fraction of the total trailblazer population. We will clarify this point in the Discussion section in the revised manuscript. Our re-sults have begun to reveal mechanisms for the transcriptional regulation of trailblazer cell heter-ogeneity. We plan to continue delineating the regulatory programs conferring specific transcrip-tion state, defining approaches for the prospective isolation of distinct trailblazer subpopulations and determining trailblazer subpopulation specific biomarkers to understand the specific contri-bution of distinct trailblazer subpopulations towards metastasis. Given the scope of this analysis, it is not feasible to incorporate these future studies into this manuscript.
2) The invasion of cancer cells is dependent on 3D matrix composition. In other studies, collec-tive cancer invasion is performed in exclusively collagen type 1 gels or in other instances entirely in 3D reconstituted basement membrane gel, e.g. lung cancer invasion studies. In this study, the authors use a mixture composed of both matrices. Given the invasion suppressive effects of matrigel, particularly for epithelial type cells, further studies would be important to determine whether the invasion phenotypes seen in this study are generalizable across matrix environ-ments.
The invasion of C3-TAg and PyMT organoids embedded in a 100% pure reconstituted base-ment is shown in Fig. 1–figure supplement 1G. We will emphasize that trailblazer invasion was evaluated in multiple ECM compositions with revised text and figure graphic. We also provide images for the reviewer showing that C3-TAg organoids collectively invade in a pure Collagen I ECM. Importantly, these findings are consistent with our results showing that Vimentin express-ing cells are associated with basal-like mammary tumor cell invasion in the complex ECM of C3-TAg GEMM primary tumors (Figure 2G) and patient primary tumors (Figure 3D). Moreover, Vimentin expressing cells disseminated to the lungs in the TNBC PDX that we evaluated (Figure 3F).
The ECM composition selected for experiments is dictated by the experimental question(s) being addressed. It is unlikely that mammary tumor cells would only ever collectively invade through an ECM that is either pure Collagen I or pure reconstituted basement membrane (BM). Indeed, it has been proposed that mixtures of Collagen I and BM proteins best reconstitute the complexity of primary tumor ECM (Hooper et al, Methods Enzymol, 2006, 10.1016/S0076-6879(06)06049-6). In line this observation, mixtures of Collagen I and BM proteins have been routinely used for the past 20 years to define mechanisms of 3D invasion; Xiang and Muthuswamy, Methods En-zymol, 2006, 10.1016/S0076-6879(06)06054-X; Calvo et al, Nat Cell Biol, 2013 10.1038/ncb2756; and Kato et al, eLife, 2023, 10.7554/eLife.76520, as examples).
Consistent with the known complexity of the ECM in the tumor microenvironment (TME), we detect Collagen I and Collagen IV (a key component of experimental BM) in the TME of primary breast cancer tumor models (Westcott et al, J Clin Invest, 2015, 10.1172/JCI77767). Important-ly, we have found that a mixture of collagen I and experimentally derived BM proteins reliably reveals breast cancer trailblazer cell invasion mechanisms that promote the malignant progres-sion and metastasis of primary tumors and whose expression correlates with poor patient out-come (Westcott et al, J Clin Invest, 2015, 10.1172/JCI77767 and Westcott et al, Cancer Res, 2020, 10.1158/0008-5472.CAN-20-0014, as examples). Notably, the relative differences in trail-blazer and opportunist cell invasive phenotypes are not dictated by the ECM composition used in our 3D assays. We have previously tested the invasion of trailblazer and opportunist subpopula-tions in different ECM compositions using both spheroid vertical invasion assays (Westcott et al, J Clin Invest, 2015, 10.1172/JCI77767). Increasing collagen I concentration enhanced the rela-tive rate of trailblazer cell invasion, with trailblazer cells always showing a significantly enhanced invasion relative to opportunist cells.
The relationship between trailblazer and opportunist cells that we have detected in primary tu-mors is recapitulated when using mixtures of Collagen I and BM proteins in our past publications and in this manuscript. The clonal opportunist cell lines derived from a C3-TAg tumor expressed high levels of the transcription factor p63 (Figure 2–figure supplement 1A-B). We previously showed that p63 restricts induction of a trailblazer state in human breast cancer trailblazer cell lines (Westcott et al, Cancer Res, 2020, 10.1158/0008-5472.CAN-20-0014). Notably, we showed that p63 expressing C3-TAg cells were not able to initiate collective invasion in the same ECM composition used in our current manuscript. Moreover, p63 cells in primary C3-TAg tumors were noninvasive opportunist cells that were limited to trailing p63-low trailblazer cells when collective-ly invading in primary tumors and in organoids (Westcott et al, Cancer Res, 2020). We now show that p63 expressing opportunist cell lines are limited to invading behind primary C3-TAg trailblazer cells and trailblazer cell lines in our 3D invasion assays (Figure 1B and Figure 1–figure supplement 1D-E). Together, these results indicate that the ECM employed in our 3D assays reveals the mechanistic underpinnings of both trailblazer and opportunist cell invasion in primary tumors.
With respect to lung cancer invasion, leader cells that we would classify as trailblazer cells have been isolated from 2 non-small cell lung cancer cell line spheroid models grown in pure reconsti-tuted BM extract (Konen et al, Nat Comm, 2017, 10.1038/ncomms15078). However, it unclear whether these cell line derived NSCLC trailblazer cells are more intrinsically invasive than non-trailblazer siblings in primary NCSCLC tumors or if the traits associated cell line NSCLC trail-blazer cells are required for metastasis. These tests have never been reported to the best of our knowledge. Similarly, it is not clear whether these NSCLC cell line derived trailblazer cells reflect features of primary NSLC primary tumor cells, as we are unaware of any such comparisons be-ing reported. Thus, there is no reason to consider pure reconstituted BM to be an equivalent or preferred experimental option to define trailblazer cell features. Nevertheless, as we mentioned before, our discovery approach identifies trailblazer cells that are intrinsically more invasive than opportunist siblings across multiple ECM conditions, including pure reconstituted BM and, im-portantly, in primary tumors.
3) TGF-beta is well known to induce EMT. Although this study identifies potential transcriptional mediators of the invasion/trailblazer program, is this program reversible?
We have previously shown the breast cancer trailblazer cells can convert to an opportunist state, demonstrating that trailblazer states are reversible (Westcott et al, J Clin Invest, 2015, 10.1172/JCI77767). In this manuscript. we show that C3-TAg organoid lines derived in the Tgfbr1 inhibitor A83-01 have few if any cells with a trailblazer phenotype relative to C3-TAg pri-mary tumors, suggesting a reversion of the trailblazer state (Fig. 4C and Figure 4–figure sup-plement 2A-C). However, our results do not entirely rule out the possibility that only non-trailblazer cells grew to establish the organoid lines. Indeed, the problem of tracing phenotypic conversions when evaluating heterogeneous populations is a systemic challenge that extends beyond our analysis of trailblazer cells. Clearly defining the conversion rates for trailblazer cells will require multiple genetic markers to distinguish the different trailblazer states we have now identified, in addition to phenotypic and molecular analysis over multiple days, or possibly weeks. Thus, further definition of the rate of reversion of different trailblazer cells is worthy line of future investigation rather than a feasible objective of this study.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
We thank the reviewers for their careful and overall positive assessment of our work.
Reviewer #1 (Public Review):
This paper describes the discovery, functional analysis and structure of TcaP, a protein encoded by the Vibrio phage satellite PLE that forms a size-determining scaffold around PLE procapsids made from helper phage ICP1 structural proteins. The system displays a fascinating similarity to the P2/P4 system, which had previously been unique in its use of a size-determining external scaffolding protein, Sid. The work is interesting, comprehensive and of high quality. The presentation could be improved as listed in the suggestions below.
An interesting observation is that PLE appears to be dependent on small capsids for efficient transduction. This is not completely surprising if the element uses a cos site type mechanism for packaging, since this requires an integer number of genomes to be packaged when the capsid is full, and this might be more difficult to accomplish when the helper capsid is much larger than the satellite, as is the case with ICP1. The authors mention in a few places that this is the first known satellite to have this requirement. However, this is not quite correct: a similar defect was seen in phi12/SaPIbov5, where the large phi12 capsid was not quite the right size for either two or three copies of the wildtype ("unevolved") SaPIbov5 (Carpena et al. 2016).
We thank the reviewer for bringing up this point. First, we agree that for cos type packaging systems, this would not be surprising. However, ICP1 is a pac type phage and we have evidence that PLE is also a pac rather than a cos type packaging satellite; therefore, PLE is the first headful satellite to show such a defect. For cos packaging elements, both SaPIbov5 and P4, non-integer genome lengths have been shown to pack less efficiently into capsids as pointed out above and shown in Carpena et al 2016 and Shore 1978. However, in both of these cases, the genomes were manipulated to change their size, suggesting that naturally occurring cos satellites maintain their genome sizes to be proportional to their capsid sizes or in integer proportion to their helper capsids. We will include a short summary of these previous findings in the main text to provide context for the rare decreases in transduction efficiency reported in the cos satellites.
The authors present several micrographs showing capsids formed in the presence or absence of wildtype or mutant TcaP and CP (Fig. 1, Fig 2., Fig 3). However, each micrograph shows only a handful of particles of the "correct" size, in addition to a few shells that are aberrant or of a different size. I miss a more statistically rigorous enumeration of shells of different size (PLE or ICP1 sized, or different), empty vs. full, aberrant shells etc. This could be presented as a size distribution graph, a histogram or in table form.
We thank the reviewer for this recommendation and agree that it would add to the manuscript. We will quantify these particles and present the data in the main text.
In the abstract, the term "divergent satellite P4" is vague and unclear. Divergent from what? Probably they mean distinct from or unrelated to PLE. Please clarify.
Yes, we did mean unrelated to PLE, and we will clarify in the text.
How do they know that gp123 is a decoration protein? Was this previously determined, does it have (sequence) similarity to other known decoration proteins, or is it simply the most likely designation based on its position in the genome?
Gp123 was annotated based on its position. While there is sequence similarity to other annotated Vibrio phages’ decoration proteins, we will clarify in the text that Gp123 is a putative decoration protein.
Although the reconstruction and modeling statistics are good, it is difficult to assess the quality of the map and the model from the presented figures. Details of the density and FSC curves (half-map and model-to-map) should be shown. It is also difficult to see the TcaP structure and how it compares to Sid from the figures presented.
We will address this concern in the revised manuscript.
Introduction, Paragraph 3: "...which is the number of coat proteins divided by 60" is not strictly speaking the definition of T number. The T number corresponds to the number of subtriangles that one triangular face of the icosahedron is divided into. It corresponds to the number of coat proteins divided by 60 in the canonical case, but in tailed phages, 5 copies are removed to make way for the portal protein. (Other viruses could be described as having architecture corresponding to a specific T number, but with divergent numbers of subunits, e.g. adenoviruses or polyomaviruses.)
We agree that our simplified explanation of the T number is not entirely accurate and will modify the sentence appropriately.
Reviewer #2 (Public Review):
Phage satellites are fascinating elements that have evolved to hijack phages for induction, packaging, and transfer, promoting their widespread dissemination in nature. It is remarkable how different satellites use conserved strategies of parasitism, utilising unrelated proteins that perform similar roles in their cognate elements. In the current manuscript, Dr. Seed and coworkers elucidated the mechanism used by one family of satellites, the PLEs, to produce small capsids, a process that inhibits phage reproduction while increasing PLE transmission. The work is presented beautifully, and the results are astonishing. The authors identified the gene responsible for generating the small capsids, characterised its role in the PLE transfer and phage inhibition, and determined the structure of the PLE-sized small capsids. It is a truly impressive piece of work.
We thank the reviewer for their positive evaluation of our work.
Reviewer #3 (Public Review):
The manuscript by Boyd and co-authors "A Vibrio cholerae viral satellite maximizes its spread and inhibits phage by remodelling hijacked phage coat proteins into small capsids" reports important results related to self-defending mechanisms that bacteria are used against phages that infect them. It has been shown previously that bacteria produce phage-inducible chromosomal island-like elements (PLE) that encode proteins that are integrated into bacterial genome. These proteins are used by bacteria to amend the phage capsids and to create phage-like particles (satellites) that move between cells and transfer the genetic material of PLE to another bacteria. That study highlights the interactions between a PLE-encoded protein, TcaP, and capsid proteins of the phage ICP1.
The manuscript is well written, provides a lot of new information and the results are supported by biochemical analysis.
We thank the reviewer for their supportive evaluation of our work.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
We would like to thank the reviewers for their time in evaluating our manuscript. The reviewers provided constructive comments and suggested changes to improve our manuscript. The main comment was about the framing. We agree with the reviewers and will rewrite the manuscript to focus more on migration patterns than conservation. We will add and expand the paper's theoretical framework and include the studies and descriptions of migration patterns of individual species suggested by the reviewers. At the same time, some of the reviewers' comments (especially on the terms and suggestions for changing the title of the paper) are mutually exclusive. We will pay particular attention to this issue and improve the paper's theoretical basis.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Joint Public Review
Strengths
Overall, the idea that the PAG interacts with the BLA via the midline thalamus during a predator vs. foraging test is new and quite interesting. The authors have used appropriate tools to address their questions. The major impact in the field would be to add evidence to claims that the BLA can be downstream of the dPAG to evoke defensive behaviors. The study also adds to a body of evidence that the PAG mediates primal fear responses.
Weaknesses
(Anatomical concerns)
1) The authors claim that the recordings were performed in the dorsal PAG (dPAG), but the histological images in Fig. 1B and Supplementary S2 for example show the tip of the electrode in a different subregion of PAG (ventral/lateral). They should perform a more careful histological analysis of the recording sites and explain the histological inclusion and exclusion criteria. Diagrams showing the sites of all PAG and BLA recordings, as well as all fiber optics, would be helpful.
The PAG is composed of dorsomedial (dm), dorsolateral (dl), lateral (l), and ventrolateral (vl) columns that extend along the rostro-caudal axis of the aqueduct. The term “dorsal PAG” (dPAG) generally encompasses dmPAG, dlPAG, and lPAG, as substantiated by track-tracing, neurochemical, and immunohistochemical techniques (e.g., Bandler et al., 1991; Bandler & Keay, 1996; Carrive, 1993). As Bandler and Shipley (1994) summarized, “These findings suggest that what has been traditionally called the 'dorsal PAG' (a collective term for regions dorsal and lateral to the aqueduct), consists of three anatomically distinct longitudinal columns: dorsomedial and lateral columns…and a dorsolateral column…" Similarly, Schenberg et al. (2005) clarified in their review that, “According to this parcellation...the defensive behaviors (freezing, flight or fight) and aversion-related responses (switchoff behavior) were ascribed to the DMPAG, DLPAG, and LPAG (usually named the ‘dorsal’ PAG).” In our study, all recordings were conducted within the dPAG. Also, Figures 1B and S2 in our manuscript correspond to the -6.04 mm template from Paxinos & Watson’s atlas (1998), which is shown in the left panel in Author response image 1 and is considerably anterior to the location where the vlPAG emerges, as shown in the right panel. In our revised manuscript, we will provide a detailed definition of the dPAG, inclusive of dmPAG, dlPAG, and lPAG, and support this with the referenced literature.
Author response image 1.
2) Prior studies investigating the role of BLA neurons during a foraging vs. robot test similar to the one used in this study should be also cited and discussed (e.g., Amir et al 2019; Amir et al 2015). These two studies demonstrated that most neurons in the basal portion of the BLA exhibit inhibitory activity during foraging behavior and only a small fraction of neurons (~4%) display excitatory activity in response to the robot (in contrast to the 25% reported in the present study). A very accurate histological analysis of BLA recording sites should be performed to clarify whether distinct subregions of the BLA encode foraging and predator-related information, as previously shown in the two described studies.
In the revised manuscript, we will discuss papers by Amir et al. (2015) and Amir et al. (2019) that utilized a similar 'approach food-avoid predator' paradigm. These studies found a correlation between the neuronal activities in the basolateral amygdala (BL) and the velocity of animal movement during foraging, regardless of the presence or absence of predators. Specifically, the majority of BL neurons were inhibited in both conditions, with only 4.5% being responsive to predators. Consequently, Amir et al. posited that amygdala activity predominantly aligns with behavioral output such as foraging, rather than with responses to threats.
In contrast, our body of work (Kim et al., 2018; Kong et al., 2021; the present study) reveals that the majority of neurons in the BA/BLA displayed distinct responses in pre-robot and robot sessions. Kong et al. (2021) discussed in depth several factors that may account for this discrepancy, given that both Amir et al. and our research used similar behavioral paradigms. Differences in apparatus features, experimental procedures, and data analysis methodologies (refer to Amir et al., 2019) could be contributing to the conflicting results and interpretations concerning the significance of amygdalar neuronal activities.
Additionally, our studies uniquely monitored the same set of amygdalar neurons during pre-robot and robot sessions, affording us the opportunity for a direct comparison of neuronal activities under different threat conditions.
Another salient difference lines in the foraging success rates, which were markedly higher in Amir et al (~80%) compared to our studies (<3-4%). We hypothesize that there may be an inverse relationship between the pellet procurement rate and the intensity of fear. The high foraging success rate in Amir et al., which correlates with subdued amygdalar activity, stands in contrast to our findings of heightened amygdalar activity associated with a lower foraging success rate. Supporting this notion, optogeneticallyinduced amygdalar activity led naïve rats to abandon foraging and escape to the nest (Kong et al., 2021, the present study).
3) An important claim of this study that the PAG sends predator-related signals to BLA via the PVT (Fig. 4). The authors stated that PVT neurons labeled by intra-BLA injection of the retrograde tracer CTB were activated by the predator, but a proper immunohistochemical quantification with a control group was not provided to support this claim. To provide better support for their claim, the authors should quantify the doublelabeled PVT neurons (cFos plus CTB positive neurons) during the robot test.
As recommended, we will include a revised Fig. 4 in the manuscript to present the quantification of neurons that are double-labeled with c-Fos and CTB in the PVT. This updated figure will provide a more rigorous analysis and visual representation of the data.
4) The AVV anterograde tracer deposit spread to a large part of the PAG, including dorsolateral and lateral PAG, and supraoculomotor regions (Fig. 4B). Is the projection to the PVT from the dPAG or other regions of the PAG?
As previously addressed in response to Comment #1, the dPAG comprises the dmPAG, dlPAG, and lPAG. In the revised manuscript, we will acknowledge the diffusion of the AAV to the adjacent deep gray layer of the superior colliculus. Additionally, we are considering conducting more restricted AAV injections into the dPAG to verify terminal expressions in the PVT.
(Concerns about the strength of the evidence supporting a role for the PVT)
5) The authors conclude in the discussion section that the dPAG-amygdala pathway is involved in generating antipredatory defensive behavior. However, the current results are entirely based on correlational analyses of neural firing rate and there is no direct demonstration that the PAG provides information about the robot to the BLA. Therefore, the authors should tone down their interpretation or provide more evidence to support it by performing experiments applying inhibitory tools in the dPAG > PVT > BLA pathway and examining the impact on behavior and downstream neural firing.
As suggested, we will moderate the assertions about the functional implications of the PVT, based on the data from anterograde and retrograde tracers, to present a more measured interpretation in the manuscript.
(Other concerns)
6) One of the main findings of this study is the observation that BLA neurons that are responsive to PAG photostimulation are preferentially recruited during the foraging vs. robot test (Fig. 3). However, the experimental design used to address this question is problematic because the laser photostimulation of PAG neurons preceded the foraging vs. robot test. Prior photoactivation of PAG may have caused indirect shortterm synaptic plasticity in BLA cells, which would favor the response of these cells to the robot. Please see Oishi et al, 2019 PMID: 30621738, which demonstrated that 10 trains of 20Hz photoactivation (300 pulses each) was sufficient to induce LTP in brain slices.
After approximately eight photostimulation trials of the dPAG, with 40 pulses each, the animals entered a post-photostimulation testing phase (referred to as "Post"; Fig. 3C), lasting 10-15 minutes over an average of eight trials before robot testing. Although the PAG does not directly project to the BLA, the remote possibility of trans-synaptic plasticity in the BLA cannot be completely excluded and will be acknowledged. Additionally, it is noteworthy that Oishi et al's (2019) study applied a total of 3,000 pulses (i.e., 10 15-s trains of 20-Hz pulses) and investigated CA3-CA3 synaptic plasticity, as opposed to a total of 320 pulses (i.e., 8 2-s trains of 20-Hz pulses) in our study.
7) The authors should perform a longitudinal analysis of the behavioral responses of the rats across the trials to clarify whether the animals habituate to the robot or not. In Figure 1E, it appears that PAG neurons fire less across the trials, which could be associated with behavioral habituation to the predator robot. If that is the case, the activity of many other PAG and BLA neurons will also most likely vary according to the trial number, which would impact the current interpretation of the results.
In Figure 1E, the y-axis represents the Z scores of individual dPAG neurons, instead of representing repeated tests of the same neuron across multiple trials. The raster plot in Figure 1F clearly depicts that the same dPAG neurons consistently display heightened neural activity in response to the approaching robot across successive trials.
8) In Figure 1, it is unclear why the authors compared the activity of neurons that respond to the robot activation against the activity of the neurons during the retrieval of the food pellets in the pre-robot and postrobot sessions. The best comparison would be aligning the cells that were responsive to the activation of the robot with the moment in which the animals run back to the nest after consuming the pellets during the prerobot or post-robot sessions. This would enable the authors to demonstrate that the PAG responses are directly associated with the expression of escaping behavior in the presence of the robot rather than associated with the onset of goal-directed movement in direction to the next during the pre- and post-robot sessions. A graphic showing the correlation between PAG firing rate and escape response would be also informative.
Figure 1E compares the dPAG neural activity when animals enter a designated pellet zone (time-stamped by camera tracking) during both pre-robot and post-robot trials to the dPAG neural activity when entering the robot trigger zone (time-stamped by robot activation). We wish to clarify that rats carry the large (0.5 g) pellet back to the nest for consumption rather than consume it in the open arena before returning to the nest.
In our study, we aimed to investigate the direct response of dPAG neurons to the looming predator and explore the communication between dPAG and BLA in relation to antipredatory defensive responses. To build upon our previous research that suggests a potential role of dPAG in conveying such responses to the BLA (Kim et al., 2013) and the immediate firing of BLA neurons in response to predatory threats (Kim et al., 2018; Kong et al., 2021), we chose to narrow our testing window to a short latency period (< 500 ms) following robot activations. This specific time window allowed us to focus on the initial stages of the threat stimulus processing and minimize potential confounding factors such as the presence of residual firing activity triggered by the robot during the animals’ escape or any activity changes induced by the animals' behavior.
Furthermore, Figure S1C clearly demonstrates that (i) increased activity of dPAG robot cells preceded the animals’ actual turning and fleeing behavior toward the nest, as indicated by the peak values of movement speed (dark yellow), and (ii) the presence of pellets did not affect activity changes of the robot cells during pre- and post-robot sessions. These observations suggest that the heightened activity of dPAG robot cells was not due to movement changes or pellet motivation.
Lastly, as stated in the original manuscript, the vast majority of robot cells (90.9%) did not show significant correlations between movement speed and firing rates, lending further support to the interpretation that the dPAG activity observed was not merely a reflection of movement changes.
References
Bandler, R., Carrive, P., & Depaulis, A. (1991). Emerging principles of organization of the midbrain periaqueductal gray matter. The midbrain periaqueductal gray matter: functional, anatomical, and neurochemical organization, 1-8.
Bandler, R. & Keay, K. A. (1996). Columnar organization in the midbrain periaqueductal gray and the integration of emotional expression. Progress in brain research, 107, 285-300.
Bandler, R. & Shipley, M. T. (1994) Columnar organization in the midbrain periaqueductal gray: modules for emotional expression? Trends in Neurosciences, 17(9), 379-89.
Carrive, P. (1993). The periaqueductal gray and defensive behavior: functional representation and neuronal organization. Behavioural brain research, 58(1-2), 27-47.
Oishi, N., Nomoto, M., Ohkawa, N., Saitoh, Y., Sano, Y., Tsujimura, S., ... & Inokuchi, K. (2019). Artificial association of memory events by optogenetic stimulation of hippocampal CA3 cell ensembles. Molecular brain, 12, 1-10.
Paxinos, G. & Watson, C. (1998). The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego. Schenberg, L. C., Póvoa, R. M. F., Costa, A. L. P., Caldellas, A. V., Tufik, S., & Bittencourt, A. S. (2005). Functional specializations within the tectum defense systems of the rat. Neuroscience & Biobehavioral Reviews, 29(8), 1279-1298.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
We are grateful for the constructive feedback and the possibility of further improving our manuscript in terms of quality and clarity. Below, we have prepared a brief answer to the points raised in the reviewers’ feedback. We plan to address all these issues fully in the revised version of the manuscript.
We agree that some of our claims were overly enthusiastic. We will rewrite parts of the manuscript to tame our statements. Additionally, we are thankful for the comments on the use of language, which we will certainly apply while editing the manuscript. Below, we focus on the main comments.
Both reviewers: We appreciate advice on possible confounding factors. We should note here that there is substantial evidence on the effects of alpha rhythm amplitude on the excitability of a neuronal network and, as a consequence, on the amplitude of evoked responses (Baumgarten et al., 2016 Cerebral Cortex; Iemi et al., 2017 eLife; Stephani et al., 2021 eLife). This effect is due to changing the gain for evoked responses, and it is quite different compared to the baseline-shift mechanism (BSM). In BSM, the changes in the amplitude of evoked responses occur due to the generation of an additional evoked response component, which we tried to reveal in our current work. Still, we agree with suggestions to test additional factors, such as earlier evoked responses, baseline window, and head size, and we will test those.
Reviewer #2 Comment 2: Certainly, for low-density recordings, some method of data transformation is required. Here we would like to show our reasoning for why we did not use current-source density (CSD) but rather utilised other approaches. First, the CSD transform performs well for spatially localised activities since it is a spatial high-pass filter. In our case, P300 and alpha amplitude dynamics are fairly widespread with low spatial frequency, and we believe we would not benefit from applying CSD. Second, CSD has been shown to be more sensitive to surface sources in the crowns of gyri. For activity in the P300 window, we have no reason to believe that this is the case. Third, as we completely agree that low density montage is a limitation, we used source reconstruction with eLoreta (Fig. 5) to refine the spatial localisation of potential sources of P300 and alpha amplitude change.
Reviewer #1 Comment 4: Our study is indeed based on a sample of older participants. However, in our previous work (Studenova et al., 2022), we compared young and elderly participants using resting-state data. There, we measured the baseline-shift index (BSI). We found that BSIs for elderly participants were lower in comparison to those for young participants. Therefore, despite these limitations, in the current study, we were still able to detect a correspondence between BSIs and evoked responses in elderly participants. Therefore, we believe that for a sample of young participants, the results should not be different.
Reviewer #2 Comment 4: We agree that mediation analysis will provide additional insights, and we will add it to the revised version of the manuscript.
Overall, we found the reviewer's comments very helpful. We will update the manuscript accordingly.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
We would like to thank the reviewers for their comments on the manuscript. The primary concern that they raised is that the imaging data are largely qualitative. This is a fair assessment, and we agree that a careful quantitative characterization of TF clustering with and without IDRs using high resolution imaging would provide valuable insight that would extend our findings. Our goal for this study was to conduct a high level survey of IDR localization, for which we believe a qualitative overview was sufficient. We hope that this work can serve as a useful foundation for future studies of the complex roles that IDRs play in TF function.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
1) Only one PITAR siRNA was tested in majority of the experiments, which compromises the validity of the results. Some results are inconsistent. For example, Fig 2G indicates that PITAR siRNA caused G1 arrest. However, PITAR overexpression in the same cell line did not show any effect on cell cycle progression in Fig 5I.
We thank the reviewer for this comment. Indeed, we have used two siRNAs in experiments related to Fig. 2C, 2D, and 2E. Keeping the reviewer’s comment, we plan to reproduce the results of Fig. 2F, 2G, 2H, 2I, 5A, 5B, 5E, and supplementary Fig. 5A using additional siRNA targeting PITAR.
The reason for the fact that “PITAR silencing showed a robust G1 arrest, but PITAR overexpression failed to show any effect on the cell cycle profile” is as follows: since glioma cells overexpress PITAR (which keeps the p53 suppressed), silencing PITAR (which will elevate p53 levels) in glioma cells will show a robust phenotype in cell cycle profile (in the form of increase G1 arrest). In contrast, the overexpression of PITAR in glioma cells (which already has high levels of PITAR and hence drastically reduced p53 levels) is unlikely to show any significant change in the cell cycle profile. But, a phenotype for PITAR overexpression on cell cycle profile can be shown in DNA-damaged (which induces p53 levels) glioma cells. Indeed, we have done this experiment in Fig. 5L, which shows G2/M arrest (42.34%) induced by DNA damage is reduced significantly (19%) in PITAR overexpressed condition (34.42%). However, keeping reviewers' comments in the right spirit, we plan to repeat this experiment with appropriate modifications to arrive at a more robust phenotype for PITAR overexpression.
2) The conclusion that PITAR inactivates p53 through regulating TRIM28, which is highlighted in the title of the manuscript, is not supported by convincing results. Although the authors showed that a PITAR siRNA increased while PITAR overexpression decreased p53 level, the siRNA only marginally increased the stability of p53 (Fig 5E). The p53 ubiquitination level was barely affected by PITAR overexpression in Fig 5F. To convincingly demonstrate that PITAR regulates p53 through TRIM28, the authors need to show that this regulation is impaired/compromised in TRIM28-knockout conditions. The authors only showed that TRIM28 overexpression suppressed PITAR siRNAinduced increase of p53, which is not sufficient. Note that only one cell line was investigated in Fig 5.
To address this issue, we will overexpress PITAR in TRIM28 silenced cells to show the requirement of TRIM28 for PITAR to inhibit p53. In addition, we also plan to carry out PITAR silencing and overexpression experiments in another glioma cell line as recommended by the reviewer.
3) Another major weakness of this manuscript is that the authors did not provide any evidence indicating that the glioblastoma-promoting activities of PITAR were mediated by its regulation of p53 or TRIM28 (Fig 6 and Fig 7). Thus, the regulation of glioblastoma growth and the regulation of TRIM28/p53 appear to be disconnected.
We would like to respectfully disagree with the reviewer on this particular point. We have indeed provided the following evidence in the current version of the manuscript glioblastomapromoting activities of PITAR were mediated by its regulation of p53 or TRIM28.
A) In Fig. 6, we demonstrate that PITAR silencing-induced reduction in the neurosphere growth is accompanied by a reduction in TRIM28 RNA and an increase in the CDKN1A RNA without a change in p53 RNA levels. We also demonstrate that PITAR overexpression-induced neurosphere growth is accompanied by an increase in the TRIM28 RNA, and a decrease in CDKN1A RNA without a change in p53 RNA levels.
B) To add strength to the above results, we plan to do western blot experiments under similar conditions to demonstrate the appropriate changes in TRIM28, p53, and CDKN1A levels. Also, we will do a TRIM28 rescue experiment in RG5 neurosphere cells.
C) In supplementary Fig. 6 (related to Fig. 6), we show that PITAR silencing failed to decrease neurosphere growth in mutant p53 containing GSC line (MGG8).
D) In supplementary Fig. 7 (related to Fig. 6), we show that PITAR silencing failed to inhibit colony growth of p53-silenced U87 glioma cells (U87/shp53#1). We also show that while PITAR silencing decreased TRIM28 RNA levels in U87/shNT and U87/shp53#1 glioma cells, it failed to increase CDKN1A and MDM2 (p53 targets) at the RNA level.
E) In Fig. 7, we show that the TRIM28 protein level is drastically reduced in small tumors formed by U87/siPITAR cells.
F) In supplementary Fig. 8 (related to Fig. 7), we show that glioma tumor formed by U87/PITAR OE express high levels of TRIM28 protein but reduced levels of p21 protein.
G) We also plan to do additional experiments, as described below, to demonstrate that glioblastoma-promoting activities of PITAR are indeed mediated by its regulation of p53 or TRIM28. We will demonstrate the inability of PITAR overexpression to induce the growth of glioma-tumor initiated by TRIM28 silenced U87 cells.
4) It is not clear what kind of message the authors tried to deliver in Fig 7F/G. Based on the authors' hypothesis, DNA-damaging agents like TMZ would induce PITAR to inactivate p53, which would compromise TMZ's anti-cancer activity. However, the data show that TMZ was very effective in the inhibition of U87 growth. The authors may need to test whether PITAR downregulation, which would increase p53 activity, have any effects on TMZ-insensitive tumors. Such results are more therapeutically relevant.
Reviewer #1 rightly pointed out that TMZ induces PITAR expression, which should compromise TMZ's anti-cancer activity. In addition, overexpression of PITAR also promotes glioma-tumor growth. Figure 7F&G demonstrates the following two facts:1. PITAR overexpression increases the glioma-tumor growth (Figure 7G, compare red line with the blue line), 2. PITAR overexpressing glioma-tumor are resistant to TMZ chemotherapy (Figure 7G, compare the pink line with the green line).
In addition, in Figure 2I, we indeed show that PITAR-silenced cells are more sensitive to TMZ and Adriamycin chemotherapy.
However, considering reviewers’ comments, we plan to repeat Figure 7A, combining TMZ chemotherapy and PITAR silencing to demonstrate that TMZ chemotherapy-induced PITAR indeed promotes chemo-resistance.
5) Lastly, the model presented in Fig 7H is confusing. It is not clear what the exact role of PITAR in the DNA damage response based on this model. If DNA damage would induce PITAR expression, this would lead to inactivation of p53 as revealed by this manuscript. However, DNA damage is known to activate p53. Do the authors want to imply that PITAR induction by DNA damage would help to bring down the p53 level at the end of DNA damage response? The presented data do not support this role unfortunately.
We appreciate reviewer #1 comments. Based on our model in 7H, we believe DNA damageinduced PITAR attenuates DNA damage response by increasing TRIM28 protein levels. TRIM28 ubiquitinates p53 in an MDM2-dependent manner ( Wang et al., 2005). Based on this, we hypothesised that PITAR-induced TRIM28 also contributes to MDM2 mediated ending of DNA damage response.
Considering the reviewers' comments, we plan to do the following experiment.
The kinetics of p53, TRIM28, p21, MDM2 protein levels, and PITAR RNA levels after DNA damage will be monitored in PITAR-silenced conditions. It is known that reduction in the DNA damage-induced p53 levels coincides with high levels of MDM2 accumulation. We believe that in PITAR-silenced cells, p53 levels will remain high for a longer time compared to control cells because of the lack of PITAR-induced TRIM28-mediated degradation of p53.
-
-
psyarxiv.com psyarxiv.com
-
Author Response:
Reviewer #1 (Public Review):
[…] The major strength of the study is the elegant and well-powered data set. Longitudinal data on this scale is very difficult to collect, especially with patient cohorts, so this approach represents an exciting breakthrough. Analysis is straightforward and clearly presented. However, no multiple comparison correction is applied despite many different tests. While in general I am not convinced of the argument in the citation provided to justify this, I think in this case the key results are not borderline (p<0.001) and many of the key effects are replications, so there are not so many novel/exploratory hypothesis and in my opinion the results are convincing and robust as they are. The supplemental material is a comprehensive description of the data set, which is a useful resource.
The authors achieved their aims, and the results clearly support the conclusion that the AD and mean confidence in a perceptual task covary longitudinally. I think this study provides an important impact to the project of computational psychiatry.Sspecifically, it shows that the relationship between transdiagnostic symptom dimensions and behaviour is meaningful within as well as across individuals.
Response: We thank the reviewer for their appraisal of our paper and positive feedback on the main manuscript and supplementary information. We agree with the reviewer that the lack of multiple comparison corrections can also justified by key findings being replications and not borderline significance. We have added this additional justification to the manuscript (Methods, Statistical Analyses, page 15, line 568: “Adjustments for multiple comparisons were not conducted for analyses of replicated effects”)
Reviewer #2 (Public Review):
[…] The major strength and contribution of this study is the use of a longitudinal intervention design, allowing the investigation of how the well-established link between underconfidence and anxious-depressive symptoms changes after treatment. Furthermore, the large sample size of the iCBT group is commendable. The authors employed well-established measures of metacognition and clinical symptoms, used appropriate analyses, and thoroughly examined the specificity of the observed effects.
However, due to the small effect sizes, the antidepressant and control groups were underpowered, reducing comparability between interventions and the generalizability of the results. The lack of interaction effect with treatment makes it harder to interpret the observed differences in confidence, and practice effects could conceivably account for part of the difference. Finally, it was not completely clear to me why, in the exploratory analyses, the authors looked at the interaction of time and symptom change (and group), since time is already included in the symptom change index.
Response: We thank the reviewer for their succinct summary of the main results and strengths of our study. We apologise for the confusion in how we described that analysis. We examine state-dependence., i.e. the relationship between symptom change and metacognition change, in two ways in the paper – perhaps somewhat redundantly. (1) By correlating change indices for both measures (e.g. as plotted in Figure 3D) and (2) by doing a very similar regression-based repeated-measures analysis, i.e. mean confidence ~ time*anxious-depression score change. Where mean confidence is entered with two datapoints – one for pre- and one for post-treatment (i.e. within-person) and anxious-depression change is a single value per person (between-person change score). This allowed us to test if those with the biggest change in depression had a larger effect of time on confidence. This has been added to the paper for clarification (Methods, Statistical Analysis, page 14, line 553-559: “To determine the association between change in confidence and change in anxious-depression, we used (1) Pearson correlation analysis to correlate change indices for both measures and, (2) regression-based repeated-measures analysis: mean confidence ~ time*anxious-depression score change, where mean confidence is entered with two datapoints (one for pre- and one for post-treatment i.e., within-person) and anxious-depression change is a single value per person (between-person change score)”).
The analyses have also been reported as regression in the Results for consistency (Treatment Findings: iCBT, page 5, line 197-204: ‘To test if changes in confidence from baseline to follow-up scaled with changes in anxious-depression, we ran a repeated measure regression analyses with per-person changes in anxious-depression as an additional independent variable. We found this was the case, evidenced by a significant interaction effect of time and change in anxious-depression on confidence (b=-0.12, SE=0.04, p=0.002)… This was similarly evident in a simple correlation between change in confidence and change in anxious-depression (r(647)=-0.12, p=0.002)”).
This longitudinal study informs the field of metacognition in mental health about the changeability of biases in confidence. It advances our understanding of the link between anxiety-depression and underconfidence consistently found in cross-sectional studies. The small effects, however, call the clinical relevance of the findings into question. I would have found it useful to read more in the discussion about the implications of the findings (e.g., why is it important to know that the confidence bias is state-dependent; given the effect size of the association between changes in confidence and symptoms, is the state-trait dichotomy the right framework for interpreting these results; suggestions for follow-up studies to better understand the association).
Response: Thank you for this comment. We have elaborated on the implications of our findings in the Discussion, including the relevance of the state-trait dichotomy to future research and how more intensive, repeated testing may inform our understanding of the state-like nature of metacognition (Discussion, Limitations and Future Directions, page 10, line 378-380: “More intensive, repeating testing in future studies may also reveal the temporal window at which metacognition has the propensity to change, which could be more momentary in nature.”).
Reviewer #3 (Public Review):
[…] I think these findings are exciting because they directly relate to one of the big assumptions when relating cognition to mental health - are we measuring something that changes with treatment (is malleable), so might be mechanistically relevant, or even useful as a biomarker?
This work is also useful in that it replicates a finding of heightened confidence in those with compulsivity, and lowered confidence in those with elevated anxious-depression.
One caveat to the interest of this work is that it doesn't allow any causal conclusions to be drawn, and only measures two timepoints, so it's hard to tell if changes in confidence might drive treatment effects (but this would be another study). The authors do mention this in the limitations section of the paper.
Another caveat is the small sample in the antidepressant group.
Some thoughts I had whilst reading this paper: to what extent should we be confident that the changes are not purely due to practice? I appreciate there is a relationship between improvement in symptoms and confidence in the iCBT group, but this doesn't completely rule out a practice effect (for instance, you can imagine a scenario in which those whose symptoms have improved are more likely to benefit from previously having practiced the task).
Response: We thank the reviewer for commenting on the implications of our findings and we agree with the caveats listed. We thank the reviewer for raising this point about practice effects. A key thing to note is that this task does not have a learning element with respect to the core perceptual judgement (i.e., accuracy), which is the target of the confidence judgment itself. While there is a possibility of increased familiarity with the task instructions and procedures with repeated testing, the task is designed to adjust the difficulty to account of any improvements, so accuracy is stable. We see that we may not have made this clear in some of our language around accuracy vs. perceptual difficulty and have edited the Results to make this distinction clearer (Treatment Findings: iCBT, pages 4-5, lines 184-189: “Although overall accuracy remained stable due to the staircasing procedure, participants’ ability to detect differences between the visual stimuli improved. This was reflected as the overall increase in task difficulty to maintain the accuracy rates from baseline (dot difference: M=41.82, SD=11.61) to follow-up (dot difference: M=39.80, SD=12.62), (b=-2.02, SE=0.44, p<0.001, r2\=0.01)”.)
However, it is true that there can be a ‘practice’ effect in the sense that one may feel more confident (despite the same accuracy level) due to familiarity with a task. One reason we do not subscribe to the proposed explanation for the link between anxious-depression change and confidence change is that the other major aspect of behaviour that improved with practice did so in a manner unrelated to clinical change. As noted above in the quoted text, participants’ discrimination improved from baseline to follow-up, reflected in the need for higher difficulty level to maintain accuracy around 70%. Crucially, this was not associated with symptom change. This speaks against a general mechanism where symptom improvement leads to increased practice effects in general. Only changes in confidence specifically are associated with improved symptoms. We have provided more detail on this in the Discussion (page 9, lines 324-326: “This association with clinical improvements was specific to metacognitive changes, and not changes in task performance, suggesting that changes in confidence do not merely reflect greater task familiarity at follow-up.”).
Relatedly, to what extent is there a role for general task engagement in these findings? The paper might be strengthened by some kind of control analysis, perhaps using (as a proxy for engagement) the data collected about those who missed catch questions in the questionnaires.
Response: Thank you for your comment. We included the details of data quality checks in the Supplement. Given the small number of participants that failed more than one attention checks (1% of the iCBT arm) and that all those participants passed the task exclusion criteria, we made the decision to retain these individuals for analyses. We have since examined if excluding these small number of individuals impacts our findings. Excluding those that failed more than one catch item did not affect the significance of results, which has now been added to the Supplementary Information (Data Quality Checks: Task and Clinical Scales, page 5, lines 181-185: “Additionally, excluding those that failed more than one catch item in the iCBT arm did not affect the significance of results, including the change in confidence (b=0.16, SE=0.02, p<0.001), change in anxious-depression (b=-0.32, SE=0.03, p<0.001), and the association between change in confidence and change in anxious-depression (r(638)=-0.10, p=0.011)”).
I was also unclear what the findings about task difficulty might mean. Are confidence changes purely secondary to improvements in task performance generally - so confidence might not actually be 'interesting' as a construct in itself? The authors could have commented more on this issue in the discussion.
Response: Thank you for this comment and sorry it was not clear in the original paper. As we discussed in a prior reply, accuracy – i.e. proportion of correct selections (the target of confidence judgements) are different from the difficulty of the dot discrimination task that each person receives on a given trial. We had provided more details on task difficulty in the Supplement. Accuracy was tightly controlled in this task using a ‘two-down one-up’ staircase procedure, in which equally sized changes in dot difference occurred after each incorrect response and after two consecutive correct responses. The task is more difficult when the dot difference between stimuli is lower, and less difficult when the dot difference between stimuli is greater. Therefore, task difficulty refers to the average dot difference between stimuli across trials. Crucially, task accuracy did not change from baseline to follow-up, only task difficulty. Moreover, changes in task difficulty were not associated with changes in anxious-depression, while changes in confidence were, indicating confidence is the clinically relevance construct for change in symptoms.
We appreciate that this may not have been clear from the description in the main manuscript, and have added more detail on task difficulty to the Methods (Metacognition Task, page 14, lines 540-542: “Task difficulty was measured as the mean dot difference across trials, where more difficult trials had a lower dot difference between stimuli.”) and Results (Treatment Findings: iCBT, pages 4-5, lines 184-186: “Although overall accuracy remained stable due to the staircasing procedure, participants’ ability to detect differences between the visual stimuli improved.”). We have also elaborated more on how improvements in symptoms are associated with change in confidence, not task performance in the Discussion (page 9, lines 324-326: “This association with clinical improvements was specific to metacognitive changes, and not changes in task performance, suggesting that changes in confidence do not merely reflect greater task familiarity at follow-up”).
To make code more reproducible, the authors could have produced an R notebook that could be opened in the browser without someone downloading the data, so they could get a sense of the analyses without fully reproducing them.
Response: Thank you for your comment. We appreciate that an R notebook would be even better than how we currently share the data and code. While we will consider using Notebooks in future, we checked and converting our existing R script library into R Notebooks would require a considerable amount of reconfiguration that we cannot devote the time to right now. We hope that nonetheless the commitment to open science is clear in the extensive code base, commenting and data access we are making available to readers.
Rather than reporting full study details in another publication I would have found it useful if all relevant information was included in a supplement (though it seems much of it is). This avoids situations where the other publication is inaccessible (due to different access regimes) and minimises barriers for people to fully understand the reported data.
Response: We agree this is good practice – the Precision in Psychiatry study is very large, with many irrelevant components with respect to the present study (Lee et al., BMC Psychiatry, 2023). For this reason, we tried to provide all that was necessary and only refer to the Precision in Psychiatry study methods for fine-grained detail. Upon review, the only thing we think we omitted that is relevant is information on ethical approval in the manuscript, which we have now added (Methods, Participants, page 11, lines 412-417: “Further details of the PIP study procedures that are not specific to this study can be found in a prior publication (21). Ethical approval for the PIP study was obtained from the Research Ethics Committee of School of Psychology, Trinity College Dublin and the Northwest-Greater Manchester West Research Ethics Committee of the National Health Service, Health Research Authority and Health and Care Research Wales”). If any further information is lacking, we are happy to include it here also.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
The following is the authors’ response to the original reviews.
Reviewer #1 (Public Review):
She et al studied the evolution of gene expression reaction norms when individuals colonise a new environment that exposes them to physiologically challenging conditions. Their objective was to test the "plasticity first" hypothesis, which suggest that traits that are already plastic (their value changes when facing a new environment compared to the original environment) facilitates the colonisation of novel environments, which, if true, would be predicted to result in the evolution of gene expression values that are similar in the population that colonised the new environment and evolved under these particular selection pressures. To test this prediction, they studied gene expression in cardiac and muscle tissues in individuals originating from three conditions: lowland individuals in their natural environment (ancestral state), lowland individuals exposed to hypoxia (the plastic response state), and a highland population facing hypoxia for several generations (the coloniser state). They classified gene expression patterns as maladaptive or adaptive in lowland individuals responding to short term hypoxia by classifying gene expression patterns using genes that differed between the ancestral state (lowland) and colonised state (highland). Genes expressed in the same direction in lowland individuals facing hypoxia (the plastic state) as what is found in the colonised state are defined as adaptative, while genes with the opposite expression pattern were labelled as maladaptive, using the assumption that the colonised state must represent the result of natural selection. Furthermore, genes could be classified as representing reversion plasticity when the expression pattern differed between the plasticity and colonised states and as reinforcement when they were in the same direction (for example more expressed in the plastic state and the colonised state than in the ancestral state). They found that more genes had a plastic expression pattern that was labelled as maladaptive than adaptive. Therefore, some of the genes have an expression pattern in accordance with what would be predicted based on the plasticity-first hypothesis, while others do not.
Thank you for a precise summary of our work. We appreciate the very encouraging comments recognizing the value of our work. We have addressed concerns from the reviewer in greater detail below.
Q1. As pointed out by the authors themselves, the fact that temperature was not included as a variable, which would make the experimental design much more complex, misses the opportunity to more accurately reflect the environmental conditions that the colonizer individuals face at high altitude. Also pointed out by the authors, the acclimation experiment in hypoxia lasted 4 weeks. It is possible that longer term effects would be identifiable in gene expression in the lowland individuals facing hypoxia on a longer time scale. Furthermore, a sample size of 3 or 4 individuals per group depending on the tissue for wild individuals may miss some of the natural variation present in these populations. Stating that they have a n=7 for the plastic stage and n= 14 for the ancestral and colonized stages refers to the total number of tissue samples and not the number of individuals, according to supplementary table 1.
We shared the same concerns as the reviewer. This is partly because it is quite challenging to bring wild birds into captivity to conduct the hypoxia acclimation experiments. We had to work hard to perform acclimation experiments by taking lowland sparrows in a hypoxic condition for a month. We indeed have recognized the similar set of limitations as the review pointed out and have discussed the limitations in the study, i.e., considering hypoxic condition alone, short time acclimation period, etc. Regarding sample sizes, we have collected cardiac muscle from nine individuals (three individuals for each stage) and flight muscle from 12 individuals (four individuals for each stage). We have clarified this in Supplementary Table 1.
Q2. Finally, I could not find a statement indicating that the lowland individuals placed in hypoxia (plastic stage) were from the same population as the lowland individuals for which transcriptomic data was already available, used as the "ancestral state" group (which themselves seem to come from 3 populations Qinghuangdao, Beijing, and Tianjin, according to supplementary table 2) nor if they were sampled in the same time of year (pre reproduction, during breeding, after, or if they were juveniles, proportion of males or females, etc). These two aspects could affect both gene expression (through neutral or adaptive genetic variation among lowland populations that can affect gene expression, or environmental effects other than hypoxia that differ in these populations' environments or because of their sexes or age). This could potentially also affect the FST analysis done by the authors, which they use to claim that strong selective pressure acted on the expression level of some of the genes in the colonised group.
The reviewer asked how individual tree sparrows used in the transcriptomic analyses were collected. The individuals used for the hypoxia acclimation experiment and represented the ancestral lowland population were collected from the same locality (Beijing) and at the same season (i.e., pre-breeding) of the year. They are all adults and weight approximately 18g. We have clarified this in the Supplementary Table S1 and Methods. We did not distinguish males from females (both sexes look similar) under the assumption that both sexes respond similarly to hypoxia acclimation in their cardiac and flight muscle gene expression.
The Supplementary Table 2 lists the individuals that were used for sequence analyses. These individuals were only used for sequence comparisons but not for the transcriptomic analyses. The population genetic structure analyzed in a previously published study showed that there is no clear genetic divergence within the lowland population (i.e., individuals collected from Beijing, Tianjing and Qinhuangdao) or the highland population (i.e., Gangcha and Qinghai Lake). In addition, there was no clear genetic divergence between the highland and lowland populations (Qu et al. 2020).
Q4. Impact of the work
There has been work showing that populations adapted to high altitude environments show changes in their hypoxia response that differs from the short-term acclimation response of lowland population of the same species. For example, in humans, see Erzurum et al. 2007 and Peng et al. 2017, where they show that the hypoxia response cascade, which starts with the gene HIF (Hypoxia-Inducible Factor) and includes the EPO gene, which codes for erythropoietin, which in turns activates the production of red blood cell, is LESS activated in high altitude individuals compared to the activation level in lowland individuals (which gives it its name). The present work adds to this body of knowledge showing that the short-term response to hypoxia and the long term one can affect different pathways and that acclimation/plasticity does not always predict what physiological traits will evolve in populations that colonize these environments over many generations and additional selection pressure (UV exposure, temperature, nutrient availability). Altogether, this work provides new information on the evolution of reaction norms of genes associated with the physiological response to one of the main environmental variables that affects almost all animals, oxygen availability. It also provides an interesting model system to study this type of question further in a natural population of homeotherms.
Erzurum, S. C., S. Ghosh, A. J. Janocha, W. Xu, S. Bauer, N. S. Bryan, J. Tejero et al. "Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans." Proceedings of the National Academy of Sciences 104, no. 45 (2007): 17593-17598.
Peng, Y., C. Cui, Y. He, Ouzhuluobu, H. Zhang, D. Yang, Q. Zhang, Bianbazhuoma, L. Yang, Y. He, et al. 2017. Down-regulation of EPAS1 transcription and genetic adaptation of Tibetans to high-altitude hypoxia. Molecular biology and evolution 34:818-830.
Thank you for highlighting the potential novelty of our work in light of the big field. We found it very interesting to discuss our results (from a bird species) together with similar findings from humans. In the revised version of manuscript, we have discussed short-term acclimation response and long-term adaptive evolution to a high-elevation environment, as well as how our work provides understanding of the relative roles of short-term plasticity and long-term adaptation. We appreciate the two important work pointed out by the reviewer and we have also cited them in the revised version of manuscript.
Reviewer #2 (Public Review):
This is a well-written paper using gene expression in tree sparrow as model traits to distinguish between genetic effects that either reinforce or reverse initial plastic response to environmental changes. Tree sparrow tissues (cardiac and flight muscle) collected in lowland populations subject to hypoxia treatment were profiled for gene expression and compared with previously collected data in 1) highland birds; 2) lowland birds under normal condition to test for differences in directions of changes between initial plastic response and subsequent colonized response. The question is an important and interesting one but I have several major concerns on experimental design and interpretations.
Thank you for a precise summary of our work and constructive comments to improve this study. We have addressed your concerns in greater detail below.
Q1. The datasets consist of two sources of data. The hypoxia treated birds collected from the current study and highland and lowland birds in their respective native environment from a previous study. This creates a complete confounding between the hypoxia treatment and experimental batches that it is impossible to draw any conclusions. The sample size is relatively small. Basically correlation among tens of thousands of genes was computed based on merely 12 or 9 samples.
We appreciate the critical comments from the reviewer. The reviewer raised the concerns about the batch effect from birds collected from the previous study and this study. There is an important detail we didn’t describe in the previous version. All tissues from hypoxia acclimated birds and highland and lowland birds have been collected at the same time (i.e., Qu et al. 2020). RNA library construction and sequencing of these samples were also conducted at the same time, although only the transcriptomic data of lowland and highland tree sparrows were included in Qu et al. (2020). The data from acclimated birds have not been published before.
In the revised version of manuscript, we also compared log-transformed transcript per million (TPM) across all genes and determined the most conserved genes (i.e., coefficient of variance ≤ 0.3 and average TPM ≥ 1 for each sample) for the flight and cardiac muscles, respectively (Hao et al. 2023). We compared the median expression levels of these conserved genes and found no difference among the lowland, hypoxia-exposed lowland, and highland tree sparrows (Wilcoxon signed-rank test, P<0.05). As these results suggested little batch effect on the transcriptomic data, we used TPM values to calculate gene expression level and intensity. This methodological detail has been further clarified in the Methods and we also provided a new supplementary Figure (Figure S5) to show the comparative results.
The reviewer also raised the issue of sample size. We certainly would have liked to have more individuals in the study, but this was not possible due to the logistical problem of keeping wild bird in a common garden experiment for a long time. We have acknowledged this in the manuscript. In order to mitigate this we have tested the hypothesis of plasticity following by genetic change using two different tissues (cardiac and flight muscles) and two different datasets (co-expressed gene-set and muscle-associated gene-set). As all these analyses show similar results, they indicate that the main conclusion drawn from this study is robust.
Q2. Genes are classified into two classes (reversion and reinforcement) based on arbitrarily chosen thresholds. More "reversion" genes are found and this was taken as evidence reversal is more prominent. However, a trivial explanation is that genes must be expressed within a certain range and those plastic changes simply have more space to reverse direction rather than having any biological reason to do so.
Thank you for the critical comments. There are two questions raised we should like to address them separately. The first concern centered on the issue of arbitrarily chosen thresholds. In our manuscript, we used a range of thresholds, i.e., 50%, 100%, 150% and 200% of change in the gene expression levels of the ancestral lowland tree sparrow to detect genes with reinforcement and reversion plasticity. By this design we wanted to explore the magnitudes of gene expression plasticity (i.e., Ho & Zhang 2018), and whether strength of selection (i.e., genetic variation) changes with the magnitude of gene expression plasticity (i.e., Campbell-Staton et al. 2021).
As the reviewer pointed out, we have now realized that this threshold selection is arbitrarily. We have thus implemented two other categorization schemes to test the robustness of the observation of unequal proportions of genes with reinforcement and reversion plasticity. Specifically, we used a parametric bootstrap procedure as described in Ho & Zhang (2019), which aimed to identify genes resulting from genuine differences rather than random sampling errors. Bootstrap results suggested that genes exhibiting reversing plasticity significantly outnumber those exhibiting reversing plasticity, suggesting that our inference of an excess of genes with reversion plasticity is robust to random sampling errors. We have added these analyses to the revised version of manuscript, and provided results in the Figure 2d and Figure 3d.
In addition, we adapted a bin scheme (i.e., 20%, 40% and 60% bin settings along the spectrum of the reinforcement/reversion plasticity). These analyses based on different categorization schemes revealed similar results, and suggested that our inference of an excess of genes with reversion plasticity is robust. We have provided these results in the Supplementary Figure S2 and S4.
The second issue that the reviewer raised is that the plastic changes simply have more space to reverse direction rather than having any biological reason to do so. While a causal reason why there are more genes with expression levels being reversed than those with expression levels being reinforced at the late stages is still contentious, increasingly many studies show that genes expression plasticity at the early stage may be functionally maladapted to novel environment that the species have recently colonized (i.e., lizard, Campbell-Staton et al. 2021; Escherichia coli, yeast, guppies, chickens and babblers, Ho and Zhang 2018; Ho et al. 2020; Kuo et al. 2023). Our comparisons based on the two genesets that are associated with muscle phenotypes corroborated with these previous studies and showed that initial gene expression plasticity may be nonadaptive to the novel environments (i.e., Ghalambor et al. 2015; Ho & Zhang 2018; Ho et al. 2020; Kuo et al. 2023; Campbell-Staton et al. 2021).
Q3. The correlation between plastic change and evolved divergence is an artifact due to the definitions of adaptive versus maladaptive changes. For example, the definition of adaptive changes requires that plastic change and evolved divergence are in the same direction (Figure 3a), so the positive correlation was a result of this selection (Figure 3d).
The reviewer raised an issue that the correlation between plastic change and evolved divergence is an artifact because of the definition of adaptive versus maladaptive changes, for example, Figure 3d. We agree with the reviewer that the correlation analysis is circular because the definition of adaptive and maladaptive plasticity depends on the direction of plastic change matched or opposed that of the colonized tree sparrows. We have thus removed previous Figure 3d-e and related texts from the revised version of manuscript. Meanwhile, we have changed Figure 3a to further clarify the schematic framework.
Reviewer #1 (Recommendations For The Authors):
Q1. Here are private recommendations that I think could help improve the manuscript. West-Eberhard was a pioneer back in 2003 in explicating the hypothesis of "plasticity first". I think it is important to cite their main work in the first paragraph of introduction and to use the term "plasticity-first", which is widely known among evolutionary biologists studying phenotypic plasticity, instead of "plasticity followed by genetic change", since the three papers cited in paragraph 1 call it « plasticity first ».
West-Eberhard, M.J. (2003) Developmental Plasticity and Evolution, Oxford University Press.
Thank you for suggesting West-Eberhard (2003) and we have cited this important work. We have also changed “plasticity followed by genetic change” to “plasticity first”.
Q2. Introduction. Line 5, Change for « On the one hand, if plasticity changes ... »
We have modified as suggested.
Q3. Line 52, Change for « ...same direction as adaptive evolution does ...»
We have modified as suggested.
Q4. Line 66,When presenting papers that address the plasticity and evolution of gene expression in response to environmental variables, paper by Morris et al is another example that could be useful to include (but this is only a suggestion in case the authors missed it).
Thank you for suggesting this nice work. We have cited Morris et al. (2014).
Q5. Line 94, Change for "We acclimated"
We have modified as suggested.
Q6. In Figure 3, the figure in panel A and B is labelled "normaxia", but I think that "normoxia" is usually the term used.
Thank you for spot the typo. We have modified Figure 3a and we no longer used the term “normaxia”.
Material and methods
It would be important to merge supplementary table 1 and 2 and only present the individuals that were used with their respective cardiac and muscle libraries (if they come from the same individual?). Also, the origin of the individuals used in the hypoxia experiment should be explained at the beginning of the methods section and explicated in the supplementary table. Information on sex or stage of development (juvenile? Adult? Male? female?) and time of year (in breeding stage? Pre-migration (if any), etc) would allow the reader to see that individuals from lowland differed only in their exposure to hypoxia or not, or if other variables may affect gene expression patterns. Similarly, if all individuals form the highland are males and the lowland hypoxia exposed individuals are females (or juveniles versus breeders, or different time of year, etc) this should be stated in the methods. Gene expression is labile so the reader should know if other variables influence the results presented or not.
Thank you for suggestion. We have added detailed information (i.e., age, collecting time and season) to the supplementary Table 1. We have also added this information to the Methods. Because the birds used in transcriptomic analysis (Supplementary Table 1) were different individuals from those used in the sequence analyses (Supplementary Table 2), these two tables cannot be merged.
References:
Campbell-Staton SC, Velotta JP, Winchell KM. 2021. Selection on adaptive and maladaptive genes expression plasticity during thermal adaptation to urban heat islands. Nat. Commun. 12: 6195.
Ghalambor CK, Hoke KL, Ruell EW, Fischer EK, Reznick DN, Hughes KA. 2015. Non-adaptive plasticity potentiates rapid adaptive evolution of gene expression in nature. Nature 525:372–375.
Hao et al. 2023. Divergent contributions of coding and noncoding sequences to initial high-altitude adaptation in passerine birds endemic to the Qinghai–Tibet Plateau. Mol. Ecol. Doi: 10.1111/mec.16942.
Ho WC, Zhang J. 2018. Evolutionary adaptations to new environments generally reverse plastic phenotypic changes. Nat. Commun. 9: 350.
Ho WC, Zhang J. 2019. Genetic gene expression changes during environmental adaptations tend to reverse plastic changes even after correction for statistical nonindependence. Mol. Biol. Evol. 36: 604–612.
Ho WC, Li D, Zhu Q, Zhang J. 2020. Phenotypic plasticity as a long-term memory easing readaptations to ancestral environments. Sci. Adv. 6: eaba3388.
Kuo KC, Yao CT, Liao BY, Weng MP, Dong F, Hsu YC, Hung CM. 2023. Weak gene-gene interaction facilitates the evolution of gene expression plasticity. BMC Biol. 21: 57.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
The following is the authors’ response to the original reviews.
Reviewer #1 (Recommendations For The Authors):
I would recommend the authors check the results section, it seems to me that the first two paragraphs are not results, but methods.
We would like to express our appreciation to both reviewers for bringing this to our attention. Indeed, we discussed this in detail, but decided that because the methods come after the results section. We believe that providing the basic methodological approach to readers before the results is essential for better comprehension. Once again, we sincerely thank the reviewers for their valuable feedback, however, we would prefer to leave this part as it is.
In Figure 3B, why there is not male and female shown in different lines, as in the rest of figures? I recommend following the same pattern everywhere.
Has been changed accordingly, and the respective sex-specific lines were also added to Figure 4.
I recommend checking carefully all the articles included in Table 2. Maybe some of the included information here is not precise.
We thank the reviewer for highlighting this. We carefully checked the articles again, and made some small adjustments.
In Material and methods: just note that when ages are estimated, usually there is a variable accounting for the amount of estimated years, that should be included in the model, and see that it has no effect on the dependent variable. I recommend including this variable.
We sincerely appreciate the helpful comment from the reviewer, which we have carefully considered and implemented in our manuscript. However, we would like to highlight that addressing age estimation error is complex, as it involves measurement error. Thus, simply adding it as an independent variable may not fully capture its potential impact, as the effect may be positive or negative depending on the individual. Hence, the potential effect would be better accounted for by the implementation of individual random intercepts and smooths to adjust the confidence intervals, which is part of our model structures. Furthermore, we would like to emphasize that we have also conducted analyses on a reduced dataset that only included zoo-born individuals with precisely known birthdates, and the results remained consistent. So instead of changing our analyses, we now emphasize how our approach also addresses this aspect.
Creatinine: Is there any other reference, more recent and in English, to complement the original one cited?
We have now supplemented the original citation with an additional English citation: Anestis et al. 2009.
Reviewer #2 (Recommendations For The Authors):
Minor corrections
Please, in Study population, the citation of table 2 is in fact Table 3. For table 3 (in Methodology), please provide the units Body weight having a mean of 32.4, has it a median of 9 ?
Please, provide results separately for males and females
We changed the table as requested, though the table only reports sample sizes and thus only numbers without units. The values for body weight are accurate.
In Results
The two first paragraphs have to be included in methods and structured with those already present.
We would like to express our appreciation to both reviewers for bringing this to our attention. Indeed, we discussed this in detail, but decided that because the methods come after the results section, we believe that providing the basic methodological approach to readers before the results is essential for better comprehension. Once again, we sincerely thank the reviewers for their valuable feedback, however, we would prefer to leave this part as it is.
In Table 1, indicate what 'Est' means.
Has been changed accordingly
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
The cerebral cortex, or surface of the brain, is where humans do most of their conscious thinking. In humans, the grooves (sulci) and bumps (convolutions) have a particular pattern in a region of the frontal lobe called Broca's area, which is important for language. Specialists study features imprinted on the internal surfaces of braincases in early hominins by casting their interiors, which produces so-called endocasts. A major question about hominin brain evolution concerns when, where, and in which fossils a humanlike Broca's area first emerged, the answer to which may have implications for the emergence of language. The researchers used advanced imaging technology to study the endocast of a hominin (KNM-ER 3732) that lived about 1.9 million years ago (Ma) in Kenya to test a recently published hypothesis that Broca's remained primitive (apelike) prior to around 1.5 Ma. The results are consistent with the hypothesis and raise new questions about whether endocasts can be used to identify the genus and/or species of fossils.
We would like to thank Rev. 1 for their comments on our paper.
Reviewer #2 (Public Review):
The authors tried to support the hypothesis that early Homo still had a primitive condition of Broca's cap (the region in fossil endocasts corresponding to Broca's area in the brain), being more similar to the condition in chimpanzees than in humans. The evidence from the described individual points to this direction but there are some flaws in the argumentation.
We are grateful to Rev. 2 for their comments, although we partially agree with some of them.
First, we would like to rectify the statement of Rev. 2 that we “tried to support the hypothesis that early Homo still had a primitive condition of Broca's cap”, indeed, our aim was to test this hypothesis and not to try to validate it.
First, only one human and one chimpanzee were used for comparison, although we know that patterns of brain convolutions (and in addition how they leave imprints in the endocranial bones) are very variable.
We understand the point raised by Rev. 2 about the variation of brain convolutions in humans and chimpanzees. We used atlases published by Connolly (1950), Falk et al. (2018) and de Jager et al. (2019, 2022) to analyse the endocast of KNM-ER 3732 and compare it to the extant human and chimpanzee cerebral conditions. However, in Figure 2, for the sake of clarity only two Homo and Pan specimens were used to illustrate the comparison (as it has been done in other published papers, e.g., Carlson et al., 2011; Science, Gunz et al., 2020 Sci Adv). In the revised version, we modified the manuscript to explain further our approach (line 156) “We used brain and endocast atlases published in Connolly (1950), Falk et al. (2018) and de Jager et al. (2019, 2022; see also www.endomap.org) for comparing the pattern identified in KNM-ER 3732 to those described in extant humans and chimpanzees. To the best of our knowledge, these atlases are the most extensive atlases of extant human and chimpanzee brains/endocasts available to date and are widely used in the literature to explore variability in sulcal patterns. In Figure 2, the extant human and chimpanzee conditions are illustrated by one extant human (adult female) and one extant chimpanzee (adult female) specimens from the Pretoria Bone Collection at the University of Pretoria (South Africa) and in the Royal Museum for Central Africa in Tervuren (Belgium), respectively (Beaudet et al., 2018).”.
Second, the evidence from this fossil specimen adds to the evidence of previously describe individuals but still not yet fully prove the hypothesis.
We tempered our discussion by concluding that (line 116) “Overall, the present study not only demonstrates that Ponce de León et al.’s (2021) hypothesis of a primitive brain of early Homo cannot be rejected, but also adds information […]”.
Third, there is a vicious circle in using primitive and derived features to define a fossil species and then using (the same or different) features to argue that one feature is primitive or derived in a given species. In this case, we expect members of early Homo to be derived compared to their predecessors of the genus Australopithecus and that's why it seems intriguing and/or surprising to argue that early Homo has primitive features. However, we should expect that there is some kind of continuum or mosaic in a time in which a genus "evolves into" another genus. This discussion requires far more discussions about the concepts we use, maybe less discussion about what is different between the two groups but more discussion about the evolutionary processes behind them.
We fully agree with Rev. 2 on this aspect. We believe that identifying these differences/similarities between fossil and extant hominids constitute the first step of a better understanding of the evolutionary mechanisms. Our work suggests indeed a certain continuity between genera and raises questions on the genus concept and how to interpret the specimens currently attributed to early Homo. In the revised version of the manuscript we included a reference to this possible scenario (line 134): “[…] or to the absence of a definite threshold between the two genera based on the morphoarchitecture of their endocasts (Wood and Collard, 1999).”.
Fourth, the data of convolutional imprints presented are rather subjective when identifying which impressions represent which brain convolutions. Not seeing an impression does not necessarily mean that the corresponding brain feature did not exist. Interestingly, the manuscript does not mention and discuss at all the frontoorbital sulcus. This is a sulcus that usually runs from the orbital surface of the frontal lobe up to divide the inferior frontal gyrus in chimpanzees, a condition totally different than in humans who do not have a frontoorbital sulcus. Could such a sulcus be identified, this would provide a far more convincing argument for a primitive condition in this specimen. In Australopithecus sediba, e.g., the condition in this region seems to be a mosaic in which some aspects of the morphology seem to be more modern while one of the sulcual impressions can well be interpreted as a short frontoorbital sulcus. For this specimen, by the way, I would come back to my third point above: some experts in the field might argue that this specimen could belong to Homo rather than Australopithecus...
We agree that the presence of a fronto-orbital sulcus would be more conclusive. However, this sulcus has not been identified in KNM-ER3732 and the region in which we would expect to find it is not preserved. As demonstrated by Ponce de León et al. (2021), because of the topographic relationships between sulci (and cranial structures), it is possible to interpret imprints on endocasts and the evolutionary polarity of some traits even in the absence of landmarks such as the fronto-orbital sulcus. In Australopithecus sediba the main derived feature of the endocast corresponds to the ventrolateral bulge in the left inferior frontal gyrus, and not to the sulcal pattern itself (Carlson et al., 2011 Science). However, the discussion around the taxonomic status of this taxon confirms the urgent need for reconsidering specimens from that time period and clarifying the mosaic-like or concerted evolution of the derived Homo-like traits within our lineage. Regarding the subjective nature of this approach, we invite readers to examine the specimen on MorphoSource (https://www.morphosource.org/concern/media/000497752?locale=en) and to request access to the National Museums of Kenya to the physical or virtual specimen to falsify our hypothesis.
According to my arguments above, I think that this manuscript might revive interesting discussions about this topic but it is not likely to settle them because the data presented are not strong enough to fully support the hypothesis.
We would be more than happy to consider new/other specimens with similar chronological and geographical contexts and investigate further this hypothesis in the future.
Reviewer #3 (Public Review):
The authors provide a detailed analysis of the sulcal and sutural imprints preserved on the natural endocast and associated cranial vault fragments of the KNM-ER3732 early Homo specimen. The analyses indicate a primitive ape-like organization of this specimen's frontal cortex. Given the geological age of around 1.9 million years, this is the earliest well-documented evidence of a primitive brain organization in African Homo.
In the discussion, the authors re-assess one of the central questions regarding the evolution of early Homo: was there species diversity, and if yes, how can we ascertain it? The specimen KNM-ER1470 has assumed a central role in this debate because it purportedly shows a more advanced organization of the frontal cortex compared to other largely coeval specimens (Falk, 1983). However, as outlined in Ponce de León et al. 2021 (Supplementary Materials), the imprints on the ER1470 endocranium are unlikely to represent sulcal structures and are more likely to reflect taphonomic fracturing and distortion. Dean Falk, the author of the 1983 study, basically shares this view (personal communication). Overall, I agree with the authors that the hypothesis to be tested is the following: did early Homo populations with primitive versus derived frontal lobe organizations coexist in Africa, and did they represent distinct species?
I greatly appreciate that the authors make available the 3D surface data of this interesting endocast.
We are grateful to Rev. 3 for their comments and for contextualizing our finding. We would also like to point out that, although the 3D surface can be viewed on MorphoSource, permission from the National Museums of Kenya has to be requested for studying the specimen and getting access to the physical specimen and/or the 3D model.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
The following is the authors’ response to the original reviews.
We thank the reviewers for their positive and constructive evaluations. Based upon the reviewers’ helpful comments, we have performed complementary experiments. In particular, we additionally show that:
-
a complete analysis of CXCR1/2 binding chemokines in the secretions of tissular CD8+ T cells reinforces the key role of CXCL8 in CD8+ T cell-induced fibrocyte chemotaxis (new panel D in Figure 2)
-
a direct contact between fibrocytes and CD8+ T cells triggers CD8+ T cell cytotoxicity against primary basal bronchial epithelial cells (new Figure 6)
-
the interaction between CD8+ T cells and fibrocytes is bidirectional, with CD8+ T cells triggering the development of fibrocyte immune properties (new Figure 7)
-
the characteristic time to reach a stationary state reminiscent of a resolution of the COPD condition was estimated to be about 2.5 years using the simulations. Interfering with chemotaxis and adhesion processes by inhibiting CXCR1/2 and CD54, respectively was not sufficient to reverse the COPD condition, as predicted by the mathematical model (new Figure 9)
-
the massive proliferation effect induced by fibrocytes is specific to CD8+ T cells and not CD4+ T cells (new Figure 3-figure supplement 2), and that fibrocytes moderately promote the death of unactivated CD8+ T cells in direct co-culture (new Figure 3-figure supplement 3)
We have graphically summarized our findings (new Figure 10) suggesting the existence of a positive feedback loop playing a role in the vicious cycle that promotes COPD. A new table describing patient characteristics for basal bronchial epithelial cell purification has also been added (new Supplementary File 9), the Supplementary Files 7 and S8 have been up-dated to take into account the new experiments.
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the dataset identifier PXD041402.
Reviewer #1 (Recommendations For The Authors):
The experimental approaches are all rationally designed and the data clearly presented, with appropriate analyses and sample sizes. I could find no technical or interpretative concerns. The interrelationship between the observational data (histology) with the quantitative live cell imaging and the follow-on functional investigations is especially laudable. The data nicely unifies several years of accumulated data regarding the (separate) participation of CD8 T cells and fibrocytes in COPD.
We thank the reviewer for his/her comments.
I have only minor comments:
1) Line 79: The observation that T cells may influence fibrocyte differentiation/function was initially made some years earlier by Abe et al (J Immunol 2001; 7556), and should be cited in addition to the follow-on work of Niedermeyer.
This reference has been added to acknowledge this seminal work.
2) Line 632: Corticosteroids originate from the cortex of the adrenal gland. Budenoside and fluticasone are glucocorticoids, not corticosteroids.
This mistake has been corrected in the discussion of the revised manuscript (see line 802 in the revised manuscript).
3) Given the state of T cell immunotherapies, cytokine/chemokine antagonists, and emerging fibrocyte-targeted drugs, can the authors possibly speculate as to desired pathways to target therapeutically?
Chemokine-receptor based therapies could be used to inhibit fibrocyte recruitment into the lungs, such as CXCR4 blockade. We have very recently shown that using the CXCR4 antagonist, plerixafor, alleviates bronchial obstruction and reduces peri-bronchial fibrocytes density (Dupin et al., 2023). Because CXCR4 expression in human fibrocytes is dependent on mTOR signaling and is inhibited by rapamycin in vitro (Mehrad et al., 2009), alternative strategies consisting of targeting fibrocytes via mTOR have been proposed. This target has proven effective in bronchiolitis obliterans, idiopathic pulmonary fibrosis, and thyroid-associated ophthalmopathy, using rapamycin (Gillen et al., 2013; Mehrad et al., 2009), sirolimus (Manjarres et al., 2023) or an insulin-like growth factor-1 (IGF-I) receptor blocking antibody (Douglas et al., 2020; Smith et al., 2017). Inhibiting mTOR is also expected to have effects on CD8+ T cells, ranging from an immunostimulatory effect by activation of memory CD8+ T-cell formation, to an immunosuppressive effect by inhibition of T cell proliferation (Araki et al., 2010). Last, chemokine-receptor base therapies could also include strategies to inhibit the CD8+-induced fibrocyte chemotaxis, such as dual CXCR1-CXCR2 blockade. We were able to test this latter strategy in our mathematical model, see response to point 6 of reviewer 2.
Immunotherapies directly targeting the interaction between fibrocytes and CD8+ T cells could also be considered, such as CD86 or CD54 blockade. The use of abatacept and belatacept, that interfere with T cell co-stimulation, is effective in patients with rheumatoid arthritis (Pombo-Suarez & Gomez-Reino, 2019) and in kidney-transplant recipients (Vincenti et al., 2016), respectively. Targeting the IGF-I receptor by teprotumumab in the context of thyroid-associated ophthalmopathy also improved disease outcomes, possibly by altering fibrocyte-T cell interactions (Bucala, 2022; Fernando et al., 2021).
We also tested this CD86 and CD54 blocking strategy for COPD treatment by simulations, see response to point 6 of reviewer 2.
However, such therapies should be used with caution as they may favour adverse events such as infections, particularly in the COPD population (Rozelle & Genovese, 2007). Additionally, the fibrocytes-lymphocytes interaction has recently been shown to promote anti-tumoral immunity via the PD1-PDL1 immunological synapse (Afroj et al., 2021; Mitsuhashi et al., 2023). Therefore, care should be taken in the selection of patients to be treated and/or timing of treatment administration with regards to the increased risk of lung cancer in COPD patients.
The discussion section has been altered accordingly.
4) The authors may want to consider mentioning (and citing) recent insight into the immune-mediated fibrosis in thyroid-associated ophthalmopathy
These important publications are now cited in a dedicated paragraph about the possible therapeutical interventions (see answer to point 3, and discussion in the revised manuscript).
Reviewer #2 (Recommendations For The Authors):
Specific comments
1) The rationale for the selection of chemokines overexpressed by CD8+ T cells in COPD is based on literature data of n=2 patients per group. This is limited and risky. I am less concerned about false positives given the selection of chemokines and the available literature but am worried about the possibility that many chemokines may not have been selected based on insufficient power to do meaningful stats on this comparison. For example, many other CXCR1/2 binding CXCL chemokines exist and these could contribute to the migration effect in Fig 2C as well. Given the currently available single-cell resources it should be possible to extend these observations and to investigate CXCL chemokine expression in COPD CD8 T cells to the benefit of Fig 2A in full detail.
We agree with the reviewer that the rationale for the selection of chemokines of interest could be reinforced by the analysis of supplementary single-cell resources. We used data from the COPD cell atlas (Gene Expression Omnibus GSE136831 (Sauler et al., 2022)) to perform such an analysis of chemokine expression by CD8+ CD103+ and CD8+ CD103- T cells. However, the expression level of all chemokines was globally very low, and was not different between control and COPD patients (see Author response image 1).
Author response image 1.
Expression of CXC chemokines in lung CD8+ CD103+ and CD8+ CD103- T cells from patients with COPD (n=18 independent samples) in comparison with healthy control subjects (n=29 independent samples) under resting conditions by Single-Cell RNA sequencing analysis (GEO accession GSE136831). The heatmaps show the normalized expression of genes (horizontal axes) encoding CXC chemokines. PF4=CXCL4, PPBP= CXCL7.
The latter results are in discrepancy with those resulting from transcriptomic analysis of microarray data obtained on purified lung CD8+ CD103+ and CD8+ CD103- T cells, showing a significant level of chemokines expression (Hombrink et al., 2016), and a differential expression of CCL2, CCL26, CXCL2, CXCL8 and CCL3L1 between CD8+ T lymphocytes of control and COPD patients (Figure 2A in the revised manuscript). The reason for these differences is unclear, and could be attributed to biological differences (samples obtained from different patients) or, more likely, to differences in sample processing (cell sorting by flow cytometry for microarray analysis, that could activate minimally CD8+ cells) and/or methodological differences (differences of sensitivity between microarray and scRNA seq).
Nevertheless, microarray data regarding CXCL8 expression are in good agreement with our in vitro experiments, showing an enhanced CXCL8 expression by CD8+ T cells purified from COPD lungs, in comparison with that of control subjects. In addition, the CXCL8 blocking antibody fully abrogates the increase of migration induced by secretion of COPD CD8+ T cells, to the same extent as the blocking of CXCR1/2 by reparixin. This suggests that this supplementary chemotaxis is mainly due to CXCL8 and not other CXCR1/2 binding CXCL chemokines, and correlates CXCL8 measurements to functional experiments. This precision has been now added in the results section of the revised version.
2) Equally, it would strengthen the work if multiplex ELISA assays could be provided on the supernatants used in Fig 2D to provide a more comprehensive view of CXCR1/2 binding chemokines.
In order to have a complete view of CXCR1/2 binding chemokines, we have now performed supplementary ELISA assays to measure the concentrations of CXCL1, 3, 5, 6 and 7, in addition of the measurements of CXCL2 and CXCL8 already presented in the previous version of the manuscript (Figure 2D). Results of these new assays are now presented in the revised version of Figure 2. Concentrations of CXCL1, 3, 5, 6 and 7 were unchanged between the control and COPD conditions.
3) In the functional analyses, I missed information on the activation of the fibrocytes. Equally, the focus on CD8 T cells was mainly on proliferation in the functional work. RNAseq analyses on the cells, comparing CD8 T cells and fibrocytes, alone and in co-culture to each other would help to identify interaction patterns in comprehensive detail. Such an experiment would bolster the significance of the studies by providing impact analysis not only on the T cells beyond proliferation but by expanding on the effect of the interaction on the fibrocyte as well.
Regarding the activation state of fibrocytes, we apologize if this was not clear: in our in vitro co-culture experiments, we chose not to activate the fibrocytes. This setting is in agreement with previous findings, demonstrating an antigen-independent T cell proliferation effect driven by fibrocytes (Nemzek et al., 2013), and it is now explicitly written in the results of the revised manuscript.
Regarding the focus of the functional analyses:
First, we have pushed forward the analysis of the consequences of the interaction beyond CD8+ T cells proliferation. In particular, having shown that fibrocytes promote CD8+ T cells expression of cytotoxic molecules such as granzyme B, we decided to investigate the cytotoxic capacity of CD8+ T cells against primary basal bronchial epithelial cells (see new Supplementary File 9 in the revised manuscript for patient characteristics).
Direct co-culture with fibrocytes increased total and membrane expression of the cytotoxic degranulation marker CD107a, which was only significant in non-activated CD8+ T cells (see new Figure 6A-E in the revised manuscript). A parallel increase of cytotoxicity against primary epithelial cells was observed in the same condition (see new Figure 6F-H in the revised manuscript). This demonstrates that following direct interaction with fibrocytes, CD8+ T cells have the ability to kill target cells such as bronchial epithelial cells. This is now included in the results section of the revised manuscript.
Second, we have now performed proteomic analyses on fibrocytes, alone or in co-culture during 6 days with CD8+ T cells either non-activated or activated (see new Figure 7A in the revised manuscript). Of the top ten pathways that were most significantly activated in co-cultured vs mono-cultured fibrocytes, largest upregulated genes were those of the dendritic cell maturation box, the multiple sclerosis signaling pathway, the neuroinflammation signaling pathway and the macrophage classical signaling pathway, irrespective of the activation state of CD8+ T cells (see new Figure 7B in the revised manuscript). The changes were globally identical in the two conditions of CD8+ T cell activation, with some upregulation more pronounced in the activated condition. They were mostly driven by up-regulation of a core set of Major Histocompatibility Complex class I (HLA-B, C, F) and II (HLA-DMB, DPA1, DPB1, DRA, DRB1, DRB3) molecules, co-simulatory and adhesion molecules (CD40, CD86 and CD54). Another notable proteomic signature was that of increased expression of IFN signaling-mediators IKBE and STAT1, and the IFN-responsive genes GBP2, GBP4 and RNF213. We also observed a strong downregulation of CD14, suggesting fibrocyte differentiation, and an upregulation of the matrix metalloproteinase-9 (MMP9) in the non-activated condition only. Altogether, these changes suggest that the interaction between CD8+ T cells and fibrocytes promotes the development of fibrocyte immune properties, which could subsequently impact the activation of CD4+ T cells activation.
Up-regulated pathways identified in proteomic profile of fibrocytes co-cultured with CD8+ T cells are very consistent with a shift towards a proinflammatory phenotype rather than towards a reparative role. The activation of IFN-γ signaling could be triggered by CD8+ T cell secretion of IFN upon fibrocyte interaction, suggesting the existence of a positive feedback loop (see new Figure 10). Additionally, the priming of fibrocytes by CD8+ T cells could also induce CD4+ T cell activation.
4) I suggest rewording the abstract to capture the main storyline and wording more. The abstract is good, but I see so many novelties in the paper that are not well sold in the abstract, particularly the modelling aspects.
As suggested by the reviewer, we revised the abstract, as shown below and in the revised manuscript. The changes are indicated in red:
Revised abstract:
Bronchi of chronic obstructive pulmonary disease (COPD) are the site of extensive cell infiltration, allowing persistent contacts between resident cells and immune cells. Tissue fibrocytes interaction with CD8+ T cells and its consequences were investigated using a combination of in situ, in vitro experiments and mathematical modeling. We show that fibrocytes and CD8+ T cells are found in vicinity in distal airways and that potential interactions are more frequent in tissues from COPD patients compared to those of control subjects. Increased proximity and clusterization between CD8+ T cells and fibrocytes are associated with altered lung function. Tissular CD8+ T cells from COPD patients promote fibrocyte chemotaxis via the CXCL8-CXCR1/2 axis. Live imaging shows that CD8+ T cells establish short-term interactions with fibrocytes, that trigger CD8+ T cell proliferation in a CD54- and CD86-dependent manner, pro-inflammatory cytokines production, CD8+ T cell cytotoxic activity against bronchial epithelial cells and fibrocyte immunomodulatory properties. We defined a computational model describing these intercellular interactions and calibrated the parameters based on our experimental measurements. We show the model’s ability to reproduce histological ex vivo characteristics, and observe an important contribution of fibrocyte-mediated CD8+ T cell proliferation in COPD development. Using the model to test therapeutic scenarios, we predict a recovery time of several years, and the failure of targeting chemotaxis or interacting processes. Altogether, our study reveals that local interactions between fibrocytes and CD8+ T cells could jeopardize the balance between protective immunity and chronic inflammation in bronchi of COPD patients.
5) The probabilistic model appears to suggest that reduced CD8 T cell death may also explain the increase in the pathology in COPD. Did the authors find that fibrocytes reduce cell death of the CD8 T cells?
Taking advantage of the staining of CD8+ T cells with the death marker Zombie NIR™, we have quantified CD8+ T cell death in our co-culture assay. The presence of fibrocytes in the indirect co-culture assay did not affect CD8+ T cell death (see new Figure 3-figure supplement 3A-B in the revised manuscript). In direct co-culture, the death of CD8+ T cells was significantly increased in the non-activated condition but not in the activated condition (see new Figure 3-figure supplement 3C-D in the revised manuscript). Of note, these results are in agreement with a recent study showing the existence of CD8+ T cell-population-intrinsic mechanisms regulating cellular behavior, with induction of apoptosis to avoid an excessive increase in T cell population (Zenke et al., 2020). This is taken into account in our mathematical model by an increased probability p_(dC+) of dying when a CD8+ T cell is surrounded by many other T cells in its neighborhood. It also suggests that the reduced CD8+ T cell death evidenced in tissues from patients with COPD (Siena et al., 2011) might not be due to the specific interplay between fibrocyte and CD8+ T cells, but rather to a global pro-survival environment in COPD lungs.
These new data have been described in the results section.
6) Following the modeling in Figure 6, curiosity came to mind, which is how long it would take for the pathology to disappear if a drug would be applied to the patient. How much should the interactions be reduced and how long would it take to reach clinical benefit? Could such predictions be made? I understand that this may be outside the main message of the manuscript but perhaps this could be included in the discussion.
This is a very interesting question, that we have addressed by performing additional simulations to investigate the outcomes of possible therapeutic interventions. First, we applied a COPD dynamics during 20 years, to generate the COPD state, that provide the basis for treatment implementation. Then, we applied a COPD dynamic during 7 years, that mimics the placebo condition (see new Figure 9A in the revised manuscript, and below), that we compared to a control dynamics (“Total inhibition”), that mimics an ideal treatment able to restore all cellular processes. As expected the populations of fibrocytes and CD8+ T cells, as well as the density of mixed clusters, decreased. These numbers reached levels similar of healthy subjects after approximately 2.5 years, and this time point can therefore be considered as the steady state (Figure 9B-E).
Monitoring of the different processes revealed that these effects were mainly due to a reduction in fibrocyte-induced CD8+ T duplication, and a transient or more prolonged increase in basal fibrocyte and CD8+ T death (Figure 9C-D).
Then, three possible realistic treatments were considered (Figure 9A). We tested the effect of directly inhibiting the interaction between fibrocytes and CD8+ T cells by blocking CD54. This was implemented in the model by altering the increased probability of a CD8+ T cell to divide when a fibrocyte is in its neighbourhood, as shown by the co-culture results (Figure 4). We also chose to reflect the effect of a dual CXCR1/2 inhibition by setting the displacement function of fibrocyte similar to that of control dynamics, in agreement with the in vitro experiments (Figure 2E). Blocking CD54 only slightly reduced the density of CD8+ T cells compared to the placebo condition, and had no effect on fibrocyte and mixed cluster densities (Figure 9B). CXCR1/2 inhibition was a little bit more potent on the reduction of CD8+ T cells than CD54 inhibition, and it also significantly decreased the density of mixed clusters (Figure 9B). As expected, this occurred through a reduction of fibrocyte-induced duplication, which was affected more strongly by CXCR1/2 blockage than by CD54 blockage (Figure 9C-E). Combining both therapies (CD54 and CXCR1/2 inhibition) did not strongly major the effects (Figure 9B-E). In all the conditions tested, the size of the fibrocyte population remained unchanged, suggesting that other processes such as fibrocyte death or infiltration should be targeted to expect broader effects.
The results section has been altered accordingly.
Using the simulations, we were also able to estimate the characteristic time to reach a stationary state reminiscent of a resolution of the COPD condition. This time of approximately 2.5 years was totally unpredictable by in vitro experiments, and indicates that a treatment aiming at restoring these cellular processes should be continued during several years to obtain significant changes.
We have also investigated the outcomes of more realistic treatments, modifying specifically processes such as chemotaxis or targeting directly the intercellular interactions. The modification of parameters controlling these processes only slightly affected the final state, suggesting that such treatments may be more effective when used in combination with other drugs e.g. those affecting fibrocyte infiltration and/or death.
The discussion section has been altered accordingly.
Reviewer #3 (Recommendations For The Authors):
1) Broader assessment of cell types in the lung: Staining for other cell types such as dendritic cells, CD4 cells, and interstitial macrophages, and comparing their proximity to fibrocytes with that of CD8 cells would better justify the CD8 focus.
We agree with the reviewer that multiple stainings would have better justified the focus on CD8+ T cells. However, it is difficult to distinguish fibrocytes, dendritic cells and interstitial macrophages on the basis of immunohistochemistry, as we and others previously showed (Dupin et al., 2019; Mitsuhashi et al., 2015; Pilling et al., 2009). On the other hand, the study of Afroj et al. indicated the possible interaction between fibrocytes and CD8+ T cells in cancer context, with the induction of CD8+ T cell proliferation (Afroj et al., 2021). This T cell-costimulatory function of fibrocytes and CD8+ T cells was further confirmed in a very recent study, together with the antitumor effects of PD-L1 and VEGF blockade (Mitsuhashi et al., 2023). These data, along with the specific implication on CD8+ T cells in COPD, relying mainly on their abundance in COPD bronchi (O’Shaughnessy et al., 1997), their overactivation state (Roos-Engstrand et al., 2009), their cytotoxic phenotype (Freeman et al., 2010; Wang et al., 2020) and the protection against lung inflammation and emphysema induced by their depletion (Maeno et al., 2007) justified the CD8 focus.
To further justify this focus, we have now performed co-culture between fibrocytes and CD4+ T cells, indicating that the massive fibrocyte-mediated proliferation was specific to CD8+ T cells (see answer to comment 3 below). This is in agreement with the results obtained with the simulations, showing that considering fibrocytes and CD8+ T cells only was sufficient to reproduce the spatial patterns in the bronchi of healthy and COPD patients. Altogether, we think that focusing on the CD8+ T cell-fibrocyte interplay was pertinent in the context of COPD. It does obviously not exclude the possibility of other interactions, that could be the focus of other studies.
2) Transcriptomic analysis: Using n=2 and only showing the chemokines as well as selected adhesion receptor data narrows the focus but does not provide broader insights into the interactions. Using a more robust sample size and performing a comprehensive pathway analysis would represent an unbiased analysis to determine the most dysregulated pathways. Importantly, the authors could use a single-cell RNA-seq dataset to broadly assess the transcriptomes of several cell types in the lung (such as the data from (Sauler et al, Characterization of the COPD alveolar niche using single-cell RNA sequencing).
This very pertinent suggestion has also been raised by reviewer 2, see our answer to comment 1 of reviewer 2, and below:
We agree with the reviewer that the rationale for the selection of chemokines of interest could be reinforced by the analysis of supplementary single-cell resources. We used data from the COPD cell atlas (Gene Expression Omnibus GSE136831 (Sauler et al., 2022)) to perform such an analysis of chemokine expression by CD8+ CD103+ and CD8+ CD103- T cells. However, the expression level of all chemokines was globally very low, and was not different between control and COPD patients (see Figure scRNAseq, in the answer to comment 1 of reviewer 2).
These latter results are in discrepancy with those resulting from transcriptomic analysis of microarray data obtained on purified lung CD8+ CD103+ and CD8+ CD103- T cells, showing a significant level of chemokines expression (Hombrink et al., 2016), and a differential expression of CCL2, CCL26, CXCL2, CXCL8 and CCL3L1 between CD8+ T lymphocytes of control and COPD patients (Figure 2A in the revised manuscript). The reason for these differences is unclear, and could be attributed to biological differences (samples obtained from different patients) or, more likely, to differences in sample processing (cell sorting by flow cytometry for microarray analysis, that could activate minimally CD8+ cells) and/or methodological differences (differences of sensitivity between microarray and scRNA seq).
Nevertheless, microarray data regarding CXCL8 expression are in good agreement with our in vitro experiments, showing an enhanced CXCL8 expression by CD8+ T cells purified from COPD lungs, in comparison with that of control subjects. In addition, the CXCL8 blocking antibody fully abrogates the increase of migration induced by secretion of COPD CD8+ T cells, to the same extent as the blocking of CXCR1/2 by reparixin. This suggests that this supplementary chemotaxis is mainly due to CXCL8 and not other CXCR1/2 binding CXCL chemokines, and correlates CXCL8 measurements to functional experiments. This precision has been now added in the text of the revised version.
3) Inclusion of control/comparison cell types in co-culture studies would help establish that CD8 cells are more relevant for interactions with fibrocytes than for example CD4 cells.
We have now performed co-cultures between fibrocytes and CD4+ T cells, with the same settings than for CD8+ T cells. The results from these experiments show that fibrocytes did not have any significant effect of CD4+ T cells death, regardless of their activation state (see new Figure 3-figure supplement 2A-C in the revised manuscript, and below). Fibrocytes were able to promote CD4+ T cells proliferation in the activated condition but not in the non-activated condition (see new Figure 3-figure supplement 2A-D in the revised manuscript). Altogether this indicates that although fibrocyte-mediated effect on proliferation is not specific to CD8+ T cells, the amplitude of the effect is much larger on CD8+ T cells than on CD4+ T cells.
These new data have been added in the results section.
4) In vitro analysis of cells from non-COPD patients would also help assess whether the circulating cells from COPD patients have a level of baseline activation which promotes the vicious cycle but may not exist in healthy cells.
Regarding circulating cells, the present study relies on the COBRA cohort (COhort of BRonchial obstruction and Asthma), which includes only asthma and COPD patients, and therefore does not grant access to healthy subjects’ blood samples (Pretolani et al., 2017). Unfortunately, we have no other ongoing study with healthy subjects that would allow us to retrieve blood for research, and fibrocytes can only be grown from freshly drawn blood samples. We agree with the reviewer that it is a limitation of our study, which is now acknowledged at the end of the discussion section.
References
Afroj, T., Mitsuhashi, A., Ogino, H., Saijo, A., Otsuka, K., Yoneda, H., Tobiume, M., Nguyen, N. T., Goto, H., Koyama, K., Sugimoto, M., Kondoh, O., Nokihara, H., & Nishioka, Y. (2021). Blockade of PD-1/PD-L1 Pathway Enhances the Antigen-Presenting Capacity of Fibrocytes. The Journal of Immunology, 206(6), 1204‑1214. https://doi.org/10.4049/jimmunol.2000909
Araki, K., Youngblood, B., & Ahmed, R. (2010). The role of mTOR in memory CD8+ T-cell differentiation. Immunological reviews, 235(1), 234‑243. https://doi.org/10.1111/j.0105-2896.2010.00898.x
Bucala, R. J. (2022). Targeting fibrocytes in autoimmunity. Proceedings of the National Academy of Sciences, 119(5), e2121739119. https://doi.org/10.1073/pnas.2121739119
Douglas, R. S., Kahaly, G. J., Patel, A., Sile, S., Thompson, E. H. Z., Perdok, R., Fleming, J. C., Fowler, B. T., Marcocci, C., Marinò, M., Antonelli, A., Dailey, R., Harris, G. J., Eckstein, A., Schiffman, J., Tang, R., Nelson, C., Salvi, M., Wester, S., … Smith, T. J. (2020). Teprotumumab for the Treatment of Active Thyroid Eye Disease. The New England Journal of Medicine, 382(4), 341‑352. https://doi.org/10.1056/NEJMoa1910434
Dupin, I., Henrot, P., Maurat, E., Abohalaka, R., Chaigne, S., Hamrani, D. E., Eyraud, E., Prevel, R., Esteves, P., Campagnac, M., Dubreuil, M., Cardouat, G., Bouchet, C., Ousova, O., Dupuy, J.-W., Trian, T., Thumerel, M., Begueret, H., Girodet, P.-O., … Berger, P. (2023). CXCR4 blockade alleviates pulmonary and cardiac outcomes in early COPD (p. 2023.03.10.529743). bioRxiv. https://doi.org/10.1101/2023.03.10.529743
Dupin, I., Thumerel, M., Maurat, E., Coste, F., Eyraud, E., Begueret, H., Trian, T., Montaudon, M., Marthan, R., Girodet, P.-O., & Berger, P. (2019). Fibrocyte accumulation in the airway walls of COPD patients. The European Respiratory Journal, 54(3), Article 3. https://doi.org/10.1183/13993003.02173-2018
Fernando, R., Caldera, O., & Smith, T. J. (2021). Therapeutic IGF-I receptor inhibition alters fibrocyte immune phenotype in thyroid-associated ophthalmopathy. Proceedings of the National Academy of Sciences, 118(52), e2114244118. https://doi.org/10.1073/pnas.2114244118
Freeman, C. M., Han, M. K., Martinez, F. J., Murray, S., Liu, L. X., Chensue, S. W., Polak, T. J., Sonstein, J., Todt, J. C., Ames, T. M., Arenberg, D. A., Meldrum, C. A., Getty, C., McCloskey, L., & Curtis, J. L. (2010). Cytotoxic potential of lung CD8+ T cells increases with COPD severity and with in vitro stimulation by IL-18 or IL-15. Journal of immunology (Baltimore, Md. : 1950), 184(11), 6504‑6513. https://doi.org/10.4049/jimmunol.1000006
Gillen, J. R., Zhao, Y., Harris, D. A., LaPar, D. J., Stone, M. L., Fernandez, L. G., Kron, I. L., & Lau, C. L. (2013). Rapamycin Blocks Fibrocyte Migration and Attenuates Bronchiolitis Obliterans in a Murine Model. The Annals of thoracic surgery, 95(5), 1768‑1775. https://doi.org/10.1016/j.athoracsur.2013.02.021
Hombrink, P., Helbig, C., Backer, R. A., Piet, B., Oja, A. E., Stark, R., Brasser, G., Jongejan, A., Jonkers, R. E., Nota, B., Basak, O., Clevers, H. C., Moerland, P. D., Amsen, D., & van Lier, R. A. W. (2016). Programs for the persistence, vigilance and control of human CD8+ lung-resident memory T cells. Nature Immunology, 17(12), Article 12. https://doi.org/10.1038/ni.3589
Maeno, T., Houghton, A. M., Quintero, P. A., Grumelli, S., Owen, C. A., & Shapiro, S. D. (2007). CD8+ T Cells are required for inflammation and destruction in cigarette smoke-induced emphysema in mice. Journal of Immunology (Baltimore, Md.: 1950), 178(12), 8090‑8096. https://doi.org/10.4049/jimmunol.178.12.8090
Manjarres, D. C. G., Axell-House, D. B., Patel, D. C., Odackal, J., Yu, V., Burdick, M. D., & Mehrad, B. (2023). Sirolimus suppresses circulating fibrocytes in idiopathic pulmonary fibrosis in a randomized controlled crossover trial. JCI Insight. https://doi.org/10.1172/jci.insight.166901
Mehrad, B., Burdick, M. D., & Strieter, R. M. (2009). Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis. The International Journal of Biochemistry & Cell Biology, 41(8‑9), 1708‑1718. https://doi.org/10.1016/j.biocel.2009.02.020
Mitsuhashi, A., Goto, H., Saijo, A., Trung, V. T., Aono, Y., Ogino, H., Kuramoto, T., Tabata, S., Uehara, H., Izumi, K., Yoshida, M., Kobayashi, H., Takahashi, H., Gotoh, M., Kakiuchi, S., Hanibuchi, M., Yano, S., Yokomise, H., Sakiyama, S., & Nishioka, Y. (2015). Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab. Nature Communications, 6(1), Article 1. https://doi.org/10.1038/ncomms9792
Mitsuhashi, A., Koyama, K., Ogino, H., Afroj, T., Nguyen, N. T., Yoneda, H., Otsuka, K., Sugimoto, M., Kondoh, O., Nokihara, H., Hanibuchi, M., Takizawa, H., Shinohara, T., & Nishioka, Y. (2023). Identification of fibrocyte cluster in tumors reveals the role in antitumor immunity by PD-L1 blockade. Cell Reports, 112162. https://doi.org/10.1016/j.celrep.2023.112162
Nemzek, J. A., Fry, C., & Moore, B. B. (2013). Adoptive transfer of fibrocytes enhances splenic T-cell numbers and survival in septic peritonitis. Shock (Augusta, Ga.), 40(2), 106‑114. https://doi.org/10.1097/SHK.0b013e31829c3c68
O’Shaughnessy, T. C., Ansari, T. W., Barnes, N. C., & Jeffery, P. K. (1997). Inflammation in bronchial biopsies of subjects with chronic bronchitis : Inverse relationship of CD8+ T lymphocytes with FEV1. American Journal of Respiratory and Critical Care Medicine, 155(3), 852‑857. https://doi.org/10.1164/ajrccm.155.3.9117016
Pilling, D., Fan, T., Huang, D., Kaul, B., & Gomer, R. H. (2009). Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PloS One, 4(10), e7475. https://doi.org/10.1371/journal.pone.0007475
Pombo-Suarez, M., & Gomez-Reino, J. J. (2019). Abatacept for the treatment of rheumatoid arthritis. Expert Review of Clinical Immunology, 15(4), 319‑326. https://doi.org/10.1080/1744666X.2019.1579642
Pretolani, M., Soussan, D., Poirier, I., Thabut, G., Aubier, M., COBRA Study Group, & COBRA cohort Study Group. (2017). Clinical and biological characteristics of the French COBRA cohort of adult subjects with asthma. The European Respiratory Journal, 50(2), 1700019. https://doi.org/10.1183/13993003.00019-2017
Roos-Engstrand, E., Ekstrand-Hammarström, B., Pourazar, J., Behndig, A. F., Bucht, A., & Blomberg, A. (2009). Influence of smoking cessation on airway T lymphocyte subsets in COPD. COPD, 6(2), 112‑120. https://doi.org/10.1080/15412550902755358
Rozelle, A. L., & Genovese, M. C. (2007). Efficacy results from pivotal clinical trials with abatacept. Clinical and Experimental Rheumatology, 25(5 Suppl 46), S30-34.
Sauler, M., McDonough, J. E., Adams, T. S., Kothapalli, N., Barnthaler, T., Werder, R. B., Schupp, J. C., Nouws, J., Robertson, M. J., Coarfa, C., Yang, T., Chioccioli, M., Omote, N., Cosme, C., Poli, S., Ayaub, E. A., Chu, S. G., Jensen, K. H., Gomez, J. L., … Rosas, I. O. (2022). Characterization of the COPD alveolar niche using single-cell RNA sequencing. Nature Communications, 13(1), Article 1. https://doi.org/10.1038/s41467-022-28062-9
Siena, L., Gjomarkaj, M., Elliot, J., Pace, E., Bruno, A., Baraldo, S., Saetta, M., Bonsignore, M. R., & James, A. (2011). Reduced apoptosis of CD8+ T-lymphocytes in the airways of smokers with mild/moderate COPD. Respiratory Medicine, 105(10), 1491‑1500. https://doi.org/10.1016/j.rmed.2011.04.014
Smith, T. J., Kahaly, G. J., Ezra, D. G., Fleming, J. C., Dailey, R. A., Tang, R. A., Harris, G. J., Antonelli, A., Salvi, M., Goldberg, R. A., Gigantelli, J. W., Couch, S. M., Shriver, E. M., Hayek, B. R., Hink, E. M., Woodward, R. M., Gabriel, K., Magni, G., & Douglas, R. S. (2017). Teprotumumab for Thyroid-Associated Ophthalmopathy. The New England Journal of Medicine, 376(18), 1748‑1761. https://doi.org/10.1056/NEJMoa1614949
Vincenti, F., Rostaing, L., Grinyo, J., Rice, K., Steinberg, S., Gaite, L., Moal, M.-C., Mondragon-Ramirez, G. A., Kothari, J., Polinsky, M. S., Meier-Kriesche, H.-U., Munier, S., & Larsen, C. P. (2016). Belatacept and Long-Term Outcomes in Kidney Transplantation. The New England Journal of Medicine, 374(4), 333‑343. https://doi.org/10.1056/NEJMoa1506027
Wang, X., Zhang, D., Higham, A., Wolosianka, S., Gai, X., Zhou, L., Petersen, H., Pinto-Plata, V., Divo, M., Silverman, E. K., Celli, B., Singh, D., Sun, Y., & Owen, C. A. (2020). ADAM15 expression is increased in lung CD8+ T cells, macrophages, and bronchial epithelial cells in patients with COPD and is inversely related to airflow obstruction. Respiratory Research, 21(1), 188. https://doi.org/10.1186/s12931-020-01446-5
Zenke, S., Palm, M. M., Braun, J., Gavrilov, A., Meiser, P., Böttcher, J. P., Beyersdorf, N., Ehl, S., Gerard, A., Lämmermann, T., Schumacher, T. N., Beltman, J. B., & Rohr, J. C. (2020). Quorum Regulation via Nested Antagonistic Feedback Circuits Mediated by the Receptors CD28 and CTLA-4 Confers Robustness to T Cell Population Dynamics. Immunity, 52(2), 313-327.e7. https://doi.org/10.1016/j.immuni.2020.01.018
-
-
-
-
Author Response:
We are grateful to the reviewers for their insightful comments, suggestions, and criticism. In the updated version of the manuscript, all these will be properly reflected. Here we briefly address the main points raised:
Reviewer #1:
1.1. Patient selection and tumor area selection are crucial for this study but not very carefully defined. Why are some core and others not? Figure referral is an issue here (sup figure 6 where all core and non-core samples are supposed to be according to the legend of Fig 4 is likely sup fig 7 but this is then a complete copy paste of Figure 4). In the methods it is stated that the core samples are based on limited contamination of additional morphotypes (<20%) but Fig 4 suggests that all tumours listed have multiple morphotypes.
The tissue samples were obtained from a hospital cohort of patients with stage II-IV colorectal cancer (at diagnostic time), with no particular selection criteria imposed, as this was an exploratory study.
Tumor regions were marked for macro-dissection by an experienced pathologist following the standard practice for whole-tumor transcriptomics studies. The subregions (morphological regions) were marked by the same experienced pathologist for macro-dissection (in an adjacent section) and reassessed later with respect to their “morphological purity”. It is impossible to macro-dissect regions containing a single morphological pattern. Hence, those regions which contained significant amount (>=20%) of other morphologies were considered “non-core”, while the rest were called “core” regions. This distinction applies to morphological regions solely and not to whole-tumor samples.
Indeed, the reference in caption to Figure 4, should refer to Supp. Fig. 7 (which needs to be updated).
1.2. CMS subtype should be performed with single sample predictor rather than CMScaller.
We agree that a single-sample predictor for CMS is needed, however CMScaller is the de facto classifier for CMS (>130 citations) so we used it to illustrate the practical implications.
1.3. A couple of surprising observations need specification. MUC2 is a strong CMS3 reporter gene yet Mucinous tumours appear to end up in CMS4 rather than 3. Can the authors show that indeed stroma cells are very evident in these samples?
We do not have a direct estimation of the amount of stromal cells, but the high scores of the various fibroblast-related signatures in mucinous regions (Fig2 B, D) indicate that, indeed, there is an enrichment in stroma. In the follow-up study we plan to perform specific staining as well as spatial transcriptomics of these regions to further investigate our findings.
1.4. The SE PP and CT are assigned to CMS2, but in Figure 4 this appears a lot more variable than the authors would make the reader believe. The full data are not completely clear (see point 1).
In the paper, we transparently state that PP, SE, and CT were assigned to CMS2 in 62.5%, 41.7% and 41.9% of cases, respectively. These proportions referred to all samples for which CMSCaller made a prediction. In Fig.4, we also show the proportion of cases in which CMSCaller did not predict any subtype.
1.5. The tumor response rates are rather weird as this is likely dependent on the complete tumour and not so much the subareas. It is not very well described what we see in this analysis.
We did not compute any response rates but simple prognostic scores as (weighted, if weights were provided) means of genes in the specific signatures (see Methods). The question addressed was whether these scores were comparable between whole tumor and corresponding tumor regions (within same tumor). Given the observed (relative) variability, the more important follow-up question - which we cannot answer with our limited survival data – is whether a higher score in a region in comparison with whole-tumor is indeed indicative of a higher risk of relapse.
1.6. Serrated adenomas have previously been aligned with CMS4. Is this different from serrated areas in cancers?
We do not have data from adenomas to compare with the serrated carcinoma regions. But a comparison of (regions of) both traditional serrated and sessile serrated adenomas to serrated carcinoma would be interesting.
1.7. The fact that iCMS2 and iCMS3 align rather well with the current analysis of the distinct regions suggests that the analysis that was reported last year is the proper way to view tumor intrinsic signatures. The authors now propose a rather similar outcome to this issue which does take away a lot of the novelty of the findings of this study.
Our goal was not to propose another stratification paradigm for colorectal cancer, but rather to study the associations between morphology and transcriptome and its implications in practice. As such, our analyses are not limited to molecular subtypes and the respective observations are but a small part of our findings. Indeed, the intrinsic subtypes (iCMS 2/3) are stable and robust, as they are based on the genes expressed in epithelial cells, and they may well prove to be of clinical importance too. However, they do not cover all aspects (e.g. fibroblasts subtypes) and, as stated in Joanito et al. Nat Gen 54, pages 963–975 (2022), “iCMS, MSI status and CMS jointly inform the molecular classification of CRC”. Last, in our opinion, the molecular classification of CRC, while a useful point of view in tumour classification, is not covering all the necessary perspectives on tumour heterogeneity.
Reviewer #2:
2.1. Overall, the manuscript provides an interesting histological/morphological framework through which we can consider heterogeneity in colorectal carcinoma and an approach by which we might improve the performance of gene expression-based classifiers in predicting clinical behaviour and/or responses to therapy. Exploration of CRC morphotypes and their differences was quite interesting. However, more work is needed to support the claims made by the authors. While I appreciate that the authors themselves identify limitations of their study within the manuscript, I believe awareness of these limitations is not reflected in some of the claims made in the abstract and at points in the main text when discussing the use of expression-based classifiers.
We will improve the manuscript to stress the exploratory nature of our analyses and their limitations.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
The following is the authors’ response to the original reviews.
This important work reports the identification of a list of proteins that may participate in the clearance of paternal mitochondria during fertilization, which is known as essential for normal fertilization and embryonic and fetal development. While the main method used is state of the art and the supporting data are solid, the vigor of the biochemical assays and function validation is inadequate. This work will be of interest to developmental and reproductive biologists working on fertilization. Key revisions (for the authors) include 1) Use a mitochondria-enriched fraction instead of whole sperm for the assays, and add more control samples to monitor what got lost during sperm and oocyte treatments before the coincubation step. 2) Functional validation of the key proteins identified.
We thank Editors of eLife, as well as Special Issue Guest-Editors and Reviewers for a favorable assessment and helpful recommendations for key revisions. Provisional revisions included in our revised article are detailed below. We agree with Editors’ comment about the use of mitochondrion enriched fractions and additional functional validation of key proteins. In fact, we are developing experimental protocols for oocyte extract coincubation with isolated sperm heads and tails, and eventually with purified mitochondrial sheaths, to separate the ooplasmic sperm nucleus remodeling factors from the mitophagic ones. Such experiments, as well as functional validations using porcine zygotes are contingent upon anticipated post-pandemic rebound in the availability of porcine oocytes, obtained from ovaries harvested on slaughterhouse floors, requiring currently unavailable workforce which has hampered our access to this necessary resource.
Reviewer #1 (Peer Review):
Could the authors make clear how much the presented pictures reflect the described localisation? There is no information on the number of spermatozoa and embryos observed nor the fraction of these embryos showing the presented pattern of localisation. This must be included.
Two hundred spermatozoa were counted per replicate of the cell-free system co-incubation and 20 zygotes per replicate, with 3 replicates of immunolabelling for each phase/picture which were examined to establish the typical localization patterns that were observed. The displayed patterns were observed in 65 to 88% of examined spermatozoa/zygotes; varying dependent on protein, replicate, and phase of immunolabelling. In all cases, the signal displayed is the typical pattern that was displayed in most cells. This information has been added to the Materials and Methods section for clarification.
It is not clear if the authors also examined the localization of other proteins and obtained a different pattern than anticipated from the proteomic approach or if they only tested these 6 proteins and got a 100% of correlation.
These are the 6 proteins which were selected based on extensive literature review into known functions of all identified proteins, as well as extensive research into available and reliable antibodies to detect such proteins within our porcine systems. Even so, no particular localization patterns were anticipated; instead, we presented the patterns actually observed and even some patterns which defied our expectations (i.e., the localization of BAG5 in the sperm acrosome).
The authors use "MS" in the text to indicate "mitochondrial Sheath" and "Mass spectrometry". this is confusing.
The authors agree and the usage of MS as an acronym for either has been removed entirely to avoid confusion.
In the introduction the author refers to Ankel-Simons and Cummins, 1996 as a reference for the number of sperm mitochondria in mammalian species, this is incorrect since the quoted paper is about the number of mtDNA molecules and mentioned an earlier publication.
This has been revised and the appropriate citation has been used.
Reviewer #2 (Peer Review):
Major:
1) It has been proved from the earlier studies from this group that the porcine cell-free system is useful to observe spermatozoa interacting with ooplasmic proteins in a single trial and could recapitulate fertilization sperm mitophagy events that take place in a zygote without affecting later cell-division process. However, the post-fertilization sperm mitophagy process is a complex time-associated event that many processes that occur sequentially and interactively, which means ooplasmic proteins might be involved in this process but may not directly interact with sperm or may associate with sperm-ooplasmic protein complex at different time points. It is certainly a great advance already in knowledge to identify "the candidate players" from the list of 185 proteins; however, with the time-resolution (4 and 24hr) in the current study and without functional validation experiments at this stage, it is still difficult to postulate the importance of these identified proteins. The functional validation experimental designs, in my opinion, is critically important for better interpretation of the data.
The authors agree with this reviewer’s sentiments and do plan to conduct further functional analysis. This project was able to generate a list of candidate, sperm-mitophagy promoting proteins and we were further able to show that many of these proteins were detectable both via mass spectrometry and via immunocytochemistry in spermatozoa exposed to our cell-free system. Furthermore, similar localization patterns were found in spermatozoa that were detected within newly fertilized zygotes. These results boost our confidence in our cell-free system and show that our list of candidate proteins is truly a useful list for future localization and functional analyses. We are certainly aware that we have not captured every protein that may play a role in post-fertilization sperm mitophagy and that the proteins captured are just candidates until proven otherwise. Likewise, we have almost certainly captured multiple proteins that are currently candidates that will likely not be shown to play a role in postfertilization sperm mitophagy, while it is plausible that at least some of these candidate proteins do play a role in mitophagy and some of them likely participate (perhaps have yet to be described roles) in other fertilization events, in which we would be extremely interested in as well.
2) As shown in Figure 1, whole sperm was used in the co-incubation and the later MS analysis; thus, proteins identified in the current study might be relevant in fertilization processes other than postfertilization sperm mitophagy, as proteins identified in the current study may be associated with other parts of the sperm (e.g. sticky sperm head, e.g. PSMG2 associated with sperm midpieces, tail at 4hr coincubation, but then only associate with sperm head at 24hr co-incubation) rather than sperm midpiece, despite the fact that authors applied immunohistochemistry to show the localization of this protein, but the evidence is indirect, so how authors functionally differentiate these 6 identified proteins from sperm mitophagy process with other processes and to confirm (or to associate) the relevance of these proteins with sperm mitophagy process?
The authors agree that the 6 proteins which were further studied by using immunocytochemistry may be playing roles in other processes such as pronuclear formation. We discussed some potential roles including and beyond post-fertilization mitophagy, in the Supplemental Discussion. After reviewer comments, we moved the Supplemental Discussion back in the main Discussion section. Thus, this section now considers additional putative pathways in which the said 6 proteins cold participate, though we concede that thorough functional studies must still be performed.
3) Class 3 proteins were present in both the gametes or only the primed control spermatozoa, but are decreased in the spermatozoa after co-incubation, which authors interpreted as sperm-borne mitophagy determinants and/or sperm-borne proteolytic substrates of the oocyte autophagic system, this data categorization may need to be revised as sperm-borne proteolytic substrates of the oocyte autophagic system only, not for sperm borne mitophagy determinants. The argument for this disagreement is due to the fact that if the protein is a sperm-borne mitophagy determinant, after coincubation, to execute the mitophagy process, this protein should still be associated with the sperm at least at the early stage (of 4hr) (constant under MS detection when comparing control with 4hr treated) rather than being released from the sperm. Or alternatively, they could result in class 3 proteins (but not all those 6 were in class 3). Nevertheless, if these proteins serve as substrates, they can be used (consumed) and show decreased under MS detection.
This argument for redefining the Class 3 proteins more accurately is understood and we agree. The definition is revised in the paper.
4) Of particular interest among the 6 proteins that were further investigated. Unlike other proteins, MVP was highly significant (p<0.001) after 4hr incubation, but the significance became less after 24hr (p=0.19). Interpretation of this dynamic change in the relevance of the mitophagy process would facilitate the readers to understand the relevance and the role of MVP.
The differences in significance are likely influenced by the abundance of MVP detectable by mass spectrometry. As the time of cell-free system incubation increases, the variability between replicates also seemed to increase, likely due to the sustained proteolytic activity taking place in our system. This work was based on three replicates of mass spectrometry for each time point; additional replicates likely would have reduced the p-value for the 24hr cell-free data set, for MVP and potentially other proteins also. At both time points, MVP was only detectable in spermatozoa after they had been exposed to the cell-free system treatment which is the criteria that truly interested us more than the actual differences in content between the timepoints and is why it was added to our list of candidate proteins.
5) In figure 3, the association of ooplasmic MVP to sperm midpiece is not convincing enough as sperm midpiece and tail often show some levels of non-specific signals under fluorescent microscopy. And the dynamic association of ooplasmic MVP to sperm midpiece in Fig. 3F-G is difficult to reach a conclusion solely based on data presented in the manuscript. Additional negative control of sperm MVP staining from the primed and treated sperm would be helpful. Additionally, a quantitative comparison (15 vs 25hr) of sperm-associated MVP signals from the fertilized embryo or a stack image from different angles would clarify the doubts raised here.
For all images and all replicates, serum controls were also generated. These controls were then viewed under fluorescent microscope, and light intensities and exposures thresholds for each fluorescent light channel were set based on the background intensity that came from these nonimmune serum-treated control samples. We set our light intensity/acquisition time below a threshold where the non-specific signal began to appear. All the presented patterns are based on setting this peak intensity threshold and as such the signal we see should be the true signal. Furthermore, 200 spermatozoa were counted per treatment per replicate of the cell-free system co-incubation and 20 zygotes per replicate, with 3 replicates of immunolabelling for each protein and data point, which was used to represent the typical localization patterns that were observed. The displayed patterns were observed between in 65- 88% of examined spermatozoa/zygotes. Invariably, the signal displayed in the manuscript is the typical pattern that was seen in a majority of cells. This information has now been added to the Materials & Methods section for clarification.
6) Same concerns for the other 5 proteins (PSMG2, PSMA3, FUNDC2, SAMM50, BAG5) as indicated above.
See response to Question 5.
7) The patterns of these 6 proteins under the immunofluorescent study are confusing as the pattern varies after co-incubation (treated), and mostly, the signal of these proteins observed from the fertilized embryos is not really associated with sperm midpieces. Therefore, the evidence of these proteins involving in post-fertilization sperm mitophagy is, at this moment, weak based on the data presented. But the relevance of these proteins in events post-fertilization or early embryo development is certainly (evidence did not strong enough to support "sperm mitophagy," in my opinion).
The authors agree that some of these proteins seem to be playing roles beyond postfertilization sperm mitophagy and that there is a need for true functional studies before the authors can state with certainty that these proteins play a role in any of the discussed fertilization events. We state this in the discussion: “Considering the dynamic proteomic remodeling of both the oocyte and spermatozoa which takes place during early fertilization, these 185 proteins which have been identified likely play roles in processes beyond sperm mitophagy.” It should be noted that the authors went into greater detail about potential alternative protein functions based on the present data and literature review in the Supplemental Discussion. Based on this comment and other reviewer comments we have now included the Supplemental Discussion as part of the main Discussion section, and this will hopefully help clarify some of the authors’ thoughts about the 6 candidate proteins which were further analyzed during this study.
Minor:
1) To my understanding, statistical significance (relevance) is normally set at a p-value of either <0.1 or 0.05. The reason for loosening the p-value of 0.2 in the current study needs to be justified as this was not a common statistical criterium, and the interpretation of those candidates from this loosened criterium should also be careful.
The loosening of statistical relevance in this study to 0.2, only applied to our Class 1 proteins. This is because for a protein to fall into the Class 1 proteins it was a protein that was only present in samples after they were exposed to the cell-free system. In the case of these Class 1 proteins, this happened for all 3 replicates at each stated timepoint. We found this pattern of detection to be important whether the p-value fell under 0.1 or 0.2. As such, we loosened our statistical threshold for our Class 1 proteins. Any proteins added to our candidate list will be subject to further investigation before definitive conclusions can be drawn, and as such we think that capturing more proteins was more important for the goals of this study than limiting the number of proteins captured, especially for those Class 1 proteins. An explanation of this has been added to the Materials & Methods section Mass Spectrometry Data Statistical Analysis.
2) First cell cleavage of porcine embryo normally occurs within 48hr post-insemination or activation; therefore, the 4 and the 24hr time points used in the current study require justification included in the discussion or methods and material section.
First cleavage of porcine embryos normally occurs around 24 - 28 hours post-insemination. Thus, for both the cell-free system and the embryo studies we were capturing an advanced 1 cell stage zygote/zygote like system with our 24 hour and 25-hour time points.
3) In figure 2, colors used in different time points and in two different classes represent (sometimes) different protein categories, would be easier for the readers for quick comparisons if the same color could be used to represent the same protein category throughout the graph. (E.g, proteins for early zygote development are shown in red in "A", but blue in "B")
This has been corrected and the color scheme for Figure 2 has been revised for easier comparisons.
Reviewer #3 (Peer Review):
I am not used to seeing a supplementary discussion in a manuscript. I also believe it should be incorporated into normal discussion.
The Supplemental Discussion has been incorporated into the main Discussion now.
It would be very helpful to make an additional figure in which the proposed interactome of identified factors with the sperm mitochondria before and after incubation are drawn schematically and also which factors are not IDed in both cases (when comparing to somatic mito- or autophagy). This eases to get through the discussion and will beautifully summarize and illustrate the importance and progress that the authors have made with this assay.
We made a diagram that depicts the changes in protein localization patterns overtime within our cell-free system. This diagram has been added to the manuscript as Figure 9.
Reviewer #1 (Public Review):
In this manuscript, the authors used an unbiased method to identify proteins from porcine oocyte extracts associated with permeabilised boar spermatozoa in vitro. The identification of the proteins is done by mass spectrometry. A previous publication of this lab validated the cell-free extract purification methods as recapitulating early events after sperm entry in the oocyte. This novel method with mammalian gametes has the advantage that it can be done with many spermatozoa at the time and allows the identification of proteins associated with many permeabilised boar spermatozoa at the time. This allowed the authors to establish a list of proteins either enriched or depleted after incubation with the oocytes extract or even only associated with spermatozoa after incubation for 4h or 24h. The total number of proteins identified in their test is around 2 hundred and with very few present in the sample only when spermatozoa were incubated with the extracts. The list of proteins identified using this approach and these criteria provide a list of proteins likely associated with spermatozoa remnants after their entry and either removed or recruited for the transformation of spermatozoa-derived structures. Using WB and histochemistry labelling of spermatozoa and early embryos using specific antibodies the authors confirmed the association/dissociation of 6 proteins suspected to be involved in autophagy.
While this unique approach provides a list of potential proteins involved in sperm mitochondria clearance it's (only) a starting point for many future studies and does not provide the demonstration that any of these proteins has indeed a role in the processes leading to sperm mitochondria clearance since the protein identified may also be involved in other processes going-on in the oocyte at this time of early development.
We thank reviewer 1 for positive comments. We added a sentence in Discussion addressing the obvious shortcoming of present study, as further functional validations of candidate mitophagy factors are planned.
Concerning the localisation of the 6 proteins further analysed, the authors must add how much the presented picture represents the observed patterns. They must include the details on the fraction of spermatozoa and embryos displaying the presented pattern.
We now specify that the patterns depicted in manuscript are typical and representative of data from at least three replicates of immunolabeling in spermatozoa and zygotes. For each of these replicates, 200 spermatozoa were examined per replicate of the cell-free system co-incubation or 20 zygotes per replicate. The displayed patterns were observed between 65-88% in examined spermatozoa/zygotes. Invariably, the signal displayed in manuscript is the typical pattern that was seen in a majority of cells. This information has now been added to the Materials & Methods section for clarification.
Reviewer #2 (Public Review):
Mitochondria are essential cellular organelles that generate ATPs as the energy source for maintaining regular cellular functions. However, the degradation of sperm-borne mitochondria after fertilization is a conserved event known as mitophagy to ensure the exclusively maternal inheritance of the mitochondrial DNA genome. Defects on post-fertilization sperm mitophagy will lead to fatal consequences in patients. Therefore, understanding the cellular and molecular regulation of the postfertilization sperm mitophagy process is critically important. In this study, Zuidema et. al applied mass spectrometry in conjunction with a porcine cell-free system to identify potential autophagic cofactors involved in post-fertilization sperm mitophagy. They identified a list of 185 proteins that might be candidates for mitophagy determinants (or their co-factors). Despite the fact that 6 (out of 185) proteins were further studied, based on their known functions, using a porcine cell-free system in conjunction with immunocytochemistry and Western blotting, to characterize the localization and modification changes these proteins, no further functional validation experiments were performed. Nevertheless, the data presented in the current study is of great interest and could be important for future studies in this field.
We thank reviewer 2 for positive comments. As we explain in our response to Editors and Reviewer 1, further validation studies will be resumed once the availability of slaughterhouse ovaries for such studies improves. Examples of such functional validation of pro-mitophagic proteins SQSTM1 and VCP are included in our previous studies (DOI: 10.1073/pnas.1605844113 and DOI: 10.3390/cells10092450) that led to the development of cell-free system reported here, and are cited in present study.
Reviewer #3 (Public Review):
In this manuscript, a cytosolic extract of porcine oocytes is prepared. To this end, the authors have aspirated follicles from ovaries obtained from by first maturing oocytes to meiose 2 metaphase stage (one polar body) from the slaughterhouse. Cumulus cells (hyaluronidase treatment) and the zona pellucida (pronase treatment) were removed and the resulting naked mature oocytes (1000 per portion) were extracted in a buffer containing divalent cation chelator, beta-mercaptoethanol, protease inhibitors, and a creatine kinase phosphocreatine cocktail for energy regeneration which was subsequently triple frozen/thawed in liquid nitrogen and crushed by 16 kG centrifugation. The supernatant (1.5 mL) was harvested and 10 microliters of it (used for interaction with 10,000 permeabilized boar sperm per 10 microliter extract (which thus represents the cytosol fraction of 6.67 oocytes). The sperm were in this assay treated with DTT and lysoPC to prime the sperm's mitochondrial sheath. After incubation and washing these preps were used for Western blot (see point 2) for Fluorescence microscopy and for proteomic identification of proteins.
Points for consideration:
1) The treatment of sperm cells with DTT and lysoPC will permeabilize sperm cells but will also cause the liberation of soluble proteins as well as proteins that may interact with sperm structures via oxidized cysteine groups (disulfide bridges between proteins that will be reduced by DTT).
This is certainly a possibility, the lysoPC and DTT permeabilization steps were designed to mimic natural processing (plasma membrane removal and sperm protein disulfide bond reduction), which the spermatozoa would undergo during fertilization. However, we do realize that this is a chemically induced processing and thus is not a perfect recapitulation of fertilization processes. However, in this study and in previous studies with this system, we were able to show alignment between proteomic interactions taking place in the cell-free system and within the zygotes.
2) Figure 3: Did the authors really make Western blots with the amount of sperm cells and oocyte extracts as the description in the figures is not clear? This point relates to point 1. The proteins should also be detected in the following preparations (1) for the oocyte extract only (done) (2) for unextracted nude oocytes to see what is lost by the extraction procedure in proteins that may be relevant (not done) (3) for the permeabilized (LPC and DTT treated and washed) sperm only (not done) (4) For sperm that were intact (done) (5) After the assay was 10,000 permeabilized sperm and the equivalent of 6.67 oocyte extracts were incubated and were washed 3 times (or higher amounts after this incubation; not done). Note that the amount of sperm from one assay (10,000) likely will give insufficient protein for proper Western blotting and or Coomassie staining. In the materials and methods, I cannot find how after incubation material was subjected to western blotting the permeabilized sperm. I only see how 50 oocyte extracts and 100 million sperm were processed separately for Western blot.
The authors did make Western blots with the number of spermatozoa and oocytes stated in the materials and methods, a total protein equivalent of 10 to 20 million spermatozoa (equivalent to ~20-40 µg of total protein load) and 100 MII oocytes (equivalent to ~20 µg of total protein load). These numbers have been corrected in the Materials & Methods. Also, we did find in the Materials & Methods section that the Co-Incubation of Permeabilized Mammalian Spermatozoa with Porcine Oocyte Extracts section refers to using cell-free exposed spermatozoa for electrophoresis; however, for none of the presented Western blot work was this true. Rather, all of the presented Western blots as per their descriptions are utilizing ejaculated or capacitated sperm or oocytes. This line has been removed from the Materials & Methods to reduce confusion.
Regarding preparation (2), we have previously assessed the difference between oocyte extract and intact oocytes in this manner internally and we are certainly losing proteins due to the oocyte extraction process. We make caveats in this vein throughout the article such as: “Furthermore, this cell-free system while useful does not perfectly capture all the events which take place during in vivo fertilization. The cell-free system is intended to mimic early fertilization events but is presumably not the exact same as in vitro fertilization.”
3) Figures 4, 5, 6, 7, and 8 see point 2. I do miss beyond these conditions also condition 1 despite the fact that the imaged ooplasm does show positive staining.
For all the presented Western blots, the tissue type is stated in the image description and the protocol which was used to prepare these samples is stated in the Materials & Methods.
4) These points 1-3 are all required for understanding what is lost in the sperm and oocyte treatments prior to the incubation step as well as the putative origin of proteins that were shown to interact with the mitochondrial sheath of the oocyte extract incubated permeabilized sperm cells after triple washing. Is the origin from sperm only (Figs 5-8) or also from the oocyte? Is the sperm treatment prior to incubation losing factors of interest (denaturation by DTT or dissolving of interacting proteins preincubation Figs 3-8)?
The authors understand that there are proteins and interactions lost on both sides of the cellfree system equation and we have added a sentence to the Discussion to caveat this limitation in the system.
5) Mass spectrometry of the permeabilized sperm incubated with oocyte extracts and subsequent washing has been chosen to identify proteins involved in the autophagy (or cofactors thereof). The interaction of a number of such factors with the mitochondrial sheath of sperm has been shown in some cases from sperm and others for an oocyte origin. Therefore, it is surprising that the authors have not sub-fractionated the sperm after this incubation to work with a mitochondrial-enriched subfraction. I am very positive about the porcine cell-free assay approach and the results presented here. However, I feel that the shortcomings of the assay are not well discussed (see points 1-5) and some of these points could easily be experimentally implemented in a revised version of this manuscript while others should at least be discussed.
We agree that the use of a mitochondrial-enriched subfraction for further analysis would be interesting and useful. We are actively developing experimental protocols for oocyte extract coincubation with isolated sperm heads and tails, and eventually with purified mitochondrial sheaths. However, such experiments are contingent upon our access to porcine oocytes, which has continued to be a struggle since the COVID-19 pandemic compromised our ability to attain oocytes in large, cheap, and reliable quantities. This was a continuous problem with preparing materials for this very paper and has continued to be an issue for our laboratory as well as many others at our university and across the country. We continue to maximize oocytes every time we can get access to them, but the unfortunate reality is that this access has become sparce and unreliable over the past three years.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
The following is the authors’ response to the original reviews.
Reviewer #1 (Public Review):
The expression and localization of Foxc2 strongly suggest that its role is mainly confined to As undifferentiated spermatogonia (uSPGs). Lineage tracing demonstrated that all germ cells were derived from the FOXC2+ uSPGs. Specific ablation of the FOXC2+ uSPGs led to the depletion of all uSPG populations. Full spermatogenesis can be achieved through the transplantation of Foxc2+ uSPGs. Male germ cell-specific ablation of Foxc2 caused Sertoli-only testes in mice. CUT&Tag sequencing revealed that FOXC2 regulates the factors that inhibit the mitotic cell cycle, consistent with its potential role in maintaining a quiescent state in As spermatogonia. These data made the authors conclude that the FOXC2+ uSPG may be the true SSCs, essential for maintaining spermatogenesis. The conclusion is largely supported by the data presented, but two concerns should be addressed: 1) terminology used is confusing: primitive SSCs, primitive uSPGs, transit amplifying SSCs... 2) the GFP+ cells used for germ cell transplantation should be better controlled using THY1+ cells.
Thanks for your good comments. According to your suggestions, we have addressed your two concerns as follows:
1> Overall our work suggest that FOXC2+ SSCs are a subpopulation of SSCs in a quiescent state, thus we have replaced the term ‘primitive’ with ‘quiescent’ in the revised manuscript. In general, ‘transient amplifying SSCs’ is considered to be ‘progenitors’, thus we have replaced ‘transient amplifying SSCs’ with ‘progenitors’ in the revised manuscript.
2> The transplantation experiment was conducted using MACS-sorted THY1+, FACS sorted THY1+, and FACS-sorted GFP+ (FOXC2+) uSPGs simultaneously. To be consistent with the single-cell RNA-seq using the MACS-sorted THY1+ uSPGs, we only presented the results from MACS-sorted THY1+ and FACS-sorted GFP+ (FOXC2+) uSPGs in the previous manuscript. Following the reviewer’s suggestion, we have included the results derived from FACS sorted THY1+ uSPGs as the control. The overall conclusion is still fully supported by the more comprehensive dataset, i.e. FOXC2+ cells generated significant higher numbers of colonies than THY1+ cells after transplantation (Figure 2D, E).
Reviewer #2 (Public Review):
The authors found FOXC2 is mainly expressed in As of mouse undifferentiated spermatogonia (uSPG). About 60% of As uSPG were FOXC2+ MKI67-, indicating that FOXC2 uSPG were quiescent. Similar spermatogonia (ZBTB16+ FOXC2+ MKI67-) were also found in human testis.
The lineage tracing experiment using Foxc2iCreERT2/+;Rosa26LSL-T/G/LSL-T/G mice demonstrated that all germ cells were derived from the FOXC2+ uSPG. Furthermore, specific ablation of the FOXC2+ uSPGs using Foxc2iCreERT2/+;Rosa26LSL-DTA/+ mice resulted in the depletion of all uSPG population. In the regenerative condition created by busulfan injection, all FOXC2+ uSPG survived and began to proliferate at around 30 days after busulfan injection. The survived FOXC2+ uSPGs generated all germ cells eventually. To examine the role of FOXC2 in the adult testis, spermatogenesis of Foxc2f/-;Ddx4Cre/+ mice was analyzed. From a 2-month-old, the degenerative seminiferous tubules were increased and became Sertoli cell-only seminiferous tubules, indicating FOXC2 is required to maintain normal spermatogenesis in adult testes. To get insight into the role of FOXC2 in the uSPG, CUT&Tag sequencing was performed in sorted FOXC2+ uSPG from Foxc2iCreERT2/+;Rosa26LSL-T/G/LSL-T/G mice 3 days after TAM diet feeding. The results showed some unique biological processes, including negative regulation of the mitotic cell cycle, were enriched, suggesting the FOXC2 maintains a quiescent state in spermatogonia.
Lineage tracing experiments using transgenic mice of the TAM-inducing system was well-designed and demonstrated interesting results. Based on all data presented, the authors concluded that the FOXC2+ uSPG are primitive SSCs, an indispensable subpopulation to maintain adult spermatogenesis.
The conclusion of the mouse study is mostly supported by the data presented, but to accept some of the authors' claims needs additional information and explanation. Several terminologies define cell populations used in the paper may mislead readers.
1) "primitive spermatogonial stem cell (SSC)" is confusing. SSCs are considered the most immature subpopulation of uSPG. Thus, primitive uSPGs are likely SSCs. The naming, primitive SSCs, and transit-amplifying SSCs (Figure 7K) are weird. In general, the transit-amplifying cell is progenitor, not stem cell. In human and even mouse, there are several models for the classification of uSPG and SSCs, such as reserved stem cells and active stem cells. The area is highly controversial. The authors' definition of stem cells and progenitor cells should be clarified rigorously and should compare to existing models.
Thanks for your good comments. Considering that our results showed that FOXC2+ SSCs are in a quiescent state and that Mechanistically FOXC2 maintained the quiescent state of SSCs by promoting the expression of negative regulators of cell cycle, we have replaced ‘primitive SSCs’ with ‘quiescent SSCs’ in the revised manuscript. We agree with the reviewer that ‘transient amplifying SSCs’ is considered to be ‘progenitors’, thus we have replaced ‘transient amplifying SSCs’ with ‘progenitors’ in the revised manuscript. Further,from our point of view, the FOXC2+Ki67+ SSCs could be regarded as active stem cells, and the FOXC2+Ki67- SSCs could be regarded as reserved stem cells, although further research evidence is still needed to confirm this.
2) scRNA seq data analysis and an image of FOXC2+ ZBTB16+ MKI67- cells by fluorescent immunohistochemistry are not sufficient to conclude that they are human primitive SSCs as described in the Abstract. The identity of human SSCs is controversial. Although Adark spermatogonia are a candidate population of human SSCs, the molecular profile of the Adark spermatogonia seems to be heterogeneous. None of the molecular profiles was defined by a specific cell cycle phase. Thus, more rigorous analysis is required to demonstrate the identity of FOXC2+ ZBTB16+ MKI67- cells and Adark spermatogonia.
We agree with the reviewer that the identity of human SSCs remain elusive even though Adark population demonstrates certain characteristics of SSCs. To acknowledge this notion, we have revised our conclusion as such that only suggests FOXC2+ZBTB16+MKI67- represents a quiescent state of human SSCs.
3) FACS-sorted GFP+ cells and MACS-THY1 cells were used for functional transplantation assay to evaluate SSC activity. In general, the purity of MACS is significantly lower than that of FACS. Therefore, FACS-sorted THY1 cells must be used for the comparative analysis. As uSPGs in adult testes express THY1, the percentage of GFP+ cells in THY1+ cells determined by flow cytometry is important information to support the transplantation data.
Thanks for your good comments. According to your suggestions, we have addressed your concerns as follows:
1> The transplantation experiment was conducted using MACS-sorted THY1+, FACS sorted THY1+, and FACS-sorted GFP+ (FOXC2+) uSPGs simultaneously. To be consistent with the single-cell RNA-seq using the MACS-sorted THY1+ uSPGs, we only presented the results from MACS-sorted THY1+ and FACS-sorted GFP+ (FOXC2+) uSPGs in the previous manuscript. Following the reviewer’s suggestion, we have included the results derived from FACS sorted THY1+ uSPGs as the control. The overall conclusion is still fully supported by the more comprehensive dataset, i.e. FOXC2+ cells generated significant higher numbers of colonies than THY1+ cells after transplantation (Figure 2D, E).
2> We performed FACS analysis to determine the proportion of GFP+ cells in FACS-sorted THY1+ cells from Rosa26LSL-T/G/LSL-T/G or Foxc2iCreERT2/+;Rosa26LSL-T/G/LSL-T/G mice at day 3 post TAM induction, and the result showed that GFP+ cells account for approximately 20.9±0.21% of THY1+ cells, See Author response image 1.
Author response image 1.
4) The lineage tracing experiments of FOXC2+-SSCs in Foxc2iCreERT2/+;Rosa26LSL-T/G/LSL-T/G showed ~95% of spermatogenic cells and 100% progeny were derived from the FOXC2+ (GFP+) spermatogonia (Figure 2I, J) at month 4 post-TAM induction, although FOXC2+ uSPG were quiescent and a very small subpopulation (~ 60% of As, ~0.03% in all cells). This means that 40% of As spermatogonia and most of Apr/Aal spermatogonia, which were FOXC2 negative, did not contribute to spermatogenesis at all eventually. This is a striking result. There is a possibility that FOXC2CRE expresses more widely in the uSPG population although immunohistochemistry could not detect them.
Thanks for your good comments. From our lineage tracing results, over 95% of the spermatogenic cells are derived from the FOXC2+ SSCs in the testes of 4-month-old mice, which means that FOXC2+ SSCs maintain a long-term stable spermatogenesis. In addition, previous studies have shown that only a portion of As spermatogonia belong to SSCs with complete self-renewal ability (PMID: 28087628, PMID: 25133429), which is consistent with our findings. Therefore, we speculate that 40% of As spermatogonia and most of Apr/Aal spermatogonia, which were FOXC2 negative, did contribute to spermatogenesis but cannot maintain a long-term spermatogenesis due to limited self-renewal ability.
5) The CUT&Tag_FOXC2 analysis on the FACS-sorted FOXC2+ showed functional enrichment in biological processes such as DNA repair and mitotic cell cycle regulation (Figure 7D). The cells sorted were induced Cre recombinase expression by TAM diet and cut the tdTomato cassette out. DNA repair process and negative regulation of the mitotic cell cycle could be induced by the Cre/lox recombination process. The cells analyzed were not FOXC2+ uSPG in a normal physiological state.
We do appreciate the reviewer’s concern on the possibility of the functions enriched in the analysis as referred might be derived from Cre/lox recombination. However, we think it is unlikely that the Cre/lox recombination process, supposed to be rather local and specific, can trigger such a systemic and robust response by the DNA damage and cell cycle regulatory pathways. The reasons are as follows: First, as far as we are aware, there has been sufficient data to support this suggested scenario. Second, we did not observe any alteration in either the SSC behaviors or spermatogenesis in general upon the TAM-induced genomic changes, suggesting the impact from the Cre/lox recombination on DNA damage or cell cycle was not significant. Third, no factors associated with the DNA repair process were revealed in the differential analysis of single-cell transcriptomes of FOXC2-WT and FOXC2-KO.
6) Wei et al (Stem Cells Dev 27, 624-636) have published that FOXC2 is expressed predominately in As and Apr spermatogonia and requires self-renewal of mouse SSCs; however, the authors did not mention this study in Introduction, but referred shortly this at the end of Discussion. Their finding should be referred to and evaluated in advance in the Introduction.
Thanks for your good comments. According to your suggestion, we have revised the introduction to refer this latest parallel work on FOXC2. We are happy to see that our discoveries are converged to the important role of FOXC2 in regulating SSCs in adult mammals.
Reviewer #3 (Public Review):
By popular single-cell RNA-seq, the authors identified FOXC2 as an undifferentiated spermatogonia-specific expressed gene. The FOXC2+-SSCs can sufficiently initiate and sustain spermatogenesis, the ablation of this subgroup results in the depletion of the uSPG pool. The authors provide further evidence to show that this gene is essential for SSCs maintenance by negatively regulating the cell cycle in adult mice, thus well-established FOXC2 as a key regulator of SSCs quiescent state.
The experiments are well-designed and conducted, the overall conclusions are convincing. This work will be of interest to stem cell and reproductive biologists.
Thanks for the positive feedback.
Reviewer #1 (Recommendations for the Authors):
The authors should address the following concerns:
1) The most primitive uSPGs should be the true SSCs. The term "primitive SSCs" is very confusing.
2) In addition to FACS-sorted GFP+ cells, FACS-sorted THY1+ cells should also be used for transplantation.
Thanks for your good comments. According to your suggestions, we have addressed your two concerns as follows:
1) Overall our work suggest that FOXC2+ SSCs are a subpopulation of SSCs in a quiescent state, thus we have replaced the term ‘primitive’ with ‘quiescent’ in the revised manuscript.
2) The transplantation experiment was conducted using MACS-sorted THY1+, FACS sorted THY1+, and FACS-sorted GFP+ (FOXC2+) uSPGs simultaneously. To be consistent with the single-cell RNA-seq using the MACS-sorted THY1+ uSPGs, we only presented the results from MACS-sorted THY1+ and FACS-sorted GFP+ (FOXC2+) uSPGs in the previous manuscript. Following the reviewer’s suggestion, we have included the results derived from FACS sorted THY1+ uSPGs as the control. The overall conclusion is still fully supported by the more comprehensive dataset, i.e. FOXC2+ cells generated significant higher numbers of colonies than THY1+ cells after transplantation (Figure 2D, E).
Reviewer #3 (Recommendations for the Authors):
The experiments are well-designed and conducted, the overall conclusions are convincing. The only concerns are the writing, especially the introduction which was not well-rationalized. Sounds the three subtypes and three models for SSCs' self-renew are irrelevant to the major points of this manuscript. I don't think you need to talk too much about the markers of SSCs. Instead, I suggest you provide more background about the quiescent or activation states of the SSCs. In addition to that, as a nuclear-localized protein, it cannot be used to flow cytometric sorting, I don't think it should be emphasized as a marker. You identified a key transcription factor for maintaining the quiescent state of the primitive SSCs, that's quite important!
Appreciate the positive feedback and constructive suggestions on the writing. We have substantially revised our manuscript to include the relevant advances and understanding from the field as well as highlight the importance of FOXC2 in regulating the quiescent state of SSCs.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
The following is the authors’ response to the original reviews.
Reviewer 1 (Recommendations For The Authors):
1) The strikingly different conclusion from the previous Bourane study seems to stem from the experimental approaches. Rather than using genetic crosses that target all neurons from the hindbrain and spinal cord that express Npy at any point in development, Boyle et al target their manipulations specifically to the lumbar region of the superficial dorsal horn in adult mice using direct viral injections. Thus, Boyle is almost certainly manipulating much fewer neurons that the original study. How then is their behavioral effects so much greater? At the minimum, the authors need to discuss this discrepancy head on. Better would be a direct molecular/anatomical comparison of the neurons targeted by each approach. This could be done using Nyp-Cre mice crossed to a Rosa-LSL-reporter strain and quantifying the overlap with the same markers used here. Perhaps, the intersectional approach with Lbx1 resulted in labeling of a different population of neurons than the adult AAV injections? Although likely outside the scope, given this work directly questions the main conclusion of the Bourane paper, it will be important to see a replication of the original finding of selectivity to mechanical itch.
We agree that our approach should be manipulating a smaller population of neurons, and that it is therefore suprising that we see greater behavioural effects. Please see our response to "Weakness 1" of Reviewer 2 for consideration of this point. We have already provided a direct molecular comparison as requested by the reviewer, and this appears in Figure 1 supplement 1. Here we used tissue from NPY::Cre that had been crossed with Ai9 mice (i.e. a Rosa-LSL-reporter) and had received intraspinal injections of AAV.flex.GFP. We then characterised the neurochemistry of tdTomato+ cells that were GFP+ or GFP-negative.
2) The authors state that, "91.6% ± 0.3% of cells classed as Cre-positive cells were also Npy-positive, and these accounted for 62.1% ± 0.6% of Npy-positive cells" If I am reading this correctly, does that mean that 40% of the Npy+ cells are Cre negative? If so, how is this possible?
This interpretation is correct. For quantification of RNAscope data we used a cut-off level of 4 transcripts, and cells with fewer than 4 transcripts were classed as negative. It is likely that some of the NPY cells classified as negative for Cre would have had some Cre mRNA (sufficient to cause recombination), but at a level below this threshold. It is also possible that some NPY+ cells would fail to express Cre, since this is a BAC transgenic mouse, rather than a knock-in.
3) Similarly, the authors state that "great majority of FP-expressing neurons in laminae I-III were immunoreactive (IR) for NPY (78.5% ± 3.6%), and these accounted for 74.6% ± 109 1.9% of the NPY-IR neurons in this area". So does this mean 20% of the recombination is non-specific/in other cell types that could be involved in pain/itch sensation?
Our finding that 91.6% of cells with Cre mRNA were also positive for Npy mRNA (see above) indicates that Cre expression was largely restricted to NPY cells. The failure to detect NPY peptide in some of these cells probably results from the relatively low level of peptide seen in the cell bodies of peptidergic neurons, which results from the rapid transport of peptides into their axons.
4) Comparing Fig 3B and Fig4B it seems the control baseline von Frey responses are different. In fact, baseline response in Fig4b is quite like the CNO effect in Fig 3B. Unless I'm misunderstanding something, this seems quite odd?
We agree that there is a difference between the baseline responses. We are not aware of any particular reason for this, and we think that it reflects a degree of variability that is seen with the von Frey test. Interestingly, the baseline values for the SNI cohort (Fig 4E) lies between the values in Fig 3B and Fig 4B.
5) In Fig 4E, the behavior of the CNO treated mice is quite variable. Can the authors comment as to how this might be happening? Does the effect correlate with viral transduction?
We did not see any obvious correlation between the extent of viral transduction and the behaviour of individual mice.
6) Fig6, the PDyn-Cre experiment, is a bit of a non sequitur?
Please see our response to "Weakness 2" of Reviewer 2 for consideration of this point.
7) The conclusion is unusually long. I recommend trimming it to make it more concise.
We presume that this refers to the Discussion. However, this was ~1550 words, and we do not feel that that is unusually long.
Reviewer 2 (Public Review):
Weaknesses
1) There is inadequate discussion about previous studies of NPY interneurons. Specifically, the authors should address why a more restricted subset of these neurons (this study) have broader effects than seen previously.
We have expanded the discussion on the discrepancies between our findings and those reported previously. We state at the outset that we are targeting a more restricted population (lines 509-10), and we now go into more detail concerning both similarities and differences between our findings and the reasons that we think may underlie any discrepancies (various changes between lines 522-575).
2) I cannot see the reason for including results from manipulation of Dyn+ interneurons in this paper. First, the title does not reflect roles of spinal Dyn+ population. In addition, without further experiments characterizing relationships between NPY and Dyn interneurons in modulating itch and/or nociception, Dyn datasets seem to deviate from the main theme.
We had previously shown that activating Dyn-INs suppressed pruritogen-evoked itch (Huang et al 2018), but it was important to test whether silencing these cells would have the opposite effect. Our finding of overlap in function (i.e. both NPY-INs and Dyn-INs suppress itch, and that both innervate GRPR cells) provides strong evidence against the idea that neurochemically-defined interneuron populations have highly specific functions, and we now state this in the Discussion. The anatomical experiments (which follow on from the functional studies) provide important new information concerning synaptic circuitry of the dorsal horn, by showing that NPY-INs preferentially innervate GRPR cells, and provide around twice as many synapses on these cells, compared to the Dyn-INs. Interestingly, this correlates with the relatively large optogenetically-evoked IPSCs that we saw when NPY-INs were activated, compared to those reported by Liu et al (2019) when galanin-expressing (which largely correspond to Dyn-INs) were activated. By including these findings in the paper, we are able to make comparisons between these two populations.
3) While the authors provided convincing evidence that GRPR+ neurons serve as a downstream effector of NPY+ neuron evoked itch, the relationship between GRPR and NPY neurons in modulating pain is not examined. Therefore, Fig. 7B is pure speculation and should be removed.
We feel that our recent findings that GRPR neurons correspond to vertical cells, that they respond to noxious stimuli, and that activating them results in pain-related behaviours, makes it reasonable to speculate that the NPY/GRPR circuit may also be involved in the anti-nociceptive action of NPY cells. The legend for Fig 7B already refers to this as a "potential circuit", and we have toned down the corresponding part of the discussion to say that our findings "raise the possibility" that this is the case (lines 605-7). We feel that this part of the figure is important, as otherwise our summary diagram ignores some of the main findings of the paper, and we hope that this is now acceptable.
Recommendations For The Authors
1) Fig. 1G: the "misexpression" of tdTomato neurons was much more prominent in deep dorsal horn laminae but not in the superficial ones. Was this representative? Can the authors perform a laminae specific characterization?
We did test for this possibility in 2 NPY::Cre;Ai9 mice that had received intraspinal injections of AAV.flex.GFP, and found that there was a modest difference - 62% of tdTomato+ cells in laminae I-II, but only 39% of those in lamina III, were GFP+. This suggests that "misexpression" may have differed slightly between these regions. However, since the difference was quite modest, and we were only able to analyse tissue from two mice in this way, we did not include these findings in the paper.
2) I have a lot of problems interpreting the c-Fos data in Fig. 2 E and F. For the mCherry- population, how was the quantification performed? From the image, it does not look like 2030% of cells express c-Fos; at a minimum a clear stain of neurons would be needed. Similarly, the identification of NPY cells is not particularly convincing (e.g., middle arrowhead lower 2 panels in C).
We have provided further details on how the analysis was performed (changes made to lines 1016-29). NeuN staining was used to reveal all neurons, and a modified optical disector method was performed from somatotopically appropriate regions of the dorsal horn. As noted by the Reviewer, NeuN staining was required to allow identification of mCherrynegative cells. However, we have not included the NeuN immunoreactivity in the image, as this would add considerably to the complexity. These images are from single optical sections, and therefore the overall numbers of cells are low (in comparison to what would be seen in a projected image). The intensity of mCherry staining varied between cells. However, for all mCherry-positive cells (including the example referred to by the Reviewer), there was clear staining in the membrane, which could be followed in serial sections.
3) Please add individual data points for all quantifications.
These have been added.
Reviewer 3 Recommendations For The Authors:
1) It is somewhat surprising that there is no effect on CPP after activating spinal NPY neurons in neuropathic mice, given the almost complete rescue of hypersensitivity to baseline values in the nociceptive tests. Based on the methods, it appears that conditioning was carried out already 5 min after CNO injection. Yet, suppression of c-fos activity in excitatory spinal dh neurons was observed 30min after CNO injection. Also, it is not clear to me when CNO was injected prior to the nociceptive or CQ testing?
Have the authors considered that conditioning from 5-35 min after CNO injection might be too short after CNO injection to achieve a profound analgetic effect?
In a previous study (Polgár et al 2023), we had observed the timecourse of CNO-evoked itch and pain behaviours in mice in which GRPR cells expressed hM3Dq. We found that these started within 5 minutes of i.p. CNO injection (e.g. Fig S2 in that paper). In addition, the timecourse of action of gabapentin and CNO (both given i.p.) are likely to be similar, and there was a preference for the chamber paired with gabapentin. We are therefore confident that the conditioning period with CNO was adequate. We now explain this in the Methods section (lines 846-52). The timing of CNO injections for the nociceptive and CQ tests is now described (lines 749-55).
2) The authors claim that tonic pain was not affected based on the conditioned place preference test. Efficacy in withdrawal response tests and in the CPP differ by more than duration of the stimulus. I'd suggest using more cautious wording here.
We agree that caution is needed in interpreting the results of the CPP experiments. We have therefore replaced "does" with "may" in the Results section (line 336) and "did" with "may" in the Discussion (line 620).
3) On page 9 the authors state "...suggesting that they suppress the transmission of pain- and itch-related information in the dorsal horn." However, pain is not affected in the loss of function experiments suggesting some qualitative differences in the role of the NPY neurons in itch and pain. This should also be reflected more clearly in this statement and in the discussion e.g. "suppress itch" and "can suppress pain".
We accept the point made by the Reviewer. We have slightly altered the wording in lines 249-51 and 610 to reflect this.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
The following is the authors’ response to the original reviews.
Reviewer #1 (Public Review):
[...] Weaknesses
Showing that A-2 and especially A-3 are outliers in the PCA analysis is useful, but it may be hiding other interesting signals in the data. The other strains are remarkably colinear on these plots, hinting that if the outliers were removed, one main component would emerge along which they are situated. It also seems possible that this additional analysis step would allow the second dimension to better differentiate them in a way that is interesting with respect to their mutator status or mutations in key metabolic or regulatory genes.
We thank the reviewer for their positive comments and their constructive feedback on the manuscript. Following reviewer’s recommendation, we performed the PCA analysis on metabolism data after removing A-2 and A-3 data. We have detailed those results below. Consistent with a similar analysis performed on RNA-seq datasets in our previous publication, we find that removing these outliers has only a modest effect on separating mutators from non-mutators. We find that, while the new PC2 separates most mutators from the non-mutators, the separation is rather weak. Moreover, we do not see a similar distinction when looking at metabolic data in the Stationary phase. In the interest of improving the readability of the manuscript, we recommend not including these analysis in the final manuscript. We have presented the data for the reviewer’s benefit in Author response image 1, 2 and 3.
Author response image 1.
Author response image 2.
Author response image 3.
There is a missed opportunity to connect some key results to what is known about LTEE mutations that reduce the activity of pykF (pyruvate kinase I). This gene is mutated in all 12 LTEE populations, and often these mutations are frameshifts or transposon insertions that should completely knock out its activity. At first glance, inactivating an enzyme for a step in glycolysis does not make sense when the nutrient source in the growth medium is glucose, even though PykF is only one of two isozymes E. coli encodes for this reaction. There has been speculation that inactivating pykF increases the concentration of phosphoenolpyruvate (PEP) in cells and that this can lead to increased rates of glucose import because PEP is used by the phosphotransferase system of E. coli to import glucose (see https://doi.org/10.1002/bies.20629). The current study has confirmed the higher PEP levels, which is consistent with this model.
We thank the reviewer for pointing out this missed opportunity. We have expanded the discussion around the role of pykF mutations and the elevated concentrations of PEP observed in our data in section 3.4.
In the introduction, the papers cited to show the importance of changes in metabolism for adaptation do not seem to fit the focus of this study very well. They stress production of toxins and secondary metabolites, which do not seem to be mechanisms that are at work in the LTEE. I can think of two areas of background that would be more relevant: (1) studies of how bacterial metabolism evolves in adaptive laboratory evolution (ALE) experiments to optimize metabolic fluxes toward biomass production (for example, https://doi.org/10.1038/nature01149), and (2) discussions of how cross-feeding, metabolic niche specialization, and metabolic interdependence evolve in microbial communities, including in other evolution experiments (for example, https://doi.org/10.1073/pnas.0708504105 and https://doi.org/10.1128/mBio.00036-12).
We thank the reviewer for pointing out missed citations in our introduction. We agree that these papers are relevant to the topic and have added their citations. Additionally, following the suggestion of another reviewer, we have reorganized the introduction so that the concept of the role of metabolism in evolution is presented first and the LTEE second.
Reviewer #2 (Public Review):
[...] Overall, this is a significant and well-executed research study. It offers new insights into the complex relationship between genetic changes and observable traits in evolving populations and utilizes metabolomics in the LTEE, a novel approach in combination with RNA-seq and mutation datasets.
However, the paper's overall clarity is lacking. It is spread too thin and covers many topics without a clear focus. I strongly recommend a substantial rewrite of the manuscript, emphasizing structure and readability. The science is well executed, but the current writing does not do it justice.
We thank the reviewer for their positive comments and their constructive feedback on the lack of clarity in writing. Following the reviewer’s suggestions, we have rewritten parts of the manuscript and reorganizd a few sections to improve readability. We hope the revised manuscript is significantly improved.
Recommendations for the authors
Reviewer #1 (Recommendations For The Authors):
1) Title and Abstract: Add the study organism to the abstract, and probably also the title. Currently, E. coli is not mentioned in either! I'm also not sure that the LTEE is a sufficiently well-known acronym to abbreviate this in the title.
We have revised the title of the manuscript and now spell out LTEE and included E. coli in the title and the abstract.
2) Abstract: I would switch the usage of metabolome to metabolism in a few more places. For example, "changes in its metabolism", "networked and convoluted nature of metabolism". The metabolome, the concentrations of all metabolites, is what is being measured, but I think of this as a phenotypic readout of how metabolism evolving.
We have changed “metabolome” to “metabolism” in cases where we refer to what is evolving and use “metabolome” when we refer to what is being measured.
3) Line 16: Technically, the 12 LTEE populations were not initially identical. The Ara- differed from the Ara+ ancestors by one intentional mutation and one unintentional mutation that was not discovered until whole genomes were sequenced. I would rephrase this to "where 12 replicate populations of E. coli are propagated" or something similar so that it can be correct without needing to describe this unnecessary detail.
The line has been rephrased as suggested.
4) General Note: The text refers to populations as Ara-3 but the figures use A-3. I'd suggest going with A-3 and similar throughout for consistency.
Instances of Ara have been changed to A+/-, and a sentence specifying as such has been added to the intro to make mention of this.
5) Lines 43-44, 97-98. My understanding is that both S and L ecotypes in A-2 can use both glucose and acetate, but that the differentiation is related to their specialization that leads to each one being better on one or the other nutrient. The descriptions make it sound like each grows at a different time. Also, by definition, cells are not growing during "stationary phase". The change from glucose utilization (and acetate secretion) to acetate utilization during one cycle of growth is better described as a diauxic shift.
We have reworded this part to remove mention of “growth” during stationary phase and changed the wording such that it no longer sounds like they grow at different times.
6) Line 54: The statement "provide the ability to test hypotheses from previous data" is vague. Either provide an example or delete.
We have removed this sentence as suggested.
7) Lines 71-72: The terms "interphase" and "intraphase" sound too much like parts of the cell cycle. I'd suggest describing the comparisons as between and within growth phases.
The use of intra and interphase have been changed as suggested.
8) Line 79: The citrate is presumably still a chelating agent, so change phrasing to "Citrate is present in the medium because it was originally added as a chelating agent" or something similar.
This sentence has been rewritten as suggested.
9) Line 83: Write out "mutation accumulations" so it is easier to understand as "the number of mutations that have accumulated".
The phrase has been changed as suggested.
10) Line 116: It's unclear whether the abundances of metabolites are "strategies of survival" in stationary phase. An equally valid explanation is that there is less selection on the metabolome to have a specific composition during stationary phase to have high fitness.
We have added a line about the possibility for alternative hypotheses.
11) Figure 1: There seems to be some information missing from the legend. What are R06 and R07 in Panels A and B? Is panel D exponential phase and panel E stationary phase?
This information was inadvertently missing from the caption and has been added.
12) Figures 2 and 3: Gene names should be in italics. To me, the gray for deleted genes is hard to tell apart from the blue/red. Perhaps you could put a little X in these boxes instead? I think that having a little triangle pointing from each gene or metabolite name its corresponding abundance panel would help the reader track which information goes with which features. In Fig. 3 the placement of L-aspartate is a bit awkward. I'd suggest moving it down so the dashed line does not have to go through the abundance panel.
These figures have been edited to include small triangles that link a gene or metabolite and its heatmap. Additionally, an X has been added where genes have suffered inactivating mutations and the placement of some elements has been moved to improve overall clarity.
13) Lines 183-185: It would be easier to see and judge the consistency of these argR related relationships if a correlation graph of some kind was shown, probably as a supplemental figure. This plot could, for example, have genes/metabolites across the x-axis and fold-change on the y-axis with lines connecting points corresponding to each of the twelve populations across these categories (like Fig S8 but with lines added). Alternatively, it could be a heat map with the populations across one axis and the genes/metabolites across the other axis (like Fig S3).
We have added a supplementary figure consisting of heatmaps showing the consistency of these changes within an evolved line. It is now figure S9.
14) Line 195: I think adding a sentence elaborating on what exactly mutation accumulation means in this context would be helpful to readers.
We have attempted to clarify the meaning of this by specifically stating that it is due to the accumulation of deleterious mutations.
15) Line 293: Is standard LTEE medium DM25? These omics experiments with the LTEE sometimes use similar media with different glucose concentrations, and this is a very important detail to precisely specify.
We reference “standard” LTEE medium in the methods section and have additionally specified the amount of sugar to make it clear that we are not supplementing the media with additional sugar.
16) Figure S8B. Is "cystine" used instead of "cysteine" on purpose here since the compound is oxidized in the metabolomics treatment?
The use of cystine is intentional, we detect the oxidized compound.
Reviewer #2 (Recommendations For The Authors):
Title:
The abbreviation "LTEE" should not be in the title. Most readers will not recognize what it means. Instead, either the full name of the experiment, "Long-Term Evolution Experiment with E. coli," should be used, or the title should be rephrased to "Linking genotypic and phenotypic changes during a long-term evolution experiment using metabolomics."
We have spelled out LTEE and included E. coli in the title.
Abstract:
Sentence 1: Consider softening the statement: "Do changes in an organism's environment, genome, or gene expression patterns often lead to changes in its metabolome?"
We have rephrased this sentence to “Changes in an organism's environment, genome, or gene expression patterns can lead to changes in its metabolism”.
Sentence 4: Use a hyphen for "Long-Term."
This addition has been made.
Sentence 4: Replace "transduce" with a more appropriate term: "...how the effects of mutations can be distributed through a cellular network to eventually affect metabolism and fitness."
We have rewritten this sentence as “to understand how mutations can eventually affect metabolism and perhaps fitness”.
Sentence 5: Clarify the use of "both" to refer to the ancestor of the LTEE and its descendant populations as two classes.
We have reworded this sentence so it’s clear that the ancestors and evolved lines are two separate classes “We used mass-spectrometry to broadly survey the metabolomes of the ancestral strains and all 12 evolved lines…”.
Sentence 6: Reverse the order for better emphasis: "Our work provides a better understanding of how mutations might affect fitness through the metabolome in the LTEE, and thus provides a major step in developing a complete genotype-phenotype map for this experimental system."
We have rearranged this sentence per the reviewers suggestion.
Introduction:
Revise the introduction for clarity, readability, and logical narrative progression. Start with the second paragraph to set up the basic scientific principles being studied and then transition to describing the LTEE as a model system to examine those principles.
The introduction has been rearranged and reworded in parts to increase clarity.
Sentence 1: Revise for clarity: "The Long-Term Evolution Experiment (LTEE) has studied 12 initially identical populations of Escherichia coli as they have evolved in a carbon-limited, minimal glucose medium under a daily serial transfer regime."
Sentence 2: Suggestion: "Begun in 1988, the LTEE populations have evolved for more than 75,000 generations, making it the longest-running experiment of its kind."
Paragraph 2, sentence 2: Italicize "Drosophila."
Paragraph 3, sentence 2: Make an important distinction: "Ara-3 is unique in that it evolved the ability to grow aerobically on citrate."
Paragraph 3, sentence 4: Introduce the IS-mediated loss of the rbs operon in the LTEE as if it has not been described elsewhere.
These suggestions have been incorporated into the manuscript.
Results:
Section 3.1: The use of samples from hours 2 and 24 to represent exponential and stationary phase may present some issues. For instance, capturing Ara-3 during its exponential growth on glucose, but not citrate, at hour 2. Furthermore, except for Ara-3, the LTEE populations reach stationary phase after approximately 4 hours, and there could be significant differences between early, mid, and late stationary phase. This possibility should be acknowledged, and future follow-up work should consider exploring these differences.
We have added sentences in the first paragraph of the results section to include these details. We have also added a short paragraph to the conclusions suggesting additional studies of stationary phase, citing work on evolution of E. coli during long term stationary phase.
Paragraph 3: While Turner et al. 2017 is an essential reference regarding resource use differences between Ara-3 and other LTEE populations, it would be more suitable to reference Blount et al. 2012 for the mutations that enabled access to citrate. Also, it is important to note that the difference lies in the ability to grow aerobically on citrate, rather than the ability to metabolize it.
This citation has been added.
Paragraph 4: As mentioned elsewhere, most LTEE populations exhibit balanced polymorphisms. Therefore, it is more appropriate to state that Ara-2 is the best-understood example of long-term diversity. It is likely that there are important metabolic differences between co-existing lineages in other LTEE populations.
We now refer to Ara-2 as being the best-understood example of long term diversity..
Paragraph 5: The first sentence of this paragraph should likely end with "levels."
The word “levels” was added to the end of this sentence.
Figure 3: It is preferable to refer to the "Superpathway of arginine and polyamine biosynthesis," citing EcoCyc as a reference, rather than a descriptor.
This has been changed to a reference.
Section 3.3, Paragraph 3: While higher intracellular amino acid abundances may facilitate higher translation rates and faster growth, the higher abundances themselves do not evaluate the hypothesis. To evaluate the hypothesis, it is necessary to demonstrate that higher abundances are associated with higher translation or growth rates. Therefore, the final sentence of this paragraph is not meaningful.
We have reworded this sentence to say that it’s not possible to tell what the additional amino acids are being used for given only this data and that additional experiments are needed to confirm this hypothesis.
Section 3.4: The first paragraph of this section misstates how evolution works. The low level of glucose in the LTEE does not drive innovation; instead, innovation occurs at random through the introduction of variation by mutation. Although the existence of the citrate resource acts as a reward that selects for variation that provides access to it, it is essential to remember that evolution is blind to such a reward. Moreover, regarding the evolution of the Cit+ trait, it is incorrect to assert that low glucose contributed to its evolution. As shown by Quandt et al. (2015), it seems probable that Cit+ evolution was potentiated by adaptation to specialization on acetate, which is produced by overflow metabolism resulting from rapid growth on glucose. This rapid growth only occurs when glucose is relatively abundant. The level of glucose seems low to us because it is low relative to traditional levels in bacteriological media, but not to the bacteria.
We agree that this is a semantical, but important distinction. We have reworded this part as to not suggest that evolution has any forward thinking properties and is indeed blind to any rewards that might occur as the result of adaptation.
In general, all instances of "utilize" and its cognates should be replaced with "use" and its cognates.
Instances of “utilize” have been changed to use and its cognates.
There is some uncertainty about the expectation of ramping up the TCA cycle in the LTEE. Overflow metabolism and acetate production appear to be prevalent in the LTEE, suggesting that many lineages only partially oxidize carbon derived from glucose, thereby bypassing the TCA cycle. While it is possible that this interpretation is incorrect, it would be helpful to see it addressed in the manuscript.
We agree that this is a plausible hypothesis, we have added a paragraph at the end of this section that discusses the implications of overflow metabolism as an alternative hypothesis.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
In this study, the authors study the effect of dynactin disruption on kinetochore fiber (k-fiber) length in spindles of dividing cultured mammalian cells. Dynactin disruption is known to interfere with dynein function and hence spindle pole formation. The main findings are that poles are not required for correct average k-fiber length and that severed k-fibers can regrow to their correct length both in the presence and absence of poles by modulating their dynamic properties at both k-fiber ends. In the presence of poles, regrowth is faster and the variation between k-fiber lengths is smaller. This is a very interesting study with high-quality quantitative imaging data that provides important new insight into potential mechanisms of spindle scaling, extending in an original manner previous work on this topic in cultured cells and in Xenopus egg extract. The Discussion is interesting to read as several possible mechanisms for k-fiber length control are discussed. The technical quality of the study is very high, the experiments are very original, and most conclusions are well supported by the data. Especially, the experiments observing the regrowth of k-fibers after severing and the study of the dynamic properties of these k-fibers provide very novel insight. Addressing the following concerns could potentially improve the manuscript:
We thank the reviewer for their fair, rigorous, and conceptually engaging remarks.
(1) The phenotype generated here by disrupting dynactin via overexpressing p50 appears to be different from that caused by knocking down NuMA or dynein - as previously reported by the Dumont lab (Hueschen et al., 2019). In this study here, unfocused spindles are observed whereas earlier turbulent spindles were observed. This raises the question of whether dynein activity that contributes to pole focusing is really completely inhibited here. These discrepancies in phenotypes seem to deserve an explanation. Is k-fiber length in cultured mammalian cells only maintained in the case of this specific type of inhibition?
We thank the reviewer for the important point about the different phenotypes observed in different dynein inhibition conditions and we refer them to our response to Essential Revision #1. In summary, we believe that different dynein inhibition phenotypes are similar. Unfocused spindles appear turbulent on longer timescales and appear to reach a steady-state on shorter timescales. The amount of pole-unfocusing also seems to correspond to the severity of dynein inhibition (Figure 1—figure supplement 1). We have chosen to study inhibited spindles that were steady-state and unfocused. We have added this discussion in line 129 as well as better characterized our system of dynein inhibition by adding two new figures (Figure 1—figure supplement 1, Figure 1—figure supplement 3).
Furthermore, we address the question of whether dynein might still be responsible for length regulation despite poles being unfocused in line 433 of the Discussion: “recent work has revealed that mammalian spindles can achieve similar architecture whether or not dynein (or its recruiter NuMA) is knocked out (Neahring et al., 2021). This suggests that the severe defects in spindle coordination (Figure 1, Figure 5) and maintenance (Figure 2) observed in p50-unfocused spindles are more likely due to the loss of spindle poles than due to the loss of dynein activity per se.”
We have additionally overexpressed p50 in human RPE1 cells and observed qualitatively similarly unfocused yet generally bi-oriented spindles as in rat kangaroo PtK2 cells, showing that the formation of unfocused spindles in PtK2 is not an artifact unique to that cell line (see newly added Figure 1—figure supplement 3). However, these unfocused RPE1 spindles did not have clear, resolvable k-fibers as in PtK2, so length was not quantified. The only method we are aware of that robustly unfocuses poles in PtK2 spindles is p50 overexpression.
(2) p50 addition and also p150-cc1 addition was often used in Xenopus egg extract in order to inhibit dynein function. Considerably larger concentrations of p50 than p150-cc1 needed to be used. Can the authors estimate the level of overexpression of p50 in the cells they study? It seems that could be possible given that a mCherry fusion protein can be overexpressed. Was it necessary to select cells with a particular level of mCherry-p50 overexpression to observe the reported phenotypes?
We thank the reviewers for the suggestion to quantify p50 expression and have added Figure 1—figure supplement 1. Due to gradual red laser power loss over months, data from a single day were plotted for proper comparison, but trends were always consistent within any given day. As discussed above, we observed that higher levels of mean p50 intensity corresponded to unfocused spindles. We have clarified that we chose to study these highly overexpressing unfocused spindles in the text and methods, and we speculate that level of p50 overexpression correlates with amount of dynein inhibition and subsequent pole-unfocusing. This is also consistent with the higher concentrations of p50 needed to inhibit dynein in Xenopus.
(3) Some comparison to previous experiments using p50 and p150-cc1 addition to Xenopus egg extract spindles could put this study better into the context of the available literature. It seems from previous publications that the p50 addition produced short, unfocused, barrel-shaped spindles, indicating that spindle length is maintained without poles, whereas the p150-cc1 addition produced elongating spindles (e.g. Gaetz & Kapoor, 2004).
We appreciate the reviewer’s discussion of dynein inhibition in the Xenopus context.
While Xenopus has been used to study spindle size regulation, it has not been as useful to study k-fiber length regulation, which we focus on. Xenopus spindles have a different architecture, with k-fibers that are not discrete and continuous like in mammalian spindles. Indeed, while p50 and p150-CC1 overexpression alter spindle length in Xenopus, they do not have the same effect in mammalian spindles. Additionally, p150-CC1 does not robustly unfocus poles in mammalian spindles as it does in Xenopus; instead, it leads to an inconsistent variety of spindle disorganization phenotypes with frequently focused poles in PtK2 (data not shown). We speculate this variety of spindle phenotypes arise from a different mechanism of dynein inhibition that does not fully target pole-focusing.
However, we agree that referencing prior Xenopus work establishes important context and precedent. In line 95 of the Introduction, we state “…inhibiting dynein unfocuses poles but spindles still form albeit with altered lengths in Drosophila (Goshima et al., 2005) and Xenopus (Gaetz and Kapoor, 2004; Heald et al., 1996; Merdes et al., 1996), and without a clear effect on mammalian spindle length (Guild et al., 2017; Howell et al., 2001),” addressing the different effects of dynein inhibition in Xenopus compared to mammalian spindles. We have also added direct mentions of p50 in Xenopus in line 129 (see Essential Revision #1 response).
Finally, we have added a figure showing overexpression of p50 in a human RPE1 cells to show reproducibility of pole unfocusing across other mammalian cell types (see newly added Figure 1—figure supplement 3).
(4) In this context, it seems that some more explanation is required for the observations presented in Fig. 1D and 1E. It appears that spindle length and k-fiber length have been measured quite differently. Not much information is provided for how spindle length was defined and measured (please expand this part of the Methods). Could the two different methods of measurement be the reason for the mean k-fiber length remaining unaltered in dynactin-disrupted spindles, whereas the spindle length increases in these cells? If not, do non-k-fiber microtubules contribute to unfocused spindles being longer or are chromosomes not aligned in the metaphase plate causing the increase in spindle length by misalignment of k-fiber sister pairs?
We thank the reviewers for pointing out the lack of clarity in Figures 1D and 1E. We have expanded and clarified the Methods section describing how spindle axes were measured and how k-fiber lengths were measured, as well as included examples and cartoons to illustrate them (see newly added Figure1—figure supplement 4).
To clarify, we did not intend to directly measure spindle length, but we did approximate the size of each spindle’s “footprint” in Figure 1D as well as measure individual k-fiber length in Figure 1E. It is now clarified in the Methods line 898 as “Spindle minor and major axes lengths were determined by cropping, rotating, then thresholding spindle images with the Otsu filter using SciKit. Ellipses were fitted to thresholded spindles to approximate the length of their major and minor axes using SciKit’s region properties measurement (Figure1—figure supplement 4A). In control spindles, the major axis corresponded to spindle length along the pole-to-pole axis, and the minor axis corresponded to spindle width along the metaphase plate axis. However, unfocused spindles were disorganized along both axes to the extent where the minor axis did not always correspond to the metaphase plate axis. Thus, Figure 1D reports ”spindle minor axis length” and “spindle major axis length” rather than “spindle width” and “spindle length”. Furthermore, it is worth noting that in unfocused spindles, spindle length is decoupled from k-fiber length because of k-fiber disorganization along both axes. Thus, spindle length was not measured in unfocused spindles...”
We additionally removed the potentially confusing terminology of “wider” and “longer” in the Results section to make clear that we are approximating spindle size, not spindle length and width, and we now state in line 168,“ k-fibers were more spread out in the cell, with spindles covering a larger area compared to control along both its major and minor axes (Figure 1D).”
We believe our clarification and expansion of the Methods section, as well as inclusion of a new supplementary figure and cartoon address the reviewer’s points, and we thank them for pointing out the lack of clarity.
(5) It seems that in the Discussion it is implied that k-fibers can respond to severing in both focused and unfocused spindles by modulating their dynamics at both ends of the k-fibers, but in the Results section the wording is more cautious because of the difference in 'flux' in severed and unsevered unfocused spindles is not significant (Fig. 4D, blue data). It appears indeed that there is also a difference in flux between severed and unsevered unfocused spindles, but the number of data points is too small. Depending on how difficult these experiments are, it could be worth increasing the size of the data set to come to a clear conclusion, given that the data shown in Figs. 3 and 4 are quite remarkable and form the core of the study.
We appreciate the reviewer’s close reading and pertinent suggestions.
As detailed in our response to Essential Revision #3, we did not increase the sample size for unfocused spindles since it would not be reasonably feasible to show significant differences in flux. However, we performed more ablations and photomarking in control spindles as detailed in our response to this reviewer’s point 6 below, a different but related point.
(6) Can the authors exclude that the stopping of 'flux' at minus ends after severing is due to some sort of permanent damage induced by ablation? In other words, do severed spindles begin to flux again once they have regrown to their original length?
We thank the reviewer for their important points.
We have addressed this question in the newly added Figure 4—figure supplement 1 as described in our response to Essential Revision #3 to show that flux resumes after length recovery. In summary, we observed no adverse effects of ablation on k-fiber minus-ends. Severed k-fibers have restored lengths, and minus-end dynamics several minutes after ablation.
(7) To this reader, the conceptualization of distinguishing between 'global' and 'local' effects/behavior was a little confusing, both in the title and also later in the text. The concept of 'local' regulation of k-fiber length appears to contradict the observation that k-fiber length can be regained after severing by changes in the dynamics at both ends (so at two very different locations) which is a rather remarkable finding. Maybe distinguishing between 'individual' and 'collective' k-fiber behavior could be clearer.
We appreciate the reviewer’s consideration of terminology. We have addressed this by clearly defining our use of ‘local’ to refer to individual k-fibers as a unit where appropriate in the text (lines 271, 449). We chose these terms since they can help describe individual versus collective properties, while simultaneously emphasizing the aspects of global architecture and spatial organization in the spindle.
(8) Can the authors exclude that some of the differences between unfocused and focused spindles could be due to altered dynein activity at kinetochores? Or due to the dynein-dependent accumulation of certain spindle proteins along microtubules towards the minus ends of k-fibers or other spindle microtubules, instead of being due to only the presence versus absence of poles? Could this be tested by ablating both poles? If this is too challenging, a discussion of these possibilities could be justified.
We appreciate the reviewer’s consideration of kinetochore activity as well as other methods of removing poles. However, p50 overexpression is currently the only method to robustly unfocus spindles in PtK2 cells – ablating poles or removing pole-associated structures such as centrosomes does not abolish pole-focusing in this system (Khodjakov et al., 2000). Furthermore, we now discuss the possibility that altered dynein activity (such as activity at kinetochores) may give rise to the phenotypes we describe in our work in line 433: “…recent work has revealed that mammalian spindles can achieve similar architecture whether or not dynein (or its recruiter NuMA) is knocked out (Neahring et al., 2021). This suggests that the severe defects in spindle coordination (Figure 1, Figure 5) and maintenance (Figure 2) observed in p50-unfocused spindles are more likely due to the loss of spindle poles than due to the loss of dynein activity per se. Though we cannot exclude it, this also suggests that the findings we make in unfocused spindles are not due changes in activity of the dynein population at kinetochores.”
Reviewer #2 (Public Review):
The mitotic spindle of eukaryotic cells is a microtubule-based assembly responsible for chromosome segregation during cell division. For a given cell type, the steady-state size and shape of this structure are remarkably consistent. How this morphologic consistency is achieved, particularly when one considers the complex interplay between dynamic microtubules, spatial and temporal regulation of microtubule nucleation, and the activities of several microtubule-based motor proteins, remains a fundamental unanswered question in cell biology. In this work by Richter et al., the authors use biochemical and biophysical perturbations to explore the feedback between mitotic spindle shape and the dynamics of one of its main structural elements, kinetochore fibers (k-fibers) - bundles of microtubules that extend from kinetochores to spindle poles. Overexpression of the p50 dynactin subunit in mammalian tissue culture cells (Ptk2) was used to inhibit the microtubule motor cytoplasmic dynein resulting in misshapen spindles with unfocused poles. Measurements of k-fiber lengths in control and unfocused conditions showed that although mean k-fiber length was not statistically different, the variation of length was significantly higher in unfocused spindles, suggesting that k-fiber length is set locally, occurring in the absence of focused poles. With a clever combination of live-cell imaging with photoablation and/or photobleaching of fluorescently-labeled k-fibers, the authors went on to explore the mechanistic bases of this length regulation. K-fiber regrowth following ablation occurred in both conditions, albeit more slowly in unfocused spindles. Paired ablation and localized photobleaching on the same k-fiber revealed that microtubule dynamics, specifically those at the plus-end, can be tuned at the level of individual k-fiber. Lastly, the authors show that chromosome segregation is severely impaired when cells with unfocused spindles are forced to enter mitosis. The work's biggest strength is the application of an innovative experimental approach to address thoughtful and well-articulated hypotheses and predictions. Conclusions stemming from the experiments are generally well-supported, though the experiments addressing the "tuning" of k-fiber dynamics could be bolstered by additional data points and perhaps better presented. The manuscript would also benefit from the inclusion of some investigation of spatial differences in the observed effects as well as the molecular and biophysical basis of the observed feedback between k-fiber length and focused poles.
We appreciate the reviewer providing pertinent, rigorous, and intellectually astute suggestions.
Comments/Concerns/Questions:
1) In the discussion, the authors acknowledge that the changes in spindle morphology resulting from p50 overexpression are likely also causing changes in the well-characterized RanGTP/SAF gradients that radiate from chromosome surfaces. Why did the authors did not include an analysis of k-fiber length as a function of positioning within the spindle? The inclusion of this data would not require more experimentation and could be added as a plot showing K-fiber length versus distance from the geometric center of the spindle (defined by the intersection of the major and minor axes perhaps?).
We thank the reviewer for this pertinent suggestion and refer them to our response to Essential Revision #2. Briefly, we have added the recommended analyses to Figure 1—figure supplement 6 by correlating k-fiber length to position along the spindle’s longitudinal and latitudinal axes.
2) The authors also acknowledge the established relationship between MT length and MT end dynamics, yet in their ablation studies, the average initial k-fiber length at ablation in control spindles was higher than that for k-fibers in unfocused spindles. It seems that this difference makes the interpretation of the data, particularly the conclusion that fiber growth rates differ due to the absence of focused poles, a bit tenuous. To address this, the authors should consider including plots of grow-back rates versus k-fiber length (again, this should not require additional experiments, just more analysis).
We thank the reviewer for their critical thinking about experiments. We would like to clarify to the reviewer that initial k-fiber lengths within unfocused spindles preceding ablation were not actually longer on average compared to the average length of control k-fibers from Figure 1E (Figure 2—figure supplement 1). We apologize that this unexpected artifact was not clear in the text and have now reworded line 232 to be more straightforward: “Mean k-fiber lengths in unfocused spindles before ablation appeared to be shorter (Figure 2D); however, this was due to not capturing the full length of k-fibers in a single z-plane while imaging ablated k-fibers. Indeed, length analysis of full z-stacks from unfocused spindles before ablation yielded an indistinguishable mean k-fiber length compared to control k-fibers in Figure 1E (Figure 2—figure supplement 1). Thus, ablated k-fibers were compared to their unablated neighbors as internal controls.”
We believe that this language clearly calls out the perceived inconsistency, and that our use of internal controls overcomes this confounding factor to make meaningful conclusions. We address the relationship of k-fiber length and growth rate in our response to Essential Revision #2. We are not including it in the manuscript based on our inability to make any meaningful conclusion to either support or exclude the possibility of length-dependent growth rates.
3) As presented, the data shown in Figure 4 is confusing and does not seem very compelling. The relationship between the kymographs and time series is unclear as is the relationship between the dashed lines in the kymographs and the triangles and the plots in the 4B time series and 4C, respectively. Furthermore, it's not always clear what the triangles are pointing to (e.g. in the unfocused condition time series). The authors might want to consider reworking this figure and providing more measurements of flux following ablation in both the control and unfocused conditions. Lastly, the authors should clarify what negative displacement means.
We apologize for the unclear figure annotations and thank reviewers for their suggestions. As discussed in our response to Essential Revision #3, we believe we have improved the clarity and presentation of figures and kymographs. More measurements of flux after ablation in unfocused spindles was not feasible as discussed; however, we have performed these measurements in control spindles and added Figure 4—figure supplement 1 to strengthen conclusions about turning flux off/on after ablation.
We have additionally clarified axis titles by replacing “negative displacement” with the more intuitive descriptor “photomark position relative to minus-end” and clearly defining it in the figure legends in line 565 as follows: “Figure 3 […] (D) Minus-end dynamics, where photomark position over time describes how the mark approaches the k-fiber’s minus-end over time in control and unfocused k-fibers.”
We thank reviewers for their suggestions to improve clarity and bolster our conclusions.
-
-
www.medrxiv.org www.medrxiv.org
-
Author Response
We thank the Editor for his assessment. We agree that the data we present in this manuscript can be a starting point for more in-depth analysis. We are currently developing a mathematical model of HIV transmission dynamics; we plan to use the data that we present in this paper as parameter values.
Reviewer #1 (Public Review):
One aim of this paper was to study historical migration from Botswana during the time of the development of the HIV epidemic. The second aim was to test whether the migration networks impacted the development of the epidemic. The first aim was achieved: this paper used historical census data in a clear way, to describe the qualities of characteristics of migration in the country at four points in time, from 1981 to 2011. Very detailed data are presented in clear ways, using network chord diagrams, sharing age- and sex-specific migration rates, and urban-rural classifications. However, data was not presented to achieve the second aim. The authors reviewed some important literature about migration and HIV. They suggested that the migration patterns, such as from specific mining towns and mostly between districts, could have been important in supporting the generalized spread of HIV. But without evidence linking HIV prevalence over time in the linked districts in Botswana, this aim was not supported.
We have now made it clear that we are not testing whether the migration networks impacted the development of Botswana’s HIV epidemic: this is what the Reviewer describes as the second aim of our paper. We have only one aim: to test the hypothesis that, during the development of Botswana’s HIV epidemic, the population was extremely mobile and highly connected through migratory flows and counter-flows. This is based on the fact that these conditions are necessary for the development of a generalized HIV epidemic. However – previous to our analysis – these conditions have not been shown to occur during the development of a generalized HIV epidemic. Given that our results support our mobility hypothesis (i.e., that the population was very mobile and essentially all the districts were connected throughout the country), in the discussion (lines 338-362) we describe how the migration networks that we have identified may have impacted the development of the generalized hyperendemic HIV epidemic in Botswana. We have also clarified that our study has only one hypothesis that we are testing by referring to this single hypothesis as the mobility hypothesis (Abstract: lines 25-29).
One other limitation of the paper was that very little context, outside of migration rates, was provided. Is there any additional information about economic growth, or political event for example, that could clarify or add context to these migration flows? As it stands now, these analyses are quite basic and don't take into account underlying demographic, economic, or political trends.
In response to this concern we have expanded the text in the introduction to provide more context regarding political, demographic and economic factors (Introduction: lines 66-75). We have also expanded our discussion of the implications of our results (and of additional results that we have included: lines 263-283) for understanding the role of internal migration on urbanization in Botswana (Discussion: lines 379-420); urbanization occurred simultaneously to the development of Botswana’s generalized hyperendemic HIV epidemic.
The data presented in this paper has potential impact. As the paper stands now, it could be quite useful for future work when linked to additional data sources on HIV prevalence over time (or other questions that could have been influenced by migration patterns).
We thank this Reviewer for their helpful comments.
Reviewer #2 (Public Review):
To provide context into the HIV epidemic in Botswana over the latter half of the 20th century and the beginning of the 21st, the authors have analyzed micro census data to examine patterns of migration. They use this dataset to show how patterns between urban and rural areas have changed over several decades, and the demographic characteristics of migrants. The dataset used for this study is a very reliable source, and the insights in terms of migration patterns are interesting. The primary weakness of the analyses regards the link to HIV transmission: micro-census data only examine mobility that leads to individuals changing residence for longer periods of time, without accounting for shorter-term trips that may also lead to HIV transmission, such as seasonal migration or short trips. This is likely less of an issue with HIV than other diseases, however, due to its transmission often involving new sexual partners, which will generally be less likely to occur during short trips. Broadly, however, this is an interesting report on the migration patterns during a critical period for HIV transmission nationwide.
We thank the Reviewer for their comments.
In our current manuscript, we have discussed the potential impact of mobility on Botswana’s HIV epidemic, and focused on migration, i.e., one directional movement in terms of a permanent re-location of residency. This type of migration, by changing an individual’s sexual network and social environment, has been shown to increase the risk of acquiring HIV for both women and men. Short-term mobility (e.g., short-term circular migration, where the trip can range in duration from overnight to an entire season) can also affect HIV transmission dynamics. Circular migrants have been shown to both have an increased risk of acquiring HIV, and of transmitting HIV. The greater the number of trips and/or the duration of the trip, the greater the risk. We note that both migration and short-term mobility are important, and their relative importance to each other is likely to evolve over time as a generalized HIV epidemic diffuses through the population. Their relative importance is also likely to vary amongst countries in sub-Saharan Africa.
We have added all of the previous paragraph, with citations, to the text (Discussion: lines 364-377).
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
1) Although I found the introduction well written, I think it lacks some information or needs to develop more on some ideas (e.g., differences between the cerebellum and cerebral cortex, and folding patterns of both structures). For example, after stating that "Many aspects of the organization of the cerebellum and cerebrum are, however, very different" (1st paragraph), I think the authors need to develop more on what these differences are. Perhaps just rearranging some of the text/paragraphs will help make it better for a broad audience (e.g., authors could move the next paragraph up, i.e., "While the cx is unique to mammals (...)").
We have added additional context to the introduction and developed the differences between cerebral and cerebellar cortex, also re-arranging the text as suggested.
2) Given that the authors compare the folding patterns between the cerebrum and cerebellum, another point that could be mentioned in the introduction is the fact that the cerebellum is convoluted in every mammalian species (and non-mammalian spp as well) while the cerebrum tends to be convoluted in species with larger brains. Why is that so? Do we know about it (check Van Essen et al., 2018)? I think this is an important point to raise in the introduction and to bring it back into the discussion with the results.
We now mention in the introduction the fact that the cerebellum is folded in mammals, birds and some fishes, and provide references to the relevant literature. We have also expanded our discussion about the reasons for cortical folding in the discussion, which now contains a subsection addressing the subject (this includes references to the work of Van Essen).
3) In the results, first paragraph, what do the authors mean by the volume of the medial cerebellum? This needs clarification.
We have modified the relevant section in the results, and made the definition of the medial cerebellum more clear indicating that we refer to the vermal region of the cerebellum.
4) In the results: When the authors mention 'frequency of cerebellar folding', do they mean the degree of folding in the cerebellum? At least in non-mammalian species, many studies have tried to compare the 'degree or frequency of folding' in the cerebellum by different proxies/measurements (see Iwaniuk et al., 2006; Yopak et al., 2007; Lisney et al., 2007; Yopak et al., 2016; Cunha et al., 2022). Perhaps change the phrase in the second paragraph of the result to: "There are no comparative analyses of the frequency of cerebellar folding in mammals, to our knowledge".
We have modified the subsection in the methods referring to the measurement of folial width and folial perimeter to make the difference more clear. The folding indices that have been used previously (which we cite) are based on Zilles’s gyrification index. This index provides only a global idea of degree of folding, but it’s unable to distinguish a cortex with profuse shallow folds from one with a few deep ones. An example of this is now illustrated in Fig. 3d, where we also show how that problem is solved by the use of our two measurements (folial width and perimeter). The problem is also discussed in the section about the measurement of folding in the discussion section:
“Previous studies of cerebellar folding have relied either on a qualitative visual score (Yopak et al. 2007, Lisney et al. 2008) or a “gyrification index” based on the method introduced by Zilles et al. (1988, 1989) for the study of cerebral folding (Iwaniuk et al. 2006, Cunha et al. 2020, 2021). Zilles’s gyrification index is the ratio between the length of the outer contour of the cortex and the length of an idealised envelope meant to reflect the length of the cortex if it were not folded. For instance, a completely lissencephalic cortex would have a gyrification index close to 1, while a human cerebral cortex typically has a gyrification index of ~2.5 (Zilles et al. 1988). This method has certain limitations, as highlighted by various researchers (Germanaud et al. 2012, 2014, Rabiei et al. 2018, Schaer et al. 2008, Toro et al. 2008, Heuer et al. 2019). One important drawback is that the gyrification index produces the same value for contours with wide variations in folding frequency and amplitude, as illustrated in Fig. 3d. In reality, folding frequency (inverse of folding wavelength) and folding amplitude represent two distinct dimensions of folding that cannot be adequately captured by a single number confusing both dimensions. To address this issue we introduced 2 measurements of folding: folial width and folial perimeter. These measurements can be directly linked to folding frequency and amplitude, and are comparable to the folding depth and folding wavelength we introduced previously for cerebral 3D meshes (Heuer et al. 2019). By using these measurements, we can differentiate folding patterns that could be confused when using a single value such as the gyrification index (Fig. 3d). Additionally, these two dimensions of folding are important, because they can be related to the predictions made by biomechanical models of cortical folding, as we will discuss now.”
5) Sultan and Braitenberg (1993) measured cerebella that were sagittally sectioned (instead of coronal), right? Do you think this difference in the plane of the section could be one of the reasons explaining different results on folial width between studies? Why does the foliation index calculated by Sultan and Braitenberg (1993) not provide information about folding frequency?
The measurement of foliation should be similar as far as enough folds are sectioned perpendicular to their main axis. This will be the case for folds in the medial cerebellum (vermis) sectioned sagittally, and for folds in the lateral cerebellum sectioned coronally. The foliation index of Sultan and Braitenberg does not provide a similar account of folding frequency as we do because they only measure groups of folia (what some called lamellae), whereas we measure individual folia. It is not easy to understand exactly how Sultan and Braitenberg proceeded from their paper. We contacted Prof. Fahad Sultan (we acknowledge his help in our manuscript). Author response image 1 provides a more clear description of their procedure:
Author response image 1.
As Author response image 1 shows, each of the structures that they call a fold is composed of several folia, and so their measurements are not comparable with ours which measure individual folia (a). The flattened representation (b) is made by stacking the lengths of the fold axes (dashed lines), separating them by the total length of each fold (the solid lines), which each may contain several folia.
6) Another point that needs to be clarified is the log transformation of the data. Did the authors use log-transformed data for all types of analyses done in the study? Write this information in the material and methods.
Yes, we used the log10 transformation for all our measurements. This is now mentioned in the methods section, and again in the section concerning allometry. We are including a link to all our code to facilitate exact replication of our entire method, including this transformation.
7) The discussion needs to be expanded. The focus of the paper is on the folding pattern of the cerebellum (among different mammalian species) and its relationship with the anatomy of the cerebrum. Therefore, the discussion on this topic needs to be better developed, in my opinion (especially given the interesting results of this paper). For example, with the findings of this study, what can we say about how the folding of the cerebellum is determined across mammals? The authors found that the folial width, folial perimeter, and thickness of the molecular layer increase at a relatively slow rate across the species studied. Does this mean that these parameters have little influence on the cerebellar folding pattern? What mostly defines the folding patterns of the cerebellum given the results? Is it the interaction between section length and area? Can the authors explain why size does not seem to be a "limiting factor" for the folding of the cerebellum (for example, even relatively small cerebella are folded)? Is that because the 'white matter' core of the cerebellum is relatively small (thus more stress on it)?
We have expanded the discussion as suggested, with subsections detailing the measuring of folding, the modelling of folding for the cerebrum and the cerebellum, and the role that cerebellar folding may play in its function. We refer to the literature on cortical folding modelling, and we discuss our results in terms of the factors that this research has highlighted as critical for folding. From the discussion subsection on models of cortical folding:
“The folding of the cerebral cortex has been the focus of intense research, both from the perspective of neurobiology (Borrell 2018, Fernández and Borrell 2023) and physics (Toro and Burnod 2005, Tallinen et al. 2014, Kroenke and Bayly 2018). Current biomechanical models suggest that cortical folding should result from a buckling instability triggered by the growth of the cortical grey matter on top of the white matter core. In such systems, the growing layer should first expand without folding, increasing the stress in the core. But this configuration is unstable, and if growth continues stress is released through cortical folding. The wavelength of folding depends on cortical thickness, and folding models such as the one by Tallinen et al. (2014) predict a neocortical folding wavelength which corresponds well with the one observed in real cortices. Tallinen et al. (2014) provided a prediction for the relationship between folding wavelength λ and the mean thickness (𝑡) of the cortical layer: λ = 2π𝑡(µ/(3µ𝑠))1/3. (...)”
From this biomechanical framework, our answers to the questions of the Reviewer would be:
-
How is the folding of the cerebellum determined across mammals? By the expansion of a layer of reduced thickness on top of an elastic layer (the white matter)
-
Folial width, folial perimeter, and thickness of the molecular layer increase at a relatively slow rate across the species studied. Does this mean that these parameters have little influence on the cerebellar folding pattern? On the contrary, that indicates that the shape of individual folia is stable, providing the smallest level of granularity of a folding pattern. In the extreme case where all folia had exactly the same size, a small cerebellum would have enough space to accommodate only a few folia, whereas a large cerebellum would accommodate many more.
-
What mostly defines the folding patterns of the cerebellum given the results? Is it the interaction between section length and area? It’s the mostly 2D expansion of the cerebellar cortical layer and its thickness.
-
Can the authors explain why size does not seem to be a "limiting factor" for the folding of the cerebellum? Because even a cerebellum of very small volume would fold if its cortex were thin enough and expanded sufficiently. That’s why the cerebellum folds even while being smaller than the cerebrum: because its cortex is much thinner.
8) One caveat or point to be raised is the fact that the authors use the median of the variables measured for the whole cerebellum (e.g., median width and median perimeter across all folia). Although the cerebellum is highly uniform in its gross internal morphology and circuitry's organization across most vertebrates, there is evidence showing that the cerebellum may be organized in different functional modules. In that way, different regions or folia of the cerebellum would have different olivo-cortico-nuclear circuitries, forming, each one, a single cerebellar zone. Although it is not completely clear how these modules/zones are organized within the cerebellum, I think the authors could acknowledge this at the end of their discussion, and raise potential ideas for future studies (e.g., analyse folding of the cerebellum within the brain structure - vermis vs lateral cerebellum, for example). I think this would be a good way to emphasize the importance of the results of this study and what are the main questions remaining to be answered. For example, the expansion of the lateral cerebellum in mammals is suggested to be linked with the evolution of vocal learning in different clades (see Smaers et al., 2018). An interesting question would be to understand how foliation within the lateral cerebellum varies across mammalian clades and whether this has something to do with the cellular composition or any other aspect of the microanatomy as well as the evolution of different cognitive skills in mammals.
We now address this point in a subsection of the discussion which details the implications of our methodological decisions and the limitations of our approach. It is true that the cerebellum is regionally variable. Our measurements of folial width, folial perimeter and molecular layer thickness are local, and we should be able to use them in the future to study regional variation. However, this comes with a number of difficulties. First, it would require sampling all the cerebellum (and the cerebrum) and not just one section. But even if that were possible that would increase the number of phenotypes, beyond the current scope of this study. Our central question about brain folding in the cerebellum compared to the cerebrum is addressed by providing data for a substantial number of mammalian species. As indicated by Reviewer #3, adding more variables makes phylogenetic comparative analyses very difficult because the models to fit become too large.
Reviewer #2 (Public Review):
1) The methods section does not address all the numerical methods used to make sense of the different brain metrics.
We now provide more detailed descriptions of our measurements of foliation, phylogenetic models, analysis of partial correlations, phylogenetic principal components, and allometry. We have added illustrations (to Figs. 3 and 5), examples and references to the relevant literature.
2) In the results section, it sometimes makes it difficult for the reader to understand the reason for a sub-analysis and the interpretation of the numerical findings.
The revised version of our manuscript includes motivations for the different types of analyses, and we have also added a paragraph providing a guide to the structure of our results.
3) The originality of the article is not sufficiently brought forward:
a) the novel method to detect the depth of the molecular layer is not contextualized in order to understand the shortcomings of previously-established methods. This prevents the reader from understanding its added value and hinders its potential re-use in further studies.
The revised version of the manuscript provides additional context which highlights the novelty of our approach, in particular concerning the measurement of folding and the use of phylogenetic comparative models. The limitations of the previous approaches are stated more clearly, and illustrated in Figs. 3 and 5.
b) The numerous results reported are not sufficiently addressed in the discussion for the reader to get a full grasp of their implications, hindering the clarity of the overall conclusion of the article.
Following the Reviewer’s advice, we have thoroughly restructured our results and discussion section.
Reviewer #3 (Public Review):
1) The first problem relates to their use of the Ornstein-Uhlenbeck (OU) model: they try fitting three evolutionary models, and conclude that the Ornstein-Uhlenbeck model provides the best fit. However, it has been known for a while that OU models are prone to bias and that the apparent superiority of OU models over Brownian Motion is often an artefact, a problem that increases with smaller sample sizes. (Cooper et al (2016) Biological Journal of the Linnean Society, 2016, 118, 64-77).
Cooper et al.’s (2016) article “A Cautionary Note on the Use of Ornstein Uhlenbeck Models in Macroevolutionary Studies” suggests that comparing evolutionary models using the model’s likelihood leads often to incorrectly selecting OU over BM even for data generated from a BM process. However, Grabowski et al (2023) in their article ‘A Cautionary Note on “A Cautionary Note on the Use of Ornstein Uhlenbeck Models in Macroevolutionary Studies”’ suggest that Cooper et al.’s (2016) claim may be misleading. The work of Clavel et al. (2019) and Clavel and Morlon (2017) shows that the penalised framework implemented in mvMORPH can successfully recover the parameters of a multivariate OU process. To address more directly the concern of the Reviewer, we used simulations to evaluate the chances that we would decide for an OU model when the correct model was BM – a similar procedure to the one used by Cooper et al.’s (2016). However, instead of using the likelihood of the fitted models directly as Cooper et al. (2016) – which does not control for the number of parameters in the model – we used the Akaike Information Criterion, corrected for small sample sizes: AICc. The standard Akaike Information Criterion takes the number of parameters of the model into account, but this is not sufficient when the sample size is small. AICc provides a score which takes both aspects into account: model complexity and sample size. This information has been added to the manuscript:
“We selected the best fitting model using the Akaike Information Criterion (AIC), corrected for 𝐴𝐼𝐶 = − 2 𝑙𝑜𝑔(𝑙𝑖𝑘𝑒𝑙𝑖ℎ𝑜𝑜𝑑) + 2 𝑝. This approximation is insufficient when the𝑝 sample size small sample sizes (AICc). AIC takes into account the number of parameters in the model: is small, in which case an additional correction is required, leading to the corrected AIC: 𝐴𝐼𝐶𝑐 = 𝐴𝐼𝐶 + (2𝑝2 + 2𝑝)/(𝑛 − 𝑝 − 1), where 𝑛 is the sample size.”
In 1000 simulations of 9 correlated multivariate traits for 56 species (i.e., 56*9 data points) using our phylogenetic tree, only 0.7% of the times we would decide for OU when the real model was BM.
2) Second, for the partial correlations (e.g. fig 7) and Principal Components (fig 8) there is a concern about over-fitting: there are 9 variables and only 56 data points (violating the minimal rule of thumb that there should be >10 observations per parameter). Added to this, the inclusion of variables lacks a clear theoretical rationale. The high correlations between most variables will be in part because they are to some extent measuring the same things, e.g. the five different measures of cerebellar anatomy which include two measures of folial size. This makes it difficult to separate their effects. I get that the authors are trying to tease apart different aspects of size, but in practice, I think these results (e.g. the presence of negative coefficients in Fig 7) are really hard or impossible to interpret. The partial correlation network looks like a "correlational salad" rather than a theoretically motivated hypothesis test. It isn't clear to me that the PC analyses solve this problem, but it partly depends on the aims of these analyses, which are not made very clear.
PCA is simply a rigid rotation of the data, distances among multivariate data points are all conserved. Neither our PCA nor our partial correlation analysis involve model fitting, the concept of overfitting does not apply. PCA and partial correlations are also not used here for hypothesis testing, but as exploratory methods which provide a transformation of the data aiming at capturing the main trends of multivariate change. The aim of our analysis of correlation structure is precisely to avoid the “correlational salad” that the Reviewer mentions. The Reviewer is correct: all our variables are correlated to a varying degree (note that there are 56 data points per variable = 56*9 data points, not just 56 data points). Partial correlations and PCA aim at providing a principled way in which correlated measurements can be explored. In the revised version of the manuscript we include a more detailed description of partial correlations and PCA (phylogenetic). Whenever variables measure the same thing, they will be combined into the same principal component (these are the combinations shown in Fig. 8 b and d). Additionally, two variables may be correlated because of their correlation with a third variable (or more). Partial correlations address this possibility by looking at the correlations between the residuals of each pair of variables after all other variables have been covaried out. We provide a simple example which should make this clear, providing in particular an intuition for the meaning of negative correlations:
“All our phenotypes were strongly correlated. We used partial correlations to better understand pairwise relationships. The partial correlation between 2 vectors of measurements a and b is the correlation between their residuals after the influence of all other measurements has been covaried out. Even if the correlation between a and b is strong and positive, their partial correlation could be 0 or even negative. Consider, for example, 3 vectors of measurements a, b, c, which result from the combination of uncorrelated random vectors x, y, z. Suppose that a = 0.5 x + 0.2 y + 0.1 z, b = 0.5 x - 0.2 y + 0.1 z, and c = x. The measurements a and b will be positively correlated because of the effect of x and z. However, if we compute the residuals of a and b after covarying the effect of c (i.e., x), their partial correlation will be negative because of the opposite effect of y on a and b. The statistical significance of each partial correlation being different than 0 was estimated using the edge exclusion test introduced by Whittaker (1990).”
The rationale for our analyses has been made more clear in the revised version of the manuscript, aided by the more detailed description of our methods. In particular, we describe better the reason for our 2 measurements of folial shape – width and perimeter – which measure independent dimensions of folding (this is illustrated in Fig. 3d).
3) The claim of concerted evolution between cortical and cerebellar values (P 11-12) seems to be based on analyses that exclude body size and brain size. It, therefore, seems possible - or even likely - that all these analyses reveal overall size effects that similarly influence the cortex and cerebellum. When the authors state that they performed a second PC analysis with body and brain size removed "to better understand the patterns of neuroanatomical evolution" it isn't clear to me that is what this achieves. A test would be a model something like [cerebellar measure ~ cortical measure + rest of the brain measure], and this would deal with the problem of 'correlation salad' noted below.
The answer to this question is in the partial correlation diagram in Fig. 7c. This analysis does not exclude body weight nor brain weight. It shows that the strong correlation between cerebellar area and length is supported by a strong positive partial correlation, as is the link between cerebral area and length. There is a significant positive partial correlation between cerebellar section area and cerebral section length. That is, even after covarying everything else, there is still a correlation between cerebellar section area and cerebral section length (this partial correlation is equivalent to the suggestion of the Reviewer). Additionally, there is a positive partial correlation between body weight and cerebellar section area, but not significant partial correlation between body weight and cerebral section area or length. Our approach aims at obtaining a general view of all the relationships in the data. Testing an individual model would certainly decrease the number of correlations, however, it would provide only a partial view of the problem.
4) It is not quite clear from fig 6a that the result does indeed support isometry between the data sets (predicted 2/3 slope), and no coefficient confidence intervals are provided.
We have now added the numerical values of the CIs to all our plots in addition to the graphical representations (grey regions) in the previous version of the manuscript. The isometry slope (0.67) is either within the CIs (both for the linear and orthogonal regressions) or at the margin, indicating that if the relationships are not isometric, they are very close to it.
Referencing/discussion/attribution of previous findings
5) With respect to the discussion of the relationship between cerebellar architecture and function, and given the emphasis here on correlated evolution with cortex, Ramnani's excellent review paper goes into the issues in considerable detail, which may also help the authors develop their own discussion: Ramnani (2006) The primate cortico-cerebellar system: anatomy and function. Nature Reviews Neuroscience 7, 511-522 (2006)
We have added references to the work of Ramnani.
6) The result that humans are outliers with a more folded cerebellum than expected is interesting and adds to recent findings highlighting evolutionary changes in the hominin human cerebellum, cerebellar genes, and epigenetics. Whilst Sereno et al (2020) are cited, it would be good to explain that they found that the human cerebellum has 80% of the surface area of the cortex.
We have added this information to the introduction:
“In humans, the cerebellum has ~80% of the surface area of the cerebral cortex (Sereno et al. 2020), and contains ~80% of all brain neurons, although it represents only ~10% of the brain mass (Azevedo et al. 2009)”
7) It would surely also be relevant to highlight some of the molecular work here, such as Harrison & Montgomery (2017). Genetics of Cerebellar and Neocortical Expansion in Anthropoid Primates: A Comparative Approach. Brain Behav Evol. 2017;89(4):274-285. doi: 10.1159/000477432. Epub 2017 (especially since this paper looks at both cerebellar and cortical genes); also Guevara et al (2021) Comparative analysis reveals distinctive epigenetic features of the human cerebellum. PLoS Genet 17(5): e1009506. https://doi.org/10.1371/journal. pgen.1009506. Also relevant here is the complex folding anatomy of the dentate nucleus, which is the largest structure linking cerebellum to cortex: see Sultan et al (2010) The human dentate nucleus: a complex shape untangled. Neuroscience. 2010 Jun 2;167(4):965-8. doi: 10.1016/j.neuroscience.2010.03.007.
The information is certainly important, and could have provided a wider perspective on cerebellar evolution, but we would prefer to keep a focus on cerebellar anatomy and address genetics only indirectly through phylogeny.
8) The authors state that results confirm previous findings of a strong relationship between cerebellum and cortex (P 3 and p 16): the earliest reference given is Herculano-Houzel (2010), but this pattern was discovered ten years earlier (Barton & Harvey 2000 Nature 405, 1055-1058. https://doi.org/10.1038/35016580; Fig 1 in Barton 2002 Nature 415, 134-135 (2002). https://doi.org/10.1038/415134a) and elaborated by Whiting & Barton (2003) whose study explored in more detail the relationship between anatomical connections and correlated evolution within the cortico-cerebellar system (this paper is cited later, but only with reference to suggestions about the importance of functions of the cerebellum in the context of conservative structure, which is not its main point). In fact, Herculano-Houzel's analysis, whilst being the first to examine the question in terms of numbers of neurons, was inconclusive on that issue as it did not control for overall size or rest of the brain (A subsequent analysis using her data did, and confirmed the partially correlated evolution - Barton 2012, Philos Trans R Soc Lond B Biol Sci. 367:2097-107. doi: 10.1098/rstb.2012.0112.)
We apologise for this oversight, these references are now included.
-
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #2 (Public Review):
Root growth is driven by cell elongation, and its local control allows roots to navigate the complex soil environment. Cell growth is driven by the relaxation of the cell wall, a process requiring a drop in pH. Auxin is a key regulator of root development that inhibits root growth. Auxin effects on proton dynamics are complex, it can promote both acidification and alkalinization of the extracellular space through different signaling modules, some only recently uncovered. Serre et al. report on using a new dye to monitor extracellular pH in the region surrounding the Arabidopsis thaliana root. Their manuscript aims to clarify the relationships between pH around the root, proton flux, auxin, cell elongation, and root growth with this tool. They show a typical zonation of pH values along the root: a more acidic domain corresponding to the transit-amplifying compartment, followed by a more alkaline one at the transition and early elongation zones and a more acidic one in the late elongation/root hair zone. This zonation is in agreement with previous reports obtained by other methods. A particularly puzzling aspect is the origin of the more alkaline domain. Serre et al. present evidence supporting the involvement of the AUX1-AFB1-CNGC14 module for the emergence of this more alkaline domain and how it can contribute to the ability of the root to navigate its environment.
Serre et al. show that the more alkaline domain in the transition zone is not directly determined by the activity or localization of the AHA proton pumps but rather by the auxin influx carrier AUX1. They show that the components of the rapid auxin response pathway, in particular, the auxin co-receptor AFB1 and the calcium channel CNGC14, contribute to the emergence of this more alkaline domain. Finally, they show that mutants in these two genes, impaired in the rapid auxin response pathway, show less efficient navigation of the root tip.
The manuscript is clear and well-written. The logic is sound, and the conclusions are supported by the data.
The new dye appears as a promising tool for monitoring the pH in the rhizosphere with advantages over the previous ones. Yet, as pointed out by the authors in the discussion, it reports on pH at the organ scale in the region around the root, not in the apoplast or the cell wall, which can eventually complexify the elaboration of a mechanistic model joining auxin, proton efflux, cell wall properties, cell elongation, and root growth. Although several of the findings confirm previous reports, the manuscript brings novelty by demonstrating the involvement of the rapid auxin response. I am overall supportive of the manuscript. Yet, several points should be addressed:
-
The presentation of the more acidic and alkaline domains could be easier to visualize.
-
The authors refer to acidic and alkaline domains but do not report on absolute pH values; they monitor the emission ratio of the dye. They justify why to use relative pH value in the discussion and refer there to internal controls that are not clearly defined. In my opinion, the wording should be more consistent across the text and figures and refer to more acidic and more alkaline domains rather than acidic (pH<7) and alkaline (pH>7) domains.
-
The data related to the unaltered distribution of AHA using antibody staining should be backed up.
-
The way the pH profile and the statistical analyses should be improved.
-
The authors should test the effect of extracellular auxin perception (tmk, abp) mutants on pH zonation.
-
Conclusion could be strengthened by moving several pieces of data currently in supplemental material to the main text.
We agree with the comment to the definition of ‘acidic’ and ‘alkaline’ domains; we altered the text and explained that we observe ‘relatively alkaline’ and ‘relatively acidic’ domains in comparison to the medium pH in the first part of results.
We defined the ‘internal controls’ in the text – by this we mean mock treated or wild type plants imaged together with the treated or mutant plants.
To address the role of the apoplastic auxin pathway in the root surface pH, we analyzed the tmk1, tmk4 and abp1 mutants. Surprisingly, all three mutants appear undistinguishable from the controls, showing the crucial importance of the cytoplasmic AFB1 auxin perception pathway. We have included the data as Fig.S4-1.
-
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
This paper studies color vision in anemonefish. The central conclusion of the paper is that anemonefish use signals from their UV cones to discriminate colors that would not otherwise be distinguishable; this differs from other fish in which UV cones extend the range of wavelengths of sensitivity but do not add a dimension to color vision. The work fits into a rich history of studies investigating how color vision fits into an animal's ecological niche. My primary concerns regard the microspectrophotometry data from single cones and some aspects of the presentation of the behavioral data.
Microspectrophotometry
The spectral properties of the cone types are a key issue for interpreting the results. These were measured using MSP, and fits are shown in Figure 2. The raw data shown in Fig. S1 appears more complicated than indicated in the main text. The templates miss the measurements across broad wavelength bands in each cone type. Particularly concerning is the high UV absorbance across cone types and the long-wavelength absorbance in the UV cone. It is not clear how this picture supports the relatively simple description of cone types and spectral sensitivities given in the main text and which forms the basis of the modeling.
Microspectrophotometry is an inherently noise-prone measurement technique, particularly for very small photoreceptor outer segments such as that of single cones, which are also difficult to detect as intact, isolated (nonoverlapping) cells. As such, the absorbance curve fitting and derived lambda max (λmax) values should be treated as estimates. The accuracy of these estimates is adequate for this type of study, and visual modelling results have been shown to be robust against small errors (±10 nm λmax) in photoreceptor sensitivity for multiple species [see Lind, O. & Kelber, A. (2009). Vis Res. 49(15), 1939-1947; and Bitton, PP. et al. (2017). PLOS ONE, 12: e0169810]. We consider it highly unlikely that small shifts in cone λmax from measurement error would make a meaningful difference to the colour discrimination thresholds.
It should be noted that the raw data shown in the original Supplementary Figure 1, included all scans overlain with an average absorbance curve for presentation purposes; however, the actual lambda max values for different cone types were measured and then averaged among individual scans fitted with photopigment absorbance curve templates. For clarity and transparency, we have now provided three multipaned plots (see Figure 1 – figure supplements 1-3) showing the individual pre- and post-bleach scans of absorbance spectra, fitted absorbance curve templates, and R2 values from the best visual pigment template fit.
It is worth noting that most of the cone absorbance spectra found in our study closely resemble those in λmax and quality to those measured in another anemonefish species (Amphiprion akindynos) [see Supplementary Figure 1 in Stieb S. et al. (2019). Sci Rep. 9, 16459]. These cone λmax values can also be reconciled with previous estimates on opsin λmax based on amino acid sequences and cone opsin expression in the A. ocellaris retina characterised in Mitchell LJ et al. (2021). GBE, 13: evab184.
Evidence that the unusual long-wavelength absorbance detected in a couple of the single cone (pre-bleach) measurements were not of visual pigment in origin comes from post-bleach scans, which showed their persistence (i.e., did not show a photobleaching response) and were likely instead contaminants (e.g., blood, RPE pigment). UV absorbance in some of the double cone measurements (above that expected of the prebleached beta peak from chromophore spectral absorption) can be attributed to either noise from scans as is quite typical of MSP and/or partial (accidental) bleaching from stray light sources. Although utmost care was taken to minimise contamination and unintended bleaching sometimes it is unavoidable.
We refer the Reviewer to multiple published studies for further examples of typical MSP measurements that share similar levels of noise to ours e.g., see Figure 1 in Knott B. et al. (2013). JEB, 216:4454-4461; Figure 3 in Schott, RK et al. (2015). PNAS, 113(2): 356-361; Figure 2 in Dalton BE et al. (2014). Proc R Soc B. 281; Figure 5 in Tosetto, JE et al. (2021). Brain Behav Evol. 96: 103-123.
Presentation
The results are not presented in a straightforward way - at least for this reviewer. What is missing for me is a clear link between the psychometric curves in Figure 3A and the discrimination thresholds indicated in Figure 3B and Figure 4. Figure 3A is only discussed in the text on line 289 - after Figure 4 has been introduced and discussed. It would have been very helpful for me if the psychometric curves were first introduced and described, then the relation to Figure 3B was clearly indicated (perhaps with a single psychometric curve as an example). Similarly for Figure 4 the relationship between specific psychometric curves and the threshold plotted would be quite helpful. Currently it takes a careful reading to understand why being below the dashed line in Figure 4 is important.
We have made the following changes, including the introduction of the psychometric curves earlier in the results (lines 236-249) and moved the psychometric function comparison before the mention of Figure 4. Additionally, to make the association between the plotted colour loci and psychometric curves clearer, we have added a smaller psychometric curve plot adjacent to the colour space (in Figure 3B) using red as an example which has an averaged psychometric curve overlying the individual fish curves. The figure caption (lines 250-274) explains that the plotted colour loci and given thresholds are mean values calculated from the individual fish behavioural data.
We have also added a brief reminder that the theoretical limit of colour discrimination is predicted by the RNL model as 1∆S, where in our task fish should be just able to distinguish targets from grey distractors (see lines 222-224). To clarify, the plotted values in Figure 4B are both the individual fish thresholds (points) and average threshold (black bar) per colour set. The individual threshold values are taken at a correct choice probability of 50% from fitted psychometric curves of fish behavioural performance (shown in Figure 3A).
RNL model
The data is fit and interpreted in the context of the receptor noise limited model. The paragraph in the discussion about complementary color pairs suggests that this model is incorrect (text around line 332). Consideration of how the results depend on the RNL model is important, especially given the interpretation here.
The inability of the RNL model to account for the observed asymmetry between color discrimination thresholds implies that they cannot be solely attributed to photoreceptor noise. We can therefore infer from the asymmetry that thresholds are set by a higher-level process, whether that involves post-receptor processes within the inner retina or in the brain remains to be investigated. As explained in lines 396-397 one possibility is that activation of the UV receptor suppresses noise in the visual pathway or enhances the saliency of colors for anemonefish. The high sensitivity to violet-green, which was found in all six of the fish tested, is consistent with the heightened saliency of this color (lines 397-399).
Figure 3B
This is the key figure in the paper. But several issues make seeing the data in this figure difficult. First, the important part of the figure is buried near the origin and hard to see. Can you show a surface that connects the thresholds in the different chromatic directions, or otherwise highlight the regions of discriminable and not discriminable colors?
See previous comment. In short, we have taken the advice of the Reviewer and added highlighted areas around the regions of discriminable colors in Figure 3B to help visually separate them from the non-discriminable regions of colors (from grey). Additionally, we have added an inset showing an enlarged image of the area surrounding the centre of colour space.
Reviewer #2 (Public Review):
Mitchell and colleagues examined the contribution of a UV-sensitive cone photoreceptor to chromatic detection in Amphiprion ocellaris, a type of anemonefish. First, they used biophysical measurements to characterize the response properties of the retinal receptors, which come in four spectrally-distinct subtypes: UV, M1, M2, and L. They then used these spectral sensitivities to construct a 4-dimensional (tetrahedral) color space in which stimuli with known spectral power distributions can be represented according to the responses they elicit in the four cone types. A novel five-LED display was used to test the fish's ability to detect "chromatic" modulations in this color space against a background of random-intensity, "achromatic" distractors that produce roughly equal relative responses in the four cone types. A subset of stimuli, defined by their high positive UV contrast, were more readily detected than other colors that contained less UV information. A well-established model was used to link calculated receptor responses to behavioral thresholds. This framework also enabled statistical comparisons between models with varying number of cone types contributing to discrimination performance, allowing inferences to be drawn about the dimensionality of color vision in anemonefish.
The authors make a compelling case for how UV light in the anemonefish habitat is likely an important ecological source of information for guiding their behavior. The authors are to be commended for developing an elegant behavioral paradigm to assess visual performance and for incorporating a novel display device especially suited to addressing hypotheses about the role of UV light in color perception. While the data are suggestive of behavioral tetrachromacy in anemonefish, there are some aspects of the study that warrant additional consideration:
1) One challenge faced by many biological imaging systems is longitudinal chromatic aberration (LCA) - that is, the focal power of the system depends on wavelength. In general, focal power increases with decreasing wavelength, such that shorter wavelengths tend to focus in front of longer wavelengths. In the human eye, at least, this focal power changes nonlinearly with wavelength, with the steepest changes occurring in the shorter part of the visible spectrum (Atchison & Smith, 2005). In the fish eye, where the visible spectrum extends to even shorter wavelengths, it seems plausible that a considerable amount of LCA may exist, which could in turn cause UV-enriched stimuli to be more salient (relative to the distractor pixels) due to differences in perceived focus rather than due solely to differences in their respective spectral compositions. Such a mechanism has been proposed by Stubbs & Stubbs (2016) as a means for supporting "color vision" in monochromatic cephalopods (but see Gagnon et al. 2016). It would be worth discussing what is known about the dispersive properties of the crystalline lens in A. ocellaris (or similar species), and whether optical factors could produce sufficient cues in the retinal image that might explain aspects of the behavioral data presented in the current study.
This is an interesting point, and we appreciate the reviewer’s thoughtful comment regarding this topic especially as LCA increases exponentially in the UV. Although we certainly cannot disprove such a mechanism in the present study, we are highly sceptical that LCA could be used by reef fish and is involved in the heightened saliency of UV stimuli. Previous work has found that LCA is mostly corrected for in the teleost retina of both marine and freshwater species by graded, multifocal lenses that focus different wavelengths at the same depth as their maximally sensitive cone photoreceptors [e.g., for evidence in African cichlids see Kröger, R. H. H. et al. (1999). J Comp Physiol. A, 184, 361-369; Malkki, P. E. & Kröger, R. H. H. (2005). J Opt. A, 7, 691-700; and for various reef fishes see Karpestam, B. et al. (2007). J Exp Biol., 210, 16: 2923-2931]. In essence, LCA is corrected in the eyes of many teleosts by accurately tuning longitudinal spherical aberration through having a graded density lens. We draw particular attention to the latter reference which comparatively examined the optical properties of reef fish lenses, including diurnal, planktivorous damselfishes (from the same family as anemonefishes, Pomacentridae). They found that not only were the lenses of these species highly UV-transmissive (as we show in anemonefish), but all were multifocal and capable of focusing both visible (non-UV) and UV wavelengths. Considering the coastal cephalopod species examined thus far, all of them contain only one type of visual pigment which is packed in their long photoreceptor (150-450µm long outer segment) across an entire retina (Chung and Marshall 2016, Proceeding B). Theoretically, given these long photoreceptors, the LCA and the resulting differentials of focal length onto different patches of photoreceptors or different depth of the outer segment might provide cues for colour discrimination even though no behavioural evidence exists to prove this hypothesis yet. Unlike the cephalopod case, the four specific spectral cones arranged in a mosaic pattern along with their very short outer segments (5-10µm) in the anemonefish retina likely makes the LCA less effective in this retinal design.
We have added a short paragraph (Lines 400-412) discussing the possibility of an optical mechanism contributing to heightened UV saliency with a particular focus on LCA and our thoughts on why we consider it an unlikely mechanism in anemonefish.
2) The authors provide a quantitative description of anemonefish visual performance within the context of a well-developed receptor-based framework. However, it was less clear to me what inferences (if any) can be drawn from these data about the post-receptoral mechanisms that support tetrachromatic color vision in these organisms. Would specific cone-opponent processes account for instances where behavioral data diverged from predictions generated with the "receptor noise limited" model described in the text? The general reader may benefit from more discussion centered on what is known (or unknown) about the organization of cone-opponent processing in anemonefish and related species.
In short, we do not know the specific opponent interactions of anemonefish cones. The RNL model assumes all possible opponent interactions in its calculations. From our results, very little can be said about the post-receptor mechanisms involved in their putative tetrachromatic vision. We would like to avoid overreaching beyond what our data can show. A future directions section has now been added to the discussion (lines 467-497), which briefly mentions the known UV opponency in larval zebrafish and that future investigation in anemonefish should attempt to disentangle the specific opponent (chromatic) and non-opponent (achromatic) circuits in the anemonefish retina.
Reviewer #3 (Public Review):
The comments below focus mainly on ways that the data and analysis as currently present do not to this reviewer compel the conclusions the authors wish to draw. It is possible that further analysis and/or clarification in the presentation would more persuasively bolster the authors' position. It also seems possible that a presentation with more limited conclusions but clarity on exactly what has been demonstrated and where additional future work is needed would make a strong contribution to the literature.
- Fig 3A. It might be worth emphasizing a bit more explicitly that the x-axis (delta S) is the result of a model fit to the data being shown, since this then means that if RNL model fit the data perfectly, all of the thresholds would fall at deltaS = 1. They don't, so I would like to see some evaluation from the authors' experience with this model as to whether they think the deviations (looks like the delta S range is ~0.4 to ~1.6 in Figure 4B) represent important deviations of the data from the model, the non-significant ANOVA notwithstanding. For example, Figure 4B suggests that the sign of the fit deviations is driven by the sign of the UV contrast and that this is systematic, something that would not be picked up by the ANOVA. Quite a bit is made of the deviations below, but that the model doesn't fully account for the data should be brought out here I think. As the authors note elsewhere, deviations of the data from the RNL model indicate that factors other than receptor noise are at play, and reminding the reader of this here at the first point it becomes clear would be helpful.
We have now stated more explicitly in the figure caption for Figure 3A, that the delta S values presented were calculated by fitting fish behavioral data to the RNL model. To test the overall effect that the sign of the UV contrast had on the discrimination threshold, we have now included ‘contrast’ (positive or negative) as another fixed effect in the linear mixed effects model. We have now included details of this test in the results which shows the systematic effect (lines 338-340). Additionally, as suggested we now briefly introduce in the results the idea that factors other than receptor noise are causing the observed deviations in data from the RNL model.
- Line 217 ff, Figure 4, Supplemental Figure 4). If I'm understanding what the ANOVA is telling us, it is that the deviations of the data across color directions and fish (I think these are the two factors based on line 649) is that the predictions deviate significantly from the data, relative to the inter-fish variability), for the trichromatic models but not the tetrachromatic model. If that's not correct, please interpret this comment to mean that more explanation of the logic of the test would be helpful.
The interpretation of the ANOVA by the Reviewer is mostly correct. We had the variables color set and Fish ID, with threshold delta S as the dependent variable. This showed that deviations from the predicted threshold were significant relative to the inter-fish variability for the trichromatic models. Missing details describing the ANOVA have now been added to the methods (lines 789-798).
Assuming that the above is right about the nature of the test, then I don't think the fact that the tetrachromatic model has an additional parameter (noise level for the added receptor type) is being taken into account in the model comparison. That is, the trichromatic models are all subsets of the tetrachromatic model, and must necessarily fit the data worse. What we want to know is whether the tetrachromatic model is fitting better because its extra parameter is allowing it to account for measurement noise (overfitting), or whether it is really doing a better job accounting for systematic features of the data. This comparison requires some method of taking the different number of parameters into account, and I don't think the ANOVA is doing that work. If the models being compared were nested linear models, than an F-ratio test could be deployed, but even this doesn't seem like what is being done. And the RNL model is not linear in its parameters, so I don't think that would be the right model comparison test in any case.
Typical model comparison approaches would include a likelihood ratio test, AIC/BIC sorts of comparisons, or a cross-validation approach.
If the authors feel their current method does persuasively handle the model comparison, how it does so needs to be brought out more carefully in the manuscript, since one of the central conclusions of the work hinges at least in part on the appropriateness of such a statistical comparison.
Our visual model comparisons were aimed at assessing whether a trichromatic or tetrachromatic model best fit the colour discrimination data. The trichromatic and tetrachromatic models assume two and three opponency pathways, respectively. If the fish were not tetrachromatic, and instead trichromatic, then we would expect that the RNL model should better fit the data with two opponency mechanisms (rather than three). Our reason for making this assessment, is because of the possibility that not all the cones could be contributing to colour vision and could be used exclusively for achromatic tasks (e.g., luminance vision or motion detection). However, according to our finding that the data best fit the tetrachromatic model (i.e., how the behavioural discrimination thresholds more closely fitted the theoretical prediction of 1∆S), it is likely that anemonefish used all four cones for colour vision.
We have also now repeated our analysis using unweighed delta S values which are calculated using general n-dimensional models of colour vision (using the PAVO2 package). These models essentially follow the same initial steps followed by the RNL model (and many others) but omit the receptor noise correction stage. After comparing (using ANOVA, see lines 303-311) the predicted thresholds with the data in this non-RNL space, it was found that again the tetrachromatic model predictions did not deviate significantly from the data relative to individual fish performance; however, we also found that the trichromatic model without M2 cone input no longer differed from the predicted values. In this case, it seems that the extra noise parameter did contribute to the difference in fit. Whether this is a biologically meaningful comparison (as all photoreceptors contain noise) is an open question. We have added a short statement explicitly framing our interpretation of anemonefish having a 3-D colour space to being in accordance with the closeness of RNL model predictions (lines 370-371, 506-508).
- Also on the general point on conclusions drawn from the model fits, it seems important to note that rejecting a trichromatic version of the RNL model is not the same as rejecting all trichromatic models. For example, a trichromatic model that postulates limiting noise added after a set of opponent transformations will make predictions that are not nested within those of RNL trichromatic models. This point seems particularly important given the systematic failures of even the tetrachromatic version of the RNL model.
This is a good point. We have limited our conclusions to specifically address trichromatic models generated within the framework of the RNL model by adding in the conclusion section that fish psychophysical thresholds were best explained by the RNL model when all four cone types contributed to colour vision (see lines 370-371, 506-508). In this same sentence, we have also added in parentheses that “suggesting (but not proving) tetrachromacy” (line 508). We have also edited the abstract to state that our results were “…best described by a tetrachromatic model using all four cone types…”, rather than stating we have shown tetrachromacy (lines 36-37).
- More generally, attempts to decide whether some human observers exhibit tetrachromacy have taught us how hard this is to do. Two issues, beyond the above, are the following. 1) If the properties of a trichromatic visual system vary across the retina, then by imaging stimuli on different parts of the visual field an observer can in principle make tetrachromatic discriminations even though visual system is locally trichromatic at each retinal location. 2) When trying to show that there is no direction in a tetrachromatic receptor space to which the observer is blind, a lot of color directions need to be sampled. Here, 9 directions are studied. Is that enough? How would we know? The following paper may be of interest in this regard: Horiguchi, Hiroshi, Jonathan Winawer, Robert F. Dougherty, and Brian A. Wandell. "Human trichromacy revisited." Proceedings of the National Academy of Sciences 110, no. 3 (2013): E260-E269. Although I'm not suggesting that the authors conduct additional experiments to try to address these points, I do think they need to be discussed. We agree with the reviewer, that colour discriminability achieved by tetrachromatic vision could in theory be achieved by the combined effect of localised, distinct forms of trichromacy. Evidence in other fishes suggests that such multiple forms of trichromacy across the retina likely exist in many species. However, the behavioural effects of this retinal setup remain to be studied likely due to its extremely difficult nature. We have added a new section titled “future directions” (Lines 474-489), in which we discuss the possibility that distinct forms of trichromacy in the anemonefish retina could in theory achieve colour discrimination on par with tetrachromatic vision. We also give suggestions on how this could be investigated.
Although we tried to include as many colour directions as practically possible in our experiment, we have certainly not provided an exhaustive range that completely encompasses anemonefish colour space. Whether 9 colour directions are adequate to assess the dimensionality of their color vision is difficult to say. As addressed in the previous comment, we now acknowledge this limitation by refining our conclusion, saying that our results do not prove tetrachromacy.
- Line 277 ff. After reading through the paper several times, I remain unsure about what the authors regard as their compelling evidence that the UV cone has a higher sensitivity or makes an omnibus higher contribution to sensitivity than other cones (as stated in various forms in the title, Lines 37-41, 56-57, 125, 313, 352 and perhaps elsewhere).
At first, I thought they key point was that the receptor noise inferred via the RNL model as slightly lower (0.11) for the UV cone than for the double cones (0.14). And this is the argument made explicitly at line 326 of the discussion. But if this is the argument, what needs to be shown is that the data reject a tetrachromatic version of the RNL model where the noise value of all the cones is locked to be the same (or something similar), with the analysis taking into account the fewer parametric degrees of freedom where the noise parameters are so constrained. That is, a careful model comparison analysis would be needed. Such an analysis is not presented that I see, and I need more convincing that the difference between 0.11 and 0.14 is a real effect driven by the data. Also, I am not sanguine that the parameters of a model that in some systematic ways fails to fit the data should be taken as characterizing properties of the receptors themselves (as sometimes seems to be stated as the conclusion we should draw).
We have performed various modelling scenarios where receptor noise was adjusted for each channel; however, the UV channel was consistently found to be more sensitive than the other channels. In (the original) Supplementary Figure 6 (now Figure 4 – figure supplements 1 and 2), we show predicted dS values calculated using receptor noise levels in the exact manner that the Reviewer suggests by ranging from 0.05 to 0.15, and most importantly, included scenarios where receptor noise was held equal across cone types and others where it was varied between single cones and double cones. None of the models adjusted the data so that sensitivity was equal across all four channels, which means that by an unknown mechanism, the UV channel is more sensitive, but this is unrelated to noise levels. Our best-fit receptor noise values of 0.11 (for single cones) and 0.14 (for double cones) are estimate values and should be treated as such till actual receptor noise measurements are made.
Then, I thought maybe the argument is not that the noise levels differ, but rather that the failures of the model are in the direction of thresholds being under predicted for discriminations that involve UV cone signals. That's what seems to be being argued here at lines 277 ff, and then again at lines 328 ff of the discussion. But then the argument as I read it more detail in both places switches from being about the UV cones per se to being about postive versus negative UV contrast. That's fine, but it's distinct from an argument that favors omnibus enhanced UV sensitivity, since both the UV increments and decrements are conveyed by the UV cone; it's an argument for differential sensitivity for increments versus decrements in UV mediated discriminations. The authors get to this on lines 334 of the discussion, but if the point is an increment/decrement asymmetry the title and many of the terser earlier assertions should be reworked to be consistent with what is shown.
To clarify our argument, we found that the colour discrimination thresholds were systematically lower than predicted by the RNL model for colours which elicited higher UV cone stimulation relative to other cone types. These colours we refer to as UV positive based on the sign direction of their contrast against grey distractors produced by higher UV/V LED channel (i.e., in a positive direction). Whereas colours with UV negative chromatic contrast had lower UV cone stimulation relative to the other cone types. Therefore, our interpretation of the importance of UV cone signals for colour discrimination are congruent with the results. In the discussion, we suggest a possibility that activation of the UV receptor suppresses noise downstream in the visual pathway or enhances the saliency of colours (see lines 397-398). This activation of the UV receptor would, of course, be at its highest for colours with positive UV chromatic contrast.
Note that we have added to the discussion the possibility that colour preferences or a difference in attentiveness might have contributed to differences in discrimination thresholds (see discussion lines 412-413, 427-428, 433-435, 456-466, and 469-473). However, we consider it a less likely explanation due to a couple of reasons, including 1) a lack of difference in responsiveness across colour sets in their timing to peck the target, and 2) any non-learnt bias would have likely been overridden or at least weakened by training prior to the experiment where colours were rewarded equally (see lines 462-466).
We have edited the results (lines 334-352) to make our point clearer and by changing the subtitle to be more explicit: “Lower discrimination thresholds induced by positive UV contrast”. The subsection begins by explaining the different types of UV chromatic contrast by elevation angle and, finally, how this division among colour sets was a major determinant of colour discrimination thresholds.
Perhaps the argument with respect to model deviations and UV contrast independent of sign could be elaborated to show more systematically that the way the covariation with the contrasts of the other cone stimulations in the stimulus set goes, the data do favor deviations from the RNL in the direction of enhanced sensitivity to UV cone signals, but if this is the intent I think the authors need to think more about how to present the data in a manner that makes it more compelling than currently, and walk the reader carefully through the argument.
We have added to the results the linear mixed-effects model output with ‘contrast’ (positive/negative) added as a fixed effect. This analysis shows that the sign direction of UV contrast was a strong predictor of threshold (see address to previous comments and lines 399-401, 790-799).
- On this point, if the authors decide to stick with the enhanced UV sensitivity argument in the revision, a bit more care about what is meant by "the UV cone has a comparatively high sensitivity (line 313 and throughout)" needs more unpacking. If it is that these cones have lower inferred noise (in the context of a model that doesn't account for at least some aspects of the data), is this because of properties of the UV cones, or the way that post-receptoral processing handles the signals from these cones mimicking a cone effect in the model. And if it is thought that it is because of properties of the cones, some discussion of what those properties might be would be helpful. As I understand the RNL model, relative numbers of cones of each type are taken into account, so it isn't that. But could it be something as simple as higher photopigment density or larger entrance aperture (thus more quantum catches and higher SNR)?
It is unknown what aspect of the cone morphology or physiology sets the activation or inactivation threshold. Electrophysiological data collected from the UV cones of other fish species e.g., in goldfish and zebrafish [see Hawryshyn & Beauchamp (1985). 25, Vis Res.; and Yoshimatsu et al. (2020). 107, Neuron.] show that they have exceptionally high sensitivity. What has not been shown is that having a UV cone can improve colour discrimination.
Previous quantitative cone opsin gene expression analysis showed that the single cone opsins (SWS1 and SWS2B) are expressed at lower levels than all double cone opsin genes. This difference in expression combined with the smaller size of single cone outer segments than the double cones make it unlikely that a larger photoreceptor size, higher volume or packing density of visual pigment is responsible. Contrary to our findings, these aspects of the different cone types (if they had an effect) would instead predict that double cones have a higher SNR, and non-UV colours would be more discriminable. We have now added these details to the discussion (see lines 391-397).
- Line 288 ff. The fact that the slopes of the psychometric functions differed across color directions is, I think, a failure of the RNL model to describe this aspect of the data, and tells us that a simple summary of what happens for thresholds at delta S = 1 does not generalize across color directions for other performance levels. Since one of the directions where the slope is shallower is the UV direction, this fact would seem to place serious limits on the claim that discrimination in the UV direction is enhanced relative to other directions, but it goes by here without comment along those lines. Some comment here, both about implications for fit of RNL model and about implications for generalizations about efficacy of UV receptor mediated discrimination and UV increment/decrement asymmetries, seems important.
The variation in the psychometric functions is difficult to interpret and cannot be explained by the RNL model. What the RNL model predicts is delta S based on low level factors (namely receptor noise). In the discussion, we completely agree with the notion that the asymmetry in thresholds from predicted values, and the variation in psychometric slopes cannot be explained by the RNL model, e.g., this is heavily implied by “colour discrimination thresholds cannot be directly attributed to noise in the early stages of the visual pathway…” (lines 388-390). To clarify the inability of the RNL model to account for this aspect of the data, we have included a statement (see line 390).
It is a good point that this could be an indication of heterogeneity in colour space. Heterogeneity in discrimination thresholds across animal colour space (both surrounding the threshold area and for more saturated regions) has been explored in detail using trichromatic triggerfish by Green N. F. et al. (2022). JEB, 7(225):jeb243533. We have added this idea to the discussion (see lines 490-498). For UV, it seems that two of the five fish (#34 and 20) had noticeably shallower curves than the others tested for UV (fish #19, 33, 36). Both also varied more in their ability to distinguish targets, as shown by their wider confidence intervals. One of these two fish (#34) was retested for UV at the end of the experiment, and in the secondary assessment had a steeper psychometric curve more in line with the other fish in the experiment (see Figure 3 – figure supplement 1 and added lines 247-250). Based on this discrepancy in performance between assessments, it is also possible that individual learning effects had a role in impacting the shape of the psychometric curve. Note, this had minimal effect on colour discrimination thresholds and any differences were in the direction of change observed across colour sets in the experiment (i.e., lower dS for UV positive directions).
- Line 357 ff. Up until this point, all of the discussion of differences in threshold across stimulus sets has been in terms of sensitivity. Here the authors (correctly) raise the possibility that a difference in "preference" across stimulus sets could drive the difference in thresholds as measured. Although the discussion is interesting and germaine, it does to some extent further undercut the security of conclusions about differential sensitivity across color directions relative to the RNL model predictions, and that should be brought out for the reader here. The authors might also discuss about how a future experiment might differentiate between a preference explanation and a sensitivity explanation of threshold differences.
We have now added a paragraph (see lines 469-473) discussing that future work should test for color preferences and suggest how this could be done using a similar foraging task. We also include our thoughts immediately prior on why it is unlikely that a colour preference was a major contribution towards the results. In short, we consider it unlikely as fish showed no evidence of reduced latency for pecking at targets across the colour sets and because the training regime prior to the experiment equally rewarded fish for all colours and would likely have overridden a strong preference (at least in this specific foraging context).
- RNL model. The paper cites a lot of earlier work that used the RNL model, but I think many readers will not be familiar with it. A bit more descriptive prose would be helpful, and particularly noting that in the full dimensional receptor space, if the limiting noise at the photoreceptors is Gaussian, then the isothreshold contour will be a hyper-ellipsoid with its axes aligned with the receptor directions.
There is now added explanation of the RNL model (see lines 141-151), particularly on its assumptions that it only receives chromatic input and that discrimination is limited by noise arising in the photoreceptors and not by any specific opponent mechanisms. We also added the mention of the expected hyper-ellipsoid shape of isothreshold contours if receptor noise is Gaussian. Note, while we appreciate the importance of the reader to understand the basic functionality of the model, we wanted to avoid overloading the introduction with details on the RNL model which is not the focus of the paper. The RNL model is well-established in the field of visual ecology and animal vision research for well over a decade and has been thoroughly dissected by previous methodological reviews. We refer to one of these more recent reviews by Olsson et al. (2018) Behav Ecol. 29(2):273-282, and direct the reader to the methods section for further details on the RNL model.
- Use of cone isolating stimuli? For showing that all four cone classes contribute to what the authors call color discrimination, a more direct approach would seem to be to use stimuli that target stimulation of only one class of cone at a time. This might require a modified design in which the distractors and target were shown against a uniform background and approximately matched in their estimated effect on a putative achromatic mechanism. Did the authors consider this approach, and more generally could they discuss what they see as its advantages and disadvantages for future work.
The Reviewer is correct in that a targeted approach of isolated cone stimulation would be the optimal approach to demonstrating tetrachromatic colour vision. However, the extreme spectral overlap in the absorption curves of anemonefish cones, particularly in the mid-wavelength region makes this problematic in using the current LED display. We added to the discussion ways that this could be studied in the future (see lines 474-489). This might be possible (but still challenging) using a monochromator, but such technology severely limits the diversity of stimuli which can be created and usually restricts experiments to a simple paired choice design (or grey card experiment). The traditional paired choice experiment requires animals to be trained to distinguish a specific colour, while the Ishihara-like task trains animals to distinguish targets using an odd-one-out approach. This latter approach is highly efficient, as it does not require retraining when testing a new colour (i.e., fish learnt the task not a specific colour). Here, we wanted to assess colour discrimination in multiple directions to compare performance, and the flexible LED display combined with a generalisable task was important.
The above assumes that anemonefish do not use multiple trichromatic systems. In which case, the use of standard experimental stimuli (e.g., a monochromator, an LED display) would be unsuitable as they illuminate the whole retina. To definitively test the range of opponent interactions, it would be necessary to make electrophysiological measurements targeting the transmitting neurons using a retinal multielectrode array (MEA) approach or by in-vivo calcium imaging (lines 484-486).
We understand that our results are not a direct test of the dimensionality of anemonefish colour vision and should not be interpreted as such, as we do not have direct evidence of tetrachromacy. To recognize this limitation of our data, we have drawn back some of our conclusive statements that claimed to have demonstrated tetrachromacy.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
Precise regulation of gamete fusion ensures that offspring will have the same ploidy as the parents. However, breaking this regulation can be useful for plant breeding. Haploid induction followed by chemical-induced genome doubling can be used to fix desirable genotypes, while triparental hybrids where two sperm cells with two different genotypes fertilize an egg cell can be advantageous for bypassing hybridization barriers to create interspecies hybrids with increased fitness. This manuscript follows up on a previous study from the same research group that used a clever high throughput polyspermy detection assay (HIPOD) to show that wild-type Arabidopsis naturally forms triparental hybrids at very low frequencies (less than 0.05% of progeny) and that these triparental hybrids can bypass dosage barriers in the endosperm (Nakel, et al., 2017). Mao and co-authors hypothesized that mutants that conferred polytubey, the attraction of multiple pollen tubes by mutant female gametophytes, would also increase the rate of triparental hybrids. They used a double mutant in the endopeptidase genes ECS1 and ECS2 which had previously been reported to induce supernumerary pollen tube attraction to test this hypothesis with their two-component HIPOD system in which one pollen donor constitutively expresses the mGAL4-VP16 transcription factor while the second pollen donor carries an herbicide resistance gene regulated by the GAL4-responsive UAS promoter. Triparental hybrids are detected as herbicide-resistant progeny from wild-type Arabidopsis flowers that have been pollinated by the two paternal genotypes. The authors convincingly show that the ecs1 ecs2-1 double mutant more than doubled the frequency of triparental, triploid hybrids in HIPOD crosses. They next tested the hypothesis that this increase in triparental hybrids was due to a gametophytic effect by using an ecs1-/- ecs2-1/ECS2 maternal parent in the HIPOD assay and testing whether the ecs2-1 mutant allele was preferentially inherited in triparental hybrids. The mutant allele was inherited at a much higher rate than expected, confirming their hypothesis.
The triparental hybrid results with the ecs1 ecs2 mutant were not that surprising since the presence of extra sperm cells gives more opportunities for triparental hybrids to form, especially if gamete fusion is misregulated. However, an unexpected result came when the authors used aniline blue staining to analyze the ecs1 ecs2 polytubey phenotype. They confirmed that the double mutant had increased levels of polytubey compared to wild-type ovules, but they also noticed that 13% of seeds were not developing normally. This phenotype was confirmed with a second ecs2 allele and was complemented with both ECS1 and ECS2 transgenes under their native promoters. Microscopic analysis revealed normal gametophyte morphology before fertilization, but 8% of pollinated ovules failed to develop an embryo and 7% failed to develop endosperm, suggesting single fertilization events. In a logical set of experiments, they followed up on this result by crossing ecs1 ecs2 with pollen carrying a fluorescent reporter that would be expressed in developing embryos and endosperm. In this experiment, they were again surprised. Some of the wild-type-looking seeds lacked a paternal contribution (i.e. no fluorescent signal from the paternal reporter construct) in the embryo. This prompted them to look more closely at the progeny, upon which they detected small plants that were haploid. They confirmed the haploid nature by chromosome spreads. Finally, they used interaccession crosses between ecs1 ecs2 (Col-0) and Landsberg to verify that haploid progeny only carried maternal alleles of markers on all five chromosomes, indicating that the ecs1 ecs2 genotype can induce maternal haploids.
This interesting study highlights the importance of following up on unexpected results. The conclusions are well-supported by the data and quite exciting. Paternal haploid inducers have been discovered in several species, but this is one of only two examples of maternal haploid induction. While the percentage of maternal haploids is very low, this phenomenon could be useful for plant breeding.
Weaknesses
The data in the manuscript is intriguing, but the question of how the same mutant combination promotes the formation of both triploid and haploid progeny remains unanswered and is not thoroughly discussed, nor is any model suggested for how the ECS1/2 peptidases could play a role in regulating gamete fusion and/or repressing parthenogenesis. A second unanswered question is whether the maternal haploids are a result of failed plasmogamy or karyogamy between the egg and sperm leading to parthenogenesis or a result of paternal genome elimination after plasmogamy. In figure 3B, the authors attempted to test whether plasmogamy occurs between the male and female gametes in ecs1 ecs2 ovules by crosses with pollen that expresses a mitochondrial marker under control of the pRPS5a promoter which is active in sperm cells as well as embryos and endosperm of fertilized ovules. This experiment allowed them to detect sperm cells that had not fused with the egg and central cell at 2 days after pollination. They also counted the percentage of seeds that expressed the mitochondrial marker in both embryo and endosperm at 2 DAP and found that ecs1 ecs2 mutants had a 20% reduction of visible mitochondria in embryo sacs compared to wildtype. They conclude that the result indicates a potential plasmogamy defect. However, the dependability of this marker is questionable since only ~55% of wild-type seeds had detectable signal in the embryo and endosperm. The authors imply that this experiment could be used to test plasmogamy, but it is not clear how any conclusions related to the abnormal seed phenotype could be drawn from examining the rate of signal in both the embryo and endosperm. Since the mitochondrial marker was not expressed from a sperm-specific promoter, the fluorescent signal at 2DAP is likely due to new gene expression from pRPS5a in the fertilized embryo and endosperm, not an indication of the presence of sperm-derived mitochondria. Perhaps an earlier timepoint could be used as well as a spermspecific promoter instead of pRPS5a to answer the question of whether plasmogamy is happening in the ecs1 ecs2 ovules.
Thanks for the suggestion. We here provide two additional new data sets to provide evidence that ecs1 ecs2 mutant plants indeed exhibit single fertilization that lead to fertilization recovery.
We determined the fertilization failure by checking the decondensation HTR10-RFP labelled sperm nuclei 8-10 HAP (Figure 3B) and the frequency of heterofertilization through dual pollination experiment (Figure 3C-E) (see above).
Reviewer #2 (Public Review):
The manuscript reports the triploid and haploid productions using an ecs1ecs2 mutant as the maternal donor, in addition to the evaluation of the sexual process observed in the mutant. The indicated data show exquisite quality. To improve the content, I recommend carefully reconsidering the descriptions because some of the insights would cause a stir in the controversy regarding ECS1&2 functions in plant reproduction.
Strengths
Triploid production by a combination of ecs1ecs2 mutant and HIPOD system has potential as a future plant breeding tool. Moreover, it's intriguing that both triploid and haploid productions were achieved using the same mutant as a maternal donor. I think authors can claim the value of their results more by adding descriptions about the usefulness of the aneuploid plants in plant breeding history.
The evidence of the persistent synergid nucleus (Figure 3A) is critical insight reported by this study. As Maruyama et al. (2013) reported by live cell imaging, synergid-endosperm fusion had occurred at the two endosperm nuclei stage. It would be valuable to claim the observed fact by citing Maruyama's previous observation.
Weakness
As the authors suggested, the higher triploid frequency observed in ecs1ecs2 than WT was likely caused by the increased polyspermy. However, it also could be that reduction of normal seed number in ecs1ecs2 (whichever is due to failure of fertilization or embryo development arrest) accounts for the increased frequency of the triploid compared to WT.
The results in Figure 3C-E suggested the single fertilization for both egg and central cells at similar frequencies. This is an exciting result, but it is still possible that the fertilized egg or central cell degenerated after fertilization resulting in the disappearance of paternally inherited fluorescence. Evaluation of fertilization patterns at 7-10HAP in ecs1ecs2 mutant may provide more confident insight, although unfused sperm cell was evaluated at 1DAP (Figure 3-figure supplement 1B). The fertilization states can be distinguished depending on the HTR10RFP sperm nuclei morphology and their positions, as reported by Takahashi et al (2018).
Thank you for your suggestion. We added the requested experiment see Figure 3B in the revised manuscript. In addition, we conducted a dual pollination experiment, that provides evidence for the activation of the fertilization recovery machinery (Figure 3C-E) (see above).
Several recent studies have reported exciting insights on ECS1&2 functions; however, various results from different laboratories have raised controversy. Though, the commonly found feature is the repression of polytubey. For readers, it would be helpful to organize the explanation about which insights are concordant or different.
Thank you for your suggestion. We now indicate using terms like in line with or in contrast to, where our data confirms /or contradicts with previous data.
In addition, a drawing that explains the time course in the process from pollination to seed development (up to 6DAP) based on WT would help to understand which point is evaluated in each data.
Thank you for your suggestion. We added a model figure (Figure 4E) at the end of the manuscript that brings the concepts together and facilitates the understandings.
Reviewer #3 (Public Review):
In this manuscript, Mao et al. reported that the two proteases ECS1 and ECS2 participate in both polyspermy block and gamete fusion in Arabidopsis thaliana. The authors could observe polytubey phenotype which has been reported previously and obtain both triparental plants and haploids in ecs1 ecs2 mutants. Therefore, they proposed that the triparental plants resulted from the polytubey block defect, whereas the haploids were caused by the gamete fusion defect. Together with two other previous reports, I think it is very interesting to see these two proteases participating in so many different but connected processes. Although they did not provide the molecular mechanism of how ECS participated in polyspermy block and gamete fusion, their findings provide more options for and thus promote plant breeding. The work may have a wide application in the future and will be of broad interest to cell biologists working on gamete fusion and plant breeders.
We thank the reviewer for their positive comments.
Although most of the conclusions in this paper are well supported by the data, it could be improved with a minor revision including providing clearer data analysis and descriptions, images with higher resolution, and more discussions.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #2 (Public Review):
In the discussion, the authors suggest that the binding of CHAPS could be an inspiration to develop compounds, targeting, for instance, mammalian receptors, that would bind to both the orthosteric site and a potential groove underneath loop C (where the sterol moiety of CHAPS binds in Alpo4). A figure (SI4) shows a few homologues in surface representation, giving an idea of whether this groove is generally present in the family.
Seeing this figure, I wondered if it would be relevant to compare several conformations of one or a few chosen homologues. Given that gating always impacts the quaternary assembly, is this groove more pronounced in say the inhibited state of a given homologue than in its agonist-bound state?
The width of the groove in 7 does change as the channel transition from apo to open state. This is now demonstrated with an additional Figure 3 – figure supplement 1b and the discussion was adjusted accordingly p 18, line 379:
“The sterol group connected by a linker binds in between subunits and induces conformational changes which also change the width of the groove in Alpo4 (Figure 3f, g), therefore it likely plays an active role in the observed quaternary twist. The changes in the groove shape are not specific to Alpo4 but are also observed for example in nicotinic 7 receptor (Figure 3 – supplement 1b) suggesting that the groove can be targeted for allosteric modulation of the channel. ”
A related thought was that some of the protein binders affecting pLGIC function (toxins, VHH) contact two subunits and wrap around/below loop C. Do these have binding sites that overlap with the groove?
We inspected the structures of pLGICs homologs with bound -bungarotoxin (6UWZ, 4HQP, 7Z14, and 7KOO) and 2 with bound VHHs (6SSI and 6HJY). The toxins were bound in similar conformations but not the VHHs. The examples of the complexes are now shown as Supplementary Figure 13a (see above). In the case of ELIC, the nanobody Nb72 was bound on top of the sterol-binding cavity, but it did not interact with the interior of the cavity. This is now explained on p 17 from line 374:
“When binding sites of larger know binders, including VHH47,48 and -bungarotoxin10,49 were examined (Figure 3 – supplement 1a) a nanobody bound to ELIC in the site covering the sterol-binding groove was identified, however, its interactions with ELIC did not overlap significantly with the interior of the sterol-binding groove. This suggests that the latter is a novel target location for binders.”
Very interestingly, the binding of CHAPS stabilizes a conformation that differs from the apo one. It includes a twist of the ECDs but does not lead to a significant opening of the M2 bundle. The authors note that the direction of the twist is reversed to that often associated with the binding of ligands in homologues. This reversion is quite a feature, which deserves to be shown in a supplementary movie (e.g overlay of the Alpo apo>CHAPs transition with the nico>apo transition of a7).
We have re-examined the rotation and compared it to the conformational changes in nACh 7 and 5-HT3 receptors. Upon closer examination, it became clear that relative rotation of the ECD and the TMD provides a very simplistic view of the quaternary conformational changes which are more complex 3D quaternary changes than a simple relative domain rotation. Careful alignment of the structures to the extracellular side of the trans-membrane pore showed that in both channels resting-> open state transition is associated with clockwise rotation, but resting-> desensitized state transition in 5-HT3 involves a counterclockwise rotation. Thus, 1) the direction of rotation is not a ‘universal’ feature of pLGICs and 2) the clockwise rotation is the direction of channel activation for α7 nACh receptor and 5-HT3 and shares similarities with rearrangements observed in Alpo4. However, the relative movement of the ECDs is different between Alpo upon CHAPS binding and α7 nACh and 5-HT3 receptor upon activation. To demonstrate this, we added Video 2 which shows quaternary changes for all 3 channels and the text has been modified as follows on page 11 line 208:
“Quaternary changes in Alpo4 induced upon CHAPS binding and those associated with the activation of related α7 nACh and 5-HT3 receptors induced rotation of ECD relative to TMD in the same direction, however, the shifts of principal relative to complementary subunits were different (Video 2). In Alpo4, the complementary subunit slides upward whereas in the two other channels it consistently shifts towards the principal subunit and tilts relative to the TMD. The tilt is less pronounced in Alpo4 which is probably why it does not lead to the pore dilation.”
We are grateful to the reviewer for drawing our attention to this point, which permitted us to correct initially inaccurate statements.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #2 (Public Review):
Here, a simple model of cerebellar computation is used to study the dependence of task performance on input type: it is demonstrated that task performance and optimal representations are highly dependent on task and stimulus type. This challenges many standard models which use simple random stimuli and concludes that the granular layer is required to provide a sparse representation. This is a useful contribution to our understanding of cerebellar circuits, though, in common with many models of this type, the neural dynamics and circuit architecture are not very specific to the cerebellum, the model includes the feedforward structure and the high dimension of the granule layer, but little else. This paper has the virtue of including tasks that are more realistic, but by the paper’s own admission, the same model can be applied to the electrosensory lateral line lobe and it could, though it is not mentioned in the paper, be applied to the dentate gyrus and large pyramidal cells of CA3. The discussion does not include specific elements related to, for example, the dynamics of the Purkinje cells or the role of Golgi cells, and, in a way, the demonstration that the model can encompass different tasks and stimuli types is an indication of how abstract the model is. Nonetheless, it is useful and interesting to see a generalization of what has become a standard paradigm for discussing cerebellar function.
We appreciate the Reviewer’s positive comments. Regarding the simplifications of our model, we agree that we have taken a modeling approach that abstracts away certain details to permit comparisons across systems. We now include an in-depth discussion of our simplifying assumptions (Assumptions & Extensions section in the Discussion) and have further noted the possibility that other biophysical mechanisms we have not accounted for may also underlie differences across systems.
Our results predict that qualitative differences in the coding levels of cerebellum-like systems, across brain regions or across species, reflect an optimization to distinct tasks (Figure 7). However, it is also possible that differences in coding level arise from other physiological differences between systems.
Reviewer #3 (Public Review):
1) The paper by Xie et al is a modelling study of the mossy fiber-to-granule cell-to-Purkinje cell network, reporting that the optimal type of representations in the cerebellar granule cell layer depends on the type task. The paper stresses that the findings indicate a higher overall bias towards dense representations than stated in the literature, but it appears the authors have missed parts of the literature that already reported on this. While the modelling and analysis appear mathematically solid, the model is lacking many known constraints of the cerebellar circuitry, which makes the applicability of the findings to the biological counterpart somewhat limited.
We thank the Reviewer for suggesting additional references to include in our manuscript, and for encouraging us to extend our model toward greater biological plausibility and more critically discuss simplifying assumptions we have made. We respond to both the comment about previous literature and about applicability to cerebellar circuitry in detail below.
2) I have some concerns with the novelty of the main conclusion, here from the abstract: ’Here, we generalize theories of cerebellar learning to determine the optimal granule cell representation for tasks beyond random stimulus discrimination, including continuous input-output transformations as required for smooth motor control. We show that for such tasks, the optimal granule cell representation is substantially denser than predicted by classic theories.’ Stated like this, this has in principle already been shown, i.e. for example: Spanne and Jo¨rntell (2013) Processing of multi-dimensional sensorimotor information in the spinal and cerebellar neuronal circuitry: a new hypothesis. PLoS Comput Biol. 9(3):e1002979. Indeed, even the 2 DoF arm movement control that is used in the present paper as an application, was used in this previous paper, with similar conclusions with respect to the advantage of continuous input-output transformations and dense coding. Thus, already from the beginning of this paper, the novelty aspect of this paper is questionable. Even the conclusion in the last paragraph of the Introduction: ‘We show that, when learning input-output mappings for motor control tasks, the optimal granule cell representation is much denser than predicted by previous analyses.’ was in principle already shown by this previous paper.
We thank the Reviewer for drawing our attention to Spanne and Jo¨rntell (2013). Our study shares certain similarities with this work, including the consideration of tasks with smooth input-output mappings, such as learning the dynamics of a two-joint arm. However, our study differs substantially, most notably the fact that we focus our study on parametrically varying the degree of sparsity in the granule cell layer to determine the circumstances under which dense versus sparse coding is optimal. To the best of our ability, we can find no result in Spanne and J¨orntell (2013) that indicates the performance of a network as a function of average coding level. Instead, Spanne and Jo¨rntell (2013) propose that inhibition from Golgi cells produces heterogeneity in coding level which can improve performance, which is an interesting but complementary finding to ours. We therefore do not believe that the quantitative computations of optimal coding level that we present are redundant with the results of this previous study. We also note that a key contribution of our study is mathemetical analysis of the inductive bias of networks with different coding levels which supports our conclusions.
We have included a discussion of Spanne and Jo¨rntell (2013) and (2015) in the revised version of our manuscript:
"Other studies have considered tasks with smooth input-output mappings and low-dimensional inputs, finding that heterogeneous Golgi cell inhibition can improve performance by diversifying individual granule cell thresholds (Spanne and J¨orntell, 2013). Extending our model to include heterogeneous thresholds is an interesting direction for future work. Another proposal states that dense coding may improve generalization (Spanne and Jo¨rntell, 2015). Our theory reveals that whether or not dense coding is beneficial depends on the task."
3) However, the present paper does add several more specific investigations/characterizations that were not previously explored. Many of the main figures report interesting new model results. However, the model is implemented in a highly generic fashion. Consequently, the model relates better to general neural network theory than to specific interpretations of the function of the cerebellar neuronal circuitry. One good example is the findings reported in Figure 2. These represent an interesting extension to the main conclusion, but they are also partly based on arbitrariness as the type of mossy fiber input described in the random categorization task has not been observed in the mammalian cerebellum under behavior in vivo, whereas in contrast, the type of input for the motor control task does resemble mossy fiber input recorded under behavior (van Kan et al 1993).
We agree that the tasks we consider in Figure 2 are simplified compared to those that we consider elsewhere in the paper. The choice of random mossy fiber input was made to provide a comparison to previous modeling studies that also use random input as a benchmark (Marr 1969, Albus 1971, Brunel 2004, Babadi and Sompolinsky 2014, Billings 2014, LitwinKumar et al., 2017). This baseline permits us to specifically evaluate the effects of lowdimensional inputs (Figure 2) and richer input-output mappings (Figure 2, Figure 7). We agree with the Reviewer that the random and uncorrelated mossy fiber activity that has been extensively used in previous studies is almost certainly an unrealistic idealization of in vivo neural activity—this is a motivating factor for our study, which relaxes this assumption and examines the consequences. To provide additional context, we have updated the following paragraph in the main text Results section:
"A typical assumption in computational theories of the cerebellar cortex is that inputs are randomly distributed in a high-dimensional space (Marr, 1969; Albus, 1971; Brunel et al., 2004; Babadi and Sompolinsky, 2014; Billings et al., 2014; Litwin-Kumar et al., 2017). While this may be a reasonable simplification in some cases, many tasks, including cerebellumdependent tasks, are likely best-described as being encoded by a low-dimensional set of variables. For example, the cerebellum is often hypothesized to learn a forward model for motor control (Wolpert et al., 1998), which uses sensory input and motor efference to predict an effector’s future state. Mossy fiber activity recorded in monkeys correlates with position and velocity during natural movement (van Kan et al., 1993). Sources of motor efference copies include motor cortex, whose population activity lies on a lowdimensional manifold (Wagner et al., 2019; Huang et al., 2013; Churchland et al., 2010; Yu et al., 2009). We begin by modeling the low dimensionality of inputs and later consider more specific tasks."
4) The overall conclusion states: ‘Our results....suggest that optimal cerebellar representations are task-dependent.’ This is not a particularly strong or specific conclusion. One could interpret this statement as simply saying: ‘if I construct an arbitrary neural network, with arbitrary intrinsic properties in neurons and synapses, I can get outputs that depend on the intensity of the input that I provide to that network.’ Further, the last sentence of the Introduction states: ‘More broadly, we show that the sparsity of a neural code has a task-dependent influence on learning...’ This is very general and unspecific, and would likely not come as a surprise to anyone interested in the analysis of neural networks. It doesn’t pinpoint any specific biological problem but just says that if I change the density of the input to a [generic] network, then the learning will be impacted in one way or another.
We agree with the Reviewer that our conclusions are quite general, and we have removed the final sentence as we agree it was unspecific. However, we disagree with the Reviewer’s paraphrasing of our results.
First, we do not select arbitrary intrinsic properties of neurons and synapses. Rather, we construct a simplified model with a key quantity, the neuronal threshold, that we vary parametrically in order to assess the effect of the resulting changes in the representation on performance. Second, we do not vary the intensity/density of inputs provided to the network – this is fixed throughout our study for all key comparisons we perform. Instead, we vary the density (coding level) of the expansion layer representation and quantify its effect on inductive bias and generalization. Finally, our study’s key contribution is an explanation of the heterogeneity in average coding level observed across behaviors and cerebellum-like systems. We go beyond the empirical statement that there is a dependence of performance on the parameter that we vary by developing an analytical theory. Our theory describes the performance of the class of networks that we study and the properties of learning tasks that determine the optimal expansion layer representation.
To clarify our main contributions, we have updated the final paragraph of the Introduction. We have also removed the sentence that the Reviewer objects to, as it was less specific than the other points we make here.
"We propose that these differences can be explained by the capacity of representations with different levels of sparsity to support learning of different tasks. We show that the optimal level of sparsity depends on the structure of the input-output relationship of a task. When learning input-output mappings for motor control tasks, the optimal granule cell representation is much denser than predicted by previous analyses. To explain this result, we develop an analytic theory that predicts the performance of cerebellum-like circuits for arbitrary learning tasks. The theory describes how properties of cerebellar architecture and activity control these networks’ inductive bias: the tendency of a network toward learning particular types of input-output mappings (Sollich, 1998; Jacot et al., 2018; Bordelon et al., 2020; Canatar et al., 2021; Simon et al., 2021). The theory shows that inductive bias, rather than the dimension of the representation alone, is necessary to explain learning performance across tasks. It also suggests that cerebellar regions specialized for different functions may adjust the sparsity of their granule cell representations depending on the task."
5) The interpretation of the distribution of the mossy fiber inputs to the granule cells, which would have a crucial impact on the results of a study like this, is likely incorrect. First, unlike the papers that the authors cite, there are many studies indicating that there is a topographic organization in the mossy fiber termination, such that mossy fibers from the same inputs, representing similar types of information, are regionally co-localized in the granule cell layer. Hence, there is no support for the model assumption that there is a predominantly random termination of mossy fibers of different origins. This risks invalidating the comparisons that the authors are making, i.e. such as in Figure 3. This is a list of example papers, there are more: van Kan, Gibson and Houk (1993) Movement-related inputs to intermediate cerebellum of the monkey. Journal of Neurophysiology. Garwicz et al (1998) Cutaneous receptive fields and topography of mossy fibres and climbing fibres projecting to cat cerebellar C3 zone. The Journal of Physiology. Brown and Bower (2001) Congruence of mossy fiber and climbing fiber tactile projections in the lateral hemispheres of the rat cerebellum. The Journal of Comparative Neurology. Na, Sugihara, Shinoda (2019) The entire trajectories of single pontocerebellar axons and their lobular and longitudinal terminal distribution patterns in multiple aldolase C-positive compartments of the rat cerebellar cortex. The Journal of Comparative Neurology.
6) The nature of the mossy fiber-granule cell recording is also reviewed here: Gilbert and Miall (2022) How and Why the Cerebellum Recodes Input Signals: An Alternative to Machine Learning. The Neuroscientist. Further, considering the re-coding idea, the following paper shows that detailed information, as it is provided by mossy fibers, is transmitted through the granule cells without any evidence of re-coding: Jo¨rntell and Ekerot (2006) Journal of Neuroscience; and this paper shows that these granule inputs are powerfully transmitted to the molecular layer even in a decerebrated animal (i.e. where only the ascending sensory pathways remains) Jo¨rntell and Ekerot 2002, Neuron.
We agree that there is strong evidence for a topographic organization in mossy fiber to granule cell connectivity at the microzonal level. We thank the Reviewer for pointing us to specific examples. We acknowledge that our simplified model does not capture the structure of connectivity observed in these studies.
However, the focus of our model is on cerebellar neurons presynaptic to a single Purkinje cell. Random or disordered distribution of inputs at this local scale is compatible with topographic organization at the microzonal scale. Furthermore, while there is evidence of structured connections at the local scale, models with random connectivity are able to reproduce the dimensionality of granule cell activity within a small margin of error (Nguyen et al., 2022). Finally, our finding that dense codes are optimal for learning slowly varying tasks is consistent with evidence for the lack of re-coding – for such tasks, re-coding may absent because it is not required.
We have dedicated a section on this issue in the Assumptions and Extensions portion of our Discussion:
"Another key assumption concerning the granule cells is that they sample mossy fiber inputs randomly, as is typically assumed in Marr-Albus models (Marr, 1969; Albus, 1971; LitwinKumar et al., 2017; Cayco-Gajic et al., 2017). Other studies instead argue that granule cells sample from mossy fibers with highly similar receptive fields (Garwicz et al., 1998; Brown and Bower, 2001; J¨orntell and Ekerot, 2006) defined by the tuning of mossy fiber and climbing fiber inputs to cerebellar microzones (Apps et al., 2018). This has led to an alternative hypothesis that granule cells serve to relay similarly tuned mossy fiber inputs and enhance their signal-to-noise ratio (Jo¨rntell and Ekerot, 2006; Gilbert and Chris Miall, 2022) rather than to re-encode inputs. Another hypothesis is that granule cells enable Purkinje cells to learn piece-wise linear approximations of nonlinear functions (Spanne and J¨orntell, 2013). However, several recent studies support the existence of heterogeneous connectivity and selectivity of granule cells to multiple distinct inputs at the local scale (Huang et al., 2013; Ishikawa et al., 2015). Furthermore, the deviation of the predicted dimension in models constrained by electron-microscopy data as compared to randomly wired models is modest (Nguyen et al., 2022). Thus, topographically organized connectivity at the macroscopic scale may coexist with disordered connectivity at the local scale, allowing granule cells presynaptic to an individual Purkinje cell to sample heterogeneous combinations of the subset of sensorimotor signals relevant to the tasks that Purkinje cell participates in. Finally, we note that the optimality of dense codes for learning slowly varying tasks in our theory suggests that observations of a lack of mixing (J¨orntell and Ekerot, 2002) for such tasks are compatible with Marr-Albus models, as in this case nonlinear mixing is not required."
7) I could not find any description of the neuron model used in this paper, so I assume that the neurons are just modelled as linear summators with a threshold (in fact, Figure 5 mentions inhibition, but this appears to be just one big lump inhibition, which basically is an incorrect implementation). In reality, granule cells of course do have specific properties that can impact the input-output transformation, PARTICULARLY with respect to the comparison of sparse versus dense coding, because the low-pass filtering of input that occurs in granule cells (and other neurons) as well as their spike firing stochasticity (Saarinen et al (2008). Stochastic differential equation model for cerebellar granule cell excitability. PLoS Comput. Biol. 4:e1000004) will profoundly complicate these comparisons and make them less straight forward than what is portrayed in this paper. There are also several other factors that would be present in the biological setting but are lacking here, which makes it doubtful how much information in relation to the biological performance that this modelling study provides: What are the types of activity patterns of the inputs? What are the learning rules? What is the topography? What is the impact of Purkinje cell outputs downstream, as the Purkinje cell output does not have any direct action, it acts on the deep cerebellar nuclear neurons, which in turn act on a complex sensorimotor circuitry to exert their effect, hence predictive coding could only become interpretable after the PC output has been added to the activity in those circuits. Where is the differentiated Golgi cell inhibition?
Thank you for these critiques. We have made numerous edits to improve the presentation of the details of our model in the main text of the manuscript. Indeed, granule cells in the main text are modeled as linear sums of mossy fiber inputs with a threshold-linear activation function. A more detailed description of the model for granule cells can now be found in Equation 1 in the Results section:
"The activity of neurons in the expansion layer is given by: h = φ(Jeffx − θ), (1) where φ is a rectified linear activation function φ(u) = max(u,0) applied element-wise. Our results also hold for other threshold-polynomial activation functions. The scalar threshold θ is shared across neurons and controls the coding level, which we denote by f, defined as the average fraction of neurons in the expansion layer that are active."
Most of our analyses use the firing rate model we describe above, but several Supplemental Figures show extensions to this model. As we mention in the Discussion, our results do not depend on the specific choice of nonlinearity (Figure 2-figure supplement 2). We have also considered the possibility that the stochastic nature of granule cell spikes could impact our measures of coding level. In Figure 7-figure supplement 1 we test the robustness of our main conclusion using a spiking model where we model granule cell spikes with Poisson statistics. When measuring coding level in a population of spiking neurons, a key question is at what time window the Purkinje cell integrates spikes. For several choices of integration time windows, we show that dense coding remains optimal for learning smooth tasks. However, we agree with the Reviewer that there are other biological details our model does not address. For example, our spiking model does not capture some of the properties the Saarinen et al. (2008) model captures, including random sub-threshold oscillations and clusters of spikes. Modeling biophysical phenomena at this scale is beyond the scope of our study. We have added this reference to the relevant section of the Discussion:
"We also note that coding level is most easily defined when neurons are modeled as rate, rather than spiking units. To investigate the consistency of our results under a spiking code, we implemented a model in which granule cell spiking exhibits Poisson variability and quantify coding level as the fraction of neurons that have nonzero spike counts (Figure 7-figure supplement 1; Figure 7C). In general, increased spike count leads to improved performance as noise associated with spiking variability is reduced. Granule cells have been shown to exhibit reliable burst responses to mossy fiber stimulation (Chadderton et al., 2004), motivating models using deterministic responses or sub-Poisson spiking variability. However, further work is needed to quantitatively compare variability in model and experiment and to account for more complex biophysical properties of granule cells (Saarinen et al., 2008)."
A second concern the Reviewer raises is our implementation of Golgi cell inhibition as a homogeneous rather than heterogeneous input onto granule cells. In simplified models, adding heterogeneous inhibition does not dramatically change the qualitative properties of the expansion layer representation, in particular the dimensionality of the representation (Billings et al., 2014, Cayco-Gajic et al., 2017, Litwin-Kumar et al., 2017). We have added a section about inhibition to our Discussion:
"We also have not explicitly modeled inhibitory input provided by Golgi cells, instead assuming such input can be modeled as a change in effective threshold, as in previous studies (Billings et al., 2014; Cayco-Gajic et al., 2017; Litwin-Kumar et al., 2017). This is appropriate when considering the dimension of the granule cell representation (Litwin-Kumar et al., 2017), but more work is needed to extend our model to the case of heterogeneous inhibition."
Regarding the mossy fiber inputs, as we state in response to paragraph 3, we agree with the Reviewer that the random and uncorrelated mossy fiber activity that has been used in previous studies is an unrealistic idealization of in vivo neural activity. One of the motivations for our model was to relax this assumption and examine the consequences: we introduce correlations in the mossy fiber activity by projecting low-dimensional patterns into the mossy fiber layer (Figure 1B):
"A typical assumption in computational theories of the cerebellar cortex is that inputs are randomly distributed in a high-dimensional space (Marr, 1969; Albus, 1971; Brunel et al., 2004; Babadi and Sompolinsky, 2014; Billings et al., 2014; Litwin-Kumar et al., 2017). While this may be a reasonable simplification in some cases, many tasks, including cerebellumdependent tasks, are likely best-described as being encoded by a low-dimensional set of variables. For example, the cerebellum is often hypothesized to learn a forward model for motor control (Wolpert et al., 1998), which uses sensory input and motor efference to predict an effector’s future state. Mossy fiber activity recorded in monkeys correlates with position and velocity during natural movement (van Kan et al., 1993). Sources of motor efference copies include motor cortex, whose population activity lies on a low-dimensional manifold (Wagner et al., 2019; Huang et al., 2013; Churchland et al., 2010; Yu et al., 2009). We begin by modeling the low dimensionality of inputs and later consider more specific tasks.
We therefore assume that the inputs to our model lie on a D-dimensional subspace embedded in the N-dimensional input space, where D is typically much smaller than N (Figure 1B). We refer to this subspace as the “task subspace” (Figure 1C)."
The Reviewer also mentions the learning rule at granule cell to Purkinje cell synapses. We agree that considering online, climbing-fiber-dependent learning is an important generalization. We therefore added a new supplemental figure investigating whether we would still see a difference in optimal coding levels across tasks if online learning were used instead of the least squares solution (Figure 7-figure supplement 2). Indeed, we observed a similar task dependence as we saw in Figure 2F. We have added a new paragraph in the Discussion under Assumptions and Extensions describing our rationale and approach in detail:
"For the Purkinje cells, our model assumes that their responses to granule cell input can be modeled as an optimal linear readout. Our model therefore provides an upper bound to linear readout performance, a standard benchmark for the quality of a neural representation that does not require assumptions on the nature of climbing fiber-mediated plasticity, which is still debated. Electrophysiological studies have argued in favor of a linear approximation (Brunel et al., 2004). To improve the biological applicability of our model, we implemented an online climbing fiber-mediated learning rule and found that optimal coding levels are still task-dependent (Figure 7-figure supplement 2). We also note that although we model several timing-dependent tasks (Figure 7), our learning rule does not exploit temporal information, and we assume that temporal dynamics of granule cell responses are largely inherited from mossy fibers. Integrating temporal information into our model is an interesting direction for future investigation."
Finally, regarding the function of the Purkinje cell, our model defines a learning task as a mapping from inputs to target activity in the Purkinje cell and is thus agnostic to the cell’s downstream effects. We clarify this point when introducing the definition of a learning task:
"In our model, a learning task is defined by a mapping from task variables x to an output f(x), representing a target change in activity of a readout neuron, for example a Purkinje cell. The limited scope of this definition implies our results should not strongly depend on the influence of the readout neuron on downstream circuits."
8) The problem of these, in my impression, generic, arbitrary settings of the neurons and the network in the model becomes obvious here: ‘In contrast to the dense activity in cerebellar granule cells, odor responses in Kenyon cells, the analogs of granule cells in the Drosophila mushroom body, are sparse...’ How can this system be interpreted as an analogy to granule cells in the mammalian cerebellum when the model does not address the specifics lined up above? I.e. the ‘inductive bias’ that the authors speak of, defined as ‘the tendency of a network toward learning particular types of input-output mappings’, would be highly dependent on the specifics of the network model.
We agree with the Reviewer that our model makes several simplifying assumptions for mathematical tractability. However, we note that our study is not the first to draw analogies between cerebellum-like systems, including the mushroom body (Bell et al., 2008; Farris, 2011). All the systems we study feature a sparsely connected, expanded granule-like layer that sends parallel fiber axons onto densely connected downstream neurons known to exhibit powerful synaptic plasticity, thus motivating the key architectural assumptions of our model. We have constrained anatomical parameters of the model using data as available (Table 1). However, we agree with the Reviewer that when making comparisons across species there is always a possibility that differences are due to physiological mechanisms we have not fully understood or captured with a model. As such, we can only present a hypothesis for these differences. We have modified our Discussion section on this topic to clearly state this.
"Our results predict that qualitative differences in the coding levels of cerebellum-like systems, across brain regions or across species, reflect an optimization to distinct tasks (Figure 7). However, it is also possible that differences in coding level arise from other physiological differences between systems."
9) More detailed comments: Abstract: ‘In these models [Marr-Albus], granule cells form a sparse, combinatorial encoding of diverse sensorimotor inputs. Such sparse representations are optimal for learning to discriminate random stimuli.’ Yes, I would agree with the first part, but I contest the second part of this statement. I think what is true for sparse coding is that the learning of random stimuli will be faster, as in a perceptron, but not necessarily better. As the sparsification essentially removes information, it could be argued that the quality of the learning is poorer. So from that perspective, it is not optimal. The authors need to specify from what perspective they consider sparse representations optimal for learning.
This is an important point that we would like to clarify. It is not the case that sparse coding simply speeds up learning. In our study and many related works (Barak et al. 2013; Babadi and Sompolinsky 2014; Litwin-Kumar et al. 2017), learning performance is measured based on the generalization ability of the network – the ability to predict correct labels for previously unseen inputs. As our study and previous studies show, sparse codes are optimal in the sense that they minimize generalization error, independent of any effect on learning speed. To communicate this more effectively, we have added the following sentence to the first paragraph of the Introduction:
"Sparsity affects both learning speed (Cayco-Gajic et al., 2017), and generalization, the ability to predict correct labels for previously unseen inputs (Barak et al., 2013; Babadi and Sompolinsky, 2014; Litwin-Kumar et al., 2017)."
10) Introduction: ‘Indeed, several recent studies have reported dense activity in cerebellar granule cells in response to sensory stimulation or during motor control tasks (Knogler et al., 2017; Wagner et al., 2017; Giovannucci et al., 2017; Badura and De Zeeuw, 2017; Wagner et al., 2019), at odds with classic theories (Marr, 1969; Albus, 1971).’ In fact, this was precisely the issue that was addressed already by Jo¨rntell and Ekerot (2006) Journal of Neuroscience. The conclusion was that these actual recordings of granule cells in vivo provided essentially no support for the assumptions in the Marr-Albus theories.
In our reading, the main finding of J¨orntell and Ekerot (2006) is that individual granule cells are activated by mossy fibers with overlapping receptive fields driven by a single type of somatosensory input. However, there is also evidence of nonlinear mixed selectivity in granule cells in support of the re-coding hypothesis (Huang et al., 2013; Ishikawa et al., 2015). Jo¨rntell and Ekerot (2006) also suggest that the granule cell layer shares similar topographic organization as mossy fibers, organized into microzones. The existence of topographic organization does not invalidate Marr-Albus theories. As we have suggested earlier, a local combinatorial expansion can coexist with a global topographic organization.
We have described these considerations in the Assumptions and Extensions portion of the Discussion:
"Another key assumption concerning the granule cells is that they sample mossy fiber inputs randomly, as is typically assumed in Marr-Albus models (Marr, 1969; Albus, 1971; LitwinKumar et al., 2017; Cayco-Gajic et al., 2017). Other studies instead argue that granule cells sample from mossy fibers with highly similar receptive fields (Garwicz et al., 1998; Brown and Bower, 2001; J¨orntell and Ekerot, 2006) defined by the tuning of mossy fiber and climbing fiber inputs to cerebellar microzones (Apps et al., 2018). This has led to an alternative hypothesis that granule cells serve to relay similarly tuned mossy fiber inputs and enhance their signal-to-noise ratio (Jo¨rntell and Ekerot, 2006; Gilbert and Chris Miall, 2022) rather than to re-encode inputs. Another hypothesis is that granule cells enable Purkinje cells to learn piece-wise linear approximations of nonlinear functions (Spanne and J¨orntell, 2013). However, several recent studies support the existence of heterogeneous connectivity and selectivity of granule cells to multiple distinct inputs at the local scale (Huang et al., 2013; Ishikawa et al., 2015). Furthermore, the deviation of the predicted dimension in models constrained by electron-microscopy data as compared to randomly wired models is modest (Nguyen et al., 2022). Thus, topographically organized connectivity at the macroscopic scale may coexist with disordered connectivity at the local scale, allowing granule cells presynaptic to an individual Purkinje cell to sample heterogeneous combinations of the subset of sensorimotor signals relevant to the tasks that Purkinje cell participates in. Finally, we note that the optimality of dense codes for learning slowly varying tasks in our theory suggests that observations of a lack of mixing (J¨orntell and Ekerot, 2002) for such tasks are compatible with Marr-Albus models, as in this case nonlinear mixing is not required."
We have also included the Jo¨rntell and Ekerot (2006) study as a citation in the Introduction:
"Indeed, several recent studies have reported dense activity in cerebellar granule cells in response to sensory stimulation or during motor control tasks (Jo¨rntell and Ekerot, 2006; Knogler et al., 2017; Wagner et al., 2017; Giovannucci et al., 2017; Badura and De Zeeuw, 2017; Wagner et al., 2019), at odds with classic theories (Marr, 1969; Albus, 1971)."
11) Results: 1st para: There is no information about how the granule cells are modelled.
We agree that this should information should have been more readily available. We now more completely describe the model in the main text. Our model for granule cells can be found in Equation 1 in the Results section and also the Methods (Network Model):
"The activity of neurons in the expansion layer is given by: h = φ(Jeffx − θ), (2)
where φ is a rectified linear activation function φ(u) = max(u,0) applied element-wise. Our results also hold for other threshold-polynomial activation functions. The scalar threshold θ is shared across neurons and controls the coding level, which we denote by f, defined as the average fraction of neurons in the expansion layer that are active."
12) 2nd para: ‘A typical assumption in computational theories of the cerebellar cortex is that inputs are randomly distributed in a high-dimensional space.’ Yes, I agree, and this is in fact in conflict with the known topographical organization in the cerebellar cortex (see broader comment above). Mossy fiber inputs coding for closely related inputs are co-localized in the cerebellar cortex. I think for this model to be of interest from the point of view of the mammalian cerebellar cortex, it would need to pay more attention to this organizational feature.
As we discuss in our response to paragraphs 5 and 6, we see the random distribution assumption at the local scale (inputs presynaptic to a single Purkinje cell) as being compatible with topographic organization occurring at the microzone scale. Furthermore, as discussed earlier, we specifically model low-dimensional input as opposed to the random and high-dimensional inputs typically studied in prior models.
"A typical assumption in computational theories of the cerebellar cortex is that inputs are randomly distributed in a high-dimensional space (Marr, 1969; Albus, 1971; Brunel et al., 2004; Babadi and Sompolinsky, 2014; Billings et al., 2014; Litwin-Kumar et al., 2017). While this may be a reasonable simplification in some cases, many tasks, including cerebellumdependent tasks, are likely best-described as being encoded by a low-dimensional set of variables. For example, the cerebellum is often hypothesized to learn a forward model for motor control (Wolpert et al., 1998), which uses sensory input and motor efference to predict an effector’s future state. Mossy fiber activity recorded in monkeys correlates with position and velocity during natural movement (van Kan et al., 1993). Sources of motor efference copies include motor cortex, whose population activity lies on a low-dimensional manifold (Wagner et al., 2019; Huang et al., 2013; Churchland et al., 2010; Yu et al., 2009). We begin by modeling the low dimensionality of inputs and later consider more specific tasks. We therefore assume that the inputs to our model lie on a D-dimensional subspace embedded in the N-dimensional input space, where D is typically much smaller than N (Figure 1B). We refer to this subspace as the “task subspace” (Figure 1C)."
References
Albus, J.S. (1971). A theory of cerebellar function. Mathematical Biosciences 10, 25–61.
Apps, R., et al. (2018). Cerebellar Modules and Their Role as Operational Cerebellar Processing Units. Cerebellum 17, 654–682.
Babadi, B. and Sompolinsky, H. (2014). Sparseness and expansion in sensory representations. Neuron 83, 1213–1226.
Badura, A. and De Zeeuw, C.I. (2017). Cerebellar granule cells: dense, rich and evolving representations. Current Biology 27, R415–R418.
Barak, O., Rigotti, M., and Fusi, S. (2013). The sparseness of mixed selectivity neurons controls the generalization–discrimination trade-off. Journal of Neuroscience 33, 3844– 3856.
Bell, C.C., Han, V., and Sawtell, N.B. (2008). Cerebellum-like structures and their implications for cerebellar function. Annual Review of Neuroscience 31, 1–24.
Billings, G., Piasini, E., Lo˝rincz, A., Nusser, Z., and Silver, R.A. (2014). Network structure within the cerebellar input layer enables lossless sparse encoding. Neuron 83, 960–974.
Bordelon, B., Canatar, A., and Pehlevan, C. (2020). Spectrum dependent learning curves in kernel regression and wide neural networks. International Conference on Machine Learning 1024–1034.
Brown, I.E. and Bower, J.M. (2001). Congruence of mossy fiber and climbing fiber tactile projections in the lateral hemispheres of the rat cerebellum. Journal of Comparative Neurology 429, 59–70.
Brunel, N., Hakim, V., Isope, P., Nadal, J.P., and Barbour, B. (2004). Optimal information storage and the distribution of synaptic weights: perceptron versus Purkinje cell. Neuron 43, 745–757.
Canatar, A., Bordelon, B., and Pehlevan, C. (2021). Spectral bias and task-model alignment explain generalization in kernel regression and infinitely wide neural networks. Nature Communications 12, 1–12.
Cayco-Gajic, N.A., Clopath, C., and Silver, R.A. (2017). Sparse synaptic connectivity is required for decorrelation and pattern separation in feedforward networks. Nature Communications 8, 1–11.
Chadderton, P., Margrie, T.W., and Ha¨usser, M. (2004). Integration of quanta in cerebellar granule cells during sensory processing. Nature 428, 856–860.
Churchland, M.M., et al. (2010). Stimulus onset quenches neural variability: a widespread cortical phenomenon. Nature Neuroscience 13, 369–378.
Farris, S.M. (2011). Are mushroom bodies cerebellum-like structures? Arthropod structure & development 40, 368–379.
Garwicz, M., Jorntell, H., and Ekerot, C.F. (1998). Cutaneous receptive fields and topography of mossy fibres and climbing fibres projecting to cat cerebellar C3 zone. The Journal of Physiology 512 ( Pt 1), 277–293.
Gilbert, M. and Chris Miall, R. (2022). How and Why the Cerebellum Recodes Input Signals: An Alternative to Machine Learning. The Neuroscientist 28, 206–221.
Giovannucci, A., et al. (2017). Cerebellar granule cells acquire a widespread predictive feedback signal during motor learning. Nature Neuroscience 20, 727–734.
Huang, C.C., et al. (2013). Convergence of pontine and proprioceptive streams onto multimodal cerebellar granule cells. eLife 2, e00400.
Ishikawa, T., Shimuta, M., and Ha¨usser, M. (2015). Multimodal sensory integration in single cerebellar granule cells in vivo. eLife 4, e12916.
Jacot, A., Gabriel, F., and Hongler, C. (2018). Neural tangent kernel: Convergence and generalization in neural networks. Advances in Neural Information Processing Systems 31.
Jo¨rntell, H. and Ekerot, C.F. (2002). Reciprocal Bidirectional Plasticity of Parallel Fiber Receptive Fields in Cerebellar Purkinje Cells and Their Afferent Interneurons. Neuron 34, 797–806.
Jorntell, H. and Ekerot, C.F. (2006). Properties of Somatosensory Synaptic Integration in Cerebellar Granule Cells In Vivo. Journal of Neuroscience 26, 11786–11797.
Knogler, L.D., Markov, D.A., Dragomir, E.I., Stih, V., and Portugues, R. (2017). Senso-ˇ rimotor representations in cerebellar granule cells in larval zebrafish are dense, spatially organized, and non-temporally patterned. Current Biology 27, 1288–1302.
Litwin-Kumar, A., Harris, K.D., Axel, R., Sompolinsky, H., and Abbott, L.F. (2017). Optimal degrees of synaptic connectivity. Neuron 93, 1153–1164. Marr, D. (1969). A theory of cerebellar cortex. Journal of Physiology 202, 437–470.
Nguyen, T.M., et al. (2022). Structured cerebellar connectivity supports resilient pattern separation. Nature 1–7.
Saarinen, A., Linne, M.L., and Yli-Harja, O. (2008). Stochastic Differential Equation Model for Cerebellar Granule Cell Excitability. PLOS Computational Biology 4, e1000004.
Simon, J.B., Dickens, M., and DeWeese, M.R. (2021). A theory of the inductive bias and generalization of kernel regression and wide neural networks. arXiv: 2110.03922.
Sollich, P. (1998). Learning curves for Gaussian processes. Advances in Neural Information Processing Systems 11.
Spanne, A. and Jo¨rntell, H. (2013). Processing of Multi-dimensional Sensorimotor Information in the Spinal and Cerebellar Neuronal Circuitry: A New Hypothesis. PLOS Computational Biology 9, e1002979.
Spanne, A. and Jo¨rntell, H. (2015). Questioning the role of sparse coding in the brain. Trends in Neurosciences 38, 417–427.
van Kan, P.L., Gibson, A.R., and Houk, J.C. (1993). Movement-related inputs to intermediate cerebellum of the monkey. Journal of Neurophysiology 69, 74–94.
Wagner, M.J., Kim, T.H., Savall, J., Schnitzer, M.J., and Luo, L. (2017). Cerebellar granule cells encode the expectation of reward. Nature 544, 96–100.
Wagner, M.J., et al. (2019). Shared cortex-cerebellum dynamics in the execution and learning of a motor task. Cell 177, 669–682.e24.
Wolpert, D.M., Miall, R.C., and Kawato, M. (1998). Internal models in the cerebellum. Trends in Cognitive Sciences 2, 338–347.
Yu, B.M., et al. (2009). Gaussian-process factor analysis for low-dimensional single-trial analysis of neural population activity. Journal of Neurophysiology 102, 614–635.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
This study combines in vitro somatic and dendritic recordings and computational modeling to study how cholinergic agonists modulate the response of CA1 pyramidal neurons to triangular current injections. The authors have previously used a similar approach (Upchurch, 2022, JNeuroscience) to show that CA1 neurons exhibit asymmetric AP firing (more firing on the upward ramp) in response to such current injections and that this effect is due to Na channel inactivation. The present work builds on these results by showing that cholinergic modulation changes this response, i.e., there is more firing on the downward part of the ramp. This change appears to require an intracellular Ca2+ concentration increase (mediated via IP3 and voltage-gated Ca2+ channels), which activates TRPM4 channels. In this scheme, cholinergic activity increases IP3, and the depolarizing current injection opens voltage-gated Ca2+ channels. This study will be of some interest to cellular neurophysiology experts working on the hippocampus.
1) This study claims that the triangular current injections recapitulate hippocampal place cell activity. However, it has been shown recently that the asymmetric firing of CA1 place cells is due to synaptic weight changes resulting from synaptic plasticity (e.g., Bittner et al., 2017). This suggests that the asymmetric firing of place cells is primarily the result of asymmetric synaptic input. Therefore, the authors should test whether carbachol similarly affects a synaptically driven membrane potential ramp. If this is not the case, the strong claim that this work has implications for place cell firing is not justified, in my opinion.
We have added the results showing the effects of cholinergic modulation on a synaptically-driven membrane potential ramp, obtained by electrically stimulating the Schaffer collaterals with a stimulation frequency that was adjusted according to a linear, symmetric ramp (see also Hsu et al, Neuron 99,147-162, 2018). These results have been added to the manuscript in the Results section for new Figure 2 (lines 169-197) and in the Methods section (lines 716-726).
2) Along the same lines, it has been shown before that the precision of spike timing depends on the stimulation pattern in vitro (Mainen and Sejnowski, 1995). Constant stimuli led to imprecise AP firing trains, whereas current injections that included fluctuations resembling synaptic input generated spike trains that were more reliable and reproducible in terms of timing. This study concluded that a low intrinsic noise level in spike generation was essential in generating informative spike sequences. Following this pivotal work, the authors could add noise to their current stimulus and observe the effect on the AP firing patterns. If this is not possible, the authors should at least report the sweep-to-sweep variability for the data shown, e.g., in panels 1A2, 1B2, 1D2, and 1E2.
We thank the reviewer for this suggestion to acknowledge the variability in the data across trials and we have added the Mainen and Sejnowski, 1995 citation to the manuscript (see Results lines 128-134). We addressed sweep-to-sweep variability among the various trials.
3) In most of the data presented in this manuscript, Carbachol appears to induce a 3 mV hyperpolarization and increase input resistance. As a result, the amount of current injected during Carbachol is drastically lower than during the controls. This should be emphasized more, and the input resistance should be quantified for each experimental condition. It should also be discussed whether this change in input resistance can account for the changes in the firing pattern observed. Finally, it should be clearly stated how the amount of the current injected was chosen for each cell, and data from a range of injected current ramps should be shown for each cell.
We thank the reviewers for this comment, which made us realize that our initial presentation was not clear, in particular with regard to the traces that were chosen as examples in the initial submission of the paper. We now clarify on page 5 (lines 113-125) of the manuscript as follows:
“In some trials, under control conditions, we applied a baseline depolarization prior to the ramp, in order to capture the variability observed in vivo (Harvey et al Nature 461:941–946, 2009; Epsztein et al. Neuron 70:109–120, 2011). Application of the cholinergic agonist carbachol (CCh, 2 µM) caused a depolarization of 2-6 mV. We compensated for this depolarization by injecting tonic hyperpolarizing current to reestablish the original membrane potential (see also Losonczy, et al., Nature 452, 436-442, 2008), as indicated by an offset from the 0 pA current level in the traces of the injected current ramps. The amplitude of background fluctuations in the resting membrane potential increased from a few tenths of a mV in control to 2-4 mV in CCh. Moreover, the threshold for action potential generation became more hyperpolarized. For all these reasons, we were not able to consistently vary the membrane potential using baseline depolarizations in the presence of CCh, because baseline depolarization alone frequently evoked spiking.”
For this reason, many of the carbachol example traces in the initial submission had more hyperpolarized Vm than their control counterparts. Acetylcholine also caused a depolarization in a dose-dependent manner, that was compensated for in the same way. In this new version of the manuscript, we systematically report the effects of cholinergic agonists on membrane potential and neuronal excitability. Further, we show example traces with resting membrane potentials within 1 mV for each pharmacological comparison, therefore removing this variable and hopefully making results clearer. We also now state how the amount of injected current was chosen for each condition, and that the amount of injected current was generally lower in the presence of cholinergic agonists. Both the tonic hyperpolarizing current and the amplitude of the injected ramp for each example can now be appreciated in each figure.
Finally, the reviewers’ comment also made us realize that, in principle, the center of mass of firing could be systematically skewed by the initial membrane potential, the amplitude of the current ramp injection and/or the input resistance. For this reason, we added a supplementary figure (1-2) where the adaptation index was plotted as a function of each these variables. In all cases, it is apparent that the main factor determining whether the center of mass of firing is shifted earlier or later in the ramp is the presence or absence of carbachol rather than initial membrane potential, current injection amplitude, or input resistance.
4) It remains unclear how the current result that TRPM4 channels can mediate the firing pattern change relates to the previous finding that the current injection evoked CA1 neuronal firing pattern is due to long-term Na channel inactivation.
We thank the reviewers for this suggestion, which helps to clarify our initial results. New Figure 8 addresses the connection between long-term inactivation of Na+ channels and the activation of TRPM4 channels, as characterized by the model (see Results lines 375-391). Furthermore, the model was instrumental in assessing how the Ca2+ and voltage-dependence of TRPM4 channels synergize to contribute to the shift in the center of mass of firing (Figure 9). Figure 9 illustrates the positive feedback loop between Ca2+ entry and the additional depolarization produced by Ca2+ activation of TRPM4 channels that can potentially accelerate firing (see Results lines 392-427).
5) Figure 8: Panel C is supposed to confirm the prediction from the model that the carbachol-mediated change of firing activity is related to intracellular Ca2+ domains. However, the example cell shown is depolarized to -52 mV, and there is no hyperpolarization following Carbachol. Is this an effect of the high concentration of BAPTA? Again, what was the current injected under this experimental condition?
Again, we thank the reviewer for pointing out the lack of clarity in the presentation of our results. We have now rewritten the results section for former Figure 8 (now Figure 10) to more clearly present these findings. The reviewer is correct that with the combination of 30 mM BAPTA + 10 nM free Ca2+ added to the intracellular solution (panel C of current Figure 10) the addition of carbachol did not change the membrane potential, as there were no changes in the holding current. Also, the amplitude of the ramp is comparable in control conditions and in the presence of carbachol under these conditions.
We have now added all these details in the Results section for figure 10C.
Reviewer #2 (Public Review):
The manuscript focuses on the cholinergic modulation of TRPM4 channels in the CA1 pyramidal neurons. The authors presented solid convincing evidence that TRPM4 but not TRPC channels are the Ca2+-activated nonselective cation channel in CA1 pyramidal neurons being modulated by activation of muscarinic receptors. Using bi-directional ramp protocol, the authors revealed that ACh modulation could lead to forward shifts in place field center of mass, whereas decreased ACh modulation could contribute to backward shifts. This represents a significant molecular/cellular finding that links neuromodulation of intrinsic properties to place field shifts, a phenomenon seen in vivo. The authors used a computational approach to model this CA1 neuron spiking to further reveal the mechanism.
To further improve the manuscript, I have the following suggestions/questions:
1) The triangular ramp stimulation (introduced by the same group; Upchurch et al., 2022) makes it possible to emulate the hill-shaped depolarization during place field firing. However, one concern is the time scale/duration of the ramp (2 sec) compared to the physiological pattern (100ms~200ms in the in vivo recording in freely moving rat, Epsztein et al., 2011). Using a longer ramp to generate more spikes for calculating the adaptation index is understandable. However, considering the Ca entry/accumulation during prolonged depolarization, repeating one set of experiments with a shorter ramp is crucial to verify the major findings.
When determining the duration of the current injections for our ramps, we relied on the data recorded in vivo in freely moving rats (Epsztein et al. Neuron 70:109–120, 2011) or in head-fixed mice running on spherical a treadmill immersed in virtual reality (Harvey et al Nature 461:941–946, 2009). In those papers, the voltage deflections are shown as a function of time, and gray bars or boxes represent the time the animals spend traversing the place field. We interpret those figures as showing that the hill-shaped depolarizations have variable durations, on the order of 1-20 s; we therefore think that our experiments with 2 and 10 second-long ramps cover a fair range of these durations. The place fields in Epsztein et al., 2011 were 4 cm long, and the authors give an example in Figure 3, in which the 2 meter track is traversed 1.5 times in 3 minutes. At that rate, the rat spent on average 2.4 seconds in each place field. We interpret the numerous shorter epochs of firing on the order of 100-200 ms shown Figure 2 in Epsztein et al. as the result of ongoing theta modulation within one overall depolarization during a single place field traversal. The following quote from that paper supports our interpretation “Some (Figure 2E, trace 1), but not all (trace 2), passes revealed spiking associated with a series of large (to ~-25 mV), long-lasting (~100 ms) depolarizations (Kandel and Spencer, 1961; Wong and Prince, 1978; Traub and Llinás, 1979; Takahashi and Magee, 2009) occurring rhythmically at ~4–5 Hz (theta frequency).” We thank the reviewer for pointing out these traces; our results are more directly applicable to the traces without theta modulation. Adding theta modulation is beyond the scope of this study but will be considered in future studies. Our average results in Figure 1 show that carbachol similarly affects 2 s and 10 s ramps, therefore we decided to present only the data on 2 second ramps for all the subsequent figures (see Results lines 156-157).
2) Strictly speaking, the term "Ca2+-induced Ca2+ release (CICR)" is only used in ER Ca2+ release via ryanodine receptors (RyR) rather than IP3Rs. The author should be careful since it is used in the abstract (Line 36). In addition, pharmacology inhibition experiments should be incorporated to further dissect the role of RyR-induced CICR.
We thank the reviewer for pointing out the possible confusion regarding the use of the term Ca2+-induced Ca2+ release (CICR) and we removed it from the text. Further, for this resubmission, we have pharmacologically dissected the role of IP3 vs ryanodine receptors in the cholinergic shift in the center of mass of firing due to the activation of TRPM4 channels, as suggested by the reviewer (see new Figure 6). To our surprise, neither the IP3R antagonist, Xestospongin C (1-2 µM), nor the RyR antagonist ryanodine (40 µM) were effective in preventing the cholinergic shift of the center of mass of firing when added to the intracellular solution (see Results lines 310-340).
3) Applying strong buffering BAPTA not only removed the IP3R-TRPM nanodomain but also hindered Ca entry via VGCC. To validate the role of ER Ca2+ release in regulating TRPM, depletion of ER Ca2+ pool with SERCA inhibitor (e.g. thapsigargin) would be a more direct way to test the model (also make sure to add TRPC inhibitor to avoid the store-operated Ca2+ entry).
We agree with the reviewer that 30 mM BAPTA also disrupts intracellular Ca2+ elevation via voltage-dependent Ca2+ channels on the neuronal membrane. Given that our experiments excluded a role of Ca2+ release from the intracellular stores (see below), our new model includes a nanodomain where, during cholinergic activation, the Ca2+ entry through VGCC is amplified to reach micromolar concentrations, through a currently unknown mechanism. As pointed out by the reviewer, the experimental results with 30 mM BAPTA support the existence of a nanodomain for the activation of TRPM4 channels, regardless of the nature of the calcium source.
We have also addressed the role of ER Ca2+ release in our experiments.
4) How does the TRPM current overcome the long-term inactivation of Nav? A channel state model should be added to the manuscript to make it easier to understand.
Figure 11C now shows the Markov model of the NaV channel and new Figure 8 is devoted to explaining the mechanism by which current through the TRPM4 channels overcomes the long-term inactivation of the NaV channel.
Reviewer #3 (Public Review):
Combining slice physiology and simulation, Combe and colleagues discovered that TRPM4 channels activated by Ca2+ in nanodomains mediate ICAN currents in CA1 pyramidal neurons that drive the cholinergic modulation of firing rate. The finding is novel and interesting.
Strengths:
1) Identification of TRPM4 channels as the carrier of ICAN currents with independent pharmacological inhibitors and other supporting evidence.
2) Physiological and simulational verification of physically closely located Ca2+ source and TRPM4 channels required for ICAN activation.
Weaknesses:
1) The conclusion of the cholinergic role in down-ramp or backward firing shifts is not convincing.
We agree with the reviewer that our interpretation is somewhat speculative, and we have now included disclaimers throughout the manuscript as well as placed most of these interpretations in a portion of the discussion titled “Ideas and speculations: Implications of our results for place fields in intact rodents”. In addition, we added the word “potential” in the title.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
The manuscript by Masschelin et al. describes how Vitamin B2 deficiency affects body composition, energy expenditure, and glucose metabolism. B2 deficient mice have lower O2 consumption, and locomotor activity, with no difference in food intake. These mice also have lower liver FAD levels, which is expected given that B2 is a necessary cofactor for this coenzyme. Additionally, these mice have lower blood glucose levels following pyruvate injection, implying a lower capacity for gluconeogenesis. Using PPAR KO mice, they show that this effect on pyruvate tolerance is due to PPARα activation, though there is still a minor difference between wildtype and KO mice. Importantly, they show that fenofibrate PPAR agonism can improve glucose output following pyruvate injection in the absence of B2. The authors also perform robust metabolomics in each experimental condition and phenotype of the mouse well.
Thank you for the positive input.
1) The authors have yet to explore other explanations of differences in glucose metabolism under B2D +/Fenofibrate. The canonical targets of PPARα are involved in fatty acid oxidation, ketogenesis, and VLDL/HDL metabolism, in addition to gluconeogenesis (Bougarne et al. 2018). Gluconeogenesis is more of a fasting response due to CREB, FOXO1/PGC1a activation rather than PPAR. In response to B2D, the PPARα KO mice have increased plasma TGs, which may suggest a difference in VLDL TG secretion (Suppl. S3). Perhaps lipid metabolism is more directly affected, and changes in glucose metabolism are secondary to that of triglyceride metabolism. Regarding ketogenesis, the fenofibrate+ B2D fed mice have decreased plasma betahydroxybutyrate, suggesting decreased ketogenesis, which is a more canonical PPARα pathway (Suppl. S3). Testing each of these processes would help control that this mechanism is specific to gluconeogenesis and not secondary to something else.
We value this reviewer’s comment. To address this point, we considered other mechanisms in our revised Discussion. In future studies, we plan to further explore these metabolic effects and to use ATAC-Seq to understand the transcription factors responsive to B2D. We anticipate these studies will take additional years to complete. Nonetheless, the present studies set the foundation for future work to investigate how FAD influences transcriptional regulation of metabolism.
2) Is the effect on ISR dependent on PPARα? Is the mechanism of Fenofibrate on the liver, or on another cell type? In Figure 1, the authors state that Riboflavin deficiency alters body composition and energy expenditure, and then focuses on the liver. However, FAD levels are also increased in the heart and kidneys in addition to the liver. These tissues also respond to PPARα agonism, in addition to the muscle which plays a role in regulating glucose metabolism (B2D mice also have a higher lean mass (Fig 1e)). Additionally, the authors haven't shown specifically if the effects of Fenofibrate on electron transport and the ISR are dependent on the presence of PPARα (Figure 5, 6).
We agree that knowing whether the effects of Fenofibrate on the ISR require liver PPARA is a critical issue, which will require dedicated studies for a thorough and meaningful conclusion. In new experiments, we knocked down Ppara in the liver using AAV8-Cre administration to Pparaflox/flox mice. Our data show liver-specific Ppara knockdown recapitulates whole-body B2D effects on pyruvate tolerance and hepatic steatosis (Figure 3I). These results agree with findings in whole-body Ppara knockout mice (Supplemental Figure 4), reinforcing the idea that the direct impact of B2D mainly occurs via PPARA activity in the liver. We acknowledge in the discussion ATF4 and ISR activation may contribute to PPARA-independent responses to B2D (Biochem J 443:165–71, 2012; Gut 65:1202-1214, 2016).
An assessment of genetic requirements will require a large, rigorous set of experiments to identify the ratelimiting responses for fenofibrate activities during B2D, which we plan to do in the future. For this report, we decided to focus exclusively on tissue-specific knockout of Ppara. We will establish evidence for ISR responses to B2D in a separate study based on the feedback received here.
Reviewer #2 (Public Review):
The objective of this work by Masschelin et al. is to investigate the physiological relevance of flavin adenine dinucleotide (FAD). In particular, FAD supports the activity of flavoproteins involved in the production of cellular energy. Mutations in genes encoding flavoproteins often are associated with inborn errors of metabolism (IEMs), thus the clinical interest in investigating in more depth the physiological role of FAD. In this study, the authors first subjected male mice to a vitamin B12 deficient diet (B2D), demonstrating that loss of B12 replicates the phenotypes often observed with IEMs, including loss of body weight, hypoglycemia, and fatty liver. Using a combination of metabolomic phenotyping, transcriptomic analyses, and pharmacology (treatment with Fenofibrate, a PPARa agonist), the authors then reach the general conclusion that activation of the nuclear receptor PPARa can rescue the B2D phenotypes, thus revealing that PPARa directly controls the metabolic responses to FAD availability. Although the phenotypic analysis of the mice subjected to B2D increases our knowledge of the physiological impact of depleting the FAD pools on global energy metabolism, not all conclusions and statements made by the authors are totally supported by the data. In particular, the study is overall too descriptive and lacks mechanistic insights. While PPARa is likely an important player in the metabolic response to FAD availability, the molecular details on how FAD controls the activity of PPARa either directly or indirectly are entirely missing. Therefore, the authors are encouraged to directly assess whether B2D directly influences PPARa activity on the genes identified in the study, perform rescue experiments in the liver of PPARa KO mice and explore the possibility that other factors (including nuclear receptors) also participate in the response to B2 deficiency and diminished FAD pools.
We appreciate the input from Reviewer 2. The direct and indirect effects of B2D on PPARA activity are likely not trivial. However, we performed experiments to determine how FAD depletion affects PPARA transcriptional activity using the riboflavin analog and competitive inhibitor lumiflavin (Figure 3L). We found lumiflavin reduced PPRE-luciferase activity in the presence of PPARA agonist. Although the assay is a synthetic reporter expressed in vitro, the experiment provides evidence of how B2D influences PPARA transcriptional activity. And, yes, we agree that our manuscript does not completely reconcile the factor(s) explaining the effects of B2D on gene expression, and expanded the discussion to comment on this point. In future studies, we intend to identify which transcription factor(s) regulate the liver responses to B2D, and further elucidation of the molecular mechanisms will be a central objective of future work.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
In this manuscript, Scagliotti and colleagues investigate the role of Dlk1 in regulating pituitary size in multiple mouse models with different Dlk1 gene dosages in order to understand the mechanisms of organ size control. They find that overexpression of Dlk1 leads to pituitary overgrowth and loss of Dlk1 causes undergrowth. Authors find two compartments of Dlk1 expression in the pituitary, in the marginal zone stem cell compartment and the parenchymal differentiated cell compartment, and by combing genetic mouse models show that a specific interaction of Dlk1 expression in both regions is necessary to affect pituitary organ size. They present to suggest that Dlk1 may repress Wnt signaling during development to control a shift from progenitor proliferation to differentiation. The data are meticulous, high quality, and clear.
I have some questions about the interpretation of their data regarding the mechanism of Dlk1 regulation of pituitary organ size, as I believe there could be potential alternative explanations for their observations:
I was wondering about the cause of the enlargement of the pituitary gland in Fig 1E, and whether it is caused by an increased number of cells (hyperplasia), an increased cell size (hypertrophy), or both. Line 104 states it is hyperplasia, and that cell size was not affected in WT-TG ('not shown', line 121). However, line 444 says the TG is hypertrophic. It would be good if the authors could elaborate on this and show or state how cell size was determined. Figs 5/6 show that WT-Tg proliferation is generally similar to WT, which suggests the increased size is not hyperplasia. It would be good to know whether this is correct. Some previous studies have shown that in pregnancy, lactotroph hypertrophy can be responsible for pituitary enlargement without hyperplasia (Castrique 2010, Hodson 2012).
We have now clarified this point throughout the manuscript. We had previously counted cells per field in the analysis shown in Figure 1D as a proxy for cell number (these did not significantly differ by genotype). We have now performed a more robust examination. Cell number was determined using a well-established stereological technique: For each animal the maximal cross-sectional area (CSA) was determined from the volumetric analysis. At this level 3 independent sections were used to measure anterior pituitary CSA and count haematoxilin-stained nuclei, giving a mean cells/CSA measurement per individual. This number was multiplied by the AP volume to give an estimate of cell number.
This analysis was performed on mice from the new cohort of animals containing litter matched adults of all 4 genotypes, and shown in Figure 4E. WT-TG animals had a significant increase in cell number compared to WT littermates (p = 0.0443), therefore pituitary expansion occurs by hyperplasia.
Related to the organ size question above, I had a question about the cell number and proportions in Fig 1D/E/F, which shows the maintenance of endocrine cell proportions and an increase in the volume of ~30% in WT-Tg. For the cell proportions to be maintained, I thought the increase in volume per cell type (Fig 1G) would therefore have to also increase proportionally in every cell type, while 1G appears to show an increase in GH (sig) and PRL/TSH cells (ns). It would be good if the authors could discuss this briefly.
We agree and indeed we see this trend across all cell types. When the data in Figure 1G is compared by 2-Way ANOVA we see a significant effect by cell type (p< 0.0001) and by genotype (p = 0.0009). However, for other hormone producing cells the effect size is does not overcome the variation in a smaller cell population so the difference between genotypes does not pass multiple significance testing with the relatively small sample size used. We have modified the legend to Figure 1G to make the ANOVA result clearer.
This study is impactful and will be of interest to several research communities, including those interested in pituitary development and function, organ size control, and gene imprinting mechanisms.
Reviewer #2 (Public Review):
Scagliotti et al address how organ size is regulated by imprinted genes. Using a series of mouse models to modulate the dosage of the paternally expressed gene, Dlk1, the authors demonstrate that DLK1 is important for the maintenance of the stem cell compartment leading to the growth of the pituitary gland and the expansion of growth hormone-producing cells. The authors show that overexpression of Dlk1 leads to pituitary hyperplasia while deletion of the paternal allele leads to reduced pituitary size. Reduced pituitary size is accompanied by reduced cell proliferation in the cleft at e13.5 and an increase in the number of POU1F1+ cells, suggesting that loss of Dlk1 alters the balance between the number of cells remaining in the replicating stem cell pool and those differentiating into the POU1F1 lineage. An elegant caveat of this paper is the rescue of Dlk1 expression in the population of cells expressing Pou1f1 but not in SOX2+ stem cells. Expression of Dlk1 only in POU1F1+ cells is not sufficient to rescue pituitary size. The authors suggest that this is because DLK1 must be present in stem cells which then activate paracrine WNT signaling to promote cell proliferation in POU1F1+ cells.
Strengths:
This is an important study that provides a mechanistic understanding of how the imprinted gene, Dlk1, regulates organ size. The study employs an elegant experimental design to address the dosage requirement for Dlk1 in regulating pituitary gland size. Rescuing Dlk1 in the POU1F1+ cells, but not the marginal zone SOX2+ cells provides intriguing results about a possible role for DLK1 in paracrine signaling between these different pituitary cell types. The study uses publicly available scRNAseq and ChIPseq data to further support their findings and identify Dlk1 as a likely target of POU1F1.
Weaknesses:
The study only analyzes females for the adult time point. For embryonic and postnatal time points sexes are pooled. Gender differences in pituitary gene expression embryonically or postnatally could potentially affect experimental outcomes.
We have now added adult data for both sexes.
The authors employ a mouse model that rescues Dlk1 expression starting at e15.5 in POU1F1+ parenchymal cells but not in marginal zone stem cells. Rescuing Dlk1 expression in a specific population of cells is one of the strengths of this study. Based on this information and the fact that overexpression of Dlk1 leads to increased pituitary size, the authors suggest that DLK1+ marginal zone stem cells and DLK+ parenchymal cells may interact to promote postnatal proliferation. However, the ability to more carefully parse out the complex spatial and temporal contributions of DLK1 to pituitary size would be enhanced by the addition of a mouse model that rescues Dlk1 expression only in SOX2+ cells and a model that rescues expression in both stem cells and POU1F1+ cells.
We agree that the addition of a model where Dlk1 is only expressed in SOX2+ cells would add significant mechanistic insight. To our knowledge an inducible gain-of-function Dlk1 model does not yet exist. Moreover, use of a SOX2-Cre driver would also increase Dlk1 expression in the hypothalamus as well as Rathke’s pouch, further complicating the analysis.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
In this manuscript, Huang et al., assess cognitive flexibility in rats trained on an animal model of anorexia nervosa known as activity-based anorexia (ABA). For the first time, they do this in a way that is fully automated and free from experimenter interference, as apparently experimenter interference can affect both the development of ABA as well as the effect on behaviour. They show that animals that are more cognitively flexible (i.e. animals that had received reversal training) were better able to resist weight loss upon exposure to ABA, whereas animals exposed to ABA first show poorer cognitive flexibility (reversal performance).
Strengths:
-
The development of a fully-automated, experimenter-free behavioural assessment paradigm that is capable of identifying individual rats and therefore tracking their performance.
-
The bidirectional nature of the study - i.e. the fact that animals were tested for cognitive flexibility both before and after exposure to ABA, so that direction of causality could be established.
-
The analyses are rigorous and the sample sizes sufficient.
-
The use of touchscreens increases the translational potential of the findings.
Weaknesses
- Some descriptions of methods and results are confusing or insufficiently detailed.
We have been through all methods and results to include additional details as requested by this reviewer below.
It seems to me that performance on the pairwise discrimination task cannot be directly (statistically) compared to performance on reversal (as in Figure 4E), as these are tapping into fundamentally different cognitive processes (discrimination versus reversal learning). I think comparing groups on each assessment is valid, however.
We agree that discrimination and reversal are different cognitive processes, and statistical comparisons between these two components of the task were only made when examining the speed of learning in the validation of the novel testing system. Moreover, our inclusion of the pink and purple bars on graphs such as Figure 4C & 4E represent “main effects of ABA exposure”, regardless of learning phase (PD or reversal) rather than, as you describe, comparing PD to R1. Perhaps this comparison wasn’t clear, so we have amended the text to say ‘main effect of ABA exposure p=.0017’ rather than just “exposure”.
Not necessarily a 'weakness' but I would have loved to see some assessment of the alterations in neural mechanisms underlying these effects, and/or some different behavioural assessments in addition to those used here. In particular, the authors mention in the discussion that this manipulation can affect cholinergic functioning in the dorsal striatum We (Bradfield et al., Neuron, 2013) and a number of others have now demonstrated that cholinergic dysfunction in the dorsomedial striatum impairs a different kind of reversal learning that based on alterations in outcome identity and thus relies on a different cognitive process (i.e. 'state' rather than 'reward' prediction error). It would be interesting perhaps in the future to see if the ABA manipulation also alters performance on this alternative 'cognitive flexibility' task.
This is an excellent suggestion and we have already begun exploring this in other ongoing work in the laboratory. Due to ‘compulsive’ wheel running being a hallmark of ABA, we are interested in determining if this also translates to a goal-directed action impairment using the well-established outcome-specific devaluation task. Perhaps with ABA it may be more relevant to investigate outcome-reversals rather than stimulus-reversals, and if this is the case, it would further support the use of the ABA model for investigating cognitive dysfunction relevant to AN. We have included an additional section in the discussion text relating to our hypotheses regarding outcome-specific reversal learning in the ABA model.
Nevertheless, I certainly think the manuscript provides a solid appraisal of cognitive flexibility using more traditional tasks, and that the authors have achieved their aims. I think the work here will be of importance, certainly to other researchers using the ABA model, but perhaps also of translational importance in the future, as the causal relationship between ABA and cognitive inflexibility is near impossible to establish using human studies, but here evidence points strongly towards this being the case.
Reviewer #2 (Public Review):
Huang and colleagues present data from experiments assessing the role of cognitive inflexibility in the vulnerability to weight loss in the activity-based anorexia paradigm in rats. The experiments employ a novel in-home cage touchscreen system. The home cage touch screen system allows reduced testing time and increased throughput compared with the more widely used systems resulting in the ability to assess ABA following testing cognitive flexibility in relatively young female rats. The data demonstrate that, contrary to expectations, cognitive inflexibility does not predispose to greater ABA weight loss, but instead, rats that performed better in the reversal learning task lost more weight in the ABA paradigm. Prior ABA exposure resulted in poorer learning of the task and reversal. An additional experiment demonstrated that rats that had been trained in reversal learning resisted weight loss in the ABA paradigm. The findings are important and are clearly presented. They have implications for anorexia nervosa both in terms of potentially identifying those at risk also in understanding the high rates of relapse.
Thanks for a great summary of the manuscript.
Reviewer #3 (Public Review):
Activity-based anorexia (ABA), which combines access to a running wheel and restricted access to food, is a most common paradigm used to study anorexic behavior in rodents. And yet, the field has been plagued by persistent questions about its validity as a model of anorexia nervosa (AN) in humans. This group's previous studies supported the idea that the ABA paradigm captures cognitive inflexibility seen in AN. Here they describe a fully automated touchscreen cognitive testing system for rats that makes it possible to ask whether cognitive inflexibility predisposes individuals to severe weight loss in the ABA paradigm. They observed that cognitive inflexibility was predictive of resistance to weight loss in the ABA, the opposite of what was predicted. They also reported reciprocal effects of ABA and cognitive testing on subsequent performance in the other paradigm. Prior exposure to the ABA decreased subsequent cognitive performance, while prior exposure to the cognitive task promoted resistance to the ABA. Based on these findings, the authors argue that the ABA model can be used to identify novel therapeutic targets for AN.
The strength of this manuscript is primarily as a methods paper describing a novel automated cognitive behavioral testing system that obviates the need for experimentalist handling and single housing, which can interfere with behavioral testing, and accelerate learning on the task. Together, these features make it feasible to perform longitudinal studies to ask whether cognitive performance is predictive of behavior in a second paradigm during adolescence, a peak period of vulnerability for many psychiatric disorders. The authors also used machine learning tools to identify specific behaviors during the cognitive task that predicted later susceptibility to the ABA paradigm. While the benefits of this system are clear, the rigor and reproducibility of experiments using this paradigm would be enhanced if the authors provided clear guidelines about which parameters and analyses are most useful. In their absence, the large amount of data generated can promote p-hacking.
The authors use their automated behavioral testing paradigm to ask whether cognitive inflexibility is a cause or consequence of susceptibility to ABA, an issue that cannot be addressed in AN. They provide compelling evidence that there are reciprocal effects of the two behavioral paradigms, but do not perform the controls needed to evaluate the significance of these observations. For example, the learning task involves sucrose consumption and food restriction, conditions that can independently affect susceptibility to the ABA. Similarly, the ABA paradigm involves exercise and restricted access to food, which can both affect learning.
In the Discussion, the authors hypothesize that the ABA paradigm produces cognitive inflexibility and argue that uncovering the underlying mechanism can be used to identify new therapeutic targets for AN. The rationale for their claim of translational relevance is undermined by the fact that the biggest effect of the ABA paradigm is seen in the pair discrimination task, and not reversal learning. This pattern does not fit clinical observations in AN.
In summary, the significance of this manuscript lies in the development of a new system to test cognitive function in rats that can be combined with other paradigms to explore questions of causality. While the authors clearly demonstrate that cognitive flexibility does not promote susceptibility to ABA, the experiments presented do not provide a compelling case that their model captures important features of the pathophysiology of AN.
We thank the reviewer for this detailed review and note that we have now both explicitly defined the most useful parameters for analyses from the novel touchscreen system as well as removed some comparisons that could be considered superfluous. We argue that the additional information provided by the machine learning analyses are, at this stage, exploratory, and rather than reveal independent descriptions of behavioural change in ABA exposed versus naïve rats this information will aid in the generation of hypotheses to be tested in future studies. Therefore, the figures pertaining to these analyses have now been provided as supplements to Figures 3 & 4 (Figure 3-figure supplement 3; Figure 4-figure supplements 3&4). We have also clarified our intention to explore possible behavioural differences using this technique in the methods and discussion.
We have also completed the essential control experiment, defined in the “essential revisions” section of this review, whereby we show only moderate impairments in reversal learning following a matched period of food restriction without rapid weight loss, suggesting that the substantial impairment seen following ABA exposure was not due to food restriction alone (see updated Figure 4 and supplements).
However, we do not agree with this reviewer “that the biggest effect of the ABA paradigm is seen in the pair discrimination task” and point to the outcomes of both reciprocal experiments.
In the first experiment, rats that went onto be susceptible or resistant to ABA did not differ on pairwise discrimination learning but specifically on performance at the reversal of reward contingencies (Figure 3B & E). Although this result was not in the hypothesised direction, this suggests that reversal learning specifically and not pairwise discrimination can differentiate those rats that go on to be susceptible to weight loss. We have included additional discussion in the text related to this finding (see line 490-497).
In the second experiment, it is clear by the number of ABA exposed rats that were unable to learn the reversal component even after being able to learn pairwise discrimination, that flexible learning is more impaired by ABA. While it is true that ABA exposed rats that were successful in learning the reversal task were slower to learn the pairwise discrimination component than naïve rats (Figure 4E), this was not related to their ability to learn the reversal task overall – with equivalent learning rates in pairwise discrimination to ABA exposed rats that failed to learn the reversal component (Figure 4G-I). The absence of significant differences between ABA exposed and naïve animals in Figure 4F relates to the fact that the large proportion of ABA exposed animals never reached performance criterion in the reversal phase of the task and therefore data from these animals could not be included in the figure. This is where the trials completed within each session becomes important for interpretation (i.e. Figure 4-figure supplement 1M-O), whereby ABA exposure caused impaired responding specifically within the reversal phase of the task. The results text has been updated to better reflect this critical point.
Overall, this suggests that the impairment in cognitive flexibility caused by ABA exposure was related both to an associative learning impairment (slower to learn PD than naïve animals) and an impairment in the integration of new and existing learning (failure to learn R1 in a large proportion of animals).
-
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
Weaknesses
1) I was curious as to how novel this setup is. Although I do not do head-fixed research myself, I thought there were already some open-source, relatively cheap systems available. I'm not sure how the current setup differs from those already available. Personally, even if this system involves only the wheel turning, as this is a truly operant response, that is novel enough for my liking.
The novelty of the system stems from the synergistic combination of functionality, the low-cost open source nature of the design, and the breadth of behavioral procedures the system is able to support. The use of a wheel as an operant response was adapted from the International Brain Laboratory rig which has been used extensively for visual discrimination tasks. We adapted this wheel design to make the response closer to lever pressing through the use of the wheel brake, which ensures that subjects have to rotate the wheel in discrete rotational bouts rather than continuously spinning the wheel and potentially disengaging and allowing the wheel to rotate independently. There are no examples of systems capable of delivering 5+ solutions within a behavioral session or conducting valence testing with a modification of real-time place preference without the cost and complexity associated with virtual reality. We believe that the combination of factors, the flexibility and scalability of the system makes OHRBETS a novel and useful system for diverse motivation and consumption behaviors in head-fixed mice.
2) It would be useful to have a bit more detail in the manuscript (not just on the GitHub link - in supplemental material perhaps?) on how to build such a system, just to get a sense of how difficult building such a system might be and how many components it has.
With this submission we have included detailed assembly instructions as a supplement to the main manuscript and added reference to the file within the methods section. We have also added details, including time estimates, to the methods section.
3) I wasn't sure how to feel about the comparisons across experimental set-ups in Figures 2 and 3. Usually, these sorts of comparisons are not considered statistically valid due to the many variables that differ between set-ups. However, I do see that the intent here is a bit different - i.e. is to show that despite all these alterations in variables the behavioural outputs are still highly correlated. However, without commenting on this intent, I did find these comparisons a little jarring to read.
Thank you for highlighting this. We have added in a justification for why we measured the consistency in behavior measured with each head-fixed system.
4) The only dataset I was not wholly convinced by was that in Figure 3 (real-time place preference and aversion). I think the authors have done the best job that they can of replicating such a procedure in a head-fixed mouse, but the head-fixed version is going to necessarily differ from the freely moving version in a fundamental way when the contextual cues and spatial navigation form part of the RTPT task. Giving a discrete cue, such as a tone, just is not a sufficient substitute for contextual cues, and I think the two types of task would engage fundamentally different brain cells and circuits (e.g. only the free-moving version is likely to engage place cells in the hippocampus).
To avoid confusion regarding the place component of the real-time place preference assay name, we have renamed the head-fixed assay for assessing valence to Wheel-Time Preference (WTP). We have also added a full paragraph to the discussion where we outline the differences in the task requirements and relevant neuronal circuits between the freely-moving RTPP and head-fixed WTP. We understand that the head-fixed task is not a perfect analog of the RTPP task, however based on the similarity in the resulting time spent in the stimulation chamber/zone we believe that the WTP is able to replicate the valence assessment that many in the field uses RTPP to measure. We believe that the WTP with OHRBETS opens up new possibilities for assessing preference in head-fixed mice and this justifies keeping the figure within the main manuscript.
To thoroughly address the potential confound of spatial information during the multi-spout experiment, we have added an additional supplemental figure (Figure 4- figure supplement 5) that depicts the proportion of trials with licking and added a paragraph to the discussion centered on the potential confound associated with learning the solution identity.
5) Personally, I found having the statistics in a separate file confusing.
Thank you for raising this concern. With our initial submission, we were concerned that including all of the statistics within the main text would make the paper difficult to read due to the extensive amount of statistics. With this submission, in addition to the statistics table, we have included statistics within the figure legends and main text where applicable.
6) Line 589-594. Suggesting the medial/lateral shell recording results mean that the medial shell 'tracks value, and the range of values during the multi-spout consumption of gradients of NaCl is greater than the range of values during multi-spout consumption of gradients of sucrose" seems to engage in circular logic to me. That is, the authors should use behavioural data to infer what the animal is experiencing and whether it is a change in value, and/or a greater change in value during NaCl vs. sucrose consumption, and only then should they make an inference about what the larger medial shell response means.
Thank you for identifying this potential site of confusion. To address this concern we have modified the language to better communicate our interpretation of the data.
“If we assume that the range of values is greater during multi-spout consumption of gradients of NaCl compared to gradients of sucrose, as indicated by a greater range in licking behavior (Figure 8- Figure Supplement 4), then the greater range of dopamine release in the NacShM could imply that dopamine release in this structure tracks value.”
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
Wang, Y. et al. investigated the role of TPL2 signaling in acute and chronic neuroinflammatory conditions using small molecule inhibitors and a TPL2 kinase-dead mutant mouse line. They find that TPL2 is upregulated by various brain-resident cells, including microglia, astrocytes, and endothelial cells, during neurodegenerative disease progression and following peripheral LPS injection. They show that upon pharmacological and genetic inhibition during acute LPS stimulation, pro-inflammatory cytokine concentration, microgliosis, and neuronal loss can be reversed. In chronic neuroinflammation, as seen in a tauopathy mouse model, the loss of TPL2 rescues reactive gliosis, immune cell infiltration, neurodegeneration, and cognitive health. Interestingly, TPL2 loss of function was not significantly beneficial in models of nerve injury and stroke. By analyzing their multiple sequencing datasets and those of other research teams, the authors find that TPL2 aids to upregulate transcripts for the DAM signature, immediate early genes, and astrocyte reactivity. These data build together to further emphasize the intricacy and importance of the immune component in neurodegeneration and other neuroinflammatory conditions.
The conclusions of this paper are mostly well supported by their data, but further confirmation of sequencing results and microglia intrinsic mechanisms need to be expanded.
1) In the discussion section, it will be important to highlight that TPL2 could also be directly contributing to tauopathy disease progression through its actions in brain-resident endothelial cells. They spend a lot of time characterizing the effects of TPL2 on in vitro microglial responses and do not adequately discuss the potential that their disease phenotypes in the tauopathy model have more to do with TPL2's ability to regulate BBB permeability or facets of endothelial biology. It will be important to highlight that there are various discrete cellular mechanisms (e.g. functions for TPL2 in microglia, endothelial cells, astrocytes, peripheral immune cells, etc.) that could be underlying the disease readouts seen in their global TPL2 kinase-dead mice. They should discuss this in the context of previous literature demonstrating roles for TPL2 in other non-microglial cell types (e.g. Nanou et al PMID: 34038728).
Thank you for this comment. We agree that while TPL2 is most highly expressed in microglia in the brain, TPL2 expression in endothelial cells and other cell types could potentially contribute to the disease. We have added discussion of this to the manuscript including discussion of the Nanou et al paper which raises the possibility that the TPL2-dependent infiltration of peripheral immune cells in TauP301S mice could be due to regulation of the BBB by TPL2 activity in endothelial cells. We also discuss potential roles for TPL2 in the various other cell types. In addition, we have now added characterization of cell-autonomous TPL2-dependent phenotypes in cultured astrocytes and have provided additional analysis of TPL2-dependent changes in endothelial cells in the scRNAseq experiment in TauP301S mice.
2) Hippocampal single-cell RNA sequencing led the authors to report that TLP2KD in the PS19 model of tauopathy reduced the number of T-cell and dendritic cell (DC) infiltrates into the brain. The authors should corroborate this finding with immunohistochemistry or flow cytometry to confirm the presence of changing CD4+, CD8+, and DC populations. Most notably, it is critical for them to enumerate the cell numbers in an effort to validate that there are indeed empirical, and not just proportional, reductions in these cell populations.
Thank you for the suggestion. We have performed immunohistochemistry to examine T cells in fixed brain tissue sections. We have included the data for T cell staining in Figure 5-figure supplement 2. We focused the IHC analysis on staining for CD8+ T cells based on the substantially greater abundance of CD8+ T cells compared to CD4+ T cells or DC in the single cell data (Figure 5C, Figure 5-figure supplement 5) and the availability of an antibody that worked well in our hands. These results corroborate the single cell data by empirically showing significantly increased numbers of T cells in TauP301S mice and significantly reduced numbers in the TauP301S x TPL2KD mice (Figure 5-figure supplement 2).
3) The authors concluded from Figure 3 that TPL2 plays a key role in in vivo microglia and astrocyte activation. Adding in an in vitro study, like those done in Figures 1, 2, and S4, that looks at a cell-autonomous role for TPL2 in astrocyte reactivity would strengthen this claim and rule out a microglial-independent pathway of TPL2 inflammation.
Thank you for the suggestion. To investigate the potential cell-autonomous role of TPL2 in astrocytes, we cultured primary mouse astrocyte and stimulated astrocytes with either LPS or cytokines, in the absence or presence of TPL2 inhibitor and measured stimulation induced changes in cytokine release and gene expression. Data are included in Figure 3-figure supplement 1 and the results are discussed in the manuscript. In contrast to the broader TPL2-dependence of cytokine release by cultured microglia only a much more restricted set of cytokines exhibited TPL2-dependence in cultured astrocytes. Furthermore, RT-qPCR analysis of TPL2-dependent activated astrocyte genes identified in the LPS in vivo study found much less TPL2-dependent activation in cultured astrocytes. We discuss that these results suggest that the TPL2-dependent astrocyte activation observed in vivo was probably largely contributed to indirectly by the function of TPL2 in microglia, but there was also potentially some contribution of cell-autonomous function of TPL2 in astrocytes.
4) Although the TPL2KD mouse line is a valuable tool to impair TPL2's function while retaining its expression, the researchers failed to comment on the potential effects a global mutation in TPL2 could have in their model systems. Peripheral immunological challenges, like their IP injections of LPS, could behave differently and affect the nervous system in a microglia-independent pathway if monocyte/macrophage signaling is also impaired.
We agree that during peripheral immunological challenges TPL2 could affect the nervous system in a microglia-independent manner. We have added this point to the discussion.
5) Oligodendrocytes and OPCs have comparable numbers of DEGs to astrocytes (Figure S11a). What is changing within their transcriptional profile?
In this manuscript we focused on TPL2-dependent DEGs in the Tauopathy model, which were all in microglia. We agree the TPL2-independent changes in the TauP301S mice in other cell types are also interesting. This data set has been uploaded to public data repository (GSE180041) and analysis of the changes in oligodendrocytes has been performed from this data set, as well as other disease models, in a recent publication: “Disease-associated oligodendrocyte responses across neurodegenerative diseases” (PMID: 36001972).
-
-
www.medrxiv.org www.medrxiv.org
-
Author Response
Reviewer #1 (Public Review):
Strengths
This paper is well situated theoretically within the habit learning/OCD literature. Daily training in a motor-learning task, delivered via smartphone, was innovative, ecologically valid and more likely to assay habitual behaviors specifically. Daily training is also more similar to studies with non-humans, making a better link with that literature. The use of a sequential-learning task (cf. tasks that require a single response) is also more ecologically valid. The in-laboratory tests (after the 1 month of training) allowed the researchers to test if the OCD group preferred familiar, but more difficult, sequences over newer, simpler sequences.
The authors achieved their aims in that two groups of participants (patients with OCD and controls) engaged with the task over the course of 30 days. The repeated nature of the task meant that 'overtraining' was almost certainly established, and automaticity was demonstrated. This allowed the authors to test their hypotheses about habit learning. The results are supportive of the authors' conclusions.
We truly appreciate the positive assessment of referee 1, particularly the consideration that our study is theoretically strong and that ‘the results are supportive of the authors' conclusions’. This is an important external endorsement of our conclusions, contrasting somewhat with the views of referee 2.
Weaknesses
The sample size was relatively small. Some potentially interesting individual differences within the OCD group could have been examined more thoroughly with a bigger sample (e.g., preference for familiar sequences). A larger sample may have allowed the statistical testing of any effects due to medication status.
The authors were not able to test one criterion of habits, namely resistance to devaluation, due to the nature of the task
We agree with the reviewer that the proof of principle established in our study opens new avenues for research into the psychological and behavioral determinants of the heterogeneity of this clinical population. However, considering the study timeline and the pandemic constraints, a bigger sample was not possible. Our sample can indeed be considered small if one compares it with current online studies, which do not require in-person/laboratory testing, thus being much easier to recruit and conduct. However, given the nature of our protocol (with 2 demanding test phases, 1-month engagement per participant and the inclusion of OCD patients without comorbidities only) and the fact that this study also involved laboratory testing, we consider our sample size reasonable and comparable to other laboratory studies (typically comprising on average between 30-50 participants in each group).
This article is likely to be impactful -- the delivery of a task across 30 days to a patient group is innovative and represents a new approach for the study of habit learning that is superior to an inlaboratory approach.
An interesting aspect of this manuscript is that it prompts a comparison with previous studies of goal-directed/habitual responding in OCD that used devaluation protocols, and which may have had their effects due to deficits in goal-directed behavior and not enhanced habit learning per se.
Thank you for acknowledging the impact of our study, in particular the unique ability of our task to interrogate the habit system.
Reviewer #2 (Public Review):
In this study, the researchers employed a recently developed smartphone application to provide 30 days of training on action sequences to both OCD patients and healthy volunteers. The study tested learning and automaticity-related measures and investigated the effects of several factors on these measures. Upon training completion, the researchers conducted two preference tests comparing a learned and unlearned action sequences under different conditions. While the study provides some interesting findings, I have a few substantial concerns:
1) Throughout the entire paper, the authors' interpretations and claims revolve around the domain of habits and goal-directed behavior, despite the methods and evidence clearly focusing on motor sequence learning/procedural learning/skill learning. There is no evidence to support this framing and interpretation and thus I find them overreaching and hyperbolic, and I think they should be avoided. Although skills and habits share many characteristics, they are meaningfully distinguishable and should not be conflated or mixed up. Furthermore, if anything, the evidence in this study suggests that participants attained procedural learning, but these actions did not become habitual, as they remained deliberate actions that were not chosen to be performed when they were not in line with participants' current goals.
We acknowledge that the research on habit learning is a topic of current controversy, especially when it comes to how to induce and measure habits in humans. Therefore, within this context referee’s 2 criticism could be expected. Across disQnct fields of research, different methodologies have been used to measure habits, which represent relaQvely stereotyped and autonomous behavioral sequences enacted in response to a specific sQmulus without consideraQon, at the Qme of iniQaQon of the sequence, of the value of the outcome or any representaQon of the relaQonship that exists between the response and the outcome. Hence these are sQmulus-bound responses which may or may not require the implementaQon of a skill during subsequent performance. Behavioral neuroscienQsts define habits similarly, as sQmulus-response associaQons which are independent of reward or outcome, and use devaluaQon or conQngency degradaQon strategies to probe habits (Dickinson and Weiskrantz, 1985; Tricomi et al., 2009). Others conceptualize habits as a form of procedural memory, along with skills, and use motor sequence learning paradigms to invesQgate and dissect different components of habit learning such as acQon selecQon, execuQon and consolidaQon (Abrahamse et al., 2013; Doyon et al., 2003; Squire et al., 1993). It is also generally agreed that the autonomous nature of habits and the fluid proficiency of skills are both usually achieved with many hours of training or pracQce, respecQvely (Haith and Krakauer, 2018).
We consider that Balleine and Dezfouli (2019) made an excellent attempt to bring all these different criteria within a single framework, which we have followed. We also consider that our discussion in fact followed a rather cautious approach to interpretation solely in terms of goaldirected versus habitual control.
Referee 2 does not actually specify criteria by which they define habits and skills, except for asserting that skilled behavior is goal-directed, without mentioning what the actual goal of the implantation of such skill is in the present study: the fulfillment of a habit? We assume that their definition of habit hinges on the effects of devaluation, as a single criterion of habit, but which according to Balleine and Dezfouli (2019) is only 1 of their 4 listed criteria. We carefully addressed this specific criterion in our manuscript: “We were not, however, able to test the fourth criterion, of resistance to devaluation. Therefore, we are unable to firmly conclude that the action sequences are habits rather than, for example, goal-directed skills. Regardless of whether the trained action sequences can be defined as habits or goal-directed motor skills, it has to be considered…”. Therefore, we took due care in our conclusions concerning habits and thus found the referee’s comment misleading and unfair.
We note that our trained motor sequences did in fact fulfil the other 3 criteria listed by Balleine and Dezfouli (2019), unlike many studies employing only devaluation (e.g. Tricomi et al 2009; Gillan et al 2011). Moreover, we cited a recent study using very similar methodology where the devaluation test was applied and shown to support the habit hypothesis (Gera et al., 2022).
Whether the initiation of the trained motor sequences in experiment 3 (arbitration) are underpinned by an action-outcome association (or not) has no bearing on whether those sequences were under stimulus-response control after training (experiment 1). Transitions between habitual and goal-directed control over behavior are quite well established in the experimental literature, especially when choice opportunities become available (Bouton et al (2021), Frölich et al (2023), or a new goal-directed schemata is recruited to fulfill a habit (Fouyssac et al, 2022). This switching between habits and goal-directed responding may reflect the coordination of these systems in producing effective behavior in the real world.
-
Fouyssac M, Peña-Oliver Y, Puaud M, Lim NTY, Giuliano C, Everitt BJ, Belin D. (2021).Negative Urgency Exacerbates Relapse to Cocaine Seeking After Abstinence. Biological Psychiatry. doi: 10.1016/j.biopsych.2021.10.009
-
Frölich S, Esmeyer M, Endrass T, Smolka MN and Kiebel SJ (2023) Interaction between habits as action sequences and goal-directed behavior under time pressure. Front. Neurosci. 16:996957. doi: 10.3389/fnins.2022.996957
-
Bouton ME. 2021. Context, attention, and the switch between habit and goal-direction in behavior. Learn Behav 49:349– 362. doi:10.3758/s13420-021-00488-z
2) Some methodological aspects need more detail and clarification.
3) There are concerns regarding some of the analyses, which require addressing.
We thank referee 2 for their detailed review of the methods and analyses of our study and for the helpful feedback, which clearly helps improve our manuscript. We will clarify the methodological aspects in detail and conduct the suggested analysis. Please see below our answers to the specific points raised.
Introduction:
4) It is stated that "extensive training of sequential actions would more rapidly engage the 'habit system' as compared to single-action instrumental learning". In an attempt to describe the rationale for this statement the authors describe the concept of action chunking, its benefits and relevance to habits but there is no explanation for why sequential actions would engage the habit system more rapidly than a single-action. Clarifying this would be helpful.
We agree that there is no evidence that action sequences become habitual more readily than single actions, although action sequences clearly allow ‘chunking’ and thus likely engage neural networks including the putamen which are implicated in habit learning as well as skill. In our revised manuscript we will instead state: “we have recently postulated that extensive training of sequential actions could be a means for rapidly engaging the ‘habit system’ (Robbins et al., 2019)]”
5) In the Hypothesis section the authors state: “we expected that OCD patients... show enhanced habit attainment through a greater preference for performing familiar app sequences when given the choice to select any other, easier sequence”. I find it particularly difficult to interpret preference for familiar sequences as enhanced habit attainment.
We agree that choice of the familiar response sequence should not be a necessary criterion for habitual control although choice for a familiar sequence is, in fact, not inconsistent with this hypothesis. In a recent study, Zmigrod et al (2022) found that 'aversion to novelty' was a relevant factor in the subjective measurement of habitual tendencies. It should also be noted that this preference was present in patients with OCD. If one assumes instead, like the referee, that the familiar sequence is goal-directed, then it contravenes the well-known 'egodystonia' of OCD which suggests that such tendencies are not goal-directed.
To clarify our hypothesis, we will amend the sentence to the following: “Finally, we expected that OCD patients would generally report greater habits, as well as attribute higher intrinsic value to the familiar app sequences manifested by a greater preference for performing them when given the choice to select any other, easier sequence”.
A few notes on the task description and other task components:
6) It would be useful to give more details on the task. This includes more details on the time/condition of the gradual removal of visual and auditory stimuli and also on the within practice dynamic structure (i.e., different levels appear in the video).
These details will be included in the revised manuscript. Thank you for pointing out the need for further clarification of the task design.
7) Some more information on engagement-related exclusion criteria would be useful (what happened if participants did not use the app for more than one day, how many times were allowed to skip a day etc.).
This additional information will be added to the revised manuscript. If participants omitted to train for more than 2 days, the researcher would send a reminder to the participant to request to catch up. If the participant would not react accordingly and a third day would be skipped, then the researcher would call to understand the reasons for the lack of engagement and gauge motivation. The participant would be excluded if more than 5 sequential days of training were missed. Only 2 participants were excluded given their lack of engagement.
8) According to the (very useful) video demonstrating the task and the paper describing the task in detail (Banca et al., 2020), the task seems to include other relevant components that were not mentioned in this paper. I refer to the daily speed test, the daily random switch test, and daily ratings of each sequence's enjoyment and confidence of knowledge.
If these components were not included in this procedure, then the deviations from the procedure described in the video and Banca al. (2020) should be explicitly mentioned. If these components were included, at least some of them may be relevant, at least in part, to automaticity, habitual action control, formulation of participants' enjoyment from the app etc. I think these components should be mentioned and analyzed (or at least provide an explanation for why it has been decided not to analyze them).
This is also true for the reward removal (extinction) from the 21st day onwards which is potentially of particular relevance for the research questions.
The task procedure was indeed the same as detailed in Banca et al., 2020. We did not include these extra components in this current manuscript for reasons of succinctness and because the manuscript was already rather longer than a common research article, given that we present three different, though highly inter-dependent, experiments in order to answer key interrelated questions in an optimal manner. However, since referee 2 considers this additional analysis to be important, we will be happy to include it in the supplementary material of the revised manuscript.
Training engagement analysis:
9)I find referring to the number of trials including successful and unsuccessful trials as representing participants "commitment to training" (e.g. in Figure legend 2b) potentially inadequate. Given that participants need at least 20 successful trials to complete each practice, more errors would lead to more trials. Therefore, I think this measure may mostly represent weaker performance (of the OCD patients as shown in Figure 2b). Therefore, I find the number of performed practice runs, as used in Figure 2a (which should be perfectly aligned with the number of successful trials), a "clean" and proper measure of engagement/commitment to training.
We acknowledge referee’s concern on this matter and agree to replace the y-axis variable of Figure 2b to the number of performed practices (thus aligning with Figure 2a). This amendment will remove any potential effect of weaker performance on the engagement measurement and will provide clearer results.
10) Also, to provide stronger support for the claim about different diurnal training patterns (as presented in Figure 2c and the text) between patients and healthy individuals, it would be beneficial to conduct a statistical test comparing the two distributions. If the results of this test are not significant, I suggest emphasizing that this is a descriptive finding.
We will conduct the statistical test and report accordingly.
Learning results:
11) When describing the Learning results (p10) I think it would be useful to provide the descriptive stats for the MT0 parameter (as done above for the other two parameters).
Thank you for pointing this out. The descriptive stats for MT0 will be added to the revised version of the manuscript.
12) Sensitivity of sequence duration and IKI consistency (C) to reward:
I think it is important to add details on how incorrect trials were handled when calculating ∆MT (or C) and ∆R, specifically in cases where the trial preceding a successful trial was unsuccessful. If incorrect trials were simply ignored, this may not adequately represent trial-by-trial changes, particularly when testing the effect of a trial's outcome on performance change in the next trial.
This is an important question. Our analysis protocol was designed to ensure that incorrect trials do not contaminate or confound the results. To estimate the trial-to-trial difference in ∆MT (or C) and ∆R, we exclusively included pairs of contiguous trials where participants achieved correct performance and received feedback scores for both trials. For example, if a participant made a performance error on trial 23, we did not include ∆R or ∆MT estimates for the pairs of trials 23-22 and 24-23. Instead of excluding incorrect trials from our analyses, we retained them in our time series but assigned them a NaN (not a number) value in Matlab. As a result, ∆R and ∆MT was not defined for those two pairs of trials. Similarly for C. This approach ensured that our analyses are not confounded by incremental or decremental feedback scores between noncontiguous trials. In the past, when assessing the timing of correct actions during skilled sequence performance, we also considered events that were preceded and followed by correct actions. This excluded effects such as post-error slowing from contaminating our results (Herrojo Ruiz et al., 2009, 2019). Therefore, we do not believe that any further reanalysis is required.
-
Ruiz MH, Jabusch HC, Altenmüller E. Detecting wrong notes in advance: neuronal correlates of error monitoring in pianists. Cerebral cortex. 2009 Nov 1;19(11):2625-39.
-
Bury G, García-Huéscar M, Bhattacharya J, Ruiz MH. Cardiac afferent activity modulates early neural signature of error detection during skilled performance. NeuroImage. 2019 Oct 1;199:704-17.
13) I have a serious concern with respect to how the sensitivity of sequence duration to reward is framed and analyzed. Since reward is proportional to performance, a reduction in reward essentially indicates a trial with poor performance, and thus even regression to the mean (along with a floor effect in performance [asymptote]) could explain the observed effects. It is possible that even occasional poor performance could lead to a participant demonstrating this effect, potentially regardless of the reward. Accordingly, the reduced improvement in performance following a reward decrease as a function of training length described in Figure 5b legend may reflect training-induced increased performance that leaves less room for improvement after poor trials, which are no longer as poor as before. To address this concern, controlling for performance (e.g., by taking into consideration the baseline MT for the previous trial) may be helpful. If the authors can conduct such an analysis and still show the observed effect, it would establish the validity of their findings."
Thank you for raising this point. Figure 5b illustrates two distinct effects of reward changes on behavioral adaptation, which are expected based on previous research.
I. Practice effects: Firstly, we observe that as participants progress across bins of practice, the degree of improvement in behavior (reflected by faster movement time, MT) following a decrease in reward (∆R−) diminishes, consistent with our expectations based on previous work. Conversely, we found that ∆MT does not change across bins of practices following an increase in reward (∆R+). We appreciate the reviewer's suggestion regarding controlling for the reference movement time (MT) in the previous trial when examining the practice effect in the p(∆T|∆R−) and p(∆T|∆R+) distributions. In the revised manuscript, we will conduct the proposed control analysis to better understand whether the sensitivity of MT to score decrements changes across practice when normalising MT to the reference level on each trial. But see below for a preliminary control analysis.
II. Asymmetry of the effect of ∆R− and ∆R+ on performance: Figure 5b also depicts the distinct impact of score increments and decrements on behavioural changes. When aggregating data across practice bins, we consistently observed that the centre of the p(∆T|∆R−) distribution was smaller (more negative) than that of p(∆T|∆R+). This suggests that participants exhibited a greater acceleration following a drop in scores compared to a relative score increase, and this effect persisted throughout the practice sessions. Importantly, this enhanced sensitivity to losses or negative feedback (or relative drops in scores) aligns with previous research findings (Galea et al., 2015; Pekny et al., 2014; van Mastrigt et al., 2020).
We have conducted a preliminary control analysis to exclude the potential impact that reference movement time (MT) values could have on our analysis. We have assessed the asymmetry between behavioural responses to ∆R− and ∆R+ using the following analysis: We estimated the proportion of trials in which participants exhibited speed-up (∆T < 0) or slow-down (∆T > 0) behaviour following ∆R− and ∆R+ across different practice bins (bins 1 to 4). By discretising the series of behavioural changes (∆T) into binary values (+1 for slowing down, -1 for speeding up), we can assess the type of changes (speed-up, slow-down) without the absolute ∆T or T values contributing to our results. We obtained several key findings:
• Consistent with expectations (sanity check), participants exhibited more instances of speeding up than slowing down across all reward conditions.
• Participants demonstrated a higher frequency of speeding up following ∆R− compared to ∆R+, and this asymmetry persisted throughout the practice sessions (greater proportion of -1 events than +1 events). 53% events were speed-up events in the in the p(∆T|∆R+) distribution for the first bin of practices, and 55% for the last bin. Regarding p(∆T|∆R-), there were 63% speed-up events throughout each bin of practices, with this proportion exhibiting no change over time.
• Accordingly, the asymmetry of reward changes on behavioural adaptations, as revealed by this analysis, remained consistent across the practice bins.
Thus, these preliminary findings provide an initial response to referee 2 and offer valuable insights into the asymmetrical effects of positive/negative reward changes on behavioural adaptations. We plan to include these results in the revised manuscript, as well as the full control analysis suggested by the referee. We will further expand upon their interpretation and implications.
14) Another way to support the claim of reward change directionality effects on performance (rather than performance on performance), at least to some extent, would be to analyze the data from the last 10 days of the training, during which no rewards were given (pretending for analysis purposes that the reward was calculated and presented to participants). If the effect persists, it is less unlikely that the effect in question can be attributed to the reward dynamics.
The reviewer’s concern is addressed in the previous quesQon. Also, this analysis would not be possible because our Gaussian fit analyses use the Qme series of conQnuous reward scores, in which ∆R− or ∆R+ are embedded. These events cannot be analyzed once reward feedback is removed because we do not have behavioral events following ∆R− or ∆R+ anymore.
15) This concern is also relevant and should be considered with respect to the sensitivity of IKI consistency (C) to reward. While the relationship between previous reward/performance and future performance in terms of C is of a different structure, the similar potential confounding effects could still be present.
We will conduct this analysis for the revised manuscript, similarly to the control analysis suggested by referee 2 on MT. Our preliminary control analysis, as explained above, suggests that the fundamental asymmetry in the effect of ∆R+ and ∆R+ on behavioral changes persists when excluding the impact of reference performance values in our Gaussian fit analysis.
16) Another related question (which is also of general interest) is whether the preferred app sequence (as indicated by the participants for Phase B) was consistently the one that yielded more reward? Was the continuous sequence the preferred one? This might tell something about the effectiveness of the reward in the task.
We have now conducted this analysis. There is in fact no evidence to conclude that the continuously rewarded sequence was the preferred one. The result shows that 54.5% of HV and 29% of the OCD sample considered the continuous sequence to be their preferred one. Of note, this preference may not necessarily be linked to the trial-by-trial reward sensitive analysis. The latter assesses how learning may be affected by reward. The overall preference may be influenced by many other factors, such as, for example, the aesthetic appeal of particular combinations of finger movements.
Regarding both experiments 2 and 3:
17) The change in context in experiment 2 and 3 is substantial and include many different components. These changes should be mentioned in more detail in the Results section before describing the results of experiments 2 and 3.
Following referee’s advice, we will move these details (currently written in the Methods section) to the Results section, when we introduce Phase B and before describing the results of experiments 2 and 3.
Experiment 2:
18) In Experiment 2, the authors sometimes refer to the "explicit preference task" as testing for habitual and goal-seeking sequences. However, I do not think there is any justification for interpreting it as such. The other framings used by the authors - testing whether trained action sequences gain intrinsic/rewarding properties or value, and preference for familiar versus novel action sequences - are more suitable and justified. In support of the point I raised here, assigning intrinsic rewarding properties to the learned sequences and thereby preferring these sequences can be conceptually aligned with goal-directed behavior just as much as it could be with habit.
We clearly defined the theoretical framing of experiment 2 as a test of whether trained action sequences gain intrinsic value and we are pleased to hear that the referee agrees with this framing. If the referee is referring to the paragraph below (in the Discussion), we actually do acknowledge within this paragraph that a preference for the trained sequences can either be conceptually aligned with a habit OR a goal-directed behavior.
“On the other hand, we are describing here two potential sources of evidence in favor of enhanced habit formation in OCD. First, OCD patients show a bias towards the previously trained, apparently disadvantageous, action sequences. In terms of the discussion above, this could possibly be reinterpreted as a narrowing of goals in OCD (Robbins et al., 2019) underlying compulsive behavior, in favor of its intrinsic outcomes”
This narrowing of goals model of OCD refers to a hypothetically transiQonal stage of compulsion development driven by behavior having an abnormally strong, goal-directed nature, typically linked to specific values and concerns.
If the referee is referring to the penulQmate sentence of hypothesis secQon, this has been amended in response to Q5. We cannot find any other possible instances in this manuscript stating that experiment 2 is a test of habitual or goal-directed behavior.
Experiment 3:
19) Similar to Experiment 2, I find the framing of arbitration between goal-directed/habitual behavior in Experiment 3 inadequate and unjustified. The results of the experiment suggest that participants were primarily goal-directed and there is no evidence to support the idea that this reevaluation led participants to switch from habitual to goal-directed behavior.
Also, given the explicit choice of the sequence to perform participants had to make prior to performing it, it is reasonable to assume that this experiment mainly tested bias towards familiar sequence/stimulus and/or towards intrinsic reward associated with the sequence in value-based decision making.
This comment is aligned with (and follows) the referee’s criticism of experiment 1 not achieving automatic and habitual actions. We have addressed this matter above, in response 1 to Referee 2.
Mobile-app performance effect on symptomatology: exploratory analyses:
20) Maybe it would be worth testing if the patients with improved symptomatology (that contribute some of their symptom improvement to the app) also chose to play more during the training stage.
We have conducted analysis to address this relevant question. There is no correlation between the YBOCS score change and the number of total practices, meaning that the patients who improved symptomatology post training did not necessarily chose to play the app more during the training stage (rs = 0.25, p = 0.15). Additionally, we have statistically compared the improvers (patients with reduced YBOCS scores post-training) and the non-improvers (patients with unchanged or increased YBOCS scores post-training) in their number of app completed practices during the training phase and no differences were observed (U = 169, p = 0.19).
Discussion:
21) Based on my earlier comments highlighting the inadequacy and mis-framing of the work in terms of habit and goal-directed behavior, I suggest that the discussion section be substantially revised to reflect these concerns.
We do not agree that the work is either "inadequate or mis-framed" and will not therefore be substantially revising the Discussion. We will however clarify further the interpretation we have made and make explicit the alternative viewpoint of the referee. For example, we will retitle experiment 3 as “Re-evaluation of the learned action sequence: possible test of goal/habit arbitration” to acknowledge the referee’s viewpoint as well as our own interpretation.
22) In the sentence "Nevertheless, OCD patients disadvantageously preferred the previously trained/familiar action sequence under certain conditions" the term "disadvantageously" is not necessarily accurate. While there was potentially more effort required, considering the possible presence of intrinsic reward and chunking, this preference may not necessarily be disadvantageous. Therefore, a more cautious and accurate phrasing that better reflects the associated results would be useful.
We recognize that the term "disadvantageously" may be semantically ambiguous for some readers and therefore we will remove it.
Materials and Methods:
23) The authors mention: "The novel sequence (in condition 3) was a 6-move sequence of similar complexity and difficulty as the app sequences, but only learned on the day, before starting this task (therefore, not overtrained)." - for the sake of completeness, more details on the pre-training done on that day would be useful.
Details of the learning procedure of the novel sequence (in condition 3, experiment 3) will be provided in the methods of the revised version of the manuscript.
Minor comments:
24) In the section discussing the sensitivity of sequence duration to reward, the authors state that they only analyzed continuous reward trials because "a larger number of trials in each subsample were available to fit the Gaussian distributions, due to feedback being provided on all trials." However, feedback was also provided on all trials in the variable reward condition, even though the reward was not necessarily aligned with participants' performance. Therefore, it may be beneficial to rephrase this statement for clarity.
We will follow this referee’s advice and will rephrase the sentence for clarity.
25) With regard to experiment 2 (Preference for familiar versus novel action sequences) in the following statement "A positive correlation between COHS and the app sequence choice (Pearson r = 0.36, p = 0.005) further showed that those participants with greater habitual tendencies had a greater propensity to prefer the trained app sequence under this condition." I find the use of the word "further" here potentially misleading.
The word "further" will be removed.
-
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
The following is the authors' response to the original reviews.
Thank you for considering our manuscript “An Unexpected Role of Neutrophils in Clearing Apoptotic Hepatocytes In Vivo". We also thank the referees for their review. We have addressed their comments in detail and added new data to buttress our conclusions.
Reviewer #1 (Public Review):
This study by Cao et al. demonstrates role of Neutrophil in clearing apoptotic hepatocytes by directly burrowing into the apoptotic hepatocytes and ingesting the effete cells from inside without causing inflammation. The authors applied intravital microscopy, Immunostaining and electron microscopy to visualize perforocytosis of neutrophil in hepatocytes. They also found that neutrophil depletion impairs the clearance of apoptotic hepatocytes causing impaired liver function and generation of autoantibodies, implying a role of defective neutrophil- mediated clearance of apoptotic cells in Autoimmune Liver disease. The experiments were well designed and conducted, the results were reasonably interpreted, and the manuscript was clearly written with logical inputs.
Thank you for your comments.
One weak point is that the signals/mechanisms that determine why neutrophil specifically target apoptotic hepatocytes in liver and no other organs or cells is not clearly understood.
We are still studying why neutrophils selectively phagocytose hepatocytes but not HUVEC or 293 cells. We have some intriguing preliminary data so far showing that apoptotic 293 cells have no significant increase of IL-1β production as compared with their nonapoptotic controls; both apoptotic 293 cells and HUVECs do not have increased surface selectin proteins (new Fig. S3C).
Reviewer #2 (Public Review):
[…] By examination of HE-stained, noncancerous liver tissue sections from patients with hepatocellular carcinoma and hepatic hemangioma, the authors observed that cells with neutrophil nuclear morphology were inside apoptotic hepatocytes. The authors also further characterized this observation by staining the sections with neutrophil and apoptosis markers. In addition, the authors observed the same phenomena in mouse livers using intravital microscopy, which also recorded the time course of the disappearance of a neutrophil-associated apoptotic cell. The author went on further characterization of neutrophil-mediated efferocytosis of cultured hepatic cells in vitro and demonstrated the process was specific for apoptotic hepatic cells, but not HEK293 or endothelial cells. The in vitro system was then used to characterize the molecular bases for neutrophil-mediated efferocytosis of apoptotic hepatic cells. The evidence was provided to suggest that IL1b and IL-8 released from and selectins upregulated in apoptotic hepatic cells were important. Importantly, the authors used two methods to deplete the neutrophils and showed that the neutrophil depletion increased apoptotic cells in livers. Finally, the authors showed that neutrophil depletion caused defects in liver function parameters. At the end, the authors presented evidence to suggest that AIL disease may be due to defective neutrophils that fail to perform "perforocytosis."
Thank you for your comments.
Point #1. Although the evidence in its totality indicates that neutrophils burrow into apoptotic hepatocytes, the significance of this "perforocytosis" phenomenon and the circumstances under which it may occur remain to be better defined. In both neutrophil depletion models, the TNUEL-positive cells were not definitively identified rather than assuming they were hepatocytes.
Anatomically, the apoptotic hepatocytes are randomly distributed in the hepatic plate from the central vein to the portal region (please refer to the image below: hematoxylin staining of liver tissues, black arrowhead indicates perforocytosis sites).
Author response image 1.
Histologically, the structure of liver/hepatic lobe are well defined, and the cell types in the livers are easy to histologically identify based on their location, morphology and the relationship to hepatic plate and sinusoid. In addition, the hepatocytes are well known for its rich cytoplasmic components, cellular connection and prominent large round nucleus. Thus, hepatocytes are very easy to identify even without using specific molecular markers such as E-cadherin or albumin. Based on these characteristics, the TUNEL positive cells that we displayed in Fig. 5A are apoptotic hepatocytes.
Point #2. In addition, there are discrepancies in the number of neutrophils and apoptotic cells in mouse liver studies; Fig. 2a WT (many neutrophils; locations unclear) vs Fig. 5A Ctr (a few neutrophils that appear in or near a vessel), and Fig. 2a DTR (a few apoptotic cells) vs Fig. 5A Depletion (many apoptotic cells).
In response, Fig. 2A demonstrates a larger area of the mouse liver (bar, 100 µm), while Fig. 5A exhibits a relatively small area of the liver sample (bars, 20 µm for Ctrl and 15 µm for DTR). Similarly, apoptotic cells in Fig. 2A DTR need to zoom in to quantify. We apologize for the confusion, and we did quantify the apoptotic cells in Fig.2A WT vs DTR (see the bar graph next to the images in Fig. 2A).
Point #3. Importantly, Fig 5a Ctrl, which is presumably a section from a mouse without any surgical treatment or without inflammation, the sole TUNNEL signal does not appear to be associated with neutrophils. Does this mean that "perforocytosis" primarily occurs in inflamed livers (Of note, human liver samples in Fig 1 are from patient with tumors. There should be inflammation in the livers of these patients).
In Fig 5A Ctrl, the TUNEL signal indicates apoptotic hepatocytes. The neutrophils (stained with anti-NE antibody, red) are associated with the apoptotic hepatocyte (Fig. 5A). We observed that perforocytosis primarily occurs in normal noninflamed livers.
Human liver samples in Fig 1 are from patient with tumors, hence it is possible that neutrophil burrowing is somehow associated with cancerous/inflammatory livers as the reviewer pointed out. This possibility was ruled out based on our method of sample preparation and experimental results themselves.
1) Both noncancerous and cancerous liver samples were sliced based on the anatomical appearance of normal and cancer tissues (differences were rather easy to identify, and these samples were prepared by highly experienced pathologists from the Liver Cancer Center of Zhongshan Hospital, Shanghai). Furthermore, the results were confirmed by determining whether the surrounding tissue contained microlesions characteristic of metastatic tumors. We only counted apoptotic hepatocytes in noncancerous regions having normal liver lobes and morphologically normal hepatocytes, plates, sinusoid and Kupffer cells. We also excluded hepatoma, chronic inflammatory regions, and necrotic regions.
2) We did not observe recruitment of neutrophils into apoptotic HCC cells, indicating that the clearance of apoptotic cancer cells was not mediated by neutrophils (unpublished observations).
3) It is hard for us to obtain normal human liver samples; however, we did study samples from patients with liver hemangioma characterized by aberrant vasculature in livers but with normal liver functions and the structure of hemangioma livers that we analyzed are nearly identical to a healthy liver in histology (these liver samples contained no cancerous regions and there was no apparent cirrhosis or inflammation). And here we obtained similar results (these are shown in Fig. 1B; a total of 40 apoptotic hepatocytes were examined).
4) Our data from normal mouse livers, isolated primary cells (hepatocytes and neutrophils) and cell lines (NCTC and HL60) all confirmed the central findings in this paper (Fig. 2, 3).
Point #4. The data on human AIL patient neutrophils raises more questions: how many AIL patients have been examined? Do these AIL neutrophils lack IL1, IL8 receptors, and/or selectin ligands? Are there increases in apoptotic hepatocytes in AIL patients?
In response, we have analyzed 16 AIL patient samples (see table below).
Author response table 1.
We performed microarray assay to screen the differential gene expression of neutrophils from normal and liver autoimmune patients. We have identified that IL-1β receptor, IL1R1 and selectin binding protein, P- selectin glycoprotein ligand 1 (PSGL-1) were all decreased in neutrophils from the AIL patients (new Fig 7D). These findings are consistent with our observations using cells and mouse models.
Point #5. Additionally, the overall numbers of apoptotic cells even in the absence of neutrophils are rare; thus, it is questionable that such rarity of apoptotic cells can cause significant AIL phenotypes.
We quantified apoptotic liver cells in percentages instead of overall numbers (Fig. 5, we were not able to precisely calculate the overall numbers, which could be large since billions of cells undergoing apoptosis daily). Depletion of neutrophils increased the percentage of apoptotic cells about 5-6-fold in livers, and we observed the generation of autoantibodies (Fig. 6).
Reviewer #1 (Recommendations For The Authors):
This study by Cao et al. was well designed and conducted, the results were reasonably interpreted, and the manuscript was clearly written with logical inputs.
It would further gain the significance of this study if authors could address the following questions:
1. What are the mechanisms/ signals that prevents AIL Liver neutrophils from burrowing into hepatocytes?
We have identified that IL-1β receptor, IL1R1 and selectin binding protein, P-selectin glycoprotein ligand 1 (PSGL-1) were all decreased in neutrophils from the AIL patients (new Fig 7D).
2. Have authors looked if autoantigens expressed on hepatocytes, which are often found in autoimmune liver disease trigger signaling events that activate neutrophils to burrow?
Thank you for the comment, we have not examined autoantigens expressed in hepatocytes and plan to carry out this research as suggested.
3. Is perforocytosis observed in apoptotic hepatocytes induced by different agents like LPS, TNF-a , rapamycin, alcohol etc?
We did not observe perforocytosis in LPS or TNF-a treated hepatocytes. One possible reason is that LPS or TNF-a we used induced massive necrosis instead of apoptosis. Howere, we did observe neutrophil perforocytosis in FasL-induced apoptotic hepatocytes (unpublished observations).
Reviewer #2 (Recommendations For The Authors):
In addition to the questions raised in the "Public review" section, the authors are also recommended to address the following issues:
1) Why is CD11b+ not associated with the apoptotic sites as neutrophils express CD11b
We have co-immunostained human liver samples with CD11b antibody (from Abcam: ab133357) and MPO antibody (from R&D: AF3667) and observed that tissue infiltrating neutrophils in livers have low to undetectable levels of CD11b expression (please refer the image below; white arrowheads point to neutrophils). Few CD11b+ cells in liver tissues express MPO (the CD11b+ cells are mostly macrophages, unpublished observations).
Based on these data, we conclude that CD11b is hardly expressed in neutrophils inside livers.
Author response image 2.
2) Can TUNEL signals in Fig. S1C be from apoptotic neutrophils?
In response, the fragmentation of nucleus is a hallmark of apoptosis hence TUNEL staining will uniformly label all fragmented parts of apoptotic nucleus. The nucleus of NE+ neutrophils are not labelled by TUNEL staining in Fig. S1C. The TUNEL+ nuclear fragments seen inside neutrophils are nuclear debris of apoptotic hepatocytes phagocytosed by neutrophils (Fig. S1C).
3) The Fig 2B experiment may be done with induced apoptosis so that neutrophil burrowing steps may be recorded from the very beginning and a better time course for the entire process can be assessed.
Thank you for the suggestions, we had tried many times with various conditions, yet still had no success to capture the very beginning of perforocytosis in vivo. We are continuing to work on this.
4) In "we found thatU937 cells exhibited much lower phagocytosis of apoptotic NCTC cells than did HL60 cells (Fig. S2B, C)," the citation should be only S2C
Thank you for pointing this out, we have corrected this in the manuscript.
5) Both neutrophil depletion models cause neutrophil death, which may complicate the interpretation of the liver function and AIL disease phenotypes. A neutropenic model such as G-CSFR−/− or Cebpe-/- mice may be used to avoid the caveat of antibody/DTR-dependent depletion models.
Thank you for this thoughtful suggestion. We have also induced AIL phenotypes in mice by using α- Galcer. α-Galcer did not cause neutrophil death but impaired neutrophil perforocytosis and futher generated AIL phenotypes in mice (unpublished observations). We plan to perform the simiarl experiments in G-CSFR−/− or Cebpe−/− mice as the reviewer suggested.
6) RNAi silencing experiments need additional controls for off-target effects
These RNAi silencing constructs were purchased from Santa Cruz Biotechnology and the off-target effects have been tested by the company. No significant off-target effects have been detected according to the manufacture report.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Joint Public Review
The molecular composition of synaptic vesicles (SVs) has been defined in substantial detail, but the function of many SV-resident proteins are still unknown. The present study focused on one such protein, the 'orphan' SV-resident transporter SLC6A17. By utilizing sophisticated and extensive mouse genetics and behavioral experiments, the authors provide convincing support for the notion that certain SLC6A17 variants cause intellectual disability (ID) in humans carrying such genetic variations. This is an important and novel finding. Furthermore, the authors propose, based on LCMS analyses of isolated SVs, that SLC6A17 is responsible for glutamine (Gln) transport into SVs, leading to the provocative idea that Gln functions as a neurotransmitter and that deficits in Gln transport into SVs by SLC6A17 represents a key pathogenetic mechanism in human ID patients carrying variants of the SLC6A17 gene.
This latter aspect of the present paper is not adequately supported by the experimental evidence so that the main conceptual claims of the study appear insufficiently justified at this juncture. Key weaknesses are as follows:
A) Detection of Gln, along with classical neurotransmitters such as glutamate, GABA, or ACh, in isolated SV fractions does not prove that Gln is transported into SVs by active transport. Gln is quite abundant in extracellular compartments. Its appearance in SV samples can therefore also be explained by trapping in SVs during endocytosis, presence in other - contaminating - organelles, binding to membrane surfaces, and other processes. Direct assays of Gln uptake into SVs, which have the potential to stringently test key postulates of the authors, are lacking.
We have conducted multiple control experiments to exclude the possibility of contamination.
1). Western blot analysis of SLC6A17-HA immunoisolation (Figure 4D and Figure 4—figure supplement 1) has shown that this faction contained little other organelles and membranes. These results are strong argument that contaminations in our isolated fraction were in very low level.
2). We then examined the proportion of SLC6A17 localized SVs through quantifying the co-localization of Syp and SLC6A17 by anti-Syp immunoisolation in Slc6a17-2A-HA-iCre mice. We found that SLC6A17 is predominately localized on SVs (with 98.7% compared with classical SV marker, Author response image 1A). This further showed that immunoisolated SLC6A17 fraction was mainly composed of SVs.
3). We also analyzed other SV marker proteins such as Syt1 and Syb2 for IP-LC-MS, all results supported Gln enrichment (Author response image 1B).
4). Importantly, immunoisolation of the SLC6A17P633R-HA protein, which caused SLC6A17 mislocalization away from the SVs (Figure 3B and Figure 3—figure supplement 1C, D), showed no Gln enrichment (Author response image 1C).
5). Moreover, immunoisolation of AAV-PHP.eb overexpressed cytoplasmic membrane Gln transporter SLC38A1-HA did not show Gln enrichment (Author response image 1D).
6). We also tested whether trafficking organelles such as the lysosome could enrich Gln. As is shown in Author response image 1E, immunoisolation of AAV-PHP.eb overexpressed TMEM192-HA did not show Gln enrichment. For active transport, we tested the effects of proton dissipator FCCP, v-ATPase inhibitor NEM and ΔpH dissipator nigercin. As is shown in Author response image 1F, 1G, Gln level was reduced by these inhibitors, supporting active transport of Gln.
Author response image 1.
Control experiments to test for contamination. A. Anti-Syp immunoisolation in Slc6a17-2A-HA-iCre mice. B. Quantification of Gln level in anti-Syt1 and anti-Syb2 immunoisolated fraction. C. Anti-HA immunoisolation in SLC6A7-2A-HA and anti-Slc6a17P633R mice. D. Anti-HA immunoisolation in AAV-PHP.eb-hSyn-SLC38A1-HA overexperssion mice. E. Anti-HA immunoisolation in AAV-PHP.eb-hSyn-TMEM192-HA overexperssion mice. F. Anti-HA immunoisolation in SLC6A7-2A-HA mice under FCCP (50 μM) and NEM (200 μM). G. Anti-Syp immunoisolation in wild type mice under FCCP (50 μM) and Nigercin (20 μM).
B) The authors generated multiple potentially very useful genetic tools and models. However, the validation of these models is incomplete. Most importantly, it remains unclear whether the different mutations affect SLC6A17 expression levels, subcellular localization, or the expression and trafficking of other SV and synapse components.
The verification of transgenic mouse line is described in the Material and Methods section of our manuscript. There are numerous literatures published for CRISPR mediated gene editing in animals and the off-target effect of CRISPR-Cas9 system is widely studied with optimized design tools developed by many groups (Platt et al., 2014; Chu et al., 2015, 2016; Liu et al., 2017; Gemberling et al., 2021; Singh et al., 2022). The gRNAs used for animal generation were chosen carefully based on publically available tools. Apart from basic genomic PCR sequencing of target regions of all gene edited mouse models, Southern blots were performed by Biocytogen company for Slc6a17-HA-2A-iCre and Slc6a17P633R mice to rule out random insertions. Expression levels in Slc6a17-KO and Slc6a17P633R mice were not affected, as shown in Figure R2. HA-tagged protein in Slc6a17-HA-2A-iCre and Slc6a17P633R mice were detected by immunoisolation, immunofluorescence, and fractionation (Figure 3, 4, Figure 3—figure supplement 1, Figure 4—figure supplement 1). Both showed localizations expected from previous reports ().
C) Apart from the caveats mentioned above regarding Gln uptake into SVs, the data interpretation provided by the authors lacks stringency with respect to the biophysics of plasma membrane and SV transporters.
The biophysics of SLC6A17 was carefully studied (Para et al 2008; Zaia and Reimer, 2009). Our work focused on in vivo biochemical results, not biophysics.
Author response image 2.
Verification of genetic mouse models. A. q-PCR verification of Slc6a17-KO mice; B. q-PCR verification of Slc6a17P633R mice; C. Example of genomic primer design for Slc6a17-HA-2A-iCre mice founder mice screen; D. Example of genomic PCR for Slc6a17-HA-2A-iCre mice founder mice screen; E. Southern blot performed for Slc6a17-HA-2A-iCre mice.
Reference
Chu, Van Trung et al. “Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells.” Nature biotechnology vol. 33,5 (2015): 543-8. doi:10.1038/nbt.3198
Chu, Van Trung, et al. "Efficient generation of Rosa26 knock-in mice using CRISPR/Cas9 in C57BL/6 zygotes." BMC biotechnology 16.1 (2016): 1-15.
Gemberling, Matthew P et al. “Transgenic mice for in vivo epigenome editing with CRISPR-based systems.” Nature methods vol. 18,8 (2021): 965-974. doi:10.1038/s41592-021-01207-2
Liu, Edison T., et al. "Of mice and CRISPR: The post‐CRISPR future of the mouse as a model system for the human condition." EMBO reports 18.2 (2017): 187-193.
Madisen, Linda, et al. "A robust and high-throughput Cre reporting and characterization system for the whole mouse brain." Nature neuroscience 13.1 (2010): 133-140.
Parra, Leonardo A., et al. "The orphan transporter Rxt1/NTT4 (SLC6A17) functions as a synaptic vesicle amino acid transporter selective for proline, glycine, leucine, and alanine." Molecular pharmacology 74.6 (2008): 15211532.
Platt, R.J., Chen, S., Zhou, Y., Yim, M.J., Swiech, L., Kempton, H.R., Dahlman, J.E., Parnas, O., Eisenhaure, T.M., Jovanovic, M., et al. (2014). CRISPR-Cas9 knockin mice for genome editing and cancer mode Yang, Hui, Haoyi Wang, and Rudolf Jaenisch. "Generating genetically modified mice using CRISPR/Cas-mediated genome engineering." Nature protocols 9.8 (2014): 1956-1968.ling. Cell 159, 440-455.
Singh, Surender et al. “Opportunities and challenges with CRISPR-Cas mediated homologous recombination based precise editing in plants and animals.” Plant molecular biology, 10.1007/s11103-022-01321-5. 31 Oct. 2022, doi:10.1007/s11103-022-01321-5
Zaia, K.A., and Reimer, R.J. (2009). Synaptic vesicle protein NTT4/XT1 (SLC6A17) catalyzes Na+-coupled neutral amino acid transport. J Biol Chem 284, 8439-8448.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
eLife assessment
This study assesses homeostatic plasticity mechanisms driven by inhibitory GABAergic synapses in cultured cortical neurons. The authors report that up- or down-regulation of GABAergic synaptic strength, rather than excitatory glutamatergic synaptic strength, is critical for homeostatic regulation of neuronal firing rates. The reviewers noted that the findings are potentially important, but they also raised questions. In particular, the evidence supporting the findings is currently incomplete and demonstration of independent regulation of mEPSCs and mIPSCs is a necessary experiment to support the major claims of the study.
We appreciate the detailed, thoughtful assessment of our paper by the reviewers and editors and will submit a revised version in the future that addresses the reviewers’ comments as detailed below in response to each concern. We will include a more open discussion of alternative possibilities. Further, we will repeat the optogenetic experiments assessing AMPAergic scaling in our mouse cortical cultures in order to demonstrate independent regulation of mEPSCs and mIPSCs as suggested.
Reviewer #1 (Public Review):
In the manuscript titled "GABAergic synaptic scaling is triggered by changes in spiking activity rather than transmitter receptor activation," the authors present an investigation of the role of GABAergic synaptic scaling in the maintenance of spike rates in networks of cultured neurons. Their main findings suggest that GABAergic scaling exhibits features consistent with a key homeostatic mechanism that contributes to the stability of neuronal firing rates. Their data demonstrate that GABAergic scaling is multiplicative and emerges when postsynaptic spike rates are altered. Finally, their data suggest that, in contrast to their prior data on glutamatergic scaling, GABAergic scaling is driven by spike rates. The authors set the paper up as an argument that GABAergic scaling, rather than glutamatergic scaling, serves as the critical homeostatic mechanism for spike rate regulation.
While the paper is ambitious in its rhetorical scope and certainly presents intriguing findings, there are several serious concerns that need to be addressed to substantiate the interpretations of the data. For example, the CTZ data do not support the interpretations and conclusions drawn by the authors. Summarily, the authors argue that GABAergic scaling is measuring spiking (at the time scale of the homeostatic response, which they suggest is a key feature of a homeostat) yet their data in figure 5B show more convincingly that CTZ does not influence spiking levels - only one out of four time points is marginally significant (also, I suspect that the bootstrapping method mentioned in line 454-459 was conducted as a pairwise comparison of distributions. There is no mention of multiple comparisons corrections, and I have to assume that the significance at 3h would disappear with correction).
We certainly understand the criticism here (similar to reviewer 2’s third point). In our resubmission we will do a better job discussing these complications, which we now summarize. First, we are presenting our entire dataset to be as transparent as possible. Unlike most synaptic scaling studies (including our own) that apply drugs to alter activity and assess mPSC amplitude at the final time point, here we are actually showing CTZ’s effect on spiking activity within the culture over time. This is critical because it has informed us of the drug’s true effect on spiking, the variability that is associated with these perturbations, and the ability and timing of the cultured network to homeostatically recover initial levels. This was important because it revealed that the drugs do not always influence activity in the way we assume, and this provides greater context to our results. Second, we are showing all of our data, and presenting it using estimation statistics which go beyond the dichotomy of a simple p value yes or no (Ho J, Tumkaya T, Aryal S, Choi H, Claridge-Chang A. 2019. Moving beyond P values: data analysis with estimation graphics. Nat Methods 16: 565-66). Estimation statistics have become a more standard statistical approach in the last 15 years and is the preferred method for the Society for Neuroscience’s eNeuro Journal. This method shows the effect size and the confidence interval of the distribution. For the 3 hr time point in Fig. 5B the CTZ/ethanol vs. ethanol data points exhibit very little overlap and the effect size demonstrates a near doubling of spike frequency, and the confidence interval shows a clear separation from 0. This was a pairwise comparison as we compared values at each time point after the addition of ethanol or ethanol/CTZ. Third, the plots illustrate an upward trend in spike frequency at 1 and 6 hrs, but that there is also clear variability. It is important to note that while these recordings help us to understand effects on spiking across the cultured network, they cannot directly speak to spiking activity in the principal neurons that we target. This complication along with the variability inherent in these cultures could make simple comparisons difficult to interpret. Regardless, we do see some increase in spiking with CTZ and we clearly see increases in mIPSC amplitude, thus providing some support for the idea that spiking could be a critical player in terms of GABAergic scaling, particularly when put in the context of our other findings. However, it is important to recognize that something other than total spike rate may contribute to GABAergic scaling, such as the pattern of spiking that produces a particular calcium transient, and this will be discussed in the resubmission.
Then, the fact that TTX applied on top of CTZ drives a increase in mIPSC amplitude is interpreted as a conclusive demonstration that GABAergic scaling is sensing spiking. It is inevitable, however, that TTX will also severely reduce AMAP-R activation - a very plausible alternative explanation is that the augmentation of AMPAR activation caused by CTZ is not sufficient to overcome the dramatic impact of TTX. All together, these data do not provide substantial evidence for the conclusion drawn by the authors.
We understand this point when considering the CTZ/TTX experiments by themselves. However, spiking appears to be a more straightforward trigger when the CTZ/TTX results are coupled with the prevention of GABAergic downscaling by optogenetic restoration of spiking in the presence of AMPAR antagonists. Further, an important point here is that our results with TTX vs. TTX + CTZ are different for GABAergic scaling (no difference) and AMPAergic scaling (CTZ diminished upward scaling) suggesting different triggers for the two forms of scaling. We will make this more clear in our resubmission.
Specific points:
- The logic of the basis for the argument is somewhat flawed: A homeostat does not require a multiplicative mechanism, nor does it even need to be synaptic. Membrane excitability is a locus of homeostatic regulation of firing, for example. In addition, synapse-specific modulation can also be homeostatic. The only requirement of the homeostat is that its deployment subserves the stabilization of a biological parameter (e.g., firing rate).
We agree with the reviewer and should not have suggested that this was a necessary requirement for a spike rate hemostat. What we should have said was that historically this definition has been attributed to AMPAergic scaling, which is thought to be a spike rate homeostat. We will correct this in the resubmission.
- Line 63 parenthetically references an important, but contradictory study as a brief "however". Given the tone of the writing, it would be more balanced to give this study at least a full sentence of exposition.
Agreed, we will do this.
- The authors state (line 11) that expression of a hyperpolarizing conductance did not trigger scaling. More recent work ('Homeostatic synaptic scaling establishes the specificity of an associative memory') does this via expression of DREADDs and finds robust scaling.
The purpose of citing this study was to argue that the spike rate homeostat hypothesis doesn’t make sense for AMPAergic scaling based on a study that hyperpolarized an individual cell while leaving the rest of the network unaltered and therefore leaving network activity and neurotransmission largely normal. In this case scaling was not triggered, suggesting reduced spike rate within an individual cell was insufficient to trigger scaling. The study that the reviewer refers to hyperpolarizes a majority of cells in the network and therefore will also alter neurotransmission throughout the network, which does not separate the importance of spiking and receptor activation as in the above-mentioned study. We will make this point more clearly in the resubmission.
- Supplemental figure 1 looks largely linear to me? Out of curiosity, wouldn't you expect the left end to be aberrant because scaling up should theoretically increase the strength of some synapses that would have been previously below threshold for detection?
We agree that the scaling ratio plot is largely linear. To be clear, the linearity of the ratio plot was interesting but our main point here was that this line had a positive slope meaning ratios (CNQX mPSC amplitudes/control mPSC amplitudes) got bigger for the larger CNQX-treated mPSCs. Alternatively, a multiplicative relationship where mPSCs are all increased by a single factor (e.g. 2X) would be a flat line with 0 slope at the multiplicative value (e.g. 2). In terms of the left side of the plot, we do see values that rise abruptly from 1 - this is partially obstructed by the Y axis in this figure and we will adjust this. This left part of the plot is likely due the CNQX-induced increases in mPSC amplitudes of mini’s that were below our detection threshold of 5pA. Therefore, mini’s that were 4pAs could now be 5pAs after CNQX treatment and these are then divided by the smallest control mPSCs which are 5 pAs (ratio of 1). We will try to do a better job describing this in the resubmission.
Given that figure 2B also shows warping at the tail ends of similar distributions, how is this to be interpreted?
The left side of the ratio plot shows evidence consistent with the idea that mIPSCs are dropping into the noise after CNQX treatment (similar to above argument), while most of the distribution suggests mIPSCs are reduced to 50% by CNQX treatment. On the right side of the ratio plot the values appear to mostly increase. We are not sure why this is happening, but it looks like some mIPSCs are not purely multiplicative at 0.5, particularly in TTX. It is also important to point out that this is a relatively small percent of the total population and the biggest mPSCs can vary to a great degree from one cell to the next. We will discuss this in the resubmission.
- The readability of the figures is poor. Some of them have inconsistent boundary boxes, bizarre axes, text that appears skewed as if the figures were quickly thrown together and stretched to fit.
We will address these issues in the resubmission.
- I'm concerned about the optogenetic restoration of activity experiment. Cortical pyramidal neuron mean firing rates are log normally distributed and span multiple orders of magnitude. The stimulation experiments can only address the total firing at a network-level - given than a network level "mean" is meaningless in a lognormal distribution, how are we to think about the effect of this manipulation when it comes to individual neurons homeostatically stabilizing their own activities? In essence, the argument is made at the single-neuron level, but the experiment is conducted with a network-level resolution.
As described above, we do not have the capacity to know what the actual firing rate of a particular neuron was before and after introducing a drug and so we cannot absolutely say that we have restored the original firing rates of neurons. However, there is reason to believe that this is achieved to some extent. Our optogenetic stimulation is only 50-100 ms long activating a subset of neurons. This is sufficient to provide a synaptic barrage that then triggers a full blown network burst where the majority of spikes occur, but this is after the light is off. In other words, the optogenetic light pulse only initiates what becomes a normal network burst that fortunately allows the individual cells to express their relatively normal (pre-drug) activity pattern. In our previous study we show that this is the case for individual units - the spiking of an individual unit during a burst is similar before and after CNQX/optostim (see Figure 4b and Suppl. Fig 4 in Fong et al. 2015 Nat. Comm.). We are not claiming that we have restored spiking to exactly the pre-drug state, but bring it back toward those levels and we see this is associated with a return of the mIPSC amplitude to near control levels. We will include a description of this in the resubmission.
-
Line 198-99: multiplicativity is not a requirement of a homeostatic mechanism.
-
Line 264-265 - again, neither multiplicativity and synaptic mechanisms are fundamentally any more necessary for a homeostatic locus than anything else that can modulate firing rate in via negative feedback.
Agreed, see above discussion of homeostat requirement. Will adjust these statements in our resubmission.
- 277: do you mean AMPAR?
We were not clear enough here. We actually do mean GABAR. The idea is that CTZ increases network activity and thus increases both AMPAergic and GABAergic transmission. We will clarify this in the resubmission.
-
Example: Figure 1A is frustratingly unreadable. The axes on the raster insets are microscopic, the arrows are strangely large, and it seems unnecessary to fill so much realestate with 4 rasters. Only one is necessary to show the concept of a network burst. The effect of time+CNQX on the frequency of burst is shown in B and C.
-
Example: Figure 2 appears warped and hastily assembled. Statistical indications are shown within and outside of bounding boxes. Axes are not aligned. Labels are not aligned. Font sizes are not equal on equivalent axes.
We will adjust these issues in the resubmission.
- The discussion should include mention of the limitations and/or constraints of drawing general conclusions from cell culture.
We agree and will adjust the discussion. Also, this is why we cited studies that argue GABAergic neurons have a particularly important role in homeostatic regulation of firing following sensory deprivations in vivo.
- The discussion should include mention of the role of developmental age in the expression of specific mechanisms. It is highly likely that what is studied at ~P14 is specific to early postnatal development.
We will discuss caveats of cortical cultures at DIV 14-20.
It is essential to ensure that the data presented in the paper adequately supports the conclusions drawn. A more cautious approach in interpreting the results may lead to a stronger argument and a more robust understanding of the underlying mechanisms at play.
Agreed.
Reviewer #2 (Public Review):
Synaptic scaling has long been proposed as a homeostatic mechanism for the regulation for the activity of individual neurons and networks. The question of whether homeostasis is controlled by neuronal spiking or by the activation of specific receptor populations in individual synapses has remained open. In a previous work, the Wenner group had shown that upscaling of glutamatergic transmission is triggered by direct blockade of glutamate receptors rather than by the concomitant reduction in firing rate (Nat Comm 2015). In this manuscript they investigate the mechanisms regulating scaling of GABA-mediated responses in cortical cell cultures using whole-cell recordings to detect GABAergic currents and multielectrode arrays to monitor global firing activity, and find that spiking plays a fundamental role in scaling.
Initially, the authors show that chronic blockade (24 h) of glutamatergic transmission by CNQX first reduces spontaneous spiking (at 2 h), but later (24 h) firing grows back towards higher frequencies, suggesting a compensatory mechanism. Then it is shown that either chronic CNQX treatment or TTX cause a reduction in the amplitude of GABAergic mIPSCs. Effects of CNQX on IPSCs are then reverted by replacing spontaneous network firing by chronic optogenetic stimulation of the entire culture, also indicating that GABAergic transmission is homeostatically regulated by global firing. Enhancing glutamatergic transmission with CTZ increases mIPSC amplitude, while addition of TTX in the presence of CTZ causes the opposite effect. Finally, increasing spiking activity using bicuculline also increases mIPSC amplitude, and the authors conclude that spiking activity rather than neurotransmission control homeostatic GABA scaling. The manuscript shows interesting properties in the regulation of global GABAergic transmission and highlight the important role of spiking activity in triggering GABA scaling. However, it is strongly recommended to address some caveats in order to better support the conclusions presented in the manuscript.
Major points:
1) The reason why CNQX does not completely eliminate spiking is unclear (Fig. 1). What is the circuit mechanism by which spiking continues, although at lower frequency, in the absence of AMPA-mediated transmission and what the mechanism by which spiking frequency grows back after 24h (still in the absence of AMPA transmission)?
Is it possible that NMDA-mediated transmission takes over and triggers a different type of network plasticity?
The bursting in AMPAR blockade is due to the remaining NMDA receptor mediated transmission. We showed this in our previous study in Suppl. Figure 2 and 6 of Fong et al., 2015 Nat. Comm.. Our ability to optically induce normal looking bursts of spikes was also dependent NMDAR activation. Further, in Dr Fong’s PhD dissertation it was shown that the bursting activity was abolished when AMPA and NMDA receptors were both blocked. There are likely many factors that contribute to the recovery of activity, and certainly one of them is likely to be the weakening of inhibitory GABAergic currents. These points will be discussed in the resubmission.
2) A possible activation of NMDARs should be considered. One would think that experiments involving chronic glutamatergic blockade could have been conducted in the presence of NMDAR blockers. Why this was not the case?
Unfortunately, it was not possible to optogenetically restore normal bursting in the presence of NMDAR blockade (even when AMPAergic transmission was intact), as NMDARs appeared to be critical for the optical restoration of the normal duration of the burst (see Suppl. Figure 6 Fong et al., 2015 Nat. Comm). The reviewer raises an excellent point about a possible NMDAR contribution to altered synaptic strength, however. It is likely that NMDAR signaling is reduced in the presence of CNQX since burst frequency was reduced along with AMPAR-mediated depolarizations. We cannot rule out the possibility that NMDAR signaling could contribute to the alterations in GABAergic mIPSCs and will discuss this in the resubmission. However, previous work suggests that 24/48 hour block NMDARs (APV) did not trigger AMPAergic scaling in cortical or hippocampal cultures (see Figure 1 Turrigiano et al., 1998 Nature and Suppl. Figure 4 Sutton et al., 2006 Cell), moreover, our previous study showed that restoring NMDAergic transmission optogentically, at least to some point, had no influence on AMPAergic scaling (Fong et al., 2015, Nat. Comm.). Regardless, we cannot rule out a role for NMDAergic transmission in GABAergic scaling and this discussion will be included in the resubmission.
Also, experiments with global ChR2 stimulation with coincident pre and postsynaptic firing might also activate NMDARs and result in additional effects that should be taken into consideration for the global scaling mechanism.
To be clear, our optical stimulation was turned off before the vast majority of spiking that occurred in the bursts, which played out in a relatively natural manner (see lower panel of Figure 3B optogenetic stimulation – short duration only at onset of burst – we will make this clearer in resubmission). Therefore, we were unlikely to trigger significant synchronous activation that does not normally occur in network bursts.
3) Cultures exposed to CTZ to enhance AMPA receptors generated variable results (Fig. 5), somewhat increasing spiking activity in a non-significant manner but, at the same time, strengthening mIPSC amplitude. This result seems to suggest that spiking might be involved in GABAergic scaling, but it does not seem to prove it.Then, addition of TTX that blocked spiking reduced mIPSC amplitude. It was concluded here that the ability of CTZ to enhance GABAergic currents was primarily due to spiking, rather than the increase in AMPA-mediated currents. However, in addition to blocking action potentials, TTX would also prevent activation of AMPARs in the presence of CTZ due to the lack of glutamatergic release. Therefore, under these conditions, an effect of glutamatergic activation on GABAergic scaling cannot be ruled out.
These concerns were very similar to reviewer 1’s first comments. We will address these issues in the resubmission, but to briefly repeat our responses: We are going a step beyond most scaling studies by assessing MEA-wide firing rate, but this still provides an incomplete picture of the particular cells that we target for patch recordings in terms of their firing before and after a drug. Further, we see considerable variability in effect on firing rate from culture to culture, which we will better recognize in the resubmission. Finally, While the CTZ results are not conclusive, taken together with the optogenetic results we think our results are most consistent with idea that GABAergic scaling is a strong candidate as a spike rate homeostat.
4) The sample size is not mentioned in any figure. How many cells/culture dishes were used in each condition?
The individual dots represent either individual cells for mIPSC amplitude or individual cultures in MEA experiments. Number of cultures for figures were: Figure 2 – con = 10, TTX = 3, CNQX = 6, Figure 4 – CNQX = 4, con = 10, CNQX/photostim = 6, Figure 5 – ethanol = 3, CTZ = 3, CTZ + TTX =3, Figure 6 – con = 10, bicuculline = 4. We will include the number of cultures for mIPSC amplitude experiments in the figure legends upon resubmission.
5) Cortical cultures may typically contain about 5-10% GABAergic interneurons and 90-95 % pyramidal cells. One would think that scaling mechanisms occurring in pyramidal cells and interneurons could be distinct, with different impact on the network. Although for whole-cell recordings the authors selected pyramidal looking cells, which might bias recordings towards excitatory neurons, naked eye selection of recording cells is quite difficult in primary cultures. Some of the variability in mIPSC amplitude values (Fig. 2A for example) might be attributed to the cell type? One could use cultures where interneurons are fluorescently labeled to obtain an accurate representation. The issue of the possible differential effects of scaling in pyramidal cells vs. interneurons and the consequences in the network should be discussed.
We will include this discussion in the resubmission. Briefly, we chose large cells, which will be predominantly glutamatergic neurons as suggested by the reviewer. Ultimately, even among glutamatergic principal cells there may be variability in the response to drug application. All of these issues could contribute to variability and we will expand our description of the variability in our results, including that based on cellular heterogeneity.
Reviewer #3 (Public Review):
This paper concerns whether scaling (or homeostatic synaptic plasticity; HSP) occurs similarly at GABA and Glu synapses and comes to the surprising conclusion that these are regulated separately. This is surprising because these were thought to be co-regulated during HSP and in fact, the major mechanisms thought to underlie downscaling (TTX or CNQX driven), retinoic acid and TNF, have been shown to regulate both GABARs and AMPARs directly. (As a side note, it is unclear that the manipulations used in Josesph and Turrigiano represent HSP, and so might not be relevant). Thus the main result, that GABA HSP is dissociable from Glu HSP, is novel and exciting. This suggests either different mechanisms underlie the two processes, or that under certain conditions, another mechanism is engaged that scales one type of synapse and not the other.
However, strong claims require strong evidence, and the results presented here only address GABA HSP, relying on previous work from this lab on Glu HSP (Fong, et al., 2015). But the previous experiments were done in rat cultures, while these experiments are done in mice and at somewhat different ages (DIV). Even identical culture systems can drift over time (possibly due to changes in the components of B27 or other media and supplements). Therefore it is necessary to demonstrate in the same system the dissociation. To be convincing, they need to show the mEPSCs for Fig 4, clearly showing the dissociation. Doing the same for Fig 5 would be great, but I think Fig 4 is the key.
We understand the concern of the reviewer as we do see significant variability within our cultures and they were plated in different places, by different people, in different species (rat vs mouse). Therefore, in the resubmission to strengthen the conclusions we will repeat our optogenetic studies restoring activity in the presence of AMPAergic blockade in our mouse cortical cultures and measuring AMPA mEPSCs to assess scaling.
The paper also suggests that only receptor function or spiking could control HSP, and therefore if it is not receptor function then it must be spiking. This seems like a false dichotomy; there are of course other options. Details in the data may suggest that spiking is not the (or the only) homeostat, as TTX and CNQX causes identical changes in mIPSC amplitude but have different effects on spiking. Further, in Fig 5, CTZ had a minimal effect on spiking but a large effect on mIPSCs. Similar issues appear in Fig 6, where the induction of increased spiking is highly variable, with many cells showing control levels or lower spiking rates. Yet the synaptic changes are robust, across all cells. Overall, this is not persuasive that spiking is necessarily the homeostat for GABA synapses.
Together our results argue against AMPAR or GABAR activation as a trigger for GABAergic scaling and that this is different than our results for AMPAergic scaling. These points alone are important to recognize. While changes in spiking do not perfectly follow the changes in GABAergic scaling they do always trend in the right direction. As mentioned above, total spiking activity is only one measure of spiking. It is possible that these drugs alter the pattern of spiking that translates into an altered calcium transient that is important for triggering the plasticity. Again, it is important to note that we are going a step beyond most homeostatic plasticity studies that add a drug and simply assume it is having an effect on spiking (e.g. CNQX was initially thought to completely abolish spiking, but clearly does not). Based on the variability that we observe and the nature of our MEA recordings we cannot precisely determine how the total activity or pattern of activity changes with drug application in the specific cells that we target for whole cell recordings. However, we believe our results are more consistent with our proposal that GABAergic scaling is a strong candidate as a spike rate homeostat. Regardless, in the resubmission we will include a broader discussion about these possibilities, and the reality that there could be multiple homeostatic mechanisms that act to recover spiking activity.
The paper also suggests that the timing of the GABA changes coincides with the spiking changes, but while they have the time course of the spiking changes and recovery, they only have the 24h time point for synaptic changes. It is impossible to conclude how the time courses align without more data.
We can only say that by the 24 hour CNQX time point, when overall spiking is recovered, that GABAergic scaling has already occurred. We will state this more clearly in the resubmission.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
We are grateful to the editors for getting our study reviewed, and are pleased that the reviewers found value in our findings. We plan to submit a revision that we believe can resolve much of the remaining doubt about the major conclusions.
Our current understanding is that much of the uncertainty stems from extensive diversity among synapses. The FM-dye de-staining technique does have single synapse resolution, so it should be possible to develop new kinds of analysis that can make each of our points at the level of individual synapses. For a preview, see Figure 2D (explained in lines 126-141), and Figure 2-Figure supplement 5 of the current version.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
The following is the authors’ response to the original reviews.
We thank the reviewers for their time in evaluating the strengths and weaknesses of our manuscript.
We are pleased to see that all reviewers recognized the high significance of our work, noting that the manuscript addresses “longstanding question of which cell types are infected during congenital or perinatal rubella virus infection”. As noted by reviewer 1, “This study reveals a new cellular target that will have important implications for basic studies on rubella virus-host interactions and for the potential development of therapies or improved vaccines targeting this virus. As the rubella virus is a pathogen of high concern during human pregnancy, this study also has important implications in the field of neonatal infectious diseases”.
Below, we provide responses (in blue) to specific critiques:
Reviewer #1 (Public Review):
A weakness is that the current data do not provide information on the full replicative potential of the rubella virus in microglia, or whether the virus persists in this system.
See our response below. Briefly, we include new experimental evidence from primary tissue, microglia-transplanted organoids, and Vero cells to further characterize the dynamics of viral infection.
Reviewer #1 (Recommendations for the authors):
Most of the viral assays in the brain slices and organoids examine viral protein synthesis, which is a surrogate for genome replication. However, basic virological characterization is lacking and would improve the robustness of the model and its potential utility to understand better rubella virus-microglia interactions. Questions the authors should consider with new experiments include:
Are new virions produced? Can viruses be detected in the media?
Or, are the infections abortive, with viral protein synthesis occurring, but no virus production?
We performed RV titering experiments in dissociated microglia co-cultured with other cell types, as well as Vero cells as a control. While we can detect a robust increase in viral titer from Vero cells, it fell below detection levels in microglia co-cultures. See Author response image 1. We now include these data in Supplementary Figure 2D.
Author response image 1.
Rubella virus titering experiment performed in Vero cells (positive control) or dissociated microglia co-cultures. In primary microglia co- cultures, viral titer falls below detection levels after several days of infection.
While we could not detect an increase in the viral particles from microglia mixed cultures, we confirmed the presence of GFP from the RV-GFP reporter construct, and we believe it serves as a proof that the virus can infect microglia cells and lead to production of functional viral protein (Author response image 2, Figure 1E-F of the current manuscript):
Author response image 2.
We also observed an increase in RV RNA over time in tissue slice infections, using qPCR (Author response image 3, not included in the manuscript).
Author response image 3.
Modest increase in RV RNA over time in brain slice infections. Rubella virus RNA measured by qPCR relative to GAPDH gene, in n=3 samples (2 technical replicates each condition). Brain slices were exposed to RV, then collected at end of inoculation (4 hours post infection), or at 3 or 5 days post infection, and processed for RNA extraction and RT-qPCR.
How long do the infections persist in the model? What is the fate of infected microglia over time? Time courses to monitor infection and cell health would be useful.
We performed a longer infection with RV in organoids transplanted with microglia, and after two weeks of infection, we can detect multiple microglia cells positive for the RV capsid. These data are now included in Figure 4 of the current manuscript.
Author response image 4.
After 2 weeks post infection, microglia remain positive for RV capsid.
Reviewer #2 (Public Review):
Weaknesses
The set of data is rather descriptive. It suggests that microglia are the predominant brain target of RV in vivo, without identifying the targeting mechanism that provides cell type specificity. Moreover, what are the diffusible cues released from the brain environment that increase microglia infection and RV replication?
We agree with the reviewer that identifying molecular mechanisms that underlie this phenotype will be very interesting to explore in future research, and we acknowledge the limitation of the study in the Discussion.
It is unclear why brain organoids not supplemented by microglia are susceptible to RV inoculation.
We could not detect RV capsid in organoids without microglia after 72 hours of inoculation. We attribute any changes seen at the level of single cell transcriptomics in the absence of microglia transplantation to exposure to virus-associated particles, including but not limited to viral RNA species, viral proteins, or even other components of the viral stocks made in Vero cells. These factors may induce transcriptomic differences even in the absence of RV infection. In the text, we take care to refer to these condition as “Rubella virus-exposed” rather than “Rubella virus- infected”. We now include the following panel from Author response image 5 in Figure 4B of the current manuscript.
Author response image 5.
Organoids without microglia do not show positive RV immunofluorescence.
Reviewer #2 (Recommendations for the authors):
Several points could be further addressed to improve the data set and shed more light on some aspects of this manuscript:
• Figure 1. Additional microglia markers should be used to reinforce the evidence that microglia cells are the principal RV targets. Since Iba1 is a marker of activated microglia, does RV have a selective tropism to all microglia or only to activated ones in human fetal brain slices?
The reviewer brings up an interesting point that, in our mind, can be separated into two independent questions:
-
Are Iba1-positive cells bona fide microglia, or are there other cell populations of macrophage/monocyte origin that are labeled with Iba1? Therefore, additional markers should be used for immunolabeling;
-
Is RV infection selective for microglia “activation” status, when only 5mmune-primed cells can be infected?
For the first point, we have previously shown that in the developing human brain, virtually all Iba1-positive cells are also P2RY12-positive (unpublished; Author response image 6). Therefore, in primary human brain slices, there is a negligible amount of non-microglia macrophages. However, in culture microglia quickly lose their “homeostatic” identity, including P2RY12 expression, as quickly as six hours after ex vivo extraction (Gosselin et al., 2017; DOI: 10.1126/science.aal3222).
Author response image 6.
P2RY12 co-localizes with Iba1 in primary brain tissue from gestational week 17.5, including cells with more ameboid morphology (arrows)
However, in organoids at 2 weeks post-RV exposure, we found microglia with both ameboid and more ramified morphology (Author response image 7). It would be challenging and beyond the scope of this manuscript to use morphology or Iba1 intensity levels to determine cause and effect as microglia activation state relates to RV infectivity (i.e. do activated microglia preferentially get infected with the virus, or do infected microglia become activated and upregulate Iba1 levels and change morphology).
Author response image 7.
Examples of microglia with round (top) and ramified (bottom) morphology that co-localize with RV capsid staining.
Regarding RV tropism in the 2D culture of microglia, some Iba- cells are infected by RV as they show capsid staining. What are these cells? Are neurons and/or glia also susceptible to RV in vitro infection? Are non-microglial cells getting RV infected in the absence of microglia?
In the absence of microglia cells, a small proportion of non-microglia cells get infected with RV. There is no statistically significant difference in the number of cells that get infected with RV in the presence or absence of microglia across different cell types. We add these data as Supplement Figure 3.
Author response image 8.
Rubella infection in non-microglia cells. A. Representative images of different cell types depleted of microglia. Cell cultures were stained RV capsid (green) and DAPI. B. Quantification of total cells that are positive for RV capsid across conditions. C. Quantification of RV+ cells that are not microglia across different cell populations. No statistically significant difference was detected in RV infectivity in cells c-cultured with or without microglia.
• Figure 3. The low rate of Rubella virus infection in homogenous CD11b+ cell culture raises the question of whether the Rubella virus can infect microglia at a specific activation stage. It is also surprising that there is no infection of such cell population (also CD11b+) alone while cultured in 2D, as reported in figure 2. Why such a difference?
It is well established that culture of microglial cells isolated from brain tissue alters their molecular properties, which likely alters the cell surface protein composition. In the revised discussion, we include activation as a possible mechanism that will require further investigation.
• Fig 4A-B, it is unclear whether organoids that are not engrafted with microglia get infected upon RV (with active viral replication) inoculation. If non-microglia-supplemented organoids are indeed infected and allow RV replication, this suggests that organoids might not be the ideal system to model human fetal brain RV infection at GW18-23.
We could not detect RV capsid in organoids without microglia after 72 hours of inoculation. We include the following panel from Author respone image 9 in Figure 4 now.
Author response image 9.
Organoids without microglia do not show positive RV immunofluorescence.
• Figure 4E, why are cells derived from microglia-free organoids so much enriched in the UMAP plots as compared to the other organoid condition? Is RV impacting cell fitness, proliferation, or neurodifferentiation?
This perceived difference is due to data presentation. Based on cell proportions, cells from organoids that were treated with microglia are more represented in the scRNAseq data, and this difference most likely comes from user-introduced imbalance in cell loading and possible cell losses during demultiplexing (Author response image 10, panel A). Cell number composition across different conditions and cell types, including RV and MG treatment, are shown in Supplement Figure 4 of the current manuscript (Author response image 10, panel B).
Contribution of each condition can be visualized via UCSC single cell data browser: https://cells.ucsc.edu/?ds=rubella-organoids
Author response image 10.
Data composition depending on condition. A. Cell number contribution from organoids with and without microglia. B. Contribution of each condition to each cluster composition.
• Figure 4F-H. If microglia is the predominant target for RV in the brain, why are microglia-free organoids susceptible to RV and who are the other cellular targets, whose infection leads to activation of interleukin pathway genes and dysregulation of brain developmental markers in selected subpopulations (RGCs, ENs..).
Thank you for bringing this point. We did not detect any appreciable RV genomic RNA in our published single cell data, nor did we identify RV capsid in the RV-exposed organoids without microglia. Our experiments on dissociated cell cultures show that a small population (~1-4%) of other cell types was positive for the RV capsid, including neuron-enriched and glial-enriched fractions (Author response image 11; Supplementary Figure 3C in current manuscript). We expect a similar proportion of non-microglia cells to be infected in the brain organoids. One possible explanation for the robust interferon response even in the absence of productive infection in other cell types is exposure to virions and virus-associated particles, including but not limited to viral RNA species, viral proteins, or even other components of the viral stocks made in Vero cells (which is a cell line that should not produce interferons, but may produce other unmeasured cytokines as a virally infected cell culture).
Author response image 11.
Quantification of RV+ cells that are not microglia across different cell populations. No statistically significant difference was detected in RV infectivity in cells cultured with or without microglia.
• QRT-PCR validations of some of these key brain targets should be performed.
We agree with the reviewer that further validation of the predicted molecular changes downstream of Rubella exposure would be valuable. We have opted to validate IFITM3 and NOVA1 expression differences using immunostaining, and the results are consistent with our predictions from scRNAseq, and the data is presented in revised Figure 5 and 6 of the current manuscript.
Reviewer #3 (Public Review):
Weaknesses of the paper: Overall, additional control experiments are needed to support the stated conclusions. Affinity chromatography is used to purify microglia and other cell types, but the overall cell enrichment is not quantified.
We appreciate the reviewer concern. However, affinity based enrichments rarely guarantee purity of the enrichment, and we do not believe accurate estimation of the purification purity would alter the biological interpretation of the data.
In cell mixing experiments, the authors do not rule out the possibility that the added non- microglia cells also become infected, releasing additional infectious viruses. The finding that a diffusible factor is required for RV infection would be unusual if not unprecedented; therefore, additional data are required to support this claim and rule out other interpretations.
We provide quantification of non-microglia cells that are positive for RV capsid in the presence and absence of microglia. Small (~1-4%) of non-microglia cells get infected with the virus and can potentially release more of the virus (see Author response image 12), but we do not know how this newly produced virus would be different from the one that was applied to the cells directly. To follow up our co-culture experiments, we wanted to exclude a possibility of microglia engulfing RV- infected cells in co-cultures, therefore we separated the two cell fractions by a liquid-permeable membrane (Figure 3 of the current manuscript). It is possible that factors secreted by other cell populations in the transwell assay experiments act on microglia cells to upregulate a yet unidentified receptor on microglia surface or other infection-dependent molecule rendering them infectable by the virus.
We re-phrase the text by de-emphasizing “soluble factors” and focusing on excluding phagocytosis of infected cells as a possible mechanism of RV capsid immunoreactivity in microglia cells.
Author response image 12.
Rubella infection in non-microglia cells. A. Representative images of different cell types depleted of microglia. Cell cultures were stained RV capsid (green) and DAPI. B. Quantification of total cells that are positive for RV capsid across conditions. C. Quantification of RV+ cells that are not microglia across different cell populations. No statistically significant difference was detected in RV infectivity in cells c-cultured with or without microglia.
The methods section would be improved by including details about the iPSC line that was used.
We include the following section in Materials and Methods:
iPSC lines.
All work related to human iPS cells has been approved by the UCSF Committee on Human Research and the UCSF GESCR (Gamete, Embryo, and Stem Cell Research) Committee. Human iPS cell line “WTC-10” derived from healthy 30-year-old Japanese male fibroblasts was from the Conklin Lab, UCSF (Bershteyn et al., 2017; Kreitzer et al., 2013). Human iPSC line “13325” was derived from 9-year-old female fibroblasts originally obtained from Coriell cell repository. Human iPSC line “1323-4” derived from healthy 48-year-old Caucasian female fibroblasts (gift from the Conklin Lab, UCSF) was used for immunofluorescence validation analysis as we found that this line generates more reproducible brain organoid differentiations.
and by a more thorough description of virus-specific details, including the numbers of infectious particles added per volume of incubation media.
We now include the following data in the Materials and Methods section:
Rubella virus infection
Cells cultured in 2D were inoculated by adding RV stock virus to culture media in 1:1 dilution (250 ul of media to the equal volume of viral stock, 1.75x105 total ffu/well) to achieve a multiplicity of infection (MOI) of 2. After four hours, media was exchanged with fresh cell culture media. Cortical brain slices were treated with 500 ul of RV viral stock (3.5x105 total ffu/slice) applied over the slice culture filter for four hours, and then the viral culture media was removed and replaced with fresh slice culture media. Organoids were treated in 6-well plates with 2ml of 1:1 dilution of viral stock:organoid maintenance media (7x105 total ffu) for four hours, and then viral media was exchanged for fresh media. For all experimental conditions, cells were fixed and processed for downstream analysis at 72 hours post infection. Supernatant from non-infected Vero cells (mock) or heat-inactivated RV (650C, 30 mins) was used as control.
In addition to immunofluorescence, adding additional data to demonstrate and quantify virus infection (PCR and plaque assays. or immunofluorescence using an anti-double-stranded RNA antibody such as J2) from the infected brain slices and organoids would provide greater assurance that the virus is indeed replicating under the experimental conditions.
We performed RV titering experiment in dissociated microglia co-cultured with other cell types, as well as Vero cells control. While we can detect a robust increase in viral titer from Vero cells, it fell below detection levels in microglia co-cultures. We now include these data in Supplementary Figure 2D.
Author response image 13.
Rubella virus titering experiment performed in Vero cells (positive control) or dissociated microglia co-cultures. In primary microglia co- cultures, viral titer falls below detection levels after several days of infection.
Unfortunately, we did not find J2 staining informative because we could detect signal in both wild type RV infection conditions and in heat-inactivated RV, presumably due to native dsRNA species present in cells. We did not detect any increase or difference in the pattern of staining between RV and heat-inactivated virus-exposed conditions (Author response image 14; not included in the manuscript).
Author response image 14.
J2 antibody labels dsRNA in both RV-exposed and control heat- inactivated virus conditions, presumably due to native dsRNA that is not unique to the viral replication.
Organoid imaging with immunofluorescence would be very informative in demonstrating the presence of microglia and also in showing which cells are virus-infected in the context of organoid structures.
We provide images from 72hrs and 2 week RV infection, providing a zoomed-out view of organoids with microglia and RV capsid staining. We also provide images of 72hrs post- infection in organoids without microglia Author response image 15, Figure 4C in current manuscript).
Author response image 15.
Microglia in organoids co-localize with RV capsid staining.
GenBank accession numbers are listed for the recombinant RV and GFP-RV reporter, but a search using those numbers did not locate the deposits--perhaps the deposits were very recent?
Both viral construct information is now available on GenBank:
M33 RV strain can be found here: https://www.ncbi.nlm.nih.gov/nuccore/OM816674
RV-GFP can be found here: https://www.ncbi.nlm.nih.gov/nuccore/OM816675
The authors incorrectly refer to the GFP virus as a new strain; it is not a viral strain and should be referred to as a reporter virus.
Thank you, we changed the description to
“To confirm functional transcription and translation of the viral genome, a new reporter construct of RV designed to express GFP within the non-structural P150 gene was generated (RV-GFP, GenBank Accession OM816675)”
Given that the authors show that Vero cell cultures are infected by the Rubella virus in the absence of other cells, additional evidence is needed to demonstrate that a diffusible factor from other cells enables microglia to be infected by the Rubella virus.
We have revised the manuscript to indicate that our data is consistent with the possibility that a diffusible factor is involved. Our experiment utilizing transwell assay argues against phagocytosis and physical interactions as primary drivers, but future studies will be needed to determine if soluble factors are involved.
The authors did not detect Rubella virus transcripts in the single-cell RNA sequencing experiment, nor was a microglia cluster found.
Indeed, microglia recovery using scRNAseq is very inefficient. We note this limitation in the discussion.
Innate immune responses can be activated in the presence of viral particles but without virus replication, as in inactivated viral vaccines; therefore changes in interferon responses do not necessarily prove virus replication.
We agree with the reviewer on this point, it is difficult, if at all possible, to entirely eliminate the possibility that some of the transcriptomic changes, particularly the interferon responses, are not induced by the exposure to viral particles. We have revised the manuscript to more rigorously described the conditions as “RV-exposed”.
Figure 4: it would be helpful to define the abbreviations used in the figure legend (e.g. IPC, RG, EN). In the volcano plots, the gene names are blocked by the dots, and the figure becomes very pixelated when enlarged to read the text.
We have added abbreviations and replaced the figure files with higher resolution images (Figure 6 in current manuscript).
The value of including Supplemental Figure 2 (MOG) is not clear because it receives little mention in the text and also seems to be previously published data that could be cited.
We have removed the figure and replaced it with a citation and a link to the Cell Browser.
Supplemental Figure 4: In panel G, the legend shows "YH10" and "13325". These terms are not described in the Figure legend, nor did a search of the manuscript identify these terms. In its current form Supp. Fig. 4G is not interpretable. In addition, would be more clear to use the term "RV-infected" instead of "treated" to describe the addition of the virus.
We have expanded the Methods section to include the description of different organoid lines and added a revised legend for Supplementary Figure 4. We do not provide evidence of RV infecting organoids without microglia, therefore we have revised the claims that organoid cells become infected with the virus and replaced it with “RV-exposed” to better reflect the conditions studied.
Reviewer #3 (Recommendations for the authors):
1) Demonstrate and quantify virus replication to provide data to complement the imaging. In order of data quality, plaque assays would be most convincing in demonstrating infection and release of infectious virus, while a time course of PCR on RV transcripts would support a conclusion of replicating virus. Further, staining with an anti-double-stranded RNA antibody (J2) would represent evidence of virus replication.
In response to the reviewer’s comment, we performed an RV titering experiment in dissociated microglia co-cultured with other cell types, as well as Vero cells control. While we can detect a robust increase in viral titer from Vero cells, it fell below detection levels in microglia co-cultures. We now include these data in Supplementary Figure 2D.
Author response image 16.
Rubella virus titering experiment performed in Vero cells (positive control) or dissociated microglia co-cultures. In primary microglia co- cultures, viral titer falls below detection levels after several days of infection.
We detected a very modest increase in RV RNA in infected brain slices over time using RT- qPCR (see Author response image 17, not included in current manuscript)
Author response image 17.
Modest increase in RV RNA over time in brain slice infections. Rubella virus RNA measured by qPCR relative to GAPDH gene, in n=3 samples (2 technical replicates each condition). Brain slices were exposed to RV, then collected at end of inoculation (4 hours post infection), or at 3 or 5 days post infection, and processed for RNA extraction and RT-qPCR.
Unfortunately, we did not find J2 staining informative because we could detect signal in both wild type RV infection conditions and in heat-inactivated RV, presumably due to native dsRNA species present in cells. We did not detect any increase of difference in the pattern of staining between RV and heat-inactivated virus-exposed conditions (Author response image 18; not included in the manuscript).
Author response image 18.
J2 antibody labels dsRNA in both RV-exposed and control heat- inactivated virus conditions, presumably due to native dsRNA that is not unique to the viral replication.
We utilized FISH to detect negative-stranded (non-genomic) RV RNA as an alternative to J2 to indicate RNA replication. However, it proved to be not very sensitive, as a small quantity of negative-strand RV RNA could be detected in highly infected Vero cells, but negative-strand RV RNA was not detected in more modestly infected microglia (based on positive-strand RV RNA quantification), as in Author response image 19, not included in current manuscript.
Author response image 19.
FISH probes to positive strand (genomic) and negative strand (replication template) RV RNA in Vero cells and microglia co-cultures. A: representative images of Vero cells infected with RV (top row) or Zika virus as control (bottom row). At 72hpi, cells were fixed and processed for immunofluorescence with anti-RV capsid antibody (RVcap) or Zika virus antibody (Zika4G2), and then FISH was performed using probes to positive strand (+) or negative strand (-) RV RNA. Negative strand RV RNA difficult to visualize at low-power magnification, and required quantification within cell borders defined by wheat germ agglutinin staining with results in panel B. B: In Vero cells, negative strand RV RNA is detected in strongly infected cells. Infection strength determined by intensity of RV capsid immunofluorescence staining and positive strand RV RNA (RVcap/(+) 2/3 indicates robust infection, RVcap/(+) 1 indicates weak infection). ZIKVinf = Zika virus infected control. C: In microglia co-cultures, positive strand RV RNA detected in cells with RV capsid immunopositivity (RVcap_pos). RVinf = RV infected. RVHI = heat-inactivated RV. D: In microglia co-cultures, negative strand RV RNA quantification not significantly different between mock, heat-inactivated RV (RVHI), or RV- infected conditions (RVinf), including cells with weak positive-strand RV RNA (RVinf, (+)<8) or cells with stronger positive-strand RV RNA ((RVinf, (+)>=8). Two biological replicates (bHR60 and bHR61), n indicates number of cells counted.
While we could not detect an increase in the viral particles from microglia mixed cultures, we confirmed the presence of GFP from the RV-GFP reporter construct, and we believe it serves as a proof that the virus can infect microglia cells and lead to production of functional viral protein (see Author response image 20, Figure 1E-F of the current manuscript)
Author response image 20.
Thus, overall we detect replication of viral RNA and protein (qPCR, RV-GFP), but not an appreciable increase in released newly-made virions. The discussion now reflects this more clearly in the current manuscript.
2) The claim of requiring a diffusible factor to enable RV infection requires additional data. A suggestion would be to include further characterization of affinity-purified cells to define the levels of cell enrichment and to determine which other cell types are present, It is also important to test the RV infection of the fractionated cell types alone before adding to the microglia, in order to demonstrate whether RV is replicating in cell types other than microglia.
We performed quantifications of RV capsid-positive cells in each of the affinity-purified cell populations: neuron-enriched (purified with PSA-NCAM beads), glia-enriched (PSA-NCAM depleted cell fraction), or non-microglia fraction (“Flow through”, depleted of CD11b+ cells). We show that across each condition, we have low infectivity (ranging from ~1 to 4% of total cell population) after 72 hours post-infection. We include these data in Supplementary Figure 3.
Author response image 21.
Rubella infection in non-microglia cells. A. Representative images of different cell types depleted of microglia. Cell cultures were stained RV capsid (green) and DAPI. B. Quantification of total cells that are positive for RV capsid across conditions. C. Quantification of RV+ cells that are not microglia across different cell populations. No statistically significant difference was detected in RV infectivity in cells c-cultured with or without microglia.
Another approach to limit cell heterogeneity would be to use iPSC-derived cells, which are highly enriched as a single cell type as a specific cell type, to test the requirement for additional cell types to achieve RV infection of microglia.
In our prior publication (Popova et al. 2021) we have identified a number of molecular differences between primary and iPSC derived microglia. iPSC derived microglia like cells could show differences in infection tropism from primary microglia, and those results may be difficult to interpret biologically. We agree with the reviewer that iPSC derived cells would be an interesting model, there are now several distinct protocols for deriving microglia like cells from pluripotent stem cells and we feel that embarking on a protocol comparison project would fall outside the scope of the current manuscript.
3) Consider a longer organoid infection. The authors did not identify viral RNA transcripts in their organoid scRNAseq data after a 72-hour infection. Although the 72-hour time point seems right for cells in 2D culture, it’s possible that the infection in the organoids is slower because the virus has to spread inwardly. It would be worth trying a time course out to 2 weeks, collecting organoids every few days and then imaging and doing pcr or plaque assays. Zoomed-out views that show immunofluorescence of the entire organoid would also be beneficial in assessing organoid quality and immunofluorescent staining to identify cell types,
We performed longer RV infection for two weeks and now present data on RV capsid in microglia in 72 hrs and 2 weeks post-infection (Author response image 22, Figure 4C of the current manuscript). We have also validated one of the scRNAseq-generated gene candidates in combination with different cell type markers and present data on whole organoids immunostained with NeuN for neurons and EOMES for intermediate progenitor cells that demonstrate the overall structure of the organoids (Author response image 23; Figure 6 of the current manuscript).
Author response image 22.
Microglia in organoids co-localize with RV capsid staining. Organoid with microglia were exposed to RV for 72 hrs or two weeks.
Author response image 23.
Organoids labeled with splice regulator NOVA1 (magenta), neuronal marker NeuN (green) and intermediate progenitor cell marker EOMES (cyan).
-
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
While the CTD human brain organoids show a decrease in Cr (in absence of Cr in the culture medium) as compared to control organoids (4 times less), they are not devoid of Cr. Do these organoids express the two enzymes allowing Cr synthesis (AGAT and GAMT), and in which brain cell types? If yes, how to explain the decrease in Cr in the CTD organoids?
There is a lack of functional CRT in the CTD human brain organoids. The basal level of creatine in CTD human brain organoid is significantly lower than in healthy human brain organoids. The intracerebral creatine synthesis is due to different expression of the AGAT and GAMT enzymes and relies on functional CRT for the transport of the GAA intermediate Litterature pointed out that both enzymes are rarely co-expressed (Braissant et al., 2001, PMID: 11165387) meaning that GAA intermediate needs to be transported by CRT to neurones for complete creatine synthesis. Even if we evidenced a slight mRNA expression of AGAT and GAMT enzymes, the creatine synthesis is not effective since the GAA intermediate could not be transporterd in cell expressing GAMT due to the non functional creatine transporter in the CTD human brain organoids.
The rescue experiment, re-establishing a functional Cr transporter (CRT or SLC6A8) in the CTD human brain organoids, is very interesting, as this may help the design and development of new treatments for CTD. However, authors claim that the functional CRT expressed in the rescued CTD organoids was expressed in each cell. This may be a difficulty in the development of new CTD treatments, as CRT should be expressed in neurons and oligodendrocytes, but not in astrocytes. Authors may want to comment on this point.
As shown in Figure S2C, the whole brain organoid in the resue experiment shows the expression of the GFP protein, thus also the co-expressed wild-type CRT. In these experiments we did not make a detailed cellular characterization of the rescued organoids, and this may be a task in our next experiments for an exact characterization of the cell-specific CRT expresion and function in the rescued brain organoids. According to this, we will correct in the revision version of manuscript the statement on page 6: “SLC6A8 expressing brain organoids showed GFP fluorescence in the whole area of the organoid (Fig S2C).”
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #2 (Public Review):
The current work was basically a follow-up of a previous study in juvenile mice, and the results were also very similar to the juvenile results (Sommeijer et al., 2017). One possible interpretation of the results is that the lack of OD plasticity in adult V1 and dLGN was caused by an early blockade of the development of the inhibitory circuit in dLGN, which retains the dLGN in an immature stage till adulthood. The authors indeed claimed in the discussion that the 2-day OD shift is intact in juvenile dLGN and V1 in KO mice, and provided evidence in supplementary figure that GABAergic and cholinergic synapse amount are similar between WT and KO mice. However, the 7-day OD shift is indeed defected in juvenile V1 and dLGN in KO mice (Sommeijer et al., 2017), and it is possible that this early functional deficit didn't induce a structural remodeling in adulthood. To better support the author's claim that the lack of adult V1 OD plasticity is specifically due to reduced dLGN synaptic inhibition, the author should generate conditional KO mice that dLGN synaptic inhibition was only interfered in adulthood.
In order to address this point it is important to discuss the plasticity deficits in dLGN and V1 separately.
Concerning V1 plasticity: We have previously shown that brief MD during the standard critical period induces an OD shift in V1 of mice lacking thalamic synaptic inhibition in dLGN (Sommeijer et al, 2017). OD plasticity induced by brief MD is a hallmark of critical period plasticity in V1, and it thus seems unlikely that critical period onset in V1 is defective or that development of V1 is halted in an immature state that does not support OD plasticity in thalamus-specific GABRA1 deficient mice.
The observed plasticity deficit during the critical period was limited to the second stage of the OD shift in V1, which requires long-term monocular deprivation. The straightforward explanation for this result and our current findings is that both during the critical period and in adulthood, the second stage of OD plasticity in V1 induced by long-term monocular deprivation requires thalamic plasticity or inhibition. The proposed alternative, that lack of thalamic synaptic inhibition during development results in a possible lack of structural change in V1 that would cause a lifelong deficiency selectively affecting OD plasticity induced by long-term monocular deprivation, is not impossible but requires many more assumptions.
Concerning dLGN plasticity: The simplest explanation for the observed lack of OD plasticity in dLGN is that it is a direct consequence of the absence of synaptic inhibition in the KO mice. However, an alternative explanation could indeed be that dLGN is kept in an immature (pre-critical period-like) state due to the developmental absence of synaptic inhibition. This situation would be analogous to that in V1 of GAD65 deficient mice (which have reduced GABA release), in which OD plasticity cannot be induced by brief monocular deprivation during the critical period or in adulthood (Fagiolini and Hensch, 2000). Because this deficit can be reversed by treating the mice with benzodiazepines (positive allosteric modulators of GABA receptors) at any age, it is thought that development of V1 in GAD65 mice is halted in a pre-critical period-like state until inhibition is strengthened. We cannot exclude that something similar occurs in dLGN of mice lacking thalamic synaptic inhibition, although we did not observe any changes in hallmarks of dLGN maturity, such as reduced receptive field size (Fig. 1C), and increased cholinergic and inhibitory bouton densities (Suppl. Fig. 1).
However, if the analogy with the developmental deficit in V1 of GAD65 deficient mice is valid, the reduced plasticity is still likely to be a direct consequence of reduced inhibition. In GAD65 deficient mice, long-term monocular deprivation during the critical period causes a full OD shift, showing that no additional deficits (besides reduced inhibition) limit OD plasticity in V1 of these mice (Fagiolini and Hensch, 2000). And, as already mentioned, increasing inhibition rescues OD plasticity in GAD65 KO mice. Thus, the immature state of V1 in these mice is probably a situation in which inhibition tone is too low to support efficient OD plasticity. In dLGN, knocking out GABRA1 at a later age could therefore also create a situation in which inhibition is too low to support thalamic OD plasticity, which is not different from the situation in which the gene is inactivated at birth. Only if lack of synaptic inhibition in thalamus affects another, unknown developmental process that is of importance later in life to support OD plasticity in dLGN, the proposed experiment would result in a different outcome. We are not convinced that this scenario is likely enough to justify repeating most of this study, but now using mice in which GABRA1 is inactivated in dLGN through bilateral AAV-cre injections.
Independently of the exact cause of the plasticity deficit in dLGN, our results make clear that a cortical plasticity deficit in adulthood can have a thalamic origin, which we believe is an important insight that is highly relevant.
2) The authors found that in juveniles, dLGN OD shift is dependent on V1 feedback, but not in adults. However, a recent work showed that the effects of V1 silencing on dLGN OD plasticity could differ with various starting points and duration of the V1 silencing and MD (Li et al., 2023). Could the authors provide more details of the MD and V1 silencing for an in-depth discussion?
We would be happy to include some discussion about this interesting new paper in a revised manuscript. Some of the results may appear to contradict our findings. Most strikingly, the study by Li et al does not find evidence for OD plasticity in dLGN of 60-day old mice after 7 days of monocular deprivation. This seems to be at odds with the current work and with that of (Jaepel et al 2017) and (Huh et al. 2020). However, in the (Li et al, 2022) study, only the binocular neurons which responded to both contralateral and ipsilateral stimulus were included to measure the OD. This has important consequences for assessing OD and its plasticity. To illustrate: if dLGN neurons are monocularly responsive to the contralateral eye and become binocular after deprivation of the contralateral eye, they are excluded from analysis before deprivation but included after. This would cause an underestimation of the size of this OD shift. In our experiments, all dLGN neurons with receptive fields that were within 30o degrees away from the center of the visual field were included in the analysis, potentially explaining the different outcome of the studies.
Also, Li et al observed that an OD shift in dLGN was still present after silencing V1 at p24. This observation is not necessarily at odds with our observation that the OD shift reduces at p30 upon silencing V1, as we find that the ODI does not return to normal but remains slightly lower (though not significantly so). Moreover, the age and the duration of deprivation were different and as mentioned before, analysis was performed differently.
Interestingly, an excitotoxic lesion of V1 was found to alter OD in dLGN during development and affect OD plasticity in dLGN at various ages in the work of Li et al. This suggests that continuous crosstalk between thalamus and cortex during development guides plasticity, possibly optimizing thalamocortical and corticothalamic connections. The continued absence of corticothalamic feedback is likely to have a much larger impact on dLGN plasticity than the acute silencing we performed.
Fagiolini M, Hensch TK. Inhibitory threshold for critical-period activation in primary visual cortex. Nature. 2000 Mar 9;404(6774):183-6.
Huh CYL, Abdelaal K, Salinas KJ, Gu D, Zeitoun J, Figueroa Velez DX, Peach JP, Fowlkes CC, Gandhi SP. Long-term Monocular Deprivation during Juvenile Critical Period Disrupts Binocular Integration in Mouse Visual Thalamus. J Neurosci. 2020 Jan 15;40(3):585-604. doi: 10.1523/JNEUROSCI.1626-19.2019
Jaepel J, Hübener M, Bonhoeffer T, Rose T. Lateral geniculate neurons projecting to primary visual cortex show ocular dominance plasticity in adult mice. Nat Neurosci. 2017 Dec;20(12):1708-1714
Li N, Liu Q, Zhang Y, Yang Z, Shi X, Gu Y. Cortical feedback modulates distinct critical period development in mouse visual thalamus.. iScience. 2022 Dec 7;26(1):105752.
Sommeijer JP, Ahmadlou M, Saiepour MH, Seignette K, Min R, Heimel JA, Levelt CN. Thalamic inhibition regulates critical-period plasticity in visual cortex and thalamus. Nat Neurosci. 2017 Dec;20(12):1715-1721.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
We sincerely appreciate the reviewers for investing their valuable time in assessing our manuscript. We understand the considerable effort involved in the review process, and we will make use of these suggestions in order to make the revised manuscript more complete in terms of explanation, discussion, additional simulations, experiments and analyses.
-Specifically, we will experimentally and computationally investigate how activation via anti-CD3 antibodies relates to our mechanism.
-We will also utilize a weaker pMHC binder in the pMHC-mediated T cell activation experiments.
-We will improve the description of the function of the FG loop and the role of the connecting peptide (CP).
-Furthermore, we will improve our description of and justification for the simulation methodology. We want to emphasize that all potentials have been described, and we will draw attention to these methodological descriptions where needed.
The reviewers also suggested a number of additional simulations that are probably beyond our current capability. These include:
-simulations of TCR in complex with a weaker agonist -simulations of the proline and alanine TCR mutants in complex with a pMHC.
While we agree that such simulations would provide new insights into the mechanism of TCR triggering, they simply are not feasible at this time. We will give a more detailed explanation for these arguments in the revised manuscript.
Below, please find our point-by-point planned action items:
Reviewer #1 (Public Review):
The manuscript entitled: "TCR-pMHC complex formation triggers CD3 dynamics" by Van Eerden et al. mainly uses coarse-grained molecular dynamics to probe the dynamic changes, in terms of CDε spatial arrangements around 226 TCRs, before and after the engagements of MCC/I-Ek. The broader distributions of CDε iso-occupancies after pMHC binding correlate with the decreases of TCR-CD3 contacts and extensions of TCR conformations. Given the observed release of motion restrictions upon antigen recognition, the authors proposed a "drawbridge" model to describe the initial triggering processes from pMHC association to TCR straightening, FG-loop getaway, and CD3 enhanced mobility. In addition, the authors briefly investigated the functional effects of the rigidified connecting peptide (CP) in T-cell activation using in silico and in vitro mutagenesis. The manuscript raises an important and exciting hypothesis about the allostery of TCR-CD3 during TCR triggering; however, due to current not-yet-convincing evidence, both computationally and experimentally, in supporting their conclusions.
I would like to see additional work before supporting the publication of this manuscript in Life. See details below:
1) As mentioned by the authors, the TCR triggering and T cell activation have been illustrated by a number of models, such as mechanosensing and kinetic proofreading, "in which TCRs discriminate agonistic from antagonistic pMHCs." However, the critical feature of antigen discrimination is lacking in the drawbridge model. So far, the CDε movements qualitatively distinguish on and off states. The simulation of the antagonist or weaker binder would strengthen the manuscript by demonstrating the relevance of CDε mobility in the triggering mechanism. 226 TCR associated with K99E/I-Ek has been resolved in Ref (DOI: 10.4049/jimmunol.1100197), which can potentially serve as the "intermediate" system to formulate the gradual increase of CDε dynamics.
Planned actions:
-Explain why the current study can not easily address pMHC discrimination
-Explain why simulation of antagonist or weaker binding pMHC is technically difficult
2) The linkage between conserved motifs in CP and CDε mobility is less apparent to this reviewer. The notion of the rigidified hinge (PP) requires further clarification. Computationally, the details of fine-grained simulations are required to justify the origin of the apparent mobility increase in PP. The direct comparison between Fig. 2 and Fig. 7 can help assess the relevance of CP through the alignment by FG-loop at a fixed direction in polar coordinates. Experimentally, anti-CD3 positive experiments and, ideally, another antagonist on 3A9 TCRs can strengthen the current functional assay. The baseline level of TCR expression (after positive selection) and 0h activation (Fig. S8) is missing.
Planned actions:
-Provide additional analysis of the role of CP as a hinge
-Better clarify the FG simulation methodology
-Align the CG and the FG polar plots
-Perform experiments with anti-CD3 antibody 2C11
-Perform additional experiment using weaker agonist (HEL peptide mutant)
-Measure baseline-level TCR expression
-Perform T cell activation experiments at t=0 h
3) Regarding the section "The TCRβ FG loop acts as a gatekeeper," besides contact analysis, additional motion analysis, such as RMSF or PCA, can further establish the importance of FG loops.
Planned actions:
-Perform additional analyses of FG loop dynamics
4) The discussion on anti-CD3 antibody effects and their potential contribution to CD3 mobility is highly recommended.
Planned actions:
-We will add the discussion of anti-CD3 antibody effects
Reviewer #2 (Public Review):
In this research article a new allosteric mechanism for T cell receptor (TCR) triggering upon peptide-MHC complex binding is presented in which conformational change in the TCR facilitates activation by controlling CD3 dynamics around the TCR. The authors find that the Cb FG loop acts as a gatekeeper and Cb connecting peptide acts as a hinge to control TCR flexibility.
As an initial result, the authors set up two sets of simulations - TCR-CD3 and pMHC-TCR-CD3 in POPC bilayers and identified that the CD3e chains exhibit a wider range of mobility in the pMHC-TCR-CD3 system as compared to the TCR-CD3 system. Next, they examined the contacts between all subunits during the course of both simulations and established that CD3g and CD3eg made far fewer contacts with TCRb in the pMHC-TCR-CD3 simulations. Next, they identified that the TCR is extended in the pMHC-TCR-CD3 simulations with larger tilt angle of 150º and FG loop acts as gatekeeper that allows CD3 movements upon pMHC binding. Finally, Mutations in Cb connecting peptide regions indicated rigidified TCR leading to hypersensitive TCR, proved both by simulations and in vitro experiments.
The following major concerns must be addressed.
Major concerns:
1) The simulations were performed with intracellular regions unfolded and free from the membrane. A more complete system should have the intracellular regions embedded in the membrane. An NMR structure of CD3e is available (Xu et al., Cell, 2008) and could have been modeled into the TCR-CD3 system before the simulation. Prakaash et al., (PLoS, Comput Biol, 2021) studied cytoplasmic domain motions during in their simulation experiments.
Planned actions:
-Explain why we can not perform adequate additional simulations of ITAMs
2) Comparing Fig. 2C and Fig.7C, the movement of CD3eg is more restricted in Fig.7C. Is this because the simulation time is lower in the mutation experiments?
Planned actions:
-Explain the differences between the CG and FG polar plots
3) Only TCR-CD3 simulation were performed for PP and AA mutants. A simulation with pMHC (pMHC-TCRmutants-CD3) should be performed to show increased CD3 mobility.
Planned actions:
-Explain why TCR-CD3-pMHC simulations of the mutants are not feasible at this time
4) Using CD3e antibody, OKT3, for activation instead of pMHC as a separate experiment would add more value to this study. They can look at CD3 mobility and TCR elongation in the system with OKT3 antibody and compare it to the CD3 mobility and TCR elongation with the pMHC system. They can also use OKT3 with AA and PP mutants and perform both simulation and in vitro activation experiments.
Planned actions:
-Perform anti-CD3 (2C11) experiments
-Perform CG simulation of TCR with CD3 Fab fragment
-Explain why we cannot perform FG simulations of TCR mutants with CD3
5) The activation experimental data is rather underwhelming. The difference between WT and PP in 2hr experiment at 0.016 ug/mL looks exceedingly low. A stronger TCR-pMHC system should be considered for the in vitro activation experiments.
Planned actions:
-Explain that this is a dilution curve, which is why at lower concentrations the effect is smaller, but at higher concentrations the effect is clear
6) There is some concern that the scientific work lacks solid experimental functional data and lack of novelty due to earlier TCR-CD3 simulation studies (Pandey et al., 2021, eLife) that already reported flexibility and elongation of the complex.
Planned actions:
-Explain the similarities and difference between this and Pandey’s work; clarify how our study contributes novel findings
Reviewer #3 (Public Review):
The authors first explore structural differences of unbound TCR-CD3 complexes and pMHC-bound TCR-CD3 complexes with coarse-grained simulations. In the simulations with pMHC-bound complexes, the transmembrane (TM) domains of the TCR-CD3 complex and of pMHC are embedded in two opposing membrane patches. In the pMHC membrane patch, a pore is created and stabilised in the simulation setup with the aim to allow water transport in and out of the compartment between the membranes. The authors report a more upright conformation of the TCR extracellular (EC) domain in the simulations in which this EC domain is bound to pMHC, compared to simulations with unbound TCR, and postulate an allosteric signalling model based on these apparent conformational changes and associated changes in TCR-CD3 quaternary arrangements. Subsequently, the authors identify a GxxG motif in the TCRbeta connecting peptide between EC domain and TM domain as putative hinge in allosteric signalling, and explore the effect of double proline and double alanine substitutions in atomistic simulations and experiments.
While these simulation and experimental setups and the addressed questions are of interest in the field, the following weaknesses prevail in my overall assessment of the work:
(1) I am not convinced that the reported coarse-grained simulation results are sound or allow to draw the conclusions stated in the work. In the simulations with a pMHC-bound TCR-CD3 complex, the intermembrane distance in the setup shown in Figure S1 appears excessively large and likely leads to a rather strong force in the membrane-vertical direction and to the reported upright conformation of the TCR EC domain. This upright confirmation thus appears to be a consequence of force from the simulation setup, rather than a consequence of pMHC binding alone as suggested by the authors. While the membrane pore in principle allows water exchange, the relaxation of the intermembrane distance resulting from this water exchange in the 10 microsecond long simulation trajectories is not (but needs to be) addressed. This relaxation eventually would lead to an equilibrated membrane separation, in which essentially no force is exerted on the TCR-pMHC EC complex. However, I suspect that this computationally demanding equilibration is not achieved in the simulations, with the consequence that forces on the TCR-pMHC EC complex in the membrane-vertical direction remain.
In addition, I am not convinced that the Martini force field of the coarse-grained simulations allows a reliable assessment of the quaternary interactions between the TCR and CD3 EC domains. Getting protein structures and interactions right in coarse-grained simulations is notoriously difficult. In simulations with the coarse-grained Martini force field, secondary protein structures are constrained as a standard procedure, and the authors also use a recommended Go-potential procedure, likely to stabilise tertiary protein structures. The quaternary interactions between the TCR EC domain and the pMHC EC domain are modelled by rather strong harmonic constraints to prevent dissociation. While the treatment of the quaternary interactions between the TCR EC domain and the CD3 EC domains in the simulations is not (but needs to be) addressed in detail, I suspect that there are no additional, or only weak constraints to stabilise these interactions. In any case, I think that a faithful representation of these quaternary interactions is beyond the reach of the Martini force field, as is the reported diffusion of the CD3 EC domains around the TCR EC domain, which plays a central role in the allosteric mechanism proposed by the authors (see Fig 2 and 5).
Planned actions:
-We will provide further description and justification for the CG simulations
(2) The allosteric model suggested by the authors is motivated in an introduction that appears to omit central controversial aspects in the field, as well as experimental evidence that is not compatible with allosteric conformational changes in the TCR. These aspects are:
-
The mechanosensor model is controversial. In original versions of this model, a transversal force has been postulated to be required for T cell activation. However, more recent single-molecule force-sensor experiments reported in J Goehring et al., Nat Commun 12, 1 (2021) provide no evidence for a scenario in which transversal forces beyond 2 pN are associated with T cell activation.
-
The role of catch bonds is controversial. Evidence for TCR catch bonds has been mainly obtained in experimental setups using the biomembrane force probe, in which force is applied to TCRs on the surface of T cells, but is not reproduced in experimental setups using isolated TCRs, see e.g. L Limozin et al., PNAS 116, 16943 (2019)
-
Ref. 1 of the manuscript prominently discusses the kinetic segregation model of T cell activation, which is not (but needs to be) addressed in the introduction. In this model, exclusion of CD45 from close-contact zones around pMHC-bound TCRs triggers T cell activation. The model is supported by evidence from diverse experiments, see for example M Aramesh et al., PNAS 118, e2107535118 (2021) and Ref. 1. At least part of this evidence is not compatible with mechanosensing or allosteric models of T cell activation.
Planned actions:
-We will add the requested literature references and include a better description of the kinetic segregation model
-
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
The major criticism from the reviewers is that factors other than high-impact rare variants – such as environmental factors or epistasis – could have produced the complex tail architecture that we test for and detect. While we did explain this point in the Discussion, we agree with the reviewers that this should have been emphasized more and earlier in the manuscript.
Regarding suggestions for more complex simulations and methods, we absolutely agree that much more work is needed here to produce optimised inference of all the causes of complex tail architecture. We are performing multiple projects at various stages of completion that we hope will contribute to this, but we felt that this was a good stopping-point in this project to publish what we had completed so far, in order to: (1) introduce the idea of inferring complex genetic architecture from siblings without requiring genetic data, (2) outline an initial theoretical framework for inferring complex tail architecture from sibling data, (3) provide simple tests powered to identify enrichments of de novo or ‘Mendelian’ variants in the tails (albeit tests that make several strong simplifying assumptions), (4) enable others interested in the topic to build upon this work now. However, we plan to expand our simulations and analyses in a revised manuscript based on reviewer feedback.
We thank the reviewers for their comments about the value of our work, its mathematical robustness and the promise of our method.
-
-
www.researchsquare.com www.researchsquare.com
-
Author Response:
The following is the authors' response to the original reviews.
Reviewer #1 (Public Review):
[…] Overall, the authors build a convincing case for TEs being an important source of regulatory information. I don't have any issues with the analysis, but I am concerned about the sweeping claims made in the title. Once you get rid of eQTLs that could be altered by either SNPs or TIPs and include only those insertions that show strong evidence of selection, the number of genes is reduced to only 30. And even in those cases, the observed linkage is just that, not definitive evidence for the involvement of TEs. Although clearly beyond the scope of this analysis, transgenic constructs with the TEs present or removed, or even segregating families, would have been far more convincing.
We notice that the referee thinks that we "built a convincing case for TEs being an important source of regulatory information". This is what we wanted to convey in the title, were we were cautious to not claiming that TEs are the most important contributor to gene expression variability in rice populations. However, we agree with the referee that the title may be improved to better describe the results presented. We have therefore changed the title to "Transposons are an important contributor to gene expression variability under selection in rice populations".
With respect to demonstrating causality by removing or introducing the TEs, this is indeed a work we plant to do but that, as stated by the referee, is beyond the scope of this analysis.
The fact that many of the eQTL-TIPs were relatively old is interesting because it suggests that selection in domesticated rice was on pre-existing variation rather than new insertions. This may strengthen the argument because those older insertions are less likely to be purged due to negative effects on gene expression. Given that the sequence of these TEs is likely to have diverged from others in the same family, it would have been interesting to see if selection in favor of a regulatory function had caused these particular insertions to move away from more typical examples of the family.
The TIP-eQTL are from different classes, superfamilies and families and the number of TIP-eQTLs of the same family is too small to deduce sequence communalities (4.6 TIP-eQTLs/family in indica and 3.6 TIP-eQTLs/family in japonica). On the other hand the effect of TIPs on expression can be positive or negative (we show actually that it is often negative). In the later case, a plausible scenario would be of the insertion inactivating a promoter element, and in this case it would be the insertion itself, and not the actual sequence of the TE what would be selected.
Also, previous work done in our lab has shown that TEs can amplify and mobilize transcription factor binding sites that are bound by the TF even when they are not close to a gene and therefore probably not directly affecting gene expression (Hénaff et al.,2014. The Plant Journal). In that case, the sequence of the eQTL TEs and those that are far away from genes will not necessarily differ.
Reviewer #2 (Public Review):
In this manuscript, Castanera et al. investigated how transposable elements (TEs) altered gene expression in rice and how these changes were selected during the domestication of rice. Using GWAS, the authors found many TE polymorphisms in the proximity of genes to be correlated to distinct gene expression patterns between O. sativa ssp. japonica and O. sativa ssp. indica and between two different growing conditions (wet and drought). Thereby, the authors found some evidence of positive selection on some TE polymorphisms that could have contributed to the evolution of the different rice subspecies. These findings are underlined by some examples, which illustrate how changes in the expression of some specific genes could have been advantageous under different conditions. In this work, the authors manage to show that TEs should not be ignored when investigating the domestication of rise as they could have played an important role in contributing to the genetic diversity that was selected. However, this study stops short of identifying causations as the used method, GWAS, can only identify promising correlations. Nevertheless, this study contributes interesting insights into the role TEs played during the evolution of rice and will be of interest to a broader audience interested in the role TEs played during the evolution of plants in general.
We agree with the referee that the results presented do not allow concluding on causality, and we have been careful not to pretend they would in the manuscript. We plan to perform analysis of adding or removing TEs by CRIPR/Cas 9 approaches to address this, but, in line with referee's 1 comment, we think this is beyond the scope of this analysis.
----------
Reviewer #1 (Recommendations For The Authors):
Everything that I need to say is provided in the public portion of my review.
Reviewer #2 (Recommendations For The Authors):
Major concerns:
1. The authors compare the proportion of the variance explained by the most significant TIP and SNP on the observed eQLTs associated with TIPs and SNPs. Thereby the authors conclude that TIPs explain more variance than SNPs. If I am not mistaken the GWAS was run separately for TIPs and SNPs, however, I am wondering if running the GWAS on the combined TIP and SNP dataset might be the better way to compare the variance explained by TIPs and SNPs on gene expression differences. It would be nice to see if these results also hold true if a TIP and SNP combined dataset is used as the most significant marker in a GWAS might not be the causal mutation but might just be linked to the causal mutation. Further in the TIP dataset, the number of markers is only 45k and in the SNP dataset, it is 1 000k, which could bias the GWAS toward finding markers that explain more of the variation in the dataset with fewer markers.
We addressed the reviewer concern by using two complementary approaches, whose results are described in the text (lines 119-121) and in the new Figure 1-figure supplement 1.
First, we addressed the concern regarding the independent GWAS for TIPs and SNPs vs a combined strategy. For this, we built new japonica/indica genotype matrices containing all TIP and SNP matrix together and ran eQTL mapping again. Using the same strategy (association + FDR adjust), we found 100% of the previous TIP-eQTLs and 99% of the previous SNP-eQTLs. We repeated the same analysis (proportion of expression variance), and the results were mostly the same (Figure 1-figure supplement 1A).
Second, we addressed the two concerns (combined genotypes and different amount of TIP and SNP markers) using a single approach. SNP matrices were LD pruned using a r2 = 0.9 and later subsampled to the exact number of TIPs (Indica = 30,396, Japonica = 25,168). We verified that these SNPs covered well the 12 rice chromosomes. SNP and TIP genotypes were later merged into a single matrix, and eQTL mapping was repeated for each of the subspecies and conditions using the same parameters as in the previous version of the manuscript. 100 % of the previously reported TIP-eQTL associations were found using this new approach. Nevertheless, we found a very important drop of sensitivity in the SNP-eQTLs (only 15-20% of the previous associations were detected), possibly due to the strong reduction in the number of SNPs (> 95 %), which results in much lower number of markers at < 5Kb from genes). We repeated the analysis of Figure 1D, and observed very similar results (Figure 1-figure supplement 1D). There is a very important number of TIP-eQTL associations that do not coincide with SNP-eQTLs, (74% in indica, 83% in japonica) indicating that TIP-eQTL mapping is complementary to SNP-eQTL mapping as it uncovers additional associations (note that in this case the overlap between TIP-eQTLs and SNP-eQTLs is lower than in the previous analysis due to the lower sensitivity of SNP-eQTL mapping using less markers). In the cases were both a TIP and a SNP coincide as eQTL, TIPs explained slightly more variance than SNPs in both indica and japonica (in 54% of the cases TIP variance > SNP variance).
2. Line 146 to 152: in this section, the authors describe overlaps between TIP-eQTLs in two different growth conditions, however, in the text it is not mentioned if the TIPs have the same effect on gene expression in the two conditions or if the gene expression is up-regulated in one condition but down-regulated in the other. This information would be interesting to have here, especially as the authors go on to say that only a small number of TIP-eQTLs are stress-specific. The same comment also goes for the eQTL overlap described on lines 167 to 170.
We checked the effect type (positive or negative) of TIP-eQTLs in both scenarios (associations shared between wet/dry conditions, and associations shared between subspecies). In both cases, 100 % of the shared TIP-eQTLs have the same effect type in the two conditions or subspecies. We have updated the text accordingly (Lines 55-157 and Lines 179-181)
3. Lines 192 to 196: the authors mention that the frequency of non-eQTL-TIPs was at the same frequency in indica and japonica, which is in contrast to eQTL-TIPs. However, on line 132 it is mentioned that eQTL-TIPs were overrepresented in 1 kb regions upstream of genes. Hence, is the pattern of the frequency of non-eQTL-TIPs being at the same frequency in indica and japonica also observed in the 1 kb regions upstream of genes and/or if the distribution of non-eQTL-TIPs is matched to one of the eQTL-TIPs? Or is this pattern driven by non-eQTL-TIPs far away from genes?
We checked the frequencies of TIPs at 1Kb upstream genes and found that the general pattern is maintained, with the frequencies of TIP no-eQTLs being more correlated than that of TIP-eQTLs. We have included this information (lines 204-206) an added a new supplementary file (Figure 2-figure supplement 2)
4. In the discussion, the authors could briefly discuss how linked selection affecting TIPs could contribute to the observed results. After reading the second example in the result section where one of the example TIPs (TIP_50059) is found on the Hap B which contains "some additional structural differences" (line 290), I was left wondering how much of the increase in TIP frequency can be attributed to genetic hitchhiking? And how much of the results could be caused by linked selection, especially when considering that structural variations are not included in the GWAS analyses.
We agree with the referee in that some of the TIP eQTLs here described might be not the actual cause of expression variability (ej, TIP linked with the causal mutation), although we cannot know the exact fraction. This is stated in several places of the results and discussion sections. However, the fact that TIPs tend to explain more variance than SNPs and that TIP eQTL, but not SNP eQTL, tend to concentrate in the upstream proximal region of genes where most transcription regulatory sequences are located (Figure 1), suggest that TIP eQTLs could be more frequently the causal than SNP eQTLs. We revised the text to ensure that we convey this message appropriately.
Minor comments:
• Lines 80 to 83: the description of the rice phylogeny should be moved to the introduction.
Done (Lines 68-72)
• Line 177 to 186: It was unclear to me if the authors checked in the ancestral rice population laced the TIPs described in this section as recently inserted in the indica and japonica ssp. It would be nice to add this information to this section.
Thanks to the referee comment we noted an imprecision in the text. The approximate 1/3 of subspecies specific TIP-eQTLs refers to the TIPs at 3% MAF (ie, some of these insertions could be present at > 3% in indica, but at < 3% MAF in japonica). We now indicate only the TIPs that are truly specific to any of the two subspecies (frequency is zero in one of the two) and looked for their presence in rufipogon:
59 insertions are indica-specific. Of those, 33 are present in rufipogon.
21 insertions are japonica-specific. Of those, 5 are present in rufipogon.
We have incorporated this information in the manuscript (Lines 185-189). The species-specific TIPs are also available in the Supplementary File 3.
• Line 353: "have two of more TIPs" should be "two or more"
Done (Line 369)
• Figure 1D: Using a square layout instead of a rectangle layout for the plot will make it easier to interpret.
Done.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
The following is the authors' response to the original reviews.
Reviewer #1 (Public Review):
[…] This novel system could serve as a powerful tool for loss-of-function experiments that are often used to validate a drug target. Not only this tool can be applied in exogenous systems (like EGFRdel19 and KRASG12R in this paper), the authors successfully demonstrated that ARTi can also be used in endogenous systems by CRISPR knocking in the ARTi target sites to the 3'UTR of the gene of interest (like STAG2 in this paper).
We thank the referee for highlighting the novelty and potential of the ARTi system.
ARTi enables specific, efficient, and inducible suppression of these genes of interest, and can potentially improve therapeutic target validations. However, the system cannot be easily generalized as there are some limitations in this system:
• The authors claimed in the introduction sections that CRISPR/Cas9-based methods are associated with off-target effects, however, the author's system requires the use CRISPR/Cas9 to knock out a given endogenous genes or to knock-in ARTi target sites to the 3' UTR of the gene of interest. Though the authors used a transient CRISPR/Cas9 system to minimize the potential off-target effects, the advantages of ARTi over CRISPR are likely less than claimed.
We thank the reviewer for raising these very valid concerns about potential off-target effects related to the CRISPR/Cas9-based gene knockout or engineering of endogenous ARTi target sites. In contrast to conventional RNAi- and CRISPR-based approaches, such off-target effects can be investigated prior to loss-of-function experiments through comparison between parental and engineered cells, which in the absence of CRISPR-induced off-target events are expected to be identical. Subsequent ARTi experiments provide full control over RNAi-induced off-target activities through comparison of target-site engineered and parental cells. However, we agree that undetected CRISPR/Cas9-induced off-target events cannot be ruled out in a definitive way, which we have pointed out in our revised manuscript.
• Instead of generating gene-specific loss-of-function triggers for every new candidate gene, the authors identified a universal and potent ARTi to ensure standardized and controllable knockdown efficiency. It seems this would save time and effort in validating each lost-of-function siRNAs/sgRNAs for each gene. However, users will still have to design and validate the best sgRNA to knock out endogenous genes or to knock in ARTi target sites by CRISPR/Cas9. The latter is by no-means trivial. Users will need to design and clone an expression construct for their cDNA replacement construct of interest, which will still be challenging for big proteins.
We fully agree that the required design of gene-specific sgRNAs and subsequent CRISPR-engineering steps are by no means trivial. However, we believe that decisive advantages of the method, in particular the robustness of LOF perturbations and additional means for controlling off-target activities, can make ARTi an investment that pays off. In our experience, much time can be lost in the search for effective LOF reagents, and even when these are found, questions about off-target activity remain. While ARTi overcomes many of these challenges by providing a standardized experimental workflow, we do not propose to replace all other LOF approaches by this method. Instead, we would position ARTi as a unique orthogonal approach for the stringent validation and in-depth characterization of candidate target genes, as we have highlighted in our revised discussion.
• The approach of knocking-out an endogenous gene followed by replacement of a regulatable gene can also be achieved using regulated degrons, and by tet-regulated promoters included in the gene replacement cassette. The authors should include a discussion of the merits of these approaches compared with ARTi.
We thank the reviewer for pointing out these alternative LOF methods. We had already included a brief discussion of chemical-genetic LOF methods based on degron tags. While we certainly share the current excitement about degron technologies, they inevitably require changes to the coding sequence of target proteins, which can alter their regulation and function in ways that are hard to control for. In our revised discussion, we have added a brief comparison to conventional tet-regulatable expression systems, which unlike ARTi require the use of ectopic tet-responsive promoters. Overall, we would position ARTi as an orthogonal tool that enables inducible and reversible LOF perturbations without changing the coding sequence and the endogenous transcriptional control of candidate target genes.
Reviewer #2 (Public Review):
[…] The ARTi system is based on expression of a transgene with an artificial RNAi target site in the 3'-UTR as well as a TET-inducible miR-E-based shRNAi. Using this system, the authors convincingly show that they can target strong oncogenes such as EGFRdel19 or KRasG12 as well as synthetic lethal interactions (STAG1/2) in various human cancer cell lines in vivo and in vitro.
The system is very innovative, likely easy to be established and used by the scientific community and thus very meaningful.
We thank the reviewer for her/his enthusiasm about ARTi.
Reviewer #1 (Recommendations For The Authors):
• The authors claimed that ARTi enables specific, efficient, inducible, and reversible suppression of any gene of interest. However, there are no experiments supporting the reversible suppression of their gene of interest. Data are required to support this statement.
We thank the reviewer for pointing this out. The statement about the reversibility ARTi-mediated effects was based on a rich body of literature that has demonstrated the reversibility of Tet-shRNAmir-induced LOF perturbations and associated phenotypes. As ARTi employs the same Tet-shRNAmir expression vectors, we have no reason to believe that this feature would be lost. However, since we have not demonstrated this in our study, we have removed this statement in our revised manuscript.
• In Figure 1E, the authors did make the point by including trametinib treated samples as positive controls. However, the trametinib treated samples also made the transcriptome changes in the ARTi groups hard to read. I wonder what the PCA analysis will look like if the authors exclude the trametinib treated groups.
In Figure 1E, we used PCA as a common and easy-to-digest visualization tool to showcase the neutrality of ARTi shRNAmirs. Given the complete absence of significantly deregulated genes for all three ARTi shRNAmirs (Figure 1F), we believe that a PCA analysis of just these samples would merely represent experimental noise and not yield additional insights.
• This universal and potent ARTi should ensure standardized and controllable knockdown efficiency, however, the knockdown efficiency for KRASG12R is not as potent as that for EGFRdel19. The authors should discuss the differences.
We thank the reviewer for pointing this out. The exact level of knockdown on the protein level is hard to determine due to detection limits of the used method. The differences in the extent to mRNA knockdown could be attributable to cleavage efficiencies due to potential secondary structures in the respective mRNAs. We suspect that the KRASG12R transgene expresses at higher levels, compared to EGFRdel19. We might therefore still be looking at the same overall magnitude of knockdown. As we did not perform a detailed analysis of the respective knockdown levels, we do not feel comfortable in stating differences in knockdown levels and therefore do not think that addressing potential differences are justified.
• It is interesting to see that, unlike other cancer types, tumor burdens did not decrease after inducing knockdown of STAG1 in STAG2 knockout HCT116 lines in Figure 2L. Have the authors examined senescence markers in this set of mice?
We have not investigated these markers and thank the reviewer for this suggestion. More detailed analyses of the phenotype are planned.
• Have the authors carefully examined the transcriptome changes induced or if not across all targets at least in the case of ARTi knock into the 3'UTR of STAG1?
We thank the reviewer for this suggestion. This would indeed be interesting to conduct for STAG1/2, especially for genes with an integration of the ARTi into the 3’UTR. The reason why we did not perform this analysis with our cell lines is that we used a construct that also adds an AID tag to STAG1 (STAG1_AID_V5_P2A_Blasti_STOP_ARTi), as outlined in the methods section. After the engineering, STAG1 carries the ARTi sequence in the 3’UTR but is also fused to AID::V5. In addition a P2A::Blasticidin_resistance Protein is made from the same transcript. We chose to use this complex strategy with the aim of comparing AID mediated degradation with ARTi-mediated knockdown. Unfortunately, the AID-based approach did not work, and we were not able to observe a reduction in protein levels. We however observed lower expression of STAG1 in the engineered versus the parental cells, likely caused by the tag, and consequently did not conduct gene expression analyses, as we would not be able to assess if transcriptome changes could be solely ascribed to the changes in the 3’UTR. The knockdown levels are hence only analyzed on the protein level.
Reviewer #2 (Recommendations For The Authors):
This is a fantastic paper, easy to read and provides a very meaningful new and innovative approach for drug target validation. I think the manuscript could be further improved by adding a section to the discussion outlining other approaches that could be used to solve the same problem. For example, Bill Kaelin came up with a strategy of expressing shRNA- or sgRNA-resistant and rtTA- or tTA-regulated cDNAs of essential gene-of-interest followed by sh/sgRNA-mediated ablation of the endogenous gene (e.g.PMID: 28082722), which is conceptually quite similar to the ARTi approach. Similarly, people have used conditional degron tags such as AID tags, dTags, HALOTags, IHZF3 degrons or SMASh either knocked into the endogenous locus or as rescue transgene. Comparing and contrasting the pros and cons of these methods to the ARTi-based approach would be certainly beneficial to the readers.
We thank the referee for pointing out these alternative LOF methods. We certainly share the current excitement about various degron tags and are applying them in our own research. In our view, a major downside of these strategies is that they inevitably require changes to the coding sequence of target proteins, which can alter their regulation and function in ways that are hard to predict and control for. We had briefly mentioned this distinguishing feature in our discussion. The strategy proposed by Bill Kaelin, i.e. rescue of the the endogenous gene through Tet-regulated expression of sh/sgRNA-resistant cDNAs, indeed shares many features of the ARTi system, but requires expression of the candidate target from an ectopic promoter element. In contrast, ARTi enables similar perturbations of candidate genes without altering their endogenous transcriptional regulations – a feature that we have highlighted in our revised discussion.
All my other comments outlined below should be considered minor and are not essential.
1, Suppl Fig.1 C: Please explain what the red star means. How can the knock-out be more than 100%. Please specify what the controls are. Why does shRNA660 exhibit no knockdown at all?
The red star indicates ARTi-shRNAmirs that were selected for further characterization. Depicted GFP knockdown levels are normalized to the performance of shRen.713, a well-characterized potent control shRNA targeting Renilla Luciferase. Values of more than 100% mean that the respective shRNA exceeded effects of shRNA.713. shRNA.660 served as a neutral control – its target site was not included in the reporter construct. We thank the reviewer for bringing up these points, which we have clarified in the legend.
2, x-axis label in Suppl Fig. 1D is missing
We thank the referee for spotting this and have added this information to the figure and its legend.
3, I would argue that ARTi6634 also has a slight effect in MV4-11 similar to its effect to RN2. Maybe add that to the text.
We thank the reviewer and have added this observation to our revised text.
4, Suppl. Figure Legend 1F - specify which cell line was used (HT-1080 presumably)
We apologize for this mistake and now have indicated the cell line in the legend.
5, Fig. 2A and E, it might be nice to add the dsRED fusion to the schematics so that the reader sees the difference between the endogenous and the endogenous. One could then also change the color to red instead of blue.
We thank the reviewer for this suggestion and adapted the figure accordingly.
6, Fig. 2B - In the third lane, there appears to be a residual band of the endogenous EGFR despite the fact that it should be KO. Is this a EGFR wt lysate with EGFR::dsRED::ARTi overexpression and as such a type in the legend or is this a non-complete KO? It might be beneficial to label the legend with EGFR::dsRED::ARTi instead of EGFR::ARTi have one arrow depicting EGFR and one additional arrow showing the EGFR::dsRED fusion (as in Fig. 1F).
We thank the reviewer for this insightful comment. We interpret the WB signal in lane three as potential cleavage/degradation products of the transgene as all signal disappears upon ARTi-mediated knockdown. Due to space reasons, we would prefer to keep the label as it is. The exact nature of the transgene is stated in the text and in the methods section.
7, Suppl Fig. 2d: It is interesting that there is such a huge upregulation of DUSP6 in cells that express EGFR::ARTi compared to parental? The figure legend states: expression levels of DUSP6 in parental and engineered PC-9 cells. I assume the first box (EGFR::ARTi -/ dox -) is the parental line? Is there really a 5x upregulation of DUSP6 upon overexpression of EGFR::ARTi compared to parental (despite the fact that the endogenous EGFR::ARTi is expressed to similar levels compared to the endogenous EGFR)? Please clarify a little better which of the cells are parental and which are EGFR KO and which are transduced with EGFR::ARTi. Might suffice to just explain in the supplmental figure legend that expression of the exogenous EGFR::ARTi in EGFR KO cells leads to increased expression of ERK targets such as DUSP6 and EPHA2 etc.
We thank the reviewer for this comment. We ascribe the increased expression of DUSP6 to the forced expression of the oncogenic variant of EGFR (EGFRdel19) while only a subset of EGFR genes in PC-9 cells is mutated and the rest is wild-type. Therefore, the net-output of EGFR signaling would be higher, even if the EGFR protein levels were exactly the same, as the EGFR gene is only present in the oncogenic form in the engineered cells but a mixture of mutant and wild-type proteins would make up the EGFR pool in the parental cells. The figure legend was changed accordingly, highlighting that DUSP6 is a MAPK downstream gene.
8, Suppl Fig. 2e: Similar to my comment #7. Expression of endogenous EGFR is lost upon KO of EGFR, but cylcinD1 expression as well as expression of other ERK target genes increases upon loss of the endogenous EGFR gene with concomitant expression of EGFR::ARTi . It is nice to see that most of those genes are down-regulated upon DOX treatment. However, CyclinD1 is strongly up-regulated - any idea why? Might be nice to comment on this in the supplemental material to make it easy for the reader to interpret the data.
We agree with the reviewer that the direct MAPK target genes follow the expected pattern of strong downregulation. We have not studied the expression of CCND1 in detail and therefore cannot comment on the mechanistic basis of this observation.
9, Fig. 2F - might be nice to provide some densitometry data to quantify the effect of ARTi-mediated KRasG12R knock-down.
We thank the reviewer for this suggestion and apologize that this data is not available for this study. We will include densitometry data in upcoming studies involving ARTi. As the observed knockdown was almost complete and hence readily observable by eye, we did not measure the effects using densitometry. In addition, we would like to mention that the sensor assay contains a quantitative analysis of the knockdown levels.
10, Fig. 2I, it might be nice to add the V5 tag to the schematic and mention the V5 tag in the text: ... and homozygously inserted ARTi target sites into the 3'-UTR as well as a V5 tag to the endogenous STAG1 alleles (Fig. 2i)
We thank the reviewer for the suggestion and explained the exact makeup of the construct better in the main text. We would however like to keep the figure as simple as possible and put the focus on the endogenous engineering here.
11, Fig. 2J - might be nice to provide some densitometry data to quantify the effect of ARTi-mediated STAT1::V5 knock-down.
We thank the reviewer for this suggestion and apologize that this data is not available for this study. We will include densitometry data in upcoming studies involving ARTi. As the observed knockdown was almost complete and hence readily observable by eye, we did not measure the effects using densitometry. In addition, we would like to mention that the sensor assay contains a quantitative analysis of the knockdown levels.
12, Suppl. Fig 4B: the authors write: 'Western blotting confirmed ... the homozygous insertion of the targeting cassette into the STAG1 locus, ...' . I think the WB nicely shows insertion of the V5 tag into the STAG1 locus, but it I think WB cannot show homozygous insertion. The fact that in Suppl Fig 1B STAG1 expression is (almost) completely ablated, is a good indication, but in Fig. 2J, there is still about 50% expression. As such, proofing homozygous insertion by PCR/Sanger sequencing or densitometry over several experiments or just rephrasing the text a little might be beneficial.
We agree with the reviewer and have adapted the respective passage in the main text.
Competing interests statement: A patent application related to the design and use of the ARTi system entitled ‘Methods and molecules for RNA interference (RNAi)’ has been submitted by T.H., M.H., J.Z. and R.N. to the European Patent Office (application EP21217407.2).
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
The following is the authors' response to the original reviews.
Reply to Public Reviews:
Reply to Reviewer #1:
This is a carefully performed and well-documented study to indicate that the FUS protein interacts with the GGGGCC repeat sequence in Drosophila fly models, and the mechanism appears to include modulating the repeat structure and mitigating RAN translation. They suggest FUS, as well as a number of other G-quadruplex binding RNA proteins, are RNA chaperones, meaning they can alter the structure of the expanded repeat sequence to modulate its biological activities.
Response: We would like to thank the reviewer for her/his time for evaluating our manuscript. We are very happy to see the reviewer for highly appreciating our manuscript.
1. Overall this is a nicely done study with nice quantitation. It remains somewhat unclear from the data and discussions in exactly what way the authors mean that FUS is an RNA chaperone: is FUS changing the structure of the repeat or does FUS binding prevent it from folding into alternative in vivo structure?
Response: We appreciate the reviewer’s constructive comments. Indeed, we showed that FUS changes the higher-order structures of GGGGCC [G4C2] repeat RNA in vitro, and that FUS suppresses G4C2 RNA foci formation in vivo. According to the established definition of RNA chaperone, RNA chaperones are proteins changing the structures of misfolded RNAs without ATP use, resulting in the maintenance of proper RNAs folding (Rajkowitsich et al., 2007). Thus, we consider that FUS is classified into RNA chaperone. To clarify these interpretations, we revised the manuscript as follows.
(1) On page 10, line 215-219, the sentence “These results were in good agreement with our previous study on SCA31 showing the suppressive effects of FUS and other RBPs on RNA foci formation of UGGAA repeat RNA as RNA chaperones …” was changed to “These results were in good agreement with … RNA foci formation of UGGAA repeat RNA through altering RNA structures and preventing aggregation of misfolded repeat RNA as RNA chaperones …”.
(2) On page 17, line 363-366, the sentence “FUS directly binds to G4C2 repeat RNA and modulates its G-quadruplex structure, as evident by CD and NMR analyses (Figure 5), suggesting its functional role as an RNA chaperone.” was changed to “FUS directly binds to G4C2 repeat RNA and modulates its G-quadruplex structure as evident by CD and NMR analyses (Figure 5, Figure 5—figure supplement 2), and suppresses RNA foci formation in vivo (Figures 3A and 3B), suggesting its functional role as an RNA chaperone.”
Reply to Reviewer #2:
Fuijino et al. provide interesting data describing the RNA-binding protein, FUS, for its ability to bind the RNA produced from the hexanucleotide repeat expansion of GGGGCC (G4C2). This binding correlates with reductions in the production of toxic dipeptides and reductions in toxic phenotypes seen in (G4C2)30+ expressing Drosophila. Both FUS and G4C2 repeats of >25 are associated with ALS/FTD spectrum disorders. Thus, these data are important for increasing our understanding of potential interactions between multiple disease genes. However, further validation of some aspects of the provided data is needed, especially the expression data.
Response: We would like to thank the reviewer for her/his time for evaluating our manuscript and also for her/his important comments that helped to strengthen our manuscript.
Some points to consider when reading the work:
1. The broadly expressed GMR-GAL4 driver leads to variable tissue loss in different genotypes, potentially confounding downstream analyses dependent on viable tissue/mRNA levels.
Response: We thank the reviewer for this constructive comment. In the RT-qPCR experiments (Figures 1E, 3C, 4G, 6D and Figure 1—figure supplement 1C), the amounts of G4C2 repeat transcripts were normalized to those of gal4 transcripts expressed in the same tissue, to avoid potential confounding derived from the difference in tissue viability between genotypes, as the reviewer pointed out. To clarify this process, we have made the following change to the revised manuscript.
(1) On page 30, line 548-550, the sentence “The amounts of G4C2 repeat transcripts were normalized to those of gal4 transcripts in the same sample” was changed to “The amounts of G4C2 repeat transcripts were normalized to those of gal4 transcripts expressed in the same tissue to avoid potential confounding derived from the difference in tissue viability between genotypes”.
2. The relationship between FUS and foci formation is unclear and should be interpreted carefully.
Response: We appreciate the reviewer’s important comment. We apologize for the lack of clarity. We showed the relationship between FUS and RNA foci formation in our C9-ALS/FTD fly, that is, FUS suppresses RNA foci formation (Figures 3A and 3B), and knockdown of endogenous caz, a Drosophila homologue of FUS, enhanced it conversely (Figures 4E and 4F). We consider that FUS suppresses RNA foci formation through altering RNA structures and preventing aggregation of misfolded G4C2 repeat RNA as an RNA chaperone. To clarify these interpretations, we revised the manuscript as follows.
(1) On page 10, line 215-219, the sentence “These results were in good agreement with our previous study on SCA31 showing the suppressive effects of FUS and other RBPs on RNA foci formation of UGGAA repeat RNA as RNA chaperones …” was changed to “These results were in good agreement with … RNA foci formation of UGGAA repeat RNA through altering RNA structures and preventing aggregation of misfolded repeat RNA as RNA chaperones …”.
(2) On page 17, line 363-366, the sentence “FUS directly binds to G4C2 repeat RNA and modulates its G-quadruplex structure, as evident by CD and NMR analyses (Figure 5), suggesting its functional role as an RNA chaperone.” was changed to “FUS directly binds to G4C2 repeat RNA and modulates its G-quadruplex structure as evident by CD and NMR analyses (Figure 5, Figure 5—figure supplement 2), and suppresses RNA foci formation in vivo (Figures 3A and 3B), suggesting its functional role as an RNA chaperone.”
Reply to Reviewer #3:
In this manuscript Fujino and colleagues used C9-ALS/FTD fly models to demonstrate that FUS modulates the structure of (G4C2) repeat RNA as an RNA chaperone, and regulates RAN translation, resulting in the suppression of neurodegeneration in C9-ALS/FTD. They also confirmed that FUS preferentially binds to and modulates the G-quadruplex structure of (G4C2) repeat RNA, followed by the suppression of RAN translation. The potential significance of these findings is high since C9ORF72 repeat expansion is the most common genetic cause of ALS/FTD, especially in Caucasian populations and the DPR proteins have been considered the major cause of the neurodegenerations.
Response: We would like to thank the reviewer for her/his time for evaluating our manuscript. We are grateful to the reviewer for the insightful comments, which were very helpful for us to improve the manuscript.
1. While the effect of RBP as an RNA chaperone on (G4C2) repeat expansion is supposed to be dose-dependent according to (G4C2)n RNA expression, the first experiment of the screening for RBPs in C9-ALS/FTD flies lacks this concept. It is uncertain if the RBPs of the groups "suppression (weak)" and "no effect" were less or no ability of RNA chaperone or if the expression of the RBP was not sufficient, and if the RBPs of the group "enhancement" exacerbated the toxicity derived from (G4C2)89 RNA or the expression of the RBP was excessive. The optimal dose of any RBPs that bind to (G4C2) repeats may be able to neutralize the toxicity without the reduction of (G4C2)n RNA.
Response: We appreciate the reviewer’s constructive comments. We employed the site-directed transgenesis for the establishment of RBP fly lines, to ensure the equivalent expression levels of the inserted transgenes. We also evaluated the toxic effects of overexpressed RBPs themselves by crossbreeding with control EGFP flies, showing in Figure 1A. To clarify them, we have made the following changes to the revised manuscript.
(1) On page 8, line 166-168, the sentence “The variation in the effects of these G4C2 repeat-binding RBPs on G4C2 repeat-induced toxicity may be due to their different binding affinities to G4C2 repeat RNA, and their different roles in RNA metabolism.” was changed to “The variation in the effects of these G4C2 repeat-binding RBPs on G4C2 repeat-induced toxicity may be due to their different binding affinities to G4C2 repeat RNA, and the different toxicity of overexpressed RBPs themselves.”.
(2) On page 29, line 519-522, the sentence “By employing site-specific transgenesis using the pUASTattB vector, each transgene was inserted into the same locus of the genome, and was expected to be expressed at the equivalent levels.” was added.
2. In relation to issue 1, the rescue effect of FUS on the fly expressing (G4C2)89 (FUS-4) in Figure 4-figure supplement 1 seems weaker than the other flies expressing both FUS and (G4C2)89 in Figure 1 and Figure 1-figure supplement 2. The expression level of both FUS protein and (G4C2)89 RNA in each line is important from the viewpoint of therapeutic strategy for C9-ALS/FTD.
Response: We appreciate the reviewer’s important comment. The FUS-4 transgene is expected to be expressed at the equivalent level to the FUS-3 transgene, since they are inserted into the same locus of the genome by the site-directed transgenesis. Thus, we suppose that the weaker suppressive effect of FUS-4 coexpression on G4C2 repeat-induced eye degeneration can be attributed to the C-terminal FLAG tag that is fused to FUS protein expressed in FUS-4 fly line. Since the caz fly expresses caz protein also fused to FLAG tag at the C-terminus, we used this FUS-4 fly line to directly compare the effect of caz on G4C2 repeat-induced toxicity to that of FUS.
3. While hallmarks of C9ORF72 are the presence of DPRs and the repeat-containing RNA foci, the loss of function of C9ORF72 is also considered to somehow contribute to neurodegeneration. It is unclear if FUS reduces not only the DPRs but also the protein expression of C9ORF72 itself.
Response: We thank the reviewer for this comment. We agree that not only DPRs, but also toxic repeat RNA and the loss-of-function of C9ORF72 jointly contribute to the pathomechanisms of C9-ALS/FTD. Since Drosophila has no homolog corresponding to the human C9orf72 gene, the effect of FUS on C9orf72 expression cannot be assessed. Our fly models are useful for evaluating gain-of-toxic pathomechanisms such as RNA foci formation and RAN translation, and the association between FUS and loss-of function of C9ORF72 is beyond the scope of this study.
4. In Figure 5E-F, it cannot be distinguished whether FUS binds to GGGGCC repeats or the 5' flanking region. The same experiment should be done by using FUS-RRMmut to elucidate whether FUS binding is the major mechanism for this translational control. Authors should show that FUS binding to long GGGGCC repeats is important for RAN translation.
Response: We would like to thank the reviewer for these insightful comments. Following the reviewer’s suggestion, we perform in vitro translation assay again using FUS-RRMmut, which loses the binding ability to G4C2 repeat RNA as evident by the filter binding assay (Figure 5A), instead of BSA. The results are shown in the figures of Western blot analysis below. The addition of FUS to the translation system suppressed the expression levels of GA-Myc efficiently, whereas that of FUS-RRMmut did not. FUS decreased the expression level of GA-Myc at as low as 10nM, and nearly eliminated RAN translation activity at 100nM. At 400nM, FUS-RRMmut weakly suppressed the GA-Myc expression levels probably because of the residual RNA-binding activity. These results suggest that FUS suppresses RAN translation in vitro through direct interactions with G4C2 repeat RNA.
Unfortunately, RAN translation from short G4C2 repeat RNA was not investigated in our translation system, although the previous study reported the low efficacy of RAN translation from short G4C2 repeat RNA (Green et al., 2017).
Author response image 1.
(A) Western blot analysis of the GA-Myc protein in the samples from in vitro translation.
(B) Quantification of the GA-Myc protein levels.
We have made the following changes to the revised manuscript.
(1) Figure 5F was replaced to new Figures 5F and 5G.
(2) On page 14-15, line 326-330, the sentence “Notably, the addition of FUS to this system decreased the expression level of GA-Myc in a dose-dependent manner, whereas the addition of the control bovine serum albumin (BSA) did not (Figure 5F).” was changed to “Notably, upon the addition to this translation system, FUS suppressed RAN translation efficiently, whereas FUS-RRMmut did not. FUS decreased the expression levels of GA-Myc at as low as 10nM, and nearly eliminated RAN translation activity at 100nM. At 400nM, FUS-RRMmut weakly suppressed the GA-Myc expression levels probably because of the residual RNA-binding activity (Figure 5F and 5G).”.
(3) On page 15, line 330-332, the sentence “Taken together, these results indicate that FUS suppresses RAN translation from G4C2 repeat RNA in vitro as an RNA chaperone.” was changed to “Taken together, these results indicate that FUS suppresses RAN translation in vitro through direct interactions with G4C2 repeat RNA as an RNA chaperone.”.
(4) On page 37, line 720-723, the sentence “For preparation of the FUS protein, the human FUS (WT) gene flanked at the 5¢ end with an Nde_I recognition site and at the 3¢ end with a _Xho_I recognition site was amplified by PCR from pUAST-_FUS.” was changed to “For preparation of the FUS proteins, the human FUS (WT) and FUS-RRMmut genes flanked at the 5¢ end with an Nde_I recognition site and at the 3¢ end with a _Xho_I recognition site was amplified by PCR from pUAST-_FUS and pUAST- FUS-RRMmut, respectively.”.
(5) On page 41, line 816-819, the sentence “FUS or BSA at each concentration (10, 100, and 1,000 nM) was added for translation in the lysate.” was changed to “FUS or FUS-RRMmut at each concentration (10, 100, 200, 400, and 1,000 nM) was preincubated with mRNA for 10 min to facilitate the interaction between FUS protein and G4C2 repeat RNA, and added for translation in the lysate.”.
5. It is not possible to conclude, as the authors have, that G-quadruplex-targeting RBPs are generally important for RAN translation (Figure 6), without showing whether RBPs that do not affect (G4C2)89 RNA levels lead to decreased DPR protein level or RNA foci.
Response: We appreciate the reviewer’s critical comment. Following the suggestion by the reviewer, we evaluate the effect of these G-quadruplex-targeting RBPs on RAN translation. We additionally performed immunohistochemistry of the eye imaginal discs of fly larvae expressing (G4C2)89 and these G-quadruplex-targeting RBPs. As shown in the figures of immunohistochemistry below, we found that coexpression of EWSR1, DDX3X, DDX5, and DDX17 significantly decreased the number of poly(GA) aggregates. The results suggest that these G-quadruplex-targeting RBPs regulate RAN translation as well as FUS.
Author response image 2.
(A) Immunohistochemistry of poly(GA) in the eye imaginal discs of fly larvae expressing (G4C2)89 and the indicated G-quadruplex-targeting RBPs.
(B) Quantification of the number of poly(GA) aggregates.
We have made the following changes to the revised manuscript.
(1) Figures 6E and 6F were added.
(2) On page 6-7, line 135-137, the sentence “In addition, other G-quadruplex-targeting RBPs also suppressed G4C2 repeat-induced toxicity in our C9-ALS/FTD flies.” was changed to “In addition, other G-quadruplex-targeting RBPs also suppressed RAN translation and G4C2 repeat-induced toxicity in our C9-ALS/FTD flies.”.
(3) On page 15, line 344-346, the sentence “As expected, these RBPs also decreased the number of poly(GA) aggregates in the eye imaginal discs (Figures 6E and 6F).” was added.
(4) On page 15, line 346-347, the sentence “Their effects on G4C2 repeat-induced toxicity and repeat RNA expression were consistent with those of FUS.” was changed to “Their effects on G4C2 repeat-induced toxicity, repeat RNA expression, and RAN translation were consistent with those of FUS.”
(5) On page 16, line 355-357, the sentence “Thus, some G-quadruplex-targeting RBPs regulate G4C2 repeat-induced toxicity by binding to and possibly by modulating the G-quadruplex structure of G4C2 repeat RNA.” was changed to “Thus, some G-quadruplex-targeting RBPs regulate RAN translation and G4C2 repeat-induced toxicity by binding to and possibly by modulating the G-quadruplex structure of G4C2 repeat RNA.”
(6) On page 19, line 417-421, the sentence “We further found that G-quadruplex-targeting RNA helicases, including DDX3X, DDX5, and DDX17, which are known to bind to G4C2 repeat RNA (Cooper-Knock et al., 2014; Haeusler et al., 2014; Mori et al., 2013a; Xu et al., 2013), also alleviate G4C2 repeat-induced toxicity without altering the expression levels of G4C2 repeat RNA in our Drosophila models.” was changed to “We further found that G-quadruplex-targeting RNA helicases, … ,also suppress RAN translation and G4C2 repeat-induced toxicity without altering the expression levels of G4C2 repeat RNA in our Drosophila models.”.
Reply to Recommendations For The Authors:
1) It is not clear from the start that the flies they generated with the repeat have an artificial vs human intronic sequence ahead of the repeat. It would be nice if they presented somewhere the entire sequence of the insert. The reason being that it seems they also tested flies with the human intronic sequence, and the effect may not be as strong (line 234). In any case, in the future, with a new understanding of RAN translation, it would be nice to compare different transgenes, and so as much transparency as possible would be helpful regarding sequences. Can they include these data?
Response: We thank the editors and reviewers for this comment. We apologize for the lack of clarity. We used artificially synthesized G4C2 repeat sequences when generating constructs for (G4C2)n transgenic flies, so these constructs do not contain human intronic sequence ahead of the G4C2 repeat in the C9orf72 gene, as explained in the Materials and Methods section. To clarify the difference between our C9-ALS/FTD fly models and LDS-(G4C2)44GR-GFP fly model (Goodman et al., 2019), we have made the following change to the revised manuscript.
(1) Schema of the LDS-(G4C2)44GR-GFP construct was presented in Figure 3—figure supplement 1.
Furthermore, to maintain transparency of the study, we have provided the entire sequence of the insert as the following source file.
(2) The artificial sequences inserted in the pUAST vector for generation of the (G4C2)n flies were presented in Figure 1—figure supplement 1—source data 1.
2) It is really nice how they quantitated everything and showed individual data points.
Response: We thank the editors and reviewers for appreciating our data analysis method. All individual data points and statistical analyses are summarized in source data files.
3) So when they call FUS an RNA chaperone, are they simply meaning it is changing the structure of the repeat, or could it just be interacting with the repeat to coat the repeat and prevent it from folding into whatever in vivo structures? Can they speculate on why some RNA chaperones lead to presumed decay of the repeat and others do not? Can they discuss these points in the discussion? Detailed mechanistic understanding of RNA chaperones that ultimately promote decay of the repeat might be of highly significant therapeutic benefit.
Response: We appreciate these critical comments. Indeed, we showed that FUS changes the higher-order structures of G4C2 repeat RNA in vitro, and that FUS suppresses G4C2 RNA foci formation. According to the established definition of RNA chaperone, RNA chaperones are proteins changing the structures of misfolded RNAs without ATP use, resulting in the maintenance of proper RNAs folding (Rajkowitsich et al., 2007). Thus, we consider that FUS is classified into RNA chaperone. To clarify these interpretations, we revised the manuscript as follows.
(1) On page 10, line 215-219, the sentence “These results were in good agreement with our previous study on SCA31 showing the suppressive effects of FUS and other RBPs on RNA foci formation of UGGAA repeat RNA as RNA chaperones …” was changed to “These results were in good agreement with … RNA foci formation of UGGAA repeat RNA through altering RNA structures and preventing aggregation of misfolded repeat RNA as RNA chaperones …”.
(2) On page 17, line 363-366, the sentence “FUS directly binds to G4C2 repeat RNA and modulates its G-quadruplex structure, as evident by CD and NMR analyses (Figure 5), suggesting its functional role as an RNA chaperone.” was changed to “FUS directly binds to G4C2 repeat RNA and modulates its G-quadruplex structure as evident by CD and NMR analyses (Figure 5, Figure 5—figure supplement 2), and suppresses RNA foci formation in vivo (Figures 3A and 3B), suggesting its functional role as an RNA chaperone.”
Besides these RNA chaperones, we observed the expression of IGF2BP1, hnRNPA2B1, DHX9, and DHX36 decreased G4C2 repeat RNA expression levels. In addition, we recently reported that hnRNPA3 reduces G4C2 repeat RNA expression levels, leading to the suppression of neurodegeneration in C9-ALS/FTD fly models (Taminato et al., 2023). We speculate these RBPs could be involved in RNA decay pathways as components of the P-body or interactors with the RNA deadenylation machinery (Tran et al., 2004; Katahira et al., 2008; Geissler et al., 2016; Hubstenberger et al., 2017), possibly contributing to the reduced expression levels of G4C2 repeat RNA. To clarify these interpretations, we revised the manuscript as follows.
(3) On page 18, line 392-398, the sentences “Similarly, we recently reported that hnRNPA3 reduces G4C2 repeat RNA expression levels, leading to the suppression of neurodegeneration in C9-ALS/FTD fly models (Taminato et al., 2023). Interestingly, these RBPs have been reported to be involved in RNA decay pathways as components of the P-body or interactors with the RNA deadenylation machinery (Tran et al., 2004; Katahira et al., 2008; Geissler et al., 2016; Hubstenberger et al., 2017), possibly contributing to the reduced expression levels of G4C2 repeat RNA.” was added.
4) What is the level of the G4C2 repeat when they knock down caz? Is it possible that knockdown impacts the expression level of the repeat? Can they show this (or did they and I miss it)?
Response: We thank the editors and reviewers for this comment. The expression levels of G4C2 repeat RNA in (G4C2)89 flies were not altered by the knockdown of caz, as shown in Figure 4G.
5) A puzzling point is that FUS is supposed to be nuclear, so where is FUS in the brain in their lines? They suggest it modulates RAN translation, and presumably, that is in the cytoplasm. Is FUS when overexpressed now in part in the cytoplasm? Is the repeat dragging it into the cytoplasm? Can they address this in the discussion? If FUS is never found in vivo in the cytoplasm, then it raises the point that the impact they find of FUS on RAN translation might not reflect an in vivo situation with normal levels of FUS.
Response: We appreciate these important comments. We agree with the editors and reviewers that FUS is mainly localized in the nucleus. However, FUS is known as a nucleocytoplasmic shuttling RBP that can transport RNA into the cytoplasm. Indeed, FUS is reported to facilitate transport of actin-stabilizing protein mRNAs to function in the cytoplasm (Fujii et al., 2005). Thus, we consider that FUS binds to G4C2 repeat RNA in the cytoplasm and suppresses RAN translation in this study.
6) When they are using 2 copies of the driver and repeat, are they also using 2 copies of FUS? These are quite high levels of transgenes.
Response: We thank the editors and reviewers for this comment. We used only 1 copy of FUS when using 2 copies of GMR-Gal4 driver. Full genotypes of the fly lines used in all experiments are described in Supplementary file 1.
7) In Figure5-S1, FUS colocalizing with (G4C2)RNA is not clear. High-magnification images are recommended.
Response: We appreciate this constructive comment on the figure. Following the suggestion, high-magnification images are added in Figure 5—figure supplement 1.
8) I also suggest that the last sentence of the Discussion be revised as follows: Thus, our findings contribute not only to the elucidation of C9-ALS/FTD, but also to the elucidation of the repeat-associated pathogenic mechanisms underlying a broader range of neurodegenerative and neuropsychiatric disorders than previously thought, and it will advance the development of potential therapies for these diseases.
Response: We appreciate this recommendation. We have made the following change based on the suggested sentence.
(1) On page 20-21, line 455-459, “Thus, our findings contribute not only towards the elucidation of repeat-associated pathogenic mechanisms underlying a wider range of neuropsychiatric diseases than previously thought, but also towards the development of potential therapies for these diseases.” was changed to “Thus, our findings contribute to the elucidation of the repeat-associated pathogenic mechanisms underlying not only C9-ALS/FTD, but also a broader range of neuromuscular and neuropsychiatric diseases than previously thought, and will advance the development of potential therapies for these diseases.”.
Authors’ comment on previous eLife assessment:
We thank the editors and reviewers for appreciating our study. We mainly evaluated the function of human FUS protein on RAN translation and G4C2 repeat-induced toxicity using Drosophila expressing human FUS in vivo, and the recombinant human FUS protein in vitro. To validate that FUS functions as an endogenous regulator of RAN translation, we additionally evaluated the function of Drosophila caz protein as well. We are afraid that the first sentence of the eLife assessment, that is, “This important study demonstrates that the Drosophila FUS protein, the human homolog of which is implicated in amyotrophic lateral sclerosis (ALS) and related conditions, …” is somewhat misleading. We would be happy if you modify this sentence like “This important study demonstrates that the human FUS protein, which is implicated in amyotrophic lateral sclerosis (ALS) and related conditions, …”.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
The following is the authors' response to the original reviews.
Reviewer #1 (Recommendations For The Authors):
This is a list of suggestions the authors could use to improve the details of the manuscript:<br /> - it is not immediately clear what is meant by "modular" on line 38 and the corresponding paragraph. This aspect is not mentioned or developed in the Results.<br /> - the discussion of remapping vectors on lines 119-137 is particularly illuminating. It could have been interesting to generate surrogate manifolds separated by arbitrary remapping vectors and see how much the alignment metric (Procrustes shape) is sensitive to the dimensionality or amplitude of remapping vectors.<br /> - A visual comparison between Fig 1 D and H suggests a difference between the manifold geometry in experiments and in the model. It seems that the embedding dimensionality of ring manifolds is higher in the data than in the model. Is that the case? It could have been interesting to explore how much embedding dimensionality influences the alignment metric.<br /> - I could not find information about the initialization of the connectivity weights. An important possibility is that the degree of alignment (and the organization of remapping vectors) depends on the strength of initial random connectivity.<br /> - It might have been interesting to comment on the relationship between the top three PCS in Fig1 and the three readout vectors. To which extent are they aligned?<br /> - I found panels C and G in Fig 1 somewhat difficult to read. In panel C, the remapping seems to be aligned to the same position across all trials. This is not the case in panel G. I am not certain what the comparison is meant to convey, but it would help to have a similar alignment in C and G. Similarly, I was not sure what to conclude from the matrix in the right part of panel C, perhaps the legend should be expanded.<br /> - the comparison with remapping models of Misha Tsodyks could be expanded. The current discussion implies that the model of Romani & Tsodyks leads to less alignment than found in trained networks, but no direct evidence is given for that statement as far as I can tell.
Reviewer #2 (Recommendations For The Authors):
Minor points:
All mentions of 'modularity' should be replaced with 'compositionality'.
I found Supplementary Figure 2 highly confusing. I thought it was meant to help understand the analysis in Figure 1K and related figures. In the end, I never really understood what was happening in these figures. Do authors make perturbations along these different coding dimensions and compare the resulting maps? I wasn't sure what exactly the authors were calculating cosine similarity for. Maybe more exposition on this in the methods would help other readers as well.
Was there any behavioral difference when the maps were not aligned?
Why did the authors only go up to 10 contexts? Was this dependent on size of the network? Sorry if I missed this.
Are remapping event aligned to unit axes? Would this change with different nonlinearities? This could be interesting in the context of (Driscoll et all 2022) and (Wittington et al 2022).
Reviewer #3 (Recommendations For The Authors):
Cueva, Ardalan, et al. 2021 arXiv:2111.01275 showed that RNNs trained to remember two circular variables develop a toroidal geometry to store this information, so consider citing this in your section on the toroidal manifolds.
We thank the reviewers for their thoughtful comments. We appreciate that all three reviewers affirmed the importance of our work and the rigor of our approach. We believe that no major weaknesses were identified by the reviews. In our view, the comparisons between recurrent neural network models and experimental data are one of the most important contributions of our work, and all reviewers agreed that this was a core strength of the manuscript.
The reviewers highlighted several future modeling directions that are raised by our results and that we did not explore in the manuscript. For example, Reviewer 2 suggests that we train networks on a navigation task alone, freeze the weights, and then train on a context discrimination task. We agree that this kind of contextual learning paradigm is of interest and could provide insight into biological remapping, such as that observed by Low et al. (2021). We also agree with Reviewer 3’s broader point that “There are many choices that must be made when simulating RNNs and there is a growing awareness that these choices can influence the kinds of solutions RNNs develop.” It is notable that we were able to reproduce the qualitative features of the experimental data without finely tuning hyperparameters (we used default settings in PyTorch layers), using a very basic training protocol (gradient descent with gradient clipping), and without adding any hand crafted regularization (though we agree that regularization could make the RNN solution look even more like the data).
We believe that readers will benefit from reading the reviewers' suggestions, which are insightful and well-motivated. Having weighed the reviewer comments carefully, we feel that our manuscript stands as a complete scientific story. We hope that the public reviewer comments will inspire future investigations to fully explore these possibilities and unpack their outcomes at a level of detail that would not be possible in the context of our manuscript.
Thus, we have chosen to implement the following minor changes suggested by the reviewers, which we hope will improve the clarity of the text and figures (summarized below). These changes do not alter the fundamental content of the manuscript.
Text:
-
We corrected a few minor typos.
-
We updated the citations to follow the eLife citation style.
-
To address comments from Reviewers 1 and 2: we reworded the final paragraph of the Introduction (p. 3) to remove the term “modularity” and clarify our main finding. Those sentences now read, “The RNN geometry and algorithmic principles readily generalized from a simple task to more complex settings. Furthermore, we performed a new analysis of experimental data published in Low et al.26 and found a similar geometric structure in neural activity from a subset of sessions with more than two stable spatial maps.”
-
To address comments from Reviewer 1: in the first paragraph of the Results section A recurrent neural network model of 1D navigation and context inference remaps between aligned ring manifolds (p. 3), we added the sentence, “Remapping was not aligned to particular track positions, rewards, or landmarks.” to clarify that experimental result from Low et al. (2021).
-
To address comments from Reviewer 3: in the final paragraph of the Results section Aligned toroidal manifolds emerge in a 2D generalization of the task (p. 11) we clarified that models were trained “to estimate position on a 2D circular track.” We also added a citation to Cueva, Ardalan et al. (2021) with the following sentence, “Notably, each toroidal manifold alone is reminiscent of networks trained to store two circular variables without remapping.”
-
To address a question from Reviewer 2: in the final paragraph of the Results section Manifold alignment generalizes to three or more maps (p. 13), we added the following clarification: “In Supplemental Figure 3, we show that RNNs are capable of solving this task with larger numbers of latent states (more than three; for simplicity, we consider up to 10 states).”
-
To address a comment from Reviewer 1: in the fourth paragraph of the Discussion (p. 17), we removed the sentence, “Notably, our model captured aspects of the data that these previous forward-engineered models did not explore—namely, that the ring manifolds corresponding to the correlated spatial maps were much more aligned than expected by chance and than strictly required by the task.” to focus on the key point in the following sentence that, “forward-engineered models provide insights into how neural circuits may remap, but do not answer why they do so.”
-
To address comments from Reviewers 1 and 2: we reworded the penultimate paragraph of the Discussion (p. 17–18) to clarify our findings and remove the term “modularity” (except when referencing papers that themselves use that term (Driscoll et al., 2022; Yang et al., 2019)). Those sentences now read:
“When RNN architecture is explicitly designed to include dedicated neural subpopulations, these subpopulations can improve model performance on particular types of tasks (Beiran et al., 2021; Dubreuil et al., 2022). Thus, there is an emerging conclusion that RNNs use simple dynamical motifs as building blocks for more general and complex computations, which our results support. In particular, aligned ring attractors are a recurring, dynamical motif in our results, appearing first in a simple task setting (2 maps of a 1D environment) and subsequently as a component of RNN dynamics in more complex settings (e.g., as sub-manifolds of toroidal attractors in a 2D environment, see Figure 4). We can therefore conceptualize a pair of aligned ring manifolds as a dynamical “building block” that RNNs utilize to solve higher-dimensional generalizations of the task. Intriguingly, our novel analysis of neural data from Low et al. (2021) revealed that similar principles may hold in biological circuits—when three or more spatial maps were present in a recording, the pairs of ring manifolds tended to be aligned.”
-
To address questions from Reviewers 2 and 3: in the first paragraph of the Methods section RNN Model and Training Procedure (p. 21), we added the sentence: “The connection weights were randomly initialized from the uniform distribution 𝑈(−√1/N, √1/N), which is the default initialization scheme in PyTorch.”
-
To address a question from Reviewer 2: we added a third paragraph to the Methods section Manifold Geometry Analysis (p. 23), as follows:
“In Figure 1K, 4G, 5G, and Supplementary Figure 2B, we calculate the angles between the input and output weights and the position subspace or remapping dimension. To find this angle, we calculated the cosine similarity between each weight vector and each subspace. Cosine similarity of 0 indicates that the weights were orthogonal to the subspace, while a similarity of 1 indicates that the weight vector was contained within the subspace.”
- To address a question from Reviewer 1: we added the following sentence to the second paragraph of the Methods section Experimental Data (p. 24), “We performed the same analysis of trial-by-trial spatial stability to obtain the similarity matrices in Figure 1C and G.”
Figures and legends:
-
To address a question from Reviewer 1: in Figure 1C and G, we added x-axis labels to the similarity matrices to clarify that these are trial-by-trial correlations.
-
To address a question from Reviewer 1: we expanded the Figure 1C legend to clarify the experimental results as follows:
Old legend:
(C, left) An example medial entorhinal cortex neuron switches between two maps of the same track (top, raster; bottom, average firing rate by position; red, map 1; black, map 2). (C, right/top) Network-wide trial-by-trial correlations for the spatial firing pattern of all co-recorded neurons in the same example session (colorbar indicates correlation). (C, right/bottom) k-means map assignment.
New legend:
(C, left) An example medial entorhinal cortex neuron switches between two maps of the same track (top, spikes by trial and track position; bottom, average firing rate by position across trials from each map; red, map 1; black, map 2). (C, right/top) Correlation between the spatial firing patterns of all co-recorded neurons for each pair of trials in the same example session (dark gray, high correlation; light gray, low correlation). The population-wide activity is alternating between two stable maps across blocks of trials. (C, right/bottom) K-means clustering of spatial firing patterns results in a map assignment for each trial.
-
To address comments from Reviewer 3: in the legend of Figure 4C, we added the sentence “Note that the true tori are not linearly embeddable in 3 dimensions, so this projection is an approximation of the true torus structure.”
-
To address a question from Reviewer 2: we expanded the legend for Supplementary Figure 2 to clarify the purpose of the figure schematics as follows:
Old legend:
(A) Schematic showing the orthogonalization of the position and context input and output weights.
(B) Reproduced from Figure 1K.
(C-D) Schematic: How a single velocity input (blue arrows) updates the position estimate (yellow to red points) from the starting position (blue points).
(C) Velocity input lies in the position tuning subspace (gray plane)(hypothetical). Note that the same velocity input results in different final positions.
(D) Velocity input is orthogonal to the position tuning subspace (observed).
(E) Schematic of possible flow fields in each of the three planes (numbers correspond to planes in C and D), which would result in the correct positional estimate given orthogonal velocity inputs at different positions (D).
New legend:
(A) Schematic showing the relative orientation of the position output weights and the context input and output weights to the position and state tuning subspaces.
(B) Reproduced from Figure 1K.
(C-D) Schematic to interpret why the position input weights are orthogonal to the position tuning subspace. These schematics illustrate how a single velocity input (blue arrows) updates the position estimate (yellow to red points) from a given starting position (blue points).
(C, not observed) Velocity input lies in the position tuning subspace (gray plane). Note that the same velocity input pushes the network clockwise or counterclockwise along the ring depending on the circular position
(D, observed) Velocity input is orthogonal to the position tuning subspace and pushes neural activity out of the subspace.
(E) Schematic of possible flow fields in each of three planes (numbers correspond to planes in C and D). We conjecture that these dynamics would enable a given orthogonal velocity input to nonlinearly update the position estimate, resulting in the correct translation around the ring regardless of starting position (as in D).
-
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
The following is the authors' response to the original reviews.
We thank both reviewers for their comments, which have suggested changes that have improved the manuscript.
Reviewer #1 (Public Review):
[…] A weakness in the methodology is the link to tissue tension and conclusions about tissue mechanics. Methods that directly affect tissue tension and a more thorough and systematic application of laser ablation experiments would be needed to profoundly investigate mechanosensation and consequential effects on tissue tension by the various genetic perturbations.
Response: In revision, we have added some additional experiments that examine altered tension.
While the in-silico analysis of competing for F-actin binding sites for βH-Spec and myosin appears logical and supports the authors' claims, no point mutation or truncations were used to test these results in vivo.
In its current structure the manuscript's strength, the genetic perturbations, is compromised by missing clear assessments of knockdown efficiencies early in the manuscript and other controls such as the actual effect on myosin by ROCK overactivation.
Response: In revision, we reorganized the manuscript and figures to document the knockdown efficiency earlier in the manuscript, and have added additional figure panels illustrating the effects of altered tension on myosin levels.
Reviewer #2 (Public Review):
[…] The authors suggest that Ajuba is required for the effect of beta-heavy spectrin. However, it is still formally possible that this could be a parallel pathway that is being masked by the strong phenotype of Ajuba RNAi flies.
Response: While it is formally true that the genetic requirement for Jub could reflect a role in parallel to, rather than downstream of, spectrins, our conclusion that spectrins act through Jub is based not only on the genetic requirement for Jub, but also on the influence of spectrins on junctional tension and Jub localization, which indicate that spectrins influence Jub activity in a manner consistent with their affecting the Hippo pathway through Jub.
One of the major points of the manuscript is the observation that alpha- and beta-heavy-spectrin are potentially working independently and not as part of a spectrin tetramer. This is mostly dependent on the observation that alpha- and beta-heavy-spectrin appear to have non-overlapping localizations at the membrane and the fact that alpha- and beta-heavy-spectrin localize at the membrane seemingly independently. It is not entirely obvious that a potential lack of colocalization and the fact that protein localization at the membrane is not affected when the other partner is absent is sufficient to argue that alpha- and beta-heavy-spectrin do not form a complex. Moreover, it is possible that the spectrin complexes are only formed in specific conditions (e.g. by modulating tissue tension).
Response: Our results argue that alpha- and beta-heavy-spectrin do not form a detectable complex in the wing disc under the conditions examined, and thus that they act independently is this context. However, we agree that it is possible that they could function together contexts, eg in other tissues or under different conditions, and we have revised the text in the Discussion to note this.
If indeed spectrins function independently, would it not be expected to see additive effects when both spectrins are depleted?
Response: Not necessarily, since both alpha- and beta-heavy-spectrin act through Jub, and there may be a limit as to how much Yki activity can be increased by Jub (eg the increases in wing size induced by spectrin RNAi are similar to the increases in wing size observed with constitutive recruitment of Jub through alpha-catenin mutation (Alegot et al 2019).
Related to the two previous points, the fact that the authors suggest that both alpha- and beta-heavy-spectrin regulate Hippo signaling via Ajuba would be consistent with the necessity of an alpha- and beta-heavy-spectrin complex being formed. How would the authors explain that both spectrins require Ajuba function but work independently?
Response: The different spectrins both affect Jub because they both affect cytoskeletal tension, but our results suggest that they act in different ways to affect tension. We have made some revisions to the Discussion section to try to make this clearer.
Another major point of the manuscript is the potential competition between beta-heavy-spectrin and myosin for F-actin binding. The authors suggest that there is a mutual antagonism between the two proteins regarding apical F-actin. However, this has not been formally assessed. Moreover, despite the arguments put forward in the discussion, it seems hard to justify a competition for F-actin when beta-heavy-spectrin seems to be unable to compete with myosin. Myosin can displace beta-heavy-spectrin from F-actin but the reciprocal effect seems unlikely given the in vitro data.
Response: We show in vivo, in vitro, and in silico data that are all consistent with the inference that beta-heavy-spectrin and myosin compete for binding to F-actin. As the reviewer notes, and as we discuss, the in vitro competition experiments were limited because, for technical reason, we were unable to increase the protein concentrations higher. We also note that our in vitro experiments used an active form of myosin, which binds F-actin much more strongly than inactive myosin.
Reviewer #1 (Recommendations For The Authors): <br /> While the flow of experiments is logical in general, I see major problems regarding the structure of the manuscript and essential controls:
• It is very confusing to have samples (kst-CRISPRa) in figures 1-3 that were not introduced in the text until the second-last paragraph of the results. I would suggest introducing this elegant overexpression experiment early in the manuscript as it fits well in the scope of these experiments or alternatively (if the authors prefer) make a new figure containing all the data regarding the overexpression in the end.
Response: We have now moved these results to a new figure (new Fig 7) that is described later in the text.
• At the beginning of the manuscript, essential controls regarding the knockdown efficiency are missing in the main figure. Many of the key experiments are based on KD and as a reader, I want to assess their efficiency. Only in Figure 4, at the end of the manuscript, KST and α-Spec KD efficiency is revealed - this should be shown earlier and quantified properly. While reading the manuscript in its current form, the doubt remains that differences e.g. in α-Spec and KST KD can be explained by varying knockdown efficiencies as their levels can't be assessed.
Response: We have now moved these results to a new supplemental figure (Fig 1-supplement 1) that is cited earlier in the text.
• On a similar line, in Figure 5 where myosin activity is perturbed, induction or repression of myosin activity is only suggested but not formally shown. The authors have to demonstrate that this is indeed the case by showing the myosin signal, ideally accompanied by measurement of tissue tension.
Response: This was not included because we and others have assessed these manipulations in earlier publications. However, as requested we have now added a supplemental figure (Fig 6 supplement 1) showing myosin levels in these genotypes.
• On p. 7, the authors claim that "The epistasis of jub to kst suggests that βH-Spec regulates wing size through its tension-dependent regulation of Jub." While the authors show that KST KD increases myosin and junctional Jub, and that the wing overgrowth phenotype of KST KD depends on Jub, the tension-dependency was not demonstrated. To make that claim, the tension profile should be perturbed e.g. by overexpression of rok, myosin mutants (as the authors do in Fig 5) and the effect on Jub should be analyzed. Induction of tension in these conditions should be measured by laser ablation or a suitable alternative method. It might well be that the induction of Jub in KST KD is not via tension but an alternative mechanism such as the release of steric hindrance, interaction competition, etc. Also: Does KD of Jub affect spectrin localization?
Response: The effect of tension on Jub, and the effects of the myosin activity changes we employed on tension, have been analyzed in prior publications (eg Rauskolb et al 2014). To further address the issue raised by the reviewer here as to whether Kst affects Jub and wing growth via tension, we have also now added an additional experiment (Fig 3 supplement 1) in which we decreased tension in a βH-Spec RNAi wing disc by simultaneously expressing RNAi targeting Rok. The results show that the wing growth and Jub accumulation associated with βH-Spec RNAi are suppressed by Rok RNAi, consistent with our conclusion that these effects are mediated via cytoskeletal tension.
As KD of Jub alters the pattern of myosin accumulation in wing discs (Rauskolb et al 2019) it could be expected to have a complementary influence on βH-Spec localization, but we have not examined this.
• The authors make a very strong point in saying "The influence of βH-Spec on junctional tension is thus a direct consequence of its competition with myosin for overlapping binding sites on F-actin." While the authors provide some in vitro and in silico evidence, it was for example not possible to outcompete myosin by increasing levels of KST CH1-CH2 domains in vitro (for possible reasons the authors discuss). More importantly, the hypothesis that competition for actin binding is the definite cause of the antagonizing effect was not tested in vivo. Overexpression of a mutant version of KST that is unable to bind F-actin, or that has an increased affinity (etc) for actin was not tested. Such an experiment would be very valuable to enrich this manuscript but at least, claims like that have to be less bold and need to be written in a more speculative language.
Response: We consider creating and analyzing mutant forms of Kst in vivo to be beyond the scope of this manuscript, but as suggested we have now modified the text highlighted by the Reviewer to be more cautious.
Further points:
• Why does the thickness of the wing disc epithelium change due to KST and α Spec KD, the authors should introduce this experiment better and draw a proper conclusion. Is there any relocalization of myosin along the apical-basal axis? Can the authors speculate about the differences between KST and α Spec KD?
Response: The epithelium thickness changes with α-Spec KD, but does not change with Kst KD. We think the explanation is provided by work from the Pan lab (done mainly in pupal eyes), which reported decreased cortical tension and increased apical area when α-Spec is lost. The interpretation in essence is that with the loss of attachment of F-actin to membranes along the lateral sides of the cells, the sides of the cells are "softer" and the cells expand laterally and thus also (by conservation of volume) shorten apical-basally. This is somewhat speculative, and it's not a focus of our study, but we have added some text to try to explain this better. Myosin along apical-basal axis was not visibly altered, but it is harder to analyze as it is very weak compared to junctional myosin.
• Given the authors' observation of differences in the relative localization of KST and α Spec (Figure 4), proper quantification of KST, α Spec and myosin levels along the apical-basal cell axis would be important. This would also ease data interpretation.
Response: We have now added a higher resolution image and also a line scan of Kst, α-Spec and Myo in a new supplemental figure (Fig 6 supplement 1)
• KD of α Spec seems to induce myosin activity more, causes a bigger reduction of wing thickness, a stronger induction of Jub, and a similar effect on wing size. What lead the authors to focus on KST rather than α Spec regarding the detailed analysis of myosin competition?
Response: Our observations identify a competition between Kst and myosin, but we have no indication that α-Spec competes with myosin. (It's conceivable that β-Spec might also compete with myosin in some contexts, but wing discs would not be a good place to examine this because the localization profiles of β-Spec and Myosin are so different).
• A big criticism regarding the figures is the bad color choice which makes it difficult to decipher the fluorescent signals. Likewise, the labels are difficult to read with the present coloring. They should really be changed.
Response: We have now changed the single color images to gray scale (for multi-color images we retain RGB coloring).
A minor point:
• To make the manuscript more accessible for researchers outside the Drosophila field, I'd suggest adding explanatory labels for Drosophila-specific terms such as hyperactive myosin for sqhEE, a scheme to show where UAS-dcr2 is active, explain the purpose of Rfp expression as a control for tissue specificity, etc.
Response: We have added some explanations to the text to try to make this clearer.
Reviewer #2 (Recommendations For The Authors): <br /> Major points:
In lines 99-101, the authors mention that Deng et al., 2015 report that the depletion of spectrins leads to an increase in pMLC, with no associated changes in the colocalization of myosin and F-actin. It is more accurate to mention that Deng et al. suggest that the levels of a GFP-tagged rescue construct of MLC (Sqh) are unchanged in alpha-spectrin mutants, although this was not formally quantified. Moreover, there was not a formal assessment of colocalization between MLC and F-actin, but rather a suggestion that F-actin levels are unaffected by the alpha-spectrin mutation. Finally, Deng et al. mostly analyzed alpha-spectrin so it remains possible that the new results shown by the authors are compatible with the initial observations from Deng and colleagues.
Response: As suggested, we revised the text to note that Deng et al., 2015 specifically examined Sqh:GFP. While we agree that our focus is more on Kst and Deng et al focused on α-Spec, we also examined α-Spec, and as described our results examining Myosin and Jub differ from what was reported by Deng et al 2015.
As mentioned above, it is still possible that spectrins and Ajuba are working in parallel and Ajuba is not necessarily downstream of spectrins. The strong phenotype of Ajuba RNAi flies in adult wings could mask the effect of spectrins. Are the results similar in other settings, such as in the absence of Dicer2? Also, can Ajuba RNAi phenotypes be modified by overexpression of spectrins? This would provide further evidence of a link to Ajuba function.
Response: While formally it is true that the genetic requirement for Jub could reflect a role in parallel to, rather than downstream of, spectrins, our conclusion that spectrins act through Jub is based not only on the genetic requirement for Jub, but also on the influence of spectrins on junctional tension and Jub localization, which indicate that spectrins influence Jub activity in a manner consistent with their affecting the Hippo pathway through Jub.
We would not expect over-expression of spectrins in a jub RNAi background to further reduce Hippo signaling, and as the jub RNAi phenotype is much stronger than the Kst over-expression phenotype even if there were an effect it would likely be difficult to detect.
Regarding the potential independent functions of spectrins, it would be interesting to determine if alpha- and beta-heavy-spectrin can still interact at the level of the AJ despite the fact that their distributions appear to be partly non-overlapping. Would it be possible to assess this using PLA? If an interaction is not detected via PLA, it would be more convincing that spectrins are functioning independently.
Response: We have now performed this experiment, and no significant signal was detected by PLA. As a control, we used identical antibodies (GFP and α-Spec) to conduct PLA on α-Spec and β-Spec, and we did detect signal by PLA. These results (included in a revised Figure 4) further support the conclusion that α-Spec and βH-Spec are not physically associated in wing discs.
Related to this point, if the spectrins work independently, it is reasonable to assume that they could display additive effects. Is this the case? If alpha- and beta-heavy-spectrin are simultaneously depleted are the phenotypes more severe than either depletion alone?
Response: We disagree here. Since both alpha- and beta-heavy-spectrin act through tension and Jub, and there is likely a limit as to how much Yki activity can be increased by this pathway. For example, the increases in wing size induced by spectrin RNAi are similar to the increases in wing size observed with constitutive recruitment of Jub through alpha-catenin mutation (Alegot et al 2019), which may thus represent the maximum increase that can be induced through this pathway (as there are multiple, independent factors that regulate Hippo signaling).
Authors should modulate membrane tension and assess if this affects the localization of alpha- and beta-heavy-spectrin and, specifically, their colocalization, as their interaction could be regulated.
Response: As reported, we do see effects of tension on βH-Spec localization. We would not expect significant effects of membrane tension on α-Spec localization, but we consider analysis of this outside the scope of this manuscript.
In lines 185-187, the authors mention that beta-spectrin depletion does not affect beta-heavy-spectrin localization. Interestingly, Figure 4E appears to show that the levels of Kst-YFP appear to be lower in the beta-spectrin-depleted tissue. The localization of beta-heavy-spectrin is not necessarily affected but the overall levels could be.
Response: Indeed the levels appear slightly lower, but elucidating the reason for this will require further experiments that are beyond the scope of this manuscript (we suspect it is because cytoskeletal tension increases in β-Spec-depleted tissue as it does in α-Spec depleted tissue, which based on our observations should decrease levels of Kst at near junctions). The key point of these experiments was to show that α-Spec localization does not require βH-Spec, but does require β-Spec, which supports our conclusion that in wing discs α-Spec forms a complex with β-Spec but not with βH-Spec.
In lines 200-203, the authors state that beta-heavy-spectrin and myosin colocalize extensively at the apical region. However, this colocalization is not as clear as stated. Do the authors have alternative data that suggests that the two proteins are indeed colocalizing? Would it be possible to perform PLA to detect a potential colocalization?
Response: Unfortunately we do not have antibodies against both proteins that work well enough for PLA. However, we quantified the co-localization by analysis of Pearson's correlation coefficient, as reported in the manuscript. We also added an additional higher magnification image, and a line scan, in a supplemental figure (Fig. 6 supplement 1).
Authors should try to assess and quantify colocalization with F-actin for both beta-heavy-spectrin and myosin in wild-type conditions and when the levels (and/or activity) for each of them are modulated.
Response: We have added quantification of the co-localization of βH-Spec with F-actin and of myosin with F-actin to the revised manuscript.
Minor points:
In lines 122-124, the authors should clarify the relevance of the observation that alpha-spectrin knockdown affects the thickness of the wing disc epithelium.
Response: We have added some text to try to elaborate on this.
In the intro, it is perhaps necessary to mention that there are conflicting reports regarding the role of spectrins in the regulation of cell proliferation, at least in the follicular epithelium. For instance, Ng et al., 2016 argued that spectrins do not regulate cell proliferation in FECs.
Response: Rather than wading into a detailed discussion of issues that are peripheral to this study, we modified the text in the Introduction to avoid implying that spectrins control cell proliferation in the ovary.
In Figures 1, 2, 3, and 4 (and respective supplements), it is encouraged that, wherever appropriate, the authors mark the different compartments or the relevant boundary using dashed lines, to more clearly indicate the regions to compare.
Response: We have now done this.
In Figure 2, supplement 1 panels C and D should have an indication of the genotype for clarity.
Response: We have now added this.
In lines 362-367, the authors suggest that other actin-binding proteins are likely to influence the role of beta-heavy-spectrin. Have the authors tested the role of spectrin interactors such as Ankyrin and Adducin?
Response: No, we have not examined this.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
The following is the authors' response to the original reviews.
We were pleased with the overall enthusiastic comments of the reviewers:
-
Reviewer #1: “This manuscript by Mahlandt, et al. presents a significant advance in the manipulation of endothelial barriers with spatiotemporal precision”
-
Reviewer #2: “The immediate and repeatable responses of barrier integrity changes upon light-on and light-off switches are fascinating and impressive.”
-
Reviewer #3: “, these molecular tools will be of broad interest to cell biologists interested in this family of GTPases.”
We thank the reviewers for their fair and constructive comments that helped us to improve the manuscript.
Reviewer #1 (Recommendations For The Authors):
1) This paper is likely to attract a diverse audience. However, the order of data presented in this manuscript can be confusing or challenging to follow for the naive reader. This is because the tool characterization is split into two parts: before the barrier strength assay (selection of optogenetic platform and tool expression) and after (characterization of cell morphology with global and local optogenetic stimulation). Reorganizing the results such that the barrier strength results follows from an understanding of individual cell responses to stimulation may improve the ability of this readership to understand the factors at play in the changes in barrier strength observed when opto-RhoGEFs are activated.
We appreciate this idea, and we initially structured the paper in the proposed order and then decided, that we wanted to put more focus on the barrier strength results by already presenting them in the second figure. Therefore, we prefer to keep this order of figures.
2) While the description of the selection of iLID as the study's optogenetic platform is clear, a better job could be done motivating the need for engineering new optogenetic tools for the control of GEF recruitment. Given that iLID-based tools for GEFs of RhoA, Rac1, and Cdc42 already exist, some of which are cited in the introduction, more information on why these tools were not used would be helpful-were these tools tested in endothelial cells and found lacking.
The original system has the domain structure DHPH-tagRFP-SspB. But we wanted to work with a SspB-FP-GEF construct, which would allow easy exchange of the FP and the DHPH domain. This modular approach allowed us to generate and compare the mCherry, iRFP647 and HaloTag version. We don’t want to claim that we engineered an entirely new optogenetic tool but rather optimized an existing one with different tags. To make this more clear we added : ‘The membrane tag of the original iLID was changed to an optimized anchor. In addition, we modified the sequence of the domains to SspB, tag, GEF to simplify the exchange of GEF and genetically encoded tag. A set of plasmids with different fluorescent tags was created for more flexibility in co-imaging.’
3) Comment on the reason behind using DHPH vs. DH domains for each GEF is needed.
We have previously found (and this is supported by biochemical analysis of GEF activity) that the selected domains provide the best activity. We will add reference and the following to the text: ‘Their catalytic active DHPH domains were used for ITSN1 and TIAM1 (Reinhard et al., 2019). In case of p63 the DH domain only was used, because the PH domain of p63 inhibits the GEF activity (Van Unen et al., 2015) (Fig. 1E).’
4) Since multiple Rho GTPases (e.g., RhoA, RhoB, RhoC) exist and Rho is used as the name of the GTPase family, please use RhoA where applicable for clarity.
Since the RhoGEFp63 will activate RhoA/B/C we would rather not refer to RhoA only. We will clarify this in the text: ‘Three GEFs were selected, ITSN1, TIAM1 and RhoGEFp63, which are known to specifically activate respectively Cdc42, Rac and Rho and their isoforms.’
5) A brief comment on the use of HeLa cells for protein engineering and characterization (versus the endothelial cells motivated in the introduction) may be helpful.
We added the following to the text: ‘HeLa cells were used for the tool optimization because of easier handling and higher transfection rate in comparison to endothelial cells.’
Minor suggestions:
In figure 1C, line sections showing intensity profiles before and after protein dimerization might further emphasize the change in biosensor localization.
We are not a fan of intensity profiles as the profile depends strongly on the position of the line and it basically turns a 2D image in 1D data, for a single image. So, we prefer to stick to the quantification as shown in panel 1B (which shows data from multiple cells).
Reviewer #2 (Recommendations For The Authors):
1)The study has analyzed the effects of light-induced activation of the three optogenetic constructs in endothelial cells on their barrier function (electrical resistance) at high cell density and correlated the findings with the cellular overlap-producing effects on endothelial cells cultured at sparse cell density. It should be tried to show these effects at a cell density where these light-induced effects increase electrical resistance. Lifeact with different chromophores in adjacent cells might be useful.
We had attempted to measure the overlap in a monolayer by taking advantage of the Halotag and the variety of dyes available by staining one pool of cells red with JF 552 nm and the other far red with the JF 635 nm dye. However, the cells need at least 24 h to form a monolayer and by then they had exchanged the dye and red and far red pool could not be distinguished any longer.
Therefore, we used the Lck-mTq2-iLID construct, which already marks the plasma membrane of the cells. We created a mosaic monolayer of cells expressing mScarlet-CaaX and cells expressing Lck-mTq2-iLID + SspB-HaloTag-TIAM(DHPH). We observed and increase in the overlap between cells under this condition. The results have been added to figure 4 - figure supplement 2I&J. To the text we added:
'Additionally, cell-cell membrane overlap increased about 20 %, up on photo-activation of OptoTIAM, in a mosaic expression monolayer (figure 4 - figure supplement 2I,J, Animation 22)‘
2) The authors correctly state that some reports have shown that S1P can increase endothelial barrier function in VE-cadherin independent ways and these are related to Rac and Cdc42. This was also shown for Tie-2 in vitro and even in vitro in the absence of VE-cadherin and should also be mentioned.
We added the following to the text: ‘Not only S1P promotes endothelial barrier independent from VE-cadherin, also Tie2 can increase barrier resistance in the absence of VE-cadherin (Frye et al. 2015).’
Since a blocking antibody against VE-cadherin was used, a negative control antibody should be tested which also binds to endothelial cells.
To visualize the cell-cell junctions in the experiment shown in Supplemental Fig 3.1, we added a non-blocking VE-cadherin antibody that is directly labeled with ALEXA 647 and shows normal junction morphology. These experiments already give an indication that the live labeling antibody of VE-cadherin does not disturb the junction morphology. However, when we added the blocking antibody against VE-cadherin, known to interfere with the trans-interactions of VE-cadherin, a rapid disruption of the junctions is observed.
Additionally, previous work has shown, that VE-cadherin labeling antibody does not interfere with junction dynamics and function (see Figure 2.A, Kroon et al. 2014 ‘Real-time imaging of endothelial cell-cell junctions during neutrophil transmigration under physiological flow’, jove.). We have added the figures below, showing that addition of the control IgG and VE-cadherin 55-7H1 Abs at the timepoint where the dotted line is, did not interfere with the resistance whereas the blocking Ab drastically reduced resistance. We have added this reference to the results. ‘Previous work has shown the specific blocking effect of this antibody in comparison to the VE-cadherin (55-7H1) labeling antibody (Kroon et al., 2014).’
Author response image 1.
Reviewer #3 (Recommendations For The Authors):
Additional comments for the authors:
1) The introduction is very long and would benefit from a more concise emphasis on the information required to put the work and results in context and understand their importance.
Comment: we appreciate the comment of the reviewer. However, we wish to introduce the topic and the tools thoroughly and therefore we chose to keep the introduction as it is.
2) The N-terminal membrane-binding domain does not homogeneously translocate to the plasma membrane, since lck is a raft-associated kinase. Please comment on this.
In our hands, the Lck is among the most selective and efficient tags for plasma membrane localization (https://doi.org/10.1101/160374). We do observe homogeneous translocation, but our resolution is limited to ~200 nm and so we cannot exclude that the Lck concentrates in structures smaller than 200 nm. Given the robust performance of the lck-based iLID anchor in the optogenetics experiments, we think that the Lck anchor is a good choice.
3) Figure 1D is not very clear. What does 25 or 36% change mean? If iLID tg is conjugated to these sequences, its cytosolic localization should be reduced versus iLID alone. Is this what the graph wants to express? If so, please, label properly the ordinate axis in the graph (% of non-tagged iLID values?)
The graph is representing the recruitment efficiency of SspB to the plasma membrane for the two different membrane tags, targeting iLID to the plasma membrane. The recruitment efficiency was measured by the depletion of SspB-mScarlet intensity in the cytosol, up on light activation, and represented as a change in percentage.
We added the following to the title of the graph_: SspB recruitment efficiency for Plasma Membrane tagged iLID._
4) Supplemental figures in the main text. Fig S1D in the text refers to data in Fig S1E and Fig S1E is supposed to be Fig S1F? (page 11).
That is correct. The mistakes have been corrected (and this is now renamed to figure 1 - figure supplement 1E and 1F).
5) Figure 3. Contribution of VE-cadherin. Other junctional complexes, such as tight junctions may also intervene. However, these results would also suggest that cell-substrate adhesion rather than cell-cell junctions may modulate the barrier properties, as it has been previously demonstrated for example by imatinib-mediated activation of Rac1 (Aman et al. Circulation 2012). The ECIS system used to measure TEER in the quantitative barrier function assays can modulate these measurements and discriminate between paracellular permeability (Rb) and cell-substrate adhesion (alpha). Please, provide whether the optogenetic modulation of these GTPases does indeed regulate Rb or alpha.
The measured impedance is made up of two components: capacitance and resistance. At relatively high AC frequencies (> 32,000 Hz) more current capacitively couples directly through the plasma membranes. At relatively low frequencies (≤ 4000 Hz), the current flows in the solution channels under and between adjacent endothelial cells’ (https://www.biophysics.com/whatIsECIS.php).
Therefore, the high frequency impedance is representing cell-substrate adhesion whereas the low frequency responds more strongly to changes in cell-cell junction connections.
We only measured at 4000 Hz, representing the paracellular permeability. We chose a single frequency to maximize time resolution.
We have added this extra comment to the legend of the figure: ‘(B) Resistance of a monolayer of BOECs stably expressing Lck-mTurquoise2-iLID, solely as a control (grey), and either SspB-HaloTag-TIAM1(DHPH)(purple)/ ITSN1(DHPH) (blue) or p63RhoGEF(DH) (green) measured with ECIS at 4000 Hz, representing paracellular permeability, every 10 s.’
-
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
eLife assessment
In this work, the authors provide important mechanistic insights into how the intracellular effector protein Calcineurin B homologous protein 3 (CHP3) can be regulated in a calcium-independent manner to expose its lipid binding site. Compelling evidence demonstrates a binding partner protein (NHE1) triggers a conformation change and exposure of the myristoyl group in CHP3 resulting in membrane association. This provides mechanistic insight into the signalling mechanisms achieved by CHP3 in a target-dependent manner, which will be of broad scientific interest.
Thank you for providing an accompanying eLife assessment. As we slightly modified the name of the novel mechanism to meet the suggestion of reviewer 2, and to emphasize the binding to a lipid membrane, we suggest the following update:
“In this work, the authors provide important mechanistic insights into how the intracellular effector protein Calcineurin B homologous protein 3 (CHP3) can be regulated in a calcium-independent manner to expose its lipid membrane binding site. Compelling evidence demonstrates a binding partner protein (NHE1) triggers a conformation change and exposure of the myristoyl group in CHP3 resulting in membrane association. This provides mechanistic insight into the signalling mechanisms achieved by CHP3 in a target-binding dependent manner, which will be of broad scientific interest.
Reviewer #1 (Public Review):
This study examines the effects of Ca2+ and NHE1 peptide binding on the conformation of CHP3, one of three related calcineurin-homologous proteins. One question that is addressed is whether Ca2+ binding triggers membrane association of the myristoyl group, a so-called "Ca2+-myristoyl switch". This is convincingly demonstrated to not be the case by the experiment in Figure 6B: unlike myristoylated recoverin, mCHP3 does not show enhanced association with liposomes. In the presence of a target peptide, however, myristoylation enhances membrane association. Curiously, this interaction is not Ca2+ dependent, but the membrane association of the non-myristoylated CHP3 is Ca2+-dependent.
My concerns with this study relate to physiological relevance. First, it is unclear if Ca2+ binding has a regulatory function in any of the CHP proteins. The authors state that CHP1 and CHP2 have Ca2+ binding affinities <100 nM, so these proteins are likely saturated with Ca2+ under all physiological conditions. On the other hand, CHP3 binds Ca2+ with a Kd of 8 micromolar (in the presence of physiological concentrations of Mg2+) so it will be largely unbound under most normal cellular concentrations of Ca2+ which are in the submicromolar range. Free Ca2+ rarely reaches 1 micromolar under non-pathological concentrations, and if it does, the fraction of CHP3 bound to Ca2+ should be estimated for context. Given these caveats, I am not convinced that experiments done with millimolar concentrations of Ca2+ (e.g., Figures 2, 3, 6) are physiologically informative.
Precise knowledge on the distinct and isoform-specific molecular basis of the important physiological roles of calcineurin homologous proteins is only emerging. Here, we ruled out the suggested Ca2+-myristoyl switch and showed that instead, target-binding (NHE1-peptide) induces membrane association of myristoylated CHP3. In respect to Ca2+ response, we showed in this work and previous studies that all CHPs undergo Ca2+-induced conformational changes, a feature that is required for EFCaBPs to act as Ca2+ sensor. Millimolar Ca2+ concentrations are commonly used in this type of in vitro characterization to ensure uniform conformational states of the protein, thus we followed this approach. We agree that in future studies, the distinct molecular responses to Ca2+ signals have to be studied in cellular context. So far, one can state that for CHP1 and CHP2, affinities for Ca2+ were reported with Kd values of ~90 nM determined in vitro in the absence of Mg2+. This is close to the cellular Ca2+ concentration in the resting cell, but would not lead to saturation of all CHP1 or CHP2 molecules in the cell with Ca2+. The presence of Mg2+ in the cell may further attenuate the affinity of CHPs for Ca2+. One cannot exclude, that CHP1 and CHP2 could respond to Ca2+ signals in the cell. For target-free CHP3, a Kd of 3.5 µM for Ca2+ in the presence of Mg2+ was reported, so it is unlikely to respond to Ca2+-signals. However, target binding (at least for NHE1) does not require the presence of Ca2+ (as shown in the present study), and target binding can increase Ca2+-binding affinity of EFCaBPs up to 100 fold (reported 45-fold for CHP1 and 42-fold for CHP2). Target-bound CHP3 might have an affinity for Ca2+ that enables a response to Ca2+-signals.
Reviewer #2 (Public Review):
The manuscript by Becker and coworkers describes a target-binding myristoyl switch in the calcium-binding EF hand protein CHP3 using one of its targets, the NHE1. The work uses a suite of biophysical methods including SEC, nanoDSF, fluorescence, and native MS, to address conformations, ligand binding (Ca2+, Mg2+, NHE1), and liposome association, pinpointing a conformation switch which they term a target-dependent myristoyl switch. The strength of the manuscript is a convincing mapping of the different conformations and the conclusion that target binding, and not Ca2+ binding is necessary to expel the lipid from the protein, and that this jointly enhances membrane binding. It would have been even stronger if additional structural data had been included to address the properties of the different states and hence support if there indeed are changes in dynamics and flexibility.
We are thankful to Reviewer #2 for a number of valuable comments on our manuscript which we addressed systematically to enhance description and discussion of our results. Specifically, we clarified the use of conformation, flexibility, state, dynamics and now consistently refer to distinct states of the protein (Ca2+-, Mg2+- and apo-state) as well as defined conformations (open, closed and target-bound). We agree that structural characterization is important, yet, it is beyond the focus of the present biochemical and biophysical characterization and needs to be addressed in future studies.
Reviewer #3 (Public Review):
This work provides new insights into the regulation of the intracellular effector protein Calcineurin B homologous protein 3 (CHP3). The authors precisely delineate how intracellular calcium signals and myristoylation affect the binding of CHP3 to lipid membranes and the sodium/proton exchanger NHE1. Different mechanisms are known to trigger the exposure of the myristoyl-moiety in the calcium-binding protein family and CHP3 was proposed to use a "calcium-myristoyl switch", which leads to exposure of the myristoyl group due to conformational changes in the protein triggered by calcium-binding. Becker and Fuchs et al. now demonstrate that CHP3 uses a novel mechanism, in which not calcium-binding but binding to the target protein NHE1 triggers exposure of its myristoyl-group. This paper represents a detailed functional characterization of CHP3 and the maximum level of mechanistic interpretation that can be achieved without high-resolution structural information.
The conclusions of this paper are fully supported by the data.
Strengths
The protein biochemistry is of an exceptionally high level, both with respect to the quality of the material and the stringency with which the authors assess and assure the protein quality. The authors purify CHP3 without any affinity tags, and thus in its most representative relevant state. Their validations indicate that complete myristoylation of CHP3 is achieved and that all protein is functional with respect to calcium binding.
The authors go to extensive lengths to convince themselves of the quality of their data and their interpretation. They use an extensive amount of replicates, including both biological and technical replicates. Assays and experimental procedures are verified using model proteins, such as Recoverin. In addition, the authors employ an extensive set of complementary approaches to assure their observations are universal.
We highly appreciate the positive feedback of Reviewer #3 on our experimental design and quality of biochemical data.
Weaknesses
A small weakness is the fact that the interpretation in terms of mechanistic insights contributed by some of the assays employed is rather limited, resulting in comparably unprecise descriptions of the state of the protein such as "affects the conformation and/or flexibility of CHP3" or the "open" and "closed" conformations. As indicated by the authors, structural studies are required to precisely detail the conformational states and delineate their mechanism of action.
We updated the manuscript for a stringent use of the descriptions “conformation”, “state” and “flexibility” to match terminology commonly used for EFCaBPs.
The authors imply that the major form of CHP3 is the myristoylated state. However, it remains unclear whether the source of the biological material, which appears to be membrane-only, already implies a significant experimental bias that only allows (or highly favors) the identification of myristoylated CHP3. Without a calcium-signal, unmyristoylated CHP may not associate with membranes, or be less strong, resulting in its depletion upon isolation of the vesicles.
We agree that our data are based on membrane fractions, so referring to the “major form of CHP3” was misleading. We updated two sentences as follows: “Finally, we investigated the N-terminal myristoylation status of membrane associated CHP3 in vivo using liquid-chromatography coupled mass spectrometry (LC-MS/MS). ………Together, this suggests that myristoylated CHP3 is both NHE1-associated and membrane-anchored in agreement with a target-induced exposure and membrane integration of the N-terminal myristoyl moiety.”
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
The Introduction starts by setting up a straw-man argument, claiming that the assumption is that gene expression is set up as stable expression domains that undergo little or no subsequent change. I don't think that any current developmental biologist thinks this is true. The references used to support this claim are from the 1990s up to the early 2000s. There are numerous examples since then that show that developmental gene expression is dynamic as a rule.
Our argument might seem like a strawman for certain sector of developmental biologists who work in the field of pattern formation, or aware of the latest advances in the field. However, a look at current publications on developmental enhancers reveals that the dominant model with which enhancer biologists interpret their data is still the French Flag model (specifically, the eve-stripe-2 model of enhancer function). We meant to address this audience, and attempted to clarify this from the very beginning by stating that “Much of our models of how enhancers work during development relies on the assumption that …”. Please, note here that we are talking about “models of how enhancers work”, not models of pattern formation in general.
The Introduction then continues as a rather detailed review of enhancers, Tribolium methodology, tools for identifying enhancers, and more. The Introduction cites 99 references, which seems excessive for what is essentially an experimental paper. Significant parts of the Introduction can be trimmed or removed. There is no need to mention all the tools available for Tribolium if they are not used in the described experiments. A thorough analysis of the advantages and disadvantages of different modes of ATAC-seq is also beyond the scope of the Introduction. The authors should explain why they chose the tools they chose without excessive background.
In the revised manuscript, we shortened the discussion of Tribolium methodologies and imaging techniques. However, we think that the paragraph discussing ATAC-seq strategies are important to justify our choices as why we took the effort to cut the embryos to perform tissue-specific ATAC-seq analysis, instead of performing whole-embryo ATAC-seq.
Having said that, the Introduction actually overlooks a lot of significant work that is relevant to the subject of the paper. Specifically, the authors completely ignore all of the work on development in hemimetabolous insects such as Oncopeltus and Gryllus - the omission is glaring. There has been a lot of relevant work on dynamic gene expression patterns coming out of these species.
You are right indeed. We apologize for that. We added now citations to relevant works from those to insect to the manuscript.
The experimental setup involves cutting embryos into three sections at two time points. The results then discuss differences in "space" and "time" but there is no discussion of the embryological meaning of these terms. What is happening at the two time points from a developmental perspective? What is the difference between the three sections? There is a lot of relevant development going on at these stages and important regional differences, which have been well-studied in Tribolium and in other insects but are not even mentioned.
A good point. Correlating chromatin landscape changes with embryological events is an interesting point that needs further analysis and the application of ATAC-seq to further timepoints. We chose leaving this to future work (possibly using single cell ATAC-seq). In this work, we restricted our analysis to the benefits of applying time- and tissue-specific ATAC-seq in predicting active enhancers. We added a note on this point in the discussion.
In the preliminary results of the ATAC-seq analysis, it is clear that there are significant differences between the sections, which should come as no surprise, but fairly minor differences between the same section at the two time points. This could be because the two time points are pretty close together at a stage when there is a lot of repetitive patterning going on. A possible interpretation, which the authors don't mention because it goes against their main thesis, is that maybe most of the processes that are taking place at this stage are not dynamic enough to show up at the temporal resolution they have applied. This is worth at least a mention.
We agree with this observation. We would like to draw the reviewer’s attention to our statement “Together, our findings indicate that changes in chromatin accessibility in Tribolium at this developmental stage are primarily associated with space rather than time…””. Detailed analysis of the chromatin dynamics across time would need taking more datapoints, which is something we plan to do in future work.
The authors link each accessible site to the nearest gene when looking at putative enhancer function. This is a risky assumption since there are many examples of enhancer sites that are far upstream or downstream of the target gene and often closer to an unrelated gene than to the target gene. The authors should at least acknowledge this problem with their functional annotation.
The reviewer is correct in that, in particular for large eukaryotic genomes, enhancers are often located far away from their target genes. We have no comprehensive enhancer-target data that would enable us to perform a more accurate analysis. Furthermore, the assumption that at least for some of the enhancers the nearest genes will also be their targets, and hence, provide insight into the function of the enhancers themselves seems reasonable given the relatively compact organization of the Tribolium genome. In any case, the analysis was just presented as one of several sanity checks for our ATAC-seq data; for the sake of streamlining the manuscript we no longer include this analysis in the current version of the manuscript.
In the Discussion, the authors claim that contrary to how it may seem, the question they are addressing is not a "fringe problem". Once again, I think this is a straw man. No active researcher thinks that the question of dynamic regulation of gene expression during development is a fringe problem. On the contrary, most researchers will accept that this is one of the most interesting and important questions in current developmental biology.
This whole argument was removed from the Discussion in the revised manuscript.
Perhaps the most significant problem with the manuscript is that it is all built around the premise of enhancer switching between dynamic enhancers and static enhancers. The authors find one site that is consistent with their prediction for a dynamic enhancer and one site - regulating a different gene - that is consistent with their prediction for a static enhancer and claim that they have provided support for their model. I think this claim is grossly exaggerated. They present data that can be seen as consistent with their model but are a long way from providing evidence for it.
We actually thought we were cautious enough about this. Nowhere in our text did we mention that our data “support” the enhancer switching model. We stated quite early (in the abstract, actually) that:
“We found our data consistent with a model in which the timing of gene expression during embryonic pattern formation is mediated by a balancing act between enhancers that induce rapid changes in gene expressions (that we call ‘dynamic enhancers’) and enhancers that stabilizes gene expressions (that we call ‘static enhancers’).”
To make this message clearer, we added the following sentence to the abstract of the revised manuscript: “However, more data is needed for a strong support for this or any other alternative models.” And again at the end of the Introductions: “While these data are in line with our Enhancer Switching model, more data is needed as a strong support for the model.” Also, at the end of the Results section examining runB enhancer dynamics, we stated: “However, this merely shows that runB activity dynamics are consistent with our model, but is still far from strongly supporting the model (more on that in the Discussion).” Also for the Results section on enhancer hbA dynamics: “Again, this merely shows that hbA activity dynamics are consistent with our model, but is still far from strongly supporting it.”.
Moreover, in the opening paragraph of the Discussion, we explicitly and quite openly addressed this point, and suggested what kind of observations and experiments needed in the future to qualify as a “strong support” for the model. We even ran simulations for what kind of observation should one expect in enhancer deletion experiments if the model is correct (Figure 7).
But it seems like discussing the enhancer switching model in detail gives the impression of its central importance to the paper. In our view, our experimental system is quite general and does not depend on that model, but the point of mentioning it is that it is an example of how could an alternative model of enhancer regulation be of relevance to the problem of dynamic gene expression. This wouldn’t be obvious without this or a similar model that is showing this, even if it is hypothetical. But since our presentation is obviously giving the impression that our claims are stronger that they really are, we altered our phrasing in the introduction of the revised manuscript to make our point clearer:
“Despite its potential inaccuracies, the Enhancer Switching model exemplifies the type of alternative frameworks we need to explore in order to elucidate the mechanisms driving the generation of gene expression waves during development. Consequently, an appropriate model system is required, allowing us to test not only the Enhancer Switching model but also any other prospective model that provides a satisfactory explanation for the initiation of gene expression waves at the enhancer level.”
We hope that this addresses the reviewer’s quite legitimate concerns.
Like the Introduction, the Discussion includes long paragraphs (lines 450-480) that are more suitable for a review/hypothesis paper. The data presented in this manuscript has little relevance to the question of kinematic vs. trigger waves, and therefore there is no real reason for the question to be discussed here.
We have now significantly shortened the discussion.
Reviewer #2 (Public Review):
Open questions:
What happens with the runB enhancer at later stages of embryogenesis? With what kind of dynamics do the anterior-most stripes fade and does that agree with the model? Do they show the same dynamics throughout segmentation? I think later stages need to be shown because the prediction from the model would be that the dynamics are repeated with each wave. I am not so sure about the prediction for ageing stripes – yet it would have been interesting to see the model prediction and the activity of the static enhancer.
Yes, the dynamics repeats in the germband. This is shown in Supplementary Figure 8. The dynamics in germband were shown by visualizing yellow mRNA and intronic probes. MS2 imaging was not possible to be used because the embryo dive into the yolk for a while, and then it becomes difficult to capture the germband in the right orientation for imaging. We are currently working to use light sheet microscopy for imaging germband stages.
I understand that the mRNA of the reporter gene yellow is more stable than the runt mRNA. This might interfere with the possibility to test your prediction for static enhancers: The criterion is that the stripes should increase in strength as the wave migrates towards the anterior. You show this for runB – but given that yellow has a more stable transcript – could this lead to a “false positive” increase in intensity with the slower migration and accumulation of transcripts? I would feel more comfortable with the statement that this is a static enhancer if you could exclude that the signal is blurred by an artifact based on different mRNA stability. What about re-running the simulation (with the p–rameters that have shown to well reflect endogenous –unt mRNA levels) but i“creasing the parameter for the stability of the mRNA? Are static and dynamic enhancers still distinguishable? The claim of having found a static enhancer rests on this increase in signal, hence, other explanations need to be excluded carefully.
Good questions. Note that runB reporter dynamics were examined not only by visualizing yellow mRNAs (which indeed seem to be more stable than endogenous run mRNA; see Supplementary Figure 10), but also using MS2 (with virtually zero mRNA stability; although stability was simulated in the shown movies to show virtual mRNA dynamics), and intronic yellow mRNA (showing de novo transcription; Supplementary Figure 10; you will need to zoom in to see intronic de novo transcripts). The expected dynamics of a static enhancer reporter is quite unique: it progressively increases initially as it propagates from posterior to anterior, then it progressively decreases as it slows down and stabilizes at the anterior. Then they eventually fade. These full range of dynamics is obvious in germband embryos stained for intronic yellow to show de novo transcription of runB enhancer reporter (Supplementary Figure 10; you will need to zoom in to see intronic de novo transcripts).
Running the simulation for the model using different degradation rates for the enhancer reporter made the static enhancer’s expression either less or more persistent, but gave the same overall result: the static enhancer expression has diminished expression at the very posterior, but high expression as its expression wave exiting the growth-zone/SAZ. This is consistent with not only yellow mRNA expressions of runB, but with its intronic expression as well (Supplementary Figure 10; you will need to zoom in to see intronic de novo transcripts).
What about the head domain of the runB enhancer (e.g. Fig. 6A lowest row): This seems to be different from endogenous expression in your work and in Choe et al. Is that aspect different from endogenous expression and can this be reconciled with your model?
Yes, indeed this aspect cannot be explained by our model. We believe that head patterning in insects is regulated by a different regulatory network. This network might be (de)-activated by missing repressors in the selected DNA segment for runB enhancer. We mentioned this issue in the revised manuscript.
The claim of similar dynamics of expression visualized by in situ and MS2 in vivo relies on comparing Fig. 6C with 6A. To compare these two panels, I would need to know to what stage in A the embryo in C should be compared. Actually, the stripe in 6C appears more crisp than the stripes in 6A.
Were the enhancer dynamics tested in vivo at later stages as well? I would appreciate a clear statement on what stages can be visualized and where the technical boundaries are because this will influence any considerations by others using this system.
One really cannot be that super-precise about the timing of a very dynamic process in space and time like this one we are studying. We believe that Figure 6D shows clearly that runB activity dynamics are similar to endogenous run expression.
How do the reported accessibility dynamics of runA enhancer correlate with the activity of the reporter: E.g. is the enhancer open in the middle body region but closed at the posterior part of the embryo? Or is it closed at the anterior – and if so: why is there a signal of the reporter in the head?
You show that chromatin accessibility dynamics help in identifying active enhancers. Is this idea new or is it based on previous experience with Drosophila (e.g. PMID: 29539636 or works cited in https://doi.org/10.1002/bies.201900188)? Or in what respect is this novel?
Our manuscript contributes to the growing body of evidence confirming that accessibility per se does not imply activity. Of course, this is not a new idea, but given the widely use of accessibility as a proxy for enhancer activity in the genomics community, we do feel it is important to reiterate the message. As the reviewer correctly indicates, several published findings point to a correlation between accessibility dynamics and enhancer activity. However, to our knowledge, this is the first example in Tribolium. It is important to point out that what “dynamic” means strongly depends on the experimental design. Even in Drosophila, not enough studies have been conducted to fully understand the relationship (e.g., ideally, this should be done on a continuous time scale and at single cell level). We acknowledge in the manuscript that this relationship has been observed before in other species (and have added the references suggested by the reviewer, for which we are very grateful), but still believe that our observations are highly significant to the Tribolium community.
Reviewer #3 (Public Review):
I have two major concerns: First, the claim about differential accessibility being related to enhancer activity is not really established from the presented data, in my view. This needs to be clarified. (I do believe in the claim to some extent, but not based on presented evidence.)
We agree with the reviewer that more data – and, more importantly, independent replication – are necessary to confirm this finding. Please, refer to our response to your comment regarding the statistical significance of the findings.
Second, the evidence in support of the Enhancer Switching model for runt should be accompanied by identification of and spatiotemporal profiling of the “speed regulator”, if this is not established yet.
Experiments supporting the role of Cad as a speed regulator for both pair-rule and gap genes have been published in El-Sherif et al PLOS Genetics 2014 and Zhu et al PNAS 2017. We added a comment stressing this fact.
In addition to these two concerns, the simulations of the Enhancer Switching model need to be described, at least in the outline, in the Methods section.
Done
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
Specifically, the authors define "efficacy" (eta) of a ligand as the fractional change in binding free energy between the open and the closed states of the channel.
We assume that the word in quotes is a typo; ղ is efficiency, not efficacy (now given the symbol λ). We now emphasize the distinction immediately after Eq. 2.
1) One concern regards the clustering of the data sets in Fig. 5 into exactly 5 eta-classes. First, two clusters contain only two data points each. Second, the proposed "catch&hold LFER model" (Fig. 2) does not predict the existence of a discrete number of such eta-classes. How strong is the evidence that there are exactly 5 classes as opposed to a continuum of possible eta values.
Statistical (x means cluster) analysis indicates that the 23 agonists segregate into 5 ղ classes. Groups with only 2 members (plus the intercept) are less well defined (Fig 4) but are supported by the 5 mutational ղ classes (Fig. 7). (see above)
2) The authors do not discuss the uniqueness of the proposed model.
see above. Ln 405 Induced fits are common.
In fact, it seems to me that the existence of eta-classes might be explained just as well by an alternative model which assumes a single gating mechanism for the receptor,
We are not sure what a “single gating mechanism” means. Does non-single refer to i) the2 stage induced fits (catch-hold LFER)? … ղ classes makes this conclusion unavoidable. ii) our conjecture that are there are 5 different C versus O binding site structural pairs…? Energy derives from structure, so we the 5 energy ratios indicate 5 structural pairs. iii) multiple steps inside gating (ϕ)? …So far there have not been any alternative explanations for the organized map of ϕ. iv) catch itself?... Evidence for this induced fit is given in Fig 2 and 7 SI, and on Ln 528-547 we discuss the implications of kon to C versus O. Ln 405 Local ‘Induced fit’ rearrangements in enzymes are common. We think the evidence is strong for the bottom scheme in Fig 2A.
but distinct patterns of ligand-protein interactions for the different agonists.
ղ classes derive from distinct interactions for different agonists, but what these are and whether the ‘contact number’ idea is useful are uncertain (see above).
The pore opening-associated increase in agonist affinity is typically caused by a tightening of the substrate binding site (often called clamshell closure) …
Ln 379-386 In the Discussion we now relate catch-hold to induced fit
Ln 455, 461-463, 471-474 Fig 2SI and the induced fit to clamshell closure
Reviewer #2 (Public Review):
This is an interesting manuscript with a worthwhile approach to receptor mechanisms. The paper contains an impressive amount of new data. These single molecule concentration response curves have been compiled with care and the authors deserve great credit for obtaining these data.
Ln 233 ղ can be estimated from a CRC built from whole-cell currents…
Ln 150 …or indeed any method that estimates KdC and KdO (for example binding assays, or perhaps in silico simulations of AC and AO structures)
I judge the main result to be that there are different values of the recently-proposed agonist-related quantity "efficiency".
Ln 21, 26-27, 535-547 OK, but to us the most interesting insight is that in AChRs binding IS gating.
These values are clustered into 5 quite closely spaced groups. The authors propose that these groups are the same whether considering mutations in the binding site or different agonists.
see above
It was unclear to me in several places, what new data and what old data are included in each figure. Therefore readers may have difficulty judging the claimed advance. This difficulty is not helped by the discussion, which includes some previous findings as "results".
see above.
A further weakness is that it is unclear how general or how specific these concepts are. The authors assert that they are, by definition, completely universal. However, we do not have reference to previous work or current data on any other receptor than the muscle nicotinic. I could not square the concept that "every receptor works like this" with the evident lack of desire to demonstrate this for any other receptor.
Ln 132-136 There are reasons to think that receptors in general work according to Figure 1A. A thermalized ligand (for instance TriMA, MW 60) has the momentum of only ~3 water molecules. A momentum sensor would have terrible signal/noise.
Reviewer #3 (Public Review):
This work attempts to introduce a new attribute of the receptor- efficiency, a fraction of an agonist binding energy consumed by conformational transition of the receptor from resting to active (open) states. Furthermore, the authors use an impressive set of experimental data (single channel recordings with 23 agonists and 53 mutations) to measure the efficiency for each agonist and mutant receptor. All the estimated efficiencies fall into a few groups and inside each of the efficiency groups there is a strong correlation between agonist affinity and receptor opening efficacy.
The main finding in this study is that estimated efficiencies fall into 5 groups.
see above.
There is no clear description of the method how the efficiencies were allocated into different groups. Most importantly, it is not clear if the method used takes into account the uncertainty of the efficiency estimate. The study does not show any statistical metrics of the efficiency estimates as well as any other calculated variable such as dissociation equilibrium constants to resting or open states. Surely, the uncertainty of the efficiency should matter especially considering how near the efficiency group values are (eg. difference about 10% between 0.51 and 0.56 or 0.41 and 0.45).
see above
All the tested agonists fell into groups according to the efficiency value attributed to them. It is difficult to see why some of the agonists belong to the same group. For example, it is not obvious at all why such agonists as epibatidine, decamethonium and TMP are in the same group. The question, I guess, arises if this grouping based on efficiency has any predictability value. Furthermore, if a series of mutations with the same agonist fall into different groups, the prediction power of this approach is very limited if one attempts to design a new agonist or look for a new mutation.
see above and Ln 548-561 (last para of text). Efficiency is a relatively new idea. This report is one of only a few on the subject. More experiments with different receptors by more labs using other approaches are needed to ascertain whether ղ is general.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
This manuscript will interest cognitive scientists, neuroimaging researchers, and neuroscientists interested in the systems-level organization of brain activity. The authors describe four brain states that are present across a wide range of cognitive tasks and determine that the relative distribution of the brain states shows both commonalities and differences across task conditions.
The authors characterized the low-dimensional latent space that has been shown to capture the major features of intrinsic brain activity using four states obtained with a Hidden Markov Model. They related the four states to previously-described functional gradients in the brain and examined the relative contribution of each state under different cognitive conditions. They showed that states related to the measured behavior for each condition differed, but that a common state appears to reflect disengagement across conditions. The authors bring together a state-of-the-art analysis of systemslevel brain dynamics and cognitive neuroscience, bridging a gap that has long needed to be bridged.
The strongest aspect of the study is its rigor. The authors use appropriate null models and examine multiple datasets (not used in the original analysis) to demonstrate that their findings replicate. Their thorough analysis convincingly supports their assertion that common states are present across a variety of conditions, but that different states may predict behavioural measures for different conditions. However, the authors could have better situated their work within the existing literature. It is not that a more exhaustive literature review is needed-it is that some of their results are unsurprising given the work reported in other manuscripts; some of their work reinforces or is reinforced by prior studies; and some of their work is not compared to similar findings obtained with other analysis approaches. While space is not unlimited, some of these gaps are important enough that they are worth addressing:
We appreciate the reviewer’s thorough read of our manuscript and positive comments on its rigor and implications. We agree that the original version of the manuscript insufficiently situated this work in the existing literature. We have made extensive revisions to better place our findings in the context of prior work. These changes are described in detail below.
1) The authors' own prior work on functional connectivity signatures of attention is not discussed in comparison to the latest work. Neither is work from other groups showing signatures of arousal that change over time, particularly in resting state scans. Attention and arousal are not the same things, but they are intertwined, and both have been linked to large-scale changes in brain activity that should be captured in the HMM latent states. The authors should discuss how the current work fits with existing studies.
Thank you for raising this point. We agree that the relationship between low-dimensional latent states and predefined activity and functional connectivity signatures is an important and interesting question in both attention research and more general contexts. Here, we did not empirically relate the brain states examined in this study and functional connectivity signatures previously investigated in our lab (e.g., Rosenberg et al., 2016; Song et al., 2021a) because the research question and methodological complexities deserved separate attention that go beyond the scope of this paper. Therefore, we conceptually addressed the reviewer’s question on how functional connectivity signatures of attention are related to the brain states that were observed here. Next, we asked how arousal relates to the brain states by indirectly predicting arousal levels of each brain state based on its activity patterns’ spatial resemblance to the predefined arousal network template (Goodale et al., 2021).
Latent states and dynamic functional connectivity
Previous work suggested that, on medium time scales (~20-60 seconds), changes in functional connectivity signatures of sustained attention (Rosenberg et al., 2020) and narrative engagement (Song et al., 2021a) predicted changes in attentional states. How do these attention-related functional connectivity dynamics relate to latent state dynamics, measured on a shorter time scale (1 second)?
Theoretically, there are reasons to think that these measures are related but not redundant. Both HMM and dynamic functional connectivity provide summary measures of the whole-brain functional interactions that evolve over time. Whereas HMM identifies recurring low-dimensional brain states, dynamic functional connectivity used in our and others’ prior studies captures high-dimensional dynamical patterns. Furthermore, while the mixture Gaussian function utilized to infer emission probability in our HMM infers the states from both the BOLD activity patterns and their interactions, functional connectivity considers only pairwise interactions between regions of interests. Thus, with a theoretical ground that the brain states can be characterized at multiple scales and different methods (Greene et al., 2023), we can hypothesize that the both measures could (and perhaps, should be able to) capture brain-wide latent state changes. For example, if we were to apply kmeans clustering methods on the sliding window-based dynamic functional connectivity as in Allen et al. (2014), the resulting clusters could arguably be similar to the latent states derived from the HMM.
However, there are practical reasons why the correspondence between our prior dynamic functional connectivity models and current HMM states is difficult to test directly. A time point-bytime point matching of the HMM state sequence and dynamic functional connectivity is not feasible because, in our prior work, dynamic functional connectivity was measured in a sliding time window (~20-60 seconds), whereas the HMM state identification is conducted at every TR (1 second). An alternative would be to concatenate all time points that were categorized as each HMM state to compute representative functional connectivity of that state. This “splicing and concatenating” method, however, disrupts continuous BOLD-signal time series and has not previously been validated for use with our dynamic connectome-based predictive models. In addition, the difference in time series lengths across states would make comparisons of the four states’ functional connectomes unfair.
One main focus of our manuscript was to relate brain dynamics (HMM state dynamics) to static manifold (functional connectivity gradients). We agree that a direct link between two measures of brain dynamics, HMM and dynamic functional connectivity, is an important research question. However, due to some intricacies that needed to be addressed to answer this question, we felt that it was beyond the scope of our paper. We are eager, however, to explore these comparisons in future work which can more thoroughly address the caveats associated with comparing models of sustained attention, narrative engagement, and arousal defined using different input features and methods.
Arousal, attention, and latent neural state dynamics
Next, the reviewer posed an important question about the relationship between arousal, attention, and latent states. The current study was designed to assess the relationship between attention and latent state dynamics. However, previous neuroimaging work showed that low-dimensional brain dynamics reflect fluctuations in arousal (Raut et al., 2021; Shine et al., 2016; Zhang et al., 2023). Behavioral studies showed that attention and arousal hold a non-linear relationship, for example, mind-wandering states are associated with lower arousal and externally distracted states are associated with higher arousal, when both these states indicate low attention (Esterman and Rothlein, 2019; Unsworth and Robison, 2018, 2016).
To address the reviewer’s suggestion, we wanted to test if our brain states reflected changes in arousal, but we did not collect relevant behavioral or physiological measures. Therefore, to indirectly test for relationships, we predicted levels of arousal in brain states by applying the “arousal network template” defined by Dr. Catie Chang’s group (Chang et al., 2016; Falahpour et al., 2018; Goodale et al., 2021). The arousal network template was created from resting-state fMRI data to predict arousal levels indicated by eye monitoring and electrophysiological signals. In the original study, the arousal level at each time point was predicted by the correlation between the BOLD activity patterns of each TR to the arousal template. The more similar the whole-brain activation pattern was to the arousal network template, the higher the participant was predicted to be aroused at that moment. This activity pattern-based model was generalized to fMRI data during tasks (Goodale et al., 2021).
We correlated the arousal template to the activity patterns of the four brain states that were inferred by the HMM. The DMN state was positively correlated with the arousal template (r=0.264) and the SM state was negatively correlated with the arousal template (r=-0.303) (Author response image 1). These values were not tested for significance because they were single observations. While speculative, this may suggest that participants are in a high arousal state during the DMN state and a low arousal state during the SM state. Together with our results relating brain states to attention, it is possible that the SM state is a common state indicating low arousal and low attention. On the other hand, the DMN state, a signature of a highly aroused state, may benefit gradCPT task performance but not necessarily in engaging with a sitcom episode. However, because this was a single observation and we did not collect a physiological measure of arousal to validate this indirect prediction result, we did not include the result in the manuscript. We hope to more directly test this question in future work with behavioral and physiological measures of arousal.
Author response image 1.
Changes made to the manuscript
Importantly, we agree with the reviewer that a theoretical discussion about the relationships between functional connectivity, latent states, gradients, as well as attention and arousal was a critical omission from the original Discussion. We edited the Discussion to highlight past literature on these topics and encourage future work to investigate these relationships.
[Manuscript, page 11] “Previous studies showed that large-scale neural dynamics that evolve over tens of seconds capture meaningful variance in arousal (Raut et al., 2021; Zhang et al., 2023) and attentional states (Rosenberg et al., 2020; Yamashita et al., 2021). We asked whether latent neural state dynamics reflect ongoing changes in attention in both task and naturalistic contexts.”
[Manuscript, page 17] “Previous work showed that time-resolved whole-brain functional connectivity (i.e., paired interactions of more than a hundred parcels) predicts changes in attention during task performance (Rosenberg et al., 2020) as well as movie-watching and story-listening (Song et al., 2021a). Future work could investigate whether functional connectivity and the HMM capture the same underlying “brain states” to bridge the results from the two literatures. Furthermore, though the current study provided evidence of neural state dynamics reflecting attention, the same neural states may, in part, reflect fluctuations in arousal (Chang et al., 2016; Zhang et al., 2023). Complementing behavioral studies that demonstrated a nonlinear relationship between attention and arousal (Esterman and Rothlein, 2019; Unsworth and Robison, 2018, 2016), future studies collecting behavioral and physiological measures of arousal can assess the extent to which attention explains neural state dynamics beyond what can be explained by arousal fluctuations.”
2) The 'base state' has been described in a number of prior papers (for one early example, see https://pubmed.ncbi.nlm.nih.gov/27008543). The idea that it might serve as a hub or intermediary for other states has been raised in other studies, and discussion of the similarity or differences between those studies and this one would provide better context for the interpretation of the current work. One of the intriguing findings of the current study is that the incidence of this base state increases during sitcom watching, the strongest evidence to date is that it has a cognitive role and is not merely a configuration of activity that the brain must pass through when making a transition.
We greatly appreciate the reviewer’s suggestion of prior papers. We were not aware of previous findings of the base state at the time of writing the manuscript, so it was reassuring to see consistent findings. In the Discussion, we highlighted the findings of Chen et al. (2016) and Saggar et al. (2022). Both studies highlighted the role of the base state as a “hub”-like transition state. However, as the reviewer noted, these studies did not address the functional relevance of this state to cognitive states because both were based on resting-state fMRI.
In our revised Discussion, we write that our work replicates previous findings of the base state that consistently acted as a transitional hub state in macroscopic brain dynamics. We also note that our study expands this line of work by characterizing what functional roles the base state plays in multiple contexts: The base state indicated high attentional engagement and exhibited the highest occurrence proportion as well as longest dwell times during naturalistic movie watching. The base state’s functional involvement was comparatively minor during controlled tasks.
[Manuscript, page 17-18] “Past resting-state fMRI studies have reported the existence of the base state. Chen et al. (2016) used the HMM to detect a state that had “less apparent activation or deactivation patterns in known networks compared with other states”. This state had the highest occurrence probability among the inferred latent states, was consistently detected by the model, and was most likely to transition to and from other states, all of which mirror our findings here. The authors interpret this state as an “intermediate transient state that appears when the brain is switching between other more reproducible brain states”. The observation of the base state was not confined to studies using HMMs. Saggar et al. (2022) used topological data analysis to represent a low-dimensional manifold of resting-state whole-brain dynamics as a graph, where each node corresponds to brain activity patterns of a cluster of time points. Topologically focal “hub” nodes were represented uniformly by all functional networks, meaning that no characteristic activation above or below the mean was detected, similar to what we observe with the base state. The transition probability from other states to the hub state was the highest, demonstrating its role as a putative transition state.
However, the functional relevance of the base state to human cognition had not been explored previously. We propose that the base state, a transitional hub (Figure 2B) positioned at the center of the gradient subspace (Figure 1D), functions as a state of natural equilibrium. Transitioning to the DMN, DAN, or SM states reflects incursion away from natural equilibrium (Deco et al., 2017; Gu et al., 2015), as the brain enters a functionally modular state. Notably, the base state indicated high attentional engagement (Figure 5E and F) and exhibited the highest occurrence proportion (Figure 3B) as well as the longest dwell times (Figure 3—figure supplement 1) during naturalistic movie watching, whereas its functional involvement was comparatively minor during controlled tasks. This significant relevance to behavior verifies that the base state cannot simply be a byproduct of the model. We speculate that susceptibility to both external and internal information is maximized in the base state—allowing for roughly equal weighting of both sides so that they can be integrated to form a coherent representation of the world—at the expense of the stability of a certain functional network (Cocchi et al., 2017; Fagerholm et al., 2015). When processing rich narratives, particularly when a person is fully immersed without having to exert cognitive effort, a less modular state with high degrees of freedom to reach other states may be more likely to be involved. The role of the base state should be further investigated in future studies.”
3) The link between latent states and functional connectivity gradients should be considered in the context of prior work showing that the spatiotemporal patterns of intrinsic activity that account for most of the structure in resting state fMRI also sweep across functional connectivity gradients (https://pubmed.ncbi.nlm.nih.gov/33549755/). In fact, the spatiotemporal dynamics may give rise to the functional connectivity gradients (https://pubmed.ncbi.nlm.nih.gov/35902649/). HMM states bear a marked resemblance to the high-activity phases of these patterns and are likely to be closely linked to them. The spatiotemporal patterns are typically obtained during rest, but they have been reported during task performance (https://pubmed.ncbi.nlm.nih.gov/30753928/) which further suggests a link to the current work. Similar patterns have been observed in anesthetized animals, which also reinforces the conclusion of the current work that the states are fundamental aspects of the brain's functional organization.
We appreciate the comments that relate spatiotemporal patterns, functional connectivity gradients, and the latent states derived from the HMM. Our work was also inspired by the papers that the reviewer suggested, especially Bolt et al.’s (2022), which compared the results of numerous dimensionality and clustering algorithms and suggested three spatiotemporal patterns that seemed to be commonly supported across algorithms. We originally cited these studies throughout the manuscript, but did not discuss them comprehensively. We have revised the Discussion to situate our findings on past work that used resting-state fMRI to study low-dimensional latent brain states.
[Manuscript, page 15-16] “This perspective is supported by previous work that has used different methods to capture recurring low-dimensional states from spontaneous fMRI activity during rest. For example, to extract time-averaged latent states, early resting-state analyses identified task-positive and tasknegative networks using seed-based correlation (Fox et al., 2005). Dimensionality reduction algorithms such as independent component analysis (Smith et al., 2009) extracted latent components that explain the largest variance in fMRI time series. Other lines of work used timeresolved analyses to capture latent state dynamics. For example, variants of clustering algorithms, such as co-activation patterns (Liu et al., 2018; Liu and Duyn, 2013), k-means clustering (Allen et al., 2014), and HMM (Baker et al., 2014; Chen et al., 2016; Vidaurre et al., 2018, 2017), characterized fMRI time series as recurrences of and transitions between a small number of states. Time-lag analysis was used to identify quasiperiodic spatiotemporal patterns of propagating brain activity (Abbas et al., 2019; Yousefi and Keilholz, 2021). A recent study extensively compared these different algorithms and showed that they all report qualitatively similar latent states or components when applied to fMRI data (Bolt et al., 2022). While these studies used different algorithms to probe data-specific brain states, this work and ours report common latent axes that follow a long-standing theory of large-scale human functional systems (Mesulam, 1998). Neural dynamics span principal axes that dissociate unimodal to transmodal and sensory to motor information processing systems.”
Reviewer #2 (Public Review):
In this study, Song and colleagues applied a Hidden Markov Model to whole-brain fMRI data from the unique SONG dataset and a grad-CPT task, and in doing so observed robust transitions between lowdimensional states that they then attributed to specific psychological features extracted from the different tasks.
The methods used appeared to be sound and robust to parameter choices. Whenever choices were made regarding specific parameters, the authors demonstrated that their approach was robust to different values, and also replicated their main findings on a separate dataset.
I was mildly concerned that similarities in some of the algorithms used may have rendered some of the inter-measure results as somewhat inevitable (a hypothesis that could be tested using appropriate null models).
This work is quite integrative, linking together a number of previous studies into a framework that allows for interesting follow-up questions.
Overall, I found the work to be robust, interesting, and integrative, with a wide-ranging citation list and exciting implications for future work.
We appreciate the reviewer’s comments on the study’s robustness and future implications. Our work was highly motivated by the reviewer’s prior work.
Reviewer #3 (Public Review):
My general assessment of the paper is that the analyses done after they find the model are exemplary and show some interesting results. However, the method they use to find the number of states (Calinski-Harabasz score instead of log-likelihood), the model they use generally (HMM), and the fact that they don't show how they find the number of states on HCP, with the Schaeffer atlas, and do not report their R^2 on a test set is a little concerning. I don't think this perse impedes their results, but it is something that they can improve. They argue that the states they find align with long-standing ideas about the functional organization of the brain and align with other research, but they can improve their selection for their model.
We appreciate the reviewer’s thorough read of the paper, evaluation of our analyses linking brain states to behavior as “exemplary”, and important questions about the modeling approach. We have included detailed responses below and updated the manuscript accordingly.
Strengths:
-
Use multiple datasets, multiple ROIs, and multiple analyses to validate their results
-
Figures are convincing in the sense that patterns clearly synchronize between participants
-
Authors select the number of states using the optimal model fit (although this turns out to be a little more questionable due to what they quantify as 'optimal model fit')
We address this concern on page 30-31 of this response letter.
-
Replication with Schaeffer atlas makes results more convincing
-
The analyses around the fact that the base state acts as a flexible hub are well done and well explained
-
Their comparison of synchrony is well-done and comparing it to resting-state, which does not have any significant synchrony among participants is obvious, but still good to compare against.
-
Their results with respect to similar narrative engagement being correlated with similar neural state dynamics are well done and interesting.
-
Their results on event boundaries are compelling and well done. However, I do not find their Chang et al. results convincing (Figure 4B), it could just be because it is a different medium that explains differences in DMN response, but to me, it seems like these are just altogether different patterns that can not 100% be explained by their method/results.
We entirely agree with the reviewer that the Chang et al. (2021) data are different in many ways from our own SONG dataset. Whereas data from Chang et al. (2021) were collected while participants listened to an audio-only narrative, participants in the SONG sample watched and listened to audiovisual stimuli. They were scanned at different universities in different countries with different protocols by different research groups for different purposes. That is, there are numerous reasons why we would expect the model should not generalize. Thus, we found it compelling and surprising that, despite all of these differences between the datasets, the model trained on the SONG dataset generalized to the data from Chang et al. (2021). The results highlighted a robust increase in the DMN state occurrence and a decrease in the base state occurrence after the narrative event boundaries, irrespective of whether the stimulus was an audiovisual sitcom episode or a narrated story. This external model validation was a way that we tested the robustness of our own model and the relationship between neural state dynamics and cognitive dynamics.
- Their results that when there is no event, transition into the DMN state comes from the base state is 50% is interesting and a strong result. However, it is unclear if this is just for the sitcom or also for Chang et al.'s data.
We apologize for the lack of clarity. We show the statistical results of the two sitcom episodes as well as Chang et al.’s (2021) data in Figure 4—figure supplement 2 in our original manuscript. Here, we provide the exact values of the base-to-DMN state transition probability, and how they differ across moments after event boundaries compared to non-event boundaries.
For sitcom episode 1, the probability of base-to-DMN state transition was 44.6 ± 18.8 % at event boundaries whereas 62.0 ± 10.4 % at non-event boundaries (FDR-p = 0.0013). For sitcom episode 2, the probability of base-to-DMN state transition was 44.1 ± 18.0 % at event boundaries whereas 62.2 ± 7.6 % at non-event boundaries (FDR-p = 0.0006). For the Chang et al. (2021) dataset, the probability of base-to-DMN state transition was 33.3 ± 15.9 % at event boundaries whereas 58.1 ± 6.4 % at non-event boundaries (FDR-p < 0.0001). Thus, our result, “At non-event boundaries, the DMN state was most likely to transition from the base state, accounting for more than 50% of the transitions to the DMN state” (pg 11, line 24-25), holds true for both the internal and external datasets.
-
The involvement of the base state as being highly engaged during the comedy sitcom and the movie are interesting results that warrant further study into the base state theory they pose in this work.
-
It is good that they make sure SM states are not just because of head motion (P 12).
-
Their comparison between functional gradient and neural states is good, and their results are generally well-supported, intuitive, and interesting enough to warrant further research into them. Their findings on the context-specificity of their DMN and DAN state are interesting and relate well to the antagonistic relationship in resting-state data.
Weaknesses:
- Authors should train the model on part of the data and validate on another
Thank you for raising this issue. To the best of our knowledge, past work that applied the HMM to the fMRI data has conducted training and inference on the same data, including initial work that implemented HMM on the resting-state fMRI (Baker et al., 2014; Chen et al., 2016; Vidaurre et al., 2018, 2017) as well as more recent work that applied HMMs to the task or movie-watching fMRI (Cornblath et al., 2020; Taghia et al., 2018; van der Meer et al., 2020; Yamashita et al., 2021). That is, the parameters—emission probability, transition probability, and initial probability—were estimated from the entire dataset and the latent state sequence was inferred using the Viterbi algorithm on the same dataset.
However, we were also aware of the potential problem this may have. Therefore, in our recent work asking a different research question in another fMRI dataset (Song et al., 2021b), we trained an HMM on a subset of the dataset (moments when participants were watching movie clips in the original temporal order) and inferred latent state sequence of the fMRI time series in another subset of the dataset (moments when participants were watching movie clips in a scrambled temporal order). To the best of our knowledge, this was the first paper that used different segments of the data to fit and infer states from the HMM.
In the current study, we wanted to capture brain states that underlie brain activity across contexts. Thus, we presented the same-dataset training and inference procedure as our primary result. However, for every main result, we also showed results where we separated the data used for model fitting and state inference. That is, we fit the HMM on the SONG dataset, primarily report the inference results on the SONG dataset, but also report inference on the external datasets that were not included in model fitting. The datasets used were the Human Connectome Project dataset (Van Essen et al., 2013), Chang et al. (2021) audio-listening dataset, Rosenberg et al. (2016) gradCPT dataset, and Chen et al. (2017) Sherlock dataset.
However, to further address the concern of the reviewer whether the HMM fit is reliable when applied to held-out data, we computed the reliability of the HMM inference by conducting crossvalidations and split-half reliability analysis.
(1) Cross-validation
To separate the dataset used for HMM training and inference, we conducted cross-validation on the SONG dataset (N=27) by training the model with the data from 26 participants and inferring the latent state sequence of the held-out participant.
First, we compared the robustness of the model training by comparing the mean activity patterns of the four latent states fitted at the group level (N=27) with the mean activity patterns of the four states fitted across cross-validation folds. Pearson’s correlations between the group-level vs. cross-validated latent states’ mean activity patterns were r = 0.991 ± 0.010, with a range from 0.963 to 0.999.
Second, we compared the robustness of model inference by comparing the latent state sequences that were inferred at the group level vs. from held-out participants in a cross-validation scheme. All fMRI conditions had mean similarity higher than 90%; Rest 1: 92.74 ± 5.02 %, Rest2: 92.74 ± 4.83 %, GradCPT face: 92.97 ± 6.41 %, GradCPT scene: 93.27 ± 5.76 %, Sitcom ep1: 93.31 ± 3.92 %, Sitcom ep2: 93.13 ± 4.36 %, Documentary: 92.42 ± 4.72 %.
Third, with the latent state sequences inferred from cross-validation, we replicated the analysis of Figure 3 to test for synchrony of the latent state sequences across participants. The crossvalidated results were highly similar to manuscript Figure 3, which was generated from the grouplevel analysis. Mean synchrony of latent state sequences are as follows: Rest 1: 25.90 ± 3.81%, Rest 2: 25.75 ± 4.19 %, GradCPT face: 27.17 ± 3.86 %, GradCPT scene: 28.11 ± 3.89 %, Sitcom ep1: 40.69 ± 3.86%, Sitcom ep2: 40.53 ± 3.13%, Documentary: 30.13 ± 3.41%.
Author response image 2.
(2) Split-half reliability
To test for the internal robustness of the model, we randomly assigned SONG dataset participants into two groups and conducted HMM separately in each. Similarity (Pearson’s correlation) between the two groups’ activation patterns were DMN: 0.791, DAN: 0.838, SM: 0.944, base: 0.837. The similarity of the covariance patterns were DMN: 0.995, DAN: 0.996, SM: 0.994, base: 0.996.
Author response image 3.
We further validated the split-half reliability of the model using the HCP dataset, which contains data of a larger sample (N=119). Similarity (Pearson’s correlation) between the two groups’ activation patterns were DMN: 0.998, DAN: 0.997, SM: 0.993, base: 0.923. The similarity of the covariance patterns were DMN: 0.995, DAN: 0.996, SM: 0.994, base: 0.996.
Together the cross-validation and split-half reliability results demonstrate that the HMM results reported in the manuscript are reliable and robust to the way we conducted the analysis. The result of the split-half reliability analysis is added in the Results.
[Manuscript, page 3-4] “Neural state inference was robust to the choice of 𝐾 (Figure 1—figure supplement 1) and the fMRI preprocessing pipeline (Figure 1—figure supplement 5) and consistent when conducted on two groups of randomly split-half participants (Pearson’s correlations between the two groups’ latent state activation patterns: DMN: 0.791, DAN: 0.838, SM: 0.944, base: 0.837).”
- Comparison with just PCA/functional gradients is weak in establishing whether HMMs are good models of the timeseries. Especially given that the HMM does not explain a lot of variance in the signal (~0.5 R^2 for only 27 brain regions) for PCA. I think they don't report their own R^2 of the timeseries
We agree with the reviewer that the PCA that we conducted to compare with the explained variance of the functional gradients was not directly comparable because PCA and gradients utilize different algorithms to reduce dimensionality. To make more meaningful comparisons, we removed the data-specific PCA results and replaced them with data-specific functional gradients (derived from the SONG dataset). This allows us to directly compare SONG-specific functional gradients with predefined gradients (derived from the resting-state HCP dataset from Margulies et al. [2016]). We found that the degrees to which the first two predefined gradients explained whole-brain fMRI time series (SONG: 𝑟! = 0.097, HCP: 0.084) were comparable to the amount of variance explained by the first two data-specific gradients (SONG: 𝑟! = 0.100, HCP: 0.086). Thus, the predefined gradients explain as much variance in the SONG data time series as SONG-specific gradients do. This supports our argument that the low-dimensional manifold is largely shared across contexts, and that the common HMM latent states may tile the predefined gradients.
These analyses and results were added to the Results, Methods, and Figure 1—figure supplement 8. Here, we only attach changes to the Results section for simplicity, but please see the revised manuscript for further changes.
[Manuscript, page 5-6] “We hypothesized that the spatial gradients reported by Margulies et al. (2016) act as a lowdimensional manifold over which large-scale dynamics operate (Bolt et al., 2022; Brown et al., 2021; Karapanagiotidis et al., 2020; Turnbull et al., 2020), such that traversals within this manifold explain large variance in neural dynamics and, consequently, cognition and behavior (Figure 1C). To test this idea, we situated the mean activity values of the four latent states along the gradients defined by Margulies et al. (2016) (see Methods). The brain states tiled the two-dimensional gradient space with the base state at the center (Figure 1D; Figure1—figure supplement 7). The Euclidean distances between these four states were maximized in the two-dimensional gradient space, compared to a chance where the four states were inferred from circular-shifted time series (p < 0.001). For the SONG dataset, the DMN and SM states fell at more extreme positions of the primary gradient than expected by chance (both FDR-p values = 0.004; DAN and SM states, FDRp values = 0.171). For the HCP dataset, the DMN and DAN states fell at more extreme positions on the primary gradient (both FDR-p values = 0.004; SM and base states, FDR-p values = 0.076). No state was consistently found at the extremes of the secondary gradient (all FDR-p values > 0.021).
We asked whether the predefined gradients explain as much variance in neural dynamics as latent subspace optimized for the SONG dataset. To do so, we applied the same nonlinear dimensionality reduction algorithm to the SONG dataset’s ROI time series. Of note, the SONG dataset includes 18.95% rest, 15.07% task, and 65.98% movie-watching data whereas the data used by Margulies et al. (2016) was 100% rest. Despite these differences, the SONG-specific gradients closely resembled the predefined gradients, with significant Pearson’s correlations observed for the first (r = 0.876) and second (r = 0.877) gradient embeddings (Figure 1—figure supplement 8). Gradients identified with the HCP data also recapitulated Margulies et al.’s (2016) first (r = 0.880) and second (r = 0.871) gradients. We restricted our analysis to the first two gradients because the two gradients together explained roughly 50% of the entire variance of functional brain connectome (SONG: 46.94%, HCP: 52.08%), and the explained variance dropped drastically from the third gradients (more than 1/3 drop compared to second gradients). The degrees to which the first two predefined gradients explained whole-brain fMRI time series (SONG: 𝑟! = 0.097, HCP: 0.084) were comparable to the amount of variance explained by the first two data-specific gradients (SONG: 𝑟! = 0.100, HCP: 0.086; Figure 1—figure supplement 8). Thus, the low-dimensional manifold captured by Margulies et al. (2016) gradients is highly replicable, explaining brain activity dynamics as well as data-specific gradients, and is largely shared across contexts and datasets. This suggests that the state space of whole-brain dynamics closely recapitulates low-dimensional gradients of the static functional brain connectome.”
The reviewer also pointed out that the PCA-gradient comparison was weak in establishing whether HMMs are good models of the time series. However, we would like to point out that the purpose of the comparison was not to validate the performance of the HMM. Instead, we wanted to test whether the gradients introduced by Margulies et al. (2016) could act as a generalizable lowdimensional manifold of brain state dynamics. To argue that the predefined gradients are a shared manifold, these gradients should explain SONG data fMRI time series as much as the principal components derived directly from the SONG data. Our results showed comparable 𝑟!, both in predefined gradient vs. data-specific PC comparisons and predefined gradient vs. data-specific gradient comparisons, which supported our argument that the predefined gradients could be the shared embedding space across contexts and datasets.
The reviewer pointed out that the 𝑟2 of ~0.5 is not explaining enough variance in the fMRI signal. However, we respectfully disagree with this point because there is no established criterion for what constitutes a high or low 𝑟2 for this type of analysis. Of note, previous literature that also applied PCA to fMRI time series (Author response image 4A and 4B) (Lynn et al., 2021; Shine et al., 2019) also found that the cumulative explained variance of top 5 principal components is around 50%. Author response image 4C shows cumulative variances to which gradients explain the functional connectome of the resting-state fMRI data (Margulies et al., 2016).
Author response image 4.
Finally, the reviewer pointed out that the 𝑟! of the HMM-derived latent sequence to the fMRI time series should be reported. However, there is no standardized way of measuring the explained variance of the HMM inference. There is no report of explained variance in the traditional HMMfMRI papers (Baker et al., 2014; Chen et al., 2016; Vidaurre et al., 2018, 2017). Rather than 𝑟!, the HMM computes the log likelihood of the model fit. However, because log likelihood values are dependent on the number of data points, studies do not report log likelihood values nor do they use these metrics to interpret the goodness of model fit.
To ask whether the goodness of the HMM fit was significant above chance, we compared the log likelihood of the HMM to the log likelihood distribution of the null HMM fits. First, we extracted the log likelihood of the HMM fit with the real fMRI time series. We iterated this 1,000 times when calculating null HMMs using the circular-shifted fMRI time series. The log likelihood of the real model was significantly higher than the chance distribution, with a z-value of 2182.5 (p < 0.001). This indicates that the HMM explained a large variance in our fMRI time series data, significantly above chance.
- Authors do not specify whether they also did cross-validation for the HCP dataset to find 4 clusters
We apologize for the lack of clarity. When we computed the Calinski-Harabasz score with the HCP dataset, three was chosen as the most optimal number of states (Author response image 5A). When we set K as 3, the HMM inferred the DMN, DAN, and SM states (Author response image 5C). The base state was included when K was set to 4 (Author response image 5B). The activation pattern similarities of the DMN, DAN, and SM states were r = 0.981, 0.984, 0.911 respectively.
Author response image 5.
We did not use K = 3 for the HCP data replication because we were not trying to test whether these four states would be the optimal set of states in every dataset. Although the CalinskiHarabasz score chose K = 3 because it showed the best clustering performance, this does not mean that the base state is not meaningful to this dataset. Likewise, the latent states that are inferred when we increase/decrease the number of states are also meaningful states. For example, in Figure 1—figure supplement 1, we show an example of the SONG dataset’s latent states when we set K to 7. The seven latent states included the DAN, SM, and base states, the DMN state was subdivided into DMN-A and DMN-B states, and the FPN state and DMN+VIS state were included. Setting a higher number of states like K = 7 would mean that we are capturing brain state dynamics in a higher dimension than when using K = 4. Because we are utilizing a higher number of states, a model set to K = 7 would inevitably capture a larger variance of fMRI time series than a model set to K = 4.
The purpose of latent state replication with the HCP dataset was to validate the generalizability of the DMN, DAN, SM, and base states. Before characterizing these latent states’ relevance to cognition, we needed to verify that these latent states were not simply overfit to the SONG dataset. The fact that the HMM revealed a similar set of latent states when applied to the HCP dataset suggested that the states were not merely specific to SONG data.
To make our points clearer in the manuscript, we emphasized that we are not arguing for the four states to be the exclusive states. We made edits to Discussion as follows.
[Manuscript, page 16] “Our study adopted the assumption of low dimensionality of large-scale neural systems, which led us to intentionally identify only a small number of states underlying whole-brain dynamics. Importantly, however, we do not claim that the four states will be the optimal set of states in every dataset and participant population. Instead, latent states and patterns of state occurrence may vary as a function of individuals and tasks (Figure 1—figure supplement 2). Likewise, while the lowest dimensions of the manifold (i.e., the first two gradients) were largely shared across datasets tested here, we do not argue that it will always be identical. If individuals and tasks deviate significantly from what was tested here, the manifold may also differ along with changes in latent states (Samara et al., 2023). Brain systems operate at different dimensionalities and spatiotemporal scales (Greene et al., 2023), which may have different consequences for cognition. Asking how brain states and manifolds—probed at different dimensionalities and scales—flexibly reconfigure (or not) with changes in contexts and mental states is an important research question for understanding complex human cognition.”
- One of their main contributions is the base state but the correlation between the base state in their Song dataset and the HCP dataset is only 0.399
This is a good point. However, there is precedent for lower spatial pattern correlation of the base state compared to other states in the literature.
Compared to the DMN, DAN, and SM states, the base state did not show characteristic activation or deactivation of functional networks. Most of the functional networks showed activity levels close to the mean (z = 0). With this flattened activation pattern, relatively low activation pattern similarity was observed between the SONG base state and the HCP base state.
In Figure 1—figure supplement 6, we write, “The DMN, DAN, and SM states showed similar mean activity patterns. We refrained from making interpretations about the base state’s activity patterns because the mean activity of most of the parcels was close to z = 0”.
A similar finding has been reported in a previous work by Chen et al. (2016) that discovered the base state with HMM. State 9 (S9) of their results is comparable to our base state. They report that even though the spatial correlation coefficient of the brain state from the split-half reliability analysis was the lowest for S9 due to its low degrees of activation or deactivation, S9 was stably inferred by the HMM. The following is a direct quote from their paper:
“To the best of our knowledge, a state similar to S9 has not been presented in previous literature. We hypothesize that S9 is the “ground” state of the brain, in which brain activity (or deactivity) is similar for the entire cortex (no apparent activation or deactivation as shown in Fig. 4). Note that different groups of subjects have different spatial patterns for state S9 (Fig. 3A). Therefore, S9 has the lowest reproducible spatial pattern (Fig. 3B). However, its temporal characteristics allowed us to distinguish it consistently from other states.” (Chen et al., 2016)
Thus, we believe our data and prior results support the existence of the “base state”.
- Figure 1B: Parcellation is quite big but there seems to be a gradient within regions
This is a function of the visualization software. Mean activity (z) is the same for all voxels within a parcel. To visualize the 3D contours of the brain, we chose an option in the nilearn python function that smooths the mean activity values based on the surface reconstructed anatomy.
In the original manuscript, our Methods write, “The brain surfaces were visualized with nilearn.plotting.plot_surf_stat_map. The parcel boundaries in Figure 1B are smoothed from the volume-to-surface reconstruction.”
- Figure 1D: Why are the DMNs further apart between SONG and HCP than the other states
To address this question, we first tested whether the position of the DMN states in the gradient space is significantly different for the SONG and HCP datasets. We generated surrogate HMM states from the circular-shifted fMRI time series and positioned the four latent states and the null DMN states in the 2-dimensional gradient space (Author response image 6).
Author response image 6.
We next tested whether the Euclidean distance between the SONG dataset’s DMN state and the HCP dataset’s DMN state is larger than would be expected by chance (Author response image 7). To do so, we took the difference between the DMN state positions and compared it to the 1,000 differences generated from the surrogate latent states. The DMN states of the SONG and HCP datasets did not significantly differ in the Gradient 1 dimension (two-tailed test, p = 0.794). However, as the reviewer noted, the positions differed significantly in the Gradient 2 dimension (p = 0.047). The DMN state leaned more towards the Visual gradient in the SONG dataset, whereas it leaned more towards the Somatosensory-Motor gradient in the HCP dataset.
Author response image 7.
Though we cannot claim an exact reason for this across-dataset difference, we note a distinctive difference between the SONG and HCP datasets. Both datasets largely included resting-state, controlled tasks, and movie watching. The SONG dataset included 18.95% of rest, 15.07% of task, and 65.98% of movie watching. The task only contained the gradCPT, i.e., sustained attention task. On the other hand, the HCP dataset included 52.71% of rest, 24.35% of task, and 22.94% of movie watching. There were 7 different tasks included in the HCP dataset. It is possible that different proportions of rest, task, and movie watching, and different cognitive demands involved with each dataset may have created data-specific latent states.
- Page 5 paragraph starting at L25: Their hypothesis that functional gradients explain large variance in neural dynamics needs to be explained more, is non-trivial especially because their R^2 scores are so low (Fig 1. Supplement 8) for PCA
We address this concern on page 21-23 of this response letter.
- Generally, I do not find the PCA analysis convincing and believe they should also compare to something like ICA or a different model of dynamics. They do not explain their reasoning behind assuming an HMM, which is an extremely simplified idea of brain dynamics meaning they only change based on the previous state.
We appreciate this perspective. We replaced the Margulies et al.’s (2016) gradient vs. SONGspecific PCA comparison with a more direct Margulies et al.’s (2016) gradient vs. SONG-specific gradient comparison as described on page 21-23 of this response letter.
More broadly, we elected to use HMM because of recent work showing correspondence between low-dimensional HMM states and behavior (Cornblath et al., 2020; Taghia et al., 2018; van der Meer et al., 2020; Yamashita et al., 2021). We also found the model’s assumption—a mixture Gaussian emission probability and first-order Markovian transition probability—to be the most suited to analyzing the fMRI time series data. We do not intend to claim that other data-reduction techniques would not also capture low-dimensional, behaviorally relevant changes in brain activity. Instead, our primary focus was identifying a set of latent states that generalize (i.e., recur) across multiple contexts and understanding how those states reflect cognitive and attentional states.
Although a comparison of possible data-reduction algorithms is out of the scope of the current work, an exhaustive comparison of different models can be found in Bolt et al. (2022). The authors compared dozens of latent brain state algorithms spanning zero-lag analysis (e.g., principal component analysis, principal component analysis with Varimax rotation, Laplacian eigenmaps, spatial independent component analysis, temporal independent component analysis, hidden Markov model, seed-based correlation analysis, and co-activation patterns) to time-lag analysis (e.g., quasi-periodic pattern and lag projections). Bolt et al. (2022) writes “a range of empirical phenomena, including functional connectivity gradients, the task-positive/task-negative anticorrelation pattern, the global signal, time-lag propagation patterns, the quasiperiodic pattern and the functional connectome network structure, are manifestations of the three spatiotemporal patterns.” That is, many previous findings that used different methods essentially describe the same recurring latent states. A similar argument was made in previous papers (Brown et al., 2021; Karapanagiotidis et al., 2020; Turnbull et al., 2020).
We agree that the HMM is a simplified idea of brain dynamics. We do not argue that the four number of states can fully explain the complexity and flexibility of cognition. Instead, we hoped to show that there are different dimensionalities to which the brain systems can operate, and they may have different consequences to cognition. We “simplified” neural dynamics to a discrete sequence of a small number of states. However, what is fascinating is that these overly “simplified” brain state dynamics can explain certain cognitive and attentional dynamics, such as event segmentation and sustained attention fluctuations. We highlight this point in the Discussion.
[Manuscript, page 16] “Our study adopted the assumption of low dimensionality of large-scale neural systems, which led us to intentionally identify only a small number of states underlying whole-brain dynamics. Importantly, however, we do not claim that the four states will be the optimal set of states in every dataset and participant population. Instead, latent states and patterns of state occurrence may vary as a function of individuals and tasks (Figure 1—figure supplement 2). Likewise, while the lowest dimensions of the manifold (i.e., the first two gradients) were largely shared across datasets tested here, we do not argue that it will always be identical. If individuals and tasks deviate significantly from what was tested here, the manifold may also differ along with changes in latent states (Samara et al., 2023). Brain systems operate at different dimensionalities and spatiotemporal scales (Greene et al., 2023), which may have different consequences for cognition. Asking how brain states and manifolds—probed at different dimensionalities and scales—flexibly reconfigure (or not) with changes in contexts and mental states is an important research question for understanding complex human cognition.”
- For the 25- ROI replication it seems like they again do not try multiple K values for the number of states to validate that 4 states are in fact the correct number.
In the manuscript, we do not argue that the four will be the optimal number of states in any dataset. (We actually predict that this may differ depending on the amount of data, participant population, tasks, etc.) Instead, we claim that the four identified in the SONG dataset are not specific (i.e., overfit) to that sample, but rather recur in independent datasets as well. More broadly we argue that the complexity and flexibility of human cognition stem from the fact that computation occurs at multiple dimensions and that the low-dimensional states observed here are robustly related to cognitive and attentional states. To prevent misunderstanding of our results, we emphasized in the Discussion that we are not arguing for a fixed number of states. A paragraph included in our response to the previous comment (page 16 in the manuscript) illustrates this point.
- Fig 2B: Colorbar goes from -0.05 to 0.05 but values are up to 0.87
We apologize for the confusion. The current version of the figure is correct. The figure legend states, “The values indicate transition probabilities, such that values in each row sums to 1. The colors indicate differences from the mean of the null distribution where the HMMs were conducted on the circular-shifted time series.”
We recognize that this complicates the interpretation of the figure. However, after much consideration, we decided that it was valuable to show both the actual transition probabilities (values) and their difference from the mean of null HMMs (colors). The values demonstrate the Markovian property of latent state dynamics, with a high probability of remaining in the same state at consecutive moments and a low probability of transitioning to a different state. The colors indicate that the base state is a transitional hub state by illustrating that the DMN, DAN, and SM states are more likely to transition to the base state than would be expected by chance.
- P 16 L4 near-critical, authors need to be more specific in their terminology here especially since they talk about dynamic systems, where near-criticality has a specific definition. It is unclear which definition they are looking for here.
We agree that our explanation was vague. Because we do not have evidence for this speculative proposal, we removed the mention of near-criticality. Instead, we focus on our observation as the base state being the transitional hub state within a metastable system.
[Manuscript, page 17-18] “However, the functional relevance of the base state to human cognition had not been explored previously. We propose that the base state, a transitional hub (Figure 2B) positioned at the center of the gradient subspace (Figure 1D), functions as a state of natural equilibrium. Transitioning to the DMN, DAN, or SM states reflects incursion away from natural equilibrium (Deco et al., 2017; Gu et al., 2015), as the brain enters a functionally modular state. Notably, the base state indicated high attentional engagement (Figure 5E and F) and exhibited the highest occurrence proportion (Figure 3B) as well as the longest dwell times (Figure 3—figure supplement 1) during naturalistic movie watching, whereas its functional involvement was comparatively minor during controlled tasks. This significant relevance to behavior verifies that the base state cannot simply be a byproduct of the model. We speculate that susceptibility to both external and internal information is maximized in the base state—allowing for roughly equal weighting of both sides so that they can be integrated to form a coherent representation of the world—at the expense of the stability of a certain functional network (Cocchi et al., 2017; Fagerholm et al., 2015). When processing rich narratives, particularly when a person is fully immersed without having to exert cognitive effort, a less modular state with high degrees of freedom to reach other states may be more likely to be involved. The role of the base state should be further investigated in future studies.”
- P16 L13-L17 unnecessary
We prefer to have the last paragraph as a summary of the implications of this paper. However, if the length of this paper becomes a problem as we work towards publication with the editors, we are happy to remove these lines.
- I think this paper is solid, but my main issue is with using an HMM, never explaining why, not showing inference results on test data, not reporting an R^2 score for it, and not comparing it to other models. Secondly, they use the Calinski-Harabasz score to determine the number of states, but not the log-likelihood of the fit. This clearly creates a bias in what types of states you will find, namely states that are far away from each other, which likely also leads to the functional gradient and PCA results they have. Where they specifically talk about how their states are far away from each other in the functional gradient space and correlated to (orthogonal) components. It is completely unclear to me why they used this measure because it also seems to be one of many scores you could use with respect to clustering (with potentially different results), and even odd in the presence of a loglikelihood fit to the data and with the model they use (which does not perform clustering).
(1) Showing inference results on test data
We address this concern on page 19-21 of this response letter.
(2) Not reporting 𝑹𝟐 score
We address this concern on page 21-23 of this response letter.
(3) Not comparing the HMM model to other models
We address this concern on page 27-28 of this response letter.
(4) The use of the Calinski-Harabasz score to determine the number of states rather than the log-likelihood of the model fit
To our knowledge, the log-likelihood of the model fit is not used in the HMM literature. It is because the log-likelihood tends to increase monotonically as the number of states increases. Baker et al. (2014) illustrates this problem, writing:
“In theory, it should be possible to pick the optimal number of states by selecting the model with the greatest (negative) free energy. In practice however, we observe that the free energy increases monotonically up to K = 15 states, suggesting that the Bayes-optimal model may require an even higher number of states.”
Similarly, the following figure is the log-likelihood estimated from the SONG dataset. Similar to the findings of Baker et al. (2014), the log-likelihood monotonically increased as the number of states increased (Author response image 8, right). The measures like AIC or BIC, which account for the number of parameters, also have the same issue of monotonic increase.
Author response image 8.
Because there is “no straightforward data-driven approach to model order selection” (Baker et al., 2014), past work has used different approaches to decide on the number of states. For example, Vidaurre et al. (2018) iterated over a range of the number of states to repeat the same HMM training and inference procedures 5 times using the same hyperparameters. They selected the number of states that showed the highest consistency across iterations. Gao et al. (2021) tested the clustering performance of the model output using the Calinski-Harabasz score. The number of states that showed the highest within-cluster cohesion compared to the across-cluster separation was selected as the number of states. Chang et al. (2021) applied HMM to voxels of the ventromedial prefrontal cortex using a similar clustering algorithm, writing: “To determine the number of states for the HMM estimation procedure, we identified the number of states that maximized the average within-state spatial similarity relative to the average between-state similarity”. In our previous paper (Song et al., 2021b), we reported both the reliability and clustering performance measures to decide on the number of states.
In the current manuscript, the model consistency criterion from Vidaurre et al. (2018) was ineffective because the HMM inference was extremely robust (i.e., always inferring the exact same sequence) due to a large number of data points. Thus, we used the Calinski-Harabasz score as our criterion for the number of states selected.
We agree with the reviewer that the selection of the number of states is critical to any study that implements HMM. However, the field lacks a consensus on how to decide on the number of states in the HMM, and the Calinski-Harabasz score has been validated in previous studies. Most importantly, the latent states’ relationships with behavioral and cognitive measures give strong evidence that the latent states are indeed meaningful states. Again, we are not arguing that the optimal set of states in any dataset will be four nor are we arguing that these four states will always be the optimal states. Instead, the manuscript proposes that a small number of latent states explains meaningful variance in cognitive dynamics.
- Grammatical error: P24 L29 rendering seems to have gone wrong
Our intention was correct here. To avoid confusion, we changed “(number of participantsC2 iterations)” to “(#𝐶!iterations, where N=number of participants)” (page 26 in the manuscript).
Questions:
- Comment on subject differences, it seems like they potentially found group dynamics based on stimuli, but interesting to see individual differences in large-scale dynamics, and do they believe the states they find mostly explain global linear dynamics?
We agree with the reviewer that whether low-dimensional latent state dynamics explain individual differences—above and beyond what could be explained by the high-dimensional, temporally static neural signatures of individuals (e.g., Finn et al., 2015)—is an important research question. However, because the SONG dataset was collected in a single lab, with a focus on covering diverse contexts (rest, task, and movie watching) over 2 sessions, we were only able to collect 27 participants. Due to this small sample size, we focused on investigating group-level, shared temporal dynamics and across-condition differences, rather than on investigating individual differences.
Past work has studied individual differences (e.g., behavioral traits like well-being, intelligence, and personality) using the HMM (Vidaurre et al., 2017). In the lab, we are working on a project that investigates latent state dynamics in relation to individual differences in clinical symptoms using the Healthy Brain Network dataset (Ji et al., 2022, presented at SfN; Alexander et al., 2017).
Finally, the reviewer raises an interesting question about whether the latent state sequence that was derived here mostly explains global linear dynamics as opposed to nonlinear dynamics. We have two responses: one methodological and one theoretical. First, methodologically, we defined the emission probabilities as a linear mixture of Gaussian distributions for each input dimension with the state-specific mean (mean fMRI activity patterns of the networks) and variance (functional covariance across networks). Therefore, states are modeled with an assumption of linearity of feature combinations. Theoretically, recent work supports in favor of nonlinearity of large-scale neural dynamics, especially as tasks get richer and more complex (Cunningham and Yu, 2014; Gao et al., 2021). However, whether low-dimensional latent states should be modeled nonlinearly—that is, whether linear algorithms are insufficient at capturing latent states compared to nonlinear algorithms—is still unknown. We agree with the reviewer that the assumption of linearity is an interesting topic in systems neuroscience. However, together with prior work which showed how numerous algorithms—either linear or nonlinear—recapitulated a common set of latent states, we argue that the HMM provides a strong low-dimensional model of large-scale neural activity and interaction.
- P19 L40 why did the authors interpolate incorrect or no-responses for the gradCPT runs? It seems more logical to correct their results for these responses or to throw them out since interpolation can induce huge biases in these cases because the data is likely not missing at completely random.
Interpolating the RTs of the trials without responses (omission errors and incorrect trials) is a standardized protocol for analyzing gradCPT data (Esterman et al., 2013; Fortenbaugh et al., 2018, 2015; Jayakumar et al., 2023; Rosenberg et al., 2013; Terashima et al., 2021; Yamashita et al., 2021). The choice of this analysis is due to an assumption that sustained attention is a continuous attentional state; the RT, a proxy for the attentional state in the gradCPT literature, is a noisy measure of a smoothed, continuous attentional state. Thus, the RTs of the trials without responses are interpolated and the RT time courses are smoothed by convolving with a gaussian kernel.
References
Abbas A, Belloy M, Kashyap A, Billings J, Nezafati M, Schumacher EH, Keilholz S. 2019. Quasiperiodic patterns contribute to functional connectivity in the brain. Neuroimage 191:193–204.
Alexander LM, Escalera J, Ai L, Andreotti C, Febre K, Mangone A, Vega-Potler N, Langer N, Alexander A, Kovacs M, Litke S, O’Hagan B, Andersen J, Bronstein B, Bui A, Bushey M, Butler H, Castagna V, Camacho N, Chan E, Citera D, Clucas J, Cohen S, Dufek S, Eaves M, Fradera B, Gardner J, Grant-Villegas N, Green G, Gregory C, Hart E, Harris S, Horton M, Kahn D, Kabotyanski K, Karmel B, Kelly SP, Kleinman K, Koo B, Kramer E, Lennon E, Lord C, Mantello G, Margolis A, Merikangas KR, Milham J, Minniti G, Neuhaus R, Levine A, Osman Y, Parra LC, Pugh KR, Racanello A, Restrepo A, Saltzman T, Septimus B, Tobe R, Waltz R, Williams A, Yeo A, Castellanos FX, Klein A, Paus T, Leventhal BL, Craddock RC, Koplewicz HS, Milham MP. 2017. Data Descriptor: An open resource for transdiagnostic research in pediatric mental health and learning disorders. Sci Data 4:1–26.
Allen EA, Damaraju E, Plis SM, Erhardt EB, Eichele T, Calhoun VD. 2014. Tracking whole-brain connectivity dynamics in the resting state. Cereb Cortex 24:663–676.
Baker AP, Brookes MJ, Rezek IA, Smith SM, Behrens T, Probert Smith PJ, Woolrich M. 2014. Fast transient networks in spontaneous human brain activity. Elife 3:e01867.
Bolt T, Nomi JS, Bzdok D, Salas JA, Chang C, Yeo BTT, Uddin LQ, Keilholz SD. 2022. A Parsimonious Description of Global Functional Brain Organization in Three Spatiotemporal Patterns. Nat Neurosci 25:1093–1103.
Brown JA, Lee AJ, Pasquini L, Seeley WW. 2021. A dynamic gradient architecture generates brain activity states. Neuroimage 261:119526.
Chang C, Leopold DA, Schölvinck ML, Mandelkow H, Picchioni D, Liu X, Ye FQ, Turchi JN, Duyn JH. 2016. Tracking brain arousal fluctuations with fMRI. Proc Natl Acad Sci U S A 113:4518–4523.
Chang CHC, Lazaridi C, Yeshurun Y, Norman KA, Hasson U. 2021. Relating the past with the present: Information integration and segregation during ongoing narrative processing. J Cogn Neurosci 33:1–23.
Chang LJ, Jolly E, Cheong JH, Rapuano K, Greenstein N, Chen P-HA, Manning JR. 2021. Endogenous variation in ventromedial prefrontal cortex state dynamics during naturalistic viewing reflects affective experience. Sci Adv 7:eabf7129.
Chen J, Leong YC, Honey CJ, Yong CH, Norman KA, Hasson U. 2017. Shared memories reveal shared structure in neural activity across individuals. Nat Neurosci 20:115–125.
Chen S, Langley J, Chen X, Hu X. 2016. Spatiotemporal Modeling of Brain Dynamics Using RestingState Functional Magnetic Resonance Imaging with Gaussian Hidden Markov Model. Brain Connect 6:326–334.
Cocchi L, Gollo LL, Zalesky A, Breakspear M. 2017. Criticality in the brain: A synthesis of neurobiology, models and cognition. Prog Neurobiol 158:132–152.
Cornblath EJ, Ashourvan A, Kim JZ, Betzel RF, Ciric R, Adebimpe A, Baum GL, He X, Ruparel K, Moore TM, Gur RC, Gur RE, Shinohara RT, Roalf DR, Satterthwaite TD, Bassett DS. 2020. Temporal sequences of brain activity at rest are constrained by white matter structure and modulated by cognitive demands. Commun Biol 3:261.
Cunningham JP, Yu BM. 2014. Dimensionality reduction for large-scale neural recordings. Nat Neurosci 17:1500–1509.
Deco G, Kringelbach ML, Jirsa VK, Ritter P. 2017. The dynamics of resting fluctuations in the brain: Metastability and its dynamical cortical core. Sci Rep 7:3095.
Esterman M, Noonan SK, Rosenberg M, Degutis J. 2013. In the zone or zoning out? Tracking behavioral and neural fluctuations during sustained attention. Cereb Cortex 23:2712–2723.
Esterman M, Rothlein D. 2019. Models of sustained attention. Curr Opin Psychol 29:174–180.
Fagerholm ED, Lorenz R, Scott G, Dinov M, Hellyer PJ, Mirzaei N, Leeson C, Carmichael DW, Sharp DJ, Shew WL, Leech R. 2015. Cascades and cognitive state: Focused attention incurs subcritical dynamics. J Neurosci 35:4626–4634.
Falahpour M, Chang C, Wong CW, Liu TT. 2018. Template-based prediction of vigilance fluctuations in resting-state fMRI. Neuroimage 174:317–327.
Finn ES, Shen X, Scheinost D, Rosenberg MD, Huang J, Chun MM, Papademetris X, Constable RT. 2015. Functional connectome fingerprinting: Identifying individuals using patterns of brain connectivity. Nat Neurosci 18:1664–1671.
Fortenbaugh FC, Degutis J, Germine L, Wilmer JB, Grosso M, Russo K, Esterman M. 2015. Sustained attention across the life span in a sample of 10,000: Dissociating ability and strategy. Psychol Sci 26:1497–1510.
Fortenbaugh FC, Rothlein D, McGlinchey R, DeGutis J, Esterman M. 2018. Tracking behavioral and neural fluctuations during sustained attention: A robust replication and extension. Neuroimage 171:148–164.
Fox MD, Snyder AZ, Vincent JL, Corbetta M, Van Essen DC, Raichle ME. 2005. The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci U S A 102:9673–9678.
Gao S, Mishne G, Scheinost D. 2021. Nonlinear manifold learning in functional magnetic resonance imaging uncovers a low-dimensional space of brain dynamics. Hum Brain Mapp 42:4510–4524.
Goodale SE, Ahmed N, Zhao C, de Zwart JA, Özbay PS, Picchioni D, Duyn J, Englot DJ, Morgan VL, Chang C. 2021. Fmri-based detection of alertness predicts behavioral response variability. Elife 10:1–20.
Greene AS, Horien C, Barson D, Scheinost D, Constable RT. 2023. Why is everyone talking about brain state? Trends Neurosci.
Greene DJ, Marek S, Gordon EM, Siegel JS, Gratton C, Laumann TO, Gilmore AW, Berg JJ, Nguyen AL, Dierker D, Van AN, Ortega M, Newbold DJ, Hampton JM, Nielsen AN, McDermott KB, Roland JL, Norris SA, Nelson SM, Snyder AZ, Schlaggar BL, Petersen SE, Dosenbach NUF. 2020. Integrative and Network-Specific Connectivity of the Basal Ganglia and Thalamus Defined in Individuals. Neuron 105:742-758.e6.
Gu S, Pasqualetti F, Cieslak M, Telesford QK, Yu AB, Kahn AE, Medaglia JD, Vettel JM, Miller MB, Grafton ST, Bassett DS. 2015. Controllability of structural brain networks. Nat Commun 6:8414.
Jayakumar M, Balusu C, Aly M. 2023. Attentional fluctuations and the temporal organization of memory. Cognition 235:105408.
Ji E, Lee JE, Hong SJ, Shim W (2022). Idiosyncrasy of latent neural state dynamic in ASD during movie watching. Poster presented at the Society for Neuroscience 2022 Annual Meeting.
Karapanagiotidis T, Vidaurre D, Quinn AJ, Vatansever D, Poerio GL, Turnbull A, Ho NSP, Leech R, Bernhardt BC, Jefferies E, Margulies DS, Nichols TE, Woolrich MW, Smallwood J. 2020. The psychological correlates of distinct neural states occurring during wakeful rest. Sci Rep 10:1–11.
Liu X, Duyn JH. 2013. Time-varying functional network information extracted from brief instances of spontaneous brain activity. Proc Natl Acad Sci U S A 110:4392–4397.
Liu X, Zhang N, Chang C, Duyn JH. 2018. Co-activation patterns in resting-state fMRI signals. Neuroimage 180:485–494.
Lynn CW, Cornblath EJ, Papadopoulos L, Bertolero MA, Bassett DS. 2021. Broken detailed balance and entropy production in the human brain. Proc Natl Acad Sci 118:e2109889118.
Margulies DS, Ghosh SS, Goulas A, Falkiewicz M, Huntenburg JM, Langs G, Bezgin G, Eickhoff SB, Castellanos FX, Petrides M, Jefferies E, Smallwood J. 2016. Situating the default-mode network along a principal gradient of macroscale cortical organization. Proc Natl Acad Sci U S A 113:12574–12579.
Mesulam MM. 1998. From sensation to cognition. Brain 121:1013–1052.
Munn BR, Müller EJ, Wainstein G, Shine JM. 2021. The ascending arousal system shapes neural dynamics to mediate awareness of cognitive states. Nat Commun 12:1–9.
Raut R V., Snyder AZ, Mitra A, Yellin D, Fujii N, Malach R, Raichle ME. 2021. Global waves synchronize the brain’s functional systems with fluctuating arousal. Sci Adv 7.
Rosenberg M, Noonan S, DeGutis J, Esterman M. 2013. Sustaining visual attention in the face of distraction: A novel gradual-onset continuous performance task. Attention, Perception, Psychophys 75:426–439.
Rosenberg MD, Finn ES, Scheinost D, Papademetris X, Shen X, Constable RT, Chun MM. 2016. A neuromarker of sustained attention from whole-brain functional connectivity. Nat Neurosci 19:165–171.
Rosenberg MD, Scheinost D, Greene AS, Avery EW, Kwon YH, Finn ES, Ramani R, Qiu M, Todd Constable R, Chun MM. 2020. Functional connectivity predicts changes in attention observed across minutes, days, and months. Proc Natl Acad Sci U S A 117:3797–3807.
Saggar M, Shine JM, Liégeois R, Dosenbach NUF, Fair D. 2022. Precision dynamical mapping using topological data analysis reveals a hub-like transition state at rest. Nat Commun 13.
Schaefer A, Kong R, Gordon EM, Laumann TO, Zuo X-N, Holmes AJ, Eickhoff SB, Yeo BTT. 2018. Local-Global Parcellation of the Human Cerebral Cortex from Intrinsic Functional Connectivity MRI. Cereb Cortex 28:3095–3114.
Shine JM. 2019. Neuromodulatory Influences on Integration and Segregation in the Brain. Trends Cogn Sci 23:572–583.
Shine JM, Bissett PG, Bell PT, Koyejo O, Balsters JH, Gorgolewski KJ, Moodie CA, Poldrack RA. 2016. The Dynamics of Functional Brain Networks: Integrated Network States during Cognitive Task Performance. Neuron 92:544–554.
Shine JM, Breakspear M, Bell PT, Ehgoetz Martens K, Shine R, Koyejo O, Sporns O, Poldrack RA. 2019. Human cognition involves the dynamic integration of neural activity and neuromodulatory systems. Nat Neurosci 22:289–296.
Smith SM, Fox PT, Miller KL, Glahn DC, Fox PM, Mackay CE, Filippini N, Watkins KE, Toro R, Laird AR, Beckmann CF. 2009. Correspondence of the brain’s functional architecture during activation and rest. Proc Natl Acad Sci 106:13040–13045.
Song H, Emily FS, Rosenberg MD. 2021a. Neural signatures of attentional engagement during narratives and its consequences for event memory. Proc Natl Acad Sci 118:e2021905118.
Song H, Park B-Y, Park H, Shim WM. 2021b. Cognitive and Neural State Dynamics of Narrative Comprehension. J Neurosci 41:8972–8990.
Taghia J, Cai W, Ryali S, Kochalka J, Nicholas J, Chen T, Menon V. 2018. Uncovering hidden brain state dynamics that regulate performance and decision-making during cognition. Nat Commun 9:2505.
Terashima H, Kihara K, Kawahara JI, Kondo HM. 2021. Common principles underlie the fluctuation of auditory and visual sustained attention. Q J Exp Psychol 74:705–715.
Tian Y, Margulies DS, Breakspear M, Zalesky A. 2020. Topographic organization of the human subcortex unveiled with functional connectivity gradients. Nat Neurosci 23:1421–1432.
Turnbull A, Karapanagiotidis T, Wang HT, Bernhardt BC, Leech R, Margulies D, Schooler J, Jefferies E, Smallwood J. 2020. Reductions in task positive neural systems occur with the passage of time and are associated with changes in ongoing thought. Sci Rep 10:1–10.
Unsworth N, Robison MK. 2018. Tracking arousal state and mind wandering with pupillometry. Cogn Affect Behav Neurosci 18:638–664.
Unsworth N, Robison MK. 2016. Pupillary correlates of lapses of sustained attention. Cogn Affect Behav Neurosci 16:601–615.
van der Meer JN, Breakspear M, Chang LJ, Sonkusare S, Cocchi L. 2020. Movie viewing elicits rich and reliable brain state dynamics. Nat Commun 11:1–14.
Van Essen DC, Smith SM, Barch DM, Behrens TEJ, Yacoub E, Ugurbil K. 2013. The WU-Minn Human Connectome Project: An overview. Neuroimage 80:62–79.
Vidaurre D, Abeysuriya R, Becker R, Quinn AJ, Alfaro-Almagro F, Smith SM, Woolrich MW. 2018. Discovering dynamic brain networks from big data in rest and task. Neuroimage, Brain Connectivity Dynamics 180:646–656.
Vidaurre D, Smith SM, Woolrich MW. 2017. Brain network dynamics are hierarchically organized in time. Proc Natl Acad Sci U S A 114:12827–12832.
Yamashita A, Rothlein D, Kucyi A, Valera EM, Esterman M. 2021. Brain state-based detection of attentional fluctuations and their modulation. Neuroimage 236:118072.
Yeo BTT, Krienen FM, Sepulcre J, Sabuncu MR, Lashkari D, Hollinshead M, Roffman JL, Smoller JW, Zöllei L, Polimeni JR, Fisch B, Liu H, Buckner RL. 2011. The organization of the human cerebral cortex estimated by intrinsic functional connectivity. J Neurophysiol 106:1125–1165.
Yousefi B, Keilholz S. 2021. Propagating patterns of intrinsic activity along macroscale gradients coordinate functional connections across the whole brain. Neuroimage 231:117827.
Zhang S, Goodale SE, Gold BP, Morgan VL, Englot DJ, Chang C. 2023. Vigilance associates with the low-dimensional structure of fMRI data. Neuroimage 267.
-
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
Here the authors set out to disentangle neural responses to acoustic and linguistic aspects of speech. Participants heard a short story, which could be in a language they understood or did not (French vs. Dutch stories, presented to Dutch listeners). Additional predictors included a combination of acoustic and linguistic factors: Acoustic, Phoneme Onsets, Phoneme Surprisal, Phoneme Entropy and, Word Frequency. Accuracy of reconstruction of the acoustic amplitude envelope was used as an outcome measure.
The use of continuous speech and the use of comprehended vs. uncomprehended speech are both significant strengths of the approach. Overall, the analyses are largely appropriate to answer the questions posed.
1) The reconstruction accuracies (e.g., R^2 values Figure 1) seem lower perhaps than might be expected - some direct comparisons with prior literature would be welcome here. Specifically, the accuracies in Figure 1A are around .002-.003 whereas the range seen in some other papers is about an order of magnitude or more larger (e.g. Broderick et al. 2019 J Neurosci; Ding and Simon 2013 J Neurosci).
We thank the reviewer for their constructive comments and careful review of our paper. The important point the reviewer makes stems from whether the reconstruction accuracies presented are from the whole brain/sensor space (as in our submission) or from selected channels (Broderick) or selected sources (Ding & Simon). Moreover, we used R2 score for reconstruction accuracy which is generally of a different order of magnitude than correlation coefficients (as used in Ding and Simon 2013). Crucially when we now selected the “auditory cortex,” we can also report reconstruction accuracies around the language network on the same scale as in the previous studies. In Figure 2 A and B (Figure 1 in the first version of the manuscript), we took the average of model accuracies of each source point over whole brain, without selecting any region of interest, to investigate if each speech feature is incrementally increasing the averaged model accuracy which was a more conservative method than selecting the sources with a stronger response to the stimuli (e.g., the average R2 value over all participants of acoustic model in auditory cortex for French stories is 0.01187 and it is 0.01315 for Dutch stories, which is similar in magnitude to e.g. Broderick et al. 2019 J Neuroscience). TRF accuracies on the brain regions outside of the language network are quite small, so the average accuracy on Figure 2 A and B is almost an order of magnitude lower than previous studies. (Ding and Simon 2013 J Neurosci : “To reduce computational complexity, the MEG sensors in each hemisphere were compressed into 3 components using denoising source separation”, averaged accuracy over all subjects is around 0.2 because they used both correlation as a measure of accuracy (not R2) and backward modeling (decoding) instead of forward modeling. Reconstruction accuracy of decoding models are usually higher than forward models; Broderick et al. 2019 J Neurosci: Averaged across frontocentral channels, averaged R2 over all subjects is 0.0171) Figure 2 C shows sources where accuracies of base acoustic model were significantly different than 0. Reconstruction accuracies around the language network is in the similar scale with the previous studies. Figure 2 D shows the sources where each feature significantly improved the reconstruction accuracy compared to the previous model. Accuracy values are smaller than the accuracies of base acoustic model because they are the values that shows how much each speech feature incrementally increased the accuracy. (E.g Phoneme onset accuracy = (Accuracy of the model Acoustic features + Phoneme Onset) – (Accuracy of the model Acoustic Features). Figure captions are updated on the manuscript.
Figure 2. A) Accuracy improvement (averaged over the sources in whole brain) by each feature for Dutch Stories B) Accuracy improvement (averaged over the sources in whole brain) by each feature for French Stories (Braces in Figure A and B shows the significance values of the contrasts (difference between consecutive models, ** <0.0001, *** <0.001, <0.01, * < 0.05) in linear mixed effect models (Table 2 and 3) C) Source points where accuracies of base acoustic model were significantly different than 0 D) Source points where reconstruction accuracies of the model were significantly different than previous model. Accuracy values shows how much each linguistic feature increased the reconstruction accuracy compared to the previous model.
2) One theoretical point relevant to this and similar studies concerns the use of acoustic envelope reconstruction accuracy as the dependent measure. On the one hand, reconstruction accuracy provides an objective measure of "success", and a satisfying link between stimulus and brain activity. On the other hand, as the authors point out, envelope reconstruction is probably not the primary goal of listeners in a conversation: comprehension is. Some discussion of the implications of envelope reconstruction accuracy might be useful in guiding interpretation of the current work, and importantly, helping the field as a whole grapple with this issue.
Overall, the results support the authors' conclusions that acoustic edges and phoneme features are treated differently depending on whether a listener comprehends the language being spoken. In particular, phoneme features contribute to a greater degree when language is comprehended, whereas acoustic edges contribute similarly regardless of comprehension. These findings are important in part because of prior work suggesting that acoustic edges are critically important for "chunking" continuous speech into linguistic units; the current results re-center language units (phonemes) as critical to comprehension.
Reviewer #2 (Public Review):
In this study, the authors used an audiobook listening paradigm and encoding analysis of MEG to examine the independent contributions to MEG responses of putative acoustic and phoneme-level linguistic features in speech and their modulation by higher-level sentence/discourse constraints and language proficiency. The results indicate that:
1) Acoustic and phoneme features do indeed make independent contributions to MEG responses in frontotemporal language regions (with a left-hemisphere bias for phoneme features).
2) Brain responses to acoustic and phoneme features are enhanced when sentence/discourse constraints are low (i.e. when word entropy is high).
3) While brain responses to phoneme features are enhanced when the language is comprehended (or word entropy is high), the opposite is observed for acoustic features.
These results are taken to support widely held views on the nature of information flow during language processing. On the one hand, processing is hierarchical, consistent with finding 1 above. On the other hand, information flow between lower and high-levels of language processing is also flexible and interactive (finding 2) and modulated by behavioural goals (finding 3).
This is a methodologically sophisticated study with useful findings that I think will be of interest to the burgeoning community investigating 'neural speech tracking' and also to the wider community interested in language processing and predictive coding. Moreover, the evidence appears convincing.
I thought the impact was somewhat limited by the results presentation, which I think missed some key details and made the study somewhat hard to follow (but this issue can be addressed).
Perhaps more major, I do wonder about the novelty of the study as each of the main findings has precedent in the literature. Finding 1 (e.g. Brodbeck, Simon et al.), Finding 2 (e.g. Broderick, Lalor et al.; Molinaro et al.), Finding 3 (e.g. Brodbeck, Simon et al. although here the manipulation of behavioural goals was through a cocktail party listening manipulation and there were was no opposing modulation of acoustic vs phoneme level representations). Thus, while the study appears well executed, overall I am unsure how significant the advance is. Related to this point, the study's findings and theoretical interpretations (e.g. the brain as a hierarchical 'filter') are consistent with widely held views of language processing (at least within cognitive neuroscience) and so again I question the potential advance of the study.
We are thanking the reviewer for bringing this up. While we started our work with the aim to replicate these patterns seem in the literature – which is especially important in the burgeoning area of neural tracking of speech and language - our key extension of these findings is that we can show that phonemic features are encoded more strongly both in a comprehended language compared to an uncomprehended language, and as a function of word-level statistical information, and that there is a tradeoff between acoustic and linguistic features encoding. As the Reviewer mentions, there is a patchwork of consistent findings from very different experimental circumstances, but in order to have strong evidence for the “tradeoff” of hierarchical feature encoding, it is even more crucial to have a design where features can directly compared as we do, and where acoustic differences are carefully controlled in contrast to the presence of linguistic features and language comprehension.
While our results are consistent with Molinaro et al. (2021). – as we also provide support for a cost minimization perspective rather than the perception facilitation perspective discussed in Molinaro et al. - it is important to note that Molinaro et al. only examined the tracking of acoustic features, specifically the speech envelope, using the Phase Locking Value, and did not examine the contribution of lower-level linguistic features. Secondly, Molinaro et al. use a condition-based experimental design in contrast to our naturalistic stimulus approach. In our study, our aim was to investigate the dynamics of encoding both acoustic and linguistic features, and we utilized a multivariate linear regression method on low and high constraining words which ‘naturally’ occurred in our audiobook stimulus across languages. Our results revealed a trade-off between the encoding of acoustic and linguistic features that was dependent on the level of comprehension. Specifically, in the comprehended language, the predictability of the following word had a greater influence on the tracking of phoneme features as opposed to acoustic features, while in the uncomprehended language, this trend was reversed. To best of our knowledge, Brodbeck et al. (2020) showed an effect of attention on the tracking of acoustic features only in cocktail party problem but didn’t investigate the encoding of linguistic features. Brodbeck et al. (2018) showed that linguistic features are represented only in the attended speech but they didn’t explicitly compare the acoustics features as in the previous study. Both studies used a mixed speech and investigated the effect of attention rather than comprehension. In our study, we investigated the effect of comprehension where both stimuli were attended. We found that even in the uncomprehended language, linguistic features are represented as opposed to unattended speech in Brodbeck et al. (2018) study, however it was less strong than the comprehended language. Additionally, one of the goals in this study was to investigate the effect of context on the representations of acoustic and phoneme level features. Opposing modulation of acoustic and phonemic features in our study was driven by the contextual information. However, as we also mentioned in the discussion, we don’t expect the effect of context on the uncomprehended language so the modulation of acoustic features could be related to statistical chunking of acoustic signal for frequent words, essentially reflecting recognition of those single function words such as le, la, un, une.
We have now revised the Discussion (we revised manuscript as highlighted in red in this text) to clarify the advance of this study and how this study adds more on previous studies.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
eLife assessment
Mizukami et al. propose a scenario for the evolutionary origin of the coronary artery in amniotes by comparing the morphologies of the vasculatures across several species and developmental timepoints. They show that the coronary arteries of non-amniotes most closely resemble embryonic amniote aortic subepicardial vessels (ASVs), which are replaced by the true coronary arteries during amniote development. While the identification of common vascular structures in diverse taxa is a valuable contribution, additional developmental evidence is needed to confirm that such vessels are truly homologous.
We have extensively revised our paper by including additional animal data and references. While we were unable to obtain useful data on lungfish or coelacanth, we have obtained new data related to the physiology of coronary artery, which has been added to Fig. 7. We have also attempted to compare blood vessels at the molecular level, but found that gene expression patterns in blood vessels throughout the body were not always conserved between lineages, making it difficult to make comparisons between amphibians and amniotes. However, based on comparative morphological analysis using newly added three-dimensional data, it is reasonable to consider the amniotes' ASVs and amphibians' ASV-like vessels to be homologous.
Reviewer #3 (Public Review):
Mizukami et al. compare the structure of the coronary arteries in multiple species of amniotes, amphibians, and fish. By selecting species from each of these taxa, the authors were able to evaluate modifications to the coronary arteries during key evolutionary transitions. In mice and quail, they show two populations of vessels that are visible on the developing heart-true coronary arteries on the ventricle and a second population of vessels on the outflow tract known as the ASV., They found that in amphibians, outflow tract vessels were present but ventricular coronary arteries were completely absent. In zebrafish (a more ancestral species) an arterial branch off the rostral section of the hypobranchial artery was shown to have similar anatomical features to outflow tract vessels found in higher organisms. These zebrafish outflow tract arteries also appeared conserved in several chondriichthyes specimens. The authors conclude that rearrangement of the outflow tract vasculature or hypobranchial arteries in fish during evolution, could be homologous to the ASV population of coronary arteries in amphibians and amniotes. These data give new insight into the evolutionary origins of the coronary vasculature.
Major Points
1) The manuscript presents important data on the coronary vascular structure of several different species. However, these data alone do not conclusively demonstrate whether the developmental origins of ASV like vessels are homologous. Therefore, care should be taken when concluding that the outflow tract vessels found in all different species are conserved features. While this is a reasonable hypothesis and should be presented, the manuscript could be improved by also discussing alternate explanations. For example, ASVs in mice originate during embryonic development, while in fish and amphibians outflow tract vessels are formed only in mature animals.
We have added data on mice and amphibians (e.g., Fig. 2) and substantially revised the overall development and discussion of the paper. Morphological homology is evident for ASVs and amphibian ASV-like vessels, but the homologous relationship with the hypobranchial artery only suggests a similarity in the embryonic region.
Comparisons of developmental timings of the various structures among diferent lineages of vertebrates reveal that heterochronical shifts are not uncommon. For example, ossification of the head skeleton and vertebrae occurs during the fetal stage in amniotes, but after hatching in larval amphibians and teleosts. A similar trend is observed in the development of the limb bud (paired fins). Overall, the larval stages of amphibians and teleosts are comparable to the fetal stages of amniotes for many structures. We did not suppose this to be particularly unusual, and we did not include it in the text.
2) Figure 3 A-D: The authors state that "the ASV ran through the outflow tract, then entered the aortic root before reaching the ventricle to form a secondary orifice". Do the authors have serial sections to conclude that the vessel branching off the carotid runs the length of the aorta and is continuous with an orifice at the aortic root? The endothelial projection off the aorta in panel C could reasonably be an independent projection. For example, Chen et al., described similar looking projections in the base of the aorta that were not attached to external vessels. A whole mount approach would be the most convincing to show the attachments of the ASV vessel.
We added the data of the whole-mount immunohistochemistry. Please refer Figs. 2 and S2.
3) Figure 3E: Similar as above, how is it concluded that the orifice is continuous with the ASV and that this projection is not the coronary artery stem?
As for quail, we could not achieve as a clear whole-mount staining as in mice. It was also difficult to trace the route in sections because in quail, ASVs are not restricted to a few lines as in mice, but are the plexus of small vessels. Thus, we added the detailed data from mice (Fig. 2, S2) and we emphasized that the position of orifice in quail is exactly same as that in mice.
4) The discussion section could be improved by making some statements more consistent, using more precise or appropriate terminology accepted in the field, and being more cognizant of how the authors' findings fit within the history of the field. For example, when referring to coronary arteries, please clarify whether this refers to ASV/ outflow tract coronary arteries, or true ventricular coronary arteries. In addition, the first sentence of the discussion makes it seem like the origins of coronary arteries were unknown prior to this study, however, their origins have been described in multiple papers previously. The authors could revise their statement to acknowledge these previous findings.
We rewrote the entire text to clarify what each "coronary artery" refers to. We also changed the first section of the discussion as suggested by the reviewer.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
The following is the authors' response to the current reviews.
We appreciate the thoughtful critiques of the reviewers. While we agree that performing additional experiments and analyses probing the sensitivity of the technique would be useful for future studies, we are unable to perform additional experiments as our lab has closed. We share this technique as a starting point for further investigation, but it may need to be modified for success in other contexts. We have provided details of the scenarios (life stage, feeding, day, number of ticks) where we successfully sequenced B. burgdorferi from ticks, as well as one where we did not (unfed nymphs) as a starting point. We will clarify in proofing that our qPCR experiments show that we capture the vast majority of B. burgdorferi flaB mRNA from our input samples, suggesting that we are likely capturing the majority of the B. burgdorferi.
In this work, we were most interested in using RNA-seq to perform differential expression analysis between annotated mRNAs across our timepoints. We have provided the number of genes detected in each sample (92% of annotated transcripts on average) as well as the median number of reads covering each gene (604 on average) in the supplemental file containing sequencing statistics. This coverage is highly reproducible across replicates, with an average Pearson correlation of 0.99 between gene expression levels (as Transcripts Per Million) between any two replicates. These data and the fact that many of the gene expression changes we observed align with previous observations of others give us confidence in our differential expression analysis. For those interested in tRNAs or sRNAs, we think that it would be best to modify the protocol to focus specifically on capturing those sequences in the library preparation. We encourage others interested in other aspects of our data to download it and explore it.
We will correct remaining wording issues in proofing.
—————
The following is the authors' response to the original reviews.
Dear Reviewing Editor,
We thank you and the reviewers for the thoughtful comments on our manuscript, and we are excited to submit a revised version of our manuscript “Longitudinal map of transcriptome changes in the Lyme pathogen Borrelia burgdorferi during tick-borne transmission.” In response to the reviews, we have made the following changes to our manuscript:
-
We updated the text for increased clarity around experimental details, including statistical analyses.
-
We added additional details about the mapping of non-Bb reads as well as more information about Bb read coverage.
-
We compared our differentially expressed genes to 4 previous studies of global transcriptional changes in different tick feeding contexts.
-
We updated the discussion to address these comparisons as well as caveats of our study more directly.
Please see our responses to individual comments below.
Reviewer #1 (Public Review):
In this study, Sapiro et al sought to develop technology for a transcriptomic analysis of B. burgdorferi directly from infected ticks. The methodology has exciting implications to better understand pathogen RNA profiles during specific infection timepoints, even beyond the Lyme spirochete. The authors demonstrate successful sequencing of the B. burgdorferi transcriptome from ticks and perform mass spectrometry to identify possible tick proteins that interact with B. burgdorferi. This technology and first dataset will be useful for the field. The study is limited in that no transcripts/proteins are followed-up by additional experiments and no biological interactions/infectious-processes are investigated.
Critiques and Questions:
We thank the reviewer for these thoughtful critiques and helping us improve our manuscript.
This study largely develops a method and is a resource article. This should be more directly stated in the abstract/introduction.
We edited the abstract and introduction to more directly state that we are sharing a new method and a resource for future investigations. (Lines 29-32; 101-103)
Details of the infection experiment are currently unclear and more information in the results section is warranted. State the species of tick and life-stage (larval vs nymphal ticks) used for experiments. For RNA-seq, are mice are infected and ticks are naïve or are ticks infected and transmitting Borrelia to uninfected mice?
We updated the results section to more clearly state the tick species and life stage and to make it more clear that infected ticks are transmitting Bb to naïve mice. (Lines 113-115)
What is the limit of detection for this protocol? Experimental data should be provided about the number of B. burgdorferi required to perform this approach.
We performed this protocol on pools of 6 (for later feeding stages) to 14 (for early stages) infected nymphs. Published studies (PMID: 7485694, PMID: 11682544) suggest that one day after attachment, there may be a few thousand Bb per tick, suggesting what we’ve measured here may come from on the order of 104 Bb. We were not able to capture consistent data from Bb from unfed ticks, which may be due to lower numbers or to an altered transcriptional state caused by lack of nutrients in the unfed tick. We updated the discussion to reflect some of these limitations and uncertainties. (Lines 461-465)
More information regarding RNA-seq coverage is required. Line 147-148 "read coverage was sufficient"; what defines sufficient? Browser images of RNA-seq data across different genes would be useful to visualize the read coverage per gene. What is the distribution of reads among tRNAs, mRNAs, UTRs, and sRNAs?
As we were interested in differential expression analysis, we defined sufficient as the number of reads needed per gene to determine statistically significant expression changes across days, which with DESeq2 is typically 10 reads. We reworded this section for clarity and added additional information about the median number of reads per gene which is also useful in thinking about differential expression analysis. (Lines 163-170) As we chose to focus on differential expression analysis here, we believe these are most relevant metrics to cover.
My lab group was excited about the data generated from this paper. Therefore, we downloaded the raw RNA-seq data from GEO and ran it through our RNA-seq computational pipeline. Our QC analysis revealed that day 4 samples have a different GC% pattern and that a high percentage of E. coli sequences were detected. This should be further investigated and addressed in the paper: Are other bacteria being enriched by this method? Why would this be unique to day 4 samples? Does this affect data interpretation?
We appreciate the interest in our data and pointing out this anomaly. We found that the day 4 samples do have a high percentage of reads that mapped to a bacterial species, Pseudomonas fulva, rather than ticks as we expected. (The reads that map to E. coli also map to P. fulva.) We have updated the results to include this information (Lines 156-165). We believe this is likely due to contamination from collecting ticks after they have fallen off mice in cages on day 4, rather than pulling ticks off the mice as in days 1-3. Unfortunately, as our lab has shut down, we cannot investigate the source further. We do think the high percentage of P. fulva reads suggests that other bacteria can be enriched with the anti-Bb antibody we used. We’ve updated the discussion to highlight this caveat. (Lines 459-460)
While the presence of these bacterial reads did lower our overall Bb mapping rate and necessitate deeper sequencing for the day 4 samples, the Bb sequencing coverage of these samples is on par with samples from the other days in terms of percentage of genes with at least 10 reads and median number of reads per gene. Fewer than 0.0002% of the reads that map to Bb genes in any day 4 sample also map to P. fulva. We found that this small fraction of reads is dispersed across 334 genes in which an average of 0.05% (maximally 2.3%) of day 4 reads also map to P. fulva. Therefore, these bacterial reads do not change our interpretation of the results comparing gene expression across days, including day 4.
Comprehensive data comparisons of this study and others are warranted. While the authors note examples of known differentially expressed genes (like lines 235-241), how does this global study compare to other global approaches? Are new expression patterns emerging with this RNA-seq approach compared to other methods? What differences emerged from day 1 to day 4 ticks compared to differences observed in unfed to fed ticks or fed ticks to DMC experiments? Directly compare to the following studies (PMID: 11830671; PMID: 25425211; PMID: 36649080.
We added comparisons of our list of DE genes to those noted to change between “unfed tick” and “fed tick” culture conditions (PMID: 11830671 and 12654782), as well as fed nymph to DMC (PMID: 25425211 and 36649080) (Lines 231-252, Figure S4). These comparisons pointed us to two main findings: that global changes to Bb in different culture conditions generally agreed with the most dramatic changes we saw in our data, and that the timing of expression increases during feeding may relate to whether genes are more highly expressed in fed ticks or in mammalian conditions. Overall, the majority of our DE genes have been identified in at least one of these studies or in the other studies we compared to outlining RpoS, Rrp1, and RelBbu regulons. As many of these studies were asking slightly different questions and using different conditions and vastly different technology, we would expect some differences to arise from different contexts and some to be purely technical. The genes that were not seen in these previous studies tended to follow the same functional patterns we saw overall, heavily skewing towards genes of unknown function, outer surface proteins, and a handful of genes related to other functions. With the current state of the functional annotation of the genome, it is difficult to assess whether these amount to new expression patterns in and of themselves, so we focused on the overall trends in our data rather than those that were different from other studies.
Details about the categorization of gene functions should be further described. The authors use functional analysis from Drechtrah et al., 2015, but that study also lacks details of how that annotation file was generated. Here, the authors have seemed to supplement the Drechtrah et al., 2015 list with bacteriophage and lipoprotein predictions - which are the same categories they focus their findings. Have they introduced a bias to these functional groups? While it can be noted that many lipoproteins are upregulated (or comment on specific genes classes), there are even more "unknown" proteins upregulated. I argue that not much can be inferred from functional analysis given the current annotation of the B. burgdorferi genome.
We strongly agree that the current annotation of the Bb genome makes it difficult to perform meaningful global functional analysis, but we feel it is useful to get a general overview of gene functions. We described our methods for classifying genes into functional categories in the methods, in which we relied on previously published papers to make our best estimate of gene category (noted for each gene in the Table S4). Due to the lack of annotations for many genes, we focused on the relatively well-defined category of lipoproteins, as these are overrepresented as a group in our upregulated genes, as well as phage genes, which are not necessarily overrepresented, but are still interesting to us. We hope that others will look at the data (particular in Table S4, but also Table S3, or download the raw data and do their own analysis) with their own interests and biases and dig more into genes that we did not highlight specifically. We provide this data as a resource with the hope that some of the genes of unknown function that we see change here will be the subject of future functional studies so that this is less of problem in the future.
Reviewer #1 (Recommendations For The Authors):
In general, the paper is well written and digestible for a broad audience. However, some of the figure graphics are unnecessary and take away from the data. Please label tick species and tick life-stage in Figure 1 drawings. The legend of Figure 1 requires citations. The Figure 4B graphic is unnecessary and the colors are confusing as they are too similar to the color palette of Figure 4A, where the colors have meaning. The Figure 5A graphic is unnecessary and takes away from the data embedded within it.
We more clearly labeled the species in Figure 1 and added citations to the legend. We have simplified Figures 4A and 5A for clarity.
Clarify lines 220-259 and Figure 3. What days are being compared? Downregulated genes should also be commented on.
We considered our set of differentially expressed genes as those that changed two-fold (multiple hypothesis adjusted p-value < 0.05) in any of the three comparisons shown in Figure 2 (day1 to day2, day1 to day3, day1 to day4). We clarified this at multiple points in the results (i.e Line 273). We commented on downregulated genes throughout, although as there were fewer genes and the magnitude of change was smaller, we focused more on upregulated genes.
Line 327-329, state numbers not percentages. How many Bb proteins were actually detected?
We updated this section to include numbers (Lines 371-374). In concordance with our sequencing data, we found (and were looking for) mainly tick proteins in this experiment.
Data availability: B. burgdorferi and tick oligo sequences used for DASH should be provided in a supplemental table.
We added a supplemental table of these sequences (Table S9). Please note they have been previously published in Dynerman et al. 2020 and Ring et al. 2022.
Reviewer #2 (Recommendations For The Authors):
The manuscript is overall well written and easy to follow. The data are compelling and support the conclusions. The discussion of this work is however highly insufficient and needs to be thoroughly edited:
- Statistical analysis: The authors mention that DESeq2 was used. Please provide information on the type and the stringency of the tests used for differential gene expression analysis, including any additional potential correction for p-values (Bonferroni). The authors mention that genes with fold changes >2 were used for analysis, yet there is no information on the p-value cut off or if the genes with fold changes >2 were statistically significant. Please provide detail and rationale for the analysis.
We clarified in the results and methods (Lines 200, 642-644) that we required a adjusted p-value < 0.05 from DESeq2’s Wald test with Benjamini-Hochberg correction along with a two-fold change when determining our genes of interest. As small fold changes showed statistically significant differences, we chose to set a fold change cutoff in most of our analysis to help us focus on the most highly expressed genes, like other studies we compared our data to. We included all of the DESeq2 results in Table S3 so that others may explore the data with different cutoffs if desired.
- The field has been generating data on gene expression in ticks for decades. Yet, many of these studies are not referenced here. There is no discussion of how the data described here compares to what is known in the literature. For example, Venn diagrams or tables could be included for comparison with the data described lines 208-216. Extensive description and comparison of the data to the literature should be added in the discussion, and similarities/discrepancies should be discussed appropriately.
We added additional comparisons to four different papers looking at global gene expression in Bb in the fed tick or tick-like culture conditions (Lines 231-252, Figure S4). This information as well as comparisons to transcriptional regulons (Figure S3) is available in Table S4. In addition to discussing some examples in the results, we added more information in the discussion regarding these comparisons (Lines 420-425). The majority of the genes that we see change over feeding have been previously noted to change expression during the enzootic cycle or be regulated by transcriptional programs active during this timeframe, and we have more clearly stated that. We focused on similarities here as these papers all ask slightly different questions in different contexts and use different technology which could all account for the many differences in individual genes between all of them and our work.
- There is no discussion of the caveats of the study: for example, the authors are using an anti-OspA antibody, which could induce bias. The authors provide in-vitro pull down data supporting that this should not be an issue, but the pull down is performed from BSK-grown bacteria. This caveat should be discussed.
We’ve added a paragraph to the discussion including this caveat and others (Lines 453-463).
- Timing of RNA extraction: There is over 1h of delay between initial tick collection and RNA fixation. The effects of time on gene expression should be discussed.
Although we were able to show that this timeframe did not affect cultured Bb gene expression, we added this to the discussion.
- Gene expression is compared to Day 1. This introduces analyses bias as it does not allow identification of transcripts that first change upon initial feeding. This caveat should also be discussed
We added this caveat – that we may miss gene expression changes in the first 24 hours of feeding – to the discussion.
- This study is performed with 1 strain of B. burgdorferi on one tick species. Please provide perspective on the impact of these findings on Lyme disease causing spirochetes and their vectors broadly.
We believe this method could be easily adaptable to study gene expression in other spirochete/vector pairs to determine similarities and differences and we added a comment to the discussion.
- The discussion should also include insights on how to build on this work and include additional areas of method development to increase the recovery of B. burgforferi from ticks or other organisms and facilitate future transcriptomic studies.
We added a few ideas to the discussion noting that this protocol could be modified for use in other timeframes, with other antibodies, or in other organisms. We also highlight the recent advent of TBDCapSeq by Grassmann et al. that may be used in conjunction with this type of protocol.
Minor comments:
- Consider re-wording the description of the methods and findings to the third person for coherence.
The majority of the methods are now written in third person.
- Over 90% of the reads did not map to B. burgdorferi: please provide additional information on what these reads mapped to (tick or mouse), and if the data reflects what is known in the literature
We have updated the results and discussion with information about the reads that do not map to Bb (Lines 156-166). The majority of reads mapped the tick genome, which is what we expected. While a large number of reads in our day 4 samples unexpectedly mapped to Pseudomonas fulva, we do not believe this affects the interpretation of our data as we were still able to get broad genome coverage of Bb in these samples.
- Please be more clear in the result section on the life stage of the ticks used for these studies.
We have updated the results to clarify throughout.
- Indicate how many total reads were generated for each sample
This information is present in Table S1.
- Provide statistical analyses for Figures 1C and D.
We added t tests to determine statistical differences for these panels.
Reviewing Editor (Recommendations for The Authors):
1. It is important to mention in the abstract (line 27) that 'upregulated genes' is in comparison to day 1. This is also true in the introduction (lines 92-93).
We updated in the results and introduction to more clearly include that day 1 is our baseline measurement.
2. It is also important to discuss in the manuscript that because your 'controls' are day 1 samples, initial transcriptome changes in response to the tick environment might be missed.
This has been added in the discussion as a caveat (Lines 460-463).
3. As someone who does not work with Bb, I would like to have seen a clearer description of what the feeding event looks like. Although there is some text in the introduction that touches on that ('prolonged nature of I. scapularis feeding'), I would like to see something even clearer. Maybe stating that feeding may take from x-y days would clarify that for the non-specialist.
We updated the results to more clearly state that the tick falls off of the mice by around 4 days after feeding, our last time point (Lines 113-115). Additional details of tick feeding are also in the Figure 1 legend.
4. In Fig. 3 linear DNA molecules seem to be drawn to scale. Is that also the case for plasmids? This could be clarified in the legend.
The genome is drawn approximately to scale. We noted this and updated the legend with more information about how linear and circular plasmid names denote their size.
5. Figure 5C: Colors are a bit confusing here. The legend indicates that they refer to fold changes, but the scale in the panel shows expression levels, not fold changes. Please clarify. Also, is this really TPM or RPKM? If comparisons of relative levels between different genes are made, number of reads should be normalized by gene length.
The heatmap in Figure 4C does show expression levels, and we updated the legend to more clearly state this. The highlighted gene names are meant to show which genes change two-fold during this time (those present in panel A). The data are presented as TPM (transcripts per million), which, like RPKM, is normalized by gene length (PMID: 20022975).
-
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
The following is the authors' response to the original reviews.
We have now incorporated the changes recommended by the reviewers to improve the interpretations and clarity of the manuscript. We are grateful for their thoughtful comments and suggestions, which have significantly strengthened the manuscript.
Reviewer #1 (Public Review):
Park et al demonstrate that cells on either side of a BM-BM linkage strengthen their adhesion to that matrix using a positive feedback mechanism involving a discoidin domain receptor (DDR-2) and integrin (INA-1 + PAT-3). In response to its extracellular ligand (Collagen IV/EMB-9), DDR-2 is endocytosed and initiates signaling that in turn stabilizes integrin at the membrane. DDR-2 signaling operates via Ras/LET-60. This work's strength lies in its excellent in vivo imaging, especially of endogenously tagged proteins. For example, tagged DDR-2:mNG could be seen relocating from seam cell membranes to endosomes. I also think a second strength of this system is the ability to chart the development of BM-BM linkage over time based on the stages of worm larval development. This allows the authors to show DDR signaling is needed to establish linkage, rather than maintain it. It likely is relevant to many types of cells that use integrin to adhere to BM and left me pondering a number of interesting questions.
We thank the reviewer for highlighting the strengths and impact of our work in expanding our understanding of tissue linkages and how DDR and integrins might work in other contexts.
For example: (1) Does DDR-2 activation require integrin? Perhaps integrin gets the process started and DDR-2 positively reinforces that (conversely is DDR-2 at the top of a linear pathway)?
DDR activation by receptor clustering upon exposure to its ligand collagen is well documented (Juskaite et al., 2017 eLife PMID: 285ti0245). Clustered DDR is rapidly internalized into endocytic vesicles, where full activation of tyrosine kinase activity is thought to occur (Fu et al., 2013 J Biol Chem PMID: 23335507). Supporting this model, we found that concentrated type IV collagen is required for vesicular DDR-2 localization in the utse and seam cells at the utse-seam connection. Whether DDR-2 activation requires integrin has not been fully established. However, one study using mouse and human cell lines showed that DDR1 activation occurs independent of integrin (Vogel et al., 2000 J Biol Chem PMID: 10681566), consistent with the latter possibility raised by the reviewer that DDR-2 is upstream of integrin.
To test these hypotheses, we require an experimental condition where loss or near complete loss of INA- 1 integrin is achieved by the mid-to-late L4 larval stage, when DDR-2 is activated by collagen and taken into endocytic vesicles. Currently, we can only partially deplete INA-1 by RNAi (Figure 5—figure supplement 2E), and strong loss of function mutations in ina-1 result in early larval arrest and lethality (Baum and Garriga, 1titi7 Neuron PMID: ti247263). To overcome these obstacles, we are adapting the new FLP-ON::TIR1 system developed for precise spatiotemporal protein degradation in worms (Xiao et al., 2023 Genetics PMID: 36722258). We hope to achieve a near complete knockdown of ina-1 with this timed depletion strategy. In the future, we will use this system to block DDR-2 and integrin function specifically in the utse or seam cells, to complement our current dominant negative mis-expression approach.
(2) In ddr-2(qy64) mutants, projections seem to form from the central portion of the utse cell. Does this reveal a second function for DDR-2, regulating perhaps the cytoskeleton?
We thank the reviewer for their observation and agree with their interpretation. We think it is important to comment on this and have stated in the results text, lines 208-212: “In addition, membrane projections emanating from the central body of the utse were detected in ddr-2(qy64) animals. These projections were first observed at the mid L4 stage and persisted to young adulthood (Figure 2C). These observations suggest that DDR-2 functions around the mid L4 to late L4 stages to promote utse-seam attachment, and that DDR-2 may also regulate utse morphology.”
And (3) can you use the forward genetic tools available in C. elegans to find new genes connecting DDR-2 and integrin?
This is an excellent suggestion. We found that loss of ddr-2 strongly enhanced the uterine prolapse (Rup) defect caused by RNAi mediated depletion of integrin. To find new genes connecting DDR-2 and integrin, a targeted screen for the Rup phenotype could be performed in an integrin reduction of function condition. As we cannot work with null or strong loss-of-function ina-1 alleles (described above), the screen could be conducted with either timed depletion of INA-1 with candidate RNAi treatments, or combinatorial ina-1 RNAi with candidate RNAi treatments.
I do see two areas where the manuscript could be improved. First, the authors rely on imprecise genetic methods to reach their conclusions (i.e. systemic RNAi, or expression of dominant negative constructs.) I think their conclusion would be stronger if they used tissue specific degradation to block ddr-2 function specifically in the utse or seam cells. Methods to do this are now regularly used in C. elegans and the authors have already developed the necessary tissue-specific promoters.
We agree with the reviewer that tissue specific degradation of DDR-2 in the utse and seam cells will complement and strengthen our evidence for the site of action of DDR-2. As described earlier, we are currently adapting the FLP-ON::TIR1 tissue degradation system to perform these experiments and will provide our findings in a follow-up manuscript.
Second, the manuscript is presented in the introduction as a study on formation and function of BM-BM linkage. The authors start the discussion in a similar manner. But their results are about adhesion between cells and BM. In fact they show the BM-BM linkage forms normally in ddr-2 mutants. Thus it seems like what they have really uncovered is an adhesion mechanism that works in parallel to the BM-BM linkage. Since ddr-2 appears to function equally in both utse + seam cells (based on their dominant negative data), there are likely three layers of adhesion (utse-BM, BM-BM, BM-seam) and if any of those break down, you get a partially penetrant rupture phenotype.
The reviewer raises an important and interesting point, and we agree that we did not articulate the organization of the utse-seam tissue connection clearly. The utse-seam connection is comprised of the utse and seam BMs each ~50nm thick, and a connecting matrix bridging the two BMs, which is ~100nm thick (Vogel and Hedgecock, 2001 Development PMID: 11222143). Type IV collagen builds up to high levels within the connecting matrix and links the utse and seam BMs, and its concentration is required for DDR-2 vesiculation. An important point we did not highlight is that type IV collagen is approximately 400 nm long (Timpl et al. 1ti81, Eur J Biochem PMID: 6274634). Thus, collagen molecules within the connecting matrix could span the entire length of the utse-seam connection and project into the utse and seam BMs to interact with cell surface receptors. Consistent with this possibility, we found that buildup of type IV collagen that spans the utse-seam BM-BM linkage correlated with the timing of DDR-2 activation/vesiculation within utse and seam cells. In addition, super-resolution imaging of the mouse kidney glomerular basement membrane (GBM), a tissue connection between endothelial BM and epithelial (podocyte) BM, showed type IV collagen, which spans the BMs, projects into the endothelial and podocyte BMs (Suleiman et al., 2013 eLife PMID: 24137544 ). We carefully considered these points to generate the schematics in Figure 1A and Figure 8, but failed to articulate this point in the manuscript. We are grateful for the reviewer for bringing up our error and have now stated these details in the text to address the reviewer’s concern as outlined below.
In the introduction (lines ti3-ti6): “A BM-BM tissue connection between the large, multinucleated uterine utse cell and epidermal seam cells stabilizes the uterus during egg laying. The utse-seam connection is formed by BMs of the utse and the seam cells, each ~50 nm thick, which are bridged by an ~100 nm connecting matrix (Vogel and Hedgecock 2001, Morrissey, Keeley et al. 2014, Gianakas, Keeley et al. 2023).”
In the discussion (lines 507-520): “We also found that internalization of DDR-2 at the utse-seam connection correlated with the assembly of type IV collagen at the BM-BM linkage and was dependent on type IV collagen deposition. Type IV collagen is ~400 nm in length and the utse-seam connecting matrix spans ~100 nm, while the utse and seam BMs are each ~50 nm thick (Timpl, Wiedemann et al. 1ti81, Vogel and Hedgecock 2001). Thus, collagen molecules in the connecting matrix could project into the utse and seam BMs to interact with DDR-2 on cell surfaces. Consistent with this possibility, super- resolution imaging of the mouse kidney glomerular basement membrane (tiBM), a tissue connection between podocytes and endothelial cells, showed type IV collagen within the tiBM projecting into the podocyte and endothelial BMs (Suleiman, Zhang et al. 2013). As DDR-2 is activated by ligand-induced clustering of the receptor (Juskaite, Corcoran et al. 2017, Corcoran, Juskaite et al. 201ti), it suggests that the BM-BM linking type IV collagen network, which is specifically assembled at high levels, clusters and activates DDR-2 in the utse and seam cells to coordinate cell-matrix adhesion at the tissue linkage site.”
These concerns do not undercut the significance of this work, which identifies an interesting mechanism cells use to strengthen adhesion during BM linkage formation. In fact, I am excited to read future papers detailing the connection between DDR-2 and integrin. But before undertaking those experiments the authors should be certain which cells require DDR-2 activity, and that should not be determined based solely on mis expression of a dominant negative.
We thank the reviewer for recognizing the significance of our work and reiterate that we will use tissue-specific degradation for site of action experiments in future studies on the biology of the utse- seam tissue linkage.
Reviewer #2 (Public Review):
This paper explores the mechanisms by which cells in tissues use the extracellular matrix (ECM) to reinforce and establish connections. This is a mechanistic and quantitative paper that uses imaging and genetics to establish that the Type IV collagen, DDR-2/collagen receptor discoidin domain receptor 2, signaling through Ras to strengthen an adhesion between two cell types in C. elegans. This connection needs to be strong and robust to withstand the pressure of the numerous eggs that pass through the uterus. The major strengths of this paper are in crisply designed and clear genetic experiments, beautiful imaging, and well supported conclusions. I find very few weaknesses, although, perhaps the evidence that DDR-2 promotes utse-seam linkage through regulation of MMPs could be stronger. This work is impactful because it shows how cells in vivo make and strengthen a connection between tissues through ECM interactions involving collaboration between discoidin and integrin.
We appreciate the reviewer’s assessment of the impact of our work in detailing a mechanism for how cells increase their adhesion to the ECM to establish connections between adjacent tissues. We have softened the interpretation of our MMP localization data to address the reviewer’s concern (detailed below).
Reviewer #1 (Recommendations For The Authors):
Regarding Figure 1D, is it possible to show when the BM forms on the cartoons more clearly (something like the 3rd section of Fig 3A)? I can see it in the timeline but it's hard to follow in the diagrams.
We agree with the reviewer that we could show when the BM-BM connecting matrix forms more clearly in Figure 1D. Hemicentin and fibulin, the earliest components of the connecting matrix, are detected at very low levels at the utse-seam connection during the mid-L4 stage and are more prominently localized by the mid-to-late L4 stage (Gianakas et al., 2023 J Cell Biol PMID: 36282214). For this reason, we only show the connecting matrix in yellow from the mid-to-late L4 stages onward. We have now made the BM-BM connection more prominent in the figure 1D cartoons with boxed outlines (similar to Figure 3A as the reviewer suggested). We also added a label for the time window when the BM-BM connection forms.
Regarding the RNAi induced prolapse phenotype, looking at 2B, it appears that between 5% and 10% of animals have uterine prolapse when fed control RNAi. Is this correct, it seems very high? This prolapse in control animals was not observed other RNAi experiments such as Figure 5C.
We thank the reviewer for pointing this out. For Figure 2B, the control used was wild-type N2 animals fed with OP50 E. coli bacteria, rather than HT115 bacteria carrying the L4440 empty vector (control RNAi). This is because the main comparisons were to five ddr-1 and ddr-2 mutant strains. We did notice a slightly higher baseline uterine prolapse frequency (5% on average, detailed in Figure 2—Source data 1) in wild-type animals fed OP50 bacteria, compared to HT115 bacteria fed animals (approximately 1-2% on average). It is possible this could be linked to the nutritional differences in the two bacterial strains. However, we are confident of our data in Figure 2B as we carried out 3 independent trials, and the uterine prolapse frequencies in ddr-1 mutant animals matched the baseline in wild-type animals, while the frequencies for ddr-2 mutants were all increased over the baseline in all trials (as detailed in Figure 2—Source data 1).
Relating to the point above, in reading the methods to try to understand how they did the RNAi, I noticed that they measure prolapse continually over five days. I didn't realize it takes a long time to occur. I think they should explain this in the text and in the figures. Reading the manuscript I thought prolapse occurred as soon as mutant animals began laying eggs. In the text they should explain this when they first assay the phenotype (page 7), and for figures the Y axis on the graphs could say "% uterine prolapse after 5 days."
We thank the reviewer for their suggestions. We did not articulate clearly that the utse-seam connection is able to withstand some mechanical stress, even when key components are lost. It’s only over time and repeated use that the connection breaks down. This is likely because a number of components contribute to the connection and as we have shown previously, there is feedback, such that when one components is reduced, such as collagen, hemicentin is increased in levels at the BM-BM connection. Since ruptures arising from utse-seam detachments typically occur sometime after the onset
of egg-laying, we screened the entire egg-laying period (days two to five post-L1) as described in Gianakas et al. 2023. We have now incorporated these points in the text and figures as follows:
In the introduction, we clarified that utse-seam BM-BM connection breaksdown over time, by adding (lines titi-105): “Hemicentin promotes the recruitment of type IV collagen, which accumulates at high levels at the BM-BM tissue connection and strengthens the adhesion, allowing it to resist the strong mechanical forces of egg-laying. The utse-seam connection is robust, with each component of the tissue- spanning matrix contributing to the BM-BM connection (Gianakas, Keeley et al. 2023). This likely accounts for the ability of the utse-seam connection to initially resist mechanical forces after loss of any one of these components, delaying the uterine prolapse phenotype until sometime after the initiation of egg-laying.”
We expanded the results text when we first describe the Rup phenotype (lines 183-184): “We first screened for the Rup phenotype caused by uterine prolapse, observing animals every day during the egg-laying period, from its onset (48 h post-L1) to end (120 h) (Methods)”.
We provided more detail in the Methods section (lines 784-7ti0): “Uterine prolapse frequency was assessed as described previously (Gianakas et al 2023). Briefly, synchronized L1 larvae were plated (~20 animals per plate) and after 24 h, the exact number of worms on each plate was recorded. Plates were then visually screened for ruptured worms (uterine prolapse) every 24 h during egg-laying (between 48 h to 120 h post-L1). We chose to examine the entire egg-laying period as ruptures arising from utse-seam detachments do not usually occur at the onset of egg-laying, but after cycles of egg-laying that place repeated mechanical stress on the utse-seam connection (Gianakas et al 2023).”
Finally, we modified the Y-axes of graphs in Figure 2B and 5C and the respective figure legends as suggested by the reviewer.
Then I went back and compared to the previous publication (Gianakas, 2023). I would be interested to see a time course of how many animals prolapse after 1 day, 2 days, etc.? Is this consistent with their data on hemicentrin?
We agree with the reviewer that a time course of uterine prolapse would be interesting as we saw ruptures occur throughout the egg-laying period. However, for the hemicentin knockdown experiments in Gianakas et al. 2023 as well as the experiments in this study, we recorded only the pooled number of animals with ruptures at the end of the experimental window. In future studies we will also record the uterine prolapse frequencies on each day to generate time courses that will provide more insight into the function of proteins at the utse-seam connection.
Lines 183-184: I'm not sure what it means to say "trended towards displaying a significant Rup phenotype?" Since the difference was not statistically significant, it would be better to say something like "increased but not statistically significant."
We agree with the reviewer and have now modified this sentence (lines 190-193): “Animals carrying the ddr-2(ok574) allele, which deletes a portion of the intracellular kinase domain (Unsoeld, Park et al. 2013),also showed an increased frequency of the Rup phenotype compared to wild-type animals, although this difference was not statistically significant (Figure 2A and B)”.
Line 186: 'penetrant' needs a qualifier to indicate the magnitude of the proportion of individuals with the phenotype.
As we provide the Rup frequency numbers in Figure 2—Source data 1, we modified the sentence as follows (lines 1ti3-1ti5): “We further generated a full-length ddr-2 deletion allele, ddr-2(qy64), and confirmed that complete loss of ddr-2 led to a significant uterine prolapse defect (Figure 2A and B).”
Lines 206-208; could the mounting/imaging procedure (which I assume requires squeezing the worm between agarose pad and coverslip) alter the occurrence of prolapse? I would think prolapse would occur more frequently under these conditions as compared to worms laying eggs on a plate.
The reviewer brings up an important concern. The mounting and imaging procedure does require placing the worm between an agarose pad and a coverslip. However, this did not alter the occurrence of uterine prolapse in this experiment. We were careful to perform the same procedure on both wild-type and ddr- 2(qy64) animals to control for this. As detailed in the manuscript, none of the eight wild-type animals we mounted underwent uterine prolapse after recovery off the coverslip, and among the ddr-2(qy64) mutants we mounted, only the ones that exhibited utse-seam detachments went on to rupture later.
We articulated these points more clearly by modifying lines 214-216 as follows: “Wild-type and ddr- 2(qy64) animals were mounted and imaged at the L4 larval stage for utse-seam attachment defects, recovered, and tracked to the 72-hour adult stage, where they were examined for the Rup phenotype.”
In seam cells you can see that DDR-2:mNG is present at membranes from early to mid L4, which makes sense. But I cannot see it on the membrane at any time point in the utse. Perhaps it is obscured by the yellow dotted line. Should it be visible on utse membranes before it is endocytosed?
The reviewer raises an interesting question. We think it is likely that DDR-2 is initially on the membrane of the utse like it is on the seam cells. However, we have not observed this, possibly due to the complex shape and thin membrane extensions of the utse. We are unable even to detect clear membrane enrichment of membrane markers in the utse (for example, compare the utse and seam membrane markers in Figure 3B). Thus, we refrained from speculating on DDR-2 utse membrane localization in the manuscript, and instead focused on the pattern of vesicular DDR-2 peaking at the late L4 stage, which was clearly visible in both the utse and seam cells.
Sup Fig 3A - please show quantification of seam cells not contacting utse at the same Y-axis scale as for regions that do contact utse.
We have modified the Y-axis scale for the quantification of the seam region not contacting the utse.
Figure 4A - I don't see a difference between WT and ok574 - what am I missing?
In the representative ok574 animal shown, a portion of the utse arm on the top right is detached from the seam. To make this phenotype clearer, we have recropped the image panels, readjusted the brightness and contrast of the utse and the seam, and redrawn the outline of the detachment to make this clearer.
Figure 4C+D, and lines 296-298: I'd bet that both are needed to recruit DDR-2 to membranes. But him-4 has a more severe phenotype because the RNAi knockdown is much more effective (perhaps b/c they are using the newer t444t vector).
We agree with the reviewer that the him-4 knockdown phenotype is likely more severe than emb-9 knockdown. Type IV collagen at the utse-seam connection is very stable compared to hemicentin (Gianakas et al 2023, J Cell Biol PMID: 36282214, see Fig. 5C), which could explain the lower knockdown efficiency.
We modified our interpretation of the data in the text as follows (lines 308-312): “In addition, we did not detect DDR-2 at the cell surface, suggesting that hemicentin has a role in recruiting DDR-2 to the site of utse-seam attachment. It is possible that collagen could also function in DDR-2 recruitment, but we could not assess this definitively due to the lower knockdown efficiency of emb-9 RNAi (Figure 4—figure supplement 1A).”
Reviewer #2 (Recommendations For The Authors):
Line 218 DDR-2 (typo)
We have corrected this typo.
Evidence (line 344-348) may not be strong enough to say whether or not DDR-2 promotes utse- seam linkage through regulation of MMPs.
We agree with the reviewer and have softened our conclusions as follows (lines 356-363): “The C. elegans genome harbors six MMP genes, named zinc metalloproteinase 1-6 (zmp-1-6) (Altincicek, Fischer et al. 2010). We examined four available reporters of ZMP localization (ZMP-1::tiFP, ZMP-2::tiFP, ZMP-3::tiFP, and ZMP-4::tiFP) (Kelley, Chi et al. 201ti).Only ZMP-4 was detected at the utse-seam connection and its localization was not altered by knockdown of ddr-2 (Figure 5—figure supplement 1F). These observations suggest that DDR-2 does not promote utse-seam linkage through regulation of MMPs, although we cannot rule out roles for DDR-2 in promoting the expression or localization of ZMP-5 or ZMP-6.”
The authors show the critical period is in late L4, however, is the signaling needed later too? For example, is the linkage strengthening moderated by DDR-2 important as more eggs accumulate?
The reviewer raises an interesting question. We observed that the vesicular localization of DDR-2 sharply declined before the onset of egg-laying. By young adulthood, very few punctate structures of DDR-2 were observed in the seam cells, and none in the utse (Figure 3B). Furthermore, the frequency of utse- seam detachments in ddr-2 mutant animals peaked by the late L4 stage and did not increase after this time, suggesting DDR function is no longer required after the late L4 stage (Figure 2D). Thus, we believe that DDR-2 signaling strengthens tissue linkage only during the early formation of the utse-seam connection between the mid and late L4 stage.
We incorporated these points in the discussion (lines 477-485): “Through analysis of genetic mutations in the C. elegans receptor tyrosine kinase (RTK) DDR-2, an ortholog to the two vertebrate DDR receptors (DDR1 & DDR2) (Unsoeld, Park et al. 2013), we discovered that loss of ddr-2 results in utse-seam detachment beginning at the mid L4 stage. The frequency of detachments in ddr-2 mutant animals peaked around the late L4 stage and did not increase after this time. This correlated with the levels of DDR-2::mNG at the utse-seam connection, which peaked at the late L4 stage and then sharply declined by adulthood. Together, these findings suggest that DDR-2 promotes utse-seam attachment in the early formation of the tissue connection between the mid and late L4 stage.”
Fig. 3B is the fluorescence quantification normalized to the area?
Yes, it is. We used mean fluorescence intensity for all fluorescence quantifications to normalize for the area where the signal was measured. We added a line in Methods to emphasize this (lines 73ti-740): “We measured mean fluorescence intensity for all quantifications in order to account for linescan area.”
Fig. 4B a statistical assessment of the degree of co-localization of DDR-2::mNG and the endosomal markers might be a nice addition.
We believe the reviewer is referring to Figure 3—figure supplement 1B. We have now added the statistical assessment of the degree of co-localization of DDR-2::mNG and the endosomal markers.
We want to sincerely thank the two reviewers for their thoughtful comments and suggestions. The changes we have made in response to these comments have substantially improved the manuscript.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
The following is the authors' response to the original reviews.
We appreciate the in depth review of our manuscript, and the excellent suggestions from the two reviewers. We have addressed all concerns as described in the point by point response below. We have also added all of these changes to a revised version posted to biorxiv on May 23rd 2023 (BIORXIV/2023/536585).
Reviewer #1 (Recommendations For The Authors):
It is sometimes difficult to connect the rationalizations behind the transitions between NB7 binding interaction, the compare/contrast of p84 and p101 effectors, and the synergy with phosphorylation. More explanation of the rationalizations behind these transitions in the Results would be helpful.
We agree that the manuscript would benefit from better transitions between the sections. We have added a new paragraph in the final section describing the nanobody structure before the helical domain phosphorylation that fully describes the rationale for how both inform on the critical role of helical domain dynamics in kinase activity. This paragraph is shown below.
‘The interface of NB7 with p110_g _is distant from both the putative membrane binding surface, as well as the catalytic machinery of the kinase domain. To further understand how this nanobody could so potently inhibit PI3K activity we examined any other potential modulators of PI3K activity localised in this region. There are two regulatory phosphorylation sites in the helical (Walser et al., 2013) and kinase domain (Perino et al., 2011) localised at the NB7 interface. This is intriguing as helical domain phosphorylation is activating, and kinase domain phosphorylation is inhibitory. This suggested a critical role in the regulation of p110_g _is the dynamics of this kinase-helical interface. To fully define the role of NB7 in altering the dynamics of the helical domain we needed to study other modulators of helical domain dynamics.’
The Methods section would benefit from careful copy editing for clarity and consistency.
We have gone through the methods section and edited for clarity and consistency throughout.
There's a minor ambiguity throughout when referring to the phosphorylation of S594/S595. Although close inspection makes it clear that this refers to the monophosphorylation of either site S594 or S595, there are several references to "S594/S595" that could be interpreted as phosphorylation of both residues.
We agree that this was ambiguous in the original text. We have added an explicit statement describing this as a single phosphorylation event.
‘The modification at this site results in a single phosphorylation event , but due to CID MS/MS fragmentation we cannot determine which site is modified, and will be described as S594/S595 throughout the manuscript.’
In Figure 2B, the authors show the cryo-EM density map and the structural model based on this map. It would be helpful to also include an image of the structural model fit in the density map to allow readers to evaluate the quality of the map and model. The 2F panel provides an important view of this fit, but CD3 models are difficult to discern.
We agree that this would help interpret model quality. We have added a new supplemental figure showing the fit of both p110 and NB7 into this Cryo EM density (see new Fig S2).
Paragraph starting at line 258: The shift to monitoring ATPase activity is confusing here. ATPase activity indicates production of ADP + phosphate (rather than ADP + PIP3). However, an explanation is provided that states that measuring ADP production serves as a surrogate for measuring PIP3 production. The apparent absence of membrane PIP2 substrate in Figure 4E (left) suggests that there is a true ATPase background activity in this kinase. If so, does the increase in ADP production in Fig. 4E reflect the inclusion of PIP2 substrate, increased background ATPase activity, or both?
We agree that this was worded confusingly in the original version. We have now clarified exactly what we are observing in these ATPase assays. The new paragraph is appended below
‘To further explore the potential role of phosphorylation in mediating p110g activity, we examined the kinase activity of p110g under two conditions: basal ATP turnover, and with PIP2 containing lipid membranes. The experiments in the absence of PIP2 measure turnover of ATP into ADP and phosphate, and is a readout of basal catalytic competency. Experiments with PIP2, measured ATP consumed in the generation of PIP3, as well as in non-productive ATP turnover. The p110g enzyme in the absence of stimulators is very weakly active towards PIP2 substrate with only ~2 fold increased ATP turnover compared to in the absence of membranes. This is consistent with very weak membrane recruitment of p110g complexes in the absence of lipid activators (Rathinaswamy et al., 2023). PKCb-mediated phosphorylation enhanced the ATPase activity of p110g ~2-fold in both the absence and presence of membranes (Fig. 4E). This suggests that the effect of phosphorylation is to change the intrinsic catalytic efficiency of phosphorylated p110g, with limited effect on membrane binding.’
In the section "Nanobody blocks p110gamma phosphorylation," it's not entirely convincing that "the presence of NB7 showed even lower phosphorylation than p110gamma-p101." This does not seem to be subject to a significance test in Figure 5A/B. The follow-up point about "complete abrogation of phosphorylation," however, is readily apparent.
We agree that we could have been more precise with our language, as this is not a complete block of phosphorylation, it is merely a significant decrease in phosphorylation. We have removed the comparison to p110-p101, and also removed the statement about complete abrogation of phosphorylation. This is now reworded to
‘The presence of NB7 showed a significant decrease in p110g phosphorylation at both sites (Fig. 5A-B).’
Figure 1: Legend needs to include more detail to define the data. (1A) Representations of variance need to be clarified (e.g., replicates, error bar meaning). Consider "Normalized lipid kinase activity" as a y-axis label and expand on the activity measurement and normalization in the legend. (1B) How was error calculated? (1C) Mislabeled as 1B? Also, consider clarifying the first title highlighting the comparison to class IA PI3Ks. (1D) Typo: "Y647-p84/p110gamma." Also, would it not be more accurate to say "effect of nanobody NB7 on PI3K displacement..." for this experiment?
We apologise for these oversights. See details on what has been changed in Fig 1A, 1B, 1C, and 1D.
For Fig 1A we now show the data where each replicate is indicated in the graph in the absence of error bars, and have also more clearly expanded on this activity measurement in the figure legend and also stated the replicate number.
For Fig 1B we now clearly state how the error was generated.
For Fig 1C we have fixed the typo
For Fig 1D, we have fixed this typo and also changed the sub-heading as suggested.
New figure legend is below as well
Figure 1. The inhibitory nanobody NB7 binds tightly to all p110γ complexes and inhibits kinase activity, but does not prevent membrane binding
A. Cartoon schematic depicting nanobody inhibition of activation by lipidated Gβγ (1.5 µM final concentration). Lipid kinase assays show a potent inhibition of lipid kinase activity with increasing concentrations of NB7 (3-3000 nM) for the different complexes. Experiments are carried out in triplicate (n=3) with each replicate shown. The y-axis shows lipid kinase activity normalised for each complex activated by Gβγ in the absence of nanobody. Concentrations of each protein were selected to give a lipid kinase value in the detectable range of the ATPase transcreener assay. The protein concentration of p110γ (300 nM), p110γ-p84 (330 nM) and p110γ-p101 (12 nM) was different due to intrinsic differences of each complex to be activated by lipidated Gβγ, and is likely mainly dependent for the difference seen in NB7 response.
B. Association and dissociation curves for the dose response of His-NB7 binding to p110γ, p110γ-p84 and p110γ-p101 (50 – 1.9 nM) is shown. A cartoon schematic of BLI analysis of the binding of immobilized His-NB7 to p110γ is shown on the left. Dissociation constants (KD) were calculated based on a global fit to a 1:1 model for the top three concentrations and averaged with error shown. Error was calculated from the association and dissociation value (n=3) with standard deviation shown. Full details are present in the source data.
C. Association and dissociation curves for His-NB7 binding to p110γ, p110a-p85a, p110b-p85b, and p110d-p85b. Experiments were performed in duplicate with a final concentration of 50 nM of each class I PI3K complex.
D. Effect of NB7 on PI3K recruitment to supported lipid bilayers containing H-Ras(GTP) and farnesyl-Gbg as measured by Total Internal Reflection Fluorescence Microscopy (TIRF-M). DY647-p84/p110g displays rapid equilibration kinetics and is insensitive to the addition of 500 nM nanobody (black arrow, 250 sec) on supported lipid bilayers containing H-Ras(GTP) and farnesyl-Gbg.
E. Kinetics of 50 nM DY647-p84/p110g membrane recruitment appears indistinguishable in the absence and presence of nanobody. Prior to sample injection, DY647-p84/p110g was incubated for 10 minutes with 500 nM nanobody.
F. Representative TIRF-M images showing the localization of 50 nM DY647-p84/p110g visualized in the absence or presence of 500 nM nanobody (+NB7). Membrane composition for panels C-E: 93% DOPC, 5% DOPS, 2% MCC-PE, Ras(GTP) covalently attached to MCC-PE, and 200 nM farnesyl-Gbg.
Figure 2: (1A) For consistency with the rest of the paper, p110g can be updated with the Greek character. (1B) This may have been intentional to attract attention to subdomains interacting with NB7, but "colored according to the schematic" omits the purple RBD. (2F) the figure legend should specify whether p110gamma surfaces depicted are the cryo-EM density or a surface rendition of the structural model.
We agree and have fixed the p110 typo, and have also colored the schematic the same as shown in the cartoon model.
The data shown in Fig 1B is indeed the Cryo EM density and this is now clearly indicated in the legend.
Figure 3: (3B) Specifying the [M+H] as [M+2H]2+ and [M+4H]4+ would help the reader understand the delta mass for monophosphorylation here. Given the broad readership of this journal, it would be useful to define 't' and 'e' as 'theoretical' and 'experimental' in the legend. It may also help to be explicit about the meaning of the red spectra and residues in the legend. (3C-E) autocorrect typo for "(C)" and an opportunity to update "b" for Greek character beta.
We agree that clearly defining the charge state of each spectra will make it more obvious that we are dealing with a mono-phosphorylation and have made this change as suggested in the figure. We have also clearly define m/z t and m/z e in the figure legend, as well as the black and red lines, and characters. Finally we have added PKCb for all descriptions of PKC treatment in the figure, and fixed the incorrect PKC’b’ in the legend.
Figure 4: (4C) Given the common use of "ND" for other terms, it would be useful to spell out "no deuterium" or "undeuterated." (4E) the parenthetical "(concentration, 12nM to 1000nM)" could be clarified. How are the (presumably p100gamma) concentration ranges reflected in the three plotted data points per treatment? See also Figure 5E.
We agree and have redefined ND as undeuterated. We apologise for the typo in the figure legend, as the concentrations of p110 gamma were the same for both phosphorylated and non-phosphorylated, with this being a typo (all concentrations of enzyme were 1000 nM). This has been changed here and in Fig 5E.
Figure 5: (5A/B) Some clarification that we're looking at extracted ion chromatograms would be very useful in this figure legend. On a related note, the experimental details on the LC-MS methodology for this data appear to be split between two sections of the Methods: the "Phosphorylation analysis" paragraph (line 526) and the HDX-MS section. Some more explicit cross-referencing would clarify this experiment. (5E) Clarify inclusion of PIP2 membranes here.
We have clearly described that we are looking at extracted ion chromatograms in both panel A and B. We also have normalized the experimental methods in the LC-MS as these used exactly the same procedure. Finally, we now clearly describe the assays shown in Fig 5E were performed in the absence of PIP2 membranes.
Miscellaneous typos:<br /> Line 205: reference omitted for "Previous study.."
We have added this reference
Line 196: "unambiguous"
Fixed to unambiguously
Reviewer #2 (Recommendations For The Authors):
The only mistake I spotted was that on line 729 there is a reference to Fig 3C that should actually be Fig. 4C
We have changed this to the correct Fig 4C.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
eLife assessment
In this valuable study, the authors investigate the mechanism of amyloid nucleation in a cellular system using their novel ratiometric measurements and uncover interesting insights regarding the role of polyglutamine length and the sequence features of glutamine-rich regions on amyloid formation. Overall, the problem is significant and being able to assess nucleation in cells is of considerable relevance. The data, as presented and analyzed, are currently still incomplete. The specific claims would be stronger if based on in vitro measurements that avoid the intricacies of specific cellular systems and that are more suitable for assessing sequence-intrinsic properties.
We are pleased that the editors find our study valuable. We find that the reviewers’ criticisms largely arise from misunderstandings inherent to the conceptually challenging nature of the topic, rather than fundamental flaws, as we will elaborate here. We are grateful for the opportunity afforded by eLife to engage reviewers in a constructive public dialogue.
Reviewer #1 (Public Review):
The authors take on the challenge of defining the core nucleus for amyloid formation by polyglutamine tracts. This rests on the assertion that polyQ forms amyloid structures to the exclusion of all other forms of solids. Using their unique assay, deployed in yeast, the authors attempt to infer the size of the nucleus that templates amyloid formation by polyQ. Further, through a series of sequence titrations, all studied using a single type of assay, the authors converge on an assertion stating that a single polyQ molecule is the nucleus for amyloid formation, that 12-residues make up the core of the nucleus, that it takes ca. 60 Qs in a row to unmask this nucleation potential, and that polyQ amyloid formation belongs to the same universality class as self-poisoned crystallization, which is the hallmark of crystallization from polymer melts formed by large, high molecular weight synthetic polymers. Unfortunately, the authors have decided to lean in hard on their assertions without a critical assessment of whether their findings stand up to scrutiny. If their findings are truly an intrinsic property of polyQ molecules, then their findings should be reconstituted in vitro. Unfortunately, careful and rigorous experiments in vitro show that there is a threshold concentration for forming fibrillar solids. This threshold concentration depends on the flanking sequence context on temperature and on solution conditions. The existence of a threshold concentration defies the expectation of a monomer nucleus. The findings disagree with in vitro data presented by Crick et al., and ignored by the authors. Please see: https://doi.org/10.1073/pnas.1320626110. These reports present data from very different assays, the importance of which was underscored first by Regina Murphy and colleagues. The work of Crick et al., provides a detailed thermodynamic framework - see the SI Appendix. This framework dove tails with theory and simulations of Zhang and Muthukumar, which explains exactly how a system like polyQ might work (https://doi.org/10.1063/1.3050295). The picture one paints is radically different from what the authors converge upon. One is inclined to lean toward data that are gleaned using multiple methods in vitro because the test tube does not have all the confounding effects of a cellular milieu, especially when it comes to focusing on sequence-intrinsic conformational transitions of a protein. In addition to concerns about the limitations of the DAmFRET method, which based on the work of the authors in their collaborative paper by Posey et al., are being stretched to the limit, there is the real possibility that the cellular milieu, unique to the system being studied, is enabling transitions that are not necessarily intrinsic to the sequence alone. A nod in this direction is the work of Marc Diamond, which showed that having stabilized the amyloid form of Tau through coacervation, there is a large barrier that limits the loss of amyloid-like structure for Tau. There may well be something similar going on with the polyQ system. If the authors could show that their data are achievable in vitro without anything but physiological buffers one would have more confidence in a model that appears to contradict basic physical principles of how homopolymers self-assemble. Absent such additional evidence, numerous statements seem to be too strong. There are also several claims that are difficult to understand or appreciate.
Rebuttal to the perceived necessity of in vitro experiments
The overarching concern of this reviewer and reviewing editor is whether in-cell assays can inform on sequence-intrinsic properties. We understand this concern. We believe however that the relative merit of in-cell assays is largely a matter of perspective. The truly sequence-intrinsic behavior of polyQ, i.e. in a vacuum, is less informative than the “sequence-intrinsic” behaviors of interest that emerge in the presence of extraneous molecules from the appropriate biological context. In vitro experiments typically include a tiny number of these -- water, ions, and sometimes a crowding agent meant to approximate everything else. Obviously missing are the myriad quinary interactions with other proteins that collectively round out the physiological solvent. The question is what experimental context best approximates that of a living human neuron under which the pathological sequence-dependent properties of polyQ manifest. We submit that a living yeast cell comes closer to that ideal than does buffer in a test tube.
The reviewer’s statements that our findings must be validated in vitro ignores the fact -- stressed in our introduction -- that decades of in vitro work have not yet generated definitive evidence for or against any specific nucleus model. In addition to the above, one major problem concerns the large sizes of in vitro systems that obscure the effects of primary nucleation. For example, a typical in vitro experimental volume of e.g. 1.5 ml is over one billion-fold larger than the femtoliter volume of a cell. This means that any nucleation-limited kinetics of relevant amyloid formation are lost, and any alternative amyloid polymorphs that have a kinetic growth advantage -- even if they nucleate at only a fraction the rate of relevant amyloid -- will tend to dominate the system (Buell, 2017). Novel approaches are clearly needed to address these problems. We present such an approach, stretch it to the limit (as the reviewer notes) across multiple complementary experiments, and arrive at a novel finding that is fully and uniquely consistent with all of our own data as well as the collective prior literature.
That the preceding considerations are collectively essential to understand relevant amyloid behavior is evident from recent cryoEM studies showing that in vitro-generated amyloid structures generally differ from those in patients (Arseni et al., 2022; Bansal et al., 2021; Radamaker et al., 2021; Schmidt et al., 2019; Schweighauser et al., 2020; Yang et al., 2022). This is highly relevant to the present discourse because each amyloid structure is thought to emanate from a different nucleating structure. This means that in vitro experiments have broadly missed the mark in terms of the relevant thermodynamic parameters that govern disease onset and progression. Note that the rules laid out via our studies are not only consistent with structural features of polyQ amyloid in cells, but also (as described in the discussion) explain why the endogenous structure of a physiologically relevant Q zipper amyloid differs from that of polyQ.
A recent collaboration between the Morimoto and Knowles groups (Sinnige et al.) investigated the kinetics of aggregation by Q40-YFP expressed in C. elegans body wall muscle cells, using quantitative approaches that have been well established for in vitro amyloid-forming systems of the type favored by the reviewer. They calculate a reaction order of just 1.6, slightly higher than what would be expected for a monomeric nucleus but nevertheless fully consistent with our own conclusions when one accounts for the following two aspects of their approach. First, the polyQ tract in their construct is flanked by short poly-Histidine tracts on both sides. These charges very likely disfavor monomeric nucleation because all possible configurations of a four-stranded bundle position the beginning and end of the Q tract in close proximity, and Q40 is only just long enough to achieve monomeric nucleation in the absence of such destabilization. Second, the protein is fused to YFP, a weak homodimer (Landgraf et al., 2012; Snapp et al., 2003). With these two considerations, our model -- which was generated from polyQ tracts lacking flanking charges or an oligomeric fusion -- predicts that amyloid nucleation by their construct will occur more frequently as a dimer than a monomer. Indeed, their observed reaction order of 1.6 supports a predominantly dimeric nucleus. Like us and others, Sinnige et al. did not observe phase separation prior to amyloid formation. This is important because it not only argues against nucleation occurring in a condensate, it also suggests that the reaction order they calculated has not been limited by the concentration-buffering effect of phase separation.
While we agree that our conclusions rest heavily on DAmFRET data (for good reason), we do provide supporting evidence from molecular dynamics simulations, SDD-AGE, and microscopy.
To summarize, given the extreme limitations of in vitro experiments in this field, the breadth of our current study, and supporting findings from another lab using rigorous quantitative approaches, we feel that our claims are justified without in vitro data.
Rebuttal to the perceived incompatibility of monomeric nucleation with the existence of a critical concentration for amyloid
We appreciate that the concept of a monomeric nucleus can superficially appear inconsistent with the fact that crystalline solids such as polyQ amyloid have a saturating concentration, but this is only true if one neglects that polyQ amyloids are polymer crystals with intramolecular ordering. The perceived discrepancy is perhaps most easily dispelled by protein crystallography. Folded proteins form crystals. These crystals have critical concentrations, and the protein subunits within them each have intramolecular crystalline order (in the form of secondary structure). To extrapolate these familiar examples to our present finding with polyQ, one need only appreciate the now well-established phenomenon of secondary nucleation, whereby transient interactions of soluble species with the ordered species leads to their own ordering (Törnquist et al., 2018). Transience is important here because it implies that intramolecular ordering can in principle propagate even in solutions that are subsaturated with respect to bulk crystallization. This is possible in the present case because the pairing of sufficiently short beta strands (equivalent to “stems” in the polymer crystal literature) will be more stable intramolecularly than intermolecularly, due to the reduced entropic penalty of the former. Our elucidation that Q zipper ordering can occur with shorter strands intramolecularly than intermolecularly (Fig. S4C-D) demonstrates this fact. It is also evident from published descriptions of single molecule “crystals” formed in sufficiently dilute solutions of sufficiently long polymers (Hong et al., 2015; Keller, 1957; Lauritzen and Hoffman, 1960).
In suggesting that a saturating concentration for amyloid rules out monomeric nucleation, the reviewer assumes that the Q zipper-containing monomer must be stable relative to the disordered ensemble. This is not inherent to our claim and in fact opposes the definition of a nucleus. The monomeric nucleating structure need not be more stable than the disordered state, and monomers may very well be disordered at equilibrium at low concentrations. To be clear, our claim requires that the Q zipper-containing monomer is both on pathway to amyloid and less stable than all subsequent species that are on pathway to amyloid. The former requirement is supported by our extensive mutational analysis. The latter requirement is supported by our atomistic simulations showing the Q zipper-containing monomer is stabilized by dimerization (see our 2021 preprint). Hence, requisite ordering in the nucleating monomer is stabilized by intermolecular interactions. We provide in Author response image 1 an illustration to clarify what we believe to be the discrepancy between our claim and the reviewer’s interpretation.
Author response image 1.
That the rate-limiting fluctuation for a crystalline phase can occur in a monomer can also be understood as a consequence of Ostwald’s rule of stages, which describes the general tendency of supersaturated solutes, including amyloid forming proteins (Chakraborty et al., 2023), to populate metastable phases en route to more stable phases (De Yoreo, 2022; Schmelzer and Abyzov, 2017). Our findings with polyQ are consistent with a general mechanism for Ostwald’s rule wherein the relative stabilities of competing polymorphs differ with the number of subunits (De Yoreo, 2022; Navrotsky, 2004). As illustrated in Fig. 6 of Navrotsky, a polymorph that is relatively stable at small particle sizes tends to give way to a polymorph that -- while initially unstable -- becomes more stable as the particles grow. The former is analogous to our early stage Q zipper composed of two short sheets with an intramolecular interface, while the latter is analogous to the later stage Q zipper composed of longer sheets with an intermolecular interface. Subunit addition stabilizes the latter more than the former, hence the initial Q zipper that is stabilized more by intra- than intermolecular interactions will mature with growth to one that is stabilized more by intermolecular interactions.
We apologize to the Pappu group for neglecting to cite Crick et al. 2013 in the current preprint. Contrary to the reviewer’s assessment, however, we find that the conclusions of this valuable study do more to support than to refute our findings. Briefly, Crick et al. investigated the aggregation of synthetic Q30 and Q40 peptides in vitro, wherein fibrils assembled from high concentrations of peptide were demonstrated to have saturating concentrations in the low micromolar range. As explained above, this finding of a saturating concentration does not refute our results. More relevant to the present work are their findings that “oligomers” accumulated over an hours-long timespan in solutions that are subsaturated with respect to fibrils, and these oligomers themselves have (nanomolar) critical concentrations. The authors postulated that the oligomers result from liquid–liquid demixing of intrinsically disordered polyglutamine. However, phase separation by a peptide is expected to fix its concentration in both the solute and condensed phases, and, because disordered phase separation is inherently faster than amyloid formation, the postulated explanation removes the driving force for any amyloid phase with a critical solubility greater than that of the oligomers. In place of this interpretation that truly does appear to -- in the reviewer’s words -- “contradict basic physical principles of how homopolymers self-assemble”, we interpret these oligomers as evidence of our Q zipper-containing self-poisoned multimers, rounded as an inherent consequence of self-poisoning (Ungar et al., 2005), and likely akin to semicrystalline spherulites that have been observed in other polymer crystal and amyloid-forming systems (Crist and Schultz, 2016; Vetri and Foderà, 2015). That Crick et al. also observed the formation of a relatively labile amyloid phase when the reactions were started with 50 uM peptide is unsurprising in light of the aforementioned kinetic advantage that large reaction volumes can confer to labile polymorphs, and that high concentrations (in this case, orders of magnitude higher than the likely physiological concentration of polyQ (Wild et al., 2015)) can favor the formation of labile amyloid polymorphs (Ohhashi et al., 2010). Indeed, a contemporaneous study by the Wetzel group using very similar peptide constructs and polyQ lengths -- but beginning with lower concentrations -- found that the relevant saturating concentrations for amyloid lie below their limit of detection of 100 nM (Sahoo et al., 2014).
Rebuttals to other critiques
The reviewer states that we found nucleation potential to require 60 Qs in a row. Our data are collectively consistent with nucleation occurring at and above approximately 36 Qs, a point repeated in the paper. The reviewer may be referring to our statement, ”Sixty residues proved to be the optimum length to observe both the pre- and post-nucleated states of polyQ in single experiments”. The purpose of this statement is simply to describe the practical consideration that led us to use 60 Qs for the bulk of our assays. We do appreciate that the fraction of AmFRET-positive cells is very low for lengths just above the threshold, especially Q40. They are nevertheless highly significant (p = 0.004 in [PIN+] cells, one-tailed T-test), and we will modify the figure and text to clarify this.
The reviewer characterizes self-poisoning as the hallmark of crystallization from polymer melts, which would be problematic for our conclusions if self-poisoning were limited to this non-physiological context. In fact the term was first used to describe crystallization from solution (Organ et al., 1989), wherein the phenomenon is more pronounced (Ungar et al., 2005).
Reviewer #2 (Public Review):
Numerous neurodegenerative diseases are thought to be driven by the aggregation of proteins into insoluble filaments known as "amyloids". Despite decades of research, the mechanism by which proteins convert from the soluble to insoluble state is poorly understood. In particular, the initial nucleation step is has proven especially elusive to both experiments and simulation. This is because the critical nucleus is thermodynamically unstable, and therefore, occurs too infrequently to directly observe. Furthermore, after nucleation much faster processes like growth and secondary nucleation dominate the kinetics, which makes it difficult to isolate the effects of the initial nucleation event. In this work Kandola et al. attempt to surmount these obstacles using individual yeast cells as microscopic reaction vessels. The large number of cells, and their small size, provides the statistics to separate the cells into pre- and post-nucleation populations, allowing them to obtain nucleation rates under physiological conditions. By systematically introducing mutations into the amyloid-forming polyglutamine core of huntingtin protein, they deduce the probable structure of the amyloid nucleus. This work shows that, despite the complexity of the cellular environment, the seemingly random effects of mutations can be understood with a relatively simple physical model. Furthermore, their model shows how amyloid nucleation and growth differ in significant ways, which provides testable hypotheses for probing how different steps in the aggregation pathway may lead to neurotoxicity.
In this study Kandola et al. probe the nucleation barrier by observing a bimodal distribution of cells that contain aggregates; the cells containing aggregates have had a stochastic fluctuation allowing the proteins to surmount the barrier, while those without aggregates have yet to have a fluctuation of suitable size. The authors confirm this interpretation with the selective manipulation of the PIN gene, which provides an amyloid template that allows the system to skip the nucleation event.
In simple systems lacking internal degrees of freedom (i.e., colloids or rigid molecules) the nucleation barrier comes from a significant entropic cost that comes from bringing molecules together. In large aggregates this entropic cost is balanced by attractive interactions between the particles, but small clusters are unable to form the extensive network of stabilizing contacts present in the larger aggregates. Therefore, the initial steps in nucleation incur an entropic cost without compensating attractive interactions (this imbalance can be described as a surface tension). When internal degrees of freedom are present, such as the conformational states of a polypeptide chain, there is an additional contribution to the barrier coming from the loss of conformational entropy required to the adopt aggregation-prone state(s). In such systems the clustering and conformational processes do not necessarily coincide, and a major challenge studying nucleation is to separate out these two contributions to the free energy barrier. Surprisingly, Kandola et al. find that the critical nucleus occurs within a single molecule. This means that the largest contribution to the barrier comes from the conformational entropy cost of adopting the beta-sheet state. Once this state is attained, additional molecules can be recruited with a much lower free energy barrier.
There are several caveats that come with this result. First, the height of the nucleation barrier(s) comes from the relative strength of the entropic costs compared to the binding affinities. This balance determines how large a nascent nucleus must grow before it can form interactions comparable to a mature aggregate. In amyloid nuclei the first three beta strands form immature contacts consisting of either side chain or backbone contacts, whereas the fourth strand is the first that is able to form both kinds of contacts (as in a mature fibril). This study used relatively long polypeptides of 60 amino acids. This is greater than the 20-40 amino acids found in amyloid-forming molecules like ABeta or IAPP. As a result, Kandola et al.'s molecules are able to fold enough times to create four beta strands and generate mature contacts intramolecularly. The authors make the plausible claim that these intramolecular folds explain the well-known length threshold (L~35) observed in polyQ diseases. The intramolecular folds reduce the importance of clustering multiple molecules together and increase the importance of the conformational states. Similarly, manipulating the sequence or molecular concentrations will be expected to manipulate the relative magnitude of the binding affinities and the clustering entropy, which will shift the relative heights of the entropic barriers.
The reviewer correctly notes that the majority of our manipulations were conducted with 60-residue long tracts (which corresponds to disease onset in early adulthood), and this length facilitates intramolecular nucleation. However, we also analyzed a length series of polyQ spanning the pathological threshold, as well as a synthetic sequence designed explicitly to test the model nucleus structure with a tract shorter than the pathological threshold, and both experiments corroborate our findings.
The authors make an important point that the structure of the nucleus does not necessarily resemble that of the mature fibril. They find that the critical nucleus has a serpentine structure that is required by the need to form four beta strands to get the first mature contacts. However, this structure comes at a cost because residues in the hairpins cannot form strong backbone or zipper interactions. Mature fibrils offer a beta sheet template that allows incoming molecules to form mature contacts immediately. Thus, it is expected that the role of the serpentine nucleus is to template a more extended beta sheet structure that is found in mature fibrils.
A second caveat of this work is the striking homogeneity of the nucleus structure they describe. This homogeneity is likely to be somewhat illusory. Homopolymers, like polyglutamine, have a discrete translational symmetry, which implies that the hairpins needed to form multiple beta sheets can occur at many places along the sequence. The asparagine residues introduced by the authors place limitations on where the hairpins can occur, and should be expected to increase structural homogeneity. Furthermore, the authors demonstrate that polyglutamine chains close to the minimum length of ~35 will have strict limitations on where the folds must occur in order to attain the required four beta strands.
We are unsure how to interpret the above statements as a caveat. We agree that increasing sequence complexity will tend to increase homogeneity, but this is exactly the motivation of our approach. We explicitly set out to determine the minimal complexity sequence sufficient to specify the nucleating conformation, which we ultimately identified in terms of secondary and tertiary structure. We do not specify which parts of a long polyQ tract correspond to which parts of the structure, because, as the reviewer points out, they can occur at many places. Hence, depending on the length of the polyQ tract, the nucleus we describe may have any length of sequence connecting the strand elements. We do not think that the effects of N-residue placement can be interpreted as a confounding influence on hairpin position because the striking even-odd pattern we observe implicates the sides of beta strands rather than the lengths. Moreover, we observe this pattern regardless of the residue used (Gly, Ser, Ala, and His in addition to Asn).
A novel result of this work is the observation of multiple concentration regimes in the nucleation rate. Specifically, they report a plateau-like regime at intermediate regimes in which the nucleation rate is insensitive to protein concentration. The authors attribute this effect to the "self-poisoning" phenomenon observed in growth of some crystals. This is a valid comparison because the homogeneity observed in NMR and crystallography structures of mature fibrils resemble a one-dimensional crystal. Furthermore, the typical elongation rate of amyloid fibrils (on the order of one molecule per second) is many orders of magnitude slower than the molecular collision rate (by factors of 10^6 or more), implying that the search for the beta-sheet state is very slow. This slow conformational search implies the presence of deep kinetic traps that would be prone to poisoning phenomena. However, the observation of poisoning in nucleation during nucleation is striking, particularly in consideration of the expected disorder and concentration sensitivity of the nucleus. Kandola et al.'s structural model of an ordered, intramolecular nucleus explains why the internal states responsible for poisoning are relevant in nucleation.
We thank the reviewer for noting the novelty and plausibility of the self-poisoning connection. We would like to elaborate on our finding that self-poisoning inhibits nucleation (in addition to elongation), as this could prove confusing to some readers. While self-poisoning is claimed to inhibit primary nucleation in the polymer crystal literature (Ungar et al., 2005; Zhang et al., 2018), the semantics of “nucleation” in this context warrants clarification. Technically, the same structure can be considered a nucleus in one context but not in another. The Q zipper monomer, even if it is rate-limiting for amyloid formation at low concentrations (and is therefore the “nucleus”), is not necessarily rate-limiting when self-poisoned at high concentrations. Whether it comprises the nucleus in this case depends on the rates of Q zipper formation relative to subunit addition to the poisoned state. If the latter happens slower than Q zipper formation de novo, it can be said that self-poisoning inhibits nucleation, regardless of whether the Q zipper formed. We suspect this to be the mechanism by which preemptive oligomerization blocks nucleation in the case of polyQ, though other mechanisms may be possible.
To achieve these results the authors used a novel approach involving a systematic series of simple sequences. This is significant because, while individual experiments showed seemingly random behavior, the randomness resolved into clear trends with the systematic approach. These trends provided clues to build a model and guide further experiments.
Reviewer #3 (Public Review):
Kandola et al. explore the important and difficult question regarding the initiating event that triggers (nucleates) amyloid fibril growth in glutamine-rich domains. The researchers use a fluorescence technique that they developed, dAMFRET, in a yeast system where they can manipulate the expression level over several orders of magnitude, and they can control the length of the polyglutamine domain as well as the insertion of interfering non-glutamine residues. Using flow cytometry, they can interrogate each of these yeast 'reactors' to test for self-assembly, as detected by FRET.
In the introduction, the authors provide a fairly thorough yet succinct review of the relevant literature into the mechanisms of polyglutamine-mediated aggregation over the last two decades. The presentation as well as the illustrations in Figure 1A and 1B are difficult to understand, and unfortunately, there is no clear description of the experimental technique that would allow the reader to connect the hypothetical illustrations to the measurement outcomes. The authors do not explain what the FRET signal specifically indicates or what its intensity is correlated to. FRET measures distance between donor and acceptor, but can it be reliably taken as an indicator of a specific beta-sheet conformation and of amyloid? Does the signal increase with both nucleation and with elongation, and is the signal intensity the same if, e.g., there were 5 aggregates of 10 monomers each versus 50 monomeric nuclei? Is there a reason why the AmFRET signal intensity decreases at longer Q even though the number of cells with positive signal increases? Does the number of positive cells increase with time? The authors state later that 'non-amyloid containing cells lacked AmFRET altogether', but this seems to be a tautology - isn't the lack of AmFRET taken as a proof of lack of amyloid? Overall, a clearer description of the experimental method and what is actually measured (and validation of the quantitative interpretation of the FRET signal) would greatly assist the reader in understanding and interpreting the data.
We believe the difficulty in understanding the illustrations in Figure 1A and 1B is inherent to the subject. We agree that elaborating how DAmFRET works would help the reader, and will add a few sentences to this end. Beyond this, we refer the reviewer and readers to our cited prior work describing the theory and interpretation of DAmFRET. Note that the y-axes of DAmFRET plots are not raw FRET but rather “AmFRET”, a ratio of FRET to total expression level. As explained thoroughly in our cited prior work, the discontinuity of AmFRET with expression level indicates that the high AmFRET-population formed via a disorder-to-order transition. When the query protein is predicted to be intrinsically disordered, the discontinuous transition to high AmFRET invariably (among hundreds of proteins tested in prior published and unpublished work) signifies amyloid formation as corroborated by SDD-AGE and tinctorial assays.
When performed using standard flow cytometry as in the present study, every AmFRET measurement corresponds to a cell-wide average, and hence does not directly inform on the distribution of the protein between different stoichiometric species. As there is only one fluorophore per protein molecule, monomeric nuclei have no signal. DAmFRET can distinguish cells expressing monomers from stable dimers from higher order oligomers (see e.g. Venkatesan et al. 2019), and we are therefore quite confident that AmFRET values of zero correspond to cells in which a vast majority of the respective protein is not in homo-oligomeric species (i.e. is monomeric or in hetero-complexes with endogenous proteins). The exact value of AmFRET, even for species with the same stoichiometry, will depend both on the effect of their respective geometries on the proximity of mEos3.1 fluorophores, and on the fraction of protein molecules in the species. Hence, we only attempt to interpret the plateau values of AmFRET (where the fraction of protein in an assembled state approaches unity) as directly informing on structure, as we did in Fig. S3A.
We believe that AmFRET decreases with longer polyQ because the mass fraction of fluorophore decreases in the aggregate, simply because the extra polypeptide takes up volume in the aggregate.
Yes, the fraction of positive cells in a discontinuous DAmFRET plot does increase with time. However, given the more laborious data collection and derivation of nucleation kinetics in a system with ongoing translation, especially across hundreds of experiments with other variables, ours is a snapshot measurement to approximately derive the relative contributions of intra- and intermolecular fluctuations to the nucleation barrier, rather than the barrier’s magnitude.
We will revise the tautological statement by removing “non-amyloid containing”.
The authors demonstrate that their assay shows that the fraction of cells with AmFRET signal increases strongly with an increase in polyQ length, with a 'threshold around 50-60 glutamines. This roughly correlates with the Q-length dependence of disease. The experiments in which asparagine or other amino acids are inserted at variable positions in the glutamine repeat are creative and thorough, and the data along with the simulations provide compelling support for the proposed Q zipper model. The experiments shown in Figure 5 are strongly supportive of a model where formation of the beta-sheet nucleus is within a monomer. This is a potentially important result, as there are conflicting data in the literature as to whether the nucleus in polyQ is monomer.
We thank the reviewer for these comments. We wish to clarify one important point, however, concerning the correlation of our data with the pathological length threshold. As we state in the first results section, “Our data recapitulated the pathologic threshold -- Q lengths 35 and shorter lacked AmFRET, indicating a failure to aggregate or even appreciably oligomerize, while Q lengths 40 and longer did acquire AmFRET in a length and concentration-dependent manner”. Hence, most of our experiments were conducted with 60Q not because it resembles the pathological threshold, but rather because it was most convenient for DAmFRET experiments.
I did not find the argument, that their data shows the Q zipper grows in two dimensions, compelling; there are more direct experimental methods to answer this question. I was also confused by the section that Q zippers poison themselves. It would be easier for the reader to follow if the authors first presented their results without interpretation. The data seem more consistent with an argument that, at high concentrations, non-structured polyQ oligomers form which interfere with elongation into structured amyloid assemblies - but such oligomers would not be zippers.
Self-poisoning is a widely observed and heavily studied phenomenon in polymer crystal physics, though it seems not yet to have entered the lexicon of amyloid biologists. We were new to this concept before it emerged as an extremely parsimonious explanation for our results. As described in the text, two pieces of evidence exclude the alternative mechanism suggested by the reviewer -- that non-structured oligomers form and subsequently engage and inhibit the template. Specifically, 1) inhibition occurs without any detectable FRET, even at high total protein concentration, indicating the species do not form in a concentration-dependent manner that would be expected of disordered oligomers; and 2) inhibition itself has strict sequence requirements that match those of Q zippers. Hence our data collectively suggest that inhibition is a consequence of the deposition of partially ordered molecules onto the templating surface.
Although some speculation or hypothesizing is perfectly appropriate in the discussion, overall the authors stretch this beyond what can be supported by the results. A couple of examples: The conclusion that toxicity arises from 'self-poisoned polymer crystals' is not warranted, as there is no relevant data presented in this manuscript. The authors refer to findings 'that kinetically arrested aggregates emerge from the same nucleating event responsible for amyloid formation', but I cannot recall any evidence for this statement in the results section.
We restricted any mention of toxicity to the introduction and a section in the discussion that is not worded as conclusive. Nevertheless, we will soften the subheading and text of the relevant section in the discussion to more clearly indicate the speculative nature of the statements.
We stand by our statement 'that kinetically arrested aggregates emerge from the same nucleating event responsible for amyloid formation', as this follows directly from self-poisoning.
Bibliography
Arseni D, Hasegawa M, Murzin AG, Kametani F, Arai M, Yoshida M, Ryskeldi-Falcon B. 2022. Structure of pathological TDP-43 filaments from ALS with FTLD. Nature 601:139–143. doi:10.1038/s41586-021-04199-3
Bansal A, Schmidt M, Rennegarbe M, Haupt C, Liberta F, Stecher S, Puscalau-Girtu I, Biedermann A, Fändrich M. 2021. AA amyloid fibrils from diseased tissue are structurally different from in vitro formed SAA fibrils. Nat Commun 12:1013. doi:10.1038/s41467-021-21129-z
Buell AK. 2017. The Nucleation of Protein Aggregates - From Crystals to Amyloid Fibrils. Int Rev Cell Mol Biol 329:187–226. doi:10.1016/bs.ircmb.2016.08.014
Chakraborty D, Straub JE, Thirumalai D. 2023. Energy landscapes of Aβ monomers are sculpted in accordance with Ostwald’s rule of stages. Sci Adv 9:eadd6921. doi:10.1126/sciadv.add6921 Crist B, Schultz JM. 2016. Polymer spherulites: A critical review. Prog Polym Sci 56:1–63. doi:10.1016/j.progpolymsci.2015.11.006
De Yoreo JJ. 2022. Casting a bright light on Ostwald’s rule of stages. Proc Natl Acad Sci USA 119. doi:10.1073/pnas.2121661119
Hong Y, Yuan S, Li Z, Ke Y, Nozaki K, Miyoshi T. 2015. Three-Dimensional Conformation of Folded Polymers in Single Crystals. Phys Rev Lett 115:168301. doi:10.1103/PhysRevLett.115.168301
Keller A. 1957. A note on single crystals in polymers: Evidence for a folded chain configuration. Philosophical Magazine 2:1171–1175. doi:10.1080/14786435708242746
Landgraf D, Okumus B, Chien P, Baker TA, Paulsson J. 2012. Segregation of molecules at cell division reveals native protein localization. Nat Methods 9:480–482. doi:10.1038/nmeth.1955
Lauritzen JI, Hoffman JD. 1960. Theory of Formation of Polymer Crystals with Folded Chains in Dilute Solution. J Res Natl Bur Stand A Phys Chem 64A:73–102. doi:10.6028/jres.064A.007
Navrotsky A. 2004. Energetic clues to pathways to biomineralization: precursors, clusters, and nanoparticles. Proc Natl Acad Sci USA 101:12096–12101. doi:10.1073/pnas.0404778101
Ohhashi Y, Ito K, Toyama BH, Weissman JS, Tanaka M. 2010. Differences in prion strain conformations result from non-native interactions in a nucleus. Nat Chem Biol 6:225–230. doi:10.1038/nchembio.306
Organ SJ, Ungar G, Keller A. 1989. Rate minimum in solution crystallization of long paraffins. Macromolecules 22:1995–2000. doi:10.1021/ma00194a078
Radamaker L, Baur J, Huhn S, Haupt C, Hegenbart U, Schönland S, Bansal A, Schmidt M, Fändrich M. 2021. Cryo-EM reveals structural breaks in a patient-derived amyloid fibril from systemic AL amyloidosis. Nat Commun 12:875. doi:10.1038/s41467-021-21126-2
Sahoo B, Singer D, Kodali R, Zuchner T, Wetzel R. 2014. Aggregation behavior of chemically synthesized, full-length huntingtin exon1. Biochemistry 53:3897–3907. doi:10.1021/bi500300c
Schmelzer JWP, Abyzov AS. 2017. How do crystals nucleate and grow: ostwald’s rule of stages and beyond In: Šesták J, Hubík P, Mareš JJ, editors. Thermal Physics and Thermal Analysis, Hot Topics in Thermal Analysis and Calorimetry. Cham: Springer International Publishing. pp. 195–211. doi:10.1007/978-3-319-45899-1_9
Schmidt M, Wiese S, Adak V, Engler J, Agarwal S, Fritz G, Westermark P, Zacharias M, Fändrich M. 2019. Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis. Nat Commun 10:5008. doi:10.1038/s41467-019-13038-z
Schweighauser M, Shi Y, Tarutani A, Kametani F, Murzin AG, Ghetti B, Matsubara T, Tomita T, Ando T, Hasegawa K, Murayama S, Yoshida M, Hasegawa M, Scheres SHW, Goedert M. 2020. Structures of α-synuclein filaments from multiple system atrophy. Nature 585:464–469. doi:10.1038/s41586-020-2317-6
Snapp EL, Hegde RS, Francolini M, Lombardo F, Colombo S, Pedrazzini E, Borgese N, Lippincott-Schwartz J. 2003. Formation of stacked ER cisternae by low affinity protein interactions. J Cell Biol 163:257–269. doi:10.1083/jcb.200306020
Törnquist M, Michaels TCT, Sanagavarapu K, Yang X, Meisl G, Cohen SIA, Knowles TPJ, Linse S. 2018. Secondary nucleation in amyloid formation. Chem Commun 54:8667–8684. doi:10.1039/c8cc02204f
Ungar G, Putra EGR, de Silva DSM, Shcherbina MA, Waddon AJ. 2005. The Effect of Self-Poisoning on Crystal Morphology and Growth Rates In: Allegra G, editor. Interphases and Mesophases in Polymer Crystallization I, Advances in Polymer Science. Berlin, Heidelberg: Springer Berlin Heidelberg. pp. 45–87. doi:10.1007/b107232
Vetri V, Foderà V. 2015. The route to protein aggregate superstructures: Particulates and amyloid-like spherulites. FEBS Lett 589:2448–2463. doi:10.1016/j.febslet.2015.07.006
Wild EJ, Boggio R, Langbehn D, Robertson N, Haider S, Miller JRC, Zetterberg H, Leavitt BR, Kuhn R, Tabrizi SJ, Macdonald D, Weiss A. 2015. Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington’s disease patients. The Journal of Clinical Investigation.
Yang Y, Arseni D, Zhang W, Huang M, Lövestam S, Schweighauser M, Kotecha A, Murzin AG, Peak-Chew SY, Macdonald J, Lavenir I, Garringer HJ, Gelpi E, Newell KL, Kovacs GG, Vidal R, Ghetti B, Ryskeldi-Falcon B, Scheres SHW, Goedert M. 2022. Cryo-EM structures of amyloid-β 42 filaments from human brains. Science 375:167–172. doi:10.1126/science.abm7285
Zhang X, Zhang W, Wagener KB, Boz E, Alamo RG. 2018. Effect of Self-Poisoning on Crystallization Kinetics of Dimorphic Precision Polyethylenes with Bromine. Macromolecules 51:1386–1397. doi:10.1021/acs.macromol.7b02745
-
-
www.medrxiv.org www.medrxiv.org
-
Author Response
Reviewer #1 (Public Review):
This study by Park et al. describes an interesting approach to disentangle gene-environment pathways to cognitive development and psychotic-like experiences in children. They have used data from the ABCD study and have included PGS of EA and cognition, environmental exposure data, cognitive performance data and self-reported PLEs. Although the study has several strengths, including its large sample size, interesting approach and comprehensive statistical model, I have several concerns:
- The authors have included follow-up data from the ABCD Study. However, it is not very clear from the beginning that longitudinal paths are being explored. It would be very helpful if the authors would make their (analysis) approach clearer from the introduction. Now, they describe many different things, which makes the paper more difficult to read. It would be of great help to see the proposed path model in a Figure and refer to that in the Method.
We clarified the specific longitudinal paths explored in our study in the end of the Introduction section (line 149~160). We also added a figure of the proposed path model (Figure 1) and refer to it in the Method section (line 232~239).
- There is quite a lot of causal language in the paper, particularly in the Discussion. My advice would be to tone this down.
We corrected and tone-downed all causal languages used in our manuscript. Per your suggestion, we deleted statements like ‘unbiased estimates’ and used expressions such as ‘adjustment for observed/unobserved confounding’ instead.
- I feel that the limitation section is a bit brief, and can be developed further.
We specified additional potential constraints of our study, including limited representativeness, limited periods of follow-up data, possible sample selection bias, and the use of non-randomized, observational data. These corrections can be found in line 518~538.
- I like that the assessment of CP and self-reports PEs is of good quality. However, I was wondering which 4 items from the parent-reported CBCL were used and how did they correlate with the child-reported PEs? And how was distress taken into account in the child self-reported PEs measurement? Which PEs measures were used?
We believe that the Reviewer #1’s comment for the correlations between PLEs derived from PQ-BC (total score and distress score PLEs) and from CBCL (parent-rated PLEs) might have been due to the fact that she/he was referring to the prior version of our manuscript submitted to a different journal. We obtained Pearson’s correlation coefficients between the PLEs (baseline year: r = 0.095~0.0989, p<0.0001; 1-year follow-up: r = 0.1322~0.1327, p<0.0001; 2-year follow-up: r = 0.1569~0.1632, p<0.0001) and added this information in the Method section for PLEs (line 198~201).
- What was the correlation between CP and EA PGSs?
We also added the Pearson’s correlation between the two PGSs (r =0.4331, p<0.0001) in the Methods section for PGS (line 214~215).
- Regarding the PGS: why focus on cognitive performance and EA? It should be made clearer from the introduction that EA is not only measuring cognitive ability, but is also a (genetic) marker of social factors/inequalities. I'm guessing this is one of the reasons why the EA PGS was so much more strongly correlated with PEs than the CP PGS. See the work bij Abdellaoui and the work by Nivard.
We thank the reviewer for the feedback to clarify that educational attainment (EA) is not only a genetic marker of cognitive ability but also that of socioeconomic outcomes. Per your suggestion, we included the associations of EA PGS with multiple biological and socioeconomic outcomes found in prior studies (e.g., Abdellaoui et al., 2022) in the Introduction (line 131~142).
Abdellaoui, A., Dolan, C. V., Verweij, K. J. H., & Nivard, M. G. (2022). Gene–environment correlations across geographic regions affect genome-wide association studies. Nature Genetics. doi:10.1038/s41588-022-01158-0
- Considering previous work on this topic, including analyses in the ABCD Study, I'm not surprised that the correlation was not very high. Therefore, I don't think it makes a whole of sense to adjust for the schizophrenia PGS in the sensitivity analyses, in other words, it's not really 'a more direct genetic predictor of PLEs'.
We conducted this adjustment considering that PLEs often precede the onset of schizophrenia. In addition, prior studies found that schizophrenia PGS is significantly associated with cognitive intelligence within psychosis patients (Shafee et al., 2018) and individuals at-risk of psychosis (He et al., 2021), and that significant distress psychotic-like experiences had greater positive correlation with schizophrenia PGS than PGS for psychotic-like experiences (Karcher et al., 2018).
For these reasons, we thought that it is necessary to assess whether the effects of cognitive phenotypes PGS (i.e., CP PGS and EA PGS) in the linear mixed model are significant after adjusting for schizophrenia PGS. We believe our results from the mixed linear model showed the sensitivity and specificity of the association between cognitive phenotype PGS and PLEs.
He, Q., Jantac Mam-Lam-Fook, C., Chaignaud, J., Danset-Alexandre, C., Iftimovici, A., Gradels Hauguel, J., . . . Chaumette, B. (2021). Influence of polygenic risk scores for schizophrenia and resilience on the cognition of individuals at-risk for psychosis. Translational Psychiatry, 11(1). doi:10.1038/s41398-021-01624-z
Karcher, N. R., Paul, S. E., Johnson, E. C., Hatoum, A. S., Baranger, D. A. A., Agrawal, A., . . . Bogdan, R. (2021). Psychotic-like Experiences and Polygenic Liability in the Adolescent Brain Cognitive Development Study. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. doi:https://doi.org/10.1016/j.bpsc.2021.06.012
Shafee, R., Nanda, P., Padmanabhan, J. L., Tandon, N., Alliey-Rodriguez, N., Kalapurakkel, S., . . . Robinson, E. B. (2018). Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls. Translational Psychiatry, 8(1). doi:10.1038/s41398-018-0124-8
- How did the FDR correction for multiple testing affect the results?
For all analysis results presented in our study, False Discovery Rate (FDR) correction for multiple testing compared p-values of nine key study variables: PGS (cognitive performance or educational attainment), family income, parental education, family’s financial adversity, Area Deprivation Index, years of residence, proportion of population below -125% of the poverty line, positive parenting behavior, and positive school environment. An exception was the sensitivity analysis that included schizophrenia PGS in the linear mixed model for adjustment: with another PGS variable added, FDR correction compared p-values of ten key variables. Overall, the effects of FDR correction on the results were limited; i.e., the majority of associations between the key variables and the outcomes, which were deemed highly significant, remained unchanged after the FDR correction.
Overall, I feel that this paper has the potential to present some very interesting findings. However, at the moment the paper misses direction and a clear focus. It would be a great improvement if the readers would be guided through the steps and approach, as I think the authors have undertaken important work and conducted relevant analyses.
We express our appreciation to the reviewer for the constructive feedback and guidance, which has significantly contributed to the improvement of our manuscript. As addressed in the preceding sections, we have implemented the necessary corrections and clarifications in response to the reviewer's suggestions. We remain open to making further amendments as needed, and thus invite any additional comments should any aspect of our revisions be deemed inadequate or inappropriate.
Reviewer #2 (Public Review):
This paper tried to assess the link between genetic and environmental factors on psychotic-like experiences, and the potential mediation through cognitive ability. This study was based on data from the ABCD cohort, including 6,602 children aged 9-10y. The authors report a mediating effect, suggesting that cognitive ability is a key mediating pathway in the link between several genetic and environmental (risk and protective) factors on psychotic-like experiences.
While these findings could be potentially significant, a range of methodological unclarities and ambiguities make it difficult to assess the strength of evidence provided.
Strengths of the methods:
The authors use a wide range of validated (genetic, self- and parent-reported, as well as cognitive) measures in a large dataset with a 2-year follow-up period. The statistical methods have the potential to address key limitations of previous research.
We sincerely thank the reviewer for recognizing these methodological strengths of our study. The reviewer’s positive comments are highly supportive and encouraging for us.
Weaknesses of the methods:
The rationale for the study is not completely clear. Cognitive ability is probably a more likely mediator of traits related to negative symptoms in schizophrenia, rather than positive symptoms (e.g., psychosis, psychotic-like symptom). The suggestion that cognitive ability might lead to psychotic-like symptoms in the general population needs further justification.
We sincerely thank and highly appreciate the concerns that the reviewer has raised regarding our proposal that cognitive ability may serve as a mediator of psychotic-like experiences. To the best of our knowledge, it has been proposed that cognitive ability can be a mediator of positive symptoms in schizophrenia (including psychotic-like experiences), as well as negative symptoms. This mediating role of cognitive ability was proposed in several prior studies on cognitive model of schizophrenia/psychosis. Per your suggestion, we included further justification in the Introduction section of our study (line 104~107). Specifically, we highlighted that cognitive ability has been theoretically proposed as a potential mediator of genetic & environmental influence on positive symptoms of schizophrenia such as psychotic-like experiences. We refer to studies conducted by Howes & Murray (2014) and Garety et al. (2001).
Howes, O. D., & Murray, R. M. (2014). Schizophrenia: an integrated sociodevelopmental-cognitive model. The Lancet, 383(9929), 1677-1687. doi:https://doi.org/10.1016/S0140-6736(13)62036-X
Garety, P. A., Kuipers, E., Fowler, D., Freeman, D., & Bebbington, P. E. (2001). A cognitive model of the positive symptoms of psychosis. Psychological Medicine, 31(2), 189-195. doi:10.1017/S0033291701003312
Terms are used inconsistently throughout (e.g., cognitive development, cognitive capacity, cognitive intelligence, intelligence, educational attainment...). It is overall not clear what construct exactly the authors investigated.
Thank you for your comment. We corrected the term ‘cognitive capacity’ to ‘cognitive phenotypes’ throughout our manuscript. We also added in the Introduction (line 141~143) that we will collectively refer to these two PGSs of focus as ‘cognitive phenotypes PGSs’, which is similar to the terms used in prior research (Joo et al., 2022; Okbay et al., 2022; Selzam et al., 2019).
Joo, Y. Y., Cha, J., Freese, J., & Hayes, M. G. (2022). Cognitive Capacity Genome-Wide Polygenic Scores Identify Individuals with Slower Cognitive Decline in Aging. Genes, 13(8), 1320. doi:10.3390/genes13081320
Okbay, A., Wu, Y., Wang, N., Jayashankar, H., Bennett, M., Nehzati, S. M., . . . Young, A. I. (2022). Polygenic prediction of educational attainment within and between families from genome-wide association analyses in 3 million individuals. Nature Genetics, 54(4), 437-449. doi:10.1038/s41588-022-01016-z
Selzam, S., Ritchie, S. J., Pingault, J.-B., Reynolds, C. A., O’Reilly, P. F., & Plomin, R. (2019). Comparing Within- and Between-Family Polygenic Score Prediction. The American Journal of Human Genetics, 105(2), 351-363. doi:https://doi.org/10.1016/j.ajhg.2019.06.006
Not the largest or most recent GWASes were used to generate PGSes.
Thank you for mentioning this point. The reason why we were not able to use the largest GWAS for cognitive intelligence, educational attainment and schizophrenia is because (unfortunately) our study started earlier than the point when the GWAS studies by Okbay et al. (2022) and Trubetskoy et al. (2022) were published. We corrected that our study used ‘a GWAS of European-descent individuals for educational attainment and cognitive performance’ instead of the largest GWAS (line 206~208).
It is not fully clear how neighbourhood SES was coded (higher or lower values = risk?). The rationale, strengths, and assumptions of the applied methods are not fully clear. It is also not clear how/if variables were combined into latent factors or summed (weighted by what). It is not always clear when genetic and when self-reported ethnicity was used. Some statements might be overly optimistic (e.g., providing unbiased estimates, free even of unmeasured confounding; use of representative data).
Consistent with the illustration of neighborhood SES in the Methods section, higher values of neighborhood SES indicate risk. In the original Figure 2, higher values of neighborhood SES links to lower intelligence (direct effects: β=-0.1121) and higher PLEs (indirect effects: β=-0.0126~ -0.0162). We think such confusion might have been caused by the difference between family SES (higher values = lower risk) neighborhood SES (higher values = higher risk). Thus, we changed the terms to ‘High Family SES’ and ‘Low Neighborhood SES’ in the corrected figure (Figure 3) for clarification.
Considering that shorter duration of residence may be associated with instability of residency, it may indicate neighborhood adversity (i.e., higher risk). This definition of the ‘years of residence’ variable is in line with the previous study by Karcher et al. (2021).
We represented PGSs, family SES, neighborhood SES, positive family and school environment, and PLEs as composite indicators (derived from a weighted sum of relevant observed variables). To the best of our knowledge, it has been suggested from prior studies that these variables are less likely to share a common factor and were assessed as a composite index during analyses. For instance, Judd et al. (2020) and Martin et al. (2015) analyze genetic influence of educational attainment and ADHD as composite indicators. Also, as mentioned in Judd et al. (2020), socioenvironmental influences are often analyzed as composite indicators. Studies on psychosis continuum (e.g., van Os et al., 2009) suggest that psychotic disorders are likely to have multiple background factors instead of having a common factor, and notes that numerous prior research uses composite indices to measure psychotic symptoms. These are the reasons why we used components for these constructs instead of generating latent factors (which is done in the standard SEM method). On the contrary, we represented general intelligence as a common factor that determines the underlying covariance pattern of fluid and crystallized intelligence, based on the classical g theory of intelligence. We added this explanation in line 269~285.
Moreover, during estimation, the IGSCA determines weights of each observed variable in such a way as to maximize the variances of all endogenous indicators and components. We added this explanation in the description about the IGSCA method (line 266~268).
We deleted overly optimistic statements like ‘unbiased estimates’ and used expressions such as ‘adjustment for observed/unobserved confounding’ instead, throughout our manuscript.
Judd, N., Sauce, B., Wiedenhoeft, J., Tromp, J., Chaarani, B., Schliep, A., ... & Klingberg, T. (2020). Cognitive and brain development is independently influenced by socioeconomic status and polygenic scores for educational attainment. Proceedings of the National Academy of Sciences, 117(22), 12411-12418.
Karcher, N. R., Schiffman, J., & Barch, D. M. (2021). Environmental Risk Factors and Psychotic-like Experiences in Children Aged 9–10. Journal of the American Academy of Child & Adolescent Psychiatry, 60(4), 490-500. doi:10.1016/j.jaac.2020.07.003
Martin, J., Hamshere, M. L., Stergiakouli, E., O'Donovan, M. C., & Thapar, A. (2015). Neurocognitive abilities in the general population and composite genetic risk scores for attention‐deficit hyperactivity disorder. Journal of Child Psychology and Psychiatry, 56(6), 648-656.
van Os, J., Linscott, R., Myin-Germeys, I., Delespaul, P., & Krabbendam, L. (2009). A systematic review and meta-analysis of the psychosis continuum: Evidence for a psychosis proneness–persistence–impairment model of psychotic disorder. Psychological Medicine, 39(2), 179-195. doi:10.1017/S0033291708003814
It appears that citations and references are not always used correctly.
We thoroughly checked all citations and specified the references for each statement. We deleted Plomin & von Stumm (2018) and Harden & Koellinger (2020) and cited relevant primary studies (e.g., Lee et al., 2018; Okbay et al., 2022; Abdellaoui et al., 2022) instead. We also specified the references supporting the statement that educational attainment PGS links to brain morphometry (Judd et al., 2020; Karcher et al., 2021). As Okbay et al. (2022) use PGS of cognitive intelligence (which mentions the analyses results in their supplementary materials) as well as educational attainment, we decided to continue citing this reference. These corrections can be found in line 131~141.
Strengths of the results:
The authors included a comprehensive array of analyses.
We thank the reviewer for the positive comment.
Weaknesses of the results:
Many results, which are presented in the supplemental materials, are not referenced in the main text and are so comprehensive that it can be difficult to match tables to results. Some of the methodological questions make it challenging to assess the strength of the evidence provided in the results.
As you rightly identified, we inadvertently failed to reference Table S2 in the main text. We have since corrected this omission in the Results section for the IGSCA (SEM) analysis (line 375). The remainder of the supplementary tables (Table S1, S3~S7) have been appropriately cited in the main manuscript. We recognize that the quantity of tables provided in the supplementary materials is substantial. However, given the comprehensiveness and complexity of our analyses, which encompass a wide array of study variables, these tables offer intricate results from each analysis. We deem these results, which include valuable findings from sensitivity analyses and confound testing, too significant to exclude from the supplementary materials. That said, we are open to, and would greatly welcome, any further suggestions on how to present our supplementary results in a more accessible and digestible format. We are ready and willing to implement any necessary modifications to ensure clarity and ease of comprehension. Your guidance in this matter is highly valued.
Appraisal:
The authors suggest that their findings provide evidence for policy reforms (e.g., targeting residential environment, family SES, parenting, and schooling). While this is probably correct, a range of methodological unclarities and ambiguities make it difficult to assess whether the current study provides evidence for that claim.
Impact:
The immediate impact is limited given the short follow-up period (2y), possibly concerns for selection bias and attrition in the data, and some methodological concerns.
We added as study limitations (line 518~538) that the impact of our findings for understanding cognitive and psychiatric development during later childhood may be limited due to the relatively short follow-up period, the possibility of sample selection bias, and the problems of interpreting analyses results from an observational study as causality (despite the novel causal inference methods, designed for non-randomized, observational data, that we used).
As responded above, we made necessary corrections and clarifications for the points suggested by the reviewer. As we are willing to make additional revisions, please feel free to give comments if you feel that our corrections are insufficient or inappropriate.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
This manuscript reports new findings about the role of the glutamate transporter EAAC1 in controlling neural activity in the striatum. The significance is two-fold - it addresses gaps in knowledge about the functional significance of EAAC1, as well as provides a potential explanation for how EAAC1 mutations contribute to striatal hyperexcitability and OCD-associated behaviors. The manuscript is clearly presented, and the well-designed experiments are rigorously performed and analyzed. The main results showing that EAAC1 deletion increases the dendritic arbor of MSN D1 neurons and increases excitatory synaptic connectivity, as well as reduces D1-to-D1 mediated IPSCs are convincing. These results clearly demonstrate that EAAC1 deletion can alter excitatory and inhibitory synaptic function. Modelling the potential consequences for these changes on D1 MSN neural activity, and the behavior changes are interesting. Minor weaknesses include incomplete support for the conclusions about how EAAC1 regulates GABAergic transmission.
We would like to take this opportunity to thank the reviewer. New sets of pharmacology experiments now address the minor concern about supporting the conclusions about the regulation of GABAergic transmission by EAAC1. The revised manuscript also includes new behavioral assays that allow us to examine in more depth the cell- and region-specificity of the effects of EAAC1.
Reviewer #2 (Public Review):
The manuscript by Petroccione et al., examines the modulatory role of the neuronal glutamate transporter EAAC1 on glutamatergic and GABAergic synaptic strength at D1- and D2-containing medium spiny neurons within the dorsolateral striatum. They find that pharmacological and genetic disruption of EAAC1 function increases glutamatergic synaptic strength specifically at D1-MSNs. They show that this is due to a structural change in release sites, not release probability. They also show that EAAC1 is critical in maintaining lateral inhibition specifically between D1-MSNs. Taken together, the authors conclude that EAAC1 functions to constrain D1-MSN excitation. Using a computational modeling technique, they posit that EAAC1's modulatory role at glutamatergic and GABAergic inputs onto D1-MSNs ultimately manifests as a reduction of gain of the input-output firing relationship and increases the offset. They go on to show that EAAC1 deletion leads to enhanced switching behavior in a probabilistic operant task. They speculate that this is due to a dysregulated E/I balance at D1-MSNs in the DLS. Overall, this is a very interesting study focused on an understudied glutamate transporter. Generally, the study is done in a very thorough and methodical manner and the manuscript is well written.
We thank the reviewer for the thorough analysis and insightful comments on the manuscript. Our point-to-point responses to the concerns raised on the initial submission of this work are reported below:
Major Comments/Concerns:
Regional/Local manipulations in behavior study: The manuscript would be greatly improved if they provided data linking the ex vivo electrophysiological findings within the DLS with the behavior. Although they are using a DLS-dependent task, they are nonetheless, using a constitutive EAAC1 KO mouse. Thus, they cannot make a strong conclusion that the behavioral deficits are due to the EAAC1 dysfunction in the DLS (despite the strong expression levels in the DLS).
Corrected - We concur with the reviewer. To address this concern, we performed new experiments to assess the cell- and regional-specificity of the effects of EAAC1 on task-switching behaviors.
First, we repeated the behavioral assays described in Fig. 8 in two mouse lines (D1Cre/+:EAAC1f/f and A2ACre/+:EAAC1f/f) lacking EAAC1 expression in D1- or D2-MSNs, respectively (Supp. Fig. 8-1). As in the case of EAAC1+/+ and EAAC1-/- mice, when the switch time was short (<15 s), D1Cre/+:EAAC1f/f and A2ACre/+:EAAC1f/f mice collected a similar number of rewards (Supp. Fig. 8-1K, L) and performed a similar number of lever presses (Supp. Fig. 8-1M, N). As the switch time increased (30-75 s), D1Cre/+:EAAC1f/f mice collected more rewards than A2ACre/+:EAAC1f/f mice, at low and high reward probabilities (Supp. Fig. 8-1L, N). Overall, the task switching behavior of D1Cre/+:EAAC1f/f mice was similar to that of EAAC1-/- mice, whereas that of A2ACre/+:EAAC1f/f mice was similar to that of EAAC1+/+ mice (cf. Supp. Fig. 8 and Supp. Fig. 8-1). This suggests that loss of expression of EAAC1 from D1-MSNs is sufficient to reproduce the task switching behavior of EAAC1-/- mice. Because EAAC1 limits excitation onto D1-MSNs (Fig. 2, 3) and lateral inhibition between D1-MSNs (Fig. 4-6), these findings suggest that increased excitation onto D1-MSNs and reciprocal inhibition among D1-MSNs limit execution of reward-based behaviors with task-switching intervals >30s.
Second, as noted by the reviewer, another potential limitation of the experiments performed on constitutive EAAC1-/- mice is that , on their own, they do not allow us to say whether they are due to changes in E/I onto D1MSNs within a specific domain of the striatum like the DLS. Although the DLS is recruited during task-switching, reward-based flexibility in executive control relies on neuronal activity in the VMS (Wallis 2007; Gu et al. 2008). Therefore, we asked whether limiting excitation in D1-MSNs and strengthening D1-D1 lateral inhibition via EAAC1 in the VMS could also alter reward-based task-switching behaviors. To address this question, we repeated the task switching test in EAAC1f/f mice that received stereotaxic injections of a Cre-dependent viral construct (AAV-D1Cre) that we used to remove EAAC1 expression from D1-MSNs in the DLS or VMS, respectively (Supp. Fig. 8-2). The results showed that the task switching behaviors of EAAC1f/f mice receiving AAV-D1Cre injections in the DLS or VMS were similar to each other and to those of EAAC1-/- mice, while being statistically different from those of EAAC1+/+ mice. This finding is important, as it suggests that: (i) the DLS and VMS are both recruited for the execution of task switching behaviors; (ii) the modulation of E/I onto D1-MSNs by EAAC1 may not be limited to the DLS but could extend to the VMS.
Third, we performed further tests to examine the regional-specificity of the effects of EAAC1 in D1-MSNs. D1 receptor expressing cells are present not only throughout the striatum, but also in the substantia nigra (pars compacta and reticulata; SN) and ventral tegmental area (VTA) (Cadet et al. 2010; Savasta, Dubois, and Scatton 1986; Boyson, McGonigle, and Molinoff 1986; Wamsley et al. 1989). To determine whether lack of EAAC1 in D1expressing cells in the SN/VTA could also contribute to increased compulsivity, we repeated the task switching behavioral assays in EAAC1f/f mice that received injections of AAV-D1Cre in the SN/VTA (Supp Fig. 8-3). The task switching behavior of these mice was similar to that of EAAC1+/+ , not EAAC1-/- mice, suggesting that altering EAAC1 expression in D1-MSNS of the DLS/VMS, but not the SN/VTA, is implicated with the control of task switching of reward-based behaviors in mice.
The results of these new sets of experiments are included in the revised version of the manuscript and their implications are reported in the Discussion section of the paper.
Statistics used in the study: There are some missing details regarding the precise stats using for the different comparisons. I am particularly concerned that the electrophysiology studies that were a priori designed as a 2-factor analysis did not have 2-way ANOVAs performed, but rather a series of t-tests. For example, in Figure 3b, the two factors are 1) cell type and 2) genotype. Was a 2-way ANOVA performed? It is hard for me to tell from the text.
Corrected - We apologize for any potential confusion. The statistical analysis for the experiments included in this work includes paired and unpaired t-tests, one-way ANOVA, two-way ANOVA, and ANOVA for repeated measures tests followed by post hoc t-test comparisons (reported in the text). To ensure both accuracy and readability of the manuscript, we report the results of the statistical comparisons in the main text of the manuscript, but also provide a fully detailed statistical analysis across all datasets performed in the data repository for this manuscript deposited on Open Science Framework. We revised the methods section to clarify the use of different statistical tests and values reported in the manuscript.
Moderate Concerns:
Control mice: I am moderately concerned that littermates were not used for controls for the EAAC1 KO, but rather C57Bl/6NJ presumably ordered from a vendor. It has been shown that issues like transit and rearing conditions can have long term effects on behavior. Were the control mice reared in house? How long was the acclimation time before use?
Corrected - Sorry for the potential confusion. The EAAC1-/- mice are bred in house and have been backcrossed with C57BL/6J for more than 10 generations. We perform backcrossing regularly and routinely in our animal colony. The C57BL/6J are also bread in house. They are replaced every 10 generations to avoid genetic drift. Therefore, there is no concern about transit from vendors and rearing affecting the results of our experiments. This information has been added to the Methods section of the paper.
OCD framework: I generally find the OCD framework unnecessary, particularly in the Introduction. Compulsive behaviors are not restricted to OCD. Indeed, the link between the behavioral observations and OCD phenotype seems a bit tenuous. In addition, studying the mechanisms of behavioral flexibility in and of itself is interesting. I do not think such a strong link needs to be made to OCD throughout the entirety of the paper. The authors should consider tempering this language or restricting it to the discussion and end of the abstract.
Corrected - We concur with the reviewer and have revised the manuscript accordingly. At the end of the Abstract, we refer only to behavior flexibility. We have toned down our emphasis on OCD in the Introduction, broadening the genetic link between the gene encoding EAAC1 (SLC1A1) and neuropsychiatric diseases like OCD, ADHD and ASD. This is now limited to a single sentence. We also revised the Discussion section because we agree with the reviewer on the fact that compulsive behaviors are not limited to OCD.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
1) The model's cortical neurons had no contralateral encoding, unlike their neuroimaging data.
This is a common point of confusion. In fact, this comment has prompted us to clarify our modeling decisions. For the CBGT pathways, we use a simplified model of isolated "action channels" that represent unique actions without specifying the true laterality of representations in the brain. As long as relatively distinct representations compete, which is what we observed in our human neuroimaging data, and as long as the populations representing the action are unique, regardless of hemisphere, our model assumptions are applicable despite the complicated lateralization of unimanual actions in reality.
We now specify this in the main text:
“It is important to note that, for the sake of parsimony, we adopt a simple and canonical model of CBGT pathways, with action channels that are agnostic as to the location of representations (e.g., lateralization), simply assuming that actions have unique population-level representations.”
2) Another concern with this work is that it was unclear why the spiking neuronal network model with so many model parameters was used to account for coarse-scale fMRI data - a simple firing-rate neural population model would perhaps do the work.
We see how using a complex, biologically realistic neural network has arguable scientific value when comparisons are coarse and made against macroscopic hemodynamic responses. However, it does have clear value for setting the stage for future work that can unravel the nuances of the mechanism involved.
To explain our rationale, we take an upward mapping perspective, where implementation-level models at lower levels represent the detailed biophysical properties of neurons and synapses, and models at higher levels represent the emergent properties of neural networks. This approach facilitates prediction at various levels of abstraction, including molecular, cellular, behavioral, and cognitive, by leveraging lower-level models to inform higher-level ones. For example, in other work, we are testing our model in mice using D1 and D2 optogenetic stimulation. We plan to use the same neural network to inform our predictions about these results. So, the complexity of the model does have a clear purpose for informing ongoing and future work by acting as a theoretical bridge between experiments across levels of analysis and spatiotemporal resolution. In our paper, the fMRI findings are compared with predicted dynamics at a common level of abstraction. Given the difference in resolution between these two approaches, our comparison is coarse.
To the reviewer’s concern about the number of parameters in the model, we make sure to address the dimensionality of our model in our analysis approach in the Results section:
“To test whether these shifts in v are driven by competition within and between action channels, we predicted the network's decision on each trial using a LASSO-PCR trained on the pre-decision firing rates of the network (see Measuring neural action representations). The choice of LASSO-PCR was based on prior work building reliable classifiers from whole-brain evoked responses that maximizes inferential utility (see Wager et al. 2011). The method is used when models are over-parameterized, as when there are more voxels than observations, relying on a combination of dimensionality reduction and sparsity constraints to find the true, effective complexity of a given model. While these are not considerations with our network model, they are with the human validation experiment that we describe next. Thus, we used the same classifier on our model as on our human participants to directly compare theoretical predictions and empirical observations.”
3) Moreover, the activity dynamics of the fMRI were not shown. It would have been more rigorous to show the fMRI (BOLD) signals in different (particularly CBGT) brain regions and compare that with the CBGT model simulations.
The timing of the trials and the autocorrelational structure of the BOLD response make such fine-grained analysis unproductive, as the entire trial is subsumed under a single evoked response. While we sympathize with this question, the limitations of the fMRI signal restrict our resolution for evaluating intra-trial dynamics. Our follow-up work with neurophysiological recordings in rodents may help address this. Given these limitations, we now show averaged node-by-node comparisons for the simulated and human data in Fig. 3 - Fig. Supp. 5.
4) The association between classier uncertainty and drift rate (by participants) was an order of magnitude difference between the simulated and actual participants (compare Figure 2E with Figure 4B).
You make a valid point about the difference in effect magnitude between the model and data. The greater effect observed in the simulated data is due to several factors: 1) simulated data is not affected by the same sources of noise as human data, 2) the model is not susceptible to non-task related variance, 3) the model was used to predict associations seen in humans, and fine-tuning the model using human data would result in circular inference, and 4) the simulations used only a single experimental condition with deterministic volatility, while human experiments varied the relative value of the two options and volatility, leading to increased variance in human responses. The goal was to compare the qualitative pattern of results, and the discrepancy in magnitude is addressed in the Discussion section of the revised manuscript:
“Careful attention to the effect size of our correlations between channel competition and drift rate shows that the effect is substantially smaller in humans than in the model. This is not surprising and due to several factors. Firstly, the simulated data is not affected by the same sources of noise as the hemodynamic signal, whose responses can be greatly influenced by factors such as heterogeneity of cell populations and properties of underlying neurovascular coupling. Additionally, our model is not susceptible to non-task related variance, such as fatigue or lapses of attention, which the humans likely experienced. We could have fine tuned the model results based on the empirical human data, but that would contaminate the independence of our predictions. Finally, our simulations only used a single experimental condition, whereas human experiments varied the relative value of options and volatility, which led to more variance in human responses. Yet, despite these differences we see qualitative similarities in both the model and human results, providing confirmation of a key aspect of our theory.”
5) There was also a weak effect on human reaction times (Supp. Fig. 2).
Trial-by-trial reaction times are indeed noisy. However, our estimates rely on the distribution of reaction times, rather than trial-by-trial values.
6) There were only 4 human participants that performed the experiment - the results would perhaps be better with more human participants.
We see where this comment arises from and we are sympathetic to the initial thought, but we should point out that our experimental design mirrors the type used in non-human primate research: collect an entire experiment’s worth of data from a single participant and replicate the effects across new participants. We have a total of 2,700 trials per participant (for a total of 10,800 trials across all participants). Each participant has the equivalent number of trials as what would be conducted per experiment in typical single run or single session experiments with a sample of ~40 participants. Our statistical power was focused on within-subjects replication, meaning that each participant can be thought of as their own independent experiment, with sufficient statistical power to address our primary research hypothesis. Thus, in our experimental design, each run is an observation, as opposed to each participant as in typical fMRI experiments, and each participant is then considered a replication test of the other participants.
We now emphasize the statistical power on a single-subject basis in the Results section:
“Crucially, we designed this experiment such that each participant acted as an out-of-set replication test, having performed thousands of trials individually. Specifically, to ensure we had the statistical power to detect effects on a participant-by-participant basis, we collected an extensive data set comprising 2700 trials over 45 runs from nine separate imaging sessions for each of four participants. Consequently, we amassed a grand total of 36 hours of imaging data over all participants, which was used to evaluate the replicability of our findings at the participant-by-participant level. Therefore, our statistical analyses were able to estimate effects on a single-participant basis.”
7) For such a complex biophysical computational model, there could perhaps have been more model predictions provided.
Using a biologically realistic neural network may not be useful for finer-grained comparisons, but it can inform future work. By mapping upward from lower-level to higher-level models, we can predict emergent properties at different levels of abstraction. The model's complexity is necessary for informing ongoing and future work, such as testing the model in other organisms. While the comparison with fMRI findings is coarse, we address the dimensionality of our model in our analysis approach.
Reviewer #2 (Public Review):
1) In this paper, Bond et al. build on previous behavioral modeling of a reversal-learning task. They replicate some features of human behavior with a spiking neural network model of cortical basal ganglia thalamic circuits, and they link some of these same behavioral patterns to corresponding areas with BOLD fMRI. I applaud the authors for sharing this work as a preprint, and for publicly sharing the data and code.
Thank you for your thoughtful comments on our work! We also appreciate your recognition of our efforts to openly share our data and code.
2) While the spiking neural network model offers a helpful tool to complement behavior and neuroimaging, it is not very clear which predictions are specific to this model (and thus dissociate it from, or go beyond, previous work). Thus, the main strength of this work (combining behavior, brain, and in silico experiments) is not fully fleshed out and could be stronger in the conclusions we can draw from them.
We agree that further exploration of the specific predictions that our spiking neural network model offers would be valuable in order to fully delineate its contribution to the field. In our current work, we link our simulated neural network dynamics with whole-brain hemodynamic data, which limits the temporal resolution and complexity of our comparisons. We recognize that a more detailed investigation of the unique contributions of our spiking neural network model would be an important next step in order to better understand the mechanisms underlying the observed behavioral patterns. Indeed – we are currently conducting follow-up work in mice to test finer-grained predictions of cellular dynamics.
3) It would be helpful to know more about which features of the spiking NN model are crucial in precisely replicating the behavioral patterns of interest (and to be more precise in which behaviors are replicated from previous work with the same task, vs. which ones are newly acquired because the task has changed - or the spiking CBGT model has afforded new predictions for behavior). Throughout, I am wondering if the authors can compare their results to a reasonable 'null model' which can then be falsified (e.g. Palminteri et al. 2017, TICS); this would give more intuition about what it is about this new CBGT model that helps us predict behavior. The same question about model comparison holds for the behavior: beyond relying on DIC score differences, what features of behavior can and cannot be explained by the family of DDMs?
You raise a crucial point. In our original manuscript, we only compared the single and pairwise variants of the HDDM model and a null model predicting no change in decision policy. The drift rate model best fit the data among these comparisons.
However, our main claim relies on the link between neural data, behavior, and the underlying cognitive process. Previously, we did not test other variants of this central linking hypothesis. To address this, we tested an alternative linking hypothesis using boundary height instead of drift rate as our target variable. We found a null association with classifier uncertainty. This definitely provides a more rigorous test of our primary hypothesis, and we thank the reviewer for raising this point.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #2 (Public Review):
1) The authors in reality do not analyze oscillations themselves in this manuscript but only the power of signals filtered at determined frequency bands. This is particularly misleading when the authors talk about "spindles". Spindles are classically defined as a thalamico-cortical phenomenon, not recorded from hippocampus LFPs. Thus, the fact that you filter the signal in the same frequency range matching cortical spindles does not mean you are analyzing spindles. The terminology, therefore, is misleading. I would recommend the authors to change spindles to "beta", which at least has been reported in the hippocampus, although in very particular behavioral circumstances. However, one must note that the presence of power in such bands does not guarantee one is recording from these oscillations. For example, the "fast gamma" band might be related to what is defined as fast gamma nested in theta, but it might also be related to ripples in sleep recordings. The increase of "spindle" power in sleep here is probably related to 1/f components arising from the large irregular activity of slow wave sleep local field potentials. The authors should avoid these conceptual confusions in the manuscript, or show that these band power time courses are in fact matching the oscillations they refer to (for example, their spindle band is in fact reflecting increased spindle occurrence).
We thank the reviewer for allowing us to clarify this subject. We completely agree with concerns raised in the comments. To avoid any confusion, we have replaced throughout the manuscript the word ‘spindle’ with ‘beta’.
2) The shuffling procedure to control for the occupancy difference between awake and sleep does not seem to be sufficient. From what I understand, this shuffling is not controlling for the autocorrelation of each band which would be the main source of bias to be accounted for in this instance. Thus, time shifts for each band would be more appropriate. Further, the controls for trial durations should be created using consecutive windows. If you randomly sample sleep bins from distant time points you are not effectively controlling for the difference in duration between trial types. Finally, it is not clear from the text if the UMAP is recomputed for each duration-matched control. This would be a rigorous control as it would remove the potential bias arising from the unbalance between awake and sleep data points, which could bias the subspace to be more detailed for the LFP sleep features. It is very likely the results will hold after these controls, given it is not surprising that sleep is a more diverse state than awake, but it would be good practice to have more rigorous controls to formalize these conclusions.
We are grateful to the reviewer for suggesting alternative analysis. We have used this direction, to create surrogate datasets obtained by time shifting each band and obtained their respective UMAP projections (see modified Figure 2D). Additionally, as suggested, for duration-matched controls, we have selected consecutive windows, rather than random points (Figure 2 – figure supplement 1C). UMAP projections were obtained for each duration-matched control and occupancy was computed. The text in the method section has been modified to indicate the analysis. As expected, the results were identical.
3) Lots of the observations made from the state space approach presented in this manuscript lack any physiological interpretation. For example, Figure 4F suggests a shift in the state space from Sleep1 to Sleep2. The authors comment there is a change in density but they do not make an effort to explain what the change means in terms of brain dynamics. It seems that the spectral patterns are shifting away from the Delta X Spindle region (concluding this by looking at Fig4B) which could be potentially interesting if analyzed in depth. What is the state space revealing about the brain here? It would be important to interpret the changes revealed by this method otherwise what are we learning about the brain from these analyses? This is similar to the results presented in Figure 5, which are merely descriptions of what is seen in the correlation matrix space. It seems potentially interesting that non-REM seems to be split into two clusters in the UMAP space. What does it mean for REM that delta band power in pyramidal and lm layers is anti-correlated to the power within the mid to fast gamma range? What do the transition probabilities shown in Figures 6B and C suggest about hippocampal functioning? The authors just state there are "changes" but they don't characterize these systematically in terms of biology. Overall, the abstract multivariate representation of the neural data shown here could potentially reveal novel dynamics across the awake-sleep cycle, but in the current form of this manuscript, the observations never leave the abstract level.
We thank the reviewer for allowing us to clarify this aspect of the manuscript. We have now edited the main text to include considerations on the biological relevance of the findings of Figure 4, 5 and 6.
Additions to figure 4: In particular, non-REM states in sleep2 tended to concentrate in a region of increased power in the delta and beta bands, which could be the results of increased interactions with cortical activity modulated in the same range. It is also likely that such effect was induced by the exposure to relevant behavioral experience. In fact, changes in density of individual oscillations after learning have been reported using traditional analytical methods and are thought to support memory consolidation (Bakker et al., 2015; Eschenko et al., 2008, 2006). Nevertheless, while traditional methods provide information about individual components, the novel approach used here provides additional information about the combinatorial shift in the dynamics of network oscillations after learning or exploration. Thus, it provides the basis for identifying how coordinated activity among different oscillations supports memory consolidation processes, as those occurring during non-REM sleep after exploration, which cannot be elucidated using traditional analytical methods.
Additions to figure 5: Gamma segregation and delta decoupling offer a picture of hippocampal REM sleep as being more akin to awake locomotion (with the major difference of a stronger medium gamma presence) while also suggesting a substantial independence from cortical slow oscillations. On the other hand, the across-scale coherence of non-REM sleep is consistent with this sleep stage being dominated by brain-wide collective fluctuations engaging oscillations at every range. Distinct cross frequency coupling among various individual pairs of oscillations such as theta-gamma, delta-gamma etc., have been already reported (Bandarabadi et al., 2019; Clemens et al., 2009; Hammer et al., 2021; Scheffzük et al., 2011). However, computing cross frequency coupling on the state space provides the additional information on how multiple oscillations, obtained from distinct CA1 hippocampal layers (stratum pyramidale, stratum radiatum and stratum lacunosum moleculare), are coupled with each other during distinct states of sleep and wakefulness. Furthermore, projecting the correlation matrices on 2D plane, provides a compact tool that allows to visualize the cross-frequency interactions among various hippocampal oscillations. Altogether, this approach reveals the complex nature of coupling dynamics occurring in hippocampus during distinct behavioral states
Additions to Figure 6: We found that transitions occurring from REM-to-REM sleep and non-REM-to-non-REM sleep (intra-state transitions) are more vulnerable to plasticity after exploration as compared to inter-state transitions (such as non-REM to REM, REM-to-intermediate etc.) (Fig 6E, F). These changes in intra-state transitions were observed to be beyond randomness (Fig S9 E, F) indicating a specificity in plastic changes in state transitions after exploration. In particular, while the average REM period duration is unaltered after exploration (Fig 4G), REM temporal structure is reorganized. In fact, increased probability of REM to REM transitions indicates a significant prolongation of REM bout duration. Similarly, the increase in non-REM to non-REM transition probability reflects an increased duration of non-REM bouts. Therefore, environment exploration was accompanied by an increased separation between REM and non-REM periods, possibly as a response to increased computational demands. More in general, the network state space allows to characterize the state transitions in hippocampus and how they are affected by novel experience or learning. By observing the state transition patterns, this analytical framework allows to detect and identify state-specific changes in the hippocampal oscillatory dynamics, beyond the possibilities offered by more traditional univariate and bivariate methods. We next investigated how fast the network flows on the state space and assessed whether the speed is uniform, or it exhibits specific region-dependent characteristics.
Reviewer #3 (Public Review):
1) My primary concern is to provide clear evidence that this approach will provide key insights of high physiological significance, especially for readers who may think the traditional approaches are advantageous (for example due to their simplicity). I think the authors' findings of distinct sleep state signatures or altered organization of the NLG3-KO mouse could serve this purpose. However, right now the physiological significance of these results is unclear. For example, do these sleep state signatures predict later behavior performance, or is altered organization related to other functional impairments in the disease model? Do neurons with distinct sleep state signatures form distinct ensembles and code for related information?
We are thankful to the reviewer for raising a very interesting line of questioning regarding sleep signatures and distinct ensemble. In this study, we show that sleep state signatures can predict how individual cells may participate in information processing during open field exploration. However, further analysis exploring the recruitment of neuronal ensembles are in preparation for another manuscript and is beyond the scope of this article.
We have further modified the description of the results (as also suggested by other reviewers) to highlight the key advantages of this approach over traditional methods.
Regarding functional impairment: as described in the manuscript, the altered organization in animal model of autism could possibly due to alterations in cellular and synaptic mechanisms as those described in previous reports (Modi et al 2019, Foldy et al 2013)
2) For cells with different mean firing rates during exploration: is that because they are putative fast-spiking interneurons and pyramidal cells? From the reported mean firing rates, I think some of these cells are interneurons. Since mean firing rates are well known to vary with cell type, this should be addressed. For example, the sleep state signatures may be distinct for different putative pyramidal cells and interneurons. This would be somewhat expected considering prior work that has shown different cell types have different oscillatory coupling characteristics. I think it would be more interesting to determine if pyramidal cells had distinct sleep state signatures and, if so, whether pyramidal cells from the same sleep state signature have similar properties like they code for similar things or commonly fire together in an ensemble ms the number of cells in Fig. 8 may be limited for this analysis. The authors could use the hc-11 data in addition, which was also tested in this work.
We thank the reviewer for suggesting this additional analysis to better describe the data. To this end, we have added an additional Figure in supplementary data (analysis of hc11 dataset: Figure Figure 8 – figure supplement 3), to demonstrate that interneurons and pyramidal cells have distinct sleep signatures. These findings are in agreement with dataset presented in Figure 8D, E.
As shown in the manuscript, the spatial firing (sparsity) has large variability for cells having similar network signatures (Fig 8E). Thus, additional parameters beside oscillations may be involved in cells encoding. Different network state spaces are required to be explored in future studies to further understand this phenomenon in detail.
We agree that investigating neuronal ensembles and state space are an interesting direction to follow. In another study (in preparation) which are investigating in detail the recruitment of neuronal ensemble by oscillatory state space. Thus, those findings are beyond the scope of this introductory article.
3) Example traces are needed to show how LFPs change over the state-space. Example traces should be included for key parts of the state-space in Figures 2 and 3.
We thank the reviewer for this key insight on data representation. Example traces of how LFP varies on the state space have been added (see Figure 4 – figure supplement 1).
4) What is the primary rationale for 200ms time bins? Is this time scale sufficient to capture the slow dynamics of delta rhythm (1-5Hz) with a maximum of 1s duration?
Time scale of binning depends on the scale of investigation. We also replicated the results with different time bins (such as 50 ms and 1 seconds) and the results are identical. For delta rhythms, with 200 ms time bins, the dynamics will be captured across multiple bins. Additionally, the binned power time series are also smoothed before obtaining projections.
5) Since oscillatory frequency and power are highly associated with running speed, how does speed vary over the state space. Is the relationship between speed and state-space similar to the results of previous studies for theta (Slawinska and Kasicki, Brain Res 1998; Maurer et al, Hippocampus 2005) and gamma oscillations (Ahmed and Mehta J. Neurosci 2012; Kemere et al PLOS ONE 2013), or does it provide novel insights?
We thank the reviewer for highlighting this crucial link between oscillation and locomotion. While various articles have focused on individual oscillations, the combinatorial effects of multiple oscillations from multiple brain areas in regulating the speed of the animal during exploration is definitely worth exploring with this novel approach. These set of results will be introduced in another study, currently in preparation.
6) The separation of 9 states (Fig. 6ABC) seems arbitrary, where state 1 (bin 1) is never visited. I suggest plotting the density distribution of the data in Fig. 2A or Fig. 6A to better determine how many states are there within the state space. For example, five peaks in such a density plot might suggest five states. Alternately, clustering methods could be useful to determine how the number of states.
We thank the reviewer for this this useful suggestion. We agree that additional clustering methods can be used to identify non-canonical sleep states. These are currently being explored in our lab and will be part of future studies. As for this dataset, the density plots are available in figure 4E, which determines how many states are in each part of the state space.
7) The results in Fig. 4G are very interesting and suggest more variation of sub-states during non REM periods in sleep1 than in sleep2. What might explain this difference? Was it associated with more frequent ripple events occurring in sleep2?
The reviewer is right in looking for the source of the decreased of state variability in sleep2. Considering the distribution of relative frequency power in the state space, the higher concentration in sleep 2 corresponds to higher content in the slower delta and spindle frequency bands, rather than the higher frequencies of SWRs. This result can be interpreted in the light of enhanced cortical activity (which is known to heavily recruit those bands) and possibly of enhanced cortical-hippocampal communication following relevant behavioral experience. In fact, it is also necessary to mention that with our recording setup we cannot rule out the effects of volume conductance completely, and thus we cannot exclude that the increase in the delta and spindle bands in the hippocampus were a spurious effect of purely cortical frequency modulations.
8) The state transition results in Fig. 6 are confusing because they include two fundamentally different timescales: fast transitions between oscillatory states and slow dynamics of sleep states. I recommend clarifying the description in the results and the figure caption. Furthermore, how can an animal transition between the same sleep state (Fig. 6EF)? Would they both be in a single sleep state?
The transitions capture the fast oscillatory scales (as they are investigated over a timeframe of 1 second). The sleep stages (REM, non-REM etc.) are used as labels from which the states originate on the state space. This allows us to characterize fast oscillatory dynamics in various sleep stages.
Regarding same state transition: An increase in same state transition probability corresponds to increase in prolongation of that particular state, thereby altering the temporal structure of a given sleep state.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
The paper describes a robotic system that can be used for prolonged recording of forced activity in crawling Drosophila larvae. This is mostly intended to be a proof of principle description of a tool potentially useful for the community. The system - whose value lies completely in its reproducibility and adoption - is only superficially described in the paper, but a more detailed description is made available through Github, along with the software used for the collection and analysis of data.
There is good, convincing evidence this can work as some sort of "larval conveyor belt", used to artificially prolong food crawling behaviour in the animals. More could be said about the ecological implications of the assay (for instance: how relevant is it to an animal's natural behaviour? Does the system introduce artifactual distortions in the analysis, driven by the fact that animals crawl greater distances than they would normally crawl in nature? Will this extensive activity affect their development to pupation or adulthood?).
In addition all our code being available on GitHub, we have added substantially to Materials and Methods in the manuscript (1-1.5 pages) detailing the analysis pipeline more thoroughly.
We agree that a more thorough comparison of ecological vs. laboratory conditions was warranted here, and have addressed this in new Discussion section material (6th paragraph especially). The developmental effect due to prolonged locomotion is a very good point – with only a single animal measured for more than 24 hours, we do not yet know whether instar molting or pupation is delayed, but this could certainly be a concern in longer experiments moving forward.
Reviewer #3 (Public Review):
"Continuous, long-term crawling behavior characterized by a robotic transport system" by Yu et al. presents their new robotic device to track, reposition, and feed Drosophila larvae as they crawl on an arena. By using a water droplet (or if necessary, suction) to transport larvae from the edge of the arena to the middle, long behavior trajectories can be recorded without losing larvae from the arena or camera field of view. The picker robot is also able to dispense small amounts of apple juice at precise locations to keep larvae alive for extended periods although the food was not sufficient to trigger molting and the development to the next instar stage.
The approach is interesting, but the authors could provide more details on why the approach is necessary for non-expert readers. For example, what are the advantages of using the robot picker compared to simply confining larvae in a closed arena? It's not obvious (to me) that being picked back to the center of the arena is a smaller perturbation compared to running into a chamber wall and changing direction.
Thank you for this suggestion, it’s a very good point. We have expanded our Introduction considerably, and directly address this issue (4th paragraph in particular). We do quantify the perturbation due to robot pick-ups and drop-offs (Fig. 3D), but that only addresses the short term. We prefer not to use a closed arena for three reasons: (1) in a gradient navigation experiment, reaching the edge would effectively end “navigation” and we would be unable to study that behavior over longer times, (2) larvae can crawl up the sides of walls and will be lost to the tracker (they do this all the time in the Petri dishes they are raised in), and (3) larvae often do not bounce off walls and resume crawling, they tend to dwell near edges they find. To this last point, we have added a new Supplemental figure (Figure 1 – supplement 1) illustrating this effect with a representative example.
The first paragraph of the introduction emphasizes the multiple time scales that are relevant for behavior from rapid stimulus response up to developmental times. This is to set the context of the authors' contribution but I'm not sure it's a fair representation of the state of the art. For example, the authors state that high-bandwidth measurement over long times is prohibitive and cite three Drosophila papers, but there are home-cage monitoring systems that allow continuous recording of mouse behavior over long times with high resolution. At the other end of the spectrum, there have been some long-term behaviour experiments done on worm behaviour with reasonably high time resolution (e.g Stern et al. 10.1016/j.cell.2017.10.041).
This is absolutely correct, the context needed to be much broader than our own prior larva results. We have overhauled that section and written a wider introduction that includes the C. elegans paper you mentioned, and also brings in other model systems like adult flies, mice, and rats. We frame our own work as (1) in a new animal, for long term measurements; (2) investigating non-confined free locomotion over a long time scale.
The authors train a neural network to segment and track the larvae, however, little information is given on the training process and I don't think it would be possible to reproduce the model based on the description. More details of the network, hyperparameters, and training data would be required to evaluate it.
Definitely! We have added a new section to Materials and Methods (1-1.5 pages in length), detailing our analysis pipeline, with sections for position tracking, postural analysis, and behavioral classification.
The authors also state several times that larval identity is maintained throughout the recording, but this isn't quantified. It's not clear whether identity is maintained across collisions of two or more animals by the tracking algorithm or whether these collisions simply don't happen in their data because density is low.
This has also been addressed and clarified in the same new part of the Materials and Methods section. We quantify collision rates and give the accuracy maintaining identity after collisions.
The environment is nominally isotropic, but once larvae have been crawling on the surface for hours, including periodic feeding, there will likely be multiple gradients the larvae may sense. This may not be observable in the data, but should perhaps be mentioned in the text.
This is certainly true. Other than the single animal 30-hour experiment described in the manuscript, there is no food introduced to the larvae during our 6-hour experiments. Looking ahead, the presence of food remnants in the arena could become a serious confounding factor in nominally isotropic experiments, as the reviewer points out. We have added substantially to the Discussion section to discuss various limitations of the design and experiments, and directly talk about the odor/taste stimuli being introduced by food (second to last paragraph in Discussion).
The authors show that the picking action results in a small but detectable increase in speed. The degree of perturbation overall depends on the picking frequency so some quantification of the inter-pick time interval would help to interpret whether this perturbation is relevant for a particular experiment. Is there a difference in excitation when larvae are picked successfully on the first try compared to when multiple tries or suction are required?
We have now quantified the amount of time between pickups and added that in the Materials and Methods section directly (it’s 0.87 pick-ups per hour per animal). We do not have a sufficient amount of data to determine whether there is a statistically significant difference in behavior for multiple pickup attempts – this can also be confounded because sometimes an unsuccessful pickup is one that does not touch the larva at all (so would presumably not introduce additional perturbations).
From the reconstructed trajectory in Figure 4, this interval looks very long compared to speed increase after picking. When reconstructing the trajectory, how are the segments joined? Is it simply by resetting the xy position or also updating rotating to match the previous direction of travel? (I'm guessing the larva can rotate during transport?)
We have updated the Figure 4 caption to make it clear that the segments are only joined translationally, by resetting the xy position.
The authors present a simple model in Figure 6 to illustrate the differences between individuals that can be hidden when looking at population distributions. However, the differences they show in the simulation don't seem relevant to the differences they observe in the experiments. Specifically, Fig. 6A and B show a contrast between individuals with similar mean speeds compared to individuals with different (but still unimodal) mean speeds. In contrast, the experimental data in Fig. D shows individual distributions that are quite similar but that are bimodal. So, there is indeed a difference between the individual distributions that is obscured in the population distribution, but is there evidence of larval personality types (line 444)? Similarly, the sentence beginning line 381 doesn't seem right either.
We are really glad this was brought up so that we could clarify better in the text, as it’s an important point. We have edited the text in the Results subsection related to Figure 6 and the Figure 6 caption to clear things up. The individual distributions in 6D are not bimodal, there are 38 traces shown that are all essentially unimodal. In addition to stating this directly in the text, we have quantified this by adding the average BC for individuals in both isotropic and thermal gradient contexts (they are essentially the same, i.e. equally unimodal in both cases).
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 Public Review:
1) “…The authors make reasonable assertions, but all of these need to be validated by electrophysiological studies before they can be treated as fact. Instead, they should be treated as predictions. For example, in the conclusions from the model section, that endbulb size does not strictly predict synaptic efficacy should be modified from an assertion to a prediction.”
The reviewer makes an important point. We realize that, despite describing the data as the output of a model, we needed to be clearer that the model output is in fact a set of predictions to be tested experimentally. In the reorganization of the results, we collect the model output explicitly in a section named “Model Predictions”, and list five classes of predictions that describe explorations of bushy cells. The fifth set of predictions was previously a separate section but should now be better appreciated as conveying hypotheses since it is incorporated into this newly named section. Please note that the hypotheses are constrained to varying extents by the high-resolution structural data we present, such as the estimation of synaptic weights from the counts of synapses. The compartmental models for each bushy cell also are constrained by the structural data and published biophysical and electrophysiological properties of the cells. The pipeline to create the models is described in its own section now using that terminology: “A pipeline for translating high-resolution neuron segmentation into compartmental models consistent with in vitro and in vivo data.”, which we hope conveys the notion that the modeling framework is indeed a template that can be applied to future experimental data. We explicitly make this latter point in the new Discussion section “Toward a complete computational model for globular bushy cells: strengths and limitations”.
Reviewer #2 Public Review:
1) …” While this is technically impressive (in regards to both the structure and modelling) there are significant weaknesses because this integration makes massive assumptions and lacks a means of validation; for example, by checking that the results of the structural modelling recapitulate the single-cell physiology of the neuron(s) under study. This would require the integration of in vivo recorded data, which would not be possible (unless combined with a third high throughput method such as calcium imaging) and is well beyond the present study.
We appreciate the support for our approach, and we now make explicit in the manuscript that the output of the models should be interpreted as predictions for eventual experimental testing. We also consider in the Discussion some experimental procedures that might be used to test the predictions. Ca2+ imaging is currently too slow a reporter for the rapid synaptic events and integration time constant for bushy cells, as the reviewer knows, and we think (and present in the Discussion, section 2) that focal optical stimulation simultaneous with recording from fast voltage sensors are potential avenues to achieve this goal.
2) The authors need to be more open about the limitations of their observations and their interpretations and focus on the key conclusions that they can glean from this impressive data set.
As indicated in response to a similar comment from Reviewer 1, we have collected and discuss the primary limitations in a new section within the Discussion, entitled “Toward a complete computational model for globular bushy cells: strengths and limitations”.
3) The manuscript would be considerably improved by re-writing to focus the science on the most important results and provide clear declarations of limitations in interpretation.
We have extensively re-organized and re-written the text to highlight the key structural observations (Figures 1-3, 7-8), the pipeline from structure to model (Figure 4) and interleave structural observations with the outputs of the model (Figures 5-6, 8). The latter are explicitly detailed in a new section called “Model Predictions”. These predictions are organized into five classes. We think that this new organization will improve communication of the key results, and further highlights the key discoveries from structural analysis and predicted functional mechanisms as explored in the compartmental models.
Reviewer #3 Public Review:
1) The authors extract here from the longer introductory commentary a one-sentence summary of the strengths of the manuscript, and thereafter focus on the weaknesses, since this document emphasizes our response to those critiques. To quote reviewer #3: “The strengths of this paper are that the authors obtained unprecedented high-resolution 3-D images of the AN-bushy cell circuit, and they implemented a biophysical model to simulate the neural processing of AN inputs based on these structural data. … The biophysical modeling, although lacking comparison with in vivo physiological data due to the chosen species (mice), is also solid and well documented.”
We appreciate that the reviewer acknowledges the attention to detail that entered into the nanoscale imaging, cell reconstructions, building the modeling pipeline and constructing the compartmental models.
2) Despite the high quality of the data, the paper is marred by the species they chose: there are very few published in vivo single-unit results from mouse bushy cells, so it is hard to evaluate how well the model predictions fit the real-world data, and how the structural findings address the “fundamental questions” in physiology. … No rationale (e.g. use of molecular tools or in vitro physiology) is given why the authors focus on the mouse. It seems that the analyses provided here could as well have done on a species with good low-frequency hearing, which may have provided a much more interesting case for understanding the spectacular temporal transformation performed by bushy cells.
We now report our reasons, in the first paragraph of the Results, for selecting the mouse. One reason for choosing mouse was that biophysical properties of bushy cells, which were important parameters to constrain the compartmental models, were collected from mice. These data are collected from dissociated cells and from brain slices, and these experiments continue to be more tractable in mice. The second reason is that mice are used in nanoscale and light microscopy connectomic studies because their neurons, cell groups and entire brain are smaller, so that a given volume of imaged brain will contain more cellular elements. These other connectomic studies provide a template for eventual comparisons among brain regions. Our overall goal is to image the entire cochlear nucleus, and the size of the mouse brain makes this goal tractable given current technology. Indeed, we are currently analyzing an image volume of the more rostral ventral cochlear nucleus that is about 5x larger than this image volume and collected with a much better signal to noise ratio. The third reason for choosing mouse was so that the current project could be augmented by genetic tools to further classify cochlear nucleus (CN) neurons and their extrinsic inputs, and potentially manipulate neural circuits in future studies. For example, the atoh7 (math5) and hhip gene products are markers for subsets of bushy cells, suggesting the presence of molecular subtypes of this cell class (Jing et al. 2023).
3) If we look at data from other animals such as cats and gerbils, it is true that high-frequency (globular) bushy cells show envelope phase locking, but compared to ANs they are at best only moderately enhanced (gerbils: Frisina et al. 1990: Fig 7 and 10; cats: Joris and Yin 1998 Fig 4); the most prominent enhancement is actually to the temporal fine structures of low-frequency bushy cells (cells tuned to < 1 kHz), which mice lack. Furthermore, the temporal modulation transfer function (tMTF, i.e. the vector strengths vs modulation frequency plots in Fig 7O of the paper) of (globular) bushy cells are mostly low-pass filtered, with a cutoff frequency close to 1 kHz, and the highest vector strength rarely surpasses 0.9 (cats: Rhode 1994 Fig 9, 16, Rhode 2008 Fig 8G, Joris and Yin 1998 Fig 7; and there's one report from mice: Kopp-Scheinpflug et al 2003 Fig 8). Thus, the band-pass tMTFs tuned to 100-200 Hz with vector strengths > 0.9 or 0.95 in this paper (Fig 7O, Fig 8M) do not really match known physiology (in non-mouse species). Again, we know very little about in vivo physiology of mouse (globular) bushy cells and there is of course a possibility that responses in mice may be closer to the predictions of this paper.
We agree that there are (unfortunately) few studies in mouse that can be compared with our simulations. With regard to the tMTFs, we can make a couple of points. First, we note that the stimulus used for all the panels except P2 in Figure 6 (previous Figure 7) were at 15 dB SPL, which is the level where maximal envelope phase-locking occurs in the low-threshold ANF inputs. This choice was based on previous experimental work that examined the intensity dependence for SAM stimuli in the auditory nerve (Smith and Brachman, 1980; Joris and Yin, 1992; Cooper et al, 1993; Dreyer and Delgutte, 2006, Figure 2B, Figure 3). Second, Figure 6, Supplemental Figure 1 confirms the behavior of the auditory nerve model used for input to the bushy cells (Rudnicki and Hemmert (2017) implementation), replicating Zilany et al., 2009, Figure 13D. These results show that phase-locking decreases at higher intensities as expected from the experimental work. Relevant to this topic, the lone report of responses to SAM stimuli in mice (Kopp-Scheinpflug et al. 2003) used 100% SAM at CF at 80 dB SPL. At this high intensity, it is expected that the envelope phase locking at CF will be less than at lower intensities because of rate saturation in the high and medium spontaneous rate ANFs (Carney, JARO 2019; Joris and Yin, 1998). In guinea pig, envelope phase locking is greater in low-SR fibers at 80 dB SPL than in medium and high SR fibers, but it is still lower than at its peak at about 50 dB SPL (Cooper et al., 1993). All of these experimental observations therefore lead to the prediction that the SAM envelope locking in Kopp-Scheinpflug et al. (2003) should be lower than in our simulations.
In addition, Kopp-Scheinpflug et al. (2003) did not report which VCN cell populations cells were recorded. If the recorded cells were a heterogenous mixture of bushy and multipolar cells, then their data are not directly comparable to our model predictions. The stimulus intensity also needs to be considered for comparison with the work of Rhode (1994), whose lowest stimulus level is 30 dB SPL (Figure 9), and who also used a different stimulus, 200% SAM, and with the work of Frisina et al. (1990), who used 50 dB SPL. Interestingly, Figure 14D in Rhode (1994) shows a synchrony coefficient ranging from 0.5 to 0.9 at 30 dB SPL at 300 Hz modulation, which is similar to what we predict in Figure 6P2. We also remind the reviewer that our simulations did not include the effects of feed-back inhibition at CF (Caspary and Palombi, 1994; Campagnola and Manis, 2014; Xie and Manis, 2014, Keine et al. eLife 2016), which may affect phase synchrony in complex ways (Gai and Carney, 2008). One important feedback pathways arises from the tuberculoventral cells of the DCN (Wickesberg and Oertel, 1991; Campagnola and Manis, 2014), but the envelope synchrony behavior of those cells is not known.
Thus, we now emphasize in the revised manuscript (in the Discussion) considerations of stimulus intensity used across published studies, citing the works above, the relatively high vector strengths at low modulation frequency, and that these simulation results are currently predictive. The simulations are also limited in that we used only one configuration of ANF inputs (low-threshold, high SR). This ANF SR category was selected to be consistent with the suggestion by Liberman (1991) that the globular BCs receive input principally from the low-threshold high-SR fibers. Mixtures of input SR classes would be expected to change the envelope representation at higher intensities. Finally, the parameter space is quite large (intensity x frequency x [ANF distributions], x inhibition) and is better explored in a separate study once we are able to provide better or additional constraints to the modeling framework. Also, to put the selection of SAM stimuli in context, we indicate that mice can encode temporal fine structure although only as low at 1 kHz, but at similar VS to larger rodents such as guinea pig (Taberner and Liberman 2005; Palmer and Russell 1986).
Reviewer 4: Public comments
1) The authors have collected an impressive array of physiological data and provided some beautiful 3D images of SBCs with dendrites. These are clearly strengths. The computational models for mechanisms of SBC responses, however, are made to fit what may be inadequate anatomical data. Instead of conclusions, perhaps they need to reword their discussions to refer to the anatomy as hypothetical substrates.
It is true that the SBEM image volumes have strengths and limitations. We now collect these considerations in the second section of the Discussion, “Toward a complete computational model for globular bushy cells: strengths and limitations”. One limitation of this volume is that we do not have sufficient resolution to categorize synaptic vesicles by shape and must infer their excitatory or inhibitory nature. Note that tracing inputs to a source neuron, such as tracing the endbulbs to parent auditory nerve fibers, solves this problem, but the smaller terminals remain problematic in this regard. The goal is to not only assign excitatory or inhibitory phenotype, but also a cell type of origin, so that actual spike patterns, evoked by sound, can be provided as inputs to the model. The compartmental model is detailed, and amenable to mapping this information from other experiments as it becomes available. Nanoscale imaging does provide detailed structural information in terms of surface areas, volumes and process diameters that is important in constraining the compartmental models, and that is not attainable by standard light microscopy approaches. These points are now made in the Results and in the Discussion, as mentioned earlier in this paragraph. And, as indicated in the responses to other reviewers, we highlight the model outputs as predictions to be tested experimentally.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
Ichinose et al., utilize a mixture of cultured hippocampal neurons and non-neuronal cells to identify the role of the transmembrane protein teneurin-2 (TEN-2) in the formation of inhibitory synapses along the dendritic shaft. First, they identify distinct clusters of gephyrin that are either actin-rich, microtubule-rich or contain neither actin nor microtubules and find that TEN-2 is enriched in microtubule-rich gephyrin clusters. This leads the authors to hypothesize that TEN-2 recruits microtubules (MTs) through the plus end binding protein EB1 when successfully matched with a pre-synaptic partner, and perform a variety of experiments to test this hypothesis. The authors then extend this finding to state quite strongly throughout the paper, including in the title, that TEN-2 acts as a signpost for the unloading of cargo from motor proteins without providing any supporting evidence. They use previous work to justify this conclusion, but without actual experiments to back up the claim, it seems like a reach.
The strength of the paper lies in the various lines of evidence that the authors employ to assess the role of TEN-2 in MT recruitment and synaptogenesis. They have also been very thorough in validating the expression and functionality of various knock-in constructs, knock-down vectors and antibodies that were generated during the study. However, there are some discrepancies in the findings that have not been addressed satisfactorily, as well as some instances where the data presented is not of sufficient quality to support the conclusions derived from them.
Firstly, we would like to express our sincere appreciation to Reviewer #1 for providing valuable feedback. We have carefully considered Reviewer #1 suggestions and have made significant improvements to the manuscript in response. Additionally, we have conducted an additional experiment to address the missing aspects identified in the initial submission. Furthermore, we have refined the focus of our investigation by narrowing down the number of aspects we aimed to prove and instead increased the number of confirmatory experiments. Specifically, we decided to give up on two aspects: the relationship between kinesins and cargo, and the immobilization of TEN2 in synapses (i.e., extracellular binding of TEN2). Instead, we focused on emphasizing the role of TEN2 as a platform for exocytosis. These modifications have significantly enhanced the quality of our research.
1) The emphasis placed on the clustering analysis presented in figure 1 and the two associated supplementary figures is puzzling, since the conclusion derived from the results presented would be that Neuroligin 2 (NLGN2) is the strongest candidate to test for a relationship to MT recruitment at inhibitory post synapses. Instead, the authors cite prior evidence to exclude NLGN2 from subsequent analysis and choose to focus on TEN2 instead.
We fully agree on the importance of studying NLGN2, as highlighted in the DISCUSSION section (line 463-471). While the cluster analysis suggests a correlation between NLGN2 and microtubules, previous research has reported microtubule localization outside the NLGN2 region (Uchigashima et al., 2016). However, this interpretation is based on EM observations at a single time point, so it will be important to evaluate it over time. Conversely, we had believed that further investigations are needed to explore the potential interactions between TEN2 and microtubules, because of its relatively limited characterization (line 156-161).
2) It is difficult to reach the same conclusion as the authors from the images and intensity plot shown on Figure 2 E and F. While there seems to be an obvious reduction in expression levels between the TEN2N-L and TEN2TM constructs, neither seem to co-localize with EB1.
As Reviewer #1 pointed out, the previous plots on Figure 2 were of very poor quality. Due to the dynamics of microtubules, evaluating interactions using fixed cells has limitations. Therefore, we decided to shift to live-imaging. Firstly, we observed a tendency for EB3 comets to pause at inhibitory postsynapses (Figures 1D-H). This suggests the presence of a microtubule recruiter at inhibitory synapses. Next, in dendrites expressing TEN2N-L, the velocity of EB3 comets was significantly faster compared to dendrites expressing TEN2TM or TEN2N-L2mut (Figures 7A-E). This suggests that the dominant-negative effect of TEN2N-L inhibits the function of endogenous microtubule recruiters. Additionally, the interaction between TEN2 and EB1/3 has been confirmed by GST pull-down (Figure 6A). Based on these reasoning, we propose that TEN2 present in inhibitory synapses plays a role as a microtubule recruiter through its interaction with EB1/3.
3) The authors mimic the activity of TEN-2 at the inhibitory post synapse in non-neuronal cells by immobilizing HA- tagged TEN constructs in COS-7 cells as a proxy for synaptic partner matching. Using this model, they find that by immobilizing TEN2N-L, which contains EB1 binding motifs, MTs are excluded from the cell periphery (Figure 3D). This contradicts their conclusion that MTs are recruited through EB1 by TEN-2 on synaptic partner matching. Later in the paper, when they use the same TEN2N-L construct as a dominant negative in neuronal cells, they find that MTs are recruited the membrane, even if TEN2N-L is not immobilized by synaptic partner matching (Figure 6C). Taken together, these findings call into question the sequence of events driven by TEN-2 during synaptogenesis.
We believe that the differences in the results between the COS-7 and neuron experiments are influenced by variations in the intracellular protein composition and distribution between COS-7 cells and neurons. Therefore, we consider it inappropriate to directly apply the results from COS-7 to neurons. Additionally, we attempted to replicate the experiments in neurons; however, it is worth mentioning that the culture of neurons on antibodies led to a significant decrease in cell viability. As a result, we have decided to withdraw the experiment of immobilized TEN2 using antibodies.
4) It is unclear how the authors could conclude that TEN-2 is at the semi-periphery (?) of inhibitory post synapses from the STORM data that is presented in the paper. Figure 4D and 4F show comparisons of Bassoon and TEN-2 localization vs TEN-2 and gephyrin, but the image quality is not sufficient to adequately portray a strong distinction in the distance of center of mass, which is also only depicted for the TEN2-Gephyrin pair and not the TEN2-Bassoon pair in Figure 4J.
The quality limitations of attempting a three-color dSTORM of TEN2-bassoon-gephyrin were addressed by modifying it to a two-color dSTORM. To confirm this modification, a two-color STORM was performed using VGAT instead of Bassoon (Figure 3E). The statement that TEN2 localizes to half of the synapse is supported by the observation of TEN2-gephyrin in the postsynaptic area. This observation aligns with the localization of microtubules at the postsynapse as observed by electron microscopy (Gulley & Reese, 1981; Linsalata et al., 2014).
5) The authors do not satisfactorily explain why gephyrin appears to have completely disappeared in the TEN2N-L condition (Figure 6A), instead of appearing uniformly distributed as one would expect if MTs are indiscriminately recruited to the membrane by the dominant negative construct that remains unanchored.
As pointed out by Reviewer #1, it needed to be adequately proven, and we mistakenly conflated dominant-negative and gain-of-function effects. However, through the examination of live imaging of EB3, observation of the localization of gephyrin, and the additional investigation of GABAAR localization in neurons expressing partial domains of TEN2, we found that TEN2N-L functions as a dominant-negative, inhibiting the microtubule recruitment function of endogenous TEN2 (Figure 7). On the other hand, it does not exhibit a gain-of-function effect in inducing exocytosis of GABAAR because both gephyrin and GABAAR were found to be reduced in the neurons expressing TEN2N-L (Figure 7F-H). Therefore, we have corrected this point.
6) In a similar critique to that of Figure 2E and F, the distinction that the authors wish to portray between the effect of TEN2TM and TEN2N-L constructs on EGFP-TEN-2 and MAP2 colocalization (Figure 6 E and F) appear to be driven by a difference in overall expression levels of EGFP-TEN2 rather that a true difference in localization of TEN-2 and MTs.
Regarding the previous co-localization of TEN2 and microtubules after permeabilization with saponin, we have removed it from the analysis because it is not possible to perform accurate quantitative analysis in this case. We speculate that this is a combination of two factors: the variation in transfection efficiency and the inherent variability in permeabilization between neurons. Specifically, it is particularly challenging to standardize and quantify the variability in permeabilization. Instead, the current version proposes TEN2-MT interaction via EBs by live imaging of EB3 in neurons expressing each partial domain. As observed in COS-7 cells where EB was overexpressed, whether TEN2 engages in continuous binding with microtubules or if it is a transient interaction remains an interesting topic for future investigation. We have mentioned this in the DISCUSSION section as well (line 415-422).
Reviewer #2 (Public Review):
Maturation of inhibitory synapses requires multiple vital biological steps including, i) translocation of cargos containing GABAARs and scaffolds (e.g. gephyrin) through microtubules (MTs), ii) exocytosis of inhibitory synapse proteins from cargo followed by the incorporation to the plasma membrane for lateral diffusion, and iii) incorporation of proteins to inhibitory synaptic sites where gephyrin and GABAARs are associated with actin. A number of studies have elucidated the molecular mechanisms for GABAARs and gephyrin translocation in each step. However, the molecular mechanisms underlying the transition between steps, particularly from exocytosis to lateral diffusion of inhibitory proteins, still need to be elucidated. This manuscript successfully characterizes three stages of inhibitory synapses during maturation, cluster1: an initial stage that receptors are being brought in and out by the MT system; cluster2: lateral diffusion stage; cluster 3: matured postsynapses anchored by gephyrin and actin, by quantifying the abundance of MAP2 or Actin in inhibitory synapse labeled by gephyrin. Importantly, the authors' findings suggest that TEN2, a trans-synaptic adhesion molecule that has two EB1 binding motifs, plays an important role in the transition from clusters 1 to 2, and inhibitory synapse maturation. The imaging results are impressive and compelling, these data will provide new insights into the mechanisms of protein transport during synapse development. However, the present study contains several loose ends preventing convincing conclusions. Most importantly, (1) it remains more TEN2 domain characterization on inhibitory synapse maturation, (2) further validation of the HA knock-in TEN2 mouse model is required, and (3) it requires additional physiology data that complement the authors' findings.
First we would like to thank Reviewer #2 very much for the efforts and numerous suggestions. While it is highly appealing to comprehensively explain the function of a single synapse organizer in a step-by-step manner during synapse formation, we believe that it requires the identification of changing binding partners at each step, which is currently a challenging task. Therefore, in this paper, we have focused solely on the interaction between TEN2 and microtubules. As a result, we have discovered that TEN2 provides a platform for the exocytosis of GABAR, and this process relies on the interaction between TEN2 and microtubules. The analysis of the immobilization of TEN2, which was included in the previous version, will be part of a future publication. We also plan to continue detailed analysis of other domains. Thus, issues remain regarding the analysis of TEN2, but in order to confirm what is happening in just specific one step, we have made significant revisions in this revised manuscript, including analysis in HA knock-in neurons and electrophysiological analysis. We would greatly appreciate it if Reviewer #2 would reconsider the revised manuscript.
Reviewer #3 (Public Review):
In this paper, Ichinose et al. examine mechanisms that contribute to building inhibitory synapses through differential protein release from microtubules. They find that tenurin-2 plays a role in this process in cultured hippocampal neurons via EB1 using a variety of genetic and imaging methods. Overall, the experiments are generally designed well, but it is unclear whether their findings offer a significant advance. The experimental logic flow and rational difficult for readers to follow in the manuscript's current form.
Strengths:
1) The experiments are generally well designed overall, and appropriate to the questions posed.
2) Several experimental methods are combined to validate key results.
3) Use of cutting-edge technologies (i.e. STORM imaging) to help answer key questions in the paper.
We thank Reviewer #3 for reviewing our manuscript. We sincerely appreciate the valuable feedback. The previous version of the manuscript contained numerous claims, some of which were not thoroughly validated, making it prone to reader misinterpretation. Based on the results of additional experiments, we have revised the manuscript by focusing solely on the findings that were adequately confirmed, specifically highlighting the role of TEN2 in providing a platform for GABAAR exocytosis. We are grateful for your time and effort in revisiting the revised manuscript, and we believe it meets the necessary requirements.
Weakness:
1) Simplifying the text and story line would go a long way to ensure the study results are more effectively communicated. Additional specific suggestions are provided in the recommendations for the authors.
Thank you for providing valuable suggestions. Based on the results of additional experiments, we have revised our claims accordingly.
2) The introduction overall would benefit from simplification so that the reader is given only the information they need to know to understand the question at hand.
We selected essential information from previous studies that we believe readers should be aware of before reading our manuscript.
3) MT dynamics are important for paper results, but the background in the paper does not appropriately introduce this topic.
We have provided some information in lines 57-64 of the INTRODUCTION section.
4) It is a bit unclear from the abstract and introduction how the findings of this paper have significantly advanced the field or taught something fundamentally new about how inhibitory synapses are regulated.
Thank you for your valuable feedback. In the new version, we have thoroughly examined and emphasized the significance of our research findings.
5) Figure 1 - Line 109, it is obscure why "it was found appropriate" to divide the data into three clusters. This section would better justified by starting with cellular functions and then basing the clusters on these functions.
As Reviewer #3 pointed out, we have revised the classification to be based on past knowledge rather than data-driven.
6) The proteomic screen and candidate selection is not well justified and the logic steps for arriving at TEN2 are a bit weak. Again, less is more here.
As Reviewer #3 mentioned, we have made revisions in the new version. We have not completely excluded NLGN2, but rather believe that further examination and consideration of NLGN2 are necessary going forward (lines 463-471).
7) Fig. 2 - The authors should consider whether EB1 overexpression would have functional consequences that alter the results and colocalization.
The previous Figure 2, which is now Figure 6, is intended to demonstrate protein-protein interactions rather than provide functional implications. It is likely that the original function of EB1, which should be located at the plus ends of MTs, is compromised by its presence in the MT lattice. As an alternative method to demonstrate protein-protein interactions, we have also conducted GST pull-down assays (Figure 6A). From these two experimental results, we infer that the intracellular domain of TEN2 interacts with EB1. However, we have not discussed the functional implications of the TEN2-EB1 complex based on these experimental findings. The function was discussed from the results performed in Figure 7.
8) Fig. 3 - Is immobilization of COS cells using HA tag antibodies a relevant system for study of these questions?
We agree with this suggestion regarding the replication of the experimental systems to neurons, as the results have been successful in COS-7 cells. However, when we attempted to culture neurons on antibody-coated cover glass, the survival rate was significantly reduced. We were unable to directly replicate these systems to neurons. Therefore, we have decided to withdraw this claim from the publication.
9) Fig. 4 - The authors should confirm post-synaptic localization in vivo (brain).
We agree with this suggestion. Currently, our research group does not have an effective immune-labeling method for synaptic protein in the brain. This is a future challenge that we should address.
10) Figure 4D-E - The way the STORM results are presented is confusing. The authors state is shows that TEN2 is postsynaptic but before this say that the Abs are the same size as the synaptic cleft so that the results cannot be considered conclusive. This issue should be resolved.
To improve the quality of our dSTORM experiments, we abandon three color dSTORM and instead focused on two color dSTORM to draw conclusions (Figure 3E). We utilized VGAT to detect presynaptic sites. VGAT is an inhibitory presynaptic-specific molecule that is present at the center of presynaptic terminals, eliminating concerns about the size of the antibodies used.
11) Figure 5 -The authors should examine the levels of gephyrin relative to the levels of knockdown given the knockdown variability.
Thank you for your suggestion. As shown in Figure 4D of the current version, we were able to simultaneously quantify the knockdown efficiency and synaptic density. We obtained results indicating a decrease in synaptic density associated with a decrease in TEN2 expression levels.
12) Functional validation of a reduction in inhibition following TEN2 manipulation would elevate the paper.
We conducted live imaging of EBs to measure the changes when introducing the partial domain of TEN2 (Figures 7A-E). By observing the decrease in synaptic density and the impaired MT recruitment function of endogenous TEN2 due to the dominant-negative effect of TEN2N-L, we concluded that the TEN2-MT interaction serves as the platform for GABAR exocytosis.
13) Figure 6E - The expression levels of TEN2TM and TEN2NL are important to the outcome of these experiments. How did the authors ensure that the levels of two proteins were the same to begin with?
As it was also mentioned by Reviewer #1, we reply with the same answer as follows: Regarding the previous co-localization of TEN2 and microtubules after permeabilization with saponin, we have removed it from the analysis because it is not possible to perform accurate quantitative analysis in this case. We speculate that this is a combination of two factors: the variation in transfection efficiency and the inherent variability in permeabilization between neurons. Specifically, it is particularly challenging to standardize and quantify the variability in permeabilization. Instead, the current version proposes TEN2-MT interaction via EBs by live imaging of EB3 in neurons expressing each partial domain. As observed in COS-7 cells where EB was overexpressed, whether TEN2 engages in continuous binding with microtubules or if it is a transient interaction remains an interesting topic for future investigation. We have mentioned this in the DISCUSSION section as well (line 415-422).
-
-
www.medrxiv.org www.medrxiv.org
-
Author Response
Reviewer #2 (Public Review):
In this manuscript, the authors have proposed that the suppression of hepatic GPR110, known as a tumorigenic gene, could improve non-alcoholic fatty liver disease (NALFD). With AAV-mediated GPR110 overexpression or a GalNAc-siGPR110 experiment, they have suggested that GPR110 could increase hepatic lipids through SCD1.
Major comments
1) Although the authors claimed that GPR110 could enhance SCD1-mediated hepatic de novo lipogenesis, the level of GPR110 expression was decreased in obese mice (Figure 1E-F). However, it has been reported that the levels of de novo lipogenic genes, including SCD1, are upregulated in HFDfed mice (PMID: 18249166, PMID: 31676768). Thus, they should show the levels of hepatic lipids and lipogenic gene expression, including SCD-1, in liver tissues from NCD vs. HFD-fed mice, which will provide insights between GPR110 level and hepatic lipogenic activity.
Thank you for the comment. The levels of hepatic lipids and lipogenic gene expression, including SCD-1, in liver tissues from NCD vs. HFD-fed mice are summarized in Supplementary Table 4 on page 63. Additionally, we measured the de novo lipogenic activity of primary hepatocytes with varying levels of GPR110 using stable isotopes 3H-acetate. The data are presented in Figure 5D on page 36 of the revised manuscript. These findings suggest that the HFD diet may affect hepatic lipid metabolism through changes in gene expression and lipid accumulation.
2) In Figure 2, the authors have characterized metabolic phenotypes of hepatic GPR110 overexpression upon HFD, exhibiting significant phenotypes (including GTT, ITT, HOMA-IR, serum lipids, and hepatic lipid level). However, it is likely that these phenotypes could stem from increased body weight gain. Since they cannot explain how hepatic GPR110 overexpression could increase body weight, it is hard to conclude that the increased hepatic lipid level would be a direct consequence of GPR110 overexpression. Also, given the increased fat mass in GPR110 overexpressed mice, they should test whether GPR110 overexpression would affect adipose tissue. Along the same line, they have to carefully investigate the reason of increased body weight gain in GPR110 overexpressed mice (ex., food intake, and energy expenditure).
Thank you for the comment. Firstly, we checked the expression of GPR110 in the adipose tissues of rAAV-GPR110 mice. We did not observe any change in the mRNA expression level of GPR110 in adipose tissues including SWAT, EWAT and BAT as compared to their controls (Supplementary Figure 3A on page 50). All the Ct levels for adipose GPR110 mRNA were over 40. As suggested, we use metabolic cage system to explore whether the metabolic phenotypic differences between rAAV-GFP and rAAV-GPR110 mice were due to other factors. However, we did not observe any difference in the locomotion, distance in cage locomotion, energy expenditure, daily food intake, daily water intake and respiratory exchange ratio remained similar in these two groups as shown in Supplementary Figure 3.B-G on page 50. Therefore, they shall not be the root cause of the reason of increased body weight gain in GPR110 overexpressed mice.
3) GPR110 enhances hepatic lipogenesis via SCD1 expression (Figures 5 and 6). To verify whether GPR110 would specifically regulates SCD1 transcript, they have to provide the expression levels of other lipogenic genes, including Srebf1, Chrebp, Acaca, and Fasn.
Thank you for the comment. As suggested, we added the expression levels of these lipogenic genes in Figure 5B-C on page 36 of the revised manuscript. In addition, we also measured the de novo lipogenic activity using primary hepatocytes with either overexpressing or knockdown of GPR110 to confirm that GPR110 enhances hepatic lipogenesis.
4) In Figure 6, the author should provide the molecular mechanisms how GPR110 signaling could enhance SCD-1 transcription.
Thank you for the comment. SREBP1 is a key transcription factor that regulates the expression levels of the SCD1 gene [21]. A study published in March (at the time of revising this manuscript) showed that GPR110 plays a role in mediating the activation of SREBP1 pathways by palmitic acid. This ultimately promotes the synthesis of fats in mammary gland tissues [10]. In our RNA sequencing analysis, we also found that the expression of hepatic SREBP1 was correlated with the expression of GPR110. To further investigate this relationship, we added the mRNA levels of SREBP1 in our experiments, as shown in Figure 5B-C on page 36 of the revised manuscript. Specifically, we found that the expression level of SREBP1 was increased in the GPR110 overexpression group and decreased after using ASOs to knock down hepatic GPR110 levels. These findings suggest that GPR110 regulates hepatic lipid metabolism through the SREBP1-SCD1 pathway.
5) Figure 9C shows the increased level of GPR110 with NAFLD severity. They should test whether the levels of hepatic GPR110 and SCD-1 might be elevated in a severe NAFLD mouse model. If it is the case, it would be better to show the beneficial effects of GPR110 suppression against NAFLD progression using a severe NAFLD (ex., NASH) mouse model.
Thank you for the comment. To further explore the expression pattern of GPR110 in a more severe NAFLD mouse model, we injected either CCl4 or STZ to induce NAFLD severity in HFD-fed mice. We found that after treating with CCl4 or STZ, the expression levels of GPR110 and SCD1 mRNAs were significantly increased compared to the control group without treatment with CCl4 or STZ (please see Figure 9F-G). We attempted to knock down the expression of hepatic GPR110 in the CCl4 or STZtreated HFD-fed mice. However, our ASOs were only effective in knocking down high levels of GPR110 mRNA in the virus mediated GPR110 expression systems (please see Figure 5 and 6). The expression level of hepatic GPR110 mRNA in HFD-fed mice after CCl4 or STZ treatment was too low to be effectively knocked down by ASOs. However, a previous study demonstrated that Gpr110-/- mice were resistant to liver tumorigenesis induced by DEN plus CCl4 injection [22]. We believe that GPR110 suppression also can prevent the progression of NAFLD in these severe NAFLD mouse models.
Reviewer #3 (Public Review):
In this study, the authors examined the expression of GPR110 in a HFD-fed mouse model and validated their findings in human samples. They then performed both gain- and loss-of-function studies on the cellular and systemic metabolic effects of manipulating the levels of GPR110. They further demonstrated that SCD-1 was a downstream effector of GPR110, and the effects of GPR110 could be mediated by SCD-1. This study provides a novel target in NAFLD. Overall, the data and analyses well performed and convincing. As the GPR110-SCD1-lipid metabolic phenotype axis is a central theme of the study, I would suggest that the authors further discuss the connection between GPR110 and SCD1, especially the persistent upregulation of SCD1 at late stage of HFD-fed mice (obese mouse model) when GPR110 is very low, for example, whether another regulator plays a more relevant role at this time point.
Thank you for the comment. As SCD1 is the rate limiting enzyme catalysing the biosynthesis of monounsaturated fatty acids, a very tight and complex regulation of SCD1 gene expression in response to various parameters including hormonal and nutrient factors is reported [23]. HFD treatment itself can induce the expression of hepatic SCD1 [21, 23, 24], and our study demonstrated that the expression of SCD1 can be further increased by overexpressing GPR110 in the liver of HFDfed mice (Fig. 9F and G on page 44) that will contribute to the acceleration and aggravation of NAFLD. The discussion of the connection between GPR110 and SCD1was presented on page 21, lines 455-464.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
The manuscript by Huang, Li, et al. describes the identification of variants in the gene coding for p31 comet, a protein required for silencing the spindle assembly checkpoint or SAC, in women with recurrent pregnancy loss upon IVF. In three families mutations affecting splicing or expression of full-length protein were identified. The authors show that oocytes of the patients arrest in meiosis I, are most likely to fail to inactivate the SAC without a fully functional p31 comet. Indeed, the metaphase I arrest occurring in mouse oocytes upon overexpression of Mad2 can be rescued by overexpression of wild-type p31 comet, but not a truncated version. Injection of wt p31 comet into 6 human oocytes from one patient rescued the meiosis I arrest.
Main points:
The fact that inactivation of the SAC is required for anaphase I onset in human oocytes is not novel. Biallelic mutations of TRIP13 were shown to lead to the same phenotype (Zhang et al. Am J. Hum Gen., 2020).
As pointed out by the editors and both other reviewers, the strength of this study is highlighted by the identification of genetic variants responsible for oocyte meiosis I arrest in human patients. As a fact, very few genetic variants that cause female oocyte meiotic failure are identified (Ref: Qing Sang, et al. Understanding the genetics of human infertility. Science. 2023). In this study, we for the first time reported the novel deleterious p31comet variants causing human oocyte MI arrest. Without exploring the etiological landscape of human genetic variants, it is impossible to comprehensively invent diagnostic and therapeutic approaches for female patients.
No new mechanistic insights are obtained.
To gain the molecular mechanism, we have optimized and performed a modified Smart-seq2 protocol using frozen single-cell human oocytes (Page 11 and Figure 4-figure supplement 1). These data were in well agreement with the phenotypes as reported.
The authors propose a role for female fertility, however, also a male patient with a p31 comet variant is sterile.
This manuscript focuses on screening the genetics variants responsible for the oocyte failure in female patients, rather than male patients. In addition, we had difficulties with collection of more detailed information from this male patient because he rejected to provide the consent to us. We currently only have limited information after we tried every effort to get in touch with the male patient. We have added more discussion in the MS. Certainly, further exploration of the roles of MAD2L1BP variants in the male meiosis, for example, by collection of a cohort of male patients’ samples with meiotic defects, would be an interesting direction in the future, but this is beyond the scope of this study.
The fact that the C-terminus of p31 comet is required for interaction with Mad2 and hence, turning off the SAC, is already known.
The interaction between p31comet and Mad2 is known in somatic cells, but not in oocytes. As it is widely known that the oocytes are distinct from somatic cells in that the SAC in oocytes is not effective because oocytes can proceed to anaphase I in the presence of even one unattached kinetochore, as compared with somatic cells. We provided evidence that the overexpression of Mad2 can only be rescued by overexpression of wild-type p31comet, but not the truncated p31comet variant in both mouse and human oocytes (Fig.3 and 4), which sufficiently characterized the causative roles of p31comet variants underlying female infertility.
Reviewer #2 (Public Review):
In this manuscript by Huang et al. the authors explore the genetic underpinnings that may cause human oocyte meiotic arrest. The meiotic arrest of oocytes can cause female infertility leading patients to seek treatment at IVF clinics to assist in having genetically related babies. However, because oocytes fail to develop to MII, oocytes from these patients cannot be fertilized, leaving no current options for genetically related babies for patients with this pathology. Huang et al identified 50 IVF patients with this phenotype, and after the whole exome sequence, 3 patients had mutations in a spindle assembly checkpoint regulator, Mad1bp1. This study describes these mutations in detail, shows how these mutations affect Mad1bp1 expression, evaluates gross function in mouse oocytes, and explores therapeutic treatment in human oocytes. Overall, this is an important translational study that adds to the growing body of literature that genetic mutations impact oocyte quality and fertility.
Thank you for your favorable comments.
In its current form, I find that the strengths exist in the analysis of the patients' genomes and pedigree information. This is unique data and is important for the field. The expression in oocytes, structure modeling, and conservation in evolution, while not essential for this study, add interesting information for the reader to consider. I sometimes find these distracting in manuscripts, but appreciate them here in this context. The conclusion using human oocytes to propose possible treatment takes the study to completion and is not an easy approach to carry out.
Thank you for your positive comments on this manuscript.
I do find some weaknesses that weaken the conclusions. The conclusion described is that the SAC is not satisfied in oocytes from these patients. The authors attempt to show this by analysis of mouse oocytes using polar body extrusion and its timing as an assay. There could be many reasons contributing to arrest, therefore a singular assay is not ideal to justify the conclusions. While I do suspect the authors are correct, an intact SAC should be shown at the molecular level to fully justify this conclusion. There are many assays routinely performed in mouse oocytes that the authors can consider (check papers by authors from Wassmann, FitzHarris, and Schindler labs for example).
Thanks for your good comments. Following your advice, we have performed the immunofluorescence assay to evaluate the SAC integrity using mouse oocytes by microinjection of WT and Mut Mad2l1bp cRNA, which clearly validated the intact SAC activation with Mut Mad2l1bp cRNA injection. Please see the reply as detailed below.
Reviewer #3 (Public Review):
The spindle checkpoint ensures the accuracy of chromosome segregation by sensing unattached kinetochores during mitosis and meiosis and delays the onset of anaphase. Unattached kinetochores catalyze the conformational activation of the latent open MAD2 (O-MAD2) to the active closed MAD2 (C-MAD2). C-MAD2 is then incorporated into the mitotic checkpoint complex (MCC), which inhibits the anaphase-promoting complex or cyclosome (APC/C) to delay anaphase. When all kinetochores are properly unattached, the MAD2-binding protein p31comet and the ATPase TRIP13 extract C-MAD2 from the MCC, leading to MCC disassembly and the conversion of C-MAD2 back to O-MAD2. This action turns off the spindle checkpoint, resulting in APC/C activation and anaphase onset. Cells deficient in p31comet exhibit mitotic delays.
In the current study, Huang et al. have linked p31comet mutations to female infertility. Biallelic loss-of-function alleles of p31comet cause delays in the exiting metaphase of meiosis I and polar body extrusion. The p31comet mutant proteins contain C-terminal truncations and fail to bind to MAD2. Reintroducing full-length p31comet into patient oocytes can bypass the metaphase arrest. Together with a previous study that showed biallelic mutations of TRIP13 caused female infertility, this work established a critical role of the p31comet-TRIP13 module in regulating meiotic progression during oogenesis. As such, this is a significant study.
Thank you for the very positive comments on this manuscript.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
This work reports an important demonstration of how to predict the mutational pathways to antimicrobial resistance (AMR) emergence, particularly in the enzyme DHFR (dihydrofolate reductase). Epistasis, or non-additive effects of mutations due to their background dependence, is a major confounding factor in the predictability of protein evolution, including proteins that confer antimicrobial resistance. In the first approach, they used the Rosetta to predict the mutant DHFRdrug binding affinity and the resulting selection coefficient, which then became inputs to a population genetics model. In the second approach, they use the observed clinical/environmental frequency of the variants to estimate the selection coefficient. Overall, this work is a compelling demonstration that a mechanistic model of the fitness landscape could recapitulate AMR evolution; however, considering that the number of mutations and pathways is small, a more compelling description of the robustness of the results and/or limitations of the model is needed.
Major strengths:
1) This is a compelling multi-disciplinary work that combines a mechanistic fitness landscape of DHFR (previously articulated in literature and cited by the authors), Rosetta to determine the biophysical effects of mutations, and a population genetics model.
2) The study takes advantage of extensive data on the clinical/environmental prevalence of DHFR mutations.
3) Provides a careful review of the surrounding literature.
Major weakness:
1) Considering that the number of mutations and pathways being recapitulated is rather small, I would suggest a more detailed description of the robustness of the results. For example:
a) Please report the P-value for the correlation of the predicted DDG_{binding, theory} and DDG_{binding, experimental}.
We thank the reviewer for the suggestion. We agree the available experimental data is small, limiting the statistical power of the Pearsons correlation test to determine how well Flex ddG predicts binding free energy change. However, as highlighted in the manuscript, two earlier studies by Aldeghi et al. 2018 & 2019 considered much larger datasets and found a correlation in a similar range to the one we found here. Furthermore, as suggested by the Reviewer, we carried out a onesided T-test with alternative hypothesis that the correlation is greater than 0 and found a p-value of 0.040, suggesting the correlation we observed is significant. We have included this test and p-value to the Results section.
If interested in showing the correct assignment of mutational effects, perhaps use a contingency matrix to derive a P-value.
As suggested by the Reviewer, we used a contingency matrix known as a confusion matrix to determine how accurate Flex ddG is at classifying mutations as stabilising or destabilising. This gave an accuracy of 0.89, sensitivity of 0.83 and a specificity of 1. The p-value associated with this continency table was 0.14, despite the high accuracy, sensitivity and specificity. This is likely due to the small sample size making it difficult to determine significance. This analysis has been included in the Results section.
b) Although the DDG_binding calculation in Rosetta seems to converge (Appendix figures 3 and 4), I do not think the DDG values before equilibration should be included in the final DDG estimate. In practice, there is a "burn in" number of runs where the force field optimizes the calculation to account for potential clashes in the structure, etc. This is particularly important since the starting structures are modeled from homology. Consequently, the distributions of DDG that include the equilibration runs are multimodal (Appendix figure 2), which means that calculating an average may be inappropriate.
Each Flex ddG prediction is independent (see Figure 1 of Barlow et al. 2018 for a summary of the Flex ddG method), i.e. the distribution of values does not represent a MCMC process in which there is a burn-in in order to equilibrate. The structures of both the wild-type and mutant are equilibrated in each run using the backrub algorithm. The reason so many runs are required is because each prediction is from a distribution of possible ddG values associated with that specific mutation and the authors of Flex ddG suggest running 35 runs or more and taking the average of the distribution. Therefore, in order to get an accurate prediction, enough simulations must be run per mutation to adequately characterise the distribution so that the average converges to a constant value.
2) The geographical areas over which the mutational pathways are independently estimated are not isolated, allowing for the potential that an AMR variant in one region arose due to "migration" from another area. For example, the S58R-S117N is the most frequent double mutant of PvDHFR in geographically proximate Southern/Southeastern Asia (Fig. 4). To a certain extent, similar mutational patterns occur for PfDHFR in Southern/Southeastern Asia (Fig. 3). Although accounting for mutant migration in the model may be beyond the scope of the study, a clear argument for the validity of the "isolated island" assumption is needed.
The Reviewer is correct that some variants in one region may have arisen due to “migration” from another area. This would impact the method for inferring mutational pathways from regional isolate frequency data but not when considering the worldwide population. If this occurred, we would expect to see a multiple mutant appearing in a region without the precursor (single, double etc) mutations, even in the case of large sample size. However, this does not seem to have been an issue for the pathways we have been predicting here. If it were the case that a variant migrated, and the precursor mutations could not be found in that region, we could look to mutations from neighbouring regions to infer the pathway, under the assumption of migration.
We have added some discussion on this between lines 517-523:
“When inferring pathways at a regional level, it is possible we may encounter instances where genotypes with multiple mutations are observed in a specific region, but the precursor mutations in the pathway are absent. This could happen either due to insufficient sampling of the region or due to "migration" of the variant from a neighbouring region. To infer pathways in the former case more samples would be required, whereas in the latter case we can look to the data from neighbouring regions where the variant is present and use the frequency data of the precursor mutations.”
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #2 (Public Review):
1) Analytical approaches are in the current form preliminary and not enough to draw firm biological conclusions. While the datasets are large (which is highly appreciated), they represent a relatively early stage of ENS development and possible differences between vagal and sacral-derived populations could partially be attributed to difference in maturity. Maturity will surely not explain the whole difference observed but needs to be factored into the interpretation. As scRNA-seq datasets from the mature chicken ENS are lacking (as well as detailed IHC-based neural classification system) the inference made in the paper between molecular classes and functional types are premature.
We appreciate this comment and think it is an excellent suggestion that we definitely plan to do. This made us realize that we failed to clarify in the text why we chose this particular time point for our study, which is two-fold.
First, we are particularly interested in how neural crest cells choose their prospective fates. E10 is a time when the post-umbilical gut has been completely populated by both vagal and sacral neural crest cells for 2 days so cells are in the process of differentiation but there still exists a large precursor pool. For this reason, we can capture both precursors and some differentiated neuronal subtypes. We have clarified this point in the revised manuscript and now focus much more on the precursor population to identify both genes that are common to vagal and sacral neural crest cells as well as those that are distinct. This enables us to formulate testable hypotheses for the role of potential role of particular transcription factors is allocation of cell fate. Of particular interest, we find that at E10, the sacral neuronal precursor pool is largely depleted whereas the vagal crest has a substantial neuronal precursor pool. Thus, we believe this is the perfect time point for initial analysis.
Second and perhaps even more important, in the US, chick embryos are not considered vertebrates until after E10. Thus, E10 represents the last timepoint we can raise embryos without animal approvals which are not currently in hand. We completely agree that performing experiments at later timepoints will be incredibly valuable and therefore are now applying for approvals. But realistically, these take several months and thus would delay publication of our datasets (already delayed due to Covid restrictions) for at least another year. Therefore, we propose to publish the mature dataset as a Research Advance that would focus on differences between mature neuronal subtypes between preumbilical vagal, post-umbilical vagal and sacral datasets that would nicely complement the current work. Instead, we have refocused this paper on the precursor to differentiated neuron transition.
I should mention that this refocusing seems particularly important given that our original aim was to explore differences between vagal and sacral neural crest contributions to the gut. However, the single cell data reveals strong overlap between sacral and vagal neural crest contributions to the postumbilical gut, suggesting a strong environmental influence on cell fate decisions.
Specific concerns:
1) Analysis of scRNA-sequenced sacral- versus vagal-derived ENS reveals clusters consistent with a non-ENS identity (endothelial, muscle, vascular and more). Previous studies in mouse using the neural crest tracing line Wnt1-Cre has not demonstrated such diverse progenies of neural crest from any region. An exception being a small population of mesenchymal-like cells (Ling and Sauka-Spengler, Nat Cell Biol. 2019; Zeisel et al., Cell 2018; Morarach et al., 2021; Soldatov et al., Science 2019). Therefore, the claimed broad potential of 6 of 13 neural crest giving rise to diverse gut cell populations warrants more validating experiments.
We thank the reviewer for this comment. We clarify that hematopoetic clusters have dropped out upon reanalysis. The other clusters we believe are real based on gene markers used in previous studies to identify cell types such as neural crest-derived melanocytes like Mlana, Dct, and Mitf.
2) Several earlier studies have revealed that parts of the ENS is derived from neural crest that attach to nerve bundles, obtain a schwann cell precursor-like identity and thereafter migrate into the gut (Uesaka et al. J Neurosci 2015 and Espinosa-Medina et al, PNAS 2017). The current work in chicken needs to be interpretated in the light of these findings and the publications should be discussed in relevant sections of the introduction and discussion.
Thank you for this suggestion. We agree and indeed our data cannot differentiate between SCPs, which are neural crest-derived, versus early migrating neural crest cells. We have added this point to the discussion and also discuss these papers in more detail.
3) The analysis indicates the presence of melanocytes. It is not clear why they are part of the GI-tract preparations. Could they correspond to another cell type, with partially overlapping gene expression profile as melanocytes?
We have assigned these as melanocytes based on expression of Mlana, Mitf, and Dct as highly upregulated genes. These have been used in previous studies to identify neural crest derived melanocytes in the heart (Chen et al., 2021)
4) As evident, the sacral- and vagal-derived ENS are not clonally related. To decipher differentiation paths and relations between clusters, individual analysis of the different datasets are needed. With only one UMAP representing the merged datasets combined with little information on markers, it is hard to evaluate the soundness of the conclusions regarding cell-identities of clusters and lineage differentiation.
This is an excellent suggestion and we apologize for not including this previously. We have now added individual pre-umbilical vagal, post-umbilical vagal and sacral neural crest datasets as well as trajectory analysis for each.
5) E10 is a relatively early stage in chicken ENS development. Around E7, the intestines do not contain differentiated neurons even. The relative high expression of Hes5 (marking mature enteric glia in the mouse; Morarach et al., 2021) in the vagal neural crest population might be explained by the more mature state of vagal versus sacral ENS. As also outlined below, Th/Dbh are known to be transiently expressed in the developing ENS why they could indicate the relative immaturity of sacral neural crest rather than differential neural identities. These issues need to be taken into account when interpreting biology from scRNA-seq data.
We completely agree. We now clarify that we are particularly interested in how neural crest cells choose their prospective fates. We chose the E10 time point because this reflects a time point when the post-umbilical gut has been completely populated by both vagal and sacral neural crest cells for 2 days so cells are in the process of differentiation but there still exists a large precursor pool. For this reason, we can capture both precursors and some differentiated neuronal subtypes. Notably, the sacral derived precursors seem to be glial in flavor whereas neuronal precursors appear to be absent. We have clarified this point in the revised manuscript.
6) Unlike the guineapig, and to some extent pig and murine ENS, the physiology of chicken enteric neurons has not been well characterized yet. Therefore, it is highly advisable to refrain from a nomenclature of clusters designating functions. Several key molecular markers are known to differ between murine, guineapig, rat and human systems. IPANs are a good example where differential expression is seen (SST in human but not mice; CGRP labels some IPANS in mouse, but not in guineapig, where Tac1 instead is expressed). IPANs are not defined in the chicken very well, and molecular markers found in other species may not be valid. Adrenergic and noradrenergic neurons have not been validated in the ENS (although, TH and Dbh have been observed in the especially in the submucosal ENS). Cholinergic neurons are also mentioned in the text, but do not appear in the figures as a defined group.
Another reason to refrain from functional nomenclature is that a rather early stage is analysed in the present study, without possibilities to compare with scRNA-seq data from the mature chicken ENS (which was performed in Morarach et al, 2021 for the mouse). Recent data suggest that considerable differentiation may occur even in postmitotic neurons, and several markers are known to display a transient expression pattern (TH, DBH and NOS1; Baetge and Gershon 1990; Bergner et al., 2014; Morarach et al., 2021) why caution should be taken to infer neuronal identities to clusters.
This is an excellent point and we thank the reviewer for this valuable input. Accordingly, we have now renamed the clusters based on prominent gene expression rather than neuronal or precursor subtype. Indeed we struggled with finding appropriate names making this comment all the more useful.
7) The immunohistochemical analysis (Figure 5,6) is an essential complementary addition and validation of scRNA-seq. However, it is very difficult to discern staining when magenda and red are combined to display coexpression.
Good point. This has been changed to be more readily discernible and higher magnification views have been added.
8) To give more information to the field and body of evidence for claims made, quantifications relating to the analysis in Figures 5 and 6 are warranted as well as an expanded set of marker genes that align with the scRNA-seq results.
Good point. We have added additional markers as suggested. In terms of quantitation, we can include numbers of labeled cells in a particular region but this may give a false impression of degree of contribution since we are using different viruses for vagal vs sacral that may have different titers making it a bit like comparing apples and oranges. We now emphasize that our labeling approach does not mark the entire population and that the degree of labeling can be variable.
9) Correlations between genes and functions/neuron class are in many cases wrong (including Grm3, Gad1, Nts, Gfra3, Myo9d, Cck and more).
Good point. We have toned this down.
10) Attempts to subcluster neuronal populations are needed (Figure 7). However, to understand the biology, it is important to address which cells are sacral versus vagal-derived. Additionally, related to previous comment, as the vagal and sacral neurons are not clonally related, it would be important to make separate analysis of neurons relating to each region.
Good point. We have added additional analysis to address this important point in what is now Fig 6 and in particular validated sacral contributions to glial cells (new Fig 8).
-
-
www.medrxiv.org www.medrxiv.org
-
Author Response
Reviewer #2 (Public Review):
In this study, Yang et al. used single-cell technology to construct the cell profiles of normal and pathological ligaments and identified the critical cell subpopulations and signaling pathways involved in ligament degeneration. The authors identified four major cell types: fibroblasts, endothelial cells, pericytes, and immune cells from four normal and four pathological human ligament samples. They further revealed the increased number of fibroblast subpopulations associated with ECM remodelling and inflammation in pathological ligaments. In addition, the authors further resolved the heterogeneity of endothelial and immune cells and identified an increase in pericyte subpopulations with muscle cell characteristics and macrophages in pathological ACL. Ligand-receptor interaction analysis revealed the involvement of FGF7 and TGFB signaling in interactions between pathological tendon subpopulations. Spatial transcriptome data analysis also validated the spatial proximity of disease-specific fibroblast subpopulations to endothelial and macrophages, suggesting their interactions in pathological ligaments. This study offers a comprehensive atlas of normal and pathological cells in human ligaments, providing valuable data for understanding the cellular composition of ligaments and screening for critical pathological targets. However, more in-depth analyses and experimental validation are needed to enhance the study.
1) In this study, the authors performed deconvolution analysis between bulk RNA sequencing results and scRNA-seq results (L204-L208). However, the analysis of this section is not sufficiently in-depth and the authors failed to present the proportion of different cell subpopulations of the bulk sequencing samples to further increase the reliability of the results of the single cell data analysis.
Thank you for the suggestion. We selected the top 50 Degs in each subpopulation of scRNA-seq, and scored the gene sets at the bulk RNA sequencing data level by GSVA method, so as to present the proportion of different cell subpopulations of the bulk sequencing samples to some extent. The results illustrated that, in the bulk RNA-seq data, fibroblast subpopulations (fibroblast 1,2,8,9) scored higher in the diseased group than in the normal group and fibroblast subpopulations (fibroblast 3,4) scored higher in the normal group than in the diseased group, which are consistent with the results of scRNA-seq.
2) In results 5, the authors should clearly describe whether the analysis is based only on pathological subpopulations of ligament cells or includes a mixture of normal and pathological subpopulations; the corresponding description should also be indicated in Figure 5. Besides, although the authors claimed that "the TGF-β pathway was involved in many cell-cell interactions among fibroblasts subpopulations and macrophages", Figure 5C displayed that the CD8+NKT-like cells displayed the most TGFB signaling interactions with fibroblasts subpopulations.
Thank you for your great questions. In results 5, our analysis is based on the mixture of normal and diseased subpopulations. We have also added a description of the data sample in the corresponding position in our manuscript.
As for the question of the TGF-β pathway in cell-cell interaction analysis, we claimed that “the TGF-β pathway was involved in many cell-cell interactions among fibroblasts subpopulations and macrophages”, because we took into account the proportion of each subpopulation of immune cells. Macrophages are the largest subpopulation of immune cells, and the number of macrophages is significantly increased in the degenerative group, suggesting that they are closely related to disease progression. However, the proportion of CD8+NKT-like cells in immune cells was very small, and the number of them was basically unchanged between the normal and diseased groups. So, macrophages are the focus of our attention, and after comprehensive analysis, we did not mention the strength TGFB signaling interactions of CD8+NKT-like cells.
3) In result 6, the authors performed spatial transcriptome sequencing, however, the sample numbers were relatively limited, with only one sample from each group; in addition, the results of this part failed to correlate and correspond well with the single-cell results. The subgroups labelled in L382 and L384 should be carefully checked. Besides, expression data of FGF7 and TGFB ligand and receptor molecules based on the spatial transcriptomes should be added to further confirm the critical signalling pathway in regulating the cellular interactions in pathological ACL.
Thanks for your reminding. The purpose of our spatial transcriptome sequencing (spRNA-seq) was to verify the scRNA-seq results, so only one representative sample from each group was selected for spRNA-seq. We believe that the results of our spRNA-seq were correlated and corresponded well with the scRNA-seq results. The scRNA-seq results were validated on the spRNA-seq data using marker transfer and spotlight methods, respectively. The results showed that more fibroblast4 in the normal group and more fibroblast9 in the diseased group of the scRNA-seq data were also consistent in the distribution of spRNA-seq samples. As shown in the spotlight plots, the more fibroblast subsets (fibroblast1,2,8,9) identified in the scRNA-seq data of the disease group were more widely distributed in the spRNA-seq sample of the disease group, and were closer to endothelial cells and immune cells in spatial location. We have revised the subgroups labelled in L382 and L384.
According to your suggestions, FGF7 and TGFB related ligand and receptor genes were mapped on spRNA-seq data, and the results were consistent with the results of cellchat analysis in scRNA-seq.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
It has been previously shown that defective autophagy and disorganized microtubule network contribute to the pathogenesis of Duchenne muscular dystrophy (DMD). The authors previously reported that nitrite oxide synthase 2 (NOX2) regulates these alterations. It was also shown that acetylated tubulin facilitates autophagosome-lysosome fusion and thus autophagy. In the present study, the authors showed that autophagy is differentially regulated by redox and acetylation modifications in dystrophic mdx mice. The ablation of Nox2 in mdx mice activated the autophagosome maturation but not its fusion with the lysosome. On the other hand, the inhibition of histone acetylase 6 (HDAC6) restored microtubule acetylation, promoted autophagosome-lysosome fusion, and improved muscle function in mdx mice. The strength of this paper is the combination of different approaches to decipher the mechanism, including the evaluation of the level and interaction of several proteins involved in the maturation of autophagosomes and in the fusion between autophagosomes and lysosomes.
This study reveals an important molecular mechanism by which increasing microtubule acetylation improves autophagy and muscle function in dystrophic mice. This has a translational impact on several diseases in which autophagy is impaired. The improvement of autophagosome-lysosome fusion with HDAC6 inhibitor is supported by several data, but some parts merit further analysis:
1) To add appropriate controls (e.g. without antibodies) to support protein-protein interaction for all co-immunoprecipitation assays.
Thank you for your valuable suggestion. We appreciate your input and have taken it into consideration. Based on your recommendation, we have conducted an experiment by including IP-IgG as a negative control to support the protein-protein interaction results obtained from the co-immunoprecipitation assays. The results of the negative control have been included in the respective figures. Additionally, to ensure the accuracy of the negative control, we ran the positive controls on the same blot. We have immunoprecipitated the same amount of samples for the negative control as we did for the actual IP samples presented in the manuscript. We believe that the inclusion of the negative control has strengthened the validity of our results and the conclusion drawn from our study.
2) The simple evaluation of the protein levels of p62 and LC3-II is not sufficient to claim autophagy improvement after HDAC6 inhibition. It would be good to evaluate the autophagic flux in vivo in all groups of mice (to treat the mice with or without autophagy inhibitor and evaluate whether the difference in the level of LC3-II between the two conditions is higher with HDAC6 inhibitor than without in the mdx mice).
Thank you for your suggestion to further evaluate the role of TubA on autophagic flux in vivo. We have included data using chloroquine to test the effect of TubA on autophagic flux in vivo. We found that chloroquine increased LC3 and p62 in skeletal muscle from mdx and mdx + TubA mice, suggesting. We have now included this information in the revised manuscript.
Reviewer #2 (Public Review):
Agrawal et al. propose an interesting model in which the autophagy pathway in adult mouse skeletal muscle fibers is orchestrated by two independent mechanisms: a) the activity of the NADPH oxidase (Nox) 2 enzyme necessary for autophagosome biogenesis and maturation and b) the level of acetylation of the microtubule (MT) network more selectively responsible for the fusion of the autophagosomes to the lysosomes. Using the well-known mdx mouse, a model for Duchenne muscular dystrophy, the authors perform a quite impressive (but rather traditional) biochemical characterization of the autophagy pathway and found that biogenesis and maturation of the autophagosomes are impaired in mdx mice muscle fibers by means of altered expression of components of the class III phosphatidylinositol 3-kinase complex (PI3K) such as Beclin, VPS15 (both upregulated in mdx mice), ATG14L and VPS34 (both downregulated), and by the reduced expression of JNK and JIP-1, required for the formation of the heterodimer between Beclin and ATG14L-VPS34. In mdx mice, defective nucleation of the phagophore appears to be coupled to altered elongation and expansion as confirmed by decreased expression of WIPI-1, an early marker of autophagosome formation, required for the assembly of the ATG5-12 complex. Clearance of sequestered cytosolic components necessitates the fusion of the autophagosome with the lysosome, a process that the authors found impaired in mdx mice due to altered formation of the SNARE tertiary complex (STX17-SNAP29-VAMP8), as a result of the marked reduction of STX17 expression.
In a previous work (Pal et al., Nat Commun 2014), the same group described the generation of an mdx-based mouse model where Nox2 activity was abolished by genetic ablation of the p47phox component. These mice presented with a better outcome in terms of dystrophic pathophysiology by means of reduced oxidative stress and improved autophagy. Further characterization of these mice in the present study reveals that in p47-/-/mdx mice abolishment of Nox2 activity restores autophagosome nucleation and maturation thanks to the increased expression of p-JNK, JIP-1 and improved stability of the Beclin-ATG14L complex, but no amelioration is observed on the formation of the SNARE tertiary complex indicating that the biogenesis of autophagosomes is dependent on Nox2 activity but not the fusion between autophagosomes and lysosomes. Given the existing body of evidence in non-muscle cells pointing at alpha-tubulin acetylation as a regulator of MT activity facilitating the fusion of autophagosomes to lysosomes, the authors thought to investigate the level of MT acetylation in mdx mice muscle fibers and found that acetylation is reduced but can be restored by inhibiting the HDAC6 enzyme via the FDA-approved, highly selective pharmacological inhibitor Tubastatin A (Tub A). Treatment of mdx mice at 3 weeks of age (before the onset of pathological manifestations) with Tub A not only restored the normal level of alpha-tubulin acetylation (without altering the organization and density of the MT network) but also curbed the intracellular redox status and improved the autophagic flux by stabilizing the SNARE tertiary complex. Interestingly, treatment of dystrophic mice with Tub A results in substantial improvement of the dystrophic phenotype as confirmed by a reduced level of apoptosis, diminished tissue inflammation, improved sarcolemma integrity, and superior force generation capacity in ex vivo experiments using the diaphragm and Extensor Digitorum Longus (EDL) muscle fibers of Tub A-treated mdx mice compared to untreated mdx and healthy counterparts.
The in-depth characterization of the steps orchestrating the autophagy pathway in the mdx mouse model on the one hand, and the comprehensive evaluation of the phenotype of the mdx mice treated with the HDAC6 inhibitor Tubastatin A on the other, support the conclusions proposed by the authors. Nonetheless, some aspects deserve consideration.
1) The effect of increased alpha-tubulin acetylation by means of genetic and pharmacological strategies (i.e., in vivo overexpression of alpha-tubulin acetyltransferase-aTAT1 and treatment with Tubacin or Tubastatin A, respectively) has been previously explored in isolated cardiomyocytes and skeletal muscle fibers and revealed that augmented MT acetylation, due to selective inhibition of HDAC6, increases cytoskeletal stiffness and favors Nox2 activation (Coleman et al., J Gen Physiol 2021).
We have added a discussion of the work by Coleman and colleagues. In brief, that work was in wild-type cardiac and skeletal muscle and showed that MT acetylation controlled stiffness in control muscle cells. Interestingly, while they did not quantify MT organization, their data suggest that HDAC6 inhibition does not alter organization. Here, we are assessing the role of MT acetylation is a diseased model, mdx. Taken together, our data along with that from Ward and colleagues highlight the importance of a proper balance of tubulin acetylation in order to maintain cellular signaling, which is different between non-diseased and diseased skeletal muscle.
2) Altered organization and density of the MT network in mdx FDB muscle fibers with loss of vertical directionality is not a novelty as well and it has been reported by others (see Randazzo et al., Hum Mol Genet 2019), who also observed that overexpression of a single beta-tubulin (tubb6) in normal Flexor Digitorum Brevis (FDB) muscle fibers mimic the disruption to the MT network of mdx FDB fibers, increases the level of detyrosinated tubulin and increases Nox2 activity (through elevated expression of gp91phox). Conversely, downregulation of the same beta-tubulin restores normal MT organization in mdx FDB. Previous work from the authors (Loehr et al., eLife 2018) reported that in p47-/-/mdx mice MT organization in diaphragm muscle fibers is normalized and autophagy improved. Accordingly, it is puzzling that increased alphatubulin acetylation determines such a wide range of ameliorations in terms of physiological and morphological aspects in dystrophic skeletal muscle fibers treated with Tubastatin A whereas no improvement in the overall MT organization is observed, as reported by Agrawal and colleagues.
Our findings are also supported by Coleman et al who show that HDAC6 inhibition did not alter levels of DT-tubulin. Although that group did not specifically measure MT organization viewing and analyzing their representative images of alpha-tubulin (Figure 1D, control and tubacin) shows that HDAC6 inhibition does not alter MT organization in wild-type FDBs
3) Given that p47-/-/mdx mice present with levels of acetylated alpha-tubulin and HDAC6 expression comparable to mdx while showing significant improvement of the dystrophic phenotype despite partial rescue of the autophagic flux (as reported in Loehr et al., eLife 2018), it would have been of great interest to investigate the effect of HDAC6 inhibition in p47-/-/mdx mice as well.
We would like to thank the reviewer for acknowledging our in-depth characterization of the steps orchestrating the autophagy pathway in the mdx mouse model and the comprehensive evaluation of the phenotype of the mdx mice treated with the HDAC6 inhibitor Tubastatin A. While we believe these experiments are of interest, we think that they merit a detailed investigation that is beyond the scope of the current work
-
-
www.medrxiv.org www.medrxiv.org
-
Author Response
Reviewer #1 (Public Review):
This study provided evidence to interpret and understand the aging and developmental processes in children. The main strength of the study is it measures a set of biological age measures and a set of developmental measures, thus providing multi-faceted evidence to explain the associations between aging and development in children. The main weakness of this study is that how to measure and test the aging hypothesis of "a buildup of biological capital model" and "wear and tear" is not well-explained. Why the observed associations between biological age measures and developmental measures could support the aforementioned aging theories?
Thank you. On reflection we agree that how to test the aging hypotheses of "a buildup of biological capital model" and "wear and tear" is not well-explained in the manuscript. We have addressed this issue in the point-by-point responses below:
1) Abstract - conclusion: The aging hypothesis of "a buildup of biological capital model" and "wear and tear" were mentioned in the conclusion without an explanation of these theories in the previous section. Readers who are not experts in the field may not understand the logic.
We have replaced these phrases in the abstract with the following interpretation, which we hope will be more readily understood:
“Patterns of associations suggested that accelerated immunometabolic age may be beneficial for some aspects of child development while accelerated DNA methylation age and telomere attrition may reflect early detrimental aspects of biological ageing, apparent even in children.”
2) Result - Biological age marker performance: the correlation between transcriptome age and chronological age is very strong (r =0.94). I am afraid that very little age-independent information could be captured by the transcriptome age. Is it possible to down-regulate the age dependency of the transcriptome age in the training process?
Thank you for this important comment: We agree the high accuracy of this clock may in fact reduce its relevance as a biological age marker and note that this is a concern generally in the field. We have explored the possibility of using a less accurate transcriptome age model as follows: Instead of elastic net modelling we tested using the lasso penalisation only, which will result in more parsimonious (sparse) models as less important features are dropped as the strength of the lambda parameter is increased. Plotting the correlation in the test set against number of features in models, as the lambda is sequentially increased, we can see (as shown in Author response image 1 by the blue line) that after the inclusion of around 200 features, the gain in accuracy becomes less steep.
Author response image 1.
We then tested the sensitivity of a model optimised for sparsity at the expense of some prediction accuracy, selected based on visual inspection (blue line, r in test set =0.87, number of features= 187) of the above plot, against developmental measures, compared to the most accurate model as presently included in the manuscript:
Author response image 2.
We find that, across all outcomes tested, the less accurate model, based on only the most important features, does not provide an improvement in sensitivity to developmental outcomes compared to the currently used model.
We therefore prefer to keep the more accurate model in this study. Especially as it is consistent with the methodology used in the Horvath and Immunometabolic age models and generally in the field, and otherwise it is not obvious how the biological clock should be trained (especially for children without mortality data) without altering the whole approach of the study. We have acknowledged and discussed this issue on page 15.
3) The study population comes from several cohorts, which might influence the results. How the cohort effects were controlled for in the analyses?
The possible influence of cohort is a limitation of the study which we have discussed on page 16. We did not include cohort as a predictor in any of the candidate biological clocks since this may reduce detection of some age -related features. Instead, we include a variable for cohort as a fixed effect in all analyses with risk factors and developmental outcomes and examined the performance of candidate biological clocks in predicting chronological age within each cohort. As a further check, we have added an additional sensitivity analysis (Figure 4-figure supplement 6), against developmental outcomes significant in the main analysis, stratified by cohort. We find generally consistent effects across cohorts.
4) Figure 3 only showed the number of p values. Can the author also provide the number of point estimates and 95% confidence intervals, perhaps in the supplemental table?
This information was originally provided in supplemental table 5 (now Supplementary file 7), combined with the sensitivity analyses. To make this information easier to find, we have made this a stand-alone table (table 3). We now direct readers to this information within the caption of Figure 4 (previously figure 2).
Reviewer #2 (Public Review):
The study had an especially relevant aim for aging research and utilized various data types in an especially interesting human population. Multi-omics perspective adds great value to the work. The researchers aimed to evaluate how different indicators of biological age (BA) behave in children during their developmental stage. In the analysis, relationships between indicators of BA, health risk factors, and developmental factors were assessed in cross-sectional data comprising children aged 5-12 years. The manuscript is well-written and easy to follow. The methodology is good. The authors succeeded to reach the aim in most parts.
In the study, previously known and unknown biological age indicators were used. Known indicators included telomere length and Horvath's epigenetic age. Unknown (novel) indicators, transcriptomic and immunometabolic clocks, were developed in the present study and they showed a strong correlation with calendar age in this population, also in the validation data set. Although the transcriptomic and immunometabolic clocks have the potential of being true indicators of biological age, they are still lacking scientific evidence of being such indicators in adults. That is, their associations with age-related diseases and mortality are yet to be shown. Thus, the major remark of the study relates to the phrasing: these novel transcriptomic and immunometabolic clocks should be presented as BA indicator candidates waiting for the needed evidence.
Thank you for this important observation. However, we still find that “biological age indicator” is a useful umbrella term in this manuscript and there is not an obvious alternative. We therefore have added the following sentence on page 8, and highlighted the difference between the markers at key points in the abstract, introduction, results and discussion.
“We note that since a common definition of markers of biological age is that they should be associated with age-related disease and mortality [69] these new clocks may only currently be considered “candidate” biological age markers. However, we have referred to both the established and candidate markers as biological age markers throughout to simplify presentation.”
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
In the manuscript, titled "Comparative single-cell profiling reveals distinct cardiac resident macrophages essential for zebrafish heart regeneration," Wei et al. perform bulk and single-cell RNA-sequencing on uninjured and injured zebrafish hearts with or without prior macrophage depletion by clodronate. For the single-cell RNA sequencing, the authors sort macrophages and neutrophils prior to sequencing by using fluorescent reporters for each of the two lineages. The authors characterize the differential gene expression between injured and uninjured hearts with and without prior macrophage depletion. The single-cell analyses allow the characterization of nine discrete subpopulations of macrophages and two distinct neutrophil types. The manuscript is largely descriptive with lots of discussion of specific differentially expressed genes. The authors conclude that tissue-resident macrophages are important for heart regeneration through the remodeling of the microenvironment and by promoting revascularization. Circulating monocyte-derived macrophages cannot adequately replace the resident macrophages even after recovery from clodronate depletion.
The manuscript presents a very large catalog of useful gene expression data and further characterizes the diversity of macrophages and neutrophils in the heart following injury. Although the conclusions that resident macrophages are important for regeneration and that circulating macrophages cannot adequately substitute for them are not particularly novel, this manuscript provides additional support for those ideas and extends that work by providing a wealth of gene expression data from the different macrophage sub-populations in the zebrafish and how they respond to and promote regeneration. The authors also present a nice analysis supporting the interactions of macrophages with neutrophils via comparing receptors and ligands (from gene expression data) on the two populations - this should be a useful resource.
We appreciate how reviewer #1 recognizes the work we have put into sample preparation, data collection, and all the bioinformatic analyses to delineate and characterize the inflammatory cells during zebrafish heart regeneration.
Reviewer #2 (Public Review):
Wei et al. analysed the composition of immune cells, mostly macrophages, and neutrophils, in the context of zebrafish cardiac injury while utilizing clodronate liposomes (CL) to inhibit regeneration via alteration of the immune response. This work is a direct continuation of Shih-Lei et al. which compared the regenerative outcomes of zebrafish vs the non-cardiac regenerative medaka. In that work, the authors used CL to pre-deplete macrophages and showed significant effects on neutrophil clearance, revascularization, and cardiomyocyte proliferation. In this work, the authors used the same pre-depletion method to study the dynamics, composition, and transcriptomic state of macrophages and neutrophils, to overall assess the effect on cardiac regeneration. Using bulk RNA-seq at CL vs PBS treated hearts 7 and 21 days post cryo injury (dpci) a delayed\altered immune response was evident. Single-cell analysis at 1,3 and 7 dpci showed a wide range of immune populations in which most diverse are the macrophage populations. Pre-depletion using CL, altered the composition of immune cells resulting in the complete removal of a single resident macrophage population (M2) or dramatically reducing the overall numbers of other resident populations, while other populations were retained. Looking at the injury time course and distribution of macrophage populations, the authors identified several macrophage populations and neutrophil population 1 as pro-regenerative as their presence compared to CL-treated hearts correlates with regeneration. CL-treated hearts also show a marked sustained neutrophil retention suggesting that interaction with depleted macrophage populations is required for neutrophil clearance. As the marked reduction in populations 2 and 3 occurs after CL treatment, the authors tested whether early CL treatment (8 days or 1 month prior to injury) could reduce the non-recoverable populations and affect regenerative outcomes and indeed they observed a reduction in key genes characterizing M2 and M3 which caused marked reduction in revascularization, CM proliferation, neutrophil retention, and overall higher scaring of the heart.
The findings of this paper could be broadly separated into the characterization of myeloid cells after injury and in non-regenerating animals and assessing the effects of early pre-depletion of macrophages on various cardiac functions involved in regeneration. Both parts draw conclusions that are supported by the facts however several questions remain to be clarified.
We thank the reviewer for recognizing that the conclusions we drew were supported by the data we presented and further replied to the specific suggestions below.
1) In figures 2 and 3 the main claim is that the main resident macrophage populations, M2 and M3 are depleted and are largely unable to replenish after injury, similar to resident macrophages in mice 1. However, as the identification of this population is made solely using scRNA-seq, an alternative explanation would be that these cell populations do replenish but are sufficiently changed due to CL treatment (directly or indirectly) and thus would be a part of another cluster. To address this, we suggest:
A. Run trajectory analysis to ascertain whether the different cell clusters are due to differentiating states of the cells
B. Create a reporter line for M2 and M3 macrophages and assess whether they are indeed depleted or changing.
We followed the reviewer’s suggestion and performed trajectory analyses (Figure 6). The results suggest that Mac 2 and Mac 3 form unique trajectory, which was not shifted by -1d_CL treatment but only diminished in number. Conditionally-enriched gene ontology analysis (Figure 4) also suggests that Mac 2 and 3 do not change property under -1d_CL condition (unlike monocyte-derived Mac 1 and some other clusters). When we examine homx1a expression (Mac2) and timp4.3 expression (Mac3) in -8d_CL treated hearts, we again observed diminished cell numbers (Figure 8C and Figure 7-figure supplement 1D). These results support the resident macrophages Mac 2 and Mac 3 are more likely to be non-recoverable than changing their property so much thus grouped into other subsets.
We also agree with the reviewer that the specific reporter and CreER driver lines for the lineage tracing experiment will provide the most concrete answer to this question. We have now generated an endogenous Tg(mpeg1-2A-CreERT2) line in the lab (collaborative work with McGrail lab) and reporter lines using Mac2/3 enriched genes. Unfortunately, this work will take much longer time and might not fit into the scope of the current study.
2) One of the major findings of this paper is that some macrophage populations can persist throughout injury and promote the regenerative response. Considering that macrophages have a half-life of less than a day in tissue 2 (although could be different in zebrafish and in this population), we estimate that the resident populations should be proliferative. As there is only a single proliferating macrophage population (M5) we speculate that it is a combination of several populations which are clustered together due to the high expression of cell cycle genes. To verify whether the resident populations are proliferating we suggest:
A. Perform cell-cycle scoring and regression (found in Seurat package) and assess whether after regressing out cell cycle genes there are contributions of M5 to other clusters.
B. Perform EDU labelling experiments with cell cycle identifiers (staining for hbaa1, Timp4.3) and assess their proliferative dynamics.
We followed the reviewer’s suggestion and performed cell-cycle scoring and regression (Figure 2-figure supplement 4). Cell cycle scoring suggests there are cells in both Mac 2 and 3 in the G2/M phase and presumably proliferative. Cell-cycle regression results suggest that most macrophage subsets, including Mac 5, still stand as unique clusters after regression (Figure 2-figure supplement 4). These results suggest that Mac 5 might not be constitute of proliferating cells from other clusters.
On the other hand, we also tried to double-stain the proliferating resident macrophages by EdU and ISH of hbaa1 and timp4.3. Unfortunately, these methods were not comparable in our hands, and we failed to confirm their proliferative dynamics. We did show proliferating macrophages residing in the untouched hearts and will further check their identity once we have the cluster-specific reporter lines ready.
Last but not least, using the Tg(mpeg1-2A-CreERT2) line to label embryonic macrophages under the Tg(ubi:loxP-EGFP-loxP-mCherry)cz1701 background before 7 dpf, we observed mCherry+ macrophages in juvenile fish at 50 dpf, suggesting some embryonically derived macrophages can last more than a week in the system presumably by self-renewing. As replied previously, these results might not be included in this study.
3) In connection to the previous point if indeed these resident macrophage populations are proliferative, even a smaller portion of remaining cells should be sufficient to partly replenish given sufficient time after CL 1. However as seen in Fig. 3B, the M2 population has a similar proportion of cells on days 1 and 3 after CL treatment and by day 7 it declines in numbers. Given that CL should not be present anymore, we expect this population to increase in numbers over time.
We thank the reviewer for pointing out that Figure 3B might be misleading as the proportion of the macrophage subsets was calculated. The persistence of Mac 2 proportion at 1 and 3 dpci might be due to the overall depletion of both resident and recruited macrophages after CL treatment. 2 days after CL treatment still have profound effects on total macrophage numbers (Figure 7-figure supplement 1A and Lai et al., 2017) and the overall macrophage numbers only recovered to the same level as those in untouched or PBS-treated injured hearts by 7 days (Figure 7-figure supplement 1A and Lai et al., 2017). We have also confirmed that Mac 2 diminished in CL-treated hearts by both qPCR and ISH/IHC of homx1a in Figure 7-figure supplement 1C and Figure 8B.
4) In Figure 6 the authors show a reduction in mpeg+ population however a persistent, large population ({plus minus}70% of the original mpeg+) is retained. The authors suggest that this population is comprised of other, non-macrophage, cell types however as this method is the very core of the paper and the persistence of macrophages could alter our understanding of the results, it must be verified.
Dick, S. A. et al. Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction. Nature Immunology 20, 29-39, doi:10.1038/s41590-018-0272-2 (2019).
Leuschner, F. et al. Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J Exp Med 209, 123-137, doi:10.1084/jem.20111009 (2012).
We acknowledge that mpeg1 might not be the perfect marker for pan-macrophage labeling shown by the work published by Ferrero et al., J Leukoc Biol. 2020, when our profiling work had been undergone. Fortunately, scRNAseq profiling is an unbiased method to reveal gene expression/cell identity, and our results indeed identified non-macrophage/non-neutrophil populations out of the clustering and found mpeg1+ B-cells consistent with the literature. Thus, the mixed input from the mpeg1 reporter does not affect the property of Mac 2 and 3 being both mpeg1-positive macrophages, which diminished after both -1d_CL and -8d_CL treatment. Following the reviewer’s suggestion, we further verified this point by both qPCR of hbaa1 and timp4.3 and ISH/IHC of homx1a and timp4.3 in the CL-treated hearts in Figure 7-figure supplement 1C and D and Figure 8B and C.
Reviewer #3 (Public Review):
Macrophages play an important role during heart regeneration. This has been shown in the mouse and zebrafish for example by treating the animals with clodronate liposomes to eliminate phagocytic cells.
The manuscript follows up on a previous observation by the authors performing these experiments in the zebrafish (Lai et al eLife 2017). When comparing regenerative vs non-regenerative teleosts zebrafish resp Medaka they found that macrophages and neutrophils were the cell types more differentially responding in these two species to a cardiac injury.
Here the authors analyze in extenso neutrophil and macrophage populations using single-cell RNA-seq at different stages of regeneration. They perform FAC sorting of the two populations using specific reporter lines. They also assess the change in these populations upon clodronate treatment. They find that clodronate treatment affects the gene expression profiles of different subsets of macrophages and neutrophils as well as their abundance.
They also show that chlodronate treatment performed several days before cryoinjury depleted macrophages from the heart but after injury overall macrophage number recovers. However, heart regeneration does not. Cardiomyocyte is the only parameter that is not affected, but vasculogenesis and scar resolution is impaired.
The authors conclude that (1) there are different subsets of macrophages and neutrophils, (2) that they interact with each other during regeneration through specific ligand and receptor pairs, and (3) that a cardiac resident population rather than a circulating macrophage population is important for heart regeneration.
The transcriptomic characterization of the two immune cell populations is very exhaustive and rigorous. No functional validation of subpopulation marker genes was performed, but the data as it stands will already be of great value to the community. The figure quality is outstanding.
We thank the reviewer for recognizing the value of our study and the quality of the data presented. We further examined the subpopulation markers and their functional relevance in the revised manuscript, as suggested.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
In the current work, the authors aimed to investigate the genetic and non-genetic factors that impact structural asymmetry.
A major strength is the number of data samples included in the study to assess brain structural asymmetry. A consequence of the inclusion of many samples is then also the sample size.
We thank the reviewer for their supportive and insightful comments that have helped improve our paper.
Comment #1: Given that the authors also work with longitudinal data, it would be nice to be able to appreciate the individual effects across time points, this is now a little unclear.
Our lifespan analysis incorporated both single and repeat measures over time in the trajectory estimation, and hence these will be an intermediate estimate of cross-sectional and longitudinal trajectories. We have clarified this in the Methods (see 1). A comprehensive analysis of the individual-specific asymmetry change effects in the current paper is thus hindered by many properties of the data, including that many participants contribute a single measure, that participants vary in their number of repeat-measures (1-6 timepoints), that the number of repeat-measures is dependent on age, and that the degree of asymmetry change differs between cortical metrics, clusters, and along the age variable. Most importantly, the average degree of asymmetry change is small; Fig. 3 indicates thickness asymmetry typically corresponds to a ~0.1 - 0.2mm difference, such that changes therein will be smaller and thus likely unclear at the individual level. Nevertheless, we have modified the average plots in Figures 2 and 3 to allow better visualization of the individual hemispheric measures across timepoints, as well as an appreciation of the density of our longitudinal data.
1 – (line 646) “GAMMs incorporate both single and repeat measures over time to capture nonlinearity of the mean level trajectories across persons, resulting in population estimates that are intermediate between cross-sectional and longitudinal trajectories”
Comment #2: A possible less well-developed approach is the genetic basis, as this was stated as the main question, here the investigations are not that deep and may only touch upon the question.
We agree the previous formulation of our Abstract did convey this impression, and have thus made the following important amendment:
(Abstract) “Cortical asymmetry is a ubiquitous feature of brain organization that is subtly altered in some neurodevelopmental disorders, yet we lack knowledge of how its development proceeds across life in health. Achieving consensus on the precise cortical asymmetries in humans is necessary to uncover the developmental timing of asymmetry and extent to which it arises through genetic or later influences in childhood.”
Our paper aims to serve as a critical reference for the normative childhood development and lifespan change of cortical asymmetry. We performed heritability analyses as they are informative regarding development and shed light on the timing of influences shaping cortical asymmetry (also possibly prior to age ~4 at which our sample starts). Similarly, genetic correlation analysis sheds light on whether the replicable interregional correlations are underpinned by genetic differences, indicative of coordinated genetic development of asymmetries. We apologize the rationale behind these analyses was not well-specified, and have clarified this (see response #4). Thus, we respectfully disagree the genetic aspect represented the main research question, but rather lends support to our developmental perspective.
Given the density of analyses already included and that these are well-specified within the context of our overarching question, we do not see how adding more genetic analyses will be beneficial for our paper. However, we agree with the Reviewer’s subsequent comment (#8) that the genetic correlations in HCP data should also have been reported, and now incorporate these (see response #8).
Comment #3: Moreover, the association with cognition, handedness, sex, and ICV is somewhat interesting yet seems also a bit minimal to fully grasp its implications.
In the asymmetry field it has been commonplace to assume these factors are strongly related to asymmetry, particularly sex. Here, despite optimizing the delineation of asymmetries, associations with factors purportedly related to it were all very small. We believe this is an important message that may help reorient the field away from entrenched views; unless we show it is not the case, researchers may think the effects of these factors are larger than they are. Further, because questions pertaining to sex and handedness differences will certainly arise for many, we chose to address them by quantifying the average effects in big data, because our lifespan trajectory analysis was not well-suited to assessing e.g. sex differences in asymmetry trajectories (i.e. 3-way non-linear interactions; sexagehemisphere). We have strengthened the reasoning for this analysis in the Introduction (see 1):
1 – (line 118) “Therefore, as a final step, we reasoned that combining an optimal delineation of population-level cortical asymmetries with big data would optimize detection and quantification of the effects of factors commonly assumed important for asymmetry, namely general cognitive ability, handedness and sex.”
Contrary to approaches that often place emphasis on p-values (e.g. pheWAS), our targeted approach using variables long considered important for asymmetry enabled transparent reporting of the effect sizes and directions. We hope the Reviewer agrees we have taken care in this regard, and are careful to communicate the found effects are small. The small effects seem typical of structural brain associations in big data, as may be expected when relating complex phenotypes to any single structural measure. For these reasons, we opt not to extend the analysis beyond our initial targeted approach, arguing instead that the size of the effects is reason enough to report them.
Despite being small, however, we argue they are not negligible (see 2-4). Of note, though it may appear so in Fig. 7, the p-value for the cognitive association was far from just surviving Bonferroni correction (it would survive >13,000 comparisons at our alpha level [⍺=.01], whereas we corrected for our 136). Note we did not accept a 5% false positive rate. We have clarified this in the Results (see 5):
2 – (line 485) “Other factors commonly espoused to be important for asymmetry were associated with only small average effects in adults. For example, we found one region – SMG/perisylvian – wherein higher leftward areal asymmetry related to subtly higher cognitive ability. Since interhemispheric anatomy here is likely related to brain torque 2,3, this may agree with work suggesting torque relates to cognitive outcomes 4,5. Interestingly, that ~94% of humans exhibit leftward asymmetry in this region (Figure 1G) suggests tightly regulated genetic-developmental programs control its lateralized direction in humans (see Figure 6). This result may therefore suggest disruptions in areal lateralization early in life are associated with cognitive deficits detectable in later life as small effects in big data 6. While speculative, this may also agree with evidence that differences in general cognitive ability that show high lifespan stability 6 relate primarily to areal phenotypes formed early in life 7–9.”
3 – (line 461) “We also found areal asymmetry in anterior insula is, to our knowledge, the most heritable asymmetry yet reported with genomic methods 10–14, with common SNPs explaining ~19% variance. This is notably higher than in our recent report (< 5%) 14, illustrating a benefit of our approach. As we reported recently 14, we confirm asymmetry here associates with handedness.”
4 - (line 495) “Consistent with our recent analysis in UKB 14, we confirmed leftward areal asymmetry of anterior insula, and leftward somatosensory thickness asymmetry is subtly reduced in left-handers. Sha et al. 14 reported shared genetic influences upon handedness and asymmetry in anterior insula and other more focal regions. Anterior insula lies within a left-lateralized functional language network 15, and its structural asymmetry may relate to language lateralization 16–18 in which left-handers show increased atypicality 19–21. Since asymmetry here emerges early in utero 22 and is by far the most heritable (Figure 6), we agree with others 16 that this ontogenetically foundational region of cortex may be fruitful for understanding genetic-developmental mechanisms influencing laterality 23,24. Less leftward somatosensory thickness asymmetry in left-handers also echoes our recent report 14 and fits a scenario whereby thickness asymmetries may be partly shaped through use-dependent plasticity and detectable through group-level hemispheric specializations of function. Still, the small effects show cortical asymmetry cannot predict individual handedness. Associations with other factors typically assumed important were similarly small, and mostly compatible with the ENIGMA report 25 and elsewhere 26,27. 5 - (line 3221) ”Although small, we note this association was far from only just surviving correction at our predefined alpha level (⍺ = .01; corrected for 136 tests; Methods).”
6 - (line 348) “we … uncover novel and confirm previously-reported associations with factors purportedly related to asymmetry – all with small effects”
Thus, in quantifying effects we could not include in our lifespan analysis we preempt the questions likely to arise for many researchers, provide a sobering account of the effect sizes of factors typically assumed important for asymmetry, and find results that fit the developmental framework we lay out in the paper. We therefore opt to keep these together with the lifespan and heritability results in the current paper.
Comment #4: To some extent, the aim of the study could still be written with more clarity. However, the authors have in part achieved their aims - assuming it is found a consensus on the brain asymmetry patterns in humans as is stated in the abstract.
Alongside the amendment to the Abstract that better clarifies our aims (response #2), we have restated the aims in the Introduction:
1 - (line 121) Here, we first aimed to delineate population-level cortical areal and thickness asymmetries using vertex-wise analyses and their overlap in 7 international datasets. With a view to gaining insight into cortical asymmetry development, we then aimed to trace a series of lifespan and genetic analyses. Specifically, we chart the developmental and lifespan trajectories of cortical asymmetry for the first time longitudinally across the lifespan. Next, we examine phenotypic interregional asymmetry correlations, under the assumption correlations indicate coordinated development of left-right asymmetries through genes or lifespan influences. To shed light on the extent to which differences in asymmetry are genetic, we test heritability of asymmetry using genome-wide single nucleotide polymorphism (SNP) and extended twin data, and examine whether or not phenotypic associations are underpinned by genetic correlations suggestive of coordinated development through genes. Finally, we screen our set of robust, population-level asymmetries for association with general cognitive ability and factors purportedly related to asymmetry in UK Biobank (UKB). 28
Comment #5: Overall the results support the conclusions, yet the strong interpretation of early life factors in particular is not empirically investigated as far as I gather.
The reviewer is correct that we do not have data on neonates to directly support interpretations of prenatal factors. We have therefore tempered strong interpretations pertaining to prenatal accounts accordingly, have added text at the start of the Discussion to address this (see 1), and qualified all discussion of prenatal factors:
1 – (line 366) “Tracing their lifespan development, we show the trajectories of areal asymmetry primarily suggest this form of asymmetry is developmentally stable at least from age ~4, maintained throughout life, and formed early on – possibly in utero 13,29,30 (while we cannot extrapolate to ages before our sample begins, we note this agrees with findings in neonates 29,30). One interpretation of lifespan stability combined with low heritability may be stochastic early-life developmental influences determine individual differences in areal asymmetry more than later developmental change, but work linking prenatal and childhood trajectories is needed to affirm this”
2 – (Abstract) “Results suggest areal asymmetry is developmentally stable and arises early in life through genetic but mainly subject-specific stochastic effects”
We have also added argumentation regarding a just-published study suggesting the average pattern of neonatal areal asymmetry is largely similar to adults 1. In addition, we reiterate what our data can and cannot say about the developmental timing of asymmetry in several places in the Discussion (see 3 & 5). In other places, we have removed reference to prenatal factors (see 4). Still, while we agree we previously used the terms “prenatal” and “early life factors” interchangeably, we note the latter often encompasses periods of early childhood covered here and is not necessarily restricted to factors present at birth 2,3. Thus, we have amended the Discussion to qualify the age-range the interpretation pertains to (see 5), and then retain the conclusion as follows (see 6).
3 - (line 383) “For areal asymmetry, adult-like patterns of lateralization were strongly established before age ~4, indicating areal asymmetry traces back further and does not primarily emerge through later cortical expansion 33. Rather, the lifespan trajectories predominantly show stability from childhood to old age, as asymmetry was maintained through periods of developmental expansion and aging-related change that were region-specific and bilateral. This may align with evidence indicating areal asymmetry may be primarily determined in utero 29,30, including evidence suggesting little change in areal asymmetry from birth to 2 years 29,33,34, and little difference between maps derived from neonates and adults 29,30. It may also fit with the principle that the primary microstructural basis of cortical area 8 – the number of and spacing between cortical minicolumns – is determined in prenatal life 8,9, and agree with work suggesting asymmetry at this microstructural level may underly hemispheric differences in surface area 35. The developmental trajectories agree with studies indicating areal asymmetry is established and strongly directional early in life 29,36. That change in surface area later in development follows embryonic gene expression gradients may also agree with a prenatal account for areal asymmetry 9”
4 - (line 439) “The strongest relationships all pertained to asymmetries that were proximal in cortex but opposite in direction. Several of these were underpinned by high asymmetry-asymmetry SNP-based genetic correlations, illustrating some lateralizations in surface area exhibit coordinated genetic development.”
5 - (line 481) “Regardless, these results support a differentiation between early-life (i.e. before age ~4) and later developmental factors in shaping areal and thickness asymmetry, respectively.”
6 - (Conclusion) “Developmental and lifespan trajectories, interregional correlations and heritability analyses converge upon a differentiation between early-life and later-developmental factors underlying the formation of areal and thickness asymmetries, respectively. By revealing hitherto unknown principles of developmental stability and change underlying diverse aspects of cortical asymmetry, we here advance knowledge of normal human brain development.”
Overall this is a nice and thorough work on asymmetry that may inform further work on brain asymmetry, its genetic basis, development, environmentally induced change, and link to behavioural variation.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
Bacterial carboxysomes are compartments that enable the efficient fixation of carbon dioxide in certain types of bacteria. A focus of the current work is on two protein components that provide spatial regulation over carboxysomes. The McdA system is an ATPase that drives the positioning of carboxysomes. The McdB system is essential for maintaining carboxysome homeostasis, although how this role is achieved is unclear. Previous studies, by the lead author's lab, showed that the McdB system is a driver of phase separation in vitro and in cells. They proposed a putative connection between McdB phase separation and carboxysome homeostasis. The central premise of the current work is as follows: In order to understand if and how phase separation of McdB impacts carboxysome homeostasis, it is important to know how the driving forces for phase separation are encoded in the sequence and architecture of McdB. This is the central focus of the current work. The picture that emerges is of a protein that forms hexamers, which appears to be a trimer of dimers. The domains that drive that the dimerziation and trimerization appear to be essential for driving phase separation under the conditions interrogated by the authors. The N-terminal disordered region regulates the driving forces for phase separation - referred to as the solubility of McdB by the authors. To converge upon the molecular dissections, the authors use a combination of computational and biophysical methods. The work highlights the connection between oligomerization via specific interactions and emergent phase behavior that presumably derives from the concentration (and solution condition) dependent networking transitions of oligomerized McdB molecules.
Having failed to obtain specific structural resolution for the full-length McdB as a monomer or oligomer, the authors leverage a combination of computational tools, the primary one being iTASSER. This, in conjunction with disorder predictors, is used to identify / predict the domain structure of McdB. The domain structure predictions are tested using a limited proteolysis approach and, for the most part, the predictions stand up to scrutiny affirming the PONDR predictions. SEC-MALS data are used to pin down the oligomerization states of McdB and the consensus that emerges, through the investigations that are targeted toward a series of deletion constructs, is the picture summarized above.
Is the characterization of the oligomerization landscape complete and likely perfect? Quite possibly, the answer is no. Deletion constructs pose numerous challenges because they delete interactions and inevitably impose a modularity to the interpretation of the totality of the data.
This is a good point and always a possibility with truncations – the protein McdB may not be as modular in nature as it seems in our tripartite model. But the deletion constructs were more so intended to be tools for identifying key regions of oligomerization and condensate formation as others have done, and for this, they were indeed useful. Additionally, we were able to strategically aim our substitution mutations based on data from the deletion constructs. These substitutions provided data consistent with the deletions, but in the context of the full-length protein (see Fig. 5 vs. Figs. 2, 4). However, we ultimately agree with the reviewer that this is always a possibility with truncations, and we have therefore mentioned this caveat in the discussion.
Line 415 “Truncated proteins have been useful in the study of biomolecular condensates. But it is important to note that using truncation data alone to dissect modes of condensate formation can lead to erroneous models since entire regions of the protein are missing. However, data from our truncation and substitution mutants were entirely congruent. For example, deletion of the CTD or substitutions to this region caused destabilization of the hexamer to a dimer, and deletion of the IDR or substitutions to this region caused solubilization of condensates without affecting hexamer formation.”
Accordingly, we are led to believe that the N-terminal IDR plays no role whatsoever in the oligomerization.
Our updated data still strongly supports this interpretation. Both truncation of the IDR (Fig. 2) and the six-Q-substitution mutant in the IDR (Fig. 5) form a monodispersed hexamer in solution via SEC-MALS, as does wild-type McdB.
Close scrutiny, driven by the puzzling choice of nomenclature and the Lys to Gln titrations in the N-terminal IDR raise certain unresolved issues. First, the central dimerization domain is referred to as being Q-rich. This does not square with the compositional biases of this region. If anything is Q/L or just L-rich. This in fact makes more sense because the region does have the architecture of canonical Leu-zippers, which do often feature Gln residues. However, there is nothing about the sequence features that mandates the designation of being Q-rich nor are there any meaningful connections to proteins with Q-rich or polyQ tracts. This aspect of the analysis and discussion is a serious and erroneous distraction.
We changed the language here, and no longer refer to the central region as “Q-rich”. However, we would like to note that the second half of the McdB central domain is indeed enriched in glutamines (14/53 = 26.4%) to a comparable extent as the region of FUS, which has been shown to help drive condensate formation via glutamine H-bonding (14/44 = 31.8%; Murthy et al 2019). We were simply proposing that, at a molecular level, there was some insight to be gained from this comparison. We agree, however, that there is no functionally meaningful comparison between McdB and polyQ-tract proteins, as we may have previously alluded to in our discussion, and that text has been removed.
Back to the middle region that drives dimerization, the missing piece of the puzzle is the orientation of the dimers. One presumes these are canonical, antiparallel dimers. However, this issue is not addressed even though it is directly relevant to the topic of how the trimer of dimers is assembled.
Indeed, we were unable to resolve the orientation issue, despite much effort. The story we present is not a complete and final model of McdB structure, nor its molecular modes of oligomerization or condensate formation. However we now provide a discussion section “McdB homologs have polyampholytic properties between their N- and C-termini” that highlights this issue. We also mention the remaining dimer orientation issue at the end of the results section “Se7942 McdB forms a trimer-of-dimers hexamer”. However, we believe the data presented still provides useful initial models, which for example, allowed us to create a series of substitutions that tune McdB condensate solubility and verify that they do not affect oligomerization. We would like to further add that for other condensate forming proteins in bacteria, like the PopZ protein we mention in the text, there remains no detailed structural model beyond the resolution we provide here for McdB; despite PopZ being first identified in 2008. Over 40 publications on PopZ have progressively provided useful and more detailed models that are only now being used to develop PopZ as a tool for condensate technologies that are furthering our understanding of the biological implications of condensate formation across all cell types. The intention with our current report is therefore not to generate a finalized molecular model of this entirely unstudied class of McdB proteins. But instead, to generate useful insight into McdB biochemistry that can advance our understanding of this class of protein’s function in vivo. To this end, we now add in vivo data based on these initial models where we specifically link cellular phenotypes to McdB condensate solubility (Fig. 8). Of course, there are several follow-up studies that come from the current report, but we believe that speaks to the value of the presented research in advancing this field.
If the trimer is such that all binding sites are fully satisfied (with the binding sites presumably being on the C-terminal pseudo-IDR), then the hexamer should be a network terminating structure, which it does not seem to be based on the data. Instead, we find that only the full-length protein can undergo phase separation (albeit at rather high concentrations) in the absence of crowder. We also find that the driving forces for phase separation are pH dependent, with pH values above 8.5 being sufficient to dissolve condensates. Substitution of Lys to Gln in the N-terminal IDR leads to a graded weakening of the driving forces for phase separation. The totality of these data suggest a more complex interplay of the regions than is being advocated by the authors.
Thank you and we agree. As we discuss above in response #4 and below in response #7, we have changed the focus and tone of our report to say that, while the models we have generated are useful, we are aware they are incomplete at a molecular level. Furthermore, as we describe in response #6, we have added several new McdB mutants to investigate more deeply the role of the CTD, but this region was not amenable to mutagenesis as these mutants affected McdB oligomerization. Lastly, while network forming interactions are certainly important for condensate formation as the reviewer describes, so are solvent interactions. We have added new text and data related to Figs. 3, 4 that address these issues.
Almost certainly, there are complementary electrostatic interactions among the N-terminal IDR and C-terminal pseudo IDR that are important and responsible for the networking transition that drives phase separation, even if these interactions do not contribute to hexamer formation. The net charge per residue of the 18-residue N-terminal IDR is +0.22 and the NCPR of the remainder is ≈ -0.1. To understand how the N-terminal IDR is essential, in the context of the full-length protein, to enable phase separation (in the absence of crowder), it is imperative that a model be constructed for the topology of the hexamer. It is also likely that the oligomer does not have a fixed stoichiometry.
We agree and thank the reviewer for these comments. We have added several new substitution mutants aimed at addressing this (Figs. 5, S6). However, the C-terminus was not amenable to substitutions as the trimer-of-dimers was significantly destabilized in these mutants (Figs. 5, S7). Therefore, in this report we were unable to determine specifically how the basic residues in the IDR contribute to condensate formation. However, with the addition of new data in Fig. 8, we think we adequately show that the IDR mutants can be used to investigate McdB condensate formation in vivo, and that follow-up studies will be aimed at investigating these details. We have also added an new discussion section “McdB homologs have polyampholytic properties between their N- and C-termini” that highlight this very likely possibility suggested by the reviewer.
Therefore, the central weakness of the current work is that it is too preliminary. A set of interesting findings are emerging but by fixating on Lys to Gln titrations within the N-terminal IDR and referring to these titrations as impacting solubility, a premature modular and confused picture emerges from the narrative that leaves too many questions unanswered.
The work itself is very important given the growing interest in bacterial condensates. However, given that the focus is on understanding the molecular interactions that govern McdB phase behavior - a necessary pre-requisite in the authors minds for understanding if and how phase separation impacts carboxysome homeostasis - it becomes imperative that the model that emerges be reasonably robust and complete. At this juncture, the model raises far too many questions.
We agree that our previous report was focused mainly on the molecular basis of McdB condensate biochemistry, and in that report we left the model short. In this revised version, we have added several pieces of new data that strengthen the model (Figs. 3-5), although it is still incomplete. However, in this revised version, we have also shifted the focus from a complete biochemical understanding of McdB condensates to a study that links McdB condensate formation in vitro to phenotypes in vivo. In this regard, we have added the in vivo data in Fig. 8 and somewhat changed the focus in the text.
The MoRF analysis is distraction away from the central focus.
The MoRF analysis has been removed.
The problem, as I see it, is that the authors have gone down the wrong road in terms of how they have interpreted the preliminary set of results. Further, the methods used do not have the resolution to answer all the questions that need to be answered. Another issue is that a lot of standard tropes are erected and they become a distraction. For example, it is simply not true that in a protein featuring folded domains and IDRs it almost always is the case that the IDR is the driver of phase transitions. This depends on the context, the sequence details of the IDRs, and whether the interactions that contribute to the driving forces for phase separation are localized within the IDR or distributed throughout the sequence. In McdB it appears to be the latter, and much of the nuance is lost through the use of specific types of deletion constructs.
Thank you. We have removed much of this and changed the diction on how our current model of McdB condensate formation fits into the literature in the discussion.
Overall, the work represents a good beginning but the data do not permit a clear denouement that allows one to connect the molecular and mesoscales to fully describe McdB phase behavior. Significantly more work needs to be done for such a picture to emerge.
Reviewer #2 (Public Review):
In this work, Basalla et al. study the biochemical properties of the carboxysome positioning protein, McdB. Using in vitro experiments, the authors characterize McdB oligomeric states and the domains driving and modulating its phase separation. Based on bioinformatics analysis, the authors identify a putative binding recognition motif between McdB and its two-component system counterpart McdA. As McdAB-like systems emerge as spatial regulators of bacterial compartments, the data presented here may be of general interest. The study is well executed and provides exciting hypotheses to be tested in vivo.
The authors found that McdB from S. elongatus PCC 7942 consists of three domains: an N-terminal 18 aa disordered region, a Q-rich helical domain, and a helical C-terminal domain (CTD). Analyzing these domains, the authors present three key results: (i) The Q-rich domains form dimers, and the CTD drives the formation of trimers of dimers (ii) Phase separation is pH sensitive, driven by the Q-rich domain, and modulated by basic residues in the IDR, (iii) The IDR contains a putative recognition motif that binds McdA. While these three sets of results are rich in data, they are disjointed. Relating the three datasets (oligomeric states of the protein, its phase separation behavior, and its ability to bind McdA) is required to provide a complete picture of the molecular mechanism driving McdB condensation.
Specific comments:
1) The main limitation of this manuscript is the lack of integration between the three areas of results. In particular: how do the IDR basic residues disrupt phase separation? Is that through interference with either the dimer or timer interface? Does the McdB IDR regulate phase separation behavior when bound to McdA? Or, in other words, is the MoRF acting both as a binding interface and as a solubility regulator, and if so, can both functions be achieved simultaneously? It seems like the MoRF includes at least three basic residues.
Indeed, we were unable to fully resolve the specific molecular interactions that give rise to condensates versus those that give rise to oligomers, and how these two modes of self-association contribute to one another. One limitation was that, as shown in our new data, the CTD was not amenable to mutagenesis, as it caused destabilization of the trimer-of-dimers (Fig. 5, Fig. S7). Therefore, we could not dissect how the CTD contributes to oligomerization versus driving condensates. However, we did include in vivo data showing how the IDR mutations allowed us to specifically link phenotypes to McdB condensate solubility (Fig. 8). As we discuss above in responses #4, #6, and #7, we changed the focus of the revised manuscript from the molecular basis of McdB condensate formation to linking McdB condensate formation in vitro and its functionality in vivo. To this end, we think the IDR mutation set has been useful, and follow-up studies will be done to further the molecular model of McdB condensate formation. Reviewers 1 and 3 deemed the MoRF section a distraction. Therefore, MoRF analysis and discussions of McdA interactions with this potential MoRF have been removed.
Finally, what is the effective concentration of McdB in cells, and how does that translate to the in vitro studies?
In our previous version, we used McdB concentrations between 50-100 µM. We do not know the in vivo concentration of McdB. We have tried several antibodies against McdB, and a few were good enough to detect the presence of McdB, but not quantifiably. We therefore believe in vivo McdB levels are low (sub-micromolar), and definitely lower than the range we previously used in our in vitro studies. In our revised manuscript, we include a titration of McdB at lower concentrations, and see condensates at McdB concentrations lower than 2 µM.
2) How general are the conclusions made here to other McdBs? The authors have published nice work surveying the commonalities and differences between homologous McdB proteins. Can you comment on the applicability of your findings to other McdB proteins?
This is a great point, which we have added to a new discussion section titled “McdB homologs have polyampholytic properties between their N- and C-termini”.
Additional issues:
3) Using SEC and SEC-MALS, the authors demonstrated that the Q-rich domain forms a stable dimer and that the full-length protein forms hexamers, suggesting trimers of dimers assembly. The authors also suggest that the CTD is responsible for forming those trimers of dimers based on SEC-MALS measurements. However, Figure 2D shows that while the full length runs at 6.6x the monomer, the Q-rich+CTD runs at 5.4x the monomer. First, I could not find SEC-MALS of the full-length protein, and it is not clear whether SEC-MALS was used for all or a fraction of the constructs discussed in Figure 2D. Second, could it be that the Q-rich domain+CTD is an ensemble of hexamers and dimers? Perhaps the IDR is playing a secondary role in stabilizing the hexamer?
We have repeated the SEC-MALS experiments and included the full-length protein (Fig. 2). Furthermore, we have included SEC-MALS for some of the key substitution mutants (Figs. 5, S7). With the additional findings, our conclusions remain the same as in our previous version of the manuscript.
4) The analysis of the phase separation results needs to have some extra quantification. The authors show that at 100 uM protein with 10% PEG the full-length phase separates as well as IDR+Q-rich. Lines 176-178: "The CTD, on the other hand, has no effect on the Q-rich domain condensates; Q-rich+CTD condensates formed at the same protein concentration and with identical droplet morphologies at the Q-rich domain alone." It is hard to draw this conclusion solely based on the data presented in Figure 3. An alternative interpretation might be that Q-rich+CTD reduces csat. I suggest the authors include turbidity assays (as shown for pH effect) to quantitively determine csat for these different constructs and perhaps perform FRAP to determine the mobility of these different constructs. In addition, how long after the addition of PEG were these droplets imaged?
We now include an additional figure where we characterize condensates for full-length McdB (Fig. 3), including FRAP as suggested by the reviewer. We also include additional experiments for the truncations as requested (Fig. 4), and relate the truncation data to the model we propose for the full-length protein. All condensate samples were incubated for 30 mins prior to imaging unless otherwise stated, which we have added to the methods section “Microscopy of protein condensates”.
5) Solubility assays shown in Figures 4A, B, D, and 5C are missing error bars. Without replicates, it is difficult to assess, for example, the effect of KCl.
We have included replicates and error bars. Apologies for the omission.
Also, please indicate the physiological ranges of KCl and pH in Figure 6. The phase separation sensitivity to pH is intriguing. By changing basic residues to glutamines, the authors conclude that the positive charge of the IDR modulates solubility. The Q-rich domain, however, is negatively charged. Can the authors comment on the role of acidic residues in the Q-rich domain? Are they required for phase separation? Also - based on your previous bioinformatics analysis, are the charges of the IDR and the Q-rich domains conserved across McdB homologs?
Data from this report, and as described by reviewer #1, suggest that charge in the CTD, and not the central region, may be important. Our previous report (MacCready et al., Mol Biol Evol. 2020) touches on the conservation of charge in the NTD and CTD, which we have now added to the discussion section titled ““McdB homologs have polyampholytic properties between their N- and C-termini””. However, we were unable to experimentally verify electrostatic associations between the NTD and CTD because the CTD was not amenable to mutagenesis, as shown in our new data added to the manuscript (Figs. 5, S7).
6) In previous work, the authors showed a conserved RKR segment in the IDR is highly conserved and missing in S. elongatus PCC 7942 (MacCready et al., Mol Biol Evol. 2020). Given the current finding, it would be important to understand whether the RKR deletion carries functional implications for phase separation behavior.
The RKR segment is not missing, but likely relates to the KKR residues from S. elongatus PCC 7942. We describe this in more detail elsewhere (MacCready et al., Mol Biol Evol. 2020). However, as we show here, these specific residue locations do not seem to be especially important for condensate formation, but instead the overall net charge of the IDR mediates condensate solubility regardless of the specific residues mutated (Fig. 6).
7) McdB proteins with 2Q left mutated vs. 2Q middle and 2Q right seem to result in condensates with different material properties (e.g., DIC pictures show different droplet morphologies for the different constructs). Is that the case? And if so, can you comment on that?
We have included a brief mention of this in the text. However, the overall interpretation of these results remains that regardless of the residues mutated, there is a comparable degree of condensate solubilization for constructs with the same IDR net charge (Fig. 6).
Reviewer #3 (Public Review):
Through a series of rigorous in vitro studies, the authors determined McdB's domain architecture, its oligomerization domains, the regions required for phase separation, and how to fine-tune its phase separation activity. The SEC-MALS study provides clear evidence that the α-helical domains of McdB form a trimer-of-dimers hexamer. Through analysis of a small library of domain deletions by microscopy and SDS-PAGE gels of soluble and pellet fractions, the authors conclude that the Q-rich domain of McdB drives phase separation while the N-terminal IDR modulates solubility. A nicely executed study in Figure 4 demonstrated that McdB phase separation is highly sensitive to pH and is influenced by basic residues in the N terminal IDR. The study demonstrates that net charge, as opposed to specific residues, is critical for phase separation at 100 micromolar. In addition, the experimental design included analysis of McdB constructs that lack fluorescent proteins or organic dyes that may influence phase separation. Therefore, the observed material properties have full dependence on the McdB sequence.
Thank you for the kind words and this perspective. We have added a brief mention to it in the discussion section titled “McdB condensate formation follows a nuanced, multi-domain mechanism”: “Furthermore, it should be noted that the McdB constructs used in our in vitro assays were free from fluorescent proteins, organic dyes, or other modification that may influence phase separation. Therefore, the observed material properties of these condensates have full dependence on the McdB sequence.”
Studies of proteins often neglect short, disordered segments at the N- or C- terminus due to unclear models for their potential role. This study was interesting because it revealed a short IDR as a critical regulator of phase separation. This includes experiments that remove the IDR (Fig 2 & 3) and mutate the basic residues to show their importance towards McdB phase separation. In a nice set of SDS-PAGE experiments, the authors showed that as the net charge of the IDR decreased the construct became more soluble.
One challenge is in the experimental design when mutating residues is to assess their impact on phase separation. The author's avoided substitutions to alanine, as alanine substitutions have synthetically stimulated phase separation in other systems. The authors, therefore, have a good rationale for selecting potentially milder mutations of lysine/arginine to glutamine. A potential caveat of mutation to glutamine is that stretches of glutamines have been associated with amyloid/prion formation. So, the introductions of glutamines into the IDR may also have unexpected effects on material properties. Despite these caveats, the authors show mutation of six basic residues in the short IDR abolished phase separation at 100 mM.
Thank you for the thoughtful consideration, and appreciation of our work! Reviewer 1 had reservations for the Gln substitutions as well. We also used Alanine in new data added to the manuscript. But as the reviewer notes, the alanine mutations artificially drove further phase separation activity, and even aggregation. We show that mutants with the introduction of glutamines, however, remain soluble in vitro and in E. coli even at very high concentrations. Furthermore, we now include SEC-MALS of the McdB variant with 6 glutamines introduced in the IDR and show that there is no impact on oligomeric state. Together the data show no amylogenic properties of these glutamine enriched mutants.
We have added a note to this potential caveat in the discussion section “McdB condensate formation follows a nuanced, multi-domain mechanism”: “Glutamine-rich regions are known to be involved in stable protein-protein interactions such as in coiled-coils and amyloids (52, 53), and expansion of glutamine-rich regions in some proteins lead to amylogenesis and disease (54, 55). However, when we introduced glutamines into the IDR of McdB solubility was increased both in vitro and in vivo, and without any impact on hexamerization. Together, the data show that increasing the glutamine content in the IDR of McdB did not lead to amylogenesis, but rather increased solubility. Our findings therefore underpin the importance of positive charge in the IDR specifically for stabilizing McdB condensates.”
Computational studies (Fig 7) also suggest that this short N-IDR region may play a role as a MORF upon potential binding to a second protein McdA. The formulation of this hypothesis is strengthened by the fact that for other ParA/MinD-family ATPases, the associated partner proteins have also been shown to interact with their cognate ATPase via positively charged and disordered N-termini. This aspect of understanding McdB's N-IDR as a MORF is at a very early stage. This study lacks experimental evidence for an N-IDR: McdA interaction and experimental data showing conformational change upon McdA binding. However, the computation study sets up the future to consider whether and how the phase separation activity of McdB is related to its structural dynamics and interactions with McdA.
Based off of these comments and from Reviewer 1 comments, we have removed the MoRF analyses entirely. The MoRF analysis will be coupled to another study in the lab focused on McdB interactions with McdA.
In summary, this study provides a strong foundation for the contribution of domains to McdB's in vitro phase separation. This knowledge will inform and impact future studies on McdB regulating carboxysomes and how the related family of ParA/MinD-family ATPases and their cognate regulatory proteins. For example, it is unknown if and how McdB's phase separation is utilized in vivo for carboxysome regulation. However, the revealed roles of the Q-rich domain and N-IDR will provide valuable knowledge in developing future research. In addition, the systematic domain analysis of McdB can be combined with a similar analysis of a broad range of other biomolecular condensates in bacteria and eukaryotes to understand the design principles of phase separating proteins.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
When we tilt our heads, we do not perceive objects to be tilted or rotated. In this study, the authors investigate the underlying neural underpinnings by characterizing how neurons in monkey IT respond to objects when the entire body is tilted. They performed two experiments. In the first experiment, the authors record single neuron responses to objects rotating in the image plane, under two conditions - when the animals were tilted +20{degree sign} or -20{degree sign} relative to the gravitational vertical. Their main finding is that neural tuning curves for object orientation were highly correlated under these conditions. This high correlation is interpreted by the authors as indicative of encoding of object orientations relative to an absolute gravitational reference frame. To control for the possibility that the whole-body tilt could have induced compensatory torsional rotations of the eyes, the authors estimated the eye torsional rotation between the {plus minus}20{degree sign} whole-body tilt to be only {plus minus}6{degree sign}. In the second experiment, the authors recorded neural responses to objects rotated in the image plane with no whole-body tilt but with a visual horizon that could be tilted by the same {plus minus}20{degree sign} relative to the gravitational vertical. Here too they find many neurons whose tuning curves were correlated between the two horizon tilt conditions. Based on these results, the authors argue that IT neurons represent objects relative to the gravitational or absolute vertical.
The question of whether the visual system encodes objects relative to the gravitational vertical is an interesting and basic one, and I commend the authors for attempting this question through systematic testing of object selectivity under conditions of whole-body tilt. However, I found this manuscript extremely difficult to read, with important analyses and controls described in a very cursory fashion. I also have several major concerns about these results.
First, the high tuning correlation in the {plus minus}20{degree sign} whole-body tilt conditions could also occur if IT neurons encoded object orientation relative to other fixed contextual cues in the surrounding, such as the frame of the computer monitor. The authors ideally should have some experiment or analysis to address this potential confound, or else acknowledge that their findings can also be interpreted as the encoding of object orientation relative to contextual cues, which would dilute their overall conclusions.
We think there are three possible interpretations of this comment. First, that visible edges, including the horizon and ground plane (in the scene stimuli), and the screen edges and other gravitationally aligned edges in the room, could serve as visual cues for the orientation of gravity. We agree with this wholeheartedly, and in fact showed a strong degree of gravitational alignment based purely on visual scene cues in Figures 3 and 4. This is consistent with our previous results suggest computation of gravity’s direction in the middle channel of IT (Vaziri et al., Neuron 2014; Vaziri and Connor, Current Biology 2016). Our findings would not be diluted by the fact that multiple cues, not just vestibular/somatosensory but also visual, could help in computing the direction of gravity.
Second, that overlap between objects and horizon could produce a shape-configuration interaction that changes with object orientation and produces a tuning effect that remains consistent across monkey tilts. We agree this was a possibility, and that is why we tested neurons in the isolated object condition. We have added text to better explain this concern and the control importance of the isolated object condition in the discussion of Fig. 1: “The Fig. 1 example neuron was tested with both full scene stimuli (Fig. 1a), which included a textured ground surface and horizon, providing visual cues for the orientation of gravity, and isolated objects (Fig. 1b), presented on a gray background, so that primarily vestibular and somatosensory cues indicated the orientation of gravity. The contrast between the two conditions helps to elucidate the additional effects of visual cues on top of vestibular/somatosensory cues. In addition, the isolated object condition controls for the possibility that tuning is affected by a shape-configuration (i.e. overlapping orientation) interaction between the object and the horizon or by differential occlusion of the object fragment buried in the ground (which was done to make the scene condition physically realistic for the wide variety of object orientations that would otherwise appear improbably balanced on a hard ground surface).”
The comparable results in the isolated object condition address the reasonable concern about the horizon/object shape configuration interaction.: “Similar results were obtained for a partially overlapping sample of 99 IT neurons tested with isolated object stimuli with no background (i.e. no horizon or ground plane) (Fig. 2b). In this case, 60% of neurons (32/53) showed significant correlation in the gravitational reference frame, 26% (14/53) significant correlation in the retinal reference frame, and within these groups 13% (7/53) were significant in both reference frames. The population tendency toward positive correlation was again significant in this experiment along both gravitational (p = 3.63 X 10–22) and retinal axes (p = 1.63 X 10–7). This suggests that gravitational tuning can depend primarily on vestibular/somatosensory cues for self-orientation.”
Third, that the object and screen edges in the isolated object condition have an orientation interaction that influences tuning in a way that remains consistent across monkey tilt. If this was intended, we do not think this is a reasonable concern that needs mentioning in the paper itself. The closest screen edges on our large display were 28 in the periphery, and there is no reason to suspect that IT encodes orientation relationships between distant, disconnected visual elements. Screen edges have been present in all or most studies of IT, and no such interactions have been reported. We will discuss this point in online responses.
Second, I do not fully understand torsional eye movements myself, but it is not clear to me whether this is a fixed or dynamic compensation. For instance, have the authors measured torsional eye rotations on every trial? Is it fixed always at {plus minus}6{degree sign} or does it change from trial to trial? If it changes, then could the high tuning correlation between the whole-body rotations be simply driven by trials in which the eyes compensated more? The authors must provide more data or analyses to address this important control.
We now clarify that we could only measure ocular rotation outside the experiment with high-resolution closeup color photography, not possible on individual trials. The extensive literature on ocular counter-rotation has no indication that the degree of rotation is changed by any conditions other than tilt. Our measurements were consistent with previous reports showing that counterroll is limited to 20% of tilt. Moreover, they are consistent with our analyses showing that maximum correlation with retinal coordinates is obtained with a 6 correction for counterroll, indicating equivalent counterroll during experiments. Our analytical compensation for counterroll was based on this value, which optimized results in the retinal reference frame, so our measurements of counter-roll are used only to confirm this value. Ocular rotation would need to be five times greater than any previous observations to completely compensate for tilt and mimic the gravitational tuning we observed. For these reasons, counterroll is not a reasonable explanation for our results:
“Compensatory ocular counter-rolling was measured to be 6 based on iris landmarks visible in high-resolution photographs, consistent with previous measurements in humans6,7, and larger than previous measurements in monkeys41, making it unlikely that we failed to adequately account for the effects of counterroll. Eye rotation would need to be five times greater than previously observed to mimic gravitational tuning. Our rotation measurements required detailed color photographs that could only be obtained with full lighting and closeup photography. This was not possible within the experiments themselves, where only low-resolution monochromatic infrared images were available. Importantly, our analytical compensation for counter-rotation did not depend on our measurement of ocular rotation. Instead, we tested our data for correlation in retinal coordinates across a wide range of rotational compensation values. The fact that maximum correspondence was observed at a compensation value of 6 (Figure 1–figure supplement 1) indicates that counterrotation during the experiments was consistent with our measurements outside the experiments.”
Third, I find that when the objects were presented against a visual horizon, different object features are occluded at each orientation. This could reduce the correlation between the neural response in the retinal reference frame, thereby biasing all results away from purely retinal encoding. The authors should address this either through additional analyses or acknowledge this issue appropriately throughout.
This idea of a shape interaction between object and horizon/ground is essentially the same concern discussed as the second interpretation of the first point, above. As outlined there, we addressed this concern in the best way possible, by removing the horizon/background (in the isolated object condition) and showing that the same results obtained. This comment raises the related point (also cured by the isolated object condition) of differential partial occlusion at the bottom of the object, 15% (by virtual mass) of which was buried below ground to provide a realistic physical interpretation for unbalanced orientations.
We make both concerns explicit in the revised manuscript: “The Fig. 1 example neuron was tested with both full scene stimuli (Fig. 1a), which included a textured ground surface and horizon, providing visual cues for the orientation of gravity, and isolated objects (Fig. 1b), presented on a gray background, so that primarily vestibular and somatosensory cues indicated the orientation of gravity. The contrast between the two conditions helps to elucidate the additional effects of visual cues on top of vestibular/somatosensory cues. In addition, the isolated object condition controls for the possibility that tuning is affected by a shape-configuration (i.e. overlapping orientation) interaction between the object and the horizon or by differential occlusion of the object fragment buried in the ground (which was done to make the scene condition physically realistic for the wide variety of object orientations that would otherwise appear improbably balanced on a hard ground surface).”
And we report that the control produces similar results in the absence of horizon/background: “Similar results were obtained for a partially overlapping sample of 99 IT neurons tested with isolated object stimuli with no background (i.e. no horizon or ground plane) (Fig. 2b). In this case, 60% of neurons (32/53) showed significant correlation in the gravitational reference frame, 26% (14/53) significant correlation in the retinal reference frame, and within these groups 13% (7/53) were significant in both reference frames. The population tendency toward positive correlation was again significant in this experiment along both gravitational (p = 3.63 X 10–22) and retinal axes (p = 1.63 X 10–7). This suggests that gravitational tuning can depend primarily on vestibular/somatosensory cues for self-orientation.”
Reviewer #3 (Public Review):
This is a very interesting study examining for the first time the influence of lateral tilt of the whole body on orientation tuning in macaque IT. They employed two types of displays: one in which the object was embedded in a scene that had a horizon and textured ground surface, and a second one with only the object. For the first type, they examined the orientation tuning with and without tilting the subject. However, the effect of tilt for the scene stimuli is difficult to interpret in terms of gravitational reference frame since varying the orientation of the object relative to the horizon leads to changes in visual features between the horizon and object. If neurons show tolerance for the global orientation of the scene (within the 50{degree sign} manipulation range) then the consistent orientation tuning across tilts may just reflect tuning for the object-horizon features (like the angle between the object and the horizon line/surface) that is tolerant for the orientation of the whole scene. Thus, the effects of tilt can be purely visually-driven in this case and may reflect feature selectivity unrelated to gravitation. The difference between retinal and gravitational effects can just reflect neurons that do not care about the scene/horizon background but only about the object and neurons that respond to the features of the object relative to the background. Thus, I feel that the data using scenes cannot be used unambiguously as evidence for a gravitational reference frame. The authors also tested neurons with an object without a scene, and these data provide evidence for a gravitational reference frame. The authors should concentrate on these data and downplay the difficult-to-interpret results using scenes.
We still believe it is important to present these two experimental conditions in parallel, because we believe that visual driving of gravitational tuning by environmental cues is important in real life, and this is substantiated by the effects of visual cues alone. But, we have tried in this revision, in response to these comments and to comments from other reviewers, to clarify the potential concerns about visual effects in the full scene experiment, the importance and meaning of the isolated object condition as a control for concerns about other kinds of tuning, and the relationships between the two experimental conditions:
Concerns about full scene experiment and the control importance of the isolated object condition: “The Fig. 1 example neuron was tested with both full scene stimuli (Fig. 1a), which included a textured ground surface and horizon, providing visual cues for the orientation of gravity, and isolated objects (Fig. 1b), presented on a gray background, so that primarily vestibular and somatosensory cues indicated the orientation of gravity. The contrast between the two conditions helps to elucidate the additional effects of visual cues on top of vestibular/somatosensory cues. In addition, the isolated object condition controls for the possibility that tuning is affected by a shape-configuration (i.e. overlapping orientation) interaction between the object and the horizon or by differential occlusion of the object fragment buried in the ground (which was done to make the scene condition physically realistic for the wide variety of object orientations that would otherwise appear improbably balanced on a hard ground surface) …
Similar results were obtained for a partially overlapping sample of 99 IT neurons tested with isolated object stimuli with no background (i.e. no horizon or ground plane) (Fig. 2b). In this case, 60% of neurons (32/53) showed significant correlation in the gravitational reference frame, 26% (14/53) significant correlation in the retinal reference frame, and within these groups 13% (7/53) were significant in both reference frames. The population tendency toward positive correlation was again significant in this experiment along both gravitational (p = 3.63 X 10–22) and retinal axes (p = 1.63 X 10–7). This suggests that gravitational tuning can depend primarily on vestibular/somatosensory cues for self-orientation. However, we cannot rule out a contribution of visual cues for gravity in the visual periphery, including screen edges and other horizontal and vertical edges and planes, which in the real world are almost uniformly aligned with gravity and thus strong cues for its orientation (but see Figure 2–figure supplement 1). Nonetheless, the Fig. 2b result confirms that gravitational tuning did not depend on the horizon or ground surface in the background condition.”
Cell-by-cell comparisons of scene and isolated stimuli, for those cells tested with both, in Figure 2–figure supplement 6. This figure shows 8 neurons with significant gravitational tuning only in the floating object condition, 11 neurons with tuning only in the gravitational condition, and 23 neurons with significant tuning in both. Thus, a majority of significantly tuned neurons were tuned in both conditions. A two-tailed paired t-test across all 79 neurons tested in this way showed that there was no significant tendency toward stronger tuning in the scene condition. The 11 neurons with tuning only in the gravitational condition by themselves might suggest a critical role for visual cues in some neurons. However, the converse result for 8 cells, with tuning only in the floating condition, suggests a more complex dependence on cues or a conflicting effect of interaction with the background scene for a minority of cells.
Main text: “This is further confirmed through cell-by-bell comparison between scene and isolated for those cells tested with both (Figure 2–figure supplement 6).”
Furthermore, the analysis of the single object data should be improved and clarified.
We have added Figure 1–figure supplement 3–10 that expand the analysis of example cells and additional cells to include all stimuli shown and smoothed tuning curves for individual repetitions of the orientation range.
We also now present results for individual monkeys in Figure 2–supplements 2,3, and the anatomical locations of individual neurons in Figure 2–supplements 4,5.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
Comment 1:
The pharmacological tools used in this study are highly non-selective. Gd3+, used here to block NALCN is actually more commonly used to block TRP channels. 2-APB inhibits not only TRPC channels, but also TRPM and IP3 receptors while stimulating TRPV channels (Bon and Beech, 2013), while FFA actually stimulates TRPC6 channels while inhibiting other TRPCs (Foster et al., 2009).
We agree with the reviewer that the substances mentioned are not specific. Although we performed shRNA experiments against NALCN and TRPC6, we do plan to use more specific pharmacological modulators for these two channels; for this, L703,606 (the antagonist of NALCN) [1] and larixyl acetate (a potent TRPC6 inhibitor) [2] will be used. Actually, we have completed experiments of using larixyl acetate and the results are shown in Author response image 1.
Author response image 1.
Example time-course (A), traces (B) and the summaried data (C) for the effect of larixyl acetate (LA), the antagonist of TRPC6 channel, on the spontaneous firing activity of VTA DA neurons. Paired-sample T test, ** P < 0.01. n is number of neurons recorded and N is number of mice used
Comment 2:
The multimodal approach including shRNA knockdown experiments alleviates much of the concern about the non-specific pharmacological agents. Therefore, the author's claim that NALCN is involved in VTA dopaminergic neuron pacemaking is well-supported.
However, the claim that TRPC6 is the key TRPC channel in VTA spontaneous firing is somewhat, but not completely supported. As with NALCN above, the pharmacology alone is much too non-specific to support the claim that TRPC6 is the TRP channel responsible for pacemaking. However, unlike the NALCN condition, there is an issue with interpreting the shRNA knockdown experiments. The issue is that TRPC channels often form heteromers with TRPC channels of other types (Goel, Sinkins and Schilling, 2002; Strübing et al., 2003). Therefore, it is possible that knocking down TRPC6 is interfering with the normal function of another TRPC channel, such as TRPC7 or TRPC4.
According with your advice, we plan to perform single-cell qPCR experiments to check the expression level of other TRPC channels, after selective knockdown of TRPC6 in VTA DAT+ neurons, results will be shown later in the revised version. From our single-cell RNA-seq results, TRPC7 and TRPC4 are found not to be present broadly like TRPC6 in the VTA DA neurons, therefore it is possible that knocking down TRPC6 maybe not interfering with the normal function of another TRPC channel, such as TRPC7 or TRPC4.
Comment 3:
The claim that TRPC6 channels in the VTA are involved in the depressive-like symptoms of CMUS is supported.
However, the connection between the mPFC-projecting VTA neurons, TRPC6 channels, and the chronic unpredictable stress model (CMUS) of depression is not well supported. In Figure 2, it appears that the mPFC-projecting VTA neurons have very low TRPC6 expression compared to VTA neurons projecting to other targets. However, in figure 6, the authors focus on the mPFC-projecting neurons in their CMUS model and show that it is these neurons that are no longer sensitive to pharmacological agents non-specifically blocking TRPC channels (2-APB, see above comment). Finally, in figure 7, the authors show that shRNA knockdown of TRPC6 channels (in all VTA dopaminergic neurons) results in depressive-like symptoms in CMUS mice. Due to the low expression of TRPC6 in mPFC-projecting VTA neurons, the author's claims of "broad and strong expression of TRPC6 channels across VTA DA neurons" is not fully supported. Because of the messy pharmacological tools used, it cannot be clamed that TRPC6 in the mPFC-projecting VTA neurons is altered after CMUS. And because the knockdown experiments are not specific to mPFC-projecting VTA neurons, it cannot be claimed that reducing TRPC6 in these specific neurons is causing depressive symptoms.
The reason we focused on the mPFC-projecting VTA DA neurons is that this pathway is indicated in depressive-like behaviors of the CMUS model[3-5]. Although mPFC-projecting VTA DA neurons seem have lower level of TRPC6, we reason they are still functional there. However, we do agree with the reviewer that the statement “broad and strong expression of TRPC6 channels across VTA DA neurons" is not fully supported. We have changed the statements based on the reviewer suggestion. Furthermore, we also plan to selectively knockdown TRPC6 in the mPFC-projecting VTA DA neurons, and then study the behavior.
Comment 4:
It is important to note that the experiments presented in Figure 1 have all been previously performed in VTA dopaminergic neurons (Khaliq and Bean, 2010) including showing that low calcium increases VTA neuron spontaneous firing frequency and that replacement of sodium with NMDG hyperpolarizes the membrane potential.
We agree with reviewer that similar experiments have been performed previously [6]for the flow of our manuscript and for general readers.
Comment 5:
The authors explanation for the increase in firing frequency in 0 calcium conditions is that calcium-activated potassium channels would no longer be activated. However, there is a highly relevant finding that low calcium enhances the NALCN conductance through the calcium sensing receptor from Dejian Ren's lab (Lu et al., 2010) which is not cited in this paper. This increase in NALCN conductance with low calcium has been shown in SNc dopaminergic neurons (Philippart and Khaliq, 2018), and is likely a factor contributing to the low-calcium-mediated increase in spontaneous VTA neuron firing.
We agree with the reviewer and thanks for the suggestions. A discussion for this has been added.
Comment 6:
One of the only demonstrations of the expression and physiological significance of TRPCs in VTA DA neurons was published by (Rasmus et al., 2011; Klipec et al., 2016) which are not cited in this paper. In their study, TRPC4 expression was detected in a uniformly distributed subset of VTA DA neurons, and TRPC4 KO rats showed decreased VTA DA neuron tonic firing and deficits in cocaine reward and social behaviors.
We thank the reviewer for the suggestion.The references and a discussion for this has been added.
Comment 7:
Out of all seven TRPCs, TRPC5 is the only one reported to have basal/constitutive activity in heterologous expression systems (Schaefer et al., 2000; Jeon et al., 2012). Others TRPCs such as TRPC6 are typically activated by Gq-coupled GPCRs. Why would TRPC6 be spontaneously/constitutively active in VTA DA neurons?
In a complex neuronal environment where VTA DA neurons are located, multiple modulatory factors including the GPCRs could be dynamically active, this could lead to the activation of TRP channels including TRPC6.
Comment 8:
A new paper from the group of Myoung Kyu Park (Hahn et al., 2023) shows in great detail the interactions between NALCN and TRPC3 channels in pacemaking of SNc DA neurons.
The reference mentioned has been added. We thank the reviewer.
Reviewer #2 (Public Review):
Comment 1:
These results do not show that TRPC6 mediates stress effects on depression-like behavior. As stated by the authors in the first sentence of the final paragraph, "downregulation of TRPC6 proteins was correlated with reduced firing activity of the VTA DA neurons, the depression-like behaviors, and that knocking down of TRPC6 in the VTA DA neurons confer the mice with depression behaviors." Therefore, the results show associations between TRPC6 downregulation and stress effects on behavior, occlusion of the effects of one by the other on some outcome measures, and cell manipulation effects that resemble stress effects. There is no experiment that shows reversal of stress effects with cell/circuit-specific TRPC6 manipulations. Please adjust the title, abstract and interpretation accordingly.
We agree with the reviewer’s suggestion. The title was changed to ‘’The cation channel mechanisms of subthreshold inward depolarizing currents in the VTA dopaminergic neurons and their roles in the chronic stress-induced depression-like behavior” and the abstract and interpretation were also adjusted accordingly.
Comment 2:
Statistical tests and results are unclear throughout. For all analyses, please report specific tests used, factors/groups, test statistic and p-value for all data analyses reported. In some cases, the chosen test is not appropriate. For example, in Figure 6E, it is not clear how an experiment with 2 factors (stress and drug) can be analyzed with a 1-way RM ANOVA. The potential impact of inappropriate statistical tests on results makes it difficult to assess the accuracy of data interpretation.
We have redone the statistical analysis as suggested by the reviewer and added specific tests used, factors/groups, test statistic and p-value for all data analyses into the revised manuscript.
Comment 3:
Why were only male mice used? Please justify and discuss in the manuscript. Also, change the title to reflect this.
Although most similar previous studies used male mice or rats[7, 8], we do agree with the reviewer that the female animals should also be tested, in consideration possible role of sex hormones, as such we plan to repeat some key experiments on female mice.
Comment 4:
Number of recorded cells is very low in Figure 1. Where in VTA did recordings occur? Given the heterogeneity in this brain region, this n may be insufficient. Additional information (e.g., location within VTA, criteria used to identify neurons) should be included. Report the number of mice (i.e., n = 6 cells from X mice) in all figures.
Yes indeed, the number here is not high. More experiments will be performed to increase the N/n number. And the location of recorded cells in VTA and the number of used mice are now shown in all figures; criteria to identify neurons is stated in the Methods- Identification of DA neurons and electrophysiological recordings. At the end of electrophysiological recordings, the recorded VTA neurons were collected for single-cell PCR. VTA DA neurons were identified by single-cell PCR for the presence of TH and DAT.
Comment 5:
Authors refer to VTA DA neurons as those that are DAT+ in line 276, although TH expression is considered the standard of DAergic identity, and studies (e.g., Lammel et al, 2008) have shown that a subset of VTA DA neurons have low levels of DAT expression. Authors should reword/clarify that these are DAT-expressing VTA DA neurons.
The study published by Lammel[9] in 2015 has shown the low dopamine specificity of transgene expression in ventral midbrain of TH-Cre mice; on the other hand, DAT-Cre mice exhibit dopamine-specific Cre expression patterns, although DAT-Cre mice are likely to suffer from their own limitations (for example, low DAT expression in mesocortical DA neurons may make it difficult to target this subpopulation, see Lammel et al., 2008[10]). Hence, in our study, the DAT was used as criteria to identify DAT neurons. Of course, TH and DAT were all tested in single-cell PCR to identify whether the recorded cells were DA neurons.
Comment 6:
Neuronal subtype proportions should be quantified and reported (Fig. 1Aii).
Neuronal subtype proportions are now quantified and reported in Fig. 1Aii.
Comment 7:
In addition to reporting projection specificity of neurons expressing specific channels, it would be ideal to report these data according to spatial location in VTA.
The spatial location of recorded cells in VTA are now shown in all figures.
Comment 8:
The authors state that there are a small number of Glut neurons in VTA, then they state that a "significant proportion" of VTA neurons are glutamatergic.
Thanks, “a significant proportion of neurons” has been changed to “ less than half of sequenced DA neurons”.
Comment 9:
It is an overstatement that VTA DA neurons are the key determinant of abnormal behaviors in affective disorders.
Thanks, we have amended the statement to that “Dopaminergic (DA) neurons in the ventral tegmental area (VTA) play an important role in mood, reward and emotion-related behaviors”.
Reviewer #3 (Public Review):
Comment 1:
The authors of this study have examined which cation channels specifically confer to ventral tegmental area dopaminergic neurons their autonomic (spontaneous) firing properties. Having brought evidence for the key role played by NALCN and TRPC6 channels therein, the authors aimed at measuring whether these channels play some role in so-called depression-like (but see below) behaviors triggered by chronic exposure to different stressors. Following evidence for a down-regulation of TRPC6 protein expression in ventral tegmental area dopaminergic cells of stressed animals, the authors provide evidence through viral expression protocols for a causal link between such a down-regulation and so-called depression-like behaviors. The main strength of this study lies on a comprehensive bottom-up approach ranging from patch-clamp recordings to behavioral tasks. However, the interpretation of the results gathered from these behavioral tasks might also be considered one main weakness of the abovementioned approach. Thus, the authors make a confusion (widely observed in numerous publications) with regard to the use of paradigms (forced swim test, tail suspension test) initially aimed (and hence validated) at detecting the antidepressant effects of drugs and which by no means provide clues on "depression" in their subjects. Indeed, in their hands, the authors report that stress elicits changes in these tests which are opposed to those theoretically seen after antidepressant medication. However, these results do not imply that these changes reflect "depression" but rather that the individuals under scrutiny simply show different responses from those seen in nonstressed animals. These limits are even more valid in nonstressed animals injected with TRPC6 shRNAs (how can 5-min tests be compared to a complex and chronic pathological state such as depression?). With regard to anxiety, as investigated with the elevated plus-maze and the open field, the data, as reported, do not allow to check the author's interpretation as anxiety indices are either not correctly provided (e.g. absolute open arm data instead of percents of open arm visits without mention of closed arm behaviors) or subjected to possible biases (lack of distinction between central and peripheral components of the apparatus).
We agree with the reviewer that behavior tests we used here is debatable whether they represent a real depression state, and this is an open question that could be discussed from different respective. Since these testes (forced swimming and tail suspension), as the reviewer noted, were “widely observed in numerous publications”, we used these seemly only options to reflect a “depression-like” state. One could argue that since these testes were initially used for testing antidepressants (“validated”), with decreased immobility time as indications of anti-depressive effects, why not an increased immobility time reflect a “depression-like” state. As for anxiety tests, both absolute time in open and closed arms are now provided.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
This study optimized a protocol for analyzing microplastics (MPs) in bovine and human follicular fluid. The authors identified the most common plastic polymers in the follicular fluid and assessed the impact of polystyrene beads on bovine oocyte maturation based on the concentration of MPs in follicular fluid. The authors found a decrease in maturation rate in the presence of polystyrene beads and conducted proteomic analysis of oocytes treated with and without MPs, revealing protein alterations.
Strengths:
• The optimization of the protocol for analyzing MPs in follicular fluid, which is important for future research in this area.
• Investigating the effects of MPs on oocyte maturation and proteomic profiles is significant.
Thank you for the summary and for highlighting our manuscript’s strengths. Weaknesses:
• The effects of polystyrene beads on oocyte maturation and proteomic profiles are not directly demonstrated, and insufficient analysis is performed to support the claims made in the manuscript.
We disagree with this statement, as we have shown that the oocyte maturation is affected by the PS beads, which clearly have some effects on the zona pellucida as well, all supported by well thought experimental analysis. Regarding the proteomics data, as suggested to be emphasized by reviewer 3, in the oocyte maturation experiment the PS exposure was performed using cumulus-oocyte-complexes and we believe that the cumulus cells might have a protective role (to a certain extent) to the oocyte. At first, we have performed different methods to try and check incorporation of PS beads into oocyte and cumulus cells but, unfortunately, we could not validate a protocol for that. Therefore, although we have seen some changes on proteomics, indeed we were not able to directly demonstrate which pathways could have been responsible for the decreased oocyte maturation and increased zona pellucida fragility.
• The use of polystyrene beads does not fully mimic the concentration and interaction of MPs in follicular fluid, which warrants careful interpretation and discussion.
We are aware that the concentration of polystyrene (PS) used in our experiments (0.01ug/mL and 0.1ug/mL) did not fully represent the PS concentrations found in human and bovine follicular fluid (FF) (0.0013 and 0.0043 ug/mL). We note though that PS is not the only MPs detected in the FF and, in this study we selected PS concentrations that were in the range of the total MPs found in FF (0.102 and 0.025 ug/mL, for human and bovine, respectively). We will carefully re-read and revise the manuscript in order to ensure that we are not at risk of misguiding readers on the environmental relevance of the chosen experimental concentrations. Nevertheless, we firmly believe that our study was performed using a substantially more realistic concentration than the overwhelming majority of existing studies, which tend to use hundreds of thousands of times more plastic than what is naturally occurring (as described by Mills et al. - https://doi.org/10.1186/s43591-023-00059-1).
• A major weakness is the lack of mechanism. Determining the cause of meiotic arrest (decreased maturationrate) would be needed to strengthen the paper. Are spindle morphology, chromosome morphology/alignment and/or spindle assembly checkpoint mechanism perturbed in MPs-treated oocytes?
• Functional assays to validate one or more of the pathways suggested by the proteomic analysis would be necessary to strengthen the paper.
We appreciate that understanding the mechanisms underlying the observed changes is important, however, prior to this work, little was known about the effects of MPs on reproductive health. As such, the experimental plan for this work was focused on providing an assessement of the extent to which MPs occur in reproductive systems, and the effect of these MPs on general metrics of oocyte health and function. It is only with this baseline knowledge that experiments aimed at studying the mechanisms underlying these changes can/should be designed, which we will certainly consider for future research.
• The analysis of broken zona pellucida is not sufficiently convincing. Definitely the breakage of zona pellucida is most likely a result of oocyte denudation. However, this may indicate increased fragility of polystyrene beads-treated oocytes. Investigating cytoskeletal components in oocytes treated with or without polystyrene beads would strengthen this paper.
Indeed, the reviewer is correct that the breakage of the zona pellucida happened during denudation. Yet, because all groups were processed in the exact same way, the differences we observed between our experimental and control groups clearly indicate that the PS beads are causing some form of damage to the zona pellucida, or indirect effects through cumulus-oocyte interactions, irrespective of the initial breakage. This is a question we want to answer in future experiments.
• The percentage of degenerated oocytes in the control group is abnormally high which raises concern that the oocytes are not healthy.
The reviewer is correct in noting that the baseline number of degenerated oocytes is high. This is unlikely to be due to oocyte health, and is more likely attributed to the fact that the students that were working on this experiment had a period of adaptation to learn to work with these cellular types. In this regard, it is important to mention that we designed the experiment such that this effect was evenly distributed throughout all of the groups. In other words, the technique refinement did not introduce any systematic bias into the data. Thus, while the baseline number of degenerated oocytes is high, we are confident that the effects of MPs are robust.
• The small font size of the figures (such as Fig. 1C) affects the quality of the manuscript.
Thank you for pointing this out. We will improve readability of all our figures for a resubmission.
• Finally, the authors should cite previous publications on the effects of MPs on female reproduction, as this is not a novel area of research, despite the use of different concentrations. For example, "Polystyrene microplastics lead to pyroptosis and apoptosis of ovarian granulosa cells via NLRP3/Caspase-1 signaling pathway in rats (DOI: 10.1016/j.ecoenv.2021.112012)".
Yes, absolutely. We we will include this interesting and relevant work in our revised mansucript.
Reviewer #2 (Public Review):
This study presents valuable findings including the use of an improved method of Raman spectroscopy to measure accumulation of microplastics in ovarian follicular fluid obtained from cows and women and demonstration that experimental direct exposure of bovine eggs to biologically relevant levels of polystyrene, a microplastic found in both cows and women's follicular fluid, negatively influenced ova maturation status and the abundance of proteins involved in oxidative stress, DNA damage, apoptosis, and oocyte maturation.
Thank you for the summary and for highlighting our manuscript’s strengths.
The evidence supporting the claims of the authors is solid but inclusion of human population from which the follicular fluid was obtained (e.g., demographics, reason for assisted reproduction),
Agreed. We will include all information regarding the reason for IVF, age, BMI, and IVF outcomes in the revised manuscript.
and details about quality control for proteome profiling experiments (i.e., peptide count cut-off for significant proteins) would have strengthened the study. The work will be of interest to exposure scientists, reproductive toxicologists, regulatory scientists, and reproductive health clinicians.
For protein identification, the default settings of MaxQuant were used. In brief, proteins are only considered as identified with at least one unique or razor peptide. Razor peptides are non-unique and assigned to a single protein to ensure that they are only used once for identification. Additionally, a false discovery rate of 1% was applied using a decoy sequence database approach. Quantification was performed on proteins with at least two different peptides. We will include this information in the revised manuscript.
Reviewer #3 (Public Review):
The study from Grechi et al showed that emerging environmental microplastics (MPs) are present in both human and bovine follicular fluid. Moreover, based on the characterization and quantification data, authors treated bovine oocytes with environmentally relevant levels of polystyrene (PS) MPs and found that PS MPs interfered with oocyte maturation in vitro. This study is novel, particularly the first part of MP characterization and quantification, and for the first time confirms the presence of MPs in follicular fluid of humans and large farm animals. These results provide a possible mechanism by which the female infertility rate has been increasing in both humans and large farm animals.
Thank you for the summary and for highlighting our manuscript’s novelty.
The session of exposing MPs to bovine and related oocyte health evaluation can be further improved. For example, authors examined the morphology of the oocyte zona pellucida (ZP) and degeneration and stained oocyte DNA to determine the meiotic maturation status. However, a much more comprehensive oocyte health evaluation can be performed including but not limited to the examination of oocyte spindle morphology, meiotic division, fertilization, early embryo development, mitochondria, and accumulation of ROS. These additional endpoints can provide more robust evidence to determine the impact of MPs on oocyte health.
We agree with the reviewer that a more comprehensive oocyte health evaluation can be performed. Doing so, however, is beyond the scope of any single study as there are many different pathways and mechanisms by which MPs may be affecting oocytes and attempting to include all of these experiments in a single study is simply not feasible. Indeed, we plan on continuing along this line of work in future experiments.
While the oocyte proteomic analysis identified altered proteins, more functional studies and causation experiments can be performed.
As noted in our reply to reviewer 1, we appreciate that understanding the mechanisms underlying the observed changes is important, however, prior to this work, little was known about the effects of MPs on reproductive health. As such, the experimental plan for this work was focused on providing an assessement of the extent to which MPs occur in reproductive systems, and the effect of these MPs on general metrics of oocyte health and function. It is only with this baseline knowledge that experiments aimed at studying the mechanisms underlying these changes can/should be designed, which we will certainly consider for future research.
In addition, authors exposed cumulus-oocyte-complexes (COCs) but not denuded oocytes with MPs, it is crucial to determine whether MPs accumulate in cumulus cells or oocytes or both as well as the compromised oocyte quality is caused by the direct effect of MPs or the indirect impact on somatic cumulus cells to cause a secondary effect on the oocytes.
As stated previously, at first, we have performed different methods to try and check incorporation of PS beads into oocyte and cumulus cells but, unfortunately, we could not validate a protocol for that. Therefore, although we have seen some changes on proteomics, indeed we were not able to directly demonstrate which pathways could have been responsible for the decreased oocyte maturation and increased zona pellucida fragility, and what is the possible role of the cumulus cells on it.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
[...] This study brings a lot of new information on the regulation of flagellar genes, from the identification of novel sigma 28-dependent sRNAs to their effects on flagella production and motility. It represents a considerable amount of work; the experimental data are clear and solid and support the conclusions of the paper. Even though mechanistic details underlying the observed regulations by MotR or FliX sRNAs are lacking, the effect of these sRNAs on fliC, several rps/rpl genes, and flagellar genes and motility is convincing.
The connection between r-protein genes regulation and flagellar operons is exciting and raises a few questions. First, from the RILseq data, chimeric reads with mRNA for r-proteins (including rpsJ) are not restricted to the sigma 28-dependent sRNAs (e.g. rpsJ-sucD3'UTR, rpsF-DicF, rplN-DicF, rplK-ChiX, rplU-CyaR, rpsT-CyaR, rpsK-CyaR, rpsF-MicA...), suggesting that regulation of r-protein synthesis by sRNAs is not necessarily related to flagella/motility. Second, it would be interesting to know if the flagellar operons are more sensitive than other long operons to antitermination following MotR overexpression? In other words, does pMotR similarly affect antitermination in rrn or other long operons?
The general effect of pMotR or pFliX on the expression of multiple middle and late flagellar genes is also interesting even though the mechanism is not clear. While it may be difficult to fully address it, testing whether some of these regulatory events depend on the control of fliC and/or the S10 operon could be relevant (by analyzing the effects in strains deleted for fliC or nusB for instance).
We also think the connection between r-protein genes regulation and flagellar operons is exciting and raises some intriguing questions. While there are other RIL-seq chimeras for r-protein genes, the highest numbers are found for MotR and FliX. Nevertheless, understanding the impact of these other sRNAs on the r-protein operons and elucidating which long operons are most sensitive to antitermination following MotR overexpression are important directions for further studies.
Reviewer #2 (Public Review):
[...] This is a very interesting study that shows how sRNA-mediated regulation can create a complex network regulating flagella synthesis. The information is new and gives a fresh outlook at cellular mechanisms of flagellar synthesis. The presented work could benefit from additional experiments to confirm the effect of endogenous sRNAs expressed at natural level.
We agree that experiments regarding the endogenous effects of endogenous sRNAs are important. We provide such data in Figures 8 and S14 for MotR and FliX in a variety of assays: flagella numbers by electron microscopy, motility and competition assays, expression of flagellar genes by RT-qPCR and western analysis. We went to the trouble of constructing strains carrying point mutations in the chromosomal copies of these genes rather than deletions to avoid interfering with expression of motA and fliC given that MotR and FliX encompass the 5’ and 3’ UTRs respectively.
Reviewer #3 (Public Review):
[...] Overall, this comprehensive study expands the repertoire of characterized UTR derived sRNAs and integrate new layers of post-transcriptional regulation into the highly complex flagellar regulatory cascade. Moreover, these new flagella regulators (MotR, FliX) act non-canonically, and impact protein expression of their target genes by base-pairing with the CDS of the transcripts. Their findings directly connect flagella biosynthesis and motility, highly energy consuming processes, to ribosome production (MotR and FliX) and possibly to carbon metabolism (UhpU).
Specific points to be considered:
-
The authors use a crl- hyper-motile strain as WT strain for the study and sometimes also a crl+ strain is used. Can the authors comment on potential reasons why some phenotypes (e.g., UhpU and MotR effects on motility) are only detectable in the crl+ strain or vice versa? Is σS regulation important for the function of these sRNAs?
-
In several experiments, a variant of MotR sRNA, MotR that harbors a 3 nt mutation upstream of the seed sequence is used and seems to mediate stronger phenotypes (impact on flagellar number) upon overexpression compared to WT or phenotypes not retrieved for WT MotR (increased flagellin expression). It would be helpful to have some more clarification throughout the text, why this variant was used, even when OE of WT MotR already has impact on the target and how these three mutated nucleotides impact target regulation. For example, does MotR show increased RNA stability or Hfq binding compared to MotR? Does the mutation in MotR* impact MotR structure (e.g., based on secondary structure predictions) or increase the complementarity with selected targets at potential secondary binding sites (e.g., based on target predictions)? For example, Fig. S7 shows additional regions of interaction between MotR and fliC mRNA beside the seed sequence. It is also suggested that MotR might have multiple interaction sites on rpsJ mRNA. Additional structure probing or biocomputational predictions could clarify these points.
-
It is suggested that UphU impacts on motility via regulation of LrhA, which represses transcription of flhDC, and therefore the flagellar cascade. While LhrA-mediated regulation by UphU is validated based on reporter genes, the effect of UhpU OE on FlhDC levels is not directly examined (Fig. 3). Furthermore, as deletion of LrhA de-represses the flagellar cascade and UhpU was also shown to increase motility, the conclusions could be further strengthened by examining flhDC levels and/or the effect of ∆UhpU (if the sRNA part can be deleted) on motility (reduction) due to relieved down-regulation of LrhA.
-
This study provides many opportunities for future follow-work. Now that the four sRNAs and some of their targets and opposing effects on flagella biogenesis have been identified, it will be interesting to see how the sRNAs themselves are temporally regulated throughout the flagella biogenesis cascade and which other targets are regulated by them. Future studies could also provide insights into the mechanism and function of FlgO sRNA, which seems to act via a different mechanism than base-pairing to target RNAs, as well as the global effects of regulation of ribosomal genes via FliX and MotR.
We thank the reviewer for the constructive comments about the variation between the crl- and crl+ strains, and about the use of MotR versus MotR*, and will address these points in a revised version of the manuscript. Regarding the UhpU-mediated regulation, we agree that assays of flhDC expression will strengthen our conclusions. We share the reviewer opinion regarding many opportunities for future follow-up work.
-
-
-
www.medrxiv.org www.medrxiv.org
-
Author Response
Reviewer #1 (Public Review):
This article describes the development and refinement of an open-source software framework that is used to track how the COVID-19 pandemic impacted healthcare use in England over a range of key healthcare use indicators.
Important strengths of this study include the high coverage of 99% of practices in England, the development of health care indicators with the input of a clinical advisory group, extensive online documentation, and rigorous safeguards for the protection of patient confidentiality.
Perhaps the largest limitation is that only high-level descriptive data on the monthly volume of health outcomes are presented. It is not clear whether the system could be used to generate more fine-grained or stratified information, ex. weekly or daily data, or data stratified by important characteristics of practices or of patient characteristics. As such, the utility of the system for answering new scientific questions is unclear, and also what the utility and long-term potential uses of this system will be past the COVID-19 pandemic.
OpenSAFELY allows access to the full primary care record for patients registered with a TPP or EMIS practice in England.This includes medical diagnoses, clinical tests, prescriptions, as well as demographic details such as age, sex, ethnicity. Dates attached to these records allow for daily analyses to be performed. This data is updated weekly. Through linkage of other data sources, it also provides information such as hospital admissions, registered deaths or COVID-19 testing data. Detailed subgroup analysis is possible; OpenSAFELY has already been used to understand disease risk 1, monitor vaccination coverage 2,3 and novel treatments 4, assess patient safety 5, inform public health guidance and policy and much more6. These are all widely applicable beyond the COVID-19 pandemic.
Reviewer #3 (Public Review):
This manuscript by Fisher and colleagues documents the change in clinical activity in English general practices during the COVID-19 pandemic according to a set of indicators of clinical activity. The indicators include measures of clinical reviews (e.g. blood pressure, asthma, chronic obstructive pulmonary disease, medication, and cardiovascular risk reviews), blood tests (e.g. cholesterol, liver function, thyroid function, full blood counts, diabetes monitoring blood tests, and kidney function). All these measures saw a drop during the pandemic, to a varying degree, and some recovered afterwards but others did not.
Clinical activity was measured using SNOMED CT codes, which are standard codes used for recording clinical events in UK GP records.
Strengths:
This is a large and comprehensive study including data from 99% of general practices in England. The indicators are clinically relevant, cover a broad range of disease areas, and have been chosen in a sensible manner, involving relevant stakeholders such as GPs, pharmacists, and pathologists.
The OpenSAFELY platform has the ability to enable federated analyses to be run on raw coded data of almost all patients registered with a GP in England.
The study demonstrates the value of OpenSAFELY in being able to monitor clinical activity in general practice at a detailed level, which is essential for planning and improving health services. The statistical methodology is broadly sound.
Weaknesses:
The measures are all related to chronic physical diseases in adults, with a particular focus on cardiometabolic and respiratory conditions. There are no measures related to mental health, maternal or child health.
Results from preliminary analyses of a wider range of clinical conditions can be found in our previous work7. This includes mental health and female and reproductive health with details on why these were not covered by the initial key measures described.
The description of the measures does not distinguish between different types of clinical activity e.g. lab tests, clinical measurements, or diagnoses, and all are lumped together as 'codes'. This is a peculiarity of the way that information is recorded in GP systems - many different types of clinical information (such as diagnoses and lab tests) are recorded using a SNOMED CT 'code', and only the exact code differentiates what type of information is in the record.
Multiple codes of different types can arise from a single encounter, all of which could be indicative of a clinical event of interest. The codelists for each key measure, available at opencodelists.org shows the type of clinical activity (e.g procedure or observable entity) captured by each code within the codelist (see e.g.https://www.opencodelists.org/codelist/opensafely/red-blood-cell-rbc-tests/576a859e/#tree).
The codelists were broad and comprehensive, but it is unclear how necessary this is because for some measures e.g. lab tests, laboratories typically record a particular type of test using a single standardised code. Instead of using a broad set of codes in the analysis, the authors could have initially verified which codes are associated with the clinical activity being measured (e.g. a numerical value of a blood pressure measurement) in all practices, as I would expect the same single or small number of codes would be used in all practices. This would have provided a smaller and simpler final codelist.
Supplementary table 1 shows up to 5 of the most common codes for each key measure across the two electronic health record (EHR) systems used in this analysis. This shows that whilst a single code is often used for many of the clinical activities assessed here, there are exceptions and there can be variation in coded activity between different EHR systems. We have previously described how design features of EHR systems can impact clinical practice 8. Broad codelists allow us to capture activity across multiple EHR systems.
- Williamson, E. J. et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature 584, 430–436 (2020).
- Trends and clinical characteristics of 57.9 million COVID-19 vaccine recipients: a federated analysis of patients’ primary care records in situ using OpenSAFELY | British Journal of General Practice. https://bjgp.org/content/early/2021/11/08/BJGP.2021.0376.
- Parker, E. P. et al. Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study. BMJ Open 13, e066164 (2023).
- Green, A. C. A. et al. Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY. BMJ Med. 2, (2023).
- Collaborative, T. O. et al. Potentially inappropriate prescribing of DOACs to people with mechanical heart valves: a federated analysis of 57.9 million patients’ primary care records in situ using OpenSAFELY. 2021.07.27.21261136 https://www.medrxiv.org/content/10.1101/2021.07.27.21261136v1 (2021) doi:10.1101/2021.07.27.21261136.
- OpenSAFELY Pubmed search results. PubMed https://pubmed.ncbi.nlm.nih.gov/?term=OpenSAFELY.
- OpenSAFELY NHS Service Restoration Observatory 2: changes in primary care activity across six clinical areas during the COVID-19 pandemic | medRxiv. https://www.medrxiv.org/content/10.1101/2022.06.01.22275674v1.
- Suboptimal prescribing behaviour associated with clinical software design features: a retrospective cohort study in English NHS primary care | British Journal of General Practice. https://bjgp.org/content/70/698/e636.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
eLife assessment:
This important study represents a comprehensive computational analysis of Plasmodium falciparum gene expression, with a focus on var gene expression, in parasites isolated from patients; it assesses changes that occur as the parasites adapt to short-term in vitro culture conditions. The work provides technical advances to update a previously developed computational pipeline. Although the findings of the shifts in the expression of particular var genes have theoretical or practical implications beyond a single subfield, the results are incomplete and the main claims are only partially supported.
The authors would like to thank the reviewers and editors for their insightful and constructive assessment. We are particularly glad to read of the technical advances of the methods developed here. We will rephrase parts of the manuscript and move some analysis to the supplementary materials. This will improve the clarity of the results and ensure the main claims are supported.
Reviewer #1 (Public Review):
The authors took advantage of a large dataset of transcriptomic information obtained from parasites recovered from 35 patients. In addition, parasites from 13 of these patients were reared for 1 generation in vivo, 10 for 2 generations, and 1 for a third generation. This provided the authors with a remarkable resource for monitoring how parasites initially adapt to the environmental change of being grown in culture. They focused initially on var gene expression due to the importance of this gene family for parasite virulence, then subsequently assessed changes in the entire transcriptome. Their goal was to develop a more accurate and informative computational pipeline for assessing var gene expression and secondly, to document the adaptation process at the whole transcriptome level.
Overall, the authors were largely successful in their aims. They provide convincing evidence that their new computational pipeline is better able to assemble var transcripts and assess the structure of the encoded PfEMP1s. They can also assess var gene switching as a tool for examining antigenic variation. They also documented potentially important changes in the overall transcriptome that will be important for researchers who employ ex vivo samples for assessing things like drug sensitivity profiles or metabolic states. These are likely to be important tools and insights for researchers working on field samples.
One concern is that the abstract highlights "Unpredictable var gene switching..." and states that "Our results cast doubt on the validity of the common practice of using short-term cultured parasites...". This seems somewhat overly pessimistic with regard to var gene expression profiling and does not reflect the data described in the paper. In contrast, the main text of the paper repeatedly refers to "modest changes in var gene expression repertoire upon culture" or "relatively small changes in var expression from ex vivo to culture", and many additional similar assessments. On balance, it seems that transition to culture conditions causes relatively minor changes in var gene expression, at least in the initial generations. The authors do highlight that a few individuals in their analysis showed more pronounced and unpredictable changes, which certainly warrants caution for future studies but should not obscure the interesting observation that var gene expression remained relatively stable during transition to culture.
Thank you for the suggestion and we are happy to modify the wording to ensure the correct results are presented. We will reword the abstract and emphasise the main change was observed in the core transcriptome. We will also add clarity to the different var transcriptome results presented.
It is important to note this study was in a unique position to assess changes at the individual patient level as we had successive parasite generations. This is not done in most cross-sectional studies and therefore these small changes in the var transcriptome would have been missed.
Reviewer #2 (Public Review):
In this study, the authors describe a pipeline to sequence expressed var genes from RNA sequencing that improves on a previous one that they had developed. Importantly, they use this approach to determine how var gene expression changes with short-term culture. Their finding of shifts in the expression of particular var genes is compelling and casts some doubt on the comparability of gene expression in short-term culture versus var expression at the time of participant sampling. The authors appear to overstate the novelty of their pipeline, which should be better situated within the context of existing pipelines described in the literature.
Other studies have relied on short-term culture to understand var gene expression in clinical malaria studies. This study indicates the need for caution in over-interpreting findings from these studies.
The novel method of var gene assembly described by the authors needs to be appropriately situated within the context of previous studies. They neglect to mention several recent studies that present transcript-level novel assembly of var genes from clinical samples. It is important for them to situate their work within this context and compare and contrast it accordingly. A table comparing all existing methods in terms of pros and cons would be helpful to evaluate their method.
We are grateful for this suggestion and agree that a table comparing the pros and cons of all existing methods would be helpful for the reader, not just malaria researchers. This will also highlight the key benefits of our new approach. This will be included in the updated manuscript as a supplementary table.
Reviewer #3 (Public Review):
This work focuses on the important problem of how to access the highly polymorphic var gene family using short-read sequence data. The approach that was most successful, and utilized for all subsequent analyses, employed a different assembler from their prior pipeline, and impressively, more than doubles the N50 metric.
The authors then endeavor to utilize these improved assemblies to assess differential RNA expression of ex vivo and short-term cultured samples, and conclude that their results "cast doubt on the validity" of using short-term cultured parasites to infer in vivo characteristics. Readers should be aware that the various approaches to assess differential expression lack statistical clarity and appear to be contradictory. Unfortunately there is no attempt to describe the rationale for the different approaches and how they might inform one another.
It is unclear whether adjusting for life-cycle stage as reported is appropriate for the var-only expression models. The methods do not appear to describe what type of correction variable (continuous/categorical) was used in each model, and there is no discussion of the impact on var vs. core transcriptome results.
The reviewer raises a fair point, and we agree the different methods and results of the var transcriptome analysis are difficult to interpret together without further clarification. Var transcript differential expression analysis has been used several times previously and hence was used here. As mentioned above, this study was in a unique position to perform a more focussed analysis of var transcriptional changes across paired samples. This allowed for changes in the var transcriptome to be identified that would have gone unnoticed in the "traditional" differential expression analysis. To address this point, we will add further explanation to the results and move the var differential expression analysis to the supplementary, to allow for comparison with previous studies.
We thank the reviewer for this highly important comment about adjusting for life cycle stage. Var gene expression is highly stage dependent, so any quantitative comparison between samples does need adjustment for developmental stage. Var gene expression was adjusted for in the differential expression analysis by using the mixture model determined proportions as covariates in the design matrix. The var group level analysis and the global var gene expression analysis was also adjusted for life cycle stage using the same proportions, by including them as an independent variable. The rank-expression analysis did not have adjustment for life cycle stage as the values were determined as a percentage contribution to the total var transcriptome.
We will update the methods section to ensure this is clearer.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
eLife assessment
This important study addresses both the native role of the Plasmodium falciparum protein PfFKBP35 and whether this protein is the target of FK506, an immunosuppressant with antiplasmodial activity. The genetic evidence for the essentiality of FKBP35 in parasite growth is compelling. However, the conclusion that the role of FKBP35 is to secure ribosome homeostasis and the claim that FK506 exerts its antimalarial activity independently of FKBP35 rely on incomplete evidence.<br />
We thank the Reviewers and Editors for their careful evaluation of our manuscript and the constructive criticism. We realized that some of our conclusions may be regarded/misunderstood as overstatements. This was by no means our intention and we apologize for the unnecessary inconvenience. The phenotype of FKBP35 knock-out parasites clearly centers on failing ribosomes and protein synthesis, which in our opinion, provides an important leap towards understanding the role of this drug target in P. falciparum biology. It is however correct that, at this point, we can only make evidence-based hypotheses about direct interaction partners and we will emphasize this more clearly in a revised version of the manuscript. In order to prevent misinterpretation of our work, and as detailed in the point-by-point responses to the reviewer comments, we propose changing the manuscript title to “Genetic validation of Pf_FKBP35 as an antimalarial drug target”. To address the criticism regarding the effects of FK506, we will perform specific additional experiments. We are convinced that this new data set will resolve any remaining ambiguities and allows for a conclusive assessment of FK506 drug activity in _P. falciparum.
Reviewer #1 (Public Review):
In this study, the authors investigate the biological function of the FK506-binding protein FKBP35 in the malaria-causing parasite Plasmodium falciparum. Like its homologs in other organisms, PfFKBP35 harbors peptidyl-prolyl isomerase (PPIase) and chaperoning activities, and has been considered a promising drug target due to its high affinity to the macrolide compound FK506. However, PfFKBP35 has not been validated as a drug target using reverse genetics, and the link between PfFKBP35-interacting drugs and their antimalarial activity remains elusive. The manuscript is structured in two parts addressing the biological function of PfFKBP35 and the antimalarial activity of FK506, respectively.
The first part combines conditional genome editing, proteomics and transcriptomics analysis to investigate the effects of FKBP35 depletion in P. falciparum. The work is very well performed and clearly described. The data provide definitive evidence that FKBP35 is essential for P. falciparum blood stage growth. Conditional knockout of PfFKBP35 leads to a delayed death phenotype, associated with defects in ribosome maturation as detected by quantitative proteomics and stalling of protein synthesis in the parasite. The authors propose that FKBP35 regulates ribosome homeostasis but an alternative explanation could be that changes in the ribosome proteome are downstream consequences of the abrogation of FKBP35 essential activities as chaperone and/or PPIase. It is unclear whether FKBP35 has a specific function in P. falciparum as compared to other organisms. The knockdown of PfFKBP35 has no phenotypic consequence, showing that very low amounts of FKBP35 are sufficient for parasite survival and growth. In the absence of quantification of the protein during the course of the experiments, it remains unclear whether the delayed death phenotype in the knockout is due to the delayed depletion of the protein or to a delayed consequence of early protein depletion. This limitation also impacts the interpretation of the drug assays.
We thank the Reviewer for the compliments regarding our experimental setup and the clarity of our manuscript. We agree that the link between FKBP35 knock-out and ribosome homeostasis is indirect and we now emphasize this more clearly in the revised manuscript. To prevent a general misinterpretation of our manuscript, we will adapt the title accordingly.
We would still like to reiterate that the phenotype of FKBP35 knock-out parasites is best described by their defects in maintaining functional ribosomes. It is for several reasons that we believe the links between FKBP35 and ribosome function are purely evidence driven: First, pre-ribosomal and nucleolar factors are the first proteins (in generation 1 schizonts) to be affected upon knock-out of fkbp35 (Figure 2A, Table S1). We realized that Figure 2A falls short in showing this observation, which is why will update the figure accordingly. Second, the dysregulation of ribosomal factors and the general stall in protein synthesis is dominating the phenotype of FKBP35 knock-out parasites in generation 2. We thus believe it is appropriate to say that knock-out cells are most likely killed in response to defective ribosome maintenance – which is a consequence of reduced FKBP35 levels. We are aware that our experiments (and possibly any other reverse genetics approach) cannot rule out that FKBP35 affects ribosomal factors indirectly. Clearly, more work is required to disentangle this question in more detail in the future.
We agree with the Reviewer that it is not possible to tell if the delayed death-like phenotype is due to a “delayed protein depletion”. We would however like to note that the DiCre/loxP approach allows for an immediate knock-out at the genome level and is thus as precise as possible. Further, in addition to the substantial depletion of FKBP35 in knock-out cells during the phenotypically silent generation, knocking out of fkbp35 at earlier time points (TPs 24-30 and 34-40 hpi in the preceding generation) resulted in the very same phenotype cycle (Figure 1). Here, parasite death was delayed substantially longer, i.e. more than one complete cycle. Together with the dysregulation of early ribosome maturation in generation 1, these findings point towards a delayed death phenotype. It is of course still possible to explain the delayed death-like phenotype by remnant activity of proteins synthetized prior to the genomic knock-out. We address this possibility and describe the two scenarios mentioned by the Reviewer in lines 141-144. Disentangling the two possibilities in future experiments will be difficult, not only with regards to FKBP35, but regarding “delayed death” phenotypes in general.
In the second part, the authors investigate the activity of FK506 on P. falciparum, and conclude that FK506 exerts its antimalarial effects independently of FKBP35. This conclusion is based on the observation that FK506 has the same activity on FKBP35 wild type and knock-out parasites, suggesting that FK506 activity is independent of FKBP35 levels, and on the fact that FK506 kills the parasite rapidly whereas inducible gene knockout results in delayed death phenotype. However, there are alternative explanations for these observations. As mentioned above, the delayed death phenotype could be due to delayed depletion of the protein upon induction of gene knockout. FK506 could have a similar activity on WT and mutant parasites when added before sufficient depletion of FKBP35 protein. In some experiments, the authors exposed KO parasites to FK506 later, presumably when the KO is effective, and obtained similar results. However, in these conditions, the death induced by the knockout could be a confounding factor when measuring the effects of the drug. Furthermore, the authors show that FK506 binds to FKBP35, and propose that the FK506-FKBP35 complex interferes with ribosome maturation, which would point towards a role of FKBP35 in FK506 action. In summary, the study does not provide sufficient evidence to rule out that FK506 exerts its effects via FKBP35.
Noteworthy, we were also very much surprised by data indicating that the antimalarial activity of FK506 is independent of FKBP35. It is for this reason that we conducted a comprehensive set of experiments to disprove our initial observations, but couldn`t find any evidence for an FKBP35-dependent mode of action of FK506:
We were not able to see altered FK506 sensitivity in (i) inducible knock-down parasites, (ii) inducible overexpression parasites and (iii) inducible knock-out parasites. Parasites with altered FKBP35 levels (as assessed by Western blot and quantitative proteomics at 36-42 hpi, respectively) were equally sensitive to FK506. Importantly, at no sub-lethal FK506 concentration did lower FKBP35 levels lead to an altered response of FKBP35KO compared to the wild-type control population. Furthermore, (iv) induction of the knock-out in the cycle preceding FK506 exposure also had no effect on parasite sensitivity. As mentioned by the Reviewer, we also exposed the parasites to FK506 at 30-36 hpi and (v) did not see any effect, even though we measured a 19-fold difference in FKBP35 protein levels between the parasite populations at 36-42 hpi. At this point, parasite death induced by the knock-out cannot be a confounding factor (as it was mentioned by the Reviewer), because the FKBP35 knock-out has no effect on parasite survival in generation 1 in the absence of FK506 (Figure 1F). This demonstrates that the observed effect is only due to drug-mediated killing and not due to the FKBP35 knock-out.
To account for a scenario in which the drop in FKBP35 levels only occurs after 36 hpi, we will perform an additional set of experiments, in which we induce the knock-out at 0-6 hpi and treat the parasites at 36-42 hpi (i.e. the time point at which the 19-fold difference in protein levels was measured by quantitative proteomics). This setup will allow determining whether or not the parasite killing activity of FK506 depends on FKBP35 levels.
So far, our experiments cannot support any scenario in which FK506 kills P. falciparum parasites via inhibiting the essential role of FKBP35 and we would therefore want to insist that this statement is based on highly solid evidence. In this context, it is important to note that our conclusion includes two scenarios: “This indicates that either the binding of FK506 does not interfere with the essential role of _Pf_FKBP35, or that _Pf_FKBP35 is inhibited only at high FK506 concentrations that also inhibit other essential factors.” While this phrase is already present in our initial submission, we will emphasize this point more clearly in the revised manuscript. We are convinced that this information is of high importance for ongoing and future drug development.
Reviewer #2 (Public Review):
The manuscript by Thomen et al. FKBP secures ribosome homeostasis in Plasmodium falciparum and focuses on the importance of PfKBP35 protein, its interaction with the FK506 compound, and the role of PfKBP35 in ribosome biogenesis. The authors showed the interaction of the PfKBP54 with FK506, but the part of the FK506 and PfKBP54 in ribosome biogenesis based on the data is unclear.
The introduction is plotted with two parallel stories about PfKBP35 and FK506, with ribosome biogenesis as the central question at the end. In its current form, the manuscript suffers from two stories that are not entirely interconnected, unfinished, and somewhat confusing. Both stories need additional experiments to make the manuscript(s) more complete. The results from PfFBP35 need more evidence for the proposed ribosome biogenesis pathway control. On the other hand, the results from the drug FK506 point to different targets with lower EC50, and other follow-up experiments are needed to substantiate the authors' claims.
The strengths of the manuscript are the figures and experimental design. The combination of omics methods is informative and gives an opportunity for follow-up experiments.
We thank the Reviewer for the evaluation of the manuscript. We apologize for the fact that the Reviewer found the manuscript to be inaccessible. We will use the comments as an incentive to restructure the manuscript and do our best to clarify the presentation, interpretation and conclusion of the presented data in the revised version. We believe that the FKBP35 data are strongly interlinked with the findings on FK506. We will emphasize these links more clearly and are convinced that the complementary nature of the datasets are a particular strength of the presented work.
Reviewer #3 (Public Review):
The study by Thommen et al. sought to identify the native role of the Plasmodium falciparum FKBP35 protein, which has been identified as a potential drug target due to the antiplasmodial activity of the immunosuppressant FK506. This compound has multiple binding proteins in many organisms; however, only one FKBP exists in P. falciparum (FKBP35). Using genetically-modified parasites and mass spectrometry-based cellular thermal shift assays (CETSA), the authors suggest that this protein is in involved in ribosome homeostasis and that the antiplasmodial activity of FK506 is separate from its activity on the FKBP35 protein. The authors first created a conditional knockdown using the destruction domain/shield system, which demonstrated no change in asexual blood stage parasites. A conditional knockout was then generated using the DiCre system. FKBP35KO parasites survived the first generation but died in the second generation. The authors called this "a delayed death phenotype", although it was not secondary to drug treatment, so this may be a misnomer. This slow death was unrelated to apicoplast dysfunction, as demonstrated by lack of alterations in sensitivity to apicoplast inhibitors. Quantitative proteomics on the FKBP35KO vs FKBP35WT parasites demonstrated enrichment of proteins involved in pre-ribosome development and the nucleolus. Interestingly, the KO parasites were not more susceptible to cycloheximide, a translation inhibitor, in the first generation (G1), suggesting that mature ribosomes still exist at this point. The SunSET technique, which incorporates puromycin into nascent peptide chains, also showed that in G1 the FKBP35KO parasites were still able to synthesize proteins. But in the second generation (G2), there was a significant decrease in protein synthesis. Transcriptomics were also performed at multiple time points. The effects of knockout of FKBP35 were transcriptionally silent in G1, and the parasites then slowed their cell cycles as compared to the FKBP35WT parasites.
The authors next sought to evaluate whether killing by FK506 was dependent upon the inhibition of PfKBP35. Interestingly, both FKBP35KO and FKBP35WT parasites were equally susceptible to FK506. This suggested that the antiplasmodial activity of FK506 was related to activity targeting essential functions in the parasite separate from binding to FKBP35. To identify these potential targets, the authors used MS-CETSA on lysates to test for thermal stabilization of proteins after exposure to drug, which suggests drug-protein interactions. As expected, FK506 bound FKBP35 at low nM concentrations. However, given that the parasite IC50 of this compound is in the uM range, the authors searched for proteins stabilized at these concentrations as putative secondary targets. Using live cell MS-CETSA, FK506 bound FKBP35 at low nM concentrations; however, in these experiments over 50 ribosomal proteins were stabilized by the drug at higher concentrations. Of note, there was also an increase in soluble ribosomal factors in the absence of denaturing conditions. The authors suggested that the drug itself led to these smaller factors disengaging from a larger ribosomal complex, leading to an increase in soluble factors. Ultimately, the authors conclude that the native function of FKBP35 is involved in ribosome homeostasis and that the antiplasmodial activity of FK506 is not related to the binding of FKBP35, but instead results from inhibition of essential functions of secondary targets.
Strengths:
This study has many strengths. It addresses an important gap in parasite biology and drug development, by addressing the native role of the potential antiplasmodial drug target FKBP35 and whether the compound FK506 works through inhibition of that putative target. The knockout data provide compelling evidence that the KBP35 protein is essential for asexual parasite growth after one growth cycle. Analysis of the FKBP35KO line also provides evidence that the effects of FK506 are likely not solely due to inhibition of that protein, but instead must have secondary targets whose function is essential. These data are important in the field of drug development as they may guide development away from structure-based FK506 analogs that bind more specifically to the FKBP35 protein.
Weaknesses:
There are also a few notable weaknesses in the evidence that call into question the conclusion in the article title that FKBP35 is definitely involved in ribosomal homeostasis. While the proteomics supports alterations in ribosome biogenesis factors, it is unclear whether this is a direct role of the loss of the FKBP35 protein or is more related to non-specific downstream effects of knocking down the protein. The CETSA data clearly demonstrate that FK506 binds PfKB35 at low nM concentrations, which is different than the IC50 noted in the parasite; however, the evidence that the proteins stabilized by uM concentrations of drug are actual targets is not completely convincing. Especially, given the high uM amounts of drug required to stabilize these proteins. This section of the manuscript would benefit from validation of a least one or two of the putative candidates noted in the text. In the live cell CETSA, it is noted that >50 ribosomal components are stabilized in drug treated but not lysate controls. Similarly, the authors suggest that the -soluble fraction of ribosomal components increases in drug-exposed parasites even at 37{degree sign}C and suggests that this is likely from smaller ribosomal proteins disengaging from larger ribosomal complexes. While the evidence is convincing that this protein may play a role in ribosome homeostasis in some capacity, it is not sure that the title of the paper "FKBP secures ribosome homeostasis" holds true given the lack of mechanistic data. A minor weakness, but one that should nonetheless be addressed, is the use of the term "delayed death phenotype" with regards to the knockout parasite killing. This term is most frequently used in a very specific setting of apicoplast drugs that inhibit apicoplast ribosomes, so the term is misleading. It is also possible that the parasites are able to go through a normal cycle because of the kinetics of the knockout and that the time needed for protein clearance in the parasite to a level that is lethal.
Overall, the authors set out to identify the native role of FKB35 in the P. falciparum parasites and to identify whether this is, in fact, the target of FK506. The data clearly demonstrate that FKBP35 is essential for parasite growth and provide evidence that alterations in its levels have proteomic but not transcriptional changes. However, the conclusion that FKBP35 actually stabilizes ribosomal complexes remains intermediate. The data are also very compelling that FK506 has secondary targets in the parasite aside from FKBP35; however, the high uM concentrations of the drug needed to attain results and the lack of biological validation of the CETSA hits makes it difficult to know whether any of these are actually the target of the compound or instead are nonspecific downstream consequences of treatment.
We appreciate the detailed and valuable suggestions to improve the manuscript. We agree that CETSA could only identify potential targets of FK506 in the micromolar range, while FK506 showed a high affinity for FKBP35, consistent with earlier reports (2). We would however like to point out that FK506 kills P. falciparum at exactly these relatively high concentrations and not at those presumed from the high affinity interactions between FK506 and FKBP35. The relatively high FK506 concentration required to stabilize potential off target proteins is therefore not a concerning observation, but rather corroborates our conclusion that FK506 fails to inhibit the essential function of FKBP35 at concentrations that leave off targets unaffected. As mentioned in response to Reviewer 1, we will describe and discuss these data more clearly in the revised manuscript.
We thank the Reviewer for pointing out the potential issues regarding the use of the term “delayed death phenotype”. We now refer to the FKBP35 phenotype as “delayed death-like” in the revised manuscript.
We believe that follow-up work on specific FK506 CETSA hits is out of scope of the current and already quite complex manuscript.
As mentioned in the response to Reviewer 1, we realize that the short title of the manuscript can be regarded as an overstatement. Again, this was clearly not our intention and we apologize that the Reviewers had to indicate this issue. While we believe that the message of the title holds true (see response to Reviewer 1), we recognize the misconception that might arise from it, which is why we propose the new title: “Genetic validation of _Pf_FKBP35 as an antimalarial drug target”.
- Kennedy K, Cobbold SA, Hanssen E, Birnbaum J, Spillman NJ, McHugh E, et al. Delayed death in the malaria parasite Plasmodium falciparum is caused by disruption of prenylation-dependent intracellular trafficking. PLoS Biol. 2019;17(7):e3000376.
- Kotaka M, Ye H, Alag R, Hu G, Bozdech Z, Preiser PR, et al. Crystal structure of the FK506 binding domain of Plasmodium falciparum FKBP35 in complex with FK506. Biochemistry. 2008;47(22):5951-61.
- Kasahara K, Nakayama R, Shiwa Y, Kanesaki Y, Ishige T, Yoshikawa H, et al. Fpr1, a primary target of rapamycin, functions as a transcription factor for ribosomal protein genes cooperatively with Hmo1 in Saccharomyces cerevisiae. PLoS Genet. 2020;16(6):e1008865.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
The following is the authors' response to the original reviews.
eLife assessment
This study presents important findings regarding the quantification of dynamics in fish communities in changing ecosystems by combining a large-scale environmental DNA metabarcoding time series with novel statistical approaches. The methods are convincing, with controlled experiments, thorough statistical analyses, and a substantial dataset covering two years of detailed observation, which can provide sufficient power to detect fine-scale ecological interactions. This work is relevant for informing future research on assessing community stability under climate change.
Thank you so much for your careful evaluation of our manuscript. We are very pleased to hear that you found our study important. We have revised our manuscript according to the helpful comments to further improve our manuscript.
Reviewer #1 (Public Review):
[…] Their work provides a highly relevant approach to perform species-interaction strength analysis based on eDNA biodiversity assessments, and as such provides a research framework to study marine community dynamics by eDNA, which is highly relevant in the study of ecosystem dynamics. The models and analytical methods used are clearly described and made available, enabling application of these methods by anyone interested in applying it to their own site and species group of interest.
Thank you so much for your time and effort to evaluate our manuscript. We are very pleased to hear that you found our study interesting. We have further revised the manuscript according to your comments and hope that the revised manuscript is now better than the original one.
Strengths: The authors have a study setup that is suitable to measure the effects of temperature of the eDNA diversity, and have taken a large number of samples and all appropriate controls to be able to accurately measure and describe these dynamics. The applied internal spike in to enable relative eDNA copy number quantification is convincing.
We are happy to hear that you found the study design and the method to estimate eDNA copy number are suitable and convincing.
Weaknesses: The authors aim to study the relationship between species interaction strength and ecosystem complexity, and how temperature will influence this. However, there is only limited ecological context discussed explaining their results, and a link with climate change scenario's is also limited. A further discussion of this would have strengthened the manuscript.
Thank you so much for the comment. We have added discussion about how our study contributes to understanding fish community assembly process and predicting the community-level response under ongoing climate change. We have added one subsection, "Implications for fish community assembly and the effect of global climate change ", at L679. As for the ecological discussion for each specific fish-fish interaction, we provided this in Supplementary file 1c.
The authors were able to find a correlation between water temperature and interaction strengths observed. However, since water temperature is dependent on many environmental variables that are either directly or indirectly influencing ecosystem dynamics, it is hard to prove a direct correlation between the observed changes in community dynamics and the temperature alone.
Thank you for pointing this. We have discussed the possibility of the effects of other environmental variables (e.g., oxygen) and how we could overcome this issue at L661. Some of the sentences were originally in the subsection " Interaction strengths and environmental variables ", but were moved to the subsection " Potential limitations of the present study and future perspectives".
Reviewer #2 (Public Review):
In this work Ushio et al. combine environmental DNA metabarcoding with novel statistical approaches to demonstrate how fish communities respond to changing sea temperatures over a seasonal cycle. These findings are important due to the need for new techniques that can better measure community stability under climate change. The eDNA metabarcoding dataset of 550 water samples over two years is, I feel, of sufficient scale to provide power to detect fine-scale ecological interactions, the experiments are well controlled, and the statistical analysis is thorough.
Thank you so much for your time and effort to evaluate our manuscript. We are happy to hear that you found our study technically sound and important. We have revised the manuscript according to your comments to improve our manuscript further.
The major strengths of the manuscript are: (1) the magnitude of the dataset, which provides densely replicated sampling that can overcome some of the noise associated with eDNA metabarcoding data and scale up the number of data points to make unique inferences; (2) the novel method of transforming the metabarcode reads using endogenous qPCR "spike-in" data from a common reference species to obtain estimates of DNA concentration across other species; and (3) the statistical analysis of time-series and network data and translating it into interaction strengths between species provides a cross-disciplinary dimension to the work.
Thank you for your positive comments. Regarding (1), we are very pleased to hear that (1) our intensive and extensive water sampling, (2) our method for using the common fish species eDNA as "spike-in," and (3) our nonlinear time series analysis were positively evaluated.
I feel like this kind of study showcases the power of eDNA metabarcoding to answer some really interesting questions that were previously unobtainable due to the complexities and cost of such an exercise. Notwithstanding the problems associated with PCR primer bias and PCR stochasticity, the qPCR "spike-in" method is easy to implement and will likely become a standardised technique in the field. Further studies will examine and improve on it.
We must admit that our endogeneous "spike-in" method does not overcome all problems associated with PCR. However, we agree with you and believe that we are heading in a correct direction. The method
does not require the addition of external internal standard DNAs and enables post-hoc evaluation of eDNA absolute concentrations. Although this approach requires an additional experiment (qPCR), the method may be an alternative for quantifying eDNA concentrations.
Overall I found the manuscript to be clear and easy to follow for the most part. I did not identify any serious weaknesses or concerns with the study, although I am not able to comment on the more complex statistical procedures such as the "unified information-theoretic causality" method devised by the authors. The section on limitations of the study is important and acknowledges some issues with interpretation that need to be explained. The methods, while brief in parts, are clear. The code used to generate the results has been made available via a GitHub repository. The figures are clear and attractive.
We are very happy to hear that you found our manuscript clear and not containing any serious weakness.
Reviewer #1 (Recommendations For The Authors):
This is a very nice manuscript discussing highly relevant methods to use eDNA analysis to study interactions in marine ecosystems. There are some minor concerns that we will address below:
- As already mentioned above, based on the statements in the introduction we expected a very elaborate discussion section concerning the ecological interaction observed between species. This is however missing, and a more extensive general discussion of the biological interactions would be appreciated, either based on existing literature, or by suggesting further experiments. Alternatively, the claims made in e.g. line 124-128 (Overcoming these difficulties....) could be amended so this expectation is not raised.
Thank you so much for the comment. As answered in the response above, we have added discussion about how our study contributes to the fish community assembly process and predicting the community-level response under ongoing climate change at L679.
Specifically, we argued that our study provides a piece of evidence that temperature exerts influences on fish-fish interactions under field conditions at a relatively short time scale (weeks to months). We suggested that temperature effects on fish community assembly involve effects at different time scales, and thus, integrating results from different temporal (and spatial) scales are necessary to understand the fish community assembly process in nature. As stated above, we provided the detailed ecological discussion for each specific fish-fish interaction in the Supporting Information.
- A lot of negative controls were taken and described in the material & methods. However, there is no clear mention of what was done with the outcome of these negative controls. How did the results of the negative controls influence your analysis? Or were they all completely negative?
Thank you for pointing this out. The negative controls produced negligible reads (177 ± 665 reads [mean ± S.D.]), which accounted for ca. 0.1% of the positive sample reads. Moreover, all the reads were assigned to non-target taxa, such as fish species that had never been observed in the study region and freshwater fish species. Therefore, we conclude that any contaminations in our experiments were negligible, and we discarded the sequence reads from the negative control samples. We have explained this in L533–L539 in the main text.
- Line 423 states: "..suggesting that weak interactions are key to the maintenance of species-rich communities." We are wondering if this can be stated like this, as it seems the other way around would also be true, since in a species rich community it can be expected that most interactions are weak?
Thank you for pointing this. out We agree that there is a possibility that the high species diversity could be a cause of weak intearctions. To clarify this, we have revised the sentence as follows in L568: " ...suggesting that understanding the causes and effects of weak interactions is key to understanding the maintenance of species-rich communities. "
- There is a correlation between DNA concentration and temperature (e.g. shown in fig. S2b). We wondering what could be an argument to not correct for this temperature effect on eDNA concentrations (as now described) or if it would be better to apply a correction factor for this, as it is also shown that there is a correlation between DNA concentration and interaction strengths.
In the unified information theoretic (UIC) analysis, we took the effect of temperature into account if temperature had statistically clear influence on eDNA dynamics of a particular fish species (L439). This means that temperature was included as a conditional variable in the calculation of TE (i.e., Zt in Eqn. [1]). Other environmental variables were also included if they had statistically clear influence. Similarly, in the MDR S-map, we included temperature or other environmental variables as conditional variables if they had statistically clear influence on eDNA dynamics of a particular fish species. We explained this in L479.
- The models used for the interaction dynamics calculations are extensively discussed in this manuscript, although these details are also present in the original papers describing these models, and therefore the manuscript could be shortened by removing some of this explanation.
Thank you for your suggestion. As you understood, the details of the method (S-map and MDR S-map) are available in Sugihara (1994), Chang et al. (2021), and elsewhere. However, we have kept the explanation so that readers who are not familiar with the methods can briefly understand the methods without the needs to read the detail of the previoius studies.
Reviewer #2 (Recommendations For The Authors):
L50-L72: I feel like the abstract could be snappier, i.e. quicker to read with less detail. Consider reducing it a little.
Thank you for your suggestion. We have deleted some redundant phrases and shortened the abstract a little.
L173-L176: I don't understand exactly what is suggested here. Perhaps rephrase?
We have revised the sentence as follows (L165): " As our eDNA time series was taken twice a month, the interactions detected should also have the same time scale (e.g., the interactions detected may cause changes in the population size at the same time scale), which means that we tend to focus on behavior-level interactions (e.g., schooling) rather than birth-death process in the present study (except for predation)."
L228: How many PCR replicate reactions were undertaken per sample?
We performed eight technical replicates for the same eDNA template. This information is described in the third paragraph of the section "Paired-end library preparation and MiSeq sequencing." This section has been moved from the previous supplementary methods to the main text in the revision.
L236: There is no mention later of how these blanks are used to clean up or filter the dataset from the effects of contamination. Consider adding this information.
Thank you for pointing this. As in the responses above, we have described the negative controls in L533–L539 in the main text. The negative controls generated negligible reads, so we simply discarded the sequence reads.
L252-L253: "Primer sequences were removed from merged reads and reads without the primer sequences underwent quality filtering"? Wouldn't all of the reads not have primers after the primers were trimmed off? Or is something else intended here?
All primer sequences were removed after merging the paired- end reads (see "Sequence analysis"). There is no specific reason for this process, and we think that the primer removal before merging the paired- end reads will generate the same results.
L264-L265: "To refine the above taxon assignments". I assume because there were lots of assignments to species that were not known from the study area? Explain why this was done.
At present, the reference sequences are available for about 70% of 4,500 fish species in Japan. However, due to the unknown degree of intraspecific variation, using a uniform threshold of 98.5% to delineate species can result in over-splitting or over-clustering MOTUs. To solve this issue, the manual refinement of the taxon assignments was performed based on the phylogenetic tree. This has been explained in L335.
L274: More details of the qPCR assay are required, or a citation of previous study or supporting information.
The details of the qPCR assay are provided in the secion "Quantitative PCR and estimation of DNA copy numbers." This section has been moved from the previous supplementary methods to the main text in the revision.
L327: Explain further how seasonality was treated here? This is an important part of the study, so deserves further attention.
We included water temperature (if it had statistically clear influence on fish eDNA dynamics) as a conditional variable z(t) in the calculation of TE, and this took the effect of the seasonality in detecting causation into account. We have described this in L436–444.
L407: Consider giving the code repository a DOI to cite.
We have archived the analysis codes at Zenodo and provided the DOI in L39 and L521.
L411: How many MiSeq runs exactly?
We performed 21 MiSeq runs (often with other eDNA samples). We have described this in the main text (L299).
L411: What proportion of your total sequencing data were assigned to fishes? This is a useful statistic to compare methods between studies.
About 98% of the total sequence reads was assigned to fish. We have described this in the main text (L528).
Figure 2: There does not appear to be a key to the color-coded species ecologies.
We have added a legend for the fish ecology in Figure 2.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
The following is the authors' response to the original reviews.
We thank the editor and reviewers for their careful consideration of our manuscript and very helpful feedback, which guided us in improving our manuscript. We would like to highlight three main areas of improvement in this version:
-
Statistical rigor: we have added more detail to justify our 2% cutoff for GLM variable coding, implemented stricter shuffling and cutoffs for value and history coding, and provided more information on the statistical significance of our pairwise comparisons across regions and groups. These go well beyond the field standard for identifying and comparing neural encoding of task features.
-
Identification of value coding: we have implemented reviewer suggestions about kernel regression and value coding shuffles, providing even stronger evidence that value signaling among cue neurons is more prevalent than expected by chance, more prevalent than any other cue coding patterns, and present in all recorded regions. The rigor of this analysis is only possible due to our unique task design with 6 cues across two stimulus sets, and our consideration of 153 possible coding models exceeds standard practice for identifying value signals. We now implement population decoding, as well, providing additional support for a robust and widely-distributed value code.
-
Stability of value code: we have updated our terminology to better highlight that the value signals in our imaging dataset are indeed identified across days, and we add new analysis to show conservation of value-like signals across training days.
Thanks to the reviewers’ suggestions, our manuscript now has substantially stronger support for the presence of stable and distributed cue value signaling. We address the specific points below.
Excerpts from the Consensus Public Reviews:
One limitation is the lack of focus on population-level dynamics from the perspective of decoding, with the analysis focusing primarily on encoding analyses within individual neurons.
To address this limitation, we now include population-level decoding analysis (new panels, Figs. 3G-H, 4E). This new analysis reveals that, although value neurons can be used to decode cue identity on par with other cue cells, value neurons are more accurate at predicting the value of held out cues (never seen by the model), highlighting the utility of a value signal as a way to consistently represent the value of different stimulus sets.
Moreover, we find comparable value prediction performance when using value neurons from each region (Fig. 4E), adding more support for the similarity of this signal across regions:
The authors use reduced-rank kernel regression to characterize the 5332 recorded neurons on a cell-by-cell basis in terms of their responses to cues, licks, and reward, with a cell characterized as encoding one of these parameters if it accounts for at least 2% of the observed variance. At least 50% of cells met this inclusion criterion in each recorded area. 2% feels like a lenient cutoff, and it is unclear how sensitive the results are to this cutoff, though the authors argue that this cutoff should still only allow a false positive rate of 0.02% (determined by randomly shuffling the onset time of each trial.)
We have provided more information about the 2% cutoff in a new figure, Figure 2-figure supplement 3. We reanalyzed the false positive rate and found that at a cutoff of 2% (but not 0.5% or 1%) there were no false positives (Figure 2-figure supplement 3B). Thus, we are confident that all neurons contain true task-related signals. Moreover, we found that the pattern of results remains largely unchanged as we change the cutoff over a range from 0.5% to 5%. With more stringent cutoffs, we begin to lose neurons with robust task-related responses (Figure 2-figure supplement 3E), so we continue to use the 2% cutoff in this version of the manuscript.
First, they show that the correlation between cell responses on all periods except for the start of day 1 is more correlated with day 3 responses than expected by chance (although the correlation is still quite low, for example, 0.2 on day 2).
We agree that a correlation of 0.2 does not seem like a large effect, however the variability in neuronal responses and noise level of the measurement enforce a ceiling that we can estimate by predicting data from the same session that it was trained on. We have replotted these data (new panel Fig. 7G) with the correlation normalized to the cross-validated performance on the training day’s data. This shows that the models do about half as well in session 1 and session 2 compared to session 3. The original plot is in a new supplementary figure, Figure 7-figure supplement 1B.
To further emphasize the similarity across days, we have added new panels (Fig. 7E and Figure 7-figure supplement 1A) showing that, across mice, a typical neuron was more correlated with its own activity on the subsequent day than with ~90% of the other neurons (shuffle controls, 50%).
Second, they show that cue identity is able to capture the highest unique fraction of variance (around 8%) in day 3 cue cells across three days of imaging, and similarly for lick behavior in lick cells and cue+lick in cue+lick cells. Nonetheless, their sample rasters for all imaged cells also indicate that representations are not perfectly stable, and it will be interesting to see what *does* change across the three days of imaging.
We agree that the representations are not perfectly stable and that is an interesting point of further investigation. One difference we did observe is increased cue coding across training (Figs. 6H, 7H).
Importantly, the authors do not present evidence that value itself is stably encoded across days, despite the paper's title. The more conservative in its claims in the Discussion seems more appropriate: "these results demonstrate a lack of regional specialization in value coding and the stability of cue and lick [(not value)] codes in PFC."
Due to confusing terminology on our part, the reviewers were mistaken about the timing of the experiment where we assess the stability of value coding. In the imaging sessions, odor sets were always presented on separate days. Thus, when we identify value coding in our imaged population, it is across two consecutive days with different odor sets, which is in itself evidence of a stable value code. We have updated our terminology and the text to make this clearer. We also added a new set of plots (Fig. 8H-I) showing the conservation of value-like signaling in cells we tracked across the first three sessions of odor set A, and, as above, that the correlation of these neurons across days is greater than expected by chance. These analyses lend further support to the stability of the value signal.
Additional technical comments:
1) The "shuffle #33" in figure 3B is confusing. The fit kernel in this shuffle shows that the "high" and "medium" responses increase above the pre-stimulus baseline. The "high" response is a combination of set 2 CS+ and set 1 CS50, both of which strongly suppressed the cell's firing over the 2.5-second window shown. Why then does the cue kernel fit these two trials predict an increase in firing rate above baseline at the 2.5-second time point? Is it a consequence of the reduced rank regression process, and if so, how? This strange-looking fit that does not well capture the response of the original cell makes me worry that the high fraction of identified "value" cells may be due to some constraint on the shuffle fits that leads them to often perform poorly.
To address this concern, we refit the value shuffle and its models using a full kernel regression model (rather than reduced ranks). It does improve the appearance of the kernel fits (updated Fig. 3B), and we now use this new approach when fitting cue coding models in the revised manuscript. The regularization inherent in reduced rank constrains the shape of the cue kernel somewhat, which contributed to the shape of the fits (although this did not negatively impact the variance explained); however, because of the importance of the shape of these alternative cue coding models to the interpretation of the analysis, we agree with the reviewers that this was worth improving. The main constraint on the value model and its shuffles, however, is that all cues must use the same template, scaled according to particular values assigned to each cue in each shuffle, which will doubtless lead to compromised (and strange-looking) fits when the shuffled values do not match the ranking of neuron’s cue activity. Critically, this constraint is applied equally to the value model and all the shuffles and would not bias the fits of any one model.
2) The "shuffle" condition when testing for value cells always assumes two high responses, two medium responses, and two low responses. This strategy doesn't account for cells that respond to only a subset of cues, as one might expect in a sparse-coding olfactory region. We suggest adding a set of shuffles where responses are split into two groups, with either 3 conditions per group or 2 in one group and 4 in the other.
We appreciate this valuable suggestion. We added all permutations of models with high responses to 6, 5, 4, 3, 2, or 1 odor cue to the analysis. We still find that the value model is the most frequent best model, displayed in new panels Fig. 3C-D and Figure 3-figure supplement 1A-B. The additional models allowed us to identify other neurons with cue activity best fit by models highly correlated with the ranked value model, which we term “value-like” neurons, including most neurons previously described as “trial-type” neurons. All 153 models and the fraction of neurons best fit by each one are depicted in Figure 3-figure supplement 1.
After implementing the changes to both the method of model fitting (full kernel regression, as noted above) and the possible alternative models, the distribution of value cells has changed slightly. All regions contain value cells, supporting our original conclusion that the value signal is distributed, but there is slight enrichment in PFC when combining these five regions together (Fig. 4A).
We have updated the conclusions of the paper accordingly:
Introduction: “Unexpectedly, in contrast to the graded cue and lick coding across these regions, the proportion of neurons encoding cue value was more consistent across regions, with a slight enrichment in PFC but with similar value decoding performance across all regions.”
Results: “Interestingly, the frequency of value cells was similar across the recorded regions (Fig. 4A). Indeed, despite the regional variability in number of cue cells broadly (Fig. 2F-G), there were very few regions that statistically differed in their proportions of value cells (Fig. 4A, Figure 4-figure supplement 1). Overall, though, there were slightly more value cells across all of PFC than in motor and olfactory cortex (Figs. 4A, Figure 4-figure supplement 1). Although there were the most cue neurons in olfactory cortex, these were less likely to encode value than cue neurons in other regions (Figure 4-figure supplement 2). Value-like cells were also widespread; they were less frequent in motor cortex as a fraction of all neurons, but they were equivalently distributed in all regions as a fraction of cue neurons (Fig. 4B, Figure 4-figure supplement 1, Figure 4-figure supplement 2).”
Discussion: “In contrast to regional differences in the proportion of cue-responsive neurons, cue value cells were present in all regions and could be used to decode value with similar accuracy regardless of region.” AND “The distribution of cue cells with linear coding of value was mostly even across regions, with slight enrichment overall in PFC compared to motor and olfactory cortex, but no subregional differences in PFC. Importantly, cue value could be decoded from the value cells in all regions with similar accuracy.”
3) On pages 11-12, the authors write "value coding is similarly represented across the regions we sampled." I feel this isn't quite what was shown: the authors have shown that all recorded regions contain a roughly comparable number of individual cells that are modulated by value, i.e. "value cells". However, the authors also showed that some recorded cells have mixed selectivity for value and other factors- it is possible that these mixed selectivity cells do vary between brain regions in their quantity or degree of value coding. Regions could potentially also vary in the dynamics of their value response, or in the trial-to-trial variability in the activity of value cells. I suggest the authors revise their original statement, for example by writing "we find a similar proportion of value-specific cells across the regions we sampled."
We thank the reviewer for carefully reviewing our claims. In addition to showing similar proportions of value cells, we also show that the value-related activity is similar (by plotting the first principal component of value and value-like cells, Fig. 4C-D) and that cue value could be decoded from the value cells in all regions with similar accuracy (new panel, Fig. 4E). We have updated the text to more accurately reflect these observations:
“In contrast to regional differences in the proportion of cue-responsive neurons, cue value cells were present in all regions and value could be decoded from them with similar accuracy regardless of region.”
4) We appreciate the authors' idea to introduce a history term to their value cell model but worry that the distinction between history-dependent value cells and lick/cue+lick cells in Figure 4 has gotten fuzzy. At this point, history-dependent value cells are the product of a set of steps: 1) they are identified as "cue" neurons because the cue type accounts for at least 2% of the variance, while the lick rate does not, then 2) among the cue neurons, a subset are identified as "value" neurons because their activity scales with the cue type across both odor sets, and then 3) among value neurons, the "history-dependent" value neurons show a response rate that scales with a model that predicts anticipatory licking. Our concern comes down to this: your conclusion that these cells are not licking cells hinges on the initial point that licking does not account for 2% of the observed variance in cell activity. But if you had dedicated an equal number of model parameters and selection steps to your licking model, might it still not turn out that a licking model predicts their activity as well as the history-dependent cue value model?
What would bolster our confidence here would be a comparison of variance explained: if you compare the predictions of the history-dependent value-encoding cue neuron model to the predictions of a simple lick neuron model, how much better does the former predict what the cells are doing? Are all those extra parameters and selection steps really contributing to an improved description of how neurons will respond?
First, we would like to emphasize that “cue” neurons, as a population, have no discernible modulation by licks, which can be seen when comparing their activity on CS50 trials with and without reward, when licking clearly varies (Figure 2-figure supplement 2D). A new panel, Figure 5E now depicts the improvement in variance explained by the history model over a lick only model. The improvement is robust and universal. This is because even though the number of anticipatory licks per trial is used to fit the weights of our trial value model, these cue neurons have temporal dynamics that are more consistent with cue presentation than the presence of licks. We explain more below in our response to point 7.
5) The paper's title claims that the coding of cue value is both stable and distributed. While the point for value coding being distributed is well supported with analysis, the claim that cue value coding is "stable" is weaker. The authors show in Figure 6 that cue identity best accounts for unique variance among cue cells across three days of imaging, but it does not follow that cue value is similarly stable. Figure 7 shows that on day 3 of imaging, the two odor sets have similar encoding- but this analysis is only performed within day 3, not across days. Why not examine unique variance among value cells over days, as was done for a cue, lick, and both cells in Figure 6G? That seems to be an important missing piece and a logical next step. The Discussion is more conservative in its claims- "these results demonstrate a lack of regional specialization in value coding and the stability of cue and lick [(not value)] codes in PFC." But this subtlety is missing from the paper's title and introduction.
First, an important correction. “This analysis is only performed within day 3, not across days,” is a misunderstanding of our experiment brought on by our confusing terminology, which we have updated. This figure (now Figure 8) analyzes two sessions performed on consecutive days: Odor Set A day 3 (A3) and Odor Set B day 3 (B3), which constitute days 5 and 6 of our experiment (see updated panels Fig. 1B, 6A). This is why identifying value signaling across both of these sessions is justification for a stable code; by definition, it was present on two consecutive days.
A limitation of our imaging experiment prevents us from evaluating value signaling in each individual session (like we did for cues and licks). For the imaging, we only presented one odor set per session (unlike the electrophysiology, where odor sets were presented in blocks). Our method of identifying value signals relies on two odor sets, so we cannot quantify it on a per session basis in the imaging. However, to address this as best we could, we identified CS+-preferring cue cells in session A3 (odor set A day 3) and plotted them for sessions A1-A3 (Fig. 8H), which reveals a conserved value-like signal across days. We also found that the correlation of the activity of these neurons across days was higher than expected by chance (Fig. 8I).
We have edited the discussion text about coding stability, adding in more detail and caveats:
“Previous reports have observed drifting representations in PFC across time (Hyman et al., 2012; Malagon-Vina et al., 2018), and there is compelling evidence that odor representations in piriform drift over weeks when odors are experienced infrequently (Schoonover et al., 2021). On the other hand, it has been shown that coding for odor association is stable in ORB and PL, and that coding for odor identity is stable in piriform (Wang et al., 2020a), with similar findings for auditory Pavlovian cue encoding in PL (Grant et al., 2021; Otis et al., 2017) and ORB (Namboodiri et al., 2019). We were able to expand upon these data in PL by identifying both cue and lick coding and showing separable, stable coding of cues and licks across days and across sets of odors trained on separate days. We were also able to detect value coding common to two stimulus sets presented on separate days, and conserved value features across the three training sessions. Notably, the model with responses only to CS+ cues best fit a larger fraction of imaged PL neurons than the ranked value model, a departure from the electrophysiology results. It would be interesting to know if this is due to a bias introduced by the imaging approach, the slightly reduced CS50 licking relative to CS+ licking in the imaging cohort, or the shorter imaging experimental timeline.
The consistency in cue and lick representations we observed indicates that PL serves as a reliable source of information about cue associations and licking during reward seeking tasks, perhaps contrasting with other representations in PFC (Hyman et al., 2012; Malagon-Vina et al., 2018). Interestingly, the presence of lick, but not cue coding at the very beginning of the first session of training suggests that lick cells in PL are not specific to the task but that cue cells are specific to the learned cue-reward associations. Future work could expand upon these findings by examining stimulus-independent value coding within session across many consecutive days.”
6) Considering licking as the readout of value has pros and cons. Anticipatory licking may be correlated with subjective value, but certainly nonlinearly. After all, licking has a ceiling and floor (bounded rate from 0->10 Hz). Are results consistent with the objective value of the cues (which are 0, .5, 1)? Which measure better explained the data?
Thanks to this important suggestion, we tried fitting another set of models with 0, 0.5, 1 as the cue values. We found the same pattern of results. Overall, the fits were slightly better with 0, 0.5, 1, with 50.6% of potential value neurons (found with either version of the model) better fit by 0, 0.5, 1, and with mean variance explained of 0.265 with 0, 0.5, 1 (compared to 0.264 with the anticipatory lick values). Without strong evidence to choose one model over the other, we decided to use 0, 0.5, 1 because it exactly reflects reward probability, and is more objective as the reviewer notes, whereas before we relied on a noisier estimate of subjective value. We have changed the text accordingly.
7) How can a neuron encode "Cue" in a value-dependent manner and not also encode licking, given they are correlated? If the kernel window includes anticipatory licking, and anticipatory licking is by definition related to value, then how could a licking kernel not at least explain some of that neuron's variance?
The trial estimates of value from the lick linear regression are derived from typical licking patterns across all sessions and do not incorporate the particular number of licks on a given trial or the latency of licking relative to cue onset. Although the trial value model is predicting the number of licks on each trial, it only uses cue identity and reward history to make its prediction, so it is not tightly correlated with the stochastic licks on a given trial. And, importantly, we input the trial value as a cue kernel spanning the entire cue period, whereas lick kernels, per our definition, are restricted to a window around when licking occurs, which generously encompasses neural signals relating to both lick initiation and feedback. Licking can explain some of value and (history) neurons’ variance, which you can see in our new panel Fig. 5E, but it does not contribute any unique variance to the model. That is, with or without licks, the model performs just as well, so the activity of the neuron does not track any of the unique features of licks over cues (like whether or not the mouse licked on trial, when the mouse started licking on a given trial). Without cues, however, the model does worse, which means that the neuron’s activity is modulated by cues separately from when the mouse is licking. Thus, we can conclude the neuron encodes cues, but we have no evidence the neuron encodes licks (beyond the extent to which licks are correlated with cues). In our example fit in 5E, you can see how, although licks track value, they cannot recapitulate the temporal dynamics of this cue neuron. We added more description of this distinction in the manuscript.
8) The ordering analysis with the 89 permutations is very nice for showing across the population the "value ordered" gains are the best explanation of the neural activity. However, it doesn't tell you that any one neuron significantly encodes value, or the strength of this effect if they do. For the former, they could compare to a null distribution of shuffled order of neural vs CS data, and consider neurons for which model is better than chance ( a .05 FDR on a null distribution would be appropriate). This is important for supporting their conclusion of the fraction of neurons encoding value for each region.
In fact, with so many alternative models, the probability of a neuron being best fit by the value model but not encoding value above chance is extremely low. To confirm this, we ran the reviewer’s suggested shuffle analysis, and found that 100% of value neurons performed above the 0.05 FDR. We have added this result to the methods:
“To verify the robustness of value coding in the neurons best fit by the ranked value model, we fit each of those neurons with 1000 iterations of the cue value model with shuffled cue order to create a null distribution. The fits of the original value model exceeded the 98th percentile of the null for all value neurons.”
9) Similarly the 65% cutoff for trial history relative to shuffled is unusually low and therefore not convincing these neurons significantly encode the value. Usually, 95% or 99% is selected to give you a more standard significance criterion (FDR).
We have changed the cutoff to 95%. We originally selected 65% because neurons in the 65% to 95% range had clear history effects, especially at the population level, but we appreciate the importance of rigorous selection. Note this shuffle is very strict, preserving CS+, CS50, CS- ranking but shuffling within-cue fluctuations in value due to trial history. With the stricter value and history shuffling, we now observe fewer history neurons, and they are most prevalent in PFC (Fig. 5I)
10) "Regions with non-overlapping CIs were considered to have significantly different fractions of neurons of that coding type." This isn't a statistical test. Confidence intervals are not the same as significance.
We now perform Bonferroni-corrected pairwise contrasts between all regions in the generalized linear mixed effects model. We added the p-values for all the comparisons that previously relied on non-overlapping confidence intervals in supplementary tables.
Minor comments:
The methods are hard to read. Most of the information seems to be there but in general, paragraphs need to be read over multiple times for meaning to emerge.
We have edited for clarity, and if there are particular sections that remain unclear, we would be happy to know which ones.
Why is there a block predictor in the encoding model?
Because not every odor is present in every block, we did not want our models to use the specific cue predictors to try to account for differences in baseline activity that naturally occur across the session. Thus, each of the six blocks has its own predictor that serves as a constant that can adjust for changing baseline firing rate. Importantly, the block predictor simply marks the passage of blocks and contains no information about the odors present. We added more information about this to the methods:
“For electrophysiology experiments, the model also included 6 constants that identified the block number, accounting for tonic changes in firing rate across blocks. Because not all cues were present in every block, this strategy prevented the cue kernels from being used to explain baseline changes across blocks.”
Did you use an elastic net rather than a lasso? What is the alpha parameter for lasso?
We used an elastic net with alpha = 0.5. We added this information to the methods.
Figure 3F legend doesn't seem to match the figure.
Corrected.
-
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
The following is the authors' response to the original reviews.
Consolidated response to public comments:
We are grateful to the reviewers for their careful examination of our manuscript and for their insights for improving our work. We appreciate that they recognize the potential of the TARDIS approach for diverse transgenesis applications.
We address two primary concerns that the reviewers raise. First is a concern that this approach is not as innovative as stated. We acknowledge that our work builds upon previous studies in the field, such as those by Nonet, Mouridi et al., with Malaiwong coming after our initial preprint. However, we believe that our approach offers a unique contribution, in that prior work does not provide a protocol or process to provide large-scale multiplexed transgenesis. Specifically, our introduction of large sequence library arrays (TARDIS Library Arrays or TLAs). While high throughput multiplexed transgenesis is discussed in Nonet & Mouridi manuscripts, it is never demonstrated. It is the combination of library construction, heritable transmission of the library itself, and then induced transgenesis of library components at a defined location within single individuals that makes this approach particularly useful.
Second, there were concerns that we have not demonstrated that this approach will work beyond C. elegans. We agree that our discussion of the potential application of TARDIS beyond C. elegans is speculative at this point. Our intention was to highlight the potential for future development and application in other systems. In some cases, large integrations into the genome are possible, such as in the case of H11 locus in mice, which could provide a means to inherit a sequence library. We are hopeful that our success in C. elegans will inspire work in other systems. The motivation for this will naturally depend on the usefulness of actual TARDIS implementations, which will be forthcoming in due course.
Reviewer #1 (Recommendations For The Authors):
1. Section titled "Integration from TARDIS array to F1" beginning on line 161 has some missing details that make it difficult to follow. Many of those details are present in the following section titled "Generation and Integration of TARDIS promoter library", but should have been present sooner.<br /> a. How many barcodes were in the array in line PX786?<br /> b. Clarify the use of G-418, heat shock, hygromycin, etc. in this paragraph.<br /> c. Please clarify that the L1 death is due to selection with G-418 - "We found that a portion of the initially plated worms die, likely due to lack of array inheritance." is confusing unless you add that they are selected in this step.<br /> d. "These results suggest that approx. 100-200 worms need to be heat shocked to obtain an integrated line" - the math actually looks like 200-300, and this would be to get a single integrant.<br /> 2. In general, the barcoding study and results reported here read like a teaser/proof-of-concept but do not really robustly demonstrate the application of the method for barcoding and tracing individual lineages in a population of C. elegans. How many barcodes were in the array, and how many ended up in F1s? Would one need to screen for duplicate barcodes after integration?<br /> 3. The promoter library study is impressive but again, rather limited.<br /> 4. The Discussion section about extending this technology to other systems is fairly balanced, acknowledging the limitations that would need to be overcome. The language in the abstract and introduction is less balanced and oversells the current translation of this approach to systems outside C. elegans.
Reviewer #2 (Recommendations For The Authors):
As I mentioned in the Public Review, I appreciate the design of the selection markers for integration. However, I do not see a major advance in the field. The use of barcoding of individuals to address a biological question would change that impression.
Regarding the integration of promoters, I think this is something that anyone could address in diverse forms using existing knowledge.
Suggestions:<br /> - Use one or two more landing pads for barcoding of animals and check numbers, efficacy, enrichments..etc. About 500 sequences overrepresented may be too much for future applications;<br /> - Increase the number of landing pads for inserting promoters. Genomics context matters and this could help to have a better summary of the real expression patterns driven by the promoter of interest;<br /> - Other references about landing pads would be Vicencio et al, Genetics 2019, and Nonet microPublication Biology 2021.
In addition to the general comments, the reviewers provided useful suggestions to the text that we have used to clarify the manuscript.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
The following is the authors' response to the original reviews.
Reviewer #1 (Public Review):
The authors investigated state-dependent changes in evoked brain activity, using electrical stimulation combined with multisite neural activity across wakefulness and anesthesia. The approach is novel, and the results are compelling. The study benefits from an in-depth sophisticated analysis of neural signals. The effects of behavioral state on brain responses to stimulation are generally convincing.
It is possible that the authors' use of "an average reference montage that removed signals common to all EEG electrodes" could also remove useful components of the signal, which are common across EEG electrodes, especially during deep anesthesia. For example, it is possible (in fact from my experience I would be surprised if it is not the case) that under isoflurane anesthesia, electrical stimulation induces a generalized slow wave or a burst of activity across the brain. Subtracting the average signal will simply remove that from all channels. This does not only result in signals under anesthesia being affected more by the referencing procedure than during waking but also will have different effects on different channels, e.g. depending on how strong the response is in a specific channel.
We thank the reviewer for the positive comments and for raising this point. We do not believe that the average reference montage is obscuring an evoked slow wave in the isoflurane-anesthetized mice. Electrical stimulation did elicit a brief activation in nearby neurons that was followed by roughly 200 ms of quiescence, but no significant changes in firing in the other regions we recorded from (Author response image 1).
Author response image 1
ERP and evoked population activity during isoflurane anesthesia do not show evidence of global responses.
(Top). ERP (-0.2 to +0.8 s around stimulus onset) with all EEG electrode traces superimposed. Data represented is the same: red traces have been processed with the average reference montage, black traces have not. (Bottom) Population mean firing rates from the areas of interest from the same experiment as above.
We are familiar with the work from Dasilva et al. (2021), a study similar to ours because they also performed cortical electrical stimulation in mice anesthetized with isoflurane. They show widespread evoked multi-unit activity (derived from LFP) in isoflurane-anesthetized mice in response to electrical stimulation, but critical experimental differences may underlie the conflicting results presented in our study. Both works use similar levels of isoflurane to maintain anesthesia (we use a level roughly equivalent to their “deep” level). However, our experiments use only isoflurane, whereas Dasilva et al. induced anesthesia with ketamine and medetomidine followed by isoflurane. It has been shown that isoflurane and ketamine have different effects on neural dynamics (Sorrenti et al., 2021). Typically, isoflurane causes reduced spontaneous firing rates and decreased evoked response amplitudes compared to wakefulness, whereas ketamine has been shown to increase firing rates and evoked response amplitudes (Aasebø et al., 2017; Michelson & Kozai, 2018). Perhaps a more relevant difference are the electrical stimulation parameters used to perturb the brain. Dasilva et al. used 1 ms pulses of 500 μA, which would have a much larger effect than the stimulation used in this work, 0.2 ms pulses of 10-100 μA.
Additionally, we would like to clarify that the average reference montage is not impacting the main findings of this work. As the reviewer correctly pointed out, the average reference montage does change the appearance of the ERP in the butterfly plots (Top panel in Author response image 1). However, all the quantitative analyses of the EEG-ERPs are performed on the global field power, computed by taking the standard deviation across all EEG channels, which is not affected by the average reference montage.
Reviewer #2 (Public Review):
[…] The conclusions regarding the thalamic contributions to the ERP components are strongly supported by the data.
The spatiotemporal complexity is almost a side point compared to what seems to be the most important point of the paper: showing the contribution of thalamic activity to some components of the cortical ERP. Scalp ERPs have long been regarded as purely cortical phenomena, just like most EEGs, and this study shows convincing evidence to the contrary.
The data presented seemingly contradicts the results presented by Histed et al. (2009), who assert that cortical microstimulation only affects passing fibers near the tip of the electrodes, and results in distant, sparse, and somewhat random neural activation. In this study, it is clear that the maximum effect happens near the electrodes, decays with distance, and is not sparse at all, suggesting that not only passing fibers are activated but that also neuronal elements might be activated by antidromic propagation from the axonal hillock. This appears to offer proof that microstimulation might be much more effective than it was thought after the publication of Histed 2009, as the uber-successful use of DBS to treat Parkinson's disease has also shown.
We thank the reviewer for their positive comments and thoughtful suggestions. We appreciate and agree with the reviewer’s perspective that the thalamic contribution to the cortical ERP is one of the key points of this study. We also thank the reviewer for their comment on the apparently contradictory results reported by Histed et al. (2009). This gives us the opportunity to further highlight the important contribution of our study to the field.
First, we would like to highlight some key experimental differences between the two studies. In our study we used single pulse stimulation with currents between 10 and 100 μA, whereas Histed et al. used trains of pulses (100 ms in duration at 250 Hz) with lower current intensities (between 2 and 50 μA). We varied the depth of stimulation, targeting superficial and deep cortical layers; Histed et al. exclusively stimulated superficial cortical layers. In addition, the two studies used recording methods that are orthogonal in nature. We used Neuropixels probes that record from neurons that span all cortical layers depth-wise while Histed et al. used two-photon calcium imaging to record from a horizontal plane of neurons (again, in the superficial cortical layers).
Because of these important methodological differences, it is more appropriate to compare the Histed et al. results to our results from superficial stimulation at comparable current intensities. In this case, we believe the two studies show similar results: stimulation activated a small fraction of neurons even hundreds of microns away from the stimulating electrode (see Figure 4A from our manuscript). However, our study adds an important observation pointing to the critical role of the depth of the stimulating electrode. We observe significant excitation of local cortical neurons (Figure 4D) and trans-synaptic activation of the thalamus only when we delivered deep stimulation (Figure5A). This effect is likely mediated by activation of large, myelinated cortico-thalamic fibers, which are thought to be more excitable that non-myelinated horizontal fibers (Tehovnik & Slocum, 2013).
To summarize, Histed et al. (2009) concluded that microstimulation causes a sparse activation of a distributed set of neurons with little evidence of synaptically driven activation. Instead, we showed that microstimulation can robustly activate local neurons and trans-synaptically activate distant neurons when stronger stimuli are directed to deep cortical layers. Based on this, we conclude that electrical stimulation is indeed highly effective, and is a valid tool that can be used to probe and characterize the cortico-thalamo-cortical network of any behavioral state.
----------
Reviewer #1 (Recommendations for the authors):
1. I am not clear how "putative pyramidal" or RS and "putative inhibitory" fast-spiking neurons were identified. Please provide some further details on that, including average spike wave shapes, and distribution of firing rates, and it would be interesting to know the proportion of "putative" RS and FS neurons in your recorded population. Obviously, caution is warranted here because, without further work, you cannot be sure that those are indeed pyramidal cells or interneurons! Is this subdivision necessary at all?
We added details regarding the cell-type classification to the Results (lines 136-140) and the Methods section. This classification is common practice in cortical extracellular electrophysiology recordings given that cell-type specific analyses can reveal important differences between the two putative populations (Barthó et al., 2004; Bortone et al., 2014; Bruno & Simons, 2002; Jia et al., 2016; Niell & Stryker, 2008; Sirota et al., 2008). Based on our findings that the two populations respond to electrical stimulation in similar ways (excitation followed by a period of quiescence and rebound excitation), we agree the subdivision is not necessary to support our conclusions. However, we believe that some readers will appreciate seeing the two putative populations presented separately.
2. I wonder how the authors know whether the animals were awake, specifically when they were not running. Did you observe animals falling asleep when head-fixed? Providing some analyses of spontaneous EEG/LFP signals in each state could add some reassurance that only wakefulness was included, as intended.
While we cannot conclusively rule out that mice were asleep during the “quiet wakefulness” periods we analyzed, we believe they are likely to be awake for two main reasons: 1) all the experiments are performed during the dark phase of the light/dark cycle, when the mice are less likely to enter a sleep state (Franken et al., 1999); 2) the animals are not undergoing specific training to promote drowsiness or sleep. Indeed, many sleep-focused studies in head-fixed mice are performed during the light phase of the animal’s cycle to maximize the likelihood of capturing sleep states (Kobayashi et al., 2023; Turner et al., 2020; Yüzgeç et al., 2018; Zhang et al., 2022). We have added this note to the Discussion section (lines 402-406).
Because we do not specifically record during sleep states and our recording does not include electromyography, which is commonly used in conjunction with EEG to classify sleep stages, we cannot accurately perform spectral comparison between “quiet wakefulness” and sleep states in our recordings.
3. I was unsure about the meaning of some of the terminology, specifically "rebound", "rebound spiking", "rebound excitation" etc. Why do you call it "rebound"?
“Rebound” is a term often used to describe a period of enhanced spiking following a period of prolonged silence or inhibition (Guido & Weyand, 1995; Roux et al., 2014). Grenier et al. list “postinhibitory rebound excitation” as an intrinsic property of cortical and thalamic neurons (1998). We added this description to the text (lines 79-80).
Reviewer #2 (Recommendations For The Authors):
Regarding analysis, I would make three main points:
Regarding the CSD analysis, I think the authors have done a good job of circumventing several of the known issues of this technique, especially by using ERPs rather than ongoing activity. However, although I do not immediately have access to the literature to back up this claim, I've heard that many assumptions behind CSD require a laminar structure with electrodes positioned perpendicular to these layers. In Figure 1B it seems like the neuropixels probe is not really perpendicular to the cortical layers, and I wonder if this might be an issue. I am also wondering how to interpret the thalamic CSD, as this structure is not laminar, lacks the mass of neatly stacked neuronal dipoles present in the cortex, and does not have an orderly array of synaptic inputs and outputs. I understand that CSD analysis helps minimize the contributions of volume conduction, but in this case, I also wonder if the thalamic CSD is even necessary to back up the paper's claims.
One-dimensional CSD is computed assuming that the electrode is inserted perpendicular to cortex. This is mainly important for the interpretation of sinks and sources, since CSD can be also computed on radial voltages (e.g., EEG [Tenke & Kayser, 2012]). In general, our Neuropixels probes do not significantly deviate from perpendicular (mean deviation from perpendicular 15.3 degrees, minimum 5.2 degrees, and maximum 36.6 degrees). The probe represented in Figure 1B deviates from perpendicular by 31.2 degrees, which is an outlier compared to the rest of the insertions. Any deviation from perpendicular would result in the “effective” cortical thickness being larger by a factor of 1/cos(angle deviation from perpendicular) and thus would not affect the relative location of sources and sinks. We have added a statement to clarify this in the text (lines 126 and 454-456).
We agree with the statement regarding CSD analysis in the thalamus. We originally included the CSD for the thalamus in Figure 2F for completeness. As the reviewer pointed out, thalamic CSD was not used to perform any subsequent analysis and is, therefore, not necessary to back up any claims. As such, we have removed CSD plot from Figure 2F to avoid any confusion and made a comment to this effect in the legend (lines 1175-1177).
On the merits of using the z-score normalization for spike rates vs. other strategies like standardizing to maximum firing, I am aware that both procedures have limitations, but the z-score changes the range of the firing rate from [0, +Inf] to [-Inf, +Inf]. This does not seem correct considering that negative spiking rates do not exist. The standardization to maximum rate keeps the range within [0, 1], not creating negative rates. Another point that it will be worth discussing is the reported values of the z-scored values. For example, what does it mean to be 54 standard deviations away from the mean? 6 standard deviations is already a big distance from the mean.
For Figure 2, we chose to represent the neural firing rates as z-scores because we found it important to report the magnitude of both the increase and decrease of the evoked firing rates in the post-stimulus period relative to the pre-stimulus rate. The normalization we used helps to visualize the magnitude of the effects of electrical stimulation in neuronal activity for both directions, which is an important result of the study. Despite the differences between the two normalization methods, the normalization based on the maximum firing does not significantly change the qualitative interpretation of Figure 2 in the manuscript (Author response image 2).
Author response image 2
Evoked firing rates for neurons in the areas of interest in response to deep stimulation in MO during the awake state. (Left) Firing rates of all neurons normalized by the average, pre-stimulus firing rate. (Right) Firing rates of all neurons normalized by the maximum post-stimulus firing rate.
Regarding Figure 3 and the associated text, we would like to clarify that the magnitude metric is not simply a z-score value (with units of s.d.) but rather it is the integrated area under the z-scored response over the response window (with units of s.d.∙seconds). This can help explain why we see values of ~50 s.d.∙s. We chose to z-score firing rates, LFP, and CSD to normalize across the different signals and magnitudes of the evoked responses. We often observed the largest responses in the LFP (see Figure 3A), which may be partly due to the signal naturally having a larger dynamic range than the measured neural firing rates. Then we integrated the z-score response time series to capture the dynamic of the signal over the response window, rather than a static value such as the mean or maximum z-score. After performing a thorough literature search, we found no other ways to capture and compare the magnitudes of the different signals. We have added language to clarify the magnitude metric (lines 155-156) and added the appropriate units.
In reporting the p-values, I recommend increasing the number of significant digits to four because the p-value seems to be the same for different tests in several places (e.g.: lines 207 to 218), which seems odd. I also wonder whether this could be an artifact of the z-scoring procedure. In the figures, I would like to advise the use of 1 asterisk to denote "weak evidence to reject the null hypothesis (0.05 > p > 0.01)" and two asterisks to denote "strong evidence to reject the null hypothesis (0.01 > p)", and make a note of it accordingly in the manuscript and/or figure legends.
According to the reviewer’s suggestion, we have changed the statistics language to “* weak evidence to reject null hypothesis (0.05 > p > 0.01), ** strong evidence to reject null hypothesis (0.01 > p > 0.001), *** very strong evidence to reject null hypothesis (0.001 > p)” throughout the manuscript.
We have also increased the number of significant digits to four throughout the manuscript. It is true that some of the p-values reported for Figure 3 (lines 169-180) are the same for different tests. This is not an artifact of the z-scoring, but rather a consequence of performing the Wilcoxon signed-rank test (an ordinal statistical test) with small sample numbers. Because the p-value depends only on the relative ordering, not the continuous distribution of values, the small sample size (N=6-14) increases the likelihood of obtaining the exact same p-value if the relative ordering of samples is the same.
Line 202: If the magnitude corresponds to z-score data, please add "s.d." after the number, as z-scored values are expressed in standard deviation units. Please update this throughout the paper.
As stated above the magnitude metric is the integrated area under the z-scored response over the response window (with units of s.d.∙seconds). We have added the correct units in all places.
Line 214: Please report how the multiple comparisons correction was performed
We have added the test used for multiple comparisons in line 169 (formerly line 214) and in the Methods section (line 770).
Line 462: please replace "Neuropixels activity" with "LFP and single-unit activity".
We changed the wording to specify “LFP, and single neuron responses…” (now line 337).
Line 475: a short explanation of the bi-stability phenomena will be helpful for the reader.
We added the following description: “a state characterized by spontaneous alternation between bouts of activity and periods of silence” (lines 350-351).
Line 601: It is asserted that "Electrical stimulation directly activates local cells and axons that run near the stimulation site via activation of the axon initial segment" and the paper by Histed et al. 2009 is cited. This does not seem like an appropriate citation, as Histed et al. explicitly state that electrical microstimulation does not activate local neuronal bodies near the electrode tip. See my comment above.
Upon further reading, we believe we are seeing evidence of direct axonal activation and subsequent antidromic activation of local cell bodies, as you suggested in your above comment and has been proposed by many including Histed et al. (2009) and Nowak and Bullier (1998). We edited our sentence accordingly, kept the Histed et al. citation, and added other relevant citations (lines 487-490).
References
-
Aasebø, I. E. J., Lepperød, M. E., Stavrinou, M., Nøkkevangen, S., Einevoll, G., Hafting, T., & Fyhn, M. (2017). Temporal Processing in the Visual Cortex of the Awake and Anesthetized Rat. ENeuro, 4(4), 59–76. https://doi.org/10.1523/ENEURO.0059-17.2017
-
Barthó, P., Hirase, H., Monconduit, L., Zugaro, M., Harris, K. D., & Buzsáki, G. (2004). Characterization of Neocortical Principal Cells and Interneurons by Network Interactions and Extracellular Features. Journal of Neurophysiology, 92(1), 600–608. https://doi.org/10.1152/jn.01170.2003
-
Bortone, D. S., Olsen, S. R., & Scanziani, M. (2014). Translaminar Inhibitory Cells Recruited by Layer 6 Corticothalamic Neurons Suppress Visual Cortex. Neuron, 82, 474–485. https://doi.org/10.1016/j.neuron.2014.02.021
-
Bruno, R. M., & Simons, D. J. (2002). Feedforward Mechanisms of Excitatory and Inhibitory Cortical Receptive Fields. The Journal of Neuroscience, 22(24), 10966–10975. https://doi.org/10.1523/JNEUROSCI.22-24-10966.2002
-
Dasilva, M., Camassa, A., Navarro-Guzman, A., Pazienti, A., Perez-Mendez, L., Zamora-López, G., Mattia, M., & Sanchez-Vives, M. V. (2021). Modulation of cortical slow oscillations and complexity across anesthesia levels. NeuroImage, 224, 117415. https://doi.org/10.1016/j.neuroimage.2020.117415
-
Franken, P., Malafosse, A., & Tafti, M. (1999). Genetics of sleep regulation in mice-Franken et al Genetic Determinants of Sleep Regulation in Inbred Mice. SLEEP, 22(2). https://academic.oup.com/sleep/article/22/2/155/2731698
-
Grenier, F., Timofeev, I., & Steriade, M. (1998). Leading role of thalamic over cortical neurons during postinhibitory rebound excitation. Proceedings of the National Academy of Sciences of the United States of America, 95(23), 13929–13934. https://doi.org/10.1073/pnas.95.23.13929
-
Guido, W., & Weyand, T. (1995). Burst responses in thalamic relay cells of the awake behaving cat. Journal of Neurophysiology, 74(4), 1782–1786. https://doi.org/10.1152/JN.1995.74.4.1782
-
Histed, M. H., Bonin, V., & Reid, R. C. (2009). Direct Activation of Sparse, Distributed Populations of Cortical Neurons by Electrical Microstimulation. Neuron, 63(4), 508–522. https://doi.org/10.1016/j.neuron.2009.07.016
-
Jia, X., Siegle, J., Bennett, C., Gale, S., Denman, D. R., Koch, C., & Olsen, S. (2016). High-density extracellular probes reveal dendritic backpropagation and facilitate neuron classification 1 2. Journal of Neurophysiology, 121(5), 1831–1847. https://doi.org/10.1101/376863
-
Kobayashi, G., Tanaka, K. F., & Takata, N. (2023). Pupil Dynamics-derived Sleep Stage Classification of a Head-fixed Mouse Using a Recurrent Neural Network. The Keio Journal of Medicine, 2022-0020-OA. https://doi.org/10.2302/KJM.2022-0020-OA
-
Michelson, N. J., & Kozai, T. D. Y. (2018). Isoflurane and ketamine differentially influence spontaneous and evoked laminar electrophysiology in mouse V1. Journal of Neurophysiology, 120(5), 2232. https://doi.org/10.1152/JN.00299.2018
-
Niell, C. M., & Stryker, M. P. (2008). Highly selective receptive fields in mouse visual cortex. Journal of Neuroscience, 28(30), 7520–7536. https://doi.org/10.1523/JNEUROSCI.0623-08.2008
-
Nowak, L. G., & Bullier, J. (1998). Axons, but not cell bodies, are activated by electrical stimulation in cortical gray matter. II. Evidence from selective inactivation of cell bodies and axon initial segments. Experimental Brain Research, 118(4), 489–500. https://doi.org/10.1007/S002210050305/METRICS
-
Roux, L., Stark, E., Sjulson, L., & Buzsáki, G. (2014). In vivo optogenetic identification and manipulation of GABAergic interneuron subtypes. Current Opinion in Neurobiology, 26, 88–95. https://doi.org/10.1016/j.conb.2013.12.013
-
Sirota, A., Montgomery, S., Fujisawa, S., Isomura, Y., Zugaro, M., & Buzsáki, G. (2008). Entrainment of Neocortical Neurons and Gamma Oscillations by the Hippocampal Theta Rhythm. Neuron, 60(4), 683–697. https://doi.org/10.1016/j.neuron.2008.09.014
-
Sorrenti, V., Cecchetto, C., Maschietto, M., Fortinguerra, S., Buriani, A., & Vassanelli, S. (2021). Understanding the Effects of Anesthesia on Cortical Electrophysiological Recordings: A Scoping Review. International Journal of Molecular Sciences, 22(3), 1286. https://doi.org/10.3390/IJMS22031286
-
Tehovnik, E. J., & Slocum, W. M. (2013). Two-photon imaging and the activation of cortical neurons. Neuroscience, 245(March), 12–25. https://doi.org/10.1016/j.neuroscience.2013.04.022
-
Tenke, C. E., & Kayser, J. (2012). Generator localization by current source density (CSD): Implications of volume conduction and field closure at intracranial and scalp resolutions. Clinical Neurophysiology, 123(12), 2328–2345. https://doi.org/10.1016/J.CLINPH.2012.06.005
-
Turner, K. L., Gheres, K. W., Proctor, E. A., & Drew, P. J. (2020). Neurovascular coupling and bilateral connectivity during nrem and rem sleep. ELife, 9, 1. https://doi.org/10.7554/ELIFE.62071
-
Yüzgeç, Ö., Prsa, M., Zimmermann, R., & Huber, D. (2018). Pupil Size Coupling to Cortical States Protects the Stability of Deep Sleep via Parasympathetic Modulation. Current Biology, 28(3), 392. https://doi.org/10.1016/J.CUB.2017.12.049
-
Zhang, X., Landsness, E. C., Chen, W., Miao, H., Tang, M., Brier, L. M., Culver, J. P., Lee, J. M., & Anastasio, M. A. (2022). Automated sleep state classification of wide-field calcium imaging data via multiplex visibility graphs and deep learning. Journal of Neuroscience Methods, 366, 109421. https://doi.org/10.1016/J.JNEUMETH.2021.109421
-
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
The manuscript, "A versatile high-throughput assay based on 3D ring-shaped cardiac tissues generated from human induced pluripotent stem cell-derived cardiomyocytes" developed a unique culture platform with PEG hydrogel that facilitates the in-situ measurement of contractile dynamics of the engineered cardiac rings. The authors optimized the tissue seeding conditions, demonstrated tissue morphology with expressions of cardiac and fibroblast markers, mathematically modeled the equation to derive contractile forces and other parameters based on imaging analysis, and ended by testing several compounds with known cardiac responses.
To strengthen the paper, the following comments should be considered:
1) This paper provided an intriguing platform that creates miniature cardiac rings with merely thousands of CMs per tissue in a 96-well plate format. The shape of the ring and the squeezing motion can recapitulate the contraction of the cardiac chamber to a certain degree. However, Thavandiran et al (PNAS 2013) created a larger version of the cardiac ring and found the electrical propagation revealed spontaneous infinite loop-like cycles of activation propagation traversing the ring. This model was used to mimic a reentrant wave during arrhythmia. Therefore, it presents great concerns if a large number of cardiac tissues experience arrhythmia by geometry-induced re-entry current and cannot be used as a healthy tissue model. It would be interesting to see the impulse propagation/calcium transient on these miniature cardiac rings and evaluate the % of arrhythmia occurrence.
The size is a key factor impacting the electrical propagation within the generated tissues. Our ring-shaped cardiac tissues have a diameter of 360µm, which is largely smaller than other tissues proposed so far, including in Thavandiran et al (PNAS 2013) where circular tissues had a reported size > 1mm. As shown in Figure 4E (and highlighted below in Author Response Figure 1), tissues under basal conditions display regular beating rates without spontaneous arrhythmias. Videos also show that the tissue contraction is homogeneous around the pillar, suggesting that the smaller size favors the electrical propagation and limits the occurrence of spontaneous reentrant waves. Optical mapping measurements will be performed in the future to assess the occurrence of reentrant waves.
Author Response Figure 1: Poincaré plot showing the plots between successive RR intervals (Data from Figure 4E in basal conditions). Linear regression with 95% confidence interval indicates identity.
2) The platform can produce 21 cardiac rings per well in 96-well plates. The throughput has been the highest among competing platforms. The resulting tissues have good sarcomere striation due to the strain from the pillars. Now the emerging questions are culture longevity and reproducibility among tissues. According to Figure 1E, there was uneven ring formation around the pillar, which leads to the tissue thinning and breaking off. There is only 50% survival after 20 days of culture in the optimized seeding group. Is there any way to improve it? The tissues had two compartments, cardiac and fibroblast-rich regions, where fibroblasts are responsible for maintaining the attachment to the glass slides. Do the cardiac rings detach from the glass slides and roll up? The SD of the force measurement is a quarter of the value, which is not ideal with such a high replicate number. As the platform utilizes imaging analysis to derive contractile dynamics, calibration should be done based on the angle and the distance of the camera lens to the individual tissues to reduce the error. On the other hand, how reproducible of the pillars? It is highly recommended to mechanically evaluate the consistency of the hydrogel-based pillars across different wells and within the wells to understand the variance. Figure 2B reports the early results obtained as the system was tested and developed. Since then, we have tested different iPSC lines and confirm that the overall yield is higher (up to 20 tissues at D14 for some cell lines), however dependent of cell lines.
The tissues do not detach from the glass slides. It is very rare to see tissues roll up on the central pillar. As shown in Figure 1B, the pillars have a specific shape to avoid tissues to roll up as they develop and contract.
3) Does the platform allow the observation of non-synchronized beating when testing with compounds? This can be extremely important as the intended applications of this platform are drug testing and cardiac disease modeling. The author should elaborate on the method in the manuscript and explain the obtained results in detail. The arrhythmogenic effect of a drug can be derived from the regularity of the beat-to-beat time. Indeed, we show that dofetilide increases the variability in the beat-to-beat time by plotting for each beat, the beat-to-beat time with the next beat as a function of the beat-to-beat time with the previous beat.
4) The results of drug testing are interesting. Isoproterenol is typically causing positive chronotropic and positive inotropic responses, where inotropic responses are difficult to obtain due to low tissue maturity. It is inconsistent with other reported results that cardiac rings do not exhibit increased beating frequency, but slightly increased forces only. Zhao et al were using electrical pacing at a defined rate during force measurement, whereas the ring constructs are not.
We agree. The difference in the response to isoproterenol with previous papers may be explained by different incubation timing with the drug. In our case, the tissues were incubated for 5 minutes at 37•C before being recorded.
Overall, the manuscript is well written and the designed platform presented the unique advantages of high throughput cardiac tissue culture. Besides the contractile dynamics and IHC images, the paper lacks other cardiac functional evaluations, such as calcium handling, impulse propagation, and/or electrophysiology. The culture reproducibility (high SD) and longevity (<20 days) still remain unsolved.
Since the submission, we have managed to keep some tissues and analyze them up to 32 days. At that time point the tissues are still beating. Nevertheless, a specific study concerning tissue longevity has not been carried out as the tissues were usually fixed after 14 days to be stained and analyze their structure.
Reviewer #2 (Public Review):
The authors should be commended for developing a high throughput platform for the formation and study of human cardiac tissues, and for discussing its potential, advantages and limitations. The study is addressing some of the key needs in the use of engineered cardiac tissues for pharmacological studies: ease of use, reproducible preparation of tissues, and high throughput.
There are also some areas where the manuscript should be improved. The design of the platform and the experimental design should be described in more detail.
It would be of interest to comprehensively document the progression of tissue formation. To this end, it would be helpful to show the changes in tissue structure through a series of images that would correspond to the progression of contractile properties shown in Figure 3.
Our results indicate that the fibroblasts/cardiomyocytes segregation likely happens as soon as the tissue is formed, as the fibroblasts are critical for tissue generation. The change with time in the shape of the contractile ring is reported in Figure 1E, with a series of images which correspond to the timepoints of Figure 3.
The very interesting tissue morphology (separation into the two regions) that was observed in this study is inviting more discussion.
Finally, the reader would benefit from more specific comparisons of the contractile function of cardiac tissues measured in this study with data reported for other cardiac tissue models.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
We believe that these findings make a significant contribution to the field of CNS endothelial cell biology and blood-brain barrier. We thank you for your time and consideration.
Reviewers' 1 and 2 concern on endothelial cells (ECs) transcription changes on culture.
We would like to express our gratitude to the reviewers for their critical comments. We are pleased to address the concerns raised by performing FACS sorting of the CNS ECs from E-13.5 and adult brain. However, it is important to note that both E-13.5 ECs and adult ECs were cultured in the same media. It is worth mentioning that this work was initiated in 2017, whereas the article mentioned by Reviewer 1 was published in 2020. We went through a series of standardization steps before identifying the Corning endothelial cell culture media (Cat#355054) with 2% FCS as the optimal medium for preserving EC identity in culture. Conversely, if PromoCell media (C-22110) is used, a decrease in the Wnt pathway can be observed, and the use of 5% FCS enhances the Wnt pathway in E-13.5 ECs. The article mentioned by Reviewer 1 (https://elifesciences.org/articles/51276) did not take these differences in culture media into account. Additionally, we did not employ puromycin for obtaining pure ECs, and the ECs were cultured for a maximum of 8 days. Our in vitro study serves as a model for identifying the epigenetic regulators HDAC2 and PRC2 as controllers of BBB gene transcription, which is subsequently validated in an in vivo model.
Reviewer-1 Comment 2- An additional concern is that for many experiments, siRNA knockdowns are performed without validation of the efficacy of the knockdown
In the revised version of this manuscript, we will include validation results to demonstrate the effectiveness of siRNA knockdown experiments.
Reviewer-1 Comment 3- Some experiments in the paper are promising, however. For example, the knockout of HDAC2 in endothelial cells resulting in BBB leakage was striking. Investigating the mechanisms underlying this phenotype in vivo could yield important insights.
We appreciate your positive comment. The in vivo HDAC2 knockout experiment will serve as a validation of our in vitro findings, indicating that the epigenetic regulator HDAC2 can control the expression of endothelial cell (EC) genes involved in angiogenesis, blood-brain barrier (BBB) formation, and maturation. We are actively working on this model, and we plan to publish additional molecular data on epigenetically regulated CNS vascular development and maintenance in our future publications.
Reviewer 2 Comment-2 The use of qPCR assays for quantifying ChIP and transcript levels is inferior to ChIPseq and RNAseq. Whole genome methods, such as ChIPseq, permit a level of quality assessment that is not possible with qPCR methods. The authors should use whole genome NextGen sequencing approaches, show the alignment of reads to the genome from replicate experiments, and quantitatively analyze the technical quality of the data.
We appreciate the reviewer's comment. While it is true that whole-genome methods such as ChIP-seq and RNA-seq provide comprehensive and high-throughput analysis compared to qPCR assays, it would be incorrect to consider qPCR as inferior. qPCR assays offer advantages in terms of sensitivity, specificity, validation, confirmation, and targeted analysis. We agree that performing a comprehensive analysis of HDAC2 and PRC2 targeted endothelial cell (EC) genes is important. We are currently in the process of generating this data, and as soon as it is complete, we will publish it accordingly.
Reviewer 2 Comment-3 Third, the observation that pharmacologic inhibitor experiments and conditional KO experiments targeting HDAC2 and the Polycomb complex perturb EC gene expression or BBB integrity, respectively, is not particularly surprising as these proteins have broad roles in epigenetic regulation in a wide variety of cell types.
We appreciate the comments from the reviewers. Our results provide valuable insights into the specific epigenetic mechanisms that regulate BBB genes It is important to recognize that different cell types possess stage-specific distinct epigenetic landscapes and regulatory mechanisms. Rather than having broad roles across diverse cell types, it is more likely that HDAC2 (eventhough there are several other class and subtypes of HDACs) and the Polycomb complex exhibit specific functions within the context of EC gene expression or BBB integrity.
Moreover, the significance of our findings is enhanced by the fact that epigenetic modifications are often reversible with the assistance of epigenetic regulators. This makes them promising targets for BBB modulation. Targeting epigenetic regulators can have a widespread impact, as these mechanisms regulate numerous genes that collectively have the potential to promote the vascular repair.
A practical advantage is that FDA-approved HDAC2 inhibitors, as well as PRC2 inhibitors (such as those mentioned in clinical trials NCT03211988 and NCT02601950, are already available. This facilitates the repurposing of drugs and expedites their potential for clinical translation.
Please note: illustrations of Fig-1, 4 and 6 are created using Biorender.com, license purchased by Spiros Blackburn. This will be added to the Acknowledgments.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
eLife assessment
This study presents a potentially valuable discovery which indicates that activation of the P2RX7 pathway can reduce the degree of lung fibrosis caused by other inflammatory pathways. If confirmed, the study could clarify the role of specific immune networks in the establishment and progression of lung fibrosis.
Thanks for this positive comment. Indeed, knowing that lung fibrosis is partly driven by inflammation, with a dysregulated Th1/Th2/Th17 ratio (PMID 20176803, PMID 19682929), we hypothesized that modulating the immune response would be able to attenuate lung fibrosis. To address this issue, we proposed to boost the activation of P2RX7, a purinergic receptor with immunomodulatory properties (PMID 8614837, PMID 11035104), in the well characterized bleomycin-induced lung fibrosis mouse model (PMID 25959210). In this study, we used a pyroglutamic derivative compound (HEI3090) able to specifically enhance P2RX7-dependent biological activities (cationic channel and macropore opening) only in the presence of extracellular ATP, which was qualified as the first representative of an immunotherapy relying on the activation of P2RX7 expressed by dendritic cells (PMID 33510147), and we showed that lung fibrosis is attenuated in mice treated with HEI3090 as compared to vehicle treated mice.
However, the presented data and analyses are incomplete as they rely on limited pharmacological treatments and because there is an absence of key control studies, validation experiments and statistical analyses.
Quantification of lung fibrosis:
Quantification of lung fibrosis was made on the basis of a modified Ashcroft score which assigns 8 grades to quantify lung fibrosis reliably and reproducibly (PMID 18476815). To be even more accurate and not biased by patchy lesions observed in all existing lung fibrosis induced mouse models, the whole lungs (left and right lobes) were divided in section of 880 µm2 and each section was scored individually. A total of 80 to 110 sections were analyzed per mouse. We agree that our text requires clarification. In parallel, the collagen amount given by the polarization intensity of the Sirius red staining of the lung slices was quantified with a homemade ImageJ/Fiji macro program. Further, we recently analyzed by FACS the percentage of PDGFRα (a specific marker of fibroblasts and myofibroblasts) positive cells in lungs isolated from vehicle and HEI3090-treated mice. All these 3 different markers of lung damage show that HEI3090 attenuates bleomycin-induced lung fibrosis and therefore validate the use of the Ashcroft score to accurately study the extend of lung fibrosis. We are going add quantification of collagen fibers in all figures.
Limited pharmacological treatments:
We have designed and characterized HEI3090 in a previous study and have shown that it is a positive modulator of P2RX7 (PMID 33510147).
To test its effect on lung fibrosis, we tested two pharmacological regimens using HEI3090 and have shown that both regimens are effective in limiting the progression of fibrosis. While having shown the requirement of P2RX7 for the activity of HEI3090 (PMID 33510147), we used in this study p2rx7 KO mice which were adoptively transferred with splenocytes isolated from p2rx7 KO mice to demonstrate the involvement of P2RX7 to mediate the antifibrotic effect of HEI3090. This experiment also serves as control to validate the adoptive transfer experiment.
We agree that proving and validating furthermore that activation of the P2RX7/IL-18 pathway can limit the progression of fibrosis requires the use of other activators of P2RX7. However, to date, HEI3090 is the only pharmacological compound described to activate the receptor. Indeed, the other chemical compounds described in the literature are negative allosteric modulator of P2RX7 (PMID 27935479),
Absence of key control studies and validation experiments:
The importance of P2RX7 in the antifibrotic effect of HEI3090 was demonstrated thanks to P2RX7 KO mice (supplementary figures S6B). We are going to implement this figure with additional mice.
The importance of immune cells was demonstrated thanks to adoptive transfer of WT splenocytes (expressing P2RX7) into P2RX7 KO mice. We agree that lung fibrosis is attenuated in vehicle-treated P2RX7 KO mice, but lung fibrosis is still present and could be modulated by treatments as demonstrated by adoptive transfer of splenocytes isolated from IL-1B KO mice who still respond to HEI3090 as shown in Supplementary figure S6C.
As suggested by reviewers we examined the effect of genetic background using two-way Anova test and the result is “the interaction is considered not significant”.
The prevalence of transferred immune cells on endogenous cells is demonstrated in supplementary figure S5, where intravenous injection of splenocytes isolated from P2RX7 KO mice into WT mice abolishes the antifibrotic effect of HEI3090. This experiment further validates the requirement of immune cells and the efficacy of the adoptive transfer approach.
Statistical analyses:
In this study we compared side by side the effect of HEI3090 versus vehicle in different genetic backgrounds in order to characterize the implication of actors of the P2RX7/IL-18 pathway in the antifibrotic effect of HEI3090. We also examined the effect of genetic background using the two-way Anova test. Following European recommendations, and in agreement with the ARRIVE guidelines for mice studies, we performed provisional statistic to evaluate the number of mice required in the study and stopped the experiments when significantly statistical results were observed. We agree that results are heterogeneous, however this heterogeneity does not prevent data analyses as shown in supplementary figure S6D, where adoptive transfer of splenocytes isolated from IL-1B KO mice into P2RX7 KO mice dampens BLM-induced lung fibrosis (with an Ashcroft score of 1.8 versus 3 in WT mice) but still responds to HEI3090, thus indicating that IL-1B is not required to mediate the antifibrotic effect of HEI3090.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
We thank all reviewers for constructive critiques. We plan to perform new experiments and revise our manuscript accordingly. The text and Figures are currently undergoing the revision process. Below highlights our revision plan.
eLife assessment
The findings of this article provide valuable information on the changes of cell clusters induced by chronic periodontitis. The observation of a new fibroblast subpopulation, which was named as AG fibroblasts, was quite interesting, but needs further evidence. The strength of evidence presented is incomplete.
RESPONSE: We discovered a new subpopulation of gingival fibroblasts, named AG fibroblasts, using non-biased single cell RNA sequencing (scRNA-seq) of mouse gingival samples undergoing the development of ligature-induced periodontitis. AG fibroblasts exhibited a unique gene expression profile: [1] constitutive expression of type XIV collagen; and [2] ligature-induced upregulation of chemokines such as CXCL12. As a biomedical data science experiment, we validated the scRNA-seq observation using immunohistochemical experiment, which showed the presence of type XIV collagen-positive and CXCL12-positive gingival fibroblasts localized immediately under the gingival epithelium and the coronal region of periodontal ligament.
We agree that the functional/pathological role of AG fibroblasts must be further explored. We have hypothesized that AG fibroblasts initially sense the pathological stress including oral microbial stimuli and secrete inflammatory signals through chemokine expression. To address this hypothesis, in this revision, we plan to analyze a separate scRNA-seq data for AG fibroblast gene expression profile derived from mouse gingival tissues that have been stimulated by Toll-Like Receptor 9 (TLR9) ligand (unmethylated CpG oligonucleotide) and TLR2/4 ligand (LPS). This approach mimics the initial pathological stress applied to gingival tissue. The new insight of AG fibroblasts will be presented in the revision.
Reviewer #1 (Public Review):
In this article, the authors found a distinct fibroblast subpopulation named AG fibroblasts, which are capable of regulating myeloid cells, T cells and ILCs, and proposed that AG fibroblasts function as a previously unrecognized surveillant to orchestrate chronic gingival inflammation in periodontitis. Generally speaking, this article is innovative and interesting, however, there are some problems that need to be addressed to improve the quality of the manuscript.
RESPONSE: We appreciate this comment. As suggested, we further investigated the surveillant function of AG fibroblasts by reanalyzing the scRNA-seq data for stress sensing receptors such as Toll-Like Receptors (TLR). Therefore, we analyzed AG fibroblast gene expression profile when the putative ligands to TLR2/4 and TLR9 are applied to mouse gingival tissue instead of ligature placement. We believe that this first step analysis should warrant to dissect further the function of AG fibroblasts in the future.
Results:
1) It is recommended to add HE staining and immunohistochemistry staining to observe the inflammation, tissue damage, and repair status from 0 to 7 days, so that readers can understand cell phenotype changes corresponding to the periodontitis stage. The observation index can include inflammation and vascular related indicators.
RESPONSE: As recommended, representative histological figures will be included. We will further perform new immunohistochemistry experiment of mouse gingival tissue (D0, D1, D4, D7). We plan to highlight the infiltration of CD45+ immune cells. We also plan to highlight the progressive degeneration of gingival collagen fiber by picrosirius red staining.
2) Figure 1A-1D can be placed in the supplementary figure.
RESPONSE: Combining the new data above, Figure 1 will be revised as suggested.
3) I suggest the authors to put the detection of the existence of AG fibroblasts before exploring its relationship with other types of cells.
4) The layout of the picture should be closely related to the topic of the article. It is recommended to readjust the layout of the picture. Figure 1 should be the detection of AG cells and their proportion changes from 0 to 7 days. In other figures, the authors can separately describe the proportion changes of myeloid cells, T cells and ILCs, and explored the association between AG fibroblasts and these cell types.
RESPONSE: As suggested, the presentation order of Figures and text will be revised to bring the information about AG fibroblasts first. The chemokine-receptor analysis is moved below.
Methods:
It is recommended to separately list the statistical methods section. The statistical method used in the article should be one-way ANOVA.
RESPONSE: A separate statistical method section is created. As pointed out, we used one-way ANOVA with post-hoc Tukey test (when multiple groups were compared).
Reviewer #2 (Public Review):
This study proposed the AG fibroblast-neutrophil-ILC3 axis as a mechanism contributing to pathological inflammation in periodontitis. However, the immune response in the vivo is very complex. It is difficult to determine which is the cause and which is the result. This study explores the relevant issue from one dimension, which is of great significance for a deeper understanding of the pathogenesis of periodontitis. It should be fully discussed.
RESPONSE: We agree with this comment. We expanded the current understanding of oral immune signal communication in Discussion and highlight how AG fibroblast may fit to it.
1) Many host cells participate in immune responses, such as gingival epithelial cells. AG fibroblast is not the only cell involved in the immune response, and the weight of its role needs to be clarified. So the expression in the conclusion should be appropriate.
RESPONSE: Following this critique, we revised INTRODUCTION, DISCUSSION and CONCLUSION, to highlight how AG fibroblasts function within a comprehensive immune response network.
2) This study cannot directly answer the issue of the relationship between periodontitis and systemic diseases.
RESPONSE: We agree with this critique. We either deleted or de-emphasized the relationship between periodontitis and systemic diseases throughout the text.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
We appreciate the thorough, fair and concise comments and agree with most, if not all, of the interpretations and critiques. We also value the recommendations and guidance for what constitute the most important additional experiments and analyses. Thank you for your hard work and time. Your investment helps improve the impact and clarity of our work and that is very much appreciated. We look forward to submitting a revised version soon.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
Reviewer #1 (Public Review):
Overall, I find the work performed by the authors very interesting. However, the authors have not always included literature that seems relevant to their study. For instance, I do not understand why two papers Dunican et al 2013 and Dunican et al 2015, which provide important insight into Lsh/HELLS function in mouse, frog and fish were not cited. It is also important that the authors are specific about what is known and in particular about what is not known about CDCA7 function in DNA methylation regulation. Unless I am mistaken, there is currently only one study (Velasco et al 2018) investigating the effect of CDCA7 disruption on DNA methylation levels (in ICF3 patient lymphoblastoid cell lines) on a genome-wide scale (Illumina 450K arrays). Unoki et al 2019 report that CDCA7 and HELLS gene knockout in human HEK293T cells moderately and extremely reduces DNA methylation levels at pericentromeric satellite-2 and centromeric alpha-satellite repeats, respectively. No other loci were investigated, and it is therefore not known whether a CDCA7-associated maintenance methylation phenotype extends beyond (peri)centromeric satellites. Thijssen et al performed siRNA-mediated knockdown experiments in mouse embryonic fibroblasts (differentiated cells) and showed that lower levels of Zbtb24, Cdca7 and Hells protein correlate with reduced minor satellite repeat methylation, thereby implicating these factors in mouse minor satellite repeat DNA methylation maintenance. Furthermore, studies that demonstrate a HELLS-CDCA7 interaction are currently limited to Xenopus egg extract (Jenness et al 2018) and the human HEK293 cell line (Unoki et al 2019). Whether such an interaction exists in any other organism and is of relevance to DNA methylation mechanisms remains to be determined. Therefore, in my opinion, the conclusion that "Our co-evolution analysis suggests that DNA methylation-related functionalities of CDCA7 and HELLS are inherited from LECA" should be softened, as the evidence for this scenario is not very compelling and seems premature in the absence of molecular data from more species.
We appreciate this reviewer’s thorough reading of our manuscript.
Regarding the citation issues, we will cite Dunican 2013 and Dunican 2015.
As pointed out by the reviewer, the role of CDCA7 in genome DNA methylation was extensively studied in Velasco et al 2018. The result, together with Thijssen et al (2015), and Unoki et al. (2018), supports the idea that ZBTB24, CDCA7 and HELLS act within the same pathway to promote DNA methylation, the pattern of which is overlapping but distinct from DNMT3B-mediated methylation. This observation suggests that a ZBTB24-CDCA7-HELLS mechanism for DNA methylation may involve an alternative DNMT. Interestingly, our analysis of the gene presence-absence pattern revealed that the presence of CDCA7 coincides with DNMT1 more than DNMT3 genes. Indeed, while CDCA7 is lost from diverse branches of eukaryote species, genomes encoding CDCA7 always encode HELLS, and almost always encode DNMT1. Based on this observation, we speculate the role of CDCA7 is tightly linked to HELLS and DNA methylation throughout evolution.
As pointed out by Reviewer 1, the link between CDCA7, HELLS and DNA methylation has not been determined experimentally across these species. However, based on our previously published and unpublished data, we are confident about the functional interaction between CDCA7 and HELLS in Xenopus laevis and Homo sapiens. Furthermore, the importance of HELLS homologs in DNA methylation has been extensively studied in human, mouse and plants. We hope our current study will motivate the field to experimentally test the evolutionary conservation of HELLS-CDCA7 interaction, as well as their importance in DNA methylation, in other species.
The authors used BLAST searches to characterize the evolutionary conservation of CDCA7 family proteins in vertebrates. From Figure 2A, it seems that they identify a LEDGF binding motif in CDCA7/JPO1. Is this correct and if yes, could you please elaborate and show this result? This is interesting and important to clarify because previous literature (Tesina et al 2015) reports a LEDGF binding motif only in CDCA7L/JPO2.
We searched for a LEDGF binding motif ({E/D}-X-E-X-F-X-G-F, also known as IBM described in Tesina et al 2015) in vertebrate CDCA7 proteins, and reported their position in Figure 2A. Examples of identified LEDGF-binding motifs will be presented.
To provide evidence for a potential evolutionary co-selection of CDCA7, HELLS and the DNA methyltransferases (DNMTs) the authors performed CoPAP analysis. Throughout the manuscript, it is unclear to me what the authors mean when referring to "DNMT3". In the Material and Methods section, the authors mention that human DNMT3A was used in BLAST searches to identify proteins with DNA methyltransferase domains. Does this mean that "DNMT3" should be DNMT3A? And if yes, should "DNMT3" be corrected to "DNMT3A"? Is there a reason that "DNMT3A" was chosen for the BLAST searches?
As described in the Methods section, both Human DNMT1 and DNMT3A were used to initially identify any proteins containing a domain homologous to the DNA methyltransferase catalytic domain. Within Metazoa, if their orthologs exist, the top hit from BLAST search using human DNMT1 and DNMT3A show E-value 0.0, and thus their orthology is robust. This is even true for DNMT1 and DNMT3 homologs in the sponge Amphimedon queenslandica, which is one of the earliest-branching metazoan species. For other DNMTs, such as DNMT2, DNMT4, DNMT6, we conducted separate BLAST searches using those proteins as baits as described in Methods. The domain was then isolated using the NCBI conserved domains search. The selected DNMT domain sequences were aligned with CLUSTALW to generate a phylogenetic tree to further classify DNMTs (Figure S6). It has been suggested that vertebrate DNMT3A and DNMT3B are derived from duplication of a DNMT3 gene of chordates ancestor (e.g., Liu et al 2020, PMID 31969623). As such many invertebrates encode only one DNMT3. As previously shown (Yaari et al., 2019, PMID 30962443), plants have two distinct DNMT3-like protein family, the ‘true DNMT3’ and DRM, the plant specific de novo DNMT that is often considered to be a DNMT3 homolog (see Reviewer 2’s comment). Our phylogenetic analysis successfully deviated the clade of DNMT3 and DRM from the rest of DNMTs (Figure S6). Yaari et al noted that PpDNMT3a and PpDNMT3b, the two DNMT3 orthologs encoded by the basal plant Physcomitrella patens, are not orthologs of mammalian DNMT3A and DNMT3B, respectively. Therefore, to minimize such nomenclature confusions, any DNMTs that belong to either the DNMT3 or DRM clades indicated in Figure S6 are collectively referred to as ‘DNMT3’ throughout the paper (see Figure S2 for overview).
CoPAP analysis revealed that CDCA7 and HELLS are dynamically lost in the Hymenoptera clade and either co-occurs with DNMT3 or DNMT1/UHRF1 loss, which seems important. Unfortunately, the authors do not provide sufficient information in their figures or supplementary data about what is already known regarding DNA methylation levels in the different Hymenoptera species to further consider a potential impact of this observation. What is "the DNA methylation status" of all these organisms? This information cannot be easily retrieved from Table S2. A clearer presentation of what is actually known already would improve this paragraph.
As the DNA methylation status of the species in the Hymenoptera clade has not been comprehensively tested, this precluded us from adding this information to Figure 7. However, we have included the published reports of DNA methylation status for these species in Supplementary Table S2 (see column ‘5mC’; species for which 5mC is detected are marked with Y and the relevant PMID). As indicated, DNA methylation was detected in most tested species except for Microplitis demolitor. Many of these data are based on Bewick et al. 2017 (PMID 28025279). During the preparation of this response, we realized that the DNA methylation status reported for some species in Bewick et al. was inferred from the CpG frequency instead of the direct experimental detection of methylated cytosines. Therefore, we have amended Table S2 to indicate the presence of DNA methylation only for those species where this was experimentally tested. As such, we now consider the DNA methylation status of Fopius arisanus, which lacks DNMT1 and CDCA7, to be unknown. In addition, we realized that Bewick et al. reported that DNA methylation is absent in Aphidius ervi. We originally conducted synteny analysis on Aphidius gifuensis, which lacks DNMT1 and CDCA7, since Aphidius ervi protein data were not available in NCBI. By conducting tBLASTn search against the Aphidius ervi genome, we confirmed that the presence and absence pattern of CDCA7, HELLS, DNMT1, DNMT3 and UHRF1 in Aphidius ervi is identical to that of Aphidius gifuensis. In other words, DNA methylation is known to be absent in Aphidius ervi, which has lost DNMT1 and CDCA7. Altogether, among the 17 Hymenoptera species that we analyzed (listed in the amended Table S2), the 6 species that have detectable DNA methylation all encode CDCA7, whereas the 2 species that do not have detectable DNA methylation lack CDCA7. We will note this finding in the revised text.
Furthermore, A. thaliana DDM1, and mouse and human Lsh/Hells are known to preferably promote DNA methylation at satellite repeats, transposable elements and repetitive regions of the genome. On the other hand, DNA methylation in insects and other invertebrates occurs in genic rather than intergenic regions and transposable elements (e.g. Bewick et al 2017; Werren JH PlosGenetics 2013). It would be helpful to elaborate on these differences.
This point was discussed in the third paragraph of the Discussion, but we will better highlight this. It should be noted that, in the Arabidopsis ddm1 mutant, reduction of CG methylation of gene bodies is common (50% of all methylated euchromatic genes) (Zemach et al, 2013). In addition, hypomethylation is not limited to satellite repeats and transposable elements in ICF patients defective in HELLS or CDCA7 (Velasco et al., 2018).
Reviewer #2 (Public Review):
In this manuscript, Funabiki and colleagues investigated the co-evolution of DNA methylation and nucleosome remolding in eukaryotes. This study is motivated by several observations: (1) despite being ancestrally derived, many eukaryotes lost DNA methylation and/or DNA methyltransferases; (2) over many genomic loci, the establishment and maintenance of DNA methylation relies on a conserved nucleosome remodeling complex composed of CDCA7 and HELLS; (3) it remains unknown if/how this functional link influenced the evolution of DNA methylation. The authors hypothesize that if CDCA7-HELLS function was required for DNA methylation in the last eukaryote common ancestor, this should be accompanied by signatures of co-evolution during eukaryote radiation.
[...]
The data and analyses reported are significant and solid. However, using more refined phylogenetic approaches could have strengthened the orthologous relationships presented. Overall, this work is a conceptual advance in our understanding of the evolutionary coupling between nucleosome remolding and DNA methylation. It also provides a useful resource to study the early origins of DNA methylation related molecular process. Finally, it brings forward the interesting hypothesis that since eukaryotes are faced with the challenge of performing DNA methylation in the context of nucleosome packed DNA, loosing factors such as CDCA7-HELLS likely led to recurrent innovations in chromatin-based genome regulation.
Strengths: - The hypothesis linking nucleosome remodeling and the evolution of DNA methylation. - Deep mapping of DNA methylation related process in eukaryotes. - Identification and evolutionary trajectories of novel homologs/orthologs of CDCA7. - Identification of CDCA7-HELLS-DNMT co-evolution across eukaryotes.
Weaknesses: - Orthology assignment based on protein similarity. - No statistical support for the topologies of gene/proteins trees (figure S1, S3, S4, S6) which could have strengthened the hypothesis of shared ancestry.
We appreciate the reviewers’ accurate summary, nicely emphasizing the importance of the our study. We agree that better phylogenetic analysis for orthology assignment will strengthen our conclusion, and we would like to explore this. Having anticipated this weakness, we specifically conducted a CoPAP analysis exclusively for Ecdysozoa species, where orthology assignment is straightforward, which supported our major conclusion. (For example, if we conduct BLAST search the clonal raider ant Oocerea biroi using human HELLS as a query, top 1 hit is a protein sequence annotated as one of three isoforms of ‘lymphoid-specific helicase” (i.e., HELLS), with E value 0.0. Similarly, top BLAST hit from Oocerea biroi using human DNMT1 as a query also returns with isoforms of DNMT1 with E value 0.0. As such, there are little disputes in orthology assignment in Ecdysozoa. Outside of Chordata, regardless of the alternative methods employed for orthology assignment, this will never be perfect (particularly in Excavata and SAR). Our current orthology assignment for the major targets in this study (HELLS, DNMT1, DNMT3, DNMT5) is largely consistent with published results (Ponger et al., 2005 PMID 15689527; Huff et al, 2014 PMID 24630728; Yaari et al., 2019 PMID 30962443; Bewick et al., 2019 PMID 30778188). However, while we are preparing this response and re-crosschecking our assignments with these references, we realized that we erroneously missed DNMT5 orthologs of Leucosporidium creatinivorum, Postia placenta, Armillaria gallica and Saitoella complicata., and DNMT6 ortholog from Fragilariopsis cylindrus. We also had recognized that DNMT4 orthologs were identified in Fragilariopsis cylindrus and Thalassiosira pseudonana In Huff et al 2014 (PMID 24630728), but in our phylogenetic analysis, these proteins form a distinct clade between DNMT1/Dim-2 and DNMT4 (Figure S6). Due to this ambiguity, we did not count them as DNMT1 or DNMT4 in our CoPAP analysis. These minor errors and ambiguity should not affect our presence-absence pattern in our original CoPAP analysis, and thus we feel that further refinement is unlikely to significantly affect our major conclusion.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
The following is the authors' response to the current reviews.
Reviewer #1 (Public Review):
This revised manuscript by Walker et. al. addresses some of the editorial points and conceptual discussion, but in general, most of my suggestions (as the previous reviewer #1) for additional experimentation or addition were not addressed as discussed below. Therefore, my overall review has not changed.
In our previous response, we included i) extra experimental data illustrating the reproducibility of our results and ii) added transcription start site data at the request of this reviewer. We included the information because we agreed with the reviewer that these were important points to address. For the points raised again below, we explained why the additional analysis was unlikely to add much in terms of insight or rigour. We have elaborated further below.
1) For example, in point 1, the suggested analysis was not performed because it is not trivial. My reason for making this suggestion is that the original manuscript was limited to Vibrio cholerae, and the impact of the manuscript would increase if the findings here were demonstrated to be more broadly applicable. I expect papers published in eLife to have such broad applicability. But no changes were made to the manuscript in this regard. The revised version is still limited to only Vibrio cholerae.
Our paper is focused on the unexpected co-operative interactions between HapR and CRP. Such co-binding of two transcription factors to the same DNA site is unexpected. Consequently, it is this mode of DNA binding that is likely to be of broad interest. With this in mind, we did provide experimental, and bioinformatic, analyses for other regulatory regions and other vibrio species (Figures S3 and S6). This, in our view, is where the “broad applicability” for papers published in eLife comes from.
The analysis the reviewer suggests is not related to the main message of our paper. Instead, the reviewer is asking how many HapR binding sites seen here by ChIP-seq are also seen in other vibrio species by ChIP-seq. This is only likely to be of interest to readers with an extremely specific interest in both vibrio species and HapR. The reviewer states above that we did not make the change “because it is not trivial”. This is an oversimplification of the rationale we presented in our response. The analysis is indeed not straightforward. However, much more importantly, the outcome is unlikely to be of interest to many readers, and has no bearing on the rigour of work. With this in mind, we do not think our position is unreasonable. We also stress that, should a reader with this very specific interest want to explore further, all of our data are freely available for them to do so.
2) For point 2, the activity of FLAG-tag luxO could have been simply validated in a complementation assay. Yes, they demonstrated DNA binding, but that is not the only activity of LuxO.
DNA binding by LuxO is the only activity of the protein with which we are concerned in our paper. Furthermore, LuxO is very much a side issue; we found binding to only the known targets and potentially, at very low levels, one additional target. No further LuxO experiments were done for this reason. Indeed, even if these data were removed completely, our conclusions would not change or be supported any less vigorously. We are happy to remove the LuxO data if the reviewer would prefer but this would seem like overkill.
3) For point 7, the transcriptional fusions were not explored at different times or different media, which is also something that was hinted at by other reviewers. In regard to exploring expression at different time points, this seems particularly relevant for QS regulated genes.
In their previous review, the reviewer did not request that such experiments were done. Similarly, no other reviewer requested these experiments. Instead, this reviewer i) commented that lacZ fusions were not as sensitive as luciferase fusions ii) asked if we had done any time point experiments. We agreed with the first point, whilst also noting that lacZ is not unusual to use as a reporter. For the second point, we responded that we had not done such experiments (which by the reviewer’s own logic would have been complicated using lacZ as a reporter). This seems like a perfectly reasonable way to respond.
We should stress that these comments all refer to Figure 2a, which was our initial screening of 23 promoter::lacZ fusions, supported by separate in vitro transcription assays. Only one of these fusions was followed up as the main story in the paper. Given that the other 22 fusions were not investigated further, and do not form part of the main story, there would seem little value in now going back to assay them at different time points.
4) For point 13, the authors express that doing an additional CHIP-Seq is outside of the scope of this manuscript. Perhaps that is the case, but the point of the comment is to validate the in vitro binding results with an in vivo binding assay. A targeted CHIP-Seq approach specifically analyzing the promoters where cooperative binding was observed in vitro could have addressed this point.
We did appreciate the original comment, and responded as such, but we do think additional ChIP-seq assays are outside the scope of this paper.
Reviewer #2 (Public Review):
This manuscript by Walker et al describes an elegant study that synergizes our knowledge of virulence gene regulation of Vibrio cholerae. The work brings a new element of regulation for CRP, notably that CRP and the high density regulator HapR co-occupy the same site on the DNA but modeling predicts they occupy different faces of the DNA. The DNA binding and structural modeling work is nicely conducted and data of co-occupation are convincing. The work seeks to integrate the findings into our current state of knowledge of HapR and CRP regulated genes at the transition from the environment and infection. The strength of the paper is the nice ChIP-seq analysis and the structural modeling and the integration of their work with other studies.
We thank the reviewer for the positive comments.
The weakness is that it is not clear how representative these data are of multiple hapR/CRP binding sites
This comment does not consider all data in our paper. We did test our model experimentally at multiple HapR and CRP binding sites. These data are shown in Figure S6 and confirm the co-operative interaction between HapR and CRP at 4 of a further 5 shared binding sites tested. We also used bioinformatics to show the same juxtaposition of CRP and HapR sites in other vibrio species (Figure S3). Hence, the model seems representative of most sites shared by HapR and CRP.
or how the work integrates as a whole with the entire transcriptome that would include genes discovered by others.
At the request of the reviewers, our revision integrated our ChIP-seq data with dRNA-seq data. No other suggestions to ingrate transcriptome data were made by the reviewers.
Overall this is a solid work that provides an understanding of integrated gene regulation in response to multiple environmental cues.
We thank the reviewer for the positive comment.
—————
The following is the authors' response to the original reviews.
Reviewer #1 (Public Review):
This manuscript by Walker et. al. explores the interplay between the global regulators HapR (the QS master high cell density (HDC) regulator) and CRP. Using ChIP-Seq, the authors find that at several sites, the HapR and CRP binding sites overlap. A detailed exploration of the murPQ promoter finds that CRP binding promotes HapR binding, which leads to repression of murPQ. The authors have a comprehensive set of experiments that paints a nice story providing a mechanistic explanation for converging global regulation.
We thank the reviewer for their positive evaluation.
I did feel there are some weak points though, in particular the lack of integration of previously identified transcription start sites
For completeness, we have now added the position and orientation or the nearest TSSs to each HapR or LuxO binding peak in Table 1 (based on Papenfort et al.).
the lack of replication (at least replication presented in the manuscript) for many figures,
We assume that the reviewer is referring to gel images rather than any other type of assay output (were error bars, derived from replicates, are shown). As is standard, we show representative gel images. All associated DNA binding and in vitro transcription experiments have been done multiple times. Indeed, comparison between figures reveals several instances of such replication (e.g. Figures 4b & 5d, Figures 4d & 5e). We have added details of repeats done to the methods section.
some oddities in the growth curve
We do not know why cells lacking hapR have a growth curve that appears biphasic. We can only assume that this is due to some regulatory effect of HapR, distinct from the murQP locus. Despite the unusual shape of the growth curve, the data are consistent with our conclusions.
and not reexamining their HapR/CRP cooperative binding model in vivo using ChIP-Seq.
We agree that these would be interesting experiments and, in the future, we may well do such work. Even without these data, our current model is well supported by the data presented (and the reviewer seems to agree with this above).
Reviewer #2 (Public Review):
This manuscript by Walker et al describes an elegant study that synergizes our knowledge of virulence gene regulation of Vibrio cholerae. The work brings a new element of regulation for CRP, notably that CRP and the high density regulator HapR co-occupy the same site on the DNA but modeling predicts they occupy different faces of the DNA. The DNA binding and structural modeling work is nicely conducted and data of co-occupation are convincing. The work could benefit from doing a better job in the manuscript preparation to integrate the findings into our current state of knowledge of HapR and CRP regulated genes and to elevate the impact of the work to address how bacteria are responding to the nutritional environment. Importantly, the focus of the work is heavily based on the impact of use of GlcNAc as a carbon source when bacteria bind to chitin in the environment, but absent the impact during infection when CRP and HapR have known roles. Further, the impact on biological events controlled by HapR integration with the utilization of carbon sources (including biofilm formation) is not explored.
We thank the reviewer for their overall positive evaluation.
The rigor and reproducibility of the work needs to be better conveyed.
Reviewer 1 made a similar comment (see above) and we have modified the manuscript accordingly.
Specific comments to address:
1) Abstract. A comment on the impact of this work should be included in the last sentence. Specifically, how the integration of CRP with QS for gene expression under specific environments impacts the lifestyle of Vc is needed. The discussion includes comments regarding the impact of CRP regulation as a sensor of carbon source and nutrition and these could be quickly summarized as part of the abstract.
We have added an extra sentence. However, we have used cautious language as we do not show impacts on lifestyle (beyond MurNAc utilisation) directly. These can only be inferred.
2) Line 74. This paper examines the overlap of HapR with CRP, but ignores entirely AphA. HapR is repressed by Qrrs (downstream of LuxO-P) while AphA is activated by Qrrs. With LuxO activating AphA, it has a significant sized "regulon" of genes turned on at low density. It seems reasonable that there is a possibility of overlap also between CRP and AphA. While doing an AphA CHIP-seq is likely outside the scope of this work, some bioinformatic or simply a visual analysis of the promoters known AphA regulated genes would be interest to comment on with speculation in the discussion and/or supplement.
In short, everything that the reviewer suggests here has already been done and was covered in our original submission (see text towards the end of the Discussion). Also, we would like to point the referee to our earlier publication (Haycocks et al. 2019. The quorum sensing transcription factor AphA directly regulates natural competence in Vibrio cholerae. PLoS Genet. 15:e1008362).
3) Line 100. Accordingly with the above statement, the focus here on HapR indicates that the focus is on gene expression via LuxO and HapR, at high density. Thus the sentence should read "we sought to map the binding of LuxO and HapR of V. cholerae genome at high density".
Note that expression of LuxO and HapR is ectopic in these experiments (i.e. uncoupled from culture density).
4) Line 109. The identification of minor LuxO binding site in the intergenic region between VC1142 and VC1143 raises whether there may be a previously unrecognized sRNA here. As another panel in figure S1, can you provide a map of the intergenic region showing the start codons and putative -10 to -35 sites. Is there room here for an sRNA? Is there one known from the many sRNA predictions / identifications previously done? Some additional analysis would be helpful.
We have added an extra panel to Figure S1 showing the position of TSSs relative to the location of LuxO binding. We have altered the main text to accommodate this addition..
5) Line 117. This sentence states that the CHIP seq analysis in this study includes previously identified HapR regulated genes, but does not reveal that many known HapR regulated genes are absent from Table 1 and thus were missed in this study. Of 24 HapR regulated investigated by Tsou et al, only 1 is found in Table 1 of this study. A few are commented in the discussion and Figure S7. It might be useful to add a Venn Diagram to Figure 1 (and list table in supplement) for results of Tsou et al, Waters et al, Lin et al, and Nielson et al and any others). A major question is whether the trend found here for genes identified by CHIP-seq in this study hold up across the entire HapR regulon. There should also be comments in the discussion on perhaps how different methods (including growth state and carbon sources of media) may have impacted the complexity of the regulon identified by the different authors and different methods.
We have added a list of known sites to the supplementary material (new Table S1). We were unsure what was meant by the comment “A major question is whether the trend found here for genes identified by CHIP-seq in this study hold up across the entire HapR regulon”. We have added the extra comment to the discussion re growth conditions, also noting that most previous studies relied on in vitro, rather than in vivo, DNA binding assays.
6) The transcription data are generally well performed. In all figures, add comments to the figure legends that the experiments are representative gels from n=# (the number of replicate experiments for the gel based assays). Statements to the rigor of the work are currently missing.
See responses above. We have added a comment on numbers of repeats to the methods section.
7) Line 357-360. The demonstration of lack of growth on MurNAc is a nice for the impact of the work. However, more detailed comments are needed for M9 plus glucose for the uninformed reader to be reminded that growth in glucose is also impaired due to lack of cAMP in glucose replete conditions and thus minimal CRP is active. But why is this now dependent of hapR? A reminder also that in LB oligopeptides from tryptone are the main carbon source and thus CRP would be active.
We find this point a little confusing and, maybe, two issues (murQP regulation, and growth in general) are being conflated. In particular, we do not understand the comment “growth in glucose is also impaired due to lack of cAMP in glucose replete conditions and thus minimal CRP is active”.
Growth in glucose should indeed result in lower cAMP levels*, and hence less active CRP, but this does not impair growth. This is simply the cell’s strategy for using its preferred carbon source. If the reviewer were instead referring to some aspect of P_murQP_ regulation then yes, we would expect promoter activity to be lower because less active CRP would be available in the presence of glucose. The reviewer also comments “why is this now dependent of hapR?”. We assume that they are referring to some aspect of growth in minimal media with glucose. If so, the only hapR effect is the change in growth rate as cells enter mid-late log-phase (i.e. the growth curve looks somewhat biphasic). A similar effect is seen in all conditions. We do not know why this happens and can only conclude this is due to some unknown regulatory activity of HapR. Overall, the key point from these experiments is that loss if luxO, which results in constitutive hapR expression, lengthens lag phase only for growth with MurNAc as the sole carbon source.
*Although in V. fischeri (PMID: 26062003) cAMP levels increase in the presence of glucose.
8) A great final experiment to demonstrate the model would have been to show co-localization of the promoter by CRP and HapR from bacteria grown in LB media but not in LB+glucose or in M9+glycerol and M9+MurNAc but not M9+glucose. This would enhance the model by linking more directly to the carbon sources (currently only indirect via growth curves)
This is unlikely to be as straightforward as suggested. The sensitivity of CRP binding to growth conditions is not uniform across different binding sites. For instance, the CRP dependence of the E. coli melAB promoter is only evident in minimal media (PMID: 11742992) whilst the role of CRP at the acs promoter is evident in tryptone broth (PMID: 14651625). Similarly, as noted above, in Vibrio fischeri glucose causes and increase in cAMP levels. (PMID: 26062003).
9) Discussion. Comments and model focus heavily on GlcNAc-6P but HapR has a regulator role also during late infection (high density). How does CRP co-operativity impact during the in vivo conditions?
We really can’t answer this question with any certainty; we have not done any infection experiments in this work.
Does the Biphasic role of CRP play a role here (PMID: 20862321)?
Again, we cannot answer this question with any confidence as experimentation would be required. However, the suggestion is certainly plausible.
Reviewer #3 (Public Review):
Bacteria sense and respond to multiple signals and cues to regulate gene expression. To define the complex network of signaling that ultimately controls transcription of many genes in cells requires an understanding of how multiple signaling systems can converge to effect gene expression and ensuing bacterial behaviors. The global transcription factor CRP has been studied for decades as a regulator of genes in response to glucose availability. It's direct and indirect effects on gene expression have been documented in E. coli and other bacteria including pathogens including Vibrio cholerae. Likewise, the master regulator of quorum sensing (QS), HapR), is a well-studied transcription factor that directly controls many genes in Vibrio cholerae and other Vibrios in response to autoinducer molecules that accumulate at high cell density. By contrast, low cell density gene expression is governed by another regulator AphA. It has not yet been described how HapR and CRP may together work to directly control transcription and what genes are under such direct dual control.
We thank the reviewer for their assessment of our work.
Using both in vivo methods with gene fusions to lacZ and in vitro transcription assays, the authors proceed to identify the smaller subset of genes whose transcription is directly repressed (7) and activated (2) by HapR. Prior work from this group identified the direct CRP binding sites in the V. cholerae genome as well as promoters with overlapping binding sites for AphA and CRP, thus it appears a logical extension of these prior studies is to explore here promoters for potential integration of HapR and CRP. Inclusion of this rationale was not included in the introduction of CRP protein to the in vitro experiments.
We understand the reviewer’s comment. However, the rationale for adding CRP was not that we had previously seen interplay between AphA and CRP (although this is a relevant discussion point, which we did make). Rather, we had noticed that there was an almost perfect CRP site perfectly positioned to activate PmurQP. Hence, CRP was added.
Seven genes are found to be repressed by HapR in vivo, the promoter regions of only six are repressed in vitro with purified HapR protein alone. The authors propose and then present evidence that the seventh promoter, which controls murPQ, requires CRP to be repressed by HapR both using in vivo and vitro methods. This is a critical insight that drives the rest of the manuscripts focus. The DNase protection assay conducted supports the emerging model that both CRP and HapR bind at the same region of the murPQ promoter, but interpret is difficult due to the poor quality of the blot.
There are areas of apparent protection at positions +1 to +15 that are not discussed, and the areas highlighted are difficult to observe with the blot provided.
We disagree on this point. The region between +1 and +15 is inherently resistant to attack by DNAseI and there are only ever very weak bands in this region (lane 1). Other than seeing small fluctuations in overall lane intensity (e.g. lanes 7-12 have a slightly lower signal throughout) the +1 to +15 banding pattern does not change. Conversely, there are dramatic changes in the banding pattern between around -30 and -60 (again, compare lane 1 to all other lanes). That CRP and HapR bind the same region is extremely clear. Also note that this is backed up by mutagenesis of the shared binding site (Figure 4c).
The model proposed at the end of the manuscript proposes physiological changes in cells that occur at transitions from the low to high cell density. Experiments in the paper that could strengthen this argument are incomplete. For example, in Fig. 4e it is unclear at what cell density the experiment is conducted.
Such details have been added to the figure legends and methods section.
The results with the wild type strain are intermediate relative to the other strains tested.
This is correct, and exactly what we would expect to see based on our model.
Cell density should affect the result here since HapR is produced at high density but not low density. This experiment would provide important additional insights supporting their model, by measuring activity at both cell densities and also in a luxO mutant locked at the high cell density. Conducting this experiment in conditions lacking and containing glucose would also reveal whether high glucose conditions mimicking the crp results.
We agree with this idea in principle but note that the output from our reporter gene, β- galactosidase, is stable within cells and tends to accumulate. This is likely to obscure the reduction in expression as cells transition from low to high cell density. Since we have demonstrated the regulatory effects of HapR and CRP both in vivo using gene knockouts, and in vitro with purified proteins, we think that our overall model is very well supported. Further experimental additions may provide an incremental advance but will not alter our overall story. Also note the unexpected increase in intracellular cAMP due to addition of glucose, in Vibrio fischeri (PMID: 26062003).
Throughout the paper it was challenging to account for the number of genes selected, the rationale for their selection, and how they were prioritized. For example, the authors acknowledged toward the end of the Results section that in their prior work, CRP and HapR binding sites were identified (line 321-22).
This is not quite what we say, and maybe the reviewer misunderstood, which is our fault. The prior work identified CRP sites whilst the current work identified HapR sites. We have made a slight alteration to the text to avoid confusion.
It is unclear whether the loci indicated in Table 1 all from this prior study. It would be useful to denote in this table the seven genes characterized in Figure 2 and to provide the locus tag for murPQ.
Again, we are unsure if we have confused the reviewer. The results in Table 1 are all HapR sites from the current work, not a prior study. However, some of these also correspond to CRP binding regions found in prior work.
The reviewer mentions “the seven genes characterised in Figure 2” but 23 targets were characterised in Figure 2a and 9 in Figure 2b. The “VC” numbers used in Figure 2 are the same as used in Table 1 so it is easy to cross reference between the two. We have added a footnote to Table 1, also referred to in the Figure 2 legend, to allow cross referencing between gene names and locus tags (including for murQP and hapR).
Of the 32 loci shown in Table 1, five were selected for further study using EMSA (line 322), but no rationale is given for studying these five and not others in the table.
This is not quite correct, we did not select 5 from the 32 targets listed in Table 1. We selected 5 targets from Table 1 that were also targets for CRP in our prior paper. This was the rationale.
Since prior work identified a consensus CRP binding motif, the authors identify the DNA sequence to which HapR binds overlaps with a sequence also predicted to bind CRP. Genome analysis identified a total of seven sites where the CRP and HapR binding sites were offset by one nucleotide as see with murPQ. Lines 327-8 describe EMSA results with several of these DNA sequences but provides no data to support this statement. Are these loci in Table 1?
This comment is a little difficult to follow, and we may have misunderstood, but we think that the reviewer is asking where the EMSA data referred to on lines 327-328 resides. We can see that the text could be confusing in this regard. We had referred to the relevant figure (Figure S6) on line 324 but did not again include this information further down in the description of the result. We have changed the text accordingly.
Using structural models, the authors predict that HapR repression requires protein-protein interactions with CRP. Electromobility shift assays (EMSA) with purified promoter DNA, CRP and HapR (Fig 5d) and in vitro transcription using purified RNAP with these factors (Figure 5e) support this hypothesis. However, the model proports that HapR "bound tightly" and that it also had a "lower affinity" when CRP protein was used that had mutations in a putative interaction interface. These claims can be bolstered if the authors calculate the dissociation constant (Kd) value of each protein to the DNA. This provides a quantitative assessment of the binding properties of the proteins.
The reviewer is correct that we do not explicitly provide a Kd. However, in both Figures 5d and 5e, we do provide very similar quantification. In 5d, our quantification is the % of the CRP-DNA complex bound by HapR (using either wild type or E55A CRP). Since the % of DNA bound is shown, and the protein concentrations are provided in the figure legend, information regarding Kd is essentially already present. In 5e, we show the % of maximal promoter activity. This is a reasonable way of quantifying the result. Furthermore, Kd is not a metric we can measure directly in this experiment that is not a DNA binding assay.
The concentrations of each protein are not indicated in panels of the in vitro analysis, but only the geometric shapes denoting increasing protein levels.
The protein concentrations are all provided in the figure legend. It is usual to indicate relative concentrations in the body of the figure using geometric shapes.
Panel 5e appears to indicate that an intermediate level of CRP was used in the presence of HapR, which presumably coincides with levels used in lane 4, but rationale is not provided.
There was no particular rationale for this, it was simply a reasonable way to do the experiment.
How well the levels of protein used in vitro compare to levels observed in vivo is not mentioned.
The protein concentrations that we use (in the nM to low μM range) are very typical for this type of work and consistent with hundreds of prior studies of protein-DNA interactions. The general rule of thumb is that 1000 molecules of a protein per bacterial cell equates to a concentration of around 1 μM. However, molecular crowding is likely to increase the effective concentration. Additionally, in vitro, where the DNA concentration is higher.
The authors are commended for seeking to connect the in vitro and vivo results obtained under lab conditions with conditions experienced by V. cholerae in niches it may occupy, such as aquatic systems. The authors briefly review the role of MurPQ in recycling of the cell wall of V. cholerae by degrading MurNAc into GlcNAc, although no references are provided (lines 146-50). Based on this physiology and results reported, the authors propose that murPQ gene expression by these two signal transduction pathways has relevance in the environment, where Vibrios, including V. cholerae, forms biofilms on exoskeleton composed of GlcNAc.
We have added a citation to the section mentioned.
The conclusions of that work are supported by the Results presented but additional details in the text regarding the characteristics of the proteins used (Kd, concentrations) would strengthen the conclusions drawn. This work provides a roadmap for the methods and analysis required to develop the regulatory networks that converge to control gene expression in microbes. The study has the potential to inform beyond the sub-filed of Vibrios, QS and CRP regulation.
As noted above, quantification essentially equivalent to Kd is already shown (% of bound substrate is indicated in figures and all protein concentrations are given in the figure legends).
Reviewer #1 (Recommendations For The Authors):
1. As similar experiments have been performed in other Vibrios, it would be interesting to do a more detailed analysis of the similarities and differences between the species. Perhaps a Venn diagram showing how many targets were found in all studies versus how many are species specific.
We appreciate this suggestion but would prefer not to make this change. A cross-species analysis would be very time consuming and is not trivial. The presence and absence of each target gene, for all combinations of organisms, would first need to be determined. Then, the presence and absence of binding signals for HapR, or its equivalent, would need to be determined taking this into account. For most readers, we feel that this analysis is unlikely to add much to the overall story. Given the amount of effort involved, this seems a “non-essential” change to make.
2. Line 101-Are the FLAG tagged versions of LuxO and HapR completely functional? Can they complement a luxO or hapR deletion mutant?
The activity of FLAG tagged HapR (LuxR in other Vibrio species) has been shown previously (e.g. PMIDs 33693882 and 23839217). Similarly, N-terminal HapR tags are routinely used for affinity purification of the protein without ill effect. We have not tested LuxO-3xFLAG for “full” activity, though this fusion is clearly active for DNA binding, the only activity that we have measured here, since all know targets are pulled down.
3. Line 106-As the authors state later that there are additional smaller peaks for HapR that could be other direct targets, I think a brief mention of the methodology used to determine the cutoff for the 5 and 32 peaks for LuxO and HapR, respectively, would be informative here.
We have added a little more text to the methods section. The added text states “Note that our cut- off was selected to identify only completely unambiguous binding peaks. Hence, weak or less reproducible binding signals, even if representing known targets, were excluded (see Discussion for further details)”.
4. Line 118-Need a reference here to the prior HapR binding site.
This has been added.
5. Figs. 1e-What do the numbers on the x-axis refer to? Why not just present these data as bases? The authors also refer to distance to the nearest start codon, but this is irrelevant for 4/5 of the luxO targets as they are sRNAs. They should really refer to the distance to the transcription start site. Likewise, for HapR, distance to the nearest start codon is not as informative as distance to the nearest transcription start site. A recent paper used transcriptomics to map all the transcription start sites of V. cholerae, and these results should be integrated into the author's study rather than just using the nearest start codon (PMID: 25646441).
The numbers are kilo base pairs, this has been added to the axis label. We have also changed “start codon” to “gene start” (since “gene start” is also suitable for genes that encode untranslated RNAs).
Re comparing binding peak positions to transcription start sites (TSSs) rather than gene starts, this analysis would be useful if TSSs could be detected for all genes. However, some genes are not expressed under the conditions tested by PMID: 25646441, so no TSS is found. Consequently, for HapR or LuxO bound at such locations, we would not be able to calculate a meaningful position relative to the TSS. We stress that the point of the analysis is to determine how peaks are positioned with respect to genes (i.e. that sites cluster near gene 5’ ends). Also note that nearest TSSs are now shown in the revised Table 1. In some cases, these are unlikely to be the TSS actually subject to regulation (e.g. because the regulated gene is switched off).
6. Fig. 1e-Is there directionality to the site? In other words, if a HapR binding site is located between two genes that are transcribed in opposite directions, is there a way to predict which gene is regulated? It looks like this might be the case with the list presented in Table 1, but how such determination is made and what the various symbol in Table 1 mean are not clear to me. This also has ramifications for Fig. 2a as the direction to construct the fusion is critical for the experiment.
The site is a palindrome so lacks directionality. The best prediction re regulation is likely to be positioning with respect to the nearest TSS (which is now included in Table 1). However, this would remain just a prediction and, where TSSs are in odd locations with respect to binding sites (taking into account the caveats above) predictions would be unreliable.
We are unsure which symbol the reviewer refers to in Table 1, a full explanation of any symbols used is provided in the table footnotes.
With respect to Figure 2a, if sites were between divergent genes, and met our other criteria, we tested for regulation in both directions. For example, see the divergent genes VCA0662 (classified inactive) and VCA0663 (classified repressed).
7. Fig. 2a-It is a little disappointing that the authors use LacZ fusions to measure transcription as this is not the most sensitive reporter gene. Luciferase gene fusions would have been much more sensitive. Also, did the authors examine multiple time points. The methods only describe "mid-log phase" but some of the inactive promoters could be expressed at other time points. Also, it would be simple to repeat this experiment in different media, such as minimal with glucose or another non- CRP carbon source, to expand which promoters are expressed.
The reviewer is correct regarding the sensitivity of β-galactosidase, which is very stable and so accumulates as cells grow. Even so, this reporter has been used very successfully, across thousands of studies, for decades. We did not examine multiple timepoints. We appreciate that the 23 promoter::lacZ fusions could be re-examined using varying growth conditions but this is unlikely to impact the overall conclusions, though it could generate some new leads for future work.
8. Fig. 2a legend-typos
This has been corrected.
9. Line 138-I think you mean Fig. 2a here.
This has been corrected.
10. Fig. 2b and many additional figures quantify band intensity but do not show any replication or error. Therefore, it is impossible to gauge reproducibility of these experiments.
We have added a reproducibility statement (all experiments were done multiple times with similar results) as is standard throughout the literature. Also note that there is a lot of internal replication between figures. Figure 4d and Figure 5e lanes 1-9 show essentially the same experiment (albeit with slightly different protein concentrations) and very similar results. To the same effect, Figure 5e lanes 10-18 and lanes 19-27 show the same experiment for two different mutations of the same CRP residue. Again, the results are very similar. Also see the response to your comment 15 below.
11. Fig. 4a-lanes 2-4-the footprint does not change with additional CRP. In other words, it looks the same at the lowest concentration of CRP versus the highest concentration of CRP. The footprints for HapR look similar. This is somewhat troubling as in these types of experiments one would like to observe a dose dependent change in the footprint correlating with more DNA occupancy.
For CRP we agree but are not concerned at all by this. The site is simply full occupied at the lowest protein concentration tested. Given that the footprint exactly coincides with a near consensus CRP site (which, when mutated, abolishes CRP binding in EMSAs, and regulation by CRP in vivo) all our results are perfectly consistent. Note that i) our only aim in this experiment was to determine the positions of CRP and HapR binding ii) our conclusions are independently backed up using gel shifts and by making promoter mutations. With respect to HapR, there are changes at the periphery of the main footprint.
12. Fig. 4e-Why does the transcriptional activation of murQP decrease with increasing concentrations of CRP? This is also seen in Fig. 5e.
In our experience, this often does happen when doing in vitro transcription assays (with CRP and many other activators). The anecdotal explanation is that, at higher concentrations, the regulator can start to bind the DNA non-specifically and so interfere with transcription.
13. The authors demonstrate in vitro that HapR requires binding of CRP to bind the murQP promoter. It would strengthen their model if they demonstrated this in vivo. To do this, the authors only need to repeat their ChIP-Seq experiment in a delta CRP mutant and the HapR signal at murQP would be lost. In fact, such an experiment would experimentally confirm which of the in vivo HapR binding sites are CRP dependent.
We agree, appreciate the comment, and do plan to do such experiments in the future as a wider assessment of interactions between transcription factors. However, doing this does have substantial time and resource implications that we cannot devote to the project at present. We feel that our overall conclusions, regarding co-operative interactions between HapR and CRP at PmurQP, are well supported by the data already provided. This also seems the overall opinion of the reviewers.
14. Fig. 5b-I am confused by the Venn diagram. The text states that "In all cases, the CRP and HapR targets were offset by 1 bp", but the diagram only shows 7 overlapping sites. The authors need to better describe these data.
We mean that, in all cases where sites overlap, sites are offset by 1 bp (i.e. we didn’t find any sites
overlapping but offset by 2, 3 4 bp etc).
15. Line 287-288 and Fig. 5d-The authors state that HapR binds with less affinity to the CRP E55A mutant protein bound to DNA. There does seem to be a difference in the amount of shifted bands at the equivalent concentrations of HapR, but the difference is subtle. In order to make such a conclusion, the authors should show replication of the data and calculate the variability in the results. The authors should also use these data to determine the actual binding affinities of HapR to WT and the E55A mutant CRP, along with error or confidence intervals.
All of these experiments have been run multiple times and we are absolutely confident of the result. With respect to Figure 5d, this was done many times. We note that not all experiments were exact repeats. E.g. some of the first attempts had fewer HapR concentrations. Even so, the defect in HapR binding to the CRP E55A complex was always evident. The two gels to the left show the final two iterations of this experiment (these are exact repeats). The top image is that shown in Figure 5d. The lower image is an equivalent experiment run a day or so previously. Both clearly show a defect in HapR binding to the CRP E55A complex. We appreciate that our conclusion re these experiments is somewhat qualitative (i.e. that HapR binds the CRP E55A complex less readily) but this is not out of kilter with the vast majority of similar literature and our results are clearly reproducible.
16. Fig. 6a-It is odd that the locked low cell density mutants have such a growth defect in MurNAc, minimal glucose, and LB. To my knowledge, such a growth defect is not common with these strains. Perhaps this has to do with the specific growth conditions used here, but I can't find that information in the manuscript (it should be there). Furthermore, the growth rate of the luxO and hapR mutants appears to be similar up to the branch point (i.e. slope of the curve), but the lag phage of the luxO mutant is much longer. The authors need to address these issues in relationship to previous published literature and specify their growth conditions because the results are not consistent with their simple model described in Fig 6b.
This comment is a little difficult to pick apart as it covers several different issues. We’ll try and
answer these individually.
a) The unusual “biphasic growth curve with hapR and hapRluxO cells: We do not know why cells lacking hapR have a growth curve that appears biphasic. We can only assume that this is due to some regulatory effect of HapR, distinct from the murQP locus. Despite the unusual shape of the growth curve, the data are consistent with our conclusions.
b) The extended lag phase of the luxO mutant in minimal media + MurNAc: We appreciate this comment and had considered possible explanations prior to submission. In the end, we left out this speculation but are happy to include it as part of our response. The extended lag phase might be expected if CRP/HapR regulation is largely critical for controlling the basal transcription of murQP. The locus is likely also regulated by the upstream repressor MurR (VC0204) as in E. coli. So, if deprepression of MurR overwhelms the effect of HapR on murQP, we think you would expect that once the cells start growing on MurNAc, the growth rates are unchanged. But the extended lag is due to the fact that it took longer for those cells to achieve the critical threshold of intracellular MurNAc-6-P necessary to drive murR derepression. Obviously, we can not provide a definitive answer.
c) We have added further details regarding growth conditions to the methods section and the Figure 6a legend.
17. Fig. S6-The data to this point with murPQ suggested a model in which CRP binding then enabled HapR binding. But these EMSA suggest that both situations occur as in some cases, such as VCA0691, HapR binding promotes CRP binding. How does such a result fit with the structural model presented in Fig. 5?
This is to be expected and is fully consistent with the model. Cooperativity is a two-way street, and each protein will stabilise binding of the other. Clearly, it will not always be the case that the shared DNA site will have a higher affinity for CRP than HapR (as at PmurQP). Depending on the shared site sequence, expected that sometimes HapR will bind “first” and then stabilise binding of CRP.
18. Line 354-356-The HCD state of V. cholerae occurs in mid-exponential phase and several cell divisions occur before stationary phase and the cessation of growth, at least in normal laboratory conditions. Therefore, there is not support for the argument that QS is a mechanism to redirect cell wall components at HCD because cell wall synthesis is no longer needed.
We did not intent to suggest cell wall synthesis is not needed at all, rather that there is a reduced need. We made a slight change to the discussion to reflect this.
19. Line 357-360-Again, as stated in point 16, the statement that cells locked in the HCD are "defective for growth" is an oversimplification. The luxO mutants have a longer lag phage, but they actually outgrow the hapR mutants at higher cell densities and reach the maximum yield much faster.
In fairness, we do go on to specify that the defect is an extended lag phase. Also see our response above.
Reviewer #2 (Recommendations For The Authors):
Comments to improve the text
1) Line 103-106, line 130, line 136, etc. Details of the methods and the text directing to presentations of figures should be in the methods and/or figure legends with (Figure x) in citation after the statement. The sentences in lines indicated can be deleted from the results. Although several lines are noted specifically here, this comment should be applied throughout the entire results section.
We appreciate this comment but would prefer not to make this change (it seems mainly an issue of personal stylistic choice). It is sometimes helpful for the reader to include such information as it avoids them having to cross reference between different parts of the manuscript.
2) Line 115. Recommend a paragraph between content on LuxO and HapR (before "Of the 32 peaks for HapR binding")
We agree and have made this change.
3) Line 138 and Figure 1a. I am not convinced this gel shows that VC1375 is activated by HapR. Is the arrow pointing to the wrong band? There does seem to be an induced band lower down.
We understand this comment as it is a little difficult to see the induced band. This is because this is a compressed area of the gel and the transcript is near to an additional band.
4) Line 147. Add the VC0206-VC0207 next to murQP (and the gene name murQP into Table 1).
We have added the gene name to the figure foot note. The text has been changed as requested.
5) Methods. It is essential for this paper to have detailed methods on the bacterial growth conditions. Referring to prior paper, bacteria were grown in LB (add composition...is this high salt LB often used for vibrios or low salt LB often used for E. coli). Growth is to "mid log". Please provide the OD at collection. Is mid log really considered "high density". Provide a reference regarding HapR activity at mid log to support the method. Could the earlier collection of bacteria account for missing known HapR regulated genes? In preparing the requested ç, include growth conditions for other experiments in the legends.
Note that we have included a new supplementary table, rather than a Venn diagram. We have also added further details of growth conditions as mentioned above. Also not that, for the ChIP-seq, HapR and LuxO were expressed ectopically and so uncoupled from the switch between low and high cell density.
6) Content of Table 1, HapR Chip-seq peaks, needs to be closely double checked to the collected data as there seems to be some errors. Specifically, VC0880 and VC0882 listed under Chromosome I are most likely VCA0880 (MakD) and VCA0882 (MakB), both known HapR induced genes on Chromosome II with VCA0880 previously validated by EMSA. This notable error suggests the table may have other errors and thus requires a very detailed check to assure its accuracy.
We appreciate the attention to detail! We have double checked, thankfully this is not an error, the table is correct (even so, we have also checked all other entries in the table). As an aside, VCA0880 is one of the locations for which we see a weak HapR binding signal below our cut-off (included in the new Table S1). In cross checking between Table 1 and all other data in the paper we noticed that we had erroneously included assay data for VC0620 in Figure 2A. This was not one of our ChIP-seq targets but had been assayed at the same time several years ago. This datapoint, which wasn’t related to any other part of the manuscript, has been removed.
If VCA0880 and VCA0882 are correctly placed on Chr. I, then add comment to text that the Mak toxin genomic island found on Chromosome II in N16961 is on Chr. I in E7946. (See recent references PMID: 30271941, 35435721, 36194176, 34799450).
See above, this is not an error.
7) Alternatively for both comments 8 & 9, are these problems of present/missing genes or misannotations the result of the annotation of E7946 gene names not aligning with gene names of N16961? (if so, in Table 1, please give the gene name as in E7946 but include a separate column with the N16961 name for cross study comparison)
See above and below, this is not an issue.
8) Line 126-127. Also regarding Table 1, please add a column with function gene annotation. For example, VC0916 needs to be identified as vpsU. If function is unknown, type unknown in the column. This will help validate the approach of selecting "HapR target promoters where adjacent coding sequence could be used to predict protein function."
We added an extra column to Table 1 in response to a separate reviewer request (TSS locations). This leaves no space for any additional columns. Instead, to accommodate the reviewer’s request, we have added alternative gene names to the footnote.
Not following up on VCA0880 (promoter for the mak operon) is a sad missed opportunity here as it is one of the most strongly upregulated genes by HapR (PMC2677876)
As noted above, this was not an error and VCA0880 was not one of our 32 HapR targets. As such, we would not have followed this up.
9) Figure Legends. Add a unit to the bar graphs in Figure 1e (should be kb??) This has been corrected.
10) The yellow color text labels in figures 3c, 4a, 4c are difficult to read. Can you use an alternative darker color for CRP.
We have made this slightly darker (although to our eye it is easily reliable). We haven’t changed the colour too much, for consistency with colour coding elsewhere.
11) Figure S3. Binding is misspelled. Add units to the x-axis
This has been corrected.
12) Figure S7. The text in this figure is too small to read. Figure could be enlarged to full page or text enlarged. Are these 4 the only other known regulated promoters? Could all the known alternative promoters linked to HapR be similarly probed?
We have increased the font size and included a new Table S1 for all previously proposed HapR sites.
13) Figure S8. Original images..are any of these the replicate gels (see public comment 6)
We have added a statement regarding reproducibility, and also note the internal reproducibility between different figures in our reviewer response. The gels in Figure S8 are full uncropped versions of those shown in the main figures.
Reviewer #3 (Recommendations For The Authors):
None
Whilst there were no specific recommendations from this reviewer, we have still responded to the public review and made changes if required.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
Regarding the two main points emphasized by the eLife assessment:
• Potentially confounding effects of overcrowding: This is indeed an important point, which we avoided, unfortunately without explicitly mentioning it in the manuscript (assuming that it went without saying.) We will point out that our proliferation assays, already part of the original manuscript, indicated that cells were not overcroweded. Nevertheless, we will include additional evidence indicating that our cells were not overcrowded and remained subconfluent.
• Mechanisms: We will mention even more explicitly than we already did that this is beyond the scope of this story and why that is. As we did say, there are lots of factors directly or indirectly involved in translation that depend on Hsp90. Figuring out which one or which ones it might be is a whole new and totally open-ended project.
Regarding some of the other public comments:
• While we did provide quantitative (!) data on changes in cytoplasmic density (e.g. diffusion coefficients, total amount of protein relative to cell size), we will emphasize in the revised manuscript that the changes in cell size, as measured by both flow cytometry and image analyses, are a relative and approximate measure of the 3D changes in cell volume. Although our data on the diffusion coefficients, which report on cytoplasmic density, are directly comparable, our measurements of the amounts of protein relative to cell size (if this is what the comment meant with "cell density") have at least relative value.
• Results of proteomic data not shown in sufficient detail: We recognize that it is not trivial to "read" the data as presented in the paper (volcano plots, full datasets as an Excel file and through ProteomeXchange). We will add subsets of the proteomic data to the Excel file and include some Gene Ontology analyses.
• We did demonstrate that Hsf1 most likely acts transcriptionally to promote the observed cell size increase.
• We acknowledge that a large fraction of our data is "observational", but some experiments clearly go beyond providing correlations. When we manipulate some of the players genetically (KO, knockdown, overexpression) or pharmacologically, we get results that support our conclusions about underlying mechanistic connections.
• GADD34: This protein is not known to be an Hsp90 client (or interactor), which is also supported by our mass spec data since its steady-state levels don't change in Hsp90α or β KO cells compared to wild-type cells.
• Non-dividing cells: it would indeed be exciting to determine whether the same phenomena and mechanisms apply to non-dividing cells. However, there are likely to be substantial technical challenges. We would need primary human (or alternatively murine) cells such as B-cells or hepatocytes, and it is difficult to predict whether they would tolerate mild heat stress for several days. It might also be possible to explore this with a mouse model, but clearly, this must be left to future studies.
-
- May 2023
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
The following is the authors' response to the original reviews.
We’d like to take this opportunity to thank the reviewers and editors for their consideration of our work. As detailed below, we have made the majority of the suggested corrections by the reviewers and believe these have greatly improved our manuscript. The reviewer’s comment are in blue font below and our response to each of these in black font.
Reviewer #1 (Recommendations For The Authors):
Suggestions to improve the manuscript:
- Line 33 and 34: "This protein" is vague. Please reword to state whether you are referring to TcaA or to WTA
This has been corrected in the revised manuscript (Line 33)
- Intro: It would be helpful to provide more rationale for testing serum as a surrogate to whole blood in the GWAS screen. Serum is obviously lacking components of the clotting cascade, and some of these components have antimicrobial functions. However, this is easily justified in the text- e.g. to avoid clumping during the screen, to focus only on serum-derived antimicrobial compounds, etc.
This has been edited in the revised manuscript (Line 84-86)
- Line 120: Please state if the 300 clinical isolates represent 300 distinct patients, or if some of the isolates came from the same patient during sequential collections. If the latter, were there any instances in the which the tcaA SNP appeared during the course of infection?
They each came from individual patients so we were unfortunately unable to look for within host events. This information has been added to the revised manuscript (line 104).
- Line 133: the closed parenthesis sign is missing after "CC22"
This has been corrected in the revised manuscript (Line 135)
- Table 1a - NE1296 is misspelled as ME1296. Also there is a typo in the last entry of this table for the locus tag
This has been corrected in the revised manuscript.
- Table 1b - the authors should comment (in the discussion) on the potential reasons why tcaA was not identified in the CC30 background.
A comment to this effect has been added to the revised manuscript (Lines 553-59)
- Figure 2a - Why is the mutant with the empty complementation vector not significantly different from WT JE2?
The most widely used and reliable expression plasmid for complementation of mutated phenotypes in S. aureus is the pRMC2 plasmid, which requires chloramphenicol selection and anhydrotetracycline to induce expression of the cloned gene. These antibiotics, and the presence of the plasmid often affect the expression of other genes by the bacteria (as noted by this reviewer). As such, to verify complementation of a mutation the comparison we make is between the strain containing the empty plasmid induced with anhydrotetracycline with a strain with the gene containing plasmid induced with anhydrotetracycline. In that situation, the only difference between those two strains under those conditions is whether the gene is expressed or not. A comment explaining this has been added to the revised manuscript (lines 149-153).
- Line 188: Statistical analyses should be applied to figure 3C, which also appears to be underpowered.
P values have been added to this in the revised manuscript. We present data point of three biological replicates, which are the mean of three technical replicates, which we believe is sufficiently powers for this analysis.
- Figure 3 legend - Tecioplanin is mentioned in the title, but the data are not included here
This legend title has been the revised (Line 193).
- Figure 4 - here is an example where testing the actual tcaA SNP could have been enlightening. For example, what if the selective pressure makes the SNP more relevant to a specific AMP or AA?
While we agree that this would be an interesting experiment to perform, the complementing vector that we would need to use to compare the wild type and SNP contains gene requires antibiotics to select for the plasmid and another to induce expression. As such it becomes quite a complex and messy experiment where synergy between the antimicrobial agents would be likely, the results of which will be difficult to interpret.
- Lines 317-321 - Suggest moving this to discussion
We have left this here as we felt it a necessary summation/explanation of the results described in that section. It is discussed again later in the discussion section.
- Line 341 - I believe "serum" should actually be "teicoplanin"
This has been corrected in the revised manuscript (Line 342).
- Figure 6e - wouldn't it be more powerful to determine the WTA levels in the supernatants of these strains and conditions?
We could have done this both ways, but we focussed here only on how TcaA ligates WTA into the cell wall in the presence of serum.
- Figure 6 - What is the explanation for the different growth yields for JE2 in tecioplanin in panel A versus panel F? Are these actually two different concentrations? If so, please update the figure legend and the methods.
The concentration used for the A was inhibitory and for F sub-inhibitory. To improve the clarity of this we have now used a table displaying the MICs for the six strains as panel A. We have also included the concentration of teicoplanin used for each experiment in the legend.
- Line 413: Consider more precise language than "the cell wall is stronger". E.g. More crosslinks?
This has been edited in the revised manuscript (Line 421)
- Line 415: Consider changing "altered" to a directional term such as increases. It can be difficult for the reader to follow the expected change when you are discussing how the lack of a gene versus the presence of a gene changes susceptibility in one direction and another phenotype in the opposite direction.
This has been edited in the revised manuscript (Line 423).
- Figure 7: The conclusions made from panels A and B need to be supported by statistical analyses. It is unclear if these lines are truly different from one another.
These have been included in the revised fig 7.
- Line 426: I believe "tcaA" is missing following "producing"
This has been corrected in the revised manuscript (Line 434).
- Line 446: "increase" to "increases"
This has been corrected in the revised manuscript (Line 460).
- Figure 8C: if one goal of the mouse experiment was to look at survival during transit in whole blood, earlier timepoints are indicated based on the described kinetics of bloodstream dissemination in this model.
The primary goal of this experiment was to see if TcaA contributed positively or negatively to the development of the infection. Work on this protein is ongoing, and so we hope in coming years to be able to provide more detail on its activity in vivo.
- Line 506: "changes to the structural integrity of peptidoglycan" seems overstated without additional studies.
This has been edited in the revised manuscript (Line 524).
- Line 564: "represents" to "represent"
This has been corrected in the revised manuscript (Line 603).
- Line 588: The figures all refer to "100 net". Please confirm the concentration used.
This has been corrected in the revised manuscript (Line 628).
- Line 609: This refers to capsule production? Is this a copy error from a prior paper?
Yes it is, and has been corrected in the revised manuscript (Line 650).
- Line 763: Please provide the concentrations of arachidonic acid used for each experiment.
This has been included in the revised manuscript (Line 805)
- Line 836 and 837: This mentions a time course for blood culture from the infected mice. Where are these data?
Apologies, this is another cut and paste mistake from another paper, and had been removed.
- Line 870: please discuss how multiple comparisons testing was handled.
This has been included in the revised manuscript (Line 908).
- Supplemental figure 5 - Please add statistical analyses to support the conclusions in the manuscript. For example, there appears to be no differences for dalbavancin. Please also italicize tcaA in the legend.
These have been included and corrected in the revised manuscript.
Reviewer #2 (Recommendations For The Authors):
Line 65 - I would suggest adding the reference (doi: 10.1128/Spectrum.00116-21), which shows increased mortality in S. aureus bacteremia patients due to agr deficient isolates.
The suggested manuscript shows this effect of Agr dysfunction to be limited to patients with moderate to severe SOFA scores. As such it would require a nuanced description here that we think will detract from the flow of the introduction.
Line 68 - Please add DOI: 10.1016/j.cmi.2022.03.015 as a reference to support the mortality rate in S. aureus bacteremia. A systematic review and meta-analysis provides the highest level of evidence, and this is a contemporary study performed in 2022
This has been included in the revised manuscript (Line 68).
Line 70 - please add supporting reference for this statement
This has been included in the revised manuscript (Line 70).
Figure 2 - This image is low quality and appears pixelated. Please revise
This has been replaced with a higher resolution image in the revised manuscript.
Figure 3c Also appears slightly pixelated
This has been replaced with a higher resolution image in the revised manuscript.
Line 173 - I think it would helpful to mention the catalytic activity encoded by tcaA (aside from mediating sensitivity to glycopeptides) is unknown.
This has been included in the revised manuscript (Line 174)
Line 174 - also confers sensitivity to vancomycin https://doi.org/10.1128/AAC.48.6.1953- 1959.2004
This has been included in the revised manuscript, albeit at a later point than suggested here (Line 406)
Line 209 - did the authors test any other antimicrobial fatty acids such as palmitoleic acid? If common mechanism would also expect decreased sensitivity to other HDFA
No, we focused on arachidonic acid as this is the most relevant antimicrobial fatty acid in serum and it is produced by neutrophils and macrophages during the inflammatory burst.
Figure 4a-D: it would be useful to know what the MIC to these different components is and how that MIC relates to the concentration in human serum
We do not have MICs for all of these compounds tested here but can confirm that the concentrations used are physiologically relevant.
Figure 4b - Can you mention in the legend how the killing assays varied for arachadonic acid versus the other AMPs? I am not immediately clear how this experiment was performed, despite referring to methods
This has been included in the text of revised manuscript (Line 211-213) and the figure legend.
Figure 5 - there is no panel D
This has been corrected in the revised manuscript.
Figure 6a: Lines 328-329 state the experiment was performed in the MIC for each strain. The legend (line 374) states 0.5 ug/ml teicoplanin was used, which is below the MIC for all of the strains tested per supp table 2. Please correct this discrepancy.
This figure has been revised and the additional information included to improve the clarity of this section in the revised manuscript.
Figure 6a: On line 328, the authors state that the tcpA knockout increases the MIC for teicoplanin in each background. Figure 6a is performed in the presence of teicoplanin at 1x the MIC of the wild type (which will be below the MIC for the knockout). Therefore, we know each tcpA mutant will be able to grow in the presence of sub-mic concentrations of teicoplanin. Would a more informative way of conveying this information be to have MIC on the Y axis and background on the X axis?
This has been corrected and clarified in the revised manuscript with a table showing the MICs (fig. 6a).
Figure 6b-c: Similarly, would it be more helpful to show how the MIC varies with the different clinical isolate tcpA mutants?
While MICs have uses in clinical setting, they are a relatively crude and binary (growth V no growth) way to measure and compare sensitivity. For these two groups of isolates the MICs did not vary, which is why we used a concentration that sat that the threshold and quantified growth of all the isolates in this. This information has been added to the legend.
Figure 6e: The figure legends instructs us to refer to supplemental figure 3 to see the densiometry results. However, Figure 6e appears to be 4 conditions (WT and mutant +/- serum) and only examines the cell wall, whereas the supplemental figure refers to two conditions (WT + mutant) and looks at the cell wall and supernatant. I would recommend providing the densitometry data associated with the conditions in figure 6e, especially as differences seem more subtle by eye.
This has been included in the revised manuscript (fig. 6f)
Line 689-691 - description of teicoplanin concentrations used in figure 2. However, no teicoplanin was used in figure 2. Assume is referring to a different figure (figure 6?)
This has been corrected and clarified in the revised manuscript. Line 724.
Please add a section in the methods describing how the MIC was determined for JE2, SH1000 and Newman. Was it performed in CA-MHB or the media that the experiment in figure 6a was performed in. Serum can alter the MIC of several antibiotics
This has been corrected and clarified in the revised manuscript. Line 724-29.
Please add a section to the methods describing the whole blood killing assay, ideally describing how the blood was not frozen and used same day as venipuncture. This is important as freeze/thaw or time periods >12 hours are likely to severely effect the function of phagocytes, especially neutrophils.
This has been corrected and clarified in the revised manuscript. Lines 635-639
Line 588: ng/ul should read ng/µl
This has been corrected in the revised manuscript too ng/ml. Line 628
Reviewer #3 (Recommendations For The Authors):
We have now included a graphical abstract (Fig. 9)
Major:
1- Line 102: I was not able to find the accession numbers of these 300 genomes, did the authors submit it to any public repository (e.g. NCBI)?
These were submitted previously to a public repository and the associated reference cited, but we have provided these in supplementary Table 1.
Minor:
1 - Typo in line 133. Fix parenthesis after CC22.
Corrected.
2 - Typo: Fix figure 5 panels (5e should be 5d).
Corrected.
3 - Line 276: It is not clear why the extract for this experiment was supplemented at 2% while the other part of the experiment was done with 10%. Clarification is needed.
The experiments at 10% was using overnight supernatant, whereas those with 2% was a purified WTA extract. This has been clarified in the revised manuscript (lines 283 and in the figure legend)
4 - Line 278: Typo: Figure 6e should be figure 5d.
Corrected. (Line 278)
5 - Figure 5f: There is no explanation in the text or in the figure legend what the purpose of using mprF was.
A comment has been included in the figure legend.
6 - Line 328: It would be good if we the authors reports the CC of Newman and SH1000 for a better context for the readers.
This has been added. (Line 332)
7 - Line 341: Did the authors mean less sensitive to teicoplanin?
Corrected. (Line 342)
8 - Line 367: Dose dependent effect does not seem to be followed not only in panel H of Supp. Fig. 4(LL37 and EMRDA15) but also panels C, D and G.
Corrected.
9 - Line 587: Typo: Table 2.
These have all been corrected and/or clarified in the revised manuscript.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
First and foremost, we would like to thank all the editors and reviewers for their thoughtful and thorough evaluations of our manuscript. We greatly appreciate their assessment about the novelty and strength in this study and will revise the manuscript according to their recommendations. Here we offer a provisional response to Reviewer 2 to clarify our rationale for using TH-Cre rather than DAT-Cre mice in our study of frontal cortical dopaminergic projections.
We agree with Review 2 that the DAT-Cre line can provide specific labeling of midbrain dopamine neurons projecting to the striatum, as discussed in the cited study (Lammel et al., 2015). But unfortunately, mesocortical dopamine neurons in the VTA are known to express very little DAT (Lammel et al., 2008; Li, Qi, Yamaguchi, Wang, & Morales, 2013; Sesack, Hawrylak, Matus, Guido, & Levey, 1998). This limitation in the use of the DAT-Cre line to target mesocortical dopamine neurons has been acknowledged in the cited publication (Lammel et al., 2015). It is an issue we have also observed when testing the DAT-Cre line in our lab. Additionally, and interestingly, recent extensive evaluation of the DAT-Cre line reported ectopic labeling of multiple non-dopaminergic neuronal populations (Papathanou, Dumas, Pettersson, Olson, & Wallen-Mackenzie, 2019; Soden et al., 2016; Stagkourakis et al., 2018). Our own evaluation of the DAT-Cre line’s utility for cortical imaging also captured sporadic ectopic labeling of cortical cell somas.
Because mesocortical dopamine neurons have stronger TH expression than DAT (Lammel et al., 2008; Lammel et al., 2015; Li et al., 2013; Sesack et al., 1998), TH-Cre lines have been frequently used to study the mesocortical pathway (Ellwood et al., 2017; Gunaydin et al., 2014; Lammel et al., 2012; Lohani, Martig, Deisseroth, Witten, & Moghaddam, 2019; Vander Weele et al., 2018). While TH-Cre expression itself is not restricted to dopaminergic neurons, we targeted our viral injections to the VTA and optogenetic stimulation to the cortical dopaminergic projection target area (Patriarchi et al., 2018) to specifically modulate mesocortical dopaminergic axons. In addition, we tested D1 antagonist’s effects in our manipulations. Although we targeted dopamine neurons in our adolescent stimulation, the final behavioral outcome likely includes contributions from co-released neurotransmitters and non-dopaminergic neurons via network effects. We will revise our discussion and methods sections to clarify these points of interest. Additionally, we will provide DAT-Cre images in the revised supplementary materials to further explain our choice of the TH-Cre line rather than the DAT-Cre line for our study.
References
Ellwood, I. T., Patel, T., Wadia, V., Lee, A. T., Liptak, A. T., Bender, K. J., & Sohal, V. S. (2017). Tonic or Phasic Stimulation of Dopaminergic Projections to Prefrontal Cortex Causes Mice to Maintain or Deviate from Previously Learned Behavioral Strategies. J Neurosci, 37(35), 8315-8329. doi:10.1523/JNEUROSCI.1221-17.2017
Gunaydin, L. A., Grosenick, L., Finkelstein, J. C., Kauvar, I. V., Fenno, L. E., Adhikari, A., ... Deisseroth, K. (2014). Natural neural projection dynamics underlying social behavior. Cell, 157(7), 1535-1551. doi:10.1016/j.cell.2014.05.017
Lammel, S., Hetzel, A., Haeckel, O., Jones, I., Liss, B., & Roeper, J. (2008). Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron, 57(5), 760-773. doi:DOI 10.1016/j.neuron.2008.01.022
Lammel, S., Lim, B. K., Ran, C., Huang, K. W., Betley, M. J., Tye, K. M., ... Malenka, R. C. (2012). Input-specific control of reward and aversion in the ventral tegmental area. Nature, 491(7423), 212-217. doi:10.1038/nature11527
Lammel, S., Steinberg, E. E., Foldy, C., Wall, N. R., Beier, K., Luo, L., & Malenka, R. C. (2015). Diversity of transgenic mouse models for selective targeting of midbrain dopamine neurons. Neuron, 85(2), 429-438. doi:10.1016/j.neuron.2014.12.036
Li, X., Qi, J., Yamaguchi, T., Wang, H. L., & Morales, M. (2013). Heterogeneous composition of dopamine neurons of the rat A10 region: molecular evidence for diverse signaling properties. Brain Struct Funct, 218(5), 1159-1176. doi:10.1007/s00429-012-0452-z
Lohani, S., Martig, A. K., Deisseroth, K., Witten, I. B., & Moghaddam, B. (2019). Dopamine Modulation of Prefrontal Cortex Activity Is Manifold and Operates at Multiple Temporal and Spatial Scales. Cell Rep, 27(1), 99-114 e116. doi:10.1016/j.celrep.2019.03.012
Papathanou, M., Dumas, S., Pettersson, H., Olson, L., & Wallen-Mackenzie, A. (2019). Off-Target Effects in Transgenic Mice: Characterization of Dopamine Transporter (DAT)-Cre Transgenic Mouse Lines Exposes Multiple Non-Dopaminergic Neuronal Clusters Available for Selective Targeting within Limbic Neurocircuitry. Eneuro, 6(5). doi:10.1523/Eneuro.0198-19.2019
Patriarchi, T., Cho, J. R., Merten, K., Howe, M. W., Marley, A., Xiong, W. H., ... Tian, L. (2018). Ultrafast neuronal imaging of dopamine dynamics with designed genetically encoded sensors. Science, 360(6396), 1420-+. doi:10.1126/science.aat4422
Sesack, S. R., Hawrylak, V. A., Matus, C., Guido, M. A., & Levey, A. I. (1998). Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci, 18(7), 2697-2708. doi:10.1523/JNEUROSCI.18-07-02697.1998
Soden, M. E., Miller, S. M., Burgeno, L. M., Phillips, P. E. M., Hnasko, T. S., & Zweifel, L. S. (2016). Genetic Isolation of Hypothalamic Neurons that Regulate Context-Specific Male Social Behavior. Cell reports, 16(2), 304-313. doi:10.1016/j.celrep.2016.05.067
Stagkourakis, S., Spigolon, G., Williams, P., Protzmann, J., Fisone, G., & Broberger, C. (2018). A neural network for intermale aggression to establish social hierarchy. Nat Neurosci, 21(6), 834-842. doi:10.1038/s41593-018-0153-x
Vander Weele, C. M., Siciliano, C. A., Matthews, G. A., Namburi, P., Izadmehr, E. M., Espinel, I. C., ... Tye, K. M. (2018). Dopamine enhances signal-to-noise ratio in cortical-brainstem encoding of aversive stimuli. Nature, 563(7731), 397-401. doi:10.1038/s41586-018-0682-1
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
I appreciate the time and effort of both Reviewers, who have raised important points that I would like to briefly discuss before I start working on a full revision of the paper.
Generality. First, there is the question of how much these conclusions broadly apply across experimental paradigms and subjects, which could give rise to potentially very different TGMs. As the Reviewers mention, I have focussed on one specific TGM that I assumed prototypical, and it could be that these conclusions fit other TGMs less well. Further, the model has quite a few hyperparameters so that it can flexibly accommodate a broad span of scenarios. This flexibility comes at a price, as pointed out by Reviewer 1: that “a different selection of parameters could lead to similar results”, i.e. that other configurations could fit this specific TGM just as well. This is related to the next point, so I will address them jointly.
Lack of quantitative evaluation, “making it hard to draw firm conclusions”. Indeed, I have not explicitly quantified the fit of the hyperparameters to this empirical TGM using a specific measure, and (related to the previous point) I have not made a systematic search through the space of model configurations based on such measure.
There is here a trade-off between generality and specificity. In fact, it is intentional that I did not optimise the hyperparameters to this specific TGM, and that I chose not to show a quantitative measure of fitness. This is because the TGM that I show in the paper is only meant as an example. Instead of focussing on fitting a specific TGM, I aimed at characterising some prominent general features that we often see throughout the literature, which this specific TGM shows in its own specific way. That is, if the paper was meant to focus on a specific paradigm (e.g. passive vision), then the use of a specific metric to fit the model to one or various empirical TGMs would have perhaps been more adequate, but this was not the case here. In future work, when focussing on specific paradigms, I will adapt methods of Bayesian optimisation (Lorenz et al., 2017) for this purpose, as mentioned in the Discussion. Note that doing this right is not trivial and would complicate the paper significantly; for this reason, I feel it should belong to a different piece of work.
I would also like to note that evaluating the different features of the data one by one (“in a stepwise manner”) was necessary for interpretation. One can loosely think of it as a sort of F-test: one is showing how important a feature is by comparing the full model vs. a nested model that does not have that feature. While the Reviewer is right that there might be interactions between the features that we can only unveil through a joint evaluation, my approach is at least valid as a first approximation. I will discuss this limitation in an updated version of the paper in more detail.
In a future revision of the paper, I will argue more specifically why and how these model configurations are, in general terms, necessary to produce these main effects in the TGM, and why other alternative configurations could not easily generate them.
Practical guidelines for researchers. It was suggested to make it clearer how researchers could leverage this model in their own studies to understand their data better and to help relating their TGMs to specific neurobiological mechanisms.
In a future revision of the paper, I will introduce a new section explaining how to use genephys practically, emphasising both opportunities and current limitations.
Neurobiological interpretation. It was criticised that the results were a mere characterisation of sensor space data, and that these were not related clearly to any neurobiological aspect.
In a future revision, I will work toward relating the main findings to existing literature in order to strengthen the neurobiological interpretation of the results, and toward a better justification of how genephys can help shed light on specific brain mechanisms.
Above and beyond these specific points, I intend to restructure the text so that the main goals of the study become clearer. This includes clarifying in the Introduction more unambiguously what is the gap of knowledge this work is specifically tackling.
Again, I would like to thank the Reviewers for helping me realise the limitations of the current version of the paper.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
The following is the authors' response to the original reviews.
In brief, we incorporated all wording and clarity suggestions into the manuscript. We also updated figure legends to include additional details, including replicate numbers. New data have been added in response to requests from the reviewers. Volumetric intake data are included as a supplemental figure (Figure 1–Figure Supplement 1A) and we will include movies of the confocal stacks from our CaMPARI imaging. We worked hard to address all the reviewers’ concerns and provide a detailed response below to the reviewers’ public comments as well as their author-specific comments.
Reviewer #1 (Public Review):
1) All feeding data presented in the manuscript are from the interactions of individual flies with a source of liquid food, where interaction is defined as 'physical contact of a specific duration.' It would be helpful to approach the measurement of feeding from multiple angles to form the notion of hedonic feeding since the debate around hedonic feeding in Drosophila has been ongoing for some time and remains controversial. One possibility would be to measure food intake volumetrically in addition to food interaction patterns and durations (e.g. via the modified CAFE assay used by Ja).
We acknowledge that our FLIC assays address only one dimension of feeding behavior, physical interaction with liquid food. However, there is clear evidence that interactions are strongly predictive of consumption, and it would be technically difficult to measure feeding durations at the resolution of milliseconds using a Café assay. Nevertheless, we appreciate the spirit of this comment and agree that expanding our inference to other measures of feeding, as well as feeding environments, is an important next step. To this end, we now include measures of feeding on more traditional solid food, using the ConEx assay, and find that flies in the hedonic environment consume twice as much sucrose volume compared to flies in the control environment. These have been added as supplemental data (Figure 1 – Figure Supplement 1A), and the text has been updated to reflect our findings.
2) Some of the statistical analyses were presented in a way that may make understanding the data unnecessarily difficult for readers. Examples include:
a) In Table I the authors present food interaction classifications based on direct observation. These are helpful. However, the classification system is updated or incompletely used as the manuscript progresses, most importantly changing from four categories with seven total subcategories to three categories and no subcategories. In subsequent data analyses, only one or two of these categories are assessed. It would be helpful, especially when moving from direct observation to automated categorization, to quantify the exact correspondences between all of the prior and new classifications, as well as elaborate on the types of data that are being excluded.
We appreciate the feedback on our usage of the behavioral classification system and have made several adjustments to improve it. We renamed some of the behaviors to make them more intuitive (see Reviewer #2, comment #1), and updated the main text and Table 1 to reflect these changes. We updated the text and figures to be more transparent about when we group subcategories into main categories for quantification and when we quantify all subcategories separately. Because these videos required manual scoring by an experimenter, after our initial characterizations we opted to score only main categories (which contain subcategories). We agree that it would be useful to quantify correspondence between subcategories and the automated FLIC signal. However, we believe this task is better suited for more advanced and automated video tracking software, and, incidentally, more sophisticated analysis of FLIC data, which has a very high-dimensional character that has yet to be properly exploited. At the moment, therefore, we are not confident in the ability to understand the data at the desired resolution.
b) The authors switch between a variety of biological and physiological conditions with varying assays, which makes following the train of reasoning nearly impossible to follow. For example, the authors introduce us to circadian aspects of feeding behavior to introduce the concept of 'meal' and 'non-meal' periods of the day. It is then not clear in which of the subsequent experiments this paradigm is used to measure food interactions. Is it the majority of the subsequent figure panels? However, the authors also use starved flies for some assays, which would be incompatible with circadian-locked meals. The somewhat random and incompletely reported use of males and females, which the authors show behave differently, also makes the results more difficult to parse. Finally, the authors are comparing within-fly for the 'control environment' and between flies for their 'hedonic environment' (Figure 3A and subsequent panels), which I believe is not a good thing to do.
We apologize for our difficulties conveying our inference, which was also noted by Reviewer #2. We have worked hard to improve this component in the revision. With respect to the confusion about circadian feeding, we introduced circadian meal-times to complement starvation as a second (perhaps more natural) way to measure behaviors associated with hunger. Importantly, we do not use circadian meal-times beyond Figure 1; all subsequent FLIC experiments were conducted during non-meal times of day for 6 hours, which avoids confounding our data with circadian-locked meals even when we use starved flies. We have clarified this point in the revision.
The reviewer also points out that we make both within-fly and between-fly comparisons, which is a point that we note. Perhaps some concern arises, again, from the challenges that we faced in properly delineating our inferences about different types of feeding measures (and motivations). Inference about homeostatic feeding was made using within-fly measures, comparing events on sucrose vs. those on yeast. Inference about hedonic feeding was made using between fly measures (average durations of different flies on 2% vs. 20% sucrose). Treatment comparisons to control always used measures of the same type, such that inference was not made using between-fly measures for treatment and within-fly for control (i.e., all of our figure panels were either within-fly or between fly). We have worked to clarify this in the revision.
Importantly, our approach to all experiments avoided confounding by used randomized design at multiple levels (e.g., randomizing control and hedonic environments to FLIC DFMs, alternating food choice sidedness in the DFMs), by ensuring that flies in both environments are sibling flies that came from the same vial environment before being tested, and by performing each experiment multiple times.
c) Statistical analyses are not always used consistently. For example, in Figures 3B and C, post hoc test results are shown for sucrose vs. yeast interactions, but no such statistics are given for 3E and 3F, preventing readers from assessing if the assay design is measuring what the authors tell us it is measuring.
We report p-values for two-way ANOVA interaction terms for all appropriate experiments. If (and only if) the interaction term is significant, we conduct post-hoc tests for more detailed statistical analysis and report the p-values. The reviewer points out that we do not perform post-hoc tests in figures 3E and 3F. These figures had a non-significant interaction term, and thus, we did not feel a post-hoc test was warranted.
Reviewer #2 (Public Review):
1) The dissection of feeding into distinct behavioral elements and its correlation with electrical FLIC signals that allow interpreting feeding types is a fundamental new method to dissect feeding in flies. However, the categories of micro-behaviors in Table 1 are not intuitive.
We agree and have updated the Table, figures, and main text. Please see also our response to Reviewer #1, comment #1.
2) The details for the behavioral data analysis are not clear and should be made more obvious. For example, how many males and females were used in each experiment? Were any of the females mated or were they all virgins? If all virgins, why not use mated females? Mating status may have an effect on the feeding drive. If mated and virgin females were used, are there any differences between them? Similarly, for diurnal feeding experiments, it is not immediately clear from the graphs how many animals were used and how the frequencies were obtained (Fig. 1F, presumably averages for each category per fly but that is inconsistent with the legend in the supplement for this figure). Why does the transition heat map not include all micro-behaviors (Fig. 1E, no LQ data which are significant in diurnal feeding)?
We have clarified the number of flies and events for each behavioral experiment in Figure 1, and we updated the figure legend appropriately. We note that these behavioral datasets are non-overlapping, and each time we mention the number of events scored in the text, that number includes only “new” videos. Female and male flies for all experiments were mated, and we have clarified this in the main text and methods.
For the diurnal experiment in Figure 1F, we scored over 700 events from new (non-overlapping) video compilations and updated the number of flies and event number in the figure legend. The diurnal data we present in the supplement for this figure is a separate experiment conducted on 38 flies, intended only to demonstrate the circadian nature of fly feeding.
For the transition heat map, analysis of this sort seems to require a large amount of data to have sufficient power to return a transition matrix. LQ events are relatively low in frequency, so we opted to combine them with L events for this analysis. We have updated the figure and figure legend to reflect this.
3) The CaMPARI images do not look great, particularly in the pan-neuronal condition (Fig. 5A). It would be useful to include the movie of the stack. Did any other brain regions show activity differences, such as SEZ or PI? These regions are known to be involved in feeding so it seems surprising they show no effect.
We find that CaMPARI imaging is subject to high levels of noise and background, especially when using a broad driver as the reviewer has pointed out. This is why we opted to follow-up our pan-neuronal CaMPARI experiment using a more specific mushroom body driver and to test our correlational findings of increased MB activity in hedonic environments with genetic approaches in the remainder of Figure 5. We have included movies of the confocal stacks for both CaMPARI experiments, as requested.
Reviewer #1 (Recommendations For The Authors):
Main concern:
No measurements of intake, either in volume or in caloric value. Hence, 'hedonic' feeding is only indirectly supported.
I would like to suggest to the authors that they measure intake volumetrically in addition to food interaction patterns and durations. For example, William Ja developed a modified CAFE assay that measures consumption volume in real-time in freely behaving flies (http://dx.doi.org/10.1038/nprot.2017.096). Liming Wang has another capable assay. Additional values of expanding measurement methods for feeding are that it helps tie the research more directly to that of others, and it helps remove the concern that any one assay may introduce unknown biases.
For the CaMPARI, it would be helpful to provide a demonstration of its effectiveness by recapitulating a deep brain neural pathway known to be engaged by a stimulus by GCaMP or electrophysiology.
Additional concern:
The authors assume satiety states during different circadian periods (line 253, for example). It seems critical to directly measure the satiety state.
Technical concerns:
Figure 5 A, B: there is reported near zero UV transmission through the head: https://doi.org/10.1364%2FBOE.6.000514, hence the CaMPARI measurements are suspect. It appears that there may be an effect in the optic lobes that may receive greater UV illumination by being more peripheral. A positive control to demonstrate deep brain access by UV is needed.
Y-axes vary for the same measurement types within figures, for example, Figure 5 C-G. Also Figures 3F, G, I, K, M and Figures 3D, E, H, J, L. This hinders direct comparisons.
Figure 2: why are there no statistics to distinguish interaction (I) events from F and L? Why are the example graphs presented using different scale x-axes? For A-C, why no averaged response graphs for the classifications? Were there other events that did not fit these classifications?
In lines 224-226, the claim of statistical significance at p=0.061 makes the reader suspicious of the statistical interpretations throughout the manuscript.
Figure 3B starved looks the same as Figure 3C sated for females, using the same assay and conditions. This implies a huge amount of variance in behavior between experiments.
We appreciate the recommendations from Reviewer #1 and have done our best to address many of their concerns. Regarding their main concerns, we have added volumetric feeding data to the manuscript, included movies of the confocal stacks for the CaMPARI experiments, and clarified the circadian timing of our behavioral experiments. These details are outlined in our public response to both reviewers. The reviewer also expressed a few technical concerns, mostly regarding statistical analyses. We agree that there seems to be a large amount of biological variability between experiments, which we do indeed find to be the case with behavioral experiments of this sort. For this reason, we avoid making direct comparisons on absolute values between experiments, as the reviewer suggests, and thus allow our Y-axes to vary for each figure to better facilitate within-experiment comparisons. The reviewer also points out that, in one instance, we refer to a p-value of 0.061 as statistically significant in the text. While we have changed our language to reflect the perceived convention, we note that there is little inferential difference between these values, and we report exact p-values to allow the reader to make an informed decision.
Reviewer #2 (Recommendations For The Authors): The writing and data presentation in this paper is somewhat dense and confusing at times. Comments and questions below are intended to help improve data presentation and resolve questions that will help the reader navigate and understand the data to better appreciate the significance of the findings.
Comments and questions:
Line 160 cites Chen et al, 2002 as an example of behavioral characterization that is useful for read-outs of neural states, but no neural states were defined in that work. A better example where a circuit was linked to a specific behavioral category is PMID30415997 (Duistermars et al., 2018).
Line 171: were the females mated or virgin or was it variable?
The classification system in Table 1 is a bit confusing. For example, the distinction is made between Fast and Long feeding events as well as interactions with food and other events. FH meet the requirements of F and H, presumably meaning that flies are fast feeding and touching the food with their front legs. Why are front legs and hind legs touching food abbreviated H and FF respectively instead of something more obvious like IF and IH (referring to Interaction with Front legs or Interaction with Hind legs)?
Also was there never any tasting with the middle legs? In Fig1B, all the I events are grouped. Are most of these H or FF events? The frequency in Fig. 1B is shown as normalized as a frequency of all events. The statistical analyses are all parametric. Are these data normally distributed?
Lines 224-229: the relative frequency of L-type feeding is increased in starved flies and the relative frequency of F feeding is decreased. Is the relative L- or F-type feeding frequency considered on total behavior or just the sum of long and fast feeding or the sum of all types of feeding?
The events that are analyzed vary throughout the paper. Line 173 mentions 300 events, line 222, 500 events, and line 257, 700 feeding events. Are these all independent experiments, or are these overlapping data sets analyzed for different parameters?
For diurnal feeding behavior, the authors analyzed 700 events and found significantly more LQ events during meal time (i.e. at the beginning and end of the day). Based on the figure legend in the supplement to Figure 1, it appears that these data were collected on 38 female flies. But in Fig 1F, there are ~8 points per feeding type (F, L, and LQ) during meal and non-meal conditions. Shouldn't all 38 flies have an average frequency for each type of feeding during meal and non-meal times? Were these females mated or not? Is this effect also true for males? To help the reader understand the data better, it would be helpful to note the number of flies used in each experiment or in each analysis in the different figures and wherever the data are mentioned in the manuscript. It also seems likely that the mating state may have an effect on feeding so knowing the result in mated versus unmated would be a useful analysis.
It is interesting that there is a difference in feeding in starved flies versus diurnal feeding in the presumably hungry versus sated phase (meal versus non-meal phases). As mentioned by the authors earlier in the manuscript, starved flies have a relative increase in L-type feeding. However, they perform less LQ feeding than sated flies, and yet LQ feeding is the only significantly different type of feeding in the hungry state of diurnal feeding. In the morning, the transition to feeding is very abrupt compared to the gradual increase in the evening. Is there any difference between the type of feeding or the transition matrix in the evening versus morning meal times? Also, why is LQ feeding not included as a category in the transition matrix in Fig 1E?
In Fig 2, the authors examine FLIC signals with video data to identify feeding types from FLIC signals. Why are there signal durations for F-type feeding that are longer than 3 seconds when it is defined as 1-3 sec of the proboscis contact with food and conversely signals of L-type feeding shorter than 4 seconds when it is defined as >4 seconds of continuous proboscis contact? Does this mean that signal can be longer or shorter than the actual time the proboscis is in the food?
With these parameters, the authors develop an assay to identify homeostatic and hedonic feeding by applying the signal analysis to food choices representing homeostatic (2% sucrose versus yeast) and hedonic (2% sucrose versus 20%) conditions. In Fig 3C, they show that fully-fed females show a stronger preference for yeast food than sugar food compared to males (line 335). Is this in fully fed animals? The yeast preference in females looks almost the same as in the starved females in Fig 3B.
The CaMPARI images shown in Fig 5A (and to a lesser extent Fig 5B) are not particularly convincing although the quantification looks clear. Providing the movies of the stacks may help the reader better appreciate the difference in MB red signal in the hedonic state. It would also help to show the number of flies that were tested in these experiments as well as the sex and mating status. Provide the n in the figure legend and in the relevant sections in the text.
Were the mushroom bodies the only brain region with significant, measurable activity changes? One might expect changes in other feeding areas, such as the subesophageal zone (SEZ) and the peptidergic regions of the brain (PI), which are both known to affect feeding in flies. This may also be a useful method to examine differences in mated versus unmated flies.
In Fig 5C the caption reads MB lambda lobe inhibition. Shouldn't this be gamma lobe inhibition as suggested in the figure legend?
The paper largely distinguishes homeostatic from hedonic feeding only. It may be useful to discuss other non-homeostatic mechanisms as well or at least make the distinction in the introduction and or discussion.
We thank reviewer #2 for their thoughtful suggestions to improve the clarity of the manuscript. They suggest several improvements, which we implemented, including that we improve the classification system in Table 1 to make it more intuitive, state how we normalized observed behavioral frequencies, clarify that the number of events we cite for each experiment are non-overlapping, and explain the use of circadian meal vs. non-meal times. We also noticed, as did this reviewer, that the usage of L vs. LQ events differs between starved flies and flies observed during meal-time. We agree that it may be interesting to sort out the nuances of why and how these differences occur, as it suggests that starvation may in some ways be different from physiological hunger. However, our method of manually observing flies would make this difficult at present. We hope to utilize more advanced video tracking software in the future to investigate this question. The reviewer also posed several questions about the hunger/satiety state of flies that we used for each experiment, which we clarified throughout the main text, figure legends, and methods.
This reviewer points out two technical concerns, which we have addressed. The concerns about our CaMPARI imaging are noted, and we have discussed them in response to reviewer #1 and in our public response. We now include movies of the confocal stacks, as requested. There was also a question about FLIC durations of F and L events in Figure 2, with some visually identified F events producing FLIC signals longer than 4 seconds and some L events producing FLIC signals shorter than 4 seconds. Although we show that population averages from the FLIC can reliably recapitulate our visual metrics, there is occasional noise at the individual level. For example, although a fly may have contact of its proboscis with the food for less than 4 seconds, the FLIC signal may persist slightly beyond that interaction due to sustained contact with a non-proboscis body part or due to liquid food contacting the signal pad. We also occasionally observed L events that we visually identified to last longer than 4 seconds, but nevertheless did not produce a FLIC signal of equal length. This can occur when a fly feeds on the liquid food but transiently loses contact with the signal pad. Although there is some noted technical noise, we show that population-level data is sufficient to reflect our visual observations.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer 1:
The reviewer indicated the data convincingly demonstrates absence of Perlecan causes a severe perturbation of the ECM-based neural lamella, that synaptic terminals degenerate, and that axons and even entire nerve bundles break. The reviewer noted that future studies will be important to define the precise source of Perlecan and the underlying mechanism for axonal breakage, and suggested several follow-up experiments. We address these comments below.
- The reviewer noted our data indicate Perlecan’s role in synaptic retraction is not due to its absence from neurons and that some of the wording is confusing in this regard.
We’ve tried to make it clear throughout the manuscript that Perlecan functions non-cell autonomously, as our failure to rescue with neuronal re-expression or recapitulate the phenotype with neuronal-only RNAi indicates. As such, we agree that the phenotypes are not due to Perlecan loss within neurons, consistent with our data showing breakdown of the neural lamella ECM and subsequent axonal breakage. These phenotypes do manifest in neurons, but the defect is triggered non-cell autonomously as described in our study and stated by the reviewer here.
- The reviewer suggested future experiments to resolve the source(s) of Perlecan secretion from defined tissues that control neuronal stability, noting that showing ubiquitous rescue with a pan-cellular Gal4 driver would be useful.
We did do pan-cellular rescue and overexpression experiments with the ubiquitous Tubulin-Gal4 driver, but expression of our two UAS-trol transgenes with this strong driver resulted in lethality. This observation indicates too much Perlecan expression is also detrimental for ECM function. Interestingly, we found that NMJ synapses do not retract following ubiquitous Perlecan overexpression in wildtype larvae, so another aspect of ECM dysfunction is responsible for lethality under this condition. As reported in the manuscript, we found driving a Trol RNAi with multiple Gal4 lines expressed in specific cell populations was unable to recapitulate the synaptic retraction phenotype, including pan-neuronal (elavC155), neuronal and muscle (elavC155 and mef2-Gal4), glial (repo-Gal4), fat body (ppl-Gal4, Lsp2-Gal4), hemocytes (Hml-Gal4), and fat body and hemocytes (c564-Gal4) driven expression. These data suggest Perlecan secretion is required by multiple cell types to achieve sufficient accumulation in the ECM to prevent neuronal instability.
- The reviewer indicates future studies of the blood-brain barrier might reveal insights into the pathology and axonal breakage we observe. The reviewer also suggests we perform a detailed timeline of the axonal breakage timeline.
We agree with the reviewer that examination of the blood-brain barrier and glial dysfunction will be exciting experiments for future studies. For the phenotypic timeline, this was an important component of our study and was done in two ways and described in the manuscript. In Figure 4, we describe serial in vivo imaging of synapses with briefly anesthetized larvae over 4 full days of imaging. In Figure 9, we describe fixed imaging of larval axons at specific developmental stages (2nd, early 3rd, wandering 3rd instar). This set of experiments provided a detailed timeline for synaptic retraction and axonal breakage. As suggested, we also used single neuron drivers (MN1-Ib) to label a single motoneuron and examine axonal breakage and synaptic retraction at this scale. This data is shown in Figure 9E. Together, these experiments provided a timeline for the biology we observe – disruptions of the neural lamella ECM, disorganization of the axonal microtubule cytoskeleton, followed by axonal breakage and fragmentation (usually in a hemi-segment coordinated manner), with subsequent synaptic retraction at NMJs.
- The reviewer indicates the final model in Figure 10 may not be fully representative.
We feel this model best describes our complete dataset on the Trol mutant. We provide evidence for each of these phenotypic events in detail in the paper. The disruptions to the neural lamella are described in Figure 8. The onset of synaptic retraction does occur in the 3rd instar stage and not the 2nd instar stage – Figure 4 shows this with serial in vivo imaging where we see normal synaptic morphology on Day 1 (2nd instar stage) and degeneration over the 3rd instar period (Days 2-4). The figure does not indicate Perlecan functions for synaptic stability by residing at the NMJ, only that synaptic retraction occurs. Indeed, as stated in the text, we argue against a role for Perlecan function directly at the NMJ for the phenotypes we describe, but rather as a downstream consequence of ECM disruption and following axonal breakage.
Reviewer 2:
The reviewer noted the work provided a strong and thorough genetic analysis of the role of Perlecan in neuronal stability and axonal retraction. The reviewer provided some suggestions for future experiments and requested a few clarifications.
- The reviewer wondered whether mutations in other neural lamella components also cause synaptic retraction and potential genetic interactions between Trol and Vkg.
We agree further genetic studies of other neural lamella components will be of interest. In the case of Vkg, null mutations in the locus result in embryonic lethality, suggesting it plays a more critical role in overall ECM function. Although we did not perform genetic interaction studies between the two mutants (for example trans-heterozygotes), they have been shown to interact in multiple other contexts as described in the manuscript.
- The reviewer noted the lack of whole animal Trol rescue.
As described in point #2 above, we did do pan-cellular rescue experiments with the ubiquitous driver Tubulin-Gal4, but driving our two UAS-trol transgenes resulted in lethality, indicating a strong-dosage sensitivity to Perlecan function.
-
The reviewer indicated the hyperactive Mhc mutant was an interesting experiment but only examines one alternative. They wondered if we could reduce muscle contraction and see if that "rescues" the trol phenotype. The Mhc1 null mutant is embryonic lethal, and the retraction phenotypes do not occur until the 3rd instar stage, so that experiment would not be possible. However, we did attempt to block muscle contraction by expressing a UAS-tetanus toxin to eliminate evoked neurotransmitter release with our MN1-Ib Gal4 driver (pan-neuronal expression of tetanus is lethal). This did not alter the synaptic retraction phenotype, but it was difficult to make strong conclusions for this experiment as the co-innervating Is motoneuron was not expressing tetanus toxin. As such, we did not include this data in the manuscript, though it does generally support the model that synaptic retraction is independent of muscle contraction and rather occurs downstream of the axonal breakage that we highlight.
-
The reviewer wondered whether other Wnt signaling manipulations might be useful to test interactions with the Trol retraction phenotype.
Given we used the same Sgg-CA that was used to block the previously reported ghost bouton phenotype in Trol mutants and saw no effect on retraction, we did not feel that was a fruitful pathway to keep pushing on. Indeed, all our evidence point to a non-Wnt role, with neural lamella disruption and axonal breakage being the key insults.
Reviewer 3:
The reviewer indicated the work described an interesting and important role for Perlecan in motor neuron axon maintenance. The reviewer suggested experiments to elucidate the mechanism of action of Perlecan would benefit the study.
- The reviewer indicated it would be beneficial to validate the Wnt and Wallerian degeneration transgenic lines used in the study to provide a positive control.
Our study used previously published and well-established Sarm RNAi and Sgg-CA transgenic lines (Sarm RNAi from the DiAntonio lab) and Sgg-CA from Kamimura et al., 2013, via BDSC) that have been published multiple times and are well-validated in the field. These were not new lines that we generated. We also blocked Wallerian degeneration with a number of other perturbations to the pathway and did not see rescue of synaptic retraction in these cases either. Sarm is an upstream pathway component and thus the manipulation we included in the manuscript.
- The reviewer notes similar questions on cell-autonomy that we addressed in point 2 to Reviewers 1 and 2 above.
The reviewer noted it would be helpful to show that the single cell-type RNAi experiments are working by western blotting for Perlecan. We performed a similar approach by examining knockdown of the endogenous Trol-GFP by the RNAi with immunostaining. Pan-cellular knockdown with Tubulin-Gal4 eliminates the staining (validating the RNAi line, Figure 1D-I), while knockdown with the individual drivers does not (Figure 5C-G). Although we used well-established cell-type specific Gal4 drivers that have been used to many other studies, we cannot eliminate strength of expression of the driver as an issue for failure to recapitulate the phenotypes. However, other experiments we performed and presented in the figures supports a non-cell autonomous role for Perlecan in axonal breakage and synaptic retraction.
- The reviewer suggested a similar approach that Reviewer 2 did above in point 3 about the role of muscle contraction.
We agree eliminating muscle contraction altogether would be a nice assay for the role of mechanical stress, but we don’t have muscle specific drivers to eliminate contraction from only a single muscle (eliminating it everywhere is lethal). However, we did attempt to block muscle contraction by expressing a UAS-tetanus toxin to block evoked neurotransmitter release with our MN1-Ib Gal4 driver as described above. Future experiments with the newly described BoNT-C toxin produced by the Dickman lab might be a promising approach for a full elimination of all motoneuron release to achieve a similar effect and test in the Trol mutant.
- The reviewer wondered what other components of the ECM are affected beyond Vkg in the Trol mutant.
This is an exciting question to pursue in future studies. Together with genetic interaction experiments with other ECM components, as well as a detailed analysis of the effects on glia that surround larval nerves, such studies will further refine mechanistic actions on how loss of Perlecan triggers axonal breakage and downstream synaptic retraction.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
In the present study, Yasuko Isoe, Ryohei Nakamura & colleagues follow a lineage analysis study aiming at identifying the clonal organization of the dorsal telencephalon. The authors use the teleost fish medaka to conduct their experiments since it displays a clearly delineated dorsal pallium. After identifying the clonal units that constitute the dorsal telencephalon, they analyze the epigenetic landscape in each unit. The authors identify then differential open chromatin patterns that they relate to functional aspects of each unit, and additionally, use the epigenetic landscape to infer the identity of transcription factors operating as putative regulators. Overall, the study consists of an impressive amount of data that shed light on the organization of a central brain region in vertebrates.
The findings in the manuscript are organized into two main sections: lineage analysis and epigenetic organization. The authors combine genetic tools with laser dissections of specific clones and ATAC-seq and RNA-seq analysis in multiple samples, an approach that is very elegant and follows high technical standards. For lineage analysis, the authors used a basic, but appropriate, tool to induce and follow clones generated in early embryos, with the side note that lineages are followed using a non-ubiquitous promoter so that the authors restrict their analysis to neural progenitors. My overall impression is that the authors have collected a massive amount of high-quality data, which unfortunately is not properly integrated or discussed in the manuscript. There is only a superficial effort in incorporating the two main findings, which contrasts with the depth of acquired data.
The observation of clonal sectors in the pallium is a great finding that deserves a more detailed analysis in terms of their developmental and evolutionary origin: How many progenitors are used to set up the entire pallium? What is the smallest clone that contributes to it? Is there any laterality bias in the clonal architecture?
Thank you for the question. We interpret the first question as, “how many neural progenitors (or neural stem cells) at the early developmental stage contribute to the adult pallium?”. Based on the number of clonal units visualized in the pallium, we assume that there are around 50 neural stem cells at the neurula stage that provide cells in the pallium.
In terms of the smallest clone, we found a dozen of cells in the anterior lateral pallium region (Dla) as the smallest clone. But since the HuC promoter activity is not strong in Dla (shown in Figure 1 – figure supplement 2B), we didn’t observe the clones in a reproducible way, so we removed the clones in Dla from the comprehensive structural analysis. The second smallest clone is the cells in the Dcpm, in which only a few dozens of cells were labeled at once.
And for the last question, we didn’t find any lateral bias in the clonal architecture in the telencephalon (shown in Figure 1- figure supplement 3A, 3C)
We added the explanation above in the revised manuscript. (page 29, line 591 - 595)
Is the clonal architecture exclusive for progenitors or does it extend to neurons as well?
Though we used HuC promoter to visualize the clones which should label the neural progenitors, we observed long axonal projections from Dp to the olfactory bulb, which suggest that this transgenic line labels both neural progenitors and young mature neurons, at least in some brain regions. So yes, we assume this clonal architecture extends to neurons as well, and we added descriptions to the revised manuscript. (page 10, line 205-207)
How has the clonal architecture impacted the morphological diversity of the pallium among teleosts? What are possible evolutionary paths to explain this phenomenon? The authors' discussion on this point circles around one concept, illustrated in the following sentence: " (The clonal architecture) ... possibly explains how the difference in diversity between the pallium and subpallium has emerged: the subpallium is conserved because cells belong to various clonal units intertwined with each other, which has constrained their modification during evolution; whereas the pallium is diverse because of the modular nature of the clonal units which allows for the emergence of diversity". This is the concept that I have the most problems with. The authors' reason that a more defined clonal structure (pallium) makes a system more prone to evolutionary novelties, while a region where clones intermingle (subpallium) is more rigid and therefore more conserved between species. Is there experimental data that backs up this statement in any other systems? If there is, I urge the authors to share these here. If this is just a speculation, then the argument would benefit from an explanation of how this clonal organization allows for evolutionary novelty.
We appreciate the reviewer’s question. In order to make our point, we added the following paragraph to the revised manuscript,
“Our structural analysis in the adult medaka telencephalon revealed that the clonal architecture between the pallium and subpallium differs in the distribution of cells in clonal units: clonal units in the subpallium intertwine with each other, whereas the pallium is formed by the compartmentalized clonal units, giving rise to a modular structure. Modular structure is frequently seen in the animal body, including brain; central complex in insect 40, cerebellum in vertebrates 41. And the modularity of cell populations or organs is generally thought to contribute to evolutionary flexibility; one module can acquire a new phenotype without impacting the others.42, 43, 44 . We assume that the modular nature of the clonal units in the pallium plays a key role in the diversity across teleost.” (page 23, line 448-452)
Would it happen by the appearance of more clones at the early stages of development? The authors leave this central point untouched even when discussing the evolutionary origin of the pallium in teleosts.
Thank you for the comment. As shown in the previous report, when the Cre-loxp recombination was induced at the early developmental stage, a wider expression of GFP is observed across the whole brain (Okuyama et al. 2013). This suggests that the neural stem cells at the earlier developmental stage generate daughter neural stem cells which produce neural progenitors later. We added a few sentences mentioning this in the revised manuscript. (page 7, line 146-149)
Having shown the clonal architecture of the pallium and conducted a detailed epigenetic analysis in clones, the authors could also speculate on what is special about this type of organization. Particularly, how they envision that cells belonging to the same clone inherit a common epigenetic landscape that will define their function later on.
Thank you for the comment. To explain the epigenetic feature of this pallial organization, we added the following paragraph in the revised manuscript.
“As shown in mammals, the epigenetic landscape can be inherited from apical progenitors, which have a multipotency, to the late neural progenitors during development 37. Since the teleost exhibit post-hatch neurogenesis in the entire life, we think that the common epigenetic landscape is inherited in each clonal unit in the adult medaka telencephalon. And as a result, we make the assumption that function and characteristic of each clonal unit is defined already in progenitors by specific regulators (e.g. TFs), and those progenitors continuously produce neurons that possess the same property to function in a coordinated manner.” (page 22, line 433-439)
There is little analysis of the cellular organization of each clone, mainly because the authors labeled only a subset of the real, genetic clone. The authors present images of entire brains and optical horizontal and transverse sections, which largely sustain their claims for a clonal organization. The difference in the clonal arrangements between the Dld and the Vd is clear, but the authors could provide a higher-resolution image of some clones in the telencephalon to get an idea of the cellular composition of the regions they use for their analysis.
Here, we added a new panel in Figure 2 which is a combination of previous supplemental figures S3-1,2,3 to show our analysis on the cellular organization of each clone. We showed how the pallial regions, other than Dld, are formed by multiple genetic clones in different colors, and also the projection from each clone. (page 9, Figure 2B)
What is the extent of non-GFP cells in the regions they use for RNAseq and ATACseq? From the images shown it is very difficult to realize whether all cells in the clonal sector do indeed belong to the clone.
Thank you for your question. In our revised manuscript, we analyzed the ratio of cells labeled in this transgenic line (HuC:loxp-DsRed-loxp-GFP). We found that a large portion of cells (around 60-70% cells) are DsRed positive in our transgenic line (Figure 1 - figure supplement 2B). (page 7, line 142-143)
Reviewer #2 (Public Review):
In this study, Isoe and team produced an atlas of the telencephalon of the adult medaka fish with which they better defined pallial and subpallial regions, characterized the expression of neurotransmitters, and performed clonal analysis to address their organization and maintenance during the continuous neurogenesis. They show that pallial anatomical regions are formed by independent clonal units. Furthermore, the authors demonstrate that pallial compartments exhibit region-specific chromatin landscapes, suggesting that gene expression is differentially regulated. Specifically, synaptic genes have a distinct chromatin landscape and expression in one of the regions of the dorsal pallium, the Dd2. Using the region-specific RNA expression and chromatin accessibility data they have generated; the authors propose several transcription factors as candidate regulators of Dd2 specification. Lastly, the authors use the enrichment of transcription factor binding motifs to establish homology between medaka and human telencephalon, aiming to describe an evolutionary origin for the Dd2 region.
Overall, the study carefully describes diverse aspects of neurogenesis in the telencephalon of the adult medaka fish. As such, the manuscript has the potential to contribute insights to the understanding of circuits and neurogenesis in teleosts and the medaka fish, as well as the evolution of cellular heterogeneity and organization of the telencephalon. Furthermore, the atlas, if easily accessible to the broader community, could be a substantial resource to researchers interested in medaka and teleosts neuroscience. However, there are some conceptual and technical concerns that should be addressed to strengthen this work.
Improving the atlas: The different interpretations of the imaging data generated remain isolated or fragmented and could be better integrated to describe anatomical, connectivity, and ontogeny differences through pallial and subpallial regions.
In the revision process, we described the details of anatomical, and connectivity differences in the adult pallial and subpallial regions in Table 2. This document includes the description of comparing the brain regions with previous atlases.
In terms of the ontogeny differences, we described the neural stem cells localization in the telencephalon in Figure 1 figure supplement 4. “The cell-body distribution in the pallium and subpallium is consistent with the pattern of the neural stem cell (radial glial) (Figure 1 – figure supplement 4). In the teleost telencephalon, the cell bodies of radial glia are located in the surface of the hemispheres and project inside the telencephalon 15. Since neural progenitors migrate along those axons, it is consistent that the cell bodies of the pallial clonally-related units are clustered along those axons in a cylindrical way.”(page 8, line 175-179; page 22, line 427-431))
Molecular differences across regions and species: Differential gene expression and chromatin accessibility throughout regions should be better and more deeply characterized and presented, exhibiting more region-specific features, and leading to a better description of candidate transcription factors that could differentially regulate regional gene expression.
The comparison between medaka fish and human telencephalon regions would benefit from a more extensive molecular analysis. Comparison of gene expression and accessible regions could expand the analysis together with TF-binding motif enrichment.
In order to check the gene expression across brain regions in the different vertebrate species, we examined the mammal gene expression data (in situ hybridization) from the Allen Institute database. We analyzed the expression of all the Dd-specific expressing genes (809 genes) across the mammalian brain regions (12 regions), but we could not observe strong correlations with any specific brain regions in mice. Therefore, we have revised our conclusions regarding the correspondence between medaka's Dd2 and mammalian brain regions to be more cautious. (page 20, line 396 - page 21, line 401)
Lineage tracing: The authors claim that the functional compartmentalization of the pallium relies on different cell lineages, which also mostly share connectivity patterns and, at least to some extent, expression patterns. It would be interesting to see how homogenous these lineages are at the molecular level and whether their compartmentalization is retained when neurons reach maturity.
Thank you for the comment. We think single-cell RNA-seq in cell lineages in the future will allow us to see how homogenous cells that derived from the same lineages are at the molecular level and to assess the cell-type of the cells.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #2 (Public Review):
The paper by Arribas et al. examines the coding properties of adult-born granule cells in the hippocampus at both single cell and network level. To address this question, the authors combine electrophysiology and modeling. The main findings are:
Noisy stimulus patterns produce unreliable spiking in adult-born granule cells, but more reliable responses in mature granule cells.
Analysis of spike patterns with a spike response model (SRM) demonstrates that adult-born and mature GCs show different coding properties.
Whereas mature GCs are better decoders on the single cell level, heterogeneous networks comprised of both mature and adult-born cells are better encoders at the network level.
Based on these results, the authors conclude that granule cell heterogeneity confers enhanced encoding capabilities to the dentate gyrus network.
Although the manuscript contains interesting ideas and initial data, several major points need to be addressed.
Major points:
1) The authors use and noisy stimulation paradigm to activate granule cells at a relatively high frequency. However, in the intact network in vivo, granule cells fire much more sparsely. Furthermore, granule cells often fire in bursts. How these properties affect the coding properties of granule cells proposed in the present paper remains unclear. At the very least, this point needs to be better discussed.
In vivo whole cell recordings of granule cells are very scarce. In our study, we based the design of our stimulus on recordings from the intact network in vivo (PerniaAndrade and Jonas 2014), which show that granule cells receive a wide range of frequencies, with a power spectrum that exhibits a power law decay. These properties are built in our noisy stimuli. These in vivo recordings have also reported the presence of theta oscillations, showing a peak in the spectrum. However, in our approach we deliberately removed these oscillations from our stimuli because it is best to fit GLMs using white noise or noise with an exponentially decaying autocorrelation (Paninski et al. 2004).
Thus, our choice of the stimuli is far from arbitrary, but rooted on experimental evidence from intact network in vivo recordings, together with previous knowledge about GLM/SRM fitting. This comment reveals to us that we did not clarify this enough in the manuscript. We are grateful to the reviewer for revealing this omission, since this is in fact an important aspect of the study strategy. In the revised manuscript, we brought these points up front in the results section when we introduce the stimulus for the first time, and more thoroughly discussed it in the Methods section that describes the stimulus.
Still, the bursts observed in granule cells are an important feature and they have been observed to be phase locked to the theta-gamma oscillations in vivo (Pernia-Andrade and Jonas 2014). In the revised version of the manuscript we included new experiments and simulations with stimuli that include a peak in theta frequency. We found that immature neurons also improve decoding performance with these theta modulated stimuli.
2) The authors induce spiking in granule cells by injection of current waveforms. However, in the intact network, neurons are activated by synaptic conductances. As current and conductance have been shown to affect spike output differently, controls with conductance stimuli need to be provided. Dynamic clamp is not a miracle anymore these days.
The use of dynamic clamp sounds in principle like a good suggestion. However, in the manuscript we have taken a different approach to enable the use of a single neuron GLM that uses currents as inputs. To control for the differences between mature and immature neurons we used currents with amplitude normalized by the input resistance, and both types of neurons were measured with the same technique to allow for the comparison.
Importantly, the GLM type model that we use assumes that the membrane potential is a linear convolution of the input, which permits a straightforward and robust fitting approach. We argue that this is not a minor issue, since using dynamic clamp would require a drastic modification of the model. Furthermore, the use of conductance stimuli would not allow for the straightforward model fitting we perform with our approach. The key point here is that the membrane potential would not be correctly approximated as a linear function of the conductance stimulus, precluding the fitting strategy.
Finally, at the moment we do not have the equipment to perform the suggested experiment, so this suggestion would require a big amount of time to acquire the equipment and set up the experiments in mature and immature neurons. In addition, we would have to change the model and develop a different fitting strategy. With the controls that we already have in the manuscript, we do not think dynamic clamp experiments would fundamentally change the conclusions of the manuscript. Thus, we argue that this is beyond a reasonable timeframe for this revision, but could be something to further explore in future. We now mention this possibility in the discussion.
3) The greedy procedure is a good idea, but there are several issues with its implementation. First, it is unclear how the results depend on the starting value. What we end up with the same mixed network if we would start with adult-born cells? Second, the size of the greedy network is very small. It is unclear whether the main conclusion holds in larger networks, up to the level of biological network size (1 million). Finally, the fraction of adult-born granule cells in the optimal network comes out very large. This is different from the biological network, where clearly four or five-week-old granule cells cannot represent the majority. Much more work is needed to address these issues.
The reviewer approves the greedy procedure that we apply in our manuscript and poses three issues for consideration.
First, the reviewer queries what would be the result of starting the procedure with a different pool of simulated neurons, and whether we would obtain “the same mixed network if we would start with adult-born cells”. Let us remark that the outcome of the greedy procedure is not always the same mixed population of neurons. For each different mature neuron that we use to start the procedure, the trajectory (see Fig. 4A) of selected neurons will be different. Thus, the final population (network) will be different, and this is reflected in the error bars that we obtain in Fig. 4. Presumably, starting with adult-born cells will change the outcome of the greedy procedure. However, note that this is not the point of the approach. The motivation to start with mature neurons is to ask whether adult-born cells can contribute something to decoding, given that mature cells on their own perform better.
Second, the reviewer questions the size of the population that we reach with the greedy procedure. Note that for the population sizes that we show in the manuscript the decoding performance already begins to saturate, Fig. 4F-H. Furthermore, it is unfeasible to construct a 1M neurons population due to the computational cost –the time it takes to run the algorithm. These two facts motivated us to stop at 12 neurons as it strikes a good balance between computational time and saturation. Importantly, as we expand below, the aim of the greedy procedure simulation is not reconstructing the actual network of the dentate gyrus. Rather, we seek to understand whether immature neurons could improve coding in a population.
Third, the reviewer observes that the fraction of adult born cells in the reconstructed populations using the greedy procedure are large as compared to the biological network. Again, here note that the aim of the whole in-silico experiment is not to recover the biological network, where other aspects are at play. More simply, we query the possible contribution of adult born cells to coding. In fact, if we obtained the same proportion it would be by chance, since we do not think that adult-born cells in the dentate gyrus are chosen according to the greedy algorithm.
Still, this comment from the reviewer motivated us to include further simulations of the greedy procedure with constraints. In the revised manuscript we show new results using the greedy procedure, but constraining the fraction of immature neurons in the resulting populations, see Figure 4-figure supplement 2.
More generally, we think that these comments reveal a possible misunderstanding about the approach, its purpose and the interpretation of the results. The point of the greedy procedure is to show that immature neurons do in fact contribute to improve the decoding, despite being generally worse individually. We do not claim that the population obtained with the greedy procedure faithfully reflects the actual shape of the in vivo network. We are aware that it does not. We see that this may have not been clear in the original version. In the revised version, we now explain the purpose of the greedy procedure when we introduced it. Additionally, we comment on the proportion of immature neurons in the same paragraph.
4) Likewise, the idea of dynamic pattern separation seems quite nice. However, the authors focus on the differences between mixed and pure networks, which are extremely small. Furthermore, the correlation coefficients of "low", "medium", and "high" correlation groups are chosen completely arbitrarily. A correlation coefficient of 0.99, considered low here, would seem extremely high in other contexts. Whether dynamic pattern separation is possible over a wider range of input correlation coefficients is unclear (see O'Reilly and McClelland, 1995, Hippocampus, for a possible relationship). Finally, aren't code expansion and lateral inhibition the key mechanisms underlying pattern separation? None of these potential mechanisms are incorporated here.
The reviewer positively appreciates the idea of the pattern separation task that we propose in the manuscript, and poses some questions concerning the extent of the contribution of adult-born neurons.
We agree that code expansion and lateral inhibition are key mechanisms for pattern separation in the DG, and we do not claim that adult-born neurogenesis is the key mechanism behind pattern separation. Rather, in our work we explore the role of adultborn immature neurons in coding in general, and in pattern separation in particular, given that it’s a commonly attributed function to the DG.
We note that the correlation in O'Reilly and McClelland 1994 (actually, what they call pattern overlap) is of a very different nature than the one we compute in our work. They compute the overlap between different patterns of activation in a population of neurons, that is the probability that a single neuron is active in two different patterns of activation. In our manuscript we compute the correlation between different continuous time-varying stimuli that stimulate single neurons.
Importantly, previous work has shown that ablating neurogenesis particularly affects fine spatial discrimination, that is when the separation between patterns is small, but not when it is large (Clelland 2009, Science). Hence, we were actually expecting the impact of adult-born neurons to be important only for relatively large correlation coefficient values.
In the revised manuscript, we now explain the rationale for the choice of correlation values, both in the main text when we introduce the task, and in the Methods when we set the values for the low, medium and high correlation classes. We also added a sentence to the discussion on pattern separation, bringing in the importance of the ideas of lateral inhibition, code expansion, and the work of O’Reilly 1994.
5) A main conclusion of the paper is that while mature GCs are better decoders on the single cell level, heterogeneity in mixtures improves coding in neuronal networks. However, this seems to be true only for r^2 as a readout criterion (Fig. 4F). For information, the result is less clear (Fig. 4G). The results must be discussed in a more objective way. Furthermore, intuitive explanations for this paradoxical observation are not provided. Saying that "this is an interesting open question for future work" is not enough.
This is an interesting point raised by the Reviewer. While r^2 is quantified by comparing the decoded stimuli with the true stimuli, mutual information is related to the uncertainty about the decoding. That is, it quantifies the correspondence between decoded and true stimuli, but does not tell us whether it is a good approximation to it. For example, a decoder could achieve perfect mutual information but result in a poor reconstruction by performing a perfectly scrambled one-to-one mapping of the true stimulus [Schneidman et al. 2003], see also our reply to point [5] by Reviewer #1 above.
We agree that this is an important point and we realize that it was not clear in the original version of the manuscript. In the revised manuscript we added some sentences to clarify this point.
6) The authors ignore possible differences in the output of mature and adult-born granule cells in their thinking. If mature and adult-born granule cells had different outputs, this could affect their contributions to the code (either positively or negatively). At the very least, this possibility should be discussed.
Newborn neurons contact the same targets as mature neurons, born during development: pyramidal cells in CA3, and interneurons in CA3 and the DG. During the maturation, there is a sequence of connectivity with CA3 and within the DG (Toni et a. 2008). At 4 weeks, newborn cells are already contacting their postsynaptic targets. Still, there may be subtle differences in the strength of these connections compared to mature neurons.
So, although the targets are the same, there may be quantitative differences in the way they contribute to the code. Thus the point raised by the reviewer is interesting, so we decided to discuss it further in the revision.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
This manuscript by Toshima et al. describes a study of the organization of traffic in the endomembrane system of the budding yeast Saccharomyces cerevisiae. The authors address the relation between endocytosis and the Golgi (TGN: a collection of maturing membrane elements derived from the trans-Golgi). The study builds on a previous article by the group of Benjamin Glick. In that study (Day et al., 2018), it was postulated that the TGN is the first destination for yeast endocytic traffic after internalization from the plasma membrane. Additionally, Day et al. had shown that endocytic recycling traffic towards the plasma membrane departs from the TGN as well. Therefore, early endosome and recycling endosome compartments would be identical to the TGN or contained within it. Here, Toshima et al. use super-resolution confocal live imaging microscopy (SCLIM) to refine a model of endocytic pathway organization. This powerful imaging technology allows them to show that out of two partially overlapping TGN markers, namely Tlg2 and Sec7, the syntaxin Tlg2 correlates better with the arrival of fluorescently labeled endocytic cargo than alternative TGN marker Sec7. Building on this main finding, the authors conclude that a specific part of the TGN (an "independent sub-compartment") functions as the early endosome. Further experiments in mutants for GGA clathrin adaptors, required for departure of endocytic cargo from the TGN to the Rab5-positive prevacuolar endosome, show again that endocytosed cargo accumulation correlates better with Tlg2 than with Sec7. Furthermore, in GGA mutants the overlap between Tlg2 and Sec7 is decreased, suggesting that GGA is required for maturation of this Tlg2 sub-compartment.
The study is well conducted and its main conclusion that a Tlg2 subregion within the TGN functions as the early endosome seems well supported by the superb live imaging and the analysis of GGA mutants.
Although a technical feat in live superresolution imaging, this single kind of data (moving, shape-shifting blobs of fluorescently-labeled proteins) does not totally fill with meaning the terms "compartment", "sub-compartment", or "independent sub-compartment". This, I think, is the main limitation of the study. Are these compartments or sub-compartments individuated membrane elements, collections of vesicles, regions of the same cisterna or saccule? For this, electron microscopy would be needed.
We are very grateful for the reviewer’s favorable evaluation of our study. In accordance with the editors’ judgment in "Essential Revision", we have not performed electron microscopy analysis for this revision. However, we have addressed all other valuable comments.
Reviewer #2 (Public Review):
In this manuscript Toshima et al document the use of sophisticated microscopy - with powerful spatial and time resolution - to image markers of the yeast endosomal system.
The initial work documented in this paper does a good job of defining the compartment endocytic cargoes internalise to. This is convincingly shown to be a compartment that is not marked by Sec7 but is instead a distinct (sub)compartment marked by the SNARE protein Tlg2. This agrees with many previous studies, (including biochemical experiments and microscopy of cargoes in a series of membrane trafficking mutants) but has different conclusions to another study (Day et al 2018 - Developmental Cell). Although the microscopy techniques used in the two studies are different, the yeast system and many of the reporters (FP tagged Tlg1, Sec7, Vps21 and fluorescently labelled mating factor) are the same. The Day et al study is suitably referenced throughout the manuscript but as to why the authors have come to fundamentally different answers about endocytic cargoes internalising to a Sec7+ compartment, is not discussed.
According to the reviewer's suggestion, we have added a paragraph discussing about this (line 533-539).
The work goes on to show endocytic carriers (marked by Abp1) and endocytic cargoes like fluorescently labelled mating factor internalise to the Tlg2+ compartment. The forward trafficking of these molecules is then observed to transit to a later endosome compartment labelled by Vps21. The super-resolution and time lapse imaging, sometimes even using 3 colours - is of very high quality and fully support the model presented at the end of the paper for this trafficking itinerary. Trafficking mutants are also used (such as a defective allele of arp3 and deletion of VPS21 / YPT52 GTPases) to interrupt trafficking routes and define the pathways followed by endocytosed mating factor.
The endocytic trafficking from Tlg2+ to Vps21 compartments is shown to be defective in mutants lacking GGA adaptors (gga1∆ gga2∆), with cargoes accumulating in the Tlg2+ compartment and other clathrin adaptor mutants not causing this defect. This research avenue also reveals that the GGA proteins are required to maintain the distinct Tlg2 sub compartment.
The final section of the paper uses the same tools to analyse the localisation of the recycling v-SNARE protein Snc1. This is arguably the most important set of experiments in the paper, not only is Snc1 a putative v-SNARE that functionally interacts with Tlg2, but this cargo, unlike pheromone, allows the investigation of recycling back to the PM from TGN/endosomes. However, the authors do not comment on the fact that Snc1 does not localise to the plasma membrane in either experiments using different microscopy techniques (Figure 5A + 5B), calling into question whether the recycling pathway is operating properly or that the FP-tagged machinery has disrupted processing? The steady state localisation of Snc1 in WT cells only looks normal in Supplemental figure, this discrepancy should be discussed or addressed.
As the reviewer points out, fluorescent protein-tagged Snc1p usually localizes to the plasma membrane in addition to cytosolic puncta, as shown in Fig. 6–figure supplement 1A. In Fig. 6A, localization of GFP-Snc1p is demonstrated by focusing on the cell surface using a TIRF microscope, which differs from that focusing on the medial focal plane. Therefore, Fig. 6A shows that GFP-Snc1p localizes to the plasma membrane, albeit with evident punctate localization.
Localization of mCherry-Snc1p to the plasma membrane was also observed in the images obtained by SCLIM. However, since the intracellular signals of mCherry-Snc1p are partially blocked by those around the plasma membrane, in Fig. 6B the intracellular localization has been emphasized by modulating the contrast, thereby reducing the fluorescence signals at the plasma membrane. In the new manuscript, we have added an image with only slight contrast (Fig. 6–figure supplement 1C) in the same cell as that shown in Fig. 6B.
Reviewer #3 (Public Review):
The manuscript by JY Toshima et al. is an excellent and important study that demonstrates very clearly the existence of an endosomal compartment in yeast, distinct from the trans-Golgi network, to which endocytic vesicles fuse upon internalization. They show that this compartment is enriched in the SNARE protein Tlg2, a yeast homologue of syntaxin, and is segregated from the Golgi-localized Sec7-containing compartment, indicating that the organization of the endocytic system in yeast is similar to that of animal cells. Furthermore, they demonstrate the trafficking machinery required for maturation of this compartment, and that it is also a station on the pathway back to the plasma membrane. Because there have been conflicting reports in the literature as to the existence of an endosomal compartment in yeast distinct from the trans-Golgi network, this paper is of great importance for the cell biology community.
Major strengths of this study are the cutting-edge imaging technology used, and the careful, quantitative analyses carried out. The authors use a super-resolution live cell imaging approach that allows them to discriminate to a high resolution different compartments and membrane domains of highly dynamic yeast organelles, and to follow an internalizing cargo over time. With their manuscript, they have provided a full set of movies, along with quantifications, to support their conclusions.
The authors use fluorescent-protein-labelled endocytic cargo (alpha-factor) and florescent-protein-labelled compartment markers, assaying them in high resolution and super-resolution live cell imaging microscopy systems. In this way, they are able to follow trafficking of cargo through compartments in real time. The authors first demonstrate that the alpha-factor cargo substantially colocalized with the SNARE protein Tlg2, a marker of early endosomes, but very little with Sec7. They also show that Tlg2 marks a sub-compartment distinct from the Sec7 compartment, but adjacent to it. Furthermore, they demonstrate using super-resolution microscopy and triple color 4D imaging that endocytosed alpha-factor cargo structures make contact with the Tlg2 compartment, adjacent to the Sec7 compartment, then disappear, supporting the conclusion that endocytic vesicles first fuse with the Tlg2 compartment. Next the authors show that alpha factor is transported from the Tlg2 compartment to the Vps21 compartment, a process that requires the GGA adaptors Gga1 and Gga2. Finally, the authors show that recycling of the endocytic R-SNARE Snc1 also occurs by passage through the Tlg2 compartment.
The use of mutants that affect different stages of endosomal trafficking is a strength of the manuscript, as it allows elucidation of the mechanism of transport through successive compartments. Importantly, using a gga1-delta gga2-delta mutant, the authors demonstrate convincingly that the GGA adaptors Gga1 and Gga2 are required for alpha factor transport from the Tlg2 compartment to the Vps21 compartment.
Throughout this study, the authors use fluorescent protein-labelled cargo and compartment markers (EGFP, mCherry, iRFP), but don't explicitly state to what extent these fusion proteins are functional compared to the endogenous proteins. They could cite previous publications or their results describing the functionality of the fusion proteins used.
According to the reviewer's suggestion, we have cited previous publications for GFP-Tlg2 (Seron et al., MBoC, 1998), Sec7-GFP/-mCherry (Seron et al, MBoC, 1998; Llinares et al., Sci Rep, 2015), Abp1-mCherry (Kaksonen et al., Cell, 2003; Picco et al., eLife, 2015), GFP-Vps21 (Toshima et al., Nat. Comm, 2016), Gga2-mCherry (Daboussi et al., NCB, 2012), GFP-Snc1p (Lewis et al., MBoC, 2000), and GFP-Ypt31 (Kim et al., Dev Cell, 2016). We have also added data showing the functionality of Abp1-mCherry (Fig. 2–figure supplement 1A), Sec7-iRFP (Fig. 1–figure supplement 1F), Gga2-mCherry (Fig. 5–figure supplement 2G), and GFP-Ypt31p (Fig. 7–figure supplement 1A) in the new manuscript.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
Luu et al. have developed a genome-edited African elite rice variety, Komboka. The work was initiated in response to the outbreak in Eastern Africa by Xanthomonas oryzae strains that are phylogenetically related to Asian strains and carry TALes, similar to strains from China, possessing an expanded repertoire of TALes compared to those in endemic strains. As these emerging strains contain TALe targeting SWEET11a, as well as that suppressing Xa1, pthXo1, and iTALes, the authors have generated edited lines targeting promoter regions of SWEET11a, 13 and 14 in African elite rice variety, Komboka. The same team has previously generated genome-edited lines targeting the promoter regions of SWEET11a, 13, and 14 in varieties Kitaake, IR64, and Ciherang-Sub1. Bacterial blight outbreaks and emerging pathogen lineages remain to be a threat to rice production. Thus, efforts in targeting pathogen weaknesses to generate genome-edited varieties possessing broad-spectrum resistance are required. The survey, collection of isolates, and strain characterization studies on >800 strains are commendable. This study has taken advantage of this ongoing collection to stay ahead in the arms race to deploy broad-spectrum resistance in an elite rice variety using TALe targets.
Overall conclusions presented here are supported to some extent; however, I have listed some of my comments and concerns below.
1) Data in supplementary table 2 suggests that Komboka is still a moderately resistant variety under field conditions in Africa, with a disease severity scale of 2 i.e. 4-6% disease severity, compared to other varieties having a disease severity scale of 5. Thus, I am not convinced that emerging strains are of concern on the Komboka variety under field conditions, thus, question the justification of Komboka being a choice for editing to tackle emerging strains.
We apologize, because the Table 2 is admittedly hard to read with the geo data. We have thus added a new figure 1 with maps. Please note that the data in this Table are from 2022. If you look at for example the Morogoro region (Dakawa and Lunkege), it appears that also there, the initial scale (number of plants infected) was low and became more severe in the subsequent years as one might expect. We thus hypothesize, that in the upcoming analyses, the scale will also become much higher, thus this snapshot cannot serve as a measure of general susceptibility. As we noted in the response to the Editor, the Kaufmann clipping assays are widely used by breeders to evaluate resistance in greenhouse conditions, and since the assays uses severe wounding and extremely high bacterial inocula, this assay is a reliable measure of susceptibility. Note also, that Komboka was chosen before the outbreak was characterized. Our data show that Komboka is highly susceptible to Asian strains, as well as to the introduced strains. Note also that we characterized the R gene outfit as far as feasible, an found two R genes that can explain the resistance to the endemic African strains. Note that single, double and triple R gene mutant combinations have been broken in India, thus we deemed it necessary to create a rational approach that prevents SWEET gene recruitment to generate broad spectrum resistance. xa13 has likely only been broken by circumventing SWEET11a (by using SWEET13 or 14), but still stands up in quintuple breeding combinations in India. Thus, we expect that our lines will be rather robust, which will have to be tested in future field trials in Kenya where this variety is highly cultivated. We added text to Results, Discussion sections and a new section on sampling in Methods with respective references that show the correlation of data from assays with the same strains in greenhouse and field.
2) Is Xa4 from Komboka related to Xa4_Teqing? The breakdown of Xa4T was due to the mutant allele of avrXa4 in virulent Xoo CR6. But this breakdown was accompanied by a fitness penalty and residual QTL had a significant residual effect on virulent strains. Would this be why Komboka carrying Xa1 (Xa45(t) and Xa4 under field conditions still showed moderate resistance? But Xoo strains showed susceptibility in leaf clipping assays.
We apologize, this was a typo that has been corrected. Komboka is a high yielding variety, we thus cannot comment on any yield penalty here, it is superior and widely accepted now in Kenya. And we responded regarding on the moderate resistance in the previous paragraph. Komboka is fully susceptible to the Asian strains that induce SWEET11a.
3) I felt a bit of a disconnect in sections on phenotypic assays confirming the virulence profile of strains on Komboka and then understanding mechanisms underlying virulence since the same strains used in path data were not the ones mentioned in WGS and TALe analysis, leaving the readers with the only one strain to support the hypothesis of the basis for higher disease severity on Komboka due to new TALes, pthXo1, and iTALe. Do authors have pathogenicity data for African strains T19, Dak16, and Xoo3-1 that grouped with endemic African strains on Komboka? Authors present data on CIX4457, 4458, and 4462 being virulent on Komboka, and show that they cluster with Asian strains. However, in the tree, 4462 is the only one shown to be closely related to Chinese strains. Where are 4457 and 4458 placed? Do 4457 and 4458 also contain pthXo1 and iTALe? Authors could also provide path data for 4506/4509 that they included in TALe figure and in the phylogenetic tree.
We had initiated WGS of 8 strains (3 from Dakawa and 5 from Lukenge), but at the time of submission, not all genomes were fully polished. Although not all are in a publishable state by now, we were able to determine the similarity as well as presence of pthXo1 and iTALes. The number of SNPs among the 8 strains is extremely low (between 1 and 4), strongly intimating that they are siblings. They are so similar, that we can at present not trace the origin. All eight strains isolated in Dakawa in 2019 and in Lukenge in 2021 contain iTALes and the PthXo1B variant. With near certainty that they are all derived from a single introduction event. We fully understand your comment. We apologize, since we should not have used the CIX nomenclature, which was introduced to obtain a more reliable code for the strains. We have introduced a clearer nomenclature while keeping the code for the database. We added a new Figure 2-supplement 1 which shows that Komboka is susceptible not only to the three strains isolated in Dakawa in 2019, but also to one of the strains isolated from Lukenge in 2021. We replaced Fig. 3 with a new phylogenetic tree including the eight strains and provide more detailed information on the relation of those strains. In principle it would be sufficient to use a single isolate in this case. We now provide, as far as possible the new data (analysis is ongoing) as well as new data for some strains collected in 2022 and conclude that also the strains identified in 2022 are derivatives from an initial introduction in the Morogoro region. It is also clear from Fig. 2 and supplement that Komboka is fully susceptible to the strains isolated from Dakawa and Lukenge, as susceptible as to the Philippine reference strain PXO99A, which also uses PthXo1.
4) The authors present pathogenicity data on EBE-edited T0, T1, and T2 lines of Komboka which are promising against the Tanzanian strains carrying new TALes. The cas9/cpf1 system developed here to target multiple EBEs will be a valuable contribution to the scientific community. What are the agronomic characteristics of these edited lines? As the edited lines have not been tested against a diversity panel of Asian and African strains, I would be skeptical of the choice of the term "broad-spectrum" yet.
Virulence of Xoo depends critically on the recruitment of at least one of the three SWEETs (11a, 13 or 14). Single R genes, such as xa13 can be overcome by using SWEET13 or 14. All strains that are virulent carry at least one TALe that targets a SWEET. Thus, by blocking all known EBEs, we obtain broad spectrum resistance. We have not observed a single case yet where this is not working. Note that in the case of EBE edited Kitaake, we tested about 100 different strains from a world-wide collection, for IR64 and Ciherang-Sub 1 also many representative strains, and we now show data for Komboka and additional varieties. Thus, based on the current knowledge, including the information gained from Xoo genome sequences that have been published, e.g., recently from India, there is at present no strain known that can overcome this resistance.
Regardless of my comment earlier on Komboka being moderately resistant under field conditions and thus a questionable choice for EBE-editing here, the genome-edited lines in any variety imparting resistance to bacterial blight remain to be a valuable contribution to managing disease outbreaks.
We commented on the interpretation of moderate resistance above, but appreciate the comment that these lines will be valuable.
5) As this manuscript utilizes the diversity of African strains to generate edited lines, it would be good to make diagnostics and path data for 833 strains available to the scientific community (instead of select strains as indicated in the supplementary table), especially for the fact stated here in the manuscript about scarce data on Xoo in Africa and the goal of systematic comparison of the pathogen population.
We are currently preparing a manuscript that will include an extensive analysis of these strains, and focus on the diversity of African Xoo strains, i.e., MLVA-based diversity of the collection. This manuscript, which is in preparation, will include the requested data.
Reviewer #2 (Public Review):
This study describes the emergence of virulent strains of the rice bacterial blight pathogen Xanthomonas oryze pv. oryzae in the Morogoro rice-growing region in Tanzania. The aims of the study were to describe the virulence features of the emerging population, as compared to previous bacterial blight outbreaks in Africa, and generate an elite rice variety that is resistant to both pathogen populations. To achieve these aims, the authors characterized the genetic basis of the virulence of these new strains by sequencing the genomes of three representative strains and phenotyping using excellent genetic resources for identifying the susceptibility gene targets of this pathogen in rice. They then used two rounds of hybrid CRISPR-Cas9/Cpf1 to successfully edit six targets of the pathogen in an East African rice variety, which conferred resistance to all strains tested.
The strengths of this paper are the systematic analysis of the virulence of emerging pathogen strains relative to strains from previous outbreaks and the successful creation of edited lines that will form the basis for continued efforts to gain regulatory approval for the introduction of resistant rice in East Africa. The creation of the edited line is a substantial and important contribution, indeed, the authors include strains collected in 2021 and include disease severity data from 2022 in the supplementary data, illustrating the urgent need for solutions.
The weaknesses of the study are largely related to the quick turnaround between data collection and manuscript submission.
1) Different strains are used for different experimental work and sequence analysis, making relationships between different parts of the work unclear and also more challenging for the reader to follow because of changing strain designations. CIX4457, CIX4458, and CIX4462 were virulent on rice near-isogenic-lines, CIX4457 and CIX4505 were used for identifying SWEET targets and phenotyping edited lines, while whole genome sequencing was conducted with CIX4462, CIX4506, CIX4509.
We added new information which demonstrates that the strains isolated in 2019 in Dakawa and the strains from Lukenge (2021) are very closely related and differ only by a 1 to 4 core genome SNPs (see new supp Fig. 3A). We added a new Figure2-supplementary Figure 1 and expanded Table 1 to show that the strains from Lukenge and Dakawa behave in a similar manner. We are aware of the differences in the figures but hopefully have now addressed them in an acceptable manner, we did not want to combine data from different experiments. The differences in strain use are due to i) the different timing of strains sampling and isolation (those from 2019 were isolated first and the long and tedious work of leaf-clipping the whole set of NILs with all the diversity strain panel did therefore not include Tanzanian strains from 2021 that were isolated much later also due to long delay in having the infected leaf material sent out; including them in the NILs testing would have taken us another year given the volume of this experiment), and ii) the variable quality of whole genome sequencing of the strains. Overall, we have sequenced the genome of 8 newly introduced strains including 3 from Dakawa_2019 and 5 from Lukenge_2021 (see new suppl. Table 3 that gives a detailed overview of the genomic analysis of these strains). The best genome sequences were obtained for strains CIX4462, CIX4506 and CIX4509 (renamed in the revised version of this MS and for sake of clarity as iTzDak19-3, iTzLuk21-1 and iTzLuk21-2) of which a circularized chromosome could be generated. Unfortunately, these were not the strains that we had selected for SWEET characterization and phenotyping of edited lines, whereby one representative strain of each collection had been randomly picked, namely CIX4457 and CIX4505 (now iTzDak19-1 and iTzLuk21-3, respectively). To reconcile these two sets of data and show that strains from Dakawa and Lukenge are actually extremely similar, we have performed a SNP-based phylogenetic analysis of the 8 strains demonstrating that they all cluster as one homogeneous genetic lineage, in line with a scenario whereby all these strains result of a single introduction event from Asia. Careful analysis of these additional genomes also confirmed the presence of a pthXo1like allele (pthXo1B) and iTALes in all Tanzanian strains introduced from Asia. One exception is strain iTzLuk21-3 (CIX4505) where the poor quality of the pthXo1B sequence with potential frameshifts prevented any confirmatory analysis. Taken together, these data support the hypothesis that all new isolates, irrespectively of the year of sampling, are genetically very close and share the same virulence characteristics.
2) Disease survey results from 2022 are listed in Supplementary Table 2, but it is challenging for the reader to summarize across many lines of data, which appear to represent individual samples.
We agree that this was not the best way to show the data. In addition to the new suppl. Tables 1 and 3 we have now generated a new Figure 1 which contains maps of the disease distribution and severity across Tanzania in the different years as well as photos from the fields in Dakawa from 2019 and Lukenge in 2021 that highlight the massive infections.
3) The focus of the editing is Komboka but bacterial blight in 2022 was mostly on other varieties. It would be helpful to have more context on this variety and what has prevented adoption by the growers in the Morogoro region to date.
The variety was chosen several years ago after extensive consultations with breeders from IRRI, IRRI Africa, and India, since it is high yielding, and was specifically generated for Kenya where it has a high level of adoption. Tanzania has apparently not yet adopted this variety as you can see from Table 2. Also, Tanzania does NOT have any regulations for genome edited crops and we can thus NOT provide the lines to Tanzania. By contrast, Kenya has established a regulatory framework by which the local government authorities can import transgene-free edited lines. We are currently segregating the transgenes out and have established a through set of measures to validate whether the lines still contain transgenes (including vector backbone and T-DNA remnants). Tanzania will have to establish suitable guidelines. We would like to note that establishing protocols for different elite varieties is challenging and time consuming and we had early on, in 2019, decided to initiate work on transformation protocols for this variety. If Tanzania also adopt regulations, it would be possible to provide the lines to Tanzania as well, and possibly by then Tanzania has a higher level of adoption of Komboka. If you look at the maps we show, it is very likely that the disease will spread to all neighboring countries, including Kenya. Thus, our lines may become one possible measure to try to address the outbreak.
Reviewer #3 (Public Review):
One key finding of this work is the identification of Xanthomonas oryzae pv. oryzae (Xoo) strains in Africa, based on their genomes sequence and their TALE repertoires, have high similarity with Asian strains. Asian Xoo strains typically overcome NLR-mediated recognition of TALEs in rice by so-called iTALEs. Moreover, some Asian strains contain a TALE resembling PthXo1, a TALE protein that was shown to overcome xa5 resistance.
The authors now found that some of the newly identified African strains have iTALEs and PthXo1-like TALEs. Such newly evolved African strains were found to be fully virulent on the African rice elite variety Komboka, which is resistant to a broad panel of African Xoo strains.
Previous studies have shown that TALEs bind to effector binding elements (EBEs) present in promoters of rice SWEET genes to promote disease. Work from the lab of the authors and other labs has shown that TALEs can no longer promote the disease if matching EBEs are changed or deleted by CRISPR or TALEN-mediated mutagenesis. In fact, pioneering work by Bing Yang, one of the authors of this article published about ten years ago a Nature Biotechnology article where he showed that rice plants with mutated EBEs are resistant to Xoo. Recently, a combined effort of the Yang and Frommer labs resulted in two further Nature Biotechnology publications (2019), in which they described along with other useful tools rice lines where multiple EBEs were mutagenized in parallel and that provide broad spectrum resistance.
The work under review describes now CRISPR mutagenesis of an African elite cultivar resulting in a line that mediates resistance to Asian and newly evolved African strains.
Overall, the work is technically sound. Yet, the approach that has been described - mutagenesis of multiple EBEs - has been used before and is a routine procedure for labs that are focused on such undertakings. While such approaches do not provide new insights for fundamental research, they nevertheless are certainly important and useful in translational research, as demonstrated here.
We thank reviewer for the comments. If we may, we would like to add aspects of novelty. We detected an outbreak that is spreading. We determined the disease mechanism, and we used CPF1 to obtain ‘optimal’ mutations at all sites (massive improvement over 2019 publication, which used Cas9) and we try to provide a solution for the outbreak when it spreads to Kenya, or when Tanzania and neighboring Countries adopt similar guidelines. This seems highly urgent das Reviewer 2 points out.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
This study used intersectional genetic approaches to stimulate a specific brainstem region while recording swallow/laryngeal motor responses. These results, coupled with histology, demonstrate that the PiCo region of the IRt mediates swallow/laryngeal behaviors, and their coordination with breathing. The data were gathered using solid methods and difficult electrophysiological techniques. This study and its findings are interesting and relevant. The analysis (and/or the presentation of the analysis) is incomplete, as there are analyses that need to be added to the manuscript. The interpretation of the data is mostly valid, but there are claims that are too speculative and are not well-supported by the results. The introduction and discussion would benefit from more citations and a deeper exploration of how this study relates to other work - especially a thorough accounting of and comparison to other studies concerning putative swallow gates.
General/major concerns:
The field of respiratory control is far from unified regarding the role of PiCo in breathing or any other laryngeal behaviors. If anything, the current consensus does not support the triple-oscillator hypothesis (in which PiCo is one of 3 essential respiratory oscillators). The name "PiCo", short for "post-inspiratory complex", suggests a function that has not been well-supported by data - it is a putative post-inspiratory complex, at best. I suggest putting this area in context with other discussions i.e. IRt (such as in Toor et al., 2019) or Dhingra et al. 2020 showed broad activation of many brainstem sites at the post-I period (including pons, BotC, NTS)
The reviewer’s comment refers to our previous publication and not the present one. With all due respect to the reviewer, the submitted study investigates PiCo’s involvement in swallow and laryngeal activation and its coordination with breathing.
We did not feel that it is appropriate for us to critique the Dhingra paper in the present study. However, since this seems to be important to this reviewer, we would like to clarify: Because of filter characteristics, and the low temporal and spatial resolution of these field recordings, the approach used by Dhingra is inappropriate for providing insights into the presence or absence of PiCo. We therefore developed an alternative approach, which provides more detailed insights into population activity, the Neuropixel approach. This Neuropixel recording from PiCo (black trace) exemplifies how field recordings (yellow) fail to pick up post-I activity. We could provide many more examples, but as stated above, addressing the study by Dhingra is tangential to the present study.
We would also emphasize that the study by Dhingra was never designed to provide negative evidence, and Dhingra et al. never claimed that their study demonstrates the absence of PiCo. Unfortunately, the data by Dhingra were misinterpreted by Swen Hülsmann in his Journal of Physiology editorial which created considerable confusion, but also sensation in the field. Objectively, Toor et al reproduced the Anderson study in rats as we will elaborate below. Unfortunately, Toor et al added to the confusion, by renaming the PiCo area into IRt. The field of respiration would have also been confused if the first study reproducing the Smith et al. 1991 study in a different rodent species would have refused to call this area preBötC and instead would have called it e.g. ventrolateral reticular field.
Did you perform control experiments in which the opto stimulations were done on animals without the genetic channels (for example, WT or uncrossed ChAT-ires-cre, etc.), or in mice with the genetic channels that weren't crossed (uncrossed Ai32 mice)? If so, please include. If not, why?
Yes, we performed many control experiments. Aside of many recordings in which viral injections were targeted outside PiCo, we also performed optogenetic stimulations in mice lacking channelrhodopsin. We have now added the following statements and supplemental figure.
Optogenetic stimulation in mice lacking channelrhodopsin
Stimulation of PiCo, across all stimulation durations, in 3 Ai32+/+ mice and 4 ChATcre:Vglut2FlpO:ChR2 mice where the ChR2 did not transfect ChATcre:Vglut2FlpO, as confirmed by a post-hoc histological analysis, resulted in no response (Fig. S3).
How do you know that your opto activations simulate physiological activation? First, the intensive optical activation at the stim site does not occur in those neurons naturally.
This seems like a generic critique of the optogenetic approach. In none of the 10,000+ published optogenetic studies is it known to what extent optogenetic activation stimulates exactly the same neurons and the same degree of activity as during a natural behavior. What we know is that PiCo neurons are activated during postinspiration (Anderson et al. 2016) and that optogenetic activation stimulates these neurons and that this activation evokes the same muscles in the same temporal sequence as a water-evoked swallow. We assume that the reviewer’s comment does not intend to imply that “swallows” evoked by nonspecifically stimulating the SLN is more physiological than the optogenetically-evoked swallows of a specific neuron population? From the reviewer’s other comments, it is obvious that the reviewer has no problems with the results of the Toor study that used exclusively SLN stimulations, an approach which is known to be very non-specific.
Doing a natural (water) stim for comparison is good, but it cannot necessarily be directly compared to the opto stim. The water stim would activate many other brainstem regions in addition to PiCo.
Can the reviewer provide any hard evidence that “many other brainstem regions” are activated by water stimulation in comparison to optogenetic stimulation?
A caveat is that opto PiCo stim =/= water stim (in terms of underlying mechanisms) should be included. Second, in looking at the differences between water vs opto swallows in Table S2: it appears that the ChAT animals (S2A) have something weaker than a swallow with opto stim. For the Vglut2 and ChAT/Vglut2 (S2B&C), the opto swallows also aren't as "strong" as the water swallows (the X and EMG amplitudes are smaller). The interpretation/discussion attributes this to the lack of sensory input during opto stim, but does not mention the strong possibility that there is a difference in central mechanisms occurring. It also seems to be dismissed with the characterization of the swallow as "all-or-none" (see note on Fig 3 results).
With all due respect, we are somewhat surprised that the reviewer dismisses the entire paragraph in the discussion that specifically addresses the comparison between water-swallows and PiCo-stimulated swallows. We discussed the possibility that PiCo stimulated swallows may not activate the full pathway/mechanism as does the water swallow. We carefully compared and confirmed that PiCo-stimulated swallows have the same temporal motor sequence of the same muscles as those activated in water swallows. As already stated, it is surprising that the reviewer has no problem with accepting the validity of previously published methods like electrical non-specific stimulations of the cNTS or SLN, a frequently used and accepted model to produce and study swallow.
The writing needs extensive copy editing to improve clarity and precision, and to fix errors.
Thank you for this comment, we have revised and reviewed the writing.
Results/Fig 1: What proportion had no/other motor response (non-swallow, non-laryngeal) to the opto stim? I can extrapolate by subtraction, but it would be nice to see the "no/other response" on the plot.
With all due respect to this reviewer, but it is not possible to address this question. Specifically, it is not possible to know if a “No response” (meaning “no behavioral output” occurred in response to PiCo stimulation), would have resulted in a swallow or laryngeal activation. However, figure 2 contains responses other than swallows, i.e. “non swallows”, which includes both laryngeal activation as well as “no responses” meaning “no behavioral response” in response to PiCo stimulation. This was determined to assess how the respiratory rhythm is affected when a swallow is not produced by PiCo stimulation.
The explanation of genetics is too spread out and confusing. There needs to be more detail about all the genetic tools used, using the standard language for such tools, in one spot. Please also provide a clear explanation of what those tools accomplish. Include a figure if necessary.
We apologize for creating confusion. We added more explanations to the text.
Pick a conventional designator/abbreviation for the different strains, define them in the methods and in the first paragraph of the results section, and use those abbreviations throughout. I think that using ChAT as an abbreviation for your ChAT-ires-cre x Ai32 mice is confusing because it makes it sound like you're talking about the enzyme rather than the specific strain/neurons. Saying "ChAT stimulated swallows... swallows evoked by water or ChAT" makes it sound like the enzyme choline acetyltransferase itself is stimulating swallow. As is convention, pick a more precise abbreviation like ChAT-cre/Ai32 or ChAT:Ai32 or ChAT-ChR2 or ChAT/EYFP. This goes for the other strains as well.
Thank you for pointing this out. To avoid confusion the strains/neurons are now referred to as: ChATcre:Ai32, Vglut2cre:Ai32, and ChATcre:Vglut2FlpO:ChR2
For Fig S2C&D, why does it say mCherry? Isn't it tdTomato? Is it just an anti-ChAT antibody and then the tdTomato Ai65 is only labeling Vglut2? I don't see this in the methods section.
Thank you for pointing this out. We apologize for our mistake, and we have corrected the manuscript to say tdTomato.
I also don't see methods for all the staining in Fig S3. The photomicrograph says Vglut2-cre Ai6, but there's no mention of Ai6 anywhere else. Which mice are these? Did you cross Vglut2-cre with an Ai6 reporter mouse? How can you image an Ai6 mouse (which I assume expresses ZsGreen? and that you excited at 488?) and a 488 anti-goat in the same section (that's the only secondary listed in the methods that would work with your goat anti-ChAT)? Is there an error in listing the fluorophores in the methods? Please give more details on the microscopy including which filters were used for the triple staining.
We have decided to remove the CTb data from the manuscript.
Regarding the staining: I would expect the staining/maps in for the 2 different ChAT/Vglut2 intersectional strains to be similar (Fig 5A/B and S2C/D). The photomicrographs look very different to me, while the heat maps (this goes for all the heat maps in the paper) have barely distinguishable differences. In Fig 5, the staining looks much stronger than in Fig S2C. Why does it look like there are so many more transfected neurons in Fig 5A2 than there are red neurons in the corresponding panel Fig S2C2? And for Fig 5A4 and Fig S2C44? The plot and results text for Fig 5 says the avg number of neurons was 123+¬11. The plot for Fig S2D says 112+¬15, but the results text says 242+¬12 (not sure which is the correct number).
Thank you for your comments. Previously the heat maps had different scale bars if you compare Fig 5A/B and S2C/D (now figure S4C/D). We changed the heat maps keeping the same scale for all of them. Discussing the representative photomicrography, even figure Fig 5A/B and S4C/D represents the same cluster of cells (PiCo Chat/Vglut+). Figure S4D states 242 ± 12 neurons (also stated in the results section).
However, we want to point out that there are several technical differences between both, 1) figure 5A represents the transfection promoted by the virus injection, impacting the number of cells stained/transfected (133 ± 16 neurons), 2) figure S4C/D represents a intersectional mouse ChATcre: Vglut2FlpO: Ai65; (242 ± 12 neurons). In this case, we have more tdTomato positive cells because this genetic approach is able to detect most of the Chat and Vglut2 cells. The difference between figures is considered normal for anatomical studies, in some studies the same bregma can show different number of cells. Thus, the differences are due to the differences in the type of approaches (viral expressions vs. intersectional approach).
We have also added additional experiments to figure 5 (now N=7) which has been reflected in the text and figures.
The results text for Fig S2C also says the staining is "similar to the previous ChAT staining...", which I assume refers to S2A/B. The plot and results text for Fig S2B reports 403+¬39 neurons, while S2D is either 112 or 242 (not sure?). The plots have different Y scales, which should be changed to be the same. But why do the photomicrographs and the heat maps look so similar? I would expect far fewer neurons to be stained in the intersectional mice (Fig 5 and Fig S2C/D) than in the ChAT staining (Fig S2A/B). I am having trouble reconciling the different presentations/quantifications and making sense of the data in these histology figures.
We removed “similar to the previous ChAT staining” and we have reviewed the heat maps. Since the original submission, we performed more experiments and now added more animals to the analysis (now N=7), each heat map represents the correct number of neurons in PiCo, respectively to each experiment.
The Y scales has been adjust to better demonstrate the Chat staining vs. the intersectional mice triple conditioned.
How can you distinguish PiCo from non-PiCo in the histology, especially in the ChAT-only staining? It seems that you have arbitrarily defined the PiCo region, and only counted neurons within that very constrained area.
Even in ChAT-only staining, the N.ambiguus is very distinct from the cholinergic neurons located more medial to the N.ambiguus. This can be unambiguously be confirmed by combining ChAT with glutamatergic in situ staining as done in the Anderson et al. study, or unambiguously be demonstrated with the viral approach as done in the present study. Thus, we don’t see why it is arbitrary to define the distribution of PiCo neurons. What is arbitrary is the definition of the preBötC, yet the field of respiration seems to have no problem with this. We assume that the reviewer knows that Dbx1 neurons are spread along the entire ventral respiratory column and dorsal portion of the PreBötzinger Complex up to the level of the XII nucleus. Yet it is commonly accepted for authors to refer to the PreBötzinger Complex by counting dbx1 neurons within a constrained area of what is believed to be the PreBötzinger Complex, even though the borders are arbitrary. It is e.g. known that some of the ventrally located preBötC neurons are presumed rhythmogenic while the more dorsally located Dbx1 neurons are premotor. The transition from rhythmogenic to premotor is gradual. Similarly, NK1 staining, or SST staining is not restricted to the preBötC and it is arbitrary to define where preBötC begins and what to include. Indeed, our PNAS paper indicates that inspiratory bursts can be generated by optogenetically stimulating Dbx1 neurons along the entire VRC column – so it is not clear where the rhythmogenic portion of the preBötC begins rostrocaudally and dorsoventrally and where the rhythmogenic portion and preBötC itself ends. Thus, we want to re-iterate and emphasize, that for the present study, we developed a method using the cre/FlpO approach to unambiguously define the PiCo region. It is surprising that this reviewer does not acknowledge this technical advance that added significantly more specificity to the anatomical and physiological characterization of PiCo, than the Toor et al. study, and also the Anderson et al. study.
I can see stained neurons in the area immediately outside of PiCo, and I'd like to see lower-magnification images that show the staining distribution in a broader region surrounding PiCo as well, especially in the rest of the reticular formation.
We characterized the PiCo area based on the histological phenotype and in vitro and in vivo experiments performed by Anderson et al., 2016. PiCo is an area located close to the NAmb, presenting the same ChATcre phenotype. As stated above, the distribution and agglomeration of the NAmb is clearly very compact, and different then the observed ChATcre: Vglut2FlpO: Ai65 neurons located outside of NAmb. It is also important to emphasize, that like is the case for the preBötC, other transmitter phenotypes of neurons are also present in the PiCo region (i.e. GABA or Dbx1). However, the study performed by Anderson et al, 2016 paper, described only the functions of cholinergic neurons located in PiCo, and we always planned to publish a paper of the other neurons within PiCo – this area e.g. contains pacemaker neurons etc. But, I hope that the reviewer acknowledges that many investigators have studied the preBötC for the past 30 years. Hence, much more information has been accumulated on this region (which btw was at least as controversial at the beginning), and it will likely take at least another 30 years to fully identify and characterize PiCo.
Similarly, how can you be sure you're stereotaxically targeting PiCo precisely (600um in diameter?) with your opto fiber (200um in diameter). Wouldn't small variations in anatomy put the fiber outside the tiny PiCo area?
We assume the reviewer means “stereotactically”. And yes, the reviewer is correct, it is necessary to position the laser at a consistent anatomical location. Placement of the optical fibers outside of this area does not result in activation of PiCo. We have added an additional supplemental figure (Figure S6) to address this.
Please put N's and stats results in Table S1 for both swallow and laryngeal activity. I took what I assume to be the Ns (10, 11, and 4) and did some stats like the ones you presented for the laryngeal duration. The differences between vagus duration for 40 and 200 ms pulse durations are all significant for each strain, by my calculations. Also, I think there must be an error in the orange swallow plot in Fig 3A. The orange dots don't correspond to the table values. I plotted all the Table S1 values for each strain. Each line looks similar to the blue laryngeal activation plot in Fig 3A. The slopes of the Vglut2 were less than the other strains, and the slopes for the swallow behavior were less than the laryngeal behavior for all strains. Otherwise, they all look similar. Please double-check your values/stats to address these discrepancies. If it is indeed true that the stim pulse duration affects swallow duration, revise the interpretations and manuscript accordingly.
We thank the reviewer for the diligence in reviewing our manuscript. But, with all due respect, the reviewer is incorrect and misunderstood the data. To clarify: Table S1 is only presenting data for laryngeal activation, swallow data is presented in Table S2. The orange data points in Fig 3A are not detailed in Table S1 or S2. Table S2 is the average of all swallows across all laser pulse durations since the laser pulse duration does not affect swallow behavior duration. All data will be publically available after publication of the manuscript.
Figure 3A is only representing the ChATcre:Vglut2FlpO:ChR2 column of Table S1
The N’s have been added to table S1
Please add more details on stats in general, including the specific tests that were performed, F values and degrees of freedom, etc.
Thank you, this has been added throughout the results section. Please refer to the results section for this addition. However below we have provided an example.
An example: A two-way ANOVA revealed a significant interaction between time and behavior (p<0.0001, df= 4, F= 23.31) in ChATcre:Vglut2FlpO:ChR2 mice (N=7).
How do you know that you're not just activating motoneurons in the NA when you stimulate your ChAT animals, especially given the results in Fig 1B? In this case, the phase-specific results could be explained by inhibitory inputs (during inspiration) to motoneurons in the region of the opto stim.
As stated in this paper as well as the Anderson et al 2016 paper (and for that matter also the Toor et al study) this is a caveat. This major caveat motivated the development and use of the ChATcre:Vglut2FlpO:ChR2 (specifically targeting the PiCo neurons that co-express ChAT and Vglut2, not laryngeal motor neurons) experiments that have mostly the same response as the ChATcre:Ai32 mice. We cannot say this is due to inhibitory inputs to laryngeal motoneurons, since the cre/FlpO specific experiments are not directly activating laryngeal motoneurons. But we do not want to entirely exclude that some premotor mechanisms may also occur in PiCo. The reviewer may know that there is overlap of rhythmogenic and premotor functions for the Dbx1 neurons in the PreBötC, But, addressing this issue is beyond the scope of this study. In fact, we are working on a separate connectivity study using novel, still unpublished antegrade and retrograde vectors that do not reveal any direct connections to laryngeal motoneurons. Hence, we expect that the connectivity from PiCo to laryngeal motoneurons is more complex and addressing this question cannot be done as a simple add-on to an already complex study. Again, we would refer to the PreBötzinger complex, where nobody expects that one study can resolve all the physiological and anatomical characterizations that have been accumulated over 30 years in one study. We would argue that in some ways, our cre/FlpO approach is more specific than the Dbx1 stimulations which activates not only rhythmogenetic PreBötzinger complex neurons, but also pre motoneurons as well as glia cells, and many neurons rostral and caudal to the PreBötzinger complex. We are aware of these caveats, and we have discussed this in the original submission, and also in the revision.
While the study from Toor et al is cited, there needs to be a much more thorough discussion of how their findings relate to the current study.
Many thanks for asking for a more thorough discussion of Toor et al., which we are happy to provide here. Perhaps we were too polite in our original manuscript to emphasize all the problems in that study.
They demonstrated that PiCo isn't necessary for the apneic portion of swallow. Inhibiting this region also didn't affect TI.
Please note – the fact that Toor et al did not find an effect on TI confirms Anderson et al. 2016: In Figure 3G,3F of the Nature paper, the reviewer will find that injections of DAMGO and SST into PiCo inhibited post-I activity without affect inspiratory duration. This figure also shows that the inspiratory burst can terminate in the absence of postinspiratory activity.
The reviewer states: “They demonstrated that PiCo isn't necessary for the apneic portion of swallow”. With all due respect to this reviewer, this is NOT correct. Toor et al showed that inhibiting PiCo did block SLN-evoked fictive-swallows but not the apnea caused by SLN stimulation. This is not the apnea caused by swallows (which was never studied by Toor), but by the SLN stimulation. The apnea evoked by SLN stimulation has most likely nothing to do with the apnea caused by swallows. Unfortunately, the Toor et al. makes the same misleading claim as the reviewer.
PiCo cannot be the sole source of post-I timing, and the evidence overwhelmingly favors the major involvement of other regions such as the pons.
This comment seems to be unrelated to the main thrust of this paper that studies PiCo’s involvement in swallow and laryngeal activation in coordination with breathing. However, since this comment seems to discredit the Ramirez lab in general, we would like to clarify that inhibiting PiCo with DAMGO and SST inhibits post-I activity (Anderson et al 2016, Fig.3G,3F). Thus, we don’t understand the rationale or actual data for the reviewer’s conclusion that PiCo cannot be the sole source of post-I timing? We also don’t understand the basis for the reviewer’s conclusion that “the evidence overwhelmingly favors the major involvement of other regions such as the pons”. We also want to add, that no-where in the Anderson et al. study did we state that the pons plays NO role. Indeed, we specifically stated: “In this context it will be interesting to resolve the role of the PiCo in specific postinspiratory behaviors and to identify how the PiCo interacts with other neural networks such as the Kolliker-Fuse nucleus, a pontine structure that has been hypothesized to gate postinspiratory activity and the periaqueductal grey a structure involved in vocalization and the control of postinspiration”.
They also showed that inhibition of all neurons (not just ChAT/Vglut) in the PiCo region suppresses post-I activity in eupnea. This suppression was overcome by the increased respiratory drive during hypoxia.
Before comparisons are made with Toor et al. it is important to note the species and methodological differences between Toor et al. rat anesthetized, vagotomized, paralyzed and artificially ventilated model which evaluated fictive swallows (deafferented and paralyzed). By contrast this study uses a mouse anesthetized, vagal intact, freely breathing model and evaluates natural physiologic swallow via water and central stimulation. It seems that the reviewers does not acknowledge one of the main innovations of this study. For this study we introduced a genetic approach to specifically target and activate ChATcre/Vglut2FlpO PiCo neurons. This has never been done before, and developing this approach took more than 4 years of breeding and crossing and testing different options.
As for Toor et al., these authors pharmacologically, bilaterally inhibited neurons in the area of PiCo with isoguvacine, a specific GABA-A agonist. Even though this pharmacological intervention does not specifically inhibit cholinergic/glutamatergic neurons in PiCo, these authors essentially confirm the study by Anderson et al. We do not find this finding controversial. Perhaps the reviewer finds the definition of PiCo “controversial”, because Toor et al called the identical area IRt instead of PiCo, even though they exactly reproduce the finding by Anderson. Toor et al. not only arrive at the same conclusion as Anderson but they added more details – none of which is contradicting the results by Anderson et al.: Here are excerpts from the Toor study “We therefore conclude that the ongoing activity of neurons in the IRt contributes to eupneic respiratory and sympathetic post-I activities without exerting significant control on other respiratory or cardiovascular parameters” “IRt significantly inhibited the post-I components of VNA” “IRt inhibition was also associated with a reduction in PNA” “increase in respiratory cycle frequency” “due to a reduction in TE“ “with no effect on TI observed”. “Bilateral microinjection of isoguvacine selectively reduced the magnitudes of post-I VNA and rSNA, but not PNA responses to acute hypoxemia”.
In this statement the reviewer probably refers to one particular aspect, i.e. the fact that Toor et al. did not significantly block some of the post-I activity – they state: “had no significant effect on the AUC of post-I rSNA (305+/- 24 vs 230+/- 28,p=0.16,n=6)”. Please note that there is a tendency, a reduction from 305-230. Perhaps the Toor study was not sufficiently powered to fully block the effect, perhaps the drug did not inhibit the entire PiCo. These are all open questions that a critical reader should know. The reviewer will agree that it is as difficult if not more difficult to demonstrate the absence of an effect. To arrive at a negative conclusion experiments should be done with the same scrutiny than to demonstrate a positive result. We also assume that the reviewer is familiar with animal experiments and will understand that pharmacological injections are often difficult to interpret, in particular in case of local in vivo injections. It is possible that Toor et al is inhibiting e.g. parts of the Bötzinger complex.
We have added to the manuscript the following statement: It is important to note that SLN stimulation does not only trigger swallows, but also changes in the overall stiffness and tension of the vocal cords (Chhetri et al., 2013) as well as prolonged hypoglossal activation independent of swallowing (Jiang, Mitchell, & Lipski, 1991). It has been hypothesized that inhibition of the IRt blocks fictive swallow but not swallow-related apnea. Yet this apnea was generated by SLN stimulation and not by a natural swallow stimulation (Ain Summan Toor et al., 2019). It is known that SLN stimulation causes endogenous release of adenosine that activates 2A receptors on GABAergic neurons resulting in the release of GABA on inspiratory neurons and subsequent inspiratory inhibition (Abu-Shaweesh, 2007), suggesting that the SLN evoked apnea may not be the same as a swallow related apnea. Moreover, microinjections of isoguvacine into the Bötzinger complex attenuated the apneic response but not the ELM burst activity (Sun, Bautista, Berkowitz, Zhao, & Pilowsky, 2011), suggesting the Bötzinger complex, not PiCo, could be involved in modulating apnea.
We would also like to add that our current study characterized swallow-related specific muscles and nerves in both water-triggered and PiCo-triggered swallows to better characterize the physiological properties of this swallow behavior. By contrast, Toor et al. only characterized nerve activities that are involved in multiple upper airway activities and breathing. It is somewhat surprising that the reviewer did not consider the fact that Toor et al. characterized putative swallows that were triggered by SLN stimulation and that Toor et al. were content with nerve-recordings and failed to confirm that the behavior that they evoked is actually a physiological swallow. Which, according to the comments from this reviewer (see above), indicates the possibility of differences in central mechanisms occurring between fictive swallow and physiological swallows.
While we have cited Toor et al and their truly excellent work in the broad iRt we did not feel it is appropriate to critique them for the fact that they are confusing the field by using a different anatomical term for the area that was clearly defined by us as an area containing cholinergic-glutamatergic neurons. We also did not feel it is appropriate to discuss results that are similar to comparing Apples and Oranges. Toor et al. never specifically manipulated glutamatergic-cholinergic neurons, thus their entire results rest on indirect stimulation affecting this general area – which will unavoidably also include laryngeal motoneurons. We don’t want to criticize this approach, since PiCo is heterogenous, which is another misunderstanding that we find in the reviewers’ critique. We used cholinergic-glutamatergic neurons to define this area. However, like the preBötC, PiCo is also heterogenous. This region contains inhibitory neurons, it also contains glutamatergic neurons that are not cholinergic, and cholinergic neurons that are not glutamatergic. Because of this heterogeneity we compared the effects of stimulating glutamatergic neurons and cholinergic neurons as well as cholinergic-glutamatergic neurons. This is an approach that is generally accepted in the field. As already stated, there is not a single marker that uniquely characterizes the PreBötC. Thus, when stimulating Dbx1 neurons, glutamatergic neurons, or Somatostatin neurons it only captures subpopulations of this region. The recently published study by Menuet et al. in eLife, used even more indirect methods to inhibit preBötC. They used a pan-neuronal CBA promotor that targets neurons irrespective of phenotype. It is not our intention to discredit this very elegant study, but we object the statement that we “have arbitrarily defined the PiCo region”.
This study has not demonstrated some of the things that are depicted in Fig 7 and included in the discussion. While swallow can inhibit inspiration, there are many mechanisms by which this can happen other than a direct inhibitory connection from the DGS to PreBotC. You cite Sun et al., 2011 findings of "a group of neurons that inhibits inspiration" during SLN stim, but don't mention that it is the BotC and that the paper shows that swallow apnea is dependent on BotC. That is also supported by the Toor study. I don't understand how post-I (aka E) can be discussed without discussion of the BotC - this is a glaring omission.
We have removed figure 7, which was only meant as a hypothetical schematic.
Why is it necessary for PiCo to innervate the cNTS?
This was a hypothesis based on CTb data that we have now removed.
That is true if the conjecture that PiCo gates swallowing is true, as the cNTS is the only known region for central swallow gating. However, PiCo could influence afferent input to the NTS less directly, and therefore not function as a gating hub per se. The experimental evidence does not warrant the claim that PiCo gates swallowing. The definition of a swallow gate(s) is a topic of much debate and no conclusive experimental evidence has emerged for swallow gating regions to exist anywhere except in the NTS. The current study's evidence also does not meet the criteria necessary to conclusively call PiCo a swallow gate. The authors should soften this claim and language throughout the manuscript.
Although we do not know of any studies that has optogenetically gated swallow in the cNTS, it seems the reviewer objects our use of the word “gate”. We have revised the manuscript and removed any wording stating PiCo is a swallow “gate”. It would be interesting to know whether the reviewer has the same objections of the use of the word “relay” as done by Toor et al.?
It is also unclear that PiCo acts directly on the swallow pattern generator to gate swallowing. It is not just "conceivable that the gating mechanism involves" the pons, but nearly certain. Swallow gating by respiratory activity may not be able to be ascribed to one particular location. At a minimum, it likely involves the NTS/DSG, pons, and possibly IRt (inclusive of PiCo). The authors are correct that "further studies are necessary to understand the interaction between PiCo and the pontine respiratory group on the gating swallow and other airway protective behaviors." This is why it shouldn't be stated that "this small brainstem microcircuits acts as a central gating mechanism for airway protective behaviors."
We have removed all language stating PiCo is a swallow gate.
PiCo is likely part of the VSG (and thus the swallow pattern generator). PiCo, as part of the IRt/VSG could indeed be surveilling afferent information and providing output that affects swallow or other laryngeal activation and the coordination of these behaviors with breathing. However, this is not the responsibility of PiCo alone. This role is likely shared by other parts of the SPG, and may require distributed SPG network participation to be functional. If one were to stim other regions of the distributed SPG, similar results might be expected. When Toor et al silenced the PiCo area (and locations that lie at least lightly beyond the borders of what the present study defines as PiCo), stim-evoked fictive swallows were greatly suppressed. However, swallow-related apnea was unaffected. This supports the role of PiCo as a premotor relay for swallow motor activation, but not as the site that terminates inspiration. Therefore, it cannot be called a gate.
We already addressed the issue that Toor never demonstrated that the “swallow-related” apnea was unaffected. Toor et al only demonstrated that the SLN-evoked apneas were unaffected, and their conclusions were only based on nerve recordings under fictive conditions (deafferented and paralyzed). Also, to the best of our knowledge, many aspects of the putative swallow pattern generator that this reviewer mentions are purely hypothetical. However, to avoid further arguments, we have removed the word gate and Figure 7 from this manuscript.
Similarly, Fig 7 does not accurately depict things that are already well-supported by evidence. PiCo should be included as part of the swallow pattern generator (VSG), not as a separate entity acting on it. The BotC and pons are glaring omissions. This study has not demonstrated the labeled inhibitory connection from DSG to PreBotC. The legend states speculations as fact and needs to be dialed way back to either include statements with solid experimental evidence or to clearly mark things as putative/speculative.
We have removed figure 7.
The discussion of expiratory laryngeal motoneurons needs to be expanded and integrated better into the discussion of swallow, post-I, and other laryngeal motor activation. Why can't PiCo just be premotor to ELMs?
If PiCo would “only” or “just” be premotor to ELM then it would not be expected that it could trigger an all-or-none swallow response with a temporal activity pattern similar to the one of a water-evoked swallow. We would also not expect that the activation of the activity pattern is independent of the laser stimulation duration as demonstrated in Figure 3. This was our reasoning why we originally called PiCo a “gate” because at the correct phase it will gate/trigger a complex swallow sequence. But, as stated above, we avoid the word gate in the revised manuscript.
Concerning the discussion of "PiCo's influence as a gate for airway protective behaviors is blurred...": The incomplete swallow motor sequence didn't seem super different in timing or duration compared to the fully transfected animals (comparing plots from Fig 6 to Fig S1, and Table S2 to Table S3. The values for swallow durations (XII and X) for each group for water and opto seem within similar ranges, as do the differences between water & opto-evoked swallows between strains. While the motor pattern is distinctive from the normal swallow, with laryngeal activity rather than submental activity leading, one might not even be able to call that a swallow. Is it evidence against a classic all-or-nothing swallow behavior any more than the graded swallow results from (fully transfected) Table S1?
We fully agree that it is possible that this unidentified behavior may not be a swallow. We have changed the name of this behavior to “upper airway motor activity.” However we also cannot rule out the possibility of this being some portion of a graded swallow which would argue that a graded swallow response is exact evidence against the classic all or nothing swallow behavior.
Please expand on this point and put it into context with others' results: "This brings into question whether this is the first evidence against the classic dogma of swallow as an "all or nothing" behavior, and/or whether this is an indication that activating the cholinergic/glutamatergic neurons in PiCo is not only gating the SPG, but is actually involved in assembling the swallow motor pattern itself."
This has been expanded and included citation of other studies. The following paragraph can be found in the discussion
Swallow has been thought of as an “all or nothing” response as early as 1883 (Meltzer, 1883). Whether modulating spinal or vagal feedback (Huff A, 2020b), central drive for swallow/breathing (Huff, Karlen-Amarante, Pitts, & Ramirez, 2022) or lesions in swallow related areas of the brainstem (Car, 1979; Robert W Doty, Richmond, & Storey, 1967; Wang & Bieger, 1991) swallow either occurred or did not. Swallows are thought to be a fixed action pattern, with duration of stimulation having no effect on behavior duration (Fig. 3) (Dick, Oku, Romaniuk, & Cherniack, 1993). Thus, it was particularly interesting that in instances when few PiCo neurons were transfected, either unilateral or bilateral, an unknown activation of upper airway activity occurred. Motor activity no longer outlasted laser stimulation rather was contained within, and the timing of the motor sequence was reversed in comparison to a water or PiCo evoked swallow (Fig. 6). Thus, if insufficient numbers of neurons are activated, PiCo’s influence to specifically activate swallow or laryngeal activation is blurred, resulting in the uncoordinated activation of muscles involved in both behaviors. This brings possible evidence against the classic dogma of swallow as an “all or nothing” behavior, or the presence of an entirely different behavior. We are not the first to bring possible evidence against the classic dogma, “small swallows” were described but failed to be discovered if this was in-fact a partial or incomplete swallow (Miller & Sherrington, 1915). The SPG is thought to consist of bilateral circuits (hemi-CPGs) that govern ipsilateral motor activities, but receive crossing inputs from contralateral swallow interneurons in the reticular formation, thought to coordinate synchrony of swallow movements (Kinoshita et al., 2021; Sugimoto, Umezaki, Takagi, Narikawa, & Shin, 1998; Sugiyama et al., 2011). Incomplete activation of PiCo activates the muscular components of a swallow, without establishing the coordinated timing and sequence of the pattern. It is possible that PiCo is involved in assembling the swallow motor pattern itself and unilateral activation of PiCo could either desynchronize swallow interneurons or activates only one side of the SPG. Since we did not record bilateral swallow related muscles and nerves this question needs to be further examined.
Reviewer #3 (Public Review):
Huff et.al further characterise the anatomy and function of a population of excitatory medullary neurons, the Post-inspiratory Complex (PiCo), which they first described in 2016 as the origin of the laryngeal adduction that occurs in the post-inspiratory phase of quiet breathing. They propose an additional role for the glutamatergic and cholinergic PiCo interneurons in coordinating swallowing and protective airway reflexes with breathing, a critical function of the central respiratory apparatus, the neural mechanics of which have remained enigmatic. Using single allelic and intersectional allelic recombinase transgenic approaches, Huff et al. selectively excited choline acetyltransferase (ChAT) and vesicular glutamate transporter-2 (VGluT2) expressing neurons in the intermediate reticular nucleus of anesthetised mice using an optogenetic approach, evoking a stereotyped swallowing motor pattern (indistinguishable from a water-induced swallow) during the early phase of the breathing cycle (within the first 10% of the cycle) or tonic laryngeal adduction (which tracked tetanically with stimulus length) during the later phase of the breathing cycle (after 70% of the cycle).
They further refine the anatomical demarcation of the PiCo using a combination of ChAT immunohistochemistry and an intersectional transgenic strategy by which fluorescent reporter expression (tdTomato) is regulated by a combinatorial flippase and cre recombinase-dependent cassette in triple allelic mice (Vglut2-ires2-FLPO; ChAT-ires-cre; Ai65).
Lastly, they demonstrate that the PiCo is anatomically positioned to influence the induction of swallowing through a series of neuroanatomical experiments in which the retrograde tracer Cholera Toxin B (CTB) was transported from the proposed location of the putative swallowing pattern generator within the caudal nucleus of the solitary tract (NTS) to glutamatergic ChAT neurons located within the PiCo. We would like to thank the reviewer for acknowledging the technical advances of the present study and for the positive statements in general.
Methods and Results
The experimental approach is appropriate and at the cutting edge for the field: advanced neuroscience techniques for neuronal stimulation (virally driven opsin expression within a genetically intersecting subset of neurons) applied within a sophisticated in vivo preparation in the anaesthetized mouse with electrophysiological recordings from functionally discrete respiratory and swallowing muscles. This approach permits selective stimulation of target cell types and simultaneous assessment of gain-of-function on multiple respiratory and swallowing outputs. This intersectional method ensures PiCo activation occurs in isolation from surrounding glutamatergic IRt interneurons, which serve a diverse range of homeostatic and locomotor functions, and immediately adjacent cholinergic laryngeal motor neurons within the nucleus ambiguous (seen by some as a limitation of the original study that first described the PiCo and its roll in post-I rhythm generation Anderson et al., 2016 Nature 536, 76-80). These experiments are technically demanding and have been expertly performed.
Again, we would like to thank the reviewer for these positive comments acknowledging the advances of the present study.
The supplemental tracing experiments are of a lower standard. CTB is a robust retrograde tracer with some inherent limitations, paramount of which is the inadvertent labelling of neurons whose axons pass through the site of tracer deposition, commonly leading to false positives. In the context of labelling promiscuity by CTB, the small number of PiCo neurons labelled from the NTS (maybe 5 or 6 at most in an optical plane that features 20 or more PiCo neurons) is a concern. Even assuming that only a small subset of PiCo neurons makes this connection with the presumed swallowing CPG within the cNTS, interpretation is not helped by the low contrast of the tracer labelling (relative to the background) and the poor quality of the image itself. The connection the authors are trying to demonstrate between PiCo and the cNTS could be solidified using anterograde tracing data the authors should already have at hand (i.e. EYFP labelling driven by the con-fon AAV vectors from PiCo neurons (shown in Fig5), which should robustly label any projections to the cNTS).
We fully agree with the reviewer that the CTB staining is of a lower standard and have removed this approach.
The retrograde labelling from laryngeal muscles seems unnecessary: the laryngeal motor pool is well established (within the nAmb and ventral medulla), and it would be unprecedented for a population of glutamatergic neurons to form direct connections with muscles (beyond the sensory pool).
The authors support their claim that PiCo neurons gate laryngeal activity with breathing through the demonstration that selective activation of glutamatergic and cholinergic PiCo neurons is sufficient to drive oral/pharyngeal/laryngeal motor responses under anaesthesia and that such responses are qualitatively shaped by the phase of the respiratory cycle within which stimulation occurs. Optical stimulation within the first 10% of the respiratory cycle was sufficient to evoke a complete, stereotyped swallow that reset the breathing cycle, while stimuli within the later 70% of the cycle, evoked discharge of the laryngeal muscles in a stimulus length-dependent manner. Induced swallows were qualitatively indistinguishable from naturalistic swallow induced by the introduction of water into the oral cavity. The authors note that a detailed interpretation of induced laryngeal activity is probably beyond the technical limits of their recordings, but they speculate that this activity may represent the laryngeal adductor reflex. This seems like a reasonable conclusion.
We thank the reviewer for this comment. Unfortunately, we felt compelled to remove the word “gating” based on the statements by reviewer 1.
The authors propose a model whereby the PiCo impinges upon the swallowing CPG (itself a poorly resolved structure) to explain their physiological data. The anatomical data presented in this study (retrograde transport of CTB from cNTS to PiCo) are insufficient to support this claim. As suggested above, complementary, high-quality, anterograde tracing data demonstrating connectivity between these structures as well as other brain regions would help to support this claim and broaden the impact of the study.
We fully agree with this reviewer. We have been working on a thorough anatomical characterization for more than 3 years using cutting edge anterograde and retrograde viruses in collaboration with vector experts at the University of Irvine. But these are partly novel, unpublished techniques that are in development, and require many careful controls and characterization. We feel that this is a separate study as it doesn’t relate to swallowing coordination and also includes partly different authors. We hope to submit this as a separate study later this year.
This study proposes that the PiCo in addition to serving as the site of generation of the post-I rhythm also gates swallowing and respiration. The scope of the study is small, and limited to the subfields of swallowing and respiratory neuroscience, however, this is an important basic biological question within these fields. The basic biological mechanisms that link these two behaviors, breathing and swallowing, are elusive and are critical in understanding how the brain achieves robust regulation of motor patterning of the aerodigestive tract, a mechanism that prevents aspiration of food and drink during ingestion. This study pushes the PiCo as a key candidate and supports this claim with solid functional data. A more comprehensive study demonstrating the necessity of the PiCo for swallow/breathing coordination through loss of function experiments (inhibitory optogenetics applied in the same transgenic context) along with robust connectivity data would solidify this claim.
Thanks again for the positive assessment of our study.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
This paper explores the potential regulatory role of a previously unstudied phosphorylation site in the Src kinase SH3 domain. The data presented conclusively demonstrate that a phosphomimetic mutation of this site, src90E, causes an elevation in Src kinase activity, changes the structure of the Src catalytic domain as determined with a FRET sensor, disrupts certain SH3 domain interactions, causes changes in kinase intracellular dynamicity, and promotes cell invasiveness. Based on the behavior of the phosphomimetic mutant, the idea that constitutive phosphorylation of Y90 could have all of these effects is well-supported by the data. However, in wild-type cells or cells transformed by activated forms of Src, there is no constitutive phosphorylation of this site. Therefore, the question remains whether Y90 phosphorylation occurs to any significant extent in cells, and the data suggesting that it could do so is limited. It also remains to be conclusively established whether Y90 phosphorylation occurs via autophosphorylation.
Major comments:
1) Y90 was identified as a site of phosphorylation in Luo et al. It would be helpful if more information were provided about its significance relative to other sites identified in that study. Was it detected in non-transformed cells? Was it a major site? How does it relate to Y416 in abundance? The reference to the identification of the site in a different study from the White lab is made in the discussion but not in the introduction (this should be corrected). How abundant was it that study? A fuller description of its detection would strengthen the rationale for this study. Any additional phosphoproteomics studies that identified it should also be included.
As indicated in the manuscript (Figure 3C and new 3D), the amount of Y90 phosphorylation increases with the level of Src activation. Standard proteomic/phosphoproteomic data cannot be quantified in absolute values for technical reasons, only relative quantification is possible to some extent. To overcome this issue and address the question of the amount of Y90 phosphorylation, we newly prepared the corresponding stable isotope-labeled phosphopeptides and used them as internal standards. To the best of our knowledge, this allowed us to quantify for the first time the amount of specific tyrosine phosphorylation of Src kinase in cells. We found that in case of WT Src, the major phosphorylation site localized in the activation loop of the kinase domain, Y416, is phosphorylated in 22 % of molecules. In activated Src, this pool of Y416-phosphorylated molecules increases 2,5 times to 57 %. Y90 is phosphorylated in approximately 1 % of WT Src molecules but becomes 5 times more abundant in case of the activated kinase (5,3 % of phosphorylated molecules). This newly added data of absolute Src tyrosine phosphorylation (Figure 3D) is consistent with values we obtained from relative MS quantification of Src variants differing in catalytic activity (Figure 3C). Although the enrichment of Y90 phosphorylation in the catalytically active kinase is lower compared to Y416 phosphorylation in terms of percentage of phosphorylated molecules, it’s increment with respect to the basal state is significantly higher. We believe that this broader dynamic range of Y90 phosphorylation is in agreement with the demonstrated regulatory function of Y90 phosphorylation. We incorporated these new results and methodological approach into the revised manuscript. We also extended the original description of the MS protocol to include a description of relative quantification, which was included in the original manuscript.
Phosphorylation of Y90 was only detected in Luo et al. and Johnson et al. phosphoproteomic screens. However, phosphorylation of tyrosines homologous to Src Y90 was described in a vast number of proteins. Some of them are mentioned in the discussion e.g., Btk, Abl, p130Cas or Src family kinases Yes and Fyn. The presence of phosphorylation on homologous tyrosines and the evolutionary conserved nature of Y90 in SH3 domains supports relevance of Src Y90 phosphorylation despite the small number of studies that were able to identify it. In our opinion, this can be attributed to its low abundance in the basal state and the technical difficulties of its detection, as discussed below in response to point 2.
We emphasize the Luo et al. study in the introduction because it was the only study reporting Y90 phosphorylation at the time of the project’s initiation and led us to study Y90 further. Both studies are then mentioned in the discussion, which we believe is appropriate and sufficient.
2) Related to point 1, is there evidence from the literature indicating a significant site of phosphorylation in Src has been overlooked? Or, was this site only identified because of the recent advances in MS technology and increased sensitivity of this methodology? An introduction to these points would also enhance the rationale for the study.
In the manuscript discussion, we mention an early study (Erpel et al., 1995) which mapped conserved residues within the binding surface of the Src SH3 domain. It showed that mutation of Y90 to alanine led to partially deregulated Src and reduced affinity of the SH3 domain. Although they acknowledged the importance of Y90 for SH3 domain binding ability, they did not probe or discuss the effect of Y90 phosphorylation status. Furthermore, the level of Src Y90 phosphorylation in untransformed cells is relatively low (20-fold lower than Y416 phosphorylation). It is therefore not surprising that it has not been identified in most general phosphoproteomic studies performed on untransformed cells. In fact, in many of these studies, Y416 phosphorylation was not detected either. The detection of Y90 phosphorylation by Luo et al. likely reflects the fact that it was performed in Src527F-transformed cells, similarly Johnson et al. used HGF-activated cells. Last, we also cannot exclude that the tryptic peptides with Y90/pY90 are less detectable in MS depending on the experimental conditions. In fact, the "heavy" Y90 peptide was consistently much less (10-80 times less) detectable in our hands than the Y416 peptide. This could be because of its worse ionizability, stability in vacuum or some other technical reasons.
In our approach, we used immunoprecipitated Src molecules to maximize the amount of Src in the sample and targeted MS, which allowed us to specifically detect even low abundant ions/peptides. This represented the critical technical approach that allowed us to consistently detect Y90 phosphorylation in untransformed cells.
3) The explanation of the MS experiment designed to show that Y90 phosphorylation happens in cells is insufficient in the text. It is not clear why the SYF cells were not used and not clear why the FRET sensor constructs were used. It is also not clear whether or how the proteins were purified before MS analysis. Also, rather than showing the MS data as a relative level, it would be preferable to provide the number of spectra obtained for each peptide/phosphopeptide and compare this also to Y416. A fuller comparison between the phosphorylation of Y90 to that of Y416 is necessary in order to place the potential Y90-mediated phosphoregulation in context.
We are sorry for the confusing description. With the new quantification data, we have rewritten this section and hopefully made it clearer. We kept the original relative quantification data as they nicely show that abundance of Y90 phosphorylation increases with enhanced activity of Src. However, we added new MS analysis of Src tyrosine phosphorylation performed with labeled peptides as internal standards that provides absolute numbers of Y416 and Y90 phosphorylation in cells. The new <br /> measurements confirm the original data showing increased Y90 phosphorylation in activated Src variants and suggest that Y90 phosphorylation is not a rare event but represents an important regulatory element in Src activation. Our approach of MS quantification of phosphorylation events using labeled peptides as standards, allowed us, to the best of our knowledge, for the first time, to measure absolute quantities of Y416 and Y90 phosphorylation and therefore also the amount of activated Src molecules in cells.
For technical reasons, the SrcFRET biosensor was used in all these experiments. We attempted to analyze endogenous Src in several cell lines to assess its Y90 phosphorylation. However, in our hands, the amount of Src efficiently precipitated was never sufficient to detect the "very elusive" phosphopeptide containing Y90. We believe this was not caused by low amounts of Src in the cells, <br /> but rather because the anti-Src antibody performed much worse than the anti-GFP antibody used for SrcFRET biosensor (two high affinity epitopes) immunoprecipitation. We have previously shown that the SrcFRET biosensor functions in the same way as endogenous Src (Koudelková et al., 2019), and therefore we presume that it is phosphorylated in a similar manner and rate as endogenous Src.
4) I would like to see conclusive evidence that Y90 phosphorylation is due to autophosphorylation. This would involve relatively simple experiments. As one possibility, an IP kinase assay followed by immunoblotting with a site-specific antibody or MS or other types of phosphopeptide visualization/identification.
We further addressed the question of Y90 autophosphorylation using a kinase dead version of Src527F bearing K295M substitution. To quantify the amount of phosphorylated Src we applied the identical approach with labeled standards and measured phosphorylation levels of Y416 and Y90. Compared to Src WT and Src527F, phosphorylation of both tyrosines in the kinase dead variant was negligible despite the presence of endogenous Src and other SFKs in the U2OS cells we used for the experiments. These results suggest that phosphorylation of Y90 does indeed depend on the intrinsic kinase activity of Src and is therefore very likely autophosphorylation.
We have tried to address the question of Src autophosphorylation on Y90 by analyzing the level of Y90 phosphorylation in cells expressing a kinase-inactive SrcFRET construct with open conformation (527FKD) by quantitative MS. Despite the open conformation, SrcFRET527F-KD did not display any significant phosphorylation of neither Y90 nor Y416, even though we used U2OS cells which express endogenous Src and other SFKs. These results suggest that phosphorylation of Y90 depends on catalytic activity of the kinase rather than on compactness of its conformation and is therefore very likely autophosphorylation.
5) A few other mutations would be interesting to examine in both kinase and transformation assays for comparison to the mutants that were: Y527F Y416F; Y527F Y416F Y90E. The first is a low activity control and the second is for understanding whether Y90E could overcome the lack of Y416 phosphorylation.
Due to lack of time, we did not perform these experiments. However, we analyzed our new kinasedead 527F mutant for FRET and found that despite its inactive kinase domain and lack of Y416 phosphorylation, it still retains an open conformation. We believe that this is a strong indication that the Y90E kinase-dead mutant would behave the same way, maintaining an open conformation albeit the kinase domain is inactive.
6) I recommend that the results are discussed in a more circumspect manner. The results presented in Figure 7 on the double mutant, Y527F Y90F, suggest that phosphorylation of Y90 is not a very significant component of Src kinase regulation, at least in these biological contexts. That Y90 phosphorylation isn't a major regulatory factor does not diminish the value of the work describing Y90 phosphorylation. However, it does alter the interpretations. I encourage a more conservative discussion of its importance and a broader discussion of why it isn't a major site of Src phosphorylation, particularly if it is due to autophosphorylation.
We believe that given our new quantifications showing that Y90 phosphorylation is indeed considerably present and utilized in cells, the original discussion is consistent with the new data and does not need to be changed.
Reviewer #2 (Public Review):
The manuscript "Phosphorylation of tyrosine 90 in SH3 domain is a new regulatory switch controlling Src kinase" describes efforts to understand how phosphorylation of tyrosine (Y90) in the SH3 domain of Src affects the activity and function of this multi-domain kinase. The authors find that an Src variant containing a phospho-mimetic mutation (Glu) at position 90 demonstrates elevated activation levels in lysates and cells (Figure 1) and adopts a less compact autoinhibited conformation within the context of a SrcFRET biosensor in lysates (Figures 3A, 3B). A series of pulldown experiments with an isolated SH3 domain (Figure 2A, 2B) or full-length Src (Figure 2C, 2D) that contain the phospho-mimetic Y90E mutation demonstrates that phosphorylation of Tyr90 would likely disrupt the interaction of Src's SH3 domain with intermolecular binding partners and the linker that couples SH2 domain/C-tail binding to autoinhibition, which provides a mechanistic basis for the observed elevated kinase activity of Src Y90E. By performing a series of imaging experiments with a SrcFRET biosensor, the authors show that the Y90E mutation does not show enhanced localization at focal adhesions like a hyperactivated Src mutant (Y527F) that contains a non-phosphorylatable C-tail (Figure 4A). However, using ImFCS combined with TIRF microscopy (Figure 4B), the authors demonstrate that Src Y90E shows similarly reduced mobility (relative to the WT SrcFRET biosensor) at the plasma membrane (especially at focal adhesions) as Src Y527F. Consistent with the elevated kinase activity of Src Y90E, the authors go on to demonstrate that the Src Y90E variant shows an ability to transform fibroblasts-at levels that are intermediate between wild-type Src and the hyperactive Src mutant Y527F (Figure 5). Similarly, Src Y90E confers an intermediate level (between wild-type Src and Src Y527F) of invasiveness and ability to form spheroids. Together, these comprehensive experiments with a Y90 phospho-mimetic strongly support a model where phosphorylation of Src's SH3 domain at Tyr90 would lead to a more intramolecularly disengaged SH3 regulatory domain and enhanced kinase activity in cells.
Most of the conclusions in this paper are well supported by solid data, but confidence in several assays would be higher if additional technical detail or controls were provided and the biological significance of these findings would be higher if the role that Y90 phosphorylation plays in Src regulation and function were better delineated.
1) The kinase activity assays in Figures 1C,1D, and 7A need to be scaled to the Src variant levels present in the lysate (quantification of relative Src levels is not provided).
For kinase activity measurements, we used lysates of equal protein concentrations prepared from cell lines stably expressing Src variants. These cell lines were sorted and repeatedly tested for equal expression of Src constructs using immunodetection of Src on Western blots. We corrected the <br /> methods section and added this information to the description of kinase assays experimental setup.
2) More details are required for the experiments quantifying Y90 phosphorylation levels in Figure 3C. The experimental states that equal amounts of IP'd proteins were used for these analyses but there are no details on how this was confirmed. In addition, the experimental states that normalized intensities were used for your quantifying the Y90 phospho-peptide but no details are provided on how normalization was performed (the legend states that a base peptide was used but it is unclear what this means).
The paragraph on mass spectrometry analysis in the Materials and Methods section has been updated with the required information.
3) A key question is whether Y90 phosphorylation serves a regulatory role in Src's cellular activity and, if so, what is the regulatory network that mediates this phospho-event. Using a mass spectrometry readout with three Src variants (wild type vs. Y527F vs. E381G) that possess differing kinase activities, the authors demonstrate that Y90 phosphorylation levels correlate to Src's kinase activity (Figure 3C), which they suggest is an indication that this residue is an autophosphorylation site (or phosphorylated by another Src family kinase). However, as Src's kinase activity correlates with SH3 domain disengagement (which leads to a more accessible Y90), it is also entirely possible that another tyrosine kinase is responsible for this phosphorylation event. More importantly, it is unclear under which signaling regime Y90 phosphorylation would play a significant regulatory role. This phospho-event was observed in a previous phospho-proteomic study but it is unclear whether the phosphorylation levels of this site occur high enough stoichiometry to modulate the intracellular function of Src and whether there is a regulatory signaling network that influences Y90 phosphorylation levels.
We have tried to address the question of Src autophosphorylation on Y90 by analyzing the level of Y90 phosphorylation in cells expressing a kinase-inactive SrcFRET construct with open conformation (527F-KD) by quantitative MS. Despite the open conformation, SrcFRET527F-KD did not display any significant phosphorylation of neither Y90 nor Y416, even though we used U2OS cells which express endogenous Src and other SFKs. These results suggest that phosphorylation of Y90 depends on catalytic activity of the kinase rather than on compactness of its conformation and is therefore very likely autophosphorylation.
To further support our data on relevance of Y90 phosphorylation in cells, we performed a new MS analysis of Y90 and Y416 phosphorylation in WT and activated Src. This time we used corresponding stable isotope-labeled peptides and phosphopeptides as internal standards for MS quantification. This allowed us to measure absolute amounts of phosphorylated molecules and changes in their numbers, which is information that cannot be acquired by standard biochemical or proteomic approaches and is usually lacking for the majority of known phosphorylation sites. We found that in case of WT Src, the major phosphorylation site localized in the activation loop of the kinase domain, Y416, is phosphorylated in 22,6 % of molecules. In activated Src, this pool of Y416-phosphorylated molecules increases 2,5 times to 57 %. Y90 is phosphorylated in approximately 1 % of WT Src molecules but becomes 5,1 times more abundant in case of the activated kinase (5,3 % of phosphorylated molecules). This newly added data of absolute Src tyrosine phosphorylation (Figure 3D) is consistent with values we obtained from relative MS quantification of Src variants differing in catalytic activity (Figure 3C). Although the enrichment of Y90 phosphorylation in the catalytically active kinase is lower compared to Y416 phosphorylation in terms of percentage of phosphorylated molecules, it’s increment with respect to the basal state is significantly higher. We believe that this broader dynamic range of Y90 phosphorylation is consistent with and reflects the demonstrated regulatory function of Y90 phosphorylation. We incorporated these new results and methodological approach into the revised manuscript.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
This manuscript focuses on a set of neurons from the border between the central and medial amygdala (AMGc/m-PAG ) that project to neurons in the periaqueductal gray (PAG) that gate ultrasonic vocalizations (USVs). These neurons suppress vocal production and are active in contexts where vocalizations would be inappropriate (e.g. in the presence of predator cues, or aggressive encounters with conspecifics). They then further characterized these neurons, demonstrating that like in males, these neurons are GABAergic in females and in both sexes, half of these neurons express estrogen receptor alpha (Esr1). To examine the inputs into these neurons, the authors performed monosynaptically-restricted transsynaptic rabies tracing and identified numerous cortical and subcortical projections. Of particular interest, neurons from the preoptic area of the hypothalamus (POA) in addition to terminating on PAG-USV neurons also project to AMGc/m-PAG neurons. Imaging the terminals of these neurons revealed elevated activity during vocalization-promoting contexts and optogenetically stimulating them resulted in evoking USVs. Together, these experiments further identify and quantify a circuit incorporating external factors (e.g. predatory factors, social interactions) in the drive to produce vocalizations.
The authors are commended for use of male and female mice, demonstrating that even though they produce USVs in different social contexts, AMGc/m-PAG neurons share a function in suppressing USV production in both sexes. They do this convincingly with a variety of methodologies while incorporating appropriate controls (e.g. light-only and GFP-control in optogenetic experiments). The experiments are performed in a logical order and the data generated is elaborate.
We appreciate the reviewer’s commendations and for their appreciation of the convincing insights provided by our study. We provide detailed responses to their recommendations in the following section. We hope the reviewer finds these revisions satisfactorily address their concerns.
Reviewer #2 (Public Review):
The existence of PAG-USV-producing neurons has been recently established, alongside two independent pathways, POA->PAG, and AMG->PAG, that promote and inhibit the production of ultrasound vocalizations in female and male mice, respectively. Because vocalizations can be modulated in a variety of contexts, such as in the presence of a predator, the authors first show that the AMG->PAG pathway is activated in situations where mice stop vocalizing, such as in the presence of a predator or aggressive conspecifics, and can inhibit natural vocalizations in contexts where females vocalize (extending to their previous findings in male mice). Interestingly, AMG->PAG neurons also receive input from POA neurons that are known to promote vocalizations via their connection to PAG interneurons that inhibit PAG-USV-producing neurons. This POA->AMG and PAG pathway is inhibitory and therefore its capacity to promote vocalizations via these two parallel pathways might be achieved by its inhibition of AMG and PAG neurons that inhibit the PAG-USV producing neurons. While these results hint at possible mechanisms that could underlie the hierarchical control of vocalization, and how different external signals impinge on existing pathways to produce behavior flexibility, the study is missing important elements to draw such conclusions. Overall, the study is also missing important information on how experiments were performed.
We appreciate the reviewer’s efforts to evaluate our manuscript and provide constructive feedback. In the following section, we have responded to all the reviewer’s comments and concerns and provide all but one of the previously missing elements and information. We also maintain that the results and additional analysis we provide in this manuscript go beyond merely hinting at possible mechanisms, and instead provide explicit synaptic mechanisms by which vocal-promoting and vocal suppressing signals interact in the mouse’s brain.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
The authors worked towards a better understanding of the functional diversification of flavodoxins among diatoms, and this represents a quantum contribution building on the initial findings of Whitney, Lins, Hughes, Wells, Chappelle, and Jenkins (2011), with the inclusion of metatranscriptomic and other data from field collections and on-deck incubation experiments, relatively new genomic and transcriptomic datasets, and the adoption of reverse genetics tools that are not yet widely used in T. pseudonana. They hypothesize that clade I flavodoxins play a role in mitigating oxidative stress, while additional clade II flavodoxins would respond according to canon, in response to low iron availability.
The authors embarked on several field campaigns across environmental gradients where iron-responsive and oxidative stress-responsive flavodoxins were expected to show differential expression. The use of metatranscriptomics allowed taxa-specific assignment of relative transcript expression levels, and the results of both measurements across the environmental gradient and manipulative incubation experiments show the widespread taxonomic distribution of iron-responsive clade II flavodoxin. The fieldwork was well thought out, and biogeochemical trends comported to expectations. It's worth noting that the concomitant inclusion of geochemical data such as dissolved iron further strengthened the work. The authors also found clade I flavodoxins were not iron-responsive (as expected), but rather exhibited diel patterns in transcript abundance that suggest responses to photo-oxidative stress. Taken together, these field data are stunning.
We thank the reviewer for this kind assessment.
Lab experiments with five diatom species grown under varied iron and induced oxidative (H2O2) stress and transcript abundances for flavodoxin genes are reported. One reservation concerns the untoward and unknown effects of inducing outright iron starvation with the strong chelator, DFB (as opposed to achieving steady-state growth rate limitation from low iron by use of weak chelators such as EDTA). With DFB it is also difficult to predict sample timing (when cells have hit that "correct" and reproducible iron-limited space) when independent replicates are collected on different dates. Similarly, the use of DFB also makes it difficult to sample low and high iron cells at the same density or to maintain densities among replicate samples collected on different dates. pH and CO2 availability change with density unless special measures are taken.
We agree with the reviewer that DFB is a strong iron chelator that may affect diatom physiology in inadvertent ways. We designed the DFB experiments to allow us to screen multiple diatoms for whether they transcribed clade I and II flavodoxins in a short-term response to iron limitation.
We added the logic behind this experimental design (L177-179):
“In order to screen multiple diatoms for whether they transcribed clade I and II flavodoxins in response to iron limitation, we used the strong iron-chelator desferrioxamine B (DFB) and enhanced short-term iron limitation.”
Additionally, we now discuss the possible effect of DFB in our discussion (L395-410):
“Notably, we used the strong iron chelator DFB to enhance iron limitation in a variety of diatoms, as previously described (Andrew et al., 2019; Kranzler et al., 2021; Lampe et al., 2018; Timmermans et al., 2001; Wells, 1999), while recognizing that undesirable effects of DFB, that are not related to iron-limitation per se cannot be ruled out. Here, DFB was used in experiments designed to test whether transcription of the two flavodoxin clades differentially responded to iron limitation. The results from T. oceanica, and T. pseudonana agree with the literature, in which DFB was not added. In T. oceanica only the expression of one clade II flavodoxin was induced (Figure 2B-C, as in Lommer et al., 2012). The minor induction in mRNA of T. pseudonana clade I flavodoxin in response to iron limitation was detected in both long- and short-term adaptation to low iron, without added DFB (Goldman et al., 2019; Thamatrakoln et al., 2012). This flavodoxin seems to have diel regulation, and the observed induction might be specific to the circadian time and the setting of the diel cycle (Goldman et al., 2019).”
Based on the reviewer comments, we realized that our transcriptome sampling protocol was not clear. Because the diatom species have different growth rates, as well as different rates of growth-inhibition by iron limitation, we adjusted the sampling day for each species based on cell counts and photosynthetic efficiency. Importantly, the 9 samples (triplicates of 3 conditions) of each species were sampled together, at the same date and time. We also ensured that the biological replicates of each species and treatment had similar cell density at the time of harvest.
We clarified these concerns in the Results section (L188-206):
“For each diatom 6 replicates were grown in iron-replete conditions and 3 replicates in iron-limiting conditions until the low-iron cultures displayed a decrease in maximum photochemical yield of photosystem II (Fv/Fm), 3-6 days (depending on species, Figure 2 -figure supplement 1A-C, Figure 2A, supplementary file 1c), indicative of iron limitation, at which point transcriptome samples were collected for both the iron-limited and iron-replete conditions. Three of the iron-replete replicates were exposed to oxidative stress, mimicked by a lethal dose of H2O2, and transcriptome samples were collected about 1.5 h after exposure, when the cell phenotype (Fv/Fm or cell abundance) was unaltered from control.”
In the Materials and Methods section (L542-545)
"Cells were harvested by filtration onto 0.22 µm filters. Full details of the number of cells harvested per treatments, per species, and samples that failed library preparation are indicated in supplementary file 1c. The 9 samples of each diatom species were sampled together, at the same date and time. Filters were snap-frozen…”
A second set of lab experiments involved the (non-trivial) establishment and use of "knock out" clones of the clade I flavodoxin gene in the model diatom T. pseudonana to test the oxidative stress hypothesis. This is an exciting idea and the data suggest this flavodoxin may confer resistance to oxidative stress. The conclusion would be greatly strengthened if different phenotypes could be observed between WT and KO clones in response to environmentally relevant oxidative stress (such as supra-optimal irradiance), rather than exogenous H2O2 addition.
Based on the reviewer suggestion, we conducted a preliminary experiment with irradiation of up to 500 µE. As with the light level originally tested, there were no differences in growth rate or Fv/Fm between the WT and KO lines. We agree that future study of these knock-lines a series of much higher irradiation levels, photosynthetic-inhibitors, and other environmental stresses is interesting, but it is out of the scope of the current study.
We now also mention this in the revised manuscript (L417-419):
“Future studies in which the oxidative stress is driven by other environmental conditions as supra-optimal irradiation, UV radiation or biotic interactions are needed to further support the role of clade I flavodoxins in oxidative stress.”
We clarify that our use of exogenous H2O2 additions was based on previous studies with Phaeodactylum and T. pseudonana that indicate that exogenous addition of micromolar range of H2O2 is representative for other oxidative stress-responses (Graff van Creveld, 2015, Volpert 2018, Mizrachi 2019) (L185-188):
“Oxidative stress was induced by the lowest lethal dose of H2O2 (200-250 µM), as similar treatment was shown to be representative to other environmentally-relevant oxidative stressors in T. pseudonana and Phaeodactylum (Graff van Creveld et al., 2015; Mizrachi et al., 2019; Volpert et al., 2018).”
The relationship between the experimental conditions and results in Figure 3C and Supplemental Figure 3H was not clear.
Figure 3C summarize parts of Figure S3H information, Figure S3D-I present the individual clones, while Figure 3 only shows WT vs Flav-KO.
According to the reviewer comments, we modified Figure S3H (it is now Figure S3I), and specify this relationship in the legend:
“H-I. Percentage of Sytox Green-positive (dead) cells, measured by flow cytometry 24 h after treatment with H2O2 treatment. Orange and gray box plots represent a Flav-KO and WT respectively, single measurements are marked, color-coded by the individual colonies. H. Results of a single dose-response experiment. I. Results from additional experiments, experiments marked with an asterisk are summarized in main Figure 3C.”
In the introduction, the authors suggest that Fe-S-containing proteins are particularly sensitive to damage via oxygen and ROS and that reliance on ferredoxin (Fd) for electron shuttling carries an enhanced sensitivity to the ROS generated during photosynthesis. References would be helpful here. Fe-S cluster-containing proteins are not monolithic regarding their behavior or susceptibility towards ROS. My limited understanding is that (i) several 4Fe-4S cluster proteins (such as aconitase, isopropylmalate isomerase) are particularly sensitive but that (ii) this is less so for canonical 2Fe-2S cluster ferredoxins; (iii) in some phototrophs Fd catalyzes the reduction of molecular oxygen to superoxide, as part of a mechanism that keeps the electron transport chain less reduced under extremely high light. Thus, ferredoxins may not necessarily be susceptible to in vivo ROS-mediated damage.
Thank you for these comments.
We modified our original sentence (L37-39):
“Moreover, iron-sulfur-containing proteins are particularly sensitive to damage via oxygen and reactive oxygen species (ROS).”
Corrected sentence:
“Moreover, iron containing proteins are sensitive to damage via oxygen and reactive oxygen species (ROS), and Fd is down-regulated in response to oxidative stress (Singh et al., 2010, 2004).”
Reviewer #2 (Public Review):
In their manuscript, Van Creveld et al. set out to demonstrate divergent functions for two clades of flavodoxin in diatoms. To achieve their goals, the authors combined metatranscriptomic results originating from three separate research cruises in the North Pacific Ocean with laboratory experiments with a clade I flavodoxin knock-out mutant in the diatom Thalassiosira pseudonana. Overall, their field study confirmed that Clade II flavodoxin is mostly up-regulated under iron limitation in most diatoms that were represented in their metatranscriptomic data (Figure 5 A-F). Their field study also demonstrated that clade I flavodoxin is expressed at levels that are several orders of magnitude lower than clade II flavodoxin (figure 5H). The lower expression of clade I flavodoxin was also observed in laboratory culture experiments (Figure 2). The laboratory experiments also demonstrated that the clade I flavodoxins were responsive to iron limitation in some of the species studied (Their Figure 2C), such that the assignment of function based solely on the clade I and clade II flavodoxin classification may not always be straight forward, and that exceptions will likely be found as more diatom species are studied.
In their quest to determine whether Clade I flavodoxin plays a role in adaptation to oxidative stress, the authors created several knock-out mutants where the clade I flavodoxin is not functional. These mutant strains responded to iron limitation in the same way as the WT strains. However, the mutant strains defective in the clade I flavodoxin were more slightly more sensitive to oxidative stress (created by exposure to lethal doses of hydrogen peroxide) than the wild-type strains. The results of the oxidative stress challenges would have been stronger if a broader concentration range of hydrogen peroxide had been used in the experiments leading to a dose-response curve for both the mutant and wild-type strains.
Thank you for this suggestion. We now tested a broader range of H2O2 concentrations on the WT and KO strains and added a new Figure S3H, which includes responses to 0, 25, 50, 75, 100, 150, 200, 250 µM H2O2.
The supplemental information provided in the main manuscript holds a lot of important information. Take for example Figure S4 showing the placement of reads for Clade I and Clade II in a Maximum-likelihood tree for flavodoxin in the North Pacific Ocean. The results show that clade II flavodoxin is much more commonly found in the transcripts than clade I flavodoxin.
Perhaps different results would have been obtained by conducting a similar sampling of metatranscriptome in the Atlantic Ocean that is less subject to iron limitation.
We agree completely and would love to analyze metatranscriptomes from the Atlantic Ocean in the future.
Overall, the authors have provided results that support a role for Clade I flavodoxin in alleviating oxidative stress in Thalassiosira pseudonana, however, whether or not this role is universal for clade I flavodoxin in other diatom species will require further studies.
We agree with this assessment that additional experiments with additional diatoms is a fruitful research area into the future.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
In their study Mas Sandoval and colleagues estimate, from human genomic data, two important parameters that measure how intermarriages have been affected by social stratification in the Americas: sex-biased admixture (SB), which refers to sex differences in the chances to intermarry with another ethnic group, and ancestry-based assortative mating (AM), which refers to the higher probability of partners to intermarry when they carry similar genetic ancestries. To do so, the authors train a deep neural network (DNN) with simulations of admixture with non-random mating and use ancestry tract length distributions to infer the two parameters. They show that their approach estimates SB and AM parameters with a relatively good accuracy in a number of scenarios. When applying the DNN to empirical data, they find solid evidence that social stratification has constrained the admixture processes in the Americas for the last centuries.
In contrast with the vast majority of population genetic studies, which assume random mating, this study assesses if mating has been random or not in American populations. Furthermore, the study is very valuable because it leverages, for the first time, a deep learning approach and local ancestry inference to co-estimate the extent of SB and AM from genomic data.
One limitation of the study, however, is that it assumes that (i) the admixture date in the simulations is known and equals 19 generations and (ii) admixture started at the same time in all admixed American populations. The authors also implicitly assume that the variance of the difference between male and female ancestry proportions only depends on AM, and not admixture timing. This may be problematic, as it has been shown that linkage disequilibrium between local ancestry tracts depends both on AM and admixture timing (Zaitlen et al., Genetics 2017).
To clarify the assumption of fixed admixture date, we have added the following sentence in the results section (line 170) where the model is firstly described: “In both models we assume a continuous admixture process that starts 19 generations ago, knowing that the populations analysed trace the first contact of Native American and European populations in the first half of 16th century and assuming a generation time of 26 .9 years (Wang et al., 2023). In contrast with the approaches that aim to find an admixture date assuming random mating, we assume that the admixture process starts with the contact, and it is continuous and modulated with the mating parameters.”
We thank the reviewer for such an important reference we had not included in our manuscript, whose findings support the basis of our approach. It is now included on line 70 to justify the analysis of the length of the ancestry tracts: Herein, we argue that the tract length information can measure the non-randomness of mating associated with genetic ancestry and, therefore, it can also monitor the permeability of socioeconomic and cultural barriers between subpopulations with different genetic ancestries (Zaitlen et al., 2017)
This is also suggested by the authors' results, showing that AM estimates are much lower in admixed Americans under the two-pulse model, relative to the one-pulse model, i.e., when admixture extends over time. Estimates of AM in admixed Americans may thus be biased, if admixture actually started less (or more) than 19 generations ago.
We evaluated the resemblance of the footprints left by either assortative mating or gene flow, by testing how a neural network trained on models with gene flow due to a second migration pulse predicts migration size on data generated by models without a second migration pulse but assortative mating only . We then tested how neural networks trained on models with assortative mating detect assortative mating from data with no assortative mating but only migration. Results are summarised in Figures 4 – supplement 1 – supplement 2 and show a strong correlation of the predicted size of the second migration pulse and the simulated level of assortative mating. Parallelly, there is also a strong correlation between the predicted assortative mating level and the size of the second migration pulse. Below, we respond to the reviewers in more detail regarding this question.
Another potential limitation concerns local ancestry inference. The authors assume that RFMix makes no errors when inferring ancestry tracts. This can be a concern, as recent studies have shown that RFMix has reduced accuracy compared to other methods (Hilmarsson et al., bioRxiv 2022).
In response to this comment, we performed a local ancestry analysis with Gnomix and generated the tract length profile according to the results obtained. One possible issue shared by Gnomix and RFMix is that they may infer a higher fraction of short tracts (at the expense of breaking longer ones). This issue was reported by Gravel et al. (2012). In this study, authors decided to filter out the short tracts because these tracts showed a high rate of false positives and false negatives. Therefore, we conducted an experiment to test if filtering out the shortest tract length window (i) improve the accuracy of the predictions of the simulated test data through the Mean Squared Error (MSE), ii) decrease the uncertainty of the estimations, and (iii) increase the correlation between Gnomix and RFMix-based estimates through the generalised variance.
We also tested a modification of the tract lengths profile by dividing (or not) the tract lengths profile by the total amount of tracts in either the Autosomes or the X chromosome. Our goal was to force the neural network to focus on the profile shape rather than on the absolute value of tracts at each window to mitigate the possible bias in the tract length profile. Our experimental set-up consisted of three combinations of modifications of the tract length profile, in addition to the non-modified one.
In Figures 4 supplement 3 – supplement 7, we show the predicted mating parameters using the modifications of the tract length profile outcoming from the local ancestry inference. Each point represents a prediction using RFMix and Gnomix tract length profiles (x and y axis, respectively) as input for each of the 1000 trained neural networks with the same architecture. We evaluated the uncertainty of the estimations for both Gnomix and RFMix and the correlation between them through the Generalised Variance. The Generalised Variance is the determinant of the covariance matrix, which increases with low values of covariance of the bivariate distribution and high values of the respective variances.The estimations of the parameters based on the tract length profile normalised by dividing by the total amount of fragments in Autosomes or X chromosome had both low values of Generalised Variances in the Gnomix-RFmix bivariate distribution of predicted parameters and low values of MSE in the prediction of simulated test data. These results indicate that by normalising the tract length profile by the total amount of fragments, the distribution is still informative and less sensitive to possible biases introduced by errors in the local ancestry analysis .
Therefore, we present the results obtained from this RFMix profile in the main figures and tables, while showing the other predictions in the supplementary figures.
In addition, the authors do not report a measure of uncertainty for the estimation of SB and AM, which is another important weakness. Interpretation of parameter estimates is limited if no measures of uncertainty are provided.
We now provide the 95% CI for each parameter obtained from the distribution of predicted parameters from the 1000 trained neural networks, for both RFMix and Gnomix for the tract length profile.
Finally, the authors compare the likelihood of two competing models, assuming a single or two admixture pulses, but do not determine the accuracy of their model choice procedure.
We now include the confidence intervals of the composite likelihood by replicating the test for each of the 1000 bootstrapped tract length profiles for each population. None of the 95% confidence intervals includes both negative and positive results and all of them support either the one pulse or the two pulses model, except for the sub-Saharan ancestry in the Columbian (CLM) population.
Overall, besides these methodological limitations, I expect that the study by Mas Sandoval and colleagues could be of great and broad interest for the scientific community studying population genetics, anthropology, sociology and history.
Reviewer #2 (Public Review):
This paper introduces a method to quantify how genetic ancestry drives non-random mating in admixed populations. Admixed American populations are structured by racial, gender, and class hierarchies. This has the potential to cause both ancestry-related assortative mating, in which the ancestry of mates tends to be correlated, and ancestry-related sex bias, in which individuals have a preference for mates with a particular ancestry composition. By applying their method to several African American and Latin American populations, Sandoval et al. further our understanding of ancestry-based population structure in this region more broadly.
Strengths
As many others have recently done, Sandoval et al. leverage the ability of a neural network to predict demographic parameters from high-dimensional population genomic data. Sandoval et al. first develop a clever probabilistic model of mating by defining the probability of a male and female mating as a function of the difference in ancestry between the individuals. They use this model to simulate population genomic data under various demographic scenarios, and then train a neural network on these simulated data. Finally, they apply the neural network to empirical data and learn the parameters of the underlying probability distribution, which can be related back to assortative mating and sex bias.
One clear strength of this paper is their ability to jointly assess assortative mating and sex bias, as well as their ability to apply their model to multiple contemporary admixed populations.
Importantly, the authors couch their results in an intersectional understanding of populations and consistently refer to research from historians and other social scientists throughout their paper, which reflects a very thoughtful awareness of the interdisciplinary nature of this research.
Weaknesses
The definition of assortative mating is conceptually confusing - in the text, assortative mating is introduced as genetic similarity between mates, i.e. positive assortative mating. However, based on the definition of assortative mating in their model, a population can have high assortative mating for a particular ancestry component even when there is non-zero sex bias for that component (e.g. males with low Native American ancestry are more likely to mate with females with high Native American ancestry). Fundamentally, this scenario cannot reflect positive assortative mating; rather, it reflects negative assortative mating (i.e. there is structured genetic dissimilarity between mates). However, the authors do not discuss the fact that the interpretation of the assortative mating parameter changes with the value of the sex bias parameter.
We acknowledge that our definition of assortative mating requires more clarity. We now define it on line 155 as: The AM parameter measures the non-randomness of mating associated to a genetic ancestry. This includes both positive assortative mating -genetic similarity between mates- (when SB is zero) and negative assortative mating -genetic dissimilarity between mates- (when SB is not zero). This approach allows accounting for the male-female way of negative assortative mating through SB parameter.
In addition, the results of the inference in ASW are difficult to interpret. They find that males of high African ancestry are more likely to mate with females of low African ancestry. This result seems counterintuitive given the body of literature that suggests sex-biased admixture in African Americans has greater male European and female African contributions. The authors do not suggest potential explanations for this observation.
We agree that results regarding the ASW population can be confusing. Our hypothesis to explain such results is that the sex bias parameter captures both sex-biased migrations and sex-biased admixture. Therefore, it is difficult to accommodate the complex genetic history of ASW. We have extended the discussion on this aspect as follows on line 380:
In addition, African American populations might have a complex genetic history involving on one hand male-biased sub-Saharan migration and on the other hand an admixture femalebiased in the sub-Saharan ancestry. However, our current model can only accommodate this demographic scenario with a single sex-bias parameter, and the results regarding this population should be interpreted with caution.
Lastly, the authors have not done any simulations to assess how accurate parameter estimates are if the demographic model is misspecified, which weakens the interpretability of the results.
We have performed a new analysis where we vary AM to generate tract length profiles to predict GFR, and viceversa. The results of this analysis are shown in the new figure 4Supplement 1. Results show how the footprint in the genome of the admixing populations of assortative mating and multiple pulse migration is similar. In the discussion we argue that both One Pulse and Two pulse models must be considered because they are supported by results obtained using X chromosome and Autosomes, respectively. We discuss how accounting for migration reduces AM values and how the resulting admixture dynamics resemble in both cases.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer 1 (Public Review):
1) In Figure 2, electron microscopy images represent n=1 cell, making it hard to know how generalizable the mitochondrial phenotypes are. It would be useful to see a quantitative summary of a larger dataset indicating how frequently the mitochondrial defects are seen.
As requested, we performed quantitative analysis of mitochondrial ultrastructure in a larger dataset (n=163 analyzed in WT and n=206 in the KO) confirming that this finding is very consistent. This additional quantitative analysis that we included in the revised manuscript confirms a very significant and diffuse alteration of mitochondrial ultrastructure in Parl-/- vs WT spermatocytes (p=0.0002).
2) In Figure 3, representative images are shown for a single field from n=1 animal. It is hard to decisively conclude that the phenotype of Pink1-/-;Pgam5-/- and Ttc19-/- testes is completely normal based on this limited data. There may be other tubules outside the field of view that are abnormal, or more subtle changes in cell ratios. This conclusion would be significantly strengthened by cell counting (e.g. # round spermatids per Sertoli cell per tubule and # spermatocytes per Sertoli cell per tubule) or other quantitation. Likewise, the similarities in phenotype between Parl-/-, Parl-/-;Pink2-/-, and Parl-/-;Pgam5-/- should be more thoroughly documented. At least some additional images should be shown.
The goal of figure 3 is to indicate that WT, Pink1-/-;Pgam5-/- and Ttc19-/- have no gross morphological abnormality and have preserved sperm production in sharp contrast with Parl/-, Parl-/-;Pink1-/-, and Parl-/-;Pgam5-/- and the TKO that show total lack of sperm in the tubular lumen, indicating that the loss of Parl alone or in combination drives this phenotype. To strengthen these conclusions we performed additional work. We stained testis sections from all strains with an antibody for AIF-1, a marker of post-mitotic spermatids/spermatozoa included in Fig3-figure supplement 1. This additional experiment clearly confirms that production of differentiated germ cells occurs only in WT, Pink1-/-;Pgam5-/- and Ttc19-/-, but not in Parl-/, Parl-/-;Pink1-/-, and Parl-/-;Pgam5-/-. These results are consistent with the reproductive capacity of these mouse lines (the first group is fertile, the second is infertile). We acknowledge we cannot rule out minimal subclinical differences in reproductive fitness between the fertile mouse groups, but this is beyond the goal of our study.
3) In Figure 4, it looks like there is a significant decrease in CIV-driven respiration in Parl knockouts, but the text describes this as "did not significantly enhance" - that is, the absence of an increase. This result is difficult to interpret without further explanation.
We recognize this might be confusing but it is specified in the text that CIV driven (TMPD+ascorbate) respiration- relying on endogenous cytochrome c- is diminished (line 195) in Parl-/- testis mitochondria. This test reflects cytochrome c oxidase respiratory capacity/activity. We performed then an additional experiment just after the previous where we add exogenous cytochrome c in the cuvette to test the integrity of the outer mitochondrial membrane and checked if CIV-driven respiration increases or not after,compared to before, the addition of cytc. Exogenous cytochrome c does not cross intact mitochondrial outer membranes, so the test is performed to verify the good quality of mitochondrial preparations and/or pathological changes by looking if of the outer membrane integrity, not the function of CIV. CIV driven respiration increases only modestly after compared to before the addition of cytc and to a similar extent in both WT and Parl-/- indicating a good quality of the mitochondrial preparations and that the outer mitochondrial membrane of these mitochondria is overall well preserved in both WT and KO.
4) In Figure 5B, there is some variation in band intensity between replicates. Quantifying the band intensity relative to the loading control would help to increase confidence in the conclusion that coQ levels are reduced.
We performed this quantification, as suggested by the reviewer, and added the quantification in figure 5B. Quantification of the band intensity relative to the loading control confirms a significant difference between WT and KO. Moreover, we performed quantitative immunofluorescence of COQ4 in SCP-1 positive cells included now in Fig 5-figure supplement 1, which confirms a significantly decreased expression of COQ4 in Parl-/- primary spermatocytes.
5) GPX4 is not a Parl substrate, and no explanation is provided for why it might be reduced in Parl-/- testes. This makes the result and model difficult to interpret.
We thank the reviewer for pointing this out. We acknowledged this limitation in the discussion. We mentioned in the discussion that decreased GPX4 levels have been observed in other conditions (chemical inhibition, pathological conditions, etc.) and no mechanism has so far been demonstrated to our knowledge, but some evidence raises a possible link with CoQ deficiency that we discussed. Potential mechanisms including protein degradation are likely although unproven. This remains an important and intriguing issue to address in future studies.
6) Since Parl knockout induces necrosis in the brain, necrosis could be a contributing factor to cell death in spermatocytes alongside ferroptosis. No data is presented that can exclude this possibility.
Ferroptosis is actually considered, by some authors, a form of regulated necrosis (Seibt TM FRBM 2019). Therefore, we can affirm that PARL deletion leads to regulated necrosis in testis via ferroptosis through specific ferroptosis pathways that do not appear to be activated in the brain, or at least not overtly. Importantly, there is no recognized marker or specific molecular pathway for generic «accidental» necrosis that can be tested to differentiate between the 2 different cell death modalities.
7) The severe spermatogenesis phenotype implies that Parl knockout males should be infertile, but the fertility status is not described in the manuscript. It may be difficult to test fertility in these animals due to the neurodegeneration phenotype; if so, this can be clarified. If it is feasible to test fertility, demonstration of a fertility phenotype would significantly strengthen the conclusion that loss of Parl leads to spermatogenic arrest.
We specify in the text that Parl-/- mice are sterile due to total lack of sperm production caused by arrested spermatogenesis, as evidenced by detailed histological analysis and AIF1 staining. This is not due to the neurodegeneration since Parl-Ncre knockout have normal production of sperm as presented in the paper. Fertility in Parl-/- cannot be tested in vitro since these mice have no sperm due to the complete block of spermatogenesis, nor in vivo since they die young due to neurodegeneration. With these limitation Parl-/- males and WT females are kept together and in no single exception since the beginning of the colonies a pregnancy has ever been observed. Parl-/- mice are sterile.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
The authors tried to measure the accuracy of the decision-making of honey bees by carrying out behavioural experiments in which they trained the bees to forage on artificial flowers of 5 different colours that offered different levels of reward. Subsequently, the bees' decision-making behaviour was tested with flowers of the same or different colours, with no reward present. The authors found that bees tend to approach a flower only when they are highly certain of a reward, and these decisions are made quickly. The majority of flowers were rejected by the bees. Based on the results of the tests, the authors created a model to identify what circuit elements or connections would be necessary to mimic the bees' decisions. This model could be potentially used for robotics.
The study is well supported by the signal detection theory and the experiments are well designed which is a major strength. However, the methods are not completely clear, so would be better to make a clearer description. Another weakness is the lack of clear explanations of the importance and relevance of the model.
Given the experimental design was optimal, the authors could potentially achieve the aims of this study.
Thank you for expressing your interest and providing constructive inputs. Based on your suggestions, we have thoroughly revised our manuscript to offer a more comprehensive explanation of the rationale behind our approach, as well as its comparison to existing knowledge and methods in the field. We believe that these revisions will significantly enhance the comprehensibility of our study and facilitate a better understanding of our findings.
Reviewer #2 (Public Review):
By elegantly designing experiments, MaBouDi et al. elucidated honeybee's behavioral strategy to quantitatively associate sensory cues with valences. The description is simple and concise enough to understand the logic. Particularly, the authors clearly demonstrated how sensory evidence and reward likelihood quantitatively affect the decision-making process and animals' response time. Their behavioral characterization approach and proposed model could also be helpful for studies using higher animal species. I have a few doubts regarding the definition of rejection behavior and the structure of the model that is critical to lead their main conclusions.
Thank you for your interest and valuable feedback. We greatly appreciate your input, and as a result, we have thoroughly reviewed your comments and implemented significant revisions to our manuscript. We have taken care to provide more comprehensive explanations of our methods, results, and the proposed model in order to enhance the overall comprehensibility of our study. Our intention is to ensure that readers can better understand our findings through these revisions.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review)
Using in vitro assays that take advantage of thymic slices, with or without the ability to present pMHC antigens, the authors define an early period in which CCR4 expression is induced, which induces their migration to the medulla and likely encounter with cDC2 and other APCs. Notably, the timing for CCR4 expression precedes that of CCR7 and illustrates the potential role for this early expression to initiate the movement of post-positive selection thymocytes to the medulla. The evidence for supporting a role for CCR4, as well as CCR7, in sequential tolerance induction is provided using multiple approaches, and although the observed changes amount to small percent changes, the significance is clear and likely biologically relevant over the lifespan of a developing T cell repertoire. Overall, the model provides a holistic view of how tolerance to self-antigens is likely induced during T cell development, which makes this work highly topical and influential to the field.
We thank the reviewer for their comments and for highlighting the significance of identifying distinct roles for CCR4 and CCR7 in promoting medullary localization and inducing self-tolerance of thymocytes at different stages of T-cell development.
Reviewer #2: (Public Review )
This manuscript describes that CCR4 and CCR7 differentially regulate thymocyte localization with distinct outcomes for central tolerance. Overall, the data are presented clearly. The distinct roles of CCR4 and CCR7 at different phases of thymocyte deletion (shown in Figure 6C) are novel and important. However, the conclusion that expression profiles of CCR4 and CCR7 are different during DP to SP thymocyte development was documented previously. More importantly, the data presented in this manuscript do not support the conclusion that CCR7 is uncoupled from medullary entry. Moreover, it is unclear how the short-term thymus slice culture experiments reflect thymocyte migration from the cortex to the medulla.
We thank the reviewer for pointing out the significance of our finding that CCR4 and CCR7 regulate different phases of thymocyte deletion. We agree that prior reports, including our own (Cowan et al. 2014, Hu et al., 2015) have shown that CCR4 and CCR7 are expressed by different post-positive selection thymocytes. However, the expression data we present here provides a higher resolution perspective on the specific thymocyte subsets that express these two receptors, as well as the different timing with which the receptors are expressed after positive selection. These data, coupled with chemotaxis assays of the granular thymocyte subsets responding to CCR4 versus CCR7 ligands, and 2-photon imaging data showing that CCR4 and CCR7 are required for medullary accumulation of distinct thymocyte subsets, are critical for delineating the unexpectedly distinct roles of these two chemokine receptors in promoting medullary entry and central tolerance.
The reviewer raises an important question about our conclusion that CCR7 is “uncoupled” from medullary entry. We think there was likely a misunderstanding of our intended meaning, as we did not mean to imply that CCR7 does not promote medullary entry of thymocyte subsets; we have modified the wording of the abstract to replace “uncoupled” to clarify. As we detail in the Introduction, the role of CCR7 in directing chemotaxis of single-positive thymocytes towards the medulla and inducing their medullary accumulation is well established (Ehrlich et al., 2009; Kurobe et al., 2006; Kwan & Killeen, 2004; Nitta et al., 2009; Ueno et al., 2004). Instead, our data demonstrate that 1) the most immediate post-positive selection thymocyte subset (DP CD3loCD69+) does not require CCR7 for medullary entry, and 2) the next stage of post-positive selection thymocytes (CD4SP SM) express CCR7, but CCR7 recruits these cells only modestly into medulla. In contrast, CCR7 promotes robust medullary accumulation of more mature thymocyte subsets (CD4SP M1+M2), in keeping with the well-known role of CCR7 in promoting thymocyte medullary localization. We think these findings are highly significant for the field because currently, there is a widely held assumption that post-positive selection thymocytes that do not express CCR7 are located in the cortex, while those that express CCR7 are located in the medulla. Our data show that neither of these assumptions is true: CCR4 drives medullary accumulation of cells that do not yet express CCR7, and the earliest post-positive selection cells that express CCR7 continue to migrate in both the cortex and medulla. These findings form the basis of our statement that CCR7 expression is “not synonymous with” medullary localization. The finding that thymocytes do not robustly accumulate in the medulla in a CCR7-dependent manner until more the mature SP stages has important implications for central tolerance, as localization of thymocytes in the cortex versus medulla will impact which APCs and self-antigens they encounter when testing their TCRs for self-reactivity.
The reviewer also raised concerns about whether short-term thymus slice cultures reflect physiological thymocyte migration. Short-term live thymic slice cultures have been widely used to investigate the development, localization, migration, and positive and negative selection of thymocytes, as they have been shown to faithfully reflect these in vivo processes, including confirming the role of CCR7 in inducing chemotaxis of mature thymocytes from the cortex into the medulla (Au-Yeung et al., 2014; Dzhagalov et al., 2013; Ehrlich et al., 2009; Lancaster et al., 2019; Melichar et al., 2013; Ross et al., 2014). However, we acknowledge that thymic slices are not equivalent to intact thymuses and have now discussed limitations of this system in our revised Discussion.
Comment 1: Differential profiles in the expression of chemokine receptors, including CCR4, CCR7, and CXCR4, during DP to SP thymocyte development were well documented. Previous papers reported an early and transient expression of CCR4, a subsequent and persistent expression of CCR7, and an inverse reduction of CXCR4 (Campbell, et al., 1999, Cowan, et al., 2014, and Kadakia, et al. 2019). The data shown in Figures 1, 2, and 3 are repetitive to previously published data.
The expression profile of CCR4, CCR7 and CXCR4 on thymocytes has been documented previously in the studies cited above and in our prior publication (Hu et al., 2015). Campbell et al. (Campbell, Haraldsen, et al., 1999) investigated chemotactic effects of chemokines, but did not directly address expression of chemokine receptors by thymocyte subsets. Cowan et al. (Cowan et al., 2014) examined the expression of CCR4 versus CCR7 on DP and CD4SP thymocytes. However, our data provide a more detailed analysis of expression of these distinct chemokine receptors by subsets of DP, CD4SP, and CD8SP thymocyte subsets along the trajectory of differentiation after positive selection, using a gating scheme inspired by a study published after the above-cited papers (Breed et al., 2019). Our more nuanced evaluation of CCR4 versus CCR7 expression sets the stage for finding that they play distinct roles in promoting medullary entry and central tolerance of early- versus late-stage post-positive selection thymocytes. Without examining CCR4 and CCR7 expression patterns by distinct thymocyte subsets in detail, we would not have made the unexpected observation that although CCR7 is expressed at high levels by many CD4SP SM thymocytes, it does not induce strong chemotaxis or medullary accumulation of this subset, relative to its role in more mature SP thymocyte subsets. This finding has important implications for which APCs thymocytes encounter as they are tested for self-reactivity to enforce central tolerance. As we were working on these studies, Kadakia et al. reported that extinguishing CXCR4 expression was important for enabling medullary entry (Kadakia et al., 2019). Thus, we thought it was important to place CXCR4 in the context of CCR4 and CCR7 expression on thymocyte subsets in our study, and in doing so found another example of asynchronous chemokine receptor expression and function, further indicating that expression of a chemokine receptor alone is not a reliable marker of functional activity or thymocyte localization, as cells migrate dynamically between the cortex and medulla.
Through more extensive gating and simultaneous investigation of chemokine receptor expression and function, our data have provided new insights into how thymocytes respond to chemokine cues at different time points during their post-positive selection development. Moreover, our refined gating scheme (Figure 1) can be used to distinguish thymocyte subsets at different development stages without relying on chemokine receptor expression, thus providing an unbiased way of investigating chemokine receptor expression at different developmental stages.
Comment 2: The manuscript describes the lack of CCR7 at early stages during DP to SP thymocyte development (Figure 1-3). However, CCR7 expression is detected insensitively in this study. Unlike CCR4 detection with a wide fluorescence range between 0 and 2x104 on the horizontal axis, CCR7 detection has a narrow range between 0 and 2x103 on the vertical axis (Figure 1C, 1D, 4B, 4C, 6B, S2, S3), so that flow cytometric CCR7 detection in this study is 10-times less sensitive than CCR4 detection. It is therefore likely that the "CCR7-negative" cells described in this manuscript actually include "CCR7-low/intermediate" thymocytes described previously (for example, Figure S5A in Van Laethem, et al. Cell 2013 and Figure 6 in Kadakia, et al. J Exp Med 2019).
We provide new data to address the possibility that we were failing to detect low levels of CCR7 expression on early post-positive selection DPs (CD3loCD69+). We agree that CCR7 immunostaining of mouse cells is known to be more challenging than immunostaining of other chemokine receptors, including CCR4 and CXCR4. CCR7 immunostaining needs to be carried out at 37°C, which we did throughout our studies. We provide new data comparing CCR7 expression by Ccr7+/+ versus Ccr7-/- thymocyte subsets (Figure 1—figure supplement 2A-B), which confirm that CCR7 is not expressed at detectable levels by CD3loCD69+ DP cells above the background seen in CCR7-deficient cells. As thymocytes transition to theCD4SP SM stage, low/intermediate to high expression of CCR7 can be detected (Figure 1—figure supplement 2A). To further test whether we were failing to detect low levels of CCR7 by post-positive selection DPs, we incubated thymocytes at 37°C for up to 2 hours prior to immunostaining for CCR4 and CCR7, as a prior study indicated in vitro culture would enable increased cell surface expression of CCR7 by alleviating ligand-mediated CCR7 internalization (Britschgi et al., 2008). However, we did not observe increased CCR7 (or CCR4) expression by any thymocyte subset incubated at 37°C (Figure 1—figure supplement 2C-D). Lack of expression of CCR7 by CD3loCD69+ DP cells is consistent with their failure to undergo chemotaxis to CCR7 ligands in vitro, and initial expression of CCR7 by CD4SP SM is consistent with their chemotaxis towards CCR7 ligands in vitro (now show in greater detail in Figure 2—figure supplement 1), albeit at a much lower migration index than subsequent thymocyte subsets.
Comment 3: Low levels of CCR7 expression could be functionally evaluated by the chemotactic assay as shown in Figure 2. However, the data in Figure 2 are unequally interpreted for CCR4 and CCR7; CCR4 assays are sensitive where a migration index at less than 1.5 is described as positive (Figure 2A and 2B), whereas CCR7 assays are dismissal to such a small migration index and are only judged positive when the migration index exceeds 10 or 20 (Figure 2C and 2D). CCR7 chemotaxis assays should be carried out more sensitively, to equivalently evaluate the chemotactic function of CCR4 and CCR7 during thymocyte development.
We thank the reviewer for his insight about the possibility that we could have overlooked CCR7-mediated chemotaxis at lower migration indexes. When data from the chemotaxis assays were evaluated separately for each thymocyte subset, CCR7-mediated chemotaxis of CD4SP SM and subsequent DP CD3+CD69+ co-receptor reversing thymocytes could be detected. However, DP CD3loCD69+ thymocytes still did not undergo CCR7-meidated chemotaxis, but were responsive to the CCR4 ligand CCL22 (Figure 2—figure supplement 1).
We did not detect CCR7-mediated chemotaxis of CD4SP SM and DP CD3+CD69+ subsets in our previous analysis because their lower-level chemotactic index relative to mature thymocytes did not reach statistical significance when chemotaxis of all subsets were compared simultaneously (Figure 2D). We note that the magnitude of difference in the responsiveness of CD4SP SM cells compared to mature CD4SP and CD8SP M1 & M2 thymocytes (Figure 2D) is likely physiologically important as CCR7 deficiency results in severely reduced medullary accumulation of CD4SP M1+M2 cells, but only a very mild reduction in medullary accumulation of CD4SP SM cells, which is only detected with our new paired analyses in Figure 5C. We feel these new analyses provide important new insights and thank the reviewer for this suggestion.
Comment 4: Together, this manuscript suffers from the poor sensitivity for CCR7 detection both in flow cytometric analysis and chemotactic functional analysis. Conclusions that CCR7 is absent at early stages of DP to SP thymocyte development and that CCR7 is uncoupled from medullary entry are the overinterpretation of those results with the poor sensitivity for CCR7. The oversimplified scheme in Figure 3D is misleading.
We agree that the scheme in Figure 3D, as previously constructed, did not ideally display the difference in scale between thymocyte responses to CCR7 ligands versus CCR4 and CXCR4 ligands (as detected in vitro). Thus, we have now modified the schematic to include the mild response to CCR7 ligands that we observed in CD4SP SM thymocytes (comment 3) and to emphasize the higher chemotactic response of mature thymocytes to CCR7 ligands than of DPs and CD4SP SM to CCR4 ligands. Likewise, we have modified the manuscript to clarify the importance of CCR7 expression in the medullary entry and accumulation of mature thymocyte subsets.
We respectfully disagree that the sensitivity of CCR7 detection was poor in our flow cytometry and chemotactic analyses. Our CCR7 stains identified a range of CCR7 expression levels, from no expression by pre- and post-positive positive selection DP cells to high expression by CD4SP M1 cells, and we now provide new data confirming our ability to detect CCR7 expression (Figure 1—figure supplement 2), as described in response to Comment 3. Our chemotaxis assays detected CCR7 responses over a range of migration indexes from ~ 2 up to 100, showing our sensitive ability to detect CCR7-mediated chemotaxis in vitro (Figure 2 and Figure 2—figure supplement 1). In live thymic slices, we were also able to capture a range of biologic activities of CCR7, from mediating modest medullary accumulation of CD4SP SM cells to robust medullary accumulation of CD4SP M1+M2 cells (Figure 5A-C). Importantly, our results demonstrate that CCR7 is not the only chemokine receptor responsible for medullary entry and accumulation of thymocytes. Complex spatiotemporal regulation of thymocytes at distinct stages of development is achieved through tight orchestration of expression and signaling through multiple chemokine receptors, including CCR4, as shown by our data. However, our study does not negate an important role for CCR7 in mediating medullary entry of thymocytes, which we have clarified in the text.
Comment 5: The short-term thymus slice culture experiments should be described more carefully in terms of selection events during DP to SP thymocyte development, which takes at least 2 days for CD4 lineage T cells and approximately 4 days for CD8 lineage T cells (Saini, et al. Sci Signal 2010 and Kimura, et al. Nat Immunol 2016). The slice culture experiments in this manuscript examined cellular localization within 12 hours and chemokine receptor expression within 24 hours (Figures 4, 5) even for the development of CD8 lineage T cells (Figure S2), which are too short to examine entire events during DP to SP thymocyte development and are designed to only detect early phase events of thymocyte selection.
Experiments in Figures 4 and 5 were indeed designed to capture behaviors of thymocytes relatively early after introduction onto thymic slices. Figure 4 (and Figure 4—figure supplement 1) shows that the timing of CCR4 versus CCR7 expression after positive selection is dramatically different: CCR4 is expressed within hours of positive selection, concomitant with medullary entry, while CCR7 expression takes several days in the slices (sufficient time for CD8SP development, Figure 4—figure supplement 1). Figure 5 shows that medullary accumulation of CD4SP M1+M2 cells occurs robustly in the medulla of thymic slices within a couple of hours after introduction into the slices, and this localization is CCR7 dependent, while CCR4 induces more mild medullary accumulation of post-positive selection DPs. As indicated by the reviewer, it has been shown that it takes days for DP thymocytes to develop into mature CD4SP and CD8SP cells (Kimura et al., 2016; Lutes et al., 2021; Saini et al., 2010), as recapitulated in the thymus slice system (Figure 4—figure supplement 1) (Lutes et al., 2021). The relatively short time frame of our time-course experiments (up to 12 hours after addition of pre-positive selection thymocytes to positively selecting thymic slices) allowed us to detect expression of CCR4 within a few hours after positive selection and to determine that this timing correlated with medullary entry. Thus, the 12-hour time-course was important for temporal resolution of chemokine receptor expression and medullary localization after initial stages of positive selection.
Comment 6: It is unclear what the medullary density alteration measured in the thymus slice culture experiments represents. Although the manuscript describes that the increase in the medullary density reflects the entry of cortical thymocytes to the medulla (Figure 4E and S2E), this medullary density can be affected by other mechanisms, including different survival of the cells seeded on the top of different thymus microenvironments. Thymocytes seeded on the medulla may be more resistant to cell death than thymocytes seeded in the cortex, for example, because of the rich supply of cytokines by the medullary cells. So, the detected alterations in the medullary density may be affected by the differential survival of thymocytes seeded in the cortex and the medulla. Also, the medullary density is measured only within a short period of up to 12 hours. The use of MHC-II-negative slices and CCR4- or CCR7-deficient thymocytes in the thymus slice cultures may verify whether the detected alteration in the medullary density is dependent on TCR-initiated and chemokine-dependent cortex-to-medulla migration.
We thank the reviewer for pointing out these possibilities. The purpose of the positive selection timing experiment (Figure 4) was to establish the early correlation between receiving a positive selection signal, upregulating CCR4, and migrating into the medulla. In this system, cells only enter only the cortex in the first hour after migration in the slice, consistent with prior studies of localization of pre-positive selection thymocytes to the cortex (Ehrlich et al., 2009; Ross et al., 2014); subsequently, they move into the medulla. Because CCR7 is widely accepted to be essential for medullary entry, we feel it is important to demonstrate the disconnect between the timing of medullary entry and CCR7 expression in multiple ways. The timing experiment design utilized MHCII-/- and β2m-/- slices to show that positive selection was necessary for expression of CCR4. To test whether CCR4 or CCR7 were required for medullary entry of early post-positive selection DPs, we evaluated medullary accumulation of this subset from WT, Ccr4-/-, Ccr7-/-, and Ccr4-/-Cc7-/- mice. This experiment provided a more robust means of determining the extent to which CCR4 deficiency impacted medullary localization of a large cohort of cells that had passed positive selection (Figure 5), and again showed that the post-positive selection thymocytes, which express CCR4 but not CCR7, accumulate in the medulla in a CCR4-dependent manner. We note that in Figure 5, we show that all Ccr4-/-Ccr7-/- thymocyte subsets imaged have medullary:cortical density ratios of ~1, indicating an even distribution across cortex and medulla, which is highly consistent with an essential role for these two chemokine receptors in cooperating to mediate medullary accumulation of different stages of developing T cells.
The reviewer makes an interesting point that survival cues could differ in the cortex versus medulla. However, if thymocytes lacking one or both chemokine receptors had impaired survival because they didn’t enter a region of the thymus efficiently to receive survival cues, we would expect to detect increased apoptosis in Ccr4-/-, Ccr7-/-and Ccr4-/-Cc7-/- thymocytes. However, we found that chemokine receptor deficiencies resulted in diminished apoptosis of different thymocyte subsets (Figure 6). This finding is more consistent with reduced negative selection of these subsets due to reduced clonal deletion. We nonetheless discuss this possibility in our revised manuscript, as it important to consider that chemokine-mediated migration of thymocytes into different microenvironments could alter their access cytokines and other pro-survival cues.
Reviewer #3 (Public Review)
In this manuscript, Li et al. examine how the expression of the chemokine receptor CCR4 impacts the movement of thymocytes within the thymus. It is currently known that the chemokine receptor CCR7 is important for developing thymocytes to migrate from the cortical region into the medullary region and CCR7 expression is therefore often used to define medullary localization. This is important because key developmental outcomes, like enforcing tolerance to self-antigens amongst others, occur in the medullary environment. The authors demonstrate that the chemokine receptor CCR4 is induced on thymocytes prior to expression of CCR7 and thymocytes exhibit responsiveness to CCR4 ligands earlier in development. Using elegant live confocal microscopy experiments, the authors demonstrate that CCR4 expression is important for the entry and accumulation of specific thymocyte subsets while CCR7 expression is needed for the accumulation of more mature thymocyte subsets. The use of cells deficient in both CCR4 and CCR7 and competitive migration/accumulation experiments provide strong support for this conclusion. The elimination of CCR4 expression results in decreases in apoptosis of thymocyte subsets that have been signalled through their antigen receptor and are responsive to CCR4 ligands. As expected, more mature thymocyte subsets show decreased apoptosis when CCR7 is absent. Distinct antigen-presenting cells in the thymus express CCR4 ligands supporting a model where CCR4 expressing thymocytes can interact with thymic antigen-presenting cells for induction of apoptosis. The absence of CCR4 results in an increase in peripheral T cells that can respond to self-antigens presented by LPS-activated antigen-presenting cells providing further support for the model. Collectively, the manuscript convincingly demonstrates a previously unappreciated role for CCR4 in directing a subset of thymocytes to the medulla.
We thank the reviewer for appreciating the novelty of the finding that CCR4 directs distinct subsets of thymocytes into the medulla relative to CCR7, as supported by multiple lines of evidence.
-
-
www.medrxiv.org www.medrxiv.org
-
Author Response
Reviewer #1 (Public Review):
The sustainability of vaccination programs is subject to multiple threats, from a pandemic like COVID-19 to political changes. The present study assesses different strategies, including gender-neutral vaccination, to better respond to threats in HPV national immunization programs. The authors showed that vaccinating boys against HPV (compared to vaccinating girls alone), would not only prevent more cases of cervical cancer but also limit the impact of disruptions in the program. Moreover, it would help attain the goal set by the World Health Organization of eliminating cervical cancer as a public health problem sooner, even in the case of disruptions.
Strengths and weaknesses: I found the manuscript well-written and easy to read. Decision-makers may find the results helpful in policy development and other researchers may use the study as an example to investigate similar scenarios in their local contexts. Nevertheless, there are some limitations. First, it should be considered that the present study is only applicable to India and other countries with a similar HPV context. Second, because it is a study based on a mathematical model, errors might arise from the assumptions considered for its construction. It also relies on the quality of the data used to construct and calibrate the model.
Models are important tools for decision-making, they allow us to assess different scenarios when obtaining real-world data is not feasible. They also allow to carried-out multiple sensitivity analyses to test the strengths of the results. The study carries out a necessary assessment of different vaccination strategies to minimize the impact on cervical cancer prevention due to disruptions in the HPV immunization program. By using a mathematical model, the authors are able to assess different scenarios regarding vaccination coverage rates, disruption time, and cervical cancer incidence. Therefore, decision-makers can consider the scenario which best represents their current situation.
The present study is not only valuable for decision-making, but also from a methodological point of view as future research can be conducted exploring more in deep the impact of vaccination disruptions and prevention measures.
The conclusions of this paper are mostly well supported by data, but some aspects of the methodology need clarification; furthermore, some aspects of the calculations can be improved. It would be more informative, and better for comparisons between the four scenarios, to have relative measures instead of the absolute numbers of cases prevented.
We thank the reviewer for the kind acknowledgement of the merits of the paper. We have tried to address the suggestions and questions as much as possible in the revised manuscript.
We agree to the points of weaknesses raised by the reviewer regarding the applicability of our study results is limited to other countries and the possible errors arising from a using a mathematical model. We have added more elaborate discussion of these points in the manuscript, as follows: - Page 15 lines 310-312: “Extrapolation of the results of this study to other populations will be limited to those sharing similar patterns of demography, social norms, and cervical cancer epidemiology as India.” - Page 17 lines 361-363: “…, within the limitations of our model, the modelbased estimates show that shifting from GO to GN vaccination may improve the resilience of the Indian HPV vaccination programme while also enhancing progress towards the elimination of cervical cancer.”
Furthermore, we have tried to clarify the rationale, advantages, and limitations of the measure of resilience we have adopted.
Reviewer #2 (Public Review):
This study evaluated the effect of population-based HPV vaccination programs in India which is suffering from the disease burden of cervical cancer. The authors used model simulations for estimating the outcomes by adopting the latest available data in the literature. The findings provide evidence-based support for policymakers to devise efficient strategies to reduce the impacts of cervical cancer in the country.
Strengths.
The study investigated the potential impact of cervical cancer elimination when HPV vaccination was disrupted (e.g., during the COVID-19 pandemic) and for meeting the WHO's initiatives. The authors considered several settings from the low to high effects of vaccination disruption when concluding the findings. The natural history was calibrated to local-specific epidemiological data which helps highlight the validity of the estimation.
Weaknesses.
Despite the importance and strengths, the current study may likely be improved in several directions. First, the study considered the scenario of using a recently developed domestic HPV vaccine but assuming vaccine efficacy based on another foreign HPV vaccine that has been developed and used (overseas) for more than 10 years. More information should be provided to support this important setting.
Second, the authors are advised to discuss the vaccine acceptability and particularly the feasibility to achieve high coverage scenarios in relatively conservative countries where HPV vaccines aim to prevent sexually transmitted infection. Third, as the authors highlighted, the health economics of gender-neutral strategies, which is currently missing in the manuscript, would be a substantial consideration for policymakers to implement a national, population-based vaccination program.
We thank the reviewer for the kind acknowledgement of the merits and strengths of the paper.
We have tried to address the reviewer’s three points of weaknesses as comprehensively as possible in the revised manuscript.
Regarding the first two points of weaknesses, we have provided more background information about the current situation of HPV introduction and screening in India (see the more specific replies below for where changes have been made), and some data of observed coverage in India in the states where HPV vaccination has been introduced.
Regarding the reviewer’s third point about the health economics of genderneutral strategies, we agree fully that it is an important aspect to consider for the local policymakers. However, a health economic assessment is out of the scope of the present paper. In the present paper, we are interested in highlighting the potential health benefits on GN HPV vaccination. Given the current context of HPV vaccination in India we think it is too early to provide a realistic assessment of the health-economic balance of GN vaccination. Please note that one manuscript (de Carvalho et al., MedRxiv, doi: https://doi.org/10.1101/2023.04.14.23288563) based on the same modelling exercise and reporting a health economic assessment of girls-only (routine and catch-up) HPV vaccination in India is currently submitted for peer-review.
Reviewer #3 (Public Review):
The authors put together a rigorous study to model the impact of HPV vaccine programme disruptions on cervical cancer incidence and meeting WHO elimination goals in a low-income country - using India as an example. The study explores possible scenarios by varying HPV vaccination strategies for 10-year-old children between a) increasing vaccine coverage in a girls-only vaccination programme and b) vaccinating boys in addition to girls (i.e a gender-neutral vaccination programme).
The main strength of this study is the strength of the modelling methodology in helping to make predictions and in contingency planning. The study methodology is rigorous and uses models that have been validated in other settings. The study employs a high level of detail in calibrating and adapting the model to the Indian context despite poor data availability. The detailed methodology allows future studies to employ the model and techniques with locally-contextualised parameters to study the potential impact of HPV vaccine programme disruptions in other countries.
The work in this field can begin to help lower-income countries explore varying HPV vaccination strategies to reduce cervical cancer incidence, keeping in mind the potential for future supply chains or other related disruptions. However, the scenarios could be better sculpted to model potentially realistic scenarios to guide policymakers to make decisions in situations with limited vaccine supplies - in other words comparing scenario alternatives based on a fixed number of vaccines being available. Using comparative alternatives will help policymakers grapple with the decisions that need to be made regarding planning national HPV vaccination programmes. The results could afford to provide readers with a clearer measure of vaccine strategy 'resilience'.
In all, the authors are able to successfully explore the potential impact of varying HPV vaccination strategies on cervical cancer cases prevented in the context of vaccine disruptions, and make valid conclusions. The results produced are rich in information and are worthy of deeper discussion.
We thank the reviewer for the kind acknowledgement of the merits and strengths of the paper.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #3 (Public Review):
The strongest aspects of this study are the structural analysis of the 90 residue KER domain. This is an important advance, discovering a founding member of a novel class of DNA binding motifs, termed a SAH-DBD (single alpha helix-DNA binding domain). Interestingly, they define a subregion of KER (termed "middle-A", residues 155-204 of Cac1) that has nearly the same DNA binding affinity and confers similar in vivo phenotypes as the full KER domain.
This study also shows that the biological role of KER partially overlaps compensatory factors in vivo, both within the same Cac1 protein subunit (e.g. the WHD domain) and also with other proteins acting in parallel (e.g. Rtt106). That is, the presence of either WHD or Rtt106 renders the drug-resistance and silencing assays employed here insensitive to loss of the KER domain.
However, the drug resistance and gene silencing phenotypes are inherently indirect measures of the most important claim of this work, that KER is a molecular ruler for DNA for the purpose of ensuring sufficiently large templates deposition of histone H3/H4 cargoes. Therefore, this study would be of greater impact if the authors more directly tested this measurement idea in assays that directly assess histone deposition. There are multiple options. Since the authors have in hand recombinant wild-type and mutant CAF-1 complexes, one could examine the number and/or spacing of nucleosomes formed during in vitro deposition reactions. Complementary in vivo experiments using the authors' existing mutant strains could be based on the finding that CAF-1 is particularly important for histone deposition onto nascent Okazaki fragments during DNA replication (Smith and Whitehouse, 2012; pmid: 22419157), and that the spacing pattern of nucleosomes on this DNA is greatly perturbed in cac1-delete cells.
Thank you for the suggestion of approaches to obtain data that more directly addresses changes in nucleosome assembly due to CAF-1 KER mutants. We considered using an in vitro nucleosome assembly assay, such as the reconstitution of nucleosomes onto gapped DNA using purified components developed by Kadyrova et al., 2013 (doi: 10.4161/cc.26310). However, they found defects only in the amount of nucleosome assembly and not changes in nucleosome spacing without CAF-1. In addition, we didn’t have the system set up and knew that it would be unlikely to produce data in the time needed for a revision of the manuscript, or even show spacing changes in nucleosomes at all. Therefore, we chose an assay system in yeast that already has been used to assess the impact of CAF-1 DNA binding mutants on nucleosome assembly (Smith and Whitehouse, 2012; pmid: 22419157 and Mattiroli et al., 2017 doi: 10.7554/eLife.22799). This approach, developed by Smith and Whitehouse, uses a degradable Ligase I system in yeast, which reveals Okazaki fragment lengths, and shows a defect when CAF-1 activity is knocked out (Smith and Whitehouse, 2012). This assay also showed that mutations or deletions in the Cac1 WHD DNA binding domain, led to increased lengths of Okazaki fragments (Mattiroli et al., 2017). As the WHD DBD impacts Okazaki fragment lengths, we reasoned that mutations in the KER DBD might also.
We generated numerous new yeast strains that included the degradable Ligase I system and collaborated with Dr. Duncan Smith of (Smith and Whitehouse, 2012; pmid: 22419157) to detect nascent Okazaki fragments in various CAC1 mutants in strains that were RTT106 or rtt106∆. We found that the Okazaki fragment lengths from cac1∆ yeast were larger and less discrete than from CAC1 yeast (as Dr Smith published previously) and that the Okazaki fragments from the cac1∆ rtt106∆ strain were barely detectable, presumably because they were too long to be resolved on the gel. However, the assay did not have sufficient resolution to detect changes between the Okazaki fragment length distribution between wild type CAC1 or the ∆KER, ∆middle-A and 2xKER mutants of CAC1, in either the RTT106 or rtt106∆ background. Therefore, we were unable to detect direct effects of the KER mutants on Okazaki-fragment lengths. We considered using the combination of KER mutants with the WHD mutants, but as this would not directly assess the effects of the KER mutants and CAF-1 proteins lacking the KER and the WHD don’t bind to DNA (Figure 3 in Mattiroli et al., 2017), we didn’t pursue it. As the complete deletion of the KER, shortening of the KER and lengthening of the KER did not give detectable changes in this assay, we also did not pursue the other mutants tested in the manuscript. Although, we are disappointed the experiment did not reveal effects that we had hoped for, this experiment provides support for the redundant functions of CAF-1 and Rtt106 in nucleosome assembly, which has not been shown using this assay. As such, we have added Figure 1-figure supplement 1g and text to the results section, methods section and strain table. We have included Prof. Duncan Smith and his student Anne Seck as authors.
Added text lines 195 to 207: “Finally, to assess the impact of deleting the KER more directly on nucleosome assembly in vivo, we examined histone deposition onto nascent Okazaki fragments during DNA replication as we have shown previously that the length of Okazaki fragment lengths are determined by histone deposition into nucleosomes and is disrupted upon deletion of CAC1 (Smith and Whitehouse, 2012). We compared CAF-1 mutants in the WT yeast background and in yeast lacking Rtt106. We found that the Okazaki fragment length distributions of the ∆KER mutant was indistinguishable from that of WT while that of cac1∆ was disrupted (Figure 1-figure supplement Figure 1-figure supplement 3g). That we did not detect effects on Okazaki-fragment lengths for the yCAF-1 mutants lacking the intact KER is consistent with the results of the viability and silencing assays for KER mutants, which also retained the WHD. Strikingly, the Okazaki fragments from rtt106∆ cac1∆ yeast were highly disrupted (Figure 1-figure supplement Figure 1-figure supplement 3g) further highlighting the redundancy between Rtt106 and Cac1 for assembling histones onto newly replicated DNA. Therefore, t”
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #3 (Public Review):
The authors investigated the mechanism of transport of the GLUT5 sugar porter using enhanced sampling molecular dynamics simulations and biochemical analysis. The results suggest a possible general mechanism by which binding to a transported substrate stabilizes an occluded intermediate conformation between outward and inward-facing states of the alternating access conformational change of the protein, thereby enabling transport.
The authors also identified key elements of this transition, associated with residues involved in sugar binding, and through elegant biochemical experiments demonstrated how mutations of the latter affect the protein function, including mutations of gating residues that can recover the function of inactive mutants.
The general computational methodology used by authors is appropriate for addressing these questions and compared to other techniques has the advantage of bringing forth an unbiased molecular description of the transport process. The results are overall qualitatively in line with the proposed conclusions.
A major weakness of this work is that, in contrast to previous studies with the same type of methodology, the authors do not report error analysis or careful statistical assessment of the computational results. Therefore, it is not clear whether the latter is solid or if they support the proposed conclusions. The computational data might generally benefit from an improved methodological design, such as including more degrees of freedom (or collective variables) in the description of the minimum free energy pathway, e.g. the salt-bridges.
This has now been addressed in the essential revisions above.
Another weakness is that some of the details of the computational analysis are not reported, therefore other investigators would not know how to reproduce the results.
We have extended the methods section to include much more detail about the MSM construction and other computational analysis. Data files needed for reproduction are now found in a public repository with links provided in the Methods section.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
This manuscript presents an inference technique for estimating causal dependence between pairs of neurons when the population is driven by optogenetic stimulation. The key issue is how to mitigate spurious correlations between unconnected neurons that can arise due to polysynaptic and other network-level effects during stimulation. The authors propose to leverage each neuron's refractory period (which begins at approximately random times, assuming Poisson-distributed spikes and conditional on network state) as an instrumental variable, allowing the authors to tease apart causal dependence by considering how the postsynaptic neuron fires when the presynaptic neuron must be muted (i.e., is in its refractory period). The idea is interesting and novel, and the authors show that their modified instrumental variable method outperforms similar approaches.
We wish to thank the reviewer for this positive assessment.
However, the scope of the technique is limited. The authors' results suggest that the proposed technique may not be practical because it requires considerable amounts of data (more than 10^6 trials for just 200 neurons, resulting in stimulation of more than 5000 times per neuron). Even with such data sizes, the method does not appear to converge to the true solution in simulations. The method is also not tested on any experimental data, making it difficult to judge how well the assumptions of the technique would be met in real use-cases. While the manuscript offers a unique solution to inferring causal dependence, its applicability for experimental data has not yet been convincingly demonstrated, and would, therefore primarily be of interest to those looking to build on these theoretical results for further method development.
We thank the reviewer for this assessment and agree that the requirement for this many trials makes the estimators practically unsuitable for identifying causal interactions in large systems. However, in the revised manuscript, we can observe that the IV estimator can be beneficial after even a few thousand trials when introducing a newly improved error measurement (which we discovered thanks to these reviews). Moreover, we agree that this work will be of interest to the more theoretically oriented community for methodological improvements; we believe that the methods and causal inference framework will be interesting and useful for the wider neuroscience community. For example, considering the first (new) example in the introduction, even under two-photon single-neuron stimulation, the IV framework should be used to avoid bias amplification.
Reviewer #2 (Public Review):
Lepperød et al. consider the problem of inferring the causal effect of a single neuron's activity on its downstream population. While modern methods can perturb neuronal activity, the authors focus on the issue of confounding that arises when attempting to infer the causal influence of a single neuron while stimulating many neurons together. The authors adapt two basic methods from econometrics that were developed to address causal inference in purely observational data: instrumental variables and difference-in-differences, both of which help correct for unobserved correlations that confound causal inference. The authors propose an experimental procedure where neurons have spike times measured with millisecond precision and a subset of neurons are optogenetically activated. As an instrumental variable, the authors propose using the refractoriness of a stimulated neuron, resulting in absent or delayed spiking which can be used to infer its causal effect in otherwise matched conditions.
Based on this, they develop a collection of estimators to measure the pairwise causal relationship of one neuron on another. By simulating a variety of small networks, the authors show that, provided enough data is present, the proposed causal methods provide estimates that better match underlying connectivity than methods based on ordinary least squares or naive cross-correlograms (CCHs). However, the methods proposed require extensive data and highly targeted stimulation to converge.
Strengths:
The value of the paper comes from its attempt to find neuroscience applications for methods from fields where causal analysis of observational data is required. Moreover, as the field develops improved methods of measuring anatomical neuronal connectivity using molecular, physiological, and structural approaches, the question of the causal influence of one neuron's spiking on another remains vital. The authors thoughtfully lay out the necessary conditions - and difficulties - required to establish this type of causal functional influence and suggest one potential approach. The collection of models tested highlighted both the strengths and difficulties of the suggested approaches.
We wish to thank the reviewer for the positive feedback, we are delighted to share your view that obtaining methodology for estimating causal influence is vital.
Weaknesses:
1) I found the paper's introduction to its analysis techniques to be very confusingly written, particularly as it is designed to bridge fields. It is vital that the ideas are communicated more clearly. Some topics are explained multiple times, even after being used previously, other ideas and notations are introduced and immediately dropped (e.g. the "do operator", the ratio of covariances in the introduction to instrumental variables), and still others are introduced with no clear explanation (e.g. the weight term w, the "|Y->Y-Y*" notation, and the notation in the methods with "Y(Z=0)").
We thank the reviewer to point out this lack of clarity and we extensively rewrote the paper to make it more accessible. The do operator is used in the methods to define Y(Z=0), but is now removed from the introduction to reduce the number of concepts introduced early in the text. The w term is now defined from the generative model. The difference in differences notation is written out fully to be clear and a sketch of the method intuition is added to Figure 1.
1) Of particular importance, the introduction of the Z,X, and Y variables in the first full paragraph on page five, it could be made much more clear that this method is pairwise: Z and X reference the spiking of one specific stimulated neuron at two time points and Y references one specific downstream neuron. 2) In the third paragraph of the same page, the authors refer to the "refractoriness of X" and "spiking of X onto Y", but this language confuses the neurons with variables in a way that took considerable time to unpack. 3) This was not helped by Figure 1b, which suggested that Z_i, X_i, and Y_i applied to all neurons and merely reflected time points around stimulation. 4) Similarly, the introduction of the Y* variable in the difference of differences method, which the authors view as one of the main contributions, is given little clear explanation or intuition. I assume "shifted on window-size left" means measuring the presence of spiking at the same time step as X, but I see no clear definition of this. 5) The confusion about variables remains when, in Figure 1d, a "transmission probability" goes below 0 and above 1.
1) Thank you for pointing out this lack of clarity, the suggested explanation of the variables XYZ is adopted.
2) The language is clarified such that variables and neurons are separated.
3) Figure is fixed such that variables refer to the neurons they represent.
4) We have now improved the explanation of DiD with a figure for intuition.
5) We have now redefined the “transmission probability” to effective connectivity to reduce confusion.
I also found the network models studied after the first section and the relevant variables difficult to understand with the detail necessary to interpret the results. For example, the cartoon in Figure 2a does not seem to match the text description. I see no explanation for the external "excitatory confounder" and "inhibitory confounder" terms, nor what is done to control the (undefined) \sigma_max/\sigma_min term. I don't see anything in the methods about distinct inhibitory and excitatory neurons either. Further, the violin plots (e.g. Fig 2d) seem quite noisy (e.g. is Br, DiD really bimodal?), and it is not clear what distribution is being covered by them. If this is computational simulations, I would imagine more samples could be generated. The same vagueness issues hold for the networks in section 2.4 and 2.7.
We have now clarified the implementation of the excitatory and inhibitory confounder and how we distinguish between excitatory and inhibitory neurons and defined the condition number. The violin plots were removed in Fig 2 since the large variance represented changes across external drive which produced largely incomparable statistics. To illustrate variance, we now show the standard deviation of the absolute error in line plots 2e and 2g.
2) Broadly speaking, the causal estimates appear better in the sense of having smaller errors, but it's not clear to me if they are actually good or not. What does an error of 0.4 mean in terms of your ability to estimate the causal structure, and what exactly does the Error(w{greater than or equal to}0) notion refer to? It would be useful to see actual reconstructions of ground truth versus causally inferred connectivity to better understand the method's strengths and weaknesses.
To improve clarity, we have added a paragraph in the text before figure 2 explaining a new error measure. Since the estimators give the transmission probability and not the inferred connection strength directly, we previously computed a regressed error as in Das & Fiete 2020. This error measure is equivalent to the sine of the angle between $W$ and $\hat{W}$. This error measure is not ideal and gives an indirect population measure with deviations scaled during the error regression. Upon further reflection, we realized that we could define the error directly using our definition of effective connectivity on the generative model to obtain a much cleaner and more interpretable measure. This further led us to remove one of the proposed methods (brew) as it did not perform well under this new error measure. All error measurements are updated in all figures. Error(w{greater than or equal to}0) means that we only look at positive weights; now clarified in the text
3) I found the section on optogenetic modeling to be unsatisfying in its realism. The general result that 1 photon excitation hits a wide collection of neurons is undisputed, but the simulation does not account for a number of key factors - optogenetic receptor expression is distributed across the axons and dendrites of a cell, not only soma, scattering in tissue greatly affects transmission, etc. Moreover, experiments that attempt to do highly targeted activation have other methods for exactly this reason, such as multiphoton activation or electrophysiology. The message of decreasing performance as a function of stimulus size is important, but I struggle with the idea of the model being "realistic".
We thank the reviewer for pointing out this unsatisfactory comparison with realistic scenarios. To mitigate we have changed the wording, but kept the simulation as is. As the reviewer pointed out optogenetic receptor expression is distributed, and here we have assumed an expression that only affects soma (experimentally plausible according to Grødem et al 2023 (10.1038/s41467-023-36324-3)), scattering in tissue is included according to the Kubelka-Munk model.
4) The authors spend a great deal of analysis of stimulation, but little time on measurement. It seems like this approach demands a highly precise measure of spike time to know if a neuron is firing or not at a given millisecond due specifically being in a refractory state. A stimulated but refractory neuron will still likely spike as soon as it can after the momentary delay, and given the noise in the network this difference might not be easily detectable in the delay-to-spike of the downstream neuron, even assuming one spike in the presynaptic neuron is likely to cause a spike in the downstream. It would be useful to see this aspect considered with the same detail as the rest of the study.
We thank the reviewer for pointing out this. We have now added a paragraph discussing this: “As outlined in \citep{ozturk2000ill}, ill-conditioning can affect statistical analysis in three ways and therefore similarly in inverse connectivity estimates from measured activity. First, measurement errors such as a temporal shift in spike time estimate e.g. due to low sampling frequency, inaccurate spike sorting, or general noisy measurement due to animal movement etc. In the presence of ill-conditioning the outputs will be sensitive (unstable) to small input changes. If errors are included in some variables, the inference procedures will require information about the distributional properties of these errors. Second, optimized inference can give misleading results in the presence of ill-conditioning, caused by bad design or sampling.
There will always exist a natural variability in the observations which necessitates the assessment of ill-conditioning before performing statistical analysis. Third, rounding errors can lead to small changes in input under ill-conditioning. This numerical problem is often not considered in neuroscience but will become evermore relevant when large-scale recordings require large-scale inferences.”
Tags
Annotators
URL
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
HCN channels are atypically opened by the downward movement of gating charges during hyperpolarisation and have such weak coupling between the VSD and pore domain, and in the absence of an open state structure, extracting mechanistic information has been difficult. This manuscript is a continuation of a previous study on HCN channel gating that revealed how hyperpolarisation causes a downward movement of the VSD's S4, with breakage into two helices. The authors explore gating motions and the coupling between VSD and the pore domain using atomistic simulations. This includes microsecond MD with and without very strong -1V applied potentials to try to drive VSD-TMD changes to open the channel. In the end, however, the authors used a biased simulation approach (adiabatic bias) to enforce conformational change from resting to an open homology model of HCN based on hERG/rEAG. This microsecond simulation followed three interaction distances that were suggested to change between resting and open states based on free MD. This simulation caused pore opening and allowed a description of changes that may occur during gating, including a competition of S5-S6 and S6-S6 contacts and lipid binding locations, which may suggest lipid-dependent function and explain an unexpected closed structure at 0mV in micelles. While I feel the manuscript is written for the HCN expert audience, the mechanistic information in terms of hyperpolarisation-induced voltage gating makes it of much interest. The manuscript is presented at a high level, though there are a couple of points to address, including reproducibility of simulations and potential for more relation to experimental findings.
We appreciate the comments, thank you, please find a detailed answer below.
The authors carried out 1μs-MD simulations of the resting, activated, and a Y289D mutant at 0 mV, and then tried to drive the conformational change with a very large -1V voltage (double that studied previously). In 1 us MD, is the membrane stable with such a big voltage, as it would likely not be experimentally? Even with a volt applied, there was incomplete activation of the voltage sensors, despite timescales approaching that of activation.
This reviewer is correct in cautioning against membrane rupturing effects in simulations with a voltage of this magnitude. We have indeed checked that the membrane and the protein remains intact under these conditions and can confirm that no poration occurs. As membrane poration is stochastic, it could indeed occur over microsecond timescales under 1V, but the probability remains low, and we were lucky to not face this situation herein. Note that whereas potentials of this magnitude could not be applied in experiments, they are relatively routinely used in MD simulations to speed up processes that are driven by changes in transmembrane potentials.
Interestingly, other work from our lab (Rems et al. Biophysical Journal 119 (1) 190-205 (2020)) has shown that HCN1 voltage sensor domains are less prone to poration than those from other voltage sensor domains, for reasons that remain to be determined.
Author Response Figure 1. Final snapshots from the simulations of the resting (blue), intermediate (yellow) and activated (red) states. The representation of the solvent (water+ions) in cyan showed no membrane poration at the end of the 1us simulations.
For the pulling/ driving simulations (adiabatic bias MD) to change suspected interaction distances (V390-I302, N300-W281, and D290-K412), it seems to be just 1 simulation, without reproducibility. One has to wonder, if the simulation was redone from a very different initial conformation, would the results be the same (in addition to the distances themselves that were enforced by the ABMD). Moreover, the authors had to model the open state, such that the results depend on a homology model based on other CNBD channels, hERG / rEAG. Although the model stayed open for a microsecond, what other measures of accuracy of the homology model are there, such as preserved distances according to mutants/double mutants?
The ABMD simulations were repeated, please refer to the response to essential revisions point 1 for details.
For reasons mentioned by the reviewer as well as a reconsideration of our strategy to model channel opening, we have decided to omit homology models from the revised version of the paper.
The authors find that activation involves hydrophobic forces that strengthen the intra-subunit S4/S5/S6 interface, as well as lipid headgroups that make contact with hydrophilic residues at this interface, with lipid tails also contributing to hydrophobic contacts. The authors see bending and rotation of the lower S4 and a displacement of S1 away from S4 that exposes the VSD-pore interface to lipids, with increased lipid contacts at S4 and S5 during activation. This indicates lipid tails may play a role in coupling in HCN1 and may explain the closed state micelle structure at 0mV. Two sites of lipid contact are identified, one engaging VSD residues and the other polar or charged residues on S5 and S6. No experiments are presented or proposed to test the predicted lipid sites. e.g. Mutation of key residues, such as the arginine and histidine seen binding lipid headgroups could be tested as proof of their involvement, or perhaps experiments with varied phosphate moieties? In the absence of new experiments, is there existing data that could help validate the findings?
We thank this reviewer for this comment. As noted in the response to essential revisions point 3, such experiments are challenging, and have not been reported so far in HCN channels. We do agree that aspects of the mechanism we propose remain hypothetical awaiting further work, but are happy to report that importance of lipid interactions with the crucial salt bridge pair mentioned in the response to essential revisions point 3 has been completely independently validated, thus strengthening our mechanistic hypothesis substantially.
During free MD simulation, the authors see tilting of S5 caused by activation of the Y289D mutation that brings D290 and K412 positions into proximity. How do we know that the adjacent mutant of Y289 to aspartate has not caused this, or was this interaction also seen in wild-type simulation? Fig.3c might suggest the wt activated simulation may see such an interaction, but it is unclear given the large C_alpha distances, as opposed to H-bonding distances.
Indeed, Figure 3 appears to indicate that this interaction between D290 and K412 is present in the activated state when the mutation is reverted to the WT sequence. We have recalculated the interaction propensity using all atoms of the residues and present an updated Figure 3c in response.
The authors predict that a D290-K412 salt bridge may be important for gating and sought to experimentally validate the interaction in the activated-open state using cysteine cross-bridging. As this is the only experimental backing in the paper, it is important to be able to judge its ability to report on the D290-K412 salt bridge. A comparison experiment demonstrating other crosslinks that do not favour the open state would have been helpful in this regard e.g. if crossbridging at similar locations (but not predicted to change interaction during gating) had little effect on I/Imax, then the result may be bolstered. Are there existing mutagenesis experiments that may suggest the importance of these residues (as well as for other key interaction distances identified)?
Negative results in cross bridging and cysteine accessibility studies in general are difficult to interpret as the lack of a cadmium-specific effect may be due to inaccessibility of the site to cadmium, pairwise distance too far to bridge by cadmium, or bridging or the specified site without a functional effect. However, as reviewer 2 pointed out below, the Yellen group has performed extensive cross bridging experiments in the S4-S5 to Clinker region in spHCN and in most of these positions, the pairs favoring the open state are closer together in our models than pairs favoring the closed state or those without functional effect. We have added Videos 1-6 to highlight this comparison on our open state models and describe in our updated discussion section.
Rotation of the V390 side chain from a position facing the pore lumen to a position facing I302 on S5 is coupled to an increase of the pore radius at V390, an increased hydration of the pore intracellular gate, and K+ ion movement. Perhaps 5 or 6 ions cross in that single simulation. As K channel ion permeation can depend critically on starting ion configs (as well as the model/force field), reproducibility of this finding is important but does not appear to have been tested. How can we be sure that periods of permeation or no permeation in individual simulations are reliable?
As mentioned in our response to essential revisions point 1, we have modified the collective variable set used in ABMD, and repeated the simulations in 4 replicates. Whereas the number of permeation events is low in each simulation (Figure 4 S1), the consistency across repeats indicates that these open pore models indeed represent conductive states. Given how short the simulations are, however, it appears unreasonable to infer conductance values from these observations.
Reviewer #3 (Public Review):
In this work, Elbahnsi and colleagues use enhanced sampling MD simulation, to recapitulate step by step, the electromechanical coupling between VSD and the pore in HCN1 channels. Building on the available cryoEM structures of HCN1 with the VSD in resting and active state, the authors characterize by MD a subset of interactions that seemingly stabilize the open channel. This subset is, in turn, used in enhanced-sampling simulations to guide channel opening. The main findings are that S4 movement induces a rearrangement of the hydrophobic interaction at the level of S1- S4- and S5 interfaces. Occupancy of lipids seems therefore statedependent and highlights their regulatory role in HCN gating.
The approach is rather innovative, and it apparently allows the reconstruction of the whole mechanism of gating, pushing the predictive power of MD simulation well beyond its actual temporal limitations. At the same time, the initial choice of interactions is crucial for this approach, because the result cannot differ from the inputs. And reading the paper it does not emerge clearly how the correctness of the reconstructed gating pathway can be verified, if not by functional validation.
We thank the reviewer for this thoughtful review. It has pushed us to reconsider our approach to enhance the sampling of channel activation and gating. Please refer to the detailed response below as well as the response in particular to essential revisions point 1.
Here are my comments on the main interactions that were used to feed the final MD simulation:
1) W281-N300: this interaction, previously identified and studied in SpH channels (Ramentol et al, 2020; Wu et al, 2021), has been elegantly confirmed in this paper. Its inclusion in the initial subset seems appropriate. In the other two cases, the choice of interactions requires further explanations and experimental validation.
2) D290 and K412: the validation of this interaction shown in Figure 3 and suppl Figure 1 is missing a control, i.e., the effect of the addition of Cd++ on the wt channel. Please add.
We have performed the control suggested. Please also refer to the answer to essential revisions point 2.
3) Modelling the open state of HCN1 pore (page 18), is done on the structure of the distantly related hERG rather than on the available open pore structure of HCN4. This choice is justified as follows by the authors:
a) "Available structures in the CNBD channel family for which representative structures have been solved in closed and open states".
b) "The structural mechanism of pore gating (i.e. the ⍺ to 𝜋 helix occurring at the glycine657 hinge in hERG) observed in rEAG/hERG may be a conserved gating transition in the CNBD family of channels"
I encourage the authors to consider the following:
a) The structure of hERG channel is not available in the closed/open configuration, indeed the comparison must be done with the closed configuration of the related channel rEAG. On the contrary, HCN4 is available in the closed/open configurations. Moreover, one of the open pore structures shows S4-S5-S6 in a very similar conformation to the lock open mutant (F186C/S264C) of HCN1 (Saponaro et al, 2021). With an available HCN4 open structure, forcing HCN1 to the open pore structure of hERG channel (which opens in depolarization and is not regulated by cAMP) seems not necessary.
In response to this point, we reconsidered our approach and chose to instead use a biasing distance that is consistently increased in CNBD channels of resolved structures, that between neighboring and cross-subunits V390. We have detailed our rationale in the response to essential revisions point 1.
To my knowledge, hERG is the only channel of the CNBD family for which the transition ⍺ to 𝜋 helix reported by the Authors, occurs in S6. It is not reported for other CNBD family members, in particular for the CNG channels mentioned by the Authors (Zheng et al., 2020; Xue et al., 2021, 2022). Task 4 (Zheng et al) does not show it. Its pore opens by a right-handed twist of S6 at glycine 399, a conserved glycine in all CNG. Human CNGA1 too, opens the pore by a rotational movement of S6 hinged at the equivalent glycine (glycine 385) (Xue et al, 2021). And the same occurs in the non-symmetrical channel CNGA1/B1 (Xue te al, 2022). So, it seems that CNG channels do not show the ⍺ to 𝜋 helix transition in the open pore. Moreover, hERG excluded, all other members of the CNBD family, CNG, EAG, and HCN4 included, do not bend at the hinge glycine 657 of hERG, but at another glycine (gly 648 in hERG numbering) located upstream. Further, their opening is due to a rotation of S6 associated with an outward movement, rather than to the lifting of the lower part of S6, as in hERG.
After considering this reviewer’s comment, we were surprised to see that HCN1 is apparently prone to secondary structure deformation in S6, even when biasing the aforementioned distances, and thus enforcing no rotation at all in S6. We are intrigued by this observation and eagerly await experimental validation or disproval.<br /> In the meantime, we have made clear in the text that this hypothesis remains based exclusively on modeling work.
4) V390-I302: this interaction is predicted to stabilize the open pore configuration and was included in the subset. The contact between V390 on S6 and I302 on S5 is observed in the homology model discussed above when the S6 is twisted at the glycine hinge, rotating the preceding residue (V390) out of its pore-lining position and is. Again, I can only disagree with this hypothesis because it has been experimentally demonstrated (Cheng et al, J Pharmacol Exp Ther. 2007 Sep;322(3):931-9) that the side chain of Valine390 is inside the cavity of the open pore of HCN1 channels as it controls the affinity for the pore blocker ZD7288.
In accordance with other comments above, we have eliminated the bias applied to the V390I302 distance. However, the new ABMD simulations with bias applied to encourage dilation at position 390 still involve rotation of V390 away from the central pore axis, albeit with bending of S6 at the upper glycine mentioned by this reviewer. The degree of rotation is lower than in our previous simulations so that V390 still lines the inner vestibule in the open state, consistent with the observation that this position influences the apparent affinity of open pore blockers.
In conclusion, modelling the open state pore of HCN1 on hERG rather than on that of HCN4 seems not justified based on accumulated evidence in the published literature. Therefore, the choice of the authors to use it as the open pore model of HCN1 channels needs to be experimentally validated. One possibility is to mutate the glycine hinge, gly391 in HCN1, into an Alanine in order to remove the flexible hinge. If this mutation alters pore gating, it will support the choice of the Authors.
Once more, we thank the reviewer for the comments, which have led us to reconsider a larg part of our modeling work.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
We would like to thank the reviewers for their thorough evaluation of the presented manuscript and herewith would like to address their comments and suggestions.
This study was funded by a NSF-grant awarded to Prof. Celio. The animal experimentation license (including animal husbandry, breeding and experiments) that is required by law to perform animal experiments was also issued to Prof. Celio. Therefore, with the retirement of Prof. Celio, the funding for the project was discontinued and the animal license was terminated. We are thus unable to answer the reviewers’ open questions with follow-up experiments. We would however like to discuss some of the reviewers’ open questions or concerns and hope this might be insightful to the interested reader.
Reviewer #1 (Public Review):
“First, they reported that chemogenetic activation of Foxb1 hypothalamic cell groups led to tachypnea. The authors tend to attribute this effect to the activation of hM3Dq expressed in the parvofox Foxb1 but did not rule out the participation of the PMd Foxb1 cell group which may as well have expressed hM3Dq, particularly considering the large volume (200 nl) of the viral construct injected. It is also noteworthy that the activation of the Foxb1hypothalamic cell groups in this experiment did not alter the gross locomotor activity, such as time spent immobile state.”
Because an AAV2 serotype was used for expression of the chemogenetic tools, the spread of viral infection was much more restricted to the injection site in chemogenetic animals than was observed the AAV5-based expression of optogenetic tools. The more restricted spread of viral infection with AAV2 serotypes has previously been shown by a range of other groups (e.g. see https://doi.org/10.3389/fnana.2019.00093). This limited spread of the AAV2 serotype in our chemogenetic animals, together with the absence of the very strong locomotor phenotype observed during optogenetic stimulation experiments makes us hypothesize, that the respiratory phenotype is largely attributable to the ParvafoxFoxb1 neurons.
“In the second experiment, the authors applied optogenetic ChR2-mediated excitation of the Foxb1+ cell bodies' axonal endings in the dlPAG leading to freezing […]. Here it is important to consider that optogenetic ChR2-mediated excitation of the axonal endings is likely to have activated the cell bodies originating these fibers, and one cannot ascertain whether the behavioral effects are related to the activation of the terminals in the PAGdl or the cell bodies originating the projection.”
We did not consider the possibility of backpropagation induced by optogenetic axon terminal stimulation at the time of experiments. We acknowledge that this is the major limitation of our optogenetic experiments that would have to be investigated with further animal experiments.
Reviewer #2 (Public Review):
“3) Fig. 5, a great effort has been made to illustrate the point that CCK and Foxb1 are differentially expressed. Why not just perform a double in situ experiment to directly illustrate the point?”
We came across the publication in which the Cck-expressing PMd neurons’ control escape behaviors, only when we were drafting the manuscript. Because this was already after the retirement of Prof. Celio and we were not able to conduct further experiments involving animals, we leveraged on in silico methods and the publicly available high-quality dataset on the gene expression of the posterior hypothalamic area. The applied in silico method of dimensionality reduction and cluster assignment is well established and widely accepted. We believe in the quality of the dataset and the reliability of these in silico results but we agree with the reviewer that an alternative would have been to illustrate the expression patterns of Cck and Foxb1 by in-situ hybridisation.
“4) Fig. 7 data on optogenetic stimulation on immobility and breathing, since not all mice showed the same phenotype, what is the criterion for allocating these mice to hit or no hit groups?"
We defined the group allocation criteria in the section titled “Optogenetic modulation of Foxb1 terminal in the dlPAG induces immobility” as follows:
“OnTarget_antPAG animals had the tip of the optic fiber implant located above the dlPAG at an anterior-posterior level AP-4.04mm (from bregma) or proxymal. The OffTarget group contains animals with fiber tips located below (i.e. ventral to) the dlPAG and/or located more distal than AP -4.04mm.”
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
The manuscript of Parab et al. reports a beautiful phenotype analysis of the vascular brain/meningeal anatomy in a variety of reporter lines and mutants for Wnt/β-catenin signaling and angiogenic cues (Vegfaa, Vegfab Vegfc, Vegfd) during zebrafish development.<br /> The present study extends the previous work of the same Parab, Quick, and Matsuoka, that focused on fenestrated vessel formation in the zebrafish myelencephalic choroid plexus (mCP). Vegfs were shown to regulate fenestrated vessel formation in combination, but not individually, and with only little effect on neighboring non-fenestrated brain vessel development. The fenestrated endothelium is thus known to have specific angiogenic requirements.
The scale of investigation has now changed, and fenestrated vessel formation has been examined throughout the brain, in both circumventricular organs (organum vasculosum of lamina terminalis) and other choroid plexuses (CPs) including the diencephalic CP and its interface with the pineal gland, the eye choroid (choriocapillaris), and the hypophysis vasculature. The original finding is that a regionspecific code of angiogenic cues controls fenestrated vessel formation. The authors show that fenestrated vessels form independently of Wnt/β-catenin signaling and BBB vascular development but require different combinations of Vegfa and Vegfc/d-dependent angiogenesis within and across brain regions. A previously unappreciated function of autocrine and paracrine Vegfc signaling is demonstrated in this brain region-specific regulation of fenestrated capillary development.
Twenty-one different fish lines accurately genotyped and characterized and including a new Reck mutant, have been instrumental to conduct vascular pattern analysis, using confocal and stereomicroscopy imaging combined with transmission EM. High-quality illustration and robust quantification methods, previously validated, have been used. The study is well organized and reflects the high expertise and strong methodology of the investigators. Data are presented in nine dense figures and the contribution of angiogenic ligands to fenestrated vessel formation can hardly be studied more indepth.
However, and this will be my only main concern, no information is provided on the regional diversity of angiogenic receptor expression that may correlate with the regional angiogenic factor code. Without asking for a spatial transcriptomic study, the combination of Vegfr-reporter lines or in situ hybridization with a combination of receptor probes would allow for generating a comprehensive set of ligand/receptor data relative to the regional angiogenic signaling pattern involved in fenestrated vessel formation.
We appreciate this reviewer’s positive and encouraging comments highlighting both the quality and significance of our study. As we commented in response to the Essential Revisions point #1, we anticipate that a detailed expression analysis of all four Vegf receptors at different developmental stages during CP and CVO vascularization will be best addressed with new technologies combined with optimizations of existing tools/protocols. Thus, we have provided a paragraph of discussion on our perspectives for potential Vegf receptors involved in CP and CVO vascularization in the current study.
We address each of the points raised by the reviewer below.
Reviewer #2 (Public Review):
Building on their previous studies, Parab et al used a larger collection of genetically modified zebrafish lines to map the precise expression domains of different VEGF isoforms in the brain and demonstrated that different combinations of VEGF isoforms differentially control the formation of fenestrated vessels at different locations in the brain.
The authors used three Wnt signaling mutants to convincingly show wnt signaling is essential for parenchymal angiogenesis, but not required for fenestrated vessel development, such as those in choroid plexus, suggesting fenestrated vessel and barrier vessel are differentially regulated. The previous work from this group has established that VEGF isoforms are critical for myelencephalic choroid plexus development. In this study, they carefully documented the developmental vessel patterning in the diencephalic choroid plexus/pineal gland interface. They also documented the local expression pattern of VEGF isoforms with a set of BAC transgenic fish, together with the phenotype of a series of VEGF mutant fish, the data well support that different combinations of VEGF isoforms regulate fenestrated vessel development at different brain locations.
Given a larger temporal and spatial domain, VEGFs are critical for all forms of vessel development, there are potential redundancy mechanisms to maintain hemostasis of VEGF signaling, in this study, no data is provided to address whether LOF of one form of VEGF affects the expression of other isoforms.
This work provided detailed evidence of different isoform combinations of VEGF regulate formation/patterning of the fenestrated vessel at CP, OVLT, and NH in zebrafish. It will be interesting to follow in the mammalian system, how well these findings are conserved, for example, which isoform of VEGF is critical for vascular patterning during the developmental stages of the pineal gland? How VEGF isoforms participate in choroid plexus development at different ventricle regions and subsequence secretory function maintenance. However, these tasks are challenging without a good genetic tool to locally manipulate VEGF isoform expression during mammalian brain vessel development.
We appreciate this reviewer’s favorable and encouraging comments highlighting both the quality and impact of our study. We also acknowledge the great importance of the points raised by the reviewer, including the Vegf redundancy mechanisms and also our results’ conservation in mammals.
Reviewer #3 (Public Review):
Parab et al. investigate the requirement of specific Vegf ligands during the embryonic development of new blood vessels in different brain regions. The authors implement their previously published experimental paradigm (Parab et al 2021 eLife) combined with new transgenic and mutant zebrafish lines to show that vegf ligands (vegfaa, vegfab, vegfc, and vegfd) are required in various combinations to drive angiogenesis in distinct brain regions. Specifically, they show that individual loss of different vegf ligands causes either undetectable or partial effects in angiogenesis, while combined loss of vegf ligands results in severe defects in brain region-specific angiogenesis. As different blood vessel types (i.e. arteries, veins, lymphatics) require specific angiogenic cues, this study provides interesting new data on how the combination of these signals drives brain region-specific vascular development.
While the conclusions of the paper are generally well supported by the data, the authors overstate some of their findings, particularly with respect to the development of fenestrated capillaries. In this study, the authors use the zebrafish transgenic reporter line, plvap:EGFP, as an indicator of fenestrations. However, the authors do not provide any evidence of fenestrations of the blood vessels of the choroid plexuses or the cranial vessels used for quantification (Figures 1, 3, and 4). While expression of Plvap protein is often used as a marker for non-blood brain barrier endothelial cells, as Plvap is the major component of the diaphragms of fenestrated capillaries, plvap:EGFP expression alone does not indicate fenestrations. This is an important point because previous work has demonstrated that targeted deletion of Plvap does not cause a loss of fenestrations, but instead a loss of the diaphragms associated with fenestrations (Stan et al 2012 Dev Cell; Gordon et al 2019 Development). Similarly, Plvap expression alone does not necessarily indicate fenestrations as an expression of Plvap is not sufficient for fenestration formation. In fact, Plvap has initially been expressed in brain endothelial cells during initial angiogenesis to the brain without evidence of fenestrations, and subsequently, Plvap expression disappears during the maturation of the BBB. Thus, to conclude that specific vegf ligands are required for the development of fenestrated capillaries, transmission electron microscopy (TEM) should be used on the capillaries examined in this study or the language describing the results should be modified accordingly. Conversely, the authors did show TEM for the choriocapillaris (Figure 5A-C) but did not show plvap:EGFP expression in these vessels.
Additionally, the authors' usage of the phrase "development of fenestrated vessels" suggests that the study was examining signals that regulate the formation of fenestrations and not angiogenesis of vessels that may become fenestrated as demonstrated here. Therefore, as Plvap expression does not necessarily equate fenestrations (and vice-versa), the title and some of the major claims of the study are somewhat overstated.
We appreciate this reviewer’s constructive comments and suggestions to improve this study. We agree with the reviewer that the descriptions of our findings in the original manuscript were not strictly accurate in some aspects. We have now addressed the concern of the Tg(plvap:EGFP) reporter specificity by conducting additional molecular and functional characterizations of Tg(plvap:EGFP)+ vs Tg(glut1b:mCherry)+ brain vasculature, as we have commented in response to the Essential Revisions point #2. In addition, we have made substantial revisions in describing our findings, including 1) the change of the phrase "development of fenestrated vessels" into a more appropriate phrase and 2) the clarification of the primary focus of this manuscript on “angiogenesis/vascularization”. We believe that our revised manuscript now more clearly conveys the finding of signals involved in angiogenesis/vascularization of CP and CVO vascular beds.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
The following is the authors' response to the original reviews.
We are very glad that the editor and reviewers found our paper of broad interest to the community of population, evolutionary, and ecological genetics. We thank them for their positive feedback and insightful comments and suggestions. We have revised our manuscript to address some of the issues raised by the review. The main change we made was providing a detailed discussion of limitations of simulated genomes, focusing on considerations one needs to make when selecting a demographic model. This can be found in a new section “Limitations of simulated genomes” (pages 9-10). We made a few additional adjustments in other parts of the text based on the reviewers’ suggestions. They are all listed in the detailed point-by-point response to reviewers comments and questions below.
Editor:
1) It was noted that demographic models (or genomic parameters) that are inferred based on certain aspects of the genomic data (eg., site frequency spectrum, haplotype structure) may not recapitulate other aspects of the data. In other words, any inferred demographic models are expected to reliably reproduce only some aspects of the genetic variation data but not necessarily all. It would be helpful to emphasize this limitation in the manuscript and to include a table summarizing the types of variation that the demographic models for the catalogued species were based on.
This is a very important point, which we addressed in the revision by adding a section entitled “Limitations of simulated genomes”. This section discusses the considerations that one should make when selecting an inferred demographic model to implement in simulation. This includes the samples used in analysis, the method used for inference, as well as various filters. In this section we also point to the documentation page of the stdpopsim catalog, which provides information about each demographic model that can help users decide whether it is appropriate for their needs. We decided not to summarize this information in a succinct table in the manuscript because it is not straightforward to summarize the strengths and potential limitations of each model in a table. Instead, we will expand the summary provided for each demographic model in the documentation page to provide additional information. See response to the second reviewer’s comment on this topic for more details.
2) It will make stdpopsim more user-friendly to include an automated module that can visualize a demographic model given the corresponding parameters (or simulation scripts).
As mentioned in the response to the first reviewer’s comment on this subject, the documentation page of the stdpopsim catalog provides a brief summary for each demographic model, including a graphical representation. See response below for more details.
Reviewer #1:
In the introduction, the authors cite numerous efforts to generate high-quality reference genomes. That's not an issue in itself, but leading with this might send the message to some readers that it is these reference genome efforts that are driving the need for population genomics analysis and simulation tools, which is not really the case - why not instead give some citation attention to actual population genomics projects aiming to address the types of evolutionary questions this paper is concerned with? The reference genome citations would fit better in the section dealing with reference genomes, where they already appear.
Indeed, the desire to answer complex evolutionary questions is the main motivation for sequencing these genomes and also for generating realistic genome simulations. The reason we chose to lead with the genome-sequencing efforts is that high quality genome data is an important prerequisite for obtaining parameters for chromosome-scale simulations. So, with that perspective, these efforts which we cite are the driving force behind expansion of stdpopsim in the near future. Thus, we decided to leave these citations in the introduction. To balance things out, we now start the introduction with a statement about board questions in population genetics. Moreover, after we list the genome sequencing efforts, we added a list of specific types of questions that can be addressed by these newly emerging genomes, with relevant citations. The beginning of the introduction now reads:
“Population genetics allows us to answer questions across scales from deep evolutionary time to ongoing ecological dynamics, and dramatic reductions in sequencing costs enable the generation of unprecedented amounts of genomic data that can be used to address these questions (Ellegren, 2014). Ongoing efforts to systematically sequence life on Earth by initiatives such as the Earth Biogenome (Lewin et al., 2022) and its affiliated project networks, such as Vertebrate Genomes (Rhie et al., 2021), 10,000 Plants (Cheng et al., 2018) and others (Darwin Tree of Life Project Consortium, 2022), are providing the backbone for enormous increases in the amount of population-level genomic data available for model and non-model species. These data are being used, among other things, in inference of population history and demographic parameters (Beichman et al., 2018), studying adaptive introgression (Gower et al., 2021), distinguishing adaptation from drift (e.g. Hsieh et al., 2021), and understanding the implications of deleterious variation in populations of conservation concern (e.g. Robinson et al., 2023).”
Something that would be useful for the stdpopsim resource in general, though not necessarily something for the paper, would be some kind of more human-friendly representation of the demographic models implemented in the curated library. Perhaps I'm not looking in the right place, but as far as I can tell, if I want to study the curated demographic models, I need to go into the Python scripts on the stdpopsim GitHub page (e.g.
https://github.com/popsim-consortium/stdpopsim/tree/main/stdpopsim/catalog/BosTau). Here the various parameters and demographic events are hard-coded into the scripts. To understand the model being implemented, one thus needs to go dig into these scripts - something which is not necessarily very accessible to all researchers. Visual representations, such as the one for Anopheles gambiae in Fig 2. in the paper, are more widely accessible. I wonder if such figures could be produced for all the curated models and included in the GitHub folders alongside the scripts, perhaps aided by an existing model visualization software such as POPdemog. Again, I would not suggest that this is necessary for the paper, but if practically feasible I think it would be a useful addition to the resource in the longer term.
This is a very good point. The stdpopsim catalog actually has a documentation page that provides a brief summary for each demographic model, including a graphical representation. This graphical representation is generated using demesdraw applied to the demographic model object implemented in the code. Thus, potential users do not have to dig through the Python code to figure out the details of the demographic model. We used a similar approach to generate the image of the demographic history of A. gambiae for Fig. 2 of the paper. The documentation page is an important part of the stdpopsim catalog, and we now added a link to it in section “Data availability”, and we mention it in key places in the manuscript, such as the caption of Fig 2.
Reviewer #2:
An important update to the stdpopsim software is the capacity for researchers to annotate coding regions of the genome, permitting distributions of fitness effects and linked selection to be modeled. However, though this novel feature expands the breadth of processes that can be evaluated as well as is applicable to all species within the stdpopsim framework, the authors do not provide significant detail regarding this feature, stating that they will provide more details about it in a forthcoming publication. Compared to this feature, the additions of extra species, finite-site substitution models, and non-crossover recombination are more specialized updates to the software.
It would be helpful to provide additional information regarding the coding annotation (and associated distribution of fitness effects and linked selection) that is implemented in the current version of stdpopsim, but will be detailed in a forthcoming paper. This is not to take away from the forthcoming paper, but I believe this is the most important update to the software, and the current manuscript only brushes over it.
We agree that implementation of selection in simulations is a significant addition to stdpopsim. However, our intention in this manuscript is to focus on the separate effort we made in the last two years to expand the utility of stdpopsim to a more diverse set of species. We think the manuscript stands firmly even without discussing in detail the new features that allow modeling selection. The main reason we briefly mention these features in sections “Additions to stdpopsim” and “Basic setup for chromosome-level simulations” is because the released version of stdpopsim contains implemented DFEs for a few species, and we did not want to completely ignore this. We thus added a brief comment at the end of the “Basic setup” section (page 8) mentioning the three model species for which the stdpopsim catalog currently has annotations and implemented DFE models. We think that a more detailed description of how these features and how they should be used is best left to the manuscript that the PopSim community is currently writing (preprint expected later this year).
When it comes to simulating realistic genomic data, the authors clearly lay out that parameters obtained from the literature must be compatible, such as the same recombination and mutation rates used to infer a demographic history should also be used within stdpopsim if employing that demographic history for simulation. This is a highly important point, which is often overlooked. However, it is also important that readers understand that depending on the method used to estimate the demographic history, different demographic models within stdpopsim may not reproduce certain patterns of genetic variation well. The authors do touch on this a bit, providing the example that a constant size demographic history will be unable to capture variation expected from recent size changes (e.g., excess of low-frequency alleles). However, depending on the data used to estimate a demographic history, certain types of variation may be unreliably modeled (Biechman et al. 2017; G3, 7:3605-3620). For example, if a site frequency spectrum method was used to estimate a demographic history, then the simulations under this model from y stdpopsim may not recapitulate the haplotype structure well in the observed species. Similarly, if a method such as PSMC applied to a single diploid genome was used to estimate a demographic history, then the simulations under this model from stdpopsim may not recapitulate the site frequency spectrum well in the observed species. Though the authors indicate that citations are given to each demographic model and model parameter for each species, this may not be sufficient for a novice researcher in this field to understand what forms of genomic variation the models may be capable of reliably producing. A potential worry is that the inclusion of a species within stdpopsim may serve as an endorsement to users regarding the available simulation models (though I understand this is not the case by the authors), and it would be helpful if users and readers were guided on the type of variation the models should be able to reliably reproduce for each species and demographic history available for each species. It would be helpful to include a table with types of observed variation that the current set of 21 species (and associated demographic histories) are likely and unlikely to recapitulate well.
This is a very important point, which we now address in the section “Limitations of simulated genomes”, which we added to the manuscript. In this section, we expand on this topic and discuss various things that will affect the way simulated genomes reflect true sequence variation. This includes the choice of demographic inference method, but also the analyzed samples, and various filters. The main message of this section is that one should consider various things when deciding to implement a demographic model in simulation (or selecting a model among those implemented in stdpopsim). We also cite studies (including Beichman, et al. 2017), which compared different approaches to demography inference. However, we note that the conclusions of these comparisons are not as straightforward as the reviewer suggests. In particular, methods that make use of the site frequency spectrum (such as dadi) should be able to capture some aspects of haplotype structure, because this information is encoded in the demographic history. Furthermore, a demographic history inferred from a single genome (e.g., using PSMC) should do a reasonable job approximating some aspects of the site frequency spectrum. In other words, the aspects of genetic variation not modeled well by a given demographic inference method are not always predicted in a straightforward way. This is why we avoid summarizing this information in a table in the manuscript. The 2nd paragraph of the “Limitations of simulated genomes” section addresses some of these subtle considerations. In particular, we suggest that considering a demographic model for simulation requires some familiarity with the inference method and the way it was applied to data. Regarding the demographic models currently implemented in stdpopsim, we provide some information about each model in the documentation page of the catalog. When selecting a demographic model from the catalog, users should make use of this documentation to guide their decision. This is mentioned in the 3rd paragraph of the “Limitations of simulated genomes” section. Following-up on this issue, we intend to review the documentation and make sure it provides sufficient information for each demographic model. See this GitHub issue.
Reviewer #3:
- p5, 2nd paragraph: I think many Biologists, myself included, will think of horizontal gene transfer mostly as plasmids being transferred among bacteria and adding extra genetic material, not as homologous bacterial recombination. This made me confused about modelling horizontal gene transfer in the same way as gene conversion. It may be helpful for some readers if you specify that you are modelling this particular type of horizontal gene transfer. Some explanation along the lines of what is in Cury et al (2022) would be enough.
This is a good point. We modified the text in that sentence in the 2nd paragraph on page 5 to clarify that we are modeling non-crossover homologous recombination, and not incorporation of exogenous DNA (e.g., via plasmid transfer). The relevant part of the text now says:
“In bacteria and archaea, genetic material can be exchanged through horizontal gene transfer, which can add new genetic material (e.g., via the transfer of plasmids) or replace homologous sequences through homologous recombination (Thomas and Nielsen, 2005; Didelot and Maiden, 2010; Gophna and Altman-Price, 2022). However, the initial version of stdpopsim used crossover recombination to stand in for these processes. Although we cannot currently simulate varying gene content (as would be required to simulate the addition of new genetic material by horizontal gene transfer), the msprime and SLiM simulation engines now allow gene conversion, which has the same effect as non-crossover homologous recombination.
Following (Cury et al., 2022), we use this to include non-crossover homologous recombination in bacterial and archaeal species.”
- p5, 3rd paragraph: When you say gene conversion is turned off by default, you could refer to table 1 and briefly mention the consequence of ignoring gene conversion.
We agree that it is important to note that avoiding to model gene conversion may lead to faulty lengths of shared haplotypes across individuals. This is implied by the statement we make in the beginning of the 3rd paragraph on page 5, where we lay out the motivation for modeling gene conversion in simulation. Following the reviewer’s suggestion, we now added a statement about this in the end of that paragraph:
“Note that ignoring gene conversion may result in a slightly skewed distribution of shared haplotypes between individuals (see Table 1)”
- p7, item 1 and p9, 1st paragraph: I am not sure what you mean by genetic map here, can you define this term? I am not sure if it is synonymous with gene annotations, a recombination map, or something else. The linkage map doesn't seem to make sense to me here.
The term ‘genetic map’ referred to the recombination map whenever it was used in the manuscript. To avoid any confusion, we now removed all mentions of ‘genetic map’, and use ‘recombination map’ instead. The recombination map is relevant in item 1 of page 7 because in species with poor assemblies you will not be able to reliably estimate recombination maps, making chromosome-scale simulations less effective. In the 1st paragraph of page 9, we discuss the issue of lifting over coordinates from one assembly to another, and if you have a recombination map estimated in one assembly, you might need to lift it over to another assembly to apply it in your simulation.
- Table 1, last row, middle column: when you say "simulated population", I think it is a bit ambiguous. You mean "the true population that we are trying to simulate", but could be read as "the population data that was generated by simulation". I would delete the word simulated here.
What we mean here is that the selected effective population size should reflect the observed genetic diversity in real genomic data. We realize that the previous wording was confusing, and changed this to the following:
“Set the effective population size (Ne) to a value that reflects the observed genetic diversity”
- Figure 2, and other places when you refer to mutation and recombination rate (eg p11, last paragraph), can you include the units (e.g. per base pair, per generation)?
Throughout the manuscript, rates are always specified per base per generation. In Figure 2, this is specified in the caption (3rd line). We added units in other places in section “Examples of added species” on pages 12-13, where they were indeed missing.
- p11, "default effective population size": can you use a more descriptive word instead of the default? Maybe the historical average? Also, what is this value used for in the simulations when there is a demographic model specified (as in the case of Anopheles)?
We think that “default effective population size” is the most appropriate term to use here, since we are referring to the parameter in the species model in stdpopsim. It is correct that the value of this parameter should reflect the historical average size in some sense, but it is really unclear what this should be in the case of a species like Bos taurus, which experienced a very dramatic bottleneck in the recent past. We address this subtle, yet important, issue in the sentence preceding this one. If a demographic model is specified in simulation, it overrides the default effective population size, and its value is ignored (which is why we refer to it as ‘default’). We added a short sentence clarifying this in the 2nd paragraph of the “Bos Taurus” section (now page 12).
“Note that the default Ne is only used in simulation if a demographic model is not specified.”
- p8, when you say "Such simulations are useful for a number of purposes, but they cannot be used to model the influence of natural selection on patterns of genetic variation.": You may want to bring up the discussion that many of these neutral parameters taken from the literature could have been estimated assuming genome-wide neutrality, and thus ignoring the effect of background selection. Therefore the parameter values might reflect some effect of background selection that was unaccounted for during their estimation.
This is an important subtle point, which we now address in the section “Limitations of simulated genomes”, which we added to the revised manuscript. In that section, we discuss various limitations of simulations, focusing on inferred demographic models. We address the potential influence of the segments selected for analysis toward the end of 2nd paragraph in that section (page 9):
“... all methods assume that the input sequences are neutrally evolving. This implies that technical choices, such as the specific genomic segments analyzed and various filters, may also influence the inferred model and its ability to model observed genetic variation.”
Interestingly, background selection in itself typically does not have a strong effect on the inferred model. This is something that is examined in the forthcoming publication that presents simulations with natural selection in stdpopsim.
- Why are some concepts written in bold (eg effective population size, demographic model)? Were you planning to make a vocabulary box? I think this is a good idea given that you are aiming for a public that can include people who are not very familiar with some population genetics concepts.
In the “Examples of added species” section, we use boldface fonts to highlight the model parameters that were determined for each species. We added a statement clarifying this in the beginning of this section (page 11), and made sure that all the relevant parameters were consistently highlighted throughout this section. In other sections, we use boldface fonts only for titles. A few cases that did not conform to this rule were removed in the current version. We did not intend on adding a vocabulary box, but considered this when revising the manuscript, due to the reviewer’s suggestion. However, we found it difficult to converge on a small (yet comprehensive) set of terms with accurate and succinct definitions. We think that the important terms are adequately defined within the text of the manuscript, providing sufficient information also for readers who are not expert population geneticists.
- p4, 2nd paragraph: Are these automated scripts that are used to compare models publicly available? If you are suggesting that people use this approach generally when coming up with a simulation model (p8, penultimate paragraph), it would be helpful to have access to these automated scripts.
The scripts are part of the public stdpopsim repository on GitHub, and may be used by anyone. Some components of these scripts are more easy to apply in general, such as comparing a demographic model with one implemented separately by the reviewer. This step, for example, is achieved by application of the Demography.is_equivalent method in msprime. Other parts of the comparison depend on the specific structure of python objects used by stdpopsim, so they are not likely to be useful when implementing simulations outside the framework of stdpopsim.
- p9, 1st paragraph, and p.12 2nd paragraph: instead of adjusting the mutation rate to fit the demographic model (and using an old estimate of the mutation rate), would it be ok to adjust the demographic model to fit the new mutation rate? E.g. with a new mutation rate that is the double of a previous estimate, would it be ok to just divide Ne by 2 such that Ne*mu is constant (in a constant population size model)? I imagine this could get complicated with population size changes.
In principle, this could be done if you were simulating neutrally evolving sequences (without modeling natural selection). Since the coalescence is scale-free, then you can scale down all population sizes and divergence times by a multiplicative factor, and scale up migration rates and the mutation rate by the same factor, and you get the exact same distribution over the output sequences. However, making sure you get the scaling right is tricky and is quite error-prone. Especially considering the fact that you have to do this every time the mutation rate of a species is updated. Moreover, once you start modeling natural selection, this scale-free property no longer holds. Thus, the simple solution we came up with in stdpopsim is to attach to each demographic model the mutation rate used in its inference.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
The following is the authors' response to the original reviews.
We sincerely thank all the editors and reviewers for taking the time to evaluate this study. Here is our point-by-point response to the reviewers’ comments and concerns.
Reviewer #1 (Public Review):The study by Oikawa and colleagues demonstrates for the first time that a descending inhibitory pathway for nociception exists in non-mammalian organisms, such as Drosophila. This descending inhibitory pathway is mediated by a Drosophila neuropeptide called Drosulfakinin (DSK), which is homologous to mammalian cholecystokinin (CCK). The study creates and uses several Drosophila mutants to convincingly show that DSK negatively regulates nociception. They then use several sophisticated transgenic manipulations to demonstrate that a descending inhibitory pathway for nociception exists in Drosophila.
[…]
Weaknesses:
A minor weakness in the study is that it is unclear how DSK negatively regulates nociception. An earlier study at the Drosophila nmj shows that loss of DSK signaling impairs neurotransmission and synaptic growth. In the current study, loss of CCKLR-17D1 in Goro neurons seems to increase intracellular calcium levels in the presence of noxious heat. An interesting future study would be the examination of the underlying mechanisms for this increase in intracellular calcium.
We thank the reviewer for the kind and very positive evaluation of our manuscript. We agree that this study has not elucidated the intracellular molecular pathway(s) downstream of CCKLR-17D1 that are involved in the regulation of the activity of Goro neurons, and we think that it would definitely be an interesting topic for future research.
Reviewer #1 (Recommendations For The Authors):
The response latencies for the control yw larvae seem large, with many larvae appearing to be insensitive to the thermal stimulus. Is this just an effect of the yw genetic background? A brief discussion of this might be helpful.
We thank the reviewer for pointing this out. We have also noticed that the yw control larvae tend to show longer response latencies than the other control strains, and in the revised manuscript, we have added the following sentence in the Result section (Lines 91–94):
“We have noticed that the yw control strain, which was used by us to generate the dsk and receptor deletion mutants, showed relatively longer response latencies to the 42 °C probe compared to the other control strains used in this study. This may be attributed to the effect of the genetic background, although, presently, the cause for this difference is unknown.”
Reviewer #2 (Public Review):_
This is an exceptional study that provides conclusive evidence for the existence of a descending pathway from the brain that inhibits nociceptive behavioral outputs in larvae of Drosophila melanogaster. […] The study raises many interesting questions for future study such as what behavioral contexts might depend on this pathway. Using the CAMPARI approach, the authors do not find that the DSK neurons are activated in response to nociceptive input but instead suggest that these cells may be tonically active in gating nociception. Future studies may find contexts in which the output of the DSK neurons is inhibited to facilitate nociception, or contexts in which the cells are more active to inhibit nociception._
Reviewer #2 (Recommendations For The Authors):I have no recommendations for the authors as this is a very complete and thoroughly executed study. The writing is crystal clear.
We thank the reviewer for the kind and very positive evaluation of our manuscript. We are happy to know that our current manuscript was deemed to be clear and convincing by the reviewer.
Reviewer #3 (Public Review):[…] Overall the authors use clean logic to establish a role for DSK and its receptor in regulating nociception. I have made a few suggestions that I believe would strengthen the manuscript as this is an important discovery.
Major comments:
1. It's not completely clear why the authors are staining animals with an FLRFa antibody. Can the authors stain WT and DSK KO animals with a DSK antibody? Also, can the authors show in supplemental what antigen the FLRFa antibody was raised against, and what part of that peptide sequence is retained in the DSK sequence? This overall seems like a weakness in the study that could be improved on in some way by using DSK-specific tools.
We thank the reviewer for this query. We would like to clarify that we first tried the FLRFa antibody to visualize an RFamide-type neuropeptide other than DSK in Drosophila and found that the staining pattern is quite similar to that of anti-DSK, as shown by Nichols et al. [1]. According to the original paper describing the anti-FLRFa antisera [2] (already cited in the reviewed manuscript), the antigen used to raise it was the Phe-Met-Arg-Phe-NH2 peptide conjugated with succinylated thyroglobulin, and the study experimentally shows that the antibody well binds to peptides containing Met-Arg-Phe-NH2 or Leu-Arg-Phe-NH2 sequence and has 100% cross-reactivity to FLRFa. As DSK contains Met-Arg-Phe-NH2 sequence [3], the cross-reaction of this antibody to DSK is consistent with the description of the original study.
Although we were unable to use an antibody specific to DSK, our staining data with dsk deletion mutants and the expression pattern of DSK-2A-GAL4 corroborate each other (Figure 2 and Figure 2-figure supplement 1), which we believe provides compelling evidence for the specific expression of DSK in MP1 and Sv neurons, and for that DSK-2A-GAL4 is a reasonably effective tool to specifically manipulate DSK-expressing neurons.
2. What is the phenotype of DSK-Gal4 x UAS-TET animals? They should be hyper-reactive. If it's lethal maybe try an inducible approach.
We thank the reviewer for this question. Unfortunately, we have not attempted this experiment, although we agree that this would be a nice addition to further strengthen the study if TET worked well in the DSKergic neurons.
3. Figure 9. This was not totally clear, but I think the authors were evaluating spontaneous (i.e. TRPA1-driven) rolling at 35C. The critical question is "does activating DSK-expressing neurons suppress acute heat nociception" and this hasn't really been addressed. The inclusion of PPK Gal4 + DSK Gal4 in the same animal kind of clouds the overall conclusions the reader can draw. The essential experiment is to express UAS-dTRPA1 in DSK-Gal4 or GORO-Gal4 cells, heat the animals to ~29C, and then test latency to a thermal heat probe (over a range of sub and noxious temperatures). Basically prove the model in Figure 10 showing ectopic activation or inhibition for each major step, then test heat probe responses.
We thank the reviewer for suggesting ideas for alternative experiments to potentially strengthen our conclusion. Regarding experiments using heat probes, previous studies have demonstrated that (i) Blocking ppk1.9-GAL4-positive C4da neurons almost completely abolishes the larval nociceptive response to local heat stimulations [4]; (ii) Local heat stimuli above 39 °C readily activate C4da neurons and larval nociceptive rolling [5-9]; and (iii) Thermogenetically or optogenetically activating these neurons is sufficient to trigger Goro neurons and larval rolling [4, 10-12]. Thus, it has now been made clear that heat probes induce larval nociceptive rolling via excitation of the C4da pathway, and we believe that our experiments using thermogenetic activation of C4da neurons can be safely interpreted as an alternative to experiments using heat probes. Using heat probes demands a more complicated experimental set-up to be combined with CaMPARI imaging experiments, and this is another reason why we preferred to take the thermogenetic approach.
We have also considered the experiment using Goro-GAL4 instead of ppk-GAL4. However, if dTRPA1 artificially activates Goro neurons far downstream of the neuronal mechanism by which MP1 activation suppresses Goro neuron activity, the effect of MP1 activation may be bypassed and masked. As we currently do not know the epistasis between dTRPA function and the effect of MP1 activation in modulating the activity of Goro neurons, we rather chose to activate C4da neurons by using ppk-GAL4, which likely resulted in more natural activation of Goro neurons than dTRPA1-triggered direct activations.
4. It would also then be interesting to see how strong the descending inhibition circuit is in the context of UV burn. If this is a real descending circuit, it should presumably be able to override sensitization after injury.
Indeed, this is an interesting avenue to explore in future studies to understand the type of situation in which the DSKergic descending system functions to control nociception.
Reviewer #3 (Recommendations For The Authors):Overall this is a good story and the claims are generally supported with experimental evidence. The way to really improve this study would be to use more precise and definitive tools, like specific antibodies, specifically targeted genes, and better temporal control of the descending circuit to prove this is inducible sufficient to suppress acute thermal nociception and this occurs only via a descending pathway, etc. However this would be exponentially more work, and so the authors I guess need to weigh the cost-benefit of definitive proof vs. strong evidence for their claims. Overall I think this study will be the beginning of a new line of inquiry in the field that has the potential to guide our understanding also of mammalian descending pathways, and as such, this study is of value to the community.
We appreciate the reviewer’s multiple interesting ideas for experiments that could have been performed to further reinforce our findings. We agree that some experiments that the reviewer suggested would potentially strengthen this work if supplemented. However, as aforementioned, in our humble opinion, we think that the experiments that the reviewer suggested are either outside the scope of this paper or have no significant benefits over the experiments that were already conducted, and hence are not essential to the present study.
References
-
Nichols, R. and I.A. Lim, Spatial and temporal immunocytochemical analysis of drosulfakinin (Dsk) gene products in the Drosophila melanogaster central nervous system. Cell Tissue Res, 1996. 283(1): p. 107-16.
-
Marder, E., et al., Distribution and partial characterization of FMRFamide-like peptides in the stomatogastric nervous systems of the rock crab, Cancer borealis, and the spiny lobster, Panulirus interruptus. J Comp Neurol, 1987. 259(1): p. 150-63.
-
Nassel, D.R. and M.J. Williams, Cholecystokinin-like peptide (DSK) in Drosophila, not only for satiety signaling. Front Endocrinol, 2014. 5.
-
Hwang, R.Y., et al., Nociceptive neurons protect Drosophila larvae from parasitoid wasps. Curr Biol, 2007. 17(24): p. 2105-2116.
-
Tracey, W.D., Jr., et al., painless, a Drosophila gene essential for nociception. Cell, 2003. 113(2): p. 261-73.
-
Xiang, Y., et al., Light-avoidance-mediating photoreceptors tile the Drosophila larval body wall. Nature, 2010. 468(7326): p. 921-6.
-
Burgos, A., et al., Nociceptive interneurons control modular motor pathways to promote escape behavior in Drosophila. eLife, 2018. 7.
-
Honjo, K. and W.D. Tracey, Jr., BMP signaling downstream of the Highwire E3 ligase sensitizes nociceptors. PLoS Genet, 2018. 14(7): p. e1007464.
-
Im, S.H., et al., Tachykinin acts upstream of autocrine Hedgehog signaling during nociceptive sensitization in Drosophila. eLife, 2015. 4: p. e10735.
-
Ohyama, T., et al., A multilevel multimodal circuit enhances action selection in Drosophila. Nature, 2015. 520(7549): p. 633-9.
-
Honjo, K., R.Y. Hwang, and W.D. Tracey, Jr., Optogenetic manipulation of neural circuits and behavior in Drosophila larvae. Nat Protoc, 2012. 7(8): p. 1470-8.
-
Zhong, L., et al., Thermosensory and non-thermosensory isoforms of Drosophila melanogaster TRPA1 reveal heat sensor domains of a thermoTRP channel. Cell Rep, 2012. 1(1): p. 43-55.
-
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
The following is the authors' response to the original reviews.
We’d like to thank the three reviewers for reviewing in depth our work and providing insightful comments and suggestions.
Reviewer #1 (Recommendations For The Authors):
1) The evidence that MS023 is actually working in vivo in their last experiment (Fig 6) needs to be strengthened. This could be due to the timing of the experiment. Tail tips were collected 48 h after the final injection and analyzed by Western for ADMA and SDMA levels. They do see subtle changes, in the right directions, of SDMA and ADMA (but these changes are really not very obvious). Perhaps the inhibitor has already been largely metabolized two days after injection. Have they looked at MMA levels?
We have quantified the ADMA and SDMA levels of Fig. S6. We have not measured MMA levels. The text has been edited as follows:
“The average ADMA relative expression was 0.95 for vehicle treated mice and 0.83 for MS023 treated mice (p < 0.00041). The average SDMA relative expression was 0.92 for vehicle treated mice and 0.94 for MS023 treated mice (p < 0.17). These whole-body measurements as measured by tail biopsies show MS023 promotes the decrease of proteins with ADMA and a slight increase in proteins with SDMA. It is known that inhibition of type I PRMTs or PRMT1 deletion diminishes ADMA and increases SDMA due to substrate scavenging (Dhar et al, 2013).”
2) The authors need to explain why they would expect an increase in SDMA levels in these mice after MS023-treatment.
We have edited the text as follows:
“It is known that inhibition of type I PRMTs or PRMT1 deletion diminishes ADMA and increases SDMA due to substrate scavenging (Dhar et al, 2013).”
3) In the discussion, it would be valuable to address the types of CRISPR-screens that could be performed in these MS023-expanded MSCs. They mention this as a benefit in the introduction, but to expand on this idea in the discussion.
The idea here was not necessarily to perform a CRISPR screen on the MS023-treated cells (although it is an interesting idea), but rather to correct the genetic mutation by CRISPR-Cas9 to enhance the success of genetically corrected autologous cell transplantation. The addition of MS023 to MuSC in vitro would allow to expand the cells while maintaining their self-renewal potential, thereby providing the opportunity to correct the mutation on the dystrophin gene using technologies such as CRISPR prime editing (Mbakam et al., 2022 Mol Ther Nucleic Acids 30:272-285). Our results demonstrating that MS023 enhances cell engraftment suggest that this method could be used to improve autologous cell transplantation efficiency. We have edited the text in the discussion as follows:
“Our findings suggest that type I PRMT inhibitors may have therapeutic potential for treating certain skeletal muscle diseases. For instance, to improve the efficacy of autologous cell therapy, the dystrophin-deficient MuSCs collected from DMD patient and corrected by CRISPR prime editing (Happi Mbakam et al, 2022) could be treated with MS023 to maintain their stemness and enhance their cell engraftment capacity.”
4) Also, could they address the potential value of MSC culture and expansion using a combination of SETD7 inhibition and PRMT1 inhibition?
Agreed. We have edited the text as follows:
“These findings suggest that inhibiting methyltransferases can affect MuSC fate and perhaps a combination of Setd7 and MS023 inhibitors would provide a more favorable combination to promote the expansion of MuSCs while maintaining their stem cell-like properties.”
Reviewer #2 (Recommendations For The Authors):
In figure 2 the authors show that upon removal of MS023, the cells differentiate more efficiently. In figure 5E-F they show that the mice that received MS023-treated cells had more GFP mature muscle fibers. However, in figure 5C-D these cells have the same capacities to terminally differentiate. This reviewer was wondering if these cells would differentiate faster? Have the authors look into this?
The reviewer raises an interesting point. Our in vitro experiments shown in Supplemental Figure S1 indicate that MS023-treated cells are actively more cycling (more ki67+ cells) and are less committed to differentiation (less Pax7-MyoD+ cells), which would suggest that they would need to exit the cell cycle and differentiate faster to reach the same fusion capacity after 3 days of differentiation without MS023. Future experiments with a time course including earlier time points will be needed to confirm if these cells differentiate faster.
Reviewer #3 (Recommendations For The Authors):
1) MS023 is a non-selective inhibitor of type I PRMTs. It has comparable IC50 values for PRMT1 and PRMT4 (CARM1), and lower IC50 values for PRMT6 and PRMT8. The authors argue that the cellular phenotype caused by MS023 is solely mediated via PRMT1, since the specific PRMT4-inhibitor TP-064 has no effects on MuSC expansion. TP-064 treatment was not used as a control for the transplantation and muscle strength measurement experiments. Are PRMT6 and PRMT8 expressed in MuSC and are thy inhibited by the applied concentrations of MS023? Kawabe et al reported that CARM1 methylates Pax7, thereby inducing Myf5 transcription during the asymmetric division of MuSC (PMID: 22863532). Is the expression of Myf5 reduced upon MS023 treatment? scRNAseq of MuSC 4-day after culture is too late to address this question, since the majority of the cells are already committed to differentiation. Staining for Myf5 using ex vivo cultured fibers or regenerating muscles in vivo should be used.
Indeed, we mention throughout the text that MS023 is a type I PRMT inhibitor. We have edited the text as follows suggesting the effect are most likely mediated by inhibition of PRMT1 in vivo.
“Treatment of MuSCs with MS023 resulted in metabolic reprogramming of MuSCs, supporting a role for type I PRMTs as metabolic regulators. In vitro, MS023 has been shown to inhibit several type I enzymes at nM concentrations (Eram et al., 2016). It is well-documented that PRMT1 is the major cellular type I enzyme (Pawlak et al, 2000) and this is why PRMT1, but not the other type I PRMTs are embryonic lethal in mice (Guccione & Richard, 2019). The numerous published data in cellulo with MS023 are thus far only reproduced by PRMT1-deficiency by siRNA or knockout, suggesting that MS023 actions in vivo are predominantly mediated by inhibiting PRMT1 (Gao et al, 2019; Plotnikov et al, 2020; Wu et al, 2022; Zhu et al, 2019). Thus, the effects of MS023 on MuSCs are most likely mediated by inhibition of PRMT1.”
Moreover, we investigated the expression of other type I PRMTs as suggested by the reviewer. We investigated their expression from publicly available single cell RNAseq dataset (Oprescu SN et al, iScience 2020, 23:100993), which performed analysis on skeletal muscle at different time points post-cardiotoxin injury (uninjured, and 0.5, 2, 3.5, 5, 10, 21 days post-injury). The findings show that Prmt1 is by far the most expressed type I PRMT in MuSCs at every time point tested. Carm1 (Prmt4) is expressed at high level in a small/moderate subset of cells, especially during regeneration. Prmt6 is expressed at low level in a small proportion of cells, while Prmt8 expression was not detected. These findings are coherent with our observation that Prmt1 is the predominant type I Prmt in MuSCs, which further support our hypothesis that it is the main target of MS023. These findings were added in Suppl. Fig 1B.
The expression of Myf5 during asymmetric division is indeed well characterized on muscle fiber-associated MuSCs (Dumont et al., 2015 Nat Med 21:1455; Kawabe et al., 2012 Cell Stem Cell 11:333). As the reviewer states, the 4-day time point is too late to investigate Myf5 expression. Additionally, these cells were cultured ex-vivo and were not fiber-associated. Therefore, scRNAseq is not an ideal method to address the question of whether MS023 treatment modulates Myf5 expression, and further experiments would be required to examine Myf5 in an appropriate context (i.e. on ex-vivo cultured myofibers).
2) Figure 2 is not very informative, while the second paragraph of the result parts is excessive and too complicated. The extensive description of differential gene expression in each potential subpopulation is neither very informative nor helpful to convince the reader that the M3/M5 population has acquired more stemness-like features due to the MS023 treatment. From my point of view, the data just reflect the increased proliferative capacity of MS023-treated cells with elevated cell cycle markers, ribosomal protein, and metabolic state. Do the M1-M5 populations show any different distribution along the trajectory? The authors need to show cell trajectories for each sample and cluster in Figure S3A. It is also imperative to present the distribution of signature genes for each individual cluster. Essentially, M1-M5 all located together in one cloud. What justifies segregation into different subclusters? The color code for the different clusters (including the trajectories) to allow better distinction.
MS023 treated MuSCs contain a subpopulation with higher Pax7 expression (Supplementary Figure S2F, S2G), which is consistent with the IF results in Figure 1 and emphasized in the abstract. Why are these data in the supplements and not in a main figure (e.g. in figure 2)?
We appreciate the thoughtful and detailed comments on our single-cell data. Please see below for a response to each point:
To address the concern that the results section is excessive, our intention was to simply provide the reader with a descriptive overview of the identity of each subcluster that the software identified. In fact, to ensure clarity and conciseness, we elected to provide only the names of a select few cluster markers rather than list all of the significant cluster markers that were generated. We kindly refer the reviewer to Supplementary Table S1 for a more extensive list of markers.
In response to the reviewer’s comment: “The color code for the different clusters (including the trajectories) to allow better distinction,” we agree that colour-coding is helpful, please refer to Figure 2A for a colour-coded map of the clusters.
To address the reviewer’s question regarding what justifies segregation into different subclusters for M1-M5, refer to Supplementary Table S1 for a list of uniquely enriched markers for each cluster. This list was filtered to include marker genes that were present only in a given cluster, thus contributing to its uniqueness and explains why that cluster was identified as being distinct from another given cluster.
Lastly, since the elevated Pax7 levels in MS023-treated MuSCs was already presented and discussed thoroughly in Figure 1, we elected to avoid repetition in the main Figures and presented the ridge plots showing elevated Pax7 in the Supplementary Material for Figure 2
3) The same group has reported previously that PRMT1-deficient MSCs show reduced expression of MyoD due to disruption of Eya1/Six1 recruitment to the MyoD promoter (PMID: 27849571). However, the scRNAseq result does reflect this finding. MyoD levels are not significantly changed in d4 MS023 compared with d4 (Supplementary figure S2G). The authors need to provide an explanation. Furthermore, the authors previously described that "the majority of PRMT1-deficient MSCs repressed Pax7 expression at day 3 while being Ki67 positive (Fig. 5B). How does that fit to the current observations, which indicate an increase of Pax7+ cells after MS023 treatment? This discrepancy needs to be resolved.
While the scRNAseq does not show a reduction in overall MyoD expression in MS023-treated MUSCs, there is indeed a reduction in the proportion of MyoD+ myofiber-associated MuSCs (Figure 1C, 1D). Supplemental Figure S2G further shows a subpopulation in the d4MS023 group with lower MyoD expression that was not present in the d4 group, reflective of the findings in Figures 1C and 1D. Therefore, although the average expression was not shifted significantly with MS023, there was indeed a subpopulation of MuSCs with lower MyoD expression.
The reviewer additionally points out that Fig. 5B from a previous study (Blanc et al., 2017 MCB 37:e00457) performed by our group, shows that Pax7 expression was repressed at day 3 of culture in PRMT1-null MuSCs. However, this quantification was based on immunofluorescence staining where cells are marked positive or negative for Pax7 expression and does not look at the intensity of Pax7 expression levels. In our current study, we examine the expression levels of Pax7 in discrete subpopulations of MuSCs and found that there is a subpopulation of MuSCs that emerges with MS023 treatment that has higher Pax7 expression than untreated counterparts. Therefore, the results of the two experiments are not directly comparable.
4) I do have a major problem with the interpretation of the metabolic changes in MS023-treated MuSC. In the abstract, the authors wrote, "These findings suggest that type I PRMT inhibition metabolically reprograms MuSCs resulting in improved self-renewal and muscle regeneration fitness." There is simply no causal evidence to support this claim, which is solely based on a correlation. If the authors want to maintain this claim they either need to stimulate OXPHOS and glycolysis by other means to see whether such a manipulation recapitulates the effects of MS023 or attenuate OXPHOS and glycolysis to see whether this abrogates the effects of MS023. To prove whether increased OXPHIS is a cause for improved self-renewal, the authors might simply co-treat MuSC with MS023 and an OXPHIS inhibitor and analyze consequences for the Pax7+/MyoD- population.
We thank the reviewer for the excellent suggestions of experiments that would solidify a causal relationship between increased metabolism and increased self-renewal. We will certainly consider them for future studies. We agree that the relationship in the present study is correlative, and the text has been modified in the abstract as follows:
“Single cell RNA sequencing (scRNAseq) of ex vivo cultured MuSCs revealed the emergence of subpopulations in MS023-treated cells which are defined by elevated Pax7 expression and markers of MuSC quiescence, both features of enhanced self-renewal. Furthermore, the scRNAseq identified MS023-specific subpopulations to be metabolically altered with upregulated glycolysis and oxidative phosphorylation (OxPhos). Transplantation of MuSCs treated with MS023 had a better ability to repopulate the MuSC niche and contributed efficiently to muscle regeneration following injury. Interestingly, the preclinical mouse model of Duchenne muscular dystrophy had increased bilateral grip strength 10 days after a single intraperitoneal dose of MS023. Our findings show that inhibition of type I PRMTs increased the proliferation capabilities of MuSCs with altered cellular metabolism, while maintaining their stem-like properties such as self-renewal and engraftment potential.”
5) Ryall et al reported that MuSCs undergo a metabolic switch from fatty acid oxidation to glycolysis with reduced intracellular NAD+ levels and reduced activity of SIRT1, leading to elevated H4K16 acetylation. Here, both OXPHOS and glycolysis are increased after treatment of MuSC with MS023. Are the NAD+ and H4K16ac levels changed in MS023-treated MuSC?
This is another excellent study that would help to support a causal relationship between MS023 treatment and increase OXPHOS and glycolysis and could certainly be addressed in future studies.
6) In Ryall et al.'s results, there was no difference in the basal mitochondrial OCR between freshly isolated MuSCs and cultured MuSCs. Importantly, stimulation of OXPHOS will increase ROS concentration, resulting in premature differentiation of MuSC (PMID: 30106373). Furthermore, increased ROS levels will most likely enhance DNA damage rather than improve self-renewal. The authors have to address these issues and also monitor ROS and DNA damage levels.
The lack of cell death upon treatment with MS023 in the present study would indicate that there is no major ROS-induced DNA damage occurring. Additionally, the propensity of MS023-treated MuSCs to retain their stemness while in long-term culture (Supplemental figure S1E) would indicate that in this context, premature differentiation is not a concern.
7) The authors used FACS-analysis of MuSCs three weeks after transplantation to demonstrate that MS023 treatment enables better engraftment into the MuSC niche. The six-fold increase of transplanted cells in the MuSC niche is difficult to understand, Why shall transplanted cells compete so efficiently with endogenous MuSC for repopulation of the niche? Is it possible that some of the transplanted MuSC are still lingering within the interstitium and erroneously counted as bona fide MuSC? The authors have to determine the localization of transplanted MuSC. Are all transplanted cells indeed situated in the proper niche or are they also present outside the basal lamina of muscle fibers?
The hindlimbs which received the engraftment were irradiated 24h prior to engraftment, therefore the ability of endogenous MuSCs to compete is compromised. Additionally, Figure 5E shows that the regenerated muscle indeed has GFP negative fibers that would have been generated from endogenous MuSCs, indicating that MS023-treated MuSCs did not fully outcompete endogenous MuSCs.
8) The authors reported that an only 3-day treatment with MS023 is sufficient to dramatically improve muscle function in mdx mice even 30 days later, which is hard to swallow. What is the evidence that such strong effects are primarily mediated by stimulation of MuSC expansion? Are there other pathways or cells that respond to MS023 treatment and stimulate muscle strength? To support the claim of a 'better' stem cell function as the major cause for MS023-dependent stimulation of muscle strength in mdx mice, the authors need to determine the total number of Pax7+ cells, Pax7+/Ki67+, Pax7+/MyoD+, Pax7+/MyoD-, Pax7-/MyoD+ and myonuclei. It is also absolutely mandatory to include wildtype controls in the muscle strength measurements. Does MS023 treatment also increase muscle strength in wild-type controls?
Agreed. We cannot exclude if the effect is mediated by an expansion of the MuSC pool or by an effect on other cell types, such as a direct impact on the myofibers. The manuscript has been modified to include the following text:
“Furthermore, our findings show that injection of MS023 in the dystrophic mouse model mdx led to enhanced muscle strength with effects lasting up to 30 days. We cannot exclude if the effect of MS023 was mediated by an expansion of the MuSC pool or by an effect on other cell types, such as a direct impact on the myofibers. The goal of this experiment was to provide a therapeutic perspective for the possible use of type I PRMT inhibitor for the treatment of DMD.”
The goal of this figure was to provide a therapeutic perspective for the use of type I PRMT inhibitor for the treatment of DMD. Muscle wasting/weakness in DMD is a complex and multifactorial process (e.g., myofiber fragility, MuSC defects, chronic inflammation, fibrofatty accumulation). If MS023 can target multiple aspects of the physiopathology of the disease it would increase its therapeutic applicability. Further studies will be needed to determine the exact mechanism by which MS023 mediate its beneficial effect. These future studies could include the use of wild type control, as the reviewer suggests, to investigate the role of MS023 in a non-muscle degenerative context.
9) Ideally, a genetic inactivation-reactivation of PRMT1 should be done to validate the results with MS023 and to make sure that indeed the transient inhibition of PRMT1 is responsible for the beneficial effects of MS023. Of course, this would be a major effort when done in genetically manipulated mice and therefore is not adequate to ask for. However, it should be possible to use PRMT1-deficient MuSC, which the authors have in hand, and re-express PRMT1 in these cells with an AAV or a lentivirus.
We agree that genetic ablation of PRMT1 is a key experiment to validate MS023 results. Please refer to previous work from our group, which shows that PRMT1-KO MuSCs have an enhanced self-renewal phenotype (Blanc et al., 2017 MCB 37:e00457), similar to what was observed in the present study with MS023 treatment.
10) Some claims are overstated and/or to aggressive. E.g.: "Therefore, through repression of type I PRMTs with MS023, we have reprogramed MuSCs to acquire a unique and previously uncharacterized identity." I do not see clear evidence that MS023 treatment 'reprograms' MuSC to a 'unique identity'. The observed changes are in large parts compatible with a simple stimulation of proliferation.
The unique finding in our data is that treatment with MS023 resulted in a shift in identity as compared to the DMSO-treated proliferating MuSCs (M1, M2 and M4), creating transcriptionally distinct M3 and M5 clusters. M3 and M5 had elevated markers for metabolism (E.g. Eno1, Atp5k, etc) and early activation (E.g. Fos, Jun), while the untreated MuSCs in clusters M1, M2 and M4 did not. Furthermore, M3 and M5 had higher baseline levels of Pax7 expression when compared to untreated cells. Together, these findings describe a transitional subpopulation of MuSCs unique to MS023 treatment which not only harbour stem like/early activation markers Pax7, Fos and Jun, but also elevated proliferative markers related to cell cycle and energy metabolism. This particular combination of characteristics is unique to the MS023-treated MuSCs, thus identifying a unique subtype of MuSC identity. In accordance with our scRNAseq data, we validated experimentally that MS023-treated cells have higher energy metabolism and increased self-renewal potential, thereby confirming that the unique transcriptomic signature of these cells also lead to a different cell fate decision.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
The following is the authors' response to the original reviews.
1) l. 80: "evolved from a fourth domain of cellular life": I am worried a little bit about putting together what I believe are too distinct hypothesis: (i) NCLDV deriving from a complex (ancestral) cellular life form (possibly proto-eukaryotic) by reductive evolution, and (ii) NCLDV forming or deriving from a fourth domain of cellular life. To clarify for non-expert reader, I would suggest rephrasing as "evolved reductive evolution, possibly from a fourth domain of cellular life...".
Following the reviewer’s recommendation, we have clarified the sentence by writing: “These observations are at odds with the suggestion that NCLDVs originated by reductive evolution, possibly from a fourth domain of cellular life (Colson et al., 2018; Legendre et al., 2012; Patil and Kondabagil, 2021).”.
2) l. 187-198: Please provide more information on which tool (with version number and parameter) was used to search genomes for MCPs. When I downloaded the HMM model and the faa file for the MCP from the figshare repository and tried to match the two, only a small number (4) of the MCP sequences actually matched the MCP HMM model with significant e-value, but I am not sure why? (for reference, I was using hmmsearch 3.3.2, default parameters)
We used HMMER version 3.3.2 using the default parameters (hmmbuild and hmmsearch algorithms). We now include this information in the relevant section of the Methods: “Next, we constructed a set of Hidden Markov Models (HMMER version 3.3.2, hmmbuild/hmmsearch using the default parameters) for each of the 4 core proteins involved in virion morphogenesis”.
We were able to reproduce the reviewer’s observation that the Major capsid curated HMM model returns 4 significant hits when used on the Major capsid multiple alignment file provided in FigShare (significant matches: 1. maverick2_NW_021681489.1_105940131438, 2. ncbincldv_NC_011335.1, 3. ncbincldv_NC_038553.1, 4. yutin_PLVACE1). This curated HMM model was one of the models used for searching homologous protein sequences and was built from a preliminary multiple sequence alignment comprising a different set of taxa (N. taxa = 48). In contrast, the multiple sequence alignment provided in Figshare is the final multiple sequence alignment of major capsid proteins that was used in phylogenetic analyses (N. taxa = 54). Therefore, we should not expect an exact match between the two files.
We have updated the Figshare repository with a compressed file containing all the HMMs used for searching protein homologues (n = 38), which can be validated on hmmsearch on the European Bioinformatic Institute’s website (https://www.ebi.ac.uk/Tools/hmmer/search/hmmsearch).) A separate compressed file contains the final multiple sequence alignments that were used in phylogenetic inference and hypothesis testing.
3) Figure 4: The acronyms should be explained in the legend (pPOLB, MCP, mCP, pro, atp, int, TIRs, etc)
We now provide an explanation of the acronyms used for the traits matrix on Figure 4: “Acronyms refer to genes and genomic features present in the viral genomes: pPOLB (protein-primed DNA polymerase B), MCP (major capsid protein), mCP (minor capsid protein), int (rve-type integrase), pro (adenoviral-like protease), atp (FtsK/HerA DNA packaging ATPase), TIRs (terminal inverted repeats).”
4) Figure 4: I believe that "TIRs" should be "Present in some members" for the virophages, based on https://doi.org/10.1186/s13062-015-0054-9? Interestingly, this group is typically the one that branches the deepest within virophages, which would be consistent with TIRs being an ancestral trait of the Maveriviricetes class (formerly Lavidaviridae family).
As suggested, we updated the terminal inverted repeats (TIRs) trait for virophages to “Present in some members” to account for the Rumen virophages described by Yutin, Kapitonov and Koonin (2015, doi: 10.1186/s13062-015-0054-9).
Additional changes:
1) Figure 1 has been updated and now shows a polytomy between Mavericks 1/2 and PLVs. This reflects more closely the conceptual framework for our analyses since the specific branching of these groups was not specified in the phylogenetic models.
2) We have added an Acknowledgements section to the end of the manuscript:
Acknowledgements
We wish to thank Peter Simmonds and Alexander Suh for their critical reading and comments on the manuscript, which served to improve this work. We also thank the reviewers for their recommendations and feedback. This work was supported by a doctoral scholarship (Dr. Jose Gregorio Hernandez Award) to JGNB made by the National Academy of Medicine of Venezuela and Pembroke College, Oxford.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
Wang and all present an interesting body of work focused on the effects of high altitude and hypoxia on erythropoiesis, resulting in erythrocytosis. This work is specifically focused on the spleen, identifying splenic macrophages as central cells in this effect. This is logical since these cells are involved in erythrophagocytosis and iron recycling. The results suggest that hypoxia induces splenomegaly with decreased number of splenic macrophages. There is also evidence that ferroptosis is induced in these macrophages, leading to cell destruction. Finally, the data suggest that ferroptosis in splenic red pulp macrophages causes the decrease in RBC clearance, resulting in erythrocytosis aka lengthening the RBC lifespan. However, there are many issues with the presented results, with somewhat superficial data, meaning the conclusions are overstated and there is decreased confidence that the hypotheses and observed results are directly causally related to hypoxia.
Major points:
1) The spleen is a relatively poorly understood organ but what is known about its role in erythropoiesis especially in mice is that it functions both to clear as well as to generate RBCs. The later process is termed extramedullary hematopoiesis and can occur in other bones beyond the pelvis, liver, and spleen. In mice, the spleen is the main organ of extramedullary erythropoiesis. The finding of transiently decreased spleen size prior to splenomegaly under hypoxic conditions is interesting but not well developed in the manuscript. This is a shortcoming as this is an opportunity to evaluate the immediate effect of hypoxia separately from its more chronic effect. Based just on spleen size, no conclusions can be drawn about what happens in the spleen in response to hypoxia.
Thank you for your insightful comments and questions. The spleen is instrumental in both immune response and the clearance of erythrocytes, as well as serving as a significant reservoir of blood in the body. This organ, characterized by its high perfusion rate and pliability, constricts under conditions of intense stress, such as during peak physical exertion, the diving reflex, or protracted periods of apnea. This contraction can trigger an immediate release of red blood cells (RBCs) into the bloodstream in instances of substantial blood loss or significant reduction of RBCs. Moreover, elevated oxygen consumption rates in certain animal species can be partially attributed to splenic contractions, which augment hematocrit levels and the overall volume of circulating blood, thereby enhancing venous return and oxygen delivery (Dane et al. J Appl Physiol, 2006, 101:289-97; Longhurst et al. Am J Physiol, 1986, 251: H502-9). In our investigation, we noted a significant contraction of the spleen following exposure to hypoxia for a period of one day. We hypothesized that the body, under such conditions, is incapable of generating sufficient RBCs promptly enough to facilitate enhanced oxygen delivery. Consequently, the spleen reacts by releasing its stored RBCs through splenic constriction, leading to a measurable reduction in spleen size.
However, we agree with you that further investigation is required to fully understand the implications of these changes. Considering the comments, we propose to extend our research by incorporating more detailed examinations of spleen morphology and function during hypoxia, including the potential impact on extramedullary hematopoiesis. We anticipate that such an expanded analysis would not only help elucidate the initial response to hypoxia but also provide insights into the more chronic effects of this condition on spleen function and erythropoiesis.
2) Monocyte repopulation of tissue resident macrophages is a minor component of the process being described and it is surprising that monocytes in the bone marrow and spleen are also decreased. Can the authors conjecture why this is happening? Typically, the expectation would be that a decrease in tissue resident macrophages would be accompanied by an increase in monocyte migration into the organ in a compensatory manner.
We appreciate your insightful query regarding the observed decrease in monocytes in the bone marrow and spleen, particularly considering the typical compensatory increase in monocyte migration into organs following a decrease in tissue resident macrophages.
The observed decrease in monocytes within the bone marrow is likely attributable to the fact that monocytes and precursor cells for red blood cells (RBCs) both originate from the same hematopoietic stem cells within the bone marrow. It is well established that exposure to hypobaric hypoxia (HH) induces erythroid differentiation specifically within the bone marrow, originating from these hematopoietic stem cells. As such, we postulate that the differentiation into monocytes is reduced under hypoxic conditions, which may subsequently cause a decrease in migration to the spleen.
Furthermore, we hypothesize that an increased migration of monocytes to other tissues under HH exposure may also contribute to the decreased migration to the spleen. The liver, which partially contributes to the clearance of RBCs, may play a role in this process. Our investigations to date have indeed identified an increased monocyte migration to the liver. We were pleased to discover an elevation in CSF1 expression in the liver following HH exposure for both 7 and 14 days. This finding was corroborated through flow cytometry, which confirmed an increase in monocyte migration to the liver.
Consequently, we propose that under HH conditions, the liver requires an increased influx of monocytes, which in turn leads to a decrease in monocyte migration to the spleen. However, it is important to note that these findings will be discussed more comprehensively in our forthcoming publication, and as such, the data pertaining to these results have not been included in the current manuscript.
3) Figure 3 does not definitively provide evidence that cell death is specifically occurring in splenic macrophages and the fraction of Cd11b+ cells is not changed in NN vs HH. Furthermore, the IHC of F4/80 in Fig 3U is not definitive as cells can express F4/80 more or less brightly and no negative/positive controls are shown for this panel.
We appreciate your insightful comments and critiques regarding Figure 3. We acknowledge that the figure, as presented, does not definitively demonstrate that cell death is specifically occurring in splenic macrophages. While it is challenging to definitively determine the occurrence of cell death in macrophages based solely on Figure 3D-F, our single-cell analysis provides strong evidence that such an event occurs. We initially observed cell death within the spleen under hypobaric hypoxia (HH) conditions, and to discern the precise cell type involved, we conducted single-cell analyses. Regrettably, we did not articulate this clearly in our preliminary manuscript. In the revised version, we have modified the sequence of Figure 3A-C and Figure 3D-F for better clarity. Besides, we observed a significant decrease in the fraction of F4/80hiCD11bhi macrophages under HH conditions compared to NN. To make the changes more evident in CD86 and CD206, we have transformed these scatter plots into histograms in our revised manuscript.
Considering the limitations of F4/80 as a conclusive macrophage identifier, we have concurrently presented the immunohistochemical (IHC) analyses of heme oxygenase-1 (HO-1). Functioning as a macrophage marker, particularly in cells involved in iron metabolism, HO-1 offers additional diagnostic accuracy. Observations from both F4/80 and HO-1 staining suggested a primary localization of positively stained cells within the splenic red pulp. Following exposure to hypoxia-hyperoxia (HH) conditions, a decrease was noted in the expression of both F4/80 and HO-1. This decrease implies that HH conditions contribute to a reduction in macrophage population and impede the iron metabolism process. In the revised version of our manuscript, we have enhanced the clarity of Figure 3U to illustrate the presence of positive staining, with an emphasis on HO-1 staining, which is predominantly observed in the red pulp.
4) The phagocytic function of splenic red pulp macrophages relative to infection cannot be used directly to understand erythrophagocytosis. The standard approach is to use opsonized RBCs in vitro. Furthermore, RBC survival is a standard method to assess erythrophagocytosis function. In this method, biotin is injected via tail vein directly and small blood samples are collected to measure the clearance of biotinilation by flow; kits are available to accomplish this. Because the method is standard, Fig 4D is not necessary and Fig 4E needs to be performed only in blood by sampling mice repeatedly and comparing the rate of biotin decline in HH with NN (not comparing 7 d with 14 d).
We appreciate your insightful comments and suggestions. We concur that the phagocytic function of splenic red pulp macrophages in the context of infection may not be directly translatable to understanding erythrophagocytosis. Given our assessment that the use of cy5.5-labeled E.coli alone may not be sufficient to accurately evaluate the phagocytic function of macrophages, we extended our study to include the use of NHS-biotin-labeled RBCs to assess phagocytic capabilities. While the presence of biotin-labeled RBCs in the blood could provide an indication of RBC clearance, this measure does not exclusively reflect the spleen's role in the process, as it fails to account for the clearance activities of other organs.
Consequently, we propose that the remaining biotin-labeled RBCs in the spleen may provide a more direct representation of the organ's function in RBC clearance and sequestration. Our observations of diminished erythrophagocytosis at both 7 and 14 days following exposure to HH guided our subsequent efforts to quantify biotin-labeled RBCs in both the circulatory system and spleen. These measurements were conducted during the 7 to 14-day span following the confirmation of impaired erythrophagocytosis. Comparative evaluation of RBC clearance rates under NN and HH conditions provided further evidence supporting our preliminary observations, with the data revealing a decrease in the RBC clearance rate in the context of HH conditions. In response to feedback from other reviewers, we have elected to exclude the phagocytic results and the diagram of the erythrocyte labeling assay. These amendments will be incorporated into the revised manuscript. The reviewers' constructive feedback has played a crucial role in refining the methodological precision and coherence of our investigation.
5) It is unclear whether Tuftsin has a specific effect on phagocytosis of RBCs without other potential confounding effects. Furthermore, quantifying iron in red pulp splenic macrophages requires alternative readily available more quantitative methods (e.g. sorted red pulp macrophages non-heme iron concentration).
We appreciate your comments and questions regarding the potential effect of Tuftsin on the phagocytosis of RBCs and the quantification of iron in red pulp splenic macrophages. Regarding the role of Tuftsin, we concur that the literature directly associating Tuftsin with erythrophagocytosis is scant. The work of Gino Roberto Corazza et al. does suggest a link between Tuftsin and general phagocytic capacity, but it does not specifically address erythrophagocytosis (Am J Gastroenterol, 1999;94:391-397). We agree that further investigations are required to elucidate the potential confounding effects and to ascertain whether Tuftsin has a specific impact on the phagocytosis of RBCs. Concerning the quantification of iron in red pulp splenic macrophages, we acknowledge your suggestion to employ readily available and more quantitative methods. We have incorporated additional Fe2+ staining in the spleen at two time points: 7 and 14 days subsequent to HH exposure (refer to the following Figure). The resultant data reveal an escalated deposition of Fe2+ within the red pulp, as evidenced in Figures 5 (panels L and M) and Figure 7 (panels L and M).
6) In Fig 5, PBMCs are not thought to represent splenic macrophages and although of some interest, does not contribute significantly to the conclusions regarding splenic macrophages at the heart of the current work. The data is also in the wrong direction, namely providing evidence that PBMCs are relatively iron poor which is not consistent with ferroptosis which would increase cellular iron.
We appreciate your insightful critique regarding Figure 5 and the interpretation of our data on peripheral blood mononuclear cells (PBMCs) in relation to splenic macrophages. We understand that PBMCs do not directly represent splenic macrophages, and we agree that any conclusions drawn from PBMCs must be considered with caution when discussing the behavior of splenic macrophages.
The primary rationale for incorporating PBMCs into our study was to investigate the potential correspondence between their gene expression changes and those observed in the spleen after HH exposure. This was posited as a working hypothesis for further exploration rather than a conclusive statement. The gene expression in PBMCs was congruous with changes in the spleen's gene expression, demonstrating an iron deficiency phenotype, ostensibly due to the mobilization of intracellular iron for hemoglobin synthesis. Thus, it is plausible that NCOA4 may facilitate iron mobilization through the degradation of ferritin to store iron.
It remains ambiguous whether ferroptosis was initiated in the PBMCs during our study. Ferroptosis primarily occurs as a response to an increase in Fe2+ rather than an overall increase in intracellular iron. Our preliminary proposition was that relative changes in gene expression in PBMCs could potentially mirror corresponding changes in protein expression in the spleen, thereby potentially indicating alterations in iron processing capacity post-HH exposure. However, we fully acknowledge that this is a conjecture requiring further empirical substantiation or clinical validation.
7) Tfr1 increase is typically correlated with cellular iron deficiency while ferroptosis consistent with iron loading. The direction of the changes in multiple elements relevant to iron trafficking is somewhat confusing and without additional evidence, there is little confidence that the authors have reached the correct conclusion. Furthermore, the results here are analyses of total spleen samples rather than specific cells in the spleen.
We appreciate your astute comments and agree that the observed increase in transferrin receptor (TfR) expression, typically associated with cellular iron deficiency, appears contradictory to the expected iron-loading state associated with ferroptosis. We understand that this apparent contradiction might engender some uncertainty about our conclusions.
In our investigation, we evaluated total spleen samples as opposed to distinct cell types within the spleen, a factor that could have contributed to the seemingly discordant findings. An integral element to bear in mind is the existence of immature RBCs in the spleen, particularly within the hematopoietic island where these immature RBCs cluster around nurse macrophages. These immature RBCs contain abundant TfR which was needed for iron uptake and hemoglobin synthesis. These cells, which prove challenging to eliminate via perfusion, might have played a role in the observed upregulation in TfR expression, especially in the aftermath of HH exposure. Our further research revealed that the expression of TfR in macrophages diminished following hypoxic conditions, thereby suggesting that the elevated TfR expression in tissue samples may predominantly originate from other cell types, especially immature RBCs (refer to subsequent Figure).
Reviewer #2 (Public Review):
The authors aimed at elucidating the development of high altitude polycythemia which affects mice and men staying in the hypoxic atmosphere at high altitude (hypobaric hypoxia; HH). HH causes increased erythropoietin production which stimulates the production of red blood cells. The authors hypothesize that increased production is only partially responsible for exaggerated red blood cell production, i.e. polycythemia, but that decreased erythrophagocytosis in the spleen contributes to high red blood cells counts.
The main strength of the study is the use of a mouse model exposed to HH in a hypobaric chamber. However, not all of the reported results are convincing due to some smaller effects which one may doubt to result in the overall increase in red blood cells as claimed by the authors. Moreover, direct proof for reduced erythrophagocytosis is compromised due to a strong spontaneous loss of labelled red blood cells, although effects of labelled E. coli phagocytosis are shown. Their discussion addresses some of the unexpected results, such as the reduced expression of HO-1 under hypoxia but due to the above-mentioned limitations much of the discussion remains hypothetical.
Thank you for your valuable feedback and insight. We appreciate the recognition of the strength of our study model, the exposure of mice to hypobaric hypoxia (HH) in a hypobaric animal chamber. We also understand your concerns about the smaller effects and their potential impact on the overall increase in red blood cells (RBCs), as well as the apparent reduced erythrophagocytosis due to the loss of labelled RBCs.
Erythropoiesis has been predominantly attributed to the amplified production of RBCs under conditions of HH. The focus of our research was to underscore the potential acceleration of hypoxia-associated polycythemia (HAPC) as a result of compromised erythrophagocytosis. Considering the spontaneous loss of labelled RBCs in vivo, we assessed the clearance rate of RBCs at the stages of 7 and 14 days within the HH environment, and subsequently compared this rate within the period from 7 to 14 days following the clear manifestation of erythrophagocytosis impairment at the two aforementioned points identified in our study. This approach was designed to negate the effects of spontaneous loss of labelled RBCs in both NN and HH conditions. Correspondingly, the results derived from blood and spleen analyses corroborated a decline in the RBC clearance rate under HH when juxtaposed with NN conditions.
Apart from the E. coli phagocytosis and the labeled RBCs experiment (this part of the results was removed in the revision), the injection of Tuftsin further substantiated the impairment of erythrophagocytosis in the HH spleen, as evidenced by the observed decrease in iron within the red pulp of the spleen post-perfusion. Furthermore, to validate our findings, we incorporated RBCs staining in splenic cells at 7 and 14 days of HH exposure, which provided concrete confirmation of impaired erythrophagocytosis (new Figure 4E).
As for the reduced expression of heme oxygenase-1 (HO-1) under hypoxia, we agree that this was an unexpected result, and we are in the process of further exploring the underlying mechanisms. It is possible that there are other regulatory pathways at play that are yet to be identified. However, we believe that by offering possible interpretations of our data and potential directions for future research, we contribute to the ongoing scientific discourse in this area.
Reviewer #3 (Public Review):
The manuscript by Yang et al. investigated in mice how hypobaric hypoxia can modify the RBC clearance function of the spleen, a concept that is of interest. Via interpretation of their data, the authors proposed a model that hypoxia causes an increase in cellular iron levels, possibly in RPMs, leading to ferroptosis, and downregulates their erythrophagocytic capacity. However, most of the data is generated on total splenocytes/total spleen, and the conclusions are not always supported by the presented data. The model of the authors could be questioned by the paper by Youssef et al. (which the authors cite, but in an unclear context) that the ferroptosis in RPMs could be mediated by augmented erythrophagocytosis. As such, the loss of RPMs in vivo which is indeed clear in the histological section shown (and is a strong and interesting finding) can be not directly caused by hypoxia, but by enhanced RBC clearance. Such a possibility should be taken into account.
Thank you for your insightful comments and constructive feedback. In their research, Youssef et al. (2018) discerned that elevated erythrophagocytosis of stressed red blood cells (RBCs) instigates ferroptosis in red pulp macrophages (RPMs) within the spleen, as evidenced in a mouse model of transfusion. This augmentation of erythrophagocytosis was conspicuous five hours post-injection of RBCs. Conversely, our study elucidated the decrease in erythrophagocytosis in the spleen after both 7 and 14 days.
Typically, macrophages exhibit an enhanced phagocytic capacity in the immediate aftermath of stress or stimulation. Nonetheless, the temporal points of observation in our study were considerably extended (seven and fourteen days). It remains uncertain whether phagocytic capability was amplified during the acute phase of HH exposure—particularly within the first day, considering that splenoconstriction under HH for one day results in the release of stored RBCs into the bloodstream—and whether this initial response could precipitate ferroptosis and subsequently diminished erythrophagocytosis at the 7 or 14 day marks under continued HH conditions.
Major points:
1) The authors present data from total splenocytes and then relate the obtained data to RPMs, which are quantitatively a minor population in the spleen. Eg, labile iron is increased in the splenocytes upon HH, but the manuscript does not show that this occurs in the red pulp or RPMs. They also measure gene/protein expression changes in the total spleen and connect them to changes in macrophages, as indicated in the model Figure (Fig. 7). HO-1 and levels of Ferritin (L and H) can be attributed to the drop in RPMs in the spleen. Are any of these changes preserved cell-intrinsically in cultured macrophages? This should be shown to support the model (relates also to lines 487-88, where the authors again speculate that hypoxia decreases HO-1 which was not demonstrated). In the current stage, for example, we do not know if the labile iron increase in cultured cells and in the spleen in vivo upon hypoxia is the same phenomenon, and why labile iron is increased. To improve the manuscript, the authors should study specifically RPMs.
We express our gratitude for your perceptive remarks. In our initial manuscript, we did not evaluate labile iron within the red pulp and red pulp macrophages (RPMs). To address this oversight, we utilized the Lillie staining method, in accordance with the protocol outlined by Liu et al., (Chemosphere, 2021, 264(Pt 1):128413), to discern Fe2+ presence within these regions. The outcomes were consistent with our antecedent Western blot and flow cytometry findings in the spleen, corroborating an increment in labile iron specifically within the red pulp of the spleen.
However, we acknowledge the necessity for other supplementary experimental efforts to further validate these findings. Additionally, we scrutinized the expression of heme oxygenase-1 (HO-1) and iron-related proteins, including transferrin receptor (TfR), ferroportin (Fpn), ferritin (Ft), and nuclear receptor coactivator 4 (NCOA4) in primary macrophages subjected to 1% hypoxic conditions, both with and without hemoglobin treatment. Our results indicated that the expression of ferroptosis-related proteins was consistent with in vivo studies, however the expression of iron related proteins was not similar in vitro and in vivo. It suggesting that the increase in labile iron in cultured cells and the spleen in vivo upon hypoxia are not identical phenomena. However, the precise mechanism remains elusive.
In our study, we observed a decrease in HO-1 protein expression following 7 and 14 days of HH exposure, as shown in Figure 3U, 5A, and S1A. This finding contradicts previous research that identified HO-1 as a hypoxia-inducible factor (HIF) target under hypoxic conditions (P J Lee et al., 1997). Our discussion, therefore, addressed the potential discrepancy in HO-1 expression under HH. According to our findings, HO-1 regulation under HH appears to be predominantly influenced by macrophage numbers and the RBCs to be processed in the spleen or macrophages, rather than by hypoxia alone.
It is challenging to discern whether the increased labile iron observed in vitro accurately reflects the in vivo phenomenon, as replicating the iron requirements for RBCs production induced by HH in vitro is inherently difficult. However, by integrating our in vivo and in vitro studies, we determined that the elevated Fe2+ levels were not dependent on HO-1 protein expression, as HO-1 levels was increased in vitro while decreasing in vivo under hypoxic/HH exposure.
2) The paper uses flow cytometry, but how this method was applied is suboptimal: there are no gating strategies, no indication if single events were determined, and how cell viability was assessed, which are the parent populations when % of cells is shown on the graphs. How RBCs in the spleen could be analyzed without dedicated cell surface markers? A drop in splenic RPMs is presented as the key finding of the manuscript but Fig. 3M shows gating (suboptimal) for monocytes, not RPMs. RPMs are typically F4/80-high, CD11-low (again no gating strategy is shown for RPMs). Also, the authors used single-cell RNAseq to detect a drop in splenic macrophages upon HH, but they do not indicate in Fig. A-C which cluster of cells relates to macrophages. Cell clusters are not identified in these panels, hence the data is not interpretable).
Thank you for your comments and constructive critique regarding our flow cytometry methodology and presentation. We understand the need for greater transparency and detailed explanation of our procedures, and we acknowledge that the lack of gating strategies and other pertinent information in our initial manuscript may have affected the clarity of our findings.
In our initial report, we provided an overview of the decline in migrated macrophages (F4/80hiCD11bhi), including both M1 and M2 expression in migrated macrophages, as illustrated in Figure 3, but did not specifically address the changes in red pulp macrophages (RPMs). Based on previous results, it is difficult to identify CD11b- and CD11blo cells. We will repeat the results and attempt to identify F4/80hiCD11blo cells in the revised manuscript. The results of the reanalysis are now included (Figure 3M). However, single-cell in vivo analysis studies may more accurately identify specific cell types that decrease after exposure to HH.
Furthermore, we substantiated the reduction in red pulp, as evidenced by Figure 4J, given that iron processing primarily occurs within the red pulp. In Figure 3, our initial objective was merely to illustrate the reduction in total macrophages in the spleen following HH exposure.
To further clarify the characterization of various cell types, we conducted a single-cell analysis. Our findings indicated that clusters 0,1,3,4,14,18, and 29 represented B cells, clusters 2, 10, 12, and 28 represented T cells, clusters 15 and 22 corresponded to NK cells, clusters 5, 11, 13, and 19 represented NKT cells, clusters 6, 9, and 24 represented cell cycle cells, clusters 26 and 17 represented plasma cells, clusters 21 and 23 represented neutrophils, cluster 30 represented erythrocytes, and clusters 7, 8, 16, 20, 24, and 27 represented dendritic cells (DCs) and macrophages, as depicted in Figure 3E.
3) The authors draw conclusions that are not supported by the data, some examples: a) they cannot exclude eg the compensatory involvement of the liver in the RBCs clearance (the differences between HH sham and HH splenectomy is mild in Fig. 2 E, F and G).
Thank you for your insightful comments and for pointing out the potential involvement of other organs, such as the liver, in the RBC clearance under HH conditions. We concur with your observation that the differences between the HH sham and HH splenectomy conditions in Fig. 2 E, F, and G are modest. This could indeed suggest a compensatory role of other organs in RBC clearance when splenectomy is performed. Our intent, however, was to underscore the primary role of the spleen in this process under HH exposure.
In fact, after our initial investigations, we conducted a more extensive study examining the role of the liver in RBC clearance under HH conditions. Our findings, as illustrated in the figures submitted with this response, indeed support a compensatory role for the liver. Specifically, we observed an increase in macrophage numbers and phagocytic activity in the liver under HH conditions. Although the differences in RBC count between the HH sham and HH splenectomy conditions may seem minor, it is essential to consider the unit of this measurement, which is value*1012/ml. Even a small numerical difference can represent a significant biological variation at this scale.
b) splenomegaly is typically caused by increased extramedullary erythropoiesis, not RBC retention. Why do the authors support the second possibility? Related to this, why do the authors conclude that data in Fig. 4 G,H support the model of RBC retention? A significant drop in splenic RBCs (poorly gated) was observed at 7 days, between NN and HH groups, which could actually indicate increased RBC clearance capacity = less retention.
Prior investigations have predominantly suggested that spleen enlargement under hypoxic conditions stems from the spleen's extramedullary hematopoiesis. Nevertheless, an intriguing study conducted in 1994 by the General Hospital of Xizang Military Region reported substantial exaggeration and congestion of splenic sinuses in high altitude polycythemia (HAPC) patients. This finding was based on the dissection of spleens from 12 patients with HAPC (Zou Xunda, et al., Southwest Defense Medicine, 1994;5:294-296). Moreover, a recent study indicated that extramedullary erythropoiesis reaches its zenith between 3 to 7 days (Wang H et al., 2021).
Considering these findings, the present study postulates that hypoxia-induced inhibition of erythrophagocytosis may lead to RBC retention. However, we acknowledge that the manuscript in its current preprint form does not offer conclusive evidence to substantiate this hypothesis. To bridge this gap, we further conducted experiments where the spleen was perfused, and total cells were collected post HH exposure. These cells were then smeared onto slides and subjected to Wright staining. Our results unequivocally demonstrate an evident increase in deformation and retention of RBCs in the spleen following 7 and 14 days of HH exposure. This finding strengthens our initial hypothesis and contributes a novel perspective to the understanding of splenic responses under hypoxic conditions.
c) lines 452-54: there is no data for decreased phagocytosis in vivo, especially in the context of erythrophagocytosis. This should be done with stressed RBCs transfusion assays, very good examples, like from Youssef et al. or Threul et al. are available in the literature.
Thanks. In their seminal work, Youssef and colleagues demonstrated that the transfusion of stressed RBCs triggers erythrophagocytosis and subsequently incites ferroptosis in red pulp macrophages (RPMs) within a span of five hours. Given these observations, the applicability of this model to evaluate macrophage phagocytosis in the spleen or RPMs under HH conditions may be limited, as HH has already induced erythropoiesis in vivo. In addition, it was unclear whether the membrane characteristics of stress induced RBCs were similar to those of HH induced RBCs, as this is an important signal for in vivo phagocytosis. The ambiguity arises from the fact that we currently lack sufficient knowledge to discern whether the changes in phagocytosis are instigated by the presence of stressed RBCs or by changes of macrophages induced by HH in vivo. Nonetheless, we appreciate the potential value of this approach and intend to explore its utility in our future investigations. The prospect of distinguishing the effects of stressed RBCs from those of HH on macrophage phagocytosis is an intriguing line of inquiry that could yield significant insights into the mechanisms governing these physiological processes. We will investigate this issue in our further study.
d) Line 475 - ferritinophagy was not shown in response to hypoxia by the manuscript, especially that NCOA4 is decreased, at least in the total spleen.
Drawing on the research published in eLife in 2015, it was unequivocally established that ferritinophagy, facilitated by Nuclear Receptor Coactivator 4 (NCOA4), is indispensable for erythropoiesis. This process is modulated by iron-dependent HECT and RLD domain containing E3 ubiquitin protein ligase 2 (HERC2)-mediated proteolysis (Joseph D Mancias et al., eLife. 2015; 4: e10308). As is widely recognized, NCOA4 plays a critical role in directing ferritin (Ft) to the lysosome, where both NCOA4 and Ft undergo coordinated degradation.
In our study, we provide evidence that exposure to HH stimulates erythropoiesis (Figure 1). We propose that this, in turn, could promote ferritinophagy via NCOA4, resulting in a decrease in NCOA4 protein levels post-HH exposure. We will further increase experiments to verify this concern. This finding not only aligns with the established understanding of ferritinophagy and erythropoiesis but also adds a novel dimension to the understanding of cellular responses to hypoxic conditions.
4) In a few cases, the authors show only representative dot plots or histograms, without quantification for n>1. In Fig. 4B the authors write about a significant decrease (although with n=1 no statistics could be applied here; of note, it is not clear what kind of samples were analyzed here). Another example is Fig. 6I. In this case, it is even more important as the data are conflicting the cited article and the new one: PMCID: PMC9908853 which shows that hypoxia stimulates efferocytosis. Sometimes the manuscript claim that some changes are observed, although they are not visible in representative figures (eg for M1 and M2 macrophages in Fig. 3M)
We recognize that our initial portrayal of Figure 4B was lacking in precision, given that it did not include the corresponding statistical graph. While our results demonstrated a significant reduction in the ability to phagocytose E. coli, in line with the recommendations of other reviewers, we have opted to remove the results pertaining to E. coli phagocytosis in this revision, as they primarily reflected immune function. In relation to PMC9908853, which reported metabolic adaptation facilitating enhanced macrophage efferocytosis in limited-oxygen environments, it is worth noting that the macrophages investigated in this study were derived from ER-Hoxb8 macrophage progenitors following the removal of β-estradiol. Consequently, questions arise regarding the comparability between these cultured macrophages and primary macrophages obtained fresh from the spleen post HH exposure. The characteristics and functions of these two different macrophage sources may not align precisely, and this distinction necessitates further investigation.
5) There are several unclear issues in methodology:
- what is the purity of primary RPMs in the culture? RPMs are quantitatively poorly represented in splenocyte single-cell suspensions. This reviewer is quite skeptical that the processing of splenocytes from approx 1 mm3 of tissue was sufficient to establish primary RPM cultures. The authors should prove that the cultured cells were indeed RPMs, not monocyte-derived macrophages or other splenic macrophage subtypes.
Thank you for your thoughtful comments and inquiries. Firstly, I apologize if we did not make it clear in the original manuscript. The purity of the primary RPMs in our culture was found to be approximately 40%, as identified by F4/80hiCD11blo markers using flow cytometry. We recognize that RPMs are typically underrepresented in splenocyte single-cell suspensions, and the concern you raise about the potential for contamination by other cell types is valid.
We apologize for any ambiguities in the methodological description that may have led to misunderstandings during the review. Indeed, the entirety of the spleen is typically employed for splenic macrophage culture. The size of the spleen can vary dependent on the species and age of the animal, but in mice, it is commonly approximately 1 cm in length. The spleen is then dissected into minuscule fragments, each approximately 1 mm3 in volume, to aid in enzymatic digestion. This procedure does not merely utilize a single 1 mm3 tissue fragment for RPMs cultures. Although the isolation and culture of spleen macrophages can present considerable challenges, our method has been optimized to enhance the yield of this specific cell population.
- (around line 183) In the description of flow cytometry, there are several missing issues. In 1) it is unclear which type of samples were analyzed. In 2) it is not clear how splenocyte cell suspension was prepared.
1) Whole blood was extracted from the mice and collected into an anticoagulant tube, which was then set aside for subsequent thiazole orange (TO) staining. 2) Splenic tissue was procured from the mice and subsequently processed into a single-cell suspension using a 40 μm filter. The erythrocytes within the entire sample were subsequently lysed and eliminated, and the remaining cell suspension was resuspended in phosphate-buffered saline (PBS) in preparation for ensuing analyses.
We have meticulously revised these methodological details in the corresponding section of the manuscript to ensure clarity and precision.
- In line 192: what does it mean: 'This step can be omitted from cell samples'?
The methodology employed for the quantification of intracellular divalent iron content and lipid peroxidation level was executed as follows: Splenic tissue was first processed into a single cell suspension, subsequently followed by the lysis of RBCs. It should be noted that this particular stage is superfluous when dealing with isolated cell samples. Subsequently, a total of 1 × 106 cells were incubated with 100 μL of BioTracker Far-red Labile Fe2+ Dye (1 mM, Sigma, SCT037, USA) for a duration of 1 hour, or alternatively, C11-Bodipy 581/591 (10 μM, Thermo Fisher, D3861, USA) for a span of 30 minutes. Post incubation, cells were thoroughly washed twice with PBS. Flow cytometric analysis was subsequently performed, utilizing the FL6 (638 nm/660 nm) channel for the determination of intracellular divalent iron content, and the FL1 (488 nm/525 nm) channel for the quantification of the lipid peroxidation level.
- 'TO method' is not commonly used anymore and hence it was unclear to this Reviewer. Reticulocytes should be analyzed with proper gating, using cell surface markers.
We are appreciative of your astute observation pertaining to the methodology we employed to analyze reticulocytes in our study. We value your recommendation to utilize cell surface markers for effective gating, which indeed represents a more modern and accurate approach. However, as reticulocyte identification is not the central focus of our investigation, we opted for the TO staining method—due to its simplicity and credibility of results. In our initial exploration, we adopted the TO staining method in accordance with the protocol outlined (Sci Rep, 2018, 8(1):12793), primarily owing to its established use and demonstrated efficacy in reticulocyte identification.
- The description of 'phagocytosis of E. coli and RBCs' in the Methods section is unclear and incomplete. The Results section suggests that for the biotinylated RBCs, phagocytosis? or retention? Of RBCs was quantified in vivo, upon transfusion. However, the Methods section suggests either in vitro/ex vivo approach. It is vague what was indeed performed and how in detail. If RBC transfusion was done, this should be properly described. Of note, biotinylation of RBCs is typically done in vivo only, being a first step in RBC lifespan assay. The such assay is missing in the manuscript. Also, it is not clear if the detection of biotinylated RBCs was performed in permeablized cells (this would be required).
Thanks for the comments. In our initial methodology, we employed Cy5.5-labeled Escherichia coli to probe phagocytic function, albeit with the understanding that this may not constitute the most ideal model for phagocytosis detection within this context (in light of recommendations from other reviewers, we have removed the E. coli phagocytosis results from this revision, as they predominantly mirror immune function). Our fundamental aim was to ascertain whether HH compromises the erythrophagocytic potential of splenic macrophages. In pursuit of this, we subsequently analyzed the clearance of biotinylated RBCs in both the bloodstream and spleen to assess phagocytic functionality in vivo.
In the present study, instead of transfusing biotinylated RBCs into mice, we opted to inject N-Hydroxysuccinimide (NHS)-biotin into the bloodstream. NHS-biotin is capable of binding with cell membranes in vivo and can be recognized by streptavidin-fluorescein isothiocyanate (FITC) after cells are extracted from the blood or spleen in vitro. Consequently, biotin-labeled RBCs were detectable in both the blood and spleen following NHS-biotin injection for a duration of 21 days.
Ultimately, we employed flow cytometry to analyze the NHS-biotin labeled RBCs in the blood or spleen. This method facilitates the detection of live cells and is not applicable to permeabilized cells. We believe this approach better aligns with our investigative goals and offers a more robust evaluation of erythrophagocytic function under hypoxic conditions.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
“It is unclear whether the Ter sites integrated by a single copy plasmid have any effect on the replication of this region but the data show that the observed effects are dependent on expression of the Tus protein.”
-The lack of perturbation of the TerB sequence on fork progression has extensively been studied previously in both Willis et al, 2014 and Larsen et. al, 2014. Furthermore, as the detection of the SMARD signal at the TerB sites is dependent on the 7.5kb probe that spans the TerB sites (orange probe, Fig 2B & 2D), it would be impossible to study the effect on replication in this region, with and without the integration of the single copy plasmid.
“The SMARD data do not reveal what proportion of forks are arrested at Tus/Ter, or how long the fork delay is imposed.”
-The percentage of fork stalling at the TerB sites, with and without Tus expression, has been quantified in Figure 2E & 2F. Essentially, 36% forks stall at the TerB block, i.e. 18% of the forks stall in both the 5’ to 3’ (orange) and 3’ to 5’ (blue) direction when the Tus-TerB block is active.
“It is not shown whether the replication inhibitor HU leads to the same widely spread gamma H2AX response.”
-While we have not shown gH2AX accumulation via ChIP after HU treatment, Supplementary Figure 5A & 5B clearly show increased gH2AX foci when the cells are treated with HU, suggesting a global replication stress response that is in stark contrast to the response to Tus-TerB.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
First, we would like to thank eLife and the reviewers for the positive assessment of our manuscript and for providing the medium to expand the scientific dialogue on the present study. We greatly appreciate the reviewers´ assessment and will revise the manuscript considering their input. Please see our provisional response below.
Reviewer #1’s main concern is centered on the evidential strength of the study’s conclusion that age-specific effects of birth weight on brain structure are more localized and less consistent across cohorts than age-uniform, stable effects. More specifically, the reviewer points out the evidence (or lack of such) for age-specific effects. The reviewer specifies four methodological concerns: that #1 no direct statistical comparisons are conducted between samples (beyond the spin-tests) and that #2 the differential composition of samples in terms of age distribution leads to the possibility that lack of results is explained by methodological differences. Further, he/she adds that #3 some datasets have a narrow age range precluding detection of age-related effects and #4 that the modeling strategy does not allow for non-linear interaction between age and BW suggesting the use of spline models instead in a _mega-_analytical fashion. Reviewer #1 also asks for greater clarity regarding the statistical models and the provision of effect-size maps.
As a response to the reviewer’s comments, we will submit a revised version of the manuscript with a revised description of the statistical models and submit effect-size maps in an accompanying repository. We will tackle the first two concerns by performing additional statistical analyses. The planned analyses will include across-sample reliability and within-sample reliability for the time*birth weight analyses. These analyses will address the concerns that the lack of age-specific effects is due to sample differences rather than a lack of biological effects (#2) and provide further explicit statistical comparisons across samples (#1).
We do not believe concern #3 is critically problematic since time*birth weight refers to a within-subject contrast, e.g. longitudinal-only based contrast. Birth weight, even when self-reported is a highly reliable measure and the sample sizes are relatively large (n = 635, 1759, and 3324 unique individuals). Note that the smaller dataset does have longer follow-up times and more observations per participant increasing the reliability of estimations in individual change. Structural MRI measures have very high reliability (often ICC > .95). Clearly, longitudinal brain change is less reliable, yet the present sample size and the high reliability of birth weight should provide enough statistical power to capture even small time-varying effects of birth weight on brain structure.
We agree that some - if not most - brain structures follow non-linear trajectories throughout life (#4). In the present study, age regressors are used only for accounting for variance in the data rather than capturing any effect of interest. Rather, it is the time*birth weight regressor that captures age-varying changes in brain structure. Time reflects within-subject follow-up time. In any case, the inclusion of non-linear regressors is superfluous in ABCD given the small age range and will not regress out additional variance. Likewise, published data on UKB has shown that most age trajectories of cortical data follow grossly linear fits (age range in the UKB: 45 – 85 years). In LCBC, however, we recognize that non-linear modeling may be able to capture additional variance since it is a lifespan dataset. This may provide better estimates for birth weight and time*birth weight though it is unlikely that it has a big effect on the slope. In any case, #4 is a valid concern and we will repeat the main analysis using «spline models to fit age We will not follow the reviewer's suggestion for a mega-analytical approach. It is a valid approach, but it is best suited to other configurations of data than those used here where we used longitudinal data only. The use of cross-sectional data for deriving differential age trajectories is also not without problems.
We see Reviewer #2´s concerns mainly being: #1 The translation of birth-weight effects on brain volume to years of aging is inadequate and not fully supported by the data. #2 Lack of data regarding the functional relevance of brain weight effects on brain structure; suggesting the inclusion of cognitive data and (birth weight – brain structure – cognition) mediation analyses. #3 The degree to which the association between birth weight and cortical area/volume is explained by overall somatic growth. #4 The lack of non-linear regressors for fitting age.
1 We will modify the section on translation of birth weight effects into years of aging. While it is often used - see for example the literature on brain age - and is relatable, it can be easily misinterpreted and does not reflect any objective measure of effect size. #2 The degree to which birth weight relates to cognition throughout the lifespan through individual variations in brain structure is a key question in the field for which currently we only have indirect evidence. Unfortunately, the study of this triple relationship is out of the scope of the current study. This, we agree with the reviewer, warrants further research. We disagree, however, in that mediation analyses are able to provide a satisfactory answer to this question. Also, we believe that the conclusions of the present study are not affected by the omission of cognitive data beyond what has been commented on in #1. The relationship between birth weight, structure, and cognition will be further discussed in the revised version of the manuscript.
3 Indeed, part of birth weight effects on brain structure can be explained by overall somatic growth. This study does not provide - and is not designed to provide - a specific mechanism for which birth weight is associated with brain structure. Yet, research has also shown that differences in birth weight partially reflect factors associated with variations in neurodevelopmental processes in gestation. Mechanisms are thought to be partially genetic (including geneticly influenced potential for somatic growth) and partially environmental prenatal influences. The amount of variance explained by such mechanisms is unknown and may differ across samples (e.g. population samples vs. monozygotic twins). In our view, the association is no less meaningful if mostly attributed to somatic growth if it is associated with partly modifiable variance in brain growth. The revised manuscript will include further considerations on the possible mechanisms explaining the association between birth weight and cortical structure throughout the lifespan.
Concern #4 is equivalent to Reviewer #1, concern #4. In short, the age regressor is used only to account for variance. Linear modeling in the ABCD and UKB datasets has been shown to fit relatively well the different cortical regions due to the samples’ narrow age range. In LCBC, however, we recognize that non-linear modeling may be able to capture additional variance since it is a lifespan dataset. This may provide better estimates for birth weight and time*birth weight though it is unlikely that has a big effect on the slope of the effects. We will repeat the main analysis using «spline models to fit age.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
The following is the authors' response to the original reviews.
We thank the reviewers for their positive remarks, which we have addressed in detail below and which we have considered in our revised manuscript.
Reviewer #1 (Recommendations For The Authors):
The authors claim several times to have documented electrogenic chloride/oxalate exchange mediated by human SLC26A6. However, they fail to detect whole cell currents in SLC26A6-expressing HEK293 cells in oxalate bath, despite robust, saturable Cl- efflux from proteoliposomes into extracellular oxalate solution, as detected by AMCA fluorescence decay.
We interpret the low, and essentially non-detectable currents for Cl-/oxalate exchange as a consequence of the slow kinetics of transport. This lack of sensitivity is not unusual for electrogenic secondary-active transport processes recorded by patch-clamp electrophysiology in mammalian cells, which renders the recording in large X. laevis oocytes by two-electrode voltage clamp the preferred method for such investigations. In contrast to the non-detectable activity in electrophysiology, the pronounced signal in the ACMA assay reflects the influx of H+ as a consequence of the negative membrane potential established by the influx of the divalent anion oxalate, which we assume to occur in exchange with the monovalent Cl-.
Instances in the manuscript include:
Abstract Line 17 overstates the paper's findings as "we have characterized SLC26A6 as a strictly coupled exchanger of chloride with either bicarbonate or oxalate". To the extent that "strictly coupled" implies 1:1 stoichiometry, the authors conclude Cl-/bicarbonate exchange is electroneutral based on its lack of exchange current. In contrast, the lack of Cl/oxalate exchange current does not lead the authors to the same conclusion of electroneutrality for Cl-/oxalate exchange. The data presented do not measure the stoichiometry of Cl-/oxalate exchange.
We agree that our ACMA experiments do not strictly discriminate between coupled and uncoupled oxalate transport. However, it should be emphasized that, assuming that transport proceeds by an alternate access mechanism, uncoupled oxalate transport would require the change of the unloaded transporter between inward- and outward-facing conformations, which was shown to be unfavorable in Figure 1D.
We have reworded the sentence in the abstract to:
“Here we have determined the structure of the closely related human transporter SLC26A6 and characterized it as a coupled exchanger of chloride with bicarbonate and presumably also oxalate.”
Line 264 claims that "the paper's functional data has defined SLC26A6 as a coupled transporter that exchanges Cl- with either HCO3- or oxalate at equimolar stoichiometry."
We have changed the sentence to:
“Whereas our functional data has defined SLC26A6 as a coupled antiporter that exchanges Cl- with HCO3- and presumably also oxalate with equimolar stoichiometry…”
In lines 299-302, the authors claim to have "detected strict equimolar exchange of anions"...leading to the reasonable conclusion of electroneutral Cl-/HCO3- exchange and the reasonable but unsupported conclusion of coupled Cl/oxalate exchange.
We have reworded the sentence to:
“In the case of Cl-/HCO3- transport, we detect a strict equimolar exchange of anions binding to a conserved site in the mobile core domain of the transmembrane transport unit (Figure 4B, H). Although not shown unambiguously, we assume an analogous mechanism also for Cl-/oxalate exchange.”
Lines 505-508 in Methods claim that the AMCA proteoliposome assay "measured electrogenic oxalate transport." However, the assay documented extracellular oxalate- dependent anion transport that was most simply interpreted as coupled exchange.
The assay has detected H+ uptake into proteoliposomes as a consequence of electrogenic anion influx. In these experiments, oxalate is the only anion on the outside of vesicles and it requires to be transported to be able to observe any fluorescent change. The claim of electrogenic oxalate transport is thus justified. As described above, the assay does under the applied conditions not discriminate between uncoupled and coupled oxalate transport, however uncoupled oxalate transport would require the conformational change of an unloaded transporter, which was shown to be kinetically disfavored.
In contrast, other parts of the manuscript acknowledge that the evidence presented falls short of documenting stoichiometric chloride/oxalate exchange.
Results Line 151 sets out to "investigate a potentially electrogenic Cl-/oxalate exchanger. Similarly, results line 160 conservatively claims that Cl-/oxalate exchange occurs "presumably" with a 1:1 stoichiometry. This more accurate language needs to be used throughout the paper, replacing the more absolute but unjustified descriptions summarized earlier above.
We have now introduced the requested clarifications throughout.
I have otherwise only Minor points to suggest. Abstract:
"Among the eleven paralogs in humans.... ". This should be "at least 10," as the original
status of human SLC26A10 as a transcribed pseudogene vs. a truncated protein-expressing gene remains unresolved. The authors recognize this in the introduction, where on p. 3 they acknowledge "ten functional SLC26 paralogs in humans."
We have changed to ‘ten functional paralogs’
Introduction:
p. 4 line 45: membrane-inserted
We have introduced the correction.
Methods:
Construct Generation:
p. 25 lines 380-2: Add a sentence describing any C-terminal sequence extension added after C3 cleavage product, and whether/how it modified the PDZ-binding domain sequence. Has the modification been tested for PDZ-binding activity?
We have introduced the following sentence:
“As a consequence of FX cloning, expressed constructs include an additional serine at the N- terminus and an alanine at the C-terminus. Following C3-cleavage, SLC26A6 carries a seven residues long C-terminal extension (of sequence ALEVLFQ).”
We have not tested PDZ-domain binding but expect that the added residues interfere with interaction with the C-terminal binding motif.
Liposome Reconstitution:
p.28: lines 453-4: Please clarify the meaning of: "absorbance at 540 nm was used to detect liposome destabilization," followed immediately by "After the formation of stabilized liposomes".... Does destabilization mean liposomal leak of Eu.L1+ chromophore, with decline of absorbance? What is practically meant in terms of the number of 10 mL additions of 10% TTX-100 routinely added to generate stabilized liposomes without generating destabilized liposomes? Did this number vary from trial to trial? How did you know when to stop adding aliquots of TTX-100?
We have added the following sentence:
“For protein incorporation, 10 µl aliquots of 10% Triton X-100 were added in order to destabilize liposomes and permit protein incorporation. After reaching a plateau of the light scattering measured at 540 nm, 4 additional aliquots of Triton X-100 were added. The number of additions required for destabilization did not vary between reconstitutions.”
p.28 line 463: "dissolved" should be "suspended."
We have introduced the correction.
Bicarbonate Transport Assay
p. 29 line 480-1. How many repetitions represented by the phrase "sequential ultracentrifugation steps"- please provide a number or a range, as applicable.
We have defined the number of ultracentrifugation steps (two).
Pp 29-30, lines 485-7: define "cycles" - are these fluorometric excitation-emission cycles?
We have defined cycles as fluorometric excitation/emission cycles.
p. 30 line 489: delete "by"
We have deleted ‘by’
Name the fluorimeter used.
We have named the fluorimeter used as Tecan Infinite M1000 Pro microplate reader.
AMCA assay
Pp 30-31, lines 505-8: Add composition of extraliposomal oxalate-containing buffer. In Fig 1 Suppl Fig. 1 panels H and I, and Methods lines 505-508, with 150 mM oxalate substituting for 150 mM Cl- how was osmotic balance maintained in the external chloride solution?
We have added the composition of the oxalate-containing buffer. The osmolarity of the extracellular solution was not balanced.
Electrophysiology
p.32 line 532: What fold-increase of SLC26 protein levels was produced by inclusion of 3 mM valproic acid?
We consistently see an increase of expression upon addition of valproic for different membrane proteins acid but did not quantify it in this case.
Results:
Functional characterization of SLC26A6
Line 91: "comparably" to what? Otherwise, perhaps, "comparatively" was intended here?
We have changed to ‘comparatively’
Fig 1E legend: line 763 "time- and concentration-dependent". Same for line 791, line 799
We have introduced the correction.
Fig. 1G: Change Y axis legend to "Normalized [Eu.L1+] emission." Add bath ion composition for "neg" condition (black trace).
We have corrected the label on the Y-axis and added ion composition for neg.
Fig. 1H legend sentence 2 "in a concentration-dependent manner for liposomes (Mock) in
75 mM oxalate (n=5) and for SLC26A6 proteoliposomes in extracellular oxalate concentrations of 9.4 mM (n=3) etc
We have reworded the sentence:
“Traces show mean quenching of ACMA fluorescence in a time- and concentration-dependent manner for SLC26A6 proteoliposomes with outside oxalate concentrations of 9.4 mM (n = 3), 37.5 mM (n = 5), 75 mM (n = 6), 150 mM (n = 8, all from two independent reconstitutions). Neg. refers to liposomes not containing SLC26A6 assayed upon addition of 75 mM oxalate as defined in Figure1-figure supplement 1G.”
Fig. 1 Fig Suppl. 1. p.45 line 790: change "chemical formulas" to "2-D chemical structures"
We have introduced the change.
lines 799: Time-
We have introduced the change.
Fig 1 Fig Suppl. 1. p 46 lines 809-810: dashed lines indicating 0 pA are indeed red in panels A and B, but black in panels H and I.
We explicitly refer to recordings, where dashed lines at 0 pA are consistently in red.
Fig 2 Fig Suppl.1 p. 50, line 832: Two additional multi-class.
We have introduced the change.
Fig 2 Suppl Fig 2B, p. 51: Please label the residue numbers of the side chains coordinating the chloride binding site. Can those residues be indicated in Fig 2 Suppl Fig 2A in the appropriate helices? These residues might also be asterisked in the primary sequence alignment of Fig 2 Suppl Fig 3A.
We have labeled the residues in Fig. 2-figure supplement 2B but not 2A where the focus is on the general quality of the density in different parts of the protein. We have also labeled the same residues in Fig. 2-figure supplement 3A.
Fig.4 legend p. 59 line 882 – Deviating residues in SLC26A9 (typo A6) are highlighted in violet.
We have introduced the correction.
p. 60 lines 888-9: Please clarify the individual meaning of green and purple asterisks on defining the substrate cavity diameter; How do purple and green asterisks relate to the yellow and green lines in the graph? Should the asterisks be two green and two yellow asterisks, or should they be black? What is the meaning of the purple and green asterisks at the two upper corners of panel G with respect to the substrate cavity radii?
Please specify if y axis label "radius" refers to substrate cavity radius, and whether X axis label "distance" refers to axial distance along helix alpha10, alpha1, or of the helical pair. Is value "0 A" on the X axis anchored at the top of the helices as depicted in panels D-F? Is X-axis value 10.5A sited at the bottom of the helices? Please indicate on the panel G curves the x-y value range depicted in the inset images- or clarify that the inset images present the entire curves of panel G.
We have clarified these remarks in a revised legend:
“The radius of the substrate cavity of either protein is mapped along a trajectory connecting a start position at the entrance of each cavity (distance 0 Å) and an end position located outside of the cavity in the protein region (distance 10 Å). Both points are defined by asterisks in insets showing the substrate cavities for either transporter and they are indicated in the graph (green, cavity entrance towards the aqueous vestibule; violet, protein region).”
Fig. 4 p . 61-2 panel H and lines 907-8: Addition to the panel of the A5 "buried Cl- binding site" would be helpful, if possible to do without obscuring the A6 and A9 Cl-s.
Panels H and I show the cavity harboring the ion binding site in two orientations, including the surrounding residues. We prefer to show all surrounding residues for both orientations, even if this somewhat obscures the view on the ion in the left panels. An unobscured view of the ion in its cavity is provided in panels D and E.
p. 12. Results line 234: Please specify that "both proteins" here refers to A6 and A5 vs A6 and A9
We have specified this.
p. 13 Results lines 268-72: R404 is "ubiquitous in other mammalian paralogs..." should be changed to "shared by most but not all mammalian paralogs".
We have changed the text accordingly.
Fig 4C should have a red or purple asterisk placed under the yellow column corresponding to R404 of SLC26A6, so that the discussion can refer to it. It would also be helpful to remind the reader that R404 corresponds to conserved position 6 in Fig 4 Fig Suppl. 1 panels D-G.
Here the authors might note that sulfate -transporting SLC26A1 and -A2 have the shorter side chain K residue.
We have marked the position in Figure 4C with an asterisk and added the following sentence to its legend:
Asterisk marks position that harbors a basic residue in all family members except for SLC26A9 where the residue is replaced by a valine. Whereas most paralogs, including the ones operating as bicarbonate exchangers, have an arginine at this site, the sulfate transporters SLC26A1 and 2 contain a smaller lysine.
We have added the following statement to the legend of Figure4-figure supplement 1:
“‘6’ indicates the position which contains a basic residue in all family members except for SLC26A9.”
Fig 5B legend p. 63 line 916. Please specify if the 14 independent experiments include both the symmetric Cl- conditions and the asymmetric Cl-/HCO3- conditions or only one condition.
The 14 independent experiments were only recorded in symmetric chloride conditions. We have changed the legend accordingly.
Fig 5C. It would be useful for readers to add the I-V trace of WT SLC26A6 taken from Fig 1 Suppl 1B (perhaps in gray), to document the specificity of the very low magnitude R404V whole cell current. Alternatively, please note (if the case) that WT SLC26A6 currents (Fig 1 Supple 1B) are indistinguishable from the blacked dashed zero current density line.
We have now displayed the I-V trace of WT SLC26A6 as grey dashed line for comparison and added a new panel that show the differences between the currents of R404V and WT recorded at 100 mV (Fig. 5D). Although the currents for R404V were consistently lager than for WT, the difference is not statistically significant. We have explicitly mentioned this in the text and the figure legend.
Fig 5E depiction of decline in ACMA fluorescence is missing from the legend. Legend references to panels E and F seem to correspond to Fig 5 panels F and G (lucigenin fluorescence), as noted in Results p 14 lines 280-3.
We have added the legend.
Chernova et al (2005) reported electroneutral human and mouse A6-mediated Cl/HCO3- exchange in Xenopus oocytes. They also observed electrogenic Cl-/oxalate exchange by mouse SLC26A6, but detected no current generated by human SLC26A6-mediated Cl-/Oxalate exchange. That paper (already cited) might be referred to more explicitly in connection to the authors' current findings of electroneutral Cl-/HCO3- exchange by human SLC26A6 as well as their inability to detect human SLC26A6-mediated Cl-/oxalate exchange current in HEK-293 whole cell recordings.
We now have included the reference in the discussion:
“Consequently, transport would be electroneutral in case of the monovalent HCO - and electrogenic in case of the divalent oxalate (Figure 1E-H), which was already proposed in a previous study (Chernova et al., 2005). We also want to re-emphasize that the inability to measure discernable currents does not necessarily imply that the transport might not be electrogenic as, due to their slow kinetics, transport-mediated currents might be below the detection limit of patch-clamp electrophysiology.”
Reviewer #2 (Recommendations For The Authors):
- It would be helpful if the authors briefly clarify the depiction/scheme of the hypothetical SLC26A6 outward-facing conformation. Is this gleaned from a prior structure of a related SLC family or distant homolog? Functional data? Biochemical/biophysical data? As well, I would also recommend labeling this within the figure (Figure 3-figure supplement 1D labeling, for instance - inward, hypothetical outward).
As mentioned in the legend of Figure 3-figure supplement 1D, the outward conformation is hypothetical. We have also now mentioned this in the title. The displayed outward- conformation was constructed by manually moving the area depicting the core domain relative to the fixed gate domain.
- Have the authors attempted to block SLC26A6-mediated transport with the addition of a known inhibitor, such as niflumic acid? I understand that this may be technically challenging, but it would strengthen the transport assay data, especially in Figure 5D with the ACMA assay testing the SLC26A6 R404V mutant.
We have not attempted to block the currents by addition of niflumic acid.
- It could be helpful to the reader to move the schematics in Figure 1-figure supplement 1C into Figure 1.
We have now displayed the schematics illustrating the principle of the respective transport assays next to the data in Figure 1, but kept Figure 1-figure supplement 1C for a more detailed description of the assays.
- Figure 3-figure supplement 1D legend, should be "hypothetical" instead of "hypothetic."
We have introduced the correction.
- I might consider coloring the Cl- ion something that is distinct from the model colors that are used in the figures (see Figure 4 and Figure 4-figure supplement 1). This would help to clarify Figure4-figure supplement 1H, where I believed that the Cl- ions at first were from the SLC26A6 model at first glance.
We have used the green color for chloride throughout the manuscript and would prefer to keep it that way for consistency.
- Labeling in Figure 5 legend (E, F) do not match the Figure (F,G). The description of the ACMA assay is absent from the figure legend (the real Figure 5E).
This has been corrected.
Reviewer #3 (Recommendations For The Authors):
None. This is a well-done manuscript and I have no further suggestions.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #3 (Public Review):
In this manuscript, Man et al. describe a new signaling pathway for regulation of the voltage-gated calcium channel Cav1.2 and show that it can modulate synaptic plasticity in the hippocampus. Studies with specific inhibitors, phosphopecific antibodies, and gene knockdown show that activation of alpha-1 adrenergic receptors induces downstream activation of the serine/threonine protein kinase PKC and the tyrosine protein kinases Pyk2 and Src, which bind to the Cav1.2 channel through its large intracellular segment connecting domains II and III. This signaling complex leads to tyrosine phosphorylation of Cav1.2 and increased channel activity. Block of this novel signaling pathway in hippocampal slices with specific inhibitors of Pyk2 and Src reduced a specific component of long-term potentiation whose induction requires Cav1.2 channel activity.
This work is an important advance, as it presents a novel signaling pathway through which the ubiquitous neurotransmitter norepinephine and the neurohormone epinephrine can regulate synaptic plasticity, attention, learning, and memory. The experiments are comprehensive, carefully done, and clearly presented. The authors should consider revisions and responses to the points below.
1) Figure 2B, D. Inhibitors reduce Ica below control. Is there endogenous stimulation of this regulatory pathway under control conditions?
We now explicitly state in the Discussion: “Inhibitors of PKC, Pyk2, and Src reduce under nearly all conditions Cav1.2 baseline activity and also tyrosine phosphorylation of Cav1.2, Pyk2, and Src even when activators for alpha1 AR and PKC were present. Especially notable is the strong reduction of channel activity way below the control conditions by the Src inhibitor PP2 as well as the PKC inhibitor chelerythrine in Figure 2C. This effect is consistent with PP2 strongly reducing down below control conditions tyrosine phosphorylation of Src (Figure 8J), Pyk2 (Figure 8L), and Cav1.2 (Figure 9E) even with the PKC activator PMA present. These findings suggest that Pyk2 and Src experience significant although clearly by far not full activation under basal conditions as reflected by their own phosphorylation status, which translates into tyrosine phosphorylation of Cav1.2 under such basal conditions.” Because there are multiple ways Pyk2 and Src can be activated including Ca influx and cell-matrix interactions, defining the cause of this baseline activity has to remain beyond the scope of the current work.
2) As noted by the authors, it would be interesting to know if peptides from the linker between domains II and III block this signaling pathway. This would be an important result because, without this information, it is not clear if this is the correct functional site of interaction for this regulatory complex.
Briefly, we were not able to identify shorter loopII/III-derived peptides that would constitute the Pyk2 binding site and thus cannot displace Pyk2 from loop II/III either acutely with peptides or through mutagenesis of the binding site.
3) Figure 4B. The Brain IP for Src has a weak signal. The authors should replace this panel with a more convincing immunoblot.
We provide now the uncropped version in the raw dataset, which clearly illustrates clean, monospecific detection of the Src band over the full length of the blot. Also, please note that earlier work already reported that showed that Src binds to the C-terminus of Cav1.2 (Bence-Hanulec et al., 2000).
4) Scatter plots are provided for the electrophysiological results but not immunoblots. For immunoblots that are quanitified, it would be valuable to add a scatter plot of the replicates.
We now also provide scatter plots for the biochemical analysis.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
The paper addresses why and how odor discrimination ability achieved after learning occurs in select contexts. The finding is that two related odors trigger near identical Kenyon cell responses when tested in isolation, but trigger different responses to the second odor if these are experienced in sequence within a small temporal window. The authors argue that this template comparison requires some activity downstream of Kenyon cells, that is recruited by MBONs. Overall, the experiments provide very nice physiological evidence for a neural mechanism that underlies a contextual basis for the precision of memory recall.
The experiments were well designed and done. The findings are interesting, but the pitch (e.g. the last paragraph of the discussion and the title of the paper) seems to both ignore the main finding of the paper and overstate the novelty of the idea that memory recall can be flexibly regulated by context. There should be more space dedicated to clearly articulated statements/descriptions of hypotheses and candidate mechanisms to explain the interesting phenomenon described here. For instance, explaining "enhanced template mismatch detection" by potential " real-time and delay line summation" of MBON activity is not super useful for the reader as seems to use one abstraction to explain another. The authors cite Lin et al, 2014 from Miesenbock's lab which shows a key role for GABAergic APL neurons in discrimination. Is there increased activation of APL neurons when similar odourants are being compared and discrimination is required? This seems like a simple physically embodied mechanism that could/ should be examined.
Overall, I think the idea that memories are recalled with high precision (less generalisation) only when increased precision is demanded, is a fact that sure is well appreciated by behavioral biologists even beyond the two papers cited here (Campbell et al., J Neurosci 2013; Xu and Südhof, Science 2013). The new findings fill in a physiological gap in this phenomenology. I think the paper would be greatly improved if the authors highlighted what and focused on the physiological correlate uncovered, and tried to communicate (or test) possible mechanistic origins for this in more physically accessible terms.
We thank Reviewer #1 for their appreciation of our findings. We are grateful for this extremely constructive feedback on re-focussing the pitch of the paper and have extensively revised the manuscript along these lines, particularly changing the Title, Introduction and Discussion. As suggested, we now highlight how similar stimuli can be categorized together, or apart, depending on the stimulus choices animals are presented during recall.
Reviewer #2 (Public Review):
One of the key questions in circuit neuroscience is how learned information guides behavior. Modi et al. investigated this question in Drosophila's mushroom bodies (MBs), where olfactory memory traces are formed during pavlovian olfactory conditioning. They have used optogenetics to restrict the formation of memory traces in selective output compartments of the Kenyon cell (KC) axon terminals, the principal intrinsic neurons of the MB, and tested how flies use these 'minimal memories' during learned olfactory discrimination. They found that memory traces formed in some compartments support discrimination between similar odor pairs, whereas others do not. They then investigated the neural basis of this difference by comparing the responses of relevant output neurons (MBONs) to similar and dissimilar odor pairs. They discovered that MBONs' responses could predict behavioral outcomes if odor presentation profiles during calcium imaging mimic olfactory experience during behavior. This paper and previous works support the idea that flies use olfactory memory templates flexibly to suit their behavioral needs. However, one key difference between this paper and the previous works is the site of discrimination. While previous studies using intensity discrimination have pointed towards spike-latency and on and off responses of the KCs as the main mechanism behind discrimination, Modi et al. have not detected any response difference for similar odor pairs among the KCs. Therefore, they concluded that a hitherto unknown mechanism creates these context-specific responses at the MBONs. The findings will advance our understanding of how memories are recalled during behavior. However, the authors need to bolster their data by including some critical controls that are currently missing.
We thank Reviewer #2 for highlighting how our work contributes to the literature and for pointing out the gaps in our discussion of previous work, as well as the missing controls.
Reviewer #3 (Public Review):
This manuscript by Modi et al represents a novel and significant advance in the neurobiology of memory retrieval. The authors employ a novel behavioral paradigm in order to investigate memory generalization and discrimination. They investigate the role of two different populations of dopamine neurons (DANs) targeting different compartments involved in aversion learning, i.e. α3 (MB630B) and γ2α'1 (MB296B).
The behavioral platform is clear and convincing but lacks natural reinforcement comparisons. The entire paper uses optogenetic reinforcement of said DAN populations.
The authors identify that the gamma DANs can enable both easy and hard odor discrimination, while the alphas DANs can only do easy.
The odors can be separated by calcium imaging analysis of Kenyon cells. Subsequent calcium imaging of the gamma DANs themselves showed that a single training event was insufficient to enable easy odor discrimination at the gamma DAN level, but strangely not for the hard discrimination that gamma DANs can mediate. Seemingly, this is due to the lack of the temporal contiguity of odors (present in behavioral experiments but not in the initial imaging experiments. However, in gamma DANs, Odour transitions enabled discrimination of odors in hard discrimination, based on the depression of calcium activity in DANs after training that was odor-specific. The same was not true for alpha DANs, though the authors used natural electric shock pairings instead of optogenetic stimulation of DANs for the alpha experiment. However, statistical comparisons are done within group and need also be provided for between the groups for both pre and post-training. The authors persuasively show that hard discrimination can only happen in transitions. They also argue that the same engram can be read in two different ways. This is convincing overall, but they claim it is happening downstream of the Kenyon cells just because they do not see it in the Kenyon cells, and I cannot comment on the modeling in Figure 5 (expertise).
Experimental methods used are appropriate, as are data analysis strategies.
The manuscript itself is well written in parts, though at times paragraphs are quite patchy, especially in the discussion. There are also a visible number of typos. The figures are well constructed, and generally well organized. The overall document is concise and has sufficient detail.
We appreciate the reviewer’s comments on the novelty and significance of our study.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #2 (Public Review):
In Rey et al., the authors goal was to characterize the development of a myelin-like (lacunar) expansion of glial membrane in Drosophila. Although myelin is largely considered a vertebrate innovation, there are a handful of invertebrate models that have been described with glial-derived "myelin," though these systems are not amenable to the same genetic control as Drosophila. To that end, the authors first newly-developed genetics and antibodies to characterize the presence of an axon initial segment (AIS) for adult Drosophila motor neurons that is present at the border between the central and peripheral nervous systems. They show that both sodium (Para) and potassium (Shal) channels, which are typically enriched at the AIS in mammalian neurons, are enriched at this border specifically on motor neurons. They then used multiple types of transmission electron microscopy to visualize this region and found that along with clustering of channels, there is an expansion of membranes from wrapping glia that is reminiscent of myelin. At times, this expansion spirally wraps around larger axons. Finally, they show that genetic ablation of wrapping glia results in an upregulation and redistribution of Para.
Major strengths of this manuscript include the creation of new genetic tools for visualization of subcellular features (e.g. channels) by both light microscopy and electron microscopy.
While this manuscript provides an interesting set of data, but suffers from a lack of quantification and annotation to allow the reader to judge whether this is a robust phenomenon. To increase the reader's confidence in these studies, substantially more quantification of the data is required.
Furthermore, to improve the accessibility of this manuscript, I have the following suggestions:
1) Please label the panels throughout the figures with an abbreviated genotype and what the fluorophores signify. Similarly, the presence of scale bars in uneven across the figures.
This was all corrected.
2) For panels where only one channel is shown, please show these in black and white, which is easier for the visually-impaired.
We have not done this, since the color adds another layer of information (e.g. paramCherry is in magenta, whereas anti-Para staining is in green) which in our view helps to make the complex figures easier to understand.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
Inhibition of translation has been found as a conserved intervention to extend lifespan across a number of species. In this work, the authors systematically investigate the similarities and differences between pharmacological inhibition of protein synthesis at the initiation or elongation steps on longevity and stress resistance. They find that translation elongation inhibition is beneficial during times when proteostasis collapse is the primary phenotype such as proteasome dysfunction, hsf-1 mutants, and heat shock, but this intervention does not extend the lifespan of wt worms. While translation initiation inhibition extends the lifespan of wt worms and heat shock, but in an HSF-1 dependent manner. This work shows that a simple explanation of just inhibiting total protein synthesis and reduced folding load cannot explain all of the phenotypes seen from protein synthesis inhibition, as initiation and elongation inhibition repress overall translation similarly, but have different effects depending on the experiment tested. Using multiple interventions that target both initiation and elongation lends further support to their findings. These experiments are important for conceptualizing how translation inhibition actually extends lifespan and promotes proteostasis.
Major Comment:
The authors acknowledge that lifespan extension must not necessarily arise just from reducing protein synthesis, as elongation inhibition reduced protein synthesis but did not extend lifespan. Yet for the converse effects from elongation inhibition they seem to suggest that it arises from reducing protein synthesis. For example, regarding how elongation inhibition extends lifespan in an hsf-1 mutant, the authors suggest that "inhibition of elongation lowers the production of newly synthesized proteins and thus reduces the folding load on the proteostasis machinery", even though initiation inhibitors do not extend lifespan in an hsf-1 background (while presumably lowering the production of newly synthesized proteins).
Thank you for this excellent comment. It led us to conduct a crucial experiment with a new finding that is now Figure 6. As suggested, we asked if initiation inhibitors lower the concentration of newly synthesized protein in the hsf-1(sy441) background. The surprising answer is that initiation inhibitors lower the concentration of newly synthesized proteins in N2 but dramatically increase it in hsf-1(sy441). The failure to lower the concentration of newly synthesized proteins was true for the pharmacological inhibitors as well as RNAi against ifg-1. Therefore, inhibition of initiation requires HSF1 to lower the protein concentration. These new findings enable us to make a much more precise statement now added to the discussion:
Lines 372: “The inability of translation-initiation inhibitors to reduce the concentration of newly synthesized proteins in hsf-1(sy441) mutants and the inability to extend their lifespan shows that lowering the concentration of newly synthesized proteins is necessary for the beneficial effects. On the other hand, the finding that elongation inhibitors protect from proteotoxic stress but does not extend lifespan shows that lowering the concentration of newly synthesized proteins is sufficient to protect from proteotoxic stress but is not sufficient to extend lifespan in wild-type, which appears to require selective translation.”
Reviewer #2 (Public Review):
In this manuscript, Clay et al. investigate the underlying effects of reduced mRNA translation beneficial on protein aggregation and aging. They aim to test two pre-existing hypotheses: The selective translation model proposes that downregulation of overall translation increases the capacity of ribosomes to translate selected factors that in turn increase stress resistance against toxicity. The reduced folding load model suggests that during high mRNA translation rates, newly synthesized peptides and proteins can overwhelm the protein folding capacity of the cell and therefore cause protein toxicity. By generally lowering mRNA translation, lower loads of newly synthesized proteins should cause less protein folding stress and hence protein toxicity.
To understand how reduced mRNA translation mediates its beneficial effects in the context of the proposed models, the authors use different drugs established previously in other in vitro and in vivo systems to inhibit selected steps of translation. The systemic effects of translation initiation versus elongation inhibition in C. elegans are compared during heat shock, specific protein aggregation stresses and aging. These phenotypes are further tested for dependence on hsf-1, as contradictory data on the effect of translation inhibition during thermal stress in the context of hsf-1 dependency exist.
The data show that inhibition of translation initiation protects from heat stress and age-associated protein aggregation but on the contrary further sensitizes animals to protein toxicity induced by a misfunctioning proteasome. Further, inhibition of translation initiation increases lifespan in WT animals. The survival phenotypes observed during heat shock and regular lifespan assays are dependent of HSF-1, supporting the selective translation model. As stated in the manuscript, these findings themselves are not new, given that similar observations were made before using genetic models. Interestingly, the inhibition of translation elongation protects from heat stress, but, unlike initiation inhibition, also proteasome-misfunction-induced protein toxicity. Both phenotypes were observed to be independent of hsf-1. The authors further find that inhibiting elongation does not reduce protein aggregation in aged worms and does not prolong lifespan in wild-type animals. It does increase lifespan in short-lived hsf-1 mutants, where protein homeostasis is compromised. To a degree, these findings support the reduced folding load model. Overall, from these observations the authors summarize that the systemic consequences of lowering translation depend on the step in which translation is inhibited as well as the environmental context. The authors conclude that different ways to inhibit translation can protect from different insults by independent mechanisms.
Impact, strengths and weaknesses:
mRNA translation and its regulation is one of the most studied mechanisms connected to lifespan extension. However, gaps behind the protective effects of translation inhibition are so far unresolved, as stated by the authors. Therefore, testing existing hypotheses explaining the beneficial effects of translation inhibition is of great interest, not only for C. elegans researchers but a broad community working on the effects of misregulated translation during aging and disease. Overall, the conclusions made by the authors are generally supported by the data shown in this manuscript. However, some major gaps remain and need to be clarified and extended.
Thank you for your generous comments and thorough review.
Reviewer #3 (Public Review):
Clay and colleagues investigate the proteostasis and longevity benefits derived from translation inhibition in C. elegans by examining the impacts of chemical translation initiation inhibitors (IIs) and translation elongation inhibitors (EIs) on thermotolerance, protein folding stress, aggregation and longevity. They observe somewhat distinct impacts by the two chemical groups. IIs increased longevity in wild-type animals in an hsf-1 dependent manner, whereas, EIs only extended hsf-1 mutants' lifespan. Only EIs protected against proteasome dysfunction. Both protected against heat stress but with differing hsf-1 dependence. The authors utilize these observations to derive conclusions regarding two dominant points of view on the mechanism by which translation inhibition improves lifespan and proteostasis.
The study is based on interesting observations and several promising avenues of further investigation can be identified. However, the manuscript appears somewhat preliminary in nature, with many of the observations, while interesting, only explored superficially for mechanistic insights. The rationale behind some of the interpretations was also difficult to interpret. For example, the authors make conclusions about 'selective translation' being adopted upon IIs treatment without directly testing this. Protein aggregation, while possibly predictive, is not a reliable readout for selective translation of some mRNAs. Similarly, the evidence for a reduction in 'newly-synthesized protein load' by EIs is thin based on one reporter. Previous studies from the Blackwell lab have identified differential impacts of SKN-1 on select cytoprotective genes' expression and proteasomal gene expression based on inhibition of translation initiation or elongation. So there is precedence for both the differential impact of initiation vs. elongation inhibition as well as genetic background. There are several other such studies that reduce the impact of the observations presented here. With limited novelty and mechanistic insight, the impact of the study on the field is likely to be moderate.
We thank the reviewer for the thorough analysis and candid summary. Some of the criticisms rang true, and we have made considerable efforts to address them, both increasing the thoroughness of our study by establishing that these inhibitors inhibit initiation and elongation (new Figure 1) and by providing a novel mechanism showing that the ability of the initiation machinery requires HSF1 to lower the concentration of newly synthesized proteins.
Before we go into the specific criticisms, we would like to note that of the 30-40 eukaryotic translation inhibitors used in cell culture and yeast, very few have been validated in C. elegans. The go-to inhibitor was cycloheximide which, in our hands, is reliable in cell culture but unreliable in C. elegans, most likely due to its poor pharmacokinetics (data now added to the supplementary figures). To our knowledge, no C. elegans study investigating translation has made sure to equalize the concentration of newly synthesized proteins or could have because of a lack of validation of the chemical tools used in other organisms. Thus, the comment of reviewer #3 that we did not go far enough with the validation struck home, and in the revised version of Figure 1 we added more validation.
We are of the opinion that it is essential to ensure that both mechanisms reduce the concentration of newly synthesized proteins to the same degree to study mechanistic differences. Otherwise, one cannot deconvolute if any phenotypic difference is caused by the mechanistic difference or the degree of translation inhibition. The importance of monitoring the level of inhibition became evident in our new Figure 6, which shows that inhibition of the translation initiation machinery no longer reduces the concentration of newly synthesized proteins but increases it in the absence of HSF1.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
The role of HCO3 (or possibly CO2) in regulating sACs is well established yet its physiological context is less clear. The heart is indeed an excellent choice of organ to study this. Isolated mitochondria offer a tractable model for studying the model, although are not without limitations. The quality of recordings is very high, as judged by the consistency of results (i.e. lack of clustering between biological repeats). My primary concern is about distinguishing the effect of pH and HCO3. A rise in HCO3 will also raise pH unless this had been compensated by CO2. It is unclear, from the legend or results, if the bicarbonate effect is due to HCO3 or pH. Was pH controlled by matching the rise in HCO3 with an appropriate level of CO2? The swings in pH are likely to be very large and, potentially, a confounding factor. Certainly, there will be an effect on the proton motive force. A more informative test would compare the effect of 0 CO2/0HCO3 at a pH set to say 7.2, 2.5% CO2/7.5 mM HCO3, and then 5% CO2/15 mM HCO3, etc. Control experiments would then repeat these observations over a range of pH (at zero CO2/HCO3) and over a range of CO2 (at constant HCO3). Data for zero bicarbonate are not informative, as this will never be a physiological setting (results claim 0-15 mM bicarb to represent physiology). Importantly, there seems to be no significant difference in 2A between 10 v 15 mM bicarb, i.e. the physiological range.
Thank you for your clear discussion and suggestions. We agree that pH must be controlled in these experiments to avoid the confounding situation you describe. In fact, pH was carefully controlled but this was not described adequately. To make this clearer the methods section was modified.
We agree that bicarbonate concentration is above 0 in living tissue. We used that value only as a reference in Figure 2A to examine which type of adenylyl cyclase (AC) is inside mitochondria, i.e., bicarbonate-activated soluble AC as opposed to transmembrane AC which is not bicarbonate activated. The wording has been corrected to better describe this. The question of what the physiological consequences are require an assay with higher signal-to-noise ratio. In effect, this is achieved in the experiments of Fig. 2B-C which show that physiologically relevant changes in bicarbonate have a large and significant influence on mitochondrial ATP production.
There is also a question on the validity of the model. A rise in respiratory rate will produce more CO2 in the matrix. This may raise matrix HCO3, and stimulate sACs therein, but the authors claim sACs are in the IMS, rather than the matrix. Since HCO3 is impermeable, it is unclear how sACs would detect HCO3 beyond the IMM. CO2 escaping the matrix will enter the continuum of the cytoplasmic space, which has finely controlled pH. Since membranes (including IMM) are highly permeable to CO2, the gradient between matrix and cytoplasm will be small (i.e. you only need a small gradient to drive a big flux, if the permeability is massive). Since CO2 can dissipate over a large volume, it is unlikely to accumulate to any degree. CO2 will be in equilibrium with HCO3 and pH (because there are carbonic anhydrases available). Since the cytoplasm has near-constant pH, [HCO3] must also be close to constancy. It is therefore difficult to imagine how HCO3 could change dramatically to meaningfully affect sACs and hence cAMP. Evidence for major changes in IMS pH in intact cells during swings of respiratory activity would be required to make this point. Indeed, for that reason, it would be more sensible to anchor sACS in the matrix, as there, HCO3 could rise to high levels, as it is impermeable, i.e. could be confined within the mitochondrion. I am therefore not convinced the numbers are favorable to the proposed mechanism to be meaningful physiologically.
The question of how CO2/bicarbonate signaling can work in the intermembrane space (IMS) is explicitly addressed in the revisions in the results and discussion sections. CO2, a membrane permeable gas, can easily cross the IMM (permeability coefficient of 0.01 to 0.33 cm/s). Once in the IMS, CO2 can combine with water to produce bicarbonate, a fast reaction in a physiological context (i.e. mM/s in physiological saline) that can be accelerated to nearly diffusion limits by carbonic anhydrase if present. The assumption that all the “CO2 escaping the matrix will enter the continuum of the cytoplasmic space” is not supported by the structure of cardiomyocyte mitochondria. As illustrated in new Fig 2H, only a small fraction (9-15%) of the IMS occurs along the mitochondrial periphery adjacent to the outer membrane and cytosol. Most of the IMS is contained inside the cristae (the intracristal space or ICS), which in interfibrillar mitochondrion are composed of closely packed extended flat membranes that create scores of alternating layers of matrix and ICS ideal for rapid gas exchange between compartments. The cristae are connected to the peripheral IMS through narrow “crista junction” openings that restrict solute diffusion between the peripheral IMS and ICS. Thus, rather than being dominated by the ionic equilibria of the cytosol, the crista compartments are functionally distinct from the peripheral IMS region and cytosol. We cite recent publications using super-resolution light microscopy in which gradients of 0.3-0.4 pH units (dependent on metabolic state) have been detected along the cristae of respiring cells and between the peripheral IMS and crista interiors. These diffusion effects would likely be even more pronounced for cardiac muscle mitochondria, which have larger, more densely packed lamellar cristae than other cell types. Thus, the microenvironment of the cristae provide confined spaces in close communication with the matrix CO2 production, and ideal for operation of a sAC signaling system.
Reviewer #2 (Public Review):
The authors explore the role of bicarbonate-regulated soluble adenylate cyclase in modulating cardiac mitochondrial energy supply. In isolated rat mitochondria, they show that cyclic AMP (but not the permeable cAMP analog 8-Br-cAMP) increases ATP production via a Ca-independent mechanism at a location in the intermembrane space of the mitochondria, rather than in the matrix, as previously reported. Moreover, they show that inhibition of EPAC, but not PKA, inhibits the response. The effect required supplementing the mitochondria with GTP and GDP to facilitate activation of the EPAC effector GTPase Rap1. The study provides interesting new information about how the heart might adapt to changes in energy supply and demand through complementary regulatory processes involving both Ca and cyclic AMP.
The authors nicely demonstrate that soluble adenylate cyclase is localized to mitochondria. They argue, based on the effects of cyclic AMP, which is accessible to the mitochondrial intermembrane space (IMS) but not the matrix, that the signalling pathway is located in the IMS. They also find that EPAC/Rap1 is the likely downstream effector of cyclic AMP, through yet unknown targets regulating oxidative phosphorylation.
A weakness is that the components of signaling (sAC, EPAC, and rap1) are not definitively localized to a specific mitochondrial compartment using the superresolution imaging methods employed.
Thank you for the concise summary of key findings. While the super-resolution data indicates sAC and CA are localized to the interior of the mitochondria (possibly co-localized in the same subspace), identification of the particular microcompartment is not possible from the imaging data alone. We explain clearly in the manuscript that the functional experiments are critical to the conclusion that the sAC signaling pathway most likely operates in the IMS.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
This manuscript is interesting because of the exploration of a novel model organisms utilizing next-generation sequencing approaches, such as single-cell-RNA-seq. Despite the authors' efforts the manuscript lacks a cohesive narrative and suffers from being extremely preliminary in nature. For example, most of the figures are cut and pasted directly from the computational programs with very little formatting or thought to creating new knowledge from the data generated. Essentially the manuscript consists of 2-3 experiments where the authors performed single-cell-RNA-seq on different anatomical locations in the pig and also on a couple of different pig types (The Chenghua and Large White). The authors used standard computational pipelines consisting of Seurat, Monocle, Cell Chat, and others to characterize differences in their data.
There is potential in this manuscript but the authors should improve upon the manuscript by mining the data better and generating a better understanding of anatomical positions of pig skin by evaluating the Hox genes.
(1) Thanks for the reviewer's positive evaluation for our article and providing valuable feedback to improve the quality of our manuscript. To provide a more cohesive narrative, we have edited throughout the manuscript.
(2) Meanwhile, we also modified and formatted some figures including Figures 2-6, Figure 4—figure supplement 1 and 2, Figure 5—figure supplement 1 and 2, and Figure 6—figure supplement 1.
(3) We have analyzed these data of regional- or species-based differences more extensively, and the added content are in Result Section of “Heterogeneity of skin FBs in different anatomic sites” and “Heterogeneity of skin cells in different pig populations”.
(4) However, in our study, we did not identify any Hox gene among these differentially expressed genes in skin fibroblasts from both different anatomical sites and different pig populations. The differences of Hox code expression patterns might come from the heterogeneity of different species.
Reviewer #2 (Public Review):
The authors aimed to analyze different dermal compositions of various skin regions, focusing on fibroblast, endothelium and smooth muscle cells. They collect skin samples from six different skin regions of adult pig skin including the head, ear, shoulder, back, abdomen, and leg skins. After dissociating the tissues into single cells, they perform single-cell RNA analyses. A total of 215 thousand cells were analyzed. The authors identified distinct cell clusters, enriched molecules within each cell cluster, and the dynamic of cell cluster transition and interactions. Based on their findings, they conclude that tenascin N, collagen 11A1, and inhibin A are candidate genes for facilitating extracellular matrix accumulation.
Strength:
The methodology they used to prepare scRNA data is appropriate. Bioinformatic analyses are solid. The authors emphasize the heterogeneous phenotypes and composition ratios of smooth muscle cells, endothelial cells and fibroblasts in each skin region. They identify potential cell communication pathways among cell clusters. Expression of selective molecules on tissue sections were done.
Weakness:
While tenascin, collagen and inhibin are highlighted as genes important for ECM accumulation, there is no functional evaluation data. The discussion section is a compilation of comparisons, and is somewhat fragmentary. More significance from this dataset could have been extracted.
(1) We appreciate the reviewer's suggestions for evaluating the functional significance further. In our next research, we will perform some experiments in vitro and in vivo to explore the functions of these identified key genes.
(2) The discussion section have been greatly modified and it shall be more logical and readable.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
Wu et al. provide a powerful cross-species approach to better understand brain cell-type specific responses to mutant tau and aging. Therefore, they use scRNAseq of established Drosophila models that they had previously used for bulk RNAseq (Mangleburg et al., 2020) at 1, 10 and 20 days of age, which thus allows them to study the contribution of pathogenic tau (R406W-mutant) in isolation in an experimentally highly controllable manner. They find a large overlap between tau-induced and aging-induced deregulated genes, however different cell-types were primarily affected, suggesting that expression of tau does not simply induce accelerated aging. When assessing cell number abundance in response to tau expression the authors noted that certain excitatory neurons were preferentially lost. They then examined innate immune pathways downstream of NFkB, which they had already uncovered in their previous bulk studies to be associated with tau expression. Also at the scRNAseq level, they find these pathways to be deregulated after expression of tau. In addition, in control cell types that are lost when tau is expressed, they find an inverse correlation of the expression of these pathways and cellular loss, suggesting they might be predictors of neurodegeneration severity. Finally, they use this finding uncovered in Drosophila and reexamined human Alzheimer's disease snRNAseq datasets, were they also find the NFkB pathway to be deregulated.
This study has several strengths. It demonstrates the power of studying taueffects in a tractable model and then using the obtained knowledge to pin-point relevant pathways in cross-sectional studies of human tauopathy, which are otherwise not easy to interpret given the overlayed effects of other disease triggers. By examining the single-cell level they uncover cell type specific effects, which would otherwise be hidden. This study also represents a valuable resource. Given that the authors have included multiple time points the dataset provides an opportunity to understand the evolution of cell-type specific tau effects over time. The authors have also included a replication dataset, which confirms the results of the primary analysis of neuronal loss. I also appreciate the efforts to understand the apparent increase in glia cell number after expression of tau. By combining computational and experimental methods the authors reach the well supported conclusion that in fact glial cell numbers remain constant but only appear increased due to the proportional nature of the scRNAseq data and profound loss of some neurons. Overall, it is interesting that the authors nominate the innate immunity and NFkB pathways in tauopathy, based on deregulated genes and also based on vulnerable neurons. Nevertheless, this is a correlative finding and as such does not proof that it is causal.
As noted [R3], above, we agree that our findings of NFkB dysregulation are correlative. We have performed new experiments to directly test the hypothesis that neuronal immune pathways are causally linked to tau-mediated neurodegeneration; however, the results were negative. These data are included in the revision and we also carefully discuss published work from other fly models of aging and neurodegeneration as well as mouse tauopathy that strongly suggest NFkB can directly modulate neurodegeneration.
The authors correctly point out the importance of aging as a risk factor for Alzheimer's disease. However, it is unclear whether their models actually capture age-dependent neurodegeneration. Alternatively, they might represent neurodevelopmental tau toxicity. In Figure 1B it can be seen that all vulnerable cell types are already lost at day 1, most notably a'/b'-KC, a/b-KC and G-KC with a >4-fold decrease. This raises the question whether the lost cells might developmentally have not correctly formed, as suggested by a study that the authors cite (Kosmidis et al., 2010). This distinction is important in order to strengthen the translational value of the study to human tauopathies.
The elav>tauR406W model manifests both developmental toxicity and age-dependent neurodegenerative changes. Our revision includes new data highlighting specific examples and includes a more balanced discussion of these issues.
The analysis of tau expression levels relative to its impact across cell types in Figure S8 is interesting, however has caveats. The profound neuronal loss makes the interpretation of the correlation analysis of tau levels vs. neuronal vulnerability difficult - since it might be that the individual surviving a'/b'KC, a/b-KC and G-KC cells are the ones that expressed little amounts of tau, while those that are missing used to express high tau. In addition, it is unclear from the methods whether the 3' UTR from the transformation vector to generate the models was included in the counting. The majority of reads would be expected to be there.
As suggested, we have repeated the alignment and analysis of MAPT expression including the short SV40 3’UTR (135bp) from the transformation vector. The result appears very similar to that from the previous analysis, and we have updated Figure 3–figure supplement 4 with these data. Based on the feedback from Reviewer 2, we also include a new plot highlighting the non-relation between MAPT expression and cell abundance changes (Figure 3–figure supplement 4B). We acknowledge the caveat that “missing” / dead cells may have previously expressed high levels of tau, leaving behind survivors with low tau levels. We have added mention of this possible caveat in the Results (lines 197-198). However, while this scenario might impact our interpretation of cell abundance changes, it is a less likely to confound our analyses of differential expression, in which the number of differentially expressed genes show very poor correlation, if any, with MAPT transgene expression (Figure 3–figure supplement 4C).
It would be relevant to know whether the animals were in the same genetic background. I.e. is UAS-TauR406W in the same background of the fly that was crossed to elav-Gal4 to serve as the control. This is not mentioned in the paper and also not in Mangleburg et al., 2020 which the authors refer to. There is a lot of tau-induced DEGs (~1/3 of the detected genes) and it would be relevant to know whether some of them might be due to genetic background.
Our experimental design mitigates the possibility of a substantial impact from genetic background; however, we have added text in the revision noting that this is an important consideration and possible confounder.
The finding of the authors that NFkB pathways are higher in cell types that degenerate more is interesting. However, in Figure 4D it is also apparent that multiple cell types that do not degenerate have comparably high expression. Therefore, it is not a sufficient factor to explain why some neurons are vulnerable vs. others are not, but rather predicts amongst the vulnerable neurons how much they will be lost. It would be helpful to make this distinction clear in the text.
We agree with the reviewer’s interpretation, and we have tried to make this more clear in both the results and discussion (lines 286-288; 387-390). Indeed, the NFkB expression level seems to be a marker for the severity of tau-triggered cell loss among the vulnerable cells.
Reviewer 2 (Public Review):
Wu et al. conducted longitudinal single-nucleus RNA sequencing in a Drosophila transgenic line expressing pathogenic tau (Arg406 ->Trp) and control to study presenile degenerative dementia with bitemporal atrophy. Their data is consistent with previous findings on Tau neurotoxicity, which significantly affects excitatory neurons in human brain samples and transgenic mice. Authors identify aging-like signatures, and an innate immune glial response, including the NFKB pathway, in the transgenic animals.
Strength: This is a great resource for the dissection of dynamic, age-dependent gene expression changes at cellular resolution for the fly community. The article's conclusions are largely supported by the data.
We thank the reviewer for recognizing the value of this work as a resource for the field.
Weakness: No additional orthogonal validation is done on the identified pathways using immunohistochemistry. Also, the authors hypothesized that innate immune signatures might serve as predictors of neuronal subtype vulnerability in tauopathies. Although their data support stronger immune responses in the mutant lines, these findings are not validated. Moreover, the Authors need to use appropriate control animals to compare the mutant Tau animals.
Our original manuscript included experimental validation demonstrating that (1) the apparent increases in glial cell abundance is likely due to changes in cell proportions, and we also (2) confirmed the expression of Relish in both neurons and glia of the adult fly brain. For our revision, we were guided by the requested Essential Revision #3 [R3]. We have therefore performed additional experiments directly testing whether manipulation of Relish/NFkB in neurons alters tau-induced neurodegeneration. While the results of these experiments were negative, we have incorporated them into the results and discussion, along with discussion of related published studies that support a causal role for NFkB immune pathways in tauopathy. Lastly, in our response to Essential Revision #4 [R4], we address concerns about the conservation of neurotoxic mechanisms between mutant and wildtype froms of MAPT and the use of mutant MAPT transgenic models for investigations of AD, along with the caveats. New analyses have been performed and textual revisions have been made in response this feedback
Reviewer3 (Public Review):
Understanding the changes in the brain during the progression of neurodegenerative diseases may provide a critical entry point towards medical treatments. Many genes have been directly or indirectly implemented in an array of neurodegenerative diseases, including the microtubule associated protein tau (MAPT). Various studies have shown that misexpression of tau can cause behavioral, genetic as well as molecular phenotypes that display properties of human neurodegenerative diseases connected to tauopathies. Here the authors use the fruit fly as model to assess phenotypic defects at single-cell resolution. Pan-neuronal misexpression of a mutant form of tau (R406W) and single-cell RNAseq at different time points provides the basis for the investigation.
The authors assess which cell-types are affected (by comparing it with previously described brain cell atlas identities) and find that certain cell types are missing (or less abundant) while other appear unaffected. They do this comparison in relative abundance; both neurons and glia cells are affected.
As next step they compare this with the cell-cluster changes during aging and compare both types of analysis; the investigation here includes the analysis of differentially expressed genes in defined cell clusters. One particularly affected pathway in response to tau is the NFκB signaling pathway. The authors investigate the gene expression changes of the NFκB signaling pathway in the current dataset in more detail. In the last section the authors compare singlecell transcriptomic analyses between fly and human postmortem tissue, showing that the NFκB signaling pathway might be a conserved aspect of neurodegeneration.
The manuscript is overall an elegant example of how single-cell RNAseq can be employed as tool to study the impact of genetic modulators of neurodegeneration (in this case tau) and that it allows direct comparison with human tissues. The results are clean, logically presented and accordingly discussed. It shows that such approaches are indeed powerful for genetic dissection of mechanisms at a descriptive level and opening doors for functional studies.
We thank the reviewer for this positive summary of our manuscript.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
The goal of the authors was to understand how the kinase, hpk-1, could regulate and interrogate different aspects of cellular stress resilience. To this end, the authors uncovered that hpk-1 is coexpressed with several transcription factors known to regulate different stress responses and this coregulation only appears to occur in the nervous system. Taking a deeper dive, they convincingly find that hpk-1 overexpression in either serotonergic of GABAergic neurons can protect animals from heat stress or toxic protein aggregates. Interesting, it appears that hpk-1 functions in serotonergic neurons differently from GABAergic neurons in the induction of the heat shock response and autophagy.
Overall, the experiments and results are solid and the conclusions drawn reflect the result. The model suggests that the receiving cell deciphers that either heat shock response or autophagy can be induced in the same cell, but the data suggest otherwise. Perhaps the model should be reworked to reflect this point.
We thank the reviewer for their kind assessment and suggestion to refine our model. Indeed, we did not intend to imply that that the receiving cell/tissues were the same after each stimulus, but were attempting to simplify the diagram and condense space. In the revised manuscript we have altered the model (Figure 9B) to reflect that the recipient tissues are distinct.
Reviewer #2 (Public Review):
Lazaro-Pena et al. investigated how a conserved kinase called homeodomain interacting protein kinase (HPK-1), helps to preserve neuronal function, motlity and stress resilience during aging in the metazoan, C. elegans. HPK-1 is a member of the HIPK kinases that, in mammalian systems, regulate the activity of transcription factors (TFs), chromatin modifiers, signaling molecules and scaffolding proteins in response to cellular stress. The group finds that in C. elegans, HPK-1 depletion causes a premature shortening of lifespan and decreases motility and stress resilience in the whole animal. Conversely, increasing active, but not enzymatically dead, HPK-1 levels in the nervous system alone is sufficient to extend lifespan and mitigate the accumulation of aging-associated protein aggregates. The authors then identify a subset of neurons and cell stress response pathways that could be responsible for the contribution of HPK-1 to lifespan and neuronal health. This leads the authors to propose a hypothesis whereby HPK-1 activity in specific neurons preserves protein homeostasis and neuronal integrity, and thus limits the aging-induced decline in organismal function.
Overall, the authors test several functional readouts for neuronal activity to support their claim that HPK-1 activity limits functional decline during aging. These experiments are solid, and the use of a kinase dead HPK-1 in these experiments adds strong support to their claim that HPK-1 activity preserves organismal health. However, weaknesses in the experimental layout and rigor, and the statistical analyses of the publicly available data, limit the inferences that can be made, and further experimental evidence would be required to confirm the working model proposed by the authors.
We thank the reviewer for their thoughtful and balanced assessment of our study.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
The authors would like to thank the reviewers and editors for this thorough and constructive assessment of our paper. We look forward to addressing their suggestions for improvement of our work in a revised manuscript. In particular: (i) Reviewer 1 raises interesting questions regarding the potential impact of intrinsic cortical and mesh morphology on interpolation, smoothing and the resultant patterns of gene expression. We will test these ideas by developing a null model framework. (ii) Reviewer 2 suggests re-creating dense expression maps using an alternative Gaussian Processes for interpolation. We will implement this suggestion and compare the resulting maps with those generated by the current interpolation method. Notwithstanding these helpful lines of further enquiry, we believe our study provides a meaningful step forwards in multiscale analysis of the human brain by generating. validating, describing and annotating dense gene expression maps which can accelerate translation between neuroimaging and genomic analysis of the human cortical sheet.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
We thank the Reviewer for their comments.
Reviewer #2 (Public Review):
1) In Figure 4, the authors injected a retrograde tracer in the NA and an anterograde tracer in DCN to find potential "nodes" of overlap. From this experiment, the authors identify the VTA and regions of the thalamus as potential areas of tracer overlap, but it is unclear how many other brain regions were examined. Did the authors jump straight to likely locations of overlap based on previous findings, or were large swaths of the brain examined systematically? If other brain regions were examined, which regions and how was this done? A table listing which brain regions were examined and the presence/intensity of ctb-Alexa568 and GFP fluorescence would be helpful.
We thank the Reviewer for their comments. Exhaustive characterizations of inputs into nucleus accumbens (NAc) as well as of direct outputs of the deep cerebellar nuclei (DCN) have appeared elsewhere (e.g, Ma et al., 2020 doi: 10.3389/fnsys.2020.00015; Novello et al., 2022 doi: 10.1007/s12311-022-01499-w). Our anatomical investigations with retrograde and anterograde tracers were focused on putative intermediary nodal regions with robust inputs from the DCN, clear outputs to NAc, and limbic functionality. Only a handful of brain regions fulfill these criteria, and from those, we chose to target the VTA and intralaminar thalamus based on the observation that cerebellar activation induces dopamine release in the NAc medial shell and core (Holloway et al., 2019 doi: 10.1007/s12311-019-01074-w; Low et al., 2021 10.1038/s41586-021-04143-5) and on our previous work on DCN projections to the midline thalamus (Jung et al., 2022 doi: 10.3389/fnsys.2022.879634).
2) In Figure 5, the authors inject AAV1-Cre in DCN and AAV-FLEX-tdTomato in VTA or thalamus. This is an interesting experiment, but controls are missing. An important control is to inject AAV-FLEX-tdTomato in the VTA or thalamus in the absence of AAV1-Cre injection in DCN. Cre-independent expression of tdTomato should be assessed in the VTA/thalamus and the NA.
We thank the reviewer for bringing up this important control. We routinely perform this control experiment to test for any “leakiness” of floxed vectors prior to use but we did not include it in the paper. In response to the Reviewer’s comment, we show results from this control below. Briefly, we performed a large injection (300 nl) of AAV-FLEX-tdTomato in the thalamus area together with AAV-EGFP (to visualize the injection). No Cre-expressing virus was injected anywhere in the brain. PFA-fixed brain slices were obtained at 3 weeks post-injection and imaged for EGFP and tdTomato. Author Response Figure 1 shows images of the injected thalamus area. No tdTomato expression (Fig. 1C, red) was observed despite abundant EGFP expression (Fig. 1B, green), which confirms that in the absence of Cre the floxed construct does not “leak”.
Author Response Figure 1 (related to Fig. 5 of manuscript). Control experiment for “leakiness” of floxed tdTomato. A, Epifluorescence image of thalamus region in brain slice with EGFP (green) and tdTomato (red) channels merged. Gain settings in the red channel were increased intentionally, to ensure detection of any “leaky” cells. B, Cellular EGFP expression marks successful viral injection. C, No cellular expression of tdTomato without Cre. Note diffuse red signal from background fluorescence.
Reviewer #3 (Public Review):
1) The novelty of this paper lies in the mapping of projections from the interposed and the lateral nuclei of the cerebellum, as the authors themselves mention. However, in some of the experiments the medial nucleus is also clearly injected (Fig. 4B and 6B). In those experiments, it is impossible to distinguish which nucleus these projections come from, and they could be the ones from the medial nucleus that were previously described (see above).
We thank the Reviewer for their comments. As stated in the Results and in the legend of Fig. 4, in addition to experiments with injections in all DCN (Fig. 4B-D), we also performed experiments with injections in only the lateral nucleus (Fig. 4E and F). The results of these experiments support the existence of lateral DCN projections that overlap with NAc-projecting neurons in VTA and thalamus. This finding is further corroborated by our transsynaptic experiments with lateral DCN-only injections (Fig. 5E,F). Regarding the optophysiological experiments, as mentioned in the Results, all DCN were injected (Fig. 6B) in order to maximize ChR2 expression and the chances of successful stimulation of projections.
2) A strength of the paper is the use of both electrical and optogenetic stimulation. However, the responses to the two in the NAc are very different - electrical stimulation results in both excitation and inhibition, whereas opto stimulation mostly results in only excitation.
We thank the Reviewer for this comment. At least two different explanations could account for the observed differences in the prevalence of inhibitory responses elicited by optogenetic vs electrical stimulation: i) inhibitory response prevalence is sensitive to stimulation intensity (Table 1 and Fig. 2B). Because of inherent differences between optogenetic and electrical stimulation, it is not possible to directly compare intensities between the two modalities in order to determine at which intensities, if at all, the prevalence of responses should match. The observation that, at least in the VTA, the prevalence of inhibitory responses elicited by 1 mW light intensity (the lowest intensity that we tested) was comparable to the prevalence of inhibitory responses elicited by 100 µA electrical stimulation is in line with this explanation; ii) DCN electrical stimulation is not node-specific. To our knowledge, there is currently no evidence to support mesoscale topographic organization in lateral and interposed DCN that is node-specific. Consequently, electrical stimulation of DCN could, in principle, result in NAc responses through various polysynaptic pathways and/or nodes. This possibility would still exist even if electrical stimulation had limited spread of a few hundred microns (as in our experiments) and is at least partly supported by the observed long latencies of electrically-evoked inhibitory responses (NAcCore: 268 ± 25 ms (10th percentile: 42 ms), NAcMed: 259 ± 14 ms (10th percentile: 60 ms). Our recognition of this intrinsic limitation of DCN electrical stimulation was the impetus behind the node-specific optogenetic experiments.
3) The stimulation frequency at which the electrical stimulation in Fig 1 is done to identify responses in the NAc is 200 Hz for 25 ms. Is this physiological? In addition, responses in the NAc are measured for 500 ms after, which is a very long response time.
Regarding stimulation frequency, DCN neurons readily reach firing rates between 100-200 Hz in vivo and ex vivo (e.g., Beekhof et al., 2021 doi.org/10.3390/cells10102686; Sarnaik & Raman, 2018 doi:10.7554/eLife.29546; Canto et al., 2016 doi:10.1371/journal.pone.0165887). Regarding the duration of the response window, at the outset of our experiments we were agnostic to the type of responses that our stimulation protocols would evoke in NAc. We therefore established a response time window that would allow us to capture both fast neurotransmitter-mediated responses as well as neuromodulatory (e.g., dopaminergic) responses, which are known to occur at hundred-millisecond latencies or longer (Wang et al., 2017 doi.org/10.1016/j.celrep.2017.02.062; Chuhma et al., 2014 doi:10.1016/j.neuron.2013.12.027; Gonon, 1997). A posteriori analysis indicated that even if we reduced the response time window by 50%, the ratio of DCN-evoked excitatory vs inhibitory responses in NAc would not change substantially (E/I500: 4.3 vs E/I250: 5).
4) Previous studies have described how different cell types within the DCN have different downstream projections (Fujita et al. 2020). However, the experiments here bundle together all this known heterogeneity.
We agree with the Reviewer that dissecting the contributions of specific DCN cell types to NAc circuits is an important next step, which we are excited to undertake in future studies. Here we have broken new ground by identifying for the first time nodes and functional properties of DCN-NAc connectivity. Performing these studies with DCN cell type-specificity was not justified or feasible, given that the molecular identity of participating DCN neurons is currently unknown.
5) Previous studies have also highlighted the importance of different cell types within the NAc and how input streams are differentially targeted to them. Here, that heterogeneity is also obscured.
Along the same lines as #4, we agree with the Reviewer about the importance of examining the cellular identity of NAc neurons that participate in DCN-NAc circuitry. We are excited to undertake these examinations using ex vivo approaches, which are well suited to dissect cellular and molecular mechanisms.
6) In Fig. 4C, E and F, the experiments on overlap between anterograde and retrograde tracers are not particularly convincing - it's hard to see the overlap.
We thank the reviewer for this comment and have included revised figure panels 4C5, E3, Author Response Figure 1 and Figure 2 below. Single optical sections with altered color scheme and orthogonal confocal views are presented in order to show the overlap between DCN projections and NAc-projecting nodal neurons more clearly. The findings of these imaging experiments are corroborated by the results of our transsynaptic labeling approach (Fig. 5), which we have validated elsewhere (Jung et al., 2022 doi:10.3389/fnsys.2022.879634; and Author Response Figure 1).
Author Response Figure 2 (related to Fig. 4 of manuscript). Co-localization of NAc-projecting neurons with DCN axonal projections in VTA and thalamus. A-D, Single optical sections and orthogonal views are shown. Green: EGFP-expressing DCN axons; white: ctb- Alexa 568; red: anti-TH (A-B; VTA) or NeuN (C-D; thalamus). White arrows in orthogonal views point to regions of overlap.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
First, we thank the reviewer for his instructive remarks. In the following we address the queries of Reviewer 1.
1.1) At several points, the authors make claims that I believe extend beyond the data presented here. For instance, in the Abstract (line 27), the authors state "the development of adult songs requires restructuring the entire HVC, including most HVC cell types, rather than altering only neuronal subpopulations or cellular components." The gene ontology analyses performed do suggest that there is a progression from cellular transcriptional changes to organ-level changes, however caution should be taken in claiming that "most HVC cell types" exhibit transcriptional changes. In fact, according to Fig. 3D most of the transcriptional changes appear restricted to neurons. As the authors themselves note elsewhere, claims at this resolution are difficult without support from single-cell approaches. I do not suggest that the authors need to perform single-cell RNA-seq for this work, but strong claims like this should be avoided.
We have revised our claim to more accurately reflect our findings. Our intended message is that testosterone treatment leads to extensive transcriptional changes in the HVC, likely affecting a majority of neuronal subpopulations rather than solely targeting specific cellular components. The revised text in lines 29-32 now reads: "Thus, the development of adult songs stimulated by testosterone results in widespread transcriptional changes in the HVC, potentially affecting a majority of neuronal subpopulations, rather than altering only specific cellular components."
1.2) Similarly the Abstract states that parallel regulation "directly" by androgen and estrogen receptors, as well as the transcription factor SP8, "lead" to the transcriptional and neural changes observed after testosterone treatment of females. However, experiments that demonstrate such a causal role have not been performed. The authors do perform a set of bioinformatic analyses that point in this direction - enrichment of androgen and estrogen receptor binding sites in the promoters of differentially expressed genes, high coexpression of SP8 with other genes, and the enrichment of predicted SP8 binding sites in coexpressed genes. However, further support for direct regulation, at the level that the authors claim, would require some form of transcription factor binding assay, e.g. ChIP-seq or CUT&RUN. I am fully aware that these assays are enormously challenging to perform in this system (and again I don’t suggest that these experiments need to be done for this work); however, statements of direct regulation should be tempered. This is especially true for the role of SP8. This does appear to be a compelling target, but without some manipulation of the activity of SP8 (e.g. through knockdowns) and subsequent analysis of gene expression, it is too much to claim that this transcription factor is a regulatory link in the testosterone-driven responses. SP8 does appear to be a highly connected hub gene in correlation network analysis, but this alone does not indicate that it acts as a hub transcription factor in a gene regulatory network.
We appreciate the reviewer's comment and have revised the statement concerning the role of SP8. Indeed, we document the coexpression of ESR2 and SP8, and our bioinformatics analysis suggests that SP8 might play an important role in transcriptomics. We have rephrased the statement in line 29-32 as follows: "Parallel gene regulation directly by androgen and estrogen receptors, potentially amplified by coexpressed transcription factors that are themselves steroid receptor regulated, leads to substantial transcriptomic and neural changes in specific behavior-controlling brain areas, resulting in the gradual seasonal occurrence of singing behavior." In addition, we have included discussions regarding limitations of promoter sequence analyses (lines 414 to 427).
1.3. Along these lines, the in-situ hybridizations of ESR2 and SP8 presented in Figure 5 need significant improvement. The signals in the red and green channels, SP8 and ESR2, look suspiciously similar, showing almost identical subcellular colocalization. This signal pattern usually suggests bleed-through during image acquisition, as it’s highly unlikely that the mRNA of both genes would show this degree of overlap. I would suggest that control ISHs be run with one probe left out, either SP8 or ESR2, and compare these ISHs with the dual label ISHs to determine if signal intensity and cellular distribution look similar. Furthermore, on lines 354-356 the authors write, "The fact that the two genes were expressed nearby in the same cell may indicate physical interactions between the gene pair and warrant further investigation into the nature of their relationship.". Yet, even if the overlap between ESR2 and SP8 shown in Figure 5 is confirmed, close localization of transcripts does not imply that the protein products physically interact. The STRING bioinformatic analysis is more convincing that there is a putative regulatory interaction between ESR2 and the SP8 locus, and this suggestion of protein-protein interaction is weak and should be omitted. In addition, the authors note that ESR2 has not been detected in the songbird HVC in a previous study. To further demonstrate the expression of ESR2 (and SP8) in HVC, it would be useful to plot their expression from the microarray data across the different testosterone conditions.
We repeated the coexpression study using confocal microscopy and fluorescent RNAScope in situ hybridization, which is now reflected in the revised Figure 5 and a new Figure 5 - Supplement Figure 1. We have also moderated our statement regarding the sparse co-expression of ESR2 and SP8 in HVC neurons. While the presence of co-expressing neurons may provide some anatomical basis for the bioinformatic findings, we have been cautious in our interpretation and have stated that "SP8 and ESR2 mRNAs exhibited low expression levels in HVC, co-localizing in a subset of cells, predominantly GABAergic cells" (lines 369-370). We have removed the speculation about potential protein interaction based on mRNA distribution. Additionally, we have highlighted that SP8 and ESR2 were differentially upregulated at T14d (lines 362-363).
1.4) My final concern lies in the interpretation of these results as generalizable to other sex hormone-modualated behaviors. On lines 452-455, the authors write, "This suggests that the testosterone (or estrogen)-triggered induction of adult behaviors, such as parental behavior and courtship, requires a much more extensive reorganization of the transcriptome and the associated biological functions of the brain areas involved than previously thought.". The experiments and argument likely apply to other neural systems to undergo large seasonal fluctuations in sex hormones and similar morphological changes. However, the authors argue that the large number of transcriptional changes seen here may generalize broadly to sex hormone modulated adult behaviors. I think there are a couple of problems with this argument. First, as described here and in past work, testosterone drives major morphological changes the song system of adult canaries; such dramatic changes are not seen for instance in sex hormone-receptive areas underlying mating behavior in adult mammals. Similarly, the study introduced testosterone into female birds which drives a greater morphological change in HVC relative to similar manipulations in males, which again may account for the large number of differentially expressed genes. I would temper the generality of these results and note how the experimental and biological differences between this system and other sex hormone-responsive systems and behaviors may contribute to the observed transcriptional differences.
We modified this statement in lines 473-478: “The testosterone-driven changes in female HVC morphology and function represent some of the most notable modifications known in the vertebrate brain. However, how this extensive, testosterone-induced gene regulation in the HVC applies to other seasonally testosterone-sensitive brain areas remains to be seen. Endpoint analysis of testosterone-induced singing in male canaries during the non-reproductive season also indicates considerable regulation of HVC transcriptomes (Frankl-Vilches et al., 2015; Ko et al., 2021)”.
Reviewer #2 (Public Review):
First, we would like to express our gratitude to Reviewer #2 for the constructive feedback. We have addressed the concerns in detail below:
2.1). The bulk of the manuscript details WGCNA, GO terms, and promoter ARE/ERE motif abundance, using the initial pairwise comparisons for each timepoint as input lists. However, there are no p/adjp values provided for these pair-wise comparisons that form the basis of all subsequent analyses. Nor are there supplementary tables to indicate how consistent the replicates are within each group or how abundantly the genes-of-interest are expressed. With the statistical tests used here, and the lack of relevant information in the supplementary tables, I cannot determine if the data support the authors’ conclusions. These omissions mar what is otherwise a conceptually intriguing line of investigation.
We appreciate the reviewer’s concerns. Please refer to our response addressing this point and the subsequent one (2.2) together in the section below.
Reviewer #3 (Public Review):
We appreciate the positive feedback from the reviewer and below addressed the issues pointed out by the reviewer.
3.1) My biggest concern is the sample size. Most of the time points only have 5 or 6 individuals represented, and I question whether these numbers provide sufficient statistical power to uncover the effects the authors are trying to explore. This is a particular problem when it comes to evaluating the supposed "transient" of testosterone on gene expression. There is currently little basis for distinguishing such effects from noise that accrues because of low power. This can be a major problem with studies of gene expression in non-model species, like canaries, where among-individual variability in transcript abundance is quite high. Thus, it is possible that one or two outliers at a given time point cause the effect testosterone at this time point to become indistinguishable from the controls; if so, then a gene may get put into the transient category, when in fact its regulation was not likely transient.
We acknowledge that our sample sizes may appear moderate. To address the concern regarding temporal regulation analysis, we followed Reviewer 3's suggestion and conducted a probe-level power analysis (point 2 of recommendations for the authors; labelled as point 3.9 below). We then excluded differentially expressed genes with a power less than 0.8 prior to conducting temporal classification. Consequently, 93% of our differentially expressed genes demonstrated a power ≥ 0.8 (9025/9710). Following further classification by temporal regulation pattern, we identified 29 constantly upregulated, 41 constantly downregulated, 39 dynamically regulated, and 8916 transiently regulated genes. If we apply a stricter constraint by requiring each differentially expressed gene to have at least two probe-sets with a power ≥ 0.8, 83% of differentially expressed genes (8033/9710) still have sufficient power.
We recognize that our sample size may not be sufficient to detect weakly differentially expressed genes. However, we have intentionally excluded these genes from the beginning (those with |log2(fold change)| ≤ 0.5 were excluded).
The scenario outlined by the reviewer, where outliers might cause the effect of testosterone to blend with controls, leading to misclassification, is indeed plausible. This could occur either because the genes are weakly regulated, or because the power to detect differential expression is insufficient, thus preventing these genes from surpassing the threshold to be deemed significantly differentially expressed. However, this also illustrates that the effect of testosterone does not regulate every gene in the same way.
We have appended a column indicating high power genes (≥ 0.8) in the DiffExpression.tsv file, available in the Dryad repository. The power analysis has been incorporated to the method section at lines 801-808 and result section at lines 188-192.
3.2) More on the transient categorization. Would a gene whose expression is not immediately upregulated (within 1 hour), but is upregulated later on (say in the 14d group) be considered transient? If so, this seems problematic. Aren’t the authors setting the null expectation of "non-transient" as a gene that does not increase immediately after 1 hour of treatment? The authors even recognize that it is quite surprising that gene expression changes after an hour. It may be that some genes whose regulation is classified as transient are simply slower to upregulate; but, really, would we say their expression in transient per se? Maybe I’m misunderstanding the categorizations?
We appreciate the reviewer's insightful discussion regarding the transient categorization. We understand that it is indeed more challenging for a gene to be classified as constantly regulated than transiently regulated, due to smaller effects by testosterone or being undetectable owing to low power. To address this concern, we further dissected the transiently regulated category by reporting the number of time points at which a gene is differentially expressed in Figure 2 - Figure supplement 1. Approximately half of the transiently regulated genes were only regulated at one time point, further illustrating that the effect of testosterone on gene expression was not constant during the time window we examined (see lines 184 - 187).
3.3) The authors don’t fully explain the logic for using females in this study to measure a "male-typical" behavior (singing). My understanding is that females have underlying circuitry to sign, and T administration triggers it; thus, this situation that creates a natural experiment in which we can explore T’s on brain and behavior, unlike in males which have fluctuating T. First, it might be good to clarify this logic for readers, unless perhaps I’m misunderstanding something. Second, I found myself questioning this logic a little. Our understanding of basic sex differences and the role that steroid hormones play in generating them has changed over the last few decades. There are, for example, a variety of genetic factors that underlie the development of sex differences in the brain (I’m especially thinking about the incredible work from Art Arnold and many others that harness the experimental power of the four core genotype mice). Might some of these factors influence female development, such that T’s effects on the female brain and subsequent ability to increase HVC size and sing is not the same as males.
Indeed, sex-chromosome dosage compensation is absent in birds leading to higher Z-chromosomal gene expression in males. We demonstrated substantial sex differences in gene expression in our earlier work [Ko, M.-C., Frankl-Vilches, C., Bakker, A., Gahr, M., 2021. The Gene Expression Profile of the Song Control Nucleus HVC Shows Sex Specificity, Hormone Responsiveness, and Species Specificity Among Songbirds. Frontiers in Neuroscience 15].
We have revised the introduction (lines 96-98) to clarify our rationale for using female canaries as a model for adult behavioral development, not as a model for male canaries. After testosterone treatment, these females start to sing, with song structure developing over time, similar to male seasonal progression. This approach eliminates the confounding effect of fluctuating testosterone levels seen in males, supported by distinct HVC transcriptomes in testosterone-implanted singing female canaries compared to males (Ko et al., 2021).
The revised paragraph reads as below: Female canaries (Serinus canaria) are typically non-singers, with their spontaneous songs displaying less complexity than their male counterparts (Hartley et al., 1997; Herrick and Harris, 1957; Ko et al., 2020; Pesch and Güttinger, 1985). Despite their infrequent singing, these females possess the necessary underlying circuitry that can be activated by testosterone. Following testosterone treatment, these females start to produce simple songs, which gradually evolve in structure over weeks—paralleling the seasonal progression of male singing (Hartog et al., 2009; Ko et al., 2020; Shoemaker, 1939; Vallet et al., 1996; Vellema et al., 2019). Moreover, testosterone induces the differentiation of song control-related brain nuclei in adult female canaries, a critical step for song development (Fusani et al., 2003; Madison et al., 2015; Nottebohm, 1980). In this study, we focus on these testosterone-treated female canaries as a model for adult behavioral development rather than a model for male canaries. This unique model allows us to examine transcriptional cascades in parallel with the differentiation of the song control system and the progression of song development, without the confounding impact of fluctuating testosterone levels seen in males, which often results in considerable individual differences in the non-reproductive season baseline singing behavior. This approach is backed by the observation that the HVC transcriptomes of testosterone-implanted singing female canaries are distinct from those of singing males (Ko et al., 2021).
3.4) I was surprised by the authors assertion that testosterone would only influence several tens or hundreds of genes. My read of the literature says that this is low, and I would have expected 100s, if not 1,000s, of genes to be influenced. I think that the total number of genes influenced by T is therefore quite consistent with the literature.
We apologize for any confusion caused by our statement. We did not mean to imply that testosterone only influences several tens or hundreds of genes, but rather that we did not expect such an extensive transcriptional regulation in the HVC by testosterone. We have clarified this in our revised manuscript, specifically in lines 450-451. Thank you for helping us to clarify this point.
3.5) I found the GO analyses presented herein uncompelling. As the authors likely know, not all GO terms are created equally. Some GO terms are enriched by hundreds of genes and thus reflect broad functional categories, whereas other GO terms are much more specific and thus are enriched by only a few genes. The authors report broad GO terms that don’t tell us much about what is happening in the HVC functionally. This is particularly the case when a good 50% of the genome is being differentially regulated.
We appreciate the reviewer's comment. We have added KEGG pathway enrichment analysis in Figure 3 - Figure supplement 1 as an alternative. However, we believe that the GO term enrichment results still provide valuable insights, and therefore we have retained them in Fig. 3.
3.6) The Genomatix analyses are similarly uncompelling. This approach to finding putative response elements can uncover many false positives, and these should always be validated thoroughly. Don’t get me wrong-I appreciate that these validations are not trivial, and I value the authors response element analysis.
We appreciate the reviewer's comment on the presence of AR or ER motifs in promoters and acknowledge that in mammals, AR and ER predominantly bind at distal enhancers rather than promoters. Our analysis focused on promoter regions due to the limitations of available tools and resources for our study species. We understand that this approach may not capture the full complexity of AR and ER regulation. We have revised our manuscript to note the limitations of our approach and clarify that the presence of AREs and EREs alone is not indicative of active receptor binding or direct regulation (lines 416-427).
3.7) I’m sceptical about the section of the paper that speculates about modification of steroid sensitivity in the HVC. These conclusions are based on analyses of mRNA expression of AKR1D1, SRD5A2, and the like. However, this does not reflect a different in the capacity to metabolize steroids, or at least there is little evidence to suggest this. Note that many of these transcripts have different isoforms, which could also influence steroidal metabolism.
We agree that mRNA expression levels of AKR1D1, SRD5A2, and other transcripts involved in steroid metabolism do not necessarily reflect changes in steroid metabolizing capacity. However, we believe that these changes in mRNA expression are indicative of potential changes in steroid sensitivity in the HVC, which could affect the neural response to steroids. We acknowledge that isoform differences of these transcripts may influence steroid metabolism and further studies are necessary to confirm our findings and elucidate the mechanisms underlying the observed changes in gene expression. In response to this comment, we have amended the text in lines 245-249 to reflect this consideration.
-
-
www.medrxiv.org www.medrxiv.org
-
Author Response
Reviewer #1 (Public Review):
The authors have compiled and analysed a unique dataset of patients with treatment-resistant aggressive behaviours who received deep brain stimulation (DBS) of the posterior hypothalamic region. They used established analysis pipelines to identify local predictors of clinical outcomes and performed normative structural and functional connectivity analyses to derive networks associated with treatment response. Finally, Gouveia et al. perform spatial transcriptomics to determine the molecular substrates subserving the identified circuits. The inclusion of data from multiple centres is a notable strength of this retrospective study, but there are current limitations in the methodology and interpretation of findings that need to be addressed.
1) The validation of findings is heterogeneous and inconsistent across analysis pipelines. While the authors performed non-parametric permutation testing during sweet-spot mapping, structural and functional connectivity were validated using a 'four-fold consistency analysis'. The latter consists of a visual representation of streamlines and peak intensities after randomly dividing data into four groups, the findings were not validated quantitatively. If possible, the authors should apply permutation analysis in alignment with sweet-spot mapping and demonstrate the predictive ability of their identified networks in a LOO or k-fold cross-validation paradigm as carried out by similar studies. Given that the data has been derived from multiple centers, the prediction of left-out cohorts based on models generated by the remaining cohorts could be another means of validation. If validation is not possible, the authors should clearly state the limitations of their approach.
We appreciate the comment. We have now improved the validation of our connectomics analyses and removed the four-fold consistency analysis. For the functional connectivity analysis, we performed a 1000 permutation test (p<0.05). Similar brain areas were detected in the corrected and uncorrected maps. For the structural connectivity analysis, we used False Discovery Rate (FDR) correction at a significant level of p<0.001, as it is not feasible to perform a 1000 permutation test with this data. The structural connectome is composed of 12 million fibres, and every single permutation takes approximately 4 hours to be completed using our most powerful computational system. To perform 1000 permutations, it would take at least 4000 hours (i.e. 167 days or 5.5 months) of uninterrupted analysis to complete the test. However, it is important to highlight that an FDR correction at the level of p<0.001 is an extremely stringent method. This means that of the 23,000 fibres detected as being touched by the VATs, only 23 would be incorrect, while the remaining 22,977 are correct. Here again, we observed many similarities between the uncorrected and corrected maps, with the main anatomical structures being detected in both. The Methods section and Figures 4 and 5 were revised to reflect these changes.
2) In addition to a 'four-fold consistency analysis', functional connectivity was evaluated using LOOCV in a priori identified ROIs. Their network analysis, however, revealed a far more extensive network encompassing cortical, subcortical, and cerebellar structures. To avoid selection bias the authors should incorporate identified structures into their analysis and apply appropriate means of validation.
We thank the reviewer for this valuable suggestion. We originally did not explore the various significant areas but performed a more focused analysis intended to demonstrate that regions of the known ‘aggression network’ are indeed implicated in our findings. We performed a new analysis exploring the correlation between symptom improvement and the functional connectivity of all the areas described in Figure 5 (i.e., functional connectivity map). To this aim, we extracted individual connectivity values from the peak within each significant region and performed the same additive linear model, incorporating the functional connectivity of each area as well as the age of the patients to estimate individual symptomatic improvement. In addition, we performed a complete exploratory analysis considering the connectivity of any 2 brain structures and age. The resulting matrix shows to what extent functional connectivity to any two areas can be used to estimate clinical outcomes. Interestingly, this new analysis revealed the Periaqueductal Grey matter (PAG) to be the most important functionally connected area when investigated alone or in combination with brain structures critically involved in the regulation of emotional responses, namely the amygdala, anterior cingulate cortex, bed nucleus of the stria terminalis, nucleus accumbens, orbitofrontal cortex and fusiform gyrus. Also, the significance of the PAG connectivity was retained during leave-one-out cross-validation (LOOCV). The Methods, Results, Discussion and Figure 6 were revised. In addition, we added a new Table 2 and Supplementary File 1 to describe the new analysis and results.
3) Functional connectivity mapping: how were R-maps generated? The authors mention that patient-specific R-maps were p-thresholded and corrected for multiple comparisons, but it is not clear how group-level maps were generated. How did the authors perform regression on these maps? Were voxels that did not survive thresholding excluded?
This is a multiple-step analysis. First, it is necessary to localize the electrodes in each patient’s brain and estimate the volume of activated tissue (VAT) observed when stimulation parameters associated with symptomatic improvement are used. The VATs are then used as seeds for the next steps, during which we investigate how much functional influence the VTAs have on the other areas of the brain (i.e., individual r-map). This is done by correlating the BOLD time course of the VAT’s seed with the BOLD time course of all other voxels in the brain. The individual r-maps are then corrected for multiple comparisons to exclude voxels with potentially spurious correlations, resulting in an individual r-map that only included voxels surviving Bonferroni correction at the level of p<0.05. Finally, to create group-level maps, a voxel-wise linear regression analysis was performed to investigate whether each voxel of the map exerts more or less influence (corrected individual r-map with the functional connectivity of the patient’s VAT) or is more or less related to the clinical outcome (i.e. individual improvement). The last step is a permutation correction resulting in a significant group-level functional connectivity map (ppermute<0.05). We modified the Methods section and added a new Figure 1-figure supplement 1 illustrating this analysis.
4) The authors determined that age was a significant prédictor of the outcome, but it is unclear whether certain age groups presented with distinct etiologies underlying their aggressiveness. For example, aggression in epilepsy may show a better response to DBS as opposed to schizophrenia. How does patient outcome change when stratifying according to etiology? How does model performance change when controlling for etiology? The authors should include the etiology of aggressiveness in Table 1.
This is an interesting point. We observed a similar distribution between the pediatric and adult populations in relation to the most common etiologies reported. Epilepsy was the most frequent diagnosis in both populations (pediatric: 50%, adult: 62%), followed by autism spectrum disorder (pediatric: 34%, adult: 24%). The remaining etiologies were largely composed of single cases. A similar proportion of intellectual disability was also observed in pediatric and adult populations. Severe cases were observed in 75% of pediatric and 85% of adult patients. Moderate disability was present in 25% of pediatric and 15% of adult patients. Since several diagnoses were unique to some patients, the addition of this information to Table 1 could result in the identification of the patient. Thus, to preserve anonymity, the diagnoses were added to the end of Table 1 from more to less frequent. We have also revised the Results and Discussion sections to address this concern.
5) Stimulation parameters. The authors report average pulse widths of 219 µs and 142µs respectively, which is up to 4-fold higher as compared to DBS settings used conventionally in movement disorders and will significantly alter the volume of activated tissue. Did the authors account for the drastic increases in pulse width during VAT modeling?
We thank the reviewer for raising this point about the volume of activated tissue (VAT) modelled and the unusual pulse width observed in some patients in this cohort. These patients presented stimulation-induced sympathetic side effects when DBS was set with higher frequencies (e.g. increased heart rate and blood pressure). The chosen final parameters were the ones associated with a clinical benefit without generating side effects. There are a multitude of ways to estimate the VATs, from advanced axon cable models – the gold standard, which simulate axon membrane dynamics and require patient-specific diffusion-weighted imaging and tremendous computing power 1 - to simple heuristics-based models that estimate the rough extent of a VAT based on stimulation parameters without constructing an actual spatial model 2–4. The model employed in our study (and in a number of previous publications by our group 5–10) was the FieldTripSimBio ‘E-field norm’ finite element method (FEM) model. This model, which was first described by Horn et al. 11 and is freely available in Lead-DBS (https://www.lead-dbs.org/), strikes a balance between the sophisticated axon cable models and the simpler heuristic models. In particular, it constructs an electric field (E-field, by applying an electric field strength threshold, or activation threshold) and calculates the VAT associated with specific voltage settings and contact configurations, taking into account the conductivity of surrounding brain tissue and electrode components. Notably, studies comparing VAT modelling techniques 12 showed that ‘E-field norm’ FEM models closely approximate (<0.1 mm difference) the gold standard axon cable models in terms of the size of VATs constructed for monopolar stimulation settings. However, it should be acknowledged that the FieldTripSimBio model in Lead-DBS does not allow the user to specifically enter values for pulse width. Instead, it employs a standard activation/electric field strength threshold (0.2 V/mm) that reflects a combination of commonly modelled axon diameters (roughly 3.5 μm) and pulse width values (i.e., 60-90 μs). This threshold is based on work by researchers such as Astrom et al. 13 and reflects a ‘middle ground’ value that takes into account the fact that any VAT model will necessarily be an imperfect approximation of how electrical stimulation interfaces with brain tissue, depending heavily on aspects such as the diameter of local axons. Nonetheless, it is certainly understood that increased pulse width does meaningfully increase the effective range of stimulation (thus translating to a larger VAT) by lowering the activation threshold of nearby axons 12.
Given that our patient cohort included a small number of patients who were stimulated with higher pulse widths than the values assumed by our model (90 μs), it is reasonable to wonder whether we underestimated the size of these patients’ VATs. To address this aspect, we modelled these patients’ VATs using a simpler heuristic model 2 that does allow specific pulse width values to be selected by the user. More specifically, we computed a range of VATs for these patients using varied pulse width values (ranging from 90 μs up to their actual values). Not surprisingly, this endeavour did yield larger VATs when higher pulse widths were used. On average, the absolute difference in VAT diameter between 90 μs and 450 μs (the largest pulse width observed in this cohort) versions of these patients’ VATs was 2 mm. To check whether or not this difference could have potentially impacted our results, we repeated our probabilistic mapping analysis using altered VATs (specifically, VATs that were enlarged by 2 mm in diameter) for the patients with higher pulse widths. This new repeat analysis yielded a very similar average map to the original analysis: the overall map pattern and location/values of the peak corresponding to the most efficacious area for maximal symptom alleviation remaining unaltered, and only a few voxels on the periphery of the map changing in value by a couple of percentage points. This new supplementary analysis indicates that our results were not meaningfully altered by the unusual pulse width observed in these patients. We modified the Methods section to address some of these aspects and added a new Figure 3-figure supplement 2 illustrating both voxel efficacy maps.
6) Imaging transcriptomics. The methods described lack detail: How did the authors account for differences in expression across donors, samples, and regions during preprocessing of the Allen Human Brain Atlas? How was expression data collapsed into regions of interest? Did the authors apply any normalization? Recent publications have introduced reproducible workflows for processing and preparing the AHBA expression data for analysis that is publicly available.
7) 'genes with similar patterns of spatial distribution to the TFCE map were compiled in an extensive list'. It is unclear why authors used TFCE maps for spatial transcriptomics as opposed to the functional connectivity map featured in Figure 5. How was similarity measured between the TFCE map and the AHBA? How were candidate genes identified? Please provide a more comprehensive description of the analysis pipeline.
We apologize for the short description of this analysis. We performed a gene set analysis using the abagen toolbox (https://abagen.readthedocs.io/en/stable/index.html) to investigate genes with a spatial pattern distribution similar to one of clinically relevant functional connectivity. For this analysis, we used the Allen Human Brain Atlas (https://alleninstitute.org/) microarray data describing the cortical, subcortical, brainstem and cerebellar localization of over 20,000 genes in the human brain (3702 anatomical locations from 6 neurotypical adult brains) 14–17, along with a cell-specific aggregate gene set 18. These data are provided preprocessed, with gene expression values normalized across all brains, and registered to standard MNI space, allowing for a direct comparison between the spatial pattern of gene expression and the functional connectivity map (https://human.brain-map.org/microarray/search) 15. The TFCE maps were used to create clusters of clinically relevant functional connectivity with a spatial extent that overlaps with the anatomical locations from which microarray data was obtained. We parcellated both datasets (results of functional connectivity analysis and Allen Gene Atlas) according to the Harvard-Oxford brain atlas and correlated the spatial distribution of gene expression with the spatial distribution of the results of the functional connectivity mapping. The resultant list of candidate genes was used as input in gene ontology tools to investigate the associated biological processes and cell types. It is important to highlight that this process involves 2 corrections for multiple comparisons using FDR at q<0.005; one correction occurs at the level of the gene list to include only the most significant genes in the gene ontology analysis; a second correction occurs at the level of the gene ontology analysis to consider only the most significant biological processes. We have included some of these details in the revised Methods section.
8) What do the bar plots in Figure 7 (left) represent? P-values? The authors should label the axes to make this clear to the reader.
9) Interprétation of imaging transcriptomics: The authors identify a therapeutic circuit associated with deep brain stimulation of the posterior hypothalamic area, however, it is unclear how to reconcile genes associated with hormones, inflammation, and plasticity in this context. The authors mention and discuss genes implicated in hormonal processing, specifically oxytocin. The results provided in Figure 7, however, do not support this finding and it is unclear how the authors identified genes linked to oxytocin. In addition, the authors identified reductions in the number of microglia and astrocytes, while oligodendrocytes were overexpressed relative to the expected distribution of genes per cell type. These findings were attributed to DBS effects, however, both connectomic and transcriptomic data are acquired from healthy subjects, which suggests a physiological deficit/enrichment in a therapeutic circuit. How do the authors interpret findings given that no electrode implantation and stimulation were performed?
The analysis of normative datasets (functional and structural connectomics and spatial transcriptomics) is based on the idea of better understanding mechanisms of treatment considering our current knowledge of the average human brain. Unlike patient-specific studies in which imaging is acquired from a single patient or genetic profiles are extracted from tissue samples, these normative analyses rely on high-quality “atlases” derived from healthy subjects. In the case of functional and structural connectivity, these atlases are calculated from very large cohorts of subjects (around 1000 brain scans). Thus, imaging connectomics investigates the pattern of brain activity and structural connectivity related to a specific area of the brain (in this case, the volume of tissue activated (VATs) with DBS) and correlate these data with clinical outcomes to shed light on potential mechanisms of action. Similarly, the spatial transcriptomic analysis identifies spatial correlations between patterns of gene expression and brain characteristics detected by MRI 19 (in this case, the spatial pattern of functional connectivity) to investigate possible genetic underlying mechanisms. It is important to highlight that previous studies have shown that normative analyses yield results that are similar to the ones observed using patient-specific data 20–22. In the specific case of imaging connectomics, It has been shown that normative datasets can be used to create probabilistic models of optimal connectivity associated with patients’ outcomes that are meaningful to predict outcomes in patient-specific connectivity data 21. Thus, these exploratory data-driven approaches strive to simulate the presumed fingerprint that a particular patient’s individualized DBS intervention might modulate. They also allow the investigation of possible mechanisms of action in a large, previously inaccessible cohort of patients whose individual data are available. We apologize for the inaccuracy in Figure 7. Along with improving the Discussion section of the manuscript, we included the label for the bar plots in the left panel to improve the clarity of the graph and added the missing result from the KEGG 2021 Human Library that shows the oxytocin signalling pathway.
10) Data availability. Code used for data processing should be made openly available or shared as source data along with the Figures that were generated using the code. Sweet-spot, structural, and functional connectivity maps should be shared openly.
All tools and codes necessary for localizing the electrodes, estimating the volume of activated tissues, and analyzing imaging connectomics are freely available in Lead-DBS (https://www.lead-dbs.org/), a toolbox designed for DBS electrode reconstructions and computer simulations based on postoperative imaging. All codes for spatial transcriptomics are freely available in abagen (https://abagen.readthedocs.io/en/stable/), a toolbox designed to analyze the Allen Brain Atlas genetics data. Along with the codes, the websites for these tools provide manuals describing the step-by-step procedure for successful analysis. The datasets were made freely available at Zenodo (doi: 10.5281/zenodo.7344268). We improved our Data Availability Statement to address this concern.
Reviewer #2 (Public Review):
Deep brain stimulation (DBS) is an important, relatively new approach for treating refractory psychiatric illnesses including depression, addiction, and obsessive-compulsive disorder. This study examines the structural and functional connections associated with symptom improvement following DBS in the posterior hypothalamus (pHyp-DBS) for severe and refractory aggressive behavior. Behavioral assessments, outcome data, electrode placements, and structural and functional (resting-state) imaging data were collected from 33 patients from 5 sites. The results show structural connections of the effective electrodes (91% of patients responded positively) were with sensorimotor regions, emotional regulation areas, and monoamine pathways. Functional connectivity between the target, periaqueductal gray, and amygdala was highly predictive of treatment outcome.
Strengths.
This dataset is interesting and potentially valuable.
Weaknesses.
The figures seem to indicate that electrodes and symptom improvement is located lateral to the hypothalamus, perhaps in the subthalamic nucleus (STN). This is might explain why the streamlines from the tractography are strongest in motor regions. The inclusion of the monoaminergic based on the tractography is not warranted, as the resolution is not sufficient to demonstrate the distinction between the MFB (a relatively small bundle) and others flowing through this region to the brainstem.
This is an interesting point. The sweet spot identified in this work is indeed located in the posterior-inferior-lateral region of the posterior hypothalamic area, reaching the most superior part of the red nucleus, without including the STN. It is important to highlight that the voxel-efficacy mapping only shows voxels associated with a minimum of 50% symptomatic improvement following treatment. Thus, the areas not touching the red nucleus are also associated with excellent symptom alleviation. Although the structural connectivity mapping revealed tracts involved in motor and sensory information, it also showed tracts known to be involved in the regulation of emotions, such as the MFB, the Amygdalofugal Pathway and the ALIC. It is worth noting that this analysis is excellent for segregating the fibre tracts as relevant or not associated with a clinical improvement, but it is not capable of tearing apart the system to determine which of those are necessary for symptom alleviation. As a result, it is not possible to determine whether the motor projections are stronger or more relevant than others. However, the structural connectivity analysis presented here contributes to the body of knowledge on the network of aggressive behaviour and provides clinically relevant data that can be useful to improve future patient outcomes.
We agree with the reviewer that the engagement of the motor system is indeed highly relevant for the reduction of aggressive behaviours, as we have previously shown that aggressive behaviour is highly correlated with motor agitation 23,24. Additionally, in the context of ASD, self-injury behaviour is defined as a type of repetitive/stereotypic behaviour that results in physical injury to the patient’s own body. In relation to the involvement of the monoaminergic system, we would like to apologize for not being clear in the discussion of our findings. Although the functional and structural connectivity maps are related, they provide different means of exploring distinct aspects of the connectivity profile of each VAT. While the structural connectivity map may elucidate symptom improvement via direct fibre modulation (i.e. fibres that touch vs fibres that do not touch the VAT), the functional connectivity map investigates the functional dynamics of the network via BOLD signals (functional MRI). In this manuscript, we showed the functional connectivity (not fibre tracts) of the VATs with areas known to regulate monoamine production, such as the Raphe nuclei and the Substantia Nigra. Both serotonin and dopamine are critically involved in the control of aggressive behaviours, being the target of the main medications used to treat these symptoms in several patient populations. To address all the raised concerns, we incorporated a few sentences in the discussion, highlighting the relevance of the motor system and some limitations of our analysis. We also added a new Figure 3-figure supplement 1 and a discussion on the position of the sweet spot in relation to the red nucleus and subthalamic nucleus.
REFERENCES: 1. Gunalan, K., Howell, B. & McIntyre, C. C. Quantifying axonal responses in patient-specific models of subthalamic deep brain stimulation. Neuroimage 172, 263–277 (2018). 2. Dembek, T. A. et al. Probabilistic mapping of deep brain stimulation effects in essential tremor. Neuroimage Clin 13, 164–173 (2017). 3. Kuncel, A. M., Cooper, S. E. & Grill, W. M. A method to estimate the spatial extent of activation in thalamic deep brain stimulation. Clin. Neurophysiol. 119, 2148–2158 (2008). 4. Mädler, B. & Coenen, V. A. Explaining clinical effects of deep brain stimulation through simplified target-specific modeling of the volume of activated tissue. AJNR Am. J. Neuroradiol. 33, 1072–1080 (2012). 5. Elias, G. J. B. et al. Probabilistic Mapping of Deep Brain Stimulation: Insights from 15 Years of Therapy. Ann. Neurol. 89, 426–443 (2021). 6. Germann, J. et al. Brain structures and networks responsible for stimulation-induced memory flashbacks during forniceal deep brain stimulation for Alzheimer’s disease. Alzheimers. Dement. 17, 777–787 (2021). 7. Elias, G. J. B. et al. Mapping the network underpinnings of central poststroke pain and analgesic neuromodulation. Pain 161, 2805–2819 (2020). 8. Gouveia, F. V. et al. Case report: 5 Years follow-up on posterior hypothalamus deep brain stimulation for intractable aggressive behaviour associated with drug-resistant epilepsy. Brain Stimul. 14, 1201–1204 (2021). 9. Coblentz, A. et al. Mapping efficacious deep brain stimulation for pediatric dystonia. J. Neurosurg. Pediatr. 27, 346–356 (2021). 10. M Oliveira, L. et al. Probabilistic characterisation of deep brain stimulation in patients with tardive syndromes. J. Neurol. Neurosurg. Psychiatry (2021) doi:10.1136/jnnp-2020-324270. 11. Horn, A. et al. Connectivity Predicts deep brain stimulation outcome in Parkinson disease. Ann. Neurol. 82, 67–78 (2017). 12. Duffley, G., Anderson, D. N., Vorwerk, J., Dorval, A. D. & Butson, C. R. Evaluation of methodologies for computing the deep brain stimulation volume of tissue activated. J. Neural Eng. 16, 066024 (2019). 13. Astrom, M., Diczfalusy, E., Martens, H. & Wardell, K. Relationship between neural activation and electric field distribution during deep brain stimulation. IEEE Trans. Biomed. Eng. 62, 664–672 (2015). 14. Hawrylycz, M. J. et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 489, 391–399 (2012). 15. Arnatkeviciute, A., Fulcher, B. D. & Fornito, A. A practical guide to linking brain-wide gene expression and neuroimaging data. Neuroimage 189, 353–367 (2019). 16. Arnatkeviciute, A., Markello, R. D., Fulcher, B. D., Misic, B. & Fornito, A. Toward Best Practices for Imaging Transcriptomics of the Human Brain. Biol. Psychiatry 93, 391–404 (2023). 17. Markello, R. D. et al. Standardizing workflows in imaging transcriptomics with the abagen toolbox. Elife 10, (2021). 18. Seidlitz, J. et al. Transcriptomic and cellular decoding of regional brain vulnerability to neurogenetic disorders. Nat. Commun. 11, 3358 (2020). 19. Fornito, A., Arnatkevičiūtė, A. & Fulcher, B. D. Bridging the Gap between Connectome and Transcriptome. Trends Cogn. Sci. 23, 34–50 (2019). 20. Arnatkeviciute, A., Fulcher, B. D., Bellgrove, M. A. & Fornito, A. Imaging Transcriptomics of Brain Disorders. Biol Psychiatry Glob Open Sci 2, 319–331 (2022). 21. Wang, Q. et al. Normative vs. patient-specific brain connectivity in deep brain stimulation. Neuroimage 224, 117307 (2021). 22. Elias, G. J. B. et al. Normative connectomes and their use in DBS. in Connectomic Deep Brain Stimulation 245–274 (Elsevier, 2022). 23. Gouveia, F. V. et al. Bilateral Amygdala Radio-Frequency Ablation for Refractory Aggressive Behavior Alters Local Cortical Thickness to a Pattern Found in Non-refractory Patients. Front. Hum. Neurosci. 15, 653631 (2021). 24. Venetucci Gouveia, F. et al. Case report: 5 Years follow-up on posterior hypothalamus deep brain stimulation for intractable aggressive behaviour associated with drug-resistant epilepsy. Brain Stimul. (2021) doi:10.1016/j.brs.2021.07.062. 25. Gouveia, F. V. et al. Amygdala and Hypothalamus: Historical Overview With Focus on Aggression. Neurosurgery 85, 11–30 (2019). 26. Gouveia, F. V. et al. Longitudinal Changes After Amygdala Surgery for Intractable Aggressive Behavior: Clinical, Imaging Genetics, and Deformation-Based Morphometry Study-A Case Series. Neurosurgery 88, E158–E169 (2021). 27. Yan, H. et al. Deep brain stimulation for extreme behaviors associated with autism spectrum disorder converges on a common pathway: a systematic review and connectomic analysis. J. Neurosurg. 1–10 (2022). 28. Knotkova, H. et al. Neuromodulation for chronic pain. Lancet 397, 2111–2124 (2021). 29. Gray, A. M. et al. Deep brain stimulation as a treatment for neuropathic pain: a longitudinal study addressing neuropsychological outcomes. J. Pain 15, 283–292 (2014). 30. Miczek, K. A., Fish, E. W., De Bold, J. F. & De Almeida, R. M. M. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems. Psychopharmacology 163, 434–458 (2002). 31. Gouveia, F. V. et al. Reduction of aggressive behaviour following hypothalamic deep brain stimulation: involvement of 5-HT1Aand testosterone. bioRxiv (2023) doi:10.1101/2023.03.20.533520.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
The strength of the manuscript is highlighted by the application of fractal formalism, which is commonly used in colloidal systems, in conjunction with MD simulation to study the phase separation of an IDP. The weakness lies in the fact that this study does not provide any discussion on how our understanding of the network structure and dynamical behavior of biomolecular condensates and their biological significance improves through this study. The experimental part remains weak, without any measurements of the dynamics of the condensates. Whether and how the formalism can distinguish between phase-separated condensates (WT) and classical protein aggregates (Y to A variant) remains unclear.
We thank the Reviewer for their careful reading of the manuscript and their appreciation of the link between IDP phase separation and colloid chemistry. Establishment of a quantitative framework behind this link, as given by the fractal formalism, and a multiscale model of the spatial organization of a biomolecular condensate, derived from MD simulations in combination with fractal scaling, are indeed two of our main contributions. In particular, to the best of our knowledge, ours is the first atomistically resolved model of the spatial organization of a biomolecular condensate at an arbitrary scale. The key features of the proposed model, as elaborated in the Discussion of the revised manuscript (p. 18, 20-21), are the coexistence of differently sized clusters inside a condensate, and a quantitative prediction of a particular scaling of mass with cluster size (Figure 5A), as further discussed below. Moreover, our results also point to the possible formation of pre-percolation clusters with sizes below the resolution limit of typical microscopy experiments, in agreement with recent observations (https://doi.org/10.1073/pnas.2202222119).
We agree that the full understanding of biomolecular condensates also requires a detailed treatment of the dynamical aspects. Following the Reviewer’s comments, we have provided significant new results in this regard and included an experimental characterization of fusion behavior (Videos 1, 2) and condensate dynamics by FRAP (Figure 1D, E and Figure 1—figure supplement 2) as well as a detailed analysis of diffusion and viscosity in the simulated systems (Figure 4C and Figure 4—figure supplement 1D-F). The newly performed FRAP experiments provide a direct measure of the condensate dynamics. Importantly, the measured recovery half-times for WT and R>K condensates resemble those of other well-characterized in vitro condensates. We have occasionally observed elongated, amorphous Y>A precipitates, albeit in low number and only at 50-fold higher concentration than the wild-type (45 mM and above, Figure 1C). While this may be consistent with the predictions of the fractal model and hint at the differences in mesoscopic organization between the WT and R>K condensates and the Y>A precipitates, the latter are rare and we are reluctant to draw major conclusions.
Furthermore, we could show that the WT diffusion coefficient is lower than for either mutant (Figure 4C, and Supplementary File 2). Clearly, this difference is not due to the effect of protein size or a higher solvent viscosity, but primarily indicates protein slow-down due to the more extensive interactions with partners (reflected also in higher average valency, Figure 2D, or probability of interactions Figure 2—figure supplement 1D). The fact that the WT diffusion coefficient drops by about 20% over the last 0.3 µs of the MD trajectory also correlates with the formation of a single percolating cluster in the system (Figure 2C). This is an expected effect on protein diffusion upon crossing the percolation threshold (https://doi.org/10.1038/ncomms11817, https://doi.org/10.1021/acs.jpcb.7b08785). Moreover, the difference in the recovery dynamics observed for WT and R>K mutant can be interpreted using the proposed model. Namely, accurate fitting of FRAP data was only possible if using at least two components (Figure 1—figure supplement 2). According to https://doi.org/10.1016/j.tcb.2004.12.001, these components indicate the contribution of particle diffusion and interaction (binding). Thus, recovery of the centrally bleached condensates is faster for WT than for the R>K mutant, which can be related to the higher compactness of the WT particles across scales as compared to R>K. On the other hand, the FRAP results for the condensates bleached in the peripheral area highlight the contribution of the binding component. Indeed, the recovery is about 3-fold faster for the R>K mutant, which could potentially be related to the lower valency of the interactions and the ease of the replacement of inactivated fluorescent species and/or exchange with proteins in the bulk. A further connection of the developed model and condensate dynamics concerns the multimodal description of diffusion in biomolecular condensates, together with multimodal fitting of FCS and FRAP data as used recently for interpreting single particle tracking results (https://doi.org/10.1016/j.bpj.2021.01.001). Namely, the polydisperse nature of the protein phase as suggested by the model translates to multimodal diffusion, reflecting the dynamics of protein clusters of different size. For instance, regularization fits used for DLS autocorrelation curves assume a multimodal character of the diffusion and are interpreted to reflect a multimodal distribution of cluster sizes in condensates (https://doi.org/10.1073/pnas.2202222119).
Finally, a way of testing the model prediction, which would merit a study in its own right, would involve static light scattering (SLS): a linearly decreasing scattering intensity as a function of the scattering vector in a log-log representation, as frequently seen for different colloidal systems, is expected by the fractal model. In fact, fractal dimension dF could directly be estimated from SLS experiments (https://doi.org/10.1038/339360a0) from the limiting value of scattering intensity for high values of the product of the scattering vector q and the average cluster size <Rg>. As a direct test of the predictions of the model, the experimental value of dF could then be compared with the predicted one. Moreover, techniques such as DLS and MALS could be used to measure independently masses and sizes of biomolecular condensates in vitro at different scales in order to test the validity of the particular scaling predicted by the fractal model. Such experiments are not trivial and are out of scope of the present study.
Reviewer #2 (Public Review):
A key aspect of the work is to use the simulations to explain differences between (i) dilute and dense phases and (ii) wild-type and mutant variants. Here, it would be important with a clearer analysis of convergence and errors to quantify which differences are significant.
Following the Reviewer’s suggestion, we now provide an analysis of convergence and statistical significance. Specifically, in Supplementary File 1 “Technical summary” we now report the average value, standard deviation and a block-average measure of convergence for all the key observables analyzed, including radius of gyration (Rg), valency (n), and compactness (), for all modeled systems. Furthermore, in the revised manuscript, we now also include the analysis of protein translational diffusion constants and solution viscosity for all modeled systems to assess the ability of the simulations to capture protein dynamics realistically (Figure 4C, Figure 4—figure supplement 1D-F, Supplementary File 2, see also above). Moreover, we include in the revised version a new figure depicting time evolution of average compactness in the 24-copy systems (Figure 4—figure supplement 1C). Thus, it can be seen that the two key model parameters derived from MD simulations of the 24-copy system – protein valency and compactness – reach a stable plateau over the last 0.3 µs (Figure 2D and Figure 4—figure supplement 1C), which were used for final analyses, with block-averaged deviations of less than 10% throughout (see below for details). All the differences in these parameters between single-copy and 24-copy simulations, as well as those between WT and mutation simulations, were found to be significant with p-values < 2.2 10-16 according to the Wilcoxon rank sum test with continuity correction (details in Supplementary File 1). Finally, considering the sampling limitations implicit in most MD studies, we clearly recognize the possibility that with longer simulation times or more protein copies per simulation box, the simulated systems may show a qualitatively different behavior. However, we emphasize that our derivation of the formalism that links the features of simulated ensembles on the scale of 10s of nanometers with their behavior on the scale of 100s of nanometers and beyond is independent of such limitations. Once longer, larger and more accurate simulations become available, one will be able to apply the formalism without alteration and obtain a model of the spatial organization of the condensate on an arbitrary scale, starting just from the local features of individual proteins. We now discuss these details on pp. 10, 11, 13 of the revised manuscript.
It would also be useful with a clearer description of how the analytical model is predictive, of which properties, and how they have been/can be validated. Which measurable quantities does the model predict?
As pointed above, the model predicts the existence and provides a quantitative description of pre-percolation finite-size clusters (https://doi.org/10.1016/j.molcel.2022.05.018, https://doi.org/10.1073/pnas.2202222119). More generally, the model provides the fractal dimension (dF) of protein clusters and enables evaluation of different scale-dependent properties of clusters of arbitrary size, including protein density as a function of cluster size (Figure 5—figure supplement 1C, Figure 5C). Importantly, the fractal dimension can be used in combination with local MD simulations and cluster–cluster aggregation algorithms to derive a detailed model of the 3D organization of fractal clusters of a chosen size at atomistic resolution (Figure 5A, B, and Videos 4, 5, and 6). Such detailed structural understanding of the interior organization of a condensate can, for example, be used to evaluate cavity sizes and interpret partitioning experiments. Since the differences in the morphology of WT and mutant protein clusters propagate across length scales, they can even be qualitatively characterized by the analysis of microscopic images (e.g. circularity, Figure 1—figure supplement 1C, see also discussion above). Finally, static light scattering (SLS) experiments give the possibility to test the model directly, which will be the subject of our future work. Namely, the fractal formalism predicts linear behavior in the log-log representation of the SLS intensity vs. scattering vector curves, while dF, which can directly be evaluated from such experiments, providing a quantitative point of comparison between theoretical predictions and experiment (see above).
In addition to these overall questions, a number of more specific suggestions follow below.
Major:
p. 7, line 120 (Fig. S1B) The proteins do not appear particularly pure based on the presented SDS PAGE analysis. How pure is the protein estimated to be, and is the presence of the other bands expected to affect e.g. the data presented in Fig. 1?
We have quantified the purity of the constructs by densitometry of the Coomassie stained gels and included it in Figure 1—figure supplement 1A: in the case of WT and R>K, we achieve purity higher than 91%. Importantly, the observed LLPS behavior of the constructs is consistent with the simulation and in agreement with other studies on R>K substitutions (https://doi.org/10.1073/pnas.2000223117; https://doi.org/10.1016/j.molcel.2020.01.025; https://doi.org/10.1073/pnas.2200559119; https://doi.org/10.1016/j.jmb.2019.08.008). In the case of Y>A, we have obtained the least pure protein (~65%), and must note that the precipitates observed in the experiments of Figure 1C are only present at the protein concentrations that are 50-fold higher as compared to WT (45 mM and above). Therefore, at such high total protein concentration, we cannot exclude the possibility that there might be some contamination affecting the behavior of this construct.
p. 7 & 8, lines 138-159: Has the method and energy function used to calculate the interact potential been validated by comparison to experiments, including studying the effect of varying the solvent? I see the computed error bars are very small, but am more interested in the average error when comparing to experiments. The numbers in water appear different from those e.g. reported by Krainer et al (https://doi.org/10.1038/s41467-021-21181-9), though the latter are also not immediately compared to experiments. Thus, it would be useful to know how much to trust these numbers.
We thank the Reviewer for raising this important point. To the best of our knowledge, the absolute binding free energies between Y-Y, Y-R or Y-K sidechain analogs or complete amino acids have never been determined experimentally, preventing a direct validation of the computed values and/or an evaluation of the average error when comparing to experiments. On the other hand, we did compare our data against the PMF curves presented by Krainer et al. (https://doi.org/10.1038/s41467-021-21181-9) for R-Y and Y-Y and the general trends are largely similar. In particular, in both analyses the R-Y interaction is stronger than the Y-Y interaction across different conditions, except at zero salt in Krainer et al. where the two are similar. When it comes to exact quantitative differences between the studies, it should first be pointed out that Krainer et al. studied capped amino-acids, while we used amino-acid side-chain analogs. The difference in the observed binding strengths is in part certainly related to the contribution of the capped backbone. Second, the values in Krainer et al. refer to the depth of the free energy minimum in the obtained PMFs and not to the resulting G values, as in our method. The latter includes integration over the PMF and an assumption of a standard-state concentration, which could also lead to significant differences. Finally, the differences could also be due to the intrinsic properties of the interaction potentials used. In particular, the prominent free-energy minima for the R-Y pair in the Krainer et al. study could only be obtained after refitting of the original AMBERff03ws charges on the Y bound to R via semi-empirical quantum-chemical calculations. On the other hand, the interaction potential used in our study was not adjusted to the system at hand, but rather comes from a published, widely used force field, the OPLS-AA (https://doi.org/10.1021/ja9621760), that was independently tested and validated experimentally in multiple studies. For example, OPLS-AA exhibits the low average error in absolute hydration free energy of ~0.5 kcal/mol, errors of only ~2% for heats of vaporization and densities (https://doi.org/10.1021/ja9621760), and a close agreement with osmotic coefficients (https://doi.org/10.1021/acs.jcim.9b00552) or a large range of organic compounds. This raises our confidence in the accuracy of the derived binding free energies, which directly or indirectly depend on these fundamental thermodynamic properties.
Regarding the method to evaluate PMF profiles, we have used a classical all-atom Monte Carlo approach originally developed by Jorgensen and coworkers (see, e.g., https://doi.org/10.1021/ar00161a004 and https://doi.org/10.1021/ja00168a022), as implemented in the widely used BOSS program (v. 4.8) (https://doi.org/10.1002/jcc.20297). This approach has been extensively tested against experimental data on ΔΔG values of various compounds in environments of different polarity (e.g., 2). Moreover, we have previously successfully applied this methodology in studies of the free energy of association of amino acid residues (https://doi.org/10.1021/jp803640e) and other biologically important groups (https://doi.org/10.1021/acs.jcim.9b00193). The results obtained have been compared with the available experimental data and demonstrated a good agreement. As for the small error bars in the plots, the fairly good convergence achieved in our PMF calculations is a result of extensive sampling combined with small system size, although obviously this is not always the case – see, for example, PMFs in our recent work (https://doi.org/10.1021/acs.jcim.9b00193).
The above points have been discussed on pp 7-8 of the revised manuscript.
p. 8, lines 149-154: Following up on the above, the authors also write "Importantly, only in the latter case are the R-Y interactions slightly more favorable than the K-Y ones (Figure S1C). While this can potentially contribute to increasing of Csat for the R>K mutant as compared to WT, the estimated thermodynamic effect is not too strong, especially if one considers that these interactions take place in an environment with largely water-like polarity. Therefore, the effect of R>K substitution on LLPS should be further explored in the context of protein-protein interactions." In the absence of estimates of the accuracy of the predictions, these sentences are somewhat unclear. Also, it is unclear what the authors mean by that the effect of R>K should be studied; there are already several examples of this (https://doi.org/10.1016/j.cell.2018.06.006 [already cited], https://doi.org/10.1038/s41557-021-00840-w & https://doi.org/10.1073/pnas.2000223117 come to mind, but there are likely more).
As pointed above, the free-energy values were obtained using well-established computational techniques and are expected to reflect realistic trends. However, considering that there exist no equivalent experimental results to assess the accuracy of the predicted free energies, they indeed must clearly be understood as predictions. This is now stated on pp. 7-8 of the revised manuscript. Furthermore, it seems that the vague phrasing on our part in the above paragraph resulted in a misunderstanding. Namely, when we talk about “further exploration”, we only meant it in relation to our study, i.e. a connection with the MD part, and not in relation to a wider literature on the topic. In other words, we simply wanted to refer to the fact that our binding free energies for individual residues do not provide sufficient information about interactions between Lge11-80 protein chains. Following the Reviewer’s comment, we have rephrased this part and included additional references on the known role of R and K residues on phase separation.
p. 8, lines 161-162: The authors perform MD simulations of Lge1 and variants using 24 copies and a box that gives them protein concentrations "in the mM concentration range". I realize that there's a concern about what is computationally feasible, but it would be important with an argument for this choice. Why is 24 expected to be enough to represent a condensate (I expect that there could be substantial finite-size effects)? What is the exact protein concentration in the simulations of the 24 chains [and of the 1-chain simulations]? How does this protein concentration compare to that in the condensates? The authors performed simulations in the NPT ensemble; how stable were the box dimensions?
The effective protein concentration for different 24-copy systems is 6-7 mM, depending on the system (Figure 2—figure supplement 1A). This concentration range was selected in order to get a reasonable system size for microsecond all-atom MD simulations, while still being approximately one order of magnitude lower than the semi-dilute regime of the protein at hand. As a testament to the internal consistency of our framework, the fractal model predicts the concentration inside WT condensates of the size observed in the experiment to indeed be in the mM range. Moreover, as seen in many other systems, the concentration inside the observed droplets is expected to be significantly higher than Csat (https://doi.org/10.1101/2020.10.25.352823). Here, we should again emphasize that we did not aim to model the process of phase separation in our all-atom MD. We rather use multicopy simulations for the analyses of the organization of the protein crowded phase and specifically, the mode of intermolecular interactions, and then use the fractal scaling to derive a model of the internal organization of condensates at arbitrary scales.
Regarding the experimental determination of the protein concentration in the condensates, we have used different approaches to estimate Csat and CD values: spin-down analyses (https://doi.org/10.1126/science.aaw8653), volumetry analysis (https://doi.org/10.1038/nchem.2803), estimation of concentration by fluorescent intensity of the condensates (https://doi.org/10.1016/j.molcel.2018.12.007; https://doi.org/10.1016/j.cell.2019.08.008), FCS (https://doi.org/10.1038/nchem.2803; https://doi.org/10.1016/j.cell.2019.10.011; https://doi.org/10.1126/science.aaw8653). However, different approaches yield values that vary by several orders of magnitude. That is the reason why we did not report definitive numbers. In general, there are uncertainties in the field about how to reliably measure protein concentrations in a condensate, necessitating the development of new approaches (https://doi.org/10.1101/2020.10.25.352823).
With regard to the convergence and potential finite-size effects, we agree that this is an important issue and have addressed it in the revised version. In general, the convergence of our observables such as valency or compactness (Figure 2C, D and Figure 4—figure supplement 1C) gives confidence that the simulations are at least in a local equilibrium, especially when it comes to short-range properties such as contact preferences as further elaborated in our reply to the Reviewer’s specific comment about convergence below (please, see also above for our response to Editor’s comment #5). Importantly, in all 24-copy systems, the average separation between protein images lies in the 12-15 nm range, and no instances of self-interaction between images due to PBC were observed (Supplementary File 1). Finally, analysis of fluctuations in box dimensions shows that they are all in the range of picometers and largely negligible when it comes to the analysis at hand (Supplementary File 1).
In order to highlight the realistic behavior of the simulated systems in the revised version, we now also report a detailed analysis of protein translational diffusion in MD simulations (Figure 4C and Figure 4—figure supplement 1D-F and Supplementary File 2). According to this analysis, single-molecule translational diffusion coefficients of Lge11-80 variants obtained from fitting of MSD curves with applied finite-size PBC correction and rescaling by the solvent viscosity (see Methods for details) are typically in the range of 100 µm2/s (Figure 4C and Supplementary File 2), which corresponds to experimentally measured values for different proteins of similar size. Importantly, the requisite finite-size corrections applied in the case of 24-copy systems are relatively small and amount to about 35-60%, while this is almost an order of magnitude higher (450-530%) for the single-copy simulations (Supplementary File 2). Please, see also the reply above to the Editor’s statements above for more details.
Also, did the authors include the Strep- and His-tags in the simulations? If not, why not?
We did not simulate the constant part of the constructs in order to: 1. expedite computation and 2. more directly expose the effect of different mutations. Since our comparison between simulation and experiment concerned largely qualitative observables, we have primarily focused on the relative differences between the three Lge11-80 variants. Importantly, the effect of mutations on the full-length protein and its different variants was analyzed in vivo in a previous publication (https://doi.org/10.1038/s41586-020-2097-z).
Throughout: One of my major concerns about this work is the general lack of analysis of convergence of the simulations. The authors must present some solid analysis of which results are robust given the relatively short simulations and potential for bias from the chosen starting structures.
First, we would like to emphasize that we did not attempt to capture the process of phase separation or characterize two coexisting phases, for which much larger ensembles and/or simulation times would be needed. Rather, our aim was to study the conformational behavior of individual protein chains in the context of a crowded protein mixture, taken as a model for the dense phase, and then use fractal scaling to provide a model of spatial organization of a condensate at an arbitrary length scale. Having said this, it is absolutely important to address how converged the key observables are, given the finite size of the all-atom simulation setup and the limited sampling used. In the revised manuscript, we have included an additional analysis of convergence of our simulations and could show that both key MD-derived parameters required by the fractal model, protein compactness and valency, display convergent behavior over the last third of 0.3 µs MD in the 24-copy systems (Figure 4—figure supplement 1C) and all analyses were performed over this region. In particular, the block averages of compactness and valency exhibit a standard deviation of only 2-4% and 4-8%, respectively, over the last 0.3 µs of MD simulations. Moreover, since we are interested in single-chain features in the context of a crowded mixture, our sampling corresponds effectively to 24 x 0.3 µs = 7.2 µs. Finally, a detailed analysis of convergence in conformational sampling was performed for single-copy simulations using calculations of configurational entropy as evaluated by the MIST formalism (Figure 4—figure supplement 1B). For instance, in the case of the weakly self-interacting Y>A, we do observe a close convergence in terms of the configurational entropy between two independent replicas on 1 µs MD trajectory (Figure 4—figure supplement 1B). However, we still recognize the possibility that with longer simulation times and/or more protein copies per simulation, the simulated systems may show a qualitatively different behavior, as discussed on pp. 10, 11, and 13 of the revised manuscript. Finally, we would like to reiterate the point that our derivation of the formalism that links the features of simulated ensembles on the scale of 10s of nanometers with their behavior on the scale of 100 s of nanometers and beyond is independent of such limitations. Once longer, larger and more accurate simulations become available, one will be able to apply the formalism without alteration and obtain a model of the spatial organization of the condensate on an arbitrary scale, starting just from the local features of individual proteins. We now discuss these details on pp. 10, 11, and 13 of the revised manuscript.
As an example, on p. 8 the authors discuss a potential asymmetry between the interactions found in the dilute (single-copy) and dense (24-mer) phases. These observations are somewhat in contrast to other observations in the field, namely that it is the same interactions that drive compaction of monomers as those that drive condensate formation.
Obviously, both the results in the literature and those presented here could be true. But in order to substantiate the statements made here, the authors should show some substantial statistical analyses to make it clear which differences are robust. The above holds for all parts of the computational/simulation work (e.g. other aspects of Fig. 2)
Note: this comment by the Reviewer echoes in several respects the comment 7 by the Editor. Because of this, our reply in some parts is identical to that given above to the Editor. We have decided to include it here for the ease of reading and completeness.
An expectation of the symmetry between intra- and intermolecular modes of interaction emerged from the background of polymer theory, which was primarily aimed to describe the behavior of homopolymers. In the case of heteropolymers such as proteins, the asymmetry in the aforementioned modes is rather intuitive. For instance, if there is only a single Y in a protein, then Y-Y contacts will not be possible in the intramolecular context, but could occur in multichain interactions. However, we agree with the Reviewer that this is an important issue and have deepened the analysis of this phenomenon in the revised manuscript.
First, our analysis shows that the observed asymmetry between intra- and intermolecular contexts is statistically significant and is likely not a consequence of limited sampling (pp. 10-11, Figure 3—figure supplement 1B-C). Moreover, the observed symmetry breaking is in line with the recent studies by Bremer et al. (https://doi.org/10.1038/s41557-021-00840-w) and Martin et al. (https://doi.org/10.1126/science.aaw8653), which have delineated the key requirements for the symmetry between single-chain and collective phase behavior to hold. Specifically, we have compared in detail the sequence composition of Lge11-80 with that of A1-LCD variants studied by Bremer et al. When it comes to aromatic composition, Lge1 is most similar to the -12F+12Y mutant of A1-LCD, and by this token, i.e. the high frequency of stickers tyrosines, should exhibit a strong coupling between single-chain and phase behavior. However, the net charge per residue (NCPR) in Lge11-80 of 0.075 is greater than that of A1-LCD (0.059) and this could contribute to the extent of decoupling, as suggested by Bremer et al. Moreover, Lge1 is extremely abundant in Arg (13.5 % as compared to 7.4 % in A1-LCD), and is in this sense most similar to the +7R A1-LCD mutant, which showed the greatest degree of decoupling between single-chain and phase behavior in Bremer et al., in agreement with what we see here. While these authors have demonstrated that NCPR is the primary determinant of decoupling in the case of A1-LCD mutants, their analysis showed that the nature of positive and negative residues involved also makes a significant difference. In particular, the significant excess of Arg residues, as context-dependent auxiliary stickers, could create the asymmetry between interactions that determine single-chain dimensions vs. collective phase behavior.
Furthermore, Martin et al. (https://doi.org/10.1126/science.aaw8653) have shown that an approximately uniform distribution of stickers along the sequence is required for the correspondence between the driving forces behind coil-to-globule transitions and phase separation to hold. We have analyzed the patterning of Tyr residues along the Lge11-80 sequence using Waro parameter used by Martin et al. (note that Tyr is the only aromatic in the Lge11-80 sequence). Interestingly, Lge11-80 exhibits a highly non-uniform patterning of Tyr residues, with Waro of the native Lge1 sequence (0.47) falling in the middle of the distribution for its shuffled variants (p=0.57). This is in contrast to the highly patterned sequences such as that of A1-LCD with p>0.99. Taken together, in addition to the relatively high NCPR, symmetry breaking in the case of Lge11-80 could be a consequence of its complex sequence composition, including both the non-uniform patterning of tyrosines and a high abundance of arginines. Provided that our simulations are long enough to provide an equilibrium picture and are on the length-scale of a single protein not strongly influenced by finite-size effects (these potential artifacts cannot be discounted), they actually can be seen as a demonstration of such symmetry breaking in a heteropolymer.
Furthermore, analysis of pairwise contacts suggests that intra- and intermolecular interactions rely on a similar pool of contacts by amino-acid type, but differ significantly if one analyzes specific sequence location of the interacting residues involved (Figure 2—figure supplement 1B and C). For example, one observes a high correlation between the frequencies of different contacts by amino-acid type when comparing intramolecular contacts in single-copy simulations and intermolecular contacts in 24-copy simulations (Figure 3—figure supplement 1B). This correlation is completely lost (Figure 3—figure supplement 1C) if one analyzes position-resolved statistics (2D pairwise contacts maps) or statistically defined interaction modes (Figure 3A, and Figure 3—figure supplement 1A). For example, although Tyr-Tyr interactions dominate in both cases, in single-copy simulations of WT Lge11-80 the C-terminal Tyr80 barely participates in any intramolecular interactions with other residues (Figure 3—figure supplement 1A), while in 24-copy simulations it is one of the most intermolecularly interactive residues (Figure 3). In other words, while the symmetry between intra- and intermolecular interactions can be observed at the level of pairwise contact types (similar type contact used for both), the distribution of these contacts along the peptide sequence is clearly different in the two cases. Finally, it should be mentioned that the parallel between single-copy and phase behavior in both homopolymers and heteropolymers is observed primarily at the level of thermodynamic variables such as LLPS critical temperature (Tc), coil-to-globule transition temperature (Tq) or the Boyle temperature (TB). It is possible that the noted correspondence extends primarily to such and similar thermodynamic variables, while and more structural, topological features of the globule in the single-molecule case and the network in the collective phase case remain uncoupled.
Interestingly, the core of intramolecular interactions observed for a single molecule at infinite dilution and in the crowded context remain approximately the same as reflected in the high correlation between intramolecular modes obtained in single and multichain simulations. Namely, proteins keep core self-contacts and establish new ones with neighbors, but do not donate everything to the intermolecular network losing “self-identity”, as in homopolymer melts. Similar effects have also been observed elsewhere: https://doi.org/10.1073/pnas.2000223117, https://doi.org/10.1073/pnas.1804177115.
Similarly, how were the errors of the radius of gyration for WT, R>K and Y>A mutants calculated? Is the Rg for WT significantly smaller than the values for the two mutants? And are the differences in Rg between single-copy and multi-copy simulations statistically significant? I am asking since converging the Rg of IDPs of this length in all-atom MD is not easy.
The errors for Rg values correspond to the standard deviations of the underlying distributions and are reported in Figure 4A and B, together with the corresponding means and an assessment of statistical significance of the difference. In particular, the character of the distributions (especially, for 24-copy systems) also suggests significant differences. In order to deepen this part in the revised version, we have added a new supplementary table (Supplementary File 1 “Technical summary) where we have included the average values of Rg together with the standard deviations for all modeled systems. Due to distributions being non-Gaussian, we have estimated the significance of the differences in Rgs between single-copy and multicopy simulations, as well as WT and mutants, using Wilcoxon rank sum test with continuity correction, with the resulting p-values < 2.2 10-16 for all cases.
p. 12, line 251: Has the MIST formalism been validated for IDPs; if so please provide a reference.
In the present work, we have evaluated the configurational entropy using a mutual information expansion approach with maximum-spanning-tree (MIST) approximation in internal-coordinate (bond-angle-torsion) representation. The latter is particularly well-suited for the analysis of IDPs as it allows one to avoid a number of artifacts (e.g., due to fitting of disordered ensembles to the average structure) associated with the more widely-used Cartesian-coordinate-based quasi-harmonic approaches. In particular, the MIST approach was used previously for the analysis of disordered protein ensembles (https://doi.org/10.1021/acs.jctc.8b00100). Here it should also be noted that, since intramolecular couplings are in general lower in IDPs, this makes them even better suited for MIST as compared to globular proteins. We have highlighted these points on p. 13 of the revision.
p. 5, line 105, p. 16 line 334 and p. 18 line 283: It is not completely clear what the predictions are and what/which experiments they are compared to. On p. 16, exactly what does the analytical model predict? As far as I understand, the results from the MD simulations are input to the model, but I am probably missing something. Which concrete and testable predictions does the model enable?
A key contribution of the present work is the development of a quantitative model that treats the spatial organization of a biomolecular condensate across scales using two key properties of individual polymer chains in the condensate - their average valency and compactness. The main predictions of the model concern the presence of a particular scaling of condensate mass with its radius, M(R), as captured by the fractal dimension, and the consequences this has on condensate morphology across scales. In the present manuscript, we have taken the first steps in testing these predictions in four different contexts. First, we could show that the MD simulations indeed match the predictions of fractal scaling for the three smallest clusters, which relates to the discussion on p. 16 that the Reviewer refers to. Here, it is important to understand that MD simulations in the first instance just give the average valency and compactness of individual chains in the dense phase. These values are then input into the fractal scaling formalism, which is conceptually fully independent from MD simulations, to obtain the dependence of condensate mass on its radius, M(R), at any desired length scale. The analysis presented in Figure 5—figure supplement 1B and discussed on p. 16 shows that the predictions of fractal scaling for the first three smallest clusters indeed correspond to what is seen in MD. This is a non-trivial correspondence and can be taken as direct evidence that fractal organization is present even at the shortest scale, i.e. at the level of MD simulation boxes.
Second, the model was used to reconstruct the spatial organization of clusters of arbitrary size at the atomistic level (Figure 5A and B, Videos 4, 5, and 6), enabling a structural understanding of the organization of condensate interior. One direct practical application of such understanding concerns the nature of cavity sizes and interpretation of dextran partitioning experiments (p. 20). Moreover, as pointed above, differences in morphology of protein clusters propagate across scales, and can be qualitatively characterized by the analysis of microscopic images (see also discussion above). In particular, the model correctly predicts the difference in the behavior of WT and R>K as opposed to Y>A variants, solely based on the predicted fractal dimension they exhibit. Ultimately, however, static light scattering experiments would give the best possibility to test the model directly and will be the topic of our future work. In particular, the fractal formalism predicts significant regions of linear behavior in such curves in log-log representation, while the fractal dimension df, provides a quantitative point of comparison between theoretical predictions and experimental measurements (Figure 5C). These points have been further discussed on p. 21 of the revised manuscript.
p. 19, lines 408-411: The authors find that when building clusters of Y>A from the simulations they find filamentous structures that they suggest explain the aggregation of the Y>A variant at high concentrations. While that sounds like an intriguing suggestion, it would be useful with a bit more detail about the robustness of this observation. For example, the simulations of Y>A appear similar to that of R>K; are the differences in topology really significantly different?
Fractal dimension, dF, is the key parameter that defines self-similar organization of differently sized protein clusters according to the fractal model. Consequently, the difference in morphology between R>K and Y>A mutants is reflected in different values of dF for the two. In particular, with a dF of 1.63, the Y>A mutant is predicted to form low-dimensional clusters, straddling the range between a linear (1-dimensional) and a planar (2-dimensional object), unlike WT and R>K variants, which both exhibit dF values greater than 2. The qualitative behavior of the three variants, whereby WT and R>K result in spherical condensates and Y>A does not, is consistent with this. Notably, we have observed sporadic precipitates at high protein concentration in the Y>A mutant, which may be consistent with the predictions of the fractal model. However, the material properties and possible influence of sample impurities in the Y>A case at high concentrations remain unclear. Moreover, the sporadic nature of Y>A precipitates prevents an adequate statistical analysis. Hence, in the revised manuscript we refrain from commenting on these infrequently observed precipitates.
Regarding MD simulations, the morphological differences between Y>A and R>K proteins can already be seen at the level of individual proteins in multicopy simulations, highlighted by the significantly different distribution of Rg (Figure 4B). This distribution in the case of Y>A has a prominently long tail, which indicates the possibility of adopting significantly more elongated configurations. Due to the self-similarity principle, such differences in morphology may propagate across length scales. Importantly, a recent publication included the experimental study of the possibility of IDRs to form low dimensional fractal systems upon disruption of the LLPS tendency by polyalanine insertion in synthetic elastin-like polypeptides (Roberts et al., Nature Materials, 2018).
Finally, I would suggest that the authors make their code and data available in electronic format.
All sharable data has been made available as part of the article package. Due to the heterogeneous character of our analysis, we do not have a single master code to be shared, but rather a collection of different scripts in combination with different software packages as indicated in the Methods section of the manuscript (GROMACS, MATLAB, R, FracVAL).
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
This manuscript confirms previous studies suggesting a great deal of heterogeneity of gene expression at the neural plate border in early vertebrate embryos, as neural, placodal, neural crest, and epidermal lineages gradually segregate. Using scRNA-seq, the study expands previous studies by using far larger numbers of genes as evidence of this heterogeneity. The evidence for this heterogeneity and the change in heterogeneity over time is compelling.
Many studies have suggested that there is considerable heterogeneity of gene expression in the developing neural plate border as the neural, neural crest, placodal and epidermal lineages segregate. Although the evidence for such heterogeneity was strong, until the advent of scRNA-seq, the extent of this heterogeneity was not appreciated. By using scRNA-seq at different stages of chick development, the authors sought to characterize how this heterogeneity develops and resolves over time.
The work is technically sound, and the level of analysis of gene expression, clustering, synexpression groups, and dynamic changes in gene modules over time is state-of-the-art. A weakness of the results as they stand now is that the conclusions of the analysis are not tested by the authors and thus, are over-interpreted. Such tests could be performed in future studies either by gain- and loss-of-function experiments or by using lineage tracing to demonstrate that the cell states the authors observe - especially the "unstable progenitors" they characterize - are biologically meaningful. The data will nevertheless be a useful resource to investigators interested in understanding the development of different cell lineages at the neural plate border.
We thank the reviewer for the positive assessment of our work. We agree that our models will need to be tested experimentally in the future, however, this will require a substantial amount of work. We therefore opted to share our data as a resource to be used by the community.
Reviewer #2 (Public Review):
The study of Thiery et al. aims to elucidate how cells undergo fate decisions between neural crest and (pan-) placodal cells at the neural plate border (NPB). While several previous single-cell RNA-Seq studies in vertebrates have included neural plate border cells (e.g. Briggs et al., 2018; Wagner et al., 2018; Williams et al., 2022), these previous studies did not provide conclusive insights on cell fate decisions between neural crest and placodes, due to either the limited number of genes recovered, the limited number of cells sampled or the limited numbers of stages included. The present study overcomes these limitations by analyzing almost 18,000 cells at six stages of development ranging from gastrulation until after neural tube closure (8 somite-stage), with an average depth of almost 4000 genes/cell. Using this extensive and high-quality data set, the study first describes the timing of segregation of neural crest and placodal lineages at the NPB suggesting that at late neural fold stages (somite stage 4) most cells have decided between placodal and neural crest fates. It then identifies gene modules specific for neural crest and placodal lineages and characterizes their temporal and spatial expression. Focusing on an NPB-specific subset of cells, the study then shows that initially most of these cells co-express neural crest and placodal gene modules suggesting that these are undecided cells, which they term "border-located unstable progenitors" (BLUPs). The proportion of BLUPs decreases over time, while cells classified as placodal or neural crest cells increases, with few BLUPs remaining at late neural fold stages (and a few scattered BLUPs even at somite stage 8). Based on these findings, the authors propose a new model of cell fate decisions at the NPB (termed the "gradient border model"), according to which the NPB is not defined by a specific transcriptional state but is rather a region of undecided cells, which diminishes in size between gastrulation and neural fold stages due to more and more cells committing to a placodal or neural crest fate based on their mediolateral position (with medial cells becoming specified as neural crest and lateral cells as placodal cells).
The study of Thiery et al. provides an unprecedentedly detailed, methodologically careful, and well-argued analysis of cell fate decisions at the NPB. It provides novel insights into this process by clearly demonstrating that the NPB is an area of indecision, in which cells initially co-express gene modules for ectodermal fates (neural crest and placodes), which subsequently become segregated into mutually exclusive cell populations. The paper is very well written and largely succeeds in presenting the very complex strategy of data analysis in a clear way. By addressing the earliest cell fate decisions in the ectoderm and one of the earliest cell fate decisions in the developing vertebrate embryo, this study will have a significant impact and be of interest to a wide audience of developmental biologists. There are, two conceptual issues raised in the paper that require further discussion.
We thank the reviewer for the positive comments on our work and its significance; we have addressed the conceptual issues below and in the revised version of the manuscript.
First, the authors suggest that their data resolve a conflict between two previously proposed models, the "binary competence model" and the "neural plate border model". The authors correctly describe, that the binary competence model proposed by Ahrens and Schlosser (2005) and Schlosser (2006) suggests that the ectoderm is first divided into two territories (neural and non-neural), which differ in competence, with the neural territory subsequently giving rise to the neural plate and neural crest and the non-neural territory giving rise to placodes and epidermis (sequence of cell-fate decisions: ([neural or neural crest]-[epidermal or placodal]). This model was proposed as an alternative to a "neural plate border state model", which instead suggests that initially the NPB is induced as a territory characterized by a specific transcriptional state, from which then neural crest and placodes are induced by different signals (sequence of cell fate decisions: neural-[placodal or neural crest]-epidermal) (see Schlosser, 2006, 2014). Instead in this paper, the authors contrast the binary competence model with a model they call the "neural plate border" model according to which the NPB can give rise to all four ectodermal fates with equal probability. However, I think this misses the main point of contention since all previously proposed models are in agreement that initially the neural plate border region is unspecified and can give rise to all four fates and that lineage restrictions only appear over time. "Binary competence" and "Neural plate border state" model, differ, however, in their predictions about the sequence, in which these fate restrictions occur.
We appreciate the reviewer's thoughtful feedback, but respectfully disagree with their comment regarding the sequence of events predicted by the neural plate border (NPB) model. While the NPB model does suggest that the NPB is a transcriptionally distinct state, it does not make specific predictions about the sequence of fate decisions. Although several papers cited in the Schlosser 2006 and 2014 reviews suggest that the NPB gives rise to all four ectodermal fates, none of them (and, to the best of our knowledge, no other primary paper referring to the NPB model) specifically defines the sequence of fate specification from the NPB.
The key points of the NPB model are that the NPB is defined by overlapping expression of early neural/non-neural markers (which is also observed in Xenopus – see Pieper et al., 2012 supplementary material), contains progenitors for all four ectodermal fates, and that this "state" exists prior to the emergence of definitive neural crest and placodal cells.
To investigate the heterogeneity in the order of cell fate decisions at the NPB, we carried out additional pairwise co-expression analyses of forebrain, mid-hindbrain, neural crest, and placodal gene modules, which reveals multiple different hierarchies of cell fate choice depending on a cell's axial positioning, as shown in Figure 6-figure supplement 1.
Considering these findings, we have expanded our discussion of the previously proposed binary competence and neural plate border models to highlight how neither of these models is sufficient to fully characterize the heterogeneity in cell fate decisions observed in our study. We hope this clarification will help address any concerns the reviewer may have had about the NPB model and its implications for our results.
Second, the authors should be more careful when relating their data to the specification or commitment of cells. Questions of specification and commitment can only be tested by experimental manipulation and cannot be inferred from a transcriptome analysis of normal development. So the conclusion that the activation of placodal, neural and neural crest-specific modules in that sequence suggests a sequence of specification in the same temporal order (lines 706-709) is not justified. Studies from the authors' own lab previously showed that epiblast cells from pre-gastrula stages are specified to express a large number of NPB border markers including neural crest and panplacodal markers, when cultured in vitro (Trevers et al., 2018; see also Basch et al., 2006 for early specification of the neural crest), which is not easily reconciled with this interpretation. I am not aware of any experimental evidence that shows that a panplacodal regulatory state is specified prior to neural crest in the chick (although I may have missed this). In Xenopus, experimental studies have shown instead that neural crest is specified and committed during late gastrulation, while the panplacodal states are specified much later, at neural fold stages (Mancilla and Mayor, 2006; Ahrens and Schlosser, 2005). It may well be the case that the relative timing of neural crest and panplacodal specification is different between species (and such easy dissociability may even be expected from the perspective of the binary competence model).
We very much agree with the reviewer that the definitions and correct terminology is important and apologise for lack of clarity. We have reworded the text carefully.
The reviewer is correct: specification of neural crest, placodes and neural plate is observed very early in chick, prior to gastrulation. However, in specification experiments tissue is removed from its normal environment to reveal what it does autonomously in the absence of additional signals. In the current study, we assess the activation of gene modules in normal development. We have therefore reworded the text to avoid ‘specification’ in this context.
Reviewer #3 (Public Review):
The goal of this work was to better understand how cell fate decisions at the neural plate border (NPB) occur. There are two prevailing models in the field for how neural, neural crest and placode fates emerge: (i) binary competence which suggests initial segregation of ectoderm into neural/neural crest versus placode/epidermis; (ii) neural plate border, where cells have mixed identity and retain the ability to generate all the ectodermal derivatives until after neurulation begins.
The authors use single-cell sequencing to define the development of the NPB at a transcriptional level and suggest that their cell classification identified increased ectodermal cell diversity over time and that as cells age their fate probabilities become transcriptionally similar to their terminal state. The observation of a placode module emerging before the neural and neural crest modules is somewhat consistent with the binary competence model but the observation of cells with potentially mixed identity at earlier stages is consistent with the neural plate border model.
Differences in the timing of analyses and techniques used can account for the generation of these two original models, and in essence, the authors have found some evidence for both models, possibly due to the period over which they performed their studies. However, the authors propose recognizing the neural plate border as an anatomical structure, containing transcriptionally unstable progenitors and that a gradient border model defines cell fate choice in concert with spatiotemporal positioning.
The idea that the neural plate border is an anatomical structure is not new to most embryologists as this has been well-recognized in lineage tracing and transplantation assays in many different species over many decades.
We appreciate the reviewers comment and agree that the neural plate border has previously been characterised anatomically. However, many studies have applied the term literally in reference to a transcriptional state which is specified through the expression of ‘neural plate border specifiers’, prior to segregation of the placodes and neural crest. Here we highlight that treating the neural plate border as a definitive transcriptional state which can be identified through the expression of ‘neural plate border specifiers’ is false. Instead, we find these ‘specifiers’ are upregulated within either neural crest, placodal or neural cell lineages over time. Cells at the neural plate border co-express these alternate lineage markers and therefore predicted to be undecided.
The authors don't provide molecular evidence for transcriptional instability in any cells. It's a molecular term and phenomenon inaccurately applied to these cells that are simply bipotential progenitors.
We thank the reviewer for pointing this out; we have therefore refrained from using the term unstable and instead refer to the cells as ‘undecided’ as suggested by reviewer 2.
Lastly, there's no evidence of a gradient that fits the proper biochemical or molecular definition. Graded or sequential are more appropriate terms that reflect the lineage determination or segregation events the authors characterize, but there's no data provided to support a true role for a gradient such as that achieved by a concentration or time-dependent morphogen.
We agree with the reviewer that ‘gradient’ was misleading. We have now replaced ‘gradient’ with ‘graded’ and expanded figure 6 to highlight the graded co-expression of gene modules associated with alternate fates. We have changed the title to reflect this.
A limitation of the study is that much of it reads like a proof-of-principle because validation comes primarily from known genes, their expression patterns in vivo, and their subsequent in vivo functions. Thus, the authors need to qualify their interpretations and conclusions and provide caveats throughout the manuscript to reflect the fact that no functional testing was performed on any novel genes in the emerging modules classified as placode versus neural or neural crest.
We agree with the reviewer that we do not provide any functional data to validate our predictions; it is for this reason that we submitted the manuscript as a ‘resource’ to make our data available to the community.
Lastly, a limitation of gene expression studies is that it provides snapshots of cells in time, and while implying they have broad potential or are lineage fated, do not actually test and confirm their ultimate fate. Therefore, in parallel with their studies, the authors really need to consider, the wealth of lineage tracing data, especially single-cell lineage tracing, which has been performed using the embryos of the same stage as that sequenced in this study, and which has revealed critical data about the potential cells through when and where lineage segregation and cell fate determination occurs.
The reviewer rightly points out the significance of the classical experiments in the context of the neural plate border. However, only one of the mentioned studies (Bronner-Fraser and Fraser, 1989), analyses cells at a single-cell level and does not assess placodes, while the remaining studies use tissue transplantation or cell population labelling. Although these studies provide valuable insights, they do not examine the fate or potential of single cells, nor do they reveal the transcriptional signature of these progenitors.
Our findings emphasize the transcriptional heterogeneity at the neural plate border, suggesting that distinct subsets of neural plate border progenitors undergo varying sequences of fate restrictions. The upcoming challenge will be to conduct clonal analysis alongside scRNAseq to determine if neural plate border progenitors with similar transcriptional signatures experience the same fate restrictions or if external factors, such as cell-cell signalling, dictate cell fate choices.
We have amended the manuscript to clarify that predictions of fate decisions require future validation through lineage tracing. Additionally, we have acknowledged in the introduction that previous studies have demonstrated the intermingling of neural, neural crest, and placodal progenitors at the neural plate border.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Respone
Reviewer #1 (Public Review):
This article describes the application of a computational model, previously published in 2021 in Neuron, to an empirical dataset from monkeys, previously published in 2018 in eLife. The 2021 modeling paper argued that the model can be used to determine whether a particular task depends on the perirhinal cortex as opposed to being soluble using ventral visual stream structures alone. The 2018 empirical paper used a series of visual discrimination tasks in monkeys that were designed to contain high levels of 'feature ambiguity' (in which the stimuli that must be discriminated share a large proportion of overlapping features), and yet animals with rhinal cortex lesions were unimpaired, leading the authors to conclude that perirhinal cortex is not involved in the visual perception of objects. The present article revisits and revises that conclusion: when the 2018 tasks are run through the 2021 computational model, the model suggests that they should not depend on perirhinal cortex function after all, because the model of VVS function achieves the same levels of performance as both controls and PRC-lesioned animals from the 2018 paper. This leads the authors of the present study to conclude that the 2018 data are simply "non-diagnostic" in terms of the involvement of the perirhinal cortex in object perception.
We appreciate the Reviewer’s careful reading and synthesis of the background and general findings of this manuscript.
The authors have successfully applied the computational tool from 2021 to empirical data, in exactly the way the tool was designed to be used. To the extent that the model can be accepted as a veridical proxy for primate VVS function, its conclusions can be trusted and this study provides a useful piece of information in the interpretation of often contradictory literature. However, I found the contribution to be rather modest. The results of this computational study pertain to only a single empirical study from the literature on perirhinal function (Eldridge et al, 2018). Thus, it cannot be argued that by reinterpreting this study, the current contribution resolves all controversy or even most of the controversy in the foregoing literature. The Bonnen et al. 2021 paper provided a potentially useful computational tool for evaluating the empirical literature, but using that tool to evaluate (and ultimately rule out as non-diagnostic) a single study does not seem to warrant an entire manuscript: I would expect to see a reevaluation of a much larger sample of data in order to make a significant contribution to the literature, above and beyond the paper already published in 2021. In addition, the manuscript in its current form leaves the motivations for some analyses under-specified and the methods occasionally obscure.
We believe that our comments outline our rationale for focusing our current analysis on data from Eldridge et al. In brief, these data provide compelling evidence against PRC involvement in perception, and are the only such data with PRC-lesioned/-intact macaques that we were able to secure the stimuli for. As such, data from Eldridge et al. provide a singular opportunity to address discrepancies between human and macaque lesion data. For this reason, we propose the current work as a Research Advance Article type, building off of a manuscript that was previously published in eLife.
Reviewer #2 (Public Review):
The goal of this paper is to use a model-based approach, developed by one of the authors and colleagues in 2021, to critically re-evaluate the claims made in a prior paper from 2018, written by the other author of this paper (and colleagues), concerning the role of perirhinal cortex in visual perception. The prior paper compared monkeys with and without lesions to the perirhinal cortex and found that their performance was indistinguishable on a difficult perceptual task (categorizing dog-cat morphs as dogs or cats). Because the performance was the same, the conclusion was that the perirhinal cortex is not needed for this task, and probably not needed for perception in general, since this task was chosen specifically to be a task that the perirhinal cortex might be important for. Well, the current work argues that in fact the task and stimuli were poorly chosen since the task can be accomplished by a model of the ventral visual cortex. More generally, the authors start with the logic that the perirhinal cortex gets input from the ventral visual processing stream and that if a task can be performed by the ventral visual processing stream alone, then the perirhinal cortex will add no benefit to that task. Hence to determine whether the perirhinal cortex plays a role in perception, one needs a task (and stimulus set) that cannot be done by the ventral visual cortex alone (or cannot be done at the level of monkeys or humans).
There are two important questions the authors then address. First, can their model of the ventral visual cortex perform as well as macaques (with no lesion) on this task? The answer is yes, based on the analysis of this paper. The second question is, are there any tasks that humans or monkeys can perform better than their ventral visual model? If not, then maybe the ventral visual model (and biological ventral visual processing stream) is sufficient for all recognition. The answer here too is yes, there are some tasks humans can perform better than the model. These then would be good tasks to test with a lesion approach to the perirhinal cortex. It is worth noting, though, that none of the analyses showing that humans can outperform the ventral visual model are included in this paper - the papers which showed this are cited but not discussed in detail.
Major strength:
The computational and conceptual frameworks are very valuable. The authors make a compelling case that when patients (or animals) with perirhinal lesions perform equally to those without lesions, the interpretation is ambiguous: it could be that the perirhinal cortex doesn't matter for perception in general, or it could be that it doesn't matter for this stimulus set. They now have a way to distinguish these two possibilities, at least insofar as one trusts their ventral visual model (a standard convolutional neural network). While of course, the model cannot be perfectly accurate, it is nonetheless helpful to have a concrete tool to make a first-pass reasonable guess at how to disambiguate results. Here, the authors offer a potential way forward by trying to identify the kinds of stimuli that will vs won't rely on processing beyond the ventral visual stream. The re-interpretation of the 2018 paper is pretty compelling.
We thank the Reviewer for the careful reading of our manuscript and for providing a fantistics synthesis of the current work.
Major weakness:
It is not clear that an off-the-shelf convolution neural network really is a great model of the ventral visual stream. Among other things, it lacks eccentricity-dependent scaling. It also lacks recurrence (as far as I could tell).
We agree with the Reviewer completely on this point: there is little reason to expect that off-the-shelf convolutional neural networks should predict neural responses from the ventral visual stream, for the reasons outlined above (no eccentricity-dependent scaling, no recurrence) as well as others (weight sharing is biologically implausible, as well as the data distributions and objective functions use to optimize these models). Perhaps surprisingly, these models do provide quantitatively accurate accounts of information processing throughout the VVS; while this is well established within the literature, we were careless to simply assert this as a given without providing an account of these data. We appreciate the Reviewer for making this clear and we have changed the manuscript in several critical ways in order to avoid making unsubstantiated claims in the current version. We hope that these changes also make it easier for the casual reader to appreciate the logic in our analyses. First, in the introduction, we outline some of the prior experimental work that demonstrates how deep learning models are effective proxies for neural responses throughout the VVS. We also demonstrate this model-neural fit in the current paper using electrophysiological recordings, but also including comments about the limitation of these models raised by the Reviewer.
In the introduction we also more clearly demarcate prior contributions from our recent computational work, and highlight how models approximate the performance supported by a linear readout of the VVS, but fail to reach human-level performance.
Results from these analyses were essential to understanding the logic of the paper but previously (as noted by the Reviewer) this critical evidence was cited but not directly presented. We include a description to these we describe these data in the introduction more thoroughly, and substantial change Figure 1, in order to visualize these data (b).
Moreover, we include a over of the methods and data used to generate these plots in the results and methods sections.
While there is little reason to expect that off-the-shelf convolutional neural networks should predict neural responses from the ventral visual stream, we believe that these modifications to the manuscript (to the introduction and figure one, as well as the results and methods sections) make clear that these models are nonetheless useful methods for predicting VVS responses and the behaviors that depend on the VVS.
To the authors' credit, they show detailed analysis on an image-by-image basis showing that in fine detail the model is not a good approximation of monkey choice behavior. This imposes limits on how much trust one should put in model performance as a predictor of whether the ventral visual cortex is sufficient to do a task or not. For example, suppose the authors had found that their model did more poorly than the monkeys (lesioned or not lesioned). According to their own logic, they would have, it seems, been led to the interpretation that some area outside of the ventral visual cortex (but not the perirhinal cortex) contributes to perception, when in fact it could have simply been that their model missed important aspects of ventral visual processing. That didn't happen in this paper, but it is a possible limitation of the method if one wanted to generalize it. There is work suggesting that recurrence in neural networks is essential for capturing the pattern of human behavior on some difficult perceptual judgments (e.g., Kietzmann et al 2019, PNAS). In other words, if the ventral model does not match human (or macaque) performance on some recognition task, it does not imply that an area outside the ventral stream is needed - it could just be that a better ventral model (eg with recurrence, or some other property not included in the model) is needed. This weakness pertains to the generalizability of the approach, not to the specific claims made in this paper, which appear sound.
We could not agree more with the Reviewer on these points. It could have been the case that these models' lack of correspondence with known biological properties (e.g. recurrence) led them to lack something important about VVS-supported performance, and that this would derail the entire modeling effort here. Surprisingly, this has not been the case, as is evident in the clear correspondence between model performance and monkey data in Eldridge et al. 2018. Nonetheless, we would expect that other experimental paradigms should be able to reveal these model failings. And future work evaluating PRC involvement in perception must contend with this very problem in order to move forward with this modeling framework. That is, it is of critical importance that these VVS models and the VVS itself exhibit similar failure modes, otherwise it is not possible to use these models to isolate behaviors that may depend on PRC.
A second issue is that the title of the paper, "Inconsistencies between human and macaque lesion data can be resolved with a stimulus-computable model of the ventral visual stream" does not seem to be supported by the paper. The paper challenges a conclusion about macaque lesion data. What inconsistency is reconciled, and how?
It appears that this point was lost in the original manuscript; we have tried to clarify this idea in both the abstract and the introduction. In summary, the cumulative evidence from the human lesion data suggest that PRC is involved in visual object perception, while there are still studies in the monkey literature that suggest otherwise (e.g. Eldridge et al. 2018). In this manuscript, we suggest that this apparent inconsistency is, in fact, simply a consequence of reliance on information interpretations of the monkey lesion data.
We have made substantive changes to the abstract so this is an obvious, central claim.
We have also made substantive changes to the introduction to make resolving this cross-species discrepancy a more central aim of the current manuscript.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
This manuscript describes experiments that lead to a potentially impactful result and most of the data seem very nice. The authors conducted a mutant screen to find the gene BbCrpa from a fungus resistant to cyclosporine A (CsA). Microscopy indicates that the mode of action is likely sequestration of the toxin in vacuoles, mediated through the P4-ATPase pathway. They also show that expression of BbCrpa in Verticillium renders that fungus resistant to CsA. The paper then takes a very large jump across kingdoms and toxins and asks if BbCrpa, expressed in plants, will confer resistance to a different toxin (cinnamon acetate) that is produced by Verticillium. They conduct disease assays on Arabidopsis and cotton and show promising results, but these assays are less thoroughly completed. They provide microscopic evidence that the transgenics accumulate CIA in vacuoles, which is consistent with the mode of action of the other systems. Overall, my assessment of the paper is that the authors may have a nice story, but the transition to plants needs to be better described and potentially supported by additional experiments. For example, the authors seem to conclude that this resistance mechanism will be a very broad spectrum. Is there a second toxin-producing pathogen that could be used to assess whether this is true?
Thanks for your advice! To answer the question that "Is there a second toxin-producing pathogen that could be used to assess whether this is true?", we added the data of another t toxin-producing pathogens, Fusarium oxysporum and another V. dahliae race, L2-1, to support the conclusion that BbCrpa can confer resistance of plants against pathogens. As expected, the expression of BbCRPA in Arabidopsis and cotton could also significantly increase the resistance to the pathogens we tested. New data were shown in Figure 5-figure supplement 1G-J.
Reviewer #2 (Public Review):
The fungus B. bassiana is one of few fungal species resistant to cyclosporine A and tacrolimus, naturally occurring microbial compounds with antifungal and immunosuppressive properties. The authors studied the mechanism of this resistance and found a novel vesicle-mediated transport pathway that directs the compounds to vacuoles for degradation. This hitherto unknown mode of detoxification is initiated by the activity of a phospholipid flippase of the P4-ATPase type. Interestingly, transgenically expressing the fungal flippase in plant model systems induces a similar detoxification pathway and makes the plants resistant to certain fungal toxins of secondary metabolism.
Strengths
The genetic screening, isolation of cyclosporine A (CsA) resistant mutants, and characterization of the causative gene BbCrpa are very solid with two independent alleles, a synthetic knockout strain, and rescue of the mutant phenotype.
BbCrpa protein function in detoxification is demonstrated convincingly by expression in another CsA-sensitive strain, as is its reliance on sites conveying ATPase activity for proper function. It is also functionally different from a relatively closely related P4-ATPase from yeast.
Using fluorescently labeled CsA and tacrolimus (FK506), it is nicely demonstrated how the compounds are going through the anterograde pathway all the way to the vacuole.
The authors demonstrate that vacuolar targeting is key for the detoxifying function of BbCrpa and identify the targeting motif that contains a ubiquitination site.
A trans-species approach (actually, trans-kingdom) confers that BbCrpa can also enhance vacuolar targeting of small toxic compounds to vacuoles in plants, which is quite astounding, given that plant endomembrane transport has quite a number of differences from that of fungi.
Weaknesses
It is not clear at which temporal scale CsA is going through the different endosomal compartments.
Thanks for your comments! We agree your idea that it is better to provide indication of the temporal scale of CsA entering into different endosomal compartments. Actually, we had tried to trace the distribution of CsA in cells many times. Unfortunately, the fluorescence of 5-FAM is weak and decreases fast compared with eGFP or mRFP protein, which made us difficult to capture the transient localization and moving trace of CsA in the cells. Nevertheless, the trail of BbCrpa, which carried CsA from the vesicles to early/late endosome, and vacuoles, can reflect the pathway of the cargo (Figure 3K, Supplementary file 1).
Can it be ruled out that the fluorescently labeled CsA and the GFP-tagged BbCrpa are stripped off their label and we are seeing the free label only?
Thanks! We accept your comments. In order to rule out the interference from the cleaved fluorescent proteins (i.e., eGFP and mRFP) or chemical compound (i.e. 5-FAM), we took eGFP/mRFP and 5FAM as control. New data about the localization of eGFP/mRFP and 5-FAM in B. bassiana hypha were provided in the revised manuscript. Our observation indicated that the distribution of fluorescent materials alone is different with the labeled ones, confirming the bona fide localization of the fusion proteins or compound. Please see Figure 2-figure supplement 2.
Reviewer #3 (Public Review):
In this manuscript, the authors have attempted to determine the molecular mechanisms underlying the resistance of an insect fungal pathogen Bauveria barbicans to cyclosporine A (CsA) and tacrolimus (FK506), known antifungal secondary metabolites that are also used extensively as immunosuppressing agents in medicine. By screening the random insertion mutant library of this pathogen, they identified the gene responsible for conferring resistance to CsA and FK506. The amino acid sequence of the gene identified it to be P4-ATPase, designated BbCrpa, which was hypothesized to be involved in vesicle-mediated transport. The identity of this gene as a CsA resistance gene was confirmed by demonstrating that disruption of this gene in B. barbicans confers susceptibility to CsA and FK506 and the expression of the wild-type gene in the BbCRPA knockout strain restores resistance to these compounds. In addition, expression of this gene in a plant pathogen Verticillium dahliae confers resistance to CsA and FK506.
The authors hypothesized that CsA/FK506 detoxification in the resistant B. barbiana strain used is through the BbCRPA-mediated vesicle transport process transporting these toxic metabolites to vacuoles through trans-Golgi (TGN)-early endosome (EE)-late endosomes (LE) pathway. To test this hypothesis, they employed a dual labeling system using 5-carboxyfluorescein fluorescently labeled CsA and FK506 and fusions of red fluorescent proteins (RFP) with BbRab5 GTPase (a marker for early endosomes), BbRab7 GTPase (a marker for late endosome) and pleckstrin homology domain of human oxysterol binding protein (PHOSBP) (a marker for trans-Golgi). By looking at the distribution of fluorescein-labeled CsA and FK506 in the wild-type and ΔBbCRPA cells using confocal microscopy, the authors have provided compelling evidence that these metabolites are transported to the vacuole. The co-localization of CsA with endocytic marker proteins also appears to be convincing for the most part. The co-localization of CsA with mRFP:: PHOSBP as shown in Fig. 2D seems less compelling. Also, in the confocal micrographs presented in Fig. 2, the distinction between early and late endosomes seems less convincing. It seems that there is significant heterogeneity in the early endosome and late endosome populations in the fungal cells.
1) The co-localization of CsA with mRFP::PHOSBP as shown in Fig. 2D seems less compelling.
Thanks a lot! According to your suggestion, we repeated the observation and replaced the original figure with new one (Figure 2D). The new figures clear indicates the co-localization of CsA with mRFP::PHOSBP.
2) Also, in the confocal micrographs presented in Fig. 2, the distinction between early and late endosomes seems less convincing. It seems that there is significant heterogeneity in the early endosome and late endosome populations in the fungal cells.
Thanks! We agree with your comments! Rab5 is widely used as a marker for early endosomes, while Rab7 is used as a marker for late endosomes. Nevertheless, early endosome and late endosome are hardly to be distinguished strictly. According to your suggestion, we repeated the observation, and replaced the Figure 2F and 2L, and Figure 3E with new ones. Our results indicated that mRFP::BbRab5 appeared largely in the lumen of vacuoles and some punctaes (early endosomes), and mRFP::BbRab7 locates to vacuolar membrane and late endosomal compartments. These can be seen in our observations in Figure 3D and 3E, which are consistent with the observations in Fusarium graminearum described by Zheng et al. (Zheng et al., 2018, New Phytologist, 219: 654671, DOI: 10.1111/nph.15178).
The authors addressed the question of whether BbCrpa acts as a component involved in vesicle trafficking through the trans-Golgi-endosomes to vacuoles. Ten different eGFP-BbCrpa fusion proteins were constructed and shown to provide detoxification of CsA and FK506. The BbCrpa is localized to the apical plasma membrane and spitzenkorper region of the germ tube. The evidence for localization of BbCrpa in trans-Golgi and vacuole is clear. However, the experimental data shown in Fig. 3D-F claiming localization of BbCrpa in EEs and LEs are somewhat difficult for this reviewer to interpret. It is also not clear to this reviewer why the two FM4-64 staining patterns in Fig. 3C and Fig. 3F are strikingly different. The evidence for co-localization of the fluorescein-labeled CsA or FK506 with RFP-labeled BbCrpa in vacuoles (Fig.3 H and J) is convincing. Figs. 3L-M depicting dynamic trafficking of BbCrpa from TGN to vacuoles using timelapse microscopy is interesting. In Fig. 3M, eGFP should be labeled eGFP::Drs2p. The authors have identified the N-terminal vacuole targeting motif in BbCrpa and shown that the C-terminal sequence from aa1326 to aa1359 is important for detoxification of CsA and FK506 in B. barbiana. In particular, the importance of three Tyr residues located in the C-terminal domain of the enzyme for CsA resistance is interesting.
1) The experimental data shown in Fig. 3D-F claiming localization of BbCrpa in EEs and LEs are somewhat difficult for this reviewer to interpret.
Thanks for your comments! P4-ATPases are implicated in the initiation of vesicle biogenesis and moves along with the vesicle (Panatala et al., 2015, Journal of Cell Science, 128: 2021-2032, DOI: 10.1242/jcs.102715; van der Mark et a., 2013, International Journal of Molecular Sciences, 14, 7897-7922, DOI: 10.3390/ijms14047897). In this study, the crucial issue to be addressed was the journey of CsA to the vacuole, which might be through BbCrpa-mediated TGN-EE-LE vesicle transport pathway. Therefore, we observed the localization of BbCrpa in TGN, EEs and LEs. It has been reported that small GTPase Rab5 is localized to the early endosomes (Bucci et al., 1992, Cell, 70: 715-728, DOI: 10.1016/0092-8674(92)90306-w), while Rab7 is to the late endosomal compartment (Vitelli et al., 1997, The Journal of Biological Chemistry, 272: 4391-4397, DOI: 10.1074/jbc.272.7.4391). Thus, Rab5 and Rab7 are used as marker proteins to indicate EEs and LEs, respectively. Nevertheless, Rab5 and Rab7 could also be observed in MVB (multivesicular bodies) or vacuoles (Toshima J.Y.,et al., 2014, Bifurcation of the endocytic pathway into Rab5-dependent and -independent transport to the vacuole, Nature Communication, 5:3498, DOI: 10.1038/ncomms4498; Zheng et al., 2018, New Phytologist, 219: 654-671, DOI: 10.1111/nph.15178). According to your suggestion, we repeated our observation and replaced Figure 3E with new one. In Figure3D, we can see mRFP::BbRab5 appeases largely in the lumen of vacuoles and some punctaes (early endosomes), and in Figure 3E mRFP::BbRab7 locates to late endosomal compartments and vacuolar membrane, which are consistent with the observations in Fusarium graminearum described by Zheng et al.(Zheng et al., 2018, New Phytologist, 219: 654671, DOI: 10.1111/nph.15178).
2) It is also not clear to this reviewer why the two FM4-64 staining patterns in Fig. 3C and Fig. 3F are strikingly different.
Thanks for your comments! FM4-64 is a styryl dye that can bind to the outer lipid leaflet of the plasma membrane and enter into cells through endocytosis (Scheuring et al., 2015, Methods in Molecular Biology, 1242:83-92, DOI: 10.1007/978-1-4939-1902-4_8). When the dye is internalized, it can be observed firstly in the membrane of vesicles and endosomal compartments, and then appears in the vacuolar membrane (Jelníková et al., 2010, Plant Journal, 61(5): 883-892, DOI: 10.1111/j.1365-313X.2009.04102.x; Löfke et al., 2013, Journal of Integrative Plant Biology, 55(9): 864-875, DOI: 10.1111/jipb.12097). In Figure 3C, we tried to show the evidence that eGFP::BbCrpa appears in vesicles that are stained by FM4-64, while in Figure 3F, we aimed to indicate eGFP::BbCrpa accumulates in mature vacuoles. Hence, FM4-64 staining patterns in Figure 3C and Figure 3F are somehow different.
3) In Fig. 3M, eGFP should be labeled eGFP::Drs2p.
Thanks for your reminder! We have modified it according to the suggestion. Please see Figure 3M.
Finally, the authors overexpressed BbCrpa gene in transgenic Arabidopsis and cotton plants to show that transgenic plants expressing this enzyme are protected from the toxic effects of the toxin cinnamyl acetate (CA) produced by the fungal pathogen Verticillium dahlia which causes vascular wilt disease in these plants. The data reported in Fig. 5A show that the transgenic Arabidopsis seed is able to germinate in presence of CA, whereas the nontransgenic control seed is not able to germinate. Evidence is presented that CA accumulates in the vacuole in transgenic Arabidopsis. However, the seedlings emerging from transgenic seeds are only partially protected from CA (Fig. 5A). It is also clear from the data presented in Figs. 5B-G that expression of the BbCrpa gene in transgenic Arabidopsis and cotton affords protection from infection by V. dahlia although no evidence for the expression of this gene at the protein level is presented. However, it seems likely that the transgenic lines only show delayed disease symptoms and are not truly resistant to this pathogen. The authors did not state clearly if Verticillium wilt disease resistance assays were performed on homozygous transgenic plants and their corresponding null segregants as negative controls. They also fail to provide evidence that the transgenic Arabidopsis and cotton challenged with the pathogen are able to grow to maturity and set viable seeds.
1)However, the seedlings emerging from transgenic seeds are only partially protected from CA (Fig. 5A).
Thanks for your comments! In this study, at the concentration of 50 μg/ml, the germination of wildtype seeds of Arabidopsis was severely inhibited while the transgenic seeds were still able to germinate. However, the growth of transgenic seedling was suppressed obviously compared with that of the untreated seedlings (Figure 5A). According to your suggestion, in the revised manuscript, we used “tolerance”, rather than “resistance” to weaken the statement.
2) However, it seems likely that the transgenic lines only show delayed disease symptoms and are not truly resistant to this pathogen. The authors did not state clearly if Verticillium wilt disease resistance assays were performed on homozygous transgenic plants and their corresponding null segregants as negative controls. They also fail to provide evidence that the transgenic Arabidopsis and cotton challenged with the pathogen are able to grow to maturity and set viable seeds.
Thanks for your comments! In our routine procedure for generating transgenic plant lines, we identified non-transgenic plants in the segregative generation (usually in T1 generation) of transformats, and then used these non-transgenic plants (null lines) as control to rule out the somatic variation from tissue culture. In the meantime, the homologous transgenic plants were identified in the segregative generation and propagated by selfing. Relevant descriptions were added in the section of Methods & Materials (Lines 783-795).
We agree with your opinion. The resistance displayed in seedlings does not always match that in maturity stage, because the resistance of host to Verticilium pathogen can be affected by environmental conditions, for example, temperature and nutrition. Nevertheless, in the case of our transgenic plants, the resistance to Verticilium disease is endowed from the detoxic function of BbCrpa. Theoretically, such transgenic traits will not be significantly affected by the environmental conditions if the expression of transgenes is stable. We had detected the expression level of BbCRPA during plants growth and in deferent generation (to T5 generation). The expression of BbCRPA gene was stable and the resistance to the diseases is descendible.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
This is a well-conceived and well-executed investigation of how activation loop autophosphorylation and IN-box autophosphorylation synergistically activate AURKB/INCENP. An elegant chemical ligation strategy allowed construction of the intermediate phospho-forms so that the contributions of each phosphorylation event to structure, dynamics, and activity could be dissected. Autophosphorylation at both sites serves to rigidify both AURKB and the IN-box, and to coordinate opening, twisting, and activation loop movements. Consistent with previous findings, both sites are necessary for enzymatic activity; further, this work finds that activation loop autophosphorylation occurs slowly in cis while INbox autophosphorylation occurs quickly in trans.
Due to abundant previous work in the field, many of the conclusions of this paper were expected. However, that does not diminish the quality of the work, and the addition of how kinase dynamics contribute to activation is important for AURKB and many other kinases. The experimental results are clear and interpreted appropriately, with good controls. The computational work is also clearly explained and directly tied to the function of the enzyme, making it highly complementary to the experimental findings and to previously published structures.
We thank the reviewer for positive words about our work.
Some minor limitations of the study:
1) Of note when interpreting the HDX data, there is no coverage of the peptide containing the activation loop autophosphorylation site T248 (Fig S2A), and as mentioned in the Discussion, the time scale of HDX is not able to capture differences in exchange in very flexible regions like the activation loop.
The peptides spanning the region containing the phosphorylated Aurora BThr248 are not shown in our coverage map because they do not meet the stringent quality criteria for peptides that we used for HDX analysis (see Material and Methods). However, we have compared these peptides in phosphorylated and unphosphorylated enzyme complex manually and added a paragraph 4 on page 4.
“The peptides spanning the region containing the phosphorylated Aurora BThr248 are not shown in our coverage map (Figure 1-figure supplement 2A) because they did not pass the stringent peptide quality filter based on intensity, and redundancy of the peptide. However, upon manual analysis, we did not detect any changes in deuterium uptake between the phosphorylated and unphosphorylated forms in this region. Deuterium exchange in this part of the protein (which is also observed in the peptides immediately upstream of Aurora BThr248, see Supplementary file 5) is very rapid, independently of enzyme phosphorylation, so that complete exchange occurs even at the earliest time points. This is in contrast to the second part of the activation loop, which includes the Aurora BaEF helix (labeled region 3 in Figure 1A; peptide 254-260 in Supplementary file 5), where we clearly see HDX protection upon phosphorylation. It is possible that phosphorylation causes dynamic changes on a very fast scale (seconds or faster) in the part of the protein encompassing Aurora BThr248, but we could not detect them due to the limitation of our approach, which operates on the scale of minutes.“
Also, we analyzed the peptides covering this region to confirm the extent of phosphorylation in the loop (Figure 3-figure supplement 2A).
2) Some data lack robust statistical analysis, which would make the findings more compelling.
We have now included statistical analysis throughout the paper where it was possible.
3) One point that might be clarified is how the occupancy of T248 was confirmed to be either fully phosphorylated in the [AURKB/IN-box]IN-deltaC or fully dephosphorylated in the IN-box K846N/R827Q mutant. Especially because T248 autophosphorylation is found to occur in cis, it is unclear how incubating the [AURKB/IN-box]IN-deltaC with traces of wild-type [AURKB/IN-box]all-P would ensure that T248 is phosphorylated.
We confirmed phosphorylation occupancy of Aurora BThr248 by mass spectrometry in [Aurora B/IN-box]allP and [Aurora B/IN-box]loop-P but not for [AURKB/IN-box]no-P (Figure 3-figure supplement 2A). To achieve complete phosphorylation in the activation loop of [Aurora B/IN-box]IN-DC, we incubated this construct with fully active [Aurora B/IN-box]all-P. This is because, according to previous kinetic analysis, cisphosphorylation of Aurora BThr248 is only obligatory when the entire enzyme population is in the nonphosphorylated state. Once a fraction of the Aurora B population has been partially or fully activated, phosphorylation of Aurora BThr248 can also occur in trans, by the already activated enzyme. In other words, our model proposes an obligatory initial intramolecular step followed by propagation of activation in trans as reported by (Zaytsev, Segura-Peña at al, eLife.2016). We have now clarified this on page 11, paragraph 2 where we explain the results of the autoactivation kinetics.
“It is noteworthy that phosphorylation of the activation loop in cis is the first necessary step in the autoactivation process, assuming a completely unphosphorylated enzyme pool. However, a partially active or fully active enzyme can phosphorylate the activation loop in trans. This type of activation mechanism with an initial intramolecular activation step followed by an intermolecular step of activation have been previously reported for PAK2 (J. Wang et al., 2011) and for Aurora B (Zaytsev et al., 2016).”
Reviewer #2 (Public Review):
This study presents a dynamic, multi-step model for the activation of Aurora-B kinase through the interaction with INCENP and autophosphorylation. This interaction is critical to the proper execution of chromosome segregation, and key details of the mechanism are not resolved. The study is an advance on previous studies on Aurora-B and the related kinase Aurora-C, primarily because it clarifies the roles of the different phosphorylation sites. However, major differences in the details of the molecular interactions are presented that are not clearly backed up by the evidence due to limitations in the approach, when compared to previous work based on crystal structures.
Strengths. The experimental approach to the analysis of the Aurora-B/INCENP interaction is sound and novel and it is striking example of preparation of proteins in specific phosphorylation states, and of using HDX to characterise localised changes in the structural dynamics of a protein complex. The authors have generated two intermediate phosphorylation states of the complex, enabling them to dissect their contributions to the regulation of structural dynamics and activity of the complex.
Weaknesses. The major weakness of the study is the molecular dynamics simulation. The resulting model of the complex differs from the crystal structure of the Aurora-C/IN-box structure in key details, and these are neither described clearly nor explained. The challenges/limitations of simulation of phosphorylated proteins should be described.
We thank the reviewer for the positive words about our work and the criticism that helped us to improve our manuscript. We have now extended the MD studies that confirm our original observations regarding the entropic nature of the IN-box and the effect of phosphorylation on the structure and dynamics of [Aurora B/IN-box]. We clarify that the conformation of [Aurora B/IN-box]all-P observed in the simulations is not the final folded state, but a productive intermediate in the activation pathway of [Aurora B/IN-box]. For this reason, the differences from the [Aurora C/IN-box] crystal structure do not indicate flaws in the simulations. On the contrary, we believe that the data from the MD simulations provide crucial insights into the dynamical properties of the system that could not otherwise be assessed.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #2 (Public Review):
1) It has been reported that PHD fingers can bind to DNA in addition to lysine-methylated histone H3. Can the authors address whether or not the enhanced selectivity of PHD-nucleosome interactions over PHD-peptide interactions is due to PHD-DNA binding?
We apologize for not making this clearer in our initial manuscript. We did test the ability of our PHD readers to bind nucleosomal DNA of various lengths and observed no significant engagement (Figure 1 - figure supplement 1B). This is emphasized in the revised text.
2) What's the binding affinities of PHD-nucleosome interactions and PHD-peptide interactions, respectively?
The relative EC50 (EC50rel) for these interactions (Figure 1 - figure supplement 1C-D and Figure 2 - figure supplement 1H) are consistent with others using Alpha/dCypher technologies (e.g. doi.org/10.1101/ 2022.02.21.481373v1; which also contains a detailed description of EC50rel calculation and the difference between this value and an equilibrium Kd).
3) Histone H4K5acK8ac is a well-known site-specific histone acetylation mark for gene transcriptional activation, much more so than histone H3 acetylation. Does H4K5K8 acetylation enhance PHD-H4K3me3 binding in nucleosome?
We appreciate the reviewer for asking this question. In our studies, we tested H4K5ac and H4K8ac binding individually but do not have a nucleosome with the dual H4K5ac8ac nucleosome. Given the limited amount of time and resources we had for making more nucleosomes, we felt our efforts were better spent on developing heterotypic nucleosomes to answer the more striking cis vs. trans question posed by both reviewers.
4) The authors provided the data showing cis histone H3 tail lysine acetylation effects on PHDH4K3me3 binding. What about trans histone H3 lysine acetylation effects?
Thank you for this suggestion. To address this, we expended considerable resources to create new fully PTM-defined heterotypic (to accompany our homotypic) nucleosomes (note nomenclature to minimize confusion with asymmetric/symmetric DNA methylation) to directly test whether MLL1’s activity enhancement in the context of H3 tail acetylation occurs in cis or in trans. As shown in Figure 2D, enhancement of H3K4 methylation only occurs with heterotypic nucleosomes that have an available H3K4 residue with tail acetylation in cis (H3K4me3 • H3K9acK14acK18ac (hereafter H3triac)) and is not seen in H3K4 methylatable nucleosomes with tail acetylation in trans (H3 -> H3K4acK9acK14acK18ac (hereafter H3tetraac)). These exciting new findings greatly strengthen our study and provide more definitive mechanistic details of H3ac → H3K4me regulation.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #2 (Public Review):
This manuscript reports an experiment involving learning and imaging of neural activity in rats. The goal was to test if scopolamine, which is an antagonist of acetylcholine receptors, could cause memory loss (amnesia). Two types of learning were tested: first, rats learned to prefer a short path, compared to a detour path, between two rewarded locations in a linear maze; second, in a subset of the experimental sessions, a shock zone was activated in the middle of the short path, and rats had to learn to avoid it. As a control, some sessions had a clear plexiglass barrier placed in the middle of the short path, which should not have aversive properties. The order of sessions was different for different groups of rats, but shock learning was always followed by a number of 'extinction' sessions without shock. In some groups, shock learning was accompanied by a systemic (intraperitoneal) scopolamine injection, 30 min before the start of the session. This manipulation was performed on most rats once but at a different slot in the sequence of sessions (sometimes before the drug-free shock learning, sometimes after it, sometimes in the absence of preceding barrier sessions, sometimes after them). In what follows, I might use the terms 'control group' and 'test group' to refer to sessions without scopolamine and sessions with it, respectively.
The main behavioural results are that rats increase their visits to the short path with learning, then visit less the short path once the shock zone is active or when the barrier is there. When re-tested in later sessions, rats trained in the absence of the scopolamine injection still avoid the short path, while most of the rats that were given the scopolamine injection do not avoid it, suggesting a deficit in encoding or recall of the shock zone memory.
In addition to these behavioural manipulations, the authors image the activity of dorsal CA1 hippocampal neurons using calcium imaging. They detect the existence of place cells, which increase their firing on specific portions of the short path of the maze (the long path data is not analysed). When comparing data before the shock training to during shock training, control place cells were more stable (i.e. had increased between-session correlations) and had more recurrent place fields (i.e. spatially active in one session then still active in another session) with respect to test data (rats injected with scopolamine). When comparing the pre-shock session and the first extinction session, place cell activity was less similar in the control rats (no scopolamine) compared to the scopolamine rats; but note that for scopolamine rats, extinction occurred earlier, so instead of using the first extinction session, the 4th session post-shock training was used to match the control data. Place cell activity has been shown to allow decoding of the animal's position; here, position decoding accuracy was lower around the shock zone in the control group compared to the scopolamine group.
From these analyses, the manuscript proposes the following findings: 1) scopolamine injections impair avoidance learning, and 2) scopolamine affects the long-term response of place cells to the aversive experience (less "remapping"). These findings are interpreted to support the idea that 3) place cell remapping is involved in avoidance/aversive learning and 4) that scopolamine, as an antagonist of the muscarinic acetylcholine receptors in the hippocampus (or elsewhere?), produces amnesia.
These findings, if properly supported, would be very interesting to a wide range of researchers interested in the neural bases of memory and learning, specifically aversive memory and spatial learning. The manuscript is well-written, has the advantage of using both male and female rats (which have consistent results), is one of the rare studies to date to perform calcium imaging of the hippocampus in rats, and records along learning of two simple tasks which seems relatively ecological and produce robust learning effects, and uses an experimental manipulation (injection of scopolamine) instead of purely correlational measures. The authors make some analytical effort in equalizing the number of trials across different sessions (even though I do not believe this fixes the existing confounds). I particularly appreciated the nice '3D' trajectory plots that show the unfolding of behaviour along a given session and that each individual's data are generally shown in the figures.
However, the experiment and its analysis seem to have some major flaws both in the experimental design (which may be difficult to fix) as well as in the analysis (which might be easier to fix), which prevent proper interpretation of the results. Specifically:
- To demonstrate finding 1 (that scopolamine specifically impairs avoidance learning), a control would be needed to show that the injection procedures do not impair general behaviour (e.g. motivation, attention, level of stress) as well as other forms of learning. Indeed, the control rats - as far as I understood - are not injected with saline, which would have been an appropriate control. One example of non-specific confounding effects of scopolamine is that it could, for example, reduce sensitivity to pain, thus to some extent decreasing the relevance of the shock to the rats, but many other interpretations are possible; most revolve around the idea that instead of scopolamine impairing learning, scopolamine might impair behaviour, which might, in turn, impair learning. Indeed, the scopolamine injection is shown to decrease running speed and the number of trials run, even before exposure to the shock. Related to this, the "short path preference" does not seem to be quantified properly: instead of simply using the number of visits to the short path, a better measure would be to compute a relative preference index quantifying visits to the short path with respect to visits to the long path [e.g. (num short - num long) / num total], to focus on the preference regardless of global changes in behavioural activity levels. In summary: the proposition that scopolamine specifically impairs avoidance learning has not been convincingly demonstrated; the possibility that it even impairs any form of learning is not currently demonstrated either.
We have run an additional saline-only control group (along with additional scopolamine groups) to demonstrate that scopolamine does impair avoidance learning. As shown in the Supplement to Fig. 1, rats receiving saline alone show significantly greater post-training avoidance of the short path than mice receiving scopolamine.
- For similar reasons, finding 2 (that the place cell response to aversive learning is affected by the scopolamine injection) is subject to the same lack of controls and existence of possible confounds noted above. Specifically, running more slowly and running fewer laps would have affected the overall amount of excitation of place cells during the session, which might affect plasticity, as well as the amount of reactivations/replay at the reward sites, which is likely to have effects in terms of memory consolidation. One way to potentially control for this would be to have the control group run the same amount of trials as the test group (but then session durations would be different); it is unclear how to prevent the difference in running speed. To be able to claim that the effects of scopolamine are specific to aversive learning, a control with either no learning (perhaps the long path data would be useful for this?) or appetitive learning (e.g. of a reward location, which also involves place field reorganization in some cases) would be useful.
We recognize and understand the referee’s valid concerns about these potential confounds. The revised paper makes more clear that the scopolamine condition is designed as a control for whether an aversive stimulus is remembered or forgotten, and the barrier condition is a control for whether a novel path-blocking stimulus is aversive or neutral. As the referee points out, there are other confounding variables that may covary with these manipulated factors. The revised discussion (ll. 544-559) acknowledges potential confounds arising from learning-induced behavior changes, and argues that even though it is not possible to perfectly control for such changes, our current study does so more effectively than most prior studies because the rat’s behavior during isolated beeline trials is highly stereotyped and thus more similar across experimental conditions than in any prior study that we know of. The revised discussion also acknowledges the difficulty of dissociating acquisition versus extinction effects upon remapping (ll. 633-644). The significance of the barrier manipulation is now acknowledged more clearly in the abstract, introduction, and discussion.
- Statement 3 implies a causal link between the two first statements, suggesting that place cell remapping would be necessary for the memory of an aversive experience or aversive location. Given the weakness of the arguments supporting the first 2 statements, this is also non convincingly demonstrated. In any case, the current paradigm would not be sufficient to make a causal link, but it might be sufficient to show a correlational link by showing a correlation between the amount of remapping and memory performance, such as presented in supplementary figure 5 (which would still be informative even if results from the scopolamine sessions were removed?).
We agree with the referee’s point that our study’s evidence is correlational in nature. The revised manuscript prominently acknowledges this in the concluding sentence of the discussion’s opening paragraph (ll. 500-503), which now reads: “While these results do not definitively prove that place cell remapping is causally necessary for storing memories of aversive encounters, they provide correlational evidence that remapping occurs selectively under conditions where a motivationally significant (rather than neutral) stimulus occurs and is subsequently remembered rather than forgotten.”
- Statement 4 - that scopolamine causes amnesia - is both not fully defined (what form of amnesia?) and not supported by the findings for the reasons mentioned above.
It is unclear what remedy the referee is recommending for this concern. We do not present the idea that scopolamine is an amnesic drug as a novel conclusion of our study; rather, this is a widely accepted view in the literature that motivated our experimental design decision to use scopolamine as a tool for dissociating whether an aversive event was remembered or forgotten. We recognize that scopolamine’s effects on memory may vary with experimental conditions. In the revised discussion, we extensively compare and contrast our experimental findings with acute and chronic results from numerous prior studies using scopolamine and other cholinergic drugs (ll. 561-678). We hope this is sufficient to address the referees concerns.
- In addition to these concerns, a study cited here (Sun et al 2021) mentions a few references in the discussion regarding how muscarinic receptor agonists might affect the link between spikes and calcium signals. Scopolamine is a muscarinic receptor antagonist and might thus have related/reversed effects. Thus, the technique used (calcium imaging) does not seem the best to address questions related to scopolamine. The current manuscript also mentions some findings that were not replicated (e.g. lack of over-representation of the shock zone) which are probably due to the fact that the finding relied on extra-field isolated spikes, which are less likely to be detected via calcium imaging.
This is an excellent point which is now addressed in the revised discussion; it is acknowledged (ll. 536-539) that mAChRs can regulate calcium signals and thus that scopolamine may have different effects on spikes detected from calcium imaging versus electrophysiology, which in turn could account for discrepancies between our finding that place fields do not migrate to aversively reinforced locations and Milad et al.’s (2019) findings that they do. The Sun et al. (2021) paper used calcium imaging methods similar to ours, so this factor is less likely to account for the discrepancy between their prior finding that place fields were acutely disrupted by scopolamine and our current finding that they were not.
- If anything, perhaps targeted injections in a specific brain region (e.g. dorsal CA1), instead of systemic injection, might give a more precise picture of the effects of scopolamine on place cells and spatial memory, but I do not know if this is technically possible.
Unfortunately the necessary placement of the GRIN lens above the recording location prevented the direct application of scopolamine there via cannulae. To date only one series of experiments has demonstrated single unit place cell recordings with direct microdialysis (Brazhnik et al. 2003, 2004). To study the effects of aversive learning across many days, we needed to utilize a recording method capable of tracking many cells across long time periods. However, systemic scopolamine has been widely used to study both learning (Anagnostaras et al. 1999; Huang et al. 2011; Svoboda et al. 2017) and its effects on place cells (Douchamps et al. 2013; Newman et al. 2017; Sun et al. 2021), thus by utilizing this method we can directly compare our findings with previous work. We have added a paragraph to the discussion (ll. 665-678) in which it is explained why the main conclusions of our study (namely, that place cell cell remapping is related to storage of memories for aversive events) do not depend upon whether or not scopolamine’s pharmacological actions were localized to the hippocampus (almost certainly they were not).
My conclusion would be that the experiment either needs to be redesigned to address the original question (effect of scopolamine on place cell firing and aversive learning) or that some of the data could be still used to address different questions which have not been addressed with calcium imaging before, e.g. learning of the short path, activity on the short path vs long path, effects on behaviour and place cell activity of learning & extinction of the barrier and shock zone avoidance; perhaps without focusing on the scopolamine manipulations, which seem to introduce many confounds.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #2 (Public Review):
Kim et al. examined the properties of neuronal connections responsible for inhibitory cell activation to show that the characteristics examined were similar in humans and rodents. This is important, as it suggests that the many rodent studies carried out over the past decades are physiologically relevant to humans.
Strengths
1) Human brain tissues are difficult to obtain, hence the study provides valuable insights
2) An impressive multipronged approach was used for cell classifications
3) Despite the lack of novel findings, the revelation of the similarities between human and rodent synapses is important and has far-reaching implications. This important finding suggests the knowledge generated from rodent research is, at least partly, physiologically relevant to and transferrable to humans.
Weaknesses
1) The study is descriptive by design, and hence provides limited conceptual advances, especially with the retrospect that synaptic properties are similar between humans and rodents (although see strength #3). For example, very similar findings and techniques have already recently been reported by a number of the same authors in the Campagnola et al., Science 2022 paper.
We agreed that stimulus protocols of connectivity assays with multiple patch-clamp recordings in this study had been adapted from the recent publication (Campagnola et al., Science 2022). In this previous study, especially for human synaptic connectivity data, the main cell type categorization was at the level of excitatory and inhibitory neurons which identified based on morphological features and observed PSP characteristics (e.g., direction of membrane potential changes) when it connected each other. However, we went further to identify interneuron subclasses in the connectivity assays using virally labeled slice cultures and post-hoc HCR staining in addition to intrinsic classifier, which is not investigated from the recent publication (Campagnola et al., 2022). Therefore, following scientific findings and their implications are not the same shown in the previous study and we think this study provides a significant advance of our understanding in human cortical circuits organization.
2) Despite the fact that normal physiology was reported, the use of pathological human brain tissue could affect the results.
We agreed that the use of pathological human brain tissue to investigate normal physiology is not ideal, however, as mentioned in the METHODS below (section of “Acute slice preparation”), our surgically resected neocortical tissues show minimal pathology, and we believe these tissue preparations can be used to address normal physiological properties of human neurons. Importantly, we saw no effect of disease state (epilepsy vs. tumor) on the intrinsic or synaptic properties that we measured. Our METHODS state that “Surgically resected neocortical tissue was distal to the pathological core (i.e., tumor tissue or mesial temporal structures). Detailed histological assessment and using a curated panel of cellular marker antibodies indicated a lack of overt pathology in surgically resected cortical slices (Berg et al., 2021).”. We also state in the RESULTS that “These tissues were distal to the epileptic focus or tumor, and have shown minimal pathology when examined (Berg et al., 2021). Brain pathology was evaluated using six histological markers that were independently scored by three pathologists. Surgically resected tissues have been used extensively to characterize human cortical physiology and anatomy (Berg et al., 2021).”. Lastly, this is the best possible human tissue available for us to conduct physiological experiments. It is an unavoidable caveat of this work that our healthy brain tissue was derived from a donor brain exhibiting a serious disease.
3) The manuscript may not be easy to understand for the uninvited, because many concepts and abbreviations were not properly introduced.
Thank you for pointing this oversight out. We updated our manuscript and made sure that we fully describe all abbreviations. We now changed the abbreviation of MPC back to multiple patch-clamp recording, and some other abbreviations such as LAMP5, SLC17A7, DLX are now better explained. We have also changed the order of multiple figures (i.e., Figure 5 – Figure supplements to Figure 3 – Figure supplements) and removed some complicated figures (e.g., Figure 1 – Figure supplement 1) to present the data in a fashion that can be understood by a more general reader.
4) The statistical treatment is not ideal, so some conclusions may not be valid.
We performed additional statistical analyses as suggested and implemented in the text of the RESULTS.
Furthermore, we also made additional Figure supplements (Figure 4 – Figure supplement 3, Figure 4 – Figure supplement 4, Figure 6 – Figure supplement 2, and Figure 6 – Figure supplement 3) to support our conclusions.
5) The mixed usage of acute and cultured slices is not ideal and likely affects the outcome.
We agree that the mixed usage of acute and cultured slices is not ideal, and it could affect the interpretation of outcome. Therefore, we performed additional analyses to see if there is any correlated change of synaptic property (i.e., paired pulse ratio) along the days after slice culture (now implemented in Figure 4 – Figure supplement 4 and Figure 6 – Figure supplement 3) and we didn’t find any significant correlation. However, we noticed the short-term synaptic dynamics are rather differentiated between acute and slice culture condition shown in Figure 4 – Figure supplement 1d. We think this is due to sampling bias rather than tissue preparation difference and these points are now more carefully described in the DISCUSSION as “This difference we observed in this study, i.e., more facilitating synapses were detected in slice cultures than in acute slices, could either reflect an acute vs. slice culture difference. However, we believe it is more likely to reflect a selection bias for PVALB neurons when patching in unlabeled acute slices, and that the AAV-based strategy with a pan-GABAergic enhancer allows a more unbiased sampling of interneuron subclasses whose properties are preserved in culture. In support of this, PPR analysis as a function of days after slice culture shows no relationship to acute versus slice culture preparation (Figure 4 – Figure supplement 4, Figure 6 – Figure supplement 3). Furthermore, we have observed that viral targeting of GABAergic interneurons greatly facilitates sampling of the SST subclass in the human cortex compared to unbiased patch-seq experiments (Lee et al., 2022), and this selection bias likely explains synapse type sampling differences in cultured slices compared to acute preparations.”.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
We would like to extend our thanks to the reviewers who took the time to carefully read our paper and provide thoughtful insights and suggestions on how to strengthen our conclusions. All reviewers agreed that our study presented strong data supporting a role for triglyceride lipase brummer (bmm) in regulating testis lipid droplets and spermatogenesis in Drosophila, and that our findings advance our understanding of lipid biology during sperm development. Reviewers also made several helpful suggestions on how to strengthen our manuscript even further. Below, we provide a brief outline of our plans to revise this manuscript in response to reviewer comments.
The majority of reviewer comments will be addressed by text changes, rearranging figures to add images, and making a model to visually represent our findings. Together, these changes will ensure we clearly communicate our data and conclusions with readers, and properly contextualize our findings. See below for details on our planned revisions.
Reviewer #1 (Public Review):
In this study, the authors investigate the role of triglycerides in spermatogenesis. This work is based on their previous study (PMID: 31961851) on triglyceride sex differences in which they showed that somatic testicular cells play a role in whole body triglyceride homeostasis. In the current study, they show that lipid droplets (LDs) are significantly higher in the stem and progenitor cell (pre-meiotic) zone of the adult testis than in the meiotic spermatocyte stages. The distribution of LDs anti-correlates with the expression of the triglyceride lipase Brummer (Bmm), which has higher expression in spermatocytes than early germline stages. Analysis of a bmm mutant (bmm[1]) - a P-element insertion that is likely a hypomorphic - and its revertant (bmm[rev]) as a control shows that bmm acts autonomously in the germline to regulate LDs. In particular, the number of LDs is significantly higher in spermatocytes from bmm[1] mutants than from bmm[rev] controls. Testes from males with global loss of bmm (bmm[1]) are shorter than controls and have fewer differentiated spermatids. The zone of bam expression, typically close to the niche/hub in WT, is now many cell diameters away from the hub in bmm[1] mutants. There is an increase in the number of GSCs in bmm[1] homozygotes, but this phenotype is probably due to the enlarged hub. However, clonal analyses of GSCs lacking bmm indicate that a greater percentage of the GSC pool is composed of bmm[1]-mutant clones than of bmm[rev]-clones. This suggests that loss of bmm could impart a competitive advantage to GSCs, but this is not explored in greater detail. Despite the increase in number of GSCs that are bmm[1]-mutant clones, there is a significant reduction in the number of bmm[1]-mutant spermatocyte and post-meiotic clones. This suggests that fewer bmm[1]-mutant germ cells differentiate than controls. To gain insights into triglyceride homeostasis in the absence of bmm, they perform mass spec-based lipidomic profiling. Analyses of these data support their model that triglycerides are the class of lipid most affected by loss of bmm, supporting their model that excess triglycerides are the cause of spermatogenetic defects in bmm[1]. Consistent with their model, a double mutant of bmm[1] and a diacylglycerol O-acyltransferase 1 called midway (mdy) reverts the bmm-mutant germline phenotypes.
There are numerous strengths of this paper. First, the authors report rigorous measurements and statistical analyses throughout the study. Second, the authors utilize robust genetic analyses with loss-of-function mutants and lineage-specific knockdown. Third, they demonstrate the appropriate use of controls and markers. Fourth, they show rigorous lipidomic profiling. Lastly, their conclusions are appropriate for the results. In other words, they don't overstate the results.
We thank the Reviewer for their positive assessment of our paper.
There are a few weaknesses. Although the results support the germline autonomous role of bmm in spermatogenesis, one potential caveat that the mdy rescue was global, i.e., in both somatic and germline lineages. The authors did not recover somatic bmm clones, suggesting that bmm may be required for somatic stem self-renewal and/or niche residency. While this is beyond the scope of this paper, it is possible that somatic bmm does impact germline differentiation in a global bmm mutant.
In the revised manuscript, we will more clearly delineate when we used global versus germline-only loss of mdy to rescue bmm mutant phenotypes in the testis. We will also acknowledge the possibility that somatic bmm may play a role in germline differentiation in a global bmm mutant.
Regarding data presentation, I have a minor point about Fig. 3L: why aren't all data shown as box plots (only Day 14 bmm[rev] does). Finally, the authors provide a detailed pseudotime analysis of snRNA-seq of the testis in Fig. S2A-D, but this analysis is not sufficiently discussed in the text.
We will make text and presentation changes in the revised manuscript to describe our data more clearly, and will add text to describe our pseudotime analysis of single-cell RNA seq data in more detail.
Overall, the many strengths of this paper outweigh the relatively minor weaknesses. The rigorously quantified results support the major aim that appropriate regulation of triglycerides are needed in a germline cell-autonomous manner for spermatogenesis.
This paper should have a positive impact on the field. First and foremost, there is limited knowledge about the role of lipid metabolism in spermatogenesis. The lipidomic data will be useful to researchers in the field who study various lipid species. Going forward, it will be very interesting to determine what triglycerides regulate in germline biology. In other words, what functions/pathways/processes in germ cells are negatively impacted by elevated triglycerides. And as the authors point out in the discussion, it will be important to determine what regulates bmm expression such that bmm is higher in later stages of germline differentiation.
We agree with the reviewer about the many interesting future directions for this project. We will therefore add a model figure in the revised manuscript to visualize our findings and highlight remaining questions about how bmm and triglycerides support normal spermatogenesis in Drosophila.
Reviewer #2 (Public Review):
Summary:
Here, the authors show that neutral lipids play a role in spermatogenesis. Neutral lipids are components of lipid droplets, which are known to maintain lipid homeostasis, and to be involved in non-gonadal differentiation, survival, and energy. Lipid droplets are present in the testis in mice and Drosophila, but not much is known about the role of lipid droplets during spermatogenesis. The authors show that lipid droplets are present in early differentiating germ cells, and absent in spermatocytes. They further show a cell autonomous role for the lipase brummer in regulating lipid droplets and, in turn, spermatogenesis in the Drosophila testis. The data presented show that a relationship between lipid metabolism and spermatogenesis is congruous in mammals and flies, supporting Drosophila spermatogenesis as an effective model to uncover the role lipid droplets play in the testis.
We thank the Reviewer for their positive assessment of our paper.
Strengths and weaknesses:
The authors do a commendably thorough characterization of where lipid droplets are detected in normal testes: located in young somatic cells, and early differentiating germ cells. They use multiple control backgrounds in their analysis, including w[1118], Canton S, and Oregon R, which adds rigor to their interpretations. The authors employ markers that identify which lipid droplets are in somatic cells, and which are in germ cells. The authors use these markers to present measured distances of somatic and germ cell-derived lipid droplets from the hub. Because they can also measure the distance of somatic and germ cells with age-specific markers from the hub, these results allow the authors to correlate position of lipid droplets with the age of cells in which they are present. This analysis is clearly shown and well quantified.
The quantification of lipid droplet distance from the hub is applied well in comparing brummer mutant testes to wild type controls. The authors measure the number of lipid droplets of specific diameters, and the spatial distribution of lipid droplets as a function of distance from the hub. These measurements quantitatively support their findings that lipid droplets are present in an expanded population of cells further from the hub in brummer mutants. The authors further quantify lipid droplets in germline clones of specified ages; the quantitative analysis here is displayed clearly, and supports a cell autonomous role for brummer in regulating lipid droplets in spermatocytes.
Data examining testis size and number of spermatids in brummer mutants clearly indicates the importance of regulating lipid droplets to spermatogenesis. The authors show beautiful images supported by rigorous quantification supporting their findings that brummer mutants have both smaller testes with fewer spermatids at both 29 and 25C. There is also significant data supporting defects in testis size for 14-day-old brummer mutant animals compared to controls. The comparison of number of spermatids at this age is not significant, which does not detract from the the story but does not support sperm development defects specifically caused by brummer loss at 14 days. Their analysis clearly shows an expanded region beyond the testis apex that includes younger germ cells, supporting a role for lipid droplets influencing germ cell differentiation during spermatogenesis.
We thank the reviewer for pointing out this inaccuracy in our manuscript. In the revised manuscript we will choose more precise language to describe defects in sperm development in 14-day-old bmm mutants.
The authors present a series of data exploring a cell autonomous role for brummer in the germline, including clonal analysis and tissue specific manipulations. The clonal data indicating increased lipid droplets in spermatocyte clones, and a higher proportion of brummer mutant GSCs at the hub are convincing and supported by quantitation. The authors also show a tissue specific rescue of the brummer testis size phenotype by knocking down mdy specifically in germ cells, which is also supported by statistically significant quantitation. The authors present data examining the number of spermatocyte and post-meiotic clones 14 days after clonal induction. While data they present is significant with a 95% confidence interval and a p value of 0.0496, its significance is not as robust as other values reported in the study, and it is unclear how much information can be gained from that specific result.
We thank the reviewer for raising this point. In the revised manuscript we will display the p-value clearly to ensure our statistical output is clear for readers to evaluate our conclusions regarding bmm mutant clones 14 days after clone induction.
The authors do a beautiful job of validating where they detect brummer-GFP by presenting their own pseudotime analysis of publicly available single cell RNA sequencing data. Their data is presented very clearly, and supports expression of brummer in older somatic and germline cells of the age when lipid droplets are normally not detected. The authors also present a thorough lipidomic analysis of animals lacking brummer to identify triglycerides as an important lipid droplet component regulating spermatogenesis.
Impact:
The authors present data supporting the broad significance of their findings across phyla. This data represents a key strength of this manuscript. The authors show that loss of a conserved triglyceride lipase impacts testis development and spermatogenesis, and that these impacts can be rescued by supplementing diet with medium-chain triglycerides. The authors point out that these findings represent a biological similarity between Drosophila and mice, supporting the relevance of the Drosophila testis as a model for understanding the role of lipid droplets in spermatogenesis. The connection buttresses the relevance of these findings and this model to a broad scientific community.
Reviewer #3 (Public Review):
In this manuscript, Chao et al seek to understand the role of brummer, a triglyceride lipase, in the Drosophila testis. They show that Brummer regulates lipid droplet degradation during differentiation of germ and somatic cells, and that this process is essential for normal development to progress. These findings are interesting and novel, and contribute to a growing realisation that lipid biology is important for differentiation.
We thank the Reviewer for their positive assessment of our manuscript.
Major comments:
1) The data in Figs 1 and 2, while helpful in setting the scene, do not add much to what was previously shown by the same group, namely that lipid droplets are present in both early germ cells and early somatic cells in the testis, and that Bmm regulates their degradation (PMID: 31961851). Measuring the distance of lipid droplets from the hub, while helpful in quantifying what is apparent, that only stem and early differentiated stages have lipid droplets, is not as informative as the way data are presented later (Fig. 2I), where droplets in specific stages are measured. Much of this could be condensed without much overall loss to the manuscript.
We thank the reviewer for this comment and will condense the first part of the paper in our revised manuscript.
2) It would be important to show images of the clones from which the data in Fig. 2I are generated. The main argument is that Bmm regulates lipid droplets in a cell autonomous manner; these data are the strongest argument in support of this and should be emphasised at the expense of full animal mutants (which could be moved to supplementary data).
We thank the reviewer for this comment, and will add an image in our revised manuscript showing lipid droplets in bmm mutant spermatocyte clones.
Similarly, the title of Fig. S2 ("brummer regulates lipid droplets in a cell autonomous manner") should be changed as the figure has no experiments with cell (or cell-type)-specific knockdowns/mutants. This figure does show changes in lipid droplets in both lineages in bmm mutants, so an appropriate title could be "brummer regulates lipid droplets in both germ and soma".
We thank the reviewer for this comment, and will adjust the S2 figure legend title in the revised manuscript.
3) Interestingly, the clonal data show that bmm is dispensable in germ cells until spermatocyte stages, as no increase in lipid droplet number is seen until then. This should be more clearly stated, as it indicates that the important function of Bmm is to degrade lipid droplets at the transition from spermatogonial to spermatocyte stages. This is consistent with the phenotypes observed in which late stage germ cells are reduced or missing. However, the effect on niche retention of the mutant GSCs at the expense of neighbouring wildtype GSCs is hard to explain. Are lipid droplets in mutant GSCs larger than in control? Is there any discernible effect of bmm mutation on lipids in GSCs? Additionally, bam expression is delayed, suggesting that bmm may have roles on cell fate in earlier stages than its roles that can be detected on lipid droplets.
We thank the reviewer for this comment. We will include more text in the revised manuscript to clarify the key role bmm plays in regulating lipid droplets at the spermatogonia-spermatocyte transition. We will also add more detail and potentially data to our description of how bmm affects lipid droplets in cells at the earliest stages of germline development.
4) The bmm loss-of-function phenotype could be better described. Some of the data is glossed over with little description in the text (see for example the reference to Fig. 3A-C). For instance, in the discussion, the text states "loss of bmm delays germline differentiation leading to an accumulation of early-stage germ cells" (p13, l.259-60). However, this accumulation has not been clearly shown, or at least described in the manuscript. Most of the data show a reduction (or almost complete absence) of differentiated cell types. This could indeed be due to delayed differentiation, or alternatively to a block in differentiation or to death of the differentiated cells. The clonal data presented show a decrease in the number of cells recovered, but do not allow inferences as to the timing of differentiation, making it hard to distinguish between the various possibilities for the lack of differentiated spermatids. Apart from data showing that GSCs are more likely to remain at the niche, no further data are shown to support the fact that mutant germ cells accumulate in early stages. While additional experiments could help resolve some of these issues, much of this could also be resolved by tempering the conclusions drawn in the text.
We thank the reviewer for these comments. In the revised manuscript we will temper our conclusions regarding bmm’s precise role in spermatogenesis by discussing different mechanisms (e.g. differentiation or death) that could lead to the phenotypes we observe.
5) In the discussion (p.14, l-273 onwards), the authors suggest that products of triglyceride breakdown are important for spermatogenesis. However, an alternative interpretation of the results presented here (especially those using the midway mutant) could be that triglycerides impede normal differentiation directly. Indeed, preventing the cells' ability to produce triglycerides in the first place can rescue many of the defects observed. A better discussion of these results with a model for the function of triglycerides and their by-products would be a great improvement to this manuscript.
We thank the reviewer for this comment. To ensure our data is clearly communicated with readers, we will add a model to the paper suggesting how triglyceride and its by-products influence spermatogenesis.
Together, these changes will strengthen our overall finding that bmm-mediated regulation of testis triglyceride is important for normal sperm development. Because our findings in flies align with and extend data from rodent models, the developmental mechanisms we uncovered about how triglyceride lipase bmm regulates testis lipid droplets and sperm development will likely operate in other species.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
“I recommend that the authors revisit their calculation methods to provide a more convincing conclusion on the presence of positive epistasis for fitness in their dataset.”
The reviewer is right that the present description of the fitness calculation can be found insufficient. Below we provide relevant derivation. It will be included in our planned revision, probably as a supplementary text:
Expected fitness effect of multiple mutations
Fitness is the number of offspring divided by the number of progenitors, w\=No/Np. This can be the number of cells left by one cell (including itself in the case of budding cells) over a unit of time.
Assume that an organism carries multiple mutations—α, β, … ω—which are in heterozygous loci, their wild-type counterparts are marked universally with +. The fitness effect of a single mutation is wα/+, and so on. Fitness can be converted to relative fitness, i.e., expressed as a quotient of the wild-type fitness, wα/+/w+/+, and so on. Under the multiplicative model of mutation accumulation, an expected joint effect of multiple mutations on relative fitness is a product of individual quotients:
wexp/w+/+ = (wα/+/w+/+) (wβ/+/w+/+) … (wω/+/w+/+).
When a population is continuously growing, log-transformation of fitness is typically applied as it equates the rate of growth. In particular, it could be the number of doublings completed over a unit of time:
log2(wexp/w+/+) = log2[(wα/+/w+/+) (wβ/+/w+/+) … (wω/+/w+/+)].
After replacing the above log multiplicative formula with its log additive equivalent, all its terms can be normalized by dividing by log2 fitness of the wild type which turns them into relative doubling rates, for example, log2(wα/+)/log2(w+/+)=rDRα/+. The joint effect of multiple mutations is then equal to
rDRexp = 1 + (rDRα/+ ̶ 1) + (rDRβ/+ ̶ 1) + … + (rDRω/+ ̶ 1)
or
rDRexp = 1 + ∑d
where d\=rDR ̶ 1 (see Fig. 2B in the main text).
Reviewer #2 (Public Review):
“The initiation and interpretation of the results were apparently performed in a vacuum of a century of work on genomic balance.”
Indeed, we neither introduce nor discuss results obtained with organisms other than the budding yeast. We accept that researchers working with other beasts may expect to see such considerations. We will introduce them into a revised submission, to the extent allowable for non-review articles. The suggestions provided by the reviewer will be followed.
“If there is an increase in the general transcriptome size, then there might not be much reduction of the proteosome subunits as claimed and the increases might be somewhat less than indicated.”
- together with –
“A second experiment that would clarify the results would be to perform estimates of the general transcriptome size. If the general transcriptome size is actually increased, the claims of reduced expression of the proteosome might need to be revised.”
Multicellular organisms may be well heterogenic across their bodies, in terms of the cell number and (transcriptome) composition. We believe that any proper sampling of their mRNA requires careful absolute, and not only relative, quantification. We worked with clones prepared to be mostly homogeneous (about two-three divisions under conditions promoting strong growth). We maintain that we are allowed to rely on chromosomal averages expressed as proportions of the total mRNA. Our monosomic counts were very strictly around 50% of those predicted for euploids, we do not see any danger of erroneous sampling or calculation in our wonderfully simple case. Regarding the problem of a possible general increase in the transcriptome size which would help to compensate for the decrease in the proteasomic mRNAs, we adopted a strictly linear interpretation. That is, in a doubled transcriptome not only mRNAs for the proteasome but also all other proteins (prey species for the proteasome) would be doubled and thus no relief in proteolysis would happen. We follow here previous findings that in yeast the fractions of individual mRNAs are reflected in the fractions of ribosome-bound mRNA fragments and (at least roughly) mature proteins (e.g., the cited by us Larrimore et al. 2020).
“The claim of Torres et al that there are no global modulations in trans is counter to the knowledge that transcription factors are typically dosage sensitive and have multiple targets across the genome … Taken as a whole it would seem to suggest that there are many inverse relationships of global gene expression with chromosomal dosage in both yeast disomies and monosomies.”
Well, the debate about mRNA compensation in relation to aneuploidy in yeast has been intense and sometimes heated. Disparate claims can be found but we are left with an overwhelming impression that the relation between the total amount of mRNA and the number of chromosome copies is pretty much (perhaps not ideally) linear. We will consider our wording again. We will admit that such a rigid relation is somewhat unusual compared to other eukaryotes. But again, we see strict halves of mRNA for the monosomic chromosomes.
“To clarify the claims of this study, it would be informative to produce distributions of the various ratios of individual gene expression in monosomy versus diploid as performed by Hou et al. 2018.”
Such distributions are already prepared and will be likely presented in a revised msc.
“The authors claim there are no genes that are compensated on the varied chromosome but considering how many genes are upregulated across the genome, it would seem that a subset are probably upregulated on the cis chromosome as well and approach the diploid level, i.e. are dosage compensated.”
Perhaps we misstated our conclusions somewhere but it was obvious to us that some genes were upregulated on the cis chromosome (monosomic), some other were downregulated, the net result was the average 50% (Fig. 3).
Reviewer #3 (Public Review):
“1) In Figure 3b (and line 179) … What the data really show is that the level of overexpression is not correlated with the fitness effect of the deletion (since all the p values are not significant). The authors need to correct their conclusions.”
That’s right! We already mended it as we are preparing for revision.
“2) Why are some monosomic strains removed from the transcriptomics analysis, especially when the chromosome IV and XV strains show very strong positive epistasis? The authors need to provide an explanation here.”
We run out of money. In more scientific terms, we believe our sample of eight strains is unbiased and sufficient. It was truly randomly chosen. We were glad to see that it covers both slightly and most strongly affected (with profound epistasis) monosomics. All of them displayed parallel shifts in the transcriptome (RP up, proteasome down). We judged we could stop here, the additional five strains would be unlikely to change our main conclusions.
“3) The authors stated that diploidy observed in chromosome VII and XIII strains were due to endoreplication after losing the marked chromosomes (lines 97 and 117). Isn't chromosome missegregation an equally possible explanation? Since monosomic cells are generated by chromosome missegregation during mitosis, another chromosome missegregation event may occur to rescue the fitness (or viability) of monosomic cells in these strains.”
We believe that it happened in this way as the reviewer suggests, at least in most cases. By “endoreduplication”, we understand any event making two chromosomes of one, not necessarily additional DNA replication. We will check our text to make it clear in this respect.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #2 (Public Review):
The authors dissected the effects of mycolacton on endothelial cell biology and vessel integrity. The study follows up on previous work by the same group, which highlighted alterations in vascular permeability and coagulation in patients with Buruli ulcer. It provides a mechanistic explanation for these clinical observations, and suggests that blockade of Sec61 in endothelial cells contributes to tissue necrosis and slow wound healing. Overall, the generated data support their conclusions and I only have two major criticisms:
-
Replicating the effects of mycolactone on endothelial parameters with Ipomoeassin F (or its derivative ZIF-80) does not demonstrate that these effects are due to Sec61 blockade. This would require genetic proof, using for example endothelial cells expressing Sec61A mutants that confer resistance to mycolactone blockade. The authors claimed in the Discussion that they could not express such mutants in primary endothelial cells, but did they try expressing mutants in HUVEC cell lines? Without such genetic evidence all statements claiming a causative link between the observed effects on endothelial parameters and Sec61 blockade should be removed or rephrased. The same applies to speculations on the role of Sec61 in epithelial migration defects in discussion. Data corresponding to Ipomoeassin F and ZIF-80 do not add important information, and may be removed or shown as supplemental information.
-
While statistical analysis is done and P values are provided, no information is given on the statistical tests used, neither in methods nor results. This must be corrected, to evaluate the repeatability and reproducibility of their data.
We respectfully but fundamentally disagree with the comments regarding the Sec61 dependence of the effects that we observed. We showed that loss of glycocalyx and basement membrane components underpinned the phenotypic changes in endothelial cells (morphological changes, loss of adhesion, increased permeability, and reduced ability to repair scratch wounds). We demonstrated that we could phenocopy permeability increases and elongation phenotype by knocking down the type II membrane protein B3Galt6, and reverse the adhesion defect by exogenous provision of the secreted laminin-511 heterotrimer.
Our conclusion that mycolactone mediates these effects via Sec61 inhibition is not based solely on the use of alternative inhibitors but is built on several pillars of evidence:
First, the proteomics data conforms entirely to predictions based on the topology of affected vs. non-effected proteins, and agrees with independently published proteomic datasets from T lymphocytes, dendritic cells and sensory neurons (ref.12), as well as biochemical studies performed using in vitro translocation assays (ref.11,34). Furthermore, the pattern of membrane protein down regulation observed in our experiments fits perfectly with established models of protein translocation mechanisms, particularly with respect to the lack of effect on specific topologies of multipass membrane proteins, tail anchored- and type III membrane proteins (ref.34-36).
Second, since Sec61 very highly conserved amongst mammals and is found in all nucleated cells, it is hard to conceptualise a framework in which mycolactone targets Sec61 in some cells and not others, as this reviewer suggests might be the case for epithelial cells [noting that the work being referred to (ref.29) predates our 2014 work showing that mycolactone is a Sec61 inhibitor (ref.7)]. Indeed, mycolactone has been shown to target Sec61 in multiple independent approaches including forward genetic screens involving random mutagenesis and CRISPR/Cas9 (ref.10, PMID: 35939511). Genetic evidence has previously been provided for the Sec61 dependence of mycolactone effects in epithelial cells (ref.10,17). We have unpublished genetic evidence that the rounding and detachment of epithelial cells due to mycolactone is reduced when resistance mutations are over expressed, and will consider including this in the next version of the manuscript.
Third, given this weight of evidence, one would be hard-pressed to provide an alternative explanation for the specific down-regulation of glycosaminoglycan-synthesising enzymes and adhesion/basement membrane molecules while most cytosolic and non-Sec61 dependent membrane proteins are unchanged or upregulated. However, seeking to be as rigorous as possible we have here shown that a completely independent Sec61 inhibitor produces the same phenotype at the gross and molecular level. Ipomoeassin F (Ipom-F) is a glycolipid, not a polyketide lactone, yet they both compete for binding with cotransin in Sec61α (ref.6). There is significant overlap in the cellular responses to mycolactone and Ipom-F, including the induction of the integrated stress response (ref.17, PMID: 34079010), which we observed again in the current data, providing further evidence that this approach is useful when genetic approaches are technically unattainable.
Therefore, we are confident the effects seen on endothelial cells are Sec61-dependent. We are happy to provide more detail on our lengthy attempts at over-expressing mycolactone resistant SEC61A1 genes in HUVECs; primary endothelial cells derived from the umbilical vein. We are highly experienced in this area, and have previously stably expressed these proteins in epithelial cell lines, reproducing the resistance profile (ref.10,17). Notably though, these cells do not have normal ‘fitness’ in the absence of challenge. Since endothelial cells (and endothelial cell lines; PMID: 12560236) are extremely hard to transfect with plasmids, with efficiency routinely 5-10% (including in our hands), we developed a lentivirus system. We were eventually (after multiple attempts using different protocols) able to transduce primary HUVECs with constructs expressing GFP (at an efficiency of about 10-20%) and select/expand these under puromycin selection. Never-the-less, we never recovered any cells that expressed the flag-tagged SEC61A1 wild type or SEC61A1 carrying the resistance mutant D60G. We also attempted to select D60G-transduced cells with mycolactone epimers, an approach that can help the cells compete against non-transduced cells in culture flasks (ref.10). We concluded that primary endothelial cells are unable to tolerate the expression of additional Sec61α, and this was incompatible with survival.
It’s also important to note that most endothelial cell specialists would agree that endothelial cell lines are not good models of endothelial behaviour. We tested the HMEC-1 cell line, but found it did not express prototypical endothelial marker vWF in the expected way. Therefore we focussed our efforts on primary endothelial cells. Should we be able to overcome the dual challenge of the necessity to work in primary cells, and the difficulty of over-expressing Sec61, we will update this paper at a later date with this data, and will also expand the above arguments.
We apologise for the embarrassing oversight of not including information about the statistical analyses we used, which of course we will correct in full in the revised version. However, we would like to provide this information to readers of the current version of the manuscript. All data were analysed using GraphPad Prism Version 9.4.1:
Figure 1: one-way ANOVA with Dunnett’s (panel A) or Tukey’s (panel B) correction for multiple comparisons
Figure 2 supplement: one-way ANOVA with Tukey’s correction for multiple comparisons (analysed panel)
Figure 3: one-way ANOVA with Tukey’s (panel B) or Dunnett’s (panel E&F) correction for multiple comparisons
Figure 4: one-way ANOVA with Dunnett’s correction for multiple comparisons (all analysed panels)
Figure 5 and supplement: one-way ANOVA with Dunnett’s correction for multiple comparisons (all analysed panels)
Figure 6: one-way ANOVA with Dunnett’s correction for multiple comparisons (analysed panel)
Figure 6 supplement: one-way ANOVA with Dunnett’s correction for multiple comparisons (all analysed panels)
Figure 7: two-way ANOVA with Tukey’s correction for multiple comparisons (all analysed panels; panels B&C also included the Geisser Greenhouse correction for sphericity)
Figure 7 supplement: Panels A&D used a repeated measures one-way ANOVA with Dunnett’s correction for multiple comparisons (panel D also included the Geisser Greenhouse correction for sphericity). Panels B,C&E used a two-way ANOVA with Tukey’s correction for multiple comparisons (panels B&C also included the Geisser Greenhouse correction for sphericity)
-
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
Points from reviewer 1 (Public Review):
In this manuscript, Yong and colleagues link perturbations in lysosomal lipid metabolism with the generation of protein aggregates resulting from proteosome inhibition.
We apologize for any confusion in the explanation of the results. We found that both proteasome inhibition and, independently, perturbations to lysosomal lipid metabolism lead to accumulation of protein aggregates in the lysosome. There was no evidence of proteasome inhibition in the context of lysosomal lipid perturbations (Figure 4J).
Despite using various tools of lysosomal function, acidity, permeability, etc, the authors couldn't identify the link between lysosomal lipid metabolism and protein aggregate formation.
Indeed, despite testing numerous mechanistic hypotheses, we have yet to explain how perturbation of lysosomal lipid metabolism causes protein aggregates. However, we have demonstrated that lipids are both necessary (via epistasis and serum delipidation) and sufficient (media supplementation) to drive these phenotypes.
Although this work is interesting and thought-provoking, their approach to identify novel pathways involved in proteostasis is limited and this weakens the contribution of the paper in its current form.
We are glad the reviewer found the work to be thought-provoking. As a fundamental cellular process critical for longevity, we agree that the connections made here between lipids, lysosomes and protein aggregates are interesting and broaden the impact of cellular health on proteostasis. Though we have falsified multiple hypotheses for how perturbation of lysosomal lipid metabolism could influence protein aggregation, we agree that a major weakness of the current work is our limited mechanistic understanding of this process. We hope that by engaging the thoughtful and creative eLife readership, novel mechanistic hypotheses will emerge.
Points from reviewer 2 (Public Review):
This might be too much of an ask, but they should go further in excluding one very attractive alternative model: effects on proteasome activity. This explanation should be addressed definitively because the transcription factor that regulates proteasome subunit gene expression (Nrf1/NFE2L1) is processed in the ER and is therefore well placed to be influenced by membrane conditions, and because it is shown here that proteasome inhibition increase ProteoStat puncta.
We appreciate the constructive suggestion to examine loss of proteasome expression as a relevant mechanism linking cellular dyslipidemia with proteostasis impairment. We analyzed the genome-wide perturb-seq data from Replogle et al. [1], which was performed in K562 cells cultured under similar conditions to our screen. As expected, perturbation of Nrf1/NFE2L1 reduced expression of proteasome subunits, whereas perturbation of proteasome subunits that increased proteostat staining (e.g. PSMD2, PSMD13) homeostatically increased expression of multiple proteasome subunits. In contrast, other top hits, including those related to lipid-related perturbations (e.g. MYLIP, PSAP) did not reduce the expression of genes encoding the proteasome (Author response figure 1).
Author Response Figure 1. The relative expression of genes encoding proteasomal subunits for representative genes was re-plotted from genome-wide perturb-seq data in K562 cells [1]. Shown are hit genes that increase Proteostat staining along with non-targeting controls and the positive control gene NFE2L1. Proteasome expression was induced by proteasome impairment (PSMD2 and PSMD13) and repressed by NFE2L1 knockdown. Other hit genes related to lipid metabolism and lysosome function did not consistently impact the expression of proteasome subunits.
The authors address proteasome activity only by using a dye that is not referenced. Here a much more solid answer is needed.
We thank Reviewer #2 for bringing to our attention the missing reference for the proteasome activity probe we used (Me4BodipyFL-Ahx3Leu3VS). Both this probe [2] and its close derivative [3], BodipyFL-Ahx3Leu3VS, were fully characterized previously. We’ll include these references in the revision. In our hands, this probe behaved as expected under MG132 and Bortezomib treatment when quantified by flow cytometry (Fig. 4I), and by in-blot fluorescence scan (data will be included as supplementary in the revision). We further observed that HMGCR KD increased proteasome activity, consistent with what’s suggested by current literature. This validated our use of this probe and strongly suggested that proteasome activity was not perturbed by impaired lipid homeostasis.
In general, most conclusions in the paper rely essentially solely on ProteoStat assays. The entire study would be greatly strengthened if the authors incorporated biochemical or other modalities to substantiate their results.
We agree that orthogonal characterization of proteostasis impairment would be valuable. We chose the ProteoStat stain as a reporter of proteostasis because it is capable of integrating the aggregation states of multiple endogenously expressed proteins, and in the absence of exogenous stressors such as the overexpression of aggregation-prone proteins. With aging, a context where ProteoStat staining increases, hundreds of proteins exhibit reduced solubility [4], thus motivating the focus on endogenously expressed proteins. Despite the biochemical limitations, we think our work is differentiated from published screens focused on specific metastable proteins by our focus on regulators of endogenous proteostasis.
The presentation would be improved greatly if the authors provided diagrams illustrating the pathways implicated in their results, as well as their models.
We thank Reviewer #2 for the helpful suggestion. We have provided the suggested diagrams below (Author response figure 2).
Author Response Figure 2. Mechanistic models linking screen hits to accrual of lysosomal protein aggregates, related to Figure 4. Perturbations that increased cholesterol and sphingolipid levels were evaluated for effects on lysosomal pH, lysosomal proteolytic capacity, lysosomal membrane permeability, lipid peroxidation and proteasome activity. None of these mechanisms appear to play a causal role in protein aggregation in response to elevated lipids.
Author Response References
-
Replogle, J. M. et al. Mapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seq. Cell 185, 2559-2575.e28 (2022).
-
Berkers, C. R. et al. Probing the Specificity and Activity Profiles of the Proteasome Inhibitors Bortezomib and Delanzomib. Mol Pharmaceut 9, 1126–1135 (2012).
-
Berkers, C. R. et al. Profiling Proteasome Activity in Tissue with Fluorescent Probes. Mol. Pharmaceutics 4, 739–748 (2007).
-
David, D. C. et al. Widespread Protein Aggregation as an Inherent Part of Aging in C. elegans. Plos Biol 8, e1000450 (2010).
-
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
We would like to thank the reviewers and editor for their insightful comments and suggestions. We will update the manuscript accordingly. We are particularly glad to read that our software package constitutes a set of “well-written analysis routines” which have “the potential to become very valuable and foundational tools for the analysis of neurophysiological data”. Both reviewers have identified a number of weaknesses in the manuscript, and we would like to take this opportunity to provide a response to some of the remarks and clarify the objectives of our work. We would like to stress that this kind of toolkit is in continual development, and the manuscript offered a snapshot of the package at one point during this process. Since the initial submission several months ago, several improvements have been implemented and further improvements are in development by our group and a growing community of contributors. The manuscript will be updated to reflect these more recent changes, some which will directly address the reviewers’ remarks.
It was first suggested that the manuscript should better showcase the value of the analysis pipeline. As noted by the first reviewer, the online repository (i.e. GitHub page) conveys a better sense of how the toolbox can be used than the present manuscript. Our original intention was to illustrate some examples of data analysis in Figure 4 by adding the corresponding Pynapple command above each processing step. Each step takes a single line of code, meaning that, for example, one only needs to write three lines of code to decode a feature from population activity using a Bayesian decoder (Fig. 4a), or to compute a cross-correlograms of two neurons during specific stimulus presentation (Fig. 4b), or to compute the average firing rate of two neurons around a specific time of the experimental task (Fig. 4c). In our revision, we will include code snippets which will clearly show the required steps for each of these analyses. In addition, we will more clearly point the reader to the online tools (e.g. Jupyter notebooks), which offer an easier and clearer way to demonstrate the use of the toolbox.
Another remark concerns our claim that the package does not have dependencies. We agree that this claim was not well-worded. Our intention was to say that the package exclude dependencies such as scikit-learn, tensorflow or pytorch, which are often used in signal processing and which can be tedious to install. Pynapple still depends on a few packages including the most common ones: Numpy, Scipy, and Pandas. We will rephrase this statement in the manuscript and emphasize the importance of minimal dependencies for long-term backwards-compatibility in scientific computing.
We will complete the bibliography to make sure we properly reference all the packages designed for similar purpose. To note, some are not citable per se (i.e. no associated paper) but will be discussed.
It was suggested that the manuscript should better describe the integration of Pynapple into a full experimental data pipeline. This is an interesting point, which was briefly mentioned in the third paragraph of the discussion. Pynapple was not originally designed to pre-process data. However, it can load any type of data stream after the necessary pre-processing steps. Overall, this modularity is a key aspect of the Pynapple framework, and this is also the case for the integration with data pre-processing pipelines, for example spike sorting in electrophysiology and detection of region of interest in calcium imaging. We do not think there should be an integrated solution to the problem but, instead, to make it possible that any piece of code can be used for data irrespective of how the dataset was acquired. This is why we focused on making data loading straightforward and easy to adapt to any situation. This feature enables any user with any data modality and any long-established (often in-house) pre-processing scripts/software to utilize Pynapple in the analysis phase of their pipeline. Overall, not imposing a certain format compatibility from data acquisition phase is a strength for any analysis package.
Finally, the reviews raised the issue of data and intermediate result storage. We agree that this is a critical issue. In the long term, we do not believe that the current implementation of NWB is the right answer for data involved in active analysis, as it is not possible to overwrite a NWB file. This would require the creation of a new NWB file each time an intermediate result is saved, which will be computationally intensive and time consuming, further increasing the odds of writing error. Theoretically, users who need to store intermediate results in a flexible way could use any methods they prefer, writing their own data files and wrappers to reload these data into Pynapple object. However, it is desirable for the Pynapple ecosystem to have a standardized format for storing data. We are currently improving this feature by developing save and loads methods for each Pynapple core object. We aim to provide an output format that is very simple to read in future Pynapple releases. This feature will be available in the coming weeks and will be described in the revised manuscript.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
The following is the authors' response to the original reviews.
We would like to thank all Reviewers for their careful evaluation of our work. Below please find our responses and comments.
Reviewer #1 (Recommendations For The Authors):
1) The detection of cell-released GLP-1 is addressed in an indirect, averaged way in Fig. 2 - Supplement 1. This question seems like a good opportunity for an antagonist experiment (Exendin-9), which presumably would require much lower concentrations than those used to antagonize a saturating dose of GLP-1. It would also be much more convincing if GLPLight1 could be used to detect stimulated release of GLP-1 from the GLUTag cells.
We tried multiple times to acutely stimulate GLUTag cells using Forskolin and IBMX, but unfortunately we did not observe any robust fluorescence increase of GLPLight1. The only observation that was consistent was the higher baseline fluorescence of GLPLight1, and the reduced maximal response to saturating GLP-1 when GLPLight1 expressing HEK cells were cultured overnight with GLUTag cells. We considered this assay to be at best qualitative and — despite the aforementioned attempts — could not determine quantitative values.
2) The excitation-ratiometric response of the sensor, shown in Fig. 1D, is usually accompanied by strong pH-dependence of sensor function. It would be valuable to characterize this pH-dependence, using permeabilized cells in which the pH is changed; the ability of small (0.2-0.5 unit) pH changes to produce changes in fluorescence, as well as to affect the dynamic range of the sensor, should be characterized. This will prevent the misidentification of agents that affect cellular pH as having (for instance) an inhibitory effect on the binding of GLP-1 to GLPLight.
The pH sensitivity of cpGFP-based sensors is a valid concern. However, considering that the cpGFP module from GLPLight1 is intracellular (and thus largely protected from potential extracellular pH changes) we assume that GLPLight1 signal should be robust in most in-vivo or cell-based assays. In fact we have previously characterized this for a similarly-built neuropeptide sensor (PMID: 35145320) and believe that this will be the case also for GLPLight1.
3) The reported Kd for Exendin-9 is in the low nM range. Please explain the partial response at 1000x the concentration (including a discussion of the Kd of GLP-1 itself, as well as its off kinetics, and a comparison of this assay to the assays used previously).
The partial response is due to the presence of 1 uM GLP-1 in the imaging buffer, which is in constant competition with Exendin-9 for the binding to GLPLight1. Because GLP-1 has similar affinity as Exendin9 (see for example PMIDs: 34351033 and 21210113) and both are present at saturating concentration, we did expect to observe a partial response from GLPLight1. In this study, we did not exactly determine the on and off kinetics of both GLP-1 and Exendin9 on the GLPLight1 sensor due to technical challenges: to perform these experiments, we would need to set up a perfusion system where we could remove the unbound ligand and either wash off the bound ligand with buffer or compete it out with an antagonist. Unfortunately, we currently do not have access to such a set up.
4) Are the turn-on kinetics in Fig. 2C limited by drug application or by association? Are the on-rates much slower for the lower concentrations used for Fig. 2C? This is important for knowing how fast responses are likely to be at the lower concentrations likely to be achieved by endogenous release.
If we consider Fig 2B and 2C, we assumed the on-kinetics to be mostly driven by association since the ligand is expected to be homogeneously distributed.
The on-rate kinetics are indeed slower when lower concentrations of GLP-1 are used as shown in (Figure 2b) where we observe a TauOn of 4.7s with 10 uM GLP-1 and much slower kinetics when GLP-1 is applied a 1 uM for example (Figure 3d). As a result, we chose to incubate the ligand with GLPLight1 expressing cells for at least 30 minutes before the measurement of the dose-response to be close to equilibrium.
5) The parameters for the fitted dose-response curves in Fig 2C should be listed. The ~4x discrepancy between the dose-response in HEK-293 cells and neurons should be discussed. Are there known auxiliary subunits, dimerization, or lipid dependence that might account for this? It seems important to understand this if the sensors are to be used in an assay that may compare different systems.
We added the EC50 values to Fig 2C as requested. We did not consider a 4x discrepancy to be significant, because the measurement error in the EC50 region is relatively high and this difference seemed to be within the error range. In fact, the 95% confidence interval ranges are 7.8 to 11.1 nM in Neurons and 23.8 to 32.1 nM for HEK cells, if we consider the upper and lower boundaries of each, the difference drops to around 1-fold. We also performed a statistical test to compare the two fits (Extra sum of squares F-test) that confirmed the two fits were not significantly different (P value = 0.3736). Of course, the interaction partners and membrane composition are different in HEK cells and neurons and probably have an influence on the EC50 of GLPLight1, but their exact influence is unclear.
6) It seems surprising that removal of the endogenous N-terminal secretory sequence is actually helpful for membrane expression. Do the authors have any suggested explanation for this?
GLPLight1 contains an N-terminal hemagglutinin (HA) secretory motif. The hmGLP1R sequence that we chose also contained an endogenous secretory sequence that most likely interfered with the membrane transport mechanism and resulted in a lower sensor expression with both secretory sequences. We thus decided to keep the HA instead of endogenous to remain consistent with other sensors created in-house.
7) In Fig. 1, supplement 3, are the transient responses real? Do they occur with the control construct?
While we have not measured the G-protein recruitment on GLPLight-ctr, we have often observed this phenomenon for various receptors and ligands. The transient responses are thus most likely an artifact after manual addition of the ligand possibly due to:
- Temperature difference
- Exposure of the plate to ambient light before resuming measurement (phosphorescence)
- Re-suspension of the cells affecting the proximity to the detector
- Other unknown variables
If these responses were real, we would also expect them to be more sustained over time.
8) Please include a sentence or two explaining the luminescence complementation assay, and a reference.
We updated the results section of the manuscript with a section describing the luminescence complementation assay along with a reference:
“Next, we compared the coupling of GLPLight1 and its parent receptor (WT GLP1R) to downstream signaling. We first measured the agonist-induced membrane recruitment of cytosolic mini-G proteins and β-arrestin-2 using a split nanoluciferase complementation assay (Dixon et al., 2016). In this assay both the sensor/receptor and the mini-G proteins contains part of a functional luciferase (smBit on the sensor/receptor and LgBit for Mini-G proteins) that becomes active only when these two partners are in close proximity (Wan et al., 2018).”
Bravo to the authors for already making the sensor plasmids available at addgene.com. It would be helpful to include the plasmid IDs and/or a URL in the manuscript.
We would like to thank Reviewer #1 for noticing this. We have updated the data availability section of the manuscript and added the AddGene plasmid numbers of the constructs generated in this study.
Reviewer #2 (Recommendations For The Authors):
1) There are some parts of the introduction that need clarification. For example, GLP1 is quoted as an anorexigenic peptide, however, that is probably only true for centrally- derived GLP1. There is no evidence that enteroendocrine-derived GLP1 (the major pool) is anorexigenic- it is likely to be substantially degraded by DPPIV before reaching the brain. In any case, the discovery of GLP1 was always one of glucose-dependent insulin secretion, with the brain system being described decades later. Overall, the intro needs to be slightly reframed. While the tools presented here are more useful for assessment of central GLP1-releasing circuitry, they are ultimately based upon GLP1R signaling that is much better validated in the periphery.
We have slightly reframed the introduction accordingly.
2) "The human GLP1R (hmGLP1R) is a prime target for drug screening and drug development efforts, since GLP-1 receptor agonists (GLP1RAs) are among the most effective and widely-used weight-loss drugs available to date (Shah and Vella, 2014)." GLP1R was for two decades the breakthrough drug for treatment of type 2 diabetes mellitus and correction of glucose tolerance as assessed through HbA1c. It is only through reporting on millions of patients receiving GLP1RA that the weight loss effects were noted, leading to Phase1-3 trials and eventual approval for obesity indication. Again, some slight reframing of the introduction is required here.
Also for this point, we have slightly reframed the introduction accordingly.
3) GLP1 was applied at a maximal dose of 10 uM, which is 10-fold higher than maximal. Can the authors confirm absence of cytotoxic effects of exposing to peptide at such concentration? Ex4 (9-39) at such concentrations is usually cytotoxic at least in primary tissue.
We did not observe any obvious cytotoxic effect of GLP-1 at this concentration in HEK293T cells or Neurons.
4) "As expected, GLPLight1 responded to both GLP1RAs with almost maximal activation, on par with GLP1 (Figure 2a)." Such a claim is difficult to interpret without concentration-response curves, since the maximal concentration of liraglutide and semaglutide might not have been achieved in these experiments.
We agree with this statement is difficult to interpret without further clarification. We know from the literature that GLP-1, liraglutide and semaglutide all have very high affinity to the hmGLP1R (PMID: 31031702). We also proved that GLPLight signal saturates at concentrations above 1 uM of GLP-1 (figure 2C), we thus applied a 10x excess of all ligands and considered this signal as maximal.
5) "These results indicate that GLPLight1 can serve as a direct readout of pharmacological drug action on the hmGLP1R with higher temporal resolution than previously available approaches, such as downstream signaling assays (Zhang et al., 2020)." Many investigators use cAMP imaging to investigate GLP1R signaling, which is arguably of similar spatiotemporal resolution, also with the advantage of FRET quantification in some cases (e.g. EpacVV). Direct GLP1R signaling can also be inferred using cell lines heterologously-expressing GLP1R. Thus, the advantage of the current probes is that they can be used to readout direct GLP1R activation in native cells/tissues where promiscuous class B binding might limit signaling measures or where endogenous GLP1 release needs to be investigated.
We have edited the manuscript text accordingly.
6) "State-of-the-art techniques for detecting endogenous GLP-1 or glucagon release in vitro from cultured cells or tissues consist of costly and time-consuming antibody- based assays (Kuhre et al., 2016) or analytical chemistry procedures (Amao et al., 2015)." Agreed, but non-specificity/cross-reactivity of such assays is more prohibitive/problematic (e.g. against glicentin).
We have edited the introduction accordingly.
7) The studies using co-culture of GLUTag and GLP1Light1-HEK293 cells, whilst interesting, are not entirely convincing in their current form. Firstly, co-culture could influence GLP1Light expression levels (can the authors label FLAG?). Secondly, specificity of the response is not tested e.g. by adding Ex4 (9-39). Thirdly, titration with GLUTag conditioned media is not performed.
We partially addressed this issue in the answer to comment #1 from Reviewer #1. We previously performed a FLAG staining of GLPLight1 in the presence or absence of GLUTag cells and we did not notice any obvious difference. This goes in line with the fact that GLPLight1 is signaling inert, and the presence of GLP1 should not interfere with the surface expression of the sensor. We also checked that HEK293T cells did not express high levels of GLP1R according to the BioGPSCell line Gene Expression profile (https://maayanlab.cloud/Harmonizome/gene_set/HEK293/BioGPS+Cell+Line+Gene+Expression+Profiles).
We also tried to add GLUTag media after stimulation in bolus to GLPLight1 expressing cells and observed no response. This indicated that the “sniffer” cells must be present in close proximity to GLUTag cells for an extended period of time to observe any substantial difference in response, justifying our choice of experimental setup.
8) "Given that our photocage was placed at the very N-terminus of photo-GLP1, our results show that this caging approach prevents the peptide's ability to activate GLP1R but, at the same time, preserves its ability to interact with the ECD." An alternative hypothesis is that PhotoGLP1 does activate GLP1R, but this is undetectable with the sensitivity of GLP1Light. PhotoGLP1 cAMP concentration-response assays are needed (uncaged versus cage) to properly characterize and validate the compound (as would be standard for any newly-described GLP1R peptide ligand).
While we agree that there is a chance that Photo-GLP1 could activate GLP1R at high concentrations, we think that the characterization of Photo-GLP1 has to be determined by the end user directly with the technique of choice (GLPLight1 in our case) in order to get a reliable comparison of potency and efficacy. We modified the text accordingly to more accurately reflect the direct conclusions from our data, as follows:
“our results show that this caging approach prevents the peptide's ability to activate GLPLight1”.
9) "Surprisingly, GLPLight1 shows a fluorescent response in all three uncaged areas, while its fluorescence remained unaltered throughout the rest of the FOV, indicating high spatial localization of the response to GLP-1 (Figure 3f)." Why is this surprising?
We agree that this result is, indeed, not surprising and would like to thank Reviewer #2 for spotting this mistake, which has now been corrected in the manuscript.
10) The localized PhotoGLP1 experiments are interesting and show the utility of the ligand. There is however activation outside of the region of uncaging, which would argue against a pre-bound ECD mode of action. Possibly some PhotoGLP1 is pre- bound to the ECD, and some is freely diffusing? Alternatively, the scan area might be below the diffraction limit/accuracy of the microscope?
We would like to thank Reviewer #2 for this comment and agree with their observation. There could be some free Photo-GLP1 that gets photo-activated and binds regions around the uncaging area (similar to what has been observed for Photo-OXB:,PMID: 36481097). The activation around the uncaging area could also be due to lateral diffusion of the activated receptor on the membrane. There is also most likely some light diffraction at the uncaging area that could account for this phenomenon. To increase the spatial resolution, future studies could involve uncaging during sensor imaging via two-photon microscopy.
11) What was the rationale for caging native GLP1, which is then susceptible to DPPIV-mediated degradation? Would the N-terminal cage and first 2 amino acids also not be cleaved by DPPIV, thus rendering the tool of limited in vivo application? Conversely, PhotoGLP1 provides a template for similar light-activated (stabilized) GLP1R agonists such as Ex4 or liraglutide.
Thank you for making us aware of this (in vivo) limitation. We designed photoGLP1 as a tool for neurobiological experiments in the brain, where DPPIV expression would be low compared to peripheral organs (https://www.proteinatlas.org/ENSG00000197635-DPP4/tissue). We also envisage that the presence of the photocage would be enough to hinder the binding to DPP4 that cuts the first 2 AA. This hypothesis, however, was never tested experimentally, and we, therefore, acknowledge the limitation in the manuscript. We would furthermore like to thank the reviewers for his comment on additional photo-caged GLP1 agonists, which could be developed future studies.
12) It wasn't clear how GLP1Light could be used as a HTS screen for drug discovery? Surely, conventional systems (e.g. GLP1R + BAR/Ca2+/cAMP reporting) allow signal bias, an important component of GLP1RA action, to be assessed. Or could GLP1Light1 be used as a pre-screen to exclude any ligands that do not orthosterically bind GLP1R?
We would like to thank Reviewer #2 for this comment and would like to offer some clarification. We indeed thought that GLPLight1 could be used as a first line of screening to exclude ligands that do not bind in the orthosteric pocket. It is also a rather flexible method as the fluorescence increase of those sensors can be monitored using various techniques/devices that are available in most labs (e.g. microscopy, plate reader, flow cytometry).
13) Limitations of GLP1Light1 and PhotoGLP1 are not acknowledged in the discussion.
We would like to thank Reviewer #2 for pointing out the lack of description of the limitations of these tools, which have now been added to the Discussion.
14) Full characterization of PhotoGLP1 is missing, to include UV/Vis, Tr and HRMS.
PhotoGLP1 was fully characterized by UV/Vis and HRMS, and all experimental and analytical data was uploaded as supplementary data when the manuscript was initially submitted for publication in eLife.
Reviewer #3 (Recommendations For The Authors):
1) The ~1000 fold lower EC50 for GLP1 of GLPLight1 compared with native GLP1R needs to be openly acknowledged as a major limitation of the sensor, as this will substantially reduce the types of experiment for which it will be useful. Because it needs 1000 times higher GLP1 levels than wild type GLP1R to be activated, it is unlikely, for example, to be useful for monitoring the dynamics of activation of native GLP1R in vivo. The claim that the sensor could be used for in vivo imaging for fibre photometry is therefore an exaggeration.
We would like to first thank Reviewer #3 for this comment and to further provide some clarification. We recognized that the data presented in this manuscript might have been confusing when comparing the affinity of GLP1R (using cAMP) and GLPLight1 (using the fluorescence increase because there is no coupling to cAMP). We believe that the low EC50 measured in the cAMP assay cannot accurately be compared to GLPLight1 response because it is an enzymatically amplified process. In order to support this claim, we included another set of experiments where we titrated agonist- induced recruitment of miniGs protein to the GLP1R receptor and found an EC50 of 3.8 nM for native GLP-1 using this assay (added as panel l in Figure1 Supplement 3). We thus confirmed that the nature of the assay itself has a drastic influence on the EC50 measured and it is not unusual to observe 100x fold difference of EC50 for the same receptor-ligand pair.
We believe that the miniGs protein recruitment is a better comparison to GLPLight1 because it is not enzymatically amplified. This assay reveals that GLPLight1 has around 8-fold lower affinity to GLP1 compared to its parent receptor, which is in line with the EC50 loss observed previously for other GPCR-based sensors of this class. We are thus confident that GLPLight1 has to potential to be used in vivo under specific circumstances, specifically in brain tissue. We elaborated on this point in the Discussion part of the manuscript.
2) Fig2 suppl 1 is described as demonstrating a reduced response of GLPLight1 to GLP-1 when HEK cells with were cultured with GLUTag cells. However, it is speculation to conclude that this is because GLP1Light1 was partially pre-activated by endogenous GLP-1, without demonstrating the response of GLPLight1 before and after GLUTag cell stimulation. Unless additional data are generated, the presented data do not convincingly demonstrate that GLP1Light1 can detect GLP1 released from GLUTag cells.
We would like to thank Reviewer #3 for this comment which has been addressed already in the replies to Comment#1 from Reviewer #1 and Reviewer #2.
3) The authors should openly acknowledge that photo-uncaging the GLP1 probe might not be very helpful for monitoring the temporal dynamics of the GLP1-GLP1R interaction, because unless all the photocaged glp1 is released by the light stimulus, the activation of photo-released GLP1 will be slowed by the remaining caged GLP1, and the dynamics will be slower than for native GLP1. This makes it unsuitable for many temporal questions, although it might be useful to deliver GLP1 in a spatial restricted manner.
We do agree that the biggest advantage of Photo-GLP1 is its ability to be activated in a very localized manner. We also agree that the presence of caged Photo-GLP1 will influence the binding of the uncaged GLP-1. Nevertheless, there is still an advantage of using Photo-GLP1 in some assays such as pharmacological activation on brain slices. In fact, we have shown for our Photo-OXB molecule that the perfusion of OXB was much slower at eliciting neuronal depolarization compared to uncaging of Photo- OXB (see PMID: 36481097). We think that this was mainly due to the slow diffusion kinetics of the peptide into the brain tissue. We also think that uncaging can provide a more controlled activation with varying laser power and uncaging duration.
4) To claim (as currently in the discussion) that GLPLight1 has potential to be used for investigating the dynamics of endogenous GLP1, the authors would need to compare the dynamics of the GLP1Light sensor with wild type GLP1R. We do not know that its activation dynamics will reproduce native glp1r.
We would like to thank Reviewer #3 for this comment and would like to offer some clarification. Since GLPLight1 does not couple to intracellular signaling, it was impossible to compare its activation kinetics to GLP1R WT using the same assay. However, we can offer a relative comparison since we know that GLPLight1 takes around 50 seconds to be activated using 1 µM GLP-1 (figure 2B) and that it takes a similar time for GLP1R to be activated in the miniG protein recruitment assay (Fig 1 Supplement 3) using 100 nM GLP-1. Considering that GLPLight1 has a lower affinity than the GLP1R (8-10x lower), we think that the activation kinetics of both the sensor and GLP1R are comparable.
Additional comments:
1) In fig 2A,B, it is not clear whether the trace shows a partial reversal of GLP1- triggered activation by Ex9, or Ex9-independent receptor desensitization. A control trace is required to show the kinetics of GLP1-triggered activation without the addition of Ex9.
We would like to thank Reviewer #3 for this comment. We can exclude the possibility of Ex9-independent desensitization because GLPLight1 has been shown to be signaling inert to all G-proteins, Beta arrestin-2 and cAMP. Moreover, we have observed that the fluorescence signal was stable for more than 30 minutes for the GLP-1 titrations, even at high concentrations of ligand.
2) It would be helpful if the pEC50 for WT GLP1 were also shown in table 1, for comparison with the GLP1 mutants.
We would like to thank Reviewer #3 for this comment, and we have now added the respective pEC50 for WT GLP1 to Table 1.
3) Fig2 suppl 1. The methods and analysis for this figure are inadequately explained. To show that the HEK-GLPLight1 cells are responding to GLP1 released from GLUTag cells, the GLPLight1 response needs to be shown before and after GLUTag cell stimulation with an agent that should trigger GLP-1 release.
We would like to thank Reviewer #3 for this comment which has been partially addressed already in the replies to Comment#1 from Reviewer #1 and Reviewer #2.
Since we did not observe any response to acute stimulation of GLUTag cells we considered the high glucose concentration present in the culture media being a stimulation agent for GLUTag cells, which has been previously reported (PMID: 17643200).
4) Fig 3g and others: The end of the photo activation period needs to be represented correctly on the timeline. In 3g, the bar that should indicate when photoactivation was applied does not end at the zero time point (which is labelled as the time relative to photoactivation).
We would like to thank Reviewer #3 for pointing this out. The shaded area representing the photo-activation has been matched accordingly.
5) Discussion para 1: the authors claim their data show that ligand induced activation of human GLP1R occurs more slowly than others similar GPCR sensors - they should give actual data to substantiate this claim, since the time course of glp1r activation has not been analysed and compared with other sensors in the manuscript.
We added data to support this claim to the discussion: “As a reference, other previously-characterized class-A GPCR-based neuropeptide biosensors showed sub- second activation kinetics (Duffet et al., 2022a; Ino et al., 2022).”
6) Methods: what wavelength was used for recording emission from GLP1Light1? The excitation wavelength is given, but I can't see the emission wavelength(s). In fig 1d, the excitation and emission spectra should be depicted in different colours/line properties, otherwise this figure is very confusing.
We updated figure1d and changed the colors to improve data visualization. Regarding the missing wavelength, we would like to clarify that both wavelengths were already described in the methods section as: “The excitation and emission spectra were measured at λem =560nm and λex\= 470nm, respectively, on a TECAN M200 Pro plate reader at 37 °C. “. We would be happy to rewrite this paragraph, if necessary, shall it remain unclear to the reader.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
Reviewer #1 (Public Review):
This manuscript features a key technical advance in single-molecular force spectroscopy. The critical advance is to employ a click chemistry (DBCO-cycloaddition) for making a stable covalent connection between a target biomacromolecule and solid support in place of conventional antigen-antibody binding. This tweak dramatically improves the mechanical stability of the pulling system such that the pulling/relaxation can be repeated up to a thousand times (the previous limit was a few hundred cycles at best). This improvement is broadly applicable to various molecular interactions and other types of single-molecule force spectroscopy allowing for more statistically reliable force measurements. Another strength of this method is that all conjugation steps are chemically orthogonal (except for Spy-catcher conjugation to the termini of a target molecule) such that the probability of side reactions could be reduced.
The reliability of kinetic and thermodynamic parameters obtained from single-molecule force spectroscopy depends on statistics, that is, the number of pulling measurements and their distribution. By extending the number of measurements, this robust method enables fundamental/critical statistical assessment of those parameters. That is, it is an important and interesting lesson from this study that ~200 repeats can yield statistically reasonable parameters.
The authors carried out carefully designed optimization steps and inform readers of the critical aspects of each. The merit, quality, and rigor as a method-oriented manuscript are impressive. Overall, this is an excellent study.
We appreciate for the positive evaluation for our work. Additionally, the minor suggestions were helpful to improve our manuscript. Thank you!
Reviewer #2 (Public Review):
In this study, the authors have developed methods that allow for repeatedly unfolding and refolding a membrane protein using a magnetic tweezers setup. The goal is to extend the lifespan of the single-molecule construct and gather more data from the same tether under force. This is achieved through the use of a metal-free DBCO-azide click reaction that covalently attaches a DNA handle to a superparamagnetic bead, a traptavdin-dual biotin linkage that provides a strong connection between another DNA handle and the coverslip surface, and SpyTag-SpyCatcher association for covalent connection of the membrane protein to the two DNA handles.
The method may offer a long lifetime for single-molecule linkage; however, it does not represent a significant technological advancement. These reactions are commonly used in the field of single-molecule manipulation studies. The use of multiple tags including biotin and digoxygenin to enhance the connection's mechanical stability has already been explored in previous DNA mechanics studies by multiple research labs. Additionally, conducting single-molecule manipulation experiments on a single DNA or protein tether for an extended period of time (hours or even days) has been documented by several research groups.
One of the unique features of our work is the development of a robust single-molecule tweezer method that is applicable to membrane proteins, rather than simply making another stable system. As re-written in Introduction, it is not straightforward as we have to consider the membrane reconstitution. We believe that our work is expected to overcome the bottleneck in membrane protein studies that arises when using single-molecule tweezer methods.
To improve the delivery of the contextual information, we revised Introduction, Results, and Discussion. The first four paragraphs in the Introduction briefly review previous tweezer methods with an improved stability and delineate where our work is placed. In the first paragraph of the Results, we also briefly discussed how and why our DBCO tethering strategy differs from previous DBCO methods. In the first paragraph of the Discussion, we compared the previous methods regarding the stability improvement.
Additionally, the revised manuscript now includes new findings – the full dissection of structural transitions of a helical membrane protein, the observation of hidden helix-coil transitions at a constant force, and the estimation of kinetic pre-exponential factors. We believe that the new findings provide important insights into membrane protein folding, in addition to the usefulness of our method itself for membrane protein studies. We extensively edited the main text and Methods accordingly. Relevant figures are Figures 6 and 7, Figure 6–figure supplements 1–3, and Figure 7–source data 1.
Reviewer #3 (Public Review):
The authors describe a method to tether proteins via DNA linkers in magnetic tweezers and apply it to a model membrane protein. The main novelty appears to be the use of DBCO click chemistry to covalently couple to the magnetic bead, which creates stable tethers for which the authors report up to >1000 force-extension cycles. Novel and stable attachment strategies are indeed important for force spectroscopy measurements, in particular for membrane proteins that are harder and therefore less studied in this regard than soluble proteins, and recording >1000 stretch and release cycles is an impressive achievement. Unfortunately, I feel that the current work falls short in some regards to exploring the full potential of the method, or at least does not provide sufficient information to fully assess the performance of the new method. Specific questions and points of attention are included below.
We appreciate for the positive evaluation. We were able to largely improve our manuscript while preparing our responses to the comments. Thank you!
- The main improvement appears to be the more stable and robust tethering approach, compared to previous methods. However, the stability is hard to evaluate from the data provided. The much more common way to test stability in the tweezers is to report lifetimes at constant force(s). Also, there are actually previous methods that report on covalent attachment, even working using DBCO. These papers should be compared.
As shown in Figure 4E, we evaluated the robustness of our method in a way suggested by you – the lifetime measurement at a constant force. Specifically, ~12 hours at 50 pN. Definitely, our tweezer approach established here is the most robust method for membrane protein studies. Please refer to the section “Assessing robustness of our single-molecule tweezers” in page 7 and line 31.
We discussed the previous covalent methods for which quantitative data are presented in light of the system stability. Please refer to the first paragraph of Discussion. We also briefly discussed how and why our DBCO tethering strategy differs from previous DBCO methods, in the first paragraph of Results.
- The authors use the attachment to the surface via two biotin-traptavidin linkages. How does the stability of this (double) bond compare to using a single biotin? Engineered streptavidin versions have been studied previously in the magnetic tweezers, again reporting lifetimes under constant force, which appears to be a relevant point of comparison.
The papers in this comment showed that the tethering lifetimes of biotin-streptavidin variants were affected by the asymmetric bead anchoring point. However, the situation does not apply to our work as we do not anchor traptavidin to beads. Besides, the stability comparison between the single- and double-biotin systems is not the main point of our work, so we do not have the answer to the question. However, we cited the reference in the first paragraph of Discussion where we discuss the system stability.
- Very long measurements of protein unfolding and refolding have been reported previously. Here, too, a comparison would be relevant.
We briefly discussed the relevant previous works in the first paragraph of Discussion.
In light of this previous work, the statement in the abstract "However, the weak molecular tethers used in the tweezers limit a long time, repetitive mechanical manipulation because of their force-induced bond breakage" seems a little dubious. I do not doubt that there is a need for new and better attachment chemistries, but I think it is important to be clear about what has been done already.
The sentence is in Abstract, so we also had to consider the conciseness. By simply adding the phrase “used for the membrane protein studies”, we can place our work into a more proper context.
In page 2 and line 3, “…However, the weak molecular tethers used for the membrane protein studies have limited long-time, repetitive molecular transitions due to force-induced bond breakage…”
- Page 5, line 99: If the PEG layer prevents any sticking of beads, how do the authors attach reference beads, which are typically used in magnetic tweezers to subtract drift?
The PEG layer consists of biotin-PEG and methyl-PEG at a 1:27.5 molar ratio. As the reference beads are coated with streptavidin, they are attached to the PEG layer by the regular biotin-streptavidin interaction. In page 19 and line 7, you can refer to “…The polystyrene beads are attached to the PEG surface via biotin-streptavidin interaction. The beads are used as reference beads for the correction of microscope stage drifts…”
- Figure 3 left me somewhat puzzled. It appears to suggest that the "no detergent/lipid" condition actually works best, since it provides functional "single-molecule conjugation" for two different DBCO concentrations and two different DNA handles, unlike any other condition. But how can you have a membrane protein without any detergent or lipid? This seems hard to believe.
We explained the raised point in page 6 and line 18,
“…Indeed, the best condition was in the absence of any detergents or lipids (Figure 3; no detergents/lipids only during the conjugation step). This situation is possible because membrane proteins are sparsely tethered to the chamber surface, which kept them from aggregating. However, not using detergents or lipids means that the membrane proteins are definitely deformed from their native folds. Therefore, we sought an optimal solubilization condition for membrane proteins during the DBCO-azide conjugation step...”
Figure 3 also seems to imply that the bicelle conditions never work. The schematic in Figure 1 is then fairly misleading since it implies that bicelles also work.
The buffer conditions shown in Figure 3 are those ONLY during the DBCO-azide conjugation step. In this step, the bicelle conditions did not work. Therefore, after the conjugation in 0.5% DDM, the buffer was exchanged with a bicelle solution. This process is shown in Figure 2 and the finally assembled system is depicted in Figure 1.
To clarify this point, we put a note “Buffer conditions only during the DBCO-azide conjugation step” just above the buffer conditions in Figure 3. You can also find for the relevant exchange step in page 6 and line 31, “…Following a 1 h incubation of the beads in the single-molecule chamber at 25°C, unconjugated beads were washed, and the detergent micelles were exchanged with bicelles to reconstitute the lipid bilayer environment for membrane proteins…”
- When it comes to investigating the unfolding and refolding of scTMHC2, it would be nice to see some traces also at a constant force. As the authors state themselves: magnetic tweezers have the advantage that they "enable constant low-force measurements" (page 8, line 189). Why not use this advantage?<br /> In particular, I would be curious to see constant force traces in the "helix coil transition zone". Can steps in the unfolding landscape be identified? Are there intermediates?
Yes, please refer to Figure 6. We were able to dissect three distinct transitions from the fully unstructured state to the native state, including the helix-coil transitions. We also reconstructed the folding energy landscape using a deconvolution method.
Please refer to the pertinent sections in the main text, which are titled “Structural transitions and folding energy landscape over extended time scales” and “Mechanistic dissection of folding transitions”.
- Speaking of loading rates and forces: How were the forces calibrated? This seems to not be discussed.
We wrote an additional section in Methods titled “Instrumentation of single-molecule magnetic tweezers”, where we discuss the force calibration. For the actual force calibration data, please see Figure 4–figure supplement 1A.
In page 20 and line 10, “…The mechanical force applied to a bead-tethered molecule was calibrated as a function of the magnet position using the formula F = k_B_T∙L/δx_2 derived from the inverted pendulum model96, where _F is the applied force, k_B is the Boltzmann constant, _T is the absolute temperature, L is the extension, and _δx_2 is the magnitude of lateral fluctuations…”
And how were constant loading rates achieved? In Figure 4 it is stated that experiments are performed at "different pulling speeds". How is this possible? In AFM (and OT) one controls position and measures force. In MT, however, you set the force and the bead position is not directly controlled, so how is a given pulling speed ensured?<br /> It appears to me that the numbers indicated in Figures 4A and B are actually the speeds at which the magnets are moved. This is not "pulling speed" as it is usually defined in the AFM and OT literature. Even more confusing, moving the magnets at a constant speed, would NOT correspond to a constant loading rate (which seems to be suggested in Figure 4A), given that the relationship between magnet positions and force is non-linear (in fact, it is approximately exponential in the configuration shown schematically in Figure 1).
You are correct, so we simply modified the “pulling speed” to “magnet speed” in the figure caption. The loading rates provided in the figure (with the notation <>) were average loading rates in 1–50 pN to provide rough estimates. We actually specified it in the caption as “average force-loading rate”. However, this can be misleading at a glance, so we just deleted all the loading-rate values in the figure and caption.
- Finally, when it comes to the analysis of errors, I am again puzzled. For the M270 beads used in this work, the bead-to-bead variation in force is about 10%. However, it will be constant for a given bead throughout the experiment. I would expect the apparent unfolding force to exhibit fluctuations from cycle to cycle for a given bead (due to its intrinsically stochastic nature), but also some systematic trends in a bead-to-bead comparison since the actual force will be different (by 10% standard deviation) for different beads. Unfortunately, the authors average this effect away, by averaging over beads for each cycle (Figure 4). To me, it makes much more sense to average over the 1000 cycles for each bead and then compare. Not surprisingly, they find a larger error "with bead size error" than without it (Figure 5A). However, this information could likely be used (and the error corrected), if they would only first analyze the beads separately.
We might be wrong, but there seems to be a misunderstanding. First, we added Figure 5–figure supplement 1 where you can see individual traces. As expected, the levels of unfolding forces/sizes appear consistent during the progress of pulling cycles. Second, the advantage of averaging for different beads is that you can effectively remove the bead size effect. This “averaging-out” is the key strategy in our kinetic analysis. Based on the error estimation, if you average the values of kinetic parameters obtained from different beads, you can then estimate them with reasonably small errors despite the bead size variations. This becomes more evident after initial hundreds of pulling cycles. The errors for 200 and 1000 cycles are of only ~1% difference, indicating that you do not need to blindly run the pulling cycles. These results are based on the “averaging-out” strategy, which is the merit of our analysis. For more details, please see the section in the main text titled “Assessing statistical reliability of pulling-cycle experiments”, where relevant figures, figure supplements, and Method sections are referred.
What is the physical explanation of the first fast and then slow decay of the error (Figure 5B)? I would have expected the error for a given bead after N pulling cycles to decrease as 1/sqrt(N) since each cycle gives an independent measurement. Has this been tested?
If the sampling was from one population (here, unfolding probability profile), the error would follow a 1/√n decay as expected for the standard error. In our analysis, however, we estimated the expected “mean” errors, regardless of detailed shapes of the unfolding probability profiles. To this end, we sampled the data from different possible profiles (shown in Figure 5–figure supplement 5). We then averaged all the error plots to obtain the plot of the mean errors during progress of pulling cycles (black curve in Figure 5D). In this case, the plot does not have to follow the standard error curve represented by the factor 1/√n.
We tested this by fitting with the model function of y = A/√n, for various lower limit of N = 10, 30, 50, 100, 300, and 500 in the regression analysis (Figure 5–figure supplement 6). The results of the reduced chi-square (χ2) used for a goodness-of-fit test (χ2 = 1 for the best fit) indicates that the two-term exponential model (χ2 = 1.60) shows a better fit than the reciprocal square root model (χ2 = 2.30–6.01). The regression model adopted in our analysis is a phenomenological model that more properly describes the error decay curve. The trend of the first fast and then slow decay is not unusual because it is also expected for the reciprocal square root model – the plot 1/√n decays fast and then slowly, too (Figure 5–figure supplement 6).
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
eLife assessment
The authors present an exciting idea about how to integrate morphogens into a gene regulatory network with the dynamics of morphogenesis and cell movement. It represents a novel methodology, but in its current form the hypotheses, data and relationships described do not provide a sufficiently compelling model to disentangle cause and effect or elucidate the impact of cell movements on differentiation dynamics the zebrafish mesoderm.
Our aim in this work was not to disentangle causal relationships between signalling, cell movements and gene-regulatory interactions. As discussed in the specific responses below, and in the discussion of the pre-print, this would require precise experimental manipulations within the context of a modelling framework that enables multi-scalar integration of each of these three dynamic components. What we do present here is a) computational methodology to reverse-engineer GRNs in the context of tissue morphogenesis (Spiess et al.,) and b) experiments to narrow down a candidate GRN capable of recapitulating gene expression dynamics in vitro and in vivo (Fulton et al.,). We see this as the first step in tackling the causal relationships of cell movements, signalling and cell fate decision making and propose a working model for future studies to build on.
Reviewer #1 (Public Review):
In the manuscript " Cell Rearrangement Generates Pattern Emergence as a Function of Temporal Morphogen Exposure" by Fulton et al., the authors set out to link cell dynamics and single-cell gene expression states, in order to understand the dynamics of cell differentiation. This important challenge is tackled by studying somitogenesis in the zebrafish embryo and combining reverse-engineering gene regulatory networks (GRNs) with cell tracking data. The differentiation of the presomitic cells is evaluated by the differential tbx marker expression through in situ HCR and antibody staining, and live imaging of reporters. Through mathematical modelling taking into consideration the HCR tbx data, live reporter data of the morphogen activity, and the 3D tracking data at different stages, the authors find a candidate model of a gene regulatory network that recapitulates both in vivo and in vitro patterns of the dynamics of cell differentiation. Using this live-modelling approach, the authors move on to question the impact of cell movement on gene expression and conclude that pattern emerges as a function of cell rearrangements tuning the temporal exposure of the cells to the morphogen gradients.
The major strength of the manuscript is the development of a unique method for addressing cell differentiation dynamics by combining static gene expression data with live cell dynamics. Bridging spatiotemporal information is key to understanding tissue and embryo development and this work provides a great basis for it. A potential weakness is how one selects which of the GRNs predicted from the live-modelling is physiologically relevant to the system of interest, since it requires fitting techniques.
The major goal of the paper is mostly achieved. This is evident by the proposed model predicting well the dynamics of differentiation both in vivo and in vitro. To fully support the conclusion that cell rearrangements are necessary for patterning, the addition of functional experiments targeted in this direction might be beneficial.
We agree with the reviewer that functional evidence for a role of cell rearrangement in pattern formation is lacking from the pre-print. We will adjust our title and conclusions to reflect this in a revised version.
Reviewer #2 (Public Review):
Fulton et al. seek to understand the interplay between "morphogen exposure, intrinsic timers of differentiation, and cell rearrangement" that together regulate the differentiation process within the presomitic mesoderm tissue (PSM) in developing Zebrafish embryos. A combination of live-cell microscopy to measure cell movements, static measurements of gene expression, and computational and mathematical methods was used to develop a model that captures the observed differentiation profile in the PSM as a function of cell rearrangements and morphogen signaling.
The authors motivate their investigation into the link between cell rearrangements and differentiation by first comparing differentiation timing in vitro and in vivo. The authors report that a subset of cells differentiating in vitro do so synchronously while cells differentiating in vivo do so with a wide range of differentiation trajectories. By following a small group of photo-labeled cells, it is suggested that the variation of differentiation timing in vivo is related to variation in cell movements in the tissue. To explain these observations in terms of gene expression within single cells, a novel method to combine cell tracks with fixed measurements of gene expression is first used to estimate gene expression dynamics (AGET) in live cells within a tissue. A final ODE-based gene regulatory network (GRN) model is selected based on a combination of data fitting to AGETs and tissue level measurements, further in vitro experiments, and literature criteria. Importantly this model incorporates information from diverse experimental sources to generate a single unified model that can be potentially used in other contexts such as predicting how differentiation is perturbed by genetic mutations affecting cell rearrangement. The authors then use this GRN model to explain how cells starting from the same position in the PSM can have different fates due to differential movement along the A-P axis. Lastly, the model predicts and, the authors experimentally validate, that the expression of differentiation markers can be heterogeneously expressed between neighboring PSM cells.
The presented research addresses the important topic of patterning regulation accounting for individual cell motion. contributes to larger tissue patterns, this work may directly contribute to our understanding of how regulation across biological scales. Additionally, the methodology to estimate AGET is especially intriguing because of its potential applicability to a wide variety of developmental processes.
However several issues weigh down the strengths of this paper. First, some conclusions and interpretations in the paper do not obviously follow the data and require further clarification. Second, the authors should consider alternative explanations and models and include some discussion about instances where the final GRN model may not fit as well. Finally, the current manuscript lacks clarity in its presentation and this makes it difficult to follow and understand.
Major concerns:
1. A key conclusion made in this paper is that differentiation times show a high variability even when neighboring PSM cells are compared. This is based on the photoconversion experiment shown in Figure 2A-C, where a group of cells is labeled and over time, a trail of labeled cells is visible. It is crucial to understand which compartment is labeled, i.e. progenitor vs. maturation zone vs. PSM. If cells in the progenitor/marginal zone are labeled, the underlying reason for the trailing effect is not a difference in differentiation time, but rather, a difference in the timing of when cells exit the progenitor zone. This needs to be distinguished in my view. In other words, while the timing of progenitor zone exit varies (needs to), once cells are within the PSM, do they still show a difference in differentiation timing? From previous experimental evidence I would expect that in fact, PSM cells differ only very little in differentiation timing. My statement is based on previously published labeling experiments done in posterior PSM cells, not tail bud cells (in chick embryos), which showed that labeled neighboring PSM cells were incorporated into the same adjacent somites, without evidence of a 'trail' (see figure 4H in Dubrulle et al. 2001). In the case of single cell labeling, it was found that these are actually incorporated into the same somite (or adjacent one), even if labeled in the posterior PSM (Stern et al. 1988). The situation in zebrafish appears similar (see Griffin & Kimelman 2002 and Müller et al. 1996). Additionally, the scheme in Figure 2K suggests that the trailing effect reflects a sequential exit from the progenitor zone that is controlled and timed.
We place the labels in a region of the taibud containing tbxta and tbx16 positive mesodermal progenitors and not in the PSM. Therefore, we are examining the timing of exit, and show this is correlated with the onset of tbx6 expression. Taken together with previous work (Thomson et al., 2021; 10.1016/j.cdev.2021.203748), it demonstrates that in zebrafish embryos, non-directional cell movements generate a progressive exit of cells from the progenitor region in the tailbud towards the PSM. We will make these points clear in a revised version of the manuscript.
2. The data on cell movement needs to be presented more clearly. Currently, this data is mainly presented in Figure 3D, which does not provide a good description of the cell movements. Visualization of the single cell tracks and the different patterns that are in the tissue along with the characterization of the movement/timescales is needed to better communicate the data and to tie it to the main conclusions.
A thorough analysis of the tracking data and cell movements in the tailbud are presented in a previous paper (Thomson et al., 2021; 10.1016/j.cdev.2021.203748), and is cited in the pre-print.
3. The conclusion "As a result of their different patterns of movement, and therefore different Wnt and FGF dynamics, the simulated T-box gene expression dynamics differ in both cells." (Line 249) is not convincing: what part of the data shows that it is not the other way around, i.e. the signaling activities control the movement? The way I understand the rationale of this analysis: the authors take the cell movement tracks as a given input into the problem, and then ask, what signaling environment is the cell exposed to? The challenge with this view is two-fold: first, the authors seem to assume that a cell moves into a new environment and is hence exposed to a different level of signal, while in reality, these signaling gradients act short-range and maybe even at a cellular scale and hence a moving cell would carry Wnt-ligands with it, essentially contributing to the signaling environment. This aspect of 'niche construction' seems to be missing. Second, it has been shown (in chick embryos) that cell movement is, in turn, controlled by signaling levels, how would this factor into this model?
See response to reviewer 1, we have revised our conclusions to make it clear that we are not demonstrating a causal role of cell movements in this process. We instead provide a modelling framework to interrogate these complex multi-scale interactions.
4. On the comparison with the in vitro model:<br /> A. The interpretation of cells differentiating synchronously or coherently in vitro seems inconsistent with the data presented in figure 1. To me figure 1F/G does not seem compatible with the previous figure 1D/E since 1F seems to describe cells that upregulate tbx6 over a range of times, in a manner analogous to what is reported in vivo, i.e. figure 2.
We agree that once initiated, tbx6 expression is variable between individual cells as shown in Figure 1. Our conclusion is that, whatever the rate of increase in expression, cells initiate their increase at the same time (200 mins). We will make this clear in a revised version.
B. The authors conclude that in vitro, single PSM cells differentiate 'synchronously' and hence differently to what is seen in vivo, where the authors conclude that there is a "range of time scales". As noted above, the situation in vivo can be explained by a timed exit from the progenitor zone, while PSM differentiation is proceeding similarly in all PSM cells. In this view, what is seen in vitro is that all those cells that undergo PSM differentiation, initiate this process in culture more synchronously but it is the exit from the progenitor state, not the dynamics of differentiation, that might be regulated differently in vivo vs. in vitro.
We agree with this statement- the process we are examining is the timing of tbx6 onset, a proxy for the timing of switching from a progenitor to a PSM cell state. However, we don’t see how this is different from the ‘dynamics of differentiation’ as these processes are directly related.
C. Another important point to clarify is that the overall timing of differentiation is entirely different in the in vitro experiment: as has been shown previously (Rohde et al. 2021, Figure S12) both the period of the clock and the overall time it takes to differentiate is very substantially increased, in fact, more than doubled. This aspect needs to be taken into account and hence the conclusion: "Our analysis revealed that cells undergo a range of temporal trajectories in gene expression, with the fastest cells transiting through to a newly formed somite in 3 hours; half the time taken for cells to fully upregulate tbx6 in vitro (Figure 2K-L).)" (line 142) appears misleading, as it seems to emphasize how fast some cells in vivo differentiate. However, given the overall slowing down seen in vitro, which more than doubles the time it takes for differentiation (see Rohde et al. 2021, Figure S12), this statement needs to be refined.
This is indeed an interesting observation and will be discussed in a revised version.
5. The GRN proposed in this work includes inhibition of ntl/brachyury by Fgf (Figure 3f). However, it has been shown that Fgf signaling activates, not inhibits, ntl (see for instance dnFgfr1 experiments in Griffin et al., 1995). This does not seem compatible with the presented GRN, can the authors clarify?
Experiments in which signalling and/or transcription function are disrupted in vivo are very different interpret from analysing the impact of gene expression alone. As discussed, and highlighted by the reviewers, there exists a complex interplay where signals can impact cell movements and vice versa. What we propose in this work is a working model of this process through which this interplay can be explored.
6. The authors use static mRNA in situ hybridization and antibody stainings to characterize Wnt and Fgf signaling activities. First, it should be clarified in Figure 3A that this is not based on any dynamic measurement (it now states Tcf::GFP, as if GFP is the readout, so the label should be GFP mRNA). Second, and more importantly, it is not clear how this quantification has been done. Figure 3C shows a single line, while the legend says n=6 and "all data plotted"..can this be clarified? Without seeing the data it is not possible to judge if the profiles shown (the mean) are convincing. As this experimental result is used to inform the model and the remainder of the paper, it is of critical importance to provide convincing evidence, in this case, based on static snapshots.
This will be clarified in a revised version of the paper.
7. Although the AGET analysis and this specific GRN model development are of interest and warrant the explanation the authors have provided, I would be careful not to overstate the findings. In particular, I believe the word "predicted" is used too loosely throughout the manuscript to describe the agreement between model and experiments. For example, my understanding of Figure 4, and what is described in the supplemental diagram, is that the in vitro experiments are used to further refine the model selection process. Therefore, it should not be stated as a prediction of the selected model. This is not to say the final model is not predictive, but it's difficult to assess the predictive power of this model since it hasn't been tested in independent experimental conditions (e.g. by perturbing cell movement and using the model to predict the expected differentiation boundary).
We will take care with the use of the term ‘predicted’ in a revised version of the paper. The reviewer is correct that this result was used to select from an existing set of GRNs.
Reviewer #3 (Public Review):
Fulton et al. look to apply approaches for tackling the readout of gene regulatory networks (GRNs) to a system where cell position itself is continually changing. The objective is highly laudable. GRN analysis has proven to be a powerful approach for understanding how cell fates are determined by morphogenetic inputs, but it has thus far been applied in a limited number of systems. Here, the authors look to substantially extend the application of GRNs to more dynamic systems. The theoretical and experimental approaches are integrated to achieve the analysis of the GRN. In principle, this has wide potential impact and applicability to other systems.
Unfortunately, in its current form, the manuscript does not do justice to the central aims of the authors. The manuscript is unclear in nearly all sections, and figures and analysis can be substantially improved. The quantifications are not shown in a fitting manner. The modelling itself stands as the strongest part of the manuscript, but improvements are needed. Currently, the main claims of the authors cannot be evaluated based on the quality of the presented data.
This reviewer has provided a list of minor corrections that will greatly improve a revised version of the manuscript for our next submission.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
In this manuscript, Soto-Feliciano et al. investigate the tumor suppressive role of MLL3 in hepatocellular carcinoma (HCC). The authors used a variety of techniques including hydrodynamic tail vain injection (HTVI), CRISPR deletion, and shRNA to disrupt MLL3 expression in mouse models. They clearly show that MLL3 acts as a tumor suppressor in the context of MYC-induced HCC. They show that MLL3 acts by activating the Cdkn2a locus. Genomic analysis showed that MLL3 binds to enhancers and promoters, and specifically interacts with the Cdkn2a promoter. When MLL3 was downregulated, Cdkn2a levels fell and this corresponded to changes in relevant histone marks targeted by MLL3. The authors were also able to show that reintroduced MLL3 expression in a dox inducible system could rescue CDKN2A locus expression, which in turn reduced colony formation and induced apoptosis. Human genomic correlation showed that MLL3 and Cdkn2a mutations are generally mutually exclusive. Overall, the conclusions of the manuscript are well supported by a logical series of experiments with good controls and orthogonal approaches. While it would be useful to examine another HCC model such a CTNNB1-driven model, the current paper is convincing in its conclusions.
We thank the reviewer for their positive and constructive comments and suggestions. Our study primarily used MYC as the driving oncogene for two reasons: first, in an initial in vivo screen of 12 candidate tumor suppressors, MLL3 was the strongest hit that its loss cooperated with the Myc oncogene to drive HCC (Figure 1—figure supplement 1); second, in human HCCs, KMT2C (gene encoding MLL3) mutations and deletions co-occur with MYC gains and amplification.
Based on the reviewer’s suggestion, we examined MLL3 loss in conjunction with CTNNB1 activation, using HTVI of a transposon containing the constitutively active Ctnnb1. However, we did not observe oncogenic cooperation between Ctnnb1 activation and Kmt2c loss; no mice developed liver tumors by the experimental endpoint (5 months post HTVI, Figure 1—figure supplement 3). Additionally, analysis of genomic data from human HCCs showed no significant co-occurrence between CTNNB1 and KMT2C alterations (Figure 1A). These results suggest that, similar to other epigenetic regulators, the tumor suppressive function of MLL3 is likely oncogene-specific. Our in vivo screen results that nominated MLL3 as a tumor suppressor also reinforce this functional interaction with MYC oncogene. We have updated the text to reflect the context specificity of MLL3 as a tumor suppressor in our study.
Reviewer #2 (Public Review):
Soto-Feliciano et al. have characterized the function of MLL3 in hepatocellular carcinoma (HCC) suppression. MLL3 is recurrently mutated in human HCC. The authors show that Mll3 mutations cooperate with Myc overexpression to drive HCC cancer in mice. They identify Cdkn2a as a critical direct target of MLL3. Overall, the manuscript makes a compelling case that MLL3 is a bona fide HCC tumor suppressor, that it directly binds and activates the Cdkn2a locus, and that Cdkn2a acts downstream of MLL3 to suppress HCC initiation.
The strengths of the paper include mouse modeling techniques that clearly demonstrate a role for MLL3 in suppressing Myc-driven HCC, a detailed characterization of MLL3 binding sites and target gene expression, and the combined weight of several functional studies showing that MLL3 induces apoptosis in hepatocytes/HCC by inducing p16 and ARF. The major conclusions appear well-supported by the data.
The paper does have some weaknesses. Some of the genomic data require clarification. Furthermore, the authors draw broad conclusions about an epistatic relationship between MLL3 and CDKN2A based on mutually exclusive mutation patterns in human cancers. Those conclusions are not as well-supported as the mechanistic conclusions. The incidences of MLL3 and CDKN2A mutations in HCC are both relatively low (1% and 5% respectively), so it seems difficult to draw any conclusions from mutually exclusive profiles.
One additional criticism is that the paper is a bit reductive. The link to CDKN2A offers a satisfying explanation for how MLL3 suppresses HCC, but the model may oversimplify the functions of MLL3.
We thank the reviewer for their constructive comments and suggestions, which we addressed as follows with point-by-point response provided below. We agree with the concerns regarding the mutational analyses of KMT2C and CDKN2A in human cancers and the working model of the manuscript. We have removed the majority of the mutational analyses from the Results section. Importantly, our latest integrative analyses of RNA-seq and MLL3 ChIP-seq revealed other potential downstream effectors of MLL3 tumor suppressive functions (Figure 3A and Figure 3—figure supplement 1B). We have modified the Results and the Discussion to reflect this more nuanced view of MLL3 function in cancer. Nonetheless, we believe that other data continue to support our conclusion that CDKN2A is a dominant effector of MLL3 tumor suppressive functions in our model.
Reviewer #3 (Public Review):
The enhancer chromatin-modifying enzyme MLL3 functions as a tumor suppressor in multiple human cancers, however, the mechanisms underlying its tumor suppressive function remain unclear. The manuscript of SotoFeliciano et al. focused on Myc-driven liver cancer and aimed to address and fill the gap. The authors used an elegant genetic design and approach to manipulate the overexpression of the Myc oncogene and knockout of the Mll3 tumor suppressor gene in mouse liver cancer models. Their genetic mouse models showed that loss of Mll3 constrains Myc-driven liver tumorigenesis, with tumors having a slightly later onset compared to mice with Myc overexpression in conjunction with p53 inactivation. Because MLL3 is a major histone-modifying enzyme for enhancer-associated H3K4 monomethylation and is responsible for enhancer activation and the following target gene transcription, they performed ChIP-seq analysis to study the roles of Mll3 in Myc-driven mouse liver cancer. Interestingly, their ChIP-seq studies revealed that loss of Mll3 preferentially limits Mll3 enrichments at promoters and thereby attenuates promoter-associated H3K4 trimethylation and target gene transcription, whereas the unchanged Mll3 genomic binding between the two genotypes (Myc;sgTrp53 and Myc;sgKmt2c) is largely located within enhancer (intergenic) regions. They further demonstrated that the cdkn2a locus is a genomic and transcriptional target of Mll3 in Myc-driven mouse liver cancer. Supporting their findings, genomic inactivations of MLL3 and CDKN2A displays mutual exclusivity in human liver cancer and many other cancer types. Furthermore, they described a possible mechanism for MLL3's role in MYC-driven liver cancer that MLL3 mediates MYC-induced apoptosis in a CDKN2A-dependent manner by manipulating Myc overexpression, Mll3 function, and Cdkn2a regulation in their genetic mice models. This manuscript describes a potential function of MLL3 in the control of tumor suppressor gene expression via modulating their promoter chromatin landscapes. More importantly, loss of normal function of MLL3 or the downstream effector CDKN2A may impair MYC-induced apoptosis, and in turn, lead to MYC-induced tumorigenesis.
Overall, the manuscript is well written, organized, and focused on an interesting topic, and with data presented supports the authors' claims.
We thank the reviewer for their positive and constructive comments and suggestions.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
This manuscript represents a substantial and well-executed body of work that contributes new data on 32 hymenopteran genomes, systematically identifies viral endogenization and domestication events, and tests whether this phenomenon is more common in hymenopteran species with specific lifestyles, eg. endoparasitism. The authors developed a pipeline to identify endogenization that improves upon previously described pipelines and is more comprehensive for the identification of endogenization events from a variety of virus types. Significant findings include the identification of previously undocumented cases of viral endogenization in several hymenopteran species and also moderate statistical support for a higher rate of dsDNA virus endogenization and domestication in endoparasitoids.
1) The authors have tested whether the lifestyle of hymenopteran species (endoparasitism, ectoparasitism, or free-living) is related to the incidence of virus endogenization and domestication. Addressing this kind of question has only become possible with the availability of genome sequences from many taxa so that any results can be statistically supported by appropriate sample sizes. It appears that the authors have not included new genomic data from hymenopteran genomes that have been published since 2019, which are of similar or better quality than the data used in this manuscript. A number of taxa with endogenous viruses (and also without) have become available since then. The best solution would be for the authors to use their pipeline to incorporate the new data, which may have an impact on their findings and could even strengthen their conclusions about virus domestication being more common in endoparasitoids. If this is not possible, the authors should at least justify their decision not to include the most recent data and discuss how it could affect their results.
The first step of our pipeline is to extract all candidate loci from each genome. Then all these loci are clustered and further analyzed to infer endogenization and domestication (sequence alignments, phylogeny, dN/dS, genomic context, mapping…). Thus, adding new genomes requires re-run the whole analysis from the very beginning which represents a huge amount of work and computational resources together with their associated carbon costs. Additionally, this work was part of Benjamin Guinet’s Phd project which was defended on 21 Marsh 2023. In conclusion, we will not be able run again the whole pipeline in all the genomes published since 2019.
2) Please summarize in the main manuscript (results or discussion) what the limitations of the pipeline to detect EVEs and dEVEs are - what are important factors to consider, including the availability of closely related "free-living" viruses, and of closely related wasp species for dN/dS analyses.
We added a paragraph in the discussion section to discuss the limitations of our pipeline as follow:
“Because the identification of EVEs necessitates the availability of related viruses in the database, we should see these numbers as an underestimation of the real number of EVEs. In addition, our pipeline necessitates the availability of either related species sharing the same EVEs (or at least the presence of paralogs within a single species) or the availability of RNAseq data to infer domestication. Because these last conditions were only met for 701 out 1261 EVEs, the results we obtained here regarding domestication should be seen as an underestimation of the prevalence of the phenomenon.”
3) In this manuscript, a description of the methods that precede the results would make it much easier to appreciate the results shown. It appears that this is allowed in cases where it makes sense, according to the author's instructions.
The first paragraph of the result section was intended to give this overview on the methods used. However, we tried to give more details on the methods in this paragraph. We hope that this will increase readability of the paper.
4) The sensitivity and specificity of methods analysis are commendable, as is the availability of substantial supplementary data and scripts on GitHub. However, more effort could be made to align numbers reported in the text and in figures so that readers can verify support for the conclusions described.
To align numbers reported in the text and the figures, we added a new excel sheet within the supplementary file 6 named “Figure_data” in which we report the data used to build the figures 2A, 3A and 3B.
Reviewer #2 (Public Review):
Guinet et al address the question of whether the divergent lifestyles in hymenopteran insects determine the rates of acquisition and domestication of viral genetic elements. As endoparasitoids are intimately associated with their hosts and often develop as broods herein, they predicted that the acquisition rate is higher compared to free-living and ectoparasitoid hymenopterans. Following viral domestication in the new recipient wasp genome, these viral elements have been shown to contribute to endoparasitism by promoting the delivery of secreted compounds in insect hosts (where immature wasps develop). Because of this functional importance, the authors predicted that the rate of domestication is also higher in endoparasitoid wasps. I was impressed with the solid and rigorous approach that was followed to test these two hypotheses. The authors carefully ruled out confounding factors, including contamination of genome assemblies. Previously characterized hymenopteran genomes were included as positive controls to assess the developed pipelines. There was also great merit in using a Bayesian model to study endogenization within the phylogenetic framework. To summarize, this multi-pronged strategy to mine animal genomes for viral genetic elements has the potential of becoming a new benchmark for future studies.
Although the authors do partially achieve their aim of coupling endogenization with an endoparasitoid lifestyle, I am afraid some of the assumptions and generalizations hinder a more solid conclusion. I feel that categorizing hymenopterans either as free-living, endoparasitoids, or ectoparasitoids is an oversimplification. Many of the authors' arguments to associate endogenization with endoparasitoids also apply to free-living eusocial hymenopterans. Both endoparasitoid and eusocial insects can be relatively more exposed to viruses because of intimate conspecific interactions within confined spaces. As endoparasitoids intimately interact with their host, so do eusocial insects with their social guests (melittophiles, myrmecophiles, and termitophiles). Perhaps, you could even argue that some gregarious insects also fit the bill. I would be interested to see whether the conclusions hold when "free-living" is further subdivided and "eusocial" is a separate category.
To answer this question, we reran the study by separating the free-living category into "eusocial" and "free-living" subcategories. All of the new eusocial assignations and their accompanying bibliographies have been added to the Supplemental file 1 under the columns "lifestyle2" and "ref-lifestyle2". All of the new GLM results have been added to the Supplemental file 6. We also made a new violin plot figure names “Figure 4-figure supplement 3” which contains the GLM coefficients distribution of the model run on A only and A to D scaffolds.
We also added a few lines in the M&M to explain this analysis “The same analysis was carried out by splitting the free-living category into two sub-categories, namely eusocial and free-living. A new glm model was then built (GLM(Number EVEs ~ free-living + eusocial + endoparasitoid + ectoparasitoid * Branch_length, family = zero inflated neg binomial). (Lines 754-756).
Overall, the new models that included free-living eusocial hymenopterans revealed the exact same patterns as found in the main analysis. We added a new section entitled “Conclusions hold when eusociality is taken into account” to report the results.
In conclusion, when "free-living" is further subdivided, the mains findings still hold.
Second, I wonder why the authors did not include Wolbachia infection as an explanatory variable to explain the endogenization rate. Wolbachia bacteria infect the insect germline and are often associated with phages. These phages could thus be a major source of viral genetic elements. Having said that, I do not see any Symbioviridae, the phylogenetic clade in which these phages reside (https://doi.org/10.1371/journal.pgen.1010227), in Figure 2B - so perhaps this is a minor point.
In this study we chose to concentrate our attention on eukaryotic viruses, since we reasoned that they have better opportunities to integrate into the insect genomes du to their intimate relationship. This is the reason why we eliminated from our database all phage proteins (as specified in line 511).
Finally, in addition to the dsDNA virus - endoparasitoids relationship, the authors also detect a link between ssRNA viruses and free-living hymenopterans. (Maybe eusociality is biasing these results?)
Thanks to reviewer’s comment, we realize that the sentence referring to this point was misleading. In our initial analysis, ectoparasitoid species showed in fact less domestication events involving ssRNA viruses compared to all other lifestyles (Figure 4-figure supplement 1-L). We clarified this sentence in the main text as follow: “except for a lower rate of domestication of ssRNA viruses in ectoparasitoids compared to other lifestyles (Figure 4-figure supplement 1-L)” (lines 195-196).
The same effect was observed when including eusociality (see Figure 4-figure supplement 3-L).
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
Estimating the effects of mutations on the thermal stability of proteins is fundamentally important and also has practical importance, e.g, for engineering of stable proteins. Changes can be measured using calorimetric methods and values are reported as differences in free energy (dG) of the mutant compared to wt proteins, i.e., ddG. Values typically range between -1 kcal/mol through +7 kcal/mol. However, measurements are highly demanding. The manuscript introduces a novel deep learning approach to this end, which is similar in accuracy to ROSETTA-based estimates, but much faster, enabling proteomewide studies. To demonstrate this the authors apply it to over 1000 human proteins.
The main strength here is the novelty of the approach and the high speed of the computation. The main weakness is that the results are not compared to existing machine learning alternatives.
We thank Prof. Ben-Tal for taking the time to assess our work, and for his comments and suggestions below.
Reviewer 2 (Public Review):
Summary:
This work presents a new machine-learning method, RaSP, to predict changes in protein stability due to point mutations, measured by the change in folding free energy ΔΔG.<br /> The model consists of two coupled neural networks, a 3D selfsupervised convolutional neural network that produces a reduceddimensionality representation of the structural environment of a given residue, and a downstream supervised fully-connected neural network that, using the former network's structural representation as input, predicts the ΔΔG of any given amino-acid mutation. The first network is trained on a large dataset of protein structures, and the second network is trained using a dataset of the ΔΔG values of all mutants of 35 proteins, predicted by the biophysics-based method Rosetta.
The paper shows that RaSP gives good approximations of Rosetta ΔΔG predictions while being several orders of magnitude faster. As compared to experimental data, judging by a comparison made for a few proteins, RaSP and Rosetta predictions perform similarly. In addition, it is shown that both RaSP and Rosetta are robust to variations of input structure, so good predictions are obtained using either structures predicted by homology or structures predicted using AlphaFold2.<br /> Finally, the usefulness of a rapid approach such as RaSP is clearly demonstrated by applying it to calculate ΔΔG values for all mutations of a large dataset of human proteins, for which this method is shown to reproduce previous findings of the overall ΔΔG distribution and the relationship between ΔΔG and the pathological consequences of mutations. The RaSP tool and the dataset of mutations of human proteins are shared.
Strengths:
The single main strength of this work is that the model developed, RaSP, is much faster than Rosetta (5 to 6 dex), and still produces ΔΔG predictions of comparable accuracy (as compared with Rosetta, and with the experiment). The usefulness of such a rapid approach is convincingly demonstrated by its application to predicting the ΔΔG of all single-point mutations of a large dataset of human proteins, for which using this new method they reproduce previous findings on the relationship between stability and disease. Such a large-scale calculation would be prohibitive with Rosetta. Importantly, other researchers will be able to take advantage of the method because the code and data are shared, and a google colab site where RaSP can be easily run has been set up. An additional bonus is that the dataset of human proteins and their RaSP ΔΔG predictions, annotated as beneficial/pathological (according to the ClinVar database) and/or by their allele frequency (from the gnomAD database) are also made available, which may be very useful for further studies.
Weaknesses:
The paper presents a solid case in support of the speed, accuracy, and usefulness of RaSP. However, it does suffer from a few weaknesses.
The main weakness is, in my opinion, that it is not clear where RaSP is positioned in the accuracy-vs-speed landscape of current ΔΔGprediction methods. The paper does show that RaSP is much faster than Rosetta, and provides evidence that supports that its accuracy is comparable with that of Rosetta, but RaSP is not compared to any other method. For instance, FoldX has been used in large-scale studies of similar size to the one used here to exemplify RaSP. How does RaSP compare with FoldX? Is it more accurate? Is it faster? Also, as the paper mentions in the introduction, several ML methods have been developed recently; how does RaSP compare with them regarding accuracy and CPU time? How RaSP fares in comparison with other fast approaches such as FoldX and/or ML methods will strongly affect the potential usefulness and impact of the present work.
Second, this work being about presenting a new model, a notable weakness is that the model is not sufficiently described. I had to read a previous paper of 2017 on which this work builds to understand the self-supervised CNN used to model the structure, and even so, I still don't know which of 3 different 3D grids used in that original paper is used in the present work.
A third weakness is, I think, that a stronger case needs to be made for fitting RaSP to Rosetta ΔΔG predictions rather than experimental ΔΔGs. The justification put forward by the authors is that the dataset of Rosetta predictions is large and unbiased while the dataset of experimental data is smaller and biased, which may result in overfitting. While I understand that this may be a problem and that, in general, it is better to have a large unbiased dataset in place of a small biassed one, it is not so obvious to me from reading the paper how much of a problem this is, and whether trying to fix it by fitting the model to the predictions of another model rather than to empirical data does not introduce other issues.
Finally, the method is claimed to be "accurate", but it is not clear to me what this means. Accuracy is quantified by the correlation coefficient between Rosetta and RaSP predictions, R = 0.82, and by the Mean Absolute Error, MAE = 0.73 kcal/mol. Also, both RaSP and Rosetta have R ~ 0.7 with experiment for the few cases where they were tested on experimental data. This seems to be a rather modest accuracy; I wouldn't claim that a method that produces this sort of fit is "accurate". I suppose the case is that this may be as accurate as one can hope it to be, given the limitations of current experimental data, Rosetta, RaSP, and other current methods, but if this is the case, it is not clearly discussed in the paper.
We thank the reviewer for their detailed comments and suggestions.
As discussed in our general comments above and also below, we have now added additional benchmarking, making it easier to compare the accuracy of RaSP with other methods. Regarding the model description, we have now added a more detailed description of also the 3D CNN.
Regarding whether to fit the model to experiments or computational data, we agree that it is not clear cut that the former would also not work. Indeed, a main problem is that in both cases it is hard to answer which approach is better because of the scarcity of experimental data. One major problem with the larger sets of experimental data is, as we mention, the bias and variability; another is the provenance. While some databases exist, they are rarely exactly raw data, and for example may contain ∆∆G values estimated from ∆Tm values. In the revised manuscript we now explain better why we chose to target Rosetta, but also acknowledge that one might also have used experiments.
As to the question of accuracy, we agree completely that the methods could be better. One problem, however, is that it is very difficult to answer how much better because of problems with experiments. As mentioned also by reviewer 1, variation across different experiments suggest that even a “perfect” predictor would only achieve Pearson correlation coefficients in the range 0.7–0.8 (https://doi.org/10.1093/bioinformatics/bty880). Clearly, this is an issue with imperfect data curation (it is possible to measure ∆∆G quite accurately), but in the absence of larger and better curated experiments, one will not expect much better accuracy than what we report here. This is now discussed in the revised manuscript.
Reviewer 3 (Public Review):
The authors present a machine learning method for predicting the effects of mutations on the free energy of protein stability. The method performs similarly to existing methods, but has the advantage that it is faster to run. Overall this is reasonable and a faster method will likely have some potential uses. However, not improving performance beyond the reasonable but not great performance of existing methods of course makes this a less useful advance. The authors provide predictions for a set of human proteins, but the impact of their method would be much greater if they provided predictions for all substitutions in all human proteins, for example. In places the text somewhat overstates the performance of computational methods for predicting free energy changes and is potentially misleading about when ddGs are predicted vs. experimentally measured. In addition, the comparison to existing methods is rather slim and there isn't a formal evaluation of how well RASP discriminates pathological from benign variants.
We thank the reviewer for taking time to read our work and for their various suggestions.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
In this manuscript, Elkind et al. use a deep learning segmentation algorithm trained on detecting putative cell nuclei in mouse brains to count cells in the Allen Mouse Brain Connectivity Atlas. The Allen Mouse Brain Connectivity Atlas is a dataset compromising hundreds of mice brains. The authors use this increased statistical power for detecting differences in volume, cell count, and cell density between strains (C57BL/6J and FVB.CD1) as well as sex differences.
Both volume, cell count, and cell density are regularly used in neuroanatomy to normalize or benchmark results so having a large available dataset for others to compare their data would be a useful resource. The trained segmentation algorithm might also find utility in assays where investigators for one reason or another can't dedicate an entire labeled channel to count cell nuclei.
Nevertheless, because of technical reasons, I find the current work problematic.
We thank the Reviewer for acknowledging potential usefulness of our work, and the insightful, helpful comments. We believe this consideration has made our revised manuscript much stronger compared to the initial submission. We hope our revised version will also clear the Reviewer’s remaining doubts.
Major:
The authors make use of the "red" channel from the Allen Mouse Brain Connectivity Project (AMBCP). The AMBCP was acquired using two-photon tomography with the TissueCyte 1000 system (http://help.brain-map.org/download/attachments/2818171/Connectivity_Overview.pdf?version=2&modificationDate=1489022310670&api=v2). The sample is illuminated at 925 nm wavelength and the channel the authors describe as autofluorescence is collected through a 593/40 nm bandpass filter. The authors go on to describe their rationale for using this channel for quantifying cell nuclei:
"We noticed that the red (background) channel of STPT images, taken for the purpose of atlas alignment, typically features dark, round-like objects resembling cell nuclei. We had observed this phenomenon in our own imaging of mouse brains but found little more than anecdotal mentions of it in the literature8,9,10,11".
The authors here cite a Scientific Reports paper from 2021 with 11 citations, a Journal of Clinical Pathology paper from 2005 with 87 citations, and lastly a paper in Laboratory Investigation from 2016 with 41 citations. The authors completely fail to cite the work from Watt Webb's group (co-inventor of 2p microscopy) in PNAS from 2003 that entirely described the phenomena of native fluorescence by multiphoton- excitation (https://www.pnas.org/doi/10.1073/pnas.0832308100 ), citations so far: 1959 citations. This is either indicative of poor scholarship or an attempt to describe something as novel. Either way, the native fluorescence and second harmonic generation from multiphoton illumination are perfectly characterized by Webb and colleagues and they clearly show the differential effect on nucleosides, retinol, indoleamines, and collagen. This is also where the authors should have paid more attention to discrepancies in their own data when correlated to well-established cell nuclei markers (Murakami et al). The authors will note "black large spots" in the data at specific anatomical regions and structures, like the fornix and stria medullaris: https://connectivity.brain-map.org/projection/experiment/siv/263780729?imageId=263780960&imageType=TWO_PHOTON,SEGMENTATION&initImage=TWO_PHOTON&x=15702&y=18833&z=5
which is not reproduced in for example the Allen Reference Atlas H&E staining: http://atlas.brain-map.org/atlas?atlas=1&plate=100960284#atlas=1&plate=100960284&resolution=4.19&x=5507.4000244140625&y=5903.39990234375&zoom=-2
In connection here notice the poor signal in the 2p "autofluorescence" within the paraventricular nucleus: https://connectivity.brain-map.org/projection/experiment/siv/263780729?imageId=263780960&imageType=TWO_PHOTON,SEGMENTATION&initImage=TWO_PHOTON&x=15702&y=17833&z=6
and then compare it to the H&E staining: http://atlas.brain-map.org/atlas?atlas=1&plate=100960280#atlas=1&plate=100960276&resolution=1.50&x=5342.476283482143&y=5368.023856026786&zoom=0
These multiphoton-specific signals are especially pronounced in the pons and medulla which makes quantification especially dubious, which is even apparent simply from looking at Figure 1c in the manuscript.
We thank the Reviewer for the comments and sincerely apologize for missing the seminal work of Webb’s group. We included the former references for their specific mention or illustration of non-autofluorescent nuclei. We indeed entirely missed to address the underlying chemistry that Webb’s group beautifully characterized. We have added the following sentence in the Results section “Autofluorescence of STPT images displays cell nuclei” (red font for new sentence; Reference #15 corresponds to Zipfel et al.):
“We noticed that the red (background) channel of STPT images, taken for the purpose of atlas alignment, typically features dark, round-like objects resembling cell nuclei. This phenomenon was described in previous literature11,12,13,14. In particular, Zipfel et al. characterized the use of multiphoton-excited native florescence and second harmonic generation for the purpose of staining-free tissue imaging15.”
And mentioned the dependency of our method on the presence of intrinsically fluorescent molecules in the Discussion:
“The study has several limitations. First, the model is sensitive to the contrast between dark nuclei and autofluorescent surroundings, which can be limited by image quality and tissue composition. In particular, the staining-free approach depends on the presence of intrinsic molecular indicators such as NADH, retinol or collagen15, which may vary between cell or tissue components, even within the brain.”
We understand that more generally, the Reviewer’s major concern above was regarding the technical validity of our approach; that the segmentation based on small objects lacking autofluorescence, as evident in the STPT dataset, in fact corresponds to cells/nuclei.
In our initial Supplemental Figure 1 (in current version Figure 1—figure supplement 1) we provide technical validation of the method, by showing nuclear staining, and autofluorescence side-by-side, using epifluorescence microscopy. In our revision we now report appropriate statistical measures for this analysis (true positives, false positives, false negatives).
In addition, we performed the following two sets of validations –
(i) Technical validation of our staining-free quantification approach, by nuclear staining. We performed nuclear staining (Hoechst 33342) followed by STPT imaging of 9 female brains and trained a new deep neural network (DNN) to segment the resulting images (STPT was performed by TissueVision). Unfortunately, in STPT it is not technically possible to analyze nuclear staining and autofluorescence in the very same tissue. Therefore, we compared per-region density, cell count and volume of the nuclei-stained validation brains to our original DNN-based analysis of AMBCA brains. We show a correlation coefficient >0.99 for per-region cell count in AMBCA autofluorescence and our nuclear staining (and a similar correlation coefficient for volume). However, the number of cells in nuclear staining over the whole brain is 56% larger than in autofluorescence. Although we currently have no technically feasible way to prove this, one likely explanation for this discrepancy is the nature of the two signals the imaging detects; as positive (Hoechst fluorophore) or autofluorescence. Further, discrepancies between the two methods were notably higher in glial-rich tissues (e.g., CTX L1, midbrain, brainstem) – leading to the speculation that low-autofluorescent object-counts may be biased to detect neurons, rather than glia.
(ii) Independent validation of the biological findings – discussed further below. Regarding the specific concern of “black large spots” in the fornix and stria medullaris – we would like to emphasize that our DNN does not identify and segment dark regions like ventricles and tracks. We provide in the Author Response Image 1 three examples featuring “black large spots” of different shapes and size, with examples of the segmentation results as shown in Figures 1 and 2 of the manuscript. Note that colored circles, that appear as dots depending on magnification, are the objects that were detected and segmented by the DNN. In the Figure we demonstrate that (1) fiber tracts (incl. fornix, stria medullaris) are not segmented; (2) striatal patches (that are smaller still than the fiber tracts in question) are not segmented; and (3) putative blood vessels, appearing as elongated, black structures, are ignored by our DNN.
Author Response Image 1. How does the DNN deal with large black spots? Examples for fiber tracts, striatal patches, and blood vessels; adapted from Figures 1 and 2 in the manuscript. Note that dots/outlines represent segmented putative “nuclei” as detected by the model, colored by assigned region according to Allen Mouse Brain hierarchy. Example (1): fiber tracts (incl. fornix, stria medullaris) are not segmented. Example (2): Striasomes (patches in the striatum, that are smaller still than the fiber tracts in question) are not segmented, and the much smaller objects that are detected as putative nuclei are indicated by arrows. Example (3) putative blood vessels, appearing as elongated, black structures, are ignored by our DNN. Examples of the segmentation images were adapted from the manuscript’s Figure 1 to correspond to the STPT image featuring fiber tracts (and Striasomes/patches) was pointed out by the Reviewer.
Regarding the claim of problematic counting in brain stem regions, we agree, and had addressed this limitation in the manuscript’s Discussion (see below). We believe that our counting is valuable even if in some regions there is a significant systematic error: Most of the analyses in this study compare brain regions across individuals and thus systematic error is less impactful. In the revision, we nevertheless took care to validate and quantify the size of this effect. Briefly, we compared counting based on nuclear staining (Hoechst) from 9 STPT imaged brains, to our quantifications of non-autofluorescent objects. As expected, the ratio between these counts depends on the brain region, and accuracy is better in regions with high brightness, which are not on the border of the section (Figure 2—figure supplement 2). As for pons and medulla, the densities in our Hoechst quantifications are 43% and 60% higher than in our AMBCA analysis, respectively, yet rank order is kept in both.
We have revised the relevant sentences in the Discussion:
Original sentences: The study has several limitations. … In the hindbrain (pons, medulla), contrast was exceedingly weak, and we expect our quantifications in this region to strongly underestimate real cell densities, to an extent we cannot quantify.
Revised sentences: The study has several limitations. … In the hindbrain (pons, medulla), contrast was exceedingly weak, and we expect our quantifications in this region to be 66% of the value estimated by nuclear staining (Figure 2—figure supplement 2).
The authors here use the correlation on log-log coordinates between their data and that of Murakami et al to argue that the method has validity. However, the variance explained here is R^2 = 0.74 which is very poor given the log-log coordinates. A more valid metric would use linear coordinates and computing the ICC and interpret it according to established guidelines (e.g. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913118/).
As mentioned by the Reviewer, Figure 2D compares Murakami et al. cell counts and ours, across all brain regions. The value “r=0.869” represents the correlation coefficient between the two vectors in log scale and not the R^2. We also now display the correlation coefficient for the linear scale, in which case p=0.98. As suggested by the Reviewer, we added ICC values between the two vectors in linear scale. Using 6 different forms (ICC – 1-1;1-k;C-1;C-k;A-1;A-k), the ICC values were 0.98-0.99, thus corresponding to an excellent agreement (ICC values are mentioned in legend of Figure 2).
Author Response Image 2 displays the revised Figure 2D (left), and the log value of the ratio between the AMBCA-based cell count and the Murakami-based value (right), as a function of region volume. The mean value across regions is zero, corresponding to similar cell counts in both methods. Indeed, there exist outlier regions, that may be attributed to either registration errors, different experimental protocols or may stem from the fact that the Murakami values are based on 3 brains, compared to hundreds of AMBCA brains.
Author Response Image 2. Correlation with cell counts in Murakami et al. Left, revised Figure 2D; Right, ratio between AMBCA-based cell counts and Murakami et al. counts, as a function of region volume
In addition to the above concern, the authors argue that the large sample size of the AMBCP is what would enable them to find statistically significant small effect sizes that might have gone undetected in the literature. However, this argument falls flat once we examine some of the main findings the authors report. Although the authors do not directly report measures of dispersion we can estimate it from the figures and then arrive at the sample size needed to find the reported effect size. For example, the effect that describes ORBvl2/3 volume is larger in female mice compared to males would only require n=13 mice at the desired power of 0.8. Likewise, the sample size needed to detect the increased BST volume in male mice looks to be roughly n=16 mice at the desired power of 0.8. Both of these estimates are well within what is a reasonable sample size to expect in an ordinary study. This begs the question: why did the authors simply not verify some of their main findings in an independent sample obtained through traditional ways to quantify volume and cell density since it is well within reach? Such validation would strengthen the arguments of the paper.
We thank the reviewer for this comment and apologize. In the revised version we do report dispersion.
We would like to emphasize that due to our restricted time and resources, we decided to focus our experimental validation on the technical comparison of nuclear staining vs. autofluorescence-based segmentation, outlined above.
We then verified the biological findings from the initial cohort using C57BL/6J volume data from an additional 663 males vs.166 females on AMBCA. This independent cohort showed similar sexual dimorphism in the volume of MEA, BST and ORBvl2/3, as depicted in the following figure (panels A-D and also as new Figure 4—figure supplement 1).
We fully acknowledge the interesting issue raised on sample sizes required to detect our reported effect sizes. Therefore, we here also present the average p-value for sexual dimorphism in volumes of MEA, BST and ORBvl2/3, as a function of the sample size (panel E in Figure 4—figure supplement 1 of the revised manuscript). The Reviewer will note that the regions with largest effect size (MEA, BST) can be detected within more ordinary sample sizes, and indeed, MEA and BST dimorphism is evident in the literature. ORB dimorphism required much greater sample size; and our analysis (Figure 4) systematically detected many more dimorphic regions, in volume, density and count.
Reviewer #2 (Public Review):
This report describes a large-scale analysis of cell counts in mouse brains. The authors found that the Allen Mouse Connectivity project has a rich dataset for cell counting that is yet to be analyzed, and they developed methods to quantify cells in different nuclei. They go on to compare males vs females and two different strains. From this analysis, they found specific differences between male versus female brains, left versus right hemispheres, and C57BL/6 versus FVB.CD1 mice, especially with regard to cell counts and density.
Overall, the methodology is sound and the quality of the data seems high. In fact, this study uses >100 brains for the statistics, and this is one of the major strengths of this study. For researchers who are interested in interrogating the differences at the macroscopic level in brain structures, this study will be a great resource. For example, the manuscript contains an interesting finding that for most brain areas, females have larger volumes but fewer cell numbers.
We thank the Reviewer for these comments. We would like to mention that the revised version of the manuscript does not include a statement regarding BL6 female volume. We found a batch effect in the AMBCA experiments, mostly affecting the volume in their first batch (Figure 2—figure supplement 1B). That batch included mostly males, and had, for some reason, lower volume compared to all later experiments, which caused the volume differences. We emphasize that (1) the total number of cells did not show any batch effect (Figure 2—figure supplement 1C); (2) We normalized the volume and repeated the analysis. Aside the finding that females did not in fact have larger volumes, other main findings remained unchanged.
Reviewer #3 (Public Review):
Elkind et al. have devised a strategy to detect cells in whole brain samples of the large, publicly accessible Allen Mouse Brain Connectivity database. They put together an analysis pipeline to quantify cell numbers and -density as well as volumes for all annotated brain areas in these samples. This allowed them to make several important discoveries such as (1) strain-, sex- and hemisphere-specific differences in cell densities, (2) a large interindividual variability in cell numbers, and (3) an absence of linear scaling of cell count with volume, among others. The key strength of this work lies in its comprehensive analysis, the large sample size that the authors have drawn from (making their conclusions particularly robust), and the fact that they have made their analysis tools accessible. A weakness of the current manuscript is the dense layout and overplotting of several of the figures, and the lack of necessary information to understand them more easily. Another, conceptual weakness of using the autofluorescence channel for cell detection is that the identity (neuronal vs non-neuronal) of the underlying cells remains unresolved. Overall, however, I believe that this study has the potential to serve as a valuable reference point, and I would expect this work to have a lasting impact on quantitative studies of mouse brain cytoarchitecture.
We thank the Reviewer for these valuable comments. We have tried to minimize overplotting of figures and hopefully added all necessary information. For example, the revised manuscript presents more pared-down figures, with data labels omitted if they crowded the graphic. Instead, we provide the full data in Supplemental tables, and our online accessible GUI. We hope the reader will feel encouraged to both zoom the presented data, more deeply explore additional tables, and our online tool.
Regarding the question of cell types, we were unfortunately not able to provide a definitive answer, but our validation experiments provided some potential clues. For example, nuclear staining (Hoechst) uniformly detected 65% more cells than AMBCA autofluorescence quantification. And, in neuron-rich regions, the correspondence between nuclear staining and AMBCA autofluorescence was notably better than in glia-rich regions (e.g., CTX L1, midbrain, medulla). These discrepancies between the techniques may therefore point to an underlying difference in cell types composition – such that counting low-autofluorescent nuclei is biased to neurons.
In addition, however, the methods differ in their native physical properties; in that one detects presence of a fluorescent signal (e.g., the nuclear stain is detected beyond its focal plane), compared to the detection of the absence of a signal (which, in turn, is dependent on the presence of surrounding intrinsic fluorescent molecules). It is technically non-trivial to assess the extent to which these factors apply. We have added a clarification along these lines in the Discussion (below). We would further like to emphasize the nature of our study as a comparative, systematic analysis within this interesting cohort, rather than providing definitive cell counts – that we found to be greatly variable across the population.
“We further attempted to estimate the region-specific accuracy of our cell counting by comparing autofluorescence STPT with brain-wide imaging of nuclear-stained STPT. However, this comparison is technically nontrivial because of the native physical properties of direct staining vs. autofluorescence. For example, stained nuclei located off the focal plane may appear in the image, yet remain undetected by autofluorescence. In addition, tissue composition (e.g., cell types, extracellular matrix) may affect the imaged region. Indeed, in regions rich with non-neuronal cells the error of autofluorescent-based counting was larger compared to nuclear staining. Hence, one may speculate that autofluorescent-based detection is biased for neurons”
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
Alignment between high dimensional data which express their dynamics in a subspace is a challenge which has recently been addressed both with analytic-based solutions like the Procrustes transformation, and, most interestingly, via deep learning approaches based on adversarial networks. The authors have previously proposed an adversarial network approach for alignment which relied on first dimensionally-reducing the binned neural spikes using an autoencoder. Here, they use an alternative approach to align data without use of an initial dimensional-reduction step.
The results are fairly clear - the Cycle-GAN approach works better than their previous ADAN approach and one based on dimensionality reduction followed by the Procrustes transform. In general, a criticism of this entire field is to understand what alignment teaches us about the brain or how it specifically will be used in a BCI context.
There are a few issues with the paper.
1.) To increase the impact of their work, the investigators have now used it to align data in multiple types of tasks. There was an unanswered question about this related to neuroscience - does alignment in one task predict alignment for another?
This is a great question! We anticipate that it will be challenging for an alignment learned on one task to be used on another task, because we know that M1 decoders trained on data from one behavior often do not generalize when tested using a different behavior (Naufel et al., 2019)*. The same nonlinearities that prevent zero-shot decoding across tasks are also likely to impair the ability of an aligner trained on data from one task to successfully align data from another task. Furthermore, the results of Naufel et al. indicate that even if neural alignment is successful, we would need a decoder already trained on the new task to produce reliable predictions-- in which case the data needed to train that decoder could simply be used for alignment. A systematic study of the relation between the ability to align and decode from data is well warranted, but beyond the scope of our current work.
*Naufel, S., Glaser, J. I., Kording, K. P., Perreault, E. J., & Miller, L. E. (2019). A muscle-activity-dependent gain between motor cortex and EMG. Journal of neurophysiology, 121(1), 61-73.
Action in the text: none.
2) Investigators use decoding as a way of comparing alignment performance. The description of the cycle GAN was not super detailed, and it wasn't clear whether there was any dynamic information stored in the network that might create questions of causality in actual use. It seems that input is simply the neural activity at a current time point rather than neural activity across the trial, which would alleviate this concern. However, they mention temporal alignment but never describe in detail whether all periods of spikes are properly modeled by the system or if only subsets of data (specific portions of task or non-task time) will work. Perhaps this is more a question of the Wiener filter, for which precise details are missing.
As intuited by the reviewer, we did only use the neural activity at a current time point as the inputs for Cycle-GAN training, so the system is causal and can be used in real time. We have modified the text to clarify this.
We apologize for any confusion caused by our use of the term "temporal alignment", which was for the sake of consistency with earlier-published, CCA-based alignment methods (e.g., in Gallego et al., 2020), but is indeed confusing. In the revised manuscript, we have switched to the term ‘trial alignment’ which we believe better reflects this pre-processing step, and we have included additional explanations in the introduction.
Importantly, while CCA-style trial alignment is not required by our methods, we do still preprocess our data to exclude behaviors not related to the investigated task. Since monkeys were resting or performing task-irrelevant movements during inter-trial period, we chose to use data only from trial start to trial end, but without any explicit trial matching or alignment (see Appendix 1 - Behavior tasks). In the revised manuscript, we now show that our methods still works well when applied even to the continuous recordings, with Cycle-GAN significantly outperforming both ADAN and PAF.
Action in the text (page 2, lines 72-74): clarifying CCA description and replacing “temporal alignment” with “trial alignment”.
Action in the text (page 5, lines 191-192): stating that ADAN and Cycle-GAN have no knowledge of dynamics.
Action in the text (page 6, lines 258-272): documenting performance on full-day recordings without trial matching.
Action in the text (page 13, lines 647-649): again, stating that Cycle-GAN has no knowledge of dynamics.
3) In general, precise details of the algorithms should have been provided.
We appreciate the reviewer noting this-- in the submitted manuscript, the full descriptions of Cycle-GAN and ADAN were included as supplementary methods in Appendix 4, but we did not extensively reference this and it may have been missed. In the revised manuscript, we added more references to Appendix 4 and in the Methods section of the main text. We provided further details on the choice of hyperparameters for each method (including PAF) in Appendix 4 itself.
Action in the text (page 13, lines 643-644): added “For a full description of the ADAN architecture and its training strategy, please refer to “ADAN based aligner” in Appendix 4 and (Farshchian et al., 2018).”
Action in the text (page 14, lines 669): added “Further details about the Cycle-GAN based aligner are provided in “Cycle-GAN based aligner”, Appendix 4.” Action in the text (Appendix 4 Tables 1-2): We have added a summary table of hyperparameters for each method in Appendix 4 (ADAN: Appendix 4 Table 1; CycleGAN: Appendix 4 Table 2).
4) Cross validation for day-0 alignment is not explained.
As mentioned above, the training and validation details of day-0 models were included in Appendix 4, which was not extensively referenced in the manuscript and may have been missed. We have now added more references to the Appendix in the revised manuscript.
Action in the text (page 13, lines 627-629): added “(Note that this LSTM based decoder is only used for latent space discovery, not the later decoding stage that is used for performance evaluation (see “ADAN day-0 training” in Appendix 4 for full details)).”
5) Details of statistical tests is not provided.
We apologize for this omission. In the revised manuscript, we have added a section in the methods summarizing all the statistical tests. In addition, we added the sample sizes for each stat reported in the results section.
Action in the text (page 15, lines 754-768): new Methods section added.
6) (minor) The idea that for neurons that have disappeared that the CycleGAN can "infer their response properties", seems an incorrect description. A proper description should be that it "hallucinates" their response properties?
We prefer to avoid the term “hallucinate”, due to its recent increased (appropriate) use in the context of large language models describing content generation that is “nonsensical or unfaithful to the provided source content” (as per the Wikipedia article on hallucination in AI). The synthetized “responses” of vanished neurons are not nonsensical, but are indeed, inferred: they are the model’s best estimate of how these neurons would have responded, had they been observed. While not explored further here, this prediction could be of potential scientific use: a strong discrepancy between predicted and observed activity might be a clue to look for further evidence of learning or remodeling of neural representations of behavior.
Action in the text: none.
Reviewer #2 (Public Review):
In this manuscript, the authors use generative adversarial networks (GANs) to manipulate neural data recorded from intracortical arrays in the context of intracortical BCIs so that these decoders are robust. Specifically, the authors deal with the hard problem where signals from an intracortical array change over time and decoders that are trained on day 0 do not work on day K. Either the decoder or the neural data needs to be updated to achieve the same performance as initially. GANs try to alter the neural data from day K to make it indistinguishable to day 0 and thus in principle the decoder should perform better. The authors compare their GAN approach to an older GAN approach (by an overlapping group of authors) and suggest that this new GAN approach is somewhat better. Major Strengths are multiple datasets from behaving monkeys performing various tasks that involve motor function. Comparison between two different GAN approaches and a classical approach that uses factor analysis. The weakness is insufficient comparison to another state-of-the-art approach that has been applied on the same dataset (NoMAD, Karpowicz et al. BioRxiv.)
The results are very reasonable and they show their approach, Cycle GANs, does slightly better than the traditional GAN approach. However, the Cycle GANs have many more modules and also as I understand it performs a forward backward mapping of the day - 0 and day - k and thus theoretically better. But, it seems quite slow.
We are concerned that the reviewer may have mistaken the Cycle-GAN training time (the time it takes to find an alignment, Figure 4B) with its inference time (the time it takes to transform data once an alignment has been found). Whereas inference time is critical for practical deployment of a model, we argue that Cycle-GAN's somewhat longer training time is not a substantial barrier to use: it is still reasonably fast (a few minutes) and training will only need to be performed on the order of once per day. We have modified the y-axis label of Figure 4B to make this distinction clearer.
We have also now added information on the inference speed of trained models to the paper: we find that both Cycle-GAN and ADAN perform the inference step in under 1 ms per 50 ms sample of data – this is because the forward map in both models consists of a fully connected network with only two hidden layers. We also note that while forward-backward mapping between days does occur during Cycle-GAN training, only the forward mapping is performed during inference.
Action in the text (page 7, lines 303-306): added inference time for Cycle-GAN and ADAN.
I think the results are interesting but as such, I am not sure this is such a fundamental advance compared to the Farashcian et al. paper, which introduced GANs to improve decoding in the face of changing neural data. There are other approaches that also use GANs and I think they all need to be compared against each other. Finally, these are all offline results and what happens online is anyone's real guess. Of course, this is not just a weakness of this study but many such studies of its ilk.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
The study by Yang et al. reports a new mechanistic role of vinculin in inhibiting the Mef2c nuclear translation and sclerostin expression in osteocytes and promoting bone formation. The authors showed the reduction of vinculin in aged bone human bone samples. A 10kb DMP-1-Cre mouse model was generated that deleted vinculin in osteocytes. They found that vinculin deletion caused bone loss and decreased bone formation associated with increased sclerostin expression. This increase does not affect the protein level of transcription factor Met2c but interestingly enhances nuclear translocation. Vinculin is interested in Mef2c and appears to retain Mef2c in the cytosol. As expected, as a component of the mechanosensory focal adhesion complex, bone formation via tibial loading was decreased in vinculin deletion. Intriguingly, the bone loss associated with estrogen deficiency through ovariectomy was attenuated. Overall, the study unveiled an important role concerning a key player of focal adhesion and the study was well designed and executed. The paper would be strengthened by including a more thorough discussion including variables such as male vs. female, and cortical vs. trabecular bone as the vinculin deletion appeared to primarily affect trabecular bone while mechanical loading exerts anabolic effects on both bone types. The effect of estrogen deficiency effect is interesting and is worth some discussion.
Strengths:
The paper shows a novel mechanism that vinculin retains Mef2c in the cytosol via protein interaction to prevent it from migrating to the nucleus and increases transcription of sclerostin, an inhibitory factor for Wnt/β-catenin signaling, a critical pathway for osteoblast activity and bone formation. They employed various in vivo and in vitro models as well as human tissue samples including generating conditional knockout of vinculin in osteocytes in vivo and vinculin gene knockdown in MLO-Y4 cells. They also used physiological/pathological relevant models, tibial loading, and ovariectomy to study the role of vinculin under mechanical loading and estrogen deficiency. The adopted standard techniques to study bone properties include microCT, bone formation, bone histomorphometry, histochemistry as well as biochemical assays such as immunoprecipitation, ChIP assays, etc.
The study is comprehensive and thorough and the noticeable uniqueness is that after observing the phenotypes from in vivo data, they further explored the underlying mechanisms using cell models. The experiments in general are well-designed and presented with adequate repeats and statistical analysis. The paper is also logically written and the figures were clearly labeled.
We highly thank the reviewer for his/her positive comments and helpful suggestions.
Minor weaknesses:
More discussion is necessary concerning the potential difference in responses between male and female. Most of the studies were conducted in male mice except ovariectomy mice.
During the revision, we have added new results from µCT analysis. Our new results showed that vinculin loss significantly reduced bone mass in 6-month-old female mice (Figure 2-figure supplement 1. a-d).
It is interesting that the cKO of vinculin in osteocytes primarily affects trabecular bones with limited effect on cortical bones. However, sclerostin is increased in cortical bones. The promotion of bone formation by mechanical loading appears to affect both cortical and trabecular bones. If focal adhesion is a key mechanosensory complex, how to reconcile the different responses in the cKO model?
We thank the reviewer for raising this good point. In fact, we do not know why there was no marked cortical bone loss in cKO mice. During the revision, we performed three-point bending analysis to determine whether vinculin loss impaired in the mechanical properties of the long bone and found that the ultimate force and total energy absorption before fracture were decreased in the femur of 3-month-old male cKO compared to those in control mice (Figure 3-figure supplement 1. e, f). Furthermore, our new results from the calcein double labeling experiments showed that both MAR and BFR of femur cortical bones were slightly but significantly reduced in cKO mice relative to those in control mice (Figure 3-figure supplement 1. a-c).
The OVX response is interesting and it is worthwhile to elaborate more regarding the potential underlying mechanism and what's the relationship between estrogen and mechanical loading and if the action of estrogen on vinculin shares any similar mechanisms with mechanical loading, etc.
We feel that the relationship between estrogen and mechanical loading could be quite complex, which deserves further investigation in the future. Thank you for this good point.
Reviewer #3 (Public Review):
This study by Wang et al. investigates the role of the focal adhesion protein vinculin in osteocytes and its effect on bone mass. First, they showed decreased levels of vinculin in osteocytes in trabecular bone from aged individuals compared to young, suggesting a potential role for vinculin in regulating bone mass with aging. Next, they deleted vinculin in late osteoblasts and osteocytes in young and older mice and found decreased bone mineral density and trabecular bone mass. This was due to impaired bone formation, which the authors attributed to increased sclerostin levels. Further in vitro experiments showed that vinculin regulates sclerostin via the transcription factor Mefc2. Conditional knockout of vinculin in late osteoblasts and osteocytes had no effect on the bone of mice lacking Sost, further implicating an essential role for sclerostin in mediating the effects of vinculin in osteocytes. Interestingly, the vinculin conditional knockout mice had an impaired response to mechanical loading, suggesting an important role for vinculin in the osteocyte mechanoresponse. Finally, the authors showed that while ovariectomy increased osteoclast formation and bone resorption in control mice, it had no effect on the bone of the vinculin conditional knockout mice.
Overall, the authors show convincing data for the important role of vinculin in osteocytes in regulating the anabolic effects of bone formation under physiological conditions. They also show that osteocyte vinculin may be a regulator of bone resorption under conditions mimicking postmenopausal osteoporosis. However, not all of the conclusions are fully supported by the data.
Strengths:
The use of both in vivo and in vitro approaches to determine the role of vinculin in osteocytes provides compelling evidence for its importance under basal conditions and in regulating the anabolic effects of mechanical loading. The in vitro assays nicely demonstrate a potential mechanism through Mef2c/ECR5.
The creation of the vinculin and Sost double conditional knockout mouse model provides further convincing evidence for the causative role of sclerostin in the effects of vinculin knockout in osteocytes.
The use of both young and older male mice links nicely with the human samples where vinculin expression appears to be reduced in osteocytes with aging. The authors need to be careful in describing 14-month-old mice as aged though, as these mice would not be typically thought of as old.
Weaknesses:
The methods section is lacking in basic details (e.g., there is no information on the CRISPR deletion of Vcl in the MLO-Y4 cells). While referencing their previous papers is fine, a brief description of the methods should be included in this paper.
During the revision, we have added the method of CRISPR deletion of Vcl in the MLO-Y4 cells (page 22, line 16-20).
While much of the data linking vinculin to sclerostin is convincing, it is surprising that the authors show decreased trabecular bone volume in the vinculin cKO mice, yet show increased sclerostin levels in the cortical bone. If increased sclerostin is responsible for impaired bone formation in the vinculin cKO mice, why is there no cortical bone phenotype?
Please see our response to above Point 3.
It would be important for the authors to also show the sclerostin immunostaining in the trabecular bone of these animals.
During the revision, we utilized IHC to demonstrate that cKO mice also displayed increased level of the sclerostin protein in cortical bone compared to the control group (Figure 4-figure supplement 1. a, b).
The authors do not provide any potential explanation for the effects of vinculin cKO in the ovariectomized mice. Under physiological conditions, osteocyte vinculin has no effect on osteoclast number or bone resorption. How is osteocyte vinculin affecting osteoclasts after ovariectomy? Are there differences in the osteocyte expression of Rankl or Opg in response to the loss of estrogen in the vinculin cKO and control mice?
During the revision, we used IHC staining to measure the expression of Rankl and Opg in the cortical bone of control and cKO mice treated with or without OVX surgery. The results showed that in cKO mice, the increase in Rankl induced by OVX was lower than that in the control group, while the increase in Opg induced by OVX was higher than that in the control group. The Rankl/Opg ratio was decreased in cKO mice induced by OVX (Figure 7-figure supplement 1. a-d).
From their in vitro experiments, the authors deduce that loss of vinculin affects osteocyte attachment. However, their images would suggest that it is the formation of dendrites that is strongly inhibited in the cells lacking vinculin. It is surprising that no investigation of osteocyte dendrite number or connectivity was performed in the vinculin cKO mice. This is particularly important as a decrease in osteocyte dendrites and connectivity has been observed in the bones of aged mice (see Tiede-Lewis et al., Aging. 2017) and osteocyte dendrites are important for mechanosensation.
Please see our response to above Point 4.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
This manuscript investigates the mechanisms of 'summiting disease' using a previously characterised Drosophila model. The authors also show that E. muscae infiltrates the brain likey through a defective blood-brain barrier and populates regions of the brain in the medial protocerebrum. It likely releases metabolites into the haemolymph of summiting flies that has the ability to induce summiting in uninfected flies. They also show that a burst of locomotor activity precedes death. To understand the circuit basis of this, they perform a screen of more than a hundred neuronal lines and genes to identify an active DPN1>pars intercerebralis neurons> corpora allata>JH axis as being invovled in the summiting behaviour while not affecting death.
Thank you for your succinct summary of our paper.
Reviewer #2 (Public Review):
In this study, the authors aim to uncover the neuroanatomical and metabolite underpinnings of an intriguing phenomenon observed in some insects due to the infection of fungal pathogens. They very cleverly develop a high-throughput assay to examine and quantify this behaviour in a tractable model organism - Drosophila melanogaster which the authors have previously shown to also exhibit this phenomenon. They characterize the details of this behaviour and clearly show the temporal gating of this summiting-followed-by-death behavior to occur shortly before the dusk transition. They go on to examine using a candidate (over 200) screen approach potential neuronal circuits and genes based on the hypothesis that they may be related to 'arousal and gravitaxis'. They narrow down to a line that is restricted to the PI based on the fact that it has a significant effect on the summiting behaviour and that it is known to affect locomotion. They can demonstrate that flies when a subset of PI neurons (R19G10) are transiently activated, they will show summiting even without exposure to the pathogen. Based on Syt-eGFP staining they conclude that PI communicates with the carpora cardiaca (CA). They also show that CA itself is necessary for this behavior, but cannot demonstrate the role of Juvenile hormones using their pharmacological methods.
The authors then describe an automated classifier to identify an upcoming summiting behaviour. Further, they use this real-time classifier to stage different steps of the summiting and match it to the extent of pathology observed by microscopy. They also ask whether the constituents of the hemolymph differ between the summiting and not-yet summiting flies for which they conduct metabolome analysis of the hemolymphs. They are also able to show that cross-injection of uninfected or infected but not summiting flies can be induced to show summiting-like behaviour upon injection with the hemolymph. Finally, they propose the sequence by which the fungal pathogen may modulate the behaviours of the host fly so as to execute this highly gated act of increased locomotion prior to death.
This is a good summary of our findings.
Strengths
• The detailed characterization of the behaviour in D melanogaster and development of the high-throughput behavioural arena.
• Development of the automated classifier which appears to accurately predict this behaviour.
• Narrowing down to a small group of PI neurons having a strong impact on this behaviour although sufficiency is not clearly demonstrated.
Thank you for highlighting these areas of our paper. With respect to demonstrating sufficiency of the PI neurons, we believe this actually an area of comparative strength for the manuscript. With thermogenetic and complementary optogenetic experiments, we demonstrated that activating the PI-CA neurons induces a burst of locomotion consistent with that seen during summiting. A similar burst of locomotion is seen when thermogenetically activating DN1ps. These experiments demonstrate that activity in these neurons is sufficient to induce a pattern of activity like that seen during summiting. In future studies, once the molecular effectors are identified, we may be able to show that fungal alteration of the physiology of these neurons alone is sufficient to induce a burst of locomotion, but that experiment is beyond our current capabilities and beyond the scope of this study.
Weaknesses
• The evidence of temporal (circadian) gating is weak despite the proposed DN1p - PI - CA connections.
• The eventual modification of the behavior to enable enhanced locomotion and negative geotaxis to occur appears to be mediated by yet unknown factors
• The metabolite analysis did not help to narrow down to candidates that can be speculated to cause this behaviour.
With respect to evidence for temporal gating, in this study we did not aim to address the underpinnings of the timing of summiting behavior in this study and did not mean to suggest that the timing of summiting behavior is explained by DN1ps being fly clock neurons. As previously stated in response to high level comments from the editor, we interpret the data presented here as evidence that host neurons (which just happen to be clock neurons) are manipulated by the fungus to inducethe characteristic burst of pre-death locomotor activity that we believe is the key feature of summiting. We have added the following paragraph in the discussion (see Host circadian and pars intercerebralis neurons mediate summiting) to clarify this point:
“Our data indicate that the host circadian network is involved in mediating the increased locomotor activity that we now understand to define summiting. However, our data do not speak to how the timing of this behavior is determined in the zombie-fly system. That is, we have yet to address the mechanisms underlying the temporal gating of summiting and death. Our observation that E. muscae-infected fruit flies continue to die at specific times of day in the absence of proximal lighting cues (Fig 1-S1) suggests that the timing of death is under circadian control and aligns with previous work in E. muscae-infected house flies (Krasnoff et al., 1995). Given that molecular clocks are prevalent across the tree of life, it is likely that two clocks (one in the fly, one in E. muscae) are present in this system. Additional work is needed to determine if the host clock is required for the timing of death under free-running conditions and to assess if E. muscae can keep time.”
We agree that there are many unknown factors at play in this behavior. These include molecular effectors produced by the fungus that alter the physiology of host neurons, and the specific mechanisms by which JH release from the CA alters locomotion. We have endeavored to transparently present what we do and don’t know at this time and hope to be able to address these additional elements in subsequent studies.
It is true that we were unable to determine the identity of compounds driving summiting behavior. However, our analysis did serve to inform which compounds may play a role in summiting by virtue of their overabundance. While we do not yet know the structure of these compounds, their consistent detection in our samples and our new knowledge of their molecular weight with very high accuracy means that these are prime candidates to isolate, purify and functionally test moving forward.
Reviewer #3 (Public Review):
The fungus Entomophthora muscae infects flies and in turn manipulates the flies to produce a summiting behavior that is believed to enhance spore dispersal that happens upon the eventual death of the fly. In this study, the authors undertake a Herculean effort to identify the neural pathways that are manipulated by the fungus to cause summiting. In a major advance, the authors develop techniques that allow them to track behaviors of infected flies over the course of several days. This allows them to investigate summiting behaviors that occur just prior to death with unprecedented detail. In their analysis, the authors find that summiting flies show a burst of increased locomotion just prior to death. Importantly, they show that this burst of locomotion is not seen in flies that are dying from other causes (starvation or desiccation). The burst of locomotion is also found to coincide with an increase in elevation that occurs with summiting, but other results indicate that a change in elevation may be an indirect consequence of increased locomotion. With this new knowledge in hand, the authors screen for genes and neuronal pathways that either disrupt or enhance the burst of locomotion that is characteristic of summiting. These experiments clearly indicate that neurons and genes controlling circadian rhythms play a major role in summiting behaviors. The authors focus their attention on a particular subset of clock neurons (DN1p) as potentially mediating summiting behavior. It is worth noting that DN1p neurons have been implicated in a variety (and in some cases contradictory) of circadian processes and that the interpretation of manipulations of these neurons may be an oversimplification. In particular, prior studies have implicated these cells in temperature entrainment/compensation so interpreting thermogenetic manipulations of these cells might be complicated. The authors also zoom in on a specific region of the brain containing neurons of the pars intercebralis, since they find infiltration by the fungus in this region and the effects of drivers targeting the PI. Converging and convincing lines of evidence to suggest that the PI neurons output to the corpora allata and effects of summing may be mediated by the CA. The already impressive series of experiments are further clinched by the development of a machine vision-based classifier that allows the authors to automatically identify summiting flies so that they may be collected for metabolomic analyses. The authors are automatically emailed and seemingly roused themselves in the middle of the night in order to obtain the precious flies they needed. They find a bunch of compounds that appear in summiting flies and even inject hemolymph from the infected animals into naive flies to find that circulating compounds can affect behaviors. Overall, this paper is a tour de force that addresses a system of long-standing interest and brings it into the modern age. Many new questions are now raised for the future by this fascinating study.
Thank you for your gracious summary of our work and for recognizing the multifaceted approach we have taken to begin to understand the mechanistic basis of summiting. We agree that there are many new questions raised by this work and hope to address them in future publications.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
The manuscript by Gochman and colleagues reports the discovery of a very strong sensitization of TRPV2 channels by the herbal compound cannabidiol (CBD) to activation by the synthetic agonist 2aminoethoxydiphenyl borate (2-APB). Using patch-clamp electrophysiology the authors show that the ~100-fold enhancement by micromolar CBD of TRPV2 current responses to low concentrations of 2-APB reflects a robust increase in apparent affinity for the latter agonist. Cryo-EM structures of TRPV2 in lipid nanodiscs in the presence of both drugs report two-channel conformations. One conformation resembles previously solved structures whereas the second conformation reveals two distinct CBD binding sites per subunit, as well as changes in the conformation of the S4-S5 linker. Interestingly, although TRPV1 and TRPV3 are highly homologous to TRPV2 and both CBD binding sites are relatively conserved, the CBD-induced sensitization towards 2-APB is observable only for TRPV3 but not for TRPV1. Moreover, the simultaneous substitution of non-conserved residues in the CBD binding sites and the pore region of TRPV1 with the amino acids present in TRPV2 fails to confirm strong CBD-induced sensitization. The authors conclude that CBD-dependent sensitization of TRPV2 channels depends on structural features of the channel that are not restricted to the CBD binding site but involve multiple channel regions.
These are important findings that promote our understanding of the molecular mechanisms of TRPV family channels, and the data provide convincing evidence for the conclusions.
We appreciate the supportive evaluation of the reviewer.
Reviewer #2 (Public Review):
In this manuscript, Gochman et al. studied the molecular mechanism by which cannabidiol (CBD) sensitizes the TRPV2 channel to activation by 2-APB. While CBD itself can activate TRPV2 with low efficacy, it can sensitize TRPV2 current activated by 2-APB by two orders of magnitude. The authors showed, via single-channel recording, that the CBD-dependent sensitization arises from an increase in Po when the channel binds to both CBD and 2-APB. The authors then used cryo-EM to investigate how CBD binds to TRPV2 and identified two CBD binding sites in each subunit, with one site being previously reported and the other being newly discovered.
TRPV1 and TRPV2 are two channels closely related to TRPV2. All three channels can be activated by CBD and 2-APB, but only TRPV2 and 3 are strongly sensitized by CBD. To understand the molecular basis of the different sensitivity to CBD, the authors compared the residues within the CBD binding sites and generated mutants by swapping non-conserved residues between TRPV1 and TRPV2. They then performed patch-clamp recordings on these mutants and found that mutations on non-conserved residues indeed influenced the CBD-dependent sensitization, thereby supporting the observed CBD binding sites.
Unexpectedly, the authors did not identify the binding site of 2-APB, despite its robust effect in electrophysiology recordings, especially when combined with CBD. Although previous structural studies of TRPV2 have reported 2-APB binding sites, the associated densities in these studies were not wellresolved. Therefore, the authors called on the field to re-examine published structural data with regard to the 2-APB binding sites.
Overall, this is an important study with well-designed and well-conducted experiments.
We appreciated the supportive comments of the reviewer.
Reviewer #3 (Public Review):
In this paper, Gochman et al examine TRPV1-3 channel sensitization by CBD, specifically in the context of 2-APB activation. The authors primarily used classic electrophysiological techniques to address their questions about channel behavior but have also used structural biology in the form of cryo-EM to examine drug binding to TRPV2. The authors have carefully observed and quantified sensitization of the rat TRPV2 channel to 2-APB by CBD. While this sensitization has been reported previously (Pumroy et al, Nat Commun 2022), the authors have gone into much more detail here and carefully examined this process from several angles, including a comparison to some other known methods of sensitizing TRPV2. Additionally, the authors have also revealed that CBD sensitizes rat TRPV1 and mouse TRPV3 to 2-APB, which has not been reported previously. Up to this point, the work is well thought through and cohesive.
The major weakness of this paper is that the authors' efforts to track down the structural and molecular basis for CBD sensitization neither give insight into how sensitization occurs nor provide a solid footing for future work on the topic. The structural work presented in this paper lacks proper controls to interpret the observed states and the authors do nothing to follow up on a potentially interesting second binding site for CBD. Overall, the structural work feels detached from the rest of the paper. The mutations chosen to examine sensitization are based on setting up TRPV1 in opposition to TRPV2 and TRPV3, which makes little sense as all three channels show sensitization by CBD, even if to different extents. The authors chose their mutations based on the assumption that response to CBD is the key difference between the channels for sensitization, yet the overall state of each channel or the different modes of activation by 2-APB seem to be more likely candidates. As a result, it is not particularly surprising that none of the mutations the authors make reduce CBD sensitization in TRPV2 or increase CBD sensitization in TRPV1.
A difficulty in examining TRPV1-3 as a group is that while they are highly conserved in sequence and structure, there are key differences in drug responses. While it does seem likely that CBD would bind to the same location in TRPV1-3, there is extensive evidence that 2-APB binds at different sites in each channel, as the authors discuss in the paper. Without more basic information about where 2-APB binds to each channel and confirmation that CBD does indeed bind TRPV1-3 at the same site, it may not be possible to untangle this particular mode of channel sensitization.
We appreciate this reviewer’s perspective and we too were disappointed that our approach did not yield more definitive answers to why some TRPV channels are more sensitive to CBD. We have revised the results and discussion sections to more clearly articulate what we think our results reveal. We have also added a section to the discussion to present the idea that the differential sensitivity of TRPV channels to CBD may have more to do with where 2-APB binds and how it activates the channel than CBD. These challenging points are all excellent and they have helped us to present our message more clearly.
-
-
www.medrxiv.org www.medrxiv.org
-
Author Response
Reviewer #1 (Public Review):
In this study, authors examine immune signatures from patients that experienced mild, moderate, or severe COVID-19 symptoms and followed them for months to evaluate whether there was a correlation between their immune activation phenotypes, disease severity, and long COVID. Authors observed higher T cell activation/proliferation marker expression in blood samples of patients with severe disease whereas other cell types were more or less unchanged. The authors also examined the cytokine profile of the patient's serum samples to determine the potential drivers of T cell activation phenotypes. Authors then perform T-cell responses to viral peptides to determine the differences in activation phenotypes with disease severity.
The major strengths of the paper appear in the evaluation of the appropriate cohort of human samples and following them over a period of months. Additionally, the authors perform detailed T-cell analysis in an unbiased way to determine any possible activation correlations with disease severity. The authors also perform antigen-specific T-cell analysis via peptide stimulation which adds to the overall findings. However, there are a number of drawbacks that need to be mentioned. Firstly, the phenotypes of T cells prior to the 3-month time-point are not known. Hence, there is no information on baseline or during the early phase of infection. Secondly, the response is largely obtained from blood. How much information about T cells in blood correlate with lung disease is a matter of concern. Analysis of lungs, where actual disease manifestation is ideal, however close to impossible in the human cohort. Alternatively, analysis of local lymph node aspirate or nasal swabs could be useful. Thirdly, the claim that bystander T cell activation plays a role seems loose, specifically the IL-15 in vitro data. Moreover, the analysis of T cells seems very focused on activation/proliferation phenotypes. Alternative T cell phenotypes such as regulatory, IL-10 producing, or FoxP3 expression are not extensively analyzed.
Major points
1) In Figure 1, the CD4 T cell activation phenotypes do not seem consistent across the groups. Why does moderate vs. severe show increases in CXCR3 expression but not mild vs. severe? The same goes for other markers. Performing T cell stimulation with class II peptides specific for CoV-2 and looking at IFN etc. to determine antigen-specific T cells and then gating on these activation/proliferation markers may be a better way to observe differences.
Figure 1 shows activation phenotypes of total CD4+ T-cells. We performed similar analysis on SARS-C0V-2 spike-specific CD4+ T cells as suggested by Reviewer 1 (using 15-mer peptides overlapping by 10 amino acids which are able to stimulate both CD4+ and CD8+ T cells- see Figure 5), but we did not observe differences between the groups (data not shown). Importantly, as reported in the discussion (page 18 from “Our data does not support the persistence of SARS-CoV-2 antigens at 3 months….”) we did not observe significant activation of spike-specific CD4+ or CD8+ T cells which suggests that T cell activation in these patients at 3 months is not driven by persistence of SARS-CoV-2 spike antigens.
2) One major drawback is the control patients. It would have helped to include a batch of samples from uninfected patients. Or to have the plasma/blood from patients before COVID-19 symptoms. This way there is a baseline for each group that could be compared. It is difficult to draw broad conclusions across the group at 3 months if we do not know their baseline phenotypes.
We did not have access to blood samples from these patients prior to COVID-19 infection. However, we have now added an analysis of matched samples from the same patients at 12 months post infection (N=33, see Figure 2- figure supplement 1 and also response to Reviewer 2). These data show a significant decrease in T cell activation at 12 months compared to 3 months. T cell activation has decreased to largely undetectable “baseline” levels at 12 months, that are similar between patients who had experienced mild, moderate or severe COVID-19. This lack of T cell activation at 12 months likely reflects the T cell profiles that patients will have had prior to COVID-19 infection.
3) Although the authors focused on activating/proliferating markers to correlate with disease severity, this analysis does not consider alternate T cell phenotypes such as the ones with regulatory or anti-inflammatory phenotypes. Did authors detect differences in T cells with regulatory profiles such as expression of IL-10, FoxP3, etc. in their unsupervised UMAP analysis or otherwise flow experiments?
Due to limited blood volumes we were unable to analyse regulatory/anti-inflammatory T cells phenotypes. Our serum cytokine data does not suggest statistically significant differences in serum IL-10 levels in patients with mild, moderate or severe disease. However, it is possible that we may have missed differences in FoxP3+ regulatory or IL-10- producing T cells.
Reviewer #2 (Public Review):
The manuscript is well written, the data are based on well-performed experiments, and the conclusions are supported by the data. The authors study thoroughly the global phenotype of T and NK cells and also analyze antigen-specific T cell frequencies. The data confirm that individuals who had severe COVID-19 disease (required ventilation and/or ITU admission) have slightly more activated CD4 and CD8 T cells at 3 months post-infection and report more frequently long COVID symptoms, yet the novelty of this manuscript is to show that these two are not linked to each other. Moreover, the manuscript confirms that patients across all disease severities mount and maintain memory T cell and antibody responses to SARS-CoV-2.
The authors find that patients who recovered from severe COVID-19 3 months ago have more activated CD4+ and CD8+ T cells than patients who recovered from the mild disease. Although the difference is significant, the frequency of CD4+ T cells with an activated phenotype is increased only by about 2-fold (~2% vs ~1%), while the frequency of activated CD8+ T cells is about 6% vs 4%, which should be added to the results to better describe the extent of the activation.
As the authors mention in the discussion, it cannot be excluded that the more activated T cell phenotype in patients who recovered from severe COVID-19 is not rather a consequence of the increased comorbidities associated with this group. However, their Luminex analysis of the serum shows that the levels of cytokines TNF-a, IL-4, IL-12, IL-15, and IL-17A decline by 8 and 12 months, suggesting that the immune activation by 3 months is most likely a consequence of the previous severe viral infection.
To strengthen this point, PBMC is probably not available at a later time point, to see if the increased T cell activation decreases in line with the serum cytokines. Yet, the authors should at least try to repeat the experiments of coculturing CD3+ T cells from healthy volunteers with the serum of mild/severe patients at 8-12 months post-recovery (Fig. 3 D-E).
Thank you for these suggestions. We had access to PBMCs from N=33 matched patients at 12 months post admission and have now performed analyses of these samples. Our results show that CD4+ and CD8+ T cell activation at 12 months is significantly decreased compared to that observed at 3 months (Figure 2- figure supplement 1). We show that the frequencies of Ki67+ CD38+ CD4+ and CD8+ T cells are significantly decreased at 12 compared to the 3-month time point. Similarly, the frequencies of CXCR3+ CD4+ and CD8+ T cells are strongly decreased at 12 compared to 3 months post admission. Activated HLA-DR+ CD38+ and granzyme B+ CD8+ T cells are also significantly decreased from 3 to 12 months post admission. Unsupervised UMAP analyses shows that the cell distribution and density of CD4+ and CD8+ T cell populations was similar across all severity groups at 12 months post infection, while major differences are observed at 3 months between the patient groups (Figure 2- figure supplement 1 K). We added this information in the manuscript at page 9 (see tracked changes) and in Figure 2- figure supplement 1.
Thank you for suggesting we repeat the co-culture experiments of healthy donor PBMCs with serum of mild and severe patients at 12 months post admission. We co-cultured healthy PBMCS from the same donors (only 3 out of the 4 donors used for the 3 months experiment were still accessible) with serum from mild and severe patients at 12 months. Notably, we observed that IL-15R upregulation did not occur upon co-culture of healthy donor PBMCs with plasma from severe patients at 12 months. This suggests that factors inducing IL-15R upregulation present in the 3 months plasma may be absent in the 12 month plasma. We have added this new data to the manuscript (Figure 3E)
The authors tried to find if the activated T cell phenotype or increased serum cytokines at 3 months post-infection is linked with increased long COVID symptoms. The study does not find any direct association when the data are adjusted for age, sex, and severity. This is the only novelty of this study, yet it is an important piece of information in the attempt to broaden our understanding of the underlying causes of long COVID symptoms.
Overall, it would be important to understand if increased frequencies of T cell activation (~2-fold) and increased levels of serum cytokines at 3 months following severe COVID-19 that resulted in ventilation and/or ITU admission is specific to severe SARS-CoV-2 infection, or if similar consequences are resulting also from other severe acute viral infections. Addressing this question is beyond the scope of the manuscript, yet it should be discussed.
We agree this is an important question. In H7N9 influenza infection persistent T cell activation was associated with fatal disease while T cell activation early during infection associated with positive clinical outcomes (Wang et al. Nature Comms 2018). Aging is also known to alter T cell function and the persisting low-grade inflammation present in elderly individuals may also facilitate the persistence of bystander activated T cells (Yunis et al Trends in Microbiology 2023). We have added these considerations in the discussion (page 18-19).
Reviewer #3 (Public Review):
In this paper, the authors used a cohort study to link immune signatures in blood 30 days after COVID-19 infection as possible predictors of prolonged symptomatology. The paper partially achieves its aims. While the selected analyses are comprehensive, the cohort design is appropriate and the mechanistic ex vivo work is clever and convincing, the strength of conclusions is somewhat limited by the selection of imprecise clinical endpoints, and the lack of analyses examining T regulatory signatures.
Strengths of the paper are:
• The paper includes a comprehensive and structured immune analysis.
• The paper is extremely clearly written.
• The use of manual gating and unsupervised analysis in Fig 1 is complementary and helpful.
• Bystander T cell experiments with IL-15 are useful and attempt to explore mechanisms from human samples which are traditionally very challenging.
• The experiments shown in Figure 4 documenting equal Cov2 T cell responses in all 3 cohorts are an extremely important result.
Major concerns are:
• The significance of the study is somewhat limited by the small sample size.
• The symptomatic outcome scale for PASC is blunt and poorly captures severity. More state-of-the-start scales of symptomatic severity and heterogeneity exist for PASC. I suggest this and other papers as an example: https://pubmed.ncbi.nlm.nih.gov/36454631/
Thank you for this suggestion. Additional outcome measures have now been included in our analysis, refer to the results section and the updated Figure 6- source data 1 A-B.
• The omission of analyses examining T regulatory functions is a missed opportunity and these may be impaired in this population.
We have acknowledged this as a limitation of the study.
• This is a challenging question that can be applied to many exploratory studies of this nature: how can we rule out the possibility that statistically significant differences in Figs 1, 2 & 3 are statistically significant but biologically meaningless? All cellular and cytokine measures of immune responses shown in these figures are not routinely measured in the clinic. Are there studies that can be cited to show that these differences are sufficient to have a causal impact on prolonged symptoms and tissue damage rather than just correlations with these outcomes?
This is a challenging question, and we were unable to find studies correlating these measurements with tissue damage and prolonged symptoms. In our study we however suggest that prolonged T cell activation is not related to ongoing long-COVID symptoms.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
The authors introduce a computational model that simulates the dendrites of developing neurons in a 2D plane, subject to constraints inspired by known biological mechanisms such as diffusing trophic factors, trafficked resources, and an activity-dependent pruning rule. The resulting arbors are analyzed in terms of their structure, dynamics, and responses to certain manipulations. The authors conclude that 1) their model recapitulates a stereotyped timecourse of neuronal development: outgrowth, overshoot, and pruning 2) Neurons achieve near-optimal wiring lengths, and Such models can be useful to test proposed biological mechanisms- for example, to ask whether a given set of growth rules can explain a given observed phenomenon - as developmental neuroscientists are working to understand the factors that give rise to the intricate structures and functions of the many cell types of our nervous system.
Overall, my reaction to this work is that this is just one instantiation of many models that the author could have built, given their stated goals. Would other models behave similarly? This question is not well explored, and as a result, claims about interpreting these models and using them to make experimental predictions should be taken warily. I give more detailed and specific comments below.
We thank the reviewer for the summary of the work. We find the criticism “that this is one instantiation of many models [we] could have built” can apply to any model. To quote George Box, “all models are wrong, but some models are useful” was the moto that drove our modeling approach. In principle, there are infinitely many possible models. We chose one of the most minimalistic models which implements known biological mechanisms including activity-independent and -dependent phases of dendritic growth, and constrained parameters based on experimental data. We compare the proposed model to other alternatives in the Discussion section, especially to the models of Hermann Cuntz which propose very different strategies for growth.
However, the reviewer is right that within the type of model we chose, we could have more extensively explored the sensitivity to parameters. In the revised manuscript we will investigate the sensitivity of model output to variations of specific parameters, as explained below.
Point 1.1. Line 109. After reading the rest of the manuscript, I worry about the conclusion voiced here, which implies that the model will extrapolate well to manipulations of all the model components. How were the values of model parameters selected? The text implies that these were selected to be biologically plausible, but many seem far off. The density of potential synapses, for example, seems very low in the simulations compared to the density of axons/boutons in the cortex; what constitutes a potential synapse? The perfect correlations between synapses in the activity groups is flawed, even for synapses belonging to the same presynaptic cell. The density of postsynaptic cells is also orders of magnitude of, etc. Ideally, every claim made about the model's output should be supported by a parameter sensitivity study. The authors performed few explorations of parameter sensitivity and many of the choices made seem ad hoc.
It is indeed important to clarify how the model parameters were selected. Here we provide a short justification for some of these parameters, which will be included in the revised manuscript.
1) Potential synapse density: We modelled 1,500 potential synapses in a cortical sheet of size 185x185 microns squared. We used 1 pixel per μm to capture approximately 1 μm thick dendrites. Therefore, we started with initial density of 0.044 potential synapses per μm^2. From Author Response Image 1 we can see that at the end of our simulation time ~1,000 potential synapses remain. So in fact, the density of potential synapses is totally sufficient, since not many potential synapses end up connected. The rapid slowing down of growth in our model is not due to a depletion of potential synaptic partners as the number of potential synapses remains high. Nonetheless, we will explore this in the revised manuscript. (this figure will be included in the revised submission):
2) Stabilized synapse density: Since ~1,000 of the potential synapses in the modeled cortical sheet remain available, ~500 become connected to the dendrites of the 9 somas in the modeled cortical sheet. This means that the density of stable connected synapses is approximately 0.015 synapses per μm^2. This is also the number that is shown in Figure 3b, which is about 60 synapses stabilized per cell. This density is much easier to compare to experimental data, and below we provide some numbers from literature we already cited in the manuscript as well as a recent preprint.
In the developing cortex:
-
Leighton, Cheyne and Lohmann 2023 https://doi.org/10.1101/2023.03.02.530772 find up to 0.4 synapses per μm in pyramidal neurons in vivo in the developing mouse visual cortex at P8 to P13. This is almost identical to our value of 0.4 synapses per μm.
-
Ultanir et al., 2007 https://doi.org/10.1073/pnas.0704031104 find 0.7 to 1.7 spines per μm in pyramidal neurons in vivo in L2/3 of the developing mouse cortex, at P10 to P20.
-
Glynn et al., 2011 https://doi.org/10.1038/nn.2764 find 0.1 to 0.7 spines per μm^2 in pyramidal neurons in vivo and in vitro in L2/3 of the developing mouse cortex, at P8 to P60.
In the developing hippocampus:
-
Yang et al., 2014 https://doi.org/10.1016/j.celrep.2014.03.040 find 0.75 to 1 spines per μm in pyramidal neurons in vivo in CA1 of the developing mouse hippocampus, at one month of age.
-
Koshimizu et al., 2009 https://doi.org/10.1186/1756-6606-2-27 find 0.1 to 0.4 spines per μm in pyramidal neurons in slice in the developing rat hippocampus, at (Embryonic Day) ED18 to ED20.
-
Tyler and Pozzo-Miller, 2001 https://doi.org/10.1523/JNEUROSCI.21-12-04249.2001 find 0.28 to 0.1 spines per μm in slice in the developing mouse hippocampus, at P7 (14 DIV, days in vitro).
Although these values vary somewhat across experiments, in most cases they are in agreement with our chosen values, especially when taking into account that we are modeling development (rather than adulthood).
3) Soma/neuron density: Indeed, we did not exactly mention this number anywhere in the paper. But from the figures we can infer 9 somas growing dendrites on an area of ~34,000 μm^2. Thus, neuron density would be 300 neurons per mm^2. This number seems a bit low after a short search through the literature. For e.g. Keller et al., 2018 https://www.frontiersin.org/articles/10.3389/fnana.2018.00083/full reports about 90,000 neurons per mm^3, albeit in adulthood.
We are also performing a sensitivity analysis where some of these parameters are varied and will include this in the revised manuscript. In particular:
(1) We will vary the nature of the input correlations. In the current model, the synapses in each correlated group receive spike trains with a perfect correlation and there are no correlations across the groups. We will reduce the correlations within group and add non-zero correlations across the groups.
(2) We will vary the density of the neuronal somas. We expect that higher densities of somas will either yield smaller dendritic areas because the different neurons compete more or result in a state where nearby neurons have to complement each other regarding their activity preferences.
(3) We will introduce dynamics in the potential synapses to model the dynamics of axons. We plan to explore several scenarios. We could introduce a gradual increase in the density of potential synapses and implement a cap on the number of synapses that can be alive at the same time, and vary that cap. We could also introduce a lifetime of each synapse (following for example a lognormal distribution). A potential synapse can disappear if it does not form a stable synapse in its lifetime, in which case it could move to a different location.
Point 1.2. Many potentially important phenomena seem to be excluded. I realize that no model can be complete, but the choice of which phenomena to include or exclude from this model could bias studies that make use of it and is worth serious discussion. The development of axons is concurrent with dendrite outgrowth, is highly dynamic, and perhaps better understood mechanistically. In this model, the inputs are essentially static. Growing dendrites acquire and lose growth cones that are associated with rapid extension, but these do not seem to be modeled. Postsynaptic firing does not appear to be modeled, which may be critical to activity-dependent plasticity. For example, changes in firing are a potential explanation for the global changes in dendritic pruning that occur following the outgrowth phase.
As the reviewer concludes, no model can be complete. In agreement with this, here we would like to quote a paragraph from a very nice paper by Larry Abbott (“Theoretical Neuroscience Rising, Neuron 2008 https://www.sciencedirect.com/science/article/pii/S0896627308008921) which although published more than 10 years ago, still applies today:
“Identifying the minimum set of features needed to account for a particular phenomenon and describing these accurately enough to do the job is a key component of model building. Anything more than this minimum set makes the model harder to understand and more difficult to evaluate. The term ‘‘realistic’’ model is a sociological rather than a scientific term. The truly realistic model is as impossible and useless a concept as Borges’ ‘‘map of the empire that was of the same scale as the empire and that coincided with it point for point’’ (Borges, 1975). […] The art of modeling lies in deciding what this subset should be and how it should be described.”
We have clearly stated in the Introduction (e.g. lines 37-75) which phenomena we include in the model and why. The Discussion also compares our model to others (lines 315-373), pointing out that most models either focus on activity-independent or activity-dependent phases. We include both, combining literature on molecular gradients and growth factors, with activity-dependent connectivity refinements instructed by spontaneous activity. We could not think of a more tractable, more minimalist model that would include both activity-independent or activity-dependent aspects. Therefore, we feel that the current manuscript provides sufficient motivation but also a discussion of limitations of the current model.
Regarding including the concurrent development of axons, we agree this is very interesting and currently not addressed in the model. As noted at the bottom of our reply to point 1.1, bullet (3) we are now revising the manuscript to include a simplified form of axonal dynamics by allowing changes in the lifetime and location of potential synapses, which come from axons of presynaptic partners.
Regarding postsynaptic firing, this is indeed super relevant and an important point to consider. In one of our recent publications (Kirchner and Gjorgjieva, 2021 https://www.nature.com/articles/s41467-021-23557-3), we studied only an activity-dependent model for the organization of synaptic inputs on non-growing dendrites which have a fixed length. There, we considered the effect of postsynaptic firing and demonstrated that it plays an important role in establishing a global organization of synapses on the entire dendritic tree of the neuron, and not just local dendritic branches. For example, we showed that could that it could lead to the emergence of retinotopic maps which have been found experimentally (Iacaruso et al., 2017 https://www.nature.com/articles/nature23019). Since we use the same activity-dependent plasticity model in this paper, we expect that the somatic firing will have the same effect on establishing synaptic distributions on the entire dendritic tree. We will make a note of this in the Discussion in the revised paper.
Point 1.3. Line 167. There are many ways to include activity -independent and -dependent components into a model and not every such model shows stability. A key feature seems to be that larger arbors result in reduced growth and/or increased retraction, but this could be achieved in many ways (whether activity dependent or not). It's not clear that this result is due to the combination of activity-dependent and independent components in the model, or conceptually why that should be the case.
We never argued for model uniqueness. There are always going to be many different models (at different spatial and temporal scales, at different levels of abstraction). We can never study all of them and like any modeling study in systems neuroscience we have chosen one model approach and investigated this approach. We do compare the current model to others in the Discussion. If the reviewers have a specific implementation that we should compare our model to as an alternative, we could try, but not if this means doing a completely separate project.
Point 1.4. Line 183. The explanation of overshoot in terms of the different timescales of synaptic additions versus activity-dependent retractions was not something I had previously encountered and is an interesting proposal. Have these timescales been measured experimentally? To what extent is this a result of fine-tuning of simulation parameters?
We found that varying the amount of BDNF controls the timescale of the activity-dependent plasticity (see our Figure 5c). Hence, changing the balance between synaptic additions vs. retractions is already explored in Figure 5e and f. Here we show that the overshoot and retraction does not have to be fine-tuned but may be abolished if there is too much activity-dependent plasticity.
Regarding the relative timescales of synaptic additions vs. retractions: since the first is mainly due to activity-independent factors, and the second due to activity-dependent plasticity, the questions is really about the timescales of the latter two. As we write in the Introduction (lines 60-62), manipulating activity-dependent synaptic transmission has been found to not affect morphology but rather the density and specificity of synaptic connections (Ultanir et al. 2007 https://doi.org/10.1073/pnas.0704031104), supporting the sequential model we have (although we do not impose the sequence, as both activity-independent and activity-dependent mechanisms are always “on”; but note that activity-dependent plasticity can only operate on synapses that have already formed).
Point 1.5. Line 203. This result seems at odds with results that show only a very weak bias in the tuning distribution of inputs to strongly tuned cortical neurons (e.g. work by Arthur Konnerth's group). This discrepancy should be discussed.
First, we note that the correlated activity experienced by our modeled synapses (and resulting synaptic organization) does not necessarily correspond to visual orientation, or any stimulus feature, for that matter.
Nonetheless, this is a very interesting question and there is some variability in what the experimental data show. Many studies have shown that synapses on dendrites are organized into functional synaptic clusters: across brain regions, developmental ages and diverse species from rodent to primate (Kleindienst et al. 2011; Takahashi et al. 2012; Winnubst et al. 2015; Gökçe et al., 2016; Wilson et al. 2016; Iacaruso et al., 2017; Scholl et al., 2017; Niculescu et al. 2018; Kerlin et al. 2019; Ju et al. 2020). Interestingly, some in vivo studies have reported lack of fine-scale synaptic organization (Varga et al. 2011; X. Chen et al. 2011; T.-W. Chen et al. 2013; Jia et al. 2010; Jia et al. 2014), while others reported clustering for different stimulus features in different species. For example, dendritic branches in the ferret visual cortex exhibit local clustering of orientation selectivity but do not exhibit global organization of inputs according to spatial location and receptive field properties (Wilson et al. 2016; Scholl et al., 2017). In contrast, synaptic inputs in mouse visual cortex do not cluster locally by orientation, but only by receptive field overlap, and exhibit a global retinotopic organization along the proximal-distal axis (Iacaruso et al., 2017). We proposed a theoretical framework to reconcile these data: combining activity-dependent plasticity similar to the BDNF-proBDNF model that we used in the current work, and a receptive field model for the different species (Kirchner and Gjorgjieva, 2021 https://www.nature.com/articles/s41467-021-23557-3). We can mention this aspect in the revised manuscript.
Point 1.6. Line 268. How does the large variability in the size of the simulated arbors relate to the relatively consistent size of arbors of cortical cells of a given cell type? This variability suggests to me that these simulations could be sensitive to small changes in parameters (e.g. to the density or layout of presynapses).
As noted at the bottom of our reply to point 1.1, bullet (3) we are now revising the manuscript to include changes in the lifetime and location of potential synapses.
Point 1.7. The modeling of dendrites as two-dimensional will likely limit the usefulness of this model. Many phenomena- such as diffusion, random walks, topological properties, etc - fundamentally differ between two and three dimensions.
The reviewer is right about there being differences between two and three dimensions. But a simpler model does not mean a useless model even if not completely realistic. We have ongoing work that extends the current model to 3D but is beyond the scope of the current paper. In systems neuroscience, people have found very interesting results making such simplified geometric assumptions about networks, for instance the one-dimensional ring model has been used to uncover fundamental insights about computations even though highly simplified and abstracted.
Point 1.8. The description of wiring lengths as 'approximately optimal' in this text is problematic. The plotted data show that the wiring lengths are several deviations away from optimal, and the random model is not a valid instantiation of the 2D non-overlapping constraints the authors imposed. A more appropriate null should be considered.
We did not use the term “optimal” in line with previous literature. We wrongly referred to the minimal wiring length as the optimal wiring length, but neurons can optimize their wiring not only by minimizing their dendritic length (e.g. work of Hermann Cuntz). In the revised manuscript, we will replace the term “optimal wiring” with “minimal wiring”. Then we will compare the wiring length in the model with the theoretically minimal wiring length, the random wiring length and the actual data.
Point 1.9. It's not clear to me what the authors are trying to convey by repeatedly labeling this model as 'mechanistic'. The mechanisms implemented in the model are inspired by biological phenomena, but the implementations have little resemblance to the underlying biophysical mechanisms. Overall my impression is that this is a phenomenological model intended to show under what conditions particular patterns are possible. Line 363, describing another model as computational but not mechanistic, was especially unclear to me in this context.
What we mean by mechanistic is that we implement equations that model specific mechanisms i.e. we have a set of equations that implement the activity-independent attraction to potential synapses (with parameters such as the density of synapses, their spatial influence, etc) and the activity-dependent refinement of synapses (with parameters such as the ratio of BDNF and proBDNF to induce potentiation vs depression, the activity-dependent conversion of one factor to the other, etc). This is a bottom-up approach where we combine multiple elements together to get to neuronal growth and synaptic organization. This approach is in stark contrast to the so-called top-down or normative approaches where the method would involve defining an objective function (e.g. minimal dendritic length) which depends on a set of parameters and then applying a gradient descent or other mathematical optimization technique to get at the parameters that optimize the objective function. This latter approach we would not call mechanistic because it involves an abstract objective function (who could say what a neuron or a circuit should be trying to optimize) and a mathematical technique for how to optimize the function (we don’t know of neurons can compute gradients of abstract objective functions).
Hence our model is mechanistic, but it does operate at a particular level of abstraction/simplification. We don’t model individual ion channels, or biophysics of synaptic plasticity (opening and closing of NMDA channels, accumulation of proteins at synapses, protein synthesis). We do, however, provide a biophysical implementation of the plasticity mechanism though the BDNF/proBDNF model which is more than most models of plasticity achieve, because they typically model a phenomenological STDP or Hebbian rule that just uses activity patterns to potential or depress synaptic weights, disregarding how it could be implemented.
Reviewer #2 (Public Review):
This work combines a model of two-dimensional dendritic growth with attraction and stabilisation by synaptic activity. The authors find that constraining growth models with competition for synaptic inputs produces artificial dendrites that match some key features of real neurons both over development and in terms of final structure. In particular, incorporating distance-dependent competition between synapses of the same dendrite naturally produces distinct phases of dendritic growth (overshoot, pruning, and stabilisation) that are observed biologically and leads to local synaptic organisation with functional relevance. The approach is elegant and well-explained, but makes some significant modelling assumptions that might impact the biological relevance of the results.
Strengths:
The main strength of the work is the general concept of combining morphological models of growth with synaptic plasticity and stabilisation. This is an interesting way to bridge two distinct areas of neuroscience in a manner that leads to findings that could be significant for both. The modelling of both dendritic growth and distance-dependent synaptic competition is carefully done, constrained by reasonable biological mechanisms, and well-described in the text. The paper also links its findings, for example in terms of phases of dendritic growth or final morphological structure, to known data well.
Weaknesses:
The major weaknesses of the paper are the simplifying modelling assumptions that are likely to have an impact on the results. These assumptions are not discussed in enough detail in the current version of the paper.
1) Axonal dynamics.
A major, and lightly acknowledged, assumption of this paper is that potential synapses, which must come from axons, are fixed in space. This is not realistic for many neural systems, as multiple undifferentiated neurites typically grow from the soma before an axon is specified (Polleux & Snider, 2010). Further, axons are also dynamic structures in early development and, at least in some systems, undergo activity-dependent morphological changes too (O'Leary, 1987; Hall 2000). This paper does not consider the implications of joint pre- and post-synaptic growth and stabilisation.
We thank the reviewer for the summary of the strengths and weaknesses of the work. While we feel that including a full model of axonal dynamics is beyond the scope of the current manuscript, some aspects of axonal dynamics can be included. In a revised model, we will introduce a gradual increase in the density of potential synapses and implement a cap on the number of synapses that can be alive at the same time, and vary that cap. We plan to also introduce a lifetime of each synapse (following for example a lognormal distribution). A potential synapse can disappear if it does not form a stable synapse in its lifetime, in which case it could move to a different location. See also our reply to reviewer comment 1.1, bullet (3).
2) Activity correlations
On a related note, the synapses in the manuscript display correlated activity, but there is no relationship between the distance between synapses and their correlation. In reality, nearby synapses are far more likely to share the same axon and so display correlated activity. If the input activity is spatially correlated and synaptic plasticity displays distance-dependent competition in the dendrites, there is likely to be a non-trivial interaction between these two features with a major impact on the organisation of synaptic contacts onto each neuron.
We are exploring the amount of correlation (between and within correlated groups) to include in the revised manuscript (see also our reply to reviewer comment 1.1, bullet (1)).
However, previous experimental work, (Kleindienst et al., 2011 https://doi.org/10.1016/j.neuron.2011.10.015) has provided anatomical and functional analyses that it is unlikely that the functional synaptic clustering on dendritic branches is the result of individual axons making more than one synapse (see pg. 1019).
3) BDNF dynamics
The models are quite sensitive to the ratio of BDNF to proBDNF (eg Figure 5c). This ratio is also activity-dependent as synaptic activation converts proBDNF into BDNF. The models assume a fixed ratio that is not affected by synaptic activity. There should at least be more justification for this assumption, as there is likely to be a positive feedback relationship between levels of BDNF and synaptic activation.
The reviewer is correct. We used the BDNF-proBDNF model for synaptic plasticity based on our previous work: Kirchner and Gjorgjieva, 2021 https://www.nature.com/articles/s41467-021-23557-3.
There, we explored only the emergence of functionally clustered synapses on static dendrites which do not grow. In the Methods section (Parameters and data fitting) we justify the choice of the ratio of BDNF to proBDNF from published experimental work. We also performed sensitivity analysis (Supplementary Fig. 1) and perturbation simulations (Supplementary Fig. 3), which showed that the ratio is crucial in regulating the overall amount of potentiation and depression of synaptic efficacy, and therefore has a strong impact on the emergence and maintenance of synaptic organization. Since we already performed all this analysis, we do not expect there will be any differences in the current model which includes dendritic growth, as the activity-dependent mechanism has such a different timescale.
A further weakness is in the discussion of how the final morphologies conform to principles of optimal wiring, which is quite imprecise. 'Optimal wiring' in the sense of dendrites and axons (Cajal, 1895; Chklovskii, 2004; Cuntz et al, 2007, Budd et al, 2010) is not usually synonymous with 'shortest wiring' as implied here. Instead, there is assumed to be a balance between minimising total dendritic length and minimising the tree distance (ie Figure 4c here) between synapses and the site of input integration, typically the soma. The level of this balance gives the deviation from the theoretical minimum length as direct paths to synapses typically require longer dendrites. In the model this is generated by the guidance of dendritic growth directly towards the synaptic targets. The interpretation of the deviation in this results section discussing optimal wiring, with hampered diffusion of signalling molecules, does not seem to be correct.
We agree with this comment. We had wrongly used the term “optimal wiring” as neurons can optimize their wiring not only by minimizing their dendritic length but other factors as noted by the reviewer. In the revised manuscript will replace the term “optimal wiring” with “minimal wiring” and discuss these differences to previous work.
Reviewer #3 (Public Review):
The authors propose a mechanistic model of how the interplay between activity-independent growth and an activity-dependent synaptic strengthening/weaken model influences the dendrite shape, complexity and distribution of synapses. The authors focus on a model for stellate cells, which have multiple dendrites emerging from a soma. The activity independent component is provided by a random pool of presynaptic sites that represent potential synapses and that release a diffusible signal that promotes dendritic growth. Then a spontaneous activity pattern with some correlation structure is imposed at those presynaptic sites. The strength of these synapses follow a learning rule previously proposed by the lab: synapses strengthen when there is correlated firing across multiple sites, and synapses weaken if there is uncorrelated firing with the relative strength of these processes controlled by available levels of BDNF/proBDNF. Once a synapse is weakened below a threshold, the dendrite branch at that site retracts and loses its sensitivity to the growth signal
The authors run the simulation and map out how dendrites and synapses evolve and stabilize. They show that dendritic trees growing rapidly and then stabilize by balancing growth and retraction (Figure 2). They also that there is an initial bout of synaptogenesis followed by loss of synapses, reflecting the longer amount of time it takes to weaken a synapse (Figure 3). They analyze how this evolution of dendrites and synapses depends on the correlated firing of synapses (i.e. defined as being in the same "activity group"). They show that in the stabilized phase, synapses that remain connected to a given dendritic branch are likely to be from same activity group (Figure 4). The authors systemically alter the learning rule by changing the available concentration of BDNF, which alters the relative amount of synaptic strengthening, which in turn affects stabilization, density of synapses and interestingly how selective for an activity group one dendrite is (Figure 5). In addition the authors look at how altering the activity-independent factors influences outgrowth (Figure 6). Finally, one of the interesting outcomes is that the resulting dendritic trees represent "optimal wiring" solutions in the sense that dendrites use the shortest distance given the distribution of synapses. They compare this distribute to one published data to see how the model compared to what has been observed experimentally.
There are many strengths to this study. The consequence of adding the activity-dependent contribution to models of synapto- and dendritogenesis is novel. There is some exploration of parameters space with the motivation of keeping the parameters as well as the generated outcomes close to anatomical data of real dendrites. The paper is also scholarly in its comparison of this approach to previous generative models. This work represented an important advance to our understanding of how learning rules can contribute to dendrite morphogenesis
We thank the reviewer for the positive evaluation of the work and the suggestions below.
-
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
1) “It is unclear whether new in vivo experiments were conducted for this study”.
All in vivo experiments shown were conducted independently by new researchers in the lab, using the original fly stocks. This will be more clearly stated in the revised supplement. The aim of repeating the experiments was to directly compare the consequences of impaired N- and C-terminal shedding side-by-side in two Hh-dependent developmental systems.
2) “A critical shortcoming of the study is that experiments showing Shh secretion/export do not include a Shh(-) control condition. Without demonstration that the bands analyzed are specific for Shh(+) conditions, these experiments cannot be appropriately evaluated”.
C9C5 antibody reactivity and specificity is shown below, and this control will be added to the revised manuscript. We established the C9C5 immunoblotting protocol – and generated the blot shown in Author Response Image 1 - before any of the experiments in the manuscript were started. The immunoblot clearly shows Shh specificity similar to that of R&D AF464 anti-Shh antibodies that were previously used in the lab. The immunoblot also shows that both antibodies detect the same Shh signals in media, that C9C5 is more sensitive, and that AF464 and C9C5 detect 5E1-IP’d dual-lipidated and monolipidated soluble Shh equally well. Also note that, in our hands, C9C5 is highly specific: this antibody detects N-truncated C25S;Δ26-35Shh of increased electrophoretic mobility, but does not cause unspecific signals above or below, even if the blot is strongly overexposed (as shown here). Specific Shh detection by C9C5 is also discussed in our response to editor’s comments below.
Cells were transfected with constructs encoding full-length C25SShh or truncated C25S;Δ26-35Shh, and proteins in serum-containing media were 5E1 immunoprecipitated or concentrated by heparin-sepharose pulldown. Dual-lipidated R&D 8908-SH was dissolved in the same medium and subjected to the same 5E1 immunoprecipitation or heparin pulldown. The blot was incubated with antibody AF464 and (after stripping) with antibody C9C5. Immunoblot analysis revealed high specificity of both antibodies and also revealed poor interactions of dual-lipidated 8908-SH with highly charged heparin.
3) “A stably expressing Shh/Hhat cell line would reduce condition to condition and experiment to experiment variability”.
We fully agree with this reviewer and therefore aimed to establish stable Hhat expressing cell lines several years ago. However, stable Hhat expression eliminated transfected cells after several passages, or cells gradually ceased to express Hhat, preventing us to establish a stable line despite several attempts and tried strategies. For this reason, we established transient co-expression of Shh/Hhat from the same mRNA to at least eliminate variability between relative Shh/Hhat expression levels and to assure complete Shh palmitoylation in our assays.
4) “Unusual normalization strategies are used for many experiments, and quantification/statistical analyses are missing for several experiments”.
This comment refers to data shown in Fig. 3 (here, no quantification of Scube2 function in Disp-/- cells had been conducted) and to qPCR data shown in Fig. 4 (here, Shh and C25AShh were compared only indirectly via dual-lipidated R&D 8908-SH, but not directly in a side-by-side experiment, and Shh variants with an N-terminal alanine or a serine were directly compared). We agree with the reviewer and therefore currently repeat qPCR assays and quantify blots to eliminate these technical shortcomings from the final manuscript.
5) “The study provides a modest advance in the understanding of the complex issue of Shh membrane extraction”
Our investigation identified unexpected links between Disp as a furin-activated Hh exporter, sheddase-mediated Shh release, Scube2-mediated Shh release and lipoprotein-mediated Hh transport – established modes indeed but with no previously established direct connections – that increase their relevance. We also identified a previously unknown N-processed Shh variant attached to lipoproteins and show that Disp/Scube2 function absolutely requires lipoproteins. Therefore, although we do agree that our findings are confirmatory for the above modes, they also provide new mechanistic insight and challenge the currently dominating model of Disp-mediated hand-over of dual-lipidated Hh to Scube2 chaperones (this model does not predict a role for lipoprotein particles but for both Shh lipids in signaling, for a recent discussion, see PMID 36932157). Our findings suggest an answer to the intensely debated question of whether Disp/Ptch extract cholesterol from the outer or inner plasma membrane leaflet, and suggest that N-palmitate is dispensable for signaling of lipoprotein-associated Shh to Ptch receptors. Finally, we note that previous in vivo studies in flies often relied on Hh overexpression in the fat body, raising questions on their physiological relevance. Our in vivo analyses of Hh function in wing- and eye discs are more physiologically relevant and can explain the previously reported presence of non-lipidated bioactive Hh in disc tissue (PMID: 23554573).
Reviewer #2 (Public Review):
1) “However, the results concerning the roles of lipoproteins and Shh lipid modifications are largely confirmatory of previous results, and molecular identity/physiological relevance of the newly identified Shh variant remain unclear”.
Regarding the confirmatory aspects of our work, please also refer to our response to reviewer 1. In addition, we would like to reply that our unbiased experimental approach was designed to challenge the model of Shh shedding by testing whether established Shh release regulators affect it (e.g. support it) or not. As described in our work, Disp, Scube2 and lipoproteins all contribute to increased shedding (which is new), that Disp function depends on lipoprotein presence (also new), and that lipoproteins modify the outcome of Shh shedding (dual Shh shedding versus N-shedding and lipoprotein association), which is also new.
Regarding physiological relevance, we would like to reply that our finding that artificially generated monolipidated variants (C25SShh and ShhN) solubilize in uncontrolled manner from producing cells can explain previously observed, highly variable gain-of-function or loss-of-function phenotypes upon their overexpression in vivo 1, 2, 3, 4, 5. Our data is also supported by the observed presence of variably lipidated Shh/Hh variants in vivo 6, and the in vivo observation that complete removal of Scube activity in zebrafish embryos phenocopies a complete loss of Hh function that is bypassed by increased ligand expression - and even results in wild-type-like ectopic Shh target gene expression 7. The in vivo observations are compatible with our data but are incompatible with proposed alternative models of Scube-mediated dual-lipidated Shh extraction and continued Shh/Scube association to allow for morphogen transport.
2) “Thus, it would be important to demonstrate key findings in cells that secrete Shh endogenously”.
Experimental data shown in Fig. S8B demonstrates that en-controlled expression of sheddase-resistant Hh variants blocks endogenous Hh function in the same wing disc compartment. To our knowledge, this assay is the most physiologically relevant test of the mechanism of Disp-mediated Hh release. Still, we have now started to analyze Hh from Drosophila disc tissue biochemically and hope that we can include our findings in the final manuscript.
3) “The authors could use an orthogonal approach, optimally a demonstration of physical interaction, or at least fractionation by a different parameter”.
We agree with this reviewer’s assessment and are currently in the process to establish co-IP and density gradient conditions to test physical HDL/Shh interactions. The results will be included in the final version of record.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
This study presents an important finding on human m6A methyltransferase complex (including METTL3, METTL14 and WTAP). The evidence supporting the claims of the authors is convincing, although the model and assays need to be further modified. The work will be of interest to biologists working on RNA epigenetics and cancer biology.
In mammals, a large methyltransferase complex (including METTL3, METTL14 and WTAP) deposits m6A across the transcriptome, and METTL3 serves as its catalytic core component. In this manuscript, the authors identified two cleaved forms of METTL3 and described the function of METTL3a (residues 239-580) in breast tumorigenesis. METTL3a mediates the assembly of METTL3-METTL14-WTAP complex, the global m6A deposition and breast cancer progression. Furthermore, the METTL3a-mTOR axis was uncovered to mediate the METTL3 cleavage, providing potential therapeutic target for breast cancer. This study is properly performed and the findings are very interesting; however, some problems with the model and assays need to be modified. It is widely known that METTL3 and METTL14 form a stable heterodimer with the stoichiometric ratio of 1:1 (Wang X et al. Nature 534, 575-578 (2016), Su S et al. Cell Res 32(11), 982-994 (2022), Yan X et al. Cell Res 32(12), 1124-1127 (2022)), the numbers of METTL3 and METTL14 in the model of Fig 7P are not equivalent and need to be modified.
We thank for reviewer’s good suggestion. We will modify the model in Fig. 7P.
Reviewer #2 (Public Review):
In this study, Yan et al. report that a cleaved form of METTL3 (termed METTL3a) plays an essential role in regulating the assembly of the METTL3-METTL14-WTAP complex. Depletion of METTL3a leads to reduced m6A level on TMEM127, an mTOR repressor, and subsequently decreased breast cancer cell proliferation. Mechanistically, METTL3a is generated via 26S proteasome in an mTOR-dependent manner.
The manuscript follows a smooth, logical flow from one result to the next, and most of the results are clearly presented. Specifically, the molecular interaction assays are well-designed. If true, this model represents a significant addition to the current understanding of m6A-methyltransferase complex formation.
A few minor issues detailed below should be addressed to make the paper even more robust. The specific comments are contained below.
1) The existence of METTL3a and METTL3b.
In this study, the author found the cleaved form of METTL3 in breast cancer patient tissues and breast cancer cell lines. Is it a specific event that only occurs in breast cancer? The author may examine the METTL3a in other cell lines if it is a common rule.
We thank reviewer for point this out. We discovered the cleaved form of METTL3 in breast cancer, and we also observed this cleaved METTL3 in other cell lines such as lung cancer cell lines, renal cancer cell lines, HCT116 and MEF, suggesting that it is a common rule. We will add these results in the revised manuscript.
2) Generation of METTL3a and METTL3b.
1) Figure 1 shows that METTL3a and METTL3b were generated from the C-terminal of full-length METTL3. Because the sequence of METTL3a is involved in the sequences of METTL3b, can METTL3b be further cleaved to produce METTL3a?
Although the sequence of METTL3a is involved in the sequences of METTL3b, overexpression of METTL3b in T47D, MDA-MB-231 and 293T cells did not show METTL3a expression (please see Figures 3A, 3C, 3G), suggesting that METTL3b can not be further cleaved to produce METTL3a, and the METTL3 cleavage may require its N-terminal region. We will add this in the discussion.
2) Based on current data, the generation of METTL3a and METTL3b are separated. Are there any factors that affect the cleavage ratio between METTL3a and METTL3b?
We thank for reviewer’s excellent question. In this study, we show that both METTL3a and METTLb are produced through proteasomal cleavage, and both of them are positively regulated by the mTOR pathway. On the other hand, we indeed observed the differential cleavage ratios between METTL3a and METTL3b across different cell lines. For example, METTL3a/METTLb ratio was greater than 1 in MDA-MB-231 cells (see Figure 7C), less than 1 in T47D and 293T cell lines (see Figure 7A and 7B), and equal to 1 in MEF cells (see Figure 7O). Based on these results, we speculate that there may be some factors that control the cleavage ratio between METTL3a and METTL3b, which warrants further investigation. We will add this in the discussion.
3) In Figure 2G, the author shows the result that incubation of the Δ198+Δ238 METTL3 protein with T47D cell lysates cannot produce the METTL3a and METTL3b variants. The author may also show the results that Δ198 METTL3 protein or Δ238 METTL3 protein incubates with T47D cell lysates, respectively.
Following the reviewer’s suggestion, we will perform in vitro cleavage assays by incubation of METTL3-Δ238 or METTL3-Δ198 with T47D cell lysates, and will incorporate this result in the revised manuscript.
4) As well as many results published in previous studies, the in vitro methylation assay shows that WT METTL3 is capable of methylating RNA probe (figure 2H). The main point of this study is that METTL3a is required for the METTL3-METTL14 assembly. However, the absence of METTL3a in the in vitro system did not inhibit METTL3-METTL14 methylation activity. Moreover, the presence of METTL3a even resulted in a weak m6A level.
The main point of this study is that METTL3a is required for the METTL3-WTAP interaction, but dispensable for the METTL3-METTL14 assembly (see Figure 4A-4B). In this in vitro methylation assays, METTL3 and METTL14 is capable of methylating RNA probe in the absent of WTAP. In this condition, we found that METTL3 WT as well as its different variants (METTL3-Δ238, METTL3-Δ198, METTL3b and METTL3a) except the catalytically dead mutant METTL3 APPA showed methylation activity in vitro.
5) In Figure 4A, the author suggests that WTAP cannot be immunoprecipitated with METTL3a and 3b because WTAP interacted with the N-terminal of METTL3. If this assay is performed in WT cells, the endogenous full-length METTL3 may help to form the complex. In this case, WTAP is supposed to be co-immunoprecipitated.
We thank reviewer for point this out. METTL3 interacts with WTAP through its N-terminal (1-33aa) (1). Consistently, we find that the two cleaved forms METTL3a and METTL3b which lack the N-terminal region are not able to bind with WTAP. In Figure 4A, we overexpressed METTL3 WT as well as its different variants METTL3-Δ238, METTL3-Δ198, METTL3b and METTL3a respectively in WT cells, and compared their binding abilities with WTAP or METTL14 among these overexpressed METTL3 variants. We acknowledge that the exogenous METTL3a and METTL3b interact with endogenous full-length METTL3, and the endogenous full-length METTL3 may help them to form the complex with WTAP. But it is also noteworthy that the exogenous expression levels of METTL3a and METTL3b are much higher than that of endogenous full-length METTL3 (see Figure 3A and 3C). In this case, METTL3a or METTL3b predominantly interacts with itself, METTL3, METTL14 or other potential interacting proteins through its C-terminal region, this may greatly dilute the condition for the interaction between WTAP and endogenous full-length METTL3. Moreover, in Figure 4A, the comparison is among overexpressed METTL3 variants, this week indirect interaction through much lower expression levels of endogenous protein is not comparable to the direct interaction between the overexpressed METTL3 variant and WTAP.
Reference:
- Schöller, E., Weichmann, F., Treiber, T., Ringle, S., Treiber, N., Flatley, A., Feederle, R., Bruckmann, A., and Meister, G. (2018). Interactions, localization, and phosphorylation of the m6A generating METTL3–METTL14–WTAP complex. RNA 24, 499-512.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
The following is the authors' response to the original reviews.
Reviewer #1 (Public Review):
[...] The experiments are well-designed and carefully conducted. The conclusions of this work are in general well supported by the data. There are a couple of points that need to be addressed or tested.
1) It is unclear how LC phasic stimulation used in this study gates cortical plasticity without altering cellular responses (at least at the calcium imaging level). As the authors mentioned that Polack et al 2013 showed a significant effect of NE blockers in membrane potential and firing rate in V1 layer2/3 neurons during locomotion, it would be useful to test the effect of LC silencing (coupled to mismatch training) on both cellular response and cortical plasticity or applying NE antagonists in V1 in addition to LC optical stimulation. The latter experiment will also address which neuromodulator mediates plasticity, given that LC could co-release other modulators such as dopamine (Takeuchi et al. 2016 and Kempadoo et al. 2016). LC silencing experiment would establish a causal effect more convincingly than the activation experiment.
Regarding the question of how phasic stimulation could alter plasticity without affecting the response sizes or activity in general, we believe there are possibilities supported by previous literature. It has been shown that catecholamines can gate plasticity by acting on eligibility traces at synapses (He et al., 2015; Hong et al., 2022). In addition, all catecholamine receptors are metabotropic and influence intracellular signaling cascades, e.g., via adenylyl cyclase and phospholipases. Catecholamines can gate LTP and LTD via these signaling pathways in vitro (Seol et al., 2007). Both of these influences on plasticity at the molecular level do not necessitate or predict an effect on calcium activity levels. We have now expanded on this in the discussion of the revised manuscript.
While a loss of function experiment could add additional corroborating evidence that LC output is required for the plasticity seen, we did not perform loss-of-function experiments for three reasons:
-
The effects of artificial activity changes around physiological set point are likely not linear for increases and decreases. The problem with a loss of function experiment here is that neuromodulators like noradrenaline affect general aspects of neuronal function. This is apparent in Polack et al., 2013: during the pharmacological blocking experiment, the membrane hyperpolarizes, membrane variance becomes very low, and the cells are effectively silenced (Figure 7 of (Polack et al., 2013)), demonstrating an immediate impact on neuronal function when noradrenaline receptor activation is presumably taken below physiological/waking levels. In light of this, if we reduce LC output/noradrenergic receptor activation and find that plasticity is prevented, this could be the result of a direct influence on the plasticity process, or, the result of a disruption of another aspect of neuronal function, like synaptic transmission or spiking. We would therefore challenge the reviewer’s statement that a loss-of-function experiment would establish a causal effect more convincingly than the gain- of-function experiment that we performed.
-
The loss-of-function experiment is technically more difficult both in implementation and interpretation. Control mice show no sign of plasticity in locomotion modulation index (LMI) on the 10-minute timescale (Figure 4J), thus we would not expect to see any effect when blocking plasticity in this experiment. We would need to use dark-rearing and coupled-training of mice in the VR across development to elicit the relevant plasticity ((Attinger et al., 2017); manuscript Figure 5). We would then need to silence LC activity across days of VR experience to prevent the expected physiological levels of plasticity. Applying NE antagonists in V1 over the entire period of development seems very difficult. This would leave optogenetically silencing axons locally, which in addition to the problems of doing this acutely (Mahn et al., 2016; Raimondo et al., 2012), has not been demonstrated to work chronically over the duration of weeks. Thus, a negative result in this experiment will be difficult to interpret, and likely uninformative: We will not be able to distinguish whether the experimental approach did not work, or whether local LC silencing does nothing to plasticity.
Note that pharmacologically blocking noradrenaline receptors during LC stimulation in the plasticity experiment is also particularly challenging: they would need to be blocked throughout the entire 15 minute duration of the experiment with no changes in concentration of antagonist between the ‘before’ and ‘after’ phases, since the block itself is likely to affect the response size, as seen in Polack et al., 2013, creating a confound for plasticity-related changes in response size. Thus, we make no claim about which particular neuromodulator released by the LC is causing the plasticity.
- There are several loss-of-function experiments reported in the literature using different developmental plasticity paradigms alongside pharmacological or genetic knockout approaches. These experiments show that chronic suppression of noradrenergic receptor activity prevents ocular dominance plasticity and auditory plasticity (Kasamatsu and Pettigrew, 1976; Shepard et al., 2015). Almost absent from the literature, however, are convincing gain-of-function plasticity experiments.
Overall, we feel that loss-of-function experiments may be a possible direction for future work but, given the technical difficulty and – in our opinion – limited benefit that these experiments, would provide in light of the evidence already provided for the claims we make, we have chosen not to perform these experiments at this time. Note that we already discuss some of the problems with loss-of-function experiments in the discussion.
2) The cortical responses to NE often exhibit an inverted U-curve, with higher or lower doses of NE showing more inhibitory effects. It is unclear how responses induced by optical LC stimulation compare or interact with the physiological activation of the LC during the mismatch. Since the authors only used one frequency stimulation pattern, some discussion or additional tests with a frequency range would be helpful.
This is correct, we do not know how the artificial activation of LC axons relates to physiological activation, e.g. under mismatch. The stimulation strength is intrinsically consistent in our study in the sense that the stimulation level to test for changes in neuronal activity is similar to that used to probe for plasticity effects. We suspect that the artificial activation results in much stronger LC activity than seen during mismatch responses, given that no sign of the plasticity in LMI seen in high ChrimsonR occurs in low ChrimsonR or control mice (Figure 4J). Note, that our conclusions do not rely on the assumption that the stimulation is matched to physiological levels of activation during the visuomotor mismatches that we assayed. The hypothesis that we put forward is that increasing levels of activation of the LC (reflecting increasing rates or amplitude of prediction errors across the brain) will result in increased levels of plasticity. We know that LC axons can reach levels of activity far higher than that seen during visuomotor mismatches, for instance during air puff responses, which constitute a form of positive prediction error (unexpected tactile input) (Figures 2C and S1C). The visuomotor mismatches used in this study were only used to demonstrate that LC activity is consistent with prediction error signaling. We have now expanded on these points in the discussion as suggested.
Reviewer #1 (Recommendations For The Authors):
1) In Figure 3E, there is a rebound response of ChrimsonR at the offset of the mismatch. Is that common? If so, what does it mean? If not, maybe replace it with a more common example trace.
This trace in fact represents the population average, so this offset response (or ‘rebound’) reflects a significant component of the population response to visual flow onset (i.e., mismatch offset), only under conditions of LC stimulation. See our response to reviewer 2 concerning this element of the response.
2) It would be helpful to have some discussions on how a mismatch signal reaches and activates LC from cortical neurons.
We have now added a short segment on this to the discussion.
Reviewer #2 (Public Review):
[...] The study provides very compelling data on a timely and fascinating topic in neuroscience. The authors carefully designed experiments and corresponding controls to exclude any confounding factors in the interpretation of neuronal activity in LC axons and cortical neurons. The quality of the data and the rigor of the analysis are important strengths of the study. I believe this study will have an important contribution to the field of system neuroscience by shedding new light on the role of a key neuromodulator. The results provide strong support for the claims of the study. However, I also believe that some results could have been strengthened by providing additional analyses and experimental controls. These points are discussed below.
Calcium signals in LC axons tend to respond with pupil dilation, air puffs, and locomotion as the authors reported. A more quantitative analysis such as a GLM model could help understand the relative contribution (and temporal relationship) of these variables in explaining calcium signals. This could also help compare signals obtained in the sensory and motor cortical domains. Indeed, the comparison in Figure 2 seems a bit incomplete since only "posterior versus anterior" comparisons have been performed and not within-group comparisons. I believe it is hard to properly assess differences or similarities between calcium signal amplitude measured in different mice and cranial windows as they are subject to important variability (caused by different levels of viral expression for instance). The authors should at the very least provide a full statistical comparison between/within groups through a GLM model that would provide a more systematic quantification.
To provide a more detailed comparison of responses, we have expanded on the analysis in Figure 2 to include comparative heatmaps from anterior and posterior imaging sites, as well as statistical comparisons of the response curves as a function of time. This shows how similar the responses are in the two regions.
Beyond this, we are not sure how a regression analysis (GLM or otherwise) would help support the main point we aim to make here. The responses in anterior and posterior regions are similar, which supports a broadcast model of LC function in the cortex, rather than specialized routing of prediction error signals to cortical areas. Linear contributions of the signals are apparent from the stimulus triggered responses, and while non-linear interactions between the different variables are certainly an interesting question, they go beyond the point we aim to make and would also not be captured by a regression analysis. In addition, we have refined our language replacing descriptors of ‘the same’ or ‘indistinguishable’ between the two regions with ‘similar’, to highlight that while we find no evidence of a difference, our analysis does not cover all possible differences that might appear when looking at non-linear interactions.
Previous studies using stimulations of the locus coeruleus or local iontophoresis of norepinephrine in sensory cortices have shown robust responses modulations (see McBurney-Lin et al., 2019, https://doi.org/10.1016/j.neubiorev.2019.06.009 for a review). The weak modulations observed in this study seem at odds with these reports. Given that the density of ChrimsonR-expressing axons varies across mice and that there are no direct measurements of their activation (besides pupil dilation), it is difficult to appreciate how they impact the local network. How does the density of ChrimsonR-expressing axons compare to the actual density of LC axons in V1? The authors could further discuss this point.
In terms of estimating the percentage of cortical axons labelled based on our axon density measurements: we refer to cortical LC axonal immunostaining in the literature to make this comparison.
In motor cortex, an average axon density of 0.07 µm/µm2 has been reported (Yin et al., 2021), and 0.09 µm/µm2 in prefrontal cortex (Sakakibara et al., 2021). Density of LC axons varies by cortical area, with higher density in motor cortex and medial areas than sensory areas (Agster et al., 2013): V1 axon density is roughly 70% of that in cingulate cortex (adjacent to motor and prefrontal cortices) (Nomura et al., 2014). So, we approximate a maximum average axon density in V1 of approximately 0.056 µm/µm2.
Because these published measurements were made from images taken of tissue volumes with larger z-depth (~ 10 µm) than our reported measurements (~ 1 µm), they appear much larger than the ranges reported in our manuscript (0.002 to 0.007 µm/µm2). We repeated the measurements in our data using images of volumes with 10 µm z-depth, and find that the percentage axons labelled in our study in high ChrimsonR-expressing mice ranges between 0.012 to 0.039 µm/µm2. This corresponds to between 20% to 70% of the density we would expect based on previous work. Note that this is a potentially significant underestimate, and therefore should be used as a lower bound: analyses in the literature use images from immunostaining, where the signal to background ratio is very high. In contrast, we did not transcardially perfuse our mice leading to significant background (especially in the pia/L1, where axon density is high - (Agster et al., 2013; Nomura et al., 2014)), and the intensity of the tdTomato is not especially high. We therefore are likely missing some narrow, dim, and superficial fibers in our analysis.
We also can quantify how our variance in axonal labelling affects our results: For the dataset in Figure 3, there doesn’t appear to be any correlation between the level of expression and the effect of stimulating the axons on the mismatch or visual flow responses for each animal (Author Response Figure 1), while there is a significant correlation between the level of expression and the pupil dilation, consistent with the dataset shown in Figure 4. Thus, even in the most highly expressing mice, there is no clear effect on average response size at the level of the population. We have added these correlations to the revised manuscript as a new Figure S3.
Author Response Figure 1. Correlations between axon density and average effect of laser stimulation on stimulus responses and pupil dilation (data from manuscript Figure 3). Grey points show control mice, blue points show low ChrimsonR-expressing mice, and purple points show high ChrimsonR- expressing mice.
To our knowledge, there has not yet been any similar experiment reported utilizing local LC axonal optogenetic stimulation while recording cortical responses, so when comparing our results to those in the literature, there are several important methodological differences to keep in mind. The vast majority of the work demonstrating an effect of LC output/noradrenaline on responses in the cortex has been done using unit recordings, and while results are mixed, these have most often demonstrated a suppressive effect on spontaneous and/or evoked activity in the cortex (McBurney-Lin et al., 2019). In contrast to these studies, we do not see a major effect of LC stimulation either on baseline or evoked calcium activity (Figure 3), and, if anything, we see a minor potentiation of transient visual flow onset responses (see also Author Response Figure 2). There could be several reasons why our stimulation does not have the same effect as these older studies:
-
Recording location: Unit recordings are often very biased toward highly active neurons (Margrie et al., 2002) and deeper layers of the cortex, while we are imaging from layer 2/3 – a layer notorious for sparse activity. In one of the few papers to record from superficial layers, it was been demonstrated that deeper layers in V1 are affected differently by LC stimulation methods compared to more superficial ones (Sato et al., 1989), with suppression more common in superficial layers. Thus, some differences between our results and those in the majority of the literature could simply be due to recording depth and the sampling bias of unit recordings.
-
Stimulation method: Most previous studies have manipulated LC output/noradrenaline levels by either iontophoretically applying noradrenergic receptor agonists, or by electrically stimulating the LC. Arguably, even though our optogenetic stimulation is still artificial, it represents a more physiologically relevant activation compared to iontophoresis, since the LC releases a number of neuromodulators including dopamine, and these will be released in a more physiological manner in the spatial domain and in terms of neuromodulator concentration. Electrical stimulation of the LC as used by previous studies differs from our optogenetic method in that LC axons will be stimulated across much wider regions of the brain (affecting both the cortex and many of its inputs), and it is not clear whether the cause of cortical response changes is in cortex or subcortical. In addition, electrical LC stimulation is not cell type specific.
-
Temporal features of stimulation: Few previous studies had the same level of temporal control over manipulating LC output that we had using optogenetics. Given that electrical stimulation generates electrical artifacts, coincident stimulation during the stimulus was not used in previous studies. Instead, the LC is often repeatedly or tonically stimulated, sometimes for many seconds, prior to the stimulus being presented. Iontophoresis also does not have the same temporal specificity and will lead to tonically raised receptor activity over a time course determined by washout times.
-
State specificity: Most previous studies have been performed under anesthesia – which is known to impact noradrenaline levels and LC activity (Müller et al., 2011). Thus, the acute effects of LC stimulation are likely not comparable between anesthesia and in the awake animal.
Due to these differences, it is hard to infer why our results differ compared to other papers. The study with the most similar methodology to ours is (Vazey et al., 2018), which used optogenetic stimulation directly into the mouse LC while recording spiking in deep layers of the somatosensory cortex with extracellular electrodes. Like us, they found that phasic optogenetic stimulation alone did not alter baseline spiking activity (Figure 2F of Vazey et al., 2018), and they found that in layers 5 and 6, short latency transient responses to foot touch were potentiated and recruited by simultaneous LC stimulation. While this finding appears more overt than the small modulations we see, it is qualitatively not so dissimilar from our finding that transient responses appear to be slightly potentiated when visual flow begins (Author Response Figure 2). Differences in the degree of the effect may be due to differences in the layers recorded, the proportion of the LC recruited, or the fact anesthesia was used in Vazey et al., 2018.
Note that we only used one set of stimulation parameters for optogenetic stimulation, and it is always possible that using different parameters would result in different effects. We have now added a discussion on the topic to the revised manuscript.
In the analysis performed in Figure 3, it seems that red light stimulations used to drive ChrimsonR also have an indirect impact on V1 neurons through the retina. Indeed, figure 3D shows a similar response profile for ChrimsonR and control with calcium signals increasing at laser onset (ON response) and offset (OFF response). With that in mind, it is hard to interpret the results shown in Figure 3E-F without seeing the average calcium time course for Control mice. Are the responses following visual flow caused by LC activation or additional visual inputs? The authors should provide additional information to clarify this result.
This is a good point. When we plot the average difference between the stimulus response alone and the optogenetic stimulation + stimulus response, we do indeed find that there is a transient increase in response at the visual flow onset (and the offset of mismatch, which is where visual flow resumes), and this is only seen in ChrimsonR-expressing mice (Author Response Figure 2). We therefore believe that these enhanced transients at visual flow onset could be due to the effect of ChrimsonR stimulation, and indeed previous studies have shown that LC stimulation can reduce the onset latency and latency jitter of afferent-evoked activity (Devilbiss and Waterhouse, 2004; Lecas, 2004), an effect which could mediate the differences we see. We have added this analysis to the revised manuscript in Figure 3 and added discussion accordingly.
Author Response Figure 2. Difference in responses to visual stimuli caused by optogenetic stimulation, calculated by subtracting the average response when no laser was presented from the average response when the laser was presented concurrent with the visual stimulus. Pink traces show the response difference for ChrimsonR-expressing mice, and grey shows the same for control mice. Black blocks below indicate consecutive timepoints after stimulation showing a significant difference between ChrimsonR and control as determined by hierarchical bootstrapping (p<0.05).
Some aspects of the described plasticity process remained unanswered. It is not clear over which time scale the locomotion modulation index changes and how many optogenetic stimulations are necessary or sufficient to saturate this index. Some of these questions could be addressed with the dataset of Figure 3 by measuring this index over different epochs of the imaging session (from early to late) to estimate the dynamics of the ongoing plasticity process (in comparison to control mice). Also, is there any behavioural consequence of plasticity/update of functional representation in V1? If plasticity gated by repeated LC activations reproduced visuomotor responses observed in mice that were exposed to visual stimulation only in the virtual environment, then I would expect to see a change in the locomotion behaviour (such as a change in speed distribution) as a result of the repeated LC stimulation. This would provide more compelling evidence for changes in internal models for visuomotor coupling in relation to its behavioural relevance. An experiment that could confirm the existence of the LC-gated learning process would be to change the gain of the visuomotor coupling and see if mice adapt faster with LC optogenetic activation compared to control mice with no ChrimsonR expression. Authors should discuss how they imagine the behavioural manifestation of this artificially-induced learning process in V1.
Regarding the question of plasticity time course: Unfortunately, owing to the paradigm used in Figure 3, the time course of the plasticity will not be quantifiable from this experiment. This is because in the first 10 minutes, the mouse is in closed loop visuomotor VR experience, undergoing optogenetic stimulation (this is the time period in which we record mismatches). We then shift to the open loop session to quantify the effect of optogenetic stimulation on visual flow responses. Since the plasticity is presumably happening during the closed loop phase, and we have no read-out of the plasticity during this phase (we do not have uncoupled visual flow onsets to quantify LMI in closed loop), it is not possible to track the plasticity over time.
Regarding the behavioral relevance of the plasticity: The type of plasticity we describe here is consistent with predictive, visuomotor plasticity in the form of a learned suppression of responses to self-generated visual feedback during movement. Intuitive purposes of this type of plasticity would be 1) to enable better detection of external moving objects by suppressing the predictable (and therefore redundant) self-generated visual motion and 2) to better detect changes in the geometry of the world (near objects have a larger visuomotor gain that far objects). In our paradigm, we have no intuitive read-out of the mouse’s perception of these things, and it is not clear to us that they would be reflected in locomotion speed, which does not differ between groups (manuscript Figure S5). Instead, we would need to turn to other paradigms for a clear behavioral read-out of predictive forms of sensorimotor learning: for instance, sensorimotor learning paradigms in the VR (such as those used in (Heindorf et al., 2018; Leinweber et al., 2017)), or novel paradigms that reinforce the mouse for detecting changes in the gain of the VR, or moving objects in the VR, using LC stimulation during the learning phase to assess if this improves acquisition. This is certainly a direction for future work. In the case of a positive effect, however, the link between the precise form of plasticity we quantify in this manuscript and the effect on the behavior would remain indirect, so we see this as beyond the scope of the manuscript. We have added a discussion on this topic to the revised manuscript.
Finally, control mice used as a comparison to mice expressing ChrimsonR in Figure 3 were not injected with a control viral vector expressing a fluorescent protein alone. Although it is unlikely that the procedure of injection could cause the results observed, it would have been a better control for the interpretation of the results.
We agree that this indeed would have been a better control. However, we believe that this is fortunately not a major problem for the interpretation of our results for two reasons:
-
The control and ChrimsonR expressing mice do not show major differences in the effect of optogenetic LC stimulation at the level of the calcium responses for all results in Figure 3, with the exception of the locomotion modulation indices (Figure 3I). Therefore, in terms of response size, there is no major effect compared to control animals that could be caused by the injection procedure, apart from marginally increased transient responses to visual flow onset – and, as the reviewer notes, it is difficult to see how the injection procedure would cause this effect.
-
The effect on locomotion modulation index (Figure 3I) was replicated with another set of mice in Figure 4C, for which we did have a form of injected control (‘Low ChrimsonR’), which did not show the same plasticity in locomotion modulation index (Figure 4E). We therefore know that at least the injection itself is not resulting in the plasticity effect seen.
Reviewer #2 (Recommendations For The Authors):
In experiments where axonal imaging was performed on LC axons, the authors should indicate the number of mice used in addition to the number of Field of View (FoV). Indeed, samples (FoVs) are not guaranteed to be independent as LC axons can span large cortical areas and the same axon can end up in different FoVs. Please provide statistics across mice/cranial windows to confirm the robustness of the results.
All information requested regarding animal numbers in axonal imaging are provided in the statistical Table S1, as well as in the text and figures (e.g., Figure 2A). Samples will be independent in time (as different FoVs were imaged on different days), but it is indeed possible that axon segments from different FoVs within an animal come from the same axon.
Averaging across animals greatly reduces statistical power. We have therefore implemented hierarchical bootstrapping instead: bootstrapping first occurs at the level of animal and then at the level of FoV. All p-values that were reported as significant in manuscript remained significant with this test, with no major reduction in significance level, with the exception of Figure S2B, where statistical significance was lost (p = 0.04 with Rank sum, p = 0.07 with hierarchical Bootstrapping). We therefore conclude that sampling from the same animals across days is not responsible for the significance of results reported.
References
Agster, K.L., Mejias-Aponte, C.A., Clark, B.D., Waterhouse, B.D., 2013. Evidence for a regional specificityi n the density and distribution of noradrenergic varicosities in rat cortex. Journal of Comparative Neurology 521, 2195–2207. https://doi.org/10.1002/cne.23270
Attinger, A., Wang, B., Keller, G.B., 2017. Visuomotor Coupling Shapes the Functional Development of Mouse Visual Cortex. Cell 169, 1291-1302.e14. https://doi.org/10.1016/j.cell.2017.05.023
Devilbiss, D.M., Waterhouse, B.D., 2004. The Effects of Tonic Locus Ceruleus Output on Sensory-Evoked Responses of Ventral Posterior Medial Thalamic and Barrel Field Cortical Neurons in the Awake Rat. J. Neurosci. 24, 10773–10785. https://doi.org/10.1523/JNEUROSCI.1573-04.2004
He, K., Huertas, M., Hong, S.Z., Tie, X., Hell, J.W., Shouval, H., Kirkwood, A., 2015. Distinct Eligibility Traces for LTP and LTD in Cortical Synapses. Neuron 88, 528–538. https://doi.org/10.1016/j.neuron.2015.09.037
Heindorf, M., Arber, S., Keller, G.B., 2018. Mouse Motor Cortex Coordinates the Behavioral Response to Unpredicted Sensory Feedback. Neuron 0. https://doi.org/10.1016/j.neuron.2018.07.046
Hong, S.Z., Mesik, L., Grossman, C.D., Cohen, J.Y., Lee, B., Severin, D., Lee, H.-K., Hell, J.W., Kirkwood, A., 2022. Norepinephrine potentiates and serotonin depresses visual cortical responses by transforming eligibility traces. Nat Commun 13, 3202. https://doi.org/10.1038/s41467-022-30827-1
Kasamatsu, T., Pettigrew, J.D., 1976. Depletion of brain catecholamines: failure of ocular dominance shift after monocular occlusion in kittens. Science 194, 206–209. https://doi.org/10.1126/science.959850
Lecas, J.-C., 2004. Locus coeruleus activation shortens synaptic drive while decreasing spike latency and jitter in sensorimotor cortex. Implications for neuronal integration. European Journal of Neuroscience 19, 2519–2530. https://doi.org/10.1111/j.0953-816X.2004.03341.x
Leinweber, M., Ward, D.R., Sobczak, J.M., Attinger, A., Keller, G.B., 2017. A Sensorimotor Circuit in Mouse Cortex for Visual Flow Predictions. Neuron 95, 1420-1432.e5. https://doi.org/10.1016/j.neuron.2017.08.036
Mahn, M., Prigge, M., Ron, S., Levy, R., Yizhar, O., 2016. Biophysical constraints of optogenetic inhibition at presynaptic terminals. Nat Neurosci 19, 554–556. https://doi.org/10.1038/nn.4266
Margrie, T.W., Brecht, M., Sakmann, B., 2002. In vivo, low-resistance, whole-cell recordings from neurons in the anaesthetized and awake mammalian brain. Pflugers Arch. 444, 491–498. https://doi.org/10.1007/s00424-002-0831-z
McBurney-Lin, J., Lu, J., Zuo, Y., Yang, H., 2019. Locus coeruleus-norepinephrine modulation of sensory processing and perception: A focused review. Neurosci Biobehav Rev 105, 190–199. https://doi.org/10.1016/j.neubiorev.2019.06.009
Müller, C.P., Pum, M.E., Amato, D., Schüttler, J., Huston, J.P., De Souza Silva, M.A., 2011. The in vivo neurochemistry of the brain during general anesthesia. Journal of Neurochemistry 119, 419–446. https://doi.org/10.1111/j.1471-4159.2011.07445.x
Nomura, S., Bouhadana, M., Morel, C., Faure, P., Cauli, B., Lambolez, B., Hepp, R., 2014. Noradrenalin and dopamine receptors both control cAMP-PKA signaling throughout the cerebral cortex. Front Cell Neurosci 8. https://doi.org/10.3389/fncel.2014.00247
Polack, P.-O., Friedman, J., Golshani, P., 2013. Cellular mechanisms of brain-state-dependent gain modulation in visual cortex. Nat Neurosci 16, 1331–1339. https://doi.org/10.1038/nn.3464
Raimondo, J.V., Kay, L., Ellender, T.J., Akerman, C.J., 2012. Optogenetic silencing strategies differ in their effects on inhibitory synaptic transmission. Nat Neurosci 15, 1102–1104. https://doi.org/10.1038/nn.3143
Sakakibara, Y., Hirota, Y., Ibaraki, K., Takei, K., Chikamatsu, S., Tsubokawa, Y., Saito, T., Saido, T.C., Sekiya, M., Iijima, K.M., n.d. Widespread Reduced Density of Noradrenergic Locus Coeruleus Axons in the App Knock-In Mouse Model of Amyloid-β Amyloidosis. J Alzheimers Dis 82, 1513–1530. https://doi.org/10.3233/JAD-210385
Sato, H., Fox, K., Daw, N.W., 1989. Effect of electrical stimulation of locus coeruleus on the activity of neurons in the cat visual cortex. Journal of Neurophysiology. https://doi.org/10.1152/jn.1989.62.4.946
Seol, G.H., Ziburkus, J., Huang, S., Song, L., Kim, I.T., Takamiya, K., Huganir, R.L., Lee, H.-K., Kirkwood, A., 2007. Neuromodulators control the polarity of spike-timing-dependent synaptic plasticity. Neuron 55, 919–929. https://doi.org/10.1016/j.neuron.2007.08.013
Shepard, K.N., Liles, L.C., Weinshenker, D., Liu, R.C., 2015. Norepinephrine is necessary for experience-dependent plasticity in the developing mouse auditory cortex. J Neurosci 35, 2432–2437.https://doi.org/10.1523/JNEUROSCI.0532-14.2015
Vazey, E.M., Moorman, D.E., Aston-Jones, G., 2018. Phasic locus coeruleus activity regulates cortical encoding of salience information. Proceedings of the National Academy of Sciences 115, E9439– E9448. https://doi.org/10.1073/pnas.1803716115
Yin, X., Jones, N., Yang, J., Asraoui, N., Mathieu, M.-E., Cai, L., Chen, S.X., 2021. Delayed motor learning in a 16p11.2 deletion mouse model of autism is rescued by locus coeruleus activation. Nat Neurosci 24, 646–657. https://doi.org/10.1038/s41593-021-00815-7
-
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
The authors present a study of visuo-motor coupling primarily using wide-field calcium imaging to measure activity across the dorsal visual cortex. They used different mouse lines or systemically injected viral vectors to allow imaging of calcium activity from specific cell-types with a particular focus on a mouse-line that expresses GCaMP in layer 5 IT (intratelencephalic) neurons. They examined the question of how the neural response to predictable visual input, as a consequence of self-motion, differed from responses to unpredictable input. They identify layer 5 IT cells as having a different response pattern to other cell-types/layers in that they show differences in their response to closed-loop (i.e. predictable) vs open-loop (i.e. unpredictable) stimulation whereas other cell-types showed similar activity patterns between these two conditions. They analyze the latencies of responses to visuomotor prediction errors obtained by briefly pausing the display while the mouse is running, causing a negative prediction error, or by presenting an unpredicted visual input causing a positive prediction error. They suggest that neural responses related to these prediction errors originate in V1, however, I would caution against over-interpretation of this finding as judging the latency of slow calcium responses in wide-field signals is very challenging and this result was not statistically compared between areas.
Surprisingly, they find that presentation of a visual grating actually decreases the responses of L5 IT cells in V1. They interpret their results within a predictive coding framework that the last author has previously proposed. The response pattern of the L5 IT cells leads them to propose that these cells may act as 'internal representation' neurons that carry a representation of the brain's model of its environment. Though this is rather speculative. They subsequently examine the responses of these cells to anti-psychotic drugs (e.g. clozapine) with the reasoning that a leading theory of schizophrenia is a disturbance of the brain's internal model and/or a failure to correctly predict the sensory consequences of self-movement. They find that anti-psychotic drugs strongly enhance responses of L5 IT cells to locomotion while having little effect on other cell-types. Finally, they suggest that anti-psychotics reduce long-range correlations between (predominantly) L5 cells and reduce the propagation of prediction errors to higher visual areas and suggest this may be a mechanism by which these drugs reduce hallucinations/psychosis.
This is a large study containing a screening of many mouse-lines/expression profiles using wide-field calcium imaging. Wide-field imaging has its caveats, including a broad point-spread function of the signal and susceptibility to hemodynamic artifacts, which can make interpretation of results difficult. The authors acknowledge these problems and directly address the hemodynamic occlusion problem. It was reassuring to see supplementary 2-photon imaging of soma to complement this data-set, even though this is rather briefly described in the paper.
We will expand on the discussion of caveats as suggested.
Overall the paper's strengths are its identification of a very different response profile in the L5 IT cells compared other layers/cell-types which suggests an important role for these cells in handling integration of self-motion generated sensory predictions with sensory input. The interpretation of the responses to anti-psychotic drugs is more speculative but the result appears robust and provides an interesting basis for further studies of this effect with more specific recording techniques and possibly behavioral measures.
Reviewer #2 (Public Review):
Summary:
This work investigates the effects of various antipsychotic drugs on cortical responses during visuomotor integration. Using wide-field calcium imaging in a virtual reality setup, the researchers compare neuronal responses to self-generated movement during locomotion-congruent (closed loop) or locomotion-incongruent (open loop) visual stimulation. Moreover, they probe responses to unexpected visual events (halt of visual flow, sudden-onset drifting grating). The researchers find that, in contrast to a variety of excitatory and inhibitory cell types, genetically defined layer 5 excitatory neurons distinguish between the closed and the open loop condition and exhibit activity patterns in visual cortex in response to unexpected events, consistent with unsigned prediction error coding. Motivated by the idea that prediction error coding is aberrant in psychosis, the authors then inject the antipsychotic drug clozapine, and observe that this intervention specifically affects closed loop responses of layer 5 excitatory neurons, blunting the distinction between the open and closed loop conditions. Clozapine also leads to a decrease in long-range correlations between L5 activity in different brain regions, and similar effects are observed for two other antipsychotics, aripripazole and haloperidol, but not for the stimulant amphetamine. The authors suggest that altered prediction error coding in layer 5 excitatory neurons due to reduced long-range correlations in L5 neurons might be a major effect of antipsychotic drugs and speculate that this might serve as a new biomarker for drug development.
Strengths:
- Relevant and interesting research question:
The distinction between expected and unexpected stimuli is blunted in psychosis but the neural mechanisms remain unclear. Therefore, it is critical to understand whether and how antipsychotic drugs used to treat psychosis affect cortical responses to expected and unexpected stimuli. This study provides important insights into this question by identifying a specific cortical cell type and long-range interactions as potential targets. The authors identify layer 5 excitatory neurons as a site where functional effects of antipsychotic drugs manifest. This is particularly interesting as these deep layer neurons have been proposed to play a crucial role in computing the integration of predictions, which is thought to be disrupted in psychosis. This work therefore has the potential to guide future investigations on psychosis and predictive coding towards these layer 5 neurons, and ultimately improve our understanding of the neural basis of psychotic symptoms.
- Broad investigation of different cell types and cortical regions:
One of the major strengths of this study is quasi-systematic approach towards cell types and cortical regions. By analysing a wide range of genetically defined excitatory and inhibitory cell types, the authors were able to identify layer 5 excitatory neurons as exhibiting the strongest responses to unexpected vs. expected stimuli and being the most affected by antipsychotic drugs. Hence, this quasi-systematic approach provides valuable insights into the functional effects of antipsychotic drugs on the brain, and can guide future investigations towards the mechanisms by which these medications affect cortical neurons.
- Bridging theory with experiments
Another strength of this study is its theoretical framework, which is grounded in the predictive coding theory. The authors use this theory as a guiding principle to motivate their experimental approach connecting visual responses in different layers with psychosis and antipsychotic drugs. This integration of theory and experimentation is a powerful approach to tie together the various findings the authors present and to contribute to the development of a coherent model of how the brain processes visual information both in health and in disease.
Weaknesses:
- Unclear relevance for psychosis research
From the study, it remains unclear whether the findings might indeed be able to normalise altered predictive coding in psychosis. Psychosis is characterised by a blunted distinction between predicted and unpredicted stimuli. The results of this study indicate that antipsychotic drugs further blunt the distinction between predicted and unpredicted stimuli, which would suggest that antipsychotic drugs would deteriorate rather than ameliorate the predictive coding deficit found in psychosis. However, these findings were based on observations in wild-type mice at baseline. Given that antipsychotics are thought to have little effects in health but potent antipsychotic effects in psychosis, it seems possible that the presented results might be different in a condition modelling a psychotic state, for example after a dopamine-agonistic or a NMDA-antagonistic challenge. Therefore, future work in models of psychotic states is needed to further investigate the translational relevance of these findings.
We fully agree that it is unclear how the effects of antipsychotics in mice relate to the drug effects that would be observed in schizophrenic patients. It is also correct that the reduction of the difference between closed and open loop locomotion onset response in L5 IT neurons (Figure 4) is not what we would have expected to find under the assumption that psychosis is characterized by a blunted distinction between predicted and unpredicted stimuli. We are not sure how to interpret this finding. However, it is probably important to note that the difference is only reduced when using a normalized comparison. Looking just at the subtraction of the two curves, the difference between closed and open loop locomotion onset responses remains unchanged before and after antipsychotic drug injection. The finding of a decorrelation of layer 5 activity, however, is easier to interpret under the assumption that layer 5 functions as an internal representation. If speech hallucinations, for example, are the consequence of a spurious activation of internal representations in speech processing areas of cortex, then antipsychotics might reduce the probability of these spurious activation events by reducing the lateral influence between layer 5 neurons in different cortical areas.
We do indeed plan to address the question of how antipsychotics influence cortical processing in mouse models of schizophrenia in the future.
- Incomplete testing of predictive coding interpretation
While the investigation of neuronal responses to different visual flow stimuli Is interesting, it remains open whether these responses indeed reflect internal representations in the framework of predictive coding. While the responses are consistent with internal representation as defined by the researchers, i.e., unsigned prediction error signals, an alternative interpretation might be that responses simply reflect sensory bottom-up signals that are more related to some low-level stimulus characteristics than to prediction errors.
This is correct – we will expand on the discussion of this point in the manuscript.
Moreover, This interpretational uncertainty is compounded by the fact that the used experimental paradigms were not suited to test whether behaviour is impacted as a function of the visual stimulation which makes it difficult to assess what the internal representation of the animal actual was. For these reasons, the observed effects might reflect simple bottom-up sensory processing alterations and not necessarily have any functional consequences. While this potential alternative explanation does not detract from the value of the study, future work would be needed to explain the effect of antipsychotic drugs on responses to visual flow. For example, experimental designs that systematically vary the predictive strength of coupled events or that include a behavioural readout might be more suited to draw from conclusions about whether antipsychotic drugs indeed alter internal representations.
We agree that much additional work will be necessary to identify internal representation neurons. However, it is difficult to envision how behavioral output could be used to make inferences about internal representations in sensory areas of cortex. In humans, for example, there is evidence that internal representations in visual cortex and behavioral output are not always directly related: binocular rivalry activates representations of both stimuli shown in visual cortex, while the conscious experience that drives behavioral output is only of one of the two stimuli. Hence, we would assume that the internal representation in visual cortex does not necessarily relate to behavioral output.
- Methodological constraints of experimental design
While the study findings provide valuable insights into the potential effects of antipsychotic drugs, it is important to acknowledge that there may be some methodological constraints that could impact the interpretation of the results. More specifically, the experimental design does not include a negative control condition or different doses. These conditions would help to ensure that the observed effects are not due to unspecific effects related to injection-induced stress or time, and not confined to a narrow dose range that might or might not reflect therapeutic doses used in humans. Hence, future work is needed to confirm that the observed effects indeed represent specific drug effects that are relevant to antipsychotic action.
We agree that both dosages and a broader spectrum of non-antipsychotic compounds will need to be investigated. We are in the process of building a screening pipeline to perform exactly these types of experiments. We would however argue that the paper already includes a control condition in the form of the amphetamine data (Figure 7). While it is possible that amphetamine might have an effect that exactly cancels out potential i.p. injection- or stress-induced changes, we would argue it is more probable that these changes had no measurable effect on Tlx3 positive L5 IT neuron calcium activity per se. We will provide additional evidence that time or injection stress alone do not result in the observed effects.
Conclusion:
Overall, the results support the idea that antipsychotic drugs affect neural responses to predicted and unpredicted stimuli in deep layers of cortex. Although some future work is required to establish whether this observation can indeed be explained by a drug-specific effect on predictive coding, the study provides important insights into the neural underpinnings of visual processing and antipsychotic drugs, which is expected to guide future investigations on the predictive coding hypothesis of psychosis. This will be of broad interest to neuroscientists working on predictive coding in health and in disease.
Reviewer #3 (Public Review):
The study examines how different cell types in various regions of the mouse dorsal cortex respond to visuomotor integration and how antipsychotic drugs impacts these responses. Specifically, in contrast to most cell types, the authors found that activity in Layer 5 intratelencephalic neurons (Tlx3+) and Layer 6 neurons (Ntsr1+) differentiated between open loop and closed loop visuomotor conditions. Focussing on Layer 5 neurons, they found that the activity of these neurons also differentiated between negative and positive prediction errors during visuomotor integration. The authors further demonstrated that the antipsychotic drugs reduced the correlation of Layer 5 neuronal activity across regions of the cortex, and impaired the propagation of visuomotor mismatch responses (specifically, negative prediction errors) across Layer 5 neurons of the cortex, suggesting a decoupling of long-range cortical interactions.
The data when taken as a whole demonstrate that visuomotor integration in deeper cortical layers is different than in superficial layers and is more susceptible to disruption by antipsychotics. Whilst it is already known that deep layers integrate information differently from superficial layers, this study provides more specific insight into these differences. Moreover, this study provides a first step into understanding the potential mechanism by which antipsychotics may exert their effect.
Whilst the paper has several strengths, the robustness of its conclusions is limited by its questionable statistical analyses. A summary of the paper's strengths and weaknesses follow.
Strengths:
The authors perform an extensive investigation of how different cortical cell types (including Layer 2/3, 4 , 5, and 6 excitatory neurons, as well as PV, VIP, and SST inhibitory interneurons) in different cortical areas (including primary and secondary visual areas as well as motor and premotor areas), respond to visuomotor integration. This investigation provides strong support to the idea that deep layer neurons are indeed unique in their computational properties. This large data set will be of considerable interest to neuroscientists interested in cortical processing.
The authors also provide several lines of evidence that visuomotor information is differentially integrated in deep vs. superficial layers. They show that this is true across experimental paradigms of visuomotor processing (open loop, closed loop, mismatch, drifting grating conditions) and experimental manipulations, with the demonstration that Layer 5 visuomotor integration is more sensitive to disruption by the antipsychotic drug clozapine, compared with cortex as a whole.
The study further uses multiple drugs (clozapine, aripiprazole and haloperidol) to bolster its conclusion that antipsychotic drugs disrupt correlated cortical activity in Layer 5 neurons, and further demonstrates that this disruption is specific to antipsychotics, as the psychostimulant amphetamine shows no such effect.
In widefield calcium imaging experiments, the authors effectively control for the impact of hemodynamic occlusions in their results, and try to minimize this impact using a crystal skull preparation, which performs better than traditional glass windows. Moreover, they examine key findings in widefield calcium imaging experiments with two-photon imaging.
Weaknesses:
A critical weakness of the paper is its statistical analysis. The study does not use mice as its independent unit for statistical comparisons but rather relies on other definitions, without appropriate justification, which results in an inflation of sample sizes.
We will expand on both analyses and justifications throughout.
For example, in Figure 1, independent samples are defined as locomotion onsets, leading to sample sizes of approx. 400-2000 despite only using 6 mice for the experiment. This is only justified if the data from locomotion onsets within a mouse is actually statistically independent, which the authors do not test for, and which seems unlikely. With such inflated sample sizes, it becomes more likely to find spurious differences between groups as significant. It also remains unclear how many locomotion onsets come from each mouse; the results could be dominated by a small subset of mice with the most locomotion onsets. The more disciplined approach to statistical analysis of the dataset is to average the data associated with locomotion onsets within a mouse, and then use the mouse as an independent unit for statistical comparison. A second example, for instance, is in Figure 2L, where the independent statistical unit is defined as cortical regions instead of mice, with the left and right hemispheres counting as independent samples; again this is not justified. Is the activity of cortical regions within a mouse and across cortical hemispheres really statistically independent? The problem is apparent throughout the manuscript and for each data set collected.
This may partially be a misunderstanding. Figures 1F-1K indeed use locomotion onsets as a unit, but there were no statistical comparisons. In these Figures we were addressing the question of whether locomotion onsets in closed loop differ from those in open loop. Thus, we quantify variability as a unit of locomotion onsets. The question of mouse-to-mouse variability of this analysis is a slightly different one. We did include the same analysis (for visual cortex) with the variability calculated across mice as Figure S2. We will expand this supplementary figure with the equivalent data of Figure 3 to further address this concern.
For Figure 1L (we assume the reviewer means Figure 1L, not Figure 2L), the unit we used for analysis was cortical area. We will update and improve the analysis. This was indeed not optimal, and we will replace the statistical testing with hierarchical bootstrap (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906290/) to account for nested data.
An additional statistical issue is that it is unclear if the authors are correcting for the use of multiple statistical tests (as in for example Figure 1L and Figure 2B,D). In general, the use of statistics by the authors is not justified in the text.
We will update and improve the analysis shown in Figure 1L.
In Figures 2B and 2D, we think adding family-wise error correction would be slightly misleading. We could add a correction – our conclusions would remain unchanged almost independent of the choice of correction (most of the significant p values are infinitesimally small, see Table S1). However, our interpretation is not focusing on one particular comparison (of many possible comparisons) that is significant - all comparisons between closed and open loop data points were significant in the L5 IT recordings and none of them were significant in the recordings in C57BL/6 mice that expressed GCaMP brain-wide.
Finally, it is important to note that whilst the study demonstrates that antipsychotics may selectively impact visuomotor integration in L5 neurons, it does not show that this effect is necessary or sufficient for the action of antipsychotics; though this is likely beyond the scope of the study it is something for readers to keep in mind.
We fully agree, it is still unclear how the effects we observe in our work relate to the treatment relevant effects in patients. We will expand on this point in the discussion.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
Assessment note: “Whereas the results and interpretations are generally solid, the mechanistic aspect of the work and conclusions put forth rely heavily on in vitro studies performed in cultured L6 myocytes, which are highly glycolytic and generally not viewed as a good model for studying muscle metabolism and insulin action.”
While we acknowledge that in vitro models may not fully recapitulate the complexity of in vivo systems, we believe that our use of L6 myotubes is appropriate for studying the mechanisms underlying muscle metabolism and insulin action. As mentioned below (reviewer 2, point 1), L6 myotubes possess many important characteristics relevant to our research, including high insulin sensitivity and a similar mitochondrial respiration sensitivity to primary muscle fibres. Furthermore, several studies have demonstrated the utility of L6 myotubes as a model for studying insulin sensitivity and metabolism, including our own previous work (PMID: 19805130, 31693893, 19915010).
In addition, we have provided evidence of the similarities between L6 cells overexpressing SMPD5 and human muscle biopsies at protein levels and the reproducibility of the negative correlation between ceramide and Coenzyme Q observed in L6 cells in vivo, specifically in the skeletal muscle of mice in chow diet. These findings support the relevance of our in vitro results to in vivo muscle metabolism.
Finally, we will supplement our findings by demonstrating a comparable relationship between ceramide and Coenzyme Q in mice exposed to a high-fat diet, to be shown in Supplementary Figure 4 H-I. Further animal experiments will be performed to validate our cell-line based conclusions. We hope that these additional results address the concerns raised by the reviewer and further support the relevance of our in vitro findings to in vivo muscle metabolism and insulin action.
Points from reviewer 1:
- Although the authors' results suggest that higher mitochondrial ceramide levels suppress cellular insulin sensitivity, they rely solely on a partial inhibition (i.e., 30%) of insulin-stimulated GLUT4-HA translocation in L6 myocytes. It would be critical to examine how much the increased mitochondrial ceramide would inhibit insulin-induced glucose uptake in myocytes using radiolabel deoxy-glucose.
Response: The primary impact of insulin is to facilitate the translocation of glucose transporter type 4 (GLUT4) to the cell surface, which effectively enhances the maximum rate of glucose uptake into cells. Therefore, assessing the quantity of GLUT4 present at the cell surface in non-permeabilized cells is widely regarded as the most reliable measure of insulin sensitivity (PMID: 36283703, 35594055, 34285405). Additionally, plasma membrane GLUT4 and glucose uptake are highly correlated. Whilst we have routinely measured glucose uptake with radiolabelled glucose in the past, we do not believe that evaluating glucose uptake provides a better assessment of insulin sensitivity than GLUT4.
We will clarify the use of GLUT4 translocation in the Results section:
“...For this reason, several in vitro models have been employed involving incubation of insulin sensitive cell types with lipids such as palmitate to mimic lipotoxicity in vivo. In this study we will use cell surface GLUT4-HA abundance as the main readout of insulin response...”
- Another important question to be addressed is whether glycogen synthesis is affected in myocytes under these experimental conditions. Results demonstrating reductions in insulin-stimulated glucose transport and glycogen synthesis in myocytes with dysfunctional mitochondria due to ceramide accumulation would further support the authors' claim.
Response: We have carried out supplementary experiments to investigate glycogen synthesis in our insulin-resistant models. Our approach involved L6-myotubes overexpressing the mitochondrial-targeted construct ASAH1 (as described in Fig. 3). We then challenged them with palmitate and measured glycogen synthesis using 14C radiolabeled glucose. Our observations indicated that palmitate suppressed insulin-induced glycogen synthesis, which was effectively prevented by the overexpression of ASAH1 (N = 5, * p<0.05). These results provide additional evidence highlighting the role of dysfunctional mitochondria in muscle cell glucose metabolism.
These data will be added to Supplementary Figure 4K and the results modified as follows:
“Notably, mtASAH1 overexpression protected cells from palmitate-induced insulin resistance without affecting basal insulin sensitivity (Fig. 3E). Similar results were observed using insulin-induced glycogen synthesis as an ortholog technique for Glut4 translocation. These results provide additional evidence highlighting the role of dysfunctional mitochondria in muscle cell glucose metabolism (Sup. Fig. 5K). Importantly, mtASAH1 overexpression did not rescue insulin sensitivity in cells depleted…”
We will add to the method section:
“L6 myotubes overexpressing ASAH were grown and differentiated in 12-well plates, as described in the Cell lines section, and stimulated for 16 h with palmitate-BSA or EtOH-BSA, as detailed in the Induction of insulin resistance section.
On day seven of differentiation, myotubes were serum starved in plain DMEM for 3 and a half hours. After incubation for 1 hour at 37C with 2 µCi/ml D-[U-14C]-glucose in the presence or absence of 100 nM insulin, glycogen synthesis assay was performed, as previously described (Zarini S. et al., J Lipid Res, 63(10): 100270, 2022).”
- In addition, it would be critical to assess whether the increased mitochondrial ceramide and consequent lowering of energy levels affect all exocytic pathways in L6 myoblasts or just the GLUT4 trafficking. Is the secretory pathway also disrupted under these conditions?
Response: As the secretory pathway primarily involves the synthesis and transportation of soluble proteins that are secreted into the extracellular space, and given that the majority of cellular transmembrane proteins (excluding those of the mitochondria) use this pathway to arrive at their ultimate destination, we believe that the question posed by the reviewer is highly challenging and beyond the scope of our research. We will add this to the discussion:
“...the abundance of mPTP associated proteins suggesting a role of this pore in ceramide induced insulin resistance (Sup. Fig. 6E). In addition, it is yet to be determined whether the trafficking defect is specific to Glut4 or if it affects the exocytic-secretory pathway more broadly…”
Points from reviewer 2:
- The mechanistic aspect of the work and conclusions put forth rely heavily on studies performed in cultured myocytes, which are highly glycolytic and generally viewed as a poor model for studying muscle metabolism and insulin action. Nonetheless, the findings provide a strong rationale for moving this line of investigation into mouse gain/loss of function models.
Response: The relative contribution of the anaerobic (glycolysis) and aerobic (mitochondria) contribution to the muscle metabolism can change in L6 depending on differentiation stage. For instance, Serrage et al (PMID30701682) demonstrated that L6-myotubes have a higher mitochondrial abundance and aerobic metabolism than L6-myoblasts. Others have used elegant transcriptomic analysis and metabolic characterisation comparing different skeletal muscle models for studying insulin sensitivity. For instance, Abdelmoez et al in 2020 (PMID31825657) reported that L6 myotubes exhibit greater insulin-stimulated glucose uptake and oxidative capacity compared with C2C12 and Human Mesenchymal Stem Cells (HMSC). Overall, L6 cells exhibit higher metabolic rates and primarily rely on aerobic metabolism, while C2C12 and HSMC cells rely on anaerobic glycolysis. It is worth noting that L6 myotubes are the cell line most closely related to adult human muscle when compared with other muscle cell lines (PMID31825657). Our presented results in Figure 6 H and I provide evidence for the similarities between L6 cells overexpressing SMPD5 and human muscle biopsies. Additionally, in Figure 3J-K, we demonstrate the reproducibility of the negative correlation between ceramide and Coenzyme Q observed in L6 cells in vivo, specifically in the skeletal muscle of mice in chow diet. Furthermore, we have supplemented these findings by demonstrating a comparable relationship in mice exposed to a high-fat diet, as shown in Supplementary Figure 4 H-I (refer to point 4). We will clarify these points in the Discussion:
“In this study, we mainly utilised L6-myotubes, which share many important characteristics with primary muscle fibres relevant to our research. Both types of cells exhibit high sensitivity to insulin and respond similarly to maximal doses of insulin, with Glut4 translocation stimulated between 2 to 4 times over basal levels in response to 100 nM insulin (as shown in Fig. 1-4 and (46,47)). Additionally, mitochondrial respiration in L6-myotubes have a similar sensitivity to mitochondrial poisons, as observed in primary muscle fibres (as shown in Fig. 5 (48)). Finally, inhibiting ceramide production increases CoQ levels in both L6-myotubes and adult muscle tissue (as shown in Fig. 2-3). Therefore, L6-myotubes possess the necessary metabolic features to investigate the role of mitochondria in insulin resistance, and this relationship is likely applicable to primary muscle fibres”.
We will also add additional data - in point 2 - from differentiated human myocytes that are consistent with our observations from the L6 models. Additional experiments are in progress to further extend these findings.
- One caveat of the approach taken is that exposure of cells to palmitate alone is not reflective of in vivo physiology. It would be interesting to know if similar effects on CoQ are observed when cells are exposed to a more physiological mixture of fatty acids that includes a high ratio of palmitate, but better mimics in vivo nutrition.
Response: Palmitate is widely recognized as a trigger for insulin resistance and ceramide accumulation, which mimics the insulin resistance induced by a diet in rodents and humans. Previous studies have compared the effects of a lipid mixture versus palmitate on inducing insulin resistance in skeletal muscle, and have found that the strong disruption in insulin sensitivity caused by palmitate exposure was lessened with physiologic mixtures of fatty acids, even with a high proportion of saturated fatty acids. This was associated, in part, to the selective partitioning of fatty acids into neutral lipids (such as TAG) when muscle cells are exposed to physiologic lipid mixtures (Newsom et al PMID25793412). Hence, we think that using palmitate is a better strategy to study lipid-induced insulin resistance in vitro. We will add to results:
“In vitro, palmitate conjugated with BSA is the preferred strategy for inducing insulin resistance, as lipid mixtures tend to partition into triacylglycerides (33)”.
We are also performing additional in vivo experiments to add to the physiological relevance of the findings.
- While the utility of targeting SMPD5 to the mitochondria is appreciated, the results in Figure 5 suggest that this manoeuvre caused a rather severe form of mitochondrial dysfunction. This could be more representative of toxicity rather than pathophysiology. It would be helpful to know if these same effects are observed with other manipulations that lower CoQ to a similar degree. If not, the discrepancies should be discussed.
Response: We conducted a staining procedure using the mitochondrial marker mitoDsRED to observe the effect of SMPD5 overexpression on cell toxicity. The resulting images, displayed in the figure below (Author Response Figure 1), demonstrate that the overexpression of SMPD5 did not result in any significant changes in cell morphology or impact the differentiation potential of our myoblasts into myotubes.
In addition, we evaluated cell viability in HeLa cells following exposure to SACLAC (2 uM) to induce CoQ depletion (left panel). Specifically, we measured cell death by monitoring the uptake of Propidium iodide (PI) as shown in the right panel. Our results demonstrated that Saclac-induced CoQ depletion did not lead to cell death at the doses used for CoQ depletion (Author Response Figure 2).
Therefore, we deemed it improbable that the observed effect is caused by cellular toxicity, but rather represents a pathological condition induced by elevated levels of ceramides. We will add to discussion:
“...downregulation of the respirasome induced by ceramides may lead to CoQ depletion. Despite the significant impact of ceramide on mitochondrial respiration, we did not observe any indications of cell damage in any of the treatments, suggesting that our models are not explained by toxic/cell death events.”
- The conclusions could be strengthened by more extensive studies in mice to assess the interplay between mitochondrial ceramides, CoQ depletion and ETC/mitochondrial dysfunction in the context of a standard diet versus HF diet-induced insulin resistance. Does P053 affect mitochondrial ceramide, ETC protein abundance, mitochondrial function, and muscle insulin sensitivity in the predicted directions?
Response: We would like to note that the metabolic characterization and assessment of ETC/mitochondrial function in these mice (both fed a high-fat (HF) and chow diet, with or without P053) were previously published (Turner N, PMID30131496). In addition to this, we have conducted targeted metabolomic and lipidomic analyses to investigate the impact of P053 on ceramide and CoQ levels in HF-fed mice. As illustrated in the figures below (Author Response Figure 3), the administration of P053 led to a reduction in ceramide levels (left panel) and an increase in CoQ levels (right panel) in HF-fed mice, which is consistent with our in vitro findings.
We will add to results:
“…similar effect was observed in mice exposed to a high fat diet for 5 wks (Supp. Fig. 4H-I further phenotypic and metabolic characterization of these animals can be found in (41))”
We will further perform more in-vivo studies to corroborate these findings.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
Reviewer #1 (Public Review):
[…] The manuscript contains a large amount of data that make a major inroad on a new type of link between telomere replication and regulation of the telomerase. Nevertheless, the detailed choreography of the events as well as the role of PCNASUMO remain elusive and the data do not fully explain the role of the Stn1/Elg1 interaction. The data presented do not sufficiently support the claim that SUMOPCNA is a positive signal for telomerase activation.
We thank the reviewer for her/his review efforts and opinion. We will resubmit a new version of the manuscript in which we will clarify some of the criticisms presented.
Reviewer #2 (Public Review):
[…] The conclusions are largely supported by experiments examining protein-protein interactions at low resolution and ambiguous regarding directness of interactions like co-IP and yeast two-hybrid (Y2H) combined with genetics. However, some results appear contradictory and there's a lack of rigor in the experimental data needed to support claims. There is significant room for improvement and this work could certainly attain the quality needed to support the claims. The current version needs substantial revision and lacks the necessary experimental detail. Stronger support for the claims would add detail to help distinguish competing models.
We thank the reviewer for her/his positive opinion. We will resubmit a new version of the manuscript in which we will clarify some of the criticisms presented by the referees, and add all the missing experimental details.
Reviewer #3 (Public Review):
This paper reveals interesting physical connections between Elg1 and CST proteins that suggest a model where Elg1-mediated PCNA unloading is linked to regulation of telomere length extension via Stn1, Cdc13, and presumably Ten1 proteins. Some of these interactions appear to be modulated by sumolyation and connected with Elg1's PCNA unloading activity. The strength of the paper is in the observations of new interactions between CST, Elg1, and PCNA. These interactions should be of interest to a broad audience interested in telomeres and DNA replication.
We thank the reviewer for her/his positive opinion. We will resubmit a new version of the manuscript in which we will clarify some of the criticisms presented.
What is not well demonstrated from the paper is the functional significance of the interactions described. The model presented by the authors is one interpretation of the data shown, and proposes that the role of sumolyation is temporally regulate the Elg1, PCNA and CST interactions at telomeres. This model makes some assumptions that are not demonstrated by this work (such as Stn1 sumolyation, as noted) and are left for future testing. Alternative models that envision sumolyation as a key in promoting spatial localization could also be proposed based on the data here (as mentioned in the discussion), in addition to or instead of a role for sumolyation in enforcing a series of switches governing a tightly sequenced series of interactions and events at telomeres. Critically, the telomere length data from the paper indicates that the proposed model depicts interactions that are not necessary for telomerase activation or inhibition, as telomeres in pol30-RR strains are normal length and telomeres in elg1∆ strains are not nearly as elongated as in stn1 strains. One possibility mentioned in the paper is the PCNAS and Elg1 interactions are contributing to the negative regulation of telomerase under certain conditions that are not defined in this work. Could it also be possible that the role of these interactions is not primarily directed toward modulating telomerase activity? It will be of interest to learn more about how these interactions and regulation by Sumo function intersect with regulation of telomere extension.
We present compelling evidence for a role of SUMOylated PCNA in telomere length regulation. Figure 1 shows that this modification is both necessary and sufficient to elongate the telomeres, indicating that PCNA SUMOylation plays a positive role in telomere elongation. The model we present is consistent with all our results. There are, of course, possible alternative models, but they usually fail to explain some of the results. We agree that the fact that pol30-RR presents normal-sized telomeres implies that SUMO-PCNA is not required for telomerase to solve the "end replication problem", but rather is needed for "sustained" activity of telomerase. Since elongated telomeres (by absence of Elg1 or by over-expression of SUMO-PCNA) was the phenotype monitored, this may require sustained telomerase activity. Similar results were seen in the past for Rnr1 (Maicher et al., 2017), and this mode depends on Mec1, rather than Tel1 (Harari and Kupiec, 2018). Telomere length regulation is complex, and we may not yet understand the whole picture. It appears that for normal “end replication problem” solution, very little telomerase activity may be needed, and spontaneous interactions at a low level may suffice. Future work may find the conditions at which telomerase switches from "end replication problem" to "sustained" activity. We will add further explanations on this subject to the Discussion section.
We suspect, but could not prove, a role for Stn1 SUMOylation in the interactions. SUMOylation is usually transient, and notoriously hard to detect, and despite the fact that many telomeric proteins are SUMOylated, Stn1 SUMOylation could not be shown directly by us and others (Hang et al, 2011).
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
eLife assessment
This study provides valuable information on the biogenesis of eccDNAs during spermatogenesis, i.e., eccDNAs in spermatogenic cells are not derived from miotic recombination hotspots but represent oligonucleosomal DNA fragments from apoptotic male germ cells, whose ends are ligated through microhomology-mediated end-joining. The study is currently incomplete because the method of bioinformatics needs more details and data interpretation should take the amplification bias into consideration.
We highly appreciate the positive assessment.
The negative assessment of our bioinformatics method is probably based on Reviewer #2’ comemnts. While Reviewer #1 considered that “Results from sequencing data analysis were presented elegantly”, Reviewer #2 overlooked some details and raised several critiques regarding our bioinformatics method. We respectfully disagree with many of his or her critiques: (I) Reviewer #2 considered that our method was not fully described. However, we have illustrated the principle and steps of our eccDNA detection method by Figure 4C and Figure 4-figure supplement 2, and submited our source codes to GitHub. (II) Reviewer #2 had concerns on the reliability of our method. However, we have revealed that it has comparible sensitivity and specificity with established bioinformatics tools (Figure 4—figure supplement 2C), and even higher accuracy on the assignment of eccDNA boundaries (Figure 4—figure supplement 2A). (III) Reviewer #2 also believed that “the similarity between the eccDNA profiles of human and mouse sperm remains uncertain”. However, we believe that our Fig. 5 have clearly shown that human sperm eccDNAs have exactly the same characteritics with mouse sperm eccDNAs. Nevertheless, in revised manuscript, we will add more description to help readers to better understand our method, and perform additional analyses to further back up our claims.
The amplification bias is indeed a problem of Circle-seq. Following editors’ and Reviewer #1’s insightful suggestions, we will analyze other datasets generated either by rolling circle amplification or not to see how our findings are affected. Additionally, we will consider to add one section to remind readers of the limitations of rolling-circle amplification-based Circle-seq and our data interpretation.
Reviewer #1 (Public Review):
This study aims to address the mechanism of eccDNA generation during spermatogenesis in mice. Previous efforts for cataloging eccDNA in mammalian germ cells have provided inconclusive results, particularly in the correlation between meiotic recombination and the generation of eccDNA. The authors employed an established approach (Circle-seq) to enrich and amplify eccDNA for sequencing analyses and reported that sperm eccDNA is not associated with miotic recombination hotspots. Rather, the authors reported that eccDNAs are widespread, and oligonucleosomal DNA fragments from sperm undergoing apoptosis, with the ligation of DNA ends by microhomology-mediated end-joining, would be a major source of eccDNA.
The strength of the study includes evaluating the eccDNA contents not only in sperm but also from earlier stages of cells in spermatogenesis. The differences in eccDNA size peaks between sperm and other progenitors, in particular, the unique peak in sperm around 360 bp, are intriguing. Results from sequencing data analysis were presented elegantly.
We are grateful to Reviewer #1 for his or her recognition of the strength of this study.
I also have critiques. First, the lack of eccDNA quality control step is a concern. Previous studies employed electron microscopy to ensure that DNA species are mostly circular before rolling-circle amplification. Phi29 polymerase is widely used for DNA amplification, including whole genome amplification of linear chromosomal DNA. Phi29 polymerase has a high processivity and strand displacement activity. When those activities occur within a molecule, it creates circular DNA from linear DNA in vitro. In vitro-created eccDNA from linear DNA would be randomly distributed in the genome, which may explain the low incidence of common eccDNA between replicates. Therefore, it will be crucial to show that DNA prior to amplification is dominantly circular. Electron microscopy would be challenging for the study because the relatively small number of cells were processed to enrich eccDNA. An alternative method for quality controls includes spiking samples with linear and circular exogenous DNA and measuring the ratios of circular/linear control DNA before and after column purification/exonuclease digestion. eccDNA isolation procedures can be validated by a very high circular/linear control DNA ratio.
We highly appreciate Reviewer #1’s insightful suggestions. We would like to perform eccDNA quality control by introducing circular exogenous DNA into our samples and measuring its ratio to endogenous linear DNA before and after eccDNA isolation procedures.
Another critique is regarding the limitation of the study. It is important to remind the readers of the limitations of the study. As the authors mentioned, rolling circle amplification preferentially increases the copy numbers of smaller eccDNA. Therefore, the native composition of eccDNA is skewed. In addition, the candidate eccDNAs are identified by split reads or discordant read pairs. The details of the mapping process are unclear from the methods, but such a method would require reads with high mapping quality; the identification of eccDNA is expected to require sequencing reads that are mapped to genomic locations uniquely with high confidence, and reads mapped to more than one genomic location, such as highly similar repeat sequences or duplications, are eliminated. Such identification criteria would favor eccDNA formed by little or no homology at the junction sequences, and eliminate eccDNA formed by long homologies at the ends, such as eccDNA formed exclusively by satellite DNA. Therefore, it is not surprising that the authors found the dominance of microhomology-mediated eccDNA. It remains to be determined whether small eccDNA with microhomologies are the dominant species of eccDNA in the native composition. In this regard, it is noted that similar procedures of eccDNA enrichment (column purification, exonuclease digestion, and rolling circle amplification ) revealed variable sizes and characteristics of eccDNA in sperm (human from Henriksen et al. or mice from this study), dependent on the methods of sequencing (long-read or short-read sequencing). Considering these limitations, the last sentence of the introduction, "We conclude that germline eccDNAs are formed largely by microhomology mediated ligation of nucleosome protected fragments, and barely contribute to de novo genomic deletions at meiotic recombination hotspots" needs to be revised.
We thank Reviewer #1 for pointing out limitations of the study. We will take into account and integrate the perspectives of Reviewer #1 in our revised manuscript. We will also try to analyze eccDNA datasets generated by long-read sequencing to see how our conclusions might be affected. However, we envision that it might be challenging to examine the contribution of microhomology-mediated ligation to eccDNA biogenesis using long-read sequencing data as the sequencing error rate of nanopore long-read sequencing data is very high.
Small eccDNA (microDNA) data from various mouse tissues are available from the study by Dillion et al., (Cell Reports 2015). Authors are encouraged to examine whether the notable findings in this study (oligonucleosomal-sized eccDNA peaks and the association with apoptotic cell death) are unique to sperm or common in the eccDNA from other tissues.
We are thankful to Reviewer #1 for this suggestion. We would like to analyze additional eccDNA sequencing datasets to see whether our findings are unique to sperm or common for other tissues.
Reviewer #2 (Public Review):
This study presents a useful investigation of eccDNAs in spermatogenesis of mouse. It provides evidence about the biogenesis of eccDNAs and suggests that eccDNAs are derived from oligonucleosmal DNA fragmentation during apoptosis by MMEJ and may not be the direct products of germline deletions. However, the method of data analyses were not fully described and data analysis is incomplete. It provides additional observations about the eccDNA biogenesis and can be used as a starting point for functional studies of eccDNA in sperms. However, many aspects about data analyses and data interpretations need to be improved.
We thank Reviewer #2 for his or her critical reading. However, we respectfully disagree with some critiques on our data analyses (see below). Anyway, we will provide more method details in addition to Fig. 4C and Figure 4-figure supplement 2 that have illustrated the principle and steps of our method, as well as the performance in comparison with established methods. We will also perform additional analyses and make some clarifications in revised manuscript (see below).
• Most of the conclusions made by the work are only based on the bioinformatics analyses, the validation of these foundlings using other method (biochemistry/molecular biology method) are missing. For example, no QC results presented for the eccDNA purification, which may show whether contaminates such as linear DNA or mitochondria DNA have been fully removed. Additionally, it is also helpful to use simple PCR to test the existence of identified eccDNAs in sperm or other samples to validate the specificity of the Circle-seq method.
Following both this Reviewer’s and Reviewer #1’s suggestions, we will introduce circular exogenous DNA into our samples and measure its ratio to endogenous linear DNA and to mitochondria DNA before and after eccDNA isolation procedures. We will also try to perform PCR to test the existence of identified eccDNAs.
• The reliability of the data analysis methods is uncertain, as the authors constructed and utilized their own pipeline to identify eccDNAs, despite the availability of established bioinformatics tools such as ECCsplorer, eccFinder, and Amplicon Architect. Moreover, the lack of validation of the pipeline using either ground truth datasets or simulation data raises concerns about its accuracy. Additionally, the methodology employed for identifying eccDNA that encompasses multiple gene loci remains unclear.
In fact, we have compared the performance between our method and established methods for identification of eccDNA regions, such as Circle_finder, Circle_Map and ecc_finder. Our method has comparable sensitivity and specificity with existing methods, especially Circle_finder and Circle_Map (Figure 4—figure supplement 2C). We also used one specific genomic region to show that existing methods identified the same eccDNA regions but misassigned the eccDNA boundaries (Figure 4—figure supplement 2A). These results have been shown in Figure 4—figure supplement 2. We will highlight the information to make it more clear in our revised manuscript. We will further detect eccDNAs by ECCsplorer for comparison. Since Amplicon Architect is more specifically designed for detection of ecDNAs, it will not be included in our comparison. We will also try to perform PCR to validate the identified eccDNAs.
As pointed out by Reviewer #2, similar to ECCsplorer, Circle_finder, Circle_Map and ecc_finder, our method fails to identity ecDNAs that encompass multiple gene loci. We will remind readers of this limitation in our revised manuscript.
• Although the author stated that previous studies utilizing short-read sequencing technologies may have incorrectly annotated eccDNA breakpoints, this claim requires careful scrutiny and supporting evidence, which was not provided in the manuscript.
As abovementioned, we used one specific genomic region to show that existing methods all misassigned the eccDNA boundaries (Figure 4—figure supplement 2A). In revised manuscript, we will provide necessary statistics to support this claim.
• The similarity between the eccDNA profiles of human and mouse sperm remains uncertain, and therefore, analyses of human eccDNA data and comparisons between the two are necessary if the authors claim that their findings of widespread eccDNA formation in mouse spermatogenesis extend to human sperms.
We believe that our Fig. 5 have clearly shown that human sperm eccDNAs are also originated from oligonucleosomal fragmentation (Fig. 5A-C), not associated with meiotic recombination hotspots (Fig. 5D and E) but formed by microhomology directed ligation (Fig. 5F and G). These findings are consistent with what we observed in mouse sperm eccDNAs. Nevertheless, we will analyze additional public datasets to further back up our claim in revised manuscript.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
This is an interesting manuscript that proposes a new approach to for accounting for viral diversity within hosts in phylogenetic analyses of pathogens. Concretely, the authors consider sites for which a minor allele exist as an additional base in the substitution model. For example, if at a particular site 60% of reads have an C and 40% have a G, then this site is assigned Cg, as opposed to an C which is typical of analysing consensus sequences. Because we typically model sequence evolution as a Markovian process, as is the case here, the data become naturally more informative, given that there are more states in the Markov chain when adding these bases. As a result, phylogenetic trees estimated using these data are better resolved than those from consensus sequences. The branches of the trees are probably also longer, which is why temporal signal becomes more apparent.
I commend the authors on their rigorous simulation study and careful empirical data analyses. However, I strongly suggest they consider whether treating minor alleles as an additional base is biologically realistic and whether this may have implication for other analyses, particularly when there is very high within-host diversity and the number of states in becomes very large.
We thank the reviewer for the helpful and thorough review. We have included a paragraph in the Discussion regarding the biological interpretation of the 16-state model (Line 344-351), as well as the consequences when there’s high within-host diversity (Line 398).
Reviewer #2 (Public Review):
I agree that minor genetic variation could potentially be used to more accurately infer who-infected- whom in an outbreak scenario. Indeed, the use of minor genetic variation has proven very useful in reconstructing transmission chains for chronic infections such as HIV (e.g., see applications using Phyloscanner). To me, it seems that considering the full spectrum of viral genetic diversity within infected hosts would necessarily do the same if not better than considering only consensus-level viral sequence data. This is because there is a necessarily a loss of data and potentially a loss of information when going from considering the genetic composition of viral populations within a host to only considering the consensus sequences of those viral populations. As such, Ortiz et al.'s hypothesis stated on lines 66-70 is a reasonable one, and I was looking forward to seeing this hypothesis evaluated in detail in this manuscript.
R2.1 There are several parts of this manuscript I really like. In particular, encoding within-sample diversity as character states and using that alternative representation of sequence data for phylogenetic inference (as shown in Figure 3) is a very interesting idea, I think. There are some limitations that are not explicitly mentioned, however. For example, when using this 16-character state representation for phylogenetic inference, they assume independence between nucleotide sites. This is a major assumption that can be violated when considering longitudinal intrahost data and transmission dynamics in an outbreak setting, given genetic linkage between sites.
We have generated another set of simulations where the starting tree was a coalescent tree rather than a random phylogeny. This is described in the Results section, Line 228, and Figure 4—figure supplement 2. By using a coalescent tree, we increase the genetic linkage between sites. For all metrics used, the 16-state model performed better than the consensus sequence model. It is also important to note, as the reviewer points out, that longitudinal isolates should be removed from transmission inference, as we do in Figure 7 and Figure 7—figure supplement 2.. This point is now reflected in the Results (Line 286) and Methods (Line 534).
I have several major concerns about the work as it stands, particularly in the context of the SARS-CoV-2 application.
Concerns not related to the SARS-CoV-2 application:
R2.2 Figure 4 shows that a model using within-sample diversity can more accurately reconstruct evolutionary histories than a model that uses only consensus-level genetic data. This is really interesting. The Materials and Methods section (particularly lines 351-354) indicates that the sequence data were generated using certain specified substitution rates. The rates specified seem to be chosen in such a way to facilitate finding an improvement when using within-sample diversity. I don't know whether the relative rates of these 'substitutions' at all mirror "real-life". It would be very useful to have a broader set of analyses here to examine the effect of these 'substitution' rates on the utility of incorporating within-sample diversity into phylogenetic inference. (Also, 1, 100, 200 (line 353) inconsistent with 1, 20, 200 in Supp Table 3)
We have now corrected Supp Table 3 to reflect the rates described in the Methods section.
We defined our model with three rates: rate of minor variant acquisition, rate of minor-major variant switch, and rate of minor variant loss. We chose the rates for the simulations (1, 100, 200) to reflect a low rate of minor variant acquisition (1) and high rates of minor-major variant switch (200) and minor variant loss (100). These rates will result in pure bases (A,C,G and T) 100 times more likely to be present than low frequency variants, as seen in the base frequencies in Supp Table 1 and 3, which would in turn minimize the effect of including minor variations. We chose these rates to reflect the high turnover of minor variation often observed in real data and the frequencies of minor alleles in the SARS-CoV-2 dataset, but we agree with the reviewer that this may not always be the case. We also agree with the reviewer that changing the parameters in the simulations also affects the effect of including low frequency variation in the model. As such, we have now included simulations using different sets of rates (Figure 4—figure supplement ):
1) With a high rate of variant switch and loss compared to acquisition (1, 10, 100), reducing the frequency of minor variation.
2) With a lower rate of switch and loss (1, 10, 10), promoting a stable landscape of low frequency variation.
3) With no low frequency variation (Jukes-cantor model)
R2.3 Figure 5 is very interesting, particularly the results at bottleneck sizes of 1-10. What are the 'substitution' rates that are inferred here from using this simulated dataset? The Material and Methods section also does not mention the within-host viral generation time anywhere, as far as I can see (~line 384 states the mutation rate per base per generation cycle but not the length of the generation cycle anywhere).
Fastsimcoal2 is a coalescent simulator of population histories over several generations, given a population size and a mutation rate. For our purposes, transmissions are simulated as bottlenecks of constant size, and a generation is represented by each time step in the outbreak simulation, which corresponds to 1 day. This is further clarified in the Methods section (Line 475).
Concerns related to the SARS-CoV-2 application:
R2.4 I am very concerned about the testing of this hypothesis on the SARS-CoV-2 data presented. First, 1% is a very low variant calling threshold. Second, analysis of the 17 samples that were resequenced (out of 454) indicated that on average, 39% of iSNVS (intrahost single nucleotide variants) called between duplicate runs were only observed in one of the two runs (line 117). Their analysis in Figure 1 indicates that these discrepant (and seemingly spurious) variants occur at higher levels in high Ct samples (which makes sense; Figure 1b). They therefore decide to limit their analyses to samples with Ct values <= 30. This results in 249 samples. However, if we look at Figure 1b, only ~10% of iSNVs called across duplicate runs with Ct = 30 are shared! That means that 90% of iSNVs in the set appear to be spurious. If we assume that each duplicate run of a sample has approximately the same number of spurious iSNVs, then approximately 82% of iSNVs called in a sample with a Ct of 30 would be spurious. This fraction decreases with samples that have lower Ct values, but even at a Ct of 27, only ~60% of iSNVs called across duplicate runs are shared. All the downstream SARS-CoV-2 analyses based on within-host sample diversity therefore are based on samples where the large majority of considered sample diversity is not real. This leads to me necessarily discounting all of those downstream SARS-CoV-2 results.
We agree with the reviewer that, as the results show, datasets that incorporate within-sample low frequency variation are expected to have considerably more noise than using exclusively consensus sequences, and perhaps this wasn’t properly discussed in the manuscript. We have incorporated some notes about this in the Discussion section (Line 408-413).
The 1% variant frequency threshold was used to generate the analysis of Fig. 1 and Supp. Fig. 1-4. Looking at these results, we decided to establish the Ct cutt-off of 30 as mentioned by the reviewer, as well as a variant frequency threshold of 2% (as shown in the x-axis of Fig. 2). We overlooked this second variant frequency threshold in the manuscript, which has been added. As shown in Supp. Fig 4, this variant frequency threshold will increase the concordance between technical replicates, although some level of noise persists.
R2.5 Lines 153-167: I can't figure out how to square the quantitative results given in this paragraph with what is shown in Figure 2. To me, Figure 2 shows only that Technical Replicates have higher probabilities of sharing a variant than with 'No' relationship. What would also be helpful here so that the reader can get a better feel for the data would be to see the iSNV frequencies plotted over time for the longitudinal replicate samples in the supplement and, for the 'epidemiological' samples to show 'TV plots' in the supplement (as in Fig 3c in McCrone et al. eLife)
Figure 2 shows that technical replicates, longitudinal replicates, epidemiological samples and, in some instances, from the same department have a higher probability of sharing low frequency variants than those with no relationship (also shown in Supp Figure 5). However, also shown in Figure 2 is that the 95% CI is very wide, and therefore in many instances low frequency variants won’t be shared between epidemiological samples or samples from the same department.
We have also added Figure 2—figure supplement showing the low frequency variants plotted over time for longitudinal replicates. Unlike McCrone et al, we don’t have proven transmission between pairs of samples, although we believe our analysis also shows a pattern of shared low frequency variants among potential epidemiological links.
R2.6 Figure 6 and associated text: (a) root-to-tip distance: what units is this distance in? (b) That the authors find a temporal signal in these transmission clusters (where all consensus sequences within a cluster are the same) is interesting but also a bit baffling to me. Given the inference of very small transmission bottlenecks in previous studies (e.g., Martin & Koelle - reanalysis of Popa et al.; Lythgoe et al.; Braun et al.), I don't understand where the temporal signal comes in. Do the samples become more genetically diverse over the outbreak (this seems to be indicated in lines 260-262 but never shown and unlikely given bottleneck sizes)? Additional analyses to help the reader understand WHY within-sample diversity allows for the identification of temporal signal is important. This could involve plotting genetic diversity of the samples by collection date or some other, similar analyses.
a) The units of the y-axis (root-to-tip distance) are measured in substitutions per genome. This is now reflected in the legend of the figure.
b) As shown in Figure 5, even at small bottleneck sizes we are able to pick some of the diversity that evolves during the course of an outbreak. As hinted by the reviewer, the smaller the bottleneck the less diversity we can leverage for phylogenetic inference, and in fact for some epidemiological samples all the diversity will be lost during transmission, which is why many of the within-sample variants are not shared between the epidemiologically related samples. Figure 6 is indeed showing that the genetic distance (measured as number of substitutions per genome) increases per collection date. We have also added a Figure 6—figure supplement showing the increase in low frequency variants within outbreaks as the outbreaks progress in time (explained in Line 261 of the Results section), which explain in part the increasing temporal signal in clusters.
R2.7 Paragraph consisting of lines 229-238 and Figure 7: This analysis stops abruptly. What are the conclusions here? Figure 7a (right) seems inconsistent to me with Figure 7b and 7C results. Also, the main hypothesis put forward in this paper is that within-sample sequence data can better resolve who-infected-whom in an outbreak setting. Figure 7b and 7c however are never compared against analogous panels that use just consensus sequences. (Even though the consensus sequences are the same, according to Figure 7a, the inferences shown in Figures 7b and 7c could use additional data such as collection times, etc. that would provide information even when using exclusively consensus-level data). Also, do the analyses in Figures 7b and 7c use the 16-character state model at all? I think Supp Figure 9 is relevant here but not sure how?)
We have extended this section of the results to make it more coherent and clear (Line 284-293) and in the Discussion (Line 385-395). As added into the Discussion, we agree with the reviewer that even with equal sequences some inferences about transmission can be made with epidemiological data, specially collection dates. However, such data can’t be used to infer the genetic structure of the cluster, which complicates any analysis that can use a phylogenetic as input.
Additional concerns:
R2.8 Some of the stated conclusions, particularly in the Discussion section and in the Abstract, do not seem to be supported by the presented results. For example, line 27: 'within-sample diversity is stable among repeated serial samples from the same host': Figure 2 does not show this conclusively. Line 28: 'within-sample diversity... is transmitted between those cases with known epidemiological links': Figure 2 also does not show this conclusively. Line 29: 'within-sample diversity... improves phylogenetic inference and our understanding of who infected whom': Figure 7b/c results using within-sample diversity is never compared against results that use only consensus, so improvement not demonstrated. Line 272-273: 'samples with shorter distance in the consensus phylogeny were more likely to share low frequency variants'. Line 287: 'We demonstrated that phylogenies... were heavily biased'.
Line 27 and Line 28: We agree with the reviewer that the genomic analysis of SARS-CoV-2 sequences show only partial congruence within technical replicates and epidemiological links. We have appropriately addressed this in the Abstract.
Line 29 and Fig 7: Transmission inference using the consensus sequence in Figure 7b/c couldn’t be performed because the lack of any genetic difference between the consensus sequence meant that all sequences had the same transmission likelihood. This is now better explained in the Discussion section, lines 385-395.
Line 272-273: We have removed this section as we did not perform this analysis, as pointed out by the reviewer.
Line 287: The conclusion expressed in line 287 (now line 340) has been changed.
R2.9 The manuscript at times does not cite previous work that is highly relevant and thus overstates the novelty of the current work. For example: lines 21-23: '..conventional whole-genome sequencing phylogenetic approaches to reconstruct outbreaks exclusively use consensus sequences...' Phyloscanner uses within-sample diversity, for example, as does SCOTTI. These are finally cited in the discussion section (~line 310), but because this previous work is not acknowledged earlier in the manuscript, the novelty of the work presented here is somewhat overstated.
We have included background information in the introduction regarding the use of within-sample diversity for transmission inference (Line 69-73), as well as emphasizing that the novelty of our work lies more in the use of within-sample diversity in phylogenetic inference rather than exclusively transmission inference (Line 74, and other instance along the manuscript).
In sum, I think that the 16 character-state model is a very interesting model. More analyses on simulated data would be helpful to expand on when below-the-consensus level genetic data would truly be informative of phylogenetic relationships and who-infected-whom in outbreak settings. The SARS-CoV-2 analyses are very worrisome to me, given the inclusion of samples where the majority of considered within-sample genetic diversity is very likely not real. Some of the stated conclusions appear to either be at odds with the results presented or not directly evaluated.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #2 (Public Review):
Targeted genetic engineering with programmable nucleases and other targetable enzymes (aka "genome editing") has emerged as a technology with curative potential in hemoglobinopathies, sickle cell disease, and beta-thalassemia. Multiple ongoing clinical trials are evaluating such editing using distinct approaches: elevation of fetal hemoglobin (HbF), direct repair of the mutation causing SCD, and engineering of a Hb variant. The present work explores a different strategy: the targeted engineering of the promoter of a paralog of adult beta-globin known as HBD. This is a timely effort because there has emerged, over the past decade, a clear and charted path for advancing any such approach to human clinical trials. The study identifies three transcription factor binding sites as divergent in the HBD promoter vs the HBB one. A homology-directed repair (HDR)-based scheme using oligonucleotide repair templates in combination with a CRISPR-Cas9-induced double-strand break (DSB) is designed and used to generate pools of human immortalized cells bearing one, two, or all three such de novo introduced TF binding sites at the HBD promoter. Only the latter scheme is shown to measurably increase HBD (following erythroid differentiation) in pools of cells and single-cell-derived clones as gauged by qPCR and HPLC. A similar analysis is performed on pools of erythroid-like cells generated from genome-edited human hematopoietic stem and progenitor cells (HSPCs), as well as genetically clonal erythroid colonies bearing the edits of interest; trends in these data support the observations made on the immortalized cells. Overall the data support the notion that HBD promoter genome editing has the potential as a strategy to normalize hemoglobin synthesis in hemoglobinopathies. Further, the data support an advance of this approach down a well-established path of preclinical development in such cases: increasing the efficiency of genome editing in HSPCs to what would be deemed therapeutically useful, assessing the genotoxic burden from the editing, evaluating the potential negative impact on stemness, and determining whether this approach would normalize hemoglobin synthesis in the erythroid progeny of patient HSPCs.
We thank reviewer 2 for their input on our manuscript, especially sharing their insight from a clinical path perspective.
The genome editing scheme for the "KDT" strategy in Fig 1B involves the introduction of three binding sites for transcription factors at progressively increasing distances from the site of the DSB induced by Cas9. It would be of interest to determine from the next-generation-sequencing data whether partial gene conversion tracks are observed at the edited locus (Elliott and Jasin MCB 18: 93), and if yes, whether these affect in some way the pool-level measurement by qPCR on HBD mRNA levels (Fig 1D).
For the analysis of our NGS reads, we utilized the CRISPResso2 analysis pipeline. After CRISPResso2 aligns the reads and makes allelic calls of either unmodified, NHEJ, or HDR. It is important to note that the KDT of our HBD knock-in construct, is not identical to the HBB promoter. Through simple searching of the CRISPResso aligned-reads, we did not find any HBB promoter sequence present. In this regard, our CRISPResso analysis does not seem to find any gene-conversions between HBB and HBD. However, we cannot rule out the possibility of gene conversions altogether – it can be that since our primers for NGS anneal specifically to HBD, we are unable to amplify, and therefore unable to see, the alleles in which these gene conversion events occurred.
The data in Fig 2A show an analysis of transcription factor and RNA pol II occupancy following genome editing at HBD. The figure legend refers to these data as having been obtained on single-cell-derived clones bearing the edits in homozygous or heterozygous form, but it is unclear from fig 2A, which clones were used for which analysis.
We have now clarified this point in the figure legend.
The data in Fig 3C present an analysis of HBD levels in erythroid colonies derived from genome-edited HSPCs. It would be helpful to clarify whether an individual dot represents a single such colony (this would seem to be the case from the cognate figure legend). If so, what number of such colonies would one need to obtain to gain a clearer sense of the effect on HBD levels from the various genome editing strategies used?
Indeed, each dot represents a singular colony. We have now expanded this dataset from colonies derived from n=2 HSPC donors to n=4 HSPC donors. Figure 3C and Supp Fig 3 have been updated accordingly.
It would be helpful to comment, in the Discussion, on potential genome editing strategies to obtain high-efficiency pool-level uniform long-track gene conversion that is necessary to obtain high HBD levels in the progeny of edited CD34 cells. Would this be a good application of the AAV6 strategy developed by the Sangamo and Porteus groups? Would prime editing as developed by Liu be an option here?
Prime editing can introduce small insertions, but still has limitations of low-editing efficiency (https://doi.org/10.1016/j.tibtech.2023.03.004). Additionally, our KDT construct would require a larger insertion that prime editing would not be able to facilitate easily. In light of the adverse effects using AAV6 for biotech company Graphite Bio, we will not suggest this in the discussion.
It would be equally helpful, in the Discussion, to place the level of HbA2 obtained via the strategy shown in the manuscript in the context of other genome-editing-based approaches for normalizing Hb synthesis in the hemoglobinopathies (ie HbF elevation by editing the BCL11A enhancer, or the gammaglobin promoter; or direct repair of the SCD mutation; or engineering of Hb Makassar).
We have now added a new section in the discussion summarizing some of the recent genome editing approaches for hemoglobinopathies. Specifically, we mention CRISPR Therapeutics’ clinical trial on the BCL11A enhancer, David Liu’s most recent paper on base-editing to correct the SCD mutation, and Annarita Miccio’s recent paper on disrupting a repressor binding site on the gamma-globin promoter.
Reviewer #3 (Public Review):
This is a well-written and referenced paper from the laboratory of an outstanding senior investigator. Dr. Corn and colleagues demonstrate convincingly that correction of three transcription factor binding sites in the delta-globin gene promoter results in high levels of delta-globin expression in HUDEP-2 clonal cell populations (Fig. 2B and C) and in CD34+ HSPC (hematopoietic stem and progenitor cells) clonal cell expansions (Fig. 3C). Although correction of the mutant KLF1 binding site has previously been shown to upregulate delta-globin gene transgenes, this new data demonstrate that correction of multiple factor binding sites is required to achieve high-level expression of the delta-globin gene in the endogenous beta-globin gene locus. The results are important because high delta-globin protein levels inhibit the formation of sickle hemoglobin (HbS) polymers that cause sickle cell disease.
We thank reviewer 3 for their feedback on our manuscript.
Unfortunately, high levels of delta-globin gene expression were not observed after editing of pooled (non-clonal) populations of HUDEP-2 cells (Fig. 1D) or CD34+ HSPC pooled cell populations (Fig. 3B). This result suggests that correction of all 3 promoter elements on individual alleles in CD34+ HSPC populations is far below the level required to be clinically relevant.
We have added to the discussion on ways to improve HDR efficiency. Additionally, we show new data where we utilize an HDR enhancer drug and show that we can increase HDR and overall HBD in edited pooled populations of HSPCs (Fig 3 C and D)
Also, NHEJ is high in CD34+ HSPC (Fig. 3A); therefore, promoter deletions will inactivate many alleles, and total hemoglobin levels in erythrocytes derived from populations of edited CD34+ HSPC will be much less than normal (29 pg/cell). These cells would be extremely beta-thalassemic.
We were not completely sure about the origin of this point, since our edits are aimed at HBD, which makes up less than 5% of total hemoglobins under normal conditions. NHEJ occurring in HBB (e.g. when doing HDR for direct correction) would potentially yield thalassemic cells. But indels in the HBD promoter might at most cause a 5% decrease in total globin levels (if delta expression was completely destroyed). We have performed a new experiment to explicitly address this point. We edited n=4 CD34+ HSPCs donors and compared unedited populations to populations edited with Cas9+HBD gRNA but no repair template. This represents a “worst case” scenario, in which there can be no HDR-based promoter engineering and only NHEJ. These data are included this in Supplementary Figure 3. We observed high editing efficiency of 61 – 78% in the HBD promoter. We performed qRT-PCR of the beta-like globins in edited pools and normalized to HBA, reasoning that HBA is a neutral control for absolute levels of each globin in the beta locus because HBA is located in a different locus. By qRT-PCR, HBD transcripts were decreased by half compared to mock treated cells, while HBB and HBG1/2 were non-significantly affected. But as mentioned above, HBD expression makes up less than 5% of total hemoglobins, and therefore a half reduction in HBD represents a total reduction of 2.5% of globins. We do acknowledge that this experiment does not specifically quantify the rates of large deletions that might span from delta to beta, and further studies would be needed to address this point. But if such large deletions do exist, they do not greatly affect beta expression. We have included this in the results and the discussion section.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
In this interesting manuscript, Nasser et al explore long-term patterns of behavior and individuality in C. elegans following early-life nutritional stress. Using a rigorous, highly quantitative, high-throughput approach, they track patterns of motor behavior in many individual nematodes from L1 to young adulthood. Interestingly, they find that early-life food deprivation leads to decreased activity in young larvae and adults, but that activity between these times, during L2-L4, is largely unaffected. Further, they show that this "buffering" of stress requires dopamine signaling, as L2-L4 activity is significantly reduced by early-life starvation in cat-2 mutants. The paper also provides evidence that serotonin signaling has a role in modulating sensitivity to stress in L1 larvae and adults, but the size of these effects is modest. To evaluate patterns of individuality, the authors use principal components analysis to find that three temporal patterns of activity account for much of the variation in the data. While the paper refers to these as "individuality types," it may be more reasonable to think of these as "dimensions of individuality." Further, they provide evidence that stress may alter the strength and/or features of these dimensions. Though the circuit mechanisms underlying individuality and stress-induced changes in behavior remain unknown, this paper lays an important foundation for evaluating these questions. As the authors note, the behaviors studied here represent only a small fraction of the behavioral repertoire of this system. As such, the findings here are an interesting and very promising entry point for a deeper understanding of behavioral individuality, particularly because of the cellular/synaptic-level analysis that is possible in this system. This paper should be of interest to those studying C. elegans behavior and also more generally to those interested in behavioral plasticity and individuality.
We thank the reviewer for finding our results interesting.
Reviewer #2 (Public Review):
This paper set out to understand the impact of early life stress on the behavior and individuality of animals, and how that impact might be amplified or masked by neuromodulation. To do so, the authors built on a previously established assay (Stern et al 2017) to measure the roaming fraction and speed of individuals. This technique allowed the authors to assess the effects of early life starvation on behavior across the entire developmental trajectory of the individual. By combining this with strains with mutant neuromodulatory systems, this enabled the authors to produce a rich dataset ripe for analysis to analyze the complicated interactions between behavior, starvation intensity, developmental time, individuality, and neuromodulatory systems.
The richness of this dataset - 2 behavioral measures continuous across 5 developmental stages, 3 different neuromodulatory conditions (with the dopamine system subject to decomposition by receptor types) and 4 different levels of starvation, with ~50-500 individuals in each condition-underlies the strength of this paper. This dataset enabled the authors to convincingly demonstrate that starvation triggers a behavioral effect in L1 and adult animals that is largely masked in intermediate stages, and that this effect becomes larger with increased severity of starvation. Furthermore, they convincingly show that the masking of the effect of starvation in L2-L4 animals depends on dopaminergic systems. The richness of the dataset also allowed a careful analysis of individuality, though only neuromodulatory mutants convincingly manipulated individuality, recapitulating earlier research. Nonetheless, a few caveats exist on some of their findings and conclusions:
We thank the reviewer for the constructive comments. In the revised manuscript we include additional analyses and textual changes as detailed below, to address the points raised.
1) Lack of quantitative analysis for effects within developmental stages. In making the argument for buffered effects of starvation on behavior during periods of larval development, the authors make claims regarding the temporal structure of behavior within specific stages. However, no formal analysis is performed and and the traces are provided without confidence intervals, making it difficult to judge the significance of potential deviations between starvation conditions.
In the revised manuscript, we include additional analyses of roaming fraction effects across shorter developmental-windows, showing within-stage differences in behavioral patterns following starvation (Figure 1 - figure supplement 1E; Figure 3 - figure supplement 1C). In addition, we further temper and rewrite our conclusions to clearly describe these effects (now- “…while 1 day of early starvation modified within-stage temporal behavioral structures by shifting roaming activity peaks to later time-windows during the L2 and L3 stages…” in p. 4 and “Interestingly, during the L2 intermediate stage the effects on roaming activity patterns were more pronounced during earlier time-windows of the stage…” in p. 8).
2) Incorrect inferences from differences in significance demonstrating significant differences. The authors claim that there is an increase in PC1 inter-individual variation in tph-1 individuals, however the difference in significance is not evidence of a significant difference between conditions (see Nieuwenhuis et al. 2011). This undermines claims about an interaction of starvation, neuromodulators, and individuality.
In the revised manuscript we provide now a direct comparison of PCs inter-individual variances between starved and unstarved populations, demonstrating significant differences in inter-individual variation in specific PC individuality dimensions following stress (Figure 6 and Figure 6 - figure supplement 1). These results include the increase in PC1 inter-individual variation in tph-1 mutants following 3 and 4 days of starvation (Figure 6A,E).
3) Sensitivity of analysis to baseline effects and assumptions of additive/proportional effects. The neuromodulatory and stress conditions in this paper have a mixture of effects on baseline activity and differences from baseline. The authors normalize to the roaming fraction without starvation, making the reasonable assumption that the effect due to starvation is proportional to baseline, rather than an additive effect. This confound is most visible in the adult subpanel of figure 5d, where an ~2-3 fold difference in relative roaming due to starvation is clearly noted, however, this is from a baseline roaming fraction in tph-1 animals that are ~2 fold higher, suggesting that the effect could plausibly be comparable in absolute terms.
Unavoidably, any such assumptions on the expected interaction between multiple effects will be a gross simplification in complicated nonlinear systems, and the data are largely shown with sufficient clarity to allow the reader to make their own conclusions. However, some of the interpretations in the paper lean heavily on an assumption that the data support a direct interpretation (e.g. "neuronal mechanisms actively buffer behavioral alterations at specific development times") rather than an indirect interpretation (e.g. that serotonin reduces baseline roaming fraction which makes a fixed sized effect more noticeable). Parsing the differences requires either more detailed mechanistic study or careful characterization of the effect of different baselines on the sensitivity of behavior to perturbation-barring that it's worth noting that many of these interactions may be due to differences in biological and experimental sensitivity to change under different conditions, rather than a direct interaction of stress and neuromodulatory processes or evidence of differing neuromodulatory activity at different stages of development.
In the revised manuscript we added a discussion of the potential complicated interactions between neuromodulation and stress, altering baseline levels and deviations from baseline. We also discuss the interpretation of the results in the context of non-linear systems in which sensitivity of the behavioral response to underlying variations may be modified by specific neuromodulatory and environmental perturbations, without assuming direct differences in neuromodulatory states over development or across individuals (p. 16).
Reviewer #3 (Public Review):
In this study, Nasser et al. aim to understand how early-life experience affects 1) developmental behavior trajectory and 2) individuality. They use early life starvation and longitudinal recording of C. elegans locomotion across development as a model to address these questions. They focus on one specific behavioral response (roaming vs. dwelling) and demonstrate that early life (right after embryo hatching) starvation reduces roaming in the first larval (L1) and adult stages. However, roaming/dwelling behavior during mid-larval stages (L2 through L4) is buffered from early life starvation. Using dopamine and serotonin biosynthesis null mutant animals, they demonstrated that dopamine is important for the buffering/protection of behavioral responses to starvation in mid-larval stages, while in contrast, serotonin contributes to early-life starvation's effects on reduced roaming in the L1 and adult stages. While the technique and analysis approaches used are mostly solid and support many of the conclusions made in the manuscript for part 1), there are some technical limitations (e.g., whether the method has sufficient resolution to analyze the behaviors of younger animals) and confounding factors (e.g., size of the animal) that the authors do not yet sufficient address, and can affect interpretation of the results. Additionally, much of the study is descriptive and lacks deep mechanistic insight. Furthermore, the focus on a single behavioral parameter (dwelling vs. roaming) limits the broad applicability of the study's conclusions. Lastly, the manuscript does not provide clear presentation or analysis to address part 2), the question of how early life experience affect individuality.
We thank the reviewer for these important comments. As described below, in the revised manuscript we include new analyses (following extraction of size data), showing behavioral modifications across different conditions/genotypes also in size-matched individuals (within the same size range) (Figure 1 - figure supplement 1F; Figure 3 - figure supplement 1D,E; Figure 5 - figure supplement 1B,D). We also made edits to the text to describe these results (Methods p. 21 and Results section). In addition, while we can detect behavioral changes using our imaging method even in young L1 worms across conditions and genotypes (described in Stern et al. 2017 and this manuscript), as the reviewer correctly pointed out, we may miss some milder behavioral effects due to lower spatial imaging resolution in younger worms. We are now referring to this spatial resolution limitation in the revised manuscript (discussion part). Lastly, in the revised manuscript we added clearer and more direct analyses of changes in inter-individual variation in multiple PC dimensions following early stress, by directly comparing variation between starved and unstarved individuals within the mutant and wild-type populations (Figure 6; Figure 6 - figure supplement 1). These analyses show significant changes in inter-individual variation within specific PC individuality dimensions following early stress. Also, we made textual changes along the manuscript to increase the clarity of presentation of these results.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #2 (Public Review):
Using an approach that combines synthetic genetic array (SGA) analysis with high-throughput microscopic analysis of the GFP-tagged yeast ORF collection in the budding yeast, Saccharomyces cerevisiae, this study has examined the contribution of the critical checkpoint kinases Mec1 and Rad53 to the subcellular relocalization of 322 candidate proteins in response to HU- and MMS-induced replication stress. Previous studies have established that Mec1 is required for Rad53 activation during replication stress and that Mec1 also serves checkpoint functions independent of Rad53. Unexpectedly, this study identifies groups of proteins whose stress-induced relocalization is dependent on Rad53 but not Mec1. This data indicates that Rad53 mediates some replication stress responses in a non-canonical manner that is independent of Mec1.
The authors confirm their initial observations from the screening approach by focusing on the Rad53-dependent and Mec1-independent focus formation of GFP-Rad54. Moreover, using mass-spec analysis the authors demonstrate that some Rad53 phosphorylation sites known to be critical for Rad53 activation, including a consensus Mec1 phosphorylation site, are phosphorylated after replication stress even in the absence of Mec1. Motivated by this finding the authors screen for potential kinase and phosphatase pathways that may regulate Rad53 function during MMS-induced replication stress. Top hits identified include members of the retrograde signaling pathway, which is confirmed by conventional genetic assays while mass spec analysis supports the involvement of Rtg3 in mediating Rad53 phosphorylation during replication stress in the absence of Mec1.
Overall this is a solid study reporting unexpected new findings that significantly advance our view of the global replication checkpoint response. The data are generally of high quality, well presented and quantified, and overall support the authors' claims. The mass spec approach used here to identify Rad53 phosphorylation sites offers an unbiased alternative to the simpler and more widely employed gel-shift method to monitor Rad53 activation. The hits identified in the various screens presented here provide a platform for potential follow-up studies by the community. The main drawback is that it remains unclear how Rtg3 promotes Rad53 activation. However, this could be considered to be beyond the scope of this study.
We thank the reviewer for their positive assessment of our experimental data. We have made the changes requested by the reviewer to increase the clarity of Figure 5, and performed a second replicate to show that the FACS data are reproducible.
Reviewer #3 (Public Review):
The work by Ho et al describes the identification of Mec1/Tel1 independent activation of Rad53 after MMS treatment, which could lead to changes of GFP fusion signals for several dozens of proteins and this was partly dependent on Rtg3. Starting from an unbiased, targeted screen, the authors identified proteins whose GFP fusion signals changed intensity in rad53∆ but not in mec1∆ cells using live cell imaging, including Rad54. Using Rad54 as a readout for the subsequent experiments, a second screen amongst kinases/phosphatases and their regulators found that rtg2-3 mutants reduced Rad54-GFP intensity. Mass spectrometry data identified Rad53 phosphorylate sites in mec1∆ tel1∆ cells, consistent with the cell biological data described above. Overall, the work was well done and supported the main conclusions. The concept of Mec1/Tel1-independent and Rtg3-dependent Rad53 activation connects checkpoint signaling with the retrograde pathway.
We thank the reviewer for their positive assessment of our experimental work and appreciate the suggestions that ultimately led to interesting new data. As outlined below, we attempted to perform most of the experiments suggested by the reviewer. Unfortunately, experiments with a MEC1-AID degron allele were inconclusive, with details summarized below. However, we have identified additional proteins whose re-localization is affected by Rtg3, providing stronger support for its role in the replication stress response. We revised the manuscript to add these new details.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer 1 (Public Review):
In this paper, Reato, Steinfeld et al. investigate a question that has long puzzled neuroscientists: what features of ongoing brain activity predict trial-to-trial variability in responding to the same sensory stimuli? They record spiking activity in the auditory cortex of head-fixed mice as the animals performed a tone frequency discrimination task. They then measure both overall activity and the synchronization between neurons, and link this ’baseline state’ (after removing slow drifts) of cortex to decision accuracy. They find that cortical state fluctuations only affect subsequent evoked responses and choice behavior after errors. This indicates that it’s important to take into account the behavioral context when examining the effects of neural state on behavior.
Strengths of this work are the clear and beautiful presentation of the figures, and the careful consideration of the temporal properties of behavioral and neural signals. Indeed, slowly drifting signals are tricky as many authors have recently addressed (e.g. Ashwood, Gupta, Harris). The authors are well aware of the difficulties in correlating different signals with temporal and cross-correlation (such as in their ’epoch hypothesis’). To disentangle such slow trends from more short-lived state fluctuations, they remove the impact of the past 10 trials and continue their analyses with so-called ’innovations’ (a term that is unusual, and may more simply be replaced with ’residuals’).
The terms ‘innovations’ and ‘residuals’ are sometimes used interchangeably. We used innovations because that’s how they were introduced in the signal processing literature (i.e., Kailath, T (1968). ”An innovations approach to least-squares estimation–Part I: Linear filtering in additive white noise.” IEEE transactions on automatic control). We try to be explicit in the text about the formal definition of this quantity, to avoid problems with terminology.
I do wonder if this throws out the baby with the bathwater. If the concern is statistical confound, the ’session permutation’ method (Harris) may be better suited. If the concern is that short-term state fluctuations are more behaviorally relevant (and obscured by slow drifts), then why are the results with raw signals in the supplement (Suppfig 8) so similar?
The concern was statistical confound, although this concern is ameliorated when using a mixed model approach and focusing on fixed effects. However, our approach allowed us to assess the relative importance of slow versus single-trial timescales in the predictive relationship between cortical state (and arousal) and behavior, revealing that, in the conditions of our experiment, only the fast timescales are relevant. Because of this, we think that the baby wasn’t thrown out with the bathwater as, qualitatively, no new phenomenology was revealed when the slow components of the signals were included. In hindsight, it is true that the results we obtained suggest that maybe the effort we made to isolate the fast component of the signals was unjustified. However, this can only be known after both options have been tried, as we did. Moreover, we started using innovations based on the results in Figure 2 where, as we show, the use of innovations does make a difference, even at the level of fixed effects in a mixed model. We agree that we could have used the ‘session permutation’ method, but given the depth at which we have explored this issue in the manuscript already, and the clarity of the results, we think that adding a third method would only make reading the manuscript more difficult without adding any substantially new content.
While the authors are correct that go-nogo tasks have drawbacks in dissociating sensitivity from response bias, they only cursorily review the literature on 2AFC tasks and cortical state. In particular, it would be good to discuss how the specific method - spikes, EEG (Waschke), widefield (Jacobs) and algorithm for quantifying synchronization may affect outcomes. How do these population-based measures of cortical state relate to those described extensively with slightly different signals, notably LFP or EEG in humans (e.g. work by Saskia Haegens, Niko Busch, reviewed in https://doi.org/10.1016/j.tics.2020.05.004)? This review also points out the importance of moving beyond simple measures of accuracy and using SDT, which would be an interesting improvement for this paper too.
We thank the reviewer for pointing us towards the oscillation-based brain-state literature in humans. We have expanded the paragraph in the discussion where we compare our results with previous work in order to (i) elaborate on the literature on 2AFC tasks, (ii) specifically address the literature linking alpha power in the pre-stimulus baseline and psychophysical performance, and (iii) mention different methods for assessing desynchronization. Our view is that absence of lowfrequency power is a robust measure which can be assessed using different types of signals (spikes, imaging, LFP, EEG). That said, the relationship between desynchronization and behavior appears subtle and variable, specially within discrimination paradigms. These issues are discussed in the paragraph starting in line 527 in the text.
Regarding the use of SDT, we had already established that our main finding could be expressed as a significant interaction between FR/Synch and the stimulus-strength regressor, when predicting choice after errors (Supplementary Fig. 4A in original manuscript), which is equivalent to a cortical state-dependent increase in d′ after the mice made a mistake. In order to consider a possible effect of cortical state on the ‘criterion’ (i.e., an effect on the bias of the mice towards either response spout), we re-run this GLMM but adding the cortical state regressors as main effects. The results show that the FR-Synch predictor is only significantly greater than zero as an interaction after errors (p = 0.0025). As a main effect, it’s not significantly different from zero neither after errors (p = 0.28), nor after correct trials (p = 0.97). We have included this analysis as Figure 3-figure supplement 1B (replacing the previous Supplementary Fig. 4A) and commented on them in the text (lines 222-225).
Reviewer 2 (Public Review):
The relationship between measures of brain state, behavioral state, and performance has long been speculated to be relatively simple - with arousal and engagement reflecting EEG desynchronization and improved performance associated with increases in engagement and attention. The present study demonstrates that the outcome of the previous trial, specifically a miss, allows these associations to be seen - while a correct response appears less likely to do so. This is an interesting advance in our understanding of the relationship between brain state, behavioral state, and performance.
This is probably just a typo, but we would like to clarify that the relevant outcome in the previous trial is not a miss, but an incorrect choice in an otherwise valid trial (i.e., a trial with a response within the allowed response window).
While the study is well done, the results are likely to be specific to their trial structure and states exhibited by the mice. To examine the full range of arousal states, it needs to be demonstrated that animals are varying between near-sleep (e.g. drowsiness) and high-alertness such as in rapid running. The fact that the trials occurred rapidly means that the physiological and neural variables associated with each trial will overlap with upcoming trials - it takes a mouse more than a few seconds to relax from a previous miss or hit, for example. Spreading the rapidity of the trials out would allow for a broader range of states to be examined, and perhaps less cross-talk between adjacent trials. The interpretation of the results, therefore, must be taken in light of the trial structure and the states exhibited by the mice.
We thank the reviewer for the positive assessment of our work and also for raising this point in particular. This motivated us to look more carefully at this issue, with results that, we believe, strengthen our study.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
In this work, Roche et al. study a 13-year long time series of microbiome samples from wild baboons from Kenya. The data used in this work challenge a previous finding from the same authors that temporal dynamics in microbiome changes are largely individualized. Using a multinomial logistic-normal modeling approach, the authors detect that co-variance in temporal dynamics in microbial pair-wise associations among individuals occurs more frequently between relatives. Furthermore, the authors identify that microbial phylogenetic proximity is associated with consistent co-abundance changes over time and that their metric of universal microbial relationships is robust across hosts and is detected even in human longitudinal data. The authors conduct a thorough statistical revision of publicly available results, highlighting this time (e.g. compared to Björk et al, doi: 10.1038/s41559-022-01773-4) the consistently shared microbial properties between individuals, rather that the individual microbial signatures highlighted in their previous work.
Thank you for this summary. We would like to briefly clarify that we do not see the current work as inconsistent with our prior finding in Björk et al. that microbiome taxonomic compositions are idiosyncratic and asynchronized. However, this new analysis, which focuses on abundance correlations between pairs of taxa, indicates that the personalized compositions and dynamics we observed in Björk et al. are probably not attributable to personalized microbiome ecologies. In other words, Björk et al. showed that microbial taxa found in the guts of different baboons can be quite distinct (and remain so over time, giving rise to semi-stable individual signatures). The current study shows that, despite this taxonomic individuality, the correlations between pairs of microbes in the baboon gut are often quite consistent. To give a basic example, hot weather and ice cream, when observed, are often observed together (positively correlated), but while some places have a lot of both, some have little of either. This idea is discussed in more detail below (see response R6) and in the revised Discussion section (lines 572 to 586).
Strengths:
This work is foundational in its compelling effort to generate a rigorous method to evaluate coabundance dynamics in longitudinal microbiome data. The approach taken will likely inspire developments that will sharpen the capacity to extract co-varying microbial features, taking into account seasonality, diet, age, relatedness, and more. To the best of my understanding, their hierarchical model integrated into the Gaussian process to analyze microbial dynamics is reasonably robust and they clearly explain the implementation. Furthermore, this work introduces and defines the concept of a universality score for microbial taxon pairs. Overall, the work presented is clear and convincing and provides tools for the community to benefit from both methods and results. Furthermore, conceptually, this work stresses the value of consistent and shared microbial dynamics in groups, which enriches our understanding of host-associated microbial ecology, otherwise understood to be largely dependent on external fluctuations.
Weakness:
It is not entirely clear the extent to which the presented results revise, refute, or support the previously published analysis performed by the authors on the same dataset (doi: 10.1038/s41559-022-01773-4), which was more focused on individuality.
We agree the relationship between Björk et al. and the current manuscript was unclear in our original submission. We now elucidate the relationship between these papers in the Discussion (lines 572 to 586). Briefly, Björk et al. found that microbiome taxonomic compositions are idiosyncratic and asynchronized. The current analysis finds that pairwise bacterial abundance correlations are predominantly shared and not highly personalized. We think the most likely explanation is that, as mentioned by Reviewer 2 below, the current analyses do not account for the role that environmental gradients play in the gut. If these environments differ asynchronously across hosts, it could lead to shared abundance correlations, but individualized microbiome compositions and individualized single-taxon dynamics. We discuss this possibility and other potential explanations in the revised Discussion (lines 572 to 586).
Reviewer #2 (Public Review):
The authors of this paper identify a knowledge gap in our understanding of the generalizability of ecological associations of gut bacteria across hosts. Theoretically, it is possible that ecological associations between bacteria are consistent within a host organism but differ between hosts, or that they are universal across hosts and their environmental gradients. The authors utilize longitudinal data with a unique temporal resolution, on Amboseli baboons, 56 individuals who were sampled for gut microbiome hundreds of times over a decade. This data allows disentangling ecological dynamics within and across individuals in a way that as far as I know has never been done before. The authors show that ecological relationships among baboon gut bacteria, measure through a correlation based on covariation, are largely universal (similar within and across host individuals) and that the most universally covarying taxa are almost always positively associated with each other. They also compare these results with two sets of human data, finding similar patterns in one human data set but not in the other.
The main aim of this paper is to establish whether gut microbial ecologies are universal across hosts, and this the authors generally show to be true in a thorough and convincing way. However, some re-assessment or re-assurance on the solidity of their chosen method of estimating co-variation would be needed to fully assess the robustness of subsequent results. Specifically, the authors measure the correlation between microbial taxa from data on their abundance co-variation across samples. While necessary steps have been taken to validate the estimates across spurious correlations due to the compositional nature and autocorrelation structures present in the data, I worry that the sparsity of the data might influence the estimation of positive and negative correlations in a slightly different manner. There exist more microbial taxa than samples in the data and some taxa are present in as few as 20% of the samples, meaning that the covariation data will have a large amount of 0-0 pairs. I worry that the abundance of 0-0 pairs in the data might inflate the measures of positive co-variation, making taxa seem highly positively correlated in abundance when they in fact are missing from many samples. Of course, mutual absence is also a form of biologically meaningful covariation but taking the larger number of taxa than samples and the inability of sequencing technology to detect all low-abundance taxa in a sample, I am currently not convinced that all of the 0-0 pairs are modeled as a realistic and balanced way as a continuum of the other non-zero co-variation between taxa in the data. This may become problematic when positive and negative relationships are compared: The authors state that even though most associations between taxa were negative, the most universally correlated taxa pairs (taxa pairs with strongest correlations in abundance both within and between hosts) were enriched in positive associations. It may be possible that this is influenced by the fact that zero inflation in the data lends more weight to positive links than negative links. Whether these universal positive correlations are driven by positive non-zero abundance covariation or just 0-0 links in the data is currently unclear.
Thank you for pointing out this weakness in our original analyses. As described in response R1 above, your hunch was correct: zero inflation biased our correlation patterns such that taxa pairs with a high frequency of joint zero observations (i.e., where both members of the pair had very low or zero abundances) tended to be positively correlated (Fig. R1). Consequently, as you suggested, zero inflation in the data lent more weight to positive links than negative links in our data set. To address this problem in the revised manuscript, we now restrict our analyses to taxon pairs whose joint zero-abundance observations were less than 5% of all samples across hosts (pairs to the left of the dashed vertical line in Fig. R1 above). We also restricted our analyses to taxa observed in at least 50% of all samples. The first of these criteria was the most restrictive. As described above, our new filtering procedure retained 1,878 of the original 7,750 ASV-ASV pairs; 57 of the original 66 phylum-phylum pairs; and 473 of the original 666 class/order/family-level pairs.
Another additional result that would benefit from a more clear context is the result that taxa correlation patterns were more similar between phylogenetically close taxa and between genetically close host individuals. The former notion is to be expected if taxa abundances are driven by environmental (or host physiology-related) selective forces that favor bacteria with similar phenotypes. This yields more support to the idea that covariation is environmentally driven rather than driven by the ecological network of the bacteria themselves, and this could be more clearly emphasized. The latter notion of covariation being more similar in genetically related hosts is currently impossible to disentangle from the notion that covariation patterns were more similar with individuals harboring a more similar baseline microbiome composition since microbiome composition and genetic relatedness were apparently correlated. To understand if something about relatedness was actually influential over correlation pattern similarity, one would need to model that effect on top of the baseline similarity effect. Currently, it is not clear if this was done or not.
We agree that shared responses to environmental gradients within hosts—especially immune profiles and pH—could explain both of these findings. These ideas are now described in the Discussion in lines 559 to 562.
We also now report partial Mantel tests to control for baseline similarity in microbiome composition when testing for shared microbial correlation patterns among genetic relatives. Controlling for baseline similarity had little effect on the results, and we now report the statistics for this partial Mantel (Fig. 5B; Table S7; r2=0.009; partial Mantel p-value=0.002). See lines 391-392.
The authors also slightly overemphasize the generalizability of their results to humans, taking that only one of the human data sets they compare their results to, shows similar patterns. While they mention that the other human data set (that was not similar in patterns to theirs) was different in some key aspects (sampling frequency was much higher), the other human data set was also dissimilar to the other two (it only contained infants, not adults). Furthermore, to back up the statement that higher sampling frequency would be the reason this data set had dissimilar covariation between taxa, one would need to show that the temporal variation in this data set was different from the baboon one and show that these covariation patterns were sensitive to timescale by subsampling either data to create mock data sets with different sampling frequency and see how this would change the inference of ecological associations.
We have revised the text to tone down the generalizability of our results to humans. For instance, the abstract (line 58) now states that “universality in baboons was similar to that in human infants, and stronger than one data set from human adults” but does not state that our results are generalizable to humans.
We also considered sub-sampling the data set from Johnson et al., from daily to monthly scales, but unfortunately that data set is only 17 days long, so doing so is impossible. This is now stated in the Discussion in line 619, which states, “However, without the ability to subsample Johnson et al. [7] to monthly scales (this data set is only 17 days long), it is impossible to test this prediction.”
To the extent that the results are robust, particularly regarding to the main result of the universality of gut microbial ecological associations, the impact of this paper is not small. This question has never been so thoroughly and convincingly addressed, and the results as they stand have the power to strongly influence the expectations of gut microbial ecology across many different systems. Moreover, as the authors point out, evidence for universal gut microbial ecology is important for the future development of probiotics. An important point here, underemphasized by the authors, is that universal gut microbe ecologies will allow specific interventions that use gut microbe ecology to manipulate emergent community properties of microbiomes to be more beneficial for the host, rather than just designing compositional cocktails that should fit all. In addition to the main finding of this study, the unique data set and the methods developed as part of this study (e.g. the universality score, the enrichment measures, the model of log-ratio dynamics, the assessment of covariation from time-ordered abundance trajectories) will doubtlessly be translatable to many other studies in the future.
Thank you for these suggestions. We now mention these implications in the introduction (line 82-84) and in the discussion in lines 537-539 and line 630.
Reviewer #3 (Public Review):
This is a well-executed study, offering thorough analysis and insightful interpretations. It is wellwritten, and I find the conclusions interesting, important, and well-supported.
Thank you for your supportive comments.
References
- Silverman JD, Roche K, Holmes ZC, David LA, Mukherjee S. Bayesian Multinomial Logistic Normal Models through Marginally Latent Matrix-T Processes. Journal of Machine Learning Research. 2022;23:1-42.
- Quinn TP, Richarrson MF, Lovell D, Crowley TM. propr: An R-package for Identifying Proportionally Abundant Features Using Compositional Data Analysis Scientific Reports. 2017;7:16252.
- Cao Y, Lin W, Li H. Large covariance estimation for compositional data via compositionadjusted thresholding. . J Am Stat Assoc. 2019:759-72.
- Friedman J, Alm EJ. Inferring correlation networks from genomic survey data. PLoS Comput Biol. 2012;8(9):e1002687. doi: 10.1371/journal.pcbi.1002687. PubMed PMID: 23028285; PubMed Central PMCID: PMCPMC3447976.
- Risely A, Schmid DW, Muller-Klein N, Wilhelm K, Clutton-Brock TH, Manser MB, et al. Gut microbiota individuality is contingent on temporal scale and age in wild meerkats. Proc Biol Sci. 2022;289(1981):20220609. Epub 20220817. doi: 10.1098/rspb.2022.0609. PubMed PMID: 35975437; PubMed Central PMCID: PMCPMC9382201.
- Wilmanski T, Diener C, Rappaport N, Patwardhan S, Wiedrick J, Lapidus J, et al. Gut microbiome pattern reflects healthy ageing and predicts survival in humans. Nat Metab. 2021;3(2):274-86. Epub 20210218. doi: 10.1038/s42255-021-00348-0. PubMed PMID: 33619379; PubMed Central PMCID: PMCPMC8169080.
- Johnson AJ, Vangay P, Al-Ghalith GA, Hillmann BM, Ward TL, Shields-Cutler RR, et al. Daily Sampling Reveals Personalized Diet-Microbiome Associations in Humans. Cell Host & Microbe. 2019;25(6):789-802. Epub 2019/06/14. doi: 10.1016/j.chom.2019.05.005. PubMed PMID: 31194939.
- Franzosa EA, Huang K, Meadow JF, Gevers D, Lemon KP, Bohannan BJM, et al. Identifying personal microbiomes using metagenomic codes. Proceedings of the National Academy of Sciences. 2015;112(22):E2930-E8. doi: 10.1073/pnas.1423854112. PubMed PMID: WOS:000355832200014.
- Faith JJ, Guruge JL, Charbonneau M, Subramanian S, Seedorf H, Goodman AL, et al. The long-term stability of the human gut microbiota. Science. 2013;341(6141):1237439. Epub 2013/07/06. doi: 10.1126/science.1237439. PubMed PMID: 23828941; PubMed Central PMCID: PMC3791589.
- Bik EM, Costello EK, Switzer AD, Callahan BJ, Holmes SP, Wells RS, et al. Marine mammals harbor unique microbiotas shaped by and yet distinct from the sea. Nat Commun. 2016;7:10516. Epub 20160203. doi: 10.1038/ncomms10516. PubMed PMID: 26839246; PubMed Central PMCID: PMCPMC4742810.
- Caporaso JG, Lauber CL, Costello EK, Berg-Lyons D, Gonzalez A, Stombaugh J, et al. Moving pictures of the human microbiome. Genome Biology. 2011;12(5):R50. doi: Artn R50 Doi 10.1186/Gb-2011-12-5-R50. PubMed PMID: ISI:000295732700014.
- Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial community variation in human body habitats across space and time. Science. 2009;326(5960):1694-7. doi: Doi 10.1126/Science.1177486. PubMed PMID: ISI:000272839000053.
- Dolinsek J, Goldschmidt F, Johnson DR. Synthetic microbial ecology and the dynamic interplay between microbial genotypes. Fems Microbiology Reviews. 2016;40(6):961-79. doi: 10.1093/femsre/fuw024. PubMed PMID: WOS:000387995000010.
- Louca S, Polz MF, Mazel F, Albright MBN, Huber JA, O'Connor MI, et al. Function and functional redundancy in microbial systems. Nat Ecol Evol. 2018;2(6):936-43. Epub 2018/04/18. doi: 10.1038/s41559-018-0519-1. PubMed PMID: 29662222.
- Rainey PB, Quistad SD. Toward a dynamical understanding of microbial communities. Philos Trans R Soc Lond B Biol Sci. 2020;375(1798):20190248. Epub 2020/03/24. doi: 10.1098/rstb.2019.0248. PubMed PMID: 32200735; PubMed Central PMCID: PMCPMC7133524. 16. Martiny JB, Jones SE, Lennon JT, Martiny AC. Microbiomes in light of traits: A phylogenetic perspective. Science. 2015;350(6261):aac9323. doi: 10.1126/science.aac9323. PubMed PMID: 26542581.
- Debray R, Herbert RA, Jaffe AL, Crits-Christoph A, Power ME, Koskella B. Priority effects in microbiome assembly. Nat Rev Microbiol. 2022;20(2):109-21. Epub 20210827. doi: 10.1038/s41579-021-00604-w. PubMed PMID: 34453137.
- Gloor GB, Reid G. Compositional analysis: a valid approach to analyze microbiome highthroughput sequencing data. Can J Microbiol. 2016;62(8):692-703. Epub 2016/06/18. doi: 10.1139/cjm-2015-0821. PubMed PMID: 27314511.
- Joseph TA, Pasarkar AP, Pe'er I. Efficient and Accurate Inference of Mixed Microbial Population Trajectories from Longitudinal Count Data. Cell Syst. 2020;10(6):463-9 e6. Epub 20200624. doi: 10.1016/j.cels.2020.05.006. PubMed PMID: 32684275.
- Aijo T, Muller CL, Bonneau R. Temporal probabilistic modeling of bacterial compositions derived from 16S rRNA sequencing. Bioinformatics. 2018;34(3):372-80. doi: 10.1093/bioinformatics/btx549. PubMed PMID: 28968799; PubMed Central PMCID: PMCPMC5860357.
- Coyte KZ, Rao C, Rakoff-Nahoum S, Foster KR. Ecological rules for the assembly of microbiome communities. PLoS Biol. 2021;19(2):e3001116. Epub 20210219. doi: 10.1371/journal.pbio.3001116. PubMed PMID: 33606675; PubMed Central PMCID: PMCPMC7946185.
- Coyte KZ, Schluter J, Foster KR. The ecology of the microbiome: Networks, competition, and stability. Science. 2015;350(6261):663-6. doi: 10.1126/science.aad2602. PubMed PMID:
- Palmer JD, Foster KR. Bacterial species rarely work together. Science. 2022;376(6593):581-2. Epub 20220505. doi: 10.1126/science.abn5093. PubMed PMID:
- Reese AT, Pereira FC, Schintlmeister A, Berry D, Wagner M, Hale LP, et al. Microbial nitrogen limitation in the mammalian large intestine. Nat Microbiol. 2018. Epub 2018/10/31. doi: 10.1038/s41564-018-0267-7. PubMed PMID: 30374168.
- Firrman J, Liu L, Mahalak K, Tanes C, Bittinger K, Tu V, et al. The impact of environmental pH on the gut microbiota community structure and short chain fatty acid production. FEMS Microbiol Ecol. 2022;98(5). doi: 10.1093/femsec/fiac038. PubMed PMID: 35383853.
- de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022;71(5):1020-32. Epub 20220201. doi: 10.1136/gutjnl-2021-326789. PubMed PMID: 35105664; PubMed Central PMCID: PMCPMC8995832.
- Tamames J, Sanchez PD, Nikel PI, Pedros-Alio C. Quantifying the Relative Importance of Phylogeny and Environmental Preferences As Drivers of Gene Content in Prokaryotic Microorganisms. Front Microbiol. 2016;7:433. Epub 20160331. doi: 10.3389/fmicb.2016.00433. PubMed PMID: 27065987; PubMed Central PMCID: PMCPMC4814473.
- Gloor GB, Macklaim JM, Pawlowsky-Glahn V, Egozcue JJ. Microbiome datasets are compositional: and this is not optional. Front Microbiol. 2017;8:2224. Epub 2017/12/01. doi: 10.3389/fmicb.2017.02224. PubMed PMID: 29187837; PubMed Central PMCID: PMCPMC5695134.
- Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turnbaugh PJ, et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proceedings of the National Academy of Sciences. 2011;108:4516-22. doi: Doi 10.1073/Pnas.1000080107. PubMed PMID: ISI:000288451300002.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
This study explores the mechanisms responsible for reduced steroidogenesis of adrenocortical cells in a mouse model of systemic inflammation induced by LPS administration. Working from RNA and protein profiling data sets in adrenocortical tissue from LPS-treated mice they report that LPS perturbs the TCA cycle at the level of succinate dehydrogenase B (SDHB) impairing oxidative phosphorylation. Additional studies indicate these events are coupled to increased IL-1β levels which inhibit SDHB expression through DNA methyltransferase-dependent DNA methylation of the SDHB promoter.
In general, these are interesting studies with some novel implications. I do, however, have concerns with some of the author's rather broad conclusions given the limitations of their experimental approach. The paper could be improved by addressing the following points:
1) The limitations of using LPS as the model for systemic inflammation need to be explicitly described.
We thank the Reviewer for this suggestion. Indeed, the LPS model has several limitations as a preclinical model of sepsis, which are outlined in the revised Discussion. Despite its limitations, we chose this model over other models of sepsis, such as the cecal slurry model, due to its high reproducibility, which enabled the here presented mechanistic studies.
2) The initial in vivo findings, which support the proposed metabolic perturbation, are based on descriptive profiling data obtained at one time point following a single dose of LPS. The author's conclusion that the ultimate transcriptional pathway identified hinges critically on knowledge of the time course of this effect following LPS, which is not adequately addressed in the paper. How was this time and dose of LPS established and are there data from different dose and time points?
We thank the Reviewer for raising this question, which we indeed addressed at the beginning of our studies in order to determine a suitable time point and dose of LPS treatment. We chose 6 h as a suitable starting time point to perform transcriptional analyses, based on the fact that LPS triggers transcriptional changes in the adrenal gland and other tissues within the range of few hours (1-3). Confirming our expectations we found 2,609 differentially expressed genes (Figure 1a) in the adrenal cortex of LPS-treated mice among which many were involved in cellular metabolism (Figure 1d,e, 2a-e, Table 1, Table 2). Acute transcriptional changes, which are more likely to reflect direct effects of inflammatory signals compared to changes occurring at later time points (for instance in the range of days), would allow us to mechanistically investigate the effects of inflammation in the adrenal gland, which was the purpose of our studies. Hence, we were guided by the transcriptional changes observed at 6 h of LPS treatment and established the hypothesis that disruption of the TCA cycle in adrenocortical cells is key in the impact of inflammation on adrenal function. Along this line, we analyzed the metabolomic profile of the adrenal gland at 6 and 24 h of LPS treatment. At 6 h succinate levels as well as the succinate / fumarate ratio remained unchanged (Author response image 1A), while at 24 h post-injection these were increased by LPS (Author response image 1B, Figure 2l,o,q). The time delay of the increase in succinate levels (observed at 24 h) following downregulation of Sdhb mRNA expression (at 6 h) can be explained by the time required for reduction of SDHB protein levels, which is dependent on the protein turnover suggested to be approximately 12 h in HeLa cells (4). Based on these findings, all further metabolomic analyses were performed at 24 h of LPS treatment.
Author response image 1. LPS increases the succinate/fumarate ratio at 24 but not 6h. Mice were i.p. injected with 1 mg/kg LPS and 6 h (A) and 24 h (B) post-injection succinate and fumarate levels were determined by LC-MS/MS in the adrenal gland. n=8-10; data are presented as mean ± s.e.m. Statistical analysis was done with two-tailed Mann-Whitney test. *p < 0.05.
Having established the most suitable time points of LPS treatments to observe induced transcriptional and metabolic changes, we set out to define the LPS dose to be used in subsequent experiments. The data shown in Author response image 1, were acquired after treatment with 1 mg/kg LPS. This is a dose that was previously reported to cause transcriptional re-profiling of the adrenal gland (1, 2). However, 5 mg/kg LPS, similarly to 1 mg/kg LPS, also reduced Sdhb, Idh1 and Idh2 expression at 4 h (Author response image 2A) and increased succinate and isocitrate levels at 24 h (Author response image 2B) in the adrenal gland. Given that the effects of 1 and 5 mg/kg LPS were similar, for animal welfare reasons we continued our studies with the lower dose.
Author response image 2. Five mg/kg LPS downregulate Sdhb, Idh1 and Idh2 expression and increase succinate and isocitrate levels in the adrenal gland of mice. Sdhb, Idh1 and Idh2 expression (A) and succinate and isocitrate levels (B) were assessed in the adrenal gland of mice treated with 5 mg/kg LPS for 4 h (A) and 24 h (B). n=5; data are presented as mean ± s.d. Statistical analysis was done with two-tailed Mann-Whitney test. p < 0.05, *p < 0.01.
3) Related to the point above, the authors data supporting a break in the TCA cycle would be strengthened direct biochemical assessment (metabolic flux analysis) of step kin the TCA cycle process impacted.
We entirely agree with the Reviewer and considered performing TCA cycle metabolic flux analyses in adrenocortical cells. Unfortunately, the low yield of adrenocortical cells per mouse (approx. 3,000- 6,000) does not allow the performance of metabolic flux experiments, which require higher cell numbers per sample, several time points per condition and an adequate number of replicates per experiment. Moreover, NCI-H295R cells being adrenocortical carcinoma cells are expected to have substantially altered metabolic fluxes compared to normal cells. Since we wouldn’t have the capacity to confirm findings from metabolic flux experiments in NCI-H295R cells in primary adrenocortical cells, as we did for the rest of the experiments, we decided to not perform metabolic flux experiments in NCI-H295R cells. However, performing metabolic flux analyses in adrenocortical cells under inflammatory or other stress conditions remains an important future task that we will pursue upon establishment of a more suitable cell culture system.
4) The proposed connection of DNMT and IL1 signaling to systemic inflammation and reduced steroidogenesis could be more firmly established by additional studies in adrenal cortical cells lacking these genes.
We thank the Reviewer for this excellent suggestion. In the revised manuscript we strengthened the evidence for an IL-1β –DNMT1 link and show that DNMT1 deficiency blocks the effects of IL-1β on SDHB promoter methylation (Figure 6k), the succinate / fumarate ratio (Figure 6m), the oxygen consumption rate (Figure 6n) and steroidogenesis (Figure 6o-q) in adrenocortical cells. In order to validate the role of IL-1β in vivo, mice were simultaneously treated with LPS and Raleukin, an IL-1R antagonist. Treatment with Raleukin increased the SDH activity (Figure 6r), reduced succinate levels and the succinate / fumarate ratio (Figure 6s,t) and increased corticosterone production in LPS-treated mice (Figure 6u).
Reviewer #2 (Public Review):
The present manuscript provides a mechanistic explanation for an event in adrenal endocrinology: the resistance which develops during excessive inflammation relative to acute inflammation. The authors identify disturbances in adrenal mitochondria function that differentiate excessive inflammation. During severe inflammation the TCA in the adrenal is disrupted at the level of succinate production producing an accumulation of succinate in the adrenal cortex. The authors also provide a mechanistic explanation for the accumulation of succinate, they demonstrate that IL1b decreases expression of SDH the enzyme that degrades succinate through a methylation event in the SDH promoter. This work presents a solid explanation for an important phenomenon. Below are a few questions that should be resolved experimentally.
1) The authors should confirm through direct biochemical assays of enzymatic activity that steroidogenesis enzyme activity is not impaired. Many of these enzymes are located in the mitochondria and their activity may be diminished due to the disturbed, high succinate environment of the cortical cell as opposed to the low ATP production.
We thank the Reviewer for this question. The activity of the first and rate-limiting steroidogenic enzyme, cytochrome P450-side-chain-cleavage (SCC, CYP11A1) which generates pregnenolone from cholesterol, was recently shown to require intact SDH function (5). In agreement with this report we show that production of progesterone, the direct derivative of pregnenolone, is impaired upon SDH inhibition (Figure 5b,e,h). In addition, we assessed the activity of CYP11B1 (steroid 11β-hydroxylase), the enzyme catalyzing the conversion of 11-deoxycorticosterone to corticosterone, i.e. the last step of glucocorticoid synthesis, by determining the corticosterone and 11-deoxycorticosterone levels by LC-MS/MS and calculating the ratio of corticosterone to 11-deoxycorticosterone in ACTH-stimulated adrenocortical cells and explants. The corticosterone / 11-deoxycorticosterone ratio was not affected by Sdhb silencing in adrenocortical cells (Figure 5- Supplement 2g) nor did it change upon LPS treatment in adrenal explants (Figure 5- Supplement 2h), suggesting that CYP11B1 activity may not be altered upon SDH blockage. Hence, we propose that upon inflammation impairment of SDH function may disrupt at least the first steps of steroidogenesis (producing pregnenolone/progesterone), thereby diminishing production of all downstream adrenocortical steroids. This is now discussed in the revised manuscript.
2) What is the effect of high ROS production? Is steroidogenesis resolved if ROS is pharmacologically decreased even if the reduction of ATP is not resolved?
We thank the Reviewer for this suggestion, which helped us to broaden our findings. Indeed, ROS scavenging by the vitamin E analog Trolox (Figure 5n) partially reversed the inhibitory effect of DMM on steroidogenesis (Figure 5o,p), suggesting that impairment of SDH function impacts steroidogenesis also via enhanced ROS production (Figure 4g).
3) Does increased intracellular succinate (through cell permeable succinate treatment) inhibit steroidogenesis even if there is not a blockage of OXPHOS?
We suggest that SDH inhibition and succinate accumulation lead to reduced steroidogenesis due to impaired oxidative phosphorylation (Figure 4c,e, 5i), reduced ATP synthesis (Figure 4d, 5j-m) and increased ROS production (Figure 4g, 5o,p). Since SDH is part (complex II) of the electron chain transfer it cannot be decoupled from oxidative phosphorylation, thereby limiting the experimental means for addressing this question.
4) It should be demonstrated the genetic loss of IL1 signaling in adrenal cortical cells results in a loss of the effect of LPS on reduced steroidogenesis and increased succinate accumulation.
We thank the Reviewer for this suggestion. Development of a mouse line with genetic loss of Il-1r in adrenocortical cells was rather impossible during the short time of revisions. Instead, mice under LPS treatment were treated with the IL-1R antagonist, Raleukin, to study the in vivo effects of IL-1β in the adrenal gland. IL-1R antagonism increased SDH activity in the adrenal cortex (Figure 6r), decreased succinate levels and the succinate/fumarate ratio in the adrenal gland (Figure 6s,t) and enhanced corticosterone production (Figure 6u) in LPS-treated mice, supporting our hypothesis that IL-1β mediates the effects of systemic inflammation in the adrenal cortex.
5) It should be demonstrated the genetic loss of IL1 signaling in adrenal cortical cells results in a loss of the effect of LPS on SDH activity and ATP production and SDH promoter methylation
As outlined above, Raleukin treatment increased SDH activity in the adrenal cortex (Figure 6r) and decreased succinate levels and the succinate/fumarate ratio in the adrenal gland (Figure 6s,t) of mice treated with LPS. Furthermore, IL-1β reduced the ATP/ADP ratio (Figure 6e) and enhanced SDHB promoter methylation in NCI-H295R cells (Figure 6k).
6) It should be shown that the silencing of DNMT eliminates or diminishes the effect of LPS on reduced steroidogenesis and increased succinate accumulation.
We thank the Reviewer for this suggestion, which prompted us to strengthen the evidence for the implication of DNMT1 in the effects of LPS on adrenocortical cell metabolism and function. As mentioned above, development of a new mouse line, in this case bearing genetic loss of DNMT1 in adrenocortical cells, was considered impossible during the short time of revisions. Therefore, we assessed the role of DNMT1 by silencing it via siRNA transfections in primary adrenocortical cells and NCI-H295R cells. We show that DNMT1 silencing inhibits the effect of IL-1β on SDHB promoter methylation (Figure 6k), restores Sdhb expression (Figure 6l) and reduces the succinate/fumarate ratio in IL-1β treated adrenocortical cells (Figure 6m). Accordingly, DNMT1 silencing restores ACTH-induced production of corticosterone, 11-deoxycorticosterone and progesterone in IL-1β treated adrenocortical cells (Figure 6o-q). We chose to stimulate adrenocortical cells with IL-1β instead of LPS, as in vitro the effects of IL-1β were more robust than these of LPS (possibly due to a reduction of TLR4 expression or function in cultured adrenocortical cells) and in order to show the link between IL-1β and DNMT1.
7) Does silencing of DNMT reduce OXPHOS in adrenal cortical cells?
We measured the oxygen consumption rate in NCI-H295R cells, which were transfected with siRNA against DNMT1 and treated or not with IL-1β. IL-1β reduced the OCR in cells transfected with control siRNA, while DNMT1 silencing blunted the effect of IL-1β (Figure 6n).
8) The effects of LPS on reduced adrenal steroidogenesis are not elaborated at the physiological level. The manuscript should demonstrate the ramifications of the adrenal function decreasing after LPS. Does CORT release become less pronounced after subsequent challenges? Does baseline CORT decrease at some point? No physiological consequences are shown. Similarly, these physiological consequences of decreased adrenal function should be dependent on decreased SDH activity and OXPHOS in adrenal cells and this should be demonstrated experimentally.
We thank the Reviewer for raising this excellent question. Inflammation is a potent inducer of the Hypothalamus-Pituitary-Adrenal gland (HPA) axis, causing increased glucocorticoid production, a stress response leading to vital immune and metabolic adaptations. Accordingly, LPS treatment rapidly increases glucocorticoid production in mice (1, 6, 7). Reduced adrenal gland responsiveness to ACTH associates with decreased survival of septic mice (8). These preclinical findings stand in accordance with observations in septic patients, in which impairment of adrenal function correlates with high risk for death (9). Along this line, ACTH test was suggested to have prognostic value for identification of septic patients with high mortality risk (9, 10).
In order to confirm impairment of the adrenal gland function in septic mice, animals were subjected to sepsis via administration of a high LPS dose (10 mg / kg) and treated with ACTH 24 h later. Indeed, the ACTH-induced increase in corticosterone levels was diminished in LPS-treated mice (Author response image 3). This finding was further confirmed in adrenal explants, in which LPS pre-treatment also blunted ACTH-stimulated corticosterone production (Figure 5s).
Author response image 3. High LPS dose blunts the ACTH response in mice. C57BL/6J mice were i.p. injected with 10 mg/kg LPS or PBS and 24 h later they were i.p. injected with 1 mg/kg ACTH. One hour after ACTH administration blood was retroorbitally collected and corticosterone plasma levels were determined by LC-MS/MS. n=4-5; data are presented as mean ± s.d. Statistical analysis was done with two-tailed Mann-Whitney test. *p < 0.05.
Given that purpose of our studies was to dissect the mechanisms underlying adrenal gland dysfunction in inflammation rather than analyzing the physiological consequences thereof, we chose not to follow these lines of investigations and concentrate on the role of cell metabolism in adrenocortical cells in the context of inflammation.
References
- W. Kanczkowski, A. Chatzigeorgiou, M. Samus, N. Tran, K. Zacharowski, T. Chavakis, S. R. Bornstein, Characterization of the LPS-induced inflammation of the adrenal gland in mice. Mol Cell Endocrinol 371, 228-235 (2013).
- L. S. Chen, S. P. Singh, M. Schuster, T. Grinenko, S. R. Bornstein, W. Kanczkowski, RNA-seq analysis of LPS-induced transcriptional changes and its possible implications for the adrenal gland dysregulation during sepsis. J Steroid Biochem Mol Biol 191, 105360 (2019).
- V. I. Alexaki, G. Fodelianaki, A. Neuwirth, C. Mund, A. Kourgiantaki, E. Ieronimaki, K. Lyroni, M. Troullinaki, C. Fujii, W. Kanczkowski, A. Ziogas, M. Peitzsch, S. Grossklaus, B. Sonnichsen, A. Gravanis, S. R. Bornstein, I. Charalampopoulos, C. Tsatsanis, T. Chavakis, DHEA inhibits acute microglia-mediated inflammation through activation of the TrkA-Akt1/2-CREB-Jmjd3 pathway. Mol Psychiatry 23, 1410-1420 (2018).
- C. Yang, J. C. Matro, K. M. Huntoon, D. Y. Ye, T. T. Huynh, S. M. Fliedner, J. Breza, Z. Zhuang, K. Pacak, Missense mutations in the human SDHB gene increase protein degradation without altering intrinsic enzymatic function. FASEB J 26, 4506-4516 (2012).
- H. S. Bose, B. Marshall, D. K. Debnath, E. W. Perry, R. M. Whittal, Electron Transport Chain Complex II Regulates Steroid Metabolism. iScience 23, 101295 (2020).
- W. Kanczkowski, V. I. Alexaki, N. Tran, S. Grossklaus, K. Zacharowski, A. Martinez, P. Popovics, N. L. Block, T. Chavakis, A. V. Schally, S. R. Bornstein, Hypothalamo-pituitary and immune-dependent adrenal regulation during systemic inflammation. Proc Natl Acad Sci U S A 110, 14801-14806 (2013).
- W. Kanczkowski, A. Chatzigeorgiou, S. Grossklaus, D. Sprott, S. R. Bornstein, T. Chavakis, Role of the endothelial-derived endogenous anti-inflammatory factor Del-1 in inflammation-mediated adrenal gland dysfunction. Endocrinology 154, 1181-1189 (2013).
- C. Jennewein, N. Tran, W. Kanczkowski, L. Heerdegen, A. Kantharajah, S. Drose, S. Bornstein, B. Scheller, K. Zacharowski, Mortality of Septic Mice Strongly Correlates With Adrenal Gland Inflammation. Crit Care Med 44, e190-199 (2016).
- D. Annane, V. Sebille, G. Troche, J. C. Raphael, P. Gajdos, E. Bellissant, A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 283, 1038-1045 (2000).
- E. Boonen, S. R. Bornstein, G. Van den Berghe, New insights into the controversy of adrenal function during critical illness. Lancet Diabetes Endocrinol 3, 805-815 (2015).
- C. C. Huang, Y. Kang, The transient cortical zone in the adrenal gland: the mystery of the adrenal X-zone. J Endocrinol 241, R51-R63 (2019).
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
This study was designed to examine the bypass of Ras/Erk signaling defects that enable limited regeneration in a mouse model of hepatic regeneration. The authors show that this hepatocyte proliferation is marked by expression of CD133 by groups of cells. The CD133 appears to be located on intracellular vesicles associated with microtubules. These vesicles are loaded with mRNA. The authors conclude that the CD133 vesicles mediate an intercellular signaling pathway that supports cell proliferation. These are new observations that have broad significance to the fields of regeneration and cancer.
The primary observation is that the limited regeneration observed in livers with Ras/Erk signaling defects is associated with CD133 expression by groups of cells. The functional significance of CD133 was tested using Prom1 KO mice - the data presented are convincing.
The major weakness of the study is that some molecular mechanistic details are unclear - this is, in part, due to the extensive new biology that is described. Nevertheless, the data used to support some key points in this study are unclear:
We fully agree that some details of the molecular mechanisms are yet to be elucidated for the CD133+ vesicles (intercellsomes, as we named). This is the first report of a new direct cell-cell communication mechanism provoked in stress response to proliferative signal deficit.
Despite a huge body of literature, many questions remain open for the molecular mechanisms of exosomes/EVs.
a) What is the evidence that the observed CD133 groups of cells are not due to clonal growth. Is this conclusion based on the time course (the groups appear more rapidly than proliferation) or is this based on the GFP clonal analysis?
This is indeed a very critical point for this study. Our initial thought and efforts were indeed on finding evidence that supports clonal expansion of progenitor cells. However, the experiments showed that the CD133+ cells were negative for all other stem/progenitor cell markers and that they are mature hepatocytes. CD133 expression was upregulated dramatically in regenerating livers and disappeared upon completion of liver regeneration. Furthermore, suppression of Ras-Erk signaling by Shp2 and Mek inhibitors robustly induced CD133 expression in a variety of cancer cell lines in culture in vitro.
At 2 days after PHx, we already observed big colonies, which were unlikely derived from a single initiating cell (Figure 1). The GFP clonal analysis unambiguously demonstrated the heterogenous origin of the clustered cells (Figure 3). We detected mixed GFP-positive and -negative cells within each colony, without a single colony consisting entirely of GFP-positive cells. The original colony sizes were estimated to be 10 cells or more (Figures 3G and Figure 3–figure supplement 1B). Thus, both the sizes and compositions in the GFP clonal analyses support the assertion that CD133+ cell clusters originated from multiple mature hepatocytes.
b) What is the evidence that the CD133 vesicles mediate intercellular communication. This is an exciting hypothesis, but what is the evidence that this happens? Is this inferred from IEG mRNA diversity? or some other data. Is there direct evidence of transfer - for example, the does the GFP clonal analysis show transfer of GFP that is not mediated by clonal proliferation? Moreover, since the hepatocytes are isogenic, what distinguishes the donor and recipient cells?
Increased clarity concerning what is hypothesis and what is directly supported by data - would improve the presentation of this study.
Per the reviewer’s advice, we have clarified these points in the revised version. Our proposal that CD133 vesicles mediate intercellular communication was supported by these experimental results.
A). Data in Fig. 5 suggest direct trafficking of the vesicles, as CD133 existed on the filaments that bridge the tightly contacting cells. This was confirmed by two different CD133 antibodies in mouse and human. We are now conducting correlative light and electron microscopy to characterize these bridges and the exchange event at the cell-cell border. Of note, CD133+ vesicles are negative for CD9, CD63 or CD81, markers for exosomes/EVs. We could only isolate CD133+ vesicles from cell lysates in vitro and mouse tissue lysates, but not from cell supernatants from which exosomes/EVs are isolated.
B). More direct evidence of the transfer was presented in Fig. 6H, showing Myc-tagged CD133 molecules transferred from one cell to another. We are engineering a knock-in system to track the endogenous CD133.
C). Further experimental evidence was provided in the single and double gene KO experiments in Fig. 8E-G, suggesting the functional significance of CD133 in intercellular communication.
D). In addition to the data above, the IEG mRNA diversity analyses based on scRNA-seq support the mRNA exchange model. The isogenic CD133+ SKO hepatocytes were found to lack different IEG transcripts randomly. This is why we propose a mutually sharing model, rather than a donor and recipient model. Importantly, the mRNA diversity (entropy) model also illustrates the association of CD133 and “stemness", as described in the discussion.
In sum, we believe that a most reasonable interpretation of the current data set is a model of direct cell-cell communication via CD133+ vesicles. We take the reviewer’s point and have made changes to the text to better distinguish conclusion and hypothesis, which will be validated in future studies.
Reviewer #2 (Public Review):
The manuscript by Kaneko set out to understand the mechanisms underlying cell proliferation in hepatocytes lacking Shp2 signals. To do this, the authors focused on CD133 as the proliferating clusters of cells in the Shp2 knockout (SKO) livers are CD133 expressing. After excluding the contribution of progenitors that are CD133 to this cell population, the authors focused on the intrinsic regulation of CD133 by Met/Shp2 regulated Ras/Erk parthway and showed upregulation of CD133 to be a compensatory signal to overcome loss of Ras/Erk signal and suggested Wnt10a in the regulation of CD133 signal. The study then focused on the observed filament localization of CD133 in the CD133+ cluster of cells. The study went on to identify the CD133+ vesicles that contain primarily mRNA vs. microRNA like other EVs. Specifically, the authors identified several mRNA species that encode IEGs, indicating a potential role for these CD133+ vesicles in cell proliferation signal transmission to neighboring cells via delivery of the IEG mRNAs as cargos. Finally, they showed that the induction of CD133 (and by derivative, the CD133+ vesicles) are necessary for maintaining cell proliferation in the cell cluster with high proliferation capacities in the SKO livers; and in intestinal crypt organoids treated with Met inhibitors to block Ras/ERk signal.
1) The identification of CD133+ vesicles is largely based on staining and costainings. Though the experiments are very well done with many controls and approaches, the authors may want to perform one or two key experiments with EM to definitively demonstrate the colocalization. For example, the mCherry experiment in Fig6H and the colocalization experiments for CD133 and HuR in Fig 7.
Many thanks for the suggestion. We are now establishing a correlative light and electron microscopy system, as the classic immunogold staining method was not sufficient for this purpose. Further characterization of CD133+ vesicles is now a major focus of research in our lab, to establish, substantiate or modify the model and hypothesis presented in this article. The long-term goal is to elucidate how cells strive to proliferate under insufficient proliferative signal, which is likely relevant to drug resistance and tumor relapse.
2) Since CD133+ marks the 50nM intracellsome defined by the authors, it is unclear what the CD133- vesicles used as controls are. Are they regular EVs that are larger in size? This needs better clarification as they are used as a control for many experiments such as Fig 7A.
Per the advice, we added more explanation to the revised text. We used regular EVs as the control, since they are the well-studied intercellular communication vesicles. Since the EVs are highly heterogenous, we did not choose to select a specific subpopulation of EVs. We used the well-established polymer-based precipitation method to isolate the EV fraction from cell culture supernatant for RNA-seq analysis. We did detect the enrichment of micro-RNAs in the isolated EVs, consistent with reports in the literature. Strikingly, the CD133 vesicles isolated from cell lysates showed a completely distinct RNA profile, relative to the EVs.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
The authors present a strong set of experiments to uncover what type of role non-mutant stromal cells might be playing in the development of VM and AST, two vascular lesions that share some similarities.
Questions about experimental design.
1) For quantification of gene expression in VM and AST specimens in Figure 2, the methods say qPCR data were normalized to housekeeping genes, but it would be helpful to normalize to endothelial content. It might be that increased TGFa is due to increased endothelium.
We thank the Reviewer for this excellent suggestion. We have now added this new data as suggested with normalization of TGFA mRNA to the endothelial marker PECAM-1/CD31 mRNA. A trend towards an increased expression of TGFA mRNA was detected in VM/AST specimens in comparison to the control group. We also show in the manuscript that besides CD31-positive vascular structures, TGFA is expressed in intervascular areas, i.e. between the vessels, in the patients’ lesions (Fig.2) and in lesion-derived CD31negative intervascular stromal cells. These data altogether demonstrate that i) TGFA is expressed also in other cell types than endothelial cells and ii) indicates that the increased expression of TGFA in lesion samples is not only due to increased vasculature/endothelium in the patient samples.
The new RT-qPCR data has now been added to the manuscript as a new Fig. 2 - figure supplement 1.
2) The mutant allelic frequency for the HUVEC-PIK3CA WT versus HUVEC-PIK3CA H1047R should be provided. This is critically needed for the interpretation of the results.
Thank you for this valuable comment. To confirm that PIK3CA H1047R is still present in transduced HUVECs at the end-point of the mouse xenograft experiment, we performed a new ddPCR analysis detecting fractional abundance of PIK3CA p.H1047R from the matrigel plug-in samples. In this new data, mean fractional abundance of PIK3CA p.H1047R in fibroblast containing PIK3CA H1047R EC plugs was shown to be 27.1 % (variation 26.5-27.8 %; n=2 mice in duplicates). This corresponds to ~54 % of PIK3CA p.H1047R mutation positive cells in the plug, assuming a single copy of the mutation in each cell. As a control group, no positivity was detected in samples with fibroblast and in PIK3CAwt EC, as all the cells express the wildtype form of the PIK3CA gene. Please see Author Response Image 1 representative 2D amplification plots of the mutation analysis. Fractional abundances of PIK3CA mutations in the patient tissue samples and patient-derived CD31+ cells can also be seen in Table 1 and were in a range of 5-12 % (whole tissue) and 44-51 % (EC fraction).
3) From Figure 5, it appears that the human primary fibroblasts are not required for the mutant ECs to form perfused vessels (panel H).
We thank the Reviewer for the comment and agree that based on our H&E staining and erythrocyte analysis, perfused vessels are evident in PIK3CA mutant plugs containing ECs with fibroblasts but also in plugs containing ECs alone. This was expected as PIK3CA mutation in ECs alone has shown to be a driver of venous malformation. However, prior to our study the role of fibroblasts in PIK3CA-driven lesions had not been studied. To better understand the role of fibroblasts in lesion formation, we have now added new data to the manuscript containing example images of the PIK3CA H1047R plugs with or without fibroblasts, and added a new quantitation of their erythrocyte amount. Please see Author Response Image 2. Our data demonstrates that there are significantly: i) more CD31-positive vascular structures (Fig. 5E-G), ii) larger lumens (Fig. 5D-F) and iii) more erythrocyte-containing regions, indicative for perfused vessels (new Fig. 5H) in lesions with fibroblasts in comparison to plugs containing ECs alone. This implies that fibroblasts further induce PIK3CA-driven EC lesion formation.
Author Response Image 2. Vascular structures formed with PIK3CA H1047R ECs alone and PIK3CA H1047R ECs + FBs in mouse xenograft plugs. In the figure panel, H&E staining on each individual plug in these groups is presented. Equal size close-up images were taken from the middle of each plug covering > 50% of plug area (scale bar 250µm). More erythrocytes (red) are seen in the plugs with fibroblasts in comparison to ECs alone. Scanned images of the H&E stained whole tissue sections can be seen in the Fig. 5 – source file.
A new quantitative analysis of erythrocyte positive area in relation to whole plug area using SproutAngio quantification tool was additionally performed (). Analysis was done on a blinded manner and showed significantly increased erythrocyte amount in the plugs containing PIK3CA H1047R ECs and fibroblasts (in comparison to EC alone). Describtion of the analysis has now been added in the manuscript (p. 42, rows 839-843) Figures 5G and 5H in the manuscript were updated to show statistics and automated intensitybased quantification of the erythrocyte positive area/ plug instead of erythrocyte scoring (scale 0-3).
Is it possible that TGFa from the ECs is sufficient to drive vascular malformation?
Mutations in genes such as PIK3CA, TEK and KRAS have been shown to drive formation of vascular anomalies. Thus it is unlikely that a single growth factor, such as increased expression of TGFA, would drive this process alone. That being said, our data shows that TGFA is able to regulate proliferation of PIK3CA mutated ECs via secondary mechanism (Fig. 4F), and we show that inhibition of EGFR pathway is able to reduce PIK3CA-driven lesion growth in mice (Fig. 7). As our bulk RNA-sequencing data from patient-derived cells, showed expression of also other growth factors in lesion ECs (Table 3), it is likely that multiple angiogenic growth factors are involved in lesion formation similarly as in tumors and their expression is primarily driven by mutated cells and secondary by cell-cell crosstalk with other lesion cell types. Thus, targeting of multiple signalling pathways could be a beneficial treatment strategy in the future.
Reviewer #2 (Public Review):
In this manuscript, Ilmonen H. et al explored potential crosstalk between endothelial cells and fibroblasts in a context of sporadic vascular malformation (venous malformation and angiomatoses of soft tissue). With a high level of evidence, they found that mutated endothelial cells secrete TGFA that will activate surrounding fibroblasts, leading in turn to VEGFA secretion that will stimulate endothelial cell sprouting and vascular malformation development. Experiments are well-designed and support their hypothesis. Some controls are missing, particularly in Fig. 2. Indeed, it is mandatory to provide data from healthy skin biopsies (that are available in many laboratories): TGFa, CD31, P-EGFR staining.
We thank the Reviewer for the comments. Although it is common that VM presents in skin, in this work we solely focused on intramuscular and subcutaneous AST and VM patient samples and excluded the samples containing skin from this study. We did TGFA immunostainings from healthy skeletal muscle that can be seen Figure 2 – figure supplement 2B. CD31 staining of vessels in healthy skeletal muscle near the resection margin can be seen in Figure 1B. Please see below also tissue locations of all VM and AST samples in this study:
• Intramuscular, 42.1 % of lesions (n=16)
• Intramuscular and subcutaneous, 21.1 % of lesions (n=8)
• Intramuscular, subcutaneous and synovial membrane, 5.3 % of lesions (n=2)
• Intramuscular and synovial membrane, 2.6 % of lesions (n=1)
• Subcutaneous and synovial membrane, 2.6 % of lesions (n=1)
• Subcutaneous only, 26.3 % of lesions (n=10)
• Skin, none of the lesions
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
This paper raises an interesting question about learning signals. The most intriguing property of this system is the one-to-one convergence, plasticity, and apparently linear input/output function of the SFL-to-SAM relay. These properties suggest that, unlike structures like the insect mushroom body or mammalian cerebellum, in which the intermediate layer is thought to increase the dimensionality of the representation, the SAMs should be thought of more like the weights of a linear readout of the SFL inputs by the LNs.
What learning signal guarantees appropriate weight changes? In a few places (the section on "associativity" and the section on AFs), it is suggested that SAMs can themselves, through coordinated local activity, cause LTP, which the authors call "self LTP-induction." But what is the purpose of such plasticity? It doesn't seem like it would permit, for example, LTP which associates a pattern of SFL activity with the appropriate LNs for the correct vs. the incorrect action. Presumably, appropriately routed information from the NMs and AFs sends the appropriate learning signals to the right places. Does the pattern of innervation of NMs and AFs reveal how these signals are distributed across association modules? Does this lead to a prediction for the logic of the organization of the association modules?
We extended the discussion section to clarify some of these points. One paragraph describes our idea of “self-LTP induction” (L712-744). In addition, we address the potential role of the neuromodulatory fibers (NMs) and ascending fibers (AFs) in a paragraph titled "Perspective on the involvement of the ascending fibers (AF) and the neuromodulatory fibers (NM) in the supervision of learning" (L786). Answering how these signals manifest across different association modules requires a larger reconstruction.
One challenge for a reader who is not an expert on the VL is that the manuscript in its present form lacks discussion about the impact (or hypothesized impact) of the VL on behavior. There is a reference to a role for LNs suppressing attack behavior, but a more comprehensive picture of what the readout layer of this system is likely controlling would be helpful.
To contextualize how the VL circuitry can allow for the coincident detection of visual stimuli and environmental cues (punishing or rewarding) to control the stereotypic attack behavior of the octopus, we added two discussion sections: "Perspective on the VL involvement in octopus associative learning" (L774) and "Perspective on the involvement of ascending fibers (AF) and neuromodulatory fibers (NM) in the supervision of learning" (L786).
The authors do a thorough job of characterizing the "fan-out" architecture from SFL axons to SAMs and CAMs. A few key numbers remain to characterize the "fan-in" architecture of LNs. There appears to be a 400:1 convergence from AMs to LNs. Is it possible to estimate the approximate number of presynaptic inputs per LN? The text around Figure 7 states a median of 162 sites per 100μm dendrite length. One could combine this with an estimate of the total dendritic length for one of these cells from previously available data to estimate the number of inputs per LN. This would help determine the degree of overlap of different association modules in Figure 11, which would be interesting from a computational perspective.
Due to the limitations associated with a small EM volume, our study focused on the fanout of the VL network. We agree that a better understanding of the fan-in part of the VL network is crucial. To the best of our knowledge, previous data have not provided estimates on the dendritic length of the LNs, due to low-resolution images or lack of 3D imaging (Hochner/Shomrat/Young experiment). We intentionally avoided making a largely inaccurate estimate of the fan-in part of the network based on our data. We believe that future research can aim to combine neuron labeling with EM, or other super-resolution techniques, to allow for detailed assessment of the large neuron arborization.
Reviewer #2 (Public Review):
Octopuses are known for their abilities in solving complex tasks and numerous apparently complex cognitive behaviours such as astonishment at octopuses learning how to open jars by watching others and the mind-boggling camouflage. They are very clever molluscs. The octopus shows the famously advanced brain plan but it is one that has little research progress due to its large size and structural complexity. This was originally recognised by the work of BB Boycott, JZ Young, EG Gray, and others in mid last century. Since then, however, little progress has been achieved towards a modernday description of the octopus neural network particularly in the higher-order brain lobe, despite intense interest and indeed research progress concerning their complex behavioural and cognitive abilities.
This study applied a combination of EM-based imaging, neural tracing, and analyses to start revealing a further detailed view of a part of the lateral gyrus of the vertical lobe (learning and memory centre) of the common European octopus. It is a long overdue contribution and starts to bring octopus neuroscience a step close to the details of some vertebrates achieved. The new findings of neurons and the associated network provide new insights into this very complex but unfamiliar brain, allowing to propose a functional network that may link to the octopus memory formation. Also, this work could be of potential interest to a broad audience of neuroscientists and marine biologists as well as those in bio-imaging and deep-learning fields.
Strengths:
Current knowledge of the neuroanatomy and the associating network of the octopus vertical lobe (learning and memory centre) remains largely based on the pioneering neuroanatomical studies in the '70s, this work indeed provides a rich and new dataset using modern-day imaging technology and reveals numerous previously-unknown neuron types and the resulting further complex network than we thought before. This new dataset reveals hundreds of cell processes from seven types of neurons located in one gyrus of the vertical lobe and can be useful for planning further approaches for advanced microscopy and other approaches including electrophysiological and molecular studies.
Another strength of this study is to apply the current fashion of the deep learning technique to accelerate the imaging process on this octopus complex neural network. This could trigger some inventions to develop new algorithms for further applications on those non-model animals.
Weakness/limitations:
In an effort to match the key claims of the first connectome of the octopus vertical lobe, mapping up an entire vertical lobe is essential. However, also understandably, given challenges in imaging a large-sized brain region, this study managed to image a very small proportion of the anterior part of the lateral gyrus. Along with the current limited dataset, a partially reconstructed neural network of one gyrus, it is unclear whether the wiring pattern found in this study would appear as a similar arrangement throughout an entire lateral gyrus. Furthermore, it is also unknown if another 4 gyri might keep a similar pattern of neural network as it found in the lateral gyrus. Considering some recent immunochemistry evidence that showed distinct different signals in different gyri in terms of heterogeneity of neuron types amongst gryi, to assume this newly discovered network can represent the wiring pattern across an entire 5-gyrus vertical lobe is inadequate.
We revised the introduction (L106-113) to address this important point, and added discussion section titled "How well does a partial connectome of a small portion of one VL lateral lobule represent the connectivity patterns across all five VL lobuli?” (L894). We clarify what we believe is likely conserved across VL gyri and what is more likely to differ.
As this study is the first big step to reveal the complex network in the octopus vertical lobe system, the title may be changed to "Toward the connectome of the Octopus vulgaris vertical lobe - new insights into a memory acquisition network".
We appreciate the reviewer's suggestion for a new title for our manuscript. We feel, however, that the current title reflects the scope of our work and the significant step it makes toward understanding the neuronal network of the octopus vertical lobe. We do not claim to provide the octopus' VL connectome but how its connectomics unravels its workings and underlying principles. After deliberations, we decided to leave the title unchanged.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
It is well established that valuation and value-based decision-making is context-dependent. This manuscript presents the results of six behavioral experiments specifically designed to disentangle two prominent functional forms of value normalization during reward learning: divisive normalization and range normalization. The behavioral and modeling results are clear and convincing, showing that key features of choice behavior in the current setting are incompatible with divisive normalization but are well predicted by a non-linear transformation of range-normalized values.
Overall, this is an excellent study with important implications for reinforcement learning and decision-making research. The manuscript could be strengthened by examining individual variability in value normalization, as outlined below.
We thank the Reviewer for the positive appreciation of our work and for the very relevant suggestions. Please find our point-by-point answer below.
There is a lot of individual variation in the choice data that may potentially be explained by individual differences in normalization strategies. It would be important to examine whether there are any subgroups of subjects whose behavior is better explained by a divisive vs. range normalization process. Alternatively, it may be possible to compute an index that captures how much a given subject displays behavior compatible with divisive vs. range normalization. Seeing the distribution of such an index could provide insights into individual differences in normalization strategies.
Thank you for pointing this out, it is indeed true that there is some variability. To address this, and in line with the Reviewer’s suggestion, we extracted model attributions per participant on the individual out-of-sample log-likelihood, using the VBA_toolbox in Matlab (Daunizeau et al., 2014). In experiment 1 (presented in the main text), we found that the RANGE model accounted for 79% of the participants, while the DIVISIVE model accounted for 12%. The relative difference was even higher when including the RANGEω model in the model space: the RANGE and RANGEω models account for a total of 85% of the participants, while the DIVISIVE model accounted only for 5%.
In experiment 2 (presented in the supplementary materials), the results were comparable (see Figure 3-figure supplement 3: 73% vs 10%, 83% vs 2%).
To provide further insights into the behavioral signatures behind inter-individual differences, we plotted the transfer choice rates for each group of participants (best explained by the RANGE, DIVISIVE, or UNBIASED models), and the results are similar to our model predictions from Figure 1C:
Author Response Image 1. Behavioral data in the transfer phase, split over participants best explained by the RANGE (left), DIVISIVE (middle) or UNBIASED (right) model in experiment 1 (A) and experiment 2 (B) (versions a, b and c were pooled together).
To keep things concise, we did not include this last figure in the revised manuscript, but it will be available for the interested readers in the Rebuttal letter.
One possibility currently not considered by the authors is that both forms of value normalization are at work at the same time. It would be interesting to see the results from a hybrid model. R1.2 Thank you for the suggestion, we fitted and simulated a hybrid model as a weighted sum between both forms of normalization:
First, the HYBRID model quantitatively wins over the DIVISIVE model (oosLLHYB vs oosLLDIV : t(149)=10.19, p<.0001, d=0.41) but not over the RANGE model, which produced a marginally higher log-likelihood (oosLLHYB vs oosLLRAN : t(149)=-1.82, p=.07, d=-0.008). Second, model simulations also suggest that the model would predict a very similar (if not worse) behavior compared to the RANGE model (see figure below). This is supported by the distribution of the weight parameter over our participants: it appears that, consistently with the model attributions presented above, most participants are best explained by a range-normalization rule (weight > 0.5, 87% of the participants, see figure below). Together, these results favor the RANGE model over the DIVISIVE model in our task.
Out of curiosity, we also implemented a hybrid model as a weighted sum between absolute (UNBIASED model) and relative (RANGE model) valuations:
Model fitting, simulations and comparisons slightly favored this hybrid model over the UNBIASED model (oosLLHYB vs oosLLUNB: t(149)=2.63, p=.0094, d=0.15), but also drastically favored the range normalization account (oosLLHYB vs oosLLRAN : t(149)=-3.80, p=.00021, d=-0.40, see Author Response Image 2).
Author Response Image 2. Model simulations in the transfer phase for the RANGE model (left) and the HYBRID model (middle) defined as a weighted sum between divisive and range forms of normalization (top) and between unbiased (no normalization) and range normalization (bottom). The HYBRID model features an additional weight parameter, whose distribution favors the range normalization rule (right).
To keep things concise, we did not include this last figure in the revised manuscript, but it will be available for the interested readers in the Rebuttal letter.
Reviewer #2 (Public Review):
This paper studies how relative values are encoded in a learning task, and how they are subsequently used to make a decision. This is a topic that integrates multiple disciplines (psych, neuro, economics) and has generated significant interest. The experimental setting is based on previous work from this research team that has advanced the field's understanding of value coding in learning tasks. These experiments are well-designed to distinguish some predictions of different accounts for value encoding. However there is an additional treatment that would provide an additional (strong) test of these theories: RN would make an equivalent set of predictions if the range were equivalently adjusted downward instead (for example by adding a "68" option to "50" and "86", and then comparing to WB and WT). The predictions of DN would differ however because adding a low-value alternative to the normalization would not change it much. Would the behaviour of subjects be symmetric for equivalent ranges, as RN predicts? If so this would be a compelling result, because symmetry is a very strong theoretical assumption in this setting.
We thank the Reviewer for the overall positive appraisal concerning our work, but also for the stimulating and constructive remarks that we have addressed below. At this stage, we just wanted to mention that we also agree with the Reviewer concerning the fact that a design where we add "68" option to "50" and "86" would represent also an important test of our hypotheses. This is why we had, in fact, run this experiment. Unfortunately, their results were somehow buried in the Supplementary Materials of our original submission and not correctly highlighted in the main text. We modified the manuscript in order to make them more visible:
Behavioral results in three experiments (N=50 each) featuring a slightly different design, where we added a mid value option (NT68) between NT50 and NT87 converge to the same broad conclusion: the behavioral pattern in the transfer phase is largely incompatible with that predicted by outcome divisive normalization during the learning phase (Figure 2-figure supplement 2).
Reviewer #3 (Public Review):
Bavard & Palminteri extend their research program by devising a task that enables them to disassociate two types of normalisation: range normalisation (by which outcomes are normalised by the min and max of the options) and divisive normalisation (in which outcomes are normalised by the average of the options in ones context). By providing 4 different training contexts in which the range of outcomes and number of options vary, they successfully show using 'ex ante' simulations that different learning approaches during training (unbiased, divisive, range) should lead to different patterns of choice in a subsequent probe phase during which all options from the training are paired with one another generating novel choice pairings. These patterns are somewhat subtle but are elegantly unpacked. They then fit participants' training choices to different learning models and test how well these models predict probe phase choices. They find evidence - both in terms of quantitive (i.e. comparing out-of-sample log-likelihood scores) and qualitative (comparing the pattern of choices observed to the pattern that would be observed under each mode) fit - for the range model. This fit is further improved by adding a power parameter which suggests that alongside being relativised via range normalisation, outcomes were also transformed non-linearly.
I thought this approach to address their research question was really successful and the methods and results were strong, credible, and robust (owing to the number of experiments conducted, the design used and combination of approaches used). I do not think the paper has any major weaknesses. The paper is very clear and well-written which aids interpretability.
This is an important topic for understanding, predicting, and improving behaviour in a range of domains potentially. The findings will be of interest to researchers in interdisciplinary fields such as neuroeconomics and behavioural economics as well as reinforcement learning and cognitive psychology.
We thank Prof. Garrett for his positive evaluation and supportive attitude.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
In this study the authors sought to address the issue of whether the Steller's sea cow -- a massive extinct sirenian ("sea cow") species that differs from its living relatives (manatees and dugongs) not only in body mass but also in having inhabited cold climates in the northern Pacific -- had hemoglobin adaptations that enhanced the species' thermoregulatory capacities relative to those of the extant species, which are restricted to relatively warm waters. To do so, the authors synthesized recombinant hemoglobin proteins of all the major sea cow lineages and used these data to assess differences in O2 binding, Hb solubility, responses to allosteric effectors, and thermal sensitivity. The work presented is very innovative and in my opinion convincingly demonstrates that the Steller's sea cow had remarkable hemoglobin adaptations that allowed for an extreme range extension into cool waters despite several physiological constraints that are inherent to the sirenian (and paenungulate, afrotherian, etc.) clade. I did not detect any obvious weaknesses of the paper, whereas the use of ancient DNA to resurrect 'extinct' hemoglobins, and the various analyses of these extinct hemoglobins alongside those of extant relatives is very exciting and are major strengths of the paper that make this study a very important advance for our understanding of Steller's sea cow's paleophysiology, as well as our understanding of the potential for extreme hemoglobin phenotypes that have not been documented among living species. Moving forward, these methods can be used to study aspects of the paleophysiology of other recently extinct mammals. I applaud the authors on an excellent and innovative study that significantly augments our understanding of the Steller's sea cow.
We sincerely appreciate the constructive comments of this reviewer.
Reviewer #2 (Public Review):
This manuscript is an impressive "resurrection" of physiology regarding an enigmatic though unfortunately extinct species, and their potential adaptation to cold-water environments. I am largely convinced of their findings, which I feel are very straightforward and thorough.
One place where the authors perhaps fell a bit short was regarding some conclusions associated with maternal/fetal oxygen delivery. The sirenian versions of fetal & embryonic hemoglobin genes have been identified and assessed to some degree in previously published work the same research group. I feel the manuscript would have benefited from actual analysis of the fetal & embryonic hemoglobin (epsilon, gamma, zeta) to strengthen their assertions.
Again, we appreciate the kind words and valid concern of this reviewer regarding a potential shortcoming of the maternal/fetal gas exchange discussion. As noted above, we previously collected physiological data from two pre-natal Steller’s sea cow Hb isoforms that were initially intended to form a stand-alone publication on this topic. However, we have elected to include this data here to better support our claims and provide a more complete picture of maternal/fetal oxygen delivery in this extinct species.
Reviewer #3 (Public Review):
Signore et al. synthesized and functionally characterized the recombinant adult hemoglobin (Hb) proteins of extant, extinct, and ancestral sirenians to explore the putative role of Hb in helping Steller's sea cows adapt to life in extremely cold waters. The functional comparisons show that the Hb of the subarctic Steller's sea cows differs in multiple biochemical properties relative to the Hbs of the two extant sirenians in the study, the Florida manatee, and the dugong and also from the Hb inferred for the common ancestor of Steller's sea cow and dugong. Specifically, the Steller's sea cow shows reduced oxygen binding affinity, reduced sensitivity to the allosteric cofactors DPG, Cl-, and H+, increased solubility, and reduced thermal sensitivity. DPG plays an important role in regulating Hb oxygen affinity in mammals, and the lack of sensitivity to it is unique to the Hb of Steller's sea cow. Sequence comparisons show that the Hb of the Steller's sea cow differs at 11 amino acids from that of its sister group, the dugong, one of which is intriguing because it occurs in a position that is invariable among mammals at a site that is critical for DPG binding, a change from Lys to Asn in position 82 of the mature β/δ globin chain. To test the significance of this change, the authors use site directed mutagenesis to insert back a Lys in the Steller's sea cow Hb background (β/δ82Asn→Lys) and test its biochemical properties. The functional assays with the β/δ82Asn→Lys mutant indicate that reverting this position to its ancestral state drastically altered the biochemical properties of the Steller's sea cow Hb, making it functionally similar to the Hbs of manatee, dugong, and the Hb inferred for the common ancestor of Steller's sea cow and dugong.
The study's strength lies in comparing the different recombinant Hbs in an explicit evolutionary framework. The conclusions are supported by the analyses, and the results are relevant in the fields of evolutionary biology, physiology, and biochemistry because they suggest that a single amino acid substitution in a protein can have profound biochemical consequences that impact whole organism physiology.
We concur with the excellent synopsis of this reviewer. The finding that most of the functional differences between Steller’s sea cow and other sirenian Hbs can be attributed to a single amino acid replacement mirrors earlier sentiments of hemoglobin adaptation by pioneers in the field (e.g. Max Perutz). By contrast, more recent studies highlight the importance of multiple causative replacements of smaller effect and the significance of genetic background in hemoglobin evolution/adaptation (which is also evident for Steller’s sea cow Hb). We hope that the present work helps to bridge these two important evolutionary forces.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #3 (Public Review):
The authors described the one family showing autoinflammatory phenotypes with L236P variant of TNFAIP3 gene. The variant has not been reported on and they evaluated the function of this variant using in vitro and in silico methods. I think this is well-written manuscript and I agree with their interpretation about the pathogenicity of this variant, but the new finding is poor. The variant information was only a new finding.
I recommend the revision of the following points.
In Table 2, T647P seemed to be pathogenic which was evaluated with in vitro assay by Kadowaki.
The Kadowaki study indeed showed reduced NFκB activity for the Thr647Pro variant. This information has now been added to Table 2. However, the variant is highly frequent in the control population. According the ACMG guidelines, the variant does not fulfil all the conditions to be considered as pathogenic as its allele frequency is not compatible with the disease frequency. Therefore, as we cannot conclude on the pathogenic effect of the variation, we have described it as a variant of unknown significance.
Two other missense variants, V377I (Niwano, Rheumatology 2022) and T602S (Jiang W, Cellular Immunol 2022) were recently reported. These should be included in the discussion.
We have analyzed all additional missense variations, including the V377M (we found the report of a variation involving V377, but it was V377M and not V377I) and T602S variations and have added them to Table 2.
-
-
www.medrxiv.org www.medrxiv.org
-
Author Response
Reviewer #2 (Public Review):
Granell et al. investigated genetic factors underlying wheezing from birth to young adulthood using a robust data-driven approach with the aim of understanding the genetic architecture of different wheezing phenotypes. The association of 8.1 million single nucleotide polymorphisms (SNPs) with wheeze phenotypes derived from birth to 18 years of age was evaluated in 9,568 subjects from five independent cohorts from the United Kingdom. This meta-genome-wide association study (GWAS) revealed the suggestive association of 134 independent SNPs with at least one wheezing subtype. Among these, 85 genetic variants were found to be potentially causative. Indeed, some of these were located nearby well-known asthma loci (e.g., the 17q21 chromosome band), although ANXA1 was revealed for the first time to play an important role in early-onset persistent wheezing. This was strongly supported by functional evidence. One of the top ANXA1 SNPs associated with wheezing was found to be potentially involved in the regulation of the transcription of this gene due to its location at the promoter region. This polymorphism (rs75260654) had been previously evidenced to regulate the ANXA1 expression in immune cells, as well as in pulmonary cells through its association as an eQTL. Protein-protein network analyses revealed the interaction of ANXA1 with proteins involved in asthma pathophysiology and regulation of the inflammatory response. Additionally, the authors conducted a murine model, finding increased anxa1 levels after a challenge with house dust mite allergens. Mice deficient in anxa1 showed decreased lung function, increased eosinophilia, and Th2 cell levels after allergen stimulation. These results suggest the dysregulation of the immune response in the lungs, eosinophilia, and Th2-driven exacerbations in response to allergens as a result of decreased levels of anxa1. This coincides with evidence of lower plasmatic ANXA1 levels in patients with uncontrolled asthma, suggesting this locus is a very promising candidate as a target of novel therapeutic strategies.
Limitations of this piece of work that need to be acknowledged:
(1) the manual and visual inspection of Locus Zoom plots for the refinement of association signals and identification of functional elements does not seem to be objective enough;
This is an important observation and we have now added the following text in the Discussion which can be found on lines 400-2 Revised Main Manuscript:
“Finally, the manual and visual inspection of Locus Zoom plots for the refinement of association signals and identification of functional elements was an objective approach which might have undermined the findings.“
(2) the sample size is limited, although the statistical power was improved by the assessment of very accurate disease sub-phenotype;
This point was already mentioned as a limitation and it can now be found in lines 349-365 Revised Main Manuscript:
“By GWAS standards, our study is comparatively small and may be considered to be underpowered. The sample size may be an issue when using an aggregated definition (such as “doctor-diagnosed asthma”) but is less likely to be an issue when primary outcome is determined by deep phenotyping. This is indirectly confirmed in our analyses. Our primary outcome was derived through careful phenotyping over a period of more than two decades in five independent birth cohorts, and although comparatively smaller than some asthma GWASs, our study proved to be powered enough to detect previously identified key associations (e.g. chr17q21 locus). Precise phenotyping has the potential to identify new risk loci. For example, a comparatively small GWAS (1,173 cases and 2,522 controls) which used a specific subtype of early-onset childhood asthma with recurrent severe exacerbations as an outcome, identified a functional variant in a novel susceptibility gene CDHR3 (SNP rs6967330) as an associate of this disease subtype, but not of doctor-diagnosed asthma(51). This important discovery was made with a considerably smaller sample size but using a more precise asthma subtype. In contrast, the largest asthma GWAS to date had a ~40-fold higher sample size(7), but reported no significant association between CDHR3 and aggregated asthma diagnosis. Therefore, with careful phenotyping, smaller sample sizes may be adequately powered to identify larger effect sizes than those in large GWASs with broader outcome definitions(52).”
(3) association signals with moderate significance levels but with strong functional evidence were found;
We do not think of this as a limitation but as a strength. We were able to support our genetic results with evidence from experimental mouse models.
(4) no direct replication of the findings in independent populations including diverse ancestry groups was described.
This point was already mentioned as a limitation and it can now be found in lines 375-391 and 392-399 Revised Main Manuscript.
“We are cognisant that there may be a perception of the lack of replication of our GWAS findings. We would argue that direct replication is almost certainly not possible in other cohorts, as phenotypes for replication studies should be homogenous(56). However, there is a considerable heterogeneity in LCA-derived wheeze phenotypes between studies, and although phenotypes in different studies are usually designated with the same names, they differ between studies in temporal trajectories, distributions within a population, and associated risk factors(57). This heterogeneity is in part consequent on the number and the non-uniformity of the timepoints used, and is likely one of the factors responsible for the lack of consistent associations of discovered phenotypes with risk factors reported in previous studies(58). This will also adversely impact the ability to identify phenotype-specific genetic associates. For example, we have previously shown that less distinct wheeze phenotypes in PIAMA were identified compared to those derived in ALSPAC(59). Thus, phenotypes that are homogeneous to those in our study almost certainly cannot readily be derived in available populations. This is exemplified in our attempted replication of ANXA1 findings in PIAMA cohort (see OLS, Table E12). In this analysis, the number of individuals assigned to persistent wheezing in PIAMA was small (40), associates of this phenotype differed to those in STELAR cohorts, and the SNPs’ imputation scores were low (<0.60), which meant the conditions for replication were not met.”
“Our study population is of European descent, and we cannot generalize the results to different ethnicities or environments. It is important to highlight the under-representation of ethnically diverse populations in most GWASs(9). To mitigate against this, large consortia have been formed, which combine the results of multiple ethnically diverse GWASs to increase the overall power to identify asthma-susceptibility loci. Examples include the GABRIEL(6), EVE(60) and TAGC(7) consortia, and the value of diverse, multi-ethnic participants in large-scale genomic studies has recently been shown(61). However, such consortia do not have the depth of longitudinal data to allow the type of analyses which we carried out to derive a multivariable primary outcome.”
Nonetheless, the robustness and consistency of the findings supported by different analytical and experimental layers is the major strength of this study.
The authors successfully achieved the aims of the study, strongly supported by the results presented. This study not only provides an exciting novel locus for wheezing with potential implications in the development of alternative therapeutic strategies but also opens the path for better-powered research of asthma genetics, focused on accurate disease phenotypes derived by innovative data-driven approaches that might speed up the process to disentangle the missing heritability of asthma, making use of still useful GWAS approaches.
-
-
www.medrxiv.org www.medrxiv.org
-
Author Response
Reviewer #1 (Public Review):
This study aimed to estimate contact parameters associated with the transmission of SARS-CoV-2 in unvaccinated South African households over one year. The authors found no correlation between the frequency or duration of contacts and infection risk. Similar parameters (e.g., sharing a room with the index patient) also failed to yield an association. Reassuringly, a robust association was found with the Ct of the index case; female sex and individuals aged 13-17 years were also associated with increased risk. In a more general analysis, obesity, age >5 and <60 y, and non-smoking status were associated with increased risk.
Strengths of the study are its relatively large size (131 households involving 497 people) with detailed proximity data; frequent testing to enable high ascertainment of infections; and ability to exclude individuals seropositive at baseline. Additionally, several outcomes were evaluated in the models, partly to accommodate uncertainty in the index case. Different model structures were evaluated to gauge robustness.
Limitations of the study include the fact that many index cases were likely enrolled after their infectious period, and it is possible that apparent secondary cases in the household arose from a shared exposure with the index case but had a longer latent period. Each of these factors could weaken the perceived effect of close contacts. Statistically, there is the vexing question of what age (gender, smoking, etc.) really represents mechanistically, and whether the models may be conditioning on a collider. Another statistical consideration is that many household contacts were excluded from the study because they were seropositive at baseline. In effect, their households may already have been "challenged" with the virus, and there may be heterogeneities in household susceptibility that are not fully considered by the simple exclusion of individuals with evidence of prior infection. Separating these household types in the analysis might have yielded different results.
Although conditioning on a collider in the multivariable analysis is theoretically possible, it would be important to consider these co-variates as they had been found to be associated with transmission in both this and previous studies. The fact that there is also no signal for the contact parameters on univariate analysis support these findings.
We added another sensitivity analysis where any households where individuals were excluded due to seropositivity was excluded from the analysis. The results showed that none of the contact patterns were significantly associated with SARS-CoV-2 transmission in the household.
All that said, it is telling that in these households, infection is not clearly linked to typically defined close contacts. This is an important result that complements other strong evidence that aerosols are the dominant route of transmission for SARS-CoV-2. This information is critical for the design of effective intervention strategies. Additionally, the authors outline how future studies can be designed to improve on this work.
Reviewer #3 (Public Review):
The manuscript by Kleynhans et al analyzes data from household contacts of SARS-CoV-2 cases at two sites in South Africa. Proximity sensors were distributed to household members following diagnosis of the "index case" and measured the frequency and duration of close contacts (defined as being face-to-face within 1.5 meters for at least 20 seconds). The authors then examined the association between the duration, frequency, and average duration of contacts and the risk of a diagnosis of SARS-CoV-2 among household members in the subsequent two weeks, for both contact with the index case and all cases within the household. The risk of infection among household members was high (~60%), but was not significantly associated with the contact metrics examined. The findings may indicate that aerosols may be the predominant mode of SARS-CoV-2 transmission within households; however, there are also a number of limitations associated with the design and analysis of the study, which the authors acknowledge and which may limit the interpretability of the conclusions of this study.
One important study limitation has to do with the design of the study: Sensors were not distributed to household members until a day or two after the diagnosis of the index case. Since individuals are most infectious with SARS-CoV-2 just prior to symptom onset, contact patterns were measured only after most transmission from the index case likely occurred. Furthermore, household members may have limited their contact with the index case, particularly if the index case attempted to isolate following their diagnosis, so the contact patterns measured are unlikely to be representative of typical mixing within the household.
Another important limitation has to do with the analytical approach: The logistic regression model assumes that the first person in the household to test positive for SARS-CoV-2 (i.e. the index case) infected all subsequent cases within the household. However, this approach does not account for chains of transmission within the household or transmission from outside the household (possibly from the same source that infected the index case). While this concern is partially addressed by also assessing the association between the risk of infection and contact with all infected household members, more sophisticated methods could be used to infer the most likely infector of each case. The possibility of multiple introductions of the virus from outside the household is also only partially addressed by excluding households in which more than one variant was detected. While these limitations (and others) are appropriately acknowledged by the authors in the Discussion, nevertheless they limit the conclusions that can be drawn from the study results.
We will be considering an analytic framework to distinguish the chains of transmission in future analyses.
It is also worth noting that the contact metrics as defined and analyzed in the model may not be the measures that are most relevant to transmission. The authors examined three different contact measures: the median daily duration of contact, the median daily frequency of contact, and the median daily average duration of contact (i.e. the ratio of the two previous measures). They chose to examine the median daily values because contact duration was heavily skewed and the number of days of follow-up varied after data cleaning, but it may be that longer-duration contacts important to transmission are not appropriately captured by these metrics. Indeed, the median daily duration of the contact is quite short (only ~18 minutes on average). It would be useful to also evaluate a measure such as the total cumulative duration of contact and frequency of contacts divided by the number of days of follow-up, which differs from the measures they calculate and would take into account more prolonged and frequent contacts.
Additional contact parameters added as described in response to reviewer 2.
Lastly, the measures of association reported in the manuscript are the odds ratios (ORs) associated with one additional second of contact per day. This is not a very biologically meaningful unit of measure, and when rounded to two significant digits, the ORs are not surprisingly 1.0 with 95% confidence intervals that also round to 1.0. It would be more interpretable to report the ORs associated with a 1-minute (rather than 1-second) increase in the duration of contact, and the biological interpretation of the ORs should be described in the text.
All time-based contact parameters now expressed in minutes.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
Rapan et al. analyzed the cytoarchitectonic of the prefrontal cortex based on observer-independent analysis, confirming previous parcellations based on cyto-, myelo-, and immunoarchitectonic approaches, but also defining novel subdivisions of areas 10, 9, 8B, and 46 and identified the receptor density "fingerprint" of each area and subdivision. Furthermore, they analyzed the functional connectivity of the prefrontal cortex with caudal frontal, cingulate, parietal, and occipital areas to identify specific features for the various prefrontal subdivisions. Altogether, this study corroborates previous parcellations of the prefrontal cortex, adds new cortical subdivisions, and provides a neurochemical description of the prefrontal areas useful for comparative considerations and for guiding functional and clinical studies.
Strengths:
-
This study provides a detailed cytoarchitectonic map of the prefrontal cortex enriched with receptor density and functional connectivity data.
-
The authors shared the data via repositories and applied their map to a macaque MRI atlas to further facilitate data sharing.
Weaknesses:
- The temporal cortex should be included in the functional connectivity analysis as it is known from anatomical studies that most prefrontal areas display rich connectivity with temporal areas. The aim of creating a comprehensive view of the frontal cortex makes the manuscript data-rich but cursory in discussing the relevant anatomical and functional literature.
One of the main concerns pointed out by reviewers was that the functional connectivity analysis is incomplete without temporal lobe areas. Although our initial decision was to use only our parcellation scheme, we fully agree with reviewers. Thus, we have extended our functional connectivity analysis, and combined our frontal, parietal, cingulate and occipital parcellations with temporal areas as defined in the atlas of Kennedy and colleagues (Markov et al., 2014). In the revised version of the manuscript, old Figures 13-17, and related Supplementary Figures 12 and 13, have been replaced with new Figures 12-15 and Figures 12-15 – Figure supplements 12, 13 and 14, and the results are described in the updated Results, chapter 3.4 Functional connectivity analysis. The Discussion has also been adjusted regarding the updated results.
Reviewer #2 (Public Review):
Rapan and colleagues did perform an impressive multi-modal parcellation of the macaque frontal cortex. In addition to qualitative cytoarchitectonic and resting-state functional fMRI data analyses, the authors based their parcellation on quantitative receptor density analysis of 14 receptors. Compared with the classic Walker map of the macaque frontal cortex, the authors produced a more refined map. Those results should be discussed in light of previous work on the same topic (Petrides et al. 2012 Cortex; Reveley et al. 2017 Cerebral Cortex; Saleem and Logothetis 2012).
In the Discussion, under chapter “4.1 Comparison with previous architectonic maps of macaque prefrontal region” (pages 44-52), we compared our parcellation to previously published maps, including the work of Petrides and colleagues (i.e., Petrides and Pandya 1984, 1994, 1999,2002, 2006, 2009; Petrides 2000, 2005; Petrides et al. 2012). With the exception of Caminiti et al. (2017), which integrates work by Belmalih et al. (2009); Borra et al. (2011, 2019) and Gerbella et al. (2010, 2013), we had restricted our citations to original mapping studies because we find it is important to discuss their reliability and objectivity, since they have been widely used in tracer-tract and neuroimaging studies, as well as the parcellation maps depicted in 3D atlases. Indeed, Saleem and Logothetis (Saleem & Logothetis, 2012) use the maps of Carmichael and Price (1994), Petrides and Pandya (1999, 2002) Petrides (2005) and Preuss and Goldman-Rakic (1991) for the parcellation of the prefrontal cortex in their atlas, and Reveley et al. (Reveley et al., 2017) use the map of Saleem and Logothetis (2012) in their 3D atlas. We now provide this information in the Introduction (lines 126-132):
“In recent years, several digital macaque atlases have been created (Bezgin et al., 2012; Frey et al., 2011; McLaren et al., 2009; Moirano et al., 2019; Reveley et al., 2017; Van Essen et al., 2012) based on the previous parcellations. Indeed, maps of Carmichael and Price (1994), Petrides and Pandya (1999, 2002), Petrides (2005) and Preuss and Goldman-Rakic (1991), used in atlas of Saleem and Logothetis (2012), have been brought into stereotaxic space by Reveley et al. (2017).”
-
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
The authors have approached the study of the mechanism of maturation of retroviruses lattice, where Gag polyprotein is the main component. The Gag polyprotein is common to all retroviruses and makes up most of the observed lattice underlying the virion membrane. Within the lattice, 95% of the monomers are Gag, and 5% are Gag-Pol, which has the 6 domains of Gag followed by protease, reverse transcriptase and integrase domains (coming from Pol) embedded within the same polyprotein. For the maturation and infectivity of HIV retrovirus, the Gag proteins within the immature lattice must be cleaved by the protease formed from a dimer of Gag-Pol. Importantly, the lattice covers only 1/3 to 2/3 of the available space on the membrane. The incompleteness of the lattice results in a periphery of Gag monomers with unfulfilled intermolecular contacts. Recently, the structure of the immature lattice has been partially resolved using sub-tomogram averaging cryotomography (cryET) and it has been shown that the incompleteness of the lattice provides more accessible targets for the protease (Tan A. et al. 2021). Based on these, the authors have wondered: does the incompleteness of the lattice allow for dynamic rearrangements that ensure that protease domains embedded within the lattice can find one another to dimerize and activate? To answer this, they started from experimental cryoET data and used reaction-diffusion simulations of assembled Gag lattices with varying energies and kinetic rates to test how lattice structure and stability can support the dimerization of the Gag-Pols. They found that although they represent only 5% of the monomers that assemble into the lattice, the stochastic assembly ensure that at least a pair of them are adjacent within the lattice. They next showed that if the molecules are distant from one another, they would need to detach, diffuse, and reattach stochastically at the site of another Gag-Pol molecule.
I consider the work very interesting, which could contribute to a very important aspect of retroviruses maturation such as their infectivity. However, the observations made by the authors do not necessarily answer their initial question which seemed to be focused on studying the possible role of the incompleteness of the lattice on the protease activation rather than the mechanism of Pol activation itself. Maybe this is only a nuance to be polished in the writing.
The weakness of the work comes from both the fact their entire study has been done by computational methods and the exclusion in their computational approaches of well-known cellular components with a role in retrovirus maturation, which might obey to the fact of keeping their models into the simplest possible since handling atomistic models is already a heavy task. Maybe complementary molecular or structural studies would strengthen their results.
We appreciate Reviewer #1’s comments and interest in our work. In the revised manuscript, we have clarified our writing to emphasize that our primary goal was to quantitatively interrogate the mechanism by which dimerization of two protease domains can occur, as it is essential for activation of the protease and the subsequent maturation process. We do not address the steps that follow the essential dimerization process. The molecular details concerning how this (dimerized) protease enzyme initiates cleavage and ultimately cleaves the entire lattice off the membrane would be the subject of a separate study (see page 4).
Regarding the concern about the computational nature of our work, we agree that the model is a (necessarily) simplified representation of the true biological system, and as we elaborate further in the Discussion section, including more components in the model would strengthen connection to experiment, which we plan in future work (see page 26). However, we have not relied solely on our computational results, but made several direct and quantitative comparisons to experimental structural (now!), biochemical, and imaging data. We have also validated the parameters of our model against theory.
We agree that it would be interesting and worthwhile to make more direct comparisons as well to more molecular models of the immature lattice, particularly in future work with the inclusion of more specific co-factors like IP6, which we discuss in the Discussion section. We show that already in its current form, our model provides new quantitative evidence on the mechanisms that would allow two protease domains to find one another to initiate maturation, in a way that is consistent with structural and biochemical data. (See revisions on page 26 and 28 of the manuscript)
Reviewer #2 (Public Review):
Immature lattice assembly remains an arcane topic, and these simulations provide high resolution data such as assembly kinetics and large-scale lattice rearrangement. Further, the authors extend their model to compare directly with experiments, e.g. SNAP-HALO dimerization, which provides a basis to interpret their conclusions. The manuscript is difficult to read, as it is a technical manuscript that overuses jargon; overall, it seems written for a specialized audience. Additionally, there are several aspects of the model design that remain opaque, such as the implicit lipid method and the suppression of multi-site nucleation. Further, analyses such as time auto-correlation and mean first passage time are not given much context by the authors. Altogether, it is the opinion of this reviewer that several revisions to the manuscript should be incorporated to improve clarity and strengthen the significance of the authors' efforts.
We appreciate the constructive comments from Reviewer #2. We've revised the text in multiple places to minimize the use of technical jargon and provide clearer explanations for specialized terms or concepts. Specifically, we've provided more detailed descriptions of the implicit lipid method and the rationale behind the suppression of multi-site nucleation to help readers better understand our model design. Additionally, we've added more context for the analyses such as time auto-correlation and mean first passage time, describing their significance and relevance to our study.
Reviewer #3 (Public Review):
The manuscript concerns the cleavage of the Gag polyprotein lattice from the HIV virion membrane, a key stage in HIV lifecycle, and one that is required for HIV to become infectious. Since cleavage requires homodimerization between the small fraction (5%) of such Gag polyproteins that carry a protease domain, referred to as Gag-Pol, this raises questions regarding how such homodimerization can take place, and whether it can happen on the required timescales, given that Gag-Pol is typically embedded in a lattice that is observed to form one large connected component.
The authors address these questions in silico, using particle-based reaction diffusion simulations. Such simulations are rigid-body and "structure-resolved" meaning that they rigidly incorporate the geometry of the polyproteins, and their various binding interfaces, based on existing structural data. Other aspects of the simulations are also in-line with available data, including copy numbers, lattice curvature, and dissociation rates. This focused approach is a strength of the work and allows the authors to make credible claims that their simulations have relevance to HIV (as does their commitment to comparison with HALO-SNAP-based measurements of dimerization kinetics as well as iPALM experiments that characterize lattice dynamics).
A central part of the model is that it allows for the "possibility of imperfect alignment of molecules in the lattice", presumably due to the incompatibility of regular hexagonal tiling and surfaces with non-zero Gaussian curvature, such as a sphere. This is implemented via the ad-hoc imposition of a free-energy penalty when complete hexamers are formed, implying that hexamers are less stable than six ideal bonds. By varying this strain penalty, the authors can change the stability of the lattice independently of individual binding affinities, allowing its use as an effective fitting parameter when comparing to HALO-SNAP data. In the latter case, agreement between simulation and experiment can only be found at moderate levels of lattice stability.
However, such energetic penalties are present whenever the polyprotein structure must undergo deformations which, on surfaces with nonzero Gaussian curvature, should be the case for partial tilings as well as complete ones (where all six interfaces form bonds). This, therefore, appears to be a weakness of the work. An elastic implementation of polyprotein structure, for example, would permit strain to accumulate (and therefore stresses to propagate) throughout the lattice naturally, irrespective of whether complete hexamers were formed, and might reasonably be expected to impact the likelihood of different lattice structures. Whilst it is not clear how or whether this would lead to qualitatively or quantitatively different results, it is nevertheless worth remarking upon since the authors high-level claim is that lattice structure is an important determinant of the mean-firstpassage times to dimerization.
Overall, I find this to be a valuable study, carried out in a solid and comprehensive manner. The primary impact of the work appears to be twofold: the unification of different experimental measurements under a single model, and the further identification of the salient parts of that model that most impact biological function. The results advance the understanding of one of the steps of the HIV lifecycle, via a better description of the mechanisms underpinning Gag-Pol dimerization. Notably, the authors stop short of drawing parallels to many related concepts and models in statistical physics, such as those concerning percolation and diffusion limited aggregation as well as the notions of dislocations and defects in crystalline matter on curved surfaces. These might reasonably have provided a basis for better understanding and quantification of the authors' simulations, as well as improving the scope for extensions and conceptual clarity.
We appreciate the constructive and positive comments from Reviewer #3. We have revised the text and expanded the discussion given the points the reviewer has brought up.
We have quantified the number and organization of incomplete hexamers or defects in the simulated lattices. This allows us to compare with experimental structures and also quantify how the assembly parameters would impact this organization. As we now remark on pages 10-11, with reversible binding during assembly, we see that fewer defects are present in the lattice, indicating that the hexameric lattice can improve its organization and stability when unbinding reactions can correct for weak contacts in the lattice. We thus speculate that because our lattices are statistically in good agreement with experiment even when binding is irreversible, that the assembly process does not rely on a significant amount of annealing. Otherwise the lattice structures would be more ideal.
We further discuss on pages 27 that a model that also incorporates forces to control interactions would be important to measure the mechanical stability of the lattice, particularly as it couples to membrane bending. However, models that naturally incorporate forces (via interaction potentials) can be difficult to tune with respect to their kinetics and free energies, which are nontrivial to calculate, unlike our modeling approach here.
In these sections we have now drawn parallels, as suggested by the reviewer, to the literature on defects in crystalline matter on curved surfaces, and their possible consequences for the mechanics of the lattice (Ref 41 Negri et al, Deformation and failure of curved colloidal crystal shells. Proc Natl Acad Sci U S A, 2015. 112(47)) (Ref 59 Zandi, R. and D. Reguera, Mechanical properties of viral capsids. Phys Rev E Stat Nonlin Soft Matter Phys, 2005. 72(2 Pt 1): p. 021917.)
We did not include a connection to Diffusion-limited aggregation, as this process seems to result in fractal-like structures that lack the specific hexagonal order of the Gag protein lattice. The proteins impose a significant orientational order on the assembly process that makes growth significantly more compact, at least under the assembly conditions we used. Even for our fastest rates, the process is still only moderately diffusion influenced (ka <<109M-1s-1), with typically multiple collisions needed before succesful binding occurs, consistent with most protein-protein interactions.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #2 (Public Review):
The manuscript by Mohebi et al. examines a critical open question regarding the interaction of cholinergic interneurons of the striatum and transmitter release from dopaminergic axons in behaving animals. Activation of cholinergic interneurons in the striatum can evoke dopamine release in brain slices and in vivo as measured with voltammetry. However, it remains an open question in what context and to what extent this acetylcholine-mediated dopamine occurs in behaving animals. Here, the authors argue that CIN activity triggers dopamine release in the nucleus accumbens which encodes the motivation to obtain a reward through increasing "ramps" of dopamine release. Their data suggest that the ramps are not reflected in the firing of dopaminergic neurons. Rather, they provide compelling evidence that the ramps of dopamine release correlate with ramps in cholinergic interneuron activity as measured with GCaMP6. What's more, the authors show that ACh-mediated dopamine release has no paired-pulse depression, a striking result that differs from all prior ex vivo brain slice data. The manuscript is extremely well written and the data are of very high quality. Overall, this study represents an important step forward in our understanding of how ACh-mediated dopamine release regulates behavior, and more broadly how axons can generate behaviors independently from somatic activity.
Major comments
1) The complete absence of any short-term plasticity in CIN-mediated dopamine release is a striking result that is important for the field. The authors should strengthen this result with additional quantitative analysis demonstrating the lack of STP. They have analyzed paired-pulse ratios, but they should analyze this for stimuli at the higher frequencies (4 Hz, etc) that are more physiologically relevant. For example, Fig 1e shows a CIN-evoked DA release at many optically-stimulated frequencies. The authors should quantify short-term plasticity by generating fits of the single stimulus signal and comparing the mathematical sum predicted from 4 stim DA signals at different frequencies to the recorded data. A similar analysis has been done with Ca signals (Koester and Sakmann, 2000).
Thank you for this very helpful suggestion. We have performed this analysis as recommended, and now confirm the lack of STP even at the higher frequencies (see new Supplementary Figure 1).
2) The authors show that optical activation of CINs results in DA release as measured by dLight. To clearly establish that these signals are generated by DA release driven by nicotinic receptors (and not a partial effect of some unknown artifact), it would be useful to show that the optical CIN-evoked dLight signals shown in Fig. 1 are inhibited by nicotinic receptor antagonists such as DHbE. This control experiment would significantly strengthen the result shown here.
We agree that combining drug manipulations with photometry would be useful, but as noted above this is not a methodology in our current technical repertoire.
3) Similarly, the authors show clear correlations between CIN activity and DA release during behavior. The authors should consider determining whether CINs play a causal role in triggering DA release during behavior. For example, does infusion of DHbE in the NAc prevent the light-mediated DA release during behavior? As an alternative hypothesis, some groups have been suggesting that CIN activity has almost no direct influence over DA. Therefore, testing whether a causal relationship exists between CINs and DA release would be an important experiment in addressing these two opposing viewpoints.
As noted above we are not currently able to combine drug manipulations with photometry in behaving animals.
4) The ramps that are described in this manuscript are an order of magnitude faster (increasing over 100s of milliseconds) than ramps described in other studies that occur over seconds. In fact, the two signals may be completely different functionally. Discussion of this topic would be helpful.
Dopamine ramps have indeed been reported over multiple different time scales, and as discussed in Berke 2018, this seems to reflect the duration of the approach behavior. We think further discussion of this topic is better saved for another paper, especially as we are now actively studying ramping over longer time scales (Krausz et al. 2023).
Reviewer #3 (Public Review):
This report by Mohebi et al. provides new answers to old questions by showing that the activity of striatal cholinergic interneurons (CINs) escalates progressively during specific reward-related behaviors and that this correlates with previously observed ramps in dopamine (DA) release in the nucleus accumbens core. The report is strong and provides evidence for the authors' hypothesis that DA ramps are independent of DA neuron activity, but are instead the result of CIN activity and corresponding acetylcholine (ACh) release. The authors further demonstrate that the fidelity of CIN activation and consequent driving of DA release is even more robust in vivo than observed ex vivo slice preparations, which is fundamental for understanding the role of ACh-DA interactions in behavior. The findings complement the authors' previous evidence ventral tegmental area (VTA) DA neuron firing patterns do not show a ramping pattern; the previously reported VTA data are appropriately included here (in Fig. 3) to illustrate the absence of VTA firing during the time-locked increases in CIN activity and DA release. The present studies stop short of showing a direct link between CIN activity and DA release, however, which would require examining DA release during behavior in the presence of an antagonist of nicotinic ACh receptors. The authors also extend the understanding of the regulation of DA release by acetylcholine (ACh) by showing that optical activation of CINs in vivo promotes DA release responses that do not attenuate with repetitive stimulation. This contrasts with previous results in ex vivo striatal slices in which ACh-evoked DA release has been found to decline progressively from rundown and/or receptor desensitization. The authors propose that in vivo, AChE may be more effective in curtailing local ACh levels than in slices because of the slightly lower temperature typically used for slice studies, as well as the use of superfusion that might facilitate some AChE washout (AChE inhibitors are still effective in slices, of course). Overall, the report not only provides evidence for the cellular substrate for DA ramps but also shows the robustness of ACh-driven DA release in vivo. A few points to strengthen the report are listed below.
1) The authors give a few details about how CINs were activated at the beginning of the results, but say only that DA dynamics were monitored using fiber photometry. Given that the methods are at the end, a brief summary should be given here to indicate whether this means direct monitoring of DA or indirect via GCaMP, for example. It would be helpful to note the sensor used in the abstract, as well. In this light, as it were, RdLight1 should be described upon the first mention.
We have now clarified in both abstract and text that we are using the direct DA sensor RdLight1.
2) The authors show that infusion of DHbE in the NAc likelihood of decisions to approach the center port, as did antagonism of DA receptors. This supports the authors' argument that ramping of CIN activity and consequent ACh release underlies observed ramps in DA release. However, to show a causal interaction requires testing whether the observed DA ramps are absent after DHbE infusion in the NAc, under the same conditions that attenuated behavior.
As noted above we are not currently able to combine drug manipulations with photometry in behaving animals.
3) In Fig. 3, the y-axis title for the upper panels should specify VTA, not simply "rate". This is stated in the legend, but should also be specified in the figure panel.
We have updated the y-axis titles in this figure.
4) A recent preprint in BioRxiv by AC Krok, NX Tritsch et al. shows a related correlation between ACh and DA release in vivo in a reward task, as well as differences in other conditions. This report shows also that cortical input to CINs indeed plays a role, as suggested in the concluding sections of the present report. Consideration of the data in the preprint in the context of the present results could be valuable for the field.
We have also noted those pre-prints with interest, even though they investigated different brain regions using different approaches. There are established differences between CIN-DA interactions in dorsal vs. ventral striatum that we suspect are relevant here. But given the rapid pace of developments in this subfield, we prefer not to speculate too much at this point and instead review the overall body of work once it is published.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
“The abstract does not adequately summarize the content of the paper. There is no mention of stimulation, or bilateral connectivity, which is a large part of the paper. The names of all five species should appear in the abstract, not just X. laevis.”
In the revised manuscript, we have included all the names of the species and types of stimuli used to elicit fictive vocalizations in the abstract. In regard to bilateral connectivity, we believe that the reviewer was referring to the rostral-caudal connections between the parabrachial nucleus and nucleus ambiguus, which are critical for fast, but not for slow trill production. We have added this piece of information in the abstract. Furthermore, we have clarified the bilateral nature of the two central pattern generators (CPGs) in male X. laevis. In our previous study (Yamaguchi et al., 2017), we demonstrated that transections of the two commissures (one at the parabrachial nuclei level and the other at the nucleus ambiguus level) did not eliminate fictive advertisement calls in male X. laevis brains, indicating the presence of fast and slow trill CPGs in left and right hemi-brains of male X. laevis. This information was originally included in the results section (“Unilateral transection desynchronizes the fast clicks, but not the slow clicks across species”). We have now added this information to the introduction section to provide a clearer description of the anatomical organization of the two CPGs (p5, ln10 – 14).
“The conclusion that the "fast and slow CPGs identified in male X. laevis are conserved across species." is contradicted by the last paragraph, which states, "Fast trill-like CPGs are likely present only in fast clickers..." This inherent contradiction needs to be resolved.”
To resolve this contradiction, we have revised sentences in the abstract to clarify our findings. Specifically, we now state that “We found that even though the courtship calls of different Xenopus species vary in their click rates and duration, the CPGs used to generate clicks are conserved across species. The fast CPGs found in male X. laevis, which critically rely on reciprocal connections between the parabrachial nucleus and the nucleus ambiguus, are conserved among species that produce fast clicks. Similarly, the slow CPGs found in the caudal brainstem of male X. laevis are shared among species that produce slow clicks” (p2, ln 10 – 15) By making this change, we hope to provide greater clarity regarding our findings and help to resolve any contradictions.
“The testosterone results are over-emphasized.” “The conclusion that there is differential expression of testosterone receptors in the brain of each species is completely speculative and not supported by the data presented here.”
We have extensively revised our manuscript to ensure a more accurate interpretation of the results regarding testosterone experiments. Revised conclusions are outlined below:
Abstract: “In addition, our results suggest that testosterone plays a role in organizing fast CPGs in fast-click species, but it does not appear to have the same effect in slow-click species.” (p2, ln 15 – 17)
Introduction: “Additionally, we found that fast trill-like CPGs are present only in species that produce fast clicks and their presence appears to be regulated by testosterone in these species. “ (p6, ln 2 – 4)
Discussion: “However, this effect of testosterone appears to be limited to the fast clicker species. Male X. tropicalis, a slow clicker species, has been shown to have comparable plasma levels of testosterone to male X. laevis (mean plasma levels of testosterone of male X. laevis: 13 to 22ng/ml (Hecker et al., 2005; Hayes et al., 2010), male X. tropicalis: ~20ng/ml, (Olmstead et al., 2009)), yet the synapses between the PBN and laryngeal motoneurons in male X. tropicalis remained weak, and PBN showed little activity during fictive advertisement calls. These results suggest that testosterone acts differently on the central vocal pathways of fast and slow clickers, promoting the emergence of fast trill-like CPGs in X. laevis but not in X. tropicalis. Although further experiments with controlled testosterone levels are necessary to validate these results, we hypothesize that changes in the androgen receptors (e.g., expression patterns, ligand affinity) may have contributed to the divergence of fast and slow clickers.“ (p26, ln 13 – 24)
”The use of the word "development" implies embryology. Here, adults were treated and looked at 13 weeks later. There is no data presented about development. ”
In our revised manuscript, we have replaced the term “development” with “presence” or “acquisition” of neural circuitry to enhance the clarity and help to prevent any potential misunderstandings.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
By the in vitro DNA damage response (DDR) assay with a defined DNA substrate using Xenopus extracts and in vitro binding assays with purified proteins, the authors nicely showed the role of APE1 (APEX1) in ATRIP recruitment for DDR activation, particularly a non-enzymatic (structural) role of APE1 in the binding to both ssDNAs and ATRIP. The results described in the paper are very convincing to support the authors' claim. However, these studies lack the quantification with proper statistics (and/or mentioning the reproducibility of the results). And, given the important discovery of APE1 in the DDR activation in vitro, it would be nice to demonstrate the role of APE1(APEX1) in ATR activation in vivo using siRNA-mediated knockdown of mammalian cells or yeast cells.
Thanks for the suggestion. As shown in our response to the #2 Essential Revisions, we have addressed this question by additional experiment and added extra description in our revised manuscript showing that APE1 is important for the ATR DDR following oxidative stress in culture human cell U2OS cells (Figure 1-figure supplement 1B). In addition, we have performed at least three independent experiments and statistical analysis to support our claims.
Reviewer #2 (Public Review):
ATM and Rad3-related (ATR) interact with ATRIP and plays a central role in DNA damage response. Previous studies have established the idea that ATR is recruited to RPA-covered ssDNA via ATRIP-RPA interaction. In this paper, the authors propose a new RPA-independent mechanism for ATR recruitment.
Thanks for the nice summary of our major findings from the manuscript.
Reviewer #3 (Public Review):
In this manuscript, the authors explore the mechanism of ATRIP recruitment to single-stranded DNA (ssDNA), which is important for ATR activation and the subsequent control of DNA repair and cell cycle progression. Using Xenopus egg extracts, in vitro interaction assays, and ssDNA constructs, the authors found that AP endonuclease 1 (APE1) plays a role in the recruitment of ATRIP to ssDNA independently of RPA. Moreover, APE1 domains are characterized for ssDNA, ATRIP, and RPA interaction, determining that the nuclease activities of APE1 are not required for this new mode of ATRIP recruitment. Overall, the work presented makes a compelling case for a novel role for APE1 in ATRIP recruitment that seems crucial for ATR activation (at least in the Xenopus system). The results are likely to have an important impact on our understanding of the determinants for activation of ATR signaling and cellular responses to DNA damage and replication stress. It remains unclear whether the findings will be extended to other organisms and be relevant for different types of DNA lesions. Also, there are several points of concern in the manuscript that require further clarification, especially regarding some of the quantitative analyses presented and the claimed importance of the RPA-independent mode of ATRIP recruitment for ATR activation.
We thank the reviewer’s overall positive evaluation of our initial submission. We have included additional experimental data using mammalian cells showing the significance of APE1 in the ATR DDR, and also additional discussion of other studies in the literature. We also provided further clarifications or responses to the major/minor concerns (please see below detailed responses). In particular, we revised the proposed model of APE1 in ATRIP recruitment and ATR DDR (Please see revised Figure 5).
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
The data on embryonic "ventral nerve cord" glia are generated from whole embryos, and even provided that the ventral nerve cord harbors 75% of all glia and thus the majority is ventral nerve cord, the data should not be called vnc-specific. The vnc-specific data set (adult CNS) that is already published (Allen et al., 2020) is strangely not even mentioned in the current manuscript. The idea of having a comprehensive description of glial transcriptional profiles is great - but I was missing the integration of the midline glial cells, which can be considered as ensheathing glial cells that - as the cortex glia - also express wrapper (Stork et al., 2009).
-
We agree with Reviewer 1 that the embryonic glia dataset represents all glia and not just VNC glia. We have amended the text accordingly.
-
We now cite the Allen et al., 2020. Apologies for this omission.
-
Midline Glia:
The embryonic glial cells analysed in the previous version of our manuscript included only repo+ glia only and therefore did not include midline glia, which do not express repo (Jacobs, 2000). In the revised manuscript, we reanalysed the complete embryonic dataset and identified the midline glia based on known markers and in vivo validation (Figure 3 – figure supplement 1). We also provide a list of genes that show enriched expression in the midline glial cluster as a supplementary file (Source data file 1).
We performed hierarchical cluster analysis on midline glia, all embryonic repo+ glial clusters and embryonic neuronal clusters to determine the relationship of midline glia to other glia. Interestingly, midline glia formed an outgroup to both neurons and repo+ glia (Figure 3 – figure supplement 1F), suggesting that they are quite distinct from other (repo+) glial classes. This is expected given their mesectodermal origin (Kosman et al., 1991; Thomas et al., 1988). Indeed, although midline glia express wrapper, otherwise known as a cortex glia marker (Banerjee et al., 2017; Noordermeer et al., 1998; Stork et al., 2009), they do not resemble cortex glia in form or function but instead ensheath commissural axons and play critical roles in axon guidance and VNC morphogenesis (Jacobs, 2000). Midline glia have been characterised extensively by several groups (Hartenstein, 2011; Hidalgo, 2003; Jacobs, 2000; Kearney et al., 2004; Vasenkova et al., 2006; Wheeler et al., 2006), therefore, given their distinct origin and the ambiguity surrounding their functional classification, we instead focused our analyses on repo+ glia in this manuscript.
Unfortunately, I found most of what is reported in this work not to be entirely new. The classification of glial diversity in the adult brain was presented by the Meinerzhagen and Gaul labs (Edwards and Meinertzhagen, 2010; Edwards et al., 2012; Kremer et al., 2017). The description of two astrocyte-like cell types is a reduction of data that defined three morphologically distinct astrocyte-like cells (Peco et al., 2016), which is not discussed. Some other aspects were ignored, too. Two other morphological distinct types of ensheathing glia exist, ensheathing glia and ensheathing/wrapping or track-associated glia were described but this is not discussed (Kremer et al., 2017; Peco et al., 2016).
We respectfully disagree with Reviewer 1’s assessment that much of the work presented in not new. This work represents the first Drosophila glial cell atlas with thorough validation of cluster marker expression in vivo. It is also the first systematic exploration of the relationship between glial morphology and transcriptional signature, a controversial topic in the field of glial biology. We fully agree that much of the adult glial morphology had been characterised previously by the Meinerzhagen and Gaul labs among many others and we acknowledge this explicitly in our manuscript and in references to Figures 2 (one out of a total of 9 main figures). Indeed, it is because Drosophila glial morphology has been so well characterised that a comprehensive exploration of the relationship between morphology and transcriptional signature was even feasible. Moreover, our revised manuscript also provides more in-depth morphological characterisation and quantification of glial morphology and defines subclasses and morphologies not described previously (e.g. channel perineurial glia and astrocyte morphologies of the lobula and lobula plate). Indeed, even the channel subperineurial glia, which were identified based on lineage relationships, nuclear position and molecular markers, were not described in morphological terms.
The 3 distinct astrocyte populations defined in Peco et al., (2016) refer to cell body position and neuropil domains covered by astrocytes. We now include this categorisation in our quantification of astrocyte morphology (See response to (6) and Figure 1 – figure supplement 2) and discuss their relationship to the type 1 and type 2 astrocyte morphologies that we observed.
As well we now include the ensheathing/wrapping or tract ensheathing glia as a morphological category of ensheathing glia in the manuscript (Figure 1A,N,O).
-
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
This is a simulation study comparing the performance of two major approaches for dealing with “population structure” when carrying out Genome-wide Association Studies - Principal Component Analysis and Linear Mixed-effects Models - a subject of considerable practical importance. The author correctly notes that previous comparisons have been quite limited. In particular, any study not concluding that LMM was superior has relied on very simple models of structure.
The paper is clearly written and beautifully reviews the theoretical underpinnings (albeit in a manner that will be difficult to penetrate without deep knowledge of several fields). The simulations are well-designed and far better than previous studies. From a theoretical point of view, the work is somewhat limited by being strongly anchored in a very classical quantitative genetics framework that is focused on allele frequencies and inbreeding coefficients, and totally ignores coalescent theory, but this is a minor quibble. The simulations are limited by utilizing ridiculously small sample sizes by the standards of modern human GWAS. And of course, they do not include all the complexities of real data.
The quantitative genetics framework we used was ideal for motivating and interpreting LMMs in particular, since they model relatedness with a kinship matrix which consists of IBD probabilities, all of which arose from quantitative genetics.
We also added the following text to the discussion: “However, our conclusions are not expected to change with larger sample sizes, as cryptic family relatedness will continue to be abundant in such data, if not increase in abundance, and thus give LMMs an advantage over PCA (Henn et al., 2012; Shchur et al., 2018; Loh et al., 2018).”
The main conclusion of the study is that LMM really are generally superior - as expected on theoretical grounds. However, the authors do address whether switching to LMM really is practicable given the sample size and lack of data sharing that characterize human genetics. Nor is it clear whether the difference in performance matters in real life given that the entire framework used is an idealized one - the fact that real human data suffers from environmental confounders that are correlated with “ancestry” is not addressed, to take the most obvious example. That said, it is surely important to note that the approach routinely used by the majority of users (PCA with 10 PCs) is most used for historical reasons and has little theoretical or empirical justification.
We added simulations with environment effects correlated with ancestry, which we hope will make our study even more relevant as it does make our evaluations even more realistic than before. In the presence of environment effects, LMM without PCs remains among the best approaches, although occasionally LMM with PCs or PCA will perform slightly better. However, modeling environment directly (with the true variables) improves performance much more than by using PCs to model environment indirectly, so we believe that is not a strong reason for continuing to use PCs (in LMMs or otherwise) unless there is no choice.
We also added the following text to the discussion: “However, recent approaches not tested in this work have made LMMs more scalable and applicable to biobank-scale data (Loh et al., 2015; Zhou et al., 2018; Mbatchou et al., 2021), so one clear next step is carefully evaluating these approaches in simulations with larger sample sizes.” As stated earlier, we believe that the difference in performance between LMM and PCA will remain in larger sample sizes because cryptic relatedness is more prevalent in that setting.
We excluded the “lack of data sharing” point from our discussion because it does not align well with the goals of our manuscript. The current solution to the lack of data sharing is meta-analysis, but its use does not give PCA or LMM an inherent advantage, since it can be applied to the summary statistics of either (or even a combination of models, in theory). There is interesting recent work on “federated” PCA and LMM association (both versions exist), that allow a single model to be fit jointly to separate datasets (residing in different buildings across the world) as if they were combined into a single dataset. Thus, these issues do not explain or motivate why PCA or LMM should be used.
Reviewer #2 (Public Review):
Yao and Ochoa present a very nice paper examining the age-old question of whether LMM or PCA is a better way to adjust for structure (population, family, admixture). The authors provide a very nice and detailed overview of the previous research addressing this question, summarizing it in a table. They find that LMMs are generally better at accounting for population structure. However, I feel there are a couple of important factors that are missing. One is the consideration of environmental structure. Another is that the relationship between PCA and LMM is usually a bit more complicated in practice than depicted here, where the devil really lies in the details. Also, I think there are a couple of key reasons why LMMs haven’t been adapted as quickly as one might have expected, including case-control imbalance and cohort meta-analyses, which I feel the authors could point out. In fact, I believe LMMs have become sort of popular in recent years (e.g. Japan Biobank GWAS results).
We added environment simulations, which we agree was an important shortcoming of the previous version of our work.
We now discuss how the PCA and LMM connection can be more complicated in practice, but as the main difference is in how LD is handled, once that is correctly adjusted, PCs and random effects are still mostly modeling the same relatedness signals. Ultimately, our main conclusion is unchanged, namely that only LMMs can model family relatedness, which is their key advantage.
We briefly commented on case-control imbalance in our discussion (now made more clear), but since this involves binary traits, which we did not explicitly test in this work, it is out of scope.
Cohort meta-analysis does not influence whether to use PCA or LMM, since it can be performed with summary statistics from either model (and in theory even a combination of different models per cohort). The broad use of meta-analysis does not in itself prevent users from using PCA or LMM within individual cohorts. The use of meta-analysis is very interesting in its own right, but it is outside the scope of this work.
Reviewer #3 (Public Review):
This paper examines the relative performance of linear mixed models (LMMs), principal components (PCA), and their combination (PCA-LMM) for genetic association studies in human populations. The authors claim that previous papers examining this question are inadequate and that: (i) there remains confusion on which method is best and in which context, (ii) that the metrics used in previous evaluations were insufficient, and (iii) that the simulation settings used in previous papers were not comprehensive. To fix these problems the authors perform an extensive set of simulations within several frameworks and suggest two new metrics for evaluating performance.
Strengths:
The simulation framework used in this paper and the extensive number of simulations provide an opportunity to examine the relative properties of the three approaches (LMM, PCA, PCA-LMM) in a variety of contexts.
The parameters of the simulation framework are based on highly diverged populations, which is an increasingly common analysis choice that has not been examined in detail via simulation previously.
The evaluation metrics used in this paper are AUC and a test of the uniformity of the p-value distribution under the null. This is an improvement over some previous analyses which did not examine power and relied on less sensitive tests of type I error.
Weaknesses:
This paper has a limited set of population frameworks just like all papers before it. The breakdown of which method is best (LMM, PCA, PCA-LMM) will be a function of the simulation framework chosen.
Ameliorating this issue, we added additional simulations with low heritability and with environment effects. We are pleased to report that all of our conclusions hold at low heritability (h2 = 0.3), and for the most part under environment effects (which occasionally give LMM with PCs and PCA a small advantage, but often LMM with no PCs remains best, and we show PCs are no replacement for directly modeling these environment effects).
The frameworks chosen for this paper are certainly not comprehensive in contemporary human genetic studies. In fact, the authors make a number of unusual choices. For example, the populations in the simulated study have extremely large Fsts. While this is also a strength, the lack of more standard study designs is a weakness. More importantly, there is no simulation of family effects, which is the basis of many of the PCA-LMM papers reported in Table 1.
We now better motivate in the introduction our focus on association studies of multiethnic and admixed individuals, which are nowadays very common and which have greater FST values than earlier studies. In reference to higher simulated FSTs, we also now cite our recent work, which has found that many previous FST estimates are downwardly biased (Ochoa and Storey, 2021, 2019). We simulated data that was fit to each of our three real datasets using our unbiased methods, so those values that (understandably) appear high are actually more correct (for multiethnic populations such as those in 1000 Genomes, HGDP, etc) than previous estimates in the literature. In our previous work we also determined that only previous pairwise FST estimators are unbiased (under some conditions), and using a previous pairwise FST estimator (from Bhatia et al., 2013) we obtained equally high values between the most diverged human populations (values from a revised version of Ochoa and Storey, 2019 that isn’t on bioRxiv yet): In HGDP, the largest pairwise FST is 0.479, between Pima and PapuanSepik; In Human Origins, the largest estimate is 0.396, between Cabecar and Baining_Malasait; Lastly, in 1000 Genomes, the largest estimate is 0.135, between YRI and JPT. (1000 Genomes was generally less structured than HGDP and Human Origins, because the latter include more diverse populations.) Several previous estimates from the literature, all between one hunter-gatherer Sub-Saharan African subpopulation and one non-African subpopulation resulted in values of about 0.25 (Bowcock et al., 1991, Henn et al., 2011, Bergstrom et al., 2020). FST estimates are also greater from whole-genome sequencing versus array data (revised version of Ochoa and Storey, 2019).
Family (household) effects is a case where PCA is not expected to outperform LMM, though standard LMMs do not model this effect explicitly either and may not do much better. As this is a feature of family studies that ought to be absent in population studies (as usually only siblings are in the same household, and not more distant relatives), it is also not entirely relevant to the majority of our simulations. In these ways, including such a feature in our simulations does not align with the goals of this present work, but we agree this is an important framework that deserves more attention in future evaluations.
The discussion (and simulations) of LMM vs PCA, particularly LMMs with PCs as fixed effects misses the critical distinction of whether PCs are in-sample (in which case including PCs as fixed effects effectively serves as a preconditioner for the kinship matrix, speeding up iterative methods such as BOLT), or projections of individuals onto out-of-sample principal axes. There is also no discussion of LOO methods to address “proximal contamination”, also quite relevant in evaluating power as a function of the number of PCs.
We added the following to our discussion concerning out-of-sample PC projections: “We do not consider the case where samples are projected onto PCs estimated from an external sample (Prive et al., 2020), which is uncommon in association studies, and whose primary effect is shrinkage, so if all samples are projected then they are all equally affected and larger regression coefficients compensate for the shrinkage, although this will no longer be the case if only a portion of the sample is projected onto the PCs of the rest of the sample.”
We also added the following to the discussion concerning the LOCO approach: “Similarly, the leave-onechromosome-out (LOCO) approach for estimating kinship matrices for LMMs prevents the test locus and loci in LD with it from being modeled by the random effect as well, which is called”proximal contamination” (Lippert et al., 2011, Yang et al., 2014). While LOCO kinship estimates vary for each chromosome, they continue to model family relatedness, thus maintaining their key advantage over PCA.”
The same new discussion paragraph closes with the following thoughts concerning LOCO and related approaches: “LD effects must be adjusted for, if present, so in unfiltered data we advise the previous methods be applied. However, in this work, simulated genotypes do not have LD, and the real datasets were filtered to remove LD, so here there is no proximal contamination and LD confounding is minimized if present at all, so these evaluations may be considered the ideal situation where LD effects have been adjusted successfully, and in this setting LMM outperforms PCA. Overall, these alternative PCs or kinship matrices differ from their basic counterparts by either the extent to which LD influences the estimates (which may be a confounder in a small portion of the genome, by definition) or by sampling noise, neither of which are expected to change our key conclusion.”
Lastly, we added the following to a different discussion paragraph: “A different benefit for including PCs were recently reported for BOLT-LMM, which does not result in greater power but rather in reduced runtime, a property that may be specific to its use of scalable algorithms such as conjugate gradient and variational Bayes (Loh et al., 2018).”
There is no discussion/simulation of spatial/environmental effects or rare vs common PCs as raised in Zaidi et al 2020. There are some open questions here regarding relative performance the authors could have looked at. Same for LMMs with multiple GRMs corresponding to maf/ld bins and thresholded GRMs. For example, it would be helpful to know if multiple-GRM LMMs mitigate some of the problems raised in the Zaidi paper.
We added simulations with environment effects, which are based on a two-level hierarchy of population labels so they are spatial to the extent that these labels capture spatial relationships between populations. However, our small sample size data are not well suited to study rare variants and their structure, so its out of scope. (The sample size limitation is also covered in a new discussion paragraph.) We hope to tackle this very interesting question in future work.
We added the following paragraph to our discussion: “Another limitation of this work is ignoring rare variants, a necessity given our smaller sample sizes, where rare variant association is miscalibrated and underpowered. Using simulations mimicking the UK Biobank, recent work has found that rare variants can have a more pronounced structure than common variants, and that modeling this rare variant structure (with either PCA and LMM) may better model environment confounding, improve inflation in association studies, and ameliorate stratification in polygenic risk scores (Zaidi and Mathieson, 2020). Better modeling rare variants and their structure is a key next step in association studies.”
-
- Apr 2023
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
We thank the editors and reviewers for their assessment of our manuscript, and their agreement that we present compelling evidence for post-transcriptional regulation of AURKA through the 3’UTR.
In response to Reviewer 1, we acknowledge that much of our study is performed exclusively in U2OS cells, and that study of alternative polyadenylation in additional cell lines would serve to further generalize our findings. However, as U2OS are a well-known model cell line for cell cycle studies we believe our demonstration of cell cycle regulation of AURKA through its 3’UTR offers a depth of understanding that is perhaps of greater interest than confirming the existence of alternative AURKA 3’UTRs in additional cell lines, using our methods. We note that the recent rapid growth in RNA seq data resources allows easy confirmation of the broad existence of alternative polyadenylation events on a genome-wide scale. For example, AURKA-specific data extracted from a recent benchmark study of Nanopore long read RNA sequencing (Chen et al., 2021) clearly shows the existence of two distinct AURKA 3’UTRs differentially expressed between a number of different cancer cell lines. In addition, a recent study investigating the landscape of APA at single-cell resolution detected AURKA APA isoforms in HeLa and MDA-MB-468 cell lines (Wang et al., 2022). Their study further identifies AURKA among genes showing negative correlation between generalized distal polyA site usage index (gDPAU) and expression levels, meaning preference to use the proximal polyA site when expression levels increase, and include AURKA in the gene cluster showing slight increase in usage of the distal polyA site from G1 to M phase (Wang et al., 2022). Both studies are in support of the evidence presented in our manuscript.
We agree with Reviewer 2 that better information on translation rates would improve our understanding of the impact of translation regulation on AURKA levels. Some insight on the translation rate of AURKA in the cell cycle can be derived from inspection of the ribosome profiling dataset published by Tanenbaum et al., 2015. From their analysis, translation efficiency of AURKA mRNA in G2 is 1.59 times that in G1 and in G1 it is 0.69 times that in M phase, whilst in G2 it is 1.10 times higher than in M. Such data reveal a reversible increase in translation of AURKA mRNA, alongside other mitotic regulators, in preparation for M phase (Tanenbaum et al., 2015). These results are in accordance with our findings that translation rates contribute modestly to cell cycle changes in AURKA levels in normal cells, and we concur with Reviewer 3’s comment that the contribution of increased translation rate to AURKA levels at mitosis is less than the change in mRNA levels at this point in the cell cycle.
We think the significance of the regulatory mechanism we describe lies rather in the large effect it has on AURKA levels in interphase (when AURKA expression is normally repressed at both mRNA and translation rate). We hypothesise that it is interphase regulation that may be relevant to roles of AURKA in cancer (and to the association of APA with cancer) (Bertolin and Tramier, 2020; Naso et al., 2021). It is indeed the case that (i) AURKA regulation by miRNA, (ii) cooperation between APA and translation and (iii) cell-cycle dependent control of AURKA at the translation level, are already known. We believe the novelty of our study lies in drawing together these elements to provide new insight into AURKA regulation, using tools that allow similar investigation of other APA events, and contributing new ideas for future therapeutic interventions for disease proteins regulated via APA.
- Bertolin and Tramier (2020), Cell. Mol. Life Sci https://link.springer.com/article/10.1007/s00018-019-03310-2
- Chen et al. (2021), bioRxiv https://www.biorxiv.org/content/10.1101/2021.04.21.440736v1
- Naso et al. (2021), Oncogene https://www.nature.com/articles/s41388-021-01766-w
- Tanenbaum et al. (2015), eLife https://elifesciences.org/articles/07957
- Wang et al. (2022), PNAS https://www.pnas.org/doi/10.1073/pnas.2113504119
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
We would like to thank you for your thorough review of the manuscript. We will take all comments into account in the revised version of the manuscript. Please find below our provisional responses to your comments.
eLife assessment
This study reports useful information on the limits of the organotypic culture of neonatal mouse testes, which has been regarded as an experimental strategy that can be extended to humans in the clinical setting for the conservation and subsequent re-use of testicular tissue. The evidence that the culture of testicular fragments of 6.5-day-old mouse testes does not allow optimal differentiation of steroidogenic cells is compelling and would be useful to the scientific community in the field for further optimizations.
Thank you for this assessment. We will carefully consider all comments and make the requested revisions to improve the manuscript.
Public Reviews
Reviewer #1 (Public Review):
In this manuscript, the authors aimed to compare, from testis tissues at different ages from mice in vivo and after culture, multiple aspects of Leydig cells. These aspects included mRNA levels, proliferation, apoptosis, steroid levels, protein levels, etc. A lot of work was put into this manuscript in terms of experiments, systems, and approaches. However, as written the manuscript is incredibly difficult to follow. The Introduction and Results sections contain rather loosely organized lists of information that were altogether confusing. At the end of reading these sections, it was unclear what advance was provided by this work. The technical aspects of this work may be of interest to labs working on the specific topics of in vitro spermatogenesis for fertility preservation but fail to appeal to a broader readership. This may be best exemplified by the statements at the end of both the Abstract and Discussion which state that more work needs to be done to improve this system.
As explained below, we will rework and reorganize the manuscript to make it clearer, more meaningful and more precise. We believe that this work may be of interest to a broader readership. Indeed, the development of a model of in vitro spermatogenesis could be of interest for labs working on the specific period of puberty initiation, on germ and somatic cell maturation and on steroidogenesis during this period, and could even be useful for testing the toxicity of cancer therapies, drugs, chemicals and environmental agents (e.g. endocrine disruptors) on the developing testis.
Reviewer #2 (Public Review):
Preserving and restoring the fertility of prepubertal patients undergoing gonadotoxic treatments involves freezing testicular fragments and waking them up in a culture in the context of medically assisted procreation. This implies that spermatogenesis must be fully reproduced ex vivo. The parameters of this type of culture must be validated using non-human models. In this article, the authors make an extensive study of the quality of the organotypic culture of neonatal mouse testes, paying particular attention to the differentiation and endocrine function of Leydig cells. They show that fetal Leydig cells present at the start of culture fail to complete the differentiation process into adult Leydig cells, which has an impact on the nature of the steroids produced and even on the signaling of these hormones.
The authors make an extensive study of the different populations of Leydig cells which are supposed to succeed each other during the first month of life of the mouse to end up with a population of adult and fully functional cells. The authors combine quantitative in situ studies with more global analyzes (RT-QtPCR Western blot, hormonal assays), which range from gene to hormone. This study is well written and illustrated, the description of the methods is honest, the analyses systematic, and are accompanied by multiple relevant control conditions.
Since the aim of the study was to study Leydig cell differentiation in neonatal mouse testis cultures, the study is well conceived, the results answer the initial question and are not over-interpreted.
My main concern is to understand why the authors have undertaken so much work when they mention RNA extractions and western blot, that the necrotic central part had to be carefully removed. There is no information on how this parameter was considered for immunohistochemistry and steroid measurements. The authors describe the initial material as a quarter testis, but they don't mention the resulting size of the fragment. A brief review of the literature shows that if often the culture medium is crucial for the quality of the culture (and in particular the supplementations as discussed by the authors here), the size of the fragments is also a determining factor, especially for long cultures. The main limitation of the study is therefore that the authors cannot exclude that central necrosis can have harmful effects on the survival and/or the growth and/or the differentiation of the testis in culture. In this sense, the general interpretation that the authors make of their work is correct, the culture conditions are not optimized.
When using the organotypic culture system at a gas-liquid interphase, the central part of the testicular tissue becomes necrotic. As previously reported (Komeya et al., 2016), the central region receives insufficient nutrients and oxygen. In vitro spermatogenesis therefore only occurs in the seminiferous tubules present in the peripheral region. As in our previous publications and recent RNA-seq analyses (Dumont et al., 2023), the central necrotic area was removed so that transcript and protein levels in the healthy part of the samples (i.e. where in vitro spermatogenesis occurs) could be measured and compared with in vivo controls. For histochemical and immunohistochemical analyses, only seminiferous tubules located at the periphery of the cultured fragments (outside of the necrotic region) were analyzed. Steroid measurements were performed on the entire fragments.
The initial material was indeed a quarter testis, which represents approximately 0.75 mm3. No growth of the fragments was observed during the organotypic culture period. We agree with the reviewer that the composition of the culture medium is not the only parameter to be considered for the quality of the culture and that the size of the fragments is also a determining factor. We do not exclude that central necrosis can have harmful effects on the survival and/or the growth and/or the differentiation of the testis in culture. Optimization of the culture medium and culture design (so that the tissue center receives sufficient nutrients and oxygen) will be necessary to increase the yield of in vitro spermatogenesis.
Organotypic culture is currently trying to cross the doors of academic research laboratories to become a clinical tool, but it requires many adjustments and many quality controls. This study shows a perfect example of the pitfall often associated with this approach. The road is still long, but every piece of information is useful.
Reviewer #3 (Public Review):
Moutard, Laura, et al. investigated the gene expression and functional aspects of Leydig cells in a cryopreservation/long-term culture system. The authors found that critical genetic markers for Leydig cells were diminished when compared to the in-vivo testis. The testis also showed less androgen production and androgen responsiveness. Although they did not produce normal testosterone concentrations in basal media conditions, the cultured testis still remained highly responsive to gonadotrophin exposure, exhibiting a large increase in androgen production. Even after the hCG-dependent increase in testosterone, genetic markers of Leydig cells remained low, which means there is still a missing factor in the culture media that facilitates proper Leydig cell differentiation. Optimizing this testis culture protocol to help maintain proper Leydig cell differentiation could be useful for future human testis biopsy cultures, which will help preserve fertility and child cancer patients.
Methods: In line 226, there is mention that the central necrotic area was carefully removed before RNA extraction. This is particularly problematic for the inference of these results, especially for the RT-qPCR data. Was the central necrotic area consistent between all samples and variables (16 and 30FT)? How big was the area? This makes the in-vivo testis not a proper control for all comparisons. Leydig cells are not evenly distributed throughout the testis. A lot of Leydig cells can be found toward the center of the gonad, so the results might be driven by the loss of this region of the testis.
When using the organotypic culture system at a gas-liquid interphase, the central part of the testicular tissue becomes necrotic. As previously reported (Komeya et al., 2016), the central region receives insufficient nutrients and oxygen. In vitro spermatogenesis therefore only occurs in the seminiferous tubules present in the peripheral region. As in our previous publications and recent RNA-seq analyses (Dumont et al., 2023), the central necrotic area was removed so that transcript levels in the healthy part of the samples (i.e. where in vitro spermatogenesis occurs) could be measured and compared with in vivo controls. The transcript levels of the selected genes were of course normalized to housekeeping genes (Gapdh and Actb) or to the Leydig cell-specific gene Hsd3b1.
The central necrotic area was consistent between all samples and variables: it represents on average 16-27% of the explants.
Moreover, we would like to point out that the gonads were cut into four fragments before in vitro cultures. It is therefore the central part of these explants that was removed and not the central part of the gonads. The central part of the gonads was thus included in our analyses.
What did the morphology of the testis look like after culturing for 16 and 30 days? These images will help confirm that the culturing method is like the Nature paper Sato et al. 2011 and also give a sense of how big the necrotic region was and how it varied with culturing time.
This point will be addressed in the detailed responses to reviewers.
There are multiple comparisons being made. Bonferroni corrections on p-value should be done.
This point will be addressed in the detailed responses to reviewers.
Results: In the discussion, it is mentioned that IGF1 may be a missing factor in the media that could help Leydig cell differentiation. Have the authors tried this experiment? Improving this existing culturing method will be highly valuable.
The decreased Igf1 mRNA levels found in the present study are in line with the RNA-seq data of Yao et al., 2017. As mentioned in the Discussion section, the addition of IGF1 in the culture medium led to a modest increase in the percentages of round and elongated spermatids in cultured mouse testicular fragments (Yao et al., 2017). However, the effect of IGF1 supplementation on Leydig cell differentiation was not investigated. The supplementation of organotypic culture medium with IGF1 is currently being tested in our research team.
Add p-values and SEM for qPCR data. This was done for hormones, should be the same way for other results.
p-values and SEM are shown for both qPCR and hormone data.
Regarding all RT-qPCR data-There is a switch between 3bHSD and Actb/Gapdh as housekeeping genes. There does not seem to be as some have 3bHSD and others do not. Why do Igf1 and Dhh not use 3bHSD for housekeeping? If this is the method to be used, then 3bHSD should be used as housekeeping for the protein data, instead of ACTB. Also, based on Figure 1B and Figure 2A (Hsd3b1) there does not seem to be a strong correlation between Leydig cell # and the gene expression of Hsd3b1. If Hsd3b1 is to be used as a housekeeper and a proxy for Leydig cell number a correlation between these two measurements is necessary. If there is no correlation a housekeeping gene that is stable among all samples should be used. Sorting Leydig cells and then conducting qPCR would be optimal for these experiments.
Hsd3b1 was used as a housekeeping gene only to normalize the mRNA levels of Leydig cell-specific genes. Therefore, Igf1 and Dhh transcript levels were not normalized with Hsd3b1 since Igf1 is expressed by several cell types in the testis (Leydig cells, Sertoli cells, peritubular myoid cells) and Dhh is expressed by Sertoli cells.
Regarding western blots, the expression of AR, CYP19 and FAAH could not be normalized with 3bHSD since AR is expressed by Leydig cells, Sertoli cells and peritubular myoid cells, CYP19 is expressed by Leydig cells and germ cells and FAAH is expressed by Sertoli cells. We will review the western blot results for CYP17A1.
As shown in Figure 1B, the number of Leydig cells per cm2 of testicular tissue is not significantly different between the different time points in vivo (6 d_pp_, 22 d_pp_ and 36 d_pp_), in vitro (D16 FT and D30 FT) and between the in vivo and in vitro conditions (22 d_pp_ versus D16 FT, 36 d_pp_ versus D30 FT). Similarly, our data in Figure 2A show that Hsd3b1 mRNA levels are not significantly different between the different time points in vivo (6 d_pp_, 22 d_pp_ and 36 d_pp_), in vitro (D16 FT and D30 FT) and between 22 d_pp_ and D16 FT. However, Hsd3b1_mRNA levels were significantly lower in D30 FT tissues compared to 36 d_pp. We will measure the correlation between the number of Leydig cells per cm2 of testicular tissue and Hsd3b1 mRNA levels, as suggested by the reviewer.
Figure 2A (CYP17a1): It is surprising that the CYP17a1 gene and protein expression is very different between D30FT and 36.5dpp, however, the immunostaining looks identical between all groups. Why is this? A lower magnification image of the testis might make it easier to see the differences in Cyp17a1 expression. Leydig cells commonly have autofluorescence and need a background quencher (TrueBlack) to visualize the true signal in Leydig cells. This might reveal the true differences in Cyp17a1.
This point will be addressed in the detailed responses to reviewers.
Figure 3D: there are large differences in estradiol concentration in the testis. Could it be that the testis is becoming more female-like? Leydig and Sertoli cells with more granulosa and theca cell features? Were any female markers investigated?
We show in the present study that the expression level of the Sertoli cell-specific gene Dhh is not reduced in organotypic cultures. We also previously found that the expression level of the Sertoli-cell specific gene Amh was not reduced in in vitro matured testicular tissues (Rondanino et al., 2017). Moreover, our recent unpublished data show that Sox9, a testis-specific transcription factor, is expressed in Sertoli cells in organotypic cultures. These results suggest that Sertoli cells are not becoming granulosa-like cells and that the testis is not becoming more female-like. Markers of granulosa and theca cells were not investigated.
Figure 3D and Figure 5A: It is hard to imagine that intratesticular estradiol is maintained for 16-30 days without sufficient CYP19 activity or substrate (testosterone). 6.5 dpp was the last day with abundant CYP19 expression, so is most of the estrogen synthesized on this first day and it sticks around? Are there differences in estradiol metabolizing enzymes? Is there an alternative mechanism for E production?
This point will be addressed in the detailed responses to reviewers.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response:
Evaluation Summary:
The study provides evidence that specific transcriptional responses may underpin the observation that metabolic rates often scale inversely with body mass. The conclusions are supported by direct measurement of metabolic fluxes in mouse and rat livers, although generalizations to other settings remain to be rigorously tested. The study has broad implications for researching and studying animal metabolism and physiology.
We thank the reviewers and editors for this summary. We are pleased that they agree that the conclusions “are supported by direct measurements of metabolic fluxes in mouse and rat livers,” and that “the study has broad implications for researching and studying animal metabolism and physiology. While we fully agree that “generalizations to other settings remain to be rigorously tested,” we have now added a comment comparing our measured liver fluxes in rodents to those recently measured in people:
“While we did not have the capacity to measure liver fluxes in larger mammals in the current study, endogenous glucose production, VPC, and VCS previously measured using PINTA were 50-60% lower in overnight fasted humans than in rats (Petersen et al., 2019), assuming a liver size of 1,500 g in humans.”
Reviewer #1 (Public Review):
It is well established that the energy expenditure and metabolic rate of metazoan organisms scale inversely to body mass, based on the measurement of oxygen consumption and caloric intake. However, the underlying regulatory mechanisms for this observation are poorly defined. To investigate whether metabolic scaling is associated with reduced levels of transcription of metabolic genes in larger animals, the authors reviewed existing transcriptional datasets from liver tissues of five animals (mice, rats, monkeys, humans and cattle) with a 30,000-fold range in average adult body weights. They identified a number of metabolic genes in different pathways of central carbon metabolism whose expression inversely scaled with body size, a majority of which required oxygen, NAD/H or ATP/ADP. Metabolic flux studies on intact liver sections, as well as in live animals also revealed decreased liver metabolic fluxes in rats compared to mice. Interestingly, these differences were not observed in primary hepatocyte cultures, indicating that metabolic scaling is primarily regulated by cell-extrinsic factors and tissue context. These are interesting findings and highlight the importance of measuring metabolic processes in vivo. The measurement of cellular metabolic fluxes in different contexts (cultured, ex vivo tissue sections and live animals) is a major strength of this study. The lack of direct evidence that enzyme levels correlate with mRNA, and the absence of both transcriptional and enzyme activity measurements in cultured cells are potential weaknesses.
We are delighted, and thank Reviewer #1 for stating that “These are interesting findings and highlight the importance of measuring metabolic processes in vivo” and that “The measurement of cellular metabolic fluxes in different contexts (cultured, ex vivo tissue sections and live animals) is a major strength of this study.” In addition, we sincerely thank the reviewer for raising important weaknesses related to the importance of proteomics, transcriptional and enzyme activity measurements in cultured cells, and are pleased to have had the opportunity to add data to address each of these points.
Reviewer #2 (Public Review):
Akingbesote et al. aim to determine the molecular basis of metabolic scaling - the phenomenon that metabolic rates scale inversely with (0.75) body mass. More specifically, they test the hypothesis that expression of genes involved in the regulation of oxygen consumption and substrate metabolism as well as respective fluxes provide a molecular basis for metabolic scaling across five species: mice, rats, monkeys, humans, and cattle. To this end, Akingbesote et al. use publicly available transcriptomics data and identify genes that show decreasing (normalized) expression with increasing mass of organisms. This descriptive analysis is followed by discussing a few relevant examples and (KEGG) pathway enrichment analysis. The authors then used their published PINTA approach with data from their experiments with mice and rats to provide estimates of selected cytosolic and mitochondrial fluxes in vitro, ex vivo, and in vivo; these estimates are then employed in determining if metabolic fluxes scale. The conclusion drawn from these analyses is that estimates of selected fluxes do not differ in vitro between plated hepatocytes of mice and rats, but that differences can be detected using metabolic flux analysis in vivo. As a result, in vivo flux profiling is more relevant to assessing metabolic scaling.
The conclusions are only in part supported by the data and clarifications are needed both with respect to the analysis of transcriptomics data as well as flux estimates:
- In looking for scaling in gene expression, the authors rely on the assumption that mRNA expression correlates well with protein abundance (citing Schwanhäusser et al., 2011); however, transcripts explain about 40% of variance in protein abundance (this observation holds across multiple species). Hence, the identified patterns based on the transcript data may have little implications for protein abundance or flux.
We agree that, despite the data in the cited publication, gene expression should not be assumed to directly correlate with protein expression, and the two certainly cannot be assumed – without data to equate to metabolic flux. We have removed the citation, and replaced it with proteomics data. Half of the genes available in the proteomics analysis which were found to correlate negatively with body size in our liver transcriptomics analysis also correlated negatively with body size at the level of liver protein expression:
Additionally, we analyzed available proteomics assessment of left ventricular expression of the three proteins observed to correlate negatively with body mass in the liver proteomics analysis. One of the three genes observed to correlate negatively with body mass in the proteomics analysis of liver, GLUL, was also shown to correlate negatively with body mass when its expression was assessed in the heart:
However, as discussed in our response to the editor’s point 1, we are limited by the available data, and fully acknowledge that without the capacity to statistically compare groups, we cannot make conclusive statements regarding the proteomics data.
Additionally, we have substantially softened the description of the implications of the transcriptomics data in the Abstract, Introduction, and Discussion, including: - Editing “Together, these data reveal that metabolic scaling extends beyond oxygen consumption to numerous other metabolic pathways, and is likely regulated at the level of gene and protein expression, enzyme activity, and substrate supply” to add the parameters in red. - Removing “Considering that mRNA expression correlates well with protein expression under basal conditions, especially for metabolic genes (Schwanhäusser et al., 2011), we used mRNA expression as a proxy for the relative abundance of metabolic enzymes.” - Added “Further analysis of liver proteomics revealed that approximately half of the genes in liver that scaled at the transcriptional level also scaled at the level of protein expression,” now linking gene expression to protein expression to metabolic flux. - Editing “Numerous metabolic genes…followed the pattern of metabolic scaling, and informed our isotope tracer based in vitro and in vivo metabolic flux studies” to “Numerous metabolic genes…followed the pattern of metabolic scaling. Further analysis of liver proteomics revealed that approximately half of the genes in liver that scaled at the transcriptional level also scaled at the level of protein expression. To determine if gene and protein expression would correlate with scaling at the level of metabolic flux, we performed a comprehensive assessment of liver metabolism in vivo and in vitro using modified Positional Isotopomer NMR Tracer Analysis (PINTA)…” - Edited “Taken together, this study demonstrates systems regulation of metabolic scaling: gene expression in livers showed that scaling occurs to regulate oxygen consumption and substrate supply, isotope-based tracer studies in mice and rats demonstrated the mechanistic function of these enzymes in vivo which was only apparent in the living organism rather than plated cells” to “Taken together, this study demonstrates systems regulation of the ordering of metabolic fluxes according to body size, and provides unique insight into the regulation of metabolic flux across species.” - Removed “Interestingly, the scaling of GPT and ADIPOR1 further suggest that there is dependence on extra-hepatic organs in the scaling of in vivo gluconeogenesis and fatty acid oxidation: that is, skeletal muscle supply of alanine for the liver mediated glucose-alanine cycle and adipose tissue-derived adiponectin signaling. These findings also suggests that the scaling of mitochondrial mass (Porter and Brand, 1995) or mitochondrial proton leak (Porter and Brand, 1993) cannot fully explain metabolic scaling.” - Added “However, it should be noted that metabolic scaling cannot fully be explained at the transcriptional level, because many rate-limiting enzymes in the metabolic processes measured in vivo did not scale at the transcriptional level, and only approximately half of genes that scaled at the level of mRNA scaled at the level of protein. Thus, it is likely that both transcriptional and other mechanisms – such as enzyme activity – are responsible for variations in metabolic flux per unit mass, inversely proportionally to body size. Additionally, the currently available data do not allow us to assess whether expression of certain isoforms of key metabolic enzymes scale differentially across species.”
- While the procedure used to identify transcripts whose expression scale is clearly described, focusing the enrichment on KEGG pathways can only identify metabolic genes that scale. It would be informative and instructive to investigate if and to what extent genes involved in non-metabolic processes, that affect metabolic rates, also scale.
We acknowledge that focusing the enrichment on KEGG pathways does enrich for the identification of metabolic processes that scale. However, we would respectfully submit that because this manuscript focuses on metabolic scaling, this seems to be the most appropriate setting in which to conduct the analysis. New data added in this revision demonstrate that three metabolic enzymes that scaled in the transcriptomics analysis also scale relative to β-actin, further suggesting that the inverse correlation of gene expression with body weight is primarily confined to metabolic processes:
In addition, we measured the expression of two structural proteins (collagenase 3 [Mmp3] and Larp6) outside of metabolic pathways, relative to β-actin (Actb), and found that neither was differentially expressed relative to actin in mice versus rats:
We recognize that these data may be confounded by the fact that Actb expression could potentially be different in mice versus rats; however, the fact that metabolic genes scale relative to β-actin (Actb) expression shows that it is unlikely that global mRNA scaling is unlikely to be the sole cause of the metabolic scaling phenotype.
- The result on flux ratios and absolute fluxes, based on the equations in Table S1, rely on certain assumptions (e.g. metabolic and isotopic steady state, among the others listed in PINTA); the current presentation does not ensure that all assumptions of PINTA are met in the present setting, so the estimates may be biased, leading to alternative explanations for the observed differences in vivo or the lack thereof in vitro.
However, we fully agree with the reviewer that it is critical to ensure that key assumptions are met when presenting tracer data, and thank them for raising this important point. Thus, we have now added data demonstrating that plasma m+1, m+2, and m+7 glucose are in steady state at 100 min of the 120 min in vivo tracer infusion:
Additionally, we now show that blood glucose and plasma lactate concentrations have reached steady state as well:
With these data, we validate that the mice and rats are at metabolic and isotopic steady state by the end of the 120 min tracer infusion. We recognize that we have not validated that liver m+1 and m+2 glucose are at steady state, as that would require two additional groups of mice and rats (to sacrifice at 100 and 110 min, compared to the animals euthanized after 120 min of infusion) and introduce additional variability. Additionally, plasma m+1 and m+2 glucose come from endogenous glucose production from 13C tracer, so if m+1 and m+2 glucose are in steady state in plasma, they must be in steady state in liver.
An additional assumption is that liver glycogen is effectively depleted after the overnight fast utilized in these studies. We have now verified this assumption by comparing fed and overnight fasted liver glycogen concentrations, and detect negligible glycogen after the fast in both rats and mice:
Additionally, we validated isotopic steady state in our hepatocytes incubated in 3-13C lactate. As expected in plated cell studies, cells reached steady state in both [13C] lactate enrichment and m+1 and m+2 glucose enrichment within 60 min. Because net glucose production is measured using the accumulation of glucose, we do not expect – and did not measure – glucose concentration at steady state, but we did confirm that the accumulation of glucose is linear throughout the 6 hr incubation (thus confirming that 6 hr is a reasonable endpoint):
We very respectfully submit that after 8 prior publications using PINTA called as such (PMID 28986525, 29307489, 29483297, 31545298, 31578240, 32610084, 32132708, 32179679), in addition to several prior publications that utilized PINTA without the acronym, it would not be the most responsible use of animals to try to prove in this manuscript that PINTA is a legitimate means of assessing substrate fluxes in the current manuscript. However, we thank the reviewer for raising the important point regarding assumptions of the method, thereby allowing us to insert data verifying that the key assumptions are met.
- The findings regarding the flux estimates seem to be fully determined by observed differences in gluconeogenesis (as demonstrated in Fig. 4). Usage of more involved approaches for metabolic flux analysis may provide wider-reaching conclusions beyond selected fluxes that appear fully coupled.
Fluxes are back-calculated from total glucose production so that methodologically they are “coupled”, but this does not mean that glucose production will always mirror other flues. For example, in our 2015 manuscript using PINTA – although we had not yet named the method “PINTA” – we measured decreased endogenous glucose production (EGP) simultaneously with increased citrate synthase flux (mitochondrial oxidation, VTCA, which we have subsequently begun to call VCS in recognition of the fact that different reactions in the TCA cycle can proceed at different rates, but the calculation is the same) (Perry et al. Science 2015).
Similarly, another study demonstrated that the same mitochondrial uncoupler (CRMP) increased VCS while EGP decreased in nonhuman primates (Goedeke et al. Sci. Transl. Med. 2019).
These data demonstrate that, while fluxes are back-calculated from EGP with PINTA, the method is fully capable of detecting differences in oxidative fluxes without, or in the opposite direction of, changes in EGP. We very respectfully submit that we are not aware of what a more “involved” approach for metabolic flux analysis would entail, and that after the 8 prior publications listed in response to the previous point, we are not trying to validate PINTA in the current manuscript.
Reviewer #3 (Public Review):
This manuscript addresses a fundamental aspect of mammalian biology referred to as scaling, in which metabolic processes calibrate to the size of the organism. Longstanding observations related to scaling have been established based on rates of oxygen consumption. This manuscript extends these observations to gene expression and metabolic fluxes in order to discover the metabolic pathways that scale with body mass. The analyses are focused on the liver, which is the metabolic hub of the organism. Gene expression levels gleaned from available databases for organisms of varied sizes are analyzed and queried for scaling based on body mass. This analysis reveals that scaling is mainly a characteristic of metabolic genes. These data inform metabolic flux studies in cultured cells, liver slices and whole organisms. These studies demonstrate that scaling of metabolic fluxes occurs, but not out of the context of the whole organism or intact liver (in the form of liver slices). Scaling of metabolic fluxes is not observed in cultured hepatocytes. Overall, this is an interesting line of inquiry. The data are largely correlative in nature but add important texture to traditional characterization of oxygen consumption rates. The application of flux studies is a particular strength because these reflect the true metabolic processes. Enthusiasm was tempered by certain claims that extend beyond data (e.g., the title that suggests that metabolic scaling applies to tissues other than the liver, which was studied), as well as low numbers of biological replicates in some experiments, studies conducted in a single-gender and a writing style that includes excessive technical jargon.
We thank the reviewer for their time spent evaluating the paper, and for their very helpful comments. We agree that “the application of flux studies is a particular strength because these reflect the true metabolic processes.” We agree that the study was focused on liver, although the previous iteration did include a small amount of white adipose tissue flux data, and have edited the manuscript to make clear that this is a liver-focused manuscript. We have now added specific numbers to each figure legend, and have also added in vivo flux measurements in female rats and mice. Additionally, the manuscript has been edited extensively. We have further detailed these modifications in our point-by-point responses to the reviewer.
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #2 (Public Review):
In a neonatal model of bacterial meningitis induced by s.c. injection of E. coli, transcriptional changes were found across all major cell types including endothelial cells, fibroblasts and macrophages. Among macrophages, they describe 2 resident subsets and 2 inflammatory subsets. By immunohistochemistry of arachnoid and dura flatmounts, they show vascular changes upon infection, including clustering of CLDN5 and PECAM1, and disorganized capillary morphology, which was dependent on Tlr4 signaling but independent of arachnoid macrophages.
The manuscript would benefit from rewriting, it is not written in a concise manner and the rationale for experiments, time points for analyses and their conclusions are not clear. The model of s.c. bacterial infection is not well introduced and overall changes in the periphery, survival curves or bacterial counts (in the KO models) in the meninges/brain are not mentioned.
Thank you for those comments. We hope that the text is now more readable. We have added a separate section to describe the meninges model and added data on survival and E coli counts (Supplemental Figure 3).
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public Review):
This work puts forward a comprehensive characterisation of colorectal cancer (CCCRC), by classifying it into 4 subtypes with distinct TME features. It uses 10 public databases: 8 microarray datasets for the training of molecular classification and 2 RNAseq for validation (CRC-RNAseq) to identify the 4 subtypes using unsupervised machine learning (consensus clustering). These 4 subtypes were found to be somewhat distinct in terms of immune response and the possibilities for effective treatments. They found that one subtype may be more sensitive to chemotherapy, two to WNT pathway inhibitor SB216763 and Hedgehog pathway inhibitor vismodegib, and one to ICB treatment. They show an association with patient outcome in terms of PFS, validated in the validation cohort. They used histology to correspond the subtypes to known pathological types, as well as investigating their T cell makeup. They also investigated the genetic tumour evolution that may occur between the subtypes. A single-sample gene classifier was put forward as a way of identifying the class of cancer. The evidence for the main results of the work is convincing, but a few areas need to be clarified and extended.
In the determination of the 4 subtypes (C1-C4) the methodology is clear, and the definition of the training and validation data are clear and well presented. The techniques used are well suited to the problem. The performance of the classification as a predictor of prognosis is presented as KM curves of PFS and OS for the training and validation sets. The training data shows a significant log-rank p-value in both PFS and OS. The validation data shows a significant effect in PFS.
What follows is quite an exhaustive process of finding differences between the cohorts using a multitude of techniques and datasets, including genomics, epigenetics, transcriptomics, and proteomics. These sections are mainly descriptive and do add understanding to the classification, especially with regard to the T-cell populations that are invasive.
Improvements could be made to the latter sections of the main paper. The basis for the potential clinical responses of the subtypes is arrived at via a "pre-clinical model" based on 81 genes. It would benefit from clarification on what genes were used in model training and details of the final model. Similarly the description of the "Single-sample gene classifier" could be enhanced similarly with a better description of which genes are in the final classifier.
Thank you for taking the time to review our article and for your positive feedback. Your thorough evaluation of our work has been invaluable to us, and we appreciate your recognition of the effort we put into it.
1) The basis for the potential clinical responses of the subtypes is arrived at via a "pre-clinical model" based on 81 genes.
The exact details of the filtering criteria used to obtain the list of pre-clinical model genes have added to the Methods section of the study (Lines 1061-108, Lines 503-511) (Supplementary file 3a). To explore the treatment for each CCCRC subtype using cancer cell line drug-sensitivity experiments, we developed a pre-clinical model based on subtype-specific, cancer cell-intrinsic gene markers according to a previously published study (Eide et al., 2017). Firstly, the “limma” package was used to identify DEGs with FDR < 0.05 between each of the four subtypes and the remaining subtypes in the CRC-AFFY cohort. To identify subtype-specific genes in one of the subtypes, we excluded those that were found to be differentially expressed in comparisons between one of the other subtypes and the remaining subtypes. The upregulated subtype-specific genes (log2 (fold change, FC) > 0 and FDR < 0.05) was ranked based on their log2FC and selected the top 500 genes for further gene screening. Secondly, the GEP of human CRC tissues versus patient-derived xenografts (PDX) in the GSE35144 dataset by the R package “limma” was used to remove those genes associated with stromal and immune components. DEGs with FDR > 0.5 and log2 FC < 1 between human CRC tissues versus PDX were considered as cancer cell-intrinsic genes. Thirdly, we also utilized human CRC cell lines to obtained cancer cell-intrinsic genes. A total of 71 human CRC cell lines with RNAseq data (log2TPM) was obtained from the Genomics of Drug Sensitivity in Cancer (GDSC) database (https://depmap.org/portal/download/all/), 43 of which had dose-response curve (area under the curve, AUC) values. The MSI status, FGA and TMB information of CRC cell lines was obtained from cbioportal website (https://www.cbioportal.org/study/summary?id=ccle_broad_2019). RNAseq data for 71 human CRC cell lines was used to further determine the cancer cell-intrinsic genes and genes among the top 25% within (i) the 10−90 % percentile range of the largest expression values and (ii) the highest expression in at least three samples. The subtype-specific genes and cancer cell-intrinsic genes were intersected to generate the gene list for developing the pre-clinical model. The pre-clinical model was developed using the nearest template prediction (NTP) function of R package “CMScaller”, which can be applied to cross-tissues and cross-platform predictions (Hoshida, 2010). The GEP (log2TPM) of 71 human CRC cell lines normalized by the Z-score were input into the pre-clinical model, and the cell lines were divided into four CCCRC subtypes. (Lines 1061-1088)
Here we want to make a point that we changed from using the xgboost algorithm to using the NTP algorithm to build our pre-clinical model. Based on the genomic features of the cell line, we evaluated the reliability of the final pre-clinical model and found that the pre-clinical model built using the NTP algorithm is more reliable. As expected, the C4 subtype cell lines demonstrated the highest TMB values and MSI frequency while exhibiting the lowest FGA scores when compared to other subtypes (Figure 6-figure supplement 1G-I). In contrast, C1 and C3 subtype cell lines showed significantly higher FGA scores and significantly lower TMB values and MSI frequency. The C2 subtype cell lines had median FGA scores, TMB values, and MSI frequency. The pre-clinical model is publicly available at https://github.com/XiangkunWu/pre_clinical_model. (Lines 503-511)
2) Similarly the description of the "Single-sample gene classifier" could be enhanced similarly with a better description of which genes are in the final classifier.
We apologize for any confusion caused in our revised regarding the derivation of the CCCRC classifier. Specifically, we have added more details on the derivation of model genes and the establishment of the model, and ensured the availability of the CCCRC classifier. The method details and results of deriving the model genes and building the model are described next. (Lines 1102-1121) (Lines 562-579) (Supplementary file 3c)
In order to facilitate the widespread application of CCCRC classification system, we established a simple gene classifier to predict CCCRC subtypes. Firstly, we filtered genes based on their mean expression and variance in the CRC-AFFY cohort, and genes with expression and variance below the bottom 25% were removed. Then, we applied the Random Forest algorithm (RF) in the R package "caret" to perform feature selection on the CCCRC subtype-specific genes of the CRC-AFFY cohort. The top 20 most informative features for each subtype were ranked and selected based on the impurity measure generated by the algorithm. This allowed us to identify critical genes that are strongly associated with each CCCRC subtype and develop the CCCRC classifier. Next, we randomly divided the CRC-AFFY cohort into training and validation sets at a ratio of 7:3 using “createDataPartition” function provided in the R package "caret" (seed=123). The GEP was normalized with Z-scores prior to model training and validation. The CCCRC classifiers were trained with the top 80 subtype-specific genes using the RF, Support Vector Machine (SVM), eXtreme Gradient Boosting (xgboost), and Logistic Regression algorithms implemented in the R package "caret". Finally, we validated the CCCRC classifier on the GSE14333 and GSE17536 datasets, as well as the CRC-AFFY cohort. We evaluated the predictive performance of the CCCRC classifier by evaluating measures such as accuracy value and F1 score, which were generated using the " confusionMatrix " function provided in the R package "caret". (Lines 1102-1121)
We established the CCCRC classifier on the training set by utilizing multiple machine learning algorithms based on the GEP of 80 upregulated subtype-specific genes (Supplementary file 3c). Upon application to the test set, GSE14333, and GSE17536 datasets, the performance of the eXtreme Gradient Boosting (xgboost) algorithm was the best with the highest accuracy values and F1 scores compared to the Random Forest (RF), Support Vector Machine (SVM), and Logistic Regression algorithms (Figure 6-figure supplement 4). Notably, the CCCRC classifier based on the xgboost algorithm displayed robust performance across gene expression platforms, Affymetrix and RNA-sequencing platforms, exhibiting a balanced accuracy of > 80% for all subtypes (Supplementary file 3d). These findings demonstrated the stability and cross-platform applicability of our classifier. The CCCRC classifier based on the xgboost algorithm is publicly available at https://github.com/XiangkunWu/CCCRC_classifier, and the CCCRC subtype information of CRC patients can be obtained by directly inputting the GEP of 80 upregulated subtype-specific mRNA genes. The CCCRC classifier might facilitate the discovery of new biomarkers and the personalized treatment of clinical patients with CRC. (Lines 562-579)
Reviewer #2 (Public Review):
This study aimed to classify colorectal cancer (CRC) samples based on the expression of genes in selected gene lists, where the gene lists were chosen to represent aspects of the tumour microenvironment, tumour-associated immune cells, and tumour cells. The resulting clusters were then used to define a classifier, followed by a detailed description of molecular features of the tumours and tumour microenvironments assigned to each cluster. The authors claim this study is more "holistic" than previous work on CRC clustering/classifiers because they aimed to explicitly include additional components of the tumour microenvironment in both the clustering/classifier definition and in the subsequent description of molecular characteristics.
The CCCRC clustering and the resulting classifier presented in this paper are derived from published RNAseq studies. The multi-omics aspect of the work is restricted to smaller sample numbers for which both transcriptomic and another omics dataset were available in public resources and comprises a description or correlative analysis of each omics data type within each of the assigned CCCRC subtypes.
By applying solid computational methods to a compendium of published RNAseq datasets (n~1500 tumours), they found that tumour samples from colorectal cancers clustered into 4 subtypes ("CCCRC" subtypes) on the basis of 61 pre-defined gene expression signatures. These subtypes correlated with but did not correspond to, the previously described Consensus Molecular Subtypes (CMS) of colorectal tumours.
Other types of molecular data were available for some tumours, obtained from the same published resources: whole-slide images, mutations, tumour proteomics, and/or scRNAseq. The authors reanalysed these datasets using standard methods and drew correlations with the CCCRC subtypes they had assigned in this work. To (semi-)quantify immune infiltration characteristics from whole-slide images (WSI), they additionally performed automated segmentation in addition to review by pathologists, which in combination produced a convincing WSI-derived dataset.
In combination with existing CRC classifications, this study could facilitate future biomarker discoveries. This appears to be the authors' main claim, and the data and methods broadly support this claim.
Thank you for taking the time to review our article and for your positive feedback. Your thorough evaluation of our work has been invaluable to us, and we appreciate your recognition of the effort we put into it.
Some aspects of the work need to be clarified: 1) This work relies on the definition of 4 clusters of CRC tumours based on consensus clustering of the 61 gene lists, which in turn depends on the choice of clustering method and the choice of gene lists. Sufficient detail is provided about the gene lists and resulting clusters, but this paper does not show how robust the 4 clusters are to these choices; for example, the "Energy" gene list appears to be a relatively strong component of clusters C2 and C3.
Thank you very much for providing such detailed and insightful feedback.
1.1. The reviewer has raised a valid concern about the impact of gene list selection on the robustness of the clusters. To address this issue, we used the “pamr.predict” function of the R package “pamr” (Tibshirani et al., 2002) to extract centroids of each subtype that best represent each subtype and establish a PAMR classifier. PAM (Prediction Analysis of Microarrays) is a statistical technique to identify subsets of features that best characterize each class using nearest shrunken centroids (Tibshirani et al., 2002). The technique is general and can be used in many other classification problems. As shown in Figure 1-figure supplement 2E, a threshold of 0.566 with minimum 10-fold cross-validation error was selected to identify the 61 TME-related signatures that exhibit at least one non-zero difference between each subtype (seed = 11). These signatures were then used to construct a PAMR classifier with superior predictive capability, exhibiting an overall error rate of 15%. We used the established PAMR classifier to predict the CCCRC subtypes on the CRC-RNAseq cohort and the same four CCCRC subtypes were revealed, with similar patterns of differences in the TME components (Fig. S2F, G). This indicated that the 61 TME-related signatures best represent each subtype and are indispensable for achieving the identification of the four CCCRC subtypes. (Lines 161-168)
1.2. The reviewer has raised a valid concern about the impact of the clustering method selection on the robustness of the clusters.
We performed extensive data analysis attempts during our unsupervised clustering analysis, which primarily involved attempting various clustering methods, including K-means clustering, non-negative matrix factorization (NMF) clustering, and hierarchical clustering, as well as replacing different sources and categories of the TME-related signatures. To determine the optimal clustering method and TME panel, we evaluated whether the TME panel could reproduce the heterogeneity of TME, the stability of the clustering itself, the biological characteristics of the subtypes, the correlation between subtypes and prognosis, and the correlation between subtypes and microsatellite instability (MSI), consensus molecular subtypes (CMS) classification system, and other molecular subtype systems. Due to the abundance of exploratory data analysis results, we ultimately selected the best clustering method and TME panel combination for showcase.
1.3. Also, we analyzed the sensitivity analysis of the effect of TME-related signatures on the clustering results. Since the effect of removing one of the TME-related signatures on the clustering results was not well evaluated, we attempted to remove the entire category. We performed consensus clustering analysis again using the same parameters (partitioning around medoids (pam) clustering; "Pearson" distance; 1,000 iterations; from 2-6 clusters). When we conducted consensus clustering analysis using only immune-related signatures, we identified three subtypes: low (C2), moderate (C3), and high (C1) immune infiltration subtypes. When we included both immune-related and tumor-related signatures, we identified four subtypes: immunomodulatory (S1), cold (S2/S3), and immune-excluded (S4) subtypes. It appears that the immunosuppressed subtype in the CCCRC classification system may have been assigned to both S1 and S4 subtypes. Limiting the consensus clustering analysis to only immune-related or immune- and stroma-related signatures, as done in previous studies (Bagaev et al., 2021; He et al., 2018), did not allow reliable identification of all four CCCRC subtypes. These sensitivity analyses underscored the necessity of our well-designed TME panel to achieve the identification of the four CCCRC subtypes. (Lines 172-176) (Figure 1-figure supplement 4)
2) The authors examined whether their CCCRC classification showed differential disease progression in available retrospective cohorts of people treated with anti-PDL1 therapy. The authors presented this work as "significance of CCCRC in guiding the clinical treatment of colorectal cancer", but the data presented in this section cannot support clinical treatment decisions, which would require prospective studies and clinical trial designs. However, this section is potentially useful for generating hypotheses about potential biomarkers related to the CCCRC subtypes, and might, in the future with additional evidence, contribute to the design of a trial. The authors point out that additional experimental evidence would be required.
Thank you for your constructive suggestions. We agree that our retrospective analysis of the CCCRC classification in relation to disease progression under immune checkpoint blockade treatment does not directly support clinical treatment decisions. We acknowledge that additional experimental evidence would be required to fully support the use of the CCCRC classification as a clinical tool for guiding treatment decisions. We have highlighted in the corresponding section of the article that this research is pre-clinical and still requires substantial basic experiments and clinical trials to validate. (Lines 536, 751)
3) Other prognostic or predictive clinicopathological variables for colorectal cancer are not discussed in detail in the present work but are important for further work on the prognostic and predictive value of CRC molecular subtypes and biomarker derivation. Discrepancies in treatment response have previously been observed in separate CRC trials of biologically targeted agents with different chemotherapy backbones and other authors have suggested that treatment interactions with the tumour microenvironment might in part explain these discrepancies (e.g. Aderka (2019) PMID:31044725, and others).
3.1) Other prognostic or predictive clinicopathological variables for colorectal cancer are not discussed in detail in the present work but are important for further work on the prognostic and predictive value of CRC molecular subtypes and biomarker derivation.
Thank you for bringing up this point. We apologize for not analyzing other clinicopathological variables for colorectal cancer in more detail in my original work. We agree that these variables are important for further study of our CCCRC classification system to guide biomarker derivation and to guide clinical treatment decisions. We added in the article the relationship between CCCRC subtypes and clinicopathological variables, as well as the comparison with CMS subtypes (Lines 256-262, 661-666). In addition, we have identified a clerical error in our manuscript and have corrected it accordingly. Specifically, the use of PFS as the endpoint in some parts of the manuscript was a mistake and has been corrected to DFS. We would like to clarify that the endpoint for the CRC-AFFY and CRC-RNAseq cohorts is DFS and OS, while the endpoint for the GSE104645 dataset is PFS and OS. For the immune checkpoint blockade therapy cohort, the endpoint for PRJEB23709 (Gide) is PFS and OS, and for the GSE135222 (Jung) dataset, the endpoint is PFS. Progression Free Survival (PFS) refers to the time from randomization (or treatment initiation) to the first occurrence of disease progression or death from any cause. The definition of Disease-Free Survival (DFS) is the time from randomization to the appearance of evidence of disease recurrence.
We further analyzed the association of CCCRC subtypes with clinicopathological characteristics (Supplementary file 1f, Supplementary file 1g). We found that the C4 subtype was mostly diagnosed in right-sided CRC lesions and in females, which was consistent with the CMS1 subtype. The C1 and C3 subtypes were mainly observed in left-sided CRC lesions and in males, consistent with the CMS2 and CMS4 subtypes. The C3 subtype was strongly associated with more advanced tumor stages, which was the similarity to the CMS4 subtype, while the C4 subtype was associated with higher histopathologic grade, which was the similarity to the CMS1 subtype. Furthermore, our analysis using the Kaplan-Meier method demonstrated that patients with the C4 subtype had significantly higher disease-free survival (DFS) and overall survival (OS) compared to those with the C2 and C3 subtypes in the CRC-AFFY (Figure 1I, Figure 1-figure supplement 7A) and CRC-RNAseq cohorts (Figure 1-figure supplement 7B, C). Multivariate Cox proportional hazard regression analysis showed that the C4 subtype was an independent predictor of the best OS and DFS, whereas the C3 subtype was an independent predictor of the worst OS and DFS after adjustment for age, gender, tumor site, TNM stage, grade, adjuvant chemotherapy or not, MSI status, BRAF and KRAS mutations, and the CMS classification system in the combined cohort (the CRC-AFFY and CRC-RNAseq cohorts) (Supplementary file 1h). Considering that the C1, C2/C3, and C4 subtypes partially overlap with the CMS2, CMS4, and CMS1 subtypes, respectively, we also analyzed the prognostic differences between them in the combined cohort. We found that the DFS/OS of patients with the C1 subtype was worse than those with the CMS2 subtype (Figure 1-figure supplement 7D, E), the DFS/OS of patients with the C2 subtype was better than those with the CMS4 subtype (Figure 1-figure supplement 7F, G), the DFS/OS of patients with the C3 subtype was not significantly different from those with the CMS4 subtype (Figure 1-figure supplement 7F, G), and the DFS/OS of patients with the C4 subtype was significantly better than those with the CMS1 subtype (Figure 1-figure supplement 7H, I). Notably, the C2 subtype within the CMS4 subtype also had a better prognosis than the C3 subtype within the CMS4 subtype (Figure 1-figure supplement 7J, K). The above analysis demonstrated that the CCCRC classification system were closely associated with clinicopathological characteristics, were able to refine the CMS classification system and MSI status, as well as contributed to the understanding of the mechanisms underlying the different clinical phenotypes resulting from TME heterogeneity.
3.2) Discrepancies in treatment response have previously been observed in separate CRC trials of biologically targeted agents with different chemotherapy backbones and other authors have suggested that treatment interactions with the tumour microenvironment might in part explain these discrepancies (e.g. Aderka (2019) PMID:31044725, and others).
The reviewer's comments greatly contributed to the quality of our study. Aderka et al. discussed the reasons for the differences in the results of the CALGB/SWOG 80405 and FIRE-3 clinical trials, which may be related to differences in the chemotherapy backbone used and TME heterogeneity (Aderka et al., 2019). Both trials evaluated the combination of cetuximab or bevacizumab with a different chemotherapy backbone: in the CALGB/SWOG 80405 trial, 75% of patients received oxaliplatin, while in the FIRE-3 trial, all patients received irinotecan. The CCCRC classification system also facilitates the understanding of the differences in the results of the CALGB/SWOG 80405 and FIRE-3 clinical trials (Heinemann et al., 2014; Lenz et al., 2019). We have added this content to the discussion section of the article (Lines 753-777). Based on our examination of the results summarized in Figure 4 of the work by Aderka et al. (Aderka et al., 2019), we found that differences in the treatment outcomes of the CMS1 and CMS4 subtypes were the crucial factor behind the divergent results observed in the two clinical trials. The CMS1 and CMS4 subtypes have a microenvironment rich in CAFs. Our CCCRC classification results also showed that CMS1, in addition to mainly consisting of the C4 subtype, also contains a considerable number of the C2 subtype, while the CMS4 subtype mainly consists of the C2 and C3 subtypes. Furthermore, our study results indicated that the C2 subtype is suitable for chemotherapy in combination with bevacizumab, possibly because the combination can inhibit the CAFs and abnormal blood vessel formation in the microenvironment, thus alleviating the immune suppression of the immune cells. However, the C3 subtype is not suitable for chemotherapy in combination with bevacizumab because it only accumulates CAFs and abnormal blood vessel formation but lacks T cell infiltration. Therefore, we boldly speculate that the CMS1 and CMS4 subtypes in the CALGB/SWOG 80405 clinical trial may contain more C2 subtypes than those in the FIRE-3 clinical trial, leading to the CMS1 and CMS4 subtypes in the CALGB/SWOG 80405 clinical trial being more suitable for chemotherapy in combination with bevacizumab than cetuximab compared to the FIRE-3 clinical trial. Overall, the integration of CCCRC and CMS classification systems provides valuable insights for understanding the divergent outcomes of the two clinical trials (Lines 753-777).
Reviewer #3 (Public Review):
In their study: Comprehensive characterization of tumor microenvironment in colorectal cancer via histopathology-molecular analysis, Wu et al., aim to examine the contribution of the tumour microenvironment (TME) on biological and clinical heterogeneity in colorectal cancer (CRC).
To achieve this the authors use a vast array of publicly available datasets across a variety of biological modalities (transcriptomic, epigenetic, mutational). Using thoughtfully curated genesets the authors classify CRC into 4 holistic comprehensive characterised CRC (CCCRC) subtypes which comprise immune, stromal, and tumour features of CRC biology.
The authors investigate the association of their novel CCCRC subtypes with current "gold standard" classification schemes.
The authors' integration of deep learning methods for HE classification and subsequent association with "Tumor level" CCCRC subtypes is a refreshing addition to the study. Comment on the degree of heterogeneity observed in HE samples and correlation to the heterogeneity of CCCRC subtypes would be a welcomed addition. It is likely publicly available datasets from such platforms as 10X Genomic Visium would be available for this type of analysis.
Whilst one of the main outcomes of the study is the addition of another classification scheme to the field of colorectal cancer, the CCCRC scheme represents a holistic perspective on CRC classification.
The authors provide a welcomed graphical overview of the complex narrative of the study in Figure 7.
The authors focus on the classification of inter-patient heterogeneity and its associated predictive and prognostic utility. There appears to be a significant degree of overlap between immunosuppressive and immune excluded, and proliferative and immuno-modulatory signatures in Figure 1A. One of the major limitations of patient response to treatment is intra-patient heterogeneity, it would be nice for the authors to comment briefly on the degree of intra-patient heterogeneity of the CCCRC subtypes.
Overall the authors succeed in providing a holistic deep characterization of CRC from the perspective of a variety of biological modalities. The authors provide a novel classification scheme for the field of CRC which demonstrates prognostic and predictive utility, which would benefit from further validation from external datasets. The authors demonstrate a pathway for integration and interpretation of complex high-dimensional data into clinically translatable currency such as the H&E.
Thank you for taking the time to review our article and for your positive feedback. Your thorough evaluation of our work has been invaluable to us, and we appreciate your recognition of the effort we put into it.
1) Comment on the degree of intra-patient heterogeneity of CCCRC subtypes would be nice.
We have added intra-tumor heterogeneity analysis for each subtype (Lines 196-198). The level of intratumor heterogeneity (ITH) was significantly linked to poor prognosis and drug resistance (Caswell and Swanton, 2017). The ITH data used in our study for the CRC-RNAseq cohort was obtained from a previous study conducted by Thorsson et al. (Thorsson et al., 2018). As expected, the ITH of the C2 and C3 subtypes was higher than that of the other subtypes, while the ITH of the C4 subtype was the lowest (Figure 1F). Our analysis using the Kaplan-Meier method demonstrated that patients with the C4 subtype had significantly higher overall survival (OS) and disease-free survival (DFS) compared to those with the C2 and C3 subtypes. Furthermore, the C3 subtype was resistant to chemotherapy, cetuximab, bevacizumab, and ICB therapy. Our investigation of drug sensitivity data of cell lines also indicated that the C2 and C3 subtypes were generally not responsive to most drugs.
2) A significant degree of overlap between immunosuppressive and immune excluded, and proliferative and immuno-modulatory signatures in Figure 1A is apparent and should be commented upon.
Our research revealed that both C2 and C3 subtypes exhibited a high level of tumor stroma, while C1 and C4 subtypes were characterized by active DNA damage and repair and high tumor proliferation. Additionally, C2 and C4 subtypes had an abundance of immune components. This was consistent with our finding that there may be interconversion between the C1 and C4 subtypes, between the C4 and C2 subtypes, and between the C2 and C3 subtypes in this evolutionary pattern. The interconversion between C2 and C4 subtypes in this evolutionary pattern was the rarest situation, indicating that once the tumor enters the C2 subtype, it is difficult to reverse and will progress to the C3 subtype. (Lines 637-644)
3) It is likely publicly available datasets from such platforms as 10X Genomic Visium would be available for this type of analysis.
To investigate the spatial distribution relationship between four CCCRC subtypes of tumor cells, T cells, and stromal cells, we conducted a re-analysis of publicly available CRC spatial transcriptomics data (ST) obtained from the 10X website (https://www.10xgenomics.com/resources/datasets). The Space Ranger output files were then processed with Seurat (V4.1.1) (Hao et al., 2021) using SCTransform for normalization (Hafemeister and Satija, 2019). RunPCA were used to dimension reduction and RunUMAP to visualize the data. We used “ssGSEA” method implemented in the R package “GSVA” to score the six cell types (C1-C4 subtype cancer cells, mesenchymal cells, and T cells) (Hänzelmann et al., 2013). The “ssGSEA” method has been previously demonstrated to be highly reliable and suitable for ST data analysis (Wu et al., 2022). The cell-type-rich region was defined as the ssGSEA score of each cell type from one spot larger than the 75% quantile of this cell type. The markers for the six cell types are listed in the Supplementary file 1a and Supplementary file 3a. (Lines 1090-1102)
The Cytassist and Visium samples had a total of 9080 and 2660 spots, respectively. We used “ssGSEA” method to quantify the six cell subpopulations of each spot and also visualized only the spots corresponding to the top 25% of the score ranking for each cell type (Figure 6-figure supplement 2AB, Figure 6-figure supplement 3AB). In Cytassist samples, we observed different spatial distribution patterns of the four subtypes of tumor cells (Figure 6-figure supplement 2B). Specifically, the C3 subtype of tumor cells was predominantly located in the tumor periphery with an enrichment of mesenchymal cells and T cells (areas selected by black dashed circles). In contrast, the C4 subtype of tumor cells was mainly present in the center of the tumor, accompanied by the presence of T cells. The C1 and C2 subtypes of tumor cells were distributed in relatively uniform areas, mainly in the tumor periphery, with fewer mesenchymal cells and T cells. However, the distribution areas of C2 subtype and C3 subtype of tumor cells also partially were in overlap (the area selected by red dashed circles). The same distribution patterns can also be observed in the Visium sample (Figure 6-figure supplement 3B). Further analysis of the correlation between the ssGSEA scores of each cell type in the cell-type-rich regions and those of other cell types was conducted (Figure 6-figure supplement 2D, E, Figure 6-figure supplement 3D, E). We found that in the C3 subtype-rich region of tumor cells, the C3 subtype score of tumor cells was significantly positively correlated with the mesenchymal cell score, while in the T cell-rich region, the C3 subtype score of tumor cells was significantly negatively correlated with the T cell score. The C4 subtype score of tumor cells was significantly positively correlated with the T cell score and negatively correlated with the mesenchymal cell score in the C4 subtype-rich, T cell-rich, and mesenchymal cell-rich regions. The C1 subtype and C2 subtype scores of tumor cells were negatively correlated with mesenchymal cell and T cell scores. Overall, these results were generally consistent with previous histopathologic analysis findings. (Lines 538-562)
-
-
www.biorxiv.org www.biorxiv.org
-
Author Response
Reviewer #1 (Public review):
1.0) This paper investigates the metabolic basis of a node, posterior cingulate cortex (PCC), in the default node network (DMN). They employed sophisticated MRI-PET methods to measure both BOLD and CMRglc changes (both magnitude and dynamics) during attention-demanding and working memory tasks. They found uncoupling of BOLD and CMRglc in PCC with these different tasks. The implications of these findings are poorly interpreted, with a conclusion that is purely based on other work independent of this study. Various suggestions could allow them to place some speculations in line with a stronger interpretation of their results.
This is one of several papers in recent years investigating the metabolic underpinnings of activated (or task-positive) and deactivated (or task-negative) cortical areas in the human brain. In this study, they used BOLD fMRI and glucose PET scan to examine the metabolic distinction of the default node network (DMN), which is known to be deactivated during attention-demanding tasks, with different types of cognitively demanding tasks. Unlike the BOLD response in posteromedial DMN which is consistently negative, they found that CMRglc of the posteromedial DMN (a task-negative network) is dependent on the metabolic demands of adjacent task-positive networks like the dorsal attention network (DAN) and frontoparietal network (FPN). With attention-demanding tasks (like Tetris) the BOLD and CMRglc are both downregulated in DMN (specifically the posterior cingulate cortex, PCC, a task-negative node of DMN), but working memory induces CMRglc increase in PCC and which is decoupled from the negative BOLD response in PCC.
We thank the reviewer for the constructive feedback and the possibility to improve our manuscript. We agree that the interpretation of the results should be strengthened to provide a stronger focus on our data. Regarding the uncoupling of BOLD and CMRGlu during working memory, we acknowledge the need to further elaborate on this topic in our discussion. These suggestions and comments have been incorporated into the revised manuscript as outlined below.
1.1) These complicated results are the main findings, and to provide a biological basis to these data they rather surprisingly, but without their own experimental evidence, conclude that the negative BOLD and negative CMRglc in PCC during attention-demanding tasks is due to decreased glutamate signaling (which was not measured in this study) and the negative BOLD and positive CMRglc in PCC during working memory is due to increased GABAergic activity (which was not measured in this study). It is rather surprising that without measurement, a conclusion is made which would at best be considered a hypothesis to be tested. Thus, independent of these hypothesized mechanisms, they need to summarize their results based on their own measurements in this study (see 3 for a hint).
Thank you for bringing up this point and for the insightful suggestion concerning point 3. We have now explicitly stated that the interpretation regarding glutamate and GABAergic signaling is of speculative nature as theses were not measured in the current work, moreover, we have substantially reduced this section. As such, we agree with the reviewer that this represents an interesting hypothesis to be tested in future work. For further details please see response to comments 1.3 and 1.4.
Discussion, page 16, line 341:
On the neurotransmitter level, one of the current hypotheses regarding BOLD deactivations proposes that CMRO2 and CBF are affected by the balance of the excitatory and inhibitory neurotransmitters, specifically GABA and glutamate (Buzsáki et al., 2007; Lauritzen et al., 2012; Sten et al., 2017). In the PCC, glutamate release prevents negative BOLD responses (Hu et al., 2013), whereas a lower glutamate/GABA ratio is associated with greater deactivation (Gu et al., 2019). As glutamate elicits proportional glucose consumption (Lundgaard et al., 2015; Zimmer et al., 2017), decreases in glutamate signaling in the pmDMN could indeed explain both, the decreased BOLD response and decreased CMRGlu during the Tetris® task. Conversely, increased GABA supports a negative BOLD response in the PCC (Hu et al., 2013), as do working memory tasks (Koush et al., 2021) and pharmacological stimulation with GABAergic benzodiazepines (Walter et al., 2016). In consequence, the observed dissociation between BOLD changes and CMRGlu during working memory could indeed result from metabolically expensive (Harris et al., 2012) GABAergic suppression of the BOLD signal (Stiernman et al., 2021). However, we need to emphasize that glutamate and GABAergic signaling was not measured in the current study, thus, the above interpretations are of speculative nature. Nonetheless, future work may test this promising hypothesis, e.g., using pharmacological alteration of GABAergic and glutamatergic signaling or optogenetic approaches modulating GABAergic interneuron activity.
Furthermore, to maintain a more concise discussion that is closer aligned with the measured results, we have removed the following paragraph:
Discussion, page 15, line 309:
The associations of these metabolic demands between the DMN and task-positive networks is also reflected in their distance along a connectivity gradient, which is hierarchically organized from unimodal sensory/motor to complex associative functions and the DMN being at the end of the processing stream (Margulies et al., 2016; Smallwood et al., 2021). A corresponding decrease in pmDMN glucose metabolism was observed for tasks that activate unimodal networks and the DAN, but not for the FPN. The inverse influence of attention and control networks on the pmDMN may therefore suggest that connectivity gradients are supported by the underlying energy metabolism.
1.2) It is mentioned that the FDG-PET scans allow quantitative CMRglc, both in terms of units of glucose use but also with high time resolution. Based on the method described, it isn't clear how this is possible. Important details of either prior work or their own work have been excluded that show how the time course of CMRglc (regardless of whether it's absolute or relative) can be compared with the BOLD time course. Furthermore, it is extremely difficult to conceive that quantitative CMRglc can be estimated without additional measurements (e.g., blood samples, etc). Significant methodological details have to be provided, which even should make their way to results given the importance of their BOLD-CMRglc coupling and decoupling in the same region.
We thank the reviewer for this important comment and apologize for the lack of clarity. We would like to emphasize that in the current work only spatial patterns of CMRGlu and BOLD signal changes were compared, but not the time course of these signals. The manuscript was edited throughout to clarify this point.
Introduction, page 5, line 110:
Studies using simultaneous fPET/fMRI have shown a strong spatial correspondence between the BOLD signal changes and glucose metabolism in several task-positive networks and across various tasks requiring different levels of cognitive engagement (Hahn et al., 2020, 2016; Jamadar et al., 2019; Rischka et al., 2018; Stiernman et al., 2021; Villien et al., 2014).
Introduction, page 5, line 123
Specifically, it is unknown whether the observed dissociation between patterns of metabolism and BOLD changes in the DMN generalizes for complex cognitive tasks, and whether this in turn depends on the brain networks supporting the task performance and their interaction with the DMN.
Results, page 7, line 143:
From this dataset (DS1) we evaluated the spatial overlap of negative task responses in the cerebral metabolic rate of glucose (CMRGlu quantified with the Patlak plot) and the BOLD signal specifically in the pmDMN. […] After that, the distinct spatial activation patterns across different tasks were used to quantitatively characterize the CMRGlu response of the pmDMN in DS1.
The method of functional PET (fPET) imaging indeed enables the evaluation of changes in glucose metabolism with a relatively high temporal resolution. That is, a conventional bolus application and subsequent quantification yield a single CMRGlu image per scan of about 60 min (typical frame length ~1-5 min) or a single SUV image from a static scan. In contrast, the constant infusion employed in fPET allows to assess baseline metabolism and changes induced by different tasks in a single scan by using a frame length currently down to 6-30 s (Rischka et al., 2018), where the latter was also used in the current study. A general description of the fPET approach is now also included in the manuscript.
Introduction, page 5, line 99:
In this context, functional PET (fPET) imaging represents a promising approach to investigate the dynamics of brain metabolism. fPET refers to the assessment of stimulation-induced changes in physiological processes such as glucose metabolism (Villien et al., 2014; Hahn et al., 2016) and neurotransmitter synthesis (Hahn et al., 2021) in a single scan. The temporal resolution of this approach of 6-30 s (Rischka et al., 2018) is considerably higher than that of a conventional bolus administration. This is achieved through the constant infusion of the radioligand, thereby providing free radioligand throughout the scan that is available to bind according to the actual task demands. Here, the term “functional” is used in analogy to fMRI, where paradigms are often presented in repeated blocks of stimulation, which can subsequently be assessed by the general linear model.
Regarding the absolute quantification of CMRGlu, arterial blood samples were obtained from all subjects of DS1. These were used for absolution quantification of CMRGlu with the Patlak plot. Full details were already provided in the methods section and are now also mentioned in the results.
Results, page 7, line 140:
Simultaneous fPET/fMRI data and arterial blood samples were acquired from 50 healthy participants during the performance of the video game Tetris®, a challenging cognitive task requiring rapid visuo spatial processing and motor coordination (Hahn et al., 2020; Klug et al., 2022). From this dataset (DS1) we evaluated the spatial overlap of negative task responses in the cerebral metabolic rate of glucose (CMRGlu quantified with the Patlak plot) and the BOLD signal specifically in the pmDMN.
Methods, page 19, line 399:
For glucose metabolism, these changes are absolutely quantified in μmol/100g/min with the arterial input function and the Patlak plot.
Methods, blood sampling, page 24, line 536:
Before the PET/MRI scan blood glucose levels were assessed as triplicate (Gluplasma). During the PET/MRI acquisitions manual arterial blood samples were drawn at 3, 4, 5, 14, 25, 36 and 47 min after the start of the radiotracer administration (Rischka et al., 2018). From these samples whole-blood and plasma activity were measured in a gamma counter (Wizard2, Perkin Elmer). The arterial input function was obtained by linear interpolation of the manual samples to match PET frames and multiplication with the average plasma-to-whole-blood ratio.
Methods, cerebral metabolic rate of glucose metabolism, page 25, line 561:
Quantification was carried out with the Patlak plot (t* fixed to 15 min) and the influx constant Ki was converted to CMRGlu as CMRGlu = Ki * Gluplasma / LC * 100 with LC being the lumped constant = 0.89 (Graham et al. 2002, Wienhard 2002).
1.3) It is surmised that the glutamatergic/GABAergic involvement of these metabolic differences in PCC is from another study, but what mechanism causes the BOLD signal to decrease in both stimuli? This is where the authors have to divulge the biophysical basis of the BOLD response. At the most basic level, the BOLD signal change (dS) can be positive or negative depending on the degree of coupling with changed blood flow (dCBF) and oxidative metabolism (dCMRO2) from resting condition. Unfortunately, neither CBF nor CMRO2 was measured in this study. In the absence of these additional measurements, the authors should at least discuss the basis of the BOLD response with regard to CBF and CMRO2. If we assume that both attention-demanding and working memory tasks decreased BOLD response in PCC in the same way, we have identical dCBF/dCMRO2 in PCC with both tasks, i.e., their results seem to suggest an alteration in aerobic glycolysis with different tasks. With attention-demanding tasks, CMRglc decreases similarly to CMRO2 decreases in PCC, whereas with working memory tasks, CMRglc increases differently from CMRO2 decreases. This suggests PCC may the oxygen to glucose index (OGI=CMRO2/CMRglc) would rise in PCC attention-demanding tasks, but fall in PCC with working memory tasks. This is obviously an implication rather than a conclusion as CBF or CMRO2 were not measured.
1.4) Given the missing attention that gives rise to the BOLD contrast mechanism, it is almost necessary to discuss the biophysical basis of BOLD contrast and specifically how metabolic changes have been linked to both increases and decreases in neuronal activity in the past. Although this type of work has largely been conducted in animal models, it seems that this topic needs to be discussed as well.
We would like to thank the reviewer for sharing these insightful ideas and for bringing up these aspects that indeed appear to be essential for the manuscript. Since the points 1.3. and 1.4 complement each other, we have combined them and created a shared response. To fully address the points, the following paragraphs were added to the manuscript.
Discussion, page 15, line 310:
Metabolic and neurophysiological considerations effects
The distinct relationships between BOLD and CMRGlu signals that emerge during specific tasks highlight the different physiological processes contributing to neuronal activation of cognitive processing (Goyal and Snyder, 2021; Singh, 2012). While CMRGlu measured by fPET provides an absolute indicator for glucose consumption, the BOLD signal reflects deoxyhemoglobin concentration, which depends on various factors, such as cerebral blood flow (CBF), cerebral blood volume (CBV) and the cerebral metabolic rate of oxygen (CMRO2) (Goense et al., 2016). In simple terms, the BOLD signal relates to the ratio of ∆CBF/∆CMRO2. Assuming that the observed BOLD decreases during Tetris® and WM emerge from the same mechanisms, this would result in a comparable ∆CBF/∆CMRO2 in the pmDMN for both tasks. Given that these types of tasks (external attention and cognitive control) elicit a reduction in CBF in the pmDMN (Shulman 97, Zou 2011), CMRO2 also decreases albeit to a lesser extent (Raichle 2001). Therefore, the respective metabolic processes can be described by their oxygen-to-glucose index (OGI), the ratio of CMRO2/CMRGlu. Accordingly, our results suggest two distinct pathways underlying BOLD deactivations in the pmDMN that differ regarding their OGI. During Tetris® there is a BOLD deactivation with a high OGI, resulting from a larger decrease in CMRGlu than CMRO2. This metabolically inactive state is in line with electrophysiological recordings in humans (Fox et al., 2018) and in non-human primates showing a decrease of neuronal activity in the pmDMN that covaries with the degree of exteroceptive vigilance (Shmuel et al., 2006; Bentley et al., 2016; Hayden et al., 2009). Therefore, we suggest that the negative BOLD response during external tasks reflects a reduction of neuronal activity and their respective metabolic demands. On the other hand, the relatively increased CMRGlu without the corresponding surge in CMRO2 hints at another kind of BOLD deactivation with a low OGI in the pmDMN during working memory, indicating energy supply by aerobic glycolysis (Vaishnavi et al., 2010; Blazey et al., 2019). Previous work in non-human primates has indeed suggested a differential coupling of neuronal activity to hemodynamic oxygen supply in this region (Bentley et al., 2016). Furthermore, tonic suppression of PCC neuronal spiking during task performance was punctuated by positive phasic responses (Hayden et al., 2009), which could indicate differences between both tasks also at the level of electrophysiologically measured activity.
Reviewer #2 (Public Review):
2.0) This paper provides an important and insightful investigation into patterns of activations that emerge in external task states. The authors use state-of-the-art methods and novel analytic approaches to establish that deactivations in the default mode network during external tasks are driven by activity in brain regions that are important in the current tasks (such as the visual or dorsal attention networks). It will be important in the future to understand whether this is a symmetrical phenomenon by studying this behaviour in states that maximize activity within the default mode network and also drive reductions in networks that are not relevant to these situations.
We thank the reviewer for the encouraging feedback and the constructive comments on our manuscript. We particularly appreciate the interest in the research and the insightful suggestions for future work.
Reviewer #3 (Public Review):
3.0) The authors report a study where, using multiple datasets with [18F]FDG PET bolus + continuous infusion ("functional PET") and BOLD fMRI data, they re-evaluate the metabolic and hemodynamic properties of the default mode network (DMN) in a task-evoked context, with a focus on posteromedial DMN due to its relevance for across-network integration. They show how posterior DMN is differently engaged depending on the chosen task: while visual and motor tasks lead to BOLD deactivations and glucose metabolic decrease, specifically in the dorsal posterior cingulate cortex (PCC) area, working memory tasks produce BOLD deactivations but metabolic increases, specifically in ventral PCC, as shown in their previous paper (Stiernman et al. 2021, https://doi.org/10.1073/pnas.2021913118). This aims to solve the controversies elicited by findings of both increased and decreased glucose consumption in the presence of BOLD deactivation in the DMN.
Additionally, they show how task-evoked glucose metabolism in posterior DMN seems to be shaped by that of the corresponding task-positive networks, with a positive link with dorsal attention and a negative link with frontoparietal network metabolism. This is explored using a type of directional connectivity analysis called "metabolic connectivity mapping", drawn from their previous work (Riedl et al. 2016, https://doi.org/10.1073/pnas.1513752113; Hahn et al. 2020, https://doi.org/10.7554/eLife.52443). They go on to speculate that concomitant BOLD deactivation and reductions in glucose expense might relate to decreased glutamatergic signaling, while BOLD deactivations accompanied by increased glucose consumption might depend on increased GABAergic neuronal activity.
This is a relevant topic because it not only shows how the DMN is flexibly engaged in different tasks but also allows us to better understand the complex relationships between BOLD fMRI and [18F]FDG PET signals, which are still not fully characterized to this day. Of course, while in resting state the situation is further complicated by the more uncertain physiological meaning of the resting BOLD signal, task-evoked states are expected to provide a more interpretable intermodal link between metabolism and hemodynamics, due to the known major changes in blood flow, blood volume, and glucose metabolism - which underlie BOLD and [18F]FDG signal changes - in response to neural activation. However, even in task states, there is not always a strong association between the two responses, as previously shown by the authors themselves (Rischka et al. 2018, https://doi.org/10.1016/j.neuroimage.2018.06.079). This is something I think the authors should stress out a little more, as they have previously done (Rischka et al. 2018, https://doi.org/10.1016/j.neuroimage.2018.06.079), both in the introduction and in reference to Figure 1, which shows clear differences between BOLD and [18F]FDG activations/deactivations (e.g., widespread negative responses in the cerebellum for [18F]FDG).
Overall, the analyses reported in the manuscript are simple and seem mostly sound, drawing from well-established methods in PET and fMRI activation studies, with additional approaches previously developed by some of the authors themselves (e.g., "metabolic connectivity mapping", Riedl et al. 2016, https://doi.org/10.1073/pnas.1513752113). Moreover, a clear strength of the paper is the high number of subjects, at least from a PET perspective, i.e., n = 50 for the Tetris task, plus group averages of previously published data for working memory (Stiernman et al. 2021, https://doi.org/10.1073/pnas.2021913118) and motor tasks (Hahn et al. 2018, https://doi.org/10.1007/s00429-017-1558-0).
The conclusions are in line with the results, and, though a little speculative, are potentially relevant for further exploration aimed at characterizing the neurotransmitter pathways underlying positive and negative BOLD and [18F]FDG responses. Moreover, the language is sufficiently clear to allow a proper understanding of the aims and the results, as well as the details of the analyses. As a side note, the title should probably be adjusted to "Task-evoked metabolic demands of the posteromedial default mode network are shaped by dorsal attention and frontoparietal control networks", to emphasize that the findings do not necessarily generalize to the resting state.
In conclusion, I am overall quite positive about this manuscript, which seems to nicely position itself within the existing literature, making some additional contributions.
We thank the reviewer for the thorough evaluation and the positive feedback on our manuscript, we appreciate the constructive and insightful suggestions. We agree that the differential spatial patterns of activation between the BOLD signal and CMRGlu response require further attention. To address this point in more detail, we have added the following information to the manuscript.
Introduction, page 5, line 110:
Studies using simultaneous fPET/fMRI have shown a strong spatial correspondence between the BOLD signal changes and glucose metabolism in several task-positive networks and across various tasks requiring different levels of cognitive engagement (Hahn et al., 2020, 2016; Jamadar et al., 2019; Rischka et al., 2018; Stiernman et al., 2021; Villien et al., 2014). […]. However, also regional differences in activation patterns have been observed previously between these modalities in these and previous studies (Wehrl et al., 2013). Moreover, a dissociation between BOLD changes (negative) and glucose metabolism (positive) has recently been observed even in the same region of the DMN during working memory (Stiernman et al., 2021), namely the posteromedial default mode network (pmDMN).
Results, caption Figure 1, page 8, line 173
White clusters represent the intersection of significant CMRGlu and BOLD signal changes, irrespective of direction. Note, that also relevant differences between both imaging parameters can be observed, such as decreased CMRGlu in the cerebellum (in both datasets), without changes in the BOLD signal.
We appreciate the reviewer’s proposal for the title as it raises awareness that the activation patterns reflect task-specific inference.
Title:
Task-evoked metabolic demands of the posteromedial default mode network are shaped by dorsal attention and frontoparietal control networks
We have limited the discussion of underlying neurotransmitter effects and explicitly mention that these are of speculative nature. For manuscript adaptation on this point, we would like to refer to points 1.1, 1.3, 1.4 that address this topic as well.
-